<SEC-DOCUMENT>0001090872-23-000005.txt : 20230303
<SEC-HEADER>0001090872-23-000005.hdr.sgml : 20230303
<ACCEPTANCE-DATETIME>20230302185233
ACCESSION NUMBER:		0001090872-23-000005
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		102
CONFORMED PERIOD OF REPORT:	20230131
FILED AS OF DATE:		20230303
DATE AS OF CHANGE:		20230302

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AGILENT TECHNOLOGIES, INC.
		CENTRAL INDEX KEY:			0001090872
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				770518772
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15405
		FILM NUMBER:		23700916

	BUSINESS ADDRESS:	
		STREET 1:		5301 STEVENS CREEK BLVD
		CITY:			SANTA CLARA
		STATE:			CA
		ZIP:			95051
		BUSINESS PHONE:		(408) 345-8886

	MAIL ADDRESS:	
		STREET 1:		5301 STEVENS CREEK BLVD, MS 1A-LC
		STREET 2:		P.O. BOX 58059
		CITY:			SANTA CLARA
		STATE:			CA
		ZIP:			95052-8059

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AGILENT TECHNOLOGIES INC
		DATE OF NAME CHANGE:	19990816

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HP MEASUREMENT INC
		DATE OF NAME CHANGE:	19990716
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>a-20230131.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:bf6e4e81-d7a1-484d-a6c7-4a9890c9070b,g:1d2ec140-a31f-4aad-8309-92440730b1c7,d:e1e46d0795a24ac2a4ed23d17765eb17--><html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:a="http://www.agilent.com/20230131" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:srt="http://fasb.org/srt/2022" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>a-20230131</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180L2ZyYWc6NTJhNjc0Y2I0NjE0NDAzODllZGI5M2FiMzFkZTBkN2UvdGFibGU6NTEwYzc2ZTkwY2IwNGY2ZWEzY2JlZjIxODAxMDI0MTAvdGFibGVyYW5nZTo1MTBjNzZlOTBjYjA0ZjZlYTNjYmVmMjE4MDEwMjQxMF8xLTEtMS0xLTY4NzUx_55e042b2-1d6f-451c-8111-ca34c8601edf">0001090872</ix:nonNumeric><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180L2ZyYWc6NTJhNjc0Y2I0NjE0NDAzODllZGI5M2FiMzFkZTBkN2UvdGFibGU6NTEwYzc2ZTkwY2IwNGY2ZWEzY2JlZjIxODAxMDI0MTAvdGFibGVyYW5nZTo1MTBjNzZlOTBjYjA0ZjZlYTNjYmVmMjE4MDEwMjQxMF8zLTEtMS0xLTY4NzUx_98941c90-5b0d-47bf-97d3-125520a992c5">October 31</ix:nonNumeric><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180L2ZyYWc6NTJhNjc0Y2I0NjE0NDAzODllZGI5M2FiMzFkZTBkN2UvdGFibGU6NTEwYzc2ZTkwY2IwNGY2ZWEzY2JlZjIxODAxMDI0MTAvdGFibGVyYW5nZTo1MTBjNzZlOTBjYjA0ZjZlYTNjYmVmMjE4MDEwMjQxMF80LTEtMS0xLTY4NzUx_bf0b790e-c908-446b-a509-303589d9c30f">2023</ix:nonNumeric><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180L2ZyYWc6NTJhNjc0Y2I0NjE0NDAzODllZGI5M2FiMzFkZTBkN2UvdGFibGU6NTEwYzc2ZTkwY2IwNGY2ZWEzY2JlZjIxODAxMDI0MTAvdGFibGVyYW5nZTo1MTBjNzZlOTBjYjA0ZjZlYTNjYmVmMjE4MDEwMjQxMF81LTEtMS0xLTY4NzUx_9c972be1-4837-4bfc-9955-e9b8ca129063">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180L2ZyYWc6NTJhNjc0Y2I0NjE0NDAzODllZGI5M2FiMzFkZTBkN2UvdGFibGU6NTEwYzc2ZTkwY2IwNGY2ZWEzY2JlZjIxODAxMDI0MTAvdGFibGVyYW5nZTo1MTBjNzZlOTBjYjA0ZjZlYTNjYmVmMjE4MDEwMjQxMF82LTEtMS0xLTY4NzUx_3d73745a-1cac-49a7-82e4-15110369823a">false</ix:nonNumeric><ix:nonNumeric contextRef="i658253fffabe4343b44569144474388f_I20230131" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDQ4Mw_0923d8a4-45b0-4175-952d-a7c717b81666">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDQ5MA_9b066508-1908-4248-884a-1df299c2bc14">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i658253fffabe4343b44569144474388f_I20230131" name="us-gaap:OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDY1Mg_3682f298-9ca7-4d01-a434-54ee5feb1306">http://fasb.org/us-gaap/2022#OtherAccruedLiabilitiesCurrentAndNoncurrent http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" name="us-gaap:OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDY1OQ_fa7b70f1-0cec-4130-bca6-58ec8ae1e703">http://fasb.org/us-gaap/2022#OtherAccruedLiabilitiesCurrentAndNoncurrent http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="ibe16525b780846f0a8256296b5fb0f87_D20221101-20230131" name="us-gaap:DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTItNS0xLTEtNjg3NTE_9acfeb89-7d88-4046-b4c7-cb2eb4fcaa42">http://fasb.org/us-gaap/2022#CostOfGoodsAndServicesSold</ix:nonNumeric><ix:nonNumeric contextRef="i359eb8716c884382914b552c36e4c9cc_D20211101-20220131" name="us-gaap:DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTItNy0xLTEtNjg3NTE_4ec61448-9de2-40a0-8dd4-e126176d3a29">http://fasb.org/us-gaap/2022#CostOfGoodsAndServicesSold</ix:nonNumeric><ix:nonNumeric contextRef="ibe16525b780846f0a8256296b5fb0f87_D20221101-20230131" name="us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTctNS0xLTEtNjg3NTE_e833622d-040d-4809-bc1d-d9369471a833">http://fasb.org/us-gaap/2022#CostOfGoodsAndServicesSold</ix:nonNumeric><ix:nonNumeric contextRef="i359eb8716c884382914b552c36e4c9cc_D20211101-20220131" name="us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTctNy0xLTEtNjg3NTE_ae37cd7a-d092-478d-9c12-235792651f19">http://fasb.org/us-gaap/2022#CostOfGoodsAndServicesSold</ix:nonNumeric><ix:nonNumeric contextRef="i1e03d76a6cd14445b069223cf851a0fb_D20221101-20230131" name="us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMjUtNS0xLTEtNjg3NTE_7bdf9258-4aa3-411c-b03c-7da3efd96a29">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</ix:nonNumeric><ix:nonNumeric contextRef="i2fb1f98c73934300bcb2677be16791c7_D20211101-20220131" name="us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMjUtNy0xLTEtNjg3NTE_295a067e-a8da-4362-a6e5-55ad7d16f169">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</ix:nonNumeric><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTItNi0xLTEtNjg3NTE_c88580f0-1f89-414b-85e7-775437129012">http://fasb.org/us-gaap/2022#CostOfGoodsAndServicesSold</ix:nonNumeric><ix:nonNumeric contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" name="us-gaap:DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTItOC0xLTEtNjg3NTE_f8a759f4-726e-4284-aa80-54ef5c1c9cc9">http://fasb.org/us-gaap/2022#CostOfGoodsAndServicesSold</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="a-20230131.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if251c72c968c42798ed7df06399c339f_I20230224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-02-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i3259791ee7e54e039e20c225742b0b34_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i3782575b566e410fbbe25167e7d79c3c_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i748dc3491f9645c98ca706c3c99c1306_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifebdb786506c4e9eb46de7ebfb8b03f5_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i658253fffabe4343b44569144474388f_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i728f596925ae44e9bfb99f953f600ea9_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56485a537aba4a7691bd4bf959f3eaad_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7452fced71814cff84c1f48750a63bfa_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09a604512a0e4676affadfea2edad573_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47cbf7fc4b914e59bbe1b08345963c45_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03309ce0ed5f4d9e91d12ef6e9a11409_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id92438986c5e4e49b96bc1f9a2f4db1b_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i086d2c8106374131912a8bbf8b1f0389_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i606776969cda4cf3b6e3577e3c4bed44_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i159c212a281a41ca83ae4c377dbc7ac2_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc9a621efe2543f482d33c51bc9d5416_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i444f3ab3feb249a4b04e665424135f76_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e544c079add458db2a18a80383a6e7b_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0045b371692f47b18ee58c78620f8429_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc75cb8136f54543a29bfc1d00dfeb94_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe3a97d20a2e44a1b4614a44d8406d81_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e763681f4b045fa9fce2449566d8e3d_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17235fbc23384d9f8362cd810ffa1a21_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i222c7e31873d4892afc0e691da9b4bce_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dd61afa70ad4f12b65e7f736904b893_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a4a359dc74949868e019c988906b5d0_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice97c2676fc846c99090bf80caa8297f_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id29a4ca3e0874d32842cabb48c356b30_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8325ec83b30f404fae1f872f8bcb4f30_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie66c1641c23d4e3d9b549e52e10a56c8_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i871f3a85672446d38dfc792b021eed04_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9a62a47fae946da9a3700c66ce2854b_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i164344fd739541659db977e6b67ac77f_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10a00291ab2f4d61adf4c24df618cf71_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia26e13aca129490c96e3ddb74f2dddfc_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i353beb6720a24469809c0d404c4182ea_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b33cacf7b234159b6c800d566d9d055_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5eb4ff2fb6b34aa4b034790d18900784_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdb13e13506245be95833ade22aa694e_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8dcd748ed474187bf0b21aa9aafa830_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida8131692d1643f8a5dc1d105f4fcc7f_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bf212d52a5c43fc80953fcd23626126_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3680858c584e48c0ab29a7b1c6e0b029_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67000e3aa16f48a6b186edcc2d77662d_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33f78913651a47bb92a2c9900a5966db_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2befebaadc5845d4b2d401527b04cfaa_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d7d677f290d463982d78a58cc084bf7_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ebb4d48c62249409808fe3659039d91_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7f2de7d06eb471e9bfd5e643f5764f0_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d893a60dca04278bdac0cdc1e4d7989_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a7f1e005ab74d76ae872de230a40733_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb3d192ff70c43558d2066769b7f1110_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f9fc291277d49d591b89a8b399ecfc2_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6b3e33e9f0d48d49e7efcf7b7ef2aca_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if298d324aaf84d769b2e82d2d4124e2c_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i046a05a9e0514062bf9a677859974cf0_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01fc9bcc3b254bf39b375532b23a0c12_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d0d7a31803341648e3a045e2165534e_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ec12050ee6648a19d1b871251909434_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69383333245348d09b86b40f341453b8_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefc8abdb47254b4cb32b27b0c6fea825_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6d69f7e74f34f0195f00e307ab8c80e_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87246a3249384b37a1500f923b627ee8_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73b7b9de08cd4437b818bb9e0f9b4ee8_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i352bfe2a93f947e1bcd491c49559ee2d_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4eeadafeeecb428dbb6170dd77089aaf_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7b2543146dc41dd86c44c7ecf447270_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i433f969b78854ee3a4db35ffe5965afe_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90bc58b4dc464d058d4f7d56e61e2e21_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d83c1345e874e8fabdab7fd0ec051b6_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i405a137dbfd148ab9797e53157dcb87b_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfc4fdb619ed43958b648563fb2ca526_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23ae7b4eb6644b20adf956a785dc7849_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if846265414d142bd8d679b7776dae8eb_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a91b9cb9e834ebdae96fd116f3b54bb_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="a:EndMarketsAxis">a:PharmaceuticalandBiopharmaceuticalMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3806cb502c9f457482e587434ee21a3a_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="a:EndMarketsAxis">a:PharmaceuticalandBiopharmaceuticalMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief1e084458524e819f6e6ec4ad38798d_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="a:EndMarketsAxis">a:ChemicalandEnergyMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1c59e046fef4e9a882ae2d9736f805c_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="a:EndMarketsAxis">a:ChemicalandEnergyMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a907fa8237046bc9803dec7949c9487_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="a:EndMarketsAxis">a:DiagnosticsandClinicalMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifac394aa55dd4cd78340931392cbac84_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="a:EndMarketsAxis">a:DiagnosticsandClinicalMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i918e15743a054525a9ccefdb3ad5a96e_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="a:EndMarketsAxis">a:FoodMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62c28467676b4ec4bb9ab059f9e3ace4_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="a:EndMarketsAxis">a:FoodMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3149e70ed5cc4cf09a5de74e7be57b1c_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="a:EndMarketsAxis">a:AcademiaandGovernmentMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i791084f532a9497884a77723bd002cab_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="a:EndMarketsAxis">a:AcademiaandGovernmentMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e0adf97a40a40168240f072cee0a25e_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="a:EndMarketsAxis">a:EnvironmentalandForensicsMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4cf935018ca4152b0524665cd240808_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="a:EndMarketsAxis">a:EnvironmentalandForensicsMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4192156e4404414ad46fd4d9c955d45_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">a:InstrumentationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad9f52901e11433ca11e2fd403c4973f_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">a:InstrumentationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i912f785ffd524583ab9332e174a0fd40_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">a:NonInstrumentationandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7ae14d8d8fd4f5bab3bf7785fc6ec16_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">a:NonInstrumentationandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i760e2fe91a2a4c6185fc11aef9ce399f_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-31</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa92731b48d9431b9c71e61f579b2e2d_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i48899fe9fcfe40b0a73c87a1ed2a0395_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie790d592078944d5b3d633d03546cc1d_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bafa1d058fc442f80a7b778bd3869ed_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2339426bfd7e4abe87998a6a1ba2cd4a_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if327b7d783dc44e792963c335ca5a65b_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39c3cd014db248d291455e64255569d7_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6eca4fc7ce75413ab4ea045884e10a1e_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43fcff5de6e1452bbd0a529d852367d6_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94553cf9a1f84b418346d9811212fd96_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i959ba1e365cb46fa9d6a0d02c602c418_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86cd4d87f14b4de7b2d3da170bbf7106_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8c2f25497504473b732d53cf9c153d0_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i290a2031fda542169028caab109d3e44_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7776701abc9e4dfd9513b31afb36fc5d_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PublicUtilitiesInventoryTypeDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20cb6e7201dd4408b86351630d0bad5a_D20211101-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PublicUtilitiesInventoryTypeDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3152ba76c1df417987d29128ff805a81_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">a:LtppMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia93bc1b9aa474f94bdf99722444eb9d8_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">a:LtppMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09873915b6ae475892e5c9a10735d4d2_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">a:LTPPRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib61c5c9996464615b2178256d5815306_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">a:LTPPRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14749e019f0c4a78a5749fbc0e9602a5_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c417edb3d704da7925a02009feeff69_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdb82786efda42a99e13832f0a499c71_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e0c874f1a2f4b52bde701c5d0c5f04a_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic29288e8bc2e49b7b040c7b53788b074_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39cb63aace124a70b0cf20f2781b5388_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8aff20c1669045879c48618f094be7f4_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78c9af0b8c6542c9804e6ef220ea2418_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie41bd8ebbf7b4eb68a78111db1b20475_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3aadc25089b4d77a8b3cba419d06996_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia533acfa2c5343c2a822b9e8c8ada803_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">a:ThirdPartyTechnologyandLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6f781359e43434dbbae2d8573466196_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaecdfae8339144e08ca120f755566194_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if38c838bd72546ecb1b03552dfe899cf_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d9e00fde0b04942843ffcf15477e77f_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic775993ecc604246b97b951a0ebb69f7_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20a5d3b2a23247998eeb29965ed5cdec_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">a:ThirdPartyTechnologyandLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id63c0b222b0f4e9591e1e1ec87de74b7_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i437d3b6251fa4606a05df57d58d3c73c_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f3778491b9842b0b3c469f4bf304247_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i771947e8e65142a1a1ce68ffba8ff0b3_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b2eea0376824cb7ae764ad375383f52_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i171aadf8a79b4a8faa50f9b31b327f84_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1682ba3d772453aaed03af1031bb843_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i109ec2cab42849fbbaba1a368387a380_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i010b31c6afda45549d3eba9b0bb42875_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibaaa0ef2c25948abb1a1d1b853e18ed6_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7ced5b567134408b99ecb1dcf4ae051_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic76a06664a9c458885914a4582301f23_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0a5d971f1eb44de8d7f86aad8db9e29_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82e671a18849495b8fb217e22b89ec5e_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bb56a780b484db596a8537265a00ae7_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75a58a1a2e104511a28697e212909d94_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i520e8d9623a54c38ad726102ce099ef0_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b44dbcd02a9484b8ddc79b3a7fab6d0_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">a:ResolutionBioscienceIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0bae153c6ff4111936aa0ad12293d37_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6ceec45342244868b46e5292ec40d82_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a2fd80baf9f425780781f01120bc35f_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26efb771671d46d386db8ba65c21d53e_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a38492613ee42308d5ca58cb82e54ef_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">a:ResolutionBioscienceIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8a78ace67c24152ae9bf94ef8fff79d_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c10ebdbbadb4b66aa09bafa9c10e706_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e5a6aeaf4184c46acacaeb8daab5f0e_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd7fc31a934145e0b639ded81bd2a4d4_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7721625bbc374f08999fc25fad1ac438_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d7c15a459fa45b195a04ab621f88594_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02170c8657d54b96b0528a195ed9a6cd_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i281883c980b344c399e2833cbe9f3289_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibeffa87382834b81853275826f27932c_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9dec0e06e6d42a3a1fc2593ab243f89_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c48d568a480440bbe49a9dd5591a169_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5163f85023154e9ab98ef3ed85fa7d48_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c579659bdb34d54a78c87a9d2a18b6d_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id54402bbdc8b44b3b749044437d33713_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ec93e8012ad48e49930d3765f4c1246_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c8f6a78e1ad4a9396e91d5d4207fb18_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7281c10e5fb4984b926202c8a6449b4_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">a:ResolutionBioscienceIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b9a47671ca446ada8a588e63d75db26_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6200f5bde164b3aacc0816f6518870b_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58623f61e4ac46a6a1223beba978e707_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b98c020f64f40bca09058f4ab716c9c_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibef8720eccc140e49ee2951305a773c9_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">a:ResolutionBioscienceIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cb8b86211c5442c9bef1b1297e7aefb_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">a:ResolutionBioscienceIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">a:RevenueComponentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78c42080d0f14678bc601c2d0167baec_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">a:ResolutionBioscienceIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16a365fe29a5430f9bd225bf44aa6737_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">a:ResolutionBioscienceIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib98f34fc7f8142658a397ac37f6164c3_I20160201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="contracts"><xbrli:measure>a:contracts</xbrli:measure></xbrli:unit><xbrli:context id="i324659d1cb1d46c89cd0b89529d4034d_D20160914-20160915"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-09-14</xbrli:startDate><xbrli:endDate>2016-09-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78d62c946c8542959b4e01f2cf974dd8_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8fcf2a391464f039d40d132dd664e20_I20190816"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i904b39b3a0a541d89b9c91d944f3526e_D20190906-20190906"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-06</xbrli:startDate><xbrli:endDate>2019-09-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c598168990b490090f5881a47627e8c_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6368af5356e443e2b1bcf93e16e6d501_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia16943661c8e4bc59b6314507abbb36d_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cb76a4102ed49558e2227ab243ac8fd_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70fa0d9850894ce2bd08150dce5dd880_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0d17d231ad5405b9ae739955f35f425_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bd82f3839e44ab192c48ef9a1870c15_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17dde9e7368e4020ab08f6c0f4846ca7_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf03d71e237844c9ab4a9ebd0faa3359_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5aafc014163f40529f30fefed7819d7b_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71cd31f9f70b417fb1bb4b7d5392f0b2_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3775203ec49249b4ab76f5cf6f2294ee_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5ed8a5ca0774169b7f944d0bc113de9_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic52474b3fc2c44c7bec341cd3919960f_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:DKK</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia08df4cafe1540658c021ebd7e9ffadf_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:KRW</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61cfdf67052b485b9591582a21abe8d0_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:KRW</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i295d08acf58449ef98033f4386430180_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33d60a29c4894eb3bbb33a68e4118838_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52e8713c120048e69a3901dd8044bd07_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16cf2f8e131444838a3d586870b9b6c9_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ef13b82dfee4eb7bbf8c4421b6feda3_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:TWD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23a1060162f147c9b80ea9c15caa11f8_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:INR</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfcbd73a2af54018a2f5aeb70c0a2d56_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XXX</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia52b02295eb54f4498499beee0165955_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XXX</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie806c5c691284655bfd5c99810e88955_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9849f16147a4c6a8af2c15f51852e70_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i601ab9e19dde4d31bfab5c2b2c29aaef_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d83ab74cb7347a5997c114b0ed5304e_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57b59664cd454e6cbc394cafcff6db66_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b2775a8204c459cb7fac69d437dc90c_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iecb19970c8c74e3ea1d87896cfeb7d28_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4660a8668a594fbaae707aa7558ab4e3_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3443903b09984986b9027f5937e42b78_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87421f1569744288b0e82400d83000e1_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaab05383499649d68262077bbecf0617_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22ad5bff85274efd9620a8216896b106_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie15965d2e28741fe8be38f4bf8c301ec_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48143490c5ee44a2abd1901822b86a71_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i873674ebcbd7473eb35b8c4112bc01f3_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69c58982edd04b3c8b9b1a661fa43077_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i446051e3e67a4f3eb24fc2a9fc021f9f_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe16525b780846f0a8256296b5fb0f87_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i359eb8716c884382914b552c36e4c9cc_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1a503ae15114ad2ab5911699cb1de9d_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68beea4ee84a417ab91740679bcbab4d_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e03d76a6cd14445b069223cf851a0fb_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fb1f98c73934300bcb2677be16791c7_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7aac091b08c48afba3a0408369ffcc4_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34dcb13592ff484696f17ceb6e02417d_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i125675019576446bbc7947a564d0c89f_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e99b539b79445c1b5eceb9da39435cd_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c2a35f6169348d4bb4fe4e665306d51_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbcda6d0b469429ca1598f0fa2ebb7d7_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie73c662f34154fc49f2f4456e56cd10c_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73728e1faa1e4efda17c4a3ca7016e37_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a4bcfb758684d2488eda427cdb6b25d_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia940a16a97b2481b975ec28bbbb5866c_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ef13658ecf745f787fde75342d47896_D20190313-20190313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:A5YrUnsecuredCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-13</xbrli:startDate><xbrli:endDate>2019-03-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafd490bd02de47189afdbcca947d8d74_I20190313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:A5YrUnsecuredCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i152367a04c424a7ba2d724aaa1763fdc_I20190313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:AdditionalIncrementalTermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bdea77493e34375a99fd1155e7a9865_I20210421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:A5YrUnsecuredCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f2d43ce269b4254baf2999a8865ea28_I20210421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:AdditionalIncrementalTermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bdca111b15343188d0db9a98448ac9d_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:A5YrUnsecuredCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9fc0ac763d44a1cb45cc9609a903602_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:AdditionalIncrementalTermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a69ec0f4903459fb41ff3b295fb9cb3_I20210618"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfa1651ae6144d3fa003dba82a34e213_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="rate"><xbrli:measure>utr:Rate</xbrli:measure></xbrli:unit><xbrli:context id="i00a9160afdad455eb4f9ec0885e50ae0_I20220415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:TermLoanMaturing2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08d40d57102743d89263c457fb2d9f57_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:TermLoanMaturing2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10c0cb7fda60466cb455e2be4d15041f_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b64ba8cd1f3436782785cc805950f95_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i350ed86205aa4b80911ef00f731a2abd_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i783cb7ee1875433c87db62ff80483811_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2079ee6072754438b4665c88d5465e25_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7455386a3c3948c1a56733c226910fac_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d34be775eb5486e9dd8f335cc3b5197_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8992aace108544bd92848aeb54b66881_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d6a03bdbe0143bda21e2c1075865b76_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cad5754c77d481a8d01dd8905da7bb4_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09d3df9f558a4787b3d731f7b3eab7d8_I20210218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">a:A2021RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3f5a8f5de1849ddac4ff626ed31a5af_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">a:A2021RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd4e332392a048ae990d8d227847d292_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">a:A2021RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4f8c2b1ca13416f801985533f043e3e_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">a:A2021RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib27fcdd7d55f4e51b96ab02b41cb16f3_I20230301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">a:A2021RepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e36614039e441fc844c3eebaa2a03df_I20230109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">a:A2023RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5cee235c15894fc79e55ebd92dddd62f_D20230222-20230222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-22</xbrli:startDate><xbrli:endDate>2023-02-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a78f97293c94b7a9a3259156a44fa2e_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9481c6bfaca4632a77a30f531bb71a6_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8f1f6f3136049d4be156f4751093caf_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3afa252a57540f291b6c76329807920_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i019e110038214039b7e2ec2a8a8e7c57_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a083ba0b32e485283552d0ac7ca6ea6_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3b66509fec04f3dbca28ec34bb295c1_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i408570a1fe564491867039bfbb606643_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d54a60dc4d4494fbe0eee8846f953cb_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9f56afb4f9643e593d0341fc1aa9b85_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i251d1854299d4023ad580a36c8fdb3f4_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4876675b17484a69a10e8f4181f8a034_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i899550b909f344acbdc4d7dab570fb1d_D20221101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:SegmentTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e1195fba3dd4542a09cd93dc4067241_D20211101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:SegmentTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia34e53066283455d9839cece675eac92_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:SegmentTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i927186f756bc4f41b7276527c4ebea8a_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:SegmentTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_1"></div><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGV4dHJlZ2lvbjphZjljOGUwYmYzM2M0ZGU4YTc3ZjVjNDMwYzc5MjBmZl8yMjU3_947ca818-54da-417a-8ef2-9e05dda3f654">10-Q</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(MARK ONE)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGV4dHJlZ2lvbjphZjljOGUwYmYzM2M0ZGU4YTc3ZjVjNDMwYzc5MjBmZl8yMjU4_8f061253-5076-4c1f-add2-dc6d1e9a2522">&#9746;</ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGV4dHJlZ2lvbjphZjljOGUwYmYzM2M0ZGU4YTc3ZjVjNDMwYzc5MjBmZl8yMjU_a9f98e13-bcdf-4c40-91cb-f37184fd7f6a">January 31, 2023</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">OR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGV4dHJlZ2lvbjphZjljOGUwYmYzM2M0ZGU4YTc3ZjVjNDMwYzc5MjBmZl8yMjQ3_49d4bc5e-185c-4762-ae43-699ddab10570">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For transition period from &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGV4dHJlZ2lvbjphZjljOGUwYmYzM2M0ZGU4YTc3ZjVjNDMwYzc5MjBmZl8yMjQ2_41bedeb2-958f-4dad-9967-254c724e9925">001-15405</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGV4dHJlZ2lvbjphZjljOGUwYmYzM2M0ZGU4YTc3ZjVjNDMwYzc5MjBmZl8yMjUz_6dcebc1d-cf38-4646-aa6f-516783b9f41a">AGILENT TECHNOLOGIES,&#160;INC.</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Exact Name of registrant as specified in its charter)</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.191%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.191%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.440%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.264%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.848%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.269%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGFibGU6YzllNWM3YzNlZTY2NDRjMTgwYjE4MjA2NTZjN2QyYjUvdGFibGVyYW5nZTpjOWU1YzdjM2VlNjY0NGMxODBiMTgyMDY1NmM3ZDJiNV8wLTEtMS0xLTY4NzUx_716bd30e-6a82-4ab8-8f2c-b31b04f0e0b2">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGFibGU6YzllNWM3YzNlZTY2NDRjMTgwYjE4MjA2NTZjN2QyYjUvdGFibGVyYW5nZTpjOWU1YzdjM2VlNjY0NGMxODBiMTgyMDY1NmM3ZDJiNV8wLTUtMS0xLTY4NzUx_186ae85b-d68c-4e80-ac6a-1fb5466ee52f">77-0518772</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(IRS Employer Identification No.)</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGV4dHJlZ2lvbjphZjljOGUwYmYzM2M0ZGU4YTc3ZjVjNDMwYzc5MjBmZl8yMjU0_8aae352b-0248-4d87-9cea-a8104432a76a">5301 Stevens Creek Blvd.,</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGV4dHJlZ2lvbjphZjljOGUwYmYzM2M0ZGU4YTc3ZjVjNDMwYzc5MjBmZl8yMjU1_02638fc6-a641-4e26-8505-f7ed3951a5a1">Santa Clara,</ix:nonNumeric> <ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGV4dHJlZ2lvbjphZjljOGUwYmYzM2M0ZGU4YTc3ZjVjNDMwYzc5MjBmZl8yMjQ5_ebaf4b18-9de5-4d70-b879-1e783ee22c5c">California</ix:nonNumeric> <ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGV4dHJlZ2lvbjphZjljOGUwYmYzM2M0ZGU4YTc3ZjVjNDMwYzc5MjBmZl8yMjQ4_0aeb38d8-d827-4b1f-a197-e2b67c5f386c">95051</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant&#8217;s telephone number, including area code:&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGV4dHJlZ2lvbjphZjljOGUwYmYzM2M0ZGU4YTc3ZjVjNDMwYzc5MjBmZl8yMjUw_0b3a28b1-11d8-423c-a83a-dcee91293369">(800)</ix:nonNumeric> <ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGV4dHJlZ2lvbjphZjljOGUwYmYzM2M0ZGU4YTc3ZjVjNDMwYzc5MjBmZl8yMjU5_8af9881f-d7f1-4ebb-a029-ab38eafbc529">227-9770</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.090%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each Class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each Exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGFibGU6NDE1NDY2NzkwNzQ3NGUwMWE1ZWZmMjU1YTBjZGM3ZjAvdGFibGVyYW5nZTo0MTU0NjY3OTA3NDc0ZTAxYTVlZmYyNTVhMGNkYzdmMF8xLTAtMS0xLTY4NzUx_055af4a1-4d18-479f-8b43-48814692c95c">Common Stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGFibGU6NDE1NDY2NzkwNzQ3NGUwMWE1ZWZmMjU1YTBjZGM3ZjAvdGFibGVyYW5nZTo0MTU0NjY3OTA3NDc0ZTAxYTVlZmYyNTVhMGNkYzdmMF8xLTMtMS0xLTY4NzUx_05fbfa73-2aac-4fc4-a1e7-6166edcd6724">A</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGFibGU6NDE1NDY2NzkwNzQ3NGUwMWE1ZWZmMjU1YTBjZGM3ZjAvdGFibGVyYW5nZTo0MTU0NjY3OTA3NDc0ZTAxYTVlZmYyNTVhMGNkYzdmMF8xLTctMS0xLTY4NzUx_c4d94495-4123-4e81-b824-1a6778edb780">New York Stock Exchange</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;<ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGV4dHJlZ2lvbjphZjljOGUwYmYzM2M0ZGU4YTc3ZjVjNDMwYzc5MjBmZl8yMjUx_d7aae156-c0b1-4e37-836a-54c6c81cd3fa">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;No&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;<ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGV4dHJlZ2lvbjphZjljOGUwYmYzM2M0ZGU4YTc3ZjVjNDMwYzc5MjBmZl8yMjUy_369a649e-2749-41ae-88a4-104b1e7611a5">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and "emerging growth company" in Rule&#160;12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:21.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.170%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.102%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.170%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.170%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.104%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGFibGU6ZjkwMmVmZGJiODA1NDEwNmE3OThlZjcyMzI2MWY2YWUvdGFibGVyYW5nZTpmOTAyZWZkYmI4MDU0MTA2YTc5OGVmNzIzMjYxZjZhZV8wLTAtMS0xLTY4NzUx_55ddd14c-0fe0-499e-a8b0-54bfe6d3cdaa">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right;text-indent:18pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9746;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right;text-indent:18pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right;text-indent:18pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right;text-indent:18pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGFibGU6ZjkwMmVmZGJiODA1NDEwNmE3OThlZjcyMzI2MWY2YWUvdGFibGVyYW5nZTpmOTAyZWZkYmI4MDU0MTA2YTc5OGVmNzIzMjYxZjZhZV8xLTEtMS0xLTY4NzUx_1cd2107f-e6e1-453c-a113-8cec64d0a323">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right;text-indent:18pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGFibGU6ZjkwMmVmZGJiODA1NDEwNmE3OThlZjcyMzI2MWY2YWUvdGFibGVyYW5nZTpmOTAyZWZkYmI4MDU0MTA2YTc5OGVmNzIzMjYxZjZhZV8xLTctMS0xLTY4NzUx_115c3527-b8ef-4361-b970-0814ab336835">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:2pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).&#160;&#160;Yes&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGV4dHJlZ2lvbjphZjljOGUwYmYzM2M0ZGU4YTc3ZjVjNDMwYzc5MjBmZl8yMjU2_3ef3a74e-4609-4ff4-b203-2664326ba8e8">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of&#160;February&#160;24, 2023, the registrant had&#160;<ix:nonFraction unitRef="shares" contextRef="if251c72c968c42798ed7df06399c339f_I20230224" decimals="0" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGV4dHJlZ2lvbjphZjljOGUwYmYzM2M0ZGU4YTc3ZjVjNDMwYzc5MjBmZl8yMTgx_85767295-9f92-4e7a-b35a-a16b56a084c6">295,701,853</ix:nonFraction> shares of common stock, $0.01 par value per share, outstanding.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_7"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AGILENT TECHNOLOGIES,&#160;INC.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TABLE OF CONTENTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.228%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:59.897%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page<br/>Number</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_10">Part&#160;I.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_10">Financial Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_10">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_13">Item&#160;1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_13">Condensed Consolidated Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_13">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_16">Condensed Consolidated Statement of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_16">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_19">Condensed Consolidated Statement of Comprehensive Income (Loss)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_19">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_22">Condensed Consolidated Balance Sheet</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_22">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_25">Condensed Consolidated Statement of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_25">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_28">Condensed Consolidated Statement of Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_28">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_31">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_31">8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_82">Item&#160;2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_82">Management&#8217;s Discussion and Analysis of Financial Condition and Results&#160;of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_82">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_124">Item&#160;3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_124">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_124">42</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_127">Item&#160;4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_127">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_127">42</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_130">Part&#160;II.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_130">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_130">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_133">Item&#160;1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_133">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_133">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_136">Item&#160;1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_136">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_136">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_139">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_139">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_139">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Item&#160;6.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibits</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_142">56</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_145">Signature</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_145">57</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_10"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:2.41pt">&#8212; FINANCIAL INFORMATION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_13"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.285%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3259791ee7e54e039e20c225742b0b34_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfNC01LTEtMS02ODc1MQ_dbd7f14f-4e3d-4058-909f-363e931ca3e1">1,323</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3782575b566e410fbbe25167e7d79c3c_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfNC03LTEtMS02ODc1MQ_efd1dcc9-b725-4987-9bb7-249e620e113c">1,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services and other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748dc3491f9645c98ca706c3c99c1306_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfNS01LTEtMS02ODc1MQ_a6b0d6d1-f24c-4e5a-ab13-167809d1d6d4">433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebdb786506c4e9eb46de7ebfb8b03f5_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfNS03LTEtMS02ODc1MQ_8eda11f1-1d46-4bce-bd9c-1e30bc0c5a6b">411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfNi01LTEtMS02ODc1MQ_727f2f48-7f2e-4fb4-8ffb-1f8d3a5c4d9c">1,756</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfNi03LTEtMS02ODc1MQ_2fa035eb-f26e-4b8d-94d0-40b415de9b20">1,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3259791ee7e54e039e20c225742b0b34_D20221101-20230131" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfOC01LTEtMS02ODc1MQ_bc211eb1-8167-4e2e-b8fa-7c04056cba46">556</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3782575b566e410fbbe25167e7d79c3c_D20211101-20220131" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfOC03LTEtMS02ODc1MQ_f628db12-b917-4f08-aa97-bf7ed30fa82e">545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services and other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748dc3491f9645c98ca706c3c99c1306_D20221101-20230131" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfOS01LTEtMS02ODc1MQ_8cfcc55e-1059-4eab-b0f9-5388aa37125d">232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebdb786506c4e9eb46de7ebfb8b03f5_D20211101-20220131" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfOS03LTEtMS02ODc1MQ_c6feb77b-b6d2-46ff-ba92-7001c4b20fa0">219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTAtNS0xLTEtNjg3NTE_71274a60-f836-4ec7-acdd-6a16bff45d68">788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTAtNy0xLTEtNjg3NTE_303a202d-ff0e-4998-8382-145361d078ff">764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTEtNS0xLTEtNjg3NTE_911506da-5588-437e-a15e-d8038c27a8b9">123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTEtNy0xLTEtNjg3NTE_b9301d04-608b-4c19-be5b-88cf37fe3571">117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTItNS0xLTEtNjg3NTE_3d6c648d-12f0-4ff2-b8bb-0f845955174b">419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTItNy0xLTEtNjg3NTE_c0b10c05-3388-461e-bd5e-86ee07f9e4cf">417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTMtNS0xLTEtNjg3NTE_5a34e1b6-ffff-4362-b23a-0cc2e2b53c97">1,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTMtNy0xLTEtNjg3NTE_2c791f5c-ae3d-4b26-a8c6-e5e79ad271f4">1,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTQtNS0xLTEtNjg3NTE_474bb262-e390-4faf-8196-5c06eb43b72d">426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTQtNy0xLTEtNjg3NTE_84fd7457-6479-4024-9c60-20dc38577757">376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTUtNS0xLTEtNjg3NTE_1615350a-6d77-43e3-bbd8-9d9359e7b5c1">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTUtNy0xLTEtNjg3NTE_9e144256-cfdf-44ed-8520-d179e2019cec">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTYtNS0xLTEtNjg3NTE_350b57ce-c3a1-4a75-b4a7-29fffc0f4632">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTYtNy0xLTEtNjg3NTE_f78be576-9a67-4edd-b240-45c499ad57d1">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTctNS0xLTEtNjg3NTE_4dde0977-3384-4202-9641-26fb5b0f3fad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTctNy0xLTEtNjg3NTE_9a81c65b-033b-43c4-91ec-446905e872f2">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTgtNS0xLTEtNjg3NTE_06491e30-1662-48e3-8804-d9dfad5e6999">410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTgtNy0xLTEtNjg3NTE_8b42a7d1-a892-42b2-a9ff-690f9b5e3eb3">319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTktNS0xLTEtNjg3NTE_e05bc500-d25e-443f-9245-193ab8cadb91">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTktNy0xLTEtNjg3NTE_f66d3aa7-b68e-4724-b45d-7d63a631e8d3">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMjAtNS0xLTEtNjg3NTE_ba028988-b791-490f-8698-39ac025c762f">352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMjAtNy0xLTEtNjg3NTE_a49ae587-b9fc-4b64-9f0d-7d7faad565fe">283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMjMtNS0xLTEtNjg3NTE_ac774593-dddb-416e-8157-2fb338a31be7">1.19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMjMtNy0xLTEtNjg3NTE_6945fc11-e36b-4bd7-9303-e3488a6ec88f">0.94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMjQtNS0xLTEtNjg3NTE_5340e610-7228-4d25-8b04-155ff679328d">1.19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMjQtNy0xLTEtNjg3NTE_664cdffe-c259-4c7a-80b5-ed50135d0e2c">0.93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares used in computing net income per share:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMjctNS0xLTEtNjg3NTE_92218217-bb95-45f2-aef2-eccc34ee3c40">296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMjctNy0xLTEtNjg3NTE_5e448ea6-ad21-404a-ad7f-82bd47d65677">301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMjgtNS0xLTEtNjg3NTE_d2c6175c-a53e-44da-a448-8f391e27a694">297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMjgtNy0xLTEtNjg3NTE_90e3a438-04b1-4040-802c-220fefdc4bda">303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_19"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.017%"><tr><td style="width:1.0%"></td><td style="width:81.695%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.734%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.735%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfNC01LTEtMS02ODc1MQ_910fdead-b464-410b-b253-1577c93b2347">352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfNC03LTEtMS02ODc1MQ_0679f287-1f00-4e6b-87d2-c3c32d4494c1">283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on derivative instruments, net of tax expense (benefit) of $(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfOC0wLTEtMS02ODc1MS90ZXh0cmVnaW9uOjljMTdjZTc1YjI5ZjQxOTFiNjAzZTg0ZWMzNTExODE5Xzk0_95c937fe-77c6-4f6d-95b1-c066e2490918">9</ix:nonFraction>) and $<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfOC0wLTEtMS02ODc1MS90ZXh0cmVnaW9uOjljMTdjZTc1YjI5ZjQxOTFiNjAzZTg0ZWMzNTExODE5XzEwMQ_1a1164cf-20f9-469d-8656-c600b4b43cc0">2</ix:nonFraction></span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfOC01LTEtMS02ODc1MQ_559afccd-1796-4291-a937-6b53d9890fb6">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfOC03LTEtMS02ODc1MQ_594b7920-e0dc-42a4-8e8a-f25de51b8977">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into earnings related to derivative instruments, net of tax benefit of $(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfOS0wLTEtMS02ODc1MS90ZXh0cmVnaW9uOjI5YTE1NDE3NmM2NDQ1ZGZiZTQ2ZTg3Yjg4YWQ0YzU0XzExNQ_2242305c-b0c1-4f27-b00b-f7310eff21cc">2</ix:nonFraction>) and $(<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfOS0wLTEtMS02ODc1MS90ZXh0cmVnaW9uOjI5YTE1NDE3NmM2NDQ1ZGZiZTQ2ZTg3Yjg4YWQ0YzU0XzEyMg_484e0342-ee8d-4722-aaf3-3d6ba4f4fef4">1</ix:nonFraction>)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfOS01LTEtMS02ODc1MQ_b481566e-d2f3-4d20-a88a-71d06343686d">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfOS03LTEtMS02ODc1MQ_9474039c-07ce-4234-9d1e-0f4ca0ef6919">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation, net of tax expense (benefit) of $(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfMTAtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjo2YWY4NTNhMWY3OGM0YjQwOTk4MmViNTUxMGQ2OTZmNF82NA_33aa68f4-fc2a-469c-8eb5-de92bc451822">1</ix:nonFraction>) and $<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfMTAtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjo2YWY4NTNhMWY3OGM0YjQwOTk4MmViNTUxMGQ2OTZmNF83MQ_d9f5c029-5ae5-4e50-bf9e-6a7efbfc3b37">0</ix:nonFraction></span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfMTAtNS0xLTEtNjg3NTE_f8ff8196-fea2-4e81-9eb6-883042af7d72">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfMTAtNy0xLTEtNjg3NTE_346ef4eb-2dc8-4a04-952c-a48d8e8d378c">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net defined benefit pension cost and post retirement plan costs:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in actuarial net loss, net of tax expense of $<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfMTItMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjpjNWRjZTQ3ZmU1NmY0MjZiYWNjOTkxODg4MTk2ZjI2MV82NA_09eace8a-55f0-4554-8914-8ddf12a8c7e3">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfMTItMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjpjNWRjZTQ3ZmU1NmY0MjZiYWNjOTkxODg4MTk2ZjI2MV83MQ_cf0bc464-7a40-40ee-bac7-12bee58bcb63">2</ix:nonFraction></span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfMTItNS0xLTEtNjg3NTE_ebc1042f-5cb1-433c-8ce8-f22a84ad1c4d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfMTItNy0xLTEtNjg3NTE_763b0c92-add4-429b-afc9-ec86b6cf2467">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfMTQtNS0xLTEtNjg3NTE_01e7a032-9e0c-4533-a8d6-3292acd4c204">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfMTQtNy0xLTEtNjg3NTE_db892b2b-b84b-4168-a2f2-054c8d704f06">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfMTUtNS0xLTEtNjg3NTE_895f1be4-6fe1-4338-8883-d97d822697f1">419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfMTUtNy0xLTEtNjg3NTE_8ea0934a-0114-43a7-8eb2-f7f0fa309f6c">267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_22"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEET</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except par value and share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMy0xLTEtMS02ODc1MQ_47469734-a4df-44d9-974e-4e889cc06a80">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMy0zLTEtMS02ODc1MQ_85bd2d4b-a46b-403e-815b-3c56e61a517e">1,053</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfNS0xLTEtMS02ODc1MQ_2905457e-bc23-430b-9272-c7b6f146a82c">1,459</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfNS0zLTEtMS02ODc1MQ_c1e6fd7c-7cf8-4b37-836e-b2366960f240">1,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfNi0xLTEtMS02ODc1MQ_606cf30e-560e-4c1e-a6e0-e2e2a4c3292a">1,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfNi0zLTEtMS02ODc1MQ_1530526f-97fe-45bf-bfa9-b7fa35ef5de3">1,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfNy0xLTEtMS02ODc1MQ_efb93ac0-8a70-4d1b-bb54-861185f1d05b">258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfNy0zLTEtMS02ODc1MQ_eea09050-dfc8-4abe-9015-59f71bfcdd4c">282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfOC0xLTEtMS02ODc1MQ_8cf65efa-fe58-43d6-8c60-061b5e85d87d">4,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfOC0zLTEtMS02ODc1MQ_257f9d40-623e-47c6-9ac0-8e76ac84a3f2">3,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfOS0xLTEtMS02ODc1MQ_fd722165-2386-4706-8b64-c04989d759e9">1,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfOS0zLTEtMS02ODc1MQ_f9a79d50-a7dc-475a-9482-0f2a6e9cc9fa">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMTAtMS0xLTEtNjg3NTE_40526df2-13e1-4151-87a5-4812659c1cff">3,983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMTAtMy0xLTEtNjg3NTE_f6d8f747-8840-44db-9d90-e699cf3e1288">3,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMTEtMS0xLTEtNjg3NTE_1b7bdd87-8cb8-4d36-9d85-11ee40f970cc">810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMTEtMy0xLTEtNjg3NTE_8cee4afe-3522-4728-81c4-4a3bd7b5bb64">821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMTItMS0xLTEtNjg3NTE_be3bd701-661b-496c-89c4-79bb82e28a94">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMTItMy0xLTEtNjg3NTE_192588b6-7992-40ae-999a-3d642ffbe1c9">195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMTMtMS0xLTEtNjg3NTE_2a455952-451a-416a-82d6-02ecc500b5c2">713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMTMtMy0xLTEtNjg3NTE_4e44b883-d26f-47e3-a659-aca79f065009">686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMTQtMS0xLTEtNjg3NTE_c99bba14-be76-4fe4-94cf-296d12368f5b">10,919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMTQtMy0xLTEtNjg3NTE_714d9813-a3d3-4b57-b0d7-bb1de61cbf44">10,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIABILITIES AND EQUITY</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMTctMS0xLTEtNjg3NTE_ce2535d2-fe66-4f9b-806b-cdd63017c890">540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMTctMy0xLTEtNjg3NTE_b0be02fa-b2df-43a6-bbc4-b2df665de6e3">580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMTgtMS0xLTEtNjg3NTE_ce5badd4-117c-46b3-93b5-f99a395577d2">296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMTgtMy0xLTEtNjg3NTE_2f15be13-4df0-4c07-9561-6cc8e7de0291">455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMTktMS0xLTEtNjg3NTE_239f7a83-08ce-4014-8e61-4c3c0bbd1e06">521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMTktMy0xLTEtNjg3NTE_8340675f-0782-4c39-9d90-e4d1a48cf572">461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMjAtMS0xLTEtNjg3NTE_9b33fedd-83b8-4b66-9cc3-03e6a5641a37">238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMjAtMy0xLTEtNjg3NTE_765979c8-39b6-4710-acbc-fe380a0f09f3">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMjEtMS0xLTEtNjg3NTE_fb245dd7-dd4e-4cbf-8c7d-b0fcbe9ec278">341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMjEtMy0xLTEtNjg3NTE_f48720e1-b2b7-459f-a2bb-16a9b52b8d96">329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMjItMS0xLTEtNjg3NTE_a3a8f99d-44e4-4bb7-a4ee-61a60a416dec">1,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMjItMy0xLTEtNjg3NTE_ea2fb413-b883-4360-8c56-91fd2960f935">1,861</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMjMtMS0xLTEtNjg3NTE_cd2fbe5c-374c-4a11-b47c-fca9ee89a274">2,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMjMtMy0xLTEtNjg3NTE_76fbda24-9b27-4e5c-b338-d1c5cfc2b991">2,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement and post-retirement benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMjQtMS0xLTEtNjg3NTE_415441d6-060c-4cfb-b648-b2db3cb91c6c">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMjQtMy0xLTEtNjg3NTE_07de2aea-91bb-4efa-aef3-9925f7860143">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMjUtMS0xLTEtNjg3NTE_d6376176-d91c-4fc9-908c-06f89d8f15fa">542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMjUtMy0xLTEtNjg3NTE_7613abdd-15ce-42b1-8ae1-8325050bb793">536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMjYtMS0xLTEtNjg3NTE_fca6ff98-dd48-4d5d-a039-d082418c8703">5,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMjYtMy0xLTEtNjg3NTE_1a50aff7-7be5-4571-9a12-8b9bba3c32da">5,227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Notes 9 and 12)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMjctMS0xLTEtNjg3NTE_ac1b29d6-b15b-48ca-871b-c6845dc71970"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMjctMy0xLTEtNjg3NTE_57410165-fc99-443c-96cd-d25e6d524274"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock; $<ix:nonFraction unitRef="usdPerShare" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="2" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzAtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjpjZjZkMjFlN2NlY2E0YTk4YTA4OTAxMDkyZDY5ODA0NF8yMQ_29739779-367a-4ac5-b809-7d3968b55a51"><ix:nonFraction unitRef="usdPerShare" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="2" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzAtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjpjZjZkMjFlN2NlY2E0YTk4YTA4OTAxMDkyZDY5ODA0NF8yMQ_db02a6d9-5ecc-4680-8ca7-d95003640cd1">0.01</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzAtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjpjZjZkMjFlN2NlY2E0YTk4YTA4OTAxMDkyZDY5ODA0NF8zNQ_db188dbf-93cd-4422-8549-c0b13744633f"><ix:nonFraction unitRef="shares" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzAtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjpjZjZkMjFlN2NlY2E0YTk4YTA4OTAxMDkyZDY5ODA0NF8zNQ_e9d3efc6-9d7e-4ca5-9eb6-bded1db98374">125</ix:nonFraction></ix:nonFraction> million shares authorized; <ix:nonFraction unitRef="shares" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzAtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjpjZjZkMjFlN2NlY2E0YTk4YTA4OTAxMDkyZDY5ODA0NF81Nw_2df65bb9-fd19-4528-80a1-800debbb7ffe"><ix:nonFraction unitRef="shares" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-3" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzAtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjpjZjZkMjFlN2NlY2E0YTk4YTA4OTAxMDkyZDY5ODA0NF81Nw_44eb064f-7771-41de-aea0-f8a9435a6610"><ix:nonFraction unitRef="shares" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-3" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzAtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjpjZjZkMjFlN2NlY2E0YTk4YTA4OTAxMDkyZDY5ODA0NF81Nw_4aa6c8c2-9f4e-404c-849f-746b8b5f0191"><ix:nonFraction unitRef="shares" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzAtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjpjZjZkMjFlN2NlY2E0YTk4YTA4OTAxMDkyZDY5ODA0NF81Nw_89902682-37f3-4e23-ae42-5cdefa9bde46">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued and outstanding at January&#160;31, 2023 and October&#160;31, 2022 </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzAtMS0xLTEtNjg3NTE_108aaf00-4748-481e-bab0-226fa02b9af7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzAtMy0xLTEtNjg3NTE_ce4fd96a-351e-45c4-a8f7-c34425e59b04">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock; $<ix:nonFraction unitRef="usdPerShare" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzEtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjo2NWZjMTc2YjNmOWE0ZTc2OWExZjBiZGNjMTAxMTY2NV8xOA_1a1100fc-f65d-49e2-80d7-9ff643e5bf56"><ix:nonFraction unitRef="usdPerShare" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzEtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjo2NWZjMTc2YjNmOWE0ZTc2OWExZjBiZGNjMTAxMTY2NV8xOA_9c23ac19-d6a2-4fae-b2bd-039ab7d1d4f2">0.01</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzEtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjo2NWZjMTc2YjNmOWE0ZTc2OWExZjBiZGNjMTAxMTY2NV8zMg_dff96aa8-2384-4fad-9942-39ec4f16d9b4"><ix:nonFraction unitRef="shares" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzEtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjo2NWZjMTc2YjNmOWE0ZTc2OWExZjBiZGNjMTAxMTY2NV8zMg_e435afbd-6e5e-465f-b0c1-3e8178c69ad8">2</ix:nonFraction></ix:nonFraction> billion shares authorized; <ix:nonFraction unitRef="shares" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzEtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjo2NWZjMTc2YjNmOWE0ZTc2OWExZjBiZGNjMTAxMTY2NV81NA_34ab76ce-12eb-46e6-9154-aadfcdf3667a"><ix:nonFraction unitRef="shares" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzEtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjo2NWZjMTc2YjNmOWE0ZTc2OWExZjBiZGNjMTAxMTY2NV81NA_a957abb1-11e9-40df-ba4b-1e918640547c">296</ix:nonFraction></ix:nonFraction> million shares at January&#160;31, 2023 and <ix:nonFraction unitRef="shares" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzEtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjo2NWZjMTc2YjNmOWE0ZTc2OWExZjBiZGNjMTAxMTY2NV83NA_e671b854-2301-4a5a-89fe-d64642e2aab6"><ix:nonFraction unitRef="shares" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzEtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjo2NWZjMTc2YjNmOWE0ZTc2OWExZjBiZGNjMTAxMTY2NV83NA_f31fcde1-4e42-45e6-a173-ee922ad693f5">295</ix:nonFraction></ix:nonFraction> million shares at October&#160;31, 2022 issued and outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzEtMS0xLTEtNjg3NTE_a63bd5fa-ed24-4366-bc7f-1b1a87cd759f">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzEtMy0xLTEtNjg3NTE_d4ce826a-f230-4c15-a3ac-6ed9dcde6bb6">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in-capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzItMS0xLTEtNjg3NTE_2e0ed95d-1078-494f-b8e1-1fde4aae2a08">5,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzItMy0xLTEtNjg3NTE_c168a57f-4bf2-4e3d-a973-340cf73c5c68">5,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzMtMS0xLTEtNjg3NTE_8842cd1e-7a7b-408b-862b-7b97124d667c">541</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzMtMy0xLTEtNjg3NTE_d139869a-c936-4401-a475-4c9baa794244">324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzQtMS0xLTEtNjg3NTE_51e5fa5c-c515-483b-8ee3-41cc0534b349">280</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzQtMy0xLTEtNjg3NTE_2e2761d7-72ac-4f8d-b72d-4494a47d59f5">347</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzUtMS0xLTEtNjg3NTE_cceec090-8e62-4ecc-bf64-2bc56415c704">5,609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzUtMy0xLTEtNjg3NTE_185d5491-dd1c-446d-b897-031ec45db6ee">5,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders' equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzgtMS0xLTEtNjg3NTE_67f7d4aa-83b3-400a-a034-72e48b294107">10,919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzgtMy0xLTEtNjg3NTE_5b64cb20-41ec-4043-803f-69047a7dfeb8">10,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_25"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNC0xLTEtMS02ODc1MQ_910fdead-b464-410b-b253-1577c93b2347">352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNC0zLTEtMS02ODc1MQ_0679f287-1f00-4e6b-87d2-c3c32d4494c1">283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNi0xLTEtMS02ODc1MQ_56beae9d-3012-45c8-b8a5-4432de8ec1dc">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNi0zLTEtMS02ODc1MQ_f13c8b42-1ce9-4cfe-bb89-b23fe6235eb2">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfOC0xLTEtMS02ODc1MQ_5c1908f1-5895-426f-8ec1-484cc3b7cd8a">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfOC0zLTEtMS02ODc1MQ_207a7ab3-e8f3-470c-9a5b-5521660723c7">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfOS0xLTEtMS02ODc1MQ_5b013f4f-3a98-4007-b07b-02d2558dafcf">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfOS0zLTEtMS02ODc1MQ_5d7aa810-c522-4238-8b2d-7e2c33460e3d">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess and obsolete inventory related charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:InventoryWriteDown" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMTAtMS0xLTEtNjg3NTE_a00be058-6315-430f-b57a-f9923d302189">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:InventoryWriteDown" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMTAtMy0xLTEtNjg3NTE_6b5e1abd-aec2-49ea-a45f-95edb6205049">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss on equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMTItMS0xLTEtNjg3NTE_745156a0-1c12-4ba2-bc1a-d735294b4278">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMTItMy0xLTEtNjg3NTE_4f0970ed-717a-473e-a38d-11f285d50722">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMTQtMS0xLTEtNjg3NTE_d26e3f01-846d-4719-a855-f391bb7736e7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMTQtMy0xLTEtNjg3NTE_e6d6eaa2-6c2e-4822-9ea1-ca0e34046d1f">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-cash expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMTUtMS0xLTEtNjg3NTE_f37fe4bf-cb3e-461b-b732-e9d9d8fe5231">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMTUtMy0xLTEtNjg3NTE_a220889e-370f-432f-9cd5-901dd5ed9704">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMTctMS0xLTEtNjg3NTE_8b6d2650-643c-401d-9989-5394545ad91a">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMTctMy0xLTEtNjg3NTE_8ac6280a-dfcc-4b23-beaf-030fe4b9af68">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMTgtMS0xLTEtNjg3NTE_7e48ecb1-e50b-4729-9c13-404291ebb7e7">69</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMTgtMy0xLTEtNjg3NTE_04586015-8b63-42c5-bd02-7dae3168594e">54</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMTktMS0xLTEtNjg3NTE_b70b92c0-efe9-47d9-91c3-fdf443866556">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMTktMy0xLTEtNjg3NTE_1f5ffb07-707e-4974-b061-f8b7edc00164">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMjAtMS0xLTEtNjg3NTE_6908062f-ee49-4e15-9942-ebfa6973d45a">174</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMjAtMy0xLTEtNjg3NTE_128324ac-c5f9-4c64-a383-d048065ef143">210</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets and liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMjEtMS0xLTEtNjg3NTE_8d1ea933-51b3-401a-b612-19a5429dabbc">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMjEtMy0xLTEtNjg3NTE_1774593b-6cbd-4a37-9653-0e0cddd62e89">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMjItMS0xLTEtNjg3NTE_edc43c4e-0b2a-423d-9590-a78cb725e4a1">296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMjItMy0xLTEtNjg3NTE_95342381-81ce-416c-afdd-06626b254a66">255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMjUtMS0xLTEtNjg3NTE_0a7b8d52-dc19-4b23-a4a2-448f0dc47ee8">76</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMjUtMy0xLTEtNjg3NTE_4e301d21-5844-4bbf-9704-6557fca00f38">75</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment to acquire equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:PaymentsToAcquireEquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMzAtMS0xLTEtNjg3NTE_4b5559e9-cdcf-4cac-9d88-349219d50a5d">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:PaymentsToAcquireEquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMzAtMy0xLTEtNjg3NTE_45c40405-d41f-446d-afe3-8c0d2bb663ad">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment in exchange for convertible note</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:PaymentsToAcquireNotesReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMzEtMS0xLTEtNjg3NTE_61ecab0d-f780-44a5-8891-8e99bcf04138">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:PaymentsToAcquireNotesReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMzEtMy0xLTEtNjg3NTE_a33cda4f-d6cf-42ad-9766-101af8cdb297">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from convertible note</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:ProceedsFromCollectionOfNotesReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMzMtMS0xLTEtODkyNTk_ca16301b-98d6-4206-a987-6ea72489ae58">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:ProceedsFromCollectionOfNotesReceivable" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMzMtMy0xLTEtODkyNTk_4b6ad9bc-df07-4334-921d-c47a83367726">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMzMtMS0xLTEtNjg3NTE_ab5ca0b8-fac4-41fe-bf70-692b3b3fce29">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMzMtMy0xLTEtNjg3NTE_b9a6715e-1c9b-41a5-8fc6-6277570cdf6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions of businesses and intangible assets, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMzYtMS0xLTEtNjg3NTE_e2ee5ab2-8162-49c7-8e51-3e1a563bb27f">30</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMzYtMy0xLTEtNjg3NTE_b30bb8d6-cd5b-4e2c-87f3-d8687049c5c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMzctMS0xLTEtNjg3NTE_4b69f7c3-fcc3-436f-8c8c-0b89250568e7">104</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMzctMy0xLTEtNjg3NTE_bd79250e-3317-4b9a-8dc2-82d26b238a5a">79</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNDAtMS0xLTEtNjg3NTE_b3f54da6-e896-4363-b1cd-785bc85e5dc7">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNDAtMy0xLTEtNjg3NTE_1df4b6f2-1d70-4c40-8bef-33335f8f36ae">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of taxes related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNDEtMS0xLTEtNjg3NTE_643b20fa-24de-491f-9b36-d8b3cae95a1e">51</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNDEtMy0xLTEtNjg3NTE_eedc64fa-c463-472d-bafa-423b4ad57e82">63</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:PaymentsOfOrdinaryDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNDItMS0xLTEtNjg3NTE_edfb94b1-da55-491c-9100-efc49653b1fd">67</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:PaymentsOfOrdinaryDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNDItMy0xLTEtNjg3NTE_564086cc-735c-49ed-a79b-25dcaba95bde">63</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment for contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNTItMS0xLTEtOTExNzc_4e93f77c-8237-4886-bd0a-3e73a854337c">62</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNTItMy0xLTEtOTExNzc_6f26cc32-e608-4ad5-9b01-cae556c6a330">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNTEtMS0xLTEtNjg3NTE_c207effd-d804-4855-9b52-eead5aea539f">527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNTEtMy0xLTEtNjg3NTE_f97e1779-2b14-4a64-8121-5fb6523e0382">240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:RepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNTItMS0xLTEtNjg3NTE_296bac56-4129-4ee8-a5c7-8a7057da52cf">324</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:RepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNTItMy0xLTEtNjg3NTE_1316d207-6365-4170-8ed7-5ffefb1a568f">240</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock repurchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNTQtMS0xLTEtNjg3NTE_df55dc64-5ab5-4ecd-9f47-e7c51caefc7b">75</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNTQtMy0xLTEtNjg3NTE_b7c2a40a-277c-45f0-9cd3-0a300a6f6b69">447</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNTUtMS0xLTEtNjg3NTE_6332dc66-5c68-42f3-8497-e14ff7d281d4">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNTUtMy0xLTEtNjg3NTE_88048ac5-4161-4d2e-af4c-b3b54a0924ed">546</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate movements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNTctMS0xLTEtNjg3NTE_69bdc788-69a2-4950-88c3-3505868d9068">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNTctMy0xLTEtNjg3NTE_2033fbcf-5e29-46f1-9ae7-6f9290a13a20">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNTktMS0xLTEtNjg3NTE_1cc7f200-d87d-4735-bf65-49afe351cad1">197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNTktMy0xLTEtNjg3NTE_a6b4b201-1ad6-451c-beb6-795838459772">374</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNjEtMS0xLTEtNjg3NTE_78a23759-3a78-481e-b951-1c703c57ca44">1,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56485a537aba4a7691bd4bf959f3eaad_I20211031" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNjEtMy0xLTEtNjg3NTE_73f82754-d8a5-4d50-bd2a-602eb1a6ebc3">1,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNjItMS0xLTEtNjg3NTE_e31de443-86cf-4a9e-9c52-90f00813c7d5">1,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7452fced71814cff84c1f48750a63bfa_I20220131" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNjItMy0xLTEtNjg3NTE_0b69abe5-c8b1-4e25-a11c-a0d425dbbee4">1,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax paid, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNjUtMS0xLTEtNjg3NTE_fe6320e6-7312-468e-993e-712d2a30c144">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNjUtMy0xLTEtNjg3NTE_8f6cd71a-31df-4119-867c-322a01acf9be">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest payments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNjYtMS0xLTEtNjg3NTE_18e3bf14-a567-4b4c-b2d3-96377e8dca87">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNjYtMy0xLTEtNjg3NTE_02190026-4edf-428c-8165-16ceceba5d2e">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in property, plant and equipment included in accounts payable and accrued liabilities-increase (decrease)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09a604512a0e4676affadfea2edad573_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNjctMS0xLTEtNjg3NTE_864ac823-9899-4fd0-839f-99be4840dbc5">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47cbf7fc4b914e59bbe1b08345963c45_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNjctMy0xLTEtNjg3NTE_a1946410-04d0-4dc4-9d3b-24d2454f72ee">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_28"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENT OF EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except number of shares in thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.891%"><tr><td style="width:1.0%"></td><td style="width:42.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.892%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.892%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.892%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.892%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.892%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.899%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Three Months Ended January 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders' Equity</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of October 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i03309ce0ed5f4d9e91d12ef6e9a11409_I20221031" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMy0xLTEtMS02ODc1MQ_479996e5-a393-48f8-af43-d8609fec375c">295,259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03309ce0ed5f4d9e91d12ef6e9a11409_I20221031" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMy0zLTEtMS02ODc1MQ_e1a92dc2-1df5-4609-90a6-341c1132ef28">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id92438986c5e4e49b96bc1f9a2f4db1b_I20221031" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMy01LTEtMS02ODc1MQ_aeb09286-eded-4df0-aef6-30c6c4d4cf53">5,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i086d2c8106374131912a8bbf8b1f0389_I20221031" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMy03LTEtMS02ODc1MQ_fa029e94-d859-42f3-a89d-933ae15c4744">324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i606776969cda4cf3b6e3577e3c4bed44_I20221031" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMy05LTEtMS02ODc1MQ_091837cf-a5fb-454e-b8f7-bde877319c6f">347</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i159c212a281a41ca83ae4c377dbc7ac2_I20221031" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMy0xMS0xLTEtNjg3NTE_a31d0009-a859-4401-a3f6-e855c3082870">5,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Components of comprehensive income, net of tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc9a621efe2543f482d33c51bc9d5416_D20221101-20230131" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfNi03LTEtMS02ODc1MQ_08c1aaf3-4881-4920-8154-c1675ae0f2dc">352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i444f3ab3feb249a4b04e665424135f76_D20221101-20230131" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfNi0xMS0xLTEtNjg3NTE_30c825f3-a324-42d5-a45a-221e32933ce6">352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e544c079add458db2a18a80383a6e7b_D20221101-20230131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfNy05LTEtMS02ODc1MQ_63ee16a7-c98c-451b-b11d-32ebc4e92d14">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i444f3ab3feb249a4b04e665424135f76_D20221101-20230131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfNy0xMS0xLTEtNjg3NTE_30e8c152-5024-4ca1-95fb-0723284a51ef">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i444f3ab3feb249a4b04e665424135f76_D20221101-20230131" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfOC0xMS0xLTEtNjg3NTE_c123b553-a0cf-4021-8f74-4ff3a5a2cebf">419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="3" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTAtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjpkMTdkOTJhMWUzMjI0ZGNhYWFiM2I5OWJmNDEwODA0Ml8yOQ_06ab9f14-d5c8-4fc2-a5ff-6f18c84664f2">0.225</ix:nonFraction> per common share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc9a621efe2543f482d33c51bc9d5416_D20221101-20230131" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTAtNy0xLTEtNjg3NTE_f4b876bd-4444-434c-b5c1-c6228e255667">67</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i444f3ab3feb249a4b04e665424135f76_D20221101-20230131" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTAtMTEtMS0xLTY4NzUx_1db080d8-a92a-45e2-8db6-74a30393a26e">67</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based awards issued, net of tax of $<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTEtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjpiMDEwMzJkZDNhYjE0YTY2YTc5YTc2ODNjZmY1NDQ4MV80NQ_f04e7c74-5410-43b7-b810-462242eb2ebd">51</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0045b371692f47b18ee58c78620f8429_D20221101-20230131" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTEtMS0xLTEtNjg3NTE_f6e1bb4a-2de3-49ac-bdc5-3577c63b61c6">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc75cb8136f54543a29bfc1d00dfeb94_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTEtNS0xLTEtNjg3NTE_6c77fde7-55cc-4502-ac0b-6d3df3dbbaf2">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i444f3ab3feb249a4b04e665424135f76_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTEtMTEtMS0xLTY4NzUx_1eb2818e-ebb5-4bc4-9b32-d7e33c18163b">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0045b371692f47b18ee58c78620f8429_D20221101-20230131" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTItMS0xLTEtNjg3NTE_2db123af-2a66-487d-9cf7-3ab749896311">499</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc75cb8136f54543a29bfc1d00dfeb94_D20221101-20230131" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTItNS0xLTEtNjg3NTE_d82c8a95-bec7-435a-8490-58044f353b51">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc9a621efe2543f482d33c51bc9d5416_D20221101-20230131" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTItNy0xLTEtNjg3NTE_490db7a8-cb80-4d7e-831d-ae2b8e42dc1e">68</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i444f3ab3feb249a4b04e665424135f76_D20221101-20230131" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTItMTEtMS0xLTY4NzUx_d7fa5e93-f478-4a83-ae91-b23958aea5ca">75</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc75cb8136f54543a29bfc1d00dfeb94_D20221101-20230131" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTMtNS0xLTEtNjg3NTE_fb4791c0-7190-426b-97bb-28c105d356fe">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i444f3ab3feb249a4b04e665424135f76_D20221101-20230131" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTMtMTEtMS0xLTY4NzUx_147e8769-63e5-485d-89e7-6de6879392fd">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of January 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibe3a97d20a2e44a1b4614a44d8406d81_I20230131" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTQtMS0xLTEtNjg3NTE_603d69a0-de78-4e2c-b482-d0d90ef65b56">295,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe3a97d20a2e44a1b4614a44d8406d81_I20230131" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTQtMy0xLTEtNjg3NTE_d9892fd0-6848-4a44-b039-fd0637cd96d5">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e763681f4b045fa9fce2449566d8e3d_I20230131" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTQtNS0xLTEtNjg3NTE_1659cdf0-5b1c-4ef2-a53e-0f83ea6c4641">5,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17235fbc23384d9f8362cd810ffa1a21_I20230131" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTQtNy0xLTEtNjg3NTE_f7a5a708-b5cc-4c4b-8614-2c44f70037cd">541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i222c7e31873d4892afc0e691da9b4bce_I20230131" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTQtOS0xLTEtNjg3NTE_e64a59c3-b37d-4293-bb59-2fb3ef344625">280</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dd61afa70ad4f12b65e7f736904b893_I20230131" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTQtMTEtMS0xLTY4NzUx_2db58d48-6d75-43f5-99c2-7e29e6617f2b">5,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.298%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.887%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.298%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.887%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.298%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.887%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Three Months Ended January 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders' Equity</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of October 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7a4a359dc74949868e019c988906b5d0_I20211031" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfNC0xLTEtMS02ODc1MQ_71158e48-341c-418a-836e-130f11342a30">302,208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a4a359dc74949868e019c988906b5d0_I20211031" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfNC0zLTEtMS02ODc1MQ_0c97a1dd-f322-42b2-b603-26fb46d187cd">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice97c2676fc846c99090bf80caa8297f_I20211031" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfNC01LTEtMS02ODc1MQ_e6b0a05b-3ce5-4ebb-ba03-e70e3cf89432">5,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id29a4ca3e0874d32842cabb48c356b30_I20211031" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfNC03LTEtMS02ODc1MQ_4145ba17-d604-48da-9934-3f4fe97d846e">348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8325ec83b30f404fae1f872f8bcb4f30_I20211031" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfNC05LTEtMS02ODc1MQ_aa70a40d-a316-4d22-aae5-8b3d1cf4ec54">282</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie66c1641c23d4e3d9b549e52e10a56c8_I20211031" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfNC0xMS0xLTEtNjg3NTE_dbcc3efc-c492-411e-abd6-65206ba51299">5,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Components of comprehensive income, net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i871f3a85672446d38dfc792b021eed04_D20211101-20220131" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfNy03LTEtMS02ODc1MQ_3f9b4a16-5e72-4d9b-a277-84af7a7f2840">283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9a62a47fae946da9a3700c66ce2854b_D20211101-20220131" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfNy0xMS0xLTEtNjg3NTE_8cb3915e-e921-4096-8422-8240ca57e927">283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i164344fd739541659db977e6b67ac77f_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfOC05LTEtMS02ODc1MQ_e3c32b9f-499c-476d-9597-4eabaa4ae55d">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9a62a47fae946da9a3700c66ce2854b_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfOC0xMS0xLTEtNjg3NTE_2bda0a1d-8f24-437b-b73a-9ca80a356cc9">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9a62a47fae946da9a3700c66ce2854b_D20211101-20220131" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfOS0xMS0xLTEtNjg3NTE_9a48a24f-b7e2-42dd-9db2-caa90211cf2f">267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="3" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTEtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjo2Y2YxMTNhYWMxMzU0YWQ4YWZlNWQxODZjY2YwYzljOF8yOQ_fa975bd9-1428-4f4c-b6d0-073bb87c95c8">0.210</ix:nonFraction> per common share)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i871f3a85672446d38dfc792b021eed04_D20211101-20220131" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTEtNy0xLTEtNjg3NTE_4ea7f518-df5c-4449-a610-41299c9b2a7f">63</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9a62a47fae946da9a3700c66ce2854b_D20211101-20220131" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTEtMTEtMS0xLTY4NzUx_9e765d99-35ba-40cb-afae-0fb2d7825d5f">63</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based awards issued, net of tax of $<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTItMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjozNDU0YTM2YzZlZWY0YTFlOWUyNGIzNWVhYjVkZWU3MF80NQ_bab09a52-9aa4-436c-b65a-27be8c8c1fe2">63</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i10a00291ab2f4d61adf4c24df618cf71_D20211101-20220131" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTItMS0xLTEtNjg3NTE_d8a16b06-e6b7-4173-9239-536708c0399a">972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia26e13aca129490c96e3ddb74f2dddfc_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTItNS0xLTEtNjg3NTE_9d1ff831-94ec-4794-a3c8-5c28bf4ebbf8">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9a62a47fae946da9a3700c66ce2854b_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTItMTEtMS0xLTY4NzUx_6c463968-4109-4504-92c2-8b5751da765d">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i10a00291ab2f4d61adf4c24df618cf71_D20211101-20220131" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTMtMS0xLTEtNjg3NTE_15f2fd3f-af4e-4fe2-a94e-e95aeb3493e2">2,907</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia26e13aca129490c96e3ddb74f2dddfc_D20211101-20220131" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTMtNS0xLTEtNjg3NTE_a5ca5398-8a84-498d-af40-adb937927c1a">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i871f3a85672446d38dfc792b021eed04_D20211101-20220131" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTMtNy0xLTEtNjg3NTE_35181897-0e59-4a9c-960e-9a45ab72eaae">409</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9a62a47fae946da9a3700c66ce2854b_D20211101-20220131" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTMtMTEtMS0xLTY4NzUx_593e18a4-5139-4fe8-8672-206249e010fa">447</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia26e13aca129490c96e3ddb74f2dddfc_D20211101-20220131" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTQtNS0xLTEtNjg3NTE_56c6f30e-2675-4e78-a879-18949e1b2e44">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9a62a47fae946da9a3700c66ce2854b_D20211101-20220131" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTQtMTEtMS0xLTY4NzUx_0bcb9d6f-4691-4647-9656-4711fd11892d">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of January 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i353beb6720a24469809c0d404c4182ea_I20220131" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTUtMS0xLTEtNjg3NTE_8f140df5-45fa-490e-a7f4-71111613adce">300,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i353beb6720a24469809c0d404c4182ea_I20220131" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTUtMy0xLTEtNjg3NTE_8371d486-46b9-4be3-9155-4f61a3e1933c">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b33cacf7b234159b6c800d566d9d055_I20220131" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTUtNS0xLTEtNjg3NTE_9aa5488e-dc6c-44bd-aa55-530d2986f611">5,290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5eb4ff2fb6b34aa4b034790d18900784_I20220131" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTUtNy0xLTEtNjg3NTE_cc6d2f53-df13-4e00-b9f9-cb2f6e1e7193">159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibdb13e13506245be95833ade22aa694e_I20220131" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTUtOS0xLTEtNjg3NTE_8643a4f5-84cb-41df-96e6-1095131d1034">298</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8dcd748ed474187bf0b21aa9aafa830_I20220131" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTUtMTEtMS0xLTY4NzUx_3b91e11c-ac9f-4058-adb1-fbef99aa8d30">5,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_31"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div><div style="text-align:center"><span><br/></span></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_34"></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"> <ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfODMzOQ_a7ef7add-0727-43b8-ac18-e46836594551" continuedAt="i520d5c48f2ff481fa54888ff9de93186" escape="true">OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="i520d5c48f2ff481fa54888ff9de93186" continuedAt="ib527472c403247669db6d3cccd7b7eeb"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfODMxMg_9c881089-a94b-43d6-8527-c17b4a983d85" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Overview. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agilent Technologies, Inc. ("we," "Agilent" or the "company"), incorporated in Delaware in May 1999, is a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year-end is October&#160;31, and our fiscal quarters end on January&#160;31, April&#160;30 and July&#160;31. Unless otherwise stated, these dates refer to our fiscal year and fiscal quarters.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We have prepared the accompanying financial data for the three months ended January&#160;31, 2023 and 2022 pursuant to the rules&#160;and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles (&#8220;GAAP&#8221;) in the U.S. have been condensed or omitted pursuant to such rules&#160;and regulations. The October&#160;31, 2022 condensed balance sheet data was derived from audited financial statements but does not include all the disclosures required in audited financial statements by U.S. GAAP. The accompanying financial data and information should be read in conjunction with our Annual Report on Form 10-K for the fiscal year ended October&#160;31, 2022.  </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying condensed consolidated financial statements contain all normal and recurring adjustments necessary for a fair statement of our condensed consolidated balance sheet as of January&#160;31, 2023 and October&#160;31, 2022, condensed consolidated statement of comprehensive income (loss) for the three months ended January&#160;31, 2023 and 2022, condensed consolidated statement of operations for the three months ended January&#160;31, 2023 and 2022, condensed consolidated statement of cash flows for the three months ended January&#160;31, 2023 and 2022 and condensed consolidated statement of equity for the three months ended January&#160;31, 2023 and 2022.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfODM0MQ_78141f3d-7482-4a26-b80d-b8907b2b9f8c" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The preparation of condensed consolidated financial statements in accordance with GAAP in the U.S. requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Although these estimates are based on management&#8217;s best knowledge of current events and actions that may impact the company in the future, actual results may be different from the estimates. Our critical accounting policies are those that affect our financial statements materially and involve difficult, subjective or complex judgments by management. Those policies are revenue recognition, valuation of goodwill and purchased intangible assets,  inventory valuation, retirement and post-retirement benefit plan assumptions and accounting for income taxes.</span></ix:nonNumeric></div><div><span><br/></span></div><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfODMwOQ_7d94de1c-8b6c-4db3-8dd0-9a6d1cd4382c" escape="true"><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfODMwOQ_e5a9d672-54c5-4c30-a42b-8e22d87d0a98" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash and Restricted Cash Equivalents. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash and restricted cash equivalents are included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows.  A reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheet follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.863%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RhYmxlOjI5M2RhOTkxZWIxMjRiMDM5NWZkMmZmMmVlZWIwYzEwL3RhYmxlcmFuZ2U6MjkzZGE5OTFlYjEyNGIwMzk1ZmQyZmYyZWVlYjBjMTBfMy0xLTEtMS02ODc1MQ_42ce68c7-38e0-4008-bef3-7abed1b71157">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RhYmxlOjI5M2RhOTkxZWIxMjRiMDM5NWZkMmZmMmVlZWIwYzEwL3RhYmxlcmFuZ2U6MjkzZGE5OTFlYjEyNGIwMzk1ZmQyZmYyZWVlYjBjMTBfMy0zLTEtMS02ODc1MQ_02d22644-05b4-4f78-8d1e-3b762115378c">1,053</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:RestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RhYmxlOjI5M2RhOTkxZWIxMjRiMDM5NWZkMmZmMmVlZWIwYzEwL3RhYmxlcmFuZ2U6MjkzZGE5OTFlYjEyNGIwMzk1ZmQyZmYyZWVlYjBjMTBfNC0xLTEtMS02ODc1MQ_5904d265-a581-41ed-a50c-b281434d65c4">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:RestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RhYmxlOjI5M2RhOTkxZWIxMjRiMDM5NWZkMmZmMmVlZWIwYzEwL3RhYmxlcmFuZ2U6MjkzZGE5OTFlYjEyNGIwMzk1ZmQyZmYyZWVlYjBjMTBfNC0zLTEtMS02ODc1MQ_4fc2dd9e-ec09-435b-b48c-26923bd8e03f">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RhYmxlOjI5M2RhOTkxZWIxMjRiMDM5NWZkMmZmMmVlZWIwYzEwL3RhYmxlcmFuZ2U6MjkzZGE5OTFlYjEyNGIwMzk1ZmQyZmYyZWVlYjBjMTBfNS0xLTEtMS02ODc1MQ_f15e8118-6526-4e9c-a616-c8d3f1334ff5">1,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RhYmxlOjI5M2RhOTkxZWIxMjRiMDM5NWZkMmZmMmVlZWIwYzEwL3RhYmxlcmFuZ2U6MjkzZGE5OTFlYjEyNGIwMzk1ZmQyZmYyZWVlYjBjMTBfNS0zLTEtMS02ODc1MQ_313624df-febc-4db8-b5d2-a9d0eab27f24">1,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfODMzMA_56b4aefa-c1cf-49c4-81f3-1aac778ea314" continuedAt="i555ef2e4e8fe43578a4cf7d66214807a" escape="true">Leases. </ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i555ef2e4e8fe43578a4cf7d66214807a">As of January&#160;31, 2023 and October&#160;31, 2022, operating lease right-of-use assets where we are the lessee were  $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDQ4Mw_0923d8a4-45b0-4175-952d-a7c717b81666"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDQ4Mw_530d430b-2d80-4e9b-8136-eaa4f472ed48">155</ix:nonFraction>&#160;million</span> and $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDQ5MA_9b066508-1908-4248-884a-1df299c2bc14"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDQ5MA_7b07a319-7063-4dea-930d-99483d0dea7c">150</ix:nonFraction>&#160;million</span>, respectively, and were included within other assets in the accompanying condensed consolidated balance sheet. The associated operating lease liabilities were $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDY1Mg_3682f298-9ca7-4d01-a434-54ee5feb1306"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDY1Mg_a6684bb3-22fc-476c-b14f-a37002042d30">159</ix:nonFraction>&#160;million</span> and $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDY1OQ_fa7b70f1-0cec-4130-bca6-58ec8ae1e703"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDY1OQ_8d4b1411-98cc-499c-a0c1-34e76eabf794">152</ix:nonFraction>&#160;million</span> as of January&#160;31, 2023 and October&#160;31, 2022, respectively, and were included in other accrued liabilities and other long-term liabilities in the accompanying condensed consolidated balance sheet.</ix:continuation> </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:ConsolidationVariableInterestEntityPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfODMyMA_668ed0d1-96b1-41ee-ab3f-155e97969c42" continuedAt="id244ee122ce140b19dc7c1d39409fdf1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Interest Entities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We make a determination upon entering into an arrangement whether an entity in which we have made an investment is considered a Variable Interest Entity (&#8220;VIE&#8221;). We evaluate our investments in privately held companies on an ongoing basis. We have determined that as of January&#160;31, 2023 and October&#160;31, 2022, there were no VIEs required to be consolidated in our consolidated financial statements because we do not have a controlling financial interest in </span></ix:nonNumeric></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ib527472c403247669db6d3cccd7b7eeb"><ix:continuation id="id244ee122ce140b19dc7c1d39409fdf1"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any of the VIEs in which we have invested nor are we the primary beneficiary. We account for these investments under either the equity method or as equity investments without readily determinable fair value ("RDFV"), depending on the circumstances. We periodically reassess whether we are the primary beneficiary of a VIE. The reassessment process considers whether we have acquired the power to direct the most significant activities of the VIE through changes in governing documents or other circumstances. We also reconsider whether entities previously determined not to be VIEs have become VIEs and vice-versa, based on changes in facts and circumstances including changes in contractual arrangements and capital structure.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January&#160;31, 2023 and October&#160;31, 2022, the total carrying value of investments and loans in privately held companies considered as VIEs was $<ix:nonFraction unitRef="usd" contextRef="ida8131692d1643f8a5dc1d105f4fcc7f_I20230131" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNjEzNA_4ca8669a-8f2a-47b6-9159-47aca950bf57">71</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0bf212d52a5c43fc80953fcd23626126_I20221031" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNjE0MQ_79c882d2-6bdc-4612-b0a9-3731367c7ea3">87</ix:nonFraction> million respectively. The maximum exposure is equal to the carrying value because we do not have future funding commitments. The investments are included on the long-term investments line and the loans on the other current assets and other assets lines (depending upon tenure of loan) on the condensed consolidated balance sheet.</span></div></ix:continuation><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfODMyMQ_f660f1e7-7153-4568-9b49-9fca92199806" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value of Financial Instruments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The carrying values of certain of our financial instruments including cash and cash equivalents, accounts receivable, accounts payable, accrued compensation and other accrued liabilities approximate fair value because of their short maturities. The fair value of long-term equity investments which are readily determinable, and which are not accounted under the equity method are reported at fair value using quoted market prices for those securities when available with gains and losses included in net income. The fair value of long-term equity investments which are not readily determinable, and which are not accounted under the equity method are reported at cost with adjustments for observable changes in prices or impairments included in net income. As of January&#160;31, 2023 and October&#160;31, 2022, the fair value of the term loans approximates its carrying value.  As of January&#160;31, 2023, the fair value of our senior notes was $<ix:nonFraction unitRef="usd" contextRef="i3680858c584e48c0ab29a7b1c6e0b029_I20230131" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNzM4NQ_e1dc6f21-cd0a-4584-8ea6-c759ccd415b3">1,859</ix:nonFraction>&#160;million with a carrying value of $<ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNTQ5NzU1ODIzNTcz_796b0f5b-b5a1-43c7-bcdb-23d7f96fed99">2,133</ix:nonFraction> million. This compares to the fair value of our senior notes of $<ix:nonFraction unitRef="usd" contextRef="i67000e3aa16f48a6b186edcc2d77662d_I20221031" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNzQ4MQ_7766f0b1-c239-4d3d-aba1-f7180b759bd3">1,754</ix:nonFraction>&#160;million with a carrying value of $<ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNzUwOQ_d7b0a961-ea9f-4ad1-8e94-9362ddf93ae0">2,133</ix:nonFraction> million as of October&#160;31, 2022. The change in the fair value compared to carrying value in the three months ended January&#160;31, 2023 is primarily due to decreased market interest rates. The fair value was calculated from quoted prices which are primarily Level 1 inputs under the accounting guidance. The fair value of foreign currency contracts used for hedging purposes is estimated internally by using inputs tied to active markets. These inputs, for example, interest rate yield curves, foreign exchange rates, and forward and spot prices for currencies are observable in the market or&#160;can be corroborated by observable market data for substantially the full term of the assets or liabilities. See also Note&#160;9, "Fair Value Measurements" for additional information on the fair value of financial instruments and contingent consideration.</span></ix:nonNumeric></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_37"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;2.   <ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNy9mcmFnOmY1Njg5OTcxODQ3NDRiZjVhZWEyMTUxZDRiMDI1YjFjL3RleHRyZWdpb246ZjU2ODk5NzE4NDc0NGJmNWFlYTIxNTFkNGIwMjViMWNfMTcwOQ_c673c1e3-f5f9-4b3e-b27c-946a4b746145" continuedAt="i12942deb2d274e79a1e4789a2354a9c3" escape="true">NEW ACCOUNTING PRONOUNCEMENTS</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i12942deb2d274e79a1e4789a2354a9c3"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In November 2021, the FASB issued updates to increase the transparency in the annual disclosure requirements relating to government assistance received by business entities in Topic 832, Government Assistance. The guidance requires certain disclosures about transactions with a government that are accounted for by applying a grant or contribution model. On November 1, 2022, we adopted this guidance which did not have a material impact on our condensed consolidated financial statements and disclosures. </span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no additions to the new accounting pronouncements not yet adopted as described in our Annual Report on Form 10-K for the fiscal year ended October&#160;31, 2022.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other amendments to GAAP in the U.S. that have been issued by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on our condensed consolidated financial statements upon adoption.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_40"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.   <ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RleHRyZWdpb246NWY0NzVmZjhlODdiNGMzNDgyNWYyYmMyMzY0MWRlYjRfMzc2NQ_2c5224ed-6b9a-43e2-b255-66778ca11c48" continuedAt="i9402cb70415d4383b7917e88e9c49398" escape="true">REVENUE </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i9402cb70415d4383b7917e88e9c49398" continuedAt="i8cf5922e54fd43c3b823241a4e8a7658"><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RleHRyZWdpb246NWY0NzVmZjhlODdiNGMzNDgyNWYyYmMyMzY0MWRlYjRfMzc2Nw_43c94cf6-16d4-419c-8a4d-22e0cb323a6d" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the company&#8217;s total revenue and segment revenue disaggregated by geographical region: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.953%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.953%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended January 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Sciences and Applied Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agilent CrossLab<br/></span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diagnostics and Genomics<br/></span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Sciences and Applied Markets</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agilent CrossLab<br/></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diagnostics and Genomics<br/></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Revenue by Region</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33f78913651a47bb92a2c9900a5966db_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfNi0xLTEtMS02ODc1MQ_00d5d249-b988-4b0e-b358-f009eb4d12ca">332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2befebaadc5845d4b2d401527b04cfaa_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfNi0zLTEtMS02ODc1MQ_acdec1e2-b666-4b2a-855a-444d9f5b73be">154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7d677f290d463982d78a58cc084bf7_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfNi01LTEtMS02ODc1MQ_e378a825-eac9-4260-b257-fc96bb3fa982">201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ebb4d48c62249409808fe3659039d91_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfNi03LTEtMS02ODc1MQ_6d41eb21-ddb6-44a5-841c-370e04284bd0">687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7f2de7d06eb471e9bfd5e643f5764f0_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfNi05LTEtMS02ODc1MQ_c857853e-708f-4488-b97d-4ee94234fe8f">317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d893a60dca04278bdac0cdc1e4d7989_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfNi0xMS0xLTEtNjg3NTE_a561723a-b649-4d92-8f1e-d73004a1bc0a">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a7f1e005ab74d76ae872de230a40733_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfNi0xMy0xLTEtNjg3NTE_55a11f01-c35b-4802-9b18-fc85609a2dce">188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb3d192ff70c43558d2066769b7f1110_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfNi0xNS0xLTEtNjg3NTE_d5841d52-bd2c-4e31-9b0e-79593dc680ca">637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9fc291277d49d591b89a8b399ecfc2_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfNy0xLTEtMS02ODc1MQ_0c97850c-e949-4f25-8b19-f7e00f85a9e4">259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3e33e9f0d48d49e7efcf7b7ef2aca_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfNy0zLTEtMS02ODc1MQ_0358be2c-11d6-4e8f-bff9-37e156d6f3a5">98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if298d324aaf84d769b2e82d2d4124e2c_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfNy01LTEtMS02ODc1MQ_5ece248e-3b37-4f96-b3bd-03fbeffd7e78">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i046a05a9e0514062bf9a677859974cf0_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfNy03LTEtMS02ODc1MQ_c32c74e2-6ce9-4085-9570-b37e3aec8472">456</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01fc9bcc3b254bf39b375532b23a0c12_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfNy05LTEtMS02ODc1MQ_d31cc401-f3eb-4a31-8617-10913928e693">252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d0d7a31803341648e3a045e2165534e_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfNy0xMS0xLTEtNjg3NTE_f8b333f5-3441-4aa9-bee2-b35392757585">98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ec12050ee6648a19d1b871251909434_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfNy0xMy0xLTEtNjg3NTE_0cf534bb-3d0a-443d-9c3b-cc86ee1946b1">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69383333245348d09b86b40f341453b8_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfNy0xNS0xLTEtNjg3NTE_b28d60e9-5317-4526-b0c5-910c0a53851e">451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefc8abdb47254b4cb32b27b0c6fea825_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfOC0xLTEtMS02ODc1MQ_46b75504-078c-4fc0-ba36-1756d77ddc20">442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6d69f7e74f34f0195f00e307ab8c80e_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfOC0zLTEtMS02ODc1MQ_0e47b7f2-2a3b-42e7-a67b-5327c3d304b7">129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87246a3249384b37a1500f923b627ee8_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfOC01LTEtMS02ODc1MQ_f59c168c-7eae-4aa4-91c7-437d51178783">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73b7b9de08cd4437b818bb9e0f9b4ee8_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfOC03LTEtMS02ODc1MQ_044052cd-9296-45ca-995c-2bccdf04dd3d">613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i352bfe2a93f947e1bcd491c49559ee2d_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfOC05LTEtMS02ODc1MQ_0caf27a0-b9d7-4166-88f2-6af91cf9f6c9">407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eeadafeeecb428dbb6170dd77089aaf_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfOC0xMS0xLTEtNjg3NTE_c39ea66e-751d-4629-81af-a88326f92ac4">129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b2543146dc41dd86c44c7ecf447270_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfOC0xMy0xLTEtNjg3NTE_cb37ef5b-c297-473e-9047-8f576cca5c2a">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i433f969b78854ee3a4db35ffe5965afe_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfOC0xNS0xLTEtNjg3NTE_8be25fe6-a205-4504-a675-991b1a66be9b">586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90bc58b4dc464d058d4f7d56e61e2e21_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfOS0xLTEtMS02ODc1MQ_aa57af29-c4d7-43b5-a412-0dcc37dff10f">1,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d83c1345e874e8fabdab7fd0ec051b6_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfOS0zLTEtMS02ODc1MQ_bbd883a8-c3b2-4fec-a71b-07fc0baaef7a">381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i405a137dbfd148ab9797e53157dcb87b_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfOS01LTEtMS02ODc1MQ_4195ef91-eac1-49ef-9cc6-e955c95dfd13">342</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfOS03LTEtMS02ODc1MQ_2fbe4881-536e-4243-b20c-12d656481ad7">1,756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfc4fdb619ed43958b648563fb2ca526_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfOS05LTEtMS02ODc1MQ_99b8f271-578e-49cc-965d-40b72d4d9cc9">976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23ae7b4eb6644b20adf956a785dc7849_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfOS0xMS0xLTEtNjg3NTE_0e7dff88-06f5-4f3d-9b94-5d4bd1fa4c43">359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if846265414d142bd8d679b7776dae8eb_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfOS0xMy0xLTEtNjg3NTE_27c53acf-3332-4f9c-88de-dfa91fb1ae70">339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfOS0xNS0xLTEtNjg3NTE_e7b31a4b-ca3a-4cc5-85e1-a94a8267c2b8">1,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the company&#8217;s total revenue disaggregated by end markets and by revenue type:</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.169%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.183%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Revenue by End Markets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical and Biopharmaceutical</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a91b9cb9e834ebdae96fd116f3b54bb_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfNS01LTEtMS02ODc1MQ_2eba7f9e-1877-4c74-af56-83e9f6ec9409">639</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3806cb502c9f457482e587434ee21a3a_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfNS03LTEtMS02ODc1MQ_401eb23c-3c49-4229-84a6-7cf48d1e3ad1">602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chemicals and Advanced Materials</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief1e084458524e819f6e6ec4ad38798d_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfNi01LTEtMS02ODc1MQ_80164378-ea60-4b94-a435-b39f0cde886d">406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1c59e046fef4e9a882ae2d9736f805c_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfNi03LTEtMS02ODc1MQ_7a178855-9e37-45cb-9610-fe66582e849f">373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics and Clinical</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a907fa8237046bc9803dec7949c9487_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfNy01LTEtMS02ODc1MQ_b3588b0b-ddfa-4500-ad27-dc03a7da8973">239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifac394aa55dd4cd78340931392cbac84_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfNy03LTEtMS02ODc1MQ_f12bc4c2-fc89-4e57-8eae-d628668b1911">243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Food</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i918e15743a054525a9ccefdb3ad5a96e_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfOC01LTEtMS02ODc1MQ_4459edce-5582-470a-9b1d-9cb189e89644">160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c28467676b4ec4bb9ab059f9e3ace4_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfOC03LTEtMS02ODc1MQ_e19a638b-dbb8-4781-bc08-ffd699ad4040">158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Academia and Government</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3149e70ed5cc4cf09a5de74e7be57b1c_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfOS01LTEtMS02ODc1MQ_b3f62eec-d47f-4eed-861e-2eab7b9ad3d6">146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i791084f532a9497884a77723bd002cab_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfOS03LTEtMS02ODc1MQ_8cad11de-c3c7-49c2-87c1-752e745d6234">141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Environmental and Forensics</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e0adf97a40a40168240f072cee0a25e_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfMTAtNS0xLTEtNjg3NTE_ba6817ad-a0cd-474e-88c3-d7af60e1b3a9">166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4cf935018ca4152b0524665cd240808_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfMTAtNy0xLTEtNjg3NTE_b7bf066b-2d7e-4482-a300-299647e9e8eb">157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfMTEtNS0xLTEtNjg3NTE_329595dd-f3dd-47b7-8439-95cc79fb3054">1,756</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfMTEtNy0xLTEtNjg3NTE_7771792f-4b04-424e-98a9-a15fdcd08c67">1,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Revenue by Type</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instrumentation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4192156e4404414ad46fd4d9c955d45_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfMTQtNS0xLTEtNjg3NTE_78d41f71-756e-4362-8080-ece25099834b">759</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad9f52901e11433ca11e2fd403c4973f_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfMTQtNy0xLTEtNjg3NTE_4632c07b-c123-4b64-a287-12364a3c8b7c">691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-instrumentation and other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912f785ffd524583ab9332e174a0fd40_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfMTUtNS0xLTEtNjg3NTE_75c3af77-bdf9-4b59-a7fa-701cd7718486">997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7ae14d8d8fd4f5bab3bf7785fc6ec16_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfMTUtNy0xLTEtNjg3NTE_adfc06e1-2378-4d7b-bf15-22c0f93d434d">983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfMTYtNS0xLTEtNjg3NTE_4f2a84c3-7239-47ed-9ff6-f5af502d3d2a">1,756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfMTYtNy0xLTEtNjg3NTE_7347f346-e8c9-4cff-aae8-bbea834e763b">1,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue by region is based on the ship to location of the customer. Revenue by end market is determined by the market indicator of the customer and by customer type. Instrumentation revenue includes sales from instruments, remarketed instruments and third-party products. Non-instrumentation and other revenue include sales from contract and per incident services, our companion diagnostics and our nucleic acid solutions businesses as well as sales from spare parts, consumables, reagents, vacuum pumps, subscriptions, software licenses and associated services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Balances</span></div><div><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract assets (unbilled accounts receivable) primarily relate to the company's right to consideration for work completed but not billed at the reporting date. The unbilled receivables are reclassified to trade receivables when billed to customers. Contract assets are generally classified as current assets and are included in "Accounts receivable, net" in the condensed consolidated balance sheet. The balances of contract assets as of January&#160;31, 2023 and October&#160;31, 2022 were $<ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RleHRyZWdpb246NWY0NzVmZjhlODdiNGMzNDgyNWYyYmMyMzY0MWRlYjRfMTMwNQ_019aa969-be6e-4b84-875e-b9ef533ca340">276</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RleHRyZWdpb246NWY0NzVmZjhlODdiNGMzNDgyNWYyYmMyMzY0MWRlYjRfMTMxMg_8e2ebb49-eb5b-451e-9ef8-e84f5fd4a264">275</ix:nonFraction> million, respectively. </span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i8cf5922e54fd43c3b823241a4e8a7658" continuedAt="i614eb91cf6834ddda6e5f344312278cc"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Liabilities</span></div><div style="text-indent:27pt"><span><br/></span></div><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RleHRyZWdpb246NWY0NzVmZjhlODdiNGMzNDgyNWYyYmMyMzY0MWRlYjRfMzc2NA_e98ccd39-e769-4510-aa07-58b7c2708e25" escape="true"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about contract liabilities (deferred revenue) and the significant changes in the balances during the three months ended January&#160;31, 2023: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:78.078%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contract <br/>Liabilities</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance as of October 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjU0ZDMzYzk3ZjFkODQ3M2NiNjJlNzYxZmNkMDlhYzk5L3RhYmxlcmFuZ2U6NTRkMzNjOTdmMWQ4NDczY2I2MmU3NjFmY2QwOWFjOTlfMy0yLTEtMS02ODc1MQ_4e17eaac-9761-4a08-b6d4-fb7fbc199197">557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue deferred in the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjU0ZDMzYzk3ZjFkODQ3M2NiNjJlNzYxZmNkMDlhYzk5L3RhYmxlcmFuZ2U6NTRkMzNjOTdmMWQ4NDczY2I2MmU3NjFmY2QwOWFjOTlfNC0yLTEtMS02ODc1MQ_5d493449-a3ed-4f85-80bd-d6d131f52e57">246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized that was included in the contract liability balance at the beginning of the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjU0ZDMzYzk3ZjFkODQ3M2NiNjJlNzYxZmNkMDlhYzk5L3RhYmxlcmFuZ2U6NTRkMzNjOTdmMWQ4NDczY2I2MmU3NjFmY2QwOWFjOTlfNS0yLTEtMS02ODc1MQ_c54a0a50-2187-444f-9430-9222fd39512b">196</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in deferrals from customer cash advances, net of revenue recognized</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjU0ZDMzYzk3ZjFkODQ3M2NiNjJlNzYxZmNkMDlhYzk5L3RhYmxlcmFuZ2U6NTRkMzNjOTdmMWQ4NDczY2I2MmU3NjFmY2QwOWFjOTlfNi0yLTEtMS02ODc1MQ_ed95b411-1062-40f9-92b0-1ebae2d8df7b">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation and other adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjU0ZDMzYzk3ZjFkODQ3M2NiNjJlNzYxZmNkMDlhYzk5L3RhYmxlcmFuZ2U6NTRkMzNjOTdmMWQ4NDczY2I2MmU3NjFmY2QwOWFjOTlfOC0yLTEtMS02ODc1MQ_874f901a-2215-44ce-8e12-92156440796a">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance as of January 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjU0ZDMzYzk3ZjFkODQ3M2NiNjJlNzYxZmNkMDlhYzk5L3RhYmxlcmFuZ2U6NTRkMzNjOTdmMWQ4NDczY2I2MmU3NjFmY2QwOWFjOTlfOS0yLTEtMS02ODc1MQ_ff618d6f-1d70-42a4-afc6-c962ae7db4ca">623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended January&#160;31, 2022 revenue recognized that was included in the contract liability balance at October&#160;31, 2021 was $<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RleHRyZWdpb246NWY0NzVmZjhlODdiNGMzNDgyNWYyYmMyMzY0MWRlYjRfMTYzMQ_30efee7e-f2fe-49b9-b56d-d554d7d6cb13">191</ix:nonFraction> million.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily relate to multiple element arrangements for which billing has occurred but transfer of control of all elements to the customer has either partially or not occurred at the balance sheet date. This includes cash received from customers for products and related installation and services in advance of the transfer of control. Contract liabilities are classified as either current in deferred revenue or long-term in other long-term liabilities in the condensed consolidated balance sheet based on the timing of when we expect to complete our performance obligation.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Costs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incremental costs of obtaining a contract with a customer are recognized as an asset if we expect the benefit of those costs to be longer than one year. We have determined that certain sales incentive programs meet the requirements to be capitalized. The change in total capitalized costs to obtain a contract was immaterial during the three months ended January&#160;31, 2023 and was included in other current and long-term assets on the condensed consolidated balance sheet. We have applied the practical expedient to expense costs as incurred for costs to obtain a contract with a customer when the amortization period would have been one year or less. These costs include the company's internal sales force compensation program, as we have determined that annual compensation is commensurate with annual sales activities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transaction Price Allocated to the Remaining Performance Obligations   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have applied the practical expedient in ASC 606-10-50-14 and have not disclosed information about transaction price allocated to remaining performance obligations that have original expected durations of one year or less.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i614eb91cf6834ddda6e5f344312278cc">The estimated revenue expected to be recognized for remaining performance obligations that have an original term of more than one year, as of January&#160;31, 2023, was $<ix:nonFraction unitRef="usd" contextRef="i760e2fe91a2a4c6185fc11aef9ce399f_I20230131" decimals="-6" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RleHRyZWdpb246NWY0NzVmZjhlODdiNGMzNDgyNWYyYmMyMzY0MWRlYjRfMzUwMw_6661da46-19a3-439e-b7ab-4ff2a5533c6a">378</ix:nonFraction> million, the majority of which is expected to be recognized over the next <ix:nonNumeric contextRef="i760e2fe91a2a4c6185fc11aef9ce399f_I20230131" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RleHRyZWdpb246NWY0NzVmZjhlODdiNGMzNDgyNWYyYmMyMzY0MWRlYjRfMzU3Mg_9a0d29d1-a162-4ed3-b849-ef8ded502b19">12</ix:nonNumeric> months. Remaining performance obligations primarily include extended warranty, customer manufacturing contracts, software maintenance contracts and revenue associated with lease arrangements.</ix:continuation>  </span></div><div><span><br/></span></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_43"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.  &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfNDg1OA_acea732b-29de-4136-bc8f-de5467f77c35" continuedAt="i2caa83c769464d878924c1b3927b1da2" escape="true">SHARE-BASED COMPENSATION</ix:nonNumeric></span></div><ix:continuation id="i2caa83c769464d878924c1b3927b1da2" continuedAt="i386a2cdb2e614602af9cd6b672801092"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for share-based awards in accordance with the provisions of the authoritative accounting guidance which requires the measurement and recognition of compensation expense for all share-based payment awards made to our employees and directors including employee stock options, restricted stock units, employee stock purchases made under our employee stock purchase plan and performance share awards granted to selected members of our senior management under the long-term performance plan (&#8220;LTPP&#8221;) based on estimated fair values. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have two LTPP performance stock award programs, which are administered under the 2018 Stock Plan, for our executive officers and other key employees. Participants in our LTPP Total Stockholders&#8217; Return (&#8220;TSR&#8221;) and LTPP Earnings Per Share (&#8220;EPS&#8221;) programs are entitled to receive shares of the company's stock after the end of a three-year period, if specified performance targets for the programs are met. The LTPP-TSR awards are generally designed to meet the criteria of a </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i386a2cdb2e614602af9cd6b672801092" continuedAt="i1717992e2ca44a5b8494ce5a7e178c6c"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">performance award with the performance metrics and peer group comparison based on the TSR set at the beginning of the performance period. The LTPP-EPS awards are based on the company&#8217;s EPS performance over a three-year period. The performance targets for the LTPP-EPS for year 2 and year 3 of the performance period are set in the first quarter of year 2 and year 3, respectively. All LTPP awards are subject to a one-year post-vest holding period.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final LTPP award may vary from <ix:nonFraction unitRef="number" contextRef="iaa92731b48d9431b9c71e61f579b2e2d_D20211101-20220131" decimals="3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMTU0MA_155031f8-3263-4f91-9ee1-059b7baa8823"><ix:nonFraction unitRef="number" contextRef="iaa92731b48d9431b9c71e61f579b2e2d_D20211101-20220131" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMTU0MA_1c67ecd0-dc2a-4bcf-b4b0-051485ea3164"><ix:nonFraction unitRef="number" contextRef="i48899fe9fcfe40b0a73c87a1ed2a0395_D20221101-20230131" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMTU0MA_53848418-47ce-4d2d-9b0f-39164d53cf48"><ix:nonFraction unitRef="number" contextRef="i48899fe9fcfe40b0a73c87a1ed2a0395_D20221101-20230131" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMTU0MA_cc2dbcb0-0e44-46a9-978e-98dec3be4c07">0</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> percent to <ix:nonFraction unitRef="number" contextRef="ie790d592078944d5b3d633d03546cc1d_D20221101-20230131" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMTU0Ng_28f7ddf9-cc91-48ee-826d-7fee505a2e7c"><ix:nonFraction unitRef="number" contextRef="ie790d592078944d5b3d633d03546cc1d_D20221101-20230131" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMTU0Ng_3c26083c-3f3e-4744-9d8c-d72092964f00"><ix:nonFraction unitRef="number" contextRef="i2bafa1d058fc442f80a7b778bd3869ed_D20211101-20220131" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMTU0Ng_703e7d62-c485-4ff4-896a-04b97c4980e3"><ix:nonFraction unitRef="number" contextRef="i2bafa1d058fc442f80a7b778bd3869ed_D20211101-20220131" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMTU0Ng_a2ea2a61-d41d-4ae6-bd55-a42657e20eaf">200</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> percent of the target award. We consider the dilutive impact of these programs in our diluted net income per share calculation only to the extent that the performance conditions are expected to be met. Restricted stock units generally vest, with some exceptions, at a rate of <ix:nonFraction unitRef="number" contextRef="i2339426bfd7e4abe87998a6a1ba2cd4a_D20211101-20220131" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMTgxNw_31744297-7efb-4e1b-bde1-6f1958be4163"><ix:nonFraction unitRef="number" contextRef="i2339426bfd7e4abe87998a6a1ba2cd4a_D20211101-20220131" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMTgxNw_a5837d0d-8fd4-4bc6-a692-bd2fca189f76"><ix:nonFraction unitRef="number" contextRef="if327b7d783dc44e792963c335ca5a65b_D20221101-20230131" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMTgxNw_ba046ce4-ba7a-4c89-afbf-31fc5253ab34"><ix:nonFraction unitRef="number" contextRef="if327b7d783dc44e792963c335ca5a65b_D20221101-20230131" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMTgxNw_d8c41463-17db-4cac-941a-91f666111acc">25</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> percent per year over a period of <ix:nonNumeric contextRef="i2339426bfd7e4abe87998a6a1ba2cd4a_D20211101-20220131" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMTg0Ng_6a3a3508-e679-401a-b890-18c041c9fd31"><ix:nonNumeric contextRef="i2339426bfd7e4abe87998a6a1ba2cd4a_D20211101-20220131" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMTg0Ng_a29a5664-cc74-4a1c-bb6d-b5a36cee946a"><ix:nonNumeric contextRef="if327b7d783dc44e792963c335ca5a65b_D20221101-20230131" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMTg0Ng_a3d82439-c038-4ac5-bbfe-eee9b3013b35"><ix:nonNumeric contextRef="if327b7d783dc44e792963c335ca5a65b_D20221101-20230131" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMTg0Ng_d846a980-2ad2-4e2c-9cd1-1271cf817404">four years</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric> from the date of grant.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal year 2021, we resumed granting stock options. Stock options granted under the 2018 Stock Plan may be either "incentive stock options", as defined in Section 422 of the Internal Revenue Code, or non-statutory. Options generally vest at a rate of <ix:nonFraction unitRef="number" contextRef="i39c3cd014db248d291455e64255569d7_D20221101-20230131" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjEyOQ_6380e208-63c3-44dc-ac42-8b5f35c9abe7"><ix:nonFraction unitRef="number" contextRef="i39c3cd014db248d291455e64255569d7_D20221101-20230131" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjEyOQ_91256123-4e1f-4a35-b34d-eaf09e7d94d9"><ix:nonFraction unitRef="number" contextRef="i6eca4fc7ce75413ab4ea045884e10a1e_D20211101-20220131" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjEyOQ_b7efe269-9353-485c-973d-2ba72214c1e4"><ix:nonFraction unitRef="number" contextRef="i6eca4fc7ce75413ab4ea045884e10a1e_D20211101-20220131" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjEyOQ_e2f5b106-2171-48d9-84b3-30a1ad60d135">25</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> percent per year over a period of <ix:nonNumeric contextRef="i6eca4fc7ce75413ab4ea045884e10a1e_D20211101-20220131" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjE1OA_405362ea-3481-40a3-b9d8-0c4a80f273dd"><ix:nonNumeric contextRef="i6eca4fc7ce75413ab4ea045884e10a1e_D20211101-20220131" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjE1OA_4db32ca8-fc3e-473b-948b-ff3402040103"><ix:nonNumeric contextRef="i39c3cd014db248d291455e64255569d7_D20221101-20230131" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjE1OA_cabb3b46-7ce2-4969-84b6-e9600e119a6d"><ix:nonNumeric contextRef="i39c3cd014db248d291455e64255569d7_D20221101-20230131" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjE1OA_d92afdcd-3d8e-445c-946a-1db528d6e746">four years</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric> from the date of grant with a maximum contractual term of <ix:nonNumeric contextRef="i6eca4fc7ce75413ab4ea045884e10a1e_D20211101-20220131" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjIxOQ_2bd27c45-ff72-42f0-96eb-9c84a08a4967"><ix:nonNumeric contextRef="i39c3cd014db248d291455e64255569d7_D20221101-20230131" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjIxOQ_60f2074f-7b49-45bd-aa80-80bf47fee770"><ix:nonNumeric contextRef="i39c3cd014db248d291455e64255569d7_D20221101-20230131" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjIxOQ_a2d420df-fc7b-4997-a6bd-9428259a4704"><ix:nonNumeric contextRef="i6eca4fc7ce75413ab4ea045884e10a1e_D20211101-20220131" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjIxOQ_e8eeba1d-2136-4b26-ac32-c3d6e4d100d7">ten years</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric>. The exercise price for stock options is generally not less than <ix:nonFraction unitRef="number" contextRef="i39c3cd014db248d291455e64255569d7_D20221101-20230131" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjI4Nw_00f5546e-e2bd-45f4-9180-c20d8b053b44"><ix:nonFraction unitRef="number" contextRef="i39c3cd014db248d291455e64255569d7_D20221101-20230131" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjI4Nw_6339c774-d70e-4f83-9486-064713696c9b"><ix:nonFraction unitRef="number" contextRef="i6eca4fc7ce75413ab4ea045884e10a1e_D20211101-20220131" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjI4Nw_c4416827-55fc-4500-808c-223e1dec7e2e"><ix:nonFraction unitRef="number" contextRef="i6eca4fc7ce75413ab4ea045884e10a1e_D20211101-20220131" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjI4Nw_d5e116fc-87df-420d-96ef-32faf198065d">100</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> percent of the fair market value of our common stock on the date the stock award is granted. We issue new shares of common stock when employee stock options are exercised. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfNDg3Ng_450bfc06-5e97-42fc-9165-cbf7fd427a9b" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact on our results for share-based compensation was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products and services</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43fcff5de6e1452bbd0a529d852367d6_D20221101-20230131" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmU2NTYyOWI1YjY4ZTQyZTE4Njc5YjQ0MDEzZTY1ODJmL3RhYmxlcmFuZ2U6ZTY1NjI5YjViNjhlNDJlMTg2NzliNDQwMTNlNjU4MmZfNC01LTEtMS02ODc1MQ_bec47b0c-fab7-482a-80bc-32001b25da1e">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94553cf9a1f84b418346d9811212fd96_D20211101-20220131" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmU2NTYyOWI1YjY4ZTQyZTE4Njc5YjQ0MDEzZTY1ODJmL3RhYmxlcmFuZ2U6ZTY1NjI5YjViNjhlNDJlMTg2NzliNDQwMTNlNjU4MmZfNC03LTEtMS02ODc1MQ_e96aacab-adb6-424f-b7ac-23888682cd4a">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i959ba1e365cb46fa9d6a0d02c602c418_D20221101-20230131" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmU2NTYyOWI1YjY4ZTQyZTE4Njc5YjQ0MDEzZTY1ODJmL3RhYmxlcmFuZ2U6ZTY1NjI5YjViNjhlNDJlMTg2NzliNDQwMTNlNjU4MmZfNS01LTEtMS02ODc1MQ_da9d08c5-717b-42cf-8b63-8f25d80ba9ce">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86cd4d87f14b4de7b2d3da170bbf7106_D20211101-20220131" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmU2NTYyOWI1YjY4ZTQyZTE4Njc5YjQ0MDEzZTY1ODJmL3RhYmxlcmFuZ2U6ZTY1NjI5YjViNjhlNDJlMTg2NzliNDQwMTNlNjU4MmZfNS03LTEtMS02ODc1MQ_fb619b46-17f5-404a-922f-a7cce7d1df9c">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8c2f25497504473b732d53cf9c153d0_D20221101-20230131" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmU2NTYyOWI1YjY4ZTQyZTE4Njc5YjQ0MDEzZTY1ODJmL3RhYmxlcmFuZ2U6ZTY1NjI5YjViNjhlNDJlMTg2NzliNDQwMTNlNjU4MmZfNi01LTEtMS02ODc1MQ_671a4ada-7724-4a31-8f1e-355b0ab18610">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i290a2031fda542169028caab109d3e44_D20211101-20220131" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmU2NTYyOWI1YjY4ZTQyZTE4Njc5YjQ0MDEzZTY1ODJmL3RhYmxlcmFuZ2U6ZTY1NjI5YjViNjhlNDJlMTg2NzliNDQwMTNlNjU4MmZfNi03LTEtMS02ODc1MQ_66747176-8544-49e1-b533-93e09e42a45c">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmU2NTYyOWI1YjY4ZTQyZTE4Njc5YjQ0MDEzZTY1ODJmL3RhYmxlcmFuZ2U6ZTY1NjI5YjViNjhlNDJlMTg2NzliNDQwMTNlNjU4MmZfNy01LTEtMS02ODc1MQ_ac179141-b35e-4fba-bc61-824063e88676">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmU2NTYyOWI1YjY4ZTQyZTE4Njc5YjQ0MDEzZTY1ODJmL3RhYmxlcmFuZ2U6ZTY1NjI5YjViNjhlNDJlMTg2NzliNDQwMTNlNjU4MmZfNy03LTEtMS02ODc1MQ_7915f8f1-e907-4a22-a061-0b4463f88a44">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At January&#160;31, 2023 and October&#160;31, 2022, <ix:nonFraction unitRef="usd" contextRef="i7776701abc9e4dfd9513b31afb36fc5d_D20221101-20230131" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjU0OA_b8d9eb4b-021a-43b2-aed5-fe9ff8f02be1"><ix:nonFraction unitRef="usd" contextRef="i20cb6e7201dd4408b86351630d0bad5a_D20211101-20221031" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjU0OA_e9fd2a0e-1df6-4f0d-b2db-9fe81f9e4681">no</ix:nonFraction></ix:nonFraction> share-based compensation was capitalized within inventory. </span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                                               </span></div><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfNDg4NQ_699cfb03-d6f1-426f-b21c-3a359e34b631" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following assumptions were used to estimate the fair value of awards granted.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.654%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.159%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Option Plans:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average risk-free interest rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i39c3cd014db248d291455e64255569d7_D20221101-20230131" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfNC01LTEtMS02ODc1MQ_e02541a5-e2fd-4298-b556-4d8380f74d9f">3.9</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6eca4fc7ce75413ab4ea045884e10a1e_D20211101-20220131" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfNC03LTEtMS02ODc1MQ_de686f3b-d17f-4595-986b-4b33046ba30c">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i39c3cd014db248d291455e64255569d7_D20221101-20230131" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfNS01LTEtMS02ODc1MQ_ed07dfcc-7208-430b-9abe-309bb83e3494">0.6</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6eca4fc7ce75413ab4ea045884e10a1e_D20211101-20220131" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfNS03LTEtMS02ODc1MQ_522c6180-d283-4e03-b726-e303e67ca851">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average volatility</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i39c3cd014db248d291455e64255569d7_D20221101-20230131" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfNi01LTEtMS02ODc1MQ_84b05cd5-3fcf-4493-98b0-858c427f2de6">28</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6eca4fc7ce75413ab4ea045884e10a1e_D20211101-20220131" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfNi03LTEtMS02ODc1MQ_b2eea4f6-5b99-4c7f-aac2-d4ac3288bf17">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i39c3cd014db248d291455e64255569d7_D20221101-20230131" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfNy01LTEtMS02ODc1MQ_400ba1e6-939c-4ac6-8d07-f7b64cd75cd5">5.5</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6eca4fc7ce75413ab4ea045884e10a1e_D20211101-20220131" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfNy03LTEtMS02ODc1MQ_c0318956-fa3f-41a5-8b89-aef1d46c4a63">5.5</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LTPP:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility of Agilent shares</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3152ba76c1df417987d29128ff805a81_D20221101-20230131" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfOS01LTEtMS02ODc1MQ_98843f48-d506-47e0-80c6-e9f93627286f">31</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia93bc1b9aa474f94bdf99722444eb9d8_D20211101-20220131" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfOS03LTEtMS02ODc1MQ_2d86ff4b-4ebc-453e-9361-354372a9ace5">29</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility of selected peer-company shares</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3152ba76c1df417987d29128ff805a81_D20221101-20230131" decimals="2" name="a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfMTAtNS0xLTEtNjg3NTEvdGV4dHJlZ2lvbjo1ZGFlZWFmOGFmZjg0MGE1OWZkZDJhNWMxYjNiZDcyY180_0eb9776d-0723-4897-8ee8-2d3bde800f39">22</ix:nonFraction>%-<ix:nonFraction unitRef="number" contextRef="i3152ba76c1df417987d29128ff805a81_D20221101-20230131" decimals="2" name="a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfMTAtNS0xLTEtNjg3NTEvdGV4dHJlZ2lvbjo1ZGFlZWFmOGFmZjg0MGE1OWZkZDJhNWMxYjNiZDcyY183_1bae18b4-801b-4f42-b632-4b13fe9e81b7">84</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia93bc1b9aa474f94bdf99722444eb9d8_D20211101-20220131" decimals="2" name="a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfMTAtNy0xLTEtNjg3NTEvdGV4dHJlZ2lvbjo1MDU2OWM3Y2ZhNTQ0ZjU4OTkwY2ZiN2Y2YTk3NTdjOF80_6035b378-a199-47a7-89d0-fcbfc38b835e">23</ix:nonFraction>%-<ix:nonFraction unitRef="number" contextRef="ia93bc1b9aa474f94bdf99722444eb9d8_D20211101-20220131" decimals="2" name="a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfMTAtNy0xLTEtNjg3NTEvdGV4dHJlZ2lvbjo1MDU2OWM3Y2ZhNTQ0ZjU4OTkwY2ZiN2Y2YTk3NTdjOF83_6bb2c6db-8664-468d-b123-d29a2b4b21d3">81</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pair-wise correlation with selected peers</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3152ba76c1df417987d29128ff805a81_D20221101-20230131" decimals="2" name="a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfMTEtNS0xLTEtNjg3NTE_32b358c4-2183-467a-a50f-01d67a640af7">42</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia93bc1b9aa474f94bdf99722444eb9d8_D20211101-20220131" decimals="2" name="a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfMTEtNy0xLTEtNjg3NTE_6631c384-413b-408c-86c3-08248cf2a94d">41</ix:nonFraction>%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Post-vest holding restriction discount for all executive awards</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i09873915b6ae475892e5c9a10735d4d2_D20221101-20230131" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfMTMtNS0xLTEtNjg3NTE_9d2cd15a-2d88-4dc1-9c1d-d84fa61148e6">7.1</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib61c5c9996464615b2178256d5815306_D20211101-20220131" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfMTMtNy0xLTEtNjg3NTE_61fd766c-7f61-48d0-84ee-5150c044f37b">6.5</ix:nonFraction>%</span></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of share-based awards for our employee stock option awards was estimated using the Black-Scholes option pricing model. Shares granted under the LTPP (TSR) were valued using a Monte Carlo simulation model. The Monte Carlo simulation fair value model requires the use of highly subjective and complex assumptions, including the price volatility of the underlying stock. &#160;For the volatility of our LTPP (TSR) grants, we used our own historical stock price volatility.&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ESPP allows eligible employees to purchase shares of our common stock at <ix:nonFraction unitRef="number" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMzMwNw_0186dc59-ded5-4e1f-aeb3-051dc08d4b12"><ix:nonFraction unitRef="number" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMzMwNw_62cdfbf7-9fd3-41d0-9499-f7a0e2d756bf"><ix:nonFraction unitRef="number" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMzMwNw_84670f4c-191c-4962-abc8-c9d7c2c134f7"><ix:nonFraction unitRef="number" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMzMwNw_f3ab9ddb-1ea2-43a9-a6b4-d4fc20f1484f">85</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> percent of the price at purchase and uses the purchase date to establish the fair market value. </span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i1717992e2ca44a5b8494ce5a7e178c6c" continuedAt="i9679d8bd26d84b05a3ce447f2a7c76b1"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use historical volatility to estimate the expected stock price volatility assumption for employee stock option awards. In reaching the conclusion, we have considered many factors including the extent to which our options are currently traded and our ability to find traded options in the current market with similar terms and prices to the options we are valuing. In estimating the expected life of our options granted, we considered the historical option exercise behavior of our executives, which we believe is representative of future behavior.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of restricted stock units and LTPP (EPS) awards is determined based on the market price of our common stock on the date of grant adjusted for expected dividend yield. The compensation cost for LTPP (EPS) reflects the cost of awards that are probable to vest at the end of the performance period. </span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9679d8bd26d84b05a3ce447f2a7c76b1">All LTPP awards granted to our senior management employees have a one-year post-vest holding restriction. The estimated discount associated with post-vest holding restrictions is calculated using the Finnerty model. The model calculates the potential lost value if the employees were able to sell the shares during the lack of marketability period, instead of being required to hold the shares. The model used the same historical stock price volatility and dividend yield assumption used for the Monte Carlo simulation model and an expected dividend yield to compute the discount.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_46"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180Ni9mcmFnOmI1MTg5MWRkMjhjNzQ0MTdhNGVhMDcyOWM1ZGVmYWQwL3RleHRyZWdpb246YjUxODkxZGQyOGM3NDQxN2E0ZWEwNzI5YzVkZWZhZDBfMjI0MA_8eb451d6-3b77-4c37-95b9-5dc851d4a7f0" continuedAt="i62a4b45a74cb495a83d1b40f4a13a6e0" escape="true">INCOME TAXES </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i62a4b45a74cb495a83d1b40f4a13a6e0"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended January&#160;31, 2023, our income tax expense was $<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180Ni9mcmFnOmI1MTg5MWRkMjhjNzQ0MTdhNGVhMDcyOWM1ZGVmYWQwL3RleHRyZWdpb246YjUxODkxZGQyOGM3NDQxN2E0ZWEwNzI5YzVkZWZhZDBfMTE5_e05bc500-d25e-443f-9245-193ab8cadb91">58</ix:nonFraction> million with an effective tax rate of <ix:nonFraction unitRef="number" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180Ni9mcmFnOmI1MTg5MWRkMjhjNzQ0MTdhNGVhMDcyOWM1ZGVmYWQwL3RleHRyZWdpb246YjUxODkxZGQyOGM3NDQxN2E0ZWEwNzI5YzVkZWZhZDBfMTUy_d466ef6c-f123-4673-9662-69600f249dcb">14.1</ix:nonFraction> percent. Our effective tax rate increased in 2023 compared to 2022, primarily due to the mandatory capitalization of research and development expenses, which became effective for Agilent in the first quarter of 2023, due to a change in tax law from the Tax Cuts and Jobs Act of 2017. For the three months ended January 31, 2023, our effective tax rate and the resulting provision for income taxes were also impacted by the excess tax benefits from stock-based compensation of $<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180Ni9mcmFnOmI1MTg5MWRkMjhjNzQ0MTdhNGVhMDcyOWM1ZGVmYWQwL3RleHRyZWdpb246YjUxODkxZGQyOGM3NDQxN2E0ZWEwNzI5YzVkZWZhZDBfOTg5NTYwNDY1MzkxOA_88a70279-47aa-4116-8021-87cbd302d190">12</ix:nonFraction>&#160;million along with the expiration of various foreign statutes of limitations which resulted in the recognition of previously unrecognized tax benefits of $<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180Ni9mcmFnOmI1MTg5MWRkMjhjNzQ0MTdhNGVhMDcyOWM1ZGVmYWQwL3RleHRyZWdpb246YjUxODkxZGQyOGM3NDQxN2E0ZWEwNzI5YzVkZWZhZDBfOTg5NTYwNDY1Mzk2NA_4b163d0c-85ad-4944-9b10-fbc907f68f70">7</ix:nonFraction>&#160;million.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended January&#160;31, 2022, our income tax expense was $<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180Ni9mcmFnOmI1MTg5MWRkMjhjNzQ0MTdhNGVhMDcyOWM1ZGVmYWQwL3RleHRyZWdpb246YjUxODkxZGQyOGM3NDQxN2E0ZWEwNzI5YzVkZWZhZDBfOTIx_c70124fb-443a-4533-9ab0-e9de281b30cf">36</ix:nonFraction> million with an effective tax rate of <ix:nonFraction unitRef="number" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180Ni9mcmFnOmI1MTg5MWRkMjhjNzQ0MTdhNGVhMDcyOWM1ZGVmYWQwL3RleHRyZWdpb246YjUxODkxZGQyOGM3NDQxN2E0ZWEwNzI5YzVkZWZhZDBfOTU0_e708da18-bdff-4914-b993-0e7249bee8c2">11.3</ix:nonFraction> percent. The income taxes for the three months ended January&#160;31, 2022 include the excess tax benefits from stock-based compensation of $<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180Ni9mcmFnOmI1MTg5MWRkMjhjNzQ0MTdhNGVhMDcyOWM1ZGVmYWQwL3RleHRyZWdpb246YjUxODkxZGQyOGM3NDQxN2E0ZWEwNzI5YzVkZWZhZDBfMTEyMQ_c10babd4-b849-4548-a42c-2f30e4a3b07a">16</ix:nonFraction>&#160;million. For the three months ended January&#160;31, 2022, our effective tax rate and the resulting provision for income taxes were also impacted by the expiration of various foreign statutes of limitations which resulted in the recognition of previously unrecognized tax benefits of $<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180Ni9mcmFnOmI1MTg5MWRkMjhjNzQ0MTdhNGVhMDcyOWM1ZGVmYWQwL3RleHRyZWdpb246YjUxODkxZGQyOGM3NDQxN2E0ZWEwNzI5YzVkZWZhZDBfMTM3OA_f59fb40e-f86f-44fc-b5b9-2bd1f32f425f">8</ix:nonFraction>&#160;million.  </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In the U.S., tax years remain open back to the year 2018 for federal income tax purposes and for significant states. In other major jurisdictions where the company conducts business, the tax years generally remain open back to the year 2013.  </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With these jurisdictions and the U.S., it is reasonably possible there could be significant changes to our unrecognized tax benefits in the next twelve months due to either the expiration of a statute of limitation or a tax audit settlement which will be partially offset by an anticipated tax liability related to unremitted foreign earnings, where applicable. Given the number of years and numerous matters that remain subject to examination in various tax jurisdictions, management is unable to estimate the range of possible changes to the balance of our unrecognized tax benefits.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_49"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.   <ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180OS9mcmFnOmViNWFkNjYxZDRkZjRmNTdiNjYzZmY4MGI3YmI2ZmJiL3RleHRyZWdpb246ZWI1YWQ2NjFkNGRmNGY1N2I2NjNmZjgwYjdiYjZmYmJfMTUxNw_62eb8c33-a1dd-41df-906c-7c671452c68c" continuedAt="if8f436b174854c0fa30f38e781c06d67" escape="true">NET INCOME PER SHARE</ix:nonNumeric></span></div><ix:continuation id="if8f436b174854c0fa30f38e781c06d67" continuedAt="i609b635adde6443ea5b565482a2ea700"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180OS9mcmFnOmViNWFkNjYxZDRkZjRmNTdiNjYzZmY4MGI3YmI2ZmJiL3RleHRyZWdpb246ZWI1YWQ2NjFkNGRmNGY1N2I2NjNmZjgwYjdiYjZmYmJfMTUwNA_0b6b0a82-0a9f-4f87-9e9c-df55483b57bc" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the numerator and denominator of the basic and diluted net income per share computations for the periods presented below:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.894%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.675%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180OS9mcmFnOmViNWFkNjYxZDRkZjRmNTdiNjYzZmY4MGI3YmI2ZmJiL3RhYmxlOjdkYTc1NjcwY2I0NDRiOTg5MGE4ZWNhZDJhMWY3MmFkL3RhYmxlcmFuZ2U6N2RhNzU2NzBjYjQ0NGI5ODkwYThlY2FkMmExZjcyYWRfNS01LTEtMS02ODc1MQ_910fdead-b464-410b-b253-1577c93b2347">352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180OS9mcmFnOmViNWFkNjYxZDRkZjRmNTdiNjYzZmY4MGI3YmI2ZmJiL3RhYmxlOjdkYTc1NjcwY2I0NDRiOTg5MGE4ZWNhZDJhMWY3MmFkL3RhYmxlcmFuZ2U6N2RhNzU2NzBjYjQ0NGI5ODkwYThlY2FkMmExZjcyYWRfNS03LTEtMS02ODc1MQ_0679f287-1f00-4e6b-87d2-c3c32d4494c1">283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average shares</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180OS9mcmFnOmViNWFkNjYxZDRkZjRmNTdiNjYzZmY4MGI3YmI2ZmJiL3RhYmxlOjdkYTc1NjcwY2I0NDRiOTg5MGE4ZWNhZDJhMWY3MmFkL3RhYmxlcmFuZ2U6N2RhNzU2NzBjYjQ0NGI5ODkwYThlY2FkMmExZjcyYWRfNy01LTEtMS02ODc1MQ_92218217-bb95-45f2-aef2-eccc34ee3c40">296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180OS9mcmFnOmViNWFkNjYxZDRkZjRmNTdiNjYzZmY4MGI3YmI2ZmJiL3RhYmxlOjdkYTc1NjcwY2I0NDRiOTg5MGE4ZWNhZDJhMWY3MmFkL3RhYmxlcmFuZ2U6N2RhNzU2NzBjYjQ0NGI5ODkwYThlY2FkMmExZjcyYWRfNy03LTEtMS02ODc1MQ_5e448ea6-ad21-404a-ad7f-82bd47d65677">301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potential common shares&#8212; stock&#160;options and other employee stock plans</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180OS9mcmFnOmViNWFkNjYxZDRkZjRmNTdiNjYzZmY4MGI3YmI2ZmJiL3RhYmxlOjdkYTc1NjcwY2I0NDRiOTg5MGE4ZWNhZDJhMWY3MmFkL3RhYmxlcmFuZ2U6N2RhNzU2NzBjYjQ0NGI5ODkwYThlY2FkMmExZjcyYWRfOC01LTEtMS02ODc1MQ_aaa9c69e-97c5-4bb1-b3d5-a82916d9af1d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180OS9mcmFnOmViNWFkNjYxZDRkZjRmNTdiNjYzZmY4MGI3YmI2ZmJiL3RhYmxlOjdkYTc1NjcwY2I0NDRiOTg5MGE4ZWNhZDJhMWY3MmFkL3RhYmxlcmFuZ2U6N2RhNzU2NzBjYjQ0NGI5ODkwYThlY2FkMmExZjcyYWRfOC03LTEtMS02ODc1MQ_ded51ae7-f2ac-4ad9-ad48-b53cf07de3d4">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average shares</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180OS9mcmFnOmViNWFkNjYxZDRkZjRmNTdiNjYzZmY4MGI3YmI2ZmJiL3RhYmxlOjdkYTc1NjcwY2I0NDRiOTg5MGE4ZWNhZDJhMWY3MmFkL3RhYmxlcmFuZ2U6N2RhNzU2NzBjYjQ0NGI5ODkwYThlY2FkMmExZjcyYWRfOS01LTEtMS02ODc1MQ_03321a63-421f-435a-bc55-122f70ba4f99">297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180OS9mcmFnOmViNWFkNjYxZDRkZjRmNTdiNjYzZmY4MGI3YmI2ZmJiL3RhYmxlOjdkYTc1NjcwY2I0NDRiOTg5MGE4ZWNhZDJhMWY3MmFkL3RhYmxlcmFuZ2U6N2RhNzU2NzBjYjQ0NGI5ODkwYThlY2FkMmExZjcyYWRfOS03LTEtMS02ODc1MQ_2e5eb595-7a0c-4289-98da-6b8b58a597ed">303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The dilutive effect of share-based awards is reflected in diluted net income per share by application of the treasury stock method, which includes consideration of unamortized share-based compensation expense and the dilutive effect of in-the-money options and non-vested restricted stock units. Under the treasury stock method, the amount the employee must pay for exercising stock options and unamortized share-based compensation expense collectively are assumed proceeds to be used to repurchase hypothetical shares. An increase in the fair market value of the company's common stock can result in a greater dilutive effect from potentially dilutive awards.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We exclude stock options with exercise prices greater than the average market price of our common stock from the calculation of diluted earnings per share because their effect would be anti-dilutive. In addition, we exclude from the calculation of diluted earnings per share stock options, ESPP, LTPP and restricted stock awards whose combined exercise price and unamortized fair value were greater than the average market price of our common stock because their effect would also be anti-dilutive. &#160; </span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i609b635adde6443ea5b565482a2ea700">For the three months ended January&#160;31, 2023 and 2022, potential common shares excluded from the calculation of diluted earnings per share were <ix:nonFraction unitRef="shares" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180OS9mcmFnOmViNWFkNjYxZDRkZjRmNTdiNjYzZmY4MGI3YmI2ZmJiL3RleHRyZWdpb246ZWI1YWQ2NjFkNGRmNGY1N2I2NjNmZjgwYjdiYjZmYmJfMTQ4Nw_22da2b2f-3096-4071-9fb0-22f4ebd83364"><ix:nonFraction unitRef="shares" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180OS9mcmFnOmViNWFkNjYxZDRkZjRmNTdiNjYzZmY4MGI3YmI2ZmJiL3RleHRyZWdpb246ZWI1YWQ2NjFkNGRmNGY1N2I2NjNmZjgwYjdiYjZmYmJfMTQ4Nw_4e1d2ee0-6f62-4be7-8615-012642e5ae6c"><ix:nonFraction unitRef="shares" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180OS9mcmFnOmViNWFkNjYxZDRkZjRmNTdiNjYzZmY4MGI3YmI2ZmJiL3RleHRyZWdpb246ZWI1YWQ2NjFkNGRmNGY1N2I2NjNmZjgwYjdiYjZmYmJfMTQ4Nw_5cdbb5d1-5105-4046-a4cc-39824610dacd"><ix:nonFraction unitRef="shares" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180OS9mcmFnOmViNWFkNjYxZDRkZjRmNTdiNjYzZmY4MGI3YmI2ZmJiL3RleHRyZWdpb246ZWI1YWQ2NjFkNGRmNGY1N2I2NjNmZjgwYjdiYjZmYmJfMTQ4Nw_8cd32326-e8eb-4f79-b747-a21a6975b34c">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>t material.</ix:continuation> </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_52"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.   <ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181Mi9mcmFnOmVjMjJmOWJiZjU3YTRmY2RiMGMzMDc2Njk2MGU4ODNhL3RleHRyZWdpb246ZWMyMmY5YmJmNTdhNGZjZGIwYzMwNzY2OTYwZTg4M2FfOTA_4745fcdc-7f05-495e-bcf2-f666e55ff384" continuedAt="i992c047a88904c0ea3c0fc5cc001286c" escape="true"><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181Mi9mcmFnOmVjMjJmOWJiZjU3YTRmY2RiMGMzMDc2Njk2MGU4ODNhL3RleHRyZWdpb246ZWMyMmY5YmJmNTdhNGZjZGIwYzMwNzY2OTYwZTg4M2FfOTI_88954154-dadf-4c69-973f-10e777e77e9f" continuedAt="i8920ffc7ce9b4804abaae8c3bbd4cd69" escape="true">INVENTORY</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i992c047a88904c0ea3c0fc5cc001286c"><ix:continuation id="i8920ffc7ce9b4804abaae8c3bbd4cd69"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory as of January&#160;31, 2023 and October&#160;31, 2022 consisted of the following:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.218%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:InventoryFinishedGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181Mi9mcmFnOmVjMjJmOWJiZjU3YTRmY2RiMGMzMDc2Njk2MGU4ODNhL3RhYmxlOjg2NWU0OTE0MmNiYTQyYjE5ZjA0OWIzYzgxZjU4MjM5L3RhYmxlcmFuZ2U6ODY1ZTQ5MTQyY2JhNDJiMTlmMDQ5YjNjODFmNTgyMzlfMi0xLTEtMS02ODc1MQ_2fd2cc28-f2ef-4ae6-9e41-0a6163cce0f2">589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:InventoryFinishedGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181Mi9mcmFnOmVjMjJmOWJiZjU3YTRmY2RiMGMzMDc2Njk2MGU4ODNhL3RhYmxlOjg2NWU0OTE0MmNiYTQyYjE5ZjA0OWIzYzgxZjU4MjM5L3RhYmxlcmFuZ2U6ODY1ZTQ5MTQyY2JhNDJiMTlmMDQ5YjNjODFmNTgyMzlfMi0zLTEtMS02ODc1MQ_74f10f18-1f77-4c8a-8bb3-3df887f3c63a">555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased parts and fabricated assemblies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:InventoryWorkInProcessAndRawMaterials" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181Mi9mcmFnOmVjMjJmOWJiZjU3YTRmY2RiMGMzMDc2Njk2MGU4ODNhL3RhYmxlOjg2NWU0OTE0MmNiYTQyYjE5ZjA0OWIzYzgxZjU4MjM5L3RhYmxlcmFuZ2U6ODY1ZTQ5MTQyY2JhNDJiMTlmMDQ5YjNjODFmNTgyMzlfMy0xLTEtMS02ODc1MQ_329bf70c-146a-4a9c-9401-486cc8ce5945">522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:InventoryWorkInProcessAndRawMaterials" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181Mi9mcmFnOmVjMjJmOWJiZjU3YTRmY2RiMGMzMDc2Njk2MGU4ODNhL3RhYmxlOjg2NWU0OTE0MmNiYTQyYjE5ZjA0OWIzYzgxZjU4MjM5L3RhYmxlcmFuZ2U6ODY1ZTQ5MTQyY2JhNDJiMTlmMDQ5YjNjODFmNTgyMzlfMy0zLTEtMS02ODc1MQ_7a3c5665-45e9-4507-a7b0-29d1e01e9b49">483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181Mi9mcmFnOmVjMjJmOWJiZjU3YTRmY2RiMGMzMDc2Njk2MGU4ODNhL3RhYmxlOjg2NWU0OTE0MmNiYTQyYjE5ZjA0OWIzYzgxZjU4MjM5L3RhYmxlcmFuZ2U6ODY1ZTQ5MTQyY2JhNDJiMTlmMDQ5YjNjODFmNTgyMzlfNC0xLTEtMS02ODc1MQ_30842b6a-6b6c-41ee-80ea-cb6658643af0">1,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181Mi9mcmFnOmVjMjJmOWJiZjU3YTRmY2RiMGMzMDc2Njk2MGU4ODNhL3RhYmxlOjg2NWU0OTE0MmNiYTQyYjE5ZjA0OWIzYzgxZjU4MjM5L3RhYmxlcmFuZ2U6ODY1ZTQ5MTQyY2JhNDJiMTlmMDQ5YjNjODFmNTgyMzlfNC0zLTEtMS02ODc1MQ_f489376c-0b4b-4746-9691-89f9083a013a">1,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_55"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.   <ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RleHRyZWdpb246NTg5M2FjZGJiMjliNGIwNWI1YzdhNGQ5YTY0NTZjOTNfMjg1OQ_5aedb331-c81b-4774-a4be-75319f7726c5" continuedAt="ic287c5663ae34160b6e073ba5ae3167d" escape="true">GOODWILL AND OTHER INTANGIBLE ASSETS</ix:nonNumeric></span></div><ix:continuation id="ic287c5663ae34160b6e073ba5ae3167d" continuedAt="i27ed63d1107c405eb012d59879e2ed49"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RleHRyZWdpb246NTg5M2FjZGJiMjliNGIwNWI1YzdhNGQ5YTY0NTZjOTNfMjg1Mw_4548a5be-f51c-4f39-b20b-4514b1217a04" escape="true"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents goodwill balances and the movements for each of our reportable segments during the three months ended January&#160;31, 2023:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:50.512%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.070%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Sciences and Applied Markets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diagnostics and Genomics</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agilent CrossLab</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of October 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14749e019f0c4a78a5749fbc0e9602a5_I20221031" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjFlNGFlMDBmZTg3MDQwOTdhMWU5NjNmYzE5MzNiMmEyL3RhYmxlcmFuZ2U6MWU0YWUwMGZlODcwNDA5N2ExZTk2M2ZjMTkzM2IyYTJfMi0xLTEtMS02ODc1MQ_220fa5e9-25c0-4370-86c3-f450ed705879">1,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c417edb3d704da7925a02009feeff69_I20221031" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjFlNGFlMDBmZTg3MDQwOTdhMWU5NjNmYzE5MzNiMmEyL3RhYmxlcmFuZ2U6MWU0YWUwMGZlODcwNDA5N2ExZTk2M2ZjMTkzM2IyYTJfMi0zLTEtMS02ODc1MQ_cdc2dcdc-a598-4816-90b1-485e0bff0d20">1,953</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdb82786efda42a99e13832f0a499c71_I20221031" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjFlNGFlMDBmZTg3MDQwOTdhMWU5NjNmYzE5MzNiMmEyL3RhYmxlcmFuZ2U6MWU0YWUwMGZlODcwNDA5N2ExZTk2M2ZjMTkzM2IyYTJfMi01LTEtMS02ODc1MQ_4d4026a2-d070-47e8-a535-acacf2a42bc9">256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjFlNGFlMDBmZTg3MDQwOTdhMWU5NjNmYzE5MzNiMmEyL3RhYmxlcmFuZ2U6MWU0YWUwMGZlODcwNDA5N2ExZTk2M2ZjMTkzM2IyYTJfMi03LTEtMS02ODc1MQ_d9017a67-59aa-4091-9a6f-502f19746fbc">3,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90bc58b4dc464d058d4f7d56e61e2e21_D20221101-20230131" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjFlNGFlMDBmZTg3MDQwOTdhMWU5NjNmYzE5MzNiMmEyL3RhYmxlcmFuZ2U6MWU0YWUwMGZlODcwNDA5N2ExZTk2M2ZjMTkzM2IyYTJfMy0xLTEtMS02ODc1MQ_c4c7250a-edd3-45c6-9a72-65c253c7d1f7">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i405a137dbfd148ab9797e53157dcb87b_D20221101-20230131" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjFlNGFlMDBmZTg3MDQwOTdhMWU5NjNmYzE5MzNiMmEyL3RhYmxlcmFuZ2U6MWU0YWUwMGZlODcwNDA5N2ExZTk2M2ZjMTkzM2IyYTJfMy0zLTEtMS02ODc1MQ_1c0d6bba-20fc-4726-bfb0-c65eed32060b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d83c1345e874e8fabdab7fd0ec051b6_D20221101-20230131" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjFlNGFlMDBmZTg3MDQwOTdhMWU5NjNmYzE5MzNiMmEyL3RhYmxlcmFuZ2U6MWU0YWUwMGZlODcwNDA5N2ExZTk2M2ZjMTkzM2IyYTJfMy01LTEtMS02ODc1MQ_5f28e64b-f141-4b8c-b3a1-5697c8bfb0d5">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjFlNGFlMDBmZTg3MDQwOTdhMWU5NjNmYzE5MzNiMmEyL3RhYmxlcmFuZ2U6MWU0YWUwMGZlODcwNDA5N2ExZTk2M2ZjMTkzM2IyYTJfMy03LTEtMS02ODc1MQ_72bb07af-4bc6-4c56-a1a2-230285b37bf3">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill arising from acquisitions and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90bc58b4dc464d058d4f7d56e61e2e21_D20221101-20230131" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjFlNGFlMDBmZTg3MDQwOTdhMWU5NjNmYzE5MzNiMmEyL3RhYmxlcmFuZ2U6MWU0YWUwMGZlODcwNDA5N2ExZTk2M2ZjMTkzM2IyYTJfNC0xLTEtMS02ODc1MQ_4e7e446e-a3eb-4112-9a3c-b566a1aba9f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i405a137dbfd148ab9797e53157dcb87b_D20221101-20230131" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjFlNGFlMDBmZTg3MDQwOTdhMWU5NjNmYzE5MzNiMmEyL3RhYmxlcmFuZ2U6MWU0YWUwMGZlODcwNDA5N2ExZTk2M2ZjMTkzM2IyYTJfNC0zLTEtMS02ODc1MQ_9b22615c-9f75-4002-a7ae-f994ea024a9a">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d83c1345e874e8fabdab7fd0ec051b6_D20221101-20230131" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjFlNGFlMDBmZTg3MDQwOTdhMWU5NjNmYzE5MzNiMmEyL3RhYmxlcmFuZ2U6MWU0YWUwMGZlODcwNDA5N2ExZTk2M2ZjMTkzM2IyYTJfNC01LTEtMS02ODc1MQ_40aa4f8d-caa4-4675-985f-14ed0c3086be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjFlNGFlMDBmZTg3MDQwOTdhMWU5NjNmYzE5MzNiMmEyL3RhYmxlcmFuZ2U6MWU0YWUwMGZlODcwNDA5N2ExZTk2M2ZjMTkzM2IyYTJfNC03LTEtMS02ODc1MQ_a1af71ad-3f88-490b-81a4-c7f346cc238f">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of January 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e0c874f1a2f4b52bde701c5d0c5f04a_I20230131" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjFlNGFlMDBmZTg3MDQwOTdhMWU5NjNmYzE5MzNiMmEyL3RhYmxlcmFuZ2U6MWU0YWUwMGZlODcwNDA5N2ExZTk2M2ZjMTkzM2IyYTJfNS0xLTEtMS02ODc1MQ_005b61fb-8e0a-461a-84fe-198c15361ac4">1,755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic29288e8bc2e49b7b040c7b53788b074_I20230131" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjFlNGFlMDBmZTg3MDQwOTdhMWU5NjNmYzE5MzNiMmEyL3RhYmxlcmFuZ2U6MWU0YWUwMGZlODcwNDA5N2ExZTk2M2ZjMTkzM2IyYTJfNS0zLTEtMS02ODc1MQ_6c033982-8310-49b2-b3e0-d2092c1d0642">1,965</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39cb63aace124a70b0cf20f2781b5388_I20230131" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjFlNGFlMDBmZTg3MDQwOTdhMWU5NjNmYzE5MzNiMmEyL3RhYmxlcmFuZ2U6MWU0YWUwMGZlODcwNDA5N2ExZTk2M2ZjMTkzM2IyYTJfNS01LTEtMS02ODc1MQ_5010bcdf-59ca-47ac-af22-5fe0ff9fe924">263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjFlNGFlMDBmZTg3MDQwOTdhMWU5NjNmYzE5MzNiMmEyL3RhYmxlcmFuZ2U6MWU0YWUwMGZlODcwNDA5N2ExZTk2M2ZjMTkzM2IyYTJfNS03LTEtMS02ODc1MQ_03b55f7a-aba5-4fba-906f-63ba0cf3c377">3,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:5pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RleHRyZWdpb246NTg5M2FjZGJiMjliNGIwNWI1YzdhNGQ5YTY0NTZjOTNfMjg0OQ_f3a389ed-80ab-4c05-b9f1-050481df2cd4" escape="true"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The component parts of other intangible assets as of January&#160;31, 2023 and October&#160;31, 2022 are shown in the table below:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other&#160;Intangible&#160;Assets</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net&#160;Book<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of October 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased technology</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aff20c1669045879c48618f094be7f4_I20221031" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfNC0xLTEtMS02ODc1MQ_88844eba-d57b-4fe7-bde6-b769ddf747e0">1,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aff20c1669045879c48618f094be7f4_I20221031" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfNC0zLTEtMS02ODc1MQ_68391552-848a-4299-acca-fed57ec913c1">1,068</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aff20c1669045879c48618f094be7f4_I20221031" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfNC01LTEtMS02ODc1MQ_fc05b3b0-92bd-4f3c-9288-6a75b317ccd4">665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademark/Tradename</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78c9af0b8c6542c9804e6ef220ea2418_I20221031" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfNS0xLTEtMS02ODc1MQ_f1013f5f-b7d8-4f00-90df-1b802885531d">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78c9af0b8c6542c9804e6ef220ea2418_I20221031" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfNS0zLTEtMS02ODc1MQ_4eb047cc-bf11-4452-bb4f-8702cae0c92e">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78c9af0b8c6542c9804e6ef220ea2418_I20221031" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfNS01LTEtMS02ODc1MQ_bb6324a3-a5c0-4278-9fa5-d6a09b19318e">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie41bd8ebbf7b4eb68a78111db1b20475_I20221031" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfNi0xLTEtMS02ODc1MQ_3d535d36-f454-4947-893a-de16b71ea2c1">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie41bd8ebbf7b4eb68a78111db1b20475_I20221031" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfNi0zLTEtMS02ODc1MQ_bf0ccd17-dc7d-4d7e-9b89-67a68a984409">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie41bd8ebbf7b4eb68a78111db1b20475_I20221031" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfNi01LTEtMS02ODc1MQ_b3d0dca8-cdf3-4f11-a206-d2239ffa7584">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Backlog</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3aadc25089b4d77a8b3cba419d06996_I20221031" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfNy0xLTEtMS02ODc1MQ_0dd3a8e2-5df0-4f97-9d3b-38f79637767d">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3aadc25089b4d77a8b3cba419d06996_I20221031" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfNy0zLTEtMS02ODc1MQ_dd6a5b25-ff7a-4965-9f1f-45cc31e6cfe2">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3aadc25089b4d77a8b3cba419d06996_I20221031" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfNy01LTEtMS02ODc1MQ_8ba29057-fdd5-4aed-864b-e0b0fbc0356d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third-party technology and licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia533acfa2c5343c2a822b9e8c8ada803_I20221031" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfOC0xLTEtMS02ODc1MQ_daac5168-5ac2-40fe-af5b-13b113d75894">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia533acfa2c5343c2a822b9e8c8ada803_I20221031" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfOC0zLTEtMS02ODc1MQ_5ca8d238-ed2f-42f0-9140-7892dd5e72cb">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia533acfa2c5343c2a822b9e8c8ada803_I20221031" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfOC01LTEtMS02ODc1MQ_6177b902-60d4-4eeb-aa98-303526e2c556">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortizable intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfOS0xLTEtMS02ODc1MQ_188784b5-2566-4666-8eb4-0e4643a75078">2,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfOS0zLTEtMS02ODc1MQ_ef7053a2-fe02-4081-8bf9-84303301d2a2">1,338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfOS01LTEtMS02ODc1MQ_2d35d61b-f98d-4901-907b-c078213c3b72">811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-Process R&amp;D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6f781359e43434dbbae2d8573466196_I20221031" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTAtMS0xLTEtNjg3NTE_0ff7d37d-02d4-442a-b6c9-2e3a4316332f">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6f781359e43434dbbae2d8573466196_I20221031" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTAtNS0xLTEtNjg3NTE_38ab3e8a-be40-4ebc-b63c-d187d8896e4e">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTEtMS0xLTEtNjg3NTE_8240c05a-4829-4625-833d-5b5cbeeef911">2,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTEtMy0xLTEtNjg3NTE_584db2dc-3bd9-4a77-84d3-48b1f15957f7">1,338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTEtNS0xLTEtNjg3NTE_6b614a80-0d86-4224-b3c0-76aae476f54e">821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of January 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased technology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecdfae8339144e08ca120f755566194_I20230131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTMtMS0xLTEtNjg3NTE_5d560e14-2a5a-4eeb-9656-83418b6005b8">1,761</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecdfae8339144e08ca120f755566194_I20230131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTMtMy0xLTEtNjg3NTE_f9bd8faa-eb41-4384-a0dc-17bf54c6267d">1,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecdfae8339144e08ca120f755566194_I20230131" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTMtNS0xLTEtNjg3NTE_ba798977-a854-4f0d-adbe-c3b2c21d64a9">665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademark/Tradename</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if38c838bd72546ecb1b03552dfe899cf_I20230131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTQtMS0xLTEtNjg3NTE_0d33ed08-eea0-4177-8774-b9bdaade2b10">196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if38c838bd72546ecb1b03552dfe899cf_I20230131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTQtMy0xLTEtNjg3NTE_a367ab5f-201f-4873-8253-1fcd0c0367ff">152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if38c838bd72546ecb1b03552dfe899cf_I20230131" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTQtNS0xLTEtNjg3NTE_d8fa1e09-0a84-41ab-ae6f-23e630fbaac0">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9e00fde0b04942843ffcf15477e77f_I20230131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTUtMS0xLTEtNjg3NTE_2c8cbc05-2646-49c5-8684-2976a0764899">181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9e00fde0b04942843ffcf15477e77f_I20230131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTUtMy0xLTEtNjg3NTE_45d1020a-9886-4f10-915d-3b88666b6ef1">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9e00fde0b04942843ffcf15477e77f_I20230131" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTUtNS0xLTEtNjg3NTE_ccef5634-eea1-416d-8f8e-887a43439d22">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Backlog</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic775993ecc604246b97b951a0ebb69f7_I20230131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTYtMS0xLTEtNjg3NTE_553585bd-8a96-4958-9321-49dd304d5fc1">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic775993ecc604246b97b951a0ebb69f7_I20230131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTYtMy0xLTEtNjg3NTE_a0db7e3e-f74f-4d91-bcdd-500a882b5cba">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic775993ecc604246b97b951a0ebb69f7_I20230131" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTYtNS0xLTEtNjg3NTE_1437aeaa-ac65-4265-b260-1afdd445f0c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third-party technology and licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20a5d3b2a23247998eeb29965ed5cdec_I20230131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTctMS0xLTEtNjg3NTE_d3cc7fc8-a78e-40cf-bdec-98d90adfd189">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20a5d3b2a23247998eeb29965ed5cdec_I20230131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTctMy0xLTEtNjg3NTE_23e3067f-b2c5-429a-827d-100c0b20eb1b">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20a5d3b2a23247998eeb29965ed5cdec_I20230131" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTctNS0xLTEtNjg3NTE_a320623f-d3b3-4670-b9ca-bedf58726a0a">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTgtMS0xLTEtNjg3NTE_873faad6-bcde-4e93-8835-740319ae159e">2,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTgtMy0xLTEtNjg3NTE_2c6f5e79-937e-43cf-8218-34b46c96b110">1,379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTgtNS0xLTEtNjg3NTE_cd7f617a-fd64-4115-86c2-64a4772889cd">800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-Process R&amp;D</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id63c0b222b0f4e9591e1e1ec87de74b7_I20230131" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTktMS0xLTEtNjg3NTE_5b157b67-f8c6-4dd4-96a4-2dab719eb3ae">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id63c0b222b0f4e9591e1e1ec87de74b7_I20230131" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTktNS0xLTEtNjg3NTE_9a48714c-8fcc-4f41-b49a-2d588dc0baed">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMjAtMS0xLTEtNjg3NTE_633f0a18-9331-49ab-ac2d-e32e80916a80">2,189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMjAtMy0xLTEtNjg3NTE_7074bbfe-ecdc-4a6e-be8f-b36263701f64">1,379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMjAtNS0xLTEtNjg3NTE_0c1013c6-1f91-4663-8d8b-e8358d0e3db0">810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended January&#160;31, 2023, we recorded additions to goodwill of $<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RleHRyZWdpb246NTg5M2FjZGJiMjliNGIwNWI1YzdhNGQ5YTY0NTZjOTNfMjE5OTAyMzI2MDM5NQ_415b3961-d4d8-4f8e-984e-3c1c0aebc7ea">11</ix:nonFraction> million and to other intangible assets of $<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RleHRyZWdpb246NTg5M2FjZGJiMjliNGIwNWI1YzdhNGQ5YTY0NTZjOTNfMTcwOA_4a1c64eb-564f-42c9-b3f9-a5a0966fedc1">23</ix:nonFraction> million in our diagnostics and genomics segment related to the acquisition of one business. During the three months ended January&#160;31, 2023, other intangible assets in total increased $<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RleHRyZWdpb246NTg5M2FjZGJiMjliNGIwNWI1YzdhNGQ5YTY0NTZjOTNfMTg4OA_5ab20a56-e944-4efc-afcb-5a450f4184b7">2</ix:nonFraction> million due to the impact of foreign currency translation. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, for U.S. federal tax purposes, goodwill from asset purchases is amortizable; however, any goodwill created as part of a stock acquisition is not deductible.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each quarter we review the events and circumstances to determine if impairment of indefinite-lived intangible assets and goodwill is indicated. During the three months ended January&#160;31, 2023 and 2022 we did <ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RleHRyZWdpb246NTg5M2FjZGJiMjliNGIwNWI1YzdhNGQ5YTY0NTZjOTNfMjMwMg_795d6d73-2b96-4a28-a51e-ff4dcac1f4c4"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RleHRyZWdpb246NTg5M2FjZGJiMjliNGIwNWI1YzdhNGQ5YTY0NTZjOTNfMjMwMg_826cb311-5bf2-4abb-9075-080d0964d9e8"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RleHRyZWdpb246NTg5M2FjZGJiMjliNGIwNWI1YzdhNGQ5YTY0NTZjOTNfMjMwMg_9974c00b-3a92-43ce-9ac4-1d140f9abf51"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RleHRyZWdpb246NTg5M2FjZGJiMjliNGIwNWI1YzdhNGQ5YTY0NTZjOTNfMjMwMg_e4e9c7ff-fa30-4f96-a62a-3f9126ec470f">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>t identify any triggering events or circumstances which would indicate an impairment of goodwill or indefinite-lived intangible assets. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense of intangible assets was $<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RleHRyZWdpb246NTg5M2FjZGJiMjliNGIwNWI1YzdhNGQ5YTY0NTZjOTNfMjQ5NQ_98ec33f0-9300-4556-8928-dfd9c81abeab">36</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RleHRyZWdpb246NTg5M2FjZGJiMjliNGIwNWI1YzdhNGQ5YTY0NTZjOTNfMjU5Mw_28b945c0-a889-40b9-8854-78b8ed2eccbc">51</ix:nonFraction> million for the three months ended January&#160;31, 2023 and 2022, respectively. </span></div></ix:continuation><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i27ed63d1107c405eb012d59879e2ed49"><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RleHRyZWdpb246NTg5M2FjZGJiMjliNGIwNWI1YzdhNGQ5YTY0NTZjOTNfMjg2Mg_c7977ce2-d0dc-48e6-bba4-8131b4314246" escape="true"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future amortization expense related to existing finite-lived purchased intangible assets for the remainder of fiscal year 2023 and for each of the next five fiscal years and thereafter is estimated below:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:90.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated future amortization expense:</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjM3YTkyOWQ3MmNkNDQxMzBiNjg5MjVlMWIwMGQ3ODE0L3RhYmxlcmFuZ2U6MzdhOTI5ZDcyY2Q0NDEzMGI2ODkyNWUxYjAwZDc4MTRfMi0xLTEtMS02ODc1MQ_c6e2de66-6792-48c2-8015-783f8e396b61">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjM3YTkyOWQ3MmNkNDQxMzBiNjg5MjVlMWIwMGQ3ODE0L3RhYmxlcmFuZ2U6MzdhOTI5ZDcyY2Q0NDEzMGI2ODkyNWUxYjAwZDc4MTRfMy0xLTEtMS02ODc1MQ_07e3e3df-cba3-4197-84af-d6f265f1c57b">129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjM3YTkyOWQ3MmNkNDQxMzBiNjg5MjVlMWIwMGQ3ODE0L3RhYmxlcmFuZ2U6MzdhOTI5ZDcyY2Q0NDEzMGI2ODkyNWUxYjAwZDc4MTRfNC0xLTEtMS02ODc1MQ_db41c779-569a-4e97-98dd-7ed0b2e19e10">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjM3YTkyOWQ3MmNkNDQxMzBiNjg5MjVlMWIwMGQ3ODE0L3RhYmxlcmFuZ2U6MzdhOTI5ZDcyY2Q0NDEzMGI2ODkyNWUxYjAwZDc4MTRfNS0xLTEtMS02ODc1MQ_3497a34a-c1f0-4504-8f0c-824f4f3fad38">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjM3YTkyOWQ3MmNkNDQxMzBiNjg5MjVlMWIwMGQ3ODE0L3RhYmxlcmFuZ2U6MzdhOTI5ZDcyY2Q0NDEzMGI2ODkyNWUxYjAwZDc4MTRfNi0xLTEtMS02ODc1MQ_b29bd7c7-5ad7-43c1-8ee3-728334daeb3a">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjM3YTkyOWQ3MmNkNDQxMzBiNjg5MjVlMWIwMGQ3ODE0L3RhYmxlcmFuZ2U6MzdhOTI5ZDcyY2Q0NDEzMGI2ODkyNWUxYjAwZDc4MTRfNy0xLTEtMS02ODc1MQ_d5818ab3-6fcb-41e5-97ff-52519a93304a">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjM3YTkyOWQ3MmNkNDQxMzBiNjg5MjVlMWIwMGQ3ODE0L3RhYmxlcmFuZ2U6MzdhOTI5ZDcyY2Q0NDEzMGI2ODkyNWUxYjAwZDc4MTRfOC0xLTEtMS02ODc1MQ_b3c94576-89bd-4398-84f4-3388adaf7bd2">243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_58"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.   <ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfODI0Ng_ccb8bd80-a241-43d3-b6b6-97135fde17e6" continuedAt="i563f7e26fa174a369f09fa91f6206d32" escape="true">FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><ix:continuation id="i563f7e26fa174a369f09fa91f6206d32" continuedAt="i74a8ce09b563441da7633b52676f8d99"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The authoritative guidance defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, we consider the principal or most advantageous market and assumptions that market participants would use when pricing the asset or liability.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Hierarchy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The guidance establishes a fair value hierarchy that prioritizes the use of inputs used in valuation techniques into three levels. A financial instrument&#8217;s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. There are three levels of inputs that may be used to measure fair value:</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- applies to assets or liabilities for which there are inputs other than quoted prices included within level 1 that are observable, either directly or indirectly, for the asset or liability such as: quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in less active markets; or other inputs that can be derived principally from, or corroborated by, observable market data.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.</span></div></ix:continuation><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i74a8ce09b563441da7633b52676f8d99" continuedAt="i51b32d934ca745ec82ff1b96bfd36312"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfODI0OA_d0fa77ad-cd8d-46b9-b1bd-d5312b42248c" escape="true"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis as of January&#160;31, 2023 were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.186%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement at January 31, 2023 Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">in&#160;Active</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Markets&#160;for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Identical&#160;Assets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Observable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;3)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents (money market funds)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i437d3b6251fa4606a05df57d58d3c73c_I20230131" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfNS0xLTEtMS02ODc1MQ_cb5c15ad-8ee8-4b39-b338-bc42a94373d9">652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f3778491b9842b0b3c469f4bf304247_I20230131" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfNS0zLTEtMS02ODc1MQ_cfab7357-b2f1-4074-9e7e-5b91ec9283e1">652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i771947e8e65142a1a1ce68ffba8ff0b3_I20230131" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfNS01LTEtMS02ODc1MQ_386c67fc-9803-401a-b3db-43ad41d793e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2eea0376824cb7ae764ad375383f52_I20230131" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfNS03LTEtMS02ODc1MQ_ad0bdbb3-4206-4591-82ca-e050a3bb03a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments (foreign exchange contracts)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i437d3b6251fa4606a05df57d58d3c73c_I20230131" decimals="-6" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfNi0xLTEtMS02ODc1MQ_e617f50d-2aca-430f-9efa-9bdca3a77fcc">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f3778491b9842b0b3c469f4bf304247_I20230131" decimals="-6" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfNi0zLTEtMS02ODc1MQ_3d4bca4d-f017-4d7d-9956-e8f08e89bb77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i771947e8e65142a1a1ce68ffba8ff0b3_I20230131" decimals="-6" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfNi01LTEtMS02ODc1MQ_01ad7117-ae55-4299-be97-6cc0ecf6d7cf">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2eea0376824cb7ae764ad375383f52_I20230131" decimals="-6" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfNi03LTEtMS02ODc1MQ_be282a31-d7b0-450a-9134-f7dc2206e5e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i171aadf8a79b4a8faa50f9b31b327f84_I20230131" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfOS0xLTEtMS02ODc1MQ_00cc1042-fa59-4657-8c2f-9ef8b02f5c2b">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1682ba3d772453aaed03af1031bb843_I20230131" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfOS0zLTEtMS02ODc1MQ_ffa0fcac-79f7-44c5-8ff8-399e2e1e4a5f">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i109ec2cab42849fbbaba1a368387a380_I20230131" decimals="-6" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfOS01LTEtMS02ODc1MQ_a3e6e54d-7bfe-42a9-8254-355119dc2d23">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i010b31c6afda45549d3eba9b0bb42875_I20230131" decimals="-6" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfOS03LTEtMS02ODc1MQ_eca523b7-8291-446d-b256-e92b442fec98">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i171aadf8a79b4a8faa50f9b31b327f84_I20230131" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTAtMS0xLTEtNjg3NTE_c0b255fc-99ed-426a-98cc-3b297ec888ba">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1682ba3d772453aaed03af1031bb843_I20230131" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTAtMy0xLTEtNjg3NTE_07490c7a-aae1-4178-bfe6-ea78be215aa7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i109ec2cab42849fbbaba1a368387a380_I20230131" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTAtNS0xLTEtNjg3NTE_b9fa34e8-f6c5-49a0-896b-d9f96a02224b">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i010b31c6afda45549d3eba9b0bb42875_I20230131" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTAtNy0xLTEtNjg3NTE_1b84a55d-3b9c-4be3-83b1-9068f17534da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaaa0ef2c25948abb1a1d1b853e18ed6_I20230131" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTItMS0xLTEtNjg3NTE_990c6835-ceac-45dc-9295-79fcff436f17">723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7ced5b567134408b99ecb1dcf4ae051_I20230131" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTItMy0xLTEtNjg3NTE_6c2c1991-70c7-46f6-b8ad-e3ddfeb90824">688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76a06664a9c458885914a4582301f23_I20230131" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTItNS0xLTEtNjg3NTE_75a7c671-78aa-4169-b34b-0447c8771307">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a5d971f1eb44de8d7f86aad8db9e29_I20230131" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTItNy0xLTEtNjg3NTE_9e216aa4-c7f3-4cdf-92c2-3ce0769da7dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments (foreign exchange contracts) </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82e671a18849495b8fb217e22b89ec5e_I20230131" decimals="-6" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTUtMS0xLTEtNjg3NTE_bfe6b0fd-9e38-44c8-9c9b-32605b641775">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb56a780b484db596a8537265a00ae7_I20230131" decimals="-6" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTUtMy0xLTEtNjg3NTE_522810f8-5828-44d9-8b5f-f2a8824d8896">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75a58a1a2e104511a28697e212909d94_I20230131" decimals="-6" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTUtNS0xLTEtNjg3NTE_b98656d5-e787-48ae-9178-606e62f6206f">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i520e8d9623a54c38ad726102ce099ef0_I20230131" decimals="-6" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTUtNy0xLTEtNjg3NTE_44d503f3-9b82-442d-b98a-e01190bfe06a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82e671a18849495b8fb217e22b89ec5e_I20230131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTYtMS0xLTEtNjg3NTE_b91b7740-b723-4ea8-9559-ceb6c8647b26">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb56a780b484db596a8537265a00ae7_I20230131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTYtMy0xLTEtNjg3NTE_87a38941-c1d1-4502-a6cd-cbda230fc68a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75a58a1a2e104511a28697e212909d94_I20230131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTYtNS0xLTEtNjg3NTE_3b9b3721-1ebc-4777-82e7-a7cab4f2adca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b44dbcd02a9484b8ddc79b3a7fab6d0_I20230131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTYtNy0xLTEtNjg3NTE_d713423d-1fb1-47e0-94c1-be727dea7db4">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0bae153c6ff4111936aa0ad12293d37_I20230131" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTgtMS0xLTEtNjg3NTE_4e3af26a-44f7-41dc-bf13-75175c95337a">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6ceec45342244868b46e5292ec40d82_I20230131" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTgtMy0xLTEtNjg3NTE_8124fb4a-fe8a-4923-b8ab-f5a8da97a335">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a2fd80baf9f425780781f01120bc35f_I20230131" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTgtNS0xLTEtNjg3NTE_88db8f2a-6e2a-447a-aedd-44964e5863fa">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26efb771671d46d386db8ba65c21d53e_I20230131" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTgtNy0xLTEtNjg3NTE_2af9fdd8-0d77-4981-9593-c8886a1f93fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0bae153c6ff4111936aa0ad12293d37_I20230131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTktMS0xLTEtNjg3NTE_f21c05bd-77f7-4b19-aa39-14b51d55f776">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6ceec45342244868b46e5292ec40d82_I20230131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTktMy0xLTEtNjg3NTE_daae4483-bce8-4066-a8b3-1ae484f59f0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a2fd80baf9f425780781f01120bc35f_I20230131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTktNS0xLTEtNjg3NTE_e352c083-822e-406c-bbf8-7c42ec82024b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a38492613ee42308d5ca58cb82e54ef_I20230131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTktNy0xLTEtNjg3NTE_88415547-fc07-479c-8ffd-14c71f619713">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaaa0ef2c25948abb1a1d1b853e18ed6_I20230131" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMjAtMS0xLTEtNjg3NTE_538b137d-f450-4179-8160-816c2a86ecf4">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7ced5b567134408b99ecb1dcf4ae051_I20230131" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMjAtMy0xLTEtNjg3NTE_b4f93799-983b-42e7-a5eb-38c5cbb71238">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76a06664a9c458885914a4582301f23_I20230131" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMjAtNS0xLTEtNjg3NTE_2c040d1a-3454-45c8-8fcc-3a6f0ff643ec">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a5d971f1eb44de8d7f86aad8db9e29_I20230131" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMjAtNy0xLTEtNjg3NTE_bee0256b-120c-4788-9109-9ea1d33f24b8">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis as of October&#160;31, 2022 were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.186%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement at October 31, 2022 Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">in&#160;Active</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Markets&#160;for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Identical&#160;Assets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Observable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;3)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents (money market funds)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8a78ace67c24152ae9bf94ef8fff79d_I20221031" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfNS0xLTEtMS02ODc1MQ_998d5128-bdd1-41f1-9353-30673179b466">492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c10ebdbbadb4b66aa09bafa9c10e706_I20221031" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfNS0zLTEtMS02ODc1MQ_8a8db8bc-e4a0-411e-b99c-51082a937c6f">492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e5a6aeaf4184c46acacaeb8daab5f0e_I20221031" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfNS01LTEtMS02ODc1MQ_c90e7b61-22a7-4a65-9464-c9d8c7e9bcfc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd7fc31a934145e0b639ded81bd2a4d4_I20221031" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfNS03LTEtMS02ODc1MQ_e64fafc4-f1d9-4946-bb49-83a55dc02bc9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments (foreign exchange contracts)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8a78ace67c24152ae9bf94ef8fff79d_I20221031" decimals="-6" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfNi0xLTEtMS02ODc1MQ_fc0f06eb-dd9f-4eaf-9d33-88d737d563c7">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c10ebdbbadb4b66aa09bafa9c10e706_I20221031" decimals="-6" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfNi0zLTEtMS02ODc1MQ_76259344-5ed5-43c3-af35-f37244736b7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e5a6aeaf4184c46acacaeb8daab5f0e_I20221031" decimals="-6" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfNi01LTEtMS02ODc1MQ_18edb8c0-35d2-4341-be2f-262ebc4490ac">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd7fc31a934145e0b639ded81bd2a4d4_I20221031" decimals="-6" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfNi03LTEtMS02ODc1MQ_d0fbea8b-45fb-4426-9431-3ae014c803d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7721625bbc374f08999fc25fad1ac438_I20221031" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfOS0xLTEtMS02ODc1MQ_e1bc69ed-fad9-4ac2-9b4f-5d4bdfb7bdbe">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d7c15a459fa45b195a04ab621f88594_I20221031" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfOS0zLTEtMS02ODc1MQ_85777412-8705-48ee-9372-0ead162faac4">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02170c8657d54b96b0528a195ed9a6cd_I20221031" decimals="-6" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfOS01LTEtMS02ODc1MQ_24ec68d5-ed33-46b5-bd72-40805fe65a68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i281883c980b344c399e2833cbe9f3289_I20221031" decimals="-6" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfOS03LTEtMS02ODc1MQ_c05d0c28-ea79-45c4-ae7e-9009245a128a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7721625bbc374f08999fc25fad1ac438_I20221031" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTAtMS0xLTEtNjg3NTE_5a725580-ee25-4a9a-b3c1-4bcf218da54b">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d7c15a459fa45b195a04ab621f88594_I20221031" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTAtMy0xLTEtNjg3NTE_4efebe19-964b-4751-b7cb-b71d56d83854">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02170c8657d54b96b0528a195ed9a6cd_I20221031" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTAtNS0xLTEtNjg3NTE_0b98e729-abd1-4e55-a8d3-88929ab0df95">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i281883c980b344c399e2833cbe9f3289_I20221031" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTAtNy0xLTEtNjg3NTE_2156799c-5691-4d39-979c-922a9a7e35bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibeffa87382834b81853275826f27932c_I20221031" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTEtMS0xLTEtNjg3NTE_0d48aeac-becf-4314-9d06-1b961965e6fa">577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9dec0e06e6d42a3a1fc2593ab243f89_I20221031" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTEtMy0xLTEtNjg3NTE_58fd0f3a-557b-4e18-b648-7f67ca26ac58">523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c48d568a480440bbe49a9dd5591a169_I20221031" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTEtNS0xLTEtNjg3NTE_245aa663-eaaa-46bc-b419-c1a44c271123">54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5163f85023154e9ab98ef3ed85fa7d48_I20221031" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTEtNy0xLTEtNjg3NTE_6aa6d1b7-9b86-4e00-b6e8-bd47bfa00fce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments (foreign exchange contracts)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c579659bdb34d54a78c87a9d2a18b6d_I20221031" decimals="-6" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTQtMS0xLTEtNjg3NTE_f5722a82-22b1-41d8-ae8d-f9b3595e9feb">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id54402bbdc8b44b3b749044437d33713_I20221031" decimals="-6" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTQtMy0xLTEtNjg3NTE_4526251d-edbd-4f95-a331-41b0ab751be0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ec93e8012ad48e49930d3765f4c1246_I20221031" decimals="-6" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTQtNS0xLTEtNjg3NTE_dd823ea1-3fe6-4a54-866f-bf4e00378c19">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8f6a78e1ad4a9396e91d5d4207fb18_I20221031" decimals="-6" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTQtNy0xLTEtNjg3NTE_38fb1706-5316-4679-b276-d75262271ca9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c579659bdb34d54a78c87a9d2a18b6d_I20221031" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTUtMS0xLTEtNjg3NTE_32772517-39a2-4b02-a81e-1648d94c274e">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id54402bbdc8b44b3b749044437d33713_I20221031" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTUtMy0xLTEtNjg3NTE_767607f3-999f-4a26-9add-940ba47904e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ec93e8012ad48e49930d3765f4c1246_I20221031" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTUtNS0xLTEtNjg3NTE_13923686-76c9-45f3-abb4-f87994818c19">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7281c10e5fb4984b926202c8a6449b4_I20221031" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTUtNy0xLTEtNjg3NTE_b94414f1-4f9c-49f5-a12c-be008e03fea3">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b9a47671ca446ada8a588e63d75db26_I20221031" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTctMS0xLTEtNjg3NTE_1f7d6f22-6c34-4048-a510-fcba233a7334">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6200f5bde164b3aacc0816f6518870b_I20221031" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTctMy0xLTEtNjg3NTE_829e5282-5496-4812-8441-f2a0980de062">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58623f61e4ac46a6a1223beba978e707_I20221031" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTctNS0xLTEtNjg3NTE_725c71ca-cbbf-4272-bd3c-9f730775a9bb">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b98c020f64f40bca09058f4ab716c9c_I20221031" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTctNy0xLTEtNjg3NTE_6bfe2267-4f6a-4262-a216-40af80c2550d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b9a47671ca446ada8a588e63d75db26_I20221031" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTgtMS0xLTEtNjg3NTE_6c5a075b-c77f-49f2-80c3-3574bf82f637">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6200f5bde164b3aacc0816f6518870b_I20221031" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTgtMy0xLTEtNjg3NTE_c965a86b-cb1c-4ec3-9a0e-f2f59306559e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58623f61e4ac46a6a1223beba978e707_I20221031" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTgtNS0xLTEtNjg3NTE_1116a077-d6fa-439d-833d-bb44bcc5d9db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibef8720eccc140e49ee2951305a773c9_I20221031" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTgtNy0xLTEtNjg3NTE_d07431a4-73c1-4585-82de-69c26ae0048a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibeffa87382834b81853275826f27932c_I20221031" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTktMS0xLTEtNjg3NTE_135d99af-d8a3-4ef7-a94b-0d4b92b4efe3">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9dec0e06e6d42a3a1fc2593ab243f89_I20221031" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTktMy0xLTEtNjg3NTE_898bb00b-beb7-49b7-baab-4b380251575c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c48d568a480440bbe49a9dd5591a169_I20221031" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTktNS0xLTEtNjg3NTE_d0d9b35a-acf5-4ee2-8848-d01d1f1abe9f">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5163f85023154e9ab98ef3ed85fa7d48_I20221031" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTktNy0xLTEtNjg3NTE_e830dcc9-1513-444b-8c78-2a865e732543">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our money market funds and trading securities are generally valued using quoted market prices and therefore are classified within level&#160;1 of the fair value hierarchy. Our derivative financial instruments are classified within level 2, as there is not an active market for each hedge contract, but the inputs used to calculate the value of the instruments are tied to active </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i51b32d934ca745ec82ff1b96bfd36312" continuedAt="ie9a5af3c0eee441c875a8bce402c4ffa"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">markets.  Our deferred compensation liability is classified as level&#160;2 because, although the values are not directly based on quoted market prices, the inputs used in the calculations are observable. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other investments represent shares we own in a special fund that targets underlying investments of approximately 40 percent in debt securities and 60 percent in equity securities. These shares have been classified as level 2 because, although the shares of the fund are not traded on any active stock exchange, each of the individual underlying securities are or can be derived from and hence we have a readily determinable value for the underlying securities, from which we are able to determine the fair market value for the special fund itself. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trading securities, which are comprised of mutual funds, bonds and other similar instruments, other investments and deferred compensation liability are reported at fair value, with gains or losses resulting from changes in fair value recognized currently in net income. Certain derivative instruments are reported at fair value, with unrealized gains and losses, net of tax, included in accumulated other comprehensive income (loss) within stockholders' equity. Realized gains and losses from the sale of these instruments are recorded in net income.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:GainLossOnInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfODIzMw_ceab05a6-1f1b-4f4f-9aed-a0e42cb6c475" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains and losses reflected in other income (expense), net for our equity investments with readily determinable fair value ("RDFV") and equity investments without RDFV are summarized below:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.233%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.651%"></td><td style="width:0.1%"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss recognized during the period on equity securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOmQzNjAzYTYzYTNkODQ4NGM5ODI3NGMwMjI3ZTdiMDdiL3RhYmxlcmFuZ2U6ZDM2MDNhNjNhM2Q4NDg0Yzk4Mjc0YzAyMjdlN2IwN2JfNS01LTEtMS02ODc1MQ_44d5ebc2-9fe5-4b71-a1f6-335ab7e96f57">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOmQzNjAzYTYzYTNkODQ4NGM5ODI3NGMwMjI3ZTdiMDdiL3RhYmxlcmFuZ2U6ZDM2MDNhNjNhM2Q4NDg0Yzk4Mjc0YzAyMjdlN2IwN2JfNS03LTEtMS02ODc1MQ_7ee79f0f-95fc-44b5-bbf7-fd4be04f9950">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net loss on equity securities sold during the period</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOmQzNjAzYTYzYTNkODQ4NGM5ODI3NGMwMjI3ZTdiMDdiL3RhYmxlcmFuZ2U6ZDM2MDNhNjNhM2Q4NDg0Yzk4Mjc0YzAyMjdlN2IwN2JfNi01LTEtMS02ODc1MQ_526f163b-e7c2-4e99-8823-6c4b96344d56">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOmQzNjAzYTYzYTNkODQ4NGM5ODI3NGMwMjI3ZTdiMDdiL3RhYmxlcmFuZ2U6ZDM2MDNhNjNhM2Q4NDg0Yzk4Mjc0YzAyMjdlN2IwN2JfNi03LTEtMS02ODc1MQ_6b58362f-bd22-4895-95ee-1048983cd8e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (gain) loss on equity securities </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOmQzNjAzYTYzYTNkODQ4NGM5ODI3NGMwMjI3ZTdiMDdiL3RhYmxlcmFuZ2U6ZDM2MDNhNjNhM2Q4NDg0Yzk4Mjc0YzAyMjdlN2IwN2JfNy01LTEtMS02ODc1MQ_f8961e5b-67fd-4453-8fe5-93810c08a5dd">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOmQzNjAzYTYzYTNkODQ4NGM5ODI3NGMwMjI3ZTdiMDdiL3RhYmxlcmFuZ2U6ZDM2MDNhNjNhM2Q4NDg0Yzk4Mjc0YzAyMjdlN2IwN2JfNy03LTEtMS02ODc1MQ_e3a546d9-f2f6-474d-ab4a-6b55ac21d809">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The fair value of the contingent consideration liability relates to milestone payments in connection with the acquisition of advanced artificial intelligence technology in February 2022 and the acquisition of Resolution Bioscience in April 2021.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Resolution Bioscience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The fair value of the potential future milestone payments, which is set to certain revenue and technical targets, was based on (i) the probability of achieving the relevant revenue targets and technical milestones and (ii) the timing of achieving such milestones, which are significant unobservable inputs, and has been classified as Level 3. We used the Monte Carlo simulation approach to estimate the fair value of the revenue component which resulted in a fair value of <ix:nonFraction unitRef="usd" contextRef="i0cb8b86211c5442c9bef1b1297e7aefb_I20230131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNTIxNQ_97bea071-0e60-44aa-b524-825f261c4d9b">zero</ix:nonFraction>. A change in any of these unobservable inputs can significantly change the fair value of the contingent consideration. As of January&#160;31, 2023, the expected maximum earn-out period for the contingent payments does not exceed <ix:nonNumeric contextRef="i78c42080d0f14678bc601c2d0167baec_D20221101-20230131" name="a:BusinessCombinationsContingentConsiderationArrangements" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNTY2MA_6fd21bab-a3c0-43c5-9036-38c6bcca4137">1.9</ix:nonNumeric> years and potential future payments will not exceed $<ix:nonFraction unitRef="usd" contextRef="i16a365fe29a5430f9bd225bf44aa6737_I20230131" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNTcwOQ_6ad201e8-3da1-42dc-8fd0-3194790c7870">80</ix:nonFraction>&#160;million. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfODIzNA_52d31ddc-e44c-45ed-bf80-4eecdd8e1966" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent consideration liability is our only recurring Level 3 asset or liability.  A summary of the Level 3 activity follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:82.135%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOmUzYjY0MzQzMGIxYjQwMjQ5MjU1M2YxMDljZDk3NzlhL3RhYmxlcmFuZ2U6ZTNiNjQzNDMwYjFiNDAyNDkyNTUzZjEwOWNkOTc3OWFfNC01LTEtMS02ODc1MQ_9ea6a489-ded4-44e2-a05e-e7b7b3e2e17c">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56485a537aba4a7691bd4bf959f3eaad_I20211031" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOmUzYjY0MzQzMGIxYjQwMjQ5MjU1M2YxMDljZDk3NzlhL3RhYmxlcmFuZ2U6ZTNiNjQzNDMwYjFiNDAyNDkyNTUzZjEwOWNkOTc3OWFfNC03LTEtMS02ODc1MQ_802209e9-9494-429c-bb81-b93137d473e0">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to contingent consideration (including measurement period adjustment)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOmUzYjY0MzQzMGIxYjQwMjQ5MjU1M2YxMDljZDk3NzlhL3RhYmxlcmFuZ2U6ZTNiNjQzNDMwYjFiNDAyNDkyNTUzZjEwOWNkOTc3OWFfNS01LTEtMS02ODc1MQ_aa72ef69-4ecd-4798-a68b-ec9848e7c57c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOmUzYjY0MzQzMGIxYjQwMjQ5MjU1M2YxMDljZDk3NzlhL3RhYmxlcmFuZ2U6ZTNiNjQzNDMwYjFiNDAyNDkyNTUzZjEwOWNkOTc3OWFfNS03LTEtMS02ODc1MQ_14a06069-9ba1-495f-852b-f274c9141e27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOmUzYjY0MzQzMGIxYjQwMjQ5MjU1M2YxMDljZDk3NzlhL3RhYmxlcmFuZ2U6ZTNiNjQzNDMwYjFiNDAyNDkyNTUzZjEwOWNkOTc3OWFfNi01LTEtMS05MjA5Mg_9b54a04d-adbc-427d-a0c9-5219f6b6d891">65</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOmUzYjY0MzQzMGIxYjQwMjQ5MjU1M2YxMDljZDk3NzlhL3RhYmxlcmFuZ2U6ZTNiNjQzNDMwYjFiNDAyNDkyNTUzZjEwOWNkOTc3OWFfNi03LTEtMS05MjA5Mg_54c5a5a3-6c84-4283-b038-5572421c4a54">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value (included within selling, general and administrative expenses)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOmUzYjY0MzQzMGIxYjQwMjQ5MjU1M2YxMDljZDk3NzlhL3RhYmxlcmFuZ2U6ZTNiNjQzNDMwYjFiNDAyNDkyNTUzZjEwOWNkOTc3OWFfNi01LTEtMS02ODc1MQ_62ebb3a1-033a-4337-b8bc-7102f827cc8c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOmUzYjY0MzQzMGIxYjQwMjQ5MjU1M2YxMDljZDk3NzlhL3RhYmxlcmFuZ2U6ZTNiNjQzNDMwYjFiNDAyNDkyNTUzZjEwOWNkOTc3OWFfNi03LTEtMS02ODc1MQ_fe3c4c52-2613-45dd-ae1b-fe9e191cb84e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOmUzYjY0MzQzMGIxYjQwMjQ5MjU1M2YxMDljZDk3NzlhL3RhYmxlcmFuZ2U6ZTNiNjQzNDMwYjFiNDAyNDkyNTUzZjEwOWNkOTc3OWFfNy01LTEtMS02ODc1MQ_835d4578-e56a-4621-909b-cf3adb89112e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7452fced71814cff84c1f48750a63bfa_I20220131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOmUzYjY0MzQzMGIxYjQwMjQ5MjU1M2YxMDljZDk3NzlhL3RhYmxlcmFuZ2U6ZTNiNjQzNDMwYjFiNDAyNDkyNTUzZjEwOWNkOTc3OWFfNy03LTEtMS02ODc1MQ_08bf5e3a-fa54-4333-98ed-85af3200e208">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the contingent consideration liability as of January&#160;31, 2023, was estimated to be $<ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNTk0NA_2b5ec3dc-9b96-471b-8d08-cfa80adc738b">3</ix:nonFraction> million of which $<ix:nonFraction unitRef="usd" contextRef="i5b44dbcd02a9484b8ddc79b3a7fab6d0_I20230131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNTk1Ng_d713423d-1fb1-47e0-94c1-be727dea7db4">2</ix:nonFraction> million was recorded in other accrued liabilities and $<ix:nonFraction unitRef="usd" contextRef="i3a38492613ee42308d5ca58cb82e54ef_I20230131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNjAwNQ_88415547-fc07-479c-8ffd-14c71f619713">1</ix:nonFraction> million was recorded in other long-term liabilities on the condensed consolidated balance sheet. During the three months ended January&#160;31, 2023, we made a contingent consideration payment of $<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNTQ5NzU1ODI1NzQ2_9b54a04d-adbc-427d-a0c9-5219f6b6d891">65</ix:nonFraction>&#160;million related to the achievement of a certain technical milestone associated with our acquisition of Resolution Bioscience.</span></div></ix:continuation><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ie9a5af3c0eee441c875a8bce402c4ffa"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of Investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> There were <ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:ImpairmentOfInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNjM0NA_5894d0f2-9874-4e37-88da-6075ae6e383f"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:ImpairmentOfInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNjM0NA_956ae9b0-ff2c-4259-b698-25e27e49c278"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:ImpairmentOfInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNjM0NA_ab949d26-8fc7-4837-8752-1febc5ebba2d"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:ImpairmentOfInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNjM0NA_cadb0055-34cf-4fcd-ae3d-aa78f89dd63a">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> impairments of investments for the three months ended January&#160;31, 2023 and 2022.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended January&#160;31, 2023 and 2022 , there were <ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNjUyMg_2311adbb-7524-4f51-8e4a-220c295eba79"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNjUyMg_4b98fc8a-e8ce-4864-a0ba-a51c0c2b1219"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNjUyMg_df622140-3874-43d2-9a18-314c67222f98"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNjUyMg_e73f120d-0429-44ed-a730-05e05c53c5d5">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> impairments of long-lived assets held and used or long-lived assets held for sale. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-Marketable Equity Securities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended January&#160;31, 2023 and 2022, there were <ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNjk5OA_41f2f088-8cb8-4b1c-b6af-cf6a991f5bdd"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNjk5OA_57e505d5-e33c-4cd3-850c-e88606d5354c"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNjk5OA_950aa537-e2c1-43e1-9a3b-fd518d7831bd"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNjk5OA_9e6bdd6b-7973-448b-94a2-bc078bf98cc9"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNjk5OA_d6eabc87-ec45-426b-96ce-57f0b34afe44"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNjk5OA_f3ea6c8c-ad68-4213-aa9c-66d0727c7bed">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> impairments or unrealized gain (loss) adjustments to the carrying value of non-marketable securities without readily determinable fair value based on an observable market transaction.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January&#160;31, 2023, the cumulative net gain (loss) on our non-marketable equity securities without readily determinable fair values was comprised of a $<ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfMjE5OTAyMzI2NDU1MA_eb257cd2-2fd6-4f0c-9a06-6bad0d180404">35</ix:nonFraction>&#160;million gain and <ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfMjE5OTAyMzI2NDg0OA_a4841470-e57f-4be6-82da-512c22cb7aa5">no</ix:nonFraction> losses, and the carrying amount was $<ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfMjE5OTAyMzI2NDg2MQ_048e9dbf-050d-4205-942d-31f78f7ddbd0">126</ix:nonFraction>&#160;million. As of January&#160;31, 2022, the cumulative net gain (loss) on our non-marketable equity securities without readily determinable fair values was comprised of a $<ix:nonFraction unitRef="usd" contextRef="i7452fced71814cff84c1f48750a63bfa_I20220131" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfMjE5OTAyMzI2NDY4OQ_2d06db08-e22c-4990-9c08-d5eb4e9cfdcf">30</ix:nonFraction>&#160;million gain and <ix:nonFraction unitRef="usd" contextRef="i7452fced71814cff84c1f48750a63bfa_I20220131" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfMjE5OTAyMzI2NDcxNg_8cf44bfb-3d85-453b-bcdc-2949687dd874">no</ix:nonFraction> losses, and the carrying amount was $<ix:nonFraction unitRef="usd" contextRef="i7452fced71814cff84c1f48750a63bfa_I20220131" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfMjE5OTAyMzI2NDc0Mw_e361bb9e-513a-48b9-b3f4-8916c76ca429">125</ix:nonFraction>&#160;million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair values for the non-marketable securities included in long-term investments on the condensed consolidated balance sheet were measured using Level 3 inputs because they are primarily equity stock issued by private companies without quoted market prices. To estimate the fair value of our non-marketable securities, we use the measurement alternative to record these investments at cost and adjust for impairments and observable price changes (orderly transactions for the identical or a similar security from the same issuer) as and when they occur.</span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.   <ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfNzg3Mg_d670ed29-e5f1-461d-a724-2b483fe7a88c" continuedAt="i149074730d724d519be93bbdfaf0c6b7" escape="true">DERIVATIVES</ix:nonNumeric></span></div><ix:continuation id="i149074730d724d519be93bbdfaf0c6b7" continuedAt="ic276d3f38a6340f2bbdf4f05d5622171"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to foreign currency exchange rate fluctuations and interest rate changes in the normal course of our business. As part of our risk management strategy, we use derivative instruments, primarily forward contracts and purchased options to hedge economic and/or accounting exposures resulting from changes in foreign currency exchange rates.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flow Hedges</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into foreign exchange contracts to hedge our forecasted operational cash flow exposures resulting from changes in foreign currency exchange rates. These foreign exchange contracts, carried at fair value, have maturities between one and twelve months. These derivative instruments are designated and qualify as cash flow hedges under the criteria prescribed in the authoritative guidance and are assessed for effectiveness against the underlying exposure every reporting period. For open contracts as of January&#160;31, 2023, changes in the time value of the foreign exchange contract are excluded from the assessment of hedge effectiveness and are recognized in cost of sales over the life of the foreign exchange contract. The changes in fair value of the effective portion of the derivative instrument are recognized in accumulated other comprehensive income (loss). Amounts associated with cash flow hedges are reclassified to cost of sales in the condensed consolidated statement of operations when the forecasted transaction occurs. If it becomes probable that the forecasted transaction will not occur, the hedge relationship will be de-designated and amounts accumulated in other comprehensive income (loss) will be reclassified to other income (expense), net in the current period. Changes in the fair value of the ineffective portion of derivative instruments are recognized in other income (expense), net in the condensed consolidated statement of operations in the current period. We record the premium paid (time value) of an option on the date of purchase as an asset. For options designated as cash flow hedges, changes in the time value are excluded from the assessment of hedge effectiveness and are recognized in cost of sales over the life of the option contract. For the three months ended January&#160;31, 2023 and 2022, ineffectiveness and gains and losses recognized in other income (expense), net due to de-designation of cash flow hedge contracts were not significant.  </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, Agilent executed <ix:nonFraction unitRef="contracts" contextRef="ib98f34fc7f8142658a397ac37f6164c3_I20160201" decimals="0" name="us-gaap:NumberOfInterestRateDerivativesHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfMjM5Nw_0ea2514d-7edc-473c-8abb-3f85b87ee979">three</ix:nonFraction> forward-starting pay fixed/receive variable interest rate swaps for the notional amount of $<ix:nonFraction unitRef="usd" contextRef="ib98f34fc7f8142658a397ac37f6164c3_I20160201" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfMjQ5MQ_cd235bc1-0dc3-4fe5-8968-5bc912a73df4">300</ix:nonFraction> million in connection with future interest payments to be made on our 2026 senior notes issued on September 15, 2016. These derivative instruments were designated and qualified as cash flow hedges under the criteria prescribed in the authoritative guidance. The swap arrangements were terminated on September 15, 2016 with a payment of $<ix:nonFraction unitRef="usd" contextRef="i324659d1cb1d46c89cd0b89529d4034d_D20160914-20160915" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfMjgyMg_05148ec3-0f7f-45cb-afae-7b56119b0dfa">10</ix:nonFraction> million, and we recognized this as a deferred loss in accumulated other comprehensive income (loss) which is being amortized to interest expense over the life of the 2026 senior notes. The remaining loss to be amortized related to the interest rate swap agreements at January&#160;31, 2023 was $<ix:nonFraction unitRef="usd" contextRef="i78d62c946c8542959b4e01f2cf974dd8_D20221101-20230131" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfMzA5Mg_3956902c-974f-426e-8785-f26412cfe923">3</ix:nonFraction> million. </span></div></ix:continuation><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ic276d3f38a6340f2bbdf4f05d5622171" continuedAt="i1c261f88271b43e28aeeb5da3e22501a"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, Agilent executed treasury lock agreements for $<ix:nonFraction unitRef="usd" contextRef="ia8fcf2a391464f039d40d132dd664e20_I20190816" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfMzE2MA_c8477611-c133-465e-b685-56bdadd1a51c">250</ix:nonFraction> million in connection with future interest payments to be made on our 2029 senior notes issued on September 16, 2019. We designated the treasury lock as a cash flow hedge. The treasury lock contracts were terminated on September 6, 2019, and we recognized a deferred loss of $<ix:nonFraction unitRef="usd" contextRef="i904b39b3a0a541d89b9c91d944f3526e_D20190906-20190906" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfMzQzMA_11def5fa-7293-43bf-ac0e-52dea9ad649b">6</ix:nonFraction>&#160;million in accumulated other comprehensive income (loss) which is being amortized to interest expense over the life of the 2029 senior notes. The remaining loss to be amortized related to the treasury lock agreements at January&#160;31, 2023 was $<ix:nonFraction unitRef="usd" contextRef="i3c598168990b490090f5881a47627e8c_D20221101-20230131" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfMzY1Mg_9efc4da7-7b65-425a-a0aa-6a713bb5ae3a">4</ix:nonFraction> million. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Hedges </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into foreign exchange contracts to hedge net investments in foreign operations to mitigate the risk of adverse movements in exchange rates. These foreign exchange contracts are carried at fair value and are designated and qualify as net investment hedges under the criteria prescribed in the authoritative guidance. Changes in fair value of the effective portion of the derivative instrument are recognized in accumulated other comprehensive income (loss)- translation adjustment and are assessed for effectiveness against the underlying exposure every reporting period. If the company&#8217;s net investment changes during the year, the hedge relationship will be assessed and de-designated if the hedge notional amount is outside of prescribed tolerance with a gain/loss reclassified from other comprehensive income (loss) to other income (expense) in the current period. For the three months ended January&#160;31, 2023, ineffectiveness and the resultant effect of any gains or losses recognized in other income (expense) due to de-designation of the hedge contracts were not significant.  </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Hedges</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we enter into foreign exchange contracts to hedge monetary assets and liabilities that are denominated in currencies other than the functional currency of our subsidiaries. These foreign exchange contracts are carried at fair value and do not qualify for hedge accounting treatment and are not designated as hedging instruments. Changes in value of the derivative instruments are recognized in other income (expense), net in the condensed consolidated statement of operations, in the current period, along with the offsetting foreign currency gain or loss on the underlying assets or liabilities.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our use of derivative instruments exposes us to credit risk to the extent that the counterparties may be unable to meet the terms of the agreement. We do, however, seek to mitigate such risks by limiting our counterparties to major financial institutions which are selected based on their credit ratings and other factors.&#160;We have established policies and procedures for mitigating credit risk that include establishing counterparty credit limits, monitoring credit exposures, and continually assessing the creditworthiness of counterparties.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of our derivative agreements contain threshold limits to the net liability position with counterparties and are dependent on our corporate credit rating determined by the major credit rating agencies. The counterparties to the derivative instruments may request collateralization, in accordance with derivative agreements, on derivative instruments in net liability positions.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate fair value of all derivative instruments with credit-risk-related contingent features that were in a net liability position as of January&#160;31, 2023, was $<ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:DerivativeNetLiabilityPositionAggregateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfNjQ0NQ_7bd0e96c-6d0c-43ce-a01a-70b018847452">23</ix:nonFraction>&#160;million. The credit-risk-related contingent features underlying these agreements had not been triggered as of January&#160;31, 2023.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="contracts" contextRef="i6368af5356e443e2b1bcf93e16e6d501_I20230131" decimals="0" name="us-gaap:NumberOfForeignCurrencyDerivativesHeld" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfNjU3Ng_1d2eb610-5287-4925-aff7-98eee5a7cc7c">270</ix:nonFraction> foreign exchange forward contracts open as of January&#160;31, 2023, and designated as cash flow hedges. There were <ix:nonFraction unitRef="contracts" contextRef="ia16943661c8e4bc59b6314507abbb36d_I20230131" decimals="0" name="us-gaap:NumberOfForeignCurrencyDerivativesHeld" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfNjY3NQ_ea7376ae-d362-4d1e-afac-b67d5deb242e">189</ix:nonFraction> foreign exchange forward contracts open as of January&#160;31, 2023, and not designated as hedging instruments. There were <ix:nonFraction unitRef="contracts" contextRef="i1cb76a4102ed49558e2227ab243ac8fd_I20230131" decimals="0" name="us-gaap:NumberOfForeignCurrencyDerivativesHeld" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfNjc4MQ_859f7a2d-2ecf-4f77-9695-64a8ae076918">3</ix:nonFraction> foreign exchange forward contracts open as of January&#160;31, 2023, and designated as a net investment hedge.</span></div></ix:continuation><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i1c261f88271b43e28aeeb5da3e22501a" continuedAt="i532cf446d48b466d9dc5763128832703"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfNzg4Ng_d1d21467-77e8-416c-8112-02d5b86abfc3" continuedAt="i98094cdf048f456d9676c8ccda3d7a09" escape="true">The aggregated notional amounts by currency and designation as of January&#160;31, 2023, were as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i98094cdf048f456d9676c8ccda3d7a09"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:44.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.786%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.080%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.258%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives&#160;<br/>Designated as <br/>Cash&#160;Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives <br/>Designated as <br/>Net Investment Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives <br/>Not Designated as&#160;<br/>Hedging Instruments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Forward<br/>Contracts USD</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Forward<br/>Contracts USD</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Forward<br/>Contracts USD</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Buy/(Sell)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Buy/(Sell)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Buy/(Sell)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70fa0d9850894ce2bd08150dce5dd880_I20230131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfNC0yLTEtMS02ODc1MQ_20052d65-6758-4cd2-8bb6-f38bd2f83551">83</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0d17d231ad5405b9ae739955f35f425_I20230131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfNC02LTEtMS02ODc1MQ_4050b229-c81c-47e3-8b11-06550abf2380">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bd82f3839e44ab192c48ef9a1870c15_I20230131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfNC04LTEtMS02ODc1MQ_94d7f3d1-2c71-41a1-ae86-5a7a8a2d5d6b">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">British Pound</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17dde9e7368e4020ab08f6c0f4846ca7_I20230131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfNS0yLTEtMS02ODc1MQ_d66a7361-5493-4310-8c92-f1e7d8800d1c">67</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf03d71e237844c9ab4a9ebd0faa3359_I20230131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfNS04LTEtMS02ODc1MQ_ec44c34f-92ae-4beb-9991-6b54e710aa7f">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canadian Dollar</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5aafc014163f40529f30fefed7819d7b_I20230131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfNi0yLTEtMS02ODc1MQ_3e31e83b-e48f-450a-a70c-25794ce4107b">54</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71cd31f9f70b417fb1bb4b7d5392f0b2_I20230131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfNi04LTEtMS02ODc1MQ_2c4ca607-423c-4057-9e25-42dbc0b5680b">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japanese Yen</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3775203ec49249b4ab76f5cf6f2294ee_I20230131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfOS0yLTEtMS02ODc1MQ_bb2caa1b-fec4-4614-9ab8-34575c687ab2">89</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5ed8a5ca0774169b7f944d0bc113de9_I20230131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfOS04LTEtMS02ODc1MQ_029b75bb-db99-42f3-9be5-ebc0af8bfdd8">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danish Krone</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic52474b3fc2c44c7bec341cd3919960f_I20230131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfMTAtOC0xLTEtNjg3NTE_6f90cfb4-d86e-45c6-8bd4-d930248164be">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Korean Won</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia08df4cafe1540658c021ebd7e9ffadf_I20230131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfMTEtMi0xLTEtNjg3NTE_45dc43f7-5d0f-4eca-bfb2-883363c02338">77</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61cfdf67052b485b9591582a21abe8d0_I20230131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfMTEtOC0xLTEtNjg3NTE_76d91763-cc5c-47c2-a6b1-90779d2336cc">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore Dollar</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i295d08acf58449ef98033f4386430180_I20230131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfMTItMi0xLTEtNjg3NTE_ad01c851-7355-4b85-ba6a-b695fe74c7b1">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33d60a29c4894eb3bbb33a68e4118838_I20230131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfMTItOC0xLTEtNjg3NTE_89372417-9b9e-405a-8650-964efbfb1366">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chinese Yuan Renminbi</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52e8713c120048e69a3901dd8044bd07_I20230131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfMTQtMi0xLTEtNjg3NTE_1a6f4722-4b5b-4202-9eae-18bbd36805d5">90</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16cf2f8e131444838a3d586870b9b6c9_I20230131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfMTQtOC0xLTEtNjg3NTE_c3a86099-22e7-46f2-97a1-5692425f869f">126</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taiwan Dollar</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ef13b82dfee4eb7bbf8c4421b6feda3_I20230131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfMTctOC0xLTEtNjg3NTE_d240d731-7504-4922-852a-93e463f1b8a6">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indian Rupee</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23a1060162f147c9b80ea9c15caa11f8_I20230131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfMTgtOC0xLTEtNjg3NTE_0bf6bddd-3789-4514-83b0-971ee69114a1">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfcbd73a2af54018a2f5aeb70c0a2d56_I20230131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfMjEtMi0xLTEtNjg3NTE_3b35a8e4-772f-480e-8caf-f684874dd7a9">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia52b02295eb54f4498499beee0165955_I20230131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfMjEtOC0xLTEtNjg3NTE_8da55acf-61f0-4841-9e9d-156c23239e8d">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Totals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie806c5c691284655bfd5c99810e88955_I20230131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfMjItMi0xLTEtNjg3NTE_b1c0e425-ef32-4d5b-90cc-37f2dceb7f74">434</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9849f16147a4c6a8af2c15f51852e70_I20230131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfMjItNi0xLTEtNjg3NTE_23db4ca1-6862-4b19-a605-d62fea201080">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i601ab9e19dde4d31bfab5c2b2c29aaef_I20230131" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfMjItOC0xLTEtNjg3NTE_d2f2a130-5f8f-4269-80f1-707c5450633c">152</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfNzg3Nw_71df566a-58e6-476a-bf74-21c6f21a5a76" continuedAt="i23cfb07da6484004b047a00830dc6d02" escape="true">Derivative instruments are subject to master netting arrangements and are disclosed gross in the balance sheet in accordance with the authoritative guidance. The gross fair values and balance sheet location of derivative instruments held in the condensed consolidated balance sheet as of January&#160;31, 2023, and October&#160;31, 2022, were as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><ix:continuation id="i23cfb07da6484004b047a00830dc6d02"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:29.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.875%"></td><td style="width:0.1%"></td></tr><tr><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;text-indent:-31.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Values&#160;of&#160;Derivative&#160;Instruments</span></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset&#160;Derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability&#160;Derivatives</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;Sheet&#160;Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;Sheet&#160;Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31,<br/>2022</span></td></tr><tr><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d83ab74cb7347a5997c114b0ed5304e_I20230131" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjhkODMzMGNjNWViYzQ4M2M5ZDRkZTg4NDBmY2E1NDBhL3RhYmxlcmFuZ2U6OGQ4MzMwY2M1ZWJjNDgzYzlkNGRlODg0MGZjYTU0MGFfOC0yLTEtMS02ODc1MQ_d6c87233-13a1-4a19-a0ae-d6520b78083e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57b59664cd454e6cbc394cafcff6db66_I20221031" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjhkODMzMGNjNWViYzQ4M2M5ZDRkZTg4NDBmY2E1NDBhL3RhYmxlcmFuZ2U6OGQ4MzMwY2M1ZWJjNDgzYzlkNGRlODg0MGZjYTU0MGFfOC00LTEtMS02ODc1MQ_1c1e309e-d419-4d51-b949-08c95dee1dbf">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b2775a8204c459cb7fac69d437dc90c_I20230131" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjhkODMzMGNjNWViYzQ4M2M5ZDRkZTg4NDBmY2E1NDBhL3RhYmxlcmFuZ2U6OGQ4MzMwY2M1ZWJjNDgzYzlkNGRlODg0MGZjYTU0MGFfOC04LTEtMS02ODc1MQ_3a93136f-59bd-4378-9f2f-a3be1b7cdb7b">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb19970c8c74e3ea1d87896cfeb7d28_I20221031" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjhkODMzMGNjNWViYzQ4M2M5ZDRkZTg4NDBmY2E1NDBhL3RhYmxlcmFuZ2U6OGQ4MzMwY2M1ZWJjNDgzYzlkNGRlODg0MGZjYTU0MGFfOC0xMC0xLTEtNjg3NTE_4160d018-31d9-4284-bbee-8dc9cd48d741">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4660a8668a594fbaae707aa7558ab4e3_I20230131" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjhkODMzMGNjNWViYzQ4M2M5ZDRkZTg4NDBmY2E1NDBhL3RhYmxlcmFuZ2U6OGQ4MzMwY2M1ZWJjNDgzYzlkNGRlODg0MGZjYTU0MGFfMTItMi0xLTEtNjg3NTE_46b246f8-f234-4517-a50e-c624969870a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3443903b09984986b9027f5937e42b78_I20221031" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjhkODMzMGNjNWViYzQ4M2M5ZDRkZTg4NDBmY2E1NDBhL3RhYmxlcmFuZ2U6OGQ4MzMwY2M1ZWJjNDgzYzlkNGRlODg0MGZjYTU0MGFfMTItNC0xLTEtNjg3NTE_8d163229-51ee-49dd-b2b7-52c169574a5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87421f1569744288b0e82400d83000e1_I20230131" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjhkODMzMGNjNWViYzQ4M2M5ZDRkZTg4NDBmY2E1NDBhL3RhYmxlcmFuZ2U6OGQ4MzMwY2M1ZWJjNDgzYzlkNGRlODg0MGZjYTU0MGFfMTItOC0xLTEtNjg3NTE_e98ef60a-fca3-4b2d-93fa-eb3cb986b691">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaab05383499649d68262077bbecf0617_I20221031" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjhkODMzMGNjNWViYzQ4M2M5ZDRkZTg4NDBmY2E1NDBhL3RhYmxlcmFuZ2U6OGQ4MzMwY2M1ZWJjNDgzYzlkNGRlODg0MGZjYTU0MGFfMTItMTAtMS0xLTY4NzUx_8b69875a-4d8e-4ecf-9ec0-7ef9c8392868">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22ad5bff85274efd9620a8216896b106_I20230131" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjhkODMzMGNjNWViYzQ4M2M5ZDRkZTg4NDBmY2E1NDBhL3RhYmxlcmFuZ2U6OGQ4MzMwY2M1ZWJjNDgzYzlkNGRlODg0MGZjYTU0MGFfMTctMi0xLTEtNjg3NTE_4257520a-5b90-4da7-a32d-ebed296fef7a">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie15965d2e28741fe8be38f4bf8c301ec_I20221031" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjhkODMzMGNjNWViYzQ4M2M5ZDRkZTg4NDBmY2E1NDBhL3RhYmxlcmFuZ2U6OGQ4MzMwY2M1ZWJjNDgzYzlkNGRlODg0MGZjYTU0MGFfMTctNC0xLTEtNjg3NTE_1d39a2d6-0666-46e5-a3ef-0175ca2a477c">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48143490c5ee44a2abd1901822b86a71_I20230131" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjhkODMzMGNjNWViYzQ4M2M5ZDRkZTg4NDBmY2E1NDBhL3RhYmxlcmFuZ2U6OGQ4MzMwY2M1ZWJjNDgzYzlkNGRlODg0MGZjYTU0MGFfMTctOC0xLTEtNjg3NTE_dd32d09c-d5a7-4851-ba30-3b88d9d93010">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i873674ebcbd7473eb35b8c4112bc01f3_I20221031" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjhkODMzMGNjNWViYzQ4M2M5ZDRkZTg4NDBmY2E1NDBhL3RhYmxlcmFuZ2U6OGQ4MzMwY2M1ZWJjNDgzYzlkNGRlODg0MGZjYTU0MGFfMTctMTAtMS0xLTY4NzUx_45a5909c-3c46-4704-8567-717a4cd0a3cb">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjhkODMzMGNjNWViYzQ4M2M5ZDRkZTg4NDBmY2E1NDBhL3RhYmxlcmFuZ2U6OGQ4MzMwY2M1ZWJjNDgzYzlkNGRlODg0MGZjYTU0MGFfMTgtMi0xLTEtNjg3NTE_a55a4e2a-365e-4387-b977-03abaa3a2aae">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjhkODMzMGNjNWViYzQ4M2M5ZDRkZTg4NDBmY2E1NDBhL3RhYmxlcmFuZ2U6OGQ4MzMwY2M1ZWJjNDgzYzlkNGRlODg0MGZjYTU0MGFfMTgtNC0xLTEtNjg3NTE_fbfcab47-09c2-419a-bee6-24949c499f13">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjhkODMzMGNjNWViYzQ4M2M5ZDRkZTg4NDBmY2E1NDBhL3RhYmxlcmFuZ2U6OGQ4MzMwY2M1ZWJjNDgzYzlkNGRlODg0MGZjYTU0MGFfMTgtOC0xLTEtNjg3NTE_1ed5af3d-4045-4c02-8c7f-2ea90330d961">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjhkODMzMGNjNWViYzQ4M2M5ZDRkZTg4NDBmY2E1NDBhL3RhYmxlcmFuZ2U6OGQ4MzMwY2M1ZWJjNDgzYzlkNGRlODg0MGZjYTU0MGFfMTgtMTAtMS0xLTY4NzUx_d5715830-a185-4f8d-ae7e-f4b6af6de733">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i532cf446d48b466d9dc5763128832703"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfNzg4Mg_d268799b-abdc-43fe-91d5-e2555f977b23" continuedAt="i4d9b3fa174194ffc8a2cd35ee5ffc22c" escape="true">The effects of derivative instruments for foreign exchange contracts designated as hedging instruments and not designated as hedging instruments in our condensed consolidated statement of operations were as follows:</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i4d9b3fa174194ffc8a2cd35ee5ffc22c"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.356%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.944%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Cash Flow Hedges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in accumulated other comprehensive&#160;loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69c58982edd04b3c8b9b1a661fa43077_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTAtNS0xLTEtNjg3NTE_76b79b65-d061-49ae-869f-831bff19746b">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i446051e3e67a4f3eb24fc2a9fc021f9f_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTAtNy0xLTEtNjg3NTE_83828d7a-fbc0-4872-822c-65f3a0d97bf6">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) reclassified from accumulated other comprehensive&#160;loss into cost of sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTItNS0xLTEtNjg3NTE_9acfeb89-7d88-4046-b4c7-cb2eb4fcaa42"><ix:nonFraction unitRef="usd" contextRef="ibe16525b780846f0a8256296b5fb0f87_D20221101-20230131" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTItNS0xLTEtNjg3NTE_b4df5c84-d980-4b48-8f4d-82d138dd4ec7">6</ix:nonFraction></span>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTItNy0xLTEtNjg3NTE_4ec61448-9de2-40a0-8dd4-e126176d3a29"><ix:nonFraction unitRef="usd" contextRef="i359eb8716c884382914b552c36e4c9cc_D20211101-20220131" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTItNy0xLTEtNjg3NTE_4ee1a9f9-0462-4e03-9fcc-bc50c623fb3b">3</ix:nonFraction></span>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on time value of forward contracts recorded in cost of sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTctNS0xLTEtNjg3NTE_e833622d-040d-4809-bc1d-d9369471a833"><ix:nonFraction unitRef="usd" contextRef="ibe16525b780846f0a8256296b5fb0f87_D20221101-20230131" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTctNS0xLTEtNjg3NTE_1472c1fa-54ce-4f5d-8846-cde686551779">2</ix:nonFraction></span>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTctNy0xLTEtNjg3NTE_ae37cd7a-d092-478d-9c12-235792651f19"><ix:nonFraction unitRef="usd" contextRef="i359eb8716c884382914b552c36e4c9cc_D20211101-20220131" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTctNy0xLTEtNjg3NTE_2991a36d-def5-4bf7-8e70-e6c1498717bc">&#8212;</ix:nonFraction></span>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Net Investment Hedges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in accumulated other comprehensive loss - translation adjustment</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1a503ae15114ad2ab5911699cb1de9d_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMjEtNS0xLTEtNjg3NTE_5788f57b-a3cd-4d62-85a8-dcb40ed19280">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68beea4ee84a417ab91740679bcbab4d_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMjEtNy0xLTEtNjg3NTE_fec02099-0bc4-4a06-bdc4-17edcbe73231">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in other income (expense)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMjUtNS0xLTEtNjg3NTE_7bdf9258-4aa3-411c-b03c-7da3efd96a29">(<ix:nonFraction unitRef="usd" contextRef="i1e03d76a6cd14445b069223cf851a0fb_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMjUtNS0xLTEtNjg3NTE_c467ed55-5e28-4742-970a-24ba5b65b71c">13</ix:nonFraction>)</span></span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMjUtNy0xLTEtNjg3NTE_295a067e-a8da-4362-a6e5-55ad7d16f169">(<ix:nonFraction unitRef="usd" contextRef="i2fb1f98c73934300bcb2677be16791c7_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMjUtNy0xLTEtNjg3NTE_d759c8b5-c83d-4a47-a21f-ead407b8441a">3</ix:nonFraction>)</span></span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At January&#160;31, 2023, the amount of existing net gain that is expected to be reclassified from accumulated other comprehensive income (loss) is $<ix:nonFraction unitRef="usd" contextRef="ia7aac091b08c48afba3a0408369ffcc4_D20221101-20230131" decimals="-6" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfNzYzNg_c08a00d0-48e1-4ed1-ac13-a61a69a10151">14</ix:nonFraction> million. Within the next twelve months it is estimated that $<ix:nonFraction unitRef="usd" contextRef="i34dcb13592ff484696f17ceb6e02417d_D20221101-20230131" decimals="-6" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfNzY5MQ_1aff736f-1bc1-4b70-900e-60fe9a782740">19</ix:nonFraction> million of loss included within the net amount of accumulated other comprehensive income (loss) will be reclassified to cost of sales in respect of cash flow hedges.</span></div></ix:continuation><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.   <ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RleHRyZWdpb246YjQxMzQ5ZjQ3NTQ4NDUwZmI1MjBjOTAyNmE5OTkzYzlfNjI5_602637e0-cadf-49f0-8dc6-5e4d2be52616" continuedAt="i04739f4c9fd340d0b823c1c6c5d7142e" escape="true">RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><ix:continuation id="i04739f4c9fd340d0b823c1c6c5d7142e" continuedAt="ia55e3321b86f4dcea48315e1519cf8a9"><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RleHRyZWdpb246YjQxMzQ5ZjQ3NTQ4NDUwZmI1MjBjOTAyNmE5OTkzYzlfNjMy_72b7c827-619b-4f7b-9cac-ad9ea46e40f9" escape="true"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Components of net periodic costs (benefits).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For the three months ended January&#160;31, 2023 and 2022, our net pension and post retirement benefit costs (benefits) were comprised of the following:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:42.365%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.715%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:42.365%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.715%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended January 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S. <br/>Pension&#160;Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S.<br/>Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.&#160;Post&#160;Retirement<br/>Benefit&#160;Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost&#8212;benefits earned during the period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i125675019576446bbc7947a564d0c89f_D20221101-20230131" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfNi0xLTEtMS02ODc1MQ_664c6728-5478-4f20-82ed-24f01dba256f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e99b539b79445c1b5eceb9da39435cd_D20211101-20220131" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfNi0zLTEtMS02ODc1MQ_43152f85-f504-45f2-9944-33db7e0816c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c2a35f6169348d4bb4fe4e665306d51_D20221101-20230131" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfNi01LTEtMS02ODc1MQ_ab2ee66b-693e-4ace-8c47-5acfae73699e">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbcda6d0b469429ca1598f0fa2ebb7d7_D20211101-20220131" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfNi03LTEtMS02ODc1MQ_d162703d-eda9-4e6b-94c1-32c7f7656006">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73c662f34154fc49f2f4456e56cd10c_D20221101-20230131" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfNi05LTEtMS02ODc1MQ_7b04c26f-6bdf-4ace-a8d5-4b5211b614d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73728e1faa1e4efda17c4a3ca7016e37_D20211101-20220131" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfNi0xMS0xLTEtNjg3NTE_21733960-725f-472a-8109-c550191bea50">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i125675019576446bbc7947a564d0c89f_D20221101-20230131" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfNy0xLTEtMS02ODc1MQ_00834122-b85a-43f6-a21e-abc5b7d3f6ac">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e99b539b79445c1b5eceb9da39435cd_D20211101-20220131" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfNy0zLTEtMS02ODc1MQ_2d00651f-1f2a-47e4-ae1e-da96eb9e5062">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c2a35f6169348d4bb4fe4e665306d51_D20221101-20230131" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfNy01LTEtMS02ODc1MQ_f80a6b2c-7f4b-4cae-b6d6-1f4412b64543">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbcda6d0b469429ca1598f0fa2ebb7d7_D20211101-20220131" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfNy03LTEtMS02ODc1MQ_fe81858e-468e-4114-a95f-d3a7829654a0">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73c662f34154fc49f2f4456e56cd10c_D20221101-20230131" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfNy05LTEtMS02ODc1MQ_0dcb5737-c9ac-4935-b953-69c97781dfad">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73728e1faa1e4efda17c4a3ca7016e37_D20211101-20220131" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfNy0xMS0xLTEtNjg3NTE_c4471324-f970-4d21-981f-a48a53feb0d4">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i125675019576446bbc7947a564d0c89f_D20221101-20230131" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfOC0xLTEtMS02ODc1MQ_ed29a0fa-a8b1-4cd1-99f5-573e75d16e56">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e99b539b79445c1b5eceb9da39435cd_D20211101-20220131" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfOC0zLTEtMS02ODc1MQ_3037c4ef-858b-41c7-9b26-dfdef39766b4">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c2a35f6169348d4bb4fe4e665306d51_D20221101-20230131" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfOC01LTEtMS02ODc1MQ_e31d10b8-eec9-4fea-ba30-bd4c195b3075">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbcda6d0b469429ca1598f0fa2ebb7d7_D20211101-20220131" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfOC03LTEtMS02ODc1MQ_a486f936-f56c-4afc-9aef-c19b5613f160">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie73c662f34154fc49f2f4456e56cd10c_D20221101-20230131" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfOC05LTEtMS02ODc1MQ_cea40f5f-b7cf-417c-8728-5818443f143e">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73728e1faa1e4efda17c4a3ca7016e37_D20211101-20220131" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfOC0xMS0xLTEtNjg3NTE_d8e3b0bc-e0f2-4f84-8780-ff10b9f6738c">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial losses (gains)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i125675019576446bbc7947a564d0c89f_D20221101-20230131" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfMTAtMS0xLTEtNjg3NTE_c91ca5cc-2e98-4254-b7ed-f1e1f8afecd5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e99b539b79445c1b5eceb9da39435cd_D20211101-20220131" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfMTAtMy0xLTEtNjg3NTE_5f2df949-f880-4c91-8f14-e347ab2f8db5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c2a35f6169348d4bb4fe4e665306d51_D20221101-20230131" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfMTAtNS0xLTEtNjg3NTE_450443c6-6a19-441c-9761-2da445c8fa8d">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbcda6d0b469429ca1598f0fa2ebb7d7_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfMTAtNy0xLTEtNjg3NTE_fcf4ee8a-cd07-451b-8fae-8a322e797631">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73c662f34154fc49f2f4456e56cd10c_D20221101-20230131" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfMTAtOS0xLTEtNjg3NTE_3b78563b-7708-4a6e-85ba-8548c5a9a5a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73728e1faa1e4efda17c4a3ca7016e37_D20211101-20220131" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfMTAtMTEtMS0xLTY4NzUx_3abc16c9-7335-48d4-bf0e-701595537bd5">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net plan costs (benefits)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i125675019576446bbc7947a564d0c89f_D20221101-20230131" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfMTItMS0xLTEtNjg3NTE_c9911ba5-9bd6-49ce-acc4-77f7366ad641">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e99b539b79445c1b5eceb9da39435cd_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfMTItMy0xLTEtNjg3NTE_15845724-113c-4b89-aaa0-0c6729935885">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c2a35f6169348d4bb4fe4e665306d51_D20221101-20230131" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfMTItNS0xLTEtNjg3NTE_f82bb36d-6778-40dd-aa32-f52632dc83ce">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbcda6d0b469429ca1598f0fa2ebb7d7_D20211101-20220131" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfMTItNy0xLTEtNjg3NTE_4efdfca3-4f41-4e54-b0f9-086eafbac9d5">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73c662f34154fc49f2f4456e56cd10c_D20221101-20230131" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfMTItOS0xLTEtNjg3NTE_d1bb1723-886e-48ee-92c8-2e99c3a0f18e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73728e1faa1e4efda17c4a3ca7016e37_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfMTItMTEtMS0xLTY4NzUx_2267c458-3245-4954-8827-cd9227c1d753">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The service cost component is recorded in cost of sales and operating expenses in the condensed consolidated statement of operations. All other cost components are recorded in other income (expense), net in the condensed consolidated statement of operations.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ia55e3321b86f4dcea48315e1519cf8a9"><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="a:EmployerContributionsAndExpectedEmployerContributionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RleHRyZWdpb246YjQxMzQ5ZjQ3NTQ4NDUwZmI1MjBjOTAyNmE5OTkzYzlfNjM1_37aa043a-26cc-477b-a986-340d4c4c4a7f" escape="true"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employer contributions and expected future employer contributions for the remainder of the year were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.771%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.729%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employer Contributions</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For Remainder of Year</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. defined benefit plans</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i125675019576446bbc7947a564d0c89f_D20221101-20230131" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjFmZjY1N2ZlM2E2YjQxMWI5MTBjNDMwYmY1NWZmMDY3L3RhYmxlcmFuZ2U6MWZmNjU3ZmUzYTZiNDExYjkxMGM0MzBiZjU1ZmYwNjdfNC01LTEtMS02ODc1MQ_ff15ab19-83d7-4ece-874c-69362aa77612">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e99b539b79445c1b5eceb9da39435cd_D20211101-20220131" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjFmZjY1N2ZlM2E2YjQxMWI5MTBjNDMwYmY1NWZmMDY3L3RhYmxlcmFuZ2U6MWZmNjU3ZmUzYTZiNDExYjkxMGM0MzBiZjU1ZmYwNjdfNC03LTEtMS02ODc1MQ_99d96017-4748-40c5-bf9e-68911e397e46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a4bcfb758684d2488eda427cdb6b25d_I20230131" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjFmZjY1N2ZlM2E2YjQxMWI5MTBjNDMwYmY1NWZmMDY3L3RhYmxlcmFuZ2U6MWZmNjU3ZmUzYTZiNDExYjkxMGM0MzBiZjU1ZmYwNjdfNC0xMC0xLTEtNjg3NTE_f7867d63-05ee-410b-9fd2-fef79d0c7e8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. defined benefit plans</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c2a35f6169348d4bb4fe4e665306d51_D20221101-20230131" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjFmZjY1N2ZlM2E2YjQxMWI5MTBjNDMwYmY1NWZmMDY3L3RhYmxlcmFuZ2U6MWZmNjU3ZmUzYTZiNDExYjkxMGM0MzBiZjU1ZmYwNjdfNS01LTEtMS02ODc1MQ_9150af22-2bb8-4c45-83a2-70aa5e180611">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbcda6d0b469429ca1598f0fa2ebb7d7_D20211101-20220131" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjFmZjY1N2ZlM2E2YjQxMWI5MTBjNDMwYmY1NWZmMDY3L3RhYmxlcmFuZ2U6MWZmNjU3ZmUzYTZiNDExYjkxMGM0MzBiZjU1ZmYwNjdfNS03LTEtMS02ODc1MQ_dd1010f4-1acf-48e7-aaca-1dfae2c2dc18">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia940a16a97b2481b975ec28bbbb5866c_I20230131" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjFmZjY1N2ZlM2E2YjQxMWI5MTBjNDMwYmY1NWZmMDY3L3RhYmxlcmFuZ2U6MWZmNjU3ZmUzYTZiNDExYjkxMGM0MzBiZjU1ZmYwNjdfNS0xMC0xLTEtNjg3NTE_62f314ad-6c7c-428c-a339-b71135d090d2">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_67"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.   <ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RleHRyZWdpb246MGE5MWQzMmZiNzJjNDQ1NmFlYTZiNjhmOWQxNzE2ZjlfMTU5OA_59ad54ea-cb0e-426e-aa06-2b9ed8668537" continuedAt="i4b96cbcfc21c4723acb8c768344b23d7" escape="true">WARRANTIES AND CONTINGENCIES</ix:nonNumeric></span></div><ix:continuation id="i4b96cbcfc21c4723acb8c768344b23d7"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warranties</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue for standard warranty costs based on historical trends in actual warranty charges over the past 12 months. The accrual is reviewed regularly and periodically adjusted to reflect changes in warranty cost over the period. The standard warranty accrual balances are held in other accrued and other long-term liabilities on our condensed consolidated balance sheet. Our standard warranty terms typically extend to one year from the date of delivery, depending on the product.  </span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RleHRyZWdpb246MGE5MWQzMmZiNzJjNDQ1NmFlYTZiNjhmOWQxNzE2ZjlfMTU4MQ_a5079a71-deeb-4a95-bc3e-729c40cb6b3a" escape="true"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the standard warranty accrual activity is shown in the table below:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard warranty accrual, beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RhYmxlOmQzNzFjMzE3YjdmNTQ2OWM4ODE4ZWFlOTRiOWM3MDJlL3RhYmxlcmFuZ2U6ZDM3MWMzMTdiN2Y1NDY5Yzg4MThlYWU5NGI5YzcwMmVfNC0xLTEtMS02ODc1MQ_0db4c967-a632-4430-baec-8359189569bc">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56485a537aba4a7691bd4bf959f3eaad_I20211031" decimals="-6" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RhYmxlOmQzNzFjMzE3YjdmNTQ2OWM4ODE4ZWFlOTRiOWM3MDJlL3RhYmxlcmFuZ2U6ZDM3MWMzMTdiN2Y1NDY5Yzg4MThlYWU5NGI5YzcwMmVfNC0zLTEtMS02ODc1MQ_875a0863-135b-479a-a097-0bc83b1d86b9">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals for warranties including change in estimates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:StandardProductWarrantyAccrualWarrantiesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RhYmxlOmQzNzFjMzE3YjdmNTQ2OWM4ODE4ZWFlOTRiOWM3MDJlL3RhYmxlcmFuZ2U6ZDM3MWMzMTdiN2Y1NDY5Yzg4MThlYWU5NGI5YzcwMmVfNS0xLTEtMS02ODc1MQ_d61e48d9-13cb-46b9-aca8-f7fd05fb0e1d">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:StandardProductWarrantyAccrualWarrantiesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RhYmxlOmQzNzFjMzE3YjdmNTQ2OWM4ODE4ZWFlOTRiOWM3MDJlL3RhYmxlcmFuZ2U6ZDM3MWMzMTdiN2Y1NDY5Yzg4MThlYWU5NGI5YzcwMmVfNS0zLTEtMS02ODc1MQ_4e83c5a4-d801-4e9a-9197-27d44908b305">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements made during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:StandardProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RhYmxlOmQzNzFjMzE3YjdmNTQ2OWM4ODE4ZWFlOTRiOWM3MDJlL3RhYmxlcmFuZ2U6ZDM3MWMzMTdiN2Y1NDY5Yzg4MThlYWU5NGI5YzcwMmVfNi0xLTEtMS02ODc1MQ_6c703b06-0a91-44af-91ea-411cd32b0710">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:StandardProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RhYmxlOmQzNzFjMzE3YjdmNTQ2OWM4ODE4ZWFlOTRiOWM3MDJlL3RhYmxlcmFuZ2U6ZDM3MWMzMTdiN2Y1NDY5Yzg4MThlYWU5NGI5YzcwMmVfNi0zLTEtMS02ODc1MQ_03e97a7b-0cb6-4808-bddb-5b417a4e6ab5">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard warranty accrual, ending balance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RhYmxlOmQzNzFjMzE3YjdmNTQ2OWM4ODE4ZWFlOTRiOWM3MDJlL3RhYmxlcmFuZ2U6ZDM3MWMzMTdiN2Y1NDY5Yzg4MThlYWU5NGI5YzcwMmVfNy0xLTEtMS02ODc1MQ_1a316801-4dfd-4dd1-8129-1a510b9617a7">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7452fced71814cff84c1f48750a63bfa_I20220131" decimals="-6" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RhYmxlOmQzNzFjMzE3YjdmNTQ2OWM4ODE4ZWFlOTRiOWM3MDJlL3RhYmxlcmFuZ2U6ZDM3MWMzMTdiN2Y1NDY5Yzg4MThlYWU5NGI5YzcwMmVfNy0zLTEtMS02ODc1MQ_ffc9a5e9-29f5-428b-9575-8931cbc66b46">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals for warranties due within one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:StandardProductWarrantyAccrualCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RhYmxlOmQzNzFjMzE3YjdmNTQ2OWM4ODE4ZWFlOTRiOWM3MDJlL3RhYmxlcmFuZ2U6ZDM3MWMzMTdiN2Y1NDY5Yzg4MThlYWU5NGI5YzcwMmVfOS0xLTEtMS02ODc1MQ_8fd8b3b9-0401-496b-9a4d-785e7335456b">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7452fced71814cff84c1f48750a63bfa_I20220131" decimals="-6" name="us-gaap:StandardProductWarrantyAccrualCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RhYmxlOmQzNzFjMzE3YjdmNTQ2OWM4ODE4ZWFlOTRiOWM3MDJlL3RhYmxlcmFuZ2U6ZDM3MWMzMTdiN2Y1NDY5Yzg4MThlYWU5NGI5YzcwMmVfOS0zLTEtMS02ODc1MQ_960d3629-ef65-4d34-8f4a-a09cb324c983">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals for warranties due after one year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:StandardProductWarrantyAccrualNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RhYmxlOmQzNzFjMzE3YjdmNTQ2OWM4ODE4ZWFlOTRiOWM3MDJlL3RhYmxlcmFuZ2U6ZDM3MWMzMTdiN2Y1NDY5Yzg4MThlYWU5NGI5YzcwMmVfMTAtMS0xLTEtNjg3NTE_64c059de-0771-4a49-bf6a-56cef1cf16dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7452fced71814cff84c1f48750a63bfa_I20220131" decimals="-6" name="us-gaap:StandardProductWarrantyAccrualNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RhYmxlOmQzNzFjMzE3YjdmNTQ2OWM4ODE4ZWFlOTRiOWM3MDJlL3RhYmxlcmFuZ2U6ZDM3MWMzMTdiN2Y1NDY5Yzg4MThlYWU5NGI5YzcwMmVfMTAtMy0xLTEtNjg3NTE_a1ad60be-36b2-4a09-82ab-faafee90ba96">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard warranty accrual, ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RhYmxlOmQzNzFjMzE3YjdmNTQ2OWM4ODE4ZWFlOTRiOWM3MDJlL3RhYmxlcmFuZ2U6ZDM3MWMzMTdiN2Y1NDY5Yzg4MThlYWU5NGI5YzcwMmVfMTEtMS0xLTEtNjg3NTE_6146ed37-e288-46ca-aba1-41a417bfb887">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7452fced71814cff84c1f48750a63bfa_I20220131" decimals="-6" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RhYmxlOmQzNzFjMzE3YjdmNTQ2OWM4ODE4ZWFlOTRiOWM3MDJlL3RhYmxlcmFuZ2U6ZDM3MWMzMTdiN2Y1NDY5Yzg4MThlYWU5NGI5YzcwMmVfMTEtMy0xLTEtNjg3NTE_1c07d5e0-b373-4626-8537-4fb2eac3088c">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Bank Guarantees</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Guarantees consist primarily of outstanding standby letters of credit and bank guarantees and were approximately $<ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" name="us-gaap:BankAcceptancesExecuted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RleHRyZWdpb246MGE5MWQzMmZiNzJjNDQ1NmFlYTZiNjhmOWQxNzE2ZjlfNzY1_8019368b-da68-4527-a05e-a0aae258eacd"><ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" name="us-gaap:BankAcceptancesExecuted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RleHRyZWdpb246MGE5MWQzMmZiNzJjNDQ1NmFlYTZiNjhmOWQxNzE2ZjlfNzY1_8089b217-dabe-4f28-8291-a149e58eb520">37</ix:nonFraction></ix:nonFraction> million as of both January&#160;31, 2023 and October&#160;31, 2022, respectively. A standby letter of credit is a guarantee of payment issued by a bank on behalf of us that is used as payment of last resort should we fail to fulfill a contractual commitment with a third party. A bank guarantee is a promise from a bank or other lending institution that if we default on a loan, the bank will cover the loss.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in lawsuits, claims, investigations and proceedings, including, but not limited to, intellectual property, commercial, real estate, environmental and employment matters, which arise in the ordinary course of business. There are no matters pending that we currently believe are reasonably possible of having a material impact to our business, condensed consolidated financial condition, results of operations or cash flows.</span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_70"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.   <ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:ShortTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183MC9mcmFnOjg3MTEyNGQ1ZGE5NjRlM2ZhNjljYWUyNzdmMmUxOTE0L3RleHRyZWdpb246ODcxMTI0ZDVkYTk2NGUzZmE2OWNhZTI3N2YyZTE5MTRfMTYwNQ_1155dbe3-f324-4aee-aeae-de3a5a4b59d3" continuedAt="i1e8e22a81843423dab51234de66dd1a8" escape="true">SHORT-TERM DEBT</ix:nonNumeric></span></div><ix:continuation id="i1e8e22a81843423dab51234de66dd1a8" continuedAt="i0839e50bc0014b5dbb391ed2f5fda48d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Facilities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On <ix:nonNumeric contextRef="i2ef13658ecf745f787fde75342d47896_D20190313-20190313" name="us-gaap:LineOfCreditFacilityInitiationDate1" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183MC9mcmFnOjg3MTEyNGQ1ZGE5NjRlM2ZhNjljYWUyNzdmMmUxOTE0L3RleHRyZWdpb246ODcxMTI0ZDVkYTk2NGUzZmE2OWNhZTI3N2YyZTE5MTRfNTI_1a6d6a3f-6653-4961-9934-23028a15718e">March 13, 2019</ix:nonNumeric>, we entered into a credit agreement with a group of financial institutions which, as amended, provided for a $<ix:nonFraction unitRef="usd" contextRef="iafd490bd02de47189afdbcca947d8d74_I20190313" decimals="-9" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183MC9mcmFnOjg3MTEyNGQ1ZGE5NjRlM2ZhNjljYWUyNzdmMmUxOTE0L3RleHRyZWdpb246ODcxMTI0ZDVkYTk2NGUzZmE2OWNhZTI3N2YyZTE5MTRfMTY0_9b975601-5af2-4bbc-9420-c31f88ee72e6">1</ix:nonFraction> billion <ix:nonNumeric contextRef="i2ef13658ecf745f787fde75342d47896_D20190313-20190313" name="us-gaap:ShortTermDebtTerms" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183MC9mcmFnOjg3MTEyNGQ1ZGE5NjRlM2ZhNjljYWUyNzdmMmUxOTE0L3RleHRyZWdpb246ODcxMTI0ZDVkYTk2NGUzZmE2OWNhZTI3N2YyZTE5MTRfMTYwMQ_bc224339-aaf8-4811-b5f6-758760cc05b8">five</ix:nonNumeric>-year unsecured credit facility that will expire on <ix:nonNumeric contextRef="i2ef13658ecf745f787fde75342d47896_D20190313-20190313" name="us-gaap:LineOfCreditFacilityExpirationDate1" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183MC9mcmFnOjg3MTEyNGQ1ZGE5NjRlM2ZhNjljYWUyNzdmMmUxOTE0L3RleHRyZWdpb246ODcxMTI0ZDVkYTk2NGUzZmE2OWNhZTI3N2YyZTE5MTRfMjIz_6326ab37-b45e-4855-81cd-69ec235e2f51">March 13, 2024</ix:nonNumeric> and incremental term loan facilities in an aggregate amount of up to $<ix:nonFraction unitRef="usd" contextRef="i152367a04c424a7ba2d724aaa1763fdc_I20190313" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183MC9mcmFnOjg3MTEyNGQ1ZGE5NjRlM2ZhNjljYWUyNzdmMmUxOTE0L3RleHRyZWdpb246ODcxMTI0ZDVkYTk2NGUzZmE2OWNhZTI3N2YyZTE5MTRfMjk1_2745f324-5923-476c-96b6-524ddfe223fb">500</ix:nonFraction> million.&#160;On April 21, 2021, we entered into an incremental assumption agreement, pursuant to which the aggregate amount available for borrowing under the revolving credit facility was increased to $<ix:nonFraction unitRef="usd" contextRef="i6bdea77493e34375a99fd1155e7a9865_I20210421" decimals="-7" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183MC9mcmFnOjg3MTEyNGQ1ZGE5NjRlM2ZhNjljYWUyNzdmMmUxOTE0L3RleHRyZWdpb246ODcxMTI0ZDVkYTk2NGUzZmE2OWNhZTI3N2YyZTE5MTRfNDg3_30ba4d28-b65e-4b75-a182-e79d7f0f5fb6">1.35</ix:nonFraction>&#160;billion and the aggregate amount available for incremental facilities was refreshed to remain at $<ix:nonFraction unitRef="usd" contextRef="i2f2d43ce269b4254baf2999a8865ea28_I20210421" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183MC9mcmFnOjg3MTEyNGQ1ZGE5NjRlM2ZhNjljYWUyNzdmMmUxOTE0L3RleHRyZWdpb246ODcxMTI0ZDVkYTk2NGUzZmE2OWNhZTI3N2YyZTE5MTRfNTc5_9decf906-59ea-4111-a623-2e0f3906c728">500</ix:nonFraction>&#160;million. As of </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i0839e50bc0014b5dbb391ed2f5fda48d"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January&#160;31, 2023, we had <ix:nonFraction unitRef="usd" contextRef="i2bdca111b15343188d0db9a98448ac9d_I20230131" decimals="-6" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183MC9mcmFnOjg3MTEyNGQ1ZGE5NjRlM2ZhNjljYWUyNzdmMmUxOTE0L3RleHRyZWdpb246ODcxMTI0ZDVkYTk2NGUzZmE2OWNhZTI3N2YyZTE5MTRfNjAw_7928ddf2-0186-4908-82ba-32a9d6c6fa63">no</ix:nonFraction> borrowings outstanding under the credit facility and <ix:nonFraction unitRef="usd" contextRef="id9fc0ac763d44a1cb45cc9609a903602_I20230131" decimals="-6" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183MC9mcmFnOjg3MTEyNGQ1ZGE5NjRlM2ZhNjljYWUyNzdmMmUxOTE0L3RleHRyZWdpb246ODcxMTI0ZDVkYTk2NGUzZmE2OWNhZTI3N2YyZTE5MTRfNjU2_e5843ed5-062f-4865-8921-6b8dc33a651a">no</ix:nonFraction> borrowings under the incremental facilities. We were in compliance with the covenants for the credit facility during the three months ended January&#160;31, 2023.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercial Paper</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our U.S. commercial paper program, the company may issue and sell unsecured, short-term promissory notes in the aggregate principal amount not to exceed $<ix:nonFraction unitRef="usd" contextRef="i6a69ec0f4903459fb41ff3b295fb9cb3_I20210618" decimals="-7" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183MC9mcmFnOjg3MTEyNGQ1ZGE5NjRlM2ZhNjljYWUyNzdmMmUxOTE0L3RleHRyZWdpb246ODcxMTI0ZDVkYTk2NGUzZmE2OWNhZTI3N2YyZTE5MTRfOTc5_e1e551c3-e2cf-4b0d-9d0d-7129ed9c8a96">1.35</ix:nonFraction>&#160;billion with up to 397-day maturities. At any point in time, the company intends to maintain available commitments under its revolving credit facility in an amount at least equal to the amount of the commercial paper notes outstanding. Amounts available under the program may be borrowed, repaid and re-borrowed from time to time. The proceeds from issuances under the program may be used for general corporate purposes. During the three months ended January&#160;31, 2023, we borrowed $<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommercialPaper" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183MC9mcmFnOjg3MTEyNGQ1ZGE5NjRlM2ZhNjljYWUyNzdmMmUxOTE0L3RleHRyZWdpb246ODcxMTI0ZDVkYTk2NGUzZmE2OWNhZTI3N2YyZTE5MTRfMTQzOA_c207effd-d804-4855-9b52-eead5aea539f">527</ix:nonFraction> million and repaid $<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:RepaymentsOfCommercialPaper" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183MC9mcmFnOjg3MTEyNGQ1ZGE5NjRlM2ZhNjljYWUyNzdmMmUxOTE0L3RleHRyZWdpb246ODcxMTI0ZDVkYTk2NGUzZmE2OWNhZTI3N2YyZTE5MTRfMTQ1Mg_296bac56-4129-4ee8-a5c7-8a7057da52cf">324</ix:nonFraction> million. As </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January&#160;31, 2023</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we had borrowings of $<ix:nonFraction unitRef="usd" contextRef="idfa1651ae6144d3fa003dba82a34e213_I20230131" decimals="-6" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183MC9mcmFnOjg3MTEyNGQ1ZGE5NjRlM2ZhNjljYWUyNzdmMmUxOTE0L3RleHRyZWdpb246ODcxMTI0ZDVkYTk2NGUzZmE2OWNhZTI3N2YyZTE5MTRfNTQ5NzU1ODE1NTAy_e47d2d03-bd98-42c4-9450-952ac2f6ebfd">238</ix:nonFraction> million outstanding under our U.S. commercial paper program and had a weighted average annual interest rate of <ix:nonFraction unitRef="rate" contextRef="idfa1651ae6144d3fa003dba82a34e213_I20230131" decimals="4" name="us-gaap:ShortTermDebtWeightedAverageInterestRate" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183MC9mcmFnOjg3MTEyNGQ1ZGE5NjRlM2ZhNjljYWUyNzdmMmUxOTE0L3RleHRyZWdpb246ODcxMTI0ZDVkYTk2NGUzZmE2OWNhZTI3N2YyZTE5MTRfMTU5NA_98cfd5c7-1937-4511-b0cf-deec50a0cdd6">4.67</ix:nonFraction> percent.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_73"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.   <ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183My9mcmFnOjhmNjQzZDU2Y2UwMTQzY2RiNTg3MmIyNTlkZDY5ZWU2L3RleHRyZWdpb246OGY2NDNkNTZjZTAxNDNjZGI1ODcyYjI1OWRkNjllZTZfMTk2NQ_ad072fc1-2093-4b43-a80a-1218e85790ab" continuedAt="ie092c33359cf40ac914c65ca4e504a74" escape="true">LONG-TERM DEBT</ix:nonNumeric></span></div><ix:continuation id="ie092c33359cf40ac914c65ca4e504a74" continuedAt="i0a7f6f35f2c74c95825d6ef6db354f4c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Term Loan Facility</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 15, 2022, we entered into a term loan agreement with a group of financial institutions, which provided for a $<ix:nonFraction unitRef="usd" contextRef="i00a9160afdad455eb4f9ec0885e50ae0_I20220415" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183My9mcmFnOjhmNjQzZDU2Y2UwMTQzY2RiNTg3MmIyNTlkZDY5ZWU2L3RleHRyZWdpb246OGY2NDNkNTZjZTAxNDNjZGI1ODcyYjI1OWRkNjllZTZfNTQ5NzU1ODE3NTYx_8c302ac9-925f-4e1c-90c6-2d80ed1662d1">600</ix:nonFraction>&#160;million delayed draw term loan that will mature on April 15, 2025. As of January&#160;31, 2023, we had $<ix:nonFraction unitRef="usd" contextRef="i08d40d57102743d89263c457fb2d9f57_I20230131" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183My9mcmFnOjhmNjQzZDU2Y2UwMTQzY2RiNTg3MmIyNTlkZDY5ZWU2L3RleHRyZWdpb246OGY2NDNkNTZjZTAxNDNjZGI1ODcyYjI1OWRkNjllZTZfNTQ5NzU1ODE3NjQy_e5fe513e-ca01-4bdb-b5ef-6254f606c20f">600</ix:nonFraction>&#160;million borrowings outstanding under the term loan facility and had a weighted average interest rate of <ix:nonFraction unitRef="number" contextRef="i08d40d57102743d89263c457fb2d9f57_I20230131" decimals="4" name="us-gaap:LongtermDebtWeightedAverageInterestRate" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183My9mcmFnOjhmNjQzZDU2Y2UwMTQzY2RiNTg3MmIyNTlkZDY5ZWU2L3RleHRyZWdpb246OGY2NDNkNTZjZTAxNDNjZGI1ODcyYjI1OWRkNjllZTZfNTQ5NzU1ODE3NzQy_5beec9f4-5464-41b3-93e8-978771d10338">5.40</ix:nonFraction> percent. Loans under the term loan agreement bear interest, at our option, either at: (i) the alternate base rate, as defined in the term loan agreement, plus the applicable margin for such loans or (ii) adjusted term SOFR, as defined in the term loan agreement, plus the applicable margin for such loans. The term loan agreement contains customary representations and warranties as well as customary affirmative and negative covenants. We were in compliance with the covenants for the term loan during the three months ended January&#160;31, 2023.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Notes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183My9mcmFnOjhmNjQzZDU2Y2UwMTQzY2RiNTg3MmIyNTlkZDY5ZWU2L3RleHRyZWdpb246OGY2NDNkNTZjZTAxNDNjZGI1ODcyYjI1OWRkNjllZTZfMTk1NA_4f70b975-42d2-4448-a143-68b9e7763e4e" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the company&#8217;s long-term senior notes:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.807%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.469%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.471%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized <br/>Principal</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Principal</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c0cb7fda60466cb455e2be4d15041f_I20230131" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183My9mcmFnOjhmNjQzZDU2Y2UwMTQzY2RiNTg3MmIyNTlkZDY5ZWU2L3RhYmxlOjk5ODBhNGJiZGVmNjQzMzM5NTRmYWIyODVmMmVmYmJkL3RhYmxlcmFuZ2U6OTk4MGE0YmJkZWY2NDMzMzk1NGZhYjI4NWYyZWZiYmRfNC0xLTEtMS02ODc1MQ_b5c3f01c-1949-403b-9d29-a5502f460571">299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b64ba8cd1f3436782785cc805950f95_I20221031" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183My9mcmFnOjhmNjQzZDU2Y2UwMTQzY2RiNTg3MmIyNTlkZDY5ZWU2L3RhYmxlOjk5ODBhNGJiZGVmNjQzMzM5NTRmYWIyODVmMmVmYmJkL3RhYmxlcmFuZ2U6OTk4MGE0YmJkZWY2NDMzMzk1NGZhYjI4NWYyZWZiYmRfNC0zLTEtMS02ODc1MQ_f857a9cf-dc76-44d4-9be8-e7715ba3b68a">299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i350ed86205aa4b80911ef00f731a2abd_I20230131" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183My9mcmFnOjhmNjQzZDU2Y2UwMTQzY2RiNTg3MmIyNTlkZDY5ZWU2L3RhYmxlOjk5ODBhNGJiZGVmNjQzMzM5NTRmYWIyODVmMmVmYmJkL3RhYmxlcmFuZ2U6OTk4MGE0YmJkZWY2NDMzMzk1NGZhYjI4NWYyZWZiYmRfNS0xLTEtMS02ODc1MQ_677e6a28-bd7c-4878-9652-6ea0b0529e9a">495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i783cb7ee1875433c87db62ff80483811_I20221031" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183My9mcmFnOjhmNjQzZDU2Y2UwMTQzY2RiNTg3MmIyNTlkZDY5ZWU2L3RhYmxlOjk5ODBhNGJiZGVmNjQzMzM5NTRmYWIyODVmMmVmYmJkL3RhYmxlcmFuZ2U6OTk4MGE0YmJkZWY2NDMzMzk1NGZhYjI4NWYyZWZiYmRfNS0zLTEtMS02ODc1MQ_695e5916-ac4f-4fe2-8126-67c227992886">495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2079ee6072754438b4665c88d5465e25_I20230131" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183My9mcmFnOjhmNjQzZDU2Y2UwMTQzY2RiNTg3MmIyNTlkZDY5ZWU2L3RhYmxlOjk5ODBhNGJiZGVmNjQzMzM5NTRmYWIyODVmMmVmYmJkL3RhYmxlcmFuZ2U6OTk4MGE0YmJkZWY2NDMzMzk1NGZhYjI4NWYyZWZiYmRfNi0xLTEtMS02ODc1MQ_385076a1-c8a2-4c4c-802f-6c601bc7b4fe">496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7455386a3c3948c1a56733c226910fac_I20221031" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183My9mcmFnOjhmNjQzZDU2Y2UwMTQzY2RiNTg3MmIyNTlkZDY5ZWU2L3RhYmxlOjk5ODBhNGJiZGVmNjQzMzM5NTRmYWIyODVmMmVmYmJkL3RhYmxlcmFuZ2U6OTk4MGE0YmJkZWY2NDMzMzk1NGZhYjI4NWYyZWZiYmRfNi0zLTEtMS02ODc1MQ_7b25b847-c9b1-4a63-9088-07e05d9377c9">496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2031 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d34be775eb5486e9dd8f335cc3b5197_I20230131" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183My9mcmFnOjhmNjQzZDU2Y2UwMTQzY2RiNTg3MmIyNTlkZDY5ZWU2L3RhYmxlOjk5ODBhNGJiZGVmNjQzMzM5NTRmYWIyODVmMmVmYmJkL3RhYmxlcmFuZ2U6OTk4MGE0YmJkZWY2NDMzMzk1NGZhYjI4NWYyZWZiYmRfNy0xLTEtMS02ODc1MQ_61e8609d-fd4a-4413-9084-615226e3fbb8">843</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992aace108544bd92848aeb54b66881_I20221031" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183My9mcmFnOjhmNjQzZDU2Y2UwMTQzY2RiNTg3MmIyNTlkZDY5ZWU2L3RhYmxlOjk5ODBhNGJiZGVmNjQzMzM5NTRmYWIyODVmMmVmYmJkL3RhYmxlcmFuZ2U6OTk4MGE0YmJkZWY2NDMzMzk1NGZhYjI4NWYyZWZiYmRfNy0zLTEtMS02ODc1MQ_74be7108-077d-470d-8a2d-545e4fac77b6">843</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Senior Notes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d6a03bdbe0143bda21e2c1075865b76_I20230131" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183My9mcmFnOjhmNjQzZDU2Y2UwMTQzY2RiNTg3MmIyNTlkZDY5ZWU2L3RhYmxlOjk5ODBhNGJiZGVmNjQzMzM5NTRmYWIyODVmMmVmYmJkL3RhYmxlcmFuZ2U6OTk4MGE0YmJkZWY2NDMzMzk1NGZhYjI4NWYyZWZiYmRfOC0xLTEtMS02ODc1MQ_2ffb53f4-aaa2-47f1-867b-2ac536470e33">2,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cad5754c77d481a8d01dd8905da7bb4_I20221031" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183My9mcmFnOjhmNjQzZDU2Y2UwMTQzY2RiNTg3MmIyNTlkZDY5ZWU2L3RhYmxlOjk5ODBhNGJiZGVmNjQzMzM5NTRmYWIyODVmMmVmYmJkL3RhYmxlcmFuZ2U6OTk4MGE0YmJkZWY2NDMzMzk1NGZhYjI4NWYyZWZiYmRfOC0zLTEtMS02ODc1MQ_64d2a4fd-ed5b-4984-8fe4-4e69e2143622">2,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0a7f6f35f2c74c95825d6ef6db354f4c">All outstanding notes listed above are unsecured and rank equally in right of payment with all of Agilent&#8217;s other senior unsecured indebtedness. There have been no other changes to the principal, maturity, interest rates and interest payment terms of the Agilent senior notes, detailed in the table above, in the three months ended January&#160;31, 2023, as compared to the senior notes described in our Annual Report on Form 10-K for the fiscal year ended October&#160;31, 2022.</ix:continuation>  </span></div><div style="text-align:justify"><span><br/></span></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_76"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.   <ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfMzMzNA_f3f14c7a-d6af-43d5-9eb7-3c36e2109cde" continuedAt="i74566022b9204ab88531d19a320325a4" escape="true">STOCKHOLDERS' EQUITY </ix:nonNumeric></span></div><ix:continuation id="i74566022b9204ab88531d19a320325a4" continuedAt="i906134fb85674bc486269167377842de"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Repurchase Program </span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 16, 2021 we announced that our board of directors had approved a new share repurchase program (the "2021 repurchase program") designed, among other things, to reduce or eliminate dilution resulting from issuance of stock under the company's employee equity incentive programs. The 2021 repurchase program authorizes the purchase of up to $<ix:nonFraction unitRef="usd" contextRef="i09d3df9f558a4787b3d731f7b3eab7d8_I20210218" decimals="-7" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfMTMxOQ_ad1678cc-2872-4149-9006-fa49cfb7c3c5">2.0</ix:nonFraction>&#160;billion of our common stock at the company's discretion and has no fixed termination date. The 2021 repurchase program which became effective on February 18, 2021, replaced and terminated the 2019 repurchase program on that date. The 2021 repurchase </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i906134fb85674bc486269167377842de" continuedAt="i9080c481712542c58aaac4e6e4bb58a4"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">program does not require the company to acquire a specific number of shares and may be suspended, amended or discontinued at any time. During the three months ended January&#160;31, 2023, we repurchased and retired <ix:nonFraction unitRef="shares" contextRef="ie3f5a8f5de1849ddac4ff626ed31a5af_D20221101-20230131" decimals="0" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfMTc1Nw_9d9f11ff-1524-409b-9deb-65f0ce4cdb33">499,000</ix:nonFraction> shares for $<ix:nonFraction unitRef="usd" contextRef="ie3f5a8f5de1849ddac4ff626ed31a5af_D20221101-20230131" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfMTc3MQ_493f57d2-0b79-4cdf-9952-b7c13d01ff90">75</ix:nonFraction> million under this authorization. During the three months ended January&#160;31, 2022, we repurchased and retired <ix:nonFraction unitRef="shares" contextRef="idd4e332392a048ae990d8d227847d292_D20211101-20220131" decimals="0" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfMTkxNQ_0f4c7dd8-77e8-45b4-9075-9cbee764762f">2.9</ix:nonFraction> million shares for $<ix:nonFraction unitRef="usd" contextRef="idd4e332392a048ae990d8d227847d292_D20211101-20220131" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfMTkyOQ_966ea73d-f5ae-470f-881d-cdb9438f26d6">447</ix:nonFraction> million under this authorization. As of January&#160;31, 2023, we had remaining authorization to repurchase up to approximately $<ix:nonFraction unitRef="usd" contextRef="id4f8c2b1ca13416f801985533f043e3e_I20230131" decimals="-6" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfMjA0OA_be6c53d7-141f-44e0-8e85-9595cf198fa6">363</ix:nonFraction> million of our common stock under the 2021 repurchase program. On March 1, 2023, the 2021 repurchase program was terminated and the remaining authorization of $<ix:nonFraction unitRef="usd" contextRef="ib27fcdd7d55f4e51b96ab02b41cb16f3_I20230301" decimals="-6" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfMjE5OTAyMzI2MTkyOA_ebabced1-55cf-4fa6-96e5-a892a2d57727">339</ix:nonFraction>&#160;million expired.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 9, 2023, we announced that our board of directors had approved a share repurchase program (the "2023 repurchase program") designed, among other things, to reduce or eliminate dilution resulting from issuance of stock under the company's employee equity incentive programs. The 2023 repurchase program authorizes the purchase of up to $<ix:nonFraction unitRef="usd" contextRef="i2e36614039e441fc844c3eebaa2a03df_I20230109" decimals="-9" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfMjE5OTAyMzI2MTM2MQ_2ab093b7-bc48-4462-86b3-07b1f19255f5">2.0</ix:nonFraction>&#160;billion of our common stock at the company's discretion and has no fixed termination date. The 2023 repurchase program does not require the company to acquire a specific number of shares and may be suspended, amended or discontinued at any time. The 2023 repurchase program commenced on March 1, 2023, and also terminated and replaced the 2021 repurchase program.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Dividends on Shares of Common Stock</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended January&#160;31, 2023, we paid cash dividends of $<ix:nonFraction unitRef="usdPerShare" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="3" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfMjIwOA_6ebf8aad-f458-4321-9766-2fdf71942174">0.225</ix:nonFraction> per common share or $<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfMjIzMQ_b7e3d26a-443e-4fbd-b6fd-126145404050">67</ix:nonFraction> million  on the company's common stock. During the three months ended January&#160;31, 2022, we paid cash dividends of  $<ix:nonFraction unitRef="usdPerShare" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="3" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfMjM5OQ_07d155d7-5e98-4057-96b1-2b3e1d8e84fa">0.210</ix:nonFraction> per common share or $<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfMjQyMg_c8af8470-5ae3-450c-b932-af9c112f6315">63</ix:nonFraction> million on the company's common stock. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On <ix:nonNumeric contextRef="i5cee235c15894fc79e55ebd92dddd62f_D20230222-20230222" name="us-gaap:DividendsPayableDateDeclaredDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfNTQ5NzU1ODIyMDAy_dc2bead5-dade-4093-9321-71f9cbf5df74">February 22, 2023</ix:nonNumeric>, our board of directors declared a quarterly dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i5cee235c15894fc79e55ebd92dddd62f_D20230222-20230222" decimals="3" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfNTQ5NzU1ODIxOTUx_33d83298-802d-42a0-923d-f83fe5eb8231">0.225</ix:nonFraction> per share of common stock or approximately $<ix:nonFraction unitRef="usd" contextRef="i5cee235c15894fc79e55ebd92dddd62f_D20230222-20230222" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfNTQ5NzU1ODIxOTYx_db5d7693-630d-436a-a948-27615e70b331">67</ix:nonFraction>&#160;million which will be paid on <ix:nonNumeric contextRef="i5cee235c15894fc79e55ebd92dddd62f_D20230222-20230222" name="us-gaap:DividendPayableDateToBePaidDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfNTQ5NzU1ODIyMDIx_ad6cfeb6-a3c7-4e1d-b718-636915856ba9">April 26, 2023</ix:nonNumeric> to all shareholders of record at the close of business on <ix:nonNumeric contextRef="i5cee235c15894fc79e55ebd92dddd62f_D20230222-20230222" name="us-gaap:DividendsPayableDateOfRecordDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfNTQ5NzU1ODIyMDM3_46009cc8-86bb-4bcb-88a1-bf3a53bf5157">April 4, 2023</ix:nonNumeric>. The timing and amounts of any future dividends are subject to determination and approval by our board of directors.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Income (Loss)</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfMzMyNg_d7fa7dc1-2adc-48be-989b-e8721f52d1cc" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in accumulated other comprehensive income (loss) by component and related tax effects were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.126%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.113%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.848%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.697%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.848%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.848%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.857%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net defined benefit pension cost and post retirement plan costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended January 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prior service credits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Actuarial Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized gains (losses) on derivatives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of October 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a78f97293c94b7a9a3259156a44fa2e_I20221031" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMTctNC0xLTEtNjg3NTE_98c443ad-7a56-4c9b-8aff-ddc93eac572e">335</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9481c6bfaca4632a77a30f531bb71a6_I20221031" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMTctNi0xLTEtNjg3NTE_17a0c56c-4c97-4878-977b-85b6d78a299f">123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8f1f6f3136049d4be156f4751093caf_I20221031" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMTctOC0xLTEtNjg3NTE_f63869da-8b21-447b-84bc-67681c9030eb">155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3afa252a57540f291b6c76329807920_I20221031" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMTctMTAtMS0xLTY4NzUx_d48d7090-9595-4230-a7f8-0aa18ac10f1f">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMTctMTItMS0xLTY4NzUx_e5bc1c6c-cc56-4ae2-89cf-7fa4f8ee99fa">347</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i019e110038214039b7e2ec2a8a8e7c57_D20221101-20230131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMTktNC0xLTEtNjg3NTE_7624db94-3c88-4dbd-ae4b-6f383b3a86bb">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a083ba0b32e485283552d0ac7ca6ea6_D20221101-20230131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMTktNi0xLTEtNjg3NTE_ccddc823-25b6-41ac-8541-5e45b691f296">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3b66509fec04f3dbca28ec34bb295c1_D20221101-20230131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMTktOC0xLTEtNjg3NTE_33d42a73-c448-4e7f-a0f1-5cb9c6b7649b">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i408570a1fe564491867039bfbb606643_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMTktMTAtMS0xLTY4NzUx_0b548ad4-0613-44bf-9f34-fb513fa298d4">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMTktMTItMS0xLTY4NzUx_78943a97-0ccb-4361-aa28-f06c95a014b3">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified out of accumulated other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i019e110038214039b7e2ec2a8a8e7c57_D20221101-20230131" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjEtNC0xLTEtNjg3NTE_47416801-3b93-4ccf-9e39-d4dd4608f382">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a083ba0b32e485283552d0ac7ca6ea6_D20221101-20230131" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjEtNi0xLTEtNjg3NTE_4ec9c9a6-5743-4919-8ece-d61da0c581ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3b66509fec04f3dbca28ec34bb295c1_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjEtOC0xLTEtNjg3NTE_400a0100-b2c2-438a-a261-97bcf1a53ec5">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i408570a1fe564491867039bfbb606643_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjEtMTAtMS0xLTY4NzUx_48bfc078-a919-4bec-b0ef-bf293be9482b">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjEtMTItMS0xLTY4NzUx_faa4620f-9193-4959-8720-ee88a6559884">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i019e110038214039b7e2ec2a8a8e7c57_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjMtNC0xLTEtNjg3NTE_105c9024-3c36-49cf-8311-49b09a49906e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a083ba0b32e485283552d0ac7ca6ea6_D20221101-20230131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjMtNi0xLTEtNjg3NTE_c0a1e90c-0d06-4110-8722-2615adbaa25e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3b66509fec04f3dbca28ec34bb295c1_D20221101-20230131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjMtOC0xLTEtNjg3NTE_6e8fc3e6-0cd6-4d75-9497-90dc536a23a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i408570a1fe564491867039bfbb606643_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjMtMTAtMS0xLTY4NzUx_82f2aba1-346e-4e1f-91a3-dc3288eed0c9">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjMtMTItMS0xLTY4NzUx_30bc5163-836f-4be6-9359-ebdc64b6ddea">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i019e110038214039b7e2ec2a8a8e7c57_D20221101-20230131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjUtNC0xLTEtNjg3NTE_ca5f29e8-ee7f-4beb-b6ca-bf42d552716b">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a083ba0b32e485283552d0ac7ca6ea6_D20221101-20230131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjUtNi0xLTEtNjg3NTE_87345522-fafe-4c7d-9c89-552bfa5aae24">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3b66509fec04f3dbca28ec34bb295c1_D20221101-20230131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjUtOC0xLTEtNjg3NTE_4c33e16e-9aea-46c9-81f1-0f2f6daf70ed">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i408570a1fe564491867039bfbb606643_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjUtMTAtMS0xLTY4NzUx_e2988399-c1a5-4ef4-9b5d-ccc570b3403d">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjUtMTItMS0xLTY4NzUx_d126d6dc-ffe2-464f-a1ad-776964a2a8ce">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of January 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d54a60dc4d4494fbe0eee8846f953cb_I20230131" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjctNC0xLTEtNjg3NTE_dc7e8db6-4d74-4807-ae2c-d908007cf6b2">244</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9f56afb4f9643e593d0341fc1aa9b85_I20230131" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjctNi0xLTEtNjg3NTE_a3a3984e-c2e5-427b-8eb1-4b740ae256f0">123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i251d1854299d4023ad580a36c8fdb3f4_I20230131" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjctOC0xLTEtNjg3NTE_a324b0bd-5f6c-4f1d-acf8-4d1d194e26a7">153</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4876675b17484a69a10e8f4181f8a034_I20230131" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjctMTAtMS0xLTY4NzUx_fe373432-abae-4c3f-b264-9620bc83c0f7">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i658253fffabe4343b44569144474388f_I20230131" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjctMTItMS0xLTY4NzUx_cdb50692-0d0c-46fe-bf6f-0684da29cb69">280</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:continuation id="i9080c481712542c58aaac4e6e4bb58a4"><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfMzMzMA_58bc72d4-7f7b-4c1e-926f-c5d3712a0023" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reclassifications out of accumulated other comprehensive income (loss) for the three months ended January&#160;31, 2023 and 2022 were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center;text-indent:4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:33.504%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.973%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.826%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.973%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.731%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Details about accumulated other <br/>comprehensive income (loss) components</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amounts Reclassified from <br/>other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affected line item in<br/>statement of operations</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="12" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain on derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTItNi0xLTEtNjg3NTE_c88580f0-1f89-414b-85e7-775437129012"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTItNi0xLTEtNjg3NTE_8835540f-f237-412d-9e5c-08d13d7145a5">6</ix:nonFraction></span>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTItOC0xLTEtNjg3NTE_f8a759f4-726e-4284-aa80-54ef5c1c9cc9"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTItOC0xLTEtNjg3NTE_d86647ec-d370-45b3-a632-ca1cdcd80121">3</ix:nonFraction></span>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTQtNi0xLTEtNjg3NTE_2bdc009c-2406-4d88-a493-0bb0ecc4fbb7">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTQtOC0xLTEtNjg3NTE_2a212bd8-1a39-4d60-9a74-dd9e084166d9">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before income tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTUtNi0xLTEtNjg3NTE_7cf3f667-9f13-47f8-95d1-f2ee952c9475">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTUtOC0xLTEtNjg3NTE_3056f079-55fb-4eb2-a250-1bb3cc4b827f">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTYtNi0xLTEtNjg3NTE_b8101626-ec68-4339-819d-b1dbd00baa4c">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTYtOC0xLTEtNjg3NTE_f2f077b3-aa57-4dac-be7e-168da47b21d1">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net of income tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net defined benefit pension cost and post retirement plan costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial net gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTktNi0xLTEtNjg3NTE_9d479cdf-5c95-4cce-ab78-764b3afb300d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTktOC0xLTEtNjg3NTE_c446a000-771a-45b6-a078-99c130b7dfe3">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMjEtNi0xLTEtNjg3NTE_bf88be26-3d34-4103-bb2c-f012ad7ce3df">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMjEtOC0xLTEtNjg3NTE_c29ac514-09b9-4c59-ab61-f0a7bec695cb">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before income tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMjItNi0xLTEtNjg3NTE_27a8743e-88e2-4b0e-94f7-5a9c397fe196">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMjItOC0xLTEtNjg3NTE_e1aff65d-323a-41d0-a0f5-fadd64b0fdec">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Provision) benefit for income tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMjMtNi0xLTEtNjg3NTE_509f77b2-366c-41fd-a7bc-37e3659949f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMjMtOC0xLTEtNjg3NTE_67479d95-5d3c-4f2e-884c-c0c045ddb75c">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net of income tax</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications for the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMjUtNi0xLTEtNjg3NTE_c4bd6e94-93f6-4612-b124-1b99fbcd19d5">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMjUtOC0xLTEtNjg3NTE_08245795-bf8d-4bac-8fdf-eee99cb69075">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts in parentheses indicate reductions to income and increases to other comprehensive income (loss).</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reclassifications out of accumulated other comprehensive income (loss) of actuarial net gain (loss) in respect of retirement plans and post retirement pension plans are included in the computation of net periodic cost (see Note 11, "Retirement Plans and Post Retirement Pension Plans").</span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_79"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.   <ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RleHRyZWdpb246NDE1MGJiNmMyODBmNDZkNmI5ZGRkYTEwY2QxOTZkY2JfOTE2OQ_25053f9a-6e09-4ea4-ac7c-4e27603856f4" continuedAt="i2416e5c2d88848369c0b9203941070cf" escape="true">SEGMENT INFORMATION</ix:nonNumeric></span></div><ix:continuation id="i2416e5c2d88848369c0b9203941070cf" continuedAt="i0bbc48af343442b2897c6ccccfe9554d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Description of segments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  We are a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow.  </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to have three business segments comprised of life sciences and applied markets, diagnostics and genomics and Agilent CrossLab, each of which continues to comprise a reportable segment. The <ix:nonFraction unitRef="number" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RleHRyZWdpb246NDE1MGJiNmMyODBmNDZkNmI5ZGRkYTEwY2QxOTZkY2JfMTIyOA_199c20eb-95bd-4d93-9075-6183d147bc32"><ix:nonFraction unitRef="number" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RleHRyZWdpb246NDE1MGJiNmMyODBmNDZkNmI5ZGRkYTEwY2QxOTZkY2JfMTIyOA_baaedd7f-df6f-42ce-beb3-88d0269e3e97"><ix:nonFraction unitRef="number" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RleHRyZWdpb246NDE1MGJiNmMyODBmNDZkNmI5ZGRkYTEwY2QxOTZkY2JfMTIyOA_c5416e8c-902a-4e7f-acce-8004e3d5e892"><ix:nonFraction unitRef="number" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RleHRyZWdpb246NDE1MGJiNmMyODBmNDZkNmI5ZGRkYTEwY2QxOTZkY2JfMTIyOA_f1a4f9aa-9f37-4874-bbe7-63a4ea4f2239">three</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> operating segments were determined based primarily on how the chief operating decision maker views and evaluates our operations. Operating results are regularly reviewed by the chief operating decision maker to make decisions about resources to be allocated to the segment and to assess its performance. Other factors, including market separation and customer specific applications, go-to-market channels, products and services and manufacturing are considered in determining the formation of these operating segments.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A description of our three reportable segments is as follows:</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our life sciences and applied markets business provides application-focused solutions that include instruments, consumables and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. Key product categories include: liquid chromatography ("LC") systems and components; liquid chromatography mass spectrometry ("LCMS") systems; gas chromatography ("GC") systems and components; gas chromatography mass spectrometry ("GCMS") systems; inductively coupled plasma mass spectrometry ("ICP-MS") instruments; atomic absorption ("AA") instruments; microwave plasma-atomic emission spectrometry ("MP-AES") instruments; inductively coupled plasma optical emission spectrometry ("ICP-OES") instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software for sample tracking; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps and measurement technologies. Our consumables portfolio is designed to improve customer outcomes. Most of the portfolio is vendor neutral, meaning Agilent can serve and supply customers regardless of their instrument purchase </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i0bbc48af343442b2897c6ccccfe9554d" continuedAt="i7120d0ce964546ebacbc8991e13281fe"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">choices. Solutions range from chemistries to supplies. Key product categories in consumables include GC and LC columns, sample preparation products, custom chemistries, and a large selection of laboratory instrument supplies.  </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our diagnostics and genomics business is comprised of six areas of activity providing active pharmaceutical ingredients ("APIs") for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables, which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level.&#160;First, our genomics business includes arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, as well as next generation sequencing ("NGS") target enrichment and genetic data management and interpretation support software. This business also includes solutions that enable clinical labs to identify DNA variants associated with genetic disease and help direct cancer therapy. Second, our nucleic acid solutions business is a contract and development manufacturing organization that provides services related to and the production of synthesized oligonucleotides under pharmaceutical good manufacturing practices ("GMP") conditions for use as API in a class of drugs that utilize nucleic acid molecules for disease therapy. Third, our pathology solutions business is focused on product offerings for cancer diagnostics and anatomic pathology workflows. The broad portfolio of offerings includes immunohistochemistry ("IHC"), in situ hybridization ("ISH"), hematoxylin and eosin ("H&amp;E") staining and special staining. Fourth, we also collaborate with a number of major pharmaceutical companies to develop new potential tissue and liquid-based pharmacodiagnostics, also known as companion diagnostics, which may be used to identify patients most likely to benefit from a specific targeted therapy. Fifth, the reagent partnership business provides clinical flow cytometry reagents for routine cancer diagnostics. This business also provides bulk antibodies as raw materials and associated assay development services to IVD manufacturers, biotechnology and pharmaceutical companies. Finally, our biomolecular analysis business provides complete workflow solutions, including instruments, consumables and software, for quality control analysis of nucleic acid samples. Samples are analyzed using quantitative and qualitative techniques to ensure accuracy in further genomics analysis techniques including NGS, utilized in clinical and life science research applications.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Agilent CrossLab business spans the entire lab with its extensive services portfolio, which is designed to improve customer outcomes.  The majority of the portfolio is vendor neutral, meaning we can serve and supply customers regardless of their instrument purchase choices.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The services portfolio include repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting and various other custom services to support the customers' laboratory operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Custom services are tailored to meet the specific application needs of various industries and to keep instruments fully operational and compliant with the respective industry requirements.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant portion of the segments' expenses arise from shared services and infrastructure that we have historically provided to the segments in order to realize economies of scale and to efficiently use resources. These expenses, collectively called corporate charges, include legal, accounting, tax, real estate, insurance services, information technology services, treasury, order administration, other corporate infrastructure expenses, costs of centralized research and development and joint sales and marketing costs. Charges are allocated to the segments, and the allocations have been determined on a basis that we consider to be a reasonable reflection of the utilization of services provided to or benefits received by the segments. In addition, we do not allocate asset impairments, amortization of acquisition-related intangible assets, change in the fair value of acquisition-related contingent consideration, acquisition and integration costs, transformational initiatives expenses, business exit and divestiture costs and certain other charges to the operating margin for each segment because management does not include this information in its measurement of the performance of the operating segments. Transformational initiatives include expenses associated with targeted cost reduction activities such as manufacturing transfers, site consolidations, legal entity and other business reorganizations, in-sourcing or outsourcing of activities. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables reflect the results of our reportable segments under our management reporting system. The performance of each segment is measured based on several metrics, including segment income from operations. These results are used, in part, by the chief operating decision maker in evaluating the performance of, and in allocating resources to, each of the segments.</span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) - (Continued) </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i7120d0ce964546ebacbc8991e13281fe"><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RleHRyZWdpb246NDE1MGJiNmMyODBmNDZkNmI5ZGRkYTEwY2QxOTZkY2JfOTE1Mg_ef82e198-f0a3-4ee3-a0da-4e314f8a09b1" continuedAt="i929607871053400a883feaca6ffa728a" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The profitability of each of the segments is measured after excluding items such as transformational initiatives, acquisition and integration costs, amortization of intangible assets related to business combinations, interest income, interest expense and other items as noted in the reconciliations below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.385%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.429%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Revenue:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences and Applied Markets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90bc58b4dc464d058d4f7d56e61e2e21_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjUyMTlkNTJlNmM0MjRlMDk5OGI3YjY4MTc2YWY3MDNiL3RhYmxlcmFuZ2U6NTIxOWQ1MmU2YzQyNGUwOTk4YjdiNjgxNzZhZjcwM2JfNS01LTEtMS02ODc1MQ_602289a6-9ca9-4c13-ace3-b55e7159a82a">1,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfc4fdb619ed43958b648563fb2ca526_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjUyMTlkNTJlNmM0MjRlMDk5OGI3YjY4MTc2YWY3MDNiL3RhYmxlcmFuZ2U6NTIxOWQ1MmU2YzQyNGUwOTk4YjdiNjgxNzZhZjcwM2JfNS03LTEtMS02ODc1MQ_25f8d12c-fda2-4d16-b31f-e7d99c00ca48">976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics and Genomics</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i405a137dbfd148ab9797e53157dcb87b_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjUyMTlkNTJlNmM0MjRlMDk5OGI3YjY4MTc2YWY3MDNiL3RhYmxlcmFuZ2U6NTIxOWQ1MmU2YzQyNGUwOTk4YjdiNjgxNzZhZjcwM2JfNi01LTEtMS02ODc1MQ_4004987c-f20f-4c0e-8e53-55dd9e423358">342</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if846265414d142bd8d679b7776dae8eb_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjUyMTlkNTJlNmM0MjRlMDk5OGI3YjY4MTc2YWY3MDNiL3RhYmxlcmFuZ2U6NTIxOWQ1MmU2YzQyNGUwOTk4YjdiNjgxNzZhZjcwM2JfNi03LTEtMS02ODc1MQ_65d20ef7-88aa-4c27-91da-87f3a8f536df">339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agilent CrossLab</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d83c1345e874e8fabdab7fd0ec051b6_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjUyMTlkNTJlNmM0MjRlMDk5OGI3YjY4MTc2YWY3MDNiL3RhYmxlcmFuZ2U6NTIxOWQ1MmU2YzQyNGUwOTk4YjdiNjgxNzZhZjcwM2JfNy01LTEtMS02ODc1MQ_637cd99c-02f0-43c4-8f67-3866b2521ff4">381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23ae7b4eb6644b20adf956a785dc7849_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjUyMTlkNTJlNmM0MjRlMDk5OGI3YjY4MTc2YWY3MDNiL3RhYmxlcmFuZ2U6NTIxOWQ1MmU2YzQyNGUwOTk4YjdiNjgxNzZhZjcwM2JfNy03LTEtMS02ODc1MQ_447de2b5-9def-4a5a-ad3b-41dab750c330">359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i899550b909f344acbdc4d7dab570fb1d_D20221101-20230131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjUyMTlkNTJlNmM0MjRlMDk5OGI3YjY4MTc2YWY3MDNiL3RhYmxlcmFuZ2U6NTIxOWQ1MmU2YzQyNGUwOTk4YjdiNjgxNzZhZjcwM2JfOC01LTEtMS02ODc1MQ_52453162-4b94-487a-a350-1755c8fa55b0">1,756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e1195fba3dd4542a09cd93dc4067241_D20211101-20220131" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjUyMTlkNTJlNmM0MjRlMDk5OGI3YjY4MTc2YWY3MDNiL3RhYmxlcmFuZ2U6NTIxOWQ1MmU2YzQyNGUwOTk4YjdiNjgxNzZhZjcwM2JfOC03LTEtMS02ODc1MQ_5f3f320d-0c46-4c28-849b-812d087a1cf1">1,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Income From Operations:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences and Applied Markets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90bc58b4dc464d058d4f7d56e61e2e21_D20221101-20230131" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjUyMTlkNTJlNmM0MjRlMDk5OGI3YjY4MTc2YWY3MDNiL3RhYmxlcmFuZ2U6NTIxOWQ1MmU2YzQyNGUwOTk4YjdiNjgxNzZhZjcwM2JfMTEtNS0xLTEtNjg3NTE_767bba40-d45c-48de-a960-b1edde558c9f">314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfc4fdb619ed43958b648563fb2ca526_D20211101-20220131" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjUyMTlkNTJlNmM0MjRlMDk5OGI3YjY4MTc2YWY3MDNiL3RhYmxlcmFuZ2U6NTIxOWQ1MmU2YzQyNGUwOTk4YjdiNjgxNzZhZjcwM2JfMTEtNy0xLTEtNjg3NTE_aca57ce2-3beb-4663-b5f8-69b38ea8e9a7">282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics and Genomics</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i405a137dbfd148ab9797e53157dcb87b_D20221101-20230131" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjUyMTlkNTJlNmM0MjRlMDk5OGI3YjY4MTc2YWY3MDNiL3RhYmxlcmFuZ2U6NTIxOWQ1MmU2YzQyNGUwOTk4YjdiNjgxNzZhZjcwM2JfMTItNS0xLTEtNjg3NTE_4a8d49d7-1093-4911-af64-150c48b2b153">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if846265414d142bd8d679b7776dae8eb_D20211101-20220131" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjUyMTlkNTJlNmM0MjRlMDk5OGI3YjY4MTc2YWY3MDNiL3RhYmxlcmFuZ2U6NTIxOWQ1MmU2YzQyNGUwOTk4YjdiNjgxNzZhZjcwM2JfMTItNy0xLTEtNjg3NTE_b28ad539-6ac4-4b4f-813c-c009aa14ae55">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agilent CrossLab</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d83c1345e874e8fabdab7fd0ec051b6_D20221101-20230131" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjUyMTlkNTJlNmM0MjRlMDk5OGI3YjY4MTc2YWY3MDNiL3RhYmxlcmFuZ2U6NTIxOWQ1MmU2YzQyNGUwOTk4YjdiNjgxNzZhZjcwM2JfMTMtNS0xLTEtNjg3NTE_548fc901-d89b-4fcc-b90a-c062ea6812be">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23ae7b4eb6644b20adf956a785dc7849_D20211101-20220131" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjUyMTlkNTJlNmM0MjRlMDk5OGI3YjY4MTc2YWY3MDNiL3RhYmxlcmFuZ2U6NTIxOWQ1MmU2YzQyNGUwOTk4YjdiNjgxNzZhZjcwM2JfMTMtNy0xLTEtNjg3NTE_89ef56f2-21b3-4798-83a5-02e575e5cced">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment income from operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i899550b909f344acbdc4d7dab570fb1d_D20221101-20230131" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjUyMTlkNTJlNmM0MjRlMDk5OGI3YjY4MTc2YWY3MDNiL3RhYmxlcmFuZ2U6NTIxOWQ1MmU2YzQyNGUwOTk4YjdiNjgxNzZhZjcwM2JfMTQtNS0xLTEtNjg3NTE_06a56d5b-b4ed-47ac-aac7-b4ed01c32e98">476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e1195fba3dd4542a09cd93dc4067241_D20211101-20220131" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjUyMTlkNTJlNmM0MjRlMDk5OGI3YjY4MTc2YWY3MDNiL3RhYmxlcmFuZ2U6NTIxOWQ1MmU2YzQyNGUwOTk4YjdiNjgxNzZhZjcwM2JfMTQtNy0xLTEtNjg3NTE_e20ed75c-04c8-4e48-9823-f0a14c2099d4">441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RleHRyZWdpb246NDE1MGJiNmMyODBmNDZkNmI5ZGRkYTEwY2QxOTZkY2JfOTE3Nw_0d63d122-8418-40cc-94b4-ca7bf11cdbcb" escape="true"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles segment income from operations to Agilent&#8217;s total enterprise income before taxes:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.385%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.429%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment income from operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i899550b909f344acbdc4d7dab570fb1d_D20221101-20230131" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfNC01LTEtMS02ODc1MQ_67468402-515c-4319-bcb9-684c6d1c01d6">476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e1195fba3dd4542a09cd93dc4067241_D20211101-20220131" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfNC03LTEtMS02ODc1MQ_8fc0b411-8f05-4237-baa3-b62b863148d1">441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transformational initiatives</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="a:TransformationalPrograms" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfNS01LTEtMS02ODc1MQ_0574b593-0ec3-4043-ac0d-fd0e9619f50d">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="a:TransformationalPrograms" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfNS03LTEtMS02ODc1MQ_647461b5-9020-4f30-a3ff-0fc5c1e21b76">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets related to business combinations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfNi01LTEtMS02ODc1MQ_1fc90913-1a27-4ed3-81c4-e19fee483d09">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfNi03LTEtMS02ODc1MQ_bf2ad4be-24b0-4a16-b759-ff7165c19ca3">51</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfNy01LTEtMS02ODc1MQ_b62d725b-fc64-4d42-b823-24c2c82b9922">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfNy03LTEtMS02ODc1MQ_d773e464-8a64-498a-8bf5-522d78be4257">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfOS01LTEtMS02ODc1MQ_17d8fc12-7320-4897-b078-6d97ce8f91cd">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfOS03LTEtMS02ODc1MQ_121fa7b2-132f-4dbe-afda-2351be131e98">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:OtherNonrecurringExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfMTUtNS0xLTEtNjg3NTE_277b3046-736a-4b10-8758-21f2f07be238">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:OtherNonrecurringExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfMTUtNy0xLTEtNjg3NTE_564413e9-15dc-4c6f-a7e6-46f2c7da2071">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfMTYtNS0xLTEtNjg3NTE_1615350a-6d77-43e3-bbd8-9d9359e7b5c1">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfMTYtNy0xLTEtNjg3NTE_9e144256-cfdf-44ed-8520-d179e2019cec">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfMTctNS0xLTEtNjg3NTE_350b57ce-c3a1-4a75-b4a7-29fffc0f4632">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfMTctNy0xLTEtNjg3NTE_f78be576-9a67-4edd-b240-45c499ad57d1">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfMTgtNS0xLTEtNjg3NTE_4dde0977-3384-4202-9641-26fb5b0f3fad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfMTgtNy0xLTEtNjg3NTE_9a81c65b-033b-43c4-91ec-446905e872f2">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before taxes, as reported</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfMTktNS0xLTEtNjg3NTE_849a7012-463c-48b4-8c2b-63e238b51f6f">410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfMTktNy0xLTEtNjg3NTE_2bc7d2d6-b534-434f-9ddd-384d1d48875e">319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:9pt;text-indent:4.5pt"><span><br/></span></div><div style="padding-left:9pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) For the three months ended January&#160;31, 2023 and 2022, other income (expense), net includes net (gains) losses on the fair value of equity securities.</span></div></ix:nonNumeric><div style="padding-left:9pt;text-indent:4.5pt"><span><br/></span></div><ix:continuation id="i929607871053400a883feaca6ffa728a"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects segment assets under our management reporting system. Segment assets include allocations of corporate assets, goodwill, net other intangibles and other assets. Unallocated assets primarily consist of cash, cash equivalents, short-term and long-term investments, deferred tax assets, right-of-use assets and other assets. &#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences and Applied Markets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e0c874f1a2f4b52bde701c5d0c5f04a_I20230131" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjM0ODQ2YWIyYjk2OTQ3ZGJiYWEzYTkyNDBkZTE3ZjNmL3RhYmxlcmFuZ2U6MzQ4NDZhYjJiOTY5NDdkYmJhYTNhOTI0MGRlMTdmM2ZfMy0xLTEtMS02ODc1MQ_a9a2fdc4-6567-48d4-9215-8bc1eaf1c22b">4,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14749e019f0c4a78a5749fbc0e9602a5_I20221031" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjM0ODQ2YWIyYjk2OTQ3ZGJiYWEzYTkyNDBkZTE3ZjNmL3RhYmxlcmFuZ2U6MzQ4NDZhYjJiOTY5NDdkYmJhYTNhOTI0MGRlMTdmM2ZfMy0zLTEtMS02ODc1MQ_f59bf4d3-bf9e-47d7-a0aa-41dcc7ce2703">3,955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics and Genomics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic29288e8bc2e49b7b040c7b53788b074_I20230131" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjM0ODQ2YWIyYjk2OTQ3ZGJiYWEzYTkyNDBkZTE3ZjNmL3RhYmxlcmFuZ2U6MzQ4NDZhYjJiOTY5NDdkYmJhYTNhOTI0MGRlMTdmM2ZfNC0xLTEtMS02ODc1MQ_5903ea2c-3640-4ec7-a420-ee2627c2ffa8">3,520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c417edb3d704da7925a02009feeff69_I20221031" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjM0ODQ2YWIyYjk2OTQ3ZGJiYWEzYTkyNDBkZTE3ZjNmL3RhYmxlcmFuZ2U6MzQ4NDZhYjJiOTY5NDdkYmJhYTNhOTI0MGRlMTdmM2ZfNC0zLTEtMS02ODc1MQ_35d8cff0-8888-4df7-a6d8-dee5eb86b082">3,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agilent CrossLab</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39cb63aace124a70b0cf20f2781b5388_I20230131" decimals="-6" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjM0ODQ2YWIyYjk2OTQ3ZGJiYWEzYTkyNDBkZTE3ZjNmL3RhYmxlcmFuZ2U6MzQ4NDZhYjJiOTY5NDdkYmJhYTNhOTI0MGRlMTdmM2ZfNS0xLTEtMS02ODc1MQ_99d272c3-2878-4d44-b0c5-97e6f74a9dd6">962</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdb82786efda42a99e13832f0a499c71_I20221031" decimals="-6" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjM0ODQ2YWIyYjk2OTQ3ZGJiYWEzYTkyNDBkZTE3ZjNmL3RhYmxlcmFuZ2U6MzQ4NDZhYjJiOTY5NDdkYmJhYTNhOTI0MGRlMTdmM2ZfNS0zLTEtMS02ODc1MQ_bb0a6c15-a08b-444f-b4c7-5da83c856693">869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia34e53066283455d9839cece675eac92_I20230131" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjM0ODQ2YWIyYjk2OTQ3ZGJiYWEzYTkyNDBkZTE3ZjNmL3RhYmxlcmFuZ2U6MzQ4NDZhYjJiOTY5NDdkYmJhYTNhOTI0MGRlMTdmM2ZfNi0xLTEtMS02ODc1MQ_38f70046-ef9b-4ff4-b9c3-f0e6209aa5ca">8,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i927186f756bc4f41b7276527c4ebea8a_I20221031" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjM0ODQ2YWIyYjk2OTQ3ZGJiYWEzYTkyNDBkZTE3ZjNmL3RhYmxlcmFuZ2U6MzQ4NDZhYjJiOTY5NDdkYmJhYTNhOTI0MGRlMTdmM2ZfNi0zLTEtMS02ODc1MQ_a62f562a-db28-49a6-8b1a-6bc579e63c16">8,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_82"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS  (UNAUDITED)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion should be read in conjunction with the condensed consolidated financial statements and notes thereto included elsewhere in this Form&#160;10-Q and our Annual Report on Form 10-K. This report contains forward-looking statements including, without limitation, statements regarding growth opportunities, including for revenue and our end markets, strength and drivers of the markets into which we sell, sales funnels, our strategic direction, new product and service introductions and the position of our current products and services, market demand for and adoption of our products, the ability of our products and solutions to address customer needs and meet industry requirements, our focus on differentiating our product solutions, improving our customers&#8217; experience and growing our earnings, future financial results, our operating margin, mix, our investments, including in manufacturing infrastructure, research and development and expanding and improving our applications and solutions portfolios, expanding our position in developing countries and emerging markets, our focus on balanced capital allocation, our contributions to our pension and other defined benefit plans, impairment of goodwill and other intangible assets, the impact of foreign currency movements, our hedging programs and other actions to offset the effects of tariffs and foreign currency movements, our future effective tax rate, tax valuation allowance and unrecognized tax benefits, the impact of local government regulations on our ability to pay vendors or conduct operations, our ability to satisfy our liquidity requirements, including through cash generated from operations, the potential impact of adopting new accounting pronouncements, indemnification, source and supply of materials used in our products, our sales, our purchase commitments, our capital expenditures, the integration and effects of our acquisitions and other transactions, our stock repurchase program and dividends, macroeconomic and geopolitical uncertainties, interest rate and inflationary pressures, and the potential or anticipated direct or indirect impact of COVID-19 on our business that involve risks and uncertainties. Our actual results could differ materially from the results contemplated by these forward-looking statements due to various factors, including those discussed in Part II Item&#160;1A and elsewhere in this Form&#160;10-Q.</span></div><div><span><br/></span></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_85"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial information presented in this Form&#160;10-Q is not audited and is not necessarily indicative of our future consolidated financial position, results of operations, comprehensive income (loss) or cash flows. Our fiscal year-end is October&#160;31, and our fiscal quarters end on January&#160;31, April&#160;30 and July&#160;31. Unless otherwise stated, these dates refer to our fiscal year and fiscal periods.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_88"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Executive Summary</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agilent Technologies, Inc. ("we," "Agilent" or the "company"), incorporated in Delaware in May 1999, is a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 Pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify;text-indent:9pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Both our domestic and international operations have been and continue to be affected by the ongoing global pandemic of a novel strain of coronavirus (&#8220;COVID-19&#8221;) and the resulting volatility and uncertainty it has caused. In the first quarter of fiscal year 2023, many businesses and countries, including China where we maintain significant operations, continued responding to the evolving nature of the spread of the virus. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While conditions related to the COVID-19 pandemic have improved since 2021, the pandemic continues to be dynamic, and near-term challenges across the economy remain. The ongoing effects of COVID-19 remain difficult to predict due to numerous uncertainties, including the severity, duration and resurgence of the outbreak, new variants and the contagiousness of these new variants, the effectiveness of health and safety measures including vaccines and therapies, government and community responses including additional lockdowns, the pace and strength of the economic recovery, supply chain pressures, delivery and installation delays due to variable access to customer sites, among others. We will continue to actively monitor the effects of the pandemic and will continue to take appropriate steps to mitigate the impacts to our employees and on our business results. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Actual Results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue of $1,756 million for the three months ended January&#160;31, 2023 increased 5 percent when compared to the same period last year. Foreign currency movements for the three months ended January&#160;31, 2023 had an overall unfavorable impact on revenue growth of 5 percentage points when compared to the same period last year. Net revenue increased in all our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">segments, geographic regions and most of our end markets. Revenue generated by our life sciences and applied markets business in the three months ended January&#160;31, 2023 increased 6 percent when compared to the same period last year. Foreign currency movements for the three months ended January&#160;31, 2023, had an overall unfavorable impact on revenue growth of 5 percentage points when compared to the same period last year. Revenue generated by our diagnostics and genomics business for the three months ended January&#160;31, 2023 increased 1 percent when compared to the same period last year.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency movements for the three months ended January&#160;31, 2023 had an overall unfavorable impact on revenue growth of 4 percentage points when compared to the same period last year. Revenue generated by our Agilent CrossLab business in the three months ended January&#160;31, 2023 increased 6 percent when compared to the same period last year. Foreign currency movements for the three months ended January&#160;31, 2023 had an overall unfavorable impact on revenue growth of 7 percentage points when compared to the same period last year. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income for the three months ended January&#160;31, 2023 was $352 million compared to net income of $283 million for the corresponding period last year. In the three months ended January&#160;31, 2023, cash provided by operations was $296 million compared to cash provided by operations of $255 million in the same period last year.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividends.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the three months ended January&#160;31, 2023, we paid cash dividends of $0.225 per common share or $67 million on the company's common stock. During the three months ended January&#160;31, 2022, we paid cash dividends of  $0.210 per common share or $63 million on the company's common stock. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;22, 2023, our board of directors declared a quarterly dividend of $0.225 per share of common stock or approximately $67&#160;million which will be paid on April&#160;26, 2023 to all shareholders of record at the close of business on April&#160;4, 2023. The timing and amounts of any future dividends are subject to determination and approval by our board of directors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Repurchase Program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. During the three months ended January&#160;31, 2023, we repurchased and retired 499,000 shares for $75 million under the 2021 repurchase authorization. During the three months ended January&#160;31, 2022, we repurchased and retired 2.900 million shares for $447 million under this authorization. As of January&#160;31, 2023, we had remaining authorization to repurchase up to approximately $363 million of our common stock under the 2021 repurchase program. On March 1, 2023, the 2021 repurchase program was terminated and the remaining authorization of $339&#160;million expired.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Repurchase Program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On January 9, 2023, we announced that our board of directors had approved a share repurchase program (the "2023 repurchase program") designed, among other things, to reduce or eliminate dilution resulting from issuance of stock under the company's employee equity incentive programs. The 2023 repurchase program authorizes the purchase of up to $2.0&#160;billion of our common stock at the company's discretion and has no fixed termination date. The 2023 repurchase program does not require the company to acquire a specific number of shares and may be suspended, amended or discontinued at any time. The 2023 repurchase program commenced on March 1, 2023, and also terminated and replaced the 2021 repurchase program.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Looking forward, we remain focused on improving our customers&#8217; experience, differentiating product solutions and productivity. We expect to continue to face interest rate and inflationary pressures which we will continue to mitigate through targeted pricing and various other strategies. While we anticipate an uncertain macroeconomic environment in fiscal year 2023, we remain optimistic about our long-term growth opportunities in all of our key end markets in fiscal year 2023. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_91"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations is based upon our condensed consolidated financial statements, which have been prepared in accordance with generally accepted accounting principles (&#8220;GAAP&#8221;) in the U.S. The preparation of condensed consolidated financial statements in conformity with GAAP in the U.S. requires management to make estimates, judgments and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Our critical accounting policies are those that affect our financial statements materially and involve difficult, subjective or complex judgments by management. Those policies are revenue recognition, inventory valuation, retirement and post-retirement benefit plan assumptions, valuation of goodwill and purchased intangible assets and accounting for income taxes. There have been no significant changes to our critical accounting policies as described in our Annual Report on Form 10-K for the fiscal year ended October&#160;31, 2022. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Although these estimates are based on management&#8217;s best knowledge of current events and actions that may impact the company in the future, actual results may be different from the estimates.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An accounting policy is deemed to be critical if it requires an accounting estimate to be made based on assumptions about matters that are highly uncertain at the time the estimate is made and if different estimates that reasonably could have been used or changes in the accounting estimate that are reasonably likely to occur could materially change the financial statements.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_94"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adoption of New Pronouncements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 2, &#8220;New Accounting Pronouncements,&#8221; to the condensed consolidated financial statements for a description of new accounting pronouncements.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_97"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues, costs and expenses, and monetary assets and liabilities and equity are exposed to changes in foreign currency exchange rates as a result of our global operating and financing activities. Foreign currency movements for the three months ended January&#160;31, 2023 had an overall unfavorable impact on revenue of 5 percentage points when compared to the same period last year. When movements in foreign currency exchange rates have a negative impact on revenue, they will also have a positive impact by reducing our costs and expenses. We calculate the impact of movements in foreign currency exchange rates by applying the actual foreign currency exchange rates in effect during the last month of each quarter of the current year to both the applicable current and prior year periods. We hedge revenues, expenses and balance sheet exposures that are not denominated in the functional currencies of our subsidiaries on a short term and anticipated basis. We do experience some fluctuations within individual lines of the condensed consolidated statement of operations and balance sheet because our hedging program is not designed to offset the currency movements in each category of revenues, expenses, monetary assets and liabilities. Our hedging program is designed to hedge currency movements on a relatively short-term basis (up to a rolling twelve-month period). We may also hedge equity balances denominated in foreign currency on a long-term basis. To the extent that we are required to pay for all, or portions, of an acquisition price in foreign currencies, we may enter into foreign exchange contracts to reduce the risk that currency movements will impact the U.S. dollar cost of the transaction.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_100"></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results from Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.174%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.162%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year&#160;over&#160;Year&#160;Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Months</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services and other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,756&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,674&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td></tr></table></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue of  $1,756 million for the three months ended January&#160;31, 2023 increased 5 percent when compared to the same period last year. Foreign currency movements for the three months ended January&#160;31, 2023 had an overall unfavorable </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">impact on revenue growth of 5 percentage points when compared to the same period last year. In the three months ended January&#160;31, 2023, net revenue increased in all of our segments, geographic regions and in most of our end markets when compared to the same period last year. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from products for the three months ended January&#160;31, 2023 increased 5 percent when compared to the same period last year. Product revenue growth in the three months ended January&#160;31, 2023 was driven by our liquid chromatography, spectroscopy, nucleic acid solutions and cell analysis businesses.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services and other revenue for the three months ended January&#160;31, 2023 increased 5 percent when compared to the same period last year.&#160;Services and other revenue consist of contract repair, preventative maintenance, compliance services, relocation services, installation services and consulting services related to the companion diagnostics and nucleic acid solutions businesses. For the three months ended January&#160;31, 2023, service revenue increases reflected strong growth from the majority of the services portfolio.  </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Revenue By Segment</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:63.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.153%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.674%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.674%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.454%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.782%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year&#160;over&#160;Year&#160;Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Months</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenue by segment:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life sciences and applied markets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics and genomics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agilent CrossLab</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,756&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,674&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td></tr></table></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue in the life sciences and applied markets business for the three months ended January&#160;31, 2023 increased 6 percent when compared to the same period last year.  Foreign currency movements for the three months ended January&#160;31, 2023 had an overall unfavorable impact on revenue growth of 5 percentage points when compared to the same period last year. For the three months ended January&#160;31, 2023, we saw revenue growth across most of our end markets led by strong revenue growth within the chemical and advanced materials, the pharmaceutical and the environmental and forensics markets when compared to the same period last year.  </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue in the diagnostics and genomics business for the three months ended January&#160;31, 2023, increased 1 percent when compared to the same period last year. Foreign currency movements for the three months ended January&#160;31, 2023 had an overall unfavorable impact on revenue growth of 4 percentage points when compared to the same period last year. For the three months ended January&#160;31, 2023, revenue growth in the pharmaceutical market was strong led by our nucleic acid solutions business which was partially offset by a decline in our diagnostics and clinical and academia and government markets.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue generated by Agilent CrossLab in the three months ended January&#160;31, 2023, increased 6 percent when compared to the same period last year. Foreign currency movements for the three months ended January&#160;31, 2023 had an overall unfavorable impact on revenue growth of 7 percentage points when compared to the same period last year.  For the three months ended January&#160;31, 2023, we saw revenue growth across all of our end markets led by strong revenue growth from the pharmaceutical market when compared to the same period last year.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_103"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Results</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year&#160;over&#160;Year&#160;Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Months</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except margin data)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gross margin</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 ppt</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating margin</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 ppts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13%</span></td></tr></table></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total gross margin for the three months ended January&#160;31, 2023 increased 1 percentage point when compared to the same period last year. Gross margin for the three months ended January&#160;31, 2023 was impacted by higher sales volume, targeted sales price increases, and lower intangible amortization expense partially offset by unfavorable impact of currency movements,  higher wages and input costs.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses for the three months ended January&#160;31, 2023 increased 5 percent when compared to the same period last year. Research and development expenses for the three months ended January&#160;31, 2023 increased due to  higher wages and program costs in our life sciences and applied markets and diagnostics and genomics businesses partially offset by the favorable impact of currency movements.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses for the three months ended January&#160;31, 2023 increased 1 percent when compared to the same period last year. The increase in the three months ended January&#160;31, 2023, was due to higher wages mostly offset by lower intangible amortization expense, sales commissions and the favorable impact of currency movements.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating margin for the three months ended January&#160;31, 2023 increased 2 percentage points when compared to the same period last year. Operating margin for the three months ended January&#160;31, 2023 increased primarily due to higher sales volume.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income from operations for the three months ended January&#160;31, 2023 increased $50 million or 13 percent on  corresponding revenue increase of $82 million.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At January&#160;31, 2023, our headcount was approximately 18,300 as compared to approximately 17,200 at January&#160;31, 2022. The increase in headcount was to address the increase in business.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other income (expense), net</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the three months ended January&#160;31, 2023 other income and expense, net includes a net loss on equity securities of $10 million. In the three months ended January&#160;31, 2023 other income and expense, net also includes income of $3&#160;million related to the provision of site service costs to, and lease income from Keysight Technologies, Inc. The costs associated with these services are reported within income from operations.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In the three months ended January&#160;31, 2022 other income and expense, net includes net loss on the fair value of equity investments of approximately $47 million. In the three months ended January&#160;31, 2022 other income and expense, net also includes income of $3 million related to the provision of site service costs to, and lease income from Keysight Technologies, Inc. The costs associated with these services are reported within income from operations.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_106"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended January&#160;31, 2023, our income tax expense was $58 million with an effective tax rate of 14.1 percent. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate increased in 2023 compared to 2022 primarily due to the mandatory capitalization of research and development expenses, which became effective for Agilent in the first quarter of 2023, due to a change in tax law from the Tax Cuts and Jobs Act of 2017. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended January 31, 2023, our effective tax rate and the resulting provision for income taxes were also impacted by the excess tax benefits from stock-based compensation of $12&#160;million along with the expiration of various foreign statutes of limitations which resulted in the recognition of previously unrecognized tax benefits of $7&#160;million.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended January&#160;31, 2022, our income tax expense was $36 million with an effective tax rate of 11.3 percent. The income taxes for the three months ended January&#160;31, 2022 include the excess tax benefits from stock-based compensation of $16&#160;million. For the three months ended January&#160;31, 2022, our effective tax rate and the resulting provision for income taxes were also impacted by the expiration of various foreign statutes of limitations which resulted in the recognition of previously unrecognized tax benefits of $8&#160;million.  </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In the U.S., tax years remain open back to the year 2018 for federal income tax purposes and for significant states. In other major jurisdictions where the company conducts business, the tax years generally remain open back to the year 2013.  </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With these jurisdictions and the U.S., it is reasonably possible there could be significant changes to our unrecognized tax benefits in the next twelve months due to either the expiration of a statute of limitation or a tax audit settlement which will be partially offset by an anticipated tax liability related to unremitted foreign earnings, where applicable. Given the number of years and numerous matters that remain subject to examination in various tax jurisdictions, management is unable to estimate the range of possible changes to the balance of our unrecognized tax benefits.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_109"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Overview</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to have three business segments comprised of life sciences and applied markets, diagnostics and genomics and Agilent CrossLab. </span></div><div><span><br/></span></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_112"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Life Sciences and Applied Markets</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our life sciences and applied markets business provides application-focused solutions that include instruments, consumables and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. Key product categories include: liquid chromatography ("LC") systems and components; liquid chromatography mass spectrometry ("LCMS") systems; gas chromatography ("GC") systems and components; gas chromatography mass spectrometry ("GCMS") systems; inductively coupled plasma mass spectrometry ("ICP-MS") instruments; atomic absorption ("AA") instruments; microwave plasma-atomic emission spectrometry ("MP-AES") instruments; inductively coupled plasma optical emission spectrometry ("ICP-OES") instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software for sample tracking; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps and measurement technologies. Our consumables portfolio is designed to improve customer outcomes. Most of the portfolio is vendor neutral, meaning Agilent can serve and supply customers regardless of their instrument purchase choices. Solutions range from chemistries to supplies. Key product categories in consumables include GC and LC columns, sample preparation products, custom chemistries, and a large selection of laboratory instrument supplies. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Revenue</span></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:64.589%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.412%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.073%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year&#160;over&#160;Year&#160;Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Months</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6%</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Life sciences and applied markets business revenue for the three months ended January&#160;31, 2023 increased 6 percent when compared to the same period last year. Foreign currency movements for the three months ended January&#160;31, 2023 had an overall unfavorable impact on revenue growth of 5 percentage points when compared to the same period last year.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Geographically, revenue increased 5 percent in the Americas with no currency impact, increased 2 percent in Europe with a 9 percentage point unfavorable currency impact and increased 9 percent in Asia Pacific with a 7 percentage point unfavorable currency impact for the three months ended January&#160;31, 2023 compared to the same period last year. For the three months ended January&#160;31, 2023, revenue growth in all regions was driven by our liquid chromatography, spectroscopy and cell analysis businesses when compared to the same period last year. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended January&#160;31, 2023, revenue by end markets was strong across most end markets. Revenue growth in the pharmaceutical market was strong and primarily driven by our liquid chromatography and cell analysis businesses when compared to the same period last year. Revenue growth in the chemicals and advanced materials market was strong and mainly driven by strength in our spectroscopy and liquid chromatography businesses. Revenue growth in the environmental and forensics market was strong mainly driven by liquid chromatography and gas chromatography mass spectrometry businesses when compared to the same period last year. Revenue growth in the food market was moderate and primarily driven by our spectroscopy and liquid chromatography businesses. Revenue in the diagnostics and clinical market declined moderately driven by weakness in our liquid chromatography mass spectrometry business partially offset by strength in our cell analysis business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Looking forward, despite uncertainties around macroeconomic and geopolitical conditions as well as COVID-19 and inflationary pressures, we are optimistic about our long-term growth opportunities in the life sciences and applied markets as our broad portfolio of products and solutions are well suited to address customer needs. While we anticipate volatility in our markets, we expect long term growth across most end markets as we continue to invest in expanding and improving our applications and solutions portfolio. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Results</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:63.122%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.412%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.412%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.661%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year&#160;over&#160;Year&#160;Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Months</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except margin data)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 ppt</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating margin</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 ppts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11%</span></td></tr></table></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross margin for products and services for the three months ended January&#160;31, 2023, increased 1 percentage point when compared to the same period last year. Gross margin for the three months ended January&#160;31, 2023 was impacted by higher sales volume, targeted price increases and lower warranty cost partially offset by higher wages, input costs and the unfavorable impact of currency movements. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses for the three months ended January&#160;31, 2023, increased 4 percent when compared to the same period last year. Research and development expenses for the three months ended January&#160;31, 2023 increased due to  higher wages and program investments in liquid chromatography mass spectrometry and digital lab platform technology.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Selling, general and administrative expenses for the three months ended January&#160;31, 2023, increased 3 percent when compared to the same period last year. Selling, general and administrative expenses for the three months ended January&#160;31, 2023, increased mostly due to higher wages partially offset by lower commissions and the favorable impact of currency movements.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating margin for products and services for the three months ended January&#160;31, 2023 increased 2 percentage points when compared to the same period last year. Operating margin for the three months ended January&#160;31, 2023 was impacted by  higher sales volume with improved gross margins and lower spending partially offset by higher wages.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Income from operations for the three months ended January&#160;31, 2023, increased $32 million or 11 percent on a corresponding revenue increase of $57 million.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Income from operations for the three months ended January&#160;31, 2023 increased primarily due to higher sales volume and lower commissions partially offset by higher wages and investments in liquid chromatography mass spectrometry and digital lab platform technology and the unfavorable impact of currency movements.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_115"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diagnostics and Genomics</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our diagnostics and genomics business includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our diagnostics and genomics business is comprised of six areas of activity providing active pharmaceutical ingredients ("APIs") for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables, which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level.&#160;First, our genomics business includes arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, as well as next generation sequencing ("NGS") target enrichment and genetic data management and interpretation support software. This business also includes solutions that enable clinical labs to identify DNA variants associated with genetic disease and help direct cancer therapy. Second, our nucleic acid solutions business is a contract and development manufacturing organization that provides services related to and the production of synthesized oligonucleotides under pharmaceutical good manufacturing practices ("GMP") conditions for use as API in a class of drugs that utilize nucleic acid molecules for disease therapy. Third, our pathology solutions business is focused on product offerings for cancer diagnostics and anatomic pathology workflows. The broad portfolio of offerings includes immunohistochemistry ("IHC"), in situ hybridization ("ISH"), hematoxylin and eosin ("H&amp;E") staining and special staining. Fourth, we also collaborate with a number of major pharmaceutical companies to develop new potential tissue and liquid-based pharmacodiagnostics, also known as companion diagnostics, which may be used to identify patients most likely to benefit from a specific targeted therapy. Fifth, the reagent partnership business provides clinical flow cytometry reagents for routine cancer diagnostics. This business also provides bulk antibodies as raw materials and associated assay development services to IVD manufacturers, biotechnology and pharmaceutical companies. Finally, our biomolecular analysis business provides complete workflow solutions, including instruments, consumables and software, for quality control analysis of nucleic acid samples. Samples are analyzed using quantitative and qualitative techniques to ensure accuracy in further genomics analysis techniques including NGS, utilized in clinical and life science research applications.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Revenue</span></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:62.590%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.032%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.436%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.254%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year&#160;over&#160;Year&#160;Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Months</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1%</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostics and genomics business revenue for the three months ended January&#160;31, 2023 increased 1 percent when compared to the same period last year.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency movements for the three months ended January&#160;31, 2023 had an overall unfavorable impact on revenue growth of 4 percentage points when compared to the same period last year.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Geographically, revenue increased 7 percent in the Americas with no currency impact, decreased 1 percent in Europe with an 8 percentage point unfavorable currency impact and decreased 16 percent in Asia Pacific with a 10 percentage point unfavorable currency impact for the three months ended January&#160;31, 2023 compared to the same period last year. For the three months ended January&#160;31, 2023, the increase in the Americas was driven by strong performance in our nucleic acid solutions, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">pathology, reagent partnership and biomolecular analysis businesses and was partially offset by declines in companion diagnostics and genomics businesses. In Europe, the unfavorable impact of currency on revenue was partially offset by strong growth in the reagent partnership business</span><span style="color:#1c1d20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> The decline in Asia Pacific revenue was driven by China.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the three months ended January&#160;31, 2023, revenue growth in the pharmaceutical market was driven by our nucleic acid solutions business. The unfavorable currency impact and revenue decline in the genomics portfolio in our diagnostics and clinical market was partially offset by strong growth in the reagent partnership business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Looking forward, despite macroeconomic and geopolitical and COVID-19 uncertainties, we are optimistic about our long-term growth opportunities in our end markets and continue to invest in expanding and improving our applications and solutions portfolio. We remain positive about our growth in our end markets as our product portfolio around OMNIS and PD-L1 assays continues to gain strength with our customers in clinical oncology applications, and our next generation sequencing related solutions continue to be adopted. Market demand in the nucleic acid solutions business related to therapeutic oligo programs continues, and with the planned expansion of our nucleic acid solutions production facility in Frederick, Colorado, we are well positioned to serve more of the market demand. We are expanding our capabilities in NGS-based cancer diagnostics and will provide innovative technology to further serve the needs of the fast-growing precision medicine market. We will continue to invest in research and development and seek to expand our position in developing countries and emerging markets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Results</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.455%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year&#160;over&#160;Year&#160;Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Months</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except margin data)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2) ppts</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating margin</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3) ppts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)%</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross margin for products and services for the three months ended January&#160;31, 2023, decreased 2 percentage points when compared to the same period last year. Gross margin for the three months ended January&#160;31, 2023 decreased due to unfavorable impact of currency movements, unfavorable product mix and higher wages.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses for the three months ended January&#160;31, 2023, increased 11 percent when compared to the same period last year. Research and development expenses for the three months ended January&#160;31, 2023 increased primarily due to higher wages and program investments in our next generation products in our genomics business.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Selling, general and administrative expenses for the three months ended January&#160;31, 2023, increased 2 percent when compared to the same period last year. Selling, general and administrative expenses for the three months ended January&#160;31, 2023 increased due to  higher wages which were partially offset by the favorable impact of currency movements.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Operating margin for products and services for the three months ended January&#160;31, 2023 decreased 3 percentage points when compared to the same period last year. The decrease in operating margin for the three months ended January&#160;31, 2023 was primarily due to higher cost of sales and operating expenses.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income from operations for the three months ended January&#160;31, 2023 decreased $9 million or 13 percent on a corresponding revenue increase of $3 million. Income from operations for the three months ended January&#160;31, 2023 decreased due to unfavorable impact of currency movements,  unfavorable product mix and higher wages.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_118"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Agilent CrossLab</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Agilent CrossLab business spans the entire lab with its extensive services portfolio, which is designed to improve customer outcomes.  The majority of the portfolio is vendor neutral, meaning we can serve and supply customers regardless of their instrument purchase choices.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The services portfolio include repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting and various other custom services to support the customers' laboratory operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Custom services are tailored to meet the specific application needs of various industries and to keep instruments fully operational and compliant with the respective industry requirements.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Revenue</span></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:63.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.424%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.501%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.501%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.424%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.163%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year&#160;over&#160;Year&#160;Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Months</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6%</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agilent CrossLab business revenue for the three months ended January&#160;31, 2023 increased 6 percent when compared to the same period last year. Foreign currency movements for the three months ended January&#160;31, 2023 had an overall unfavorable impact on revenue growth of 7 percentage points when compared to the same period last year. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Geographically, revenue increased 16 percent in the Americas with no currency impact, was flat in Europe with a 10 percentage point unfavorable currency impact and was flat in Asia Pacific with a 10 percentage point unfavorable currency impact for the three months ended January&#160;31, 2023 compared to the same period last year. </span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended January&#160;31, 2023, revenue growth in all three regions reflected consistent high demand for repair services, compliance services, installation services and consultative services across the entire portfolio.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended January&#160;31, 2023, we saw strong revenue growth across all of the end markets led by the pharmaceutical market when compared to the same period last year.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Looking forward, Agilent CrossLab services are well positioned to continue their success in our key end markets by supporting a growing installed base of instruments. Digital and remote capabilities will continue to be a key factor in improving the service quality and the experience to customers. Geographically, the business is well diversified across all regions to take advantage of local market opportunities and to hedge against weakness in any one region.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Results</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:63.406%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.420%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.420%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year&#160;over&#160;Year&#160;Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Months</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except margin data)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 ppt</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating margin</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 ppts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14%</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross margin for the three months ended January&#160;31, 2023 increased 1 percentage point when compared to the same period last year.  Gross margin for the three months ended January&#160;31, 2023 was impacted by higher sales volume and targeted price increases that improved margins, which were partially offset by higher wages, unfavorable impact of currency movements and service delivery costs for logistics and parts. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses for the three months ended January&#160;31, 2023 increased 5 percent when compared to the same period last year.  Research and development expenses for the three months ended January&#160;31, 2023 increased mainly due to higher wages partially offset by the favorable impact of currency movements.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses for the three months ended January&#160;31, 2023 increased 2 percent when compared to the same period last year. Selling, general and administrative expenses for the three months ended January&#160;31, 2023 increased primarily due to higher wages partially offset by the favorable impact of currency movements.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating margin for products and services for the three months ended January&#160;31, 2023 increased 2 percentage points when compared to the same period last year. </span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating margin for the three months ended January&#160;31, 2023 increased mostly driven by higher sales volume with improved gross margins in addition to lower expenses. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income from operations for the three months ended January&#160;31, 2023 increased $12 million or 14 percent on a corresponding revenue increase of $22 million  Income from operations for the three months ended January&#160;31, 2023 increased primarily due to higher sales volume partially offset by the unfavorable impact of currency movements.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_121"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL CONDITION</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="text-align:justify;text-indent:9pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our cash and cash equivalents, cash generated from operations, and ability to access capital markets and credit lines will satisfy, for at least the next twelve months and beyond, our liquidity requirements, both globally and domestically, including the following: working capital needs, capital expenditures, business acquisitions, stock repurchases, cash dividends, contractual obligations, commitments, principal and interest payments on debt, and other liquidity requirements associated with our operations. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial position as of January&#160;31, 2023 consisted of cash and cash equivalents of $1,250 million as compared to $1,053 million as of October&#160;31, 2022.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may, from time to time, retire certain outstanding debt of ours through open market cash purchases, privately-negotiated transactions or otherwise. Such transactions, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Cash Provided by Operating Activities</span></div><div style="text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net cash inflow from operating activities was $296 million for the three months ended January&#160;31, 2023 compared to cash inflow of $255 million for the same period in 2022.  Net cash paid for income taxes in the three months ended January&#160;31, 2023 was approximately $17 million compared to income taxes paid of $22 million for the same period in 2022. Other assets and liabilities, for the three months ended January&#160;31, 2023, had cash inflow of $85 million compared to cash inflow of $40 million for the same period in 2022.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the three months ended January&#160;31, 2023, accounts receivable used cash of $5 million compared to cash used of $46 million for the same period in 2022. Days&#8217; sales outstanding ("DSO") as of January&#160;31, 2023 was 75 days when compared to 65 days as of January&#160;31, 2022. The increase in DSO was due to higher shipments near the end of the quarter. In addition, DSO increased due to higher unbilled receivables driven by growth in our nucleic acid solutions business, that has a longer cash conversion cycle. Cash used for inventory was $69 million for the three months ended January&#160;31, 2023 compared to cash used of $54 million for the same period in 2022. Inventory days on-hand was 127 days as of January&#160;31, 2023 compared to 103 days as of January&#160;31, 2022 mainly due to increased inventory levels to meet customer needs and to compensate for long lead time in ordering from our suppliers.  In the three months ended January&#160;31, 2023, accounts payable used cash of $27 million compared to cash provided of $37 million for the same period in 2022. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The employee compensation and benefits liability used cash of $174 million for the three months ended January&#160;31, 2023 compared to cash used of $210 million for the same period in 2022. This was largely due to a decrease in variable and incentive payments which were $185 million in 2023 compared to $201&#160;million in 2022. In addition, the lower use of cash was due to an increase in the vacation liability.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We contributed approximately $5 million to our defined benefit plans in both the three months ended January&#160;31, 2023 and 2022. Our annual contributions are highly dependent on the relative performance of our assets versus our projected </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">liabilities, among other factors. We expect to contribute approximately $11 million to our defined benefit plans during the remainder of 2023.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Cash Used in Investing Activities</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities was $104 million for the three months ended January&#160;31, 2023 as compared to net cash used in investing activities of $79 million in the same period of 2022. In the three months ended January&#160;31, 2023, cash used of $30 million was related to our acquisition of Avida Biomed.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in property, plant and equipment were $76 million for the three months ended January&#160;31, 2023 compared to $75 million in the same period of 2022. These continued investments in property plant and equipment are primarily due to the planned expansion of our nucleic acid solutions production facility in Frederick, Colorado. In January 2023, we announced that we will be investing $725 million to further expand our manufacturing capacity for production of nucleic acid based therapeutics in Frederick, Colorado. Hence, we expect that total capital expenditures for the current year will be approximately $500&#160;million. Some of our investment may be eligible to qualify for reimbursement incentives, which will not fully be known until the expansion is substantially complete.  </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Cash Used in Financing Activities</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities for the three months ended January&#160;31, 2023 was $17 million compared to net cash used in financing activities of $546 million for the same period of 2022. </span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock Repurchases </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our 2021 repurchase program authorizes the purchase of up to $2.0&#160;billion of our common stock at the company's discretion and has no fixed termination date. During the three months ended January&#160;31, 2023 and 2022 we repurchased and retired 499,000 shares for $75 million and 2.900 million shares for $447 million, respectively, under this authorization. As of January&#160;31, 2023, we had remaining authorization to repurchase up to approximately $363 million of our common stock under the 2021 repurchase program. On March 1, 2023, the 2021 repurchase program was terminated and the remaining authorization of $339&#160;million expired.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 9, 2023, we announced that our board of directors had approved a share repurchase program (the "2023 repurchase program") designed, among other things, to reduce or eliminate dilution resulting from issuance of stock under the company's employee equity incentive programs. The 2023 repurchase program authorizes the purchase of up to $2.0&#160;billion of our common stock at the company's discretion and has no fixed termination date. The 2023 repurchase program does not require the company to acquire a specific number of shares and may be suspended, amended or discontinued at any time. The 2023 repurchase program commenced on March 1, 2023, and also terminated and replaced the 2021 repurchase program.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividends</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended January&#160;31, 2023 and 2022, we paid cash dividends of $0.225 per common share or $67 million, and $0.210 per common share or $63 million, respectively, on the company's common stock. On February&#160;22, 2023, our board of directors declared a quarterly dividend of $0.225 per share of common stock or approximately $67&#160;million which will be paid on April&#160;26, 2023 to all shareholders of record at the close of business on April&#160;4, 2023. The timing and amounts of any future dividends are subject to determination and approval by our board of directors.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration Payment</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended January&#160;31, 2023, we paid $65 million in contingent consideration payments related to the achievement of a certain technical milestone associated with our acquisition of Resolution Bioscience. Of the $65 million payment, $3 million is included as an outflow in cash from operations.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Facilities and Short-Term Debt</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;13, 2019, we entered into a credit agreement with a group of financial institutions which, as amended, provided for a $1 billion five-year unsecured credit facility that will expire on March&#160;13, 2024 and incremental term loan facilities in an aggregate amount of up to $500 million.&#160;On April 21, 2021, we entered into an incremental assumption agreement, pursuant to which the aggregate amount available for borrowing under the revolving credit facility was increased to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.35&#160;billion, and the aggregate amount available for incremental facilities was refreshed to remain at $500&#160;million. As of January&#160;31, 2023, we had no borrowings outstanding under the credit facility and no borrowings under the incremental facilities. We were in compliance with the covenants for the credit facility during the three months ended January&#160;31, 2023.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our U.S. commercial paper program, the company may issue and sell unsecured, short-term promissory notes in the aggregate principal amount not to exceed $1.35&#160;billion with up to 397-day maturities. At any point in time, the company intends to maintain available commitments under its revolving credit facility in an amount at least equal to the amount of the commercial paper notes outstanding. Amounts available under the program may be borrowed, repaid and re-borrowed from time to time. The proceeds from issuances under the program may be used for general corporate purposes. During the three months ended January&#160;31, 2023, we borrowed $527 million and repaid $324 million. As </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January&#160;31, 2023</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we had borrowings of $238 million outstanding under our U.S. commercial paper program and had a weighted average annual interest rate of 4.67 percent.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 15, 2022, we entered into a term loan agreement with a group of financial institutions, which provided for a $600&#160;million delayed draw term loan that will mature on April 15, 2025. As of January&#160;31, 2023, we had $600&#160;million borrowings outstanding under the term loan facility and had a weighted average interest rate of 5.40 percent. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes to the principal, maturity, interest rates and interest payment terms of the Agilent outstanding senior notes in the three months ended January&#160;31, 2023 as compared to the senior notes as described in our Annual Report on Form 10-K for the fiscal year ended October&#160;31, 2022.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other </span></div><div style="padding-left:36pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commitments for indirect material and services decreased by $19&#160;million from $139 million as reported in our Annual Report on Form 10-K for the fiscal year ended October&#160;31, 2022. These commitments are related to a variety of suppliers including IT support service providers. Our commitments to contract manufacturers and suppliers decreased by $33&#160;million as supply issues improved from $1,043&#160;million as reported in our Annual Report on Form 10-K for the fiscal year ended October&#160;31, 2022. These commitments are related to a variety of suppliers, and we use several contract manufacturers to provide manufacturing services for our products. During the normal course of business, we issue purchase orders with estimates of our requirements several months ahead of the delivery dates. These open purchase orders with our suppliers have not yet been received and our agreements usually provide us the option to cancel, reschedule and adjust our requirements based on our business needs prior to the firm orders being placed. There were no other substantial changes from our Annual Report on Form 10-K for the fiscal year ended October&#160;31, 2022 to our contractual commitments in the first three months of fiscal year 2023. We have no other material non-cancelable guarantees or commitments.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term liabilities as of both January&#160;31, 2023 and October&#160;31, 2022 include  $216&#160;million, respectively, related to long-term income tax liabilities. Of these amounts, $99&#160;million  related to uncertain tax positions as of both January&#160;31, 2023 and October&#160;31, 2022, respectively. We are unable to accurately predict when these amounts will be realized or released. However, it is reasonably possible that there could be significant changes to our unrecognized tax benefits in the next twelve months due to either the expiration of a statute of limitations or a tax audit settlement. As of January&#160;31, 2023 the remaining $117&#160;million in other long-term liabilities relates to the U.S. transition tax payment which is due in installments over the next three years.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_124"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to foreign currency exchange rate risks inherent in our sales commitments, anticipated sales, and assets and liabilities and equity denominated in currencies other than the functional currency of our subsidiaries. We hedge future cash flows denominated in currencies other than the functional currency using sales forecasts up to twelve months in advance. Our exposure to exchange rate risks is mainly managed on an enterprise-wide basis. This strategy utilizes derivative financial instruments, including option and forward contracts, to hedge certain foreign currency exposures with the intent of offsetting gains and losses that occur on the underlying exposures with gains and losses on the derivative contracts hedging them. We may also hedge equity balances denominated in foreign currency on a long-term basis. We do not currently and do not intend to utilize derivative financial instruments for speculative trading purposes. To the extent that we are required to pay for all, or portions, of an acquisition price in foreign currencies, we may enter into foreign exchange contracts to reduce the risk that currency movements will impact the cost of the transaction.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations generate non-functional currency cash flows such as revenues, third party vendor payments and inter-company payments. In anticipation of these foreign currency cash flows and in view of volatility of the currency market, we enter into such foreign exchange contracts as are described above to manage our currency risk. Approximately 53 percent and 54 percent of our revenue was generated in U.S. dollars during the three months ended January&#160;31, 2023 and 2022, respectively. The overall unfavorable effect of changes in foreign currency exchange rates, principally as a result of the strength of the U.S. dollar, has decreased revenue by 5 percentage points in the three months ended January&#160;31, 2023. We calculate the impact of movements in our foreign currency exchange rates by applying the actual foreign currency exchange rates in effect during the last month of each quarter of the current year to both the applicable current and prior year periods. </span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We performed a sensitivity analysis assuming a hypothetical 10&#160;percent adverse movement in foreign exchange rates to the hedging contracts and the underlying exposures described above. As of January&#160;31, 2023, the analysis indicated that these hypothetical market movements would not have a material effect on our condensed consolidated financial position, results of operations, statement of comprehensive income or cash flows.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also exposed to interest rate risk due to the mismatch between the interest expense we pay on our loans at fixed rates and the variable rates of interest we receive from cash, cash equivalents and other short-term investments. We have issued long-term debt in U.S. dollars or foreign currencies at fixed interest rates based on the market conditions at the time of financing. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We performed a sensitivity analysis assuming a hypothetical 10&#160;percent adverse movement in interest rates relating to the underlying fair value of our fixed rate debt. As of January&#160;31, 2023, the sensitivity analyses indicated that a hypothetical 10 percent adverse movement in interest rates would result in an immaterial impact to the fair value of our fixed interest rate debt.</span></div><div><span><br/></span></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_127"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4. CONTROLS AND PROCEDURES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures as required by the Securities Exchange Act of 1934 (the "Exchange Act") Rule&#160;13a-15(b)&#160;as&#160;of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that these disclosure controls and procedures are effective at ensuring that information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding such required disclosure to the SEC.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting during the quarter ended January&#160;31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. </span></div><div><span><br/></span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_130"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II &#8212; OTHER INFORMATION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_133"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. LEGAL PROCEEDINGS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in lawsuits, claims, investigations and proceedings, including, but not limited to, intellectual property, commercial, real estate, environmental and employment matters, which arise in the ordinary course of business. There are no matters pending that we currently believe are probable and reasonably possible of having a material impact to our business, consolidated financial condition, results of operations or cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_136"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.&#160; RISK FACTORS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">Business and Strategic Risks</span></div><div style="text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">he COVID-19 pandemic has adversely impacted, and continues to pose risks to, certain elements of our business, results of operations and financial condition, the nature and extent of which are highly uncertain and unpredictable.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our global operations expose us to risks associated with public health crises, including epidemics and pandemics such as COVID-19. The global spread of COVID-19 had, and may continue to have, an adverse impact on our operations, sales and delivery and supply chains.&#160;</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many countries including the United States implemented measures such as quarantine,&#160;shelter-in-place,&#160;curfew, travel and activity restrictions and similar isolation measures, including government orders and other restrictions on the conduct of business operations.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to these measures we experienced significant and unpredictable reductions or increases in demand for certain of our products. Moreover, these measures caused delays in installations and significantly impacted our ability to service our customers on site. For example, in the second quarter of fiscal year 2022, the outbreak of COVID-19 in China led to a mandated shutdown of our facilities in Shanghai, which negatively impacted our business and results, and impacted our supply chain. Th</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e&#160;COVID-19&#160;pandemic also impacted our supply chain as we experienced </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">disruptions or delays in shipments of certain materials or components of our products. While most of our customers have returned to work and economic activity has ramped up, we are unable to accurately predict the full extent and duration of the impact of the COVID-19 pandemic on our business and operations due to numerous uncertainties, including the duration and severity of the pandemic, the efficacy and distribution of vaccines, containment measures and additional waves of infection.  As COVID-19 conditions improved, there have been increases in demand for certain of our products, which posed challenges to our supply chain. If there are supply shortages or delays and we are not able to meet increasing product demand, our results would be adversely affected.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the COVID-19 pandemic caused significant volatility in U.S. and international markets. The impact of the pandemic may increase the possibility of uncertainty in the global financial markets, high inflation and extended economic downturn, which could reduce our ability to incur debt or access capital and impact our results and financial condition even after local conditions improve. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no assurances that the credit markets or the capital markets will be available to us in the future or that the lenders participating in our credit facilities will be able to provide financing in accordance with their contractual obligations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As COVID-19 conditions have improved, the duration and sustainability of any such improvements will be uncertain and continuing adverse impacts and/or the degree of improvement may vary dramatically by geography and by business. The actions we take in response to any improvements in conditions may also vary widely by geography and by business and will likely be made with incomplete information; pose the risk that such actions may prove to be premature, incorrect or insufficient; and could have a material, adverse impact on our business and results of operations. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General economic conditions may adversely affect our operating results and financial condition.</span></div><div style="text-align:justify;text-indent:20.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is sensitive to negative changes in general economic conditions, both inside and outside the United States. Slower global economic growth, increasing interest rates, inflationary pressures, instability and uncertainty in the markets in which we operate may adversely impact our business resulting in:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reduced demand for our products, delays in the shipment of orders, or increases in order cancellations;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased risk of excess and obsolete inventories;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased price pressure for our products and services; and</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">greater risk of impairment to the value, and a detriment to the liquidity, of our investment portfolio.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our operating results and financial condition could be harmed if the markets into which we sell our products decline or do not grow as anticipated.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Visibility into our markets is limited. Our quarterly sales and operating results are highly dependent on the volume and timing of orders received during the fiscal quarter, which are difficult to forecast and may be cancelled by our customers. In addition, our revenue and earnings forecasts for future fiscal quarters are often based on the expected seasonality of our markets. However, the markets we serve do not always experience the seasonality that we expect as customer spending policies and budget allocations, particularly for capital items, may change. Any decline in our customers' markets or in general economic conditions would likely result in a reduction in demand for our products and services. Also, if our customers' markets decline, we may not be able to collect on outstanding amounts due to us. Such declines could harm our consolidated financial position, results of operations, cash flows and stock price, and could limit our profitability. Also, in such an environment, pricing pressures could intensify. Since a significant portion of our operating expenses is relatively fixed in nature due to sales, research and development and manufacturing costs, if we were unable to respond quickly enough, these pricing pressures could further reduce our operating margins.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we do not introduce successful new products and services in a timely manner to address increased competition through frequent new product and service introductions, rapid technological changes and changing industry standards, our products and services may become obsolete, and our operating results may suffer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally sell our products in industries that are characterized by increased competition through frequent new product and service introductions, rapid technological changes and changing industry standards. Without the timely introduction of new products, services and enhancements, our products and services may become technologically obsolete over time, in which case our revenue and operating results could suffer. The success of our new products and services will depend on several factors, including our ability to:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">properly identify customer needs and predict future needs;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">innovate and develop new technologies, services and applications;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">appropriately allocate our research and development spending to products and services with higher growth prospects;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">successfully commercialize new technologies in a timely manner;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">manufacture and deliver new products in sufficient volumes and on time;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">differentiate our offerings from our competitors' offerings;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">price our products competitively;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">anticipate our competitors' development of new products, services or technological innovations; and</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">control product quality in our manufacturing process.</span></div><div style="text-align:justify;text-indent:20.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if we fail to accurately predict future customer needs and preferences or fail to produce viable technologies, we may invest in research and development of products and services that do not lead to significant revenue, which would adversely affect our profitability. Even if we successfully innovate and develop new and enhanced products and services, we may incur substantial costs in doing so, and our operating results may suffer. In addition, promising new products may fail to reach the market or realize only limited commercial success because of real or perceived concerns of our customers. Furthermore, as we collaborate with pharmaceutical customers to develop drugs such as companion diagnostics assays or provide drug components like active pharmaceutical ingredients, we face risks that those drug programs may be cancelled upon clinical trial failures.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to adjust our purchases due to changing market conditions or failure to accurately estimate our customers' demand could adversely affect our income.</span></div><div style="text-align:justify;text-indent:20.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our income could be harmed if we are unable to adjust our purchases to reflect market fluctuations, including those caused by the seasonal nature of the markets in which we operate. The sales of our products and services are dependent, to a large degree, on customers whose industries are subject to seasonal trends in the demand for their products. During a market upturn, we may not be able to purchase sufficient supplies or components to meet increasing product demand, which could materially affect our results. In the past, we have experienced a shortage of parts for some of our products. In addition, some of the parts that require custom design are not readily available from alternate suppliers due to their unique design or the length of time necessary for design work. Should a supplier cease manufacturing such a component, we would be forced to reengineer our product. In addition to discontinuing parts, suppliers may also extend lead times, limit supplies or increase prices due to capacity constraints or other factors. In order to secure components for the production of products, we may continue to enter into non-cancelable purchase commitments with vendors, or at times make advance payments to suppliers, which could impact </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our ability to adjust our inventory to declining market demands. If demand for our products is less than we expect, we may experience additional excess and obsolete inventories and be forced to incur additional expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Demand for some of our products and services depends on the capital spending policies of our customers, research and development budgets and on government funding policies.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our customers include pharmaceutical companies, laboratories, universities, healthcare providers, government agencies and public and private research institutions. Many factors, including public policy spending priorities, available resources, mergers and consolidations, institutional and governmental budgetary policies and spending priorities, and product and economic cycles, have a significant effect on the capital spending policies of these entities. Fluctuations in the research and development budgets at these organizations could have a significant effect on the demand for our products and services. Research and development budgets fluctuate due to changes in available resources, consolidation, spending priorities, general economic conditions and institutional and governmental budgetary policies. The timing and amount of revenue from customers that rely on government funding or research may vary significantly due to factors that can be difficult to forecast, including changes in spending authorizations and budgetary priorities for our products and services. If demand for our products and services is adversely affected, our revenue and operating results would suffer.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business will suffer if we are not able to retain and hire key personnel.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future success depends partly on the continued service of our key research, engineering, sales, marketing, manufacturing, executive and administrative personnel. If we fail to retain and hire a sufficient number of these personnel, we will not be able to maintain or expand our business. The markets in which we operate are very dynamic, and our businesses continue to respond with reorganizations, workforce reductions and site closures. We believe our pay levels are very competitive within the regions that we operate. However, there is intense competition for certain highly technical specialties in geographic areas where we continue to recruit, and it may become more difficult to hire and retain our key employees.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Economic, political, foreign currency and other risks associated with international sales and operations could adversely affect our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we sell our products worldwide, our business is subject to risks associated with doing business internationally. We anticipate that revenue from international operations will continue to represent a majority of our total revenue. International revenue and costs are subject to the risk that fluctuations in foreign currency exchange rates could adversely affect our financial results when translated into U.S. dollars for financial reporting purposes. Foreign currency movements for the three months ended January&#160;31, 2023 had an overall unfavorable impact on revenue of approximately 5 percentage points when compared to the same period last year. When movements in foreign currency exchange rates have a negative impact on revenue, they will also have a positive impact by reducing our costs and expenses. In addition, many of our employees, contract manufacturers, suppliers, job functions, outsourcing activities and manufacturing facilities are located outside the United States. Accordingly, our future results could be harmed by a variety of factors, including:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">interruption to transportation flows for delivery of parts to us and finished goods to our customers;</span></div><div style="padding-left:63pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.15pt">ongoing instability or changes in a specific country's or region's political, economic or other conditions, including inflation, recession, interest rate fluctuations and actual or anticipated military or political conflicts, including uncertainties and instability in economic and market conditions caused by pandemics like the COVID-19, the Ukraine/Russia conflict and political and trade uncertainties in the greater China region;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in diplomatic and trade relationships, as well as, new tariffs, trade protection measures, import or export licensing requirements, new or different customs duties, trade embargoes and sanctions and other trade barriers;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">tariffs imposed by the U.S. on goods from other countries and tariffs imposed by other countries on U.S. goods, including the tariffs enacted by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods;</span></div><div style="padding-left:63pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">negative consequences from changes in or differing interpretations of laws and regulations, including those related to tax and import/export;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulty in staffing and managing widespread operations;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">differing labor regulations;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">differing protection of intellectual property;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unexpected changes in regulatory requirements; </span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">geopolitical uncertainty or turmoil, terrorism and war; and</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impact of public health crises, including pandemics and epidemics, such as COVID-19 on the global economy.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell our products into many countries and we also source many components and materials for our products from and manufacture our products in various countries. Future tariffs and tariffs already implemented could have negative impact on our business, results of operations and financial condition. It may be time-consuming and expensive for us to alter our business operations in order to adapt to any such change. Further, additional tariffs, the scope and duration of which, if implemented, remains uncertain, which have been proposed or threatened and the potential escalation of a trade war and retaliatory measures could have a material adverse effect on our business, results of operations and financial condition.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of our accounting and tax processes including general accounting, cost accounting, accounts payable, accounts receivable and tax functions are centralized at locations in India and Malaysia. If economical, political, health or other conditions change in those countries, it may adversely affect operations, including impairing our ability to pay our suppliers and collect our receivables. Our results of operations, as well as our liquidity, may be adversely affected and possible delays may occur in reporting financial results.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, although the majority of our products are priced and paid for in U.S. dollars, a significant amount of certain types of expenses, such as payroll, utilities, tax, and marketing expenses, are paid in local currencies. Our hedging programs reduce, but do not always entirely eliminate, within any given twelve-month period, the impact of currency exchange rate movements, and therefore fluctuations in exchange rates, including those caused by currency controls, could impact our business, operating results and financial condition by resulting in lower revenue or increased expenses. For expenses beyond that twelve-month period, our hedging strategy does not mitigate our exposure. In addition, our currency hedging programs involve third-party financial institutions as counterparties. The weakening or failure of financial institution counterparties may adversely affect our hedging programs and our financial condition through, among other things, a reduction in available counterparties, increasingly unfavorable terms, and the failure of the counterparties to perform under hedging contracts.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our strategic initiatives to adjust our cost structure could have long-term adverse effects on our business, and we may not realize the operational or financial benefits from such actions.</span></div><div style="text-align:justify;text-indent:20.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have implemented multiple strategic initiatives across our businesses to adjust our cost structure, and we may engage in similar activities in the future. These strategic initiatives and our regular ongoing cost reduction activities may distract management, could slow improvements in our products and services and limit our ability to increase production quickly if demand for our products increases. In addition, delays in implementing our strategic initiatives, unexpected costs or failure to meet targeted improvements may diminish the operational and financial benefits we realize from such actions. Any of the above circumstances could have an adverse effect on our business and operating results and financial condition.</span></div><div style="text-align:justify;text-indent:20.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our acquisitions, strategic investments and alliances, joint ventures, exiting of businesses and divestitures may result in financial results that are different than expected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we frequently engage in discussions with third parties relating to possible acquisitions, strategic investments and alliances, joint ventures and divestitures, and generally expect to complete several transactions per year. In addition, we may decide to exit a particular business within our product portfolio. As a result of such transactions, our financial results may differ from our own or the investment community's expectations in a given fiscal quarter or over the long term.  We may have difficulty developing, manufacturing and marketing the products of a newly acquired company in a way that enhances the performance of our combined businesses or product lines. Acquired businesses may also expose us to new risks and new markets, and we may have difficulty addressing these risks in a cost effective and timely manner. Transactions such as acquisitions have resulted, and may in the future result in, unexpected significant costs and expenses. In the future, we may be required to record charges to earnings during the period if we determine there is an impairment of goodwill or intangible assets, up to the full amount of the value of the assets, or, in the case of strategic investments and alliances, consolidate results, including losses, of third parties or write down investment values or loans and convertible notes related to the strategic investment. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integrating the operations of acquired businesses within Agilent could be a difficult, costly and time-consuming process that involves a number of risks.  Acquisitions and strategic investments and alliances may require us to integrate and collaborate with a different company culture, management team, business model, business infrastructure and sales and distribution methodology and assimilate and retain geographically dispersed, decentralized operations and personnel. Depending on the size and complexity of an acquisition, our successful integration of the entity depends on a variety of factors, including introducing new products and meeting revenue targets as expected, the retention of key employees and key customers, increased exposure to certain governmental regulations and compliance requirements and increased costs and use of resources. Further, the integration of acquired businesses is likely to result in our systems and internal controls becoming increasingly complex and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">more difficult to manage. Any difficulties in the assimilation of acquired businesses into our control system could harm our operating results or cause us to fail to meet our financial reporting obligations.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we are able to successfully integrate acquired businesses within Agilent, we may not be able to realize the revenue and other synergies and growth that we anticipated from the acquisition in the time frame that we expected, and the costs of achieving these benefits may be higher than what we expected. As a result, the acquisition and integration of acquired businesses may not contribute to our earnings as expected, we may not achieve our operating margin targets when expected, or at all, and we may not achieve the other anticipated strategic and financial benefits of such transactions.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A successful divestiture depends on various factors, including our ability to effectively transfer liabilities, contracts, facilities and employees to the purchaser, identify and separate the intellectual property to be divested from the intellectual property that we wish to keep and reduce fixed costs previously associated with the divested assets or business.  In addition, if customers of the divested business do not receive the same level of service from the new owners, this may adversely affect our other businesses to the extent that these customers also purchase other Agilent products. In exiting a business, we may still retain liabilities associated with the support and warranty of those businesses and other indemnification obligations. All of these efforts require varying levels of management resources, which may divert our attention from other business operations. If we do not realize the expected benefits or synergies of such transactions, our consolidated financial position, results of operations, cash flows and stock price could be negatively impacted.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The impact of consolidation and acquisitions of competitors is difficult to predict and may harm our business.</span></div><div style="text-align:justify;text-indent:29.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The life sciences industry is intensely competitive and has been subject to increasing consolidation. Consolidation in our industries could result in existing competitors increasing their market share through business combinations and result in stronger competitors, which could have a material adverse effect on our business, financial condition and results of operations. We may not be able to compete successfully in increasingly consolidated industries and cannot predict with certainty how industry consolidation will affect our competitors or us.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulatory, Legal and Compliance Risks</span></div><div style="text-align:justify;text-indent:20.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to maintain an effective system of internal controls, we may not be able to accurately report our financial results, which could lead to a loss of investor confidence in our financial statements and have an adverse effect on our stock price.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective internal controls are necessary for us to provide reliable and accurate financial statements and to effectively prevent fraud. We devote significant resources and time to comply with the internal control over financial reporting requirements of the Sarbanes Oxley Act of 2002 and continue to enhance our controls. However, we cannot be certain that we will be able to prevent future significant deficiencies or material weaknesses.  Inadequate internal controls could cause investors to lose confidence in our reported financial information, which could have a negative effect on investor confidence in our financial statements, the trading price of our stock and our access to capital.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our customers and we are subject to various governmental regulations. Compliance with or changes in such regulations may cause us to incur significant expenses, and if we fail to maintain satisfactory compliance with certain regulations, we may be forced to recall products and cease their manufacture and distribution, and we could be subject to civil or criminal penalties.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our customers and we are subject to various significant international, federal, state and local regulations, including but not limited to regulations in the areas of health and safety, packaging, product content, employment, labor and immigration, import/export controls, trade restrictions and anti-competition. In addition, as a global organization, we are subject to data privacy and security laws, regulations, and customer-imposed controls in numerous jurisdictions as a result of having access to and processing confidential, personal, sensitive and/or patient health data in the course of our business. Global privacy laws, including the EU's General Data Protection Regulation ("GDPR&#8221;), Brazil&#8217;s Lei Geral de Protecao de Dados, the California Consumer Privacy Act and China&#8217;s Personal Information Protection Law and Data Security Law, apply to our activities involving the processing of personal data, both in relation to our product and service offerings and the management of our workforce. The global proliferation of privacy laws, with governmental authorities around the world passing or considering passing legislative and regulatory proposals concerning privacy and data protection, continues to result in new requirements regarding the handling of personal data and when personal data may be transferred outside the country where it was collected. Many such laws impose significant penalties for non-compliance (including possible fines of up to four percent of total company revenue under the GDPR or orders to stop processing personal data in a particular jurisdiction). Each of these privacy, security and data protection laws and regulations could impose significant limitations and increase our cost of providing our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">products and services where we process personal data and could harm our results of operations and expose us to significant fines, penalties and other damages.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We must also comply with complex foreign and U.S. laws and regulations, such as the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act, and other local laws prohibiting corrupt payments to governmental officials, anti-competition regulations and sanctions imposed by the U.S. Office of Foreign Assets Control and other similar laws and regulations. Such laws demand that we implement, test, and monitor an effective compliance program, in order to detect and prevent instances of non-compliance. Violations of these laws and regulations could result in fines and penalties, criminal sanctions, restrictions on our business conduct and on our ability to offer our products in one or more countries, and could also materially affect our brand, our ability to attract and retain employees, our international operations, our business and our operating results. Although we have implemented policies and procedures designed to ensure compliance with these laws and regulations, there can be no assurance that our employees, contractors, or agents will not violate our policies.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These regulations are complex, change frequently and have tended to become more stringent over time. We may be required to incur significant expenses to comply with these regulations or to remedy any violations of these regulations. Any failure by us to comply with applicable government regulations could also result in the cessation of our operations or portions of our operations, product recalls or impositions of fines and restrictions on our ability to carry on or expand our operations. In addition, because many of our products are regulated or sold into regulated industries, we must comply with additional regulations in marketing our products. We develop, configure and market our products to meet customer needs created by these regulations. Any significant change in these regulations could reduce demand for our products, force us to modify our products to comply with new regulations or increase our costs of producing these products. If demand for our products is adversely affected or our costs increase, our operating results and business would suffer.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products and operations are also often subject to the rules of industrial standards bodies, like the International Standards Organization, as well as regulation by other agencies such as the FDA. We also must comply with work safety rules. If we fail to adequately address any of these regulations, our businesses could be harmed.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to extensive regulation by the FDA and certain similar foreign regulatory agencies, and failure to comply with such regulations could harm our reputation, business, financial condition and results of operations.</span></div><div style="text-align:justify;text-indent:20.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of our products and services are subject to regulation by the FDA, the U.S. Department of Health and Human Services, the Centers for Medicare &amp; Medicaid Services and certain similar foreign regulatory agencies. In addition, a number of our products and services may in the future be subject to regulation by the FDA and certain similar foreign regulatory agencies.  These regulations govern a wide variety of product and service-related activities, from quality management, design and development to labeling, manufacturing, promotion, sales and distribution. In addition, we are subject to inspections by these and other regulatory authorities.  If we or any of our suppliers, distributors or customers fail to comply with FDA and other applicable regulatory requirements or are perceived to potentially have failed to comply, we may face, among other things, warning letters; adverse publicity affecting both us and our customers; investigations or notices of non-compliance, fines, injunctions, and civil or criminal penalties; import or export restrictions; partial suspensions or total shutdown of production facilities or the imposition of operating restrictions; suspension or revocation of our license to operate, increased difficulty in obtaining required FDA clearances or approvals or foreign equivalents; seizures or recalls of our products or those of our customers; or the inability to sell our products. Any such FDA or other regulatory agency actions could disrupt our business and operations, lead to significant remedial costs and have a material adverse impact on our financial position and results of operations. In addition, the global regulatory environment has become increasingly stringent for our products and services. For example, the EU has started to enforce new requirements, known as the EU In Vitro Diagnostic Regulation (the &#8220;EU IVDR&#8221;), which imposes stricter requirements for the marketing and sale of in vitro diagnostics in the European Union.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These new regulations are more stringent in a variety of areas, including clinical requirements, quality systems and post-market surveillance activities. The new EU IVDR requirements became effective starting in May 2022. Failure to meet these requirements could adversely impact our business in the EU and other regions that tie their product registrations to the EU requirements.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Some of our products are subject to particularly complex regulations such as regulations of toxic substances, and failure to comply with such regulations could harm our business.</span></div><div style="text-align:justify;text-indent:20.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our products and related consumables are used in conjunction with chemicals whose manufacture, processing, distribution and notification requirements are regulated by the U.S. Environmental Protection Agency (&#8220;EPA&#8221;) under the Toxic Substances Control Act and by regulatory bodies in other countries under similar laws. The Toxic Substances Control Act regulations govern, among other things, the testing, manufacture, processing and distribution of chemicals, the testing of regulated chemicals for their effects on human health and safety and the import and export of chemicals. The Toxic Substances Control Act prohibits persons from manufacturing any chemical in the United States that has not been reviewed by the EPA for its effect on health and safety and placed on an EPA inventory of chemical substances. We must ensure conformance of the manufacturing, storing, processing, distribution of and notification about these chemicals to these laws and adapt to regulatory requirements in all applicable countries as these requirements change. If we fail to comply with the notification, record-keeping and other requirements in the manufacture or distribution of our products, then we could be subject to civil penalties, criminal prosecution and, in some cases, prohibition from distributing or marketing our products until the products or component substances are brought into compliance.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business may suffer if we fail to comply with government contracting laws and regulations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive a portion of our revenue from direct and indirect sales to U.S. federal, state, local, and foreign governments and their respective agencies. Such contracts are subject to various procurement laws and regulations and contract provisions relating to their formation, administration and performance. Failure to comply with these laws, regulations or provisions in our government contracts could result in the imposition of various civil and criminal penalties, termination of contracts, forfeiture of profits, suspension of payments, increased pricing pressure or suspension from future government contracting. If our government contracts are terminated, if we are suspended from government work, or if our ability to compete for new contracts is adversely affected, our business could suffer.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our reputation, ability to do business and financial statements may be harmed by improper conduct by any of our employees, agents or business partners.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot provide assurance that our internal controls and compliance systems will always protect us from acts committed by employees, agents or business partners of ours (or of businesses we acquire or partner with) that would violate U.S. and/or non-U.S. laws, including the laws governing payments to government officials, bribery, fraud, kickbacks and false claims, pricing, sales and marketing practices, conflicts of interest, competition, employment practices and workplace behavior, export and import compliance, money laundering and data privacy. In particular, the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act and similar anti-bribery laws in other jurisdictions generally prohibit companies and their intermediaries from making improper payments to government officials for the purpose of obtaining or retaining business, and we operate in many parts of the world that have experienced governmental corruption to some degree. Any such improper actions or allegations of such acts could damage our reputation and subject us to civil or criminal investigations in the United States and in other jurisdictions, and related shareholder lawsuits could lead to substantial civil and criminal, monetary and non-monetary penalties and could cause us to incur significant legal and investigatory fees. In addition, the government may seek to hold us liable as a successor for violations committed by companies in which we invest or that we acquire. We also rely on our suppliers to adhere to our supplier standards of conduct, and material violations of such standards of conduct could occur that could have a material effect on our business, reputation and financial statements.</span></div><div style="text-align:justify;text-indent:20.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Environmental contamination from past and ongoing operations could subject us to substantial liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain properties we have previously owned or leased are undergoing remediation for subsurface contamination.&#160; Although we are indemnified for liability relating to the required remediation at some of those properties, we may be subject to liability if these indemnification obligations are not fulfilled.&#160; In other cases, we have agreed to indemnify the current owners of certain properties for liabilities related to contamination, including companies with which we have previously been affiliated such as HP, Inc., Hewlett-Packard Enterprise (formerly Hewlett-Packard Company) and Siemens Healthineers (formerly Varian Medical Systems, Inc.).&#160; Further, other properties we have previously owned or leased at which we have operated in the past, or for which we have otherwise contractually assumed or provided indemnities, certain actual or contingent environmental liabilities, may or do require remediation. While we are not aware of any material liabilities associated with any potential environmental contamination at any of those properties or facilities, we may be exposed to material liability if environmental contamination at material levels is found to exist. In addition, in connection with the acquisition of certain companies, we have assumed other costs and potential or contingent liabilities for environmental matters.&#160; Any significant costs or liabilities could have an adverse effect on results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to environmental laws and regulations that expose us to a number of risks and could result in significant liabilities and costs.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current and historical manufacturing and research and development processes and facilities are subject to various foreign, federal, state and local environment protection and health and safety laws and regulations. As a result, we may become subject to liabilities for environmental contamination, and these liabilities may be substantial. Although our policy is to apply strict standards for environmental protection and health and safety at our sites inside and outside the United States, we may not be aware of all conditions that could subject us to liability.  Further, in the event that any future climate change legislation would require that stricter standards be imposed by domestic or international environmental regulatory authorities, we may be required to make certain changes and adaptations to our manufacturing processes and facilities. We cannot predict how changes will affect our business operations or the cost of compliance to us, our customers or our suppliers. Failure to comply with these environmental protection and health and safety laws and regulations could result in civil, criminal, regulatory, administrative or contractual sanction, including fines, penalties or suspensions, restrictions on our operations and reputational damage.  If we have any violations of, or incur liabilities pursuant to these laws or regulations, our financial condition and operating results could be adversely affected.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Third parties may claim that we are infringing their intellectual property, and we could suffer significant litigation or licensing expenses or be prevented from selling products or services.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, third parties may claim that one or more of our products or services infringe their intellectual property rights. We analyze and take action in response to such claims on a case by case basis. Any dispute or litigation regarding patents or other intellectual property could be costly and time-consuming due to the complexity of our technology and the uncertainty of intellectual property litigation and could divert our management and key personnel from our business operations. A claim of intellectual property infringement could force us to enter into a costly or restrictive license agreement, which might not be available under acceptable terms or at all, could require us to redesign our products, which would be costly and time-consuming, and/or could subject us to significant damages or to an injunction against the development and sale of certain of our products or services. Our intellectual property portfolio may not be useful in asserting a counterclaim, or negotiating a license, in response to a claim of intellectual property infringement. In certain of our businesses, we rely on third-party intellectual property licenses, and we cannot ensure that these licenses will continue to be available to us in the future or can be expanded to cover new products on favorable terms or at all.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Third parties may infringe our intellectual property, and we may suffer competitive injury or expend significant resources enforcing our rights.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends in large part on our proprietary technology, including technology we obtained through acquisitions. We rely on various intellectual property rights, including patents, copyrights, trademarks and trade secrets, as well as confidentiality provisions and licensing arrangements, to establish our proprietary rights. If we do not enforce our intellectual property rights successfully, our competitive position may suffer, which could harm our operating results.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our pending patent, copyright and trademark registration applications may not be allowed, or competitors may challenge the validity or scope of our patents, copyrights or trademarks. In addition, our patents, copyrights, trademarks and other intellectual property rights may not provide us with a significant competitive advantage.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may need to spend significant resources monitoring and enforcing our intellectual property rights, and we may not be aware of or able to detect or prove infringement by third parties. Our competitive position may be harmed if we cannot detect infringement and enforce our intellectual property rights quickly or at all. In some circumstances, we may choose to not pursue enforcement because an infringer has a dominant intellectual property position or for other business reasons. In addition, competitors might avoid infringement by designing around our intellectual property rights or by developing non-infringing competing technologies. Intellectual property rights and our ability to enforce them may be unavailable or limited in some countries, which could make it easier for competitors to capture market share and could result in lost revenues. Furthermore, some of our intellectual property is licensed to others which may allow them to compete with us using that intellectual property.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to evolving corporate governance and public disclosure expectations and regulations that impact compliance costs and risks of noncompliance.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to changing rules and regulations promulgated by a number of governmental and self-regulatory organizations, including the SEC and NYSE, as well as evolving investor expectations around corporate governance and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">environmental and social practices and disclosures. These rules and regulations continue to evolve in scope and complexity, and many new requirements have been created in response to laws enacted by the U.S. and foreign governments, making compliance more difficult and uncertain. The increase in costs to comply with such evolving expectations, rules and regulations, as well as any risk of noncompliance, could adversely impact us.</span></div><div style="text-align:justify;text-indent:20.25pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operational Risks</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to successfully manage the consolidation and streamlining of our manufacturing operations, we may not achieve desired efficiencies, and our ability to deliver products to our customers could be disrupted.</span></div><div style="text-align:justify;text-indent:29.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we utilize manufacturing facilities throughout the world, we have consolidated, and may further consolidate, our manufacturing operations to certain of our plants to achieve efficiencies and gross margin improvements. Additionally, we typically consolidate the production of products from our acquisitions into our supply chain and manufacturing processes, which are technically complex and require expertise to operate. If we are unable to establish processes to efficiently and effectively produce high quality products in the consolidated locations, we may not achieve the anticipated synergies and production may be disrupted, which could adversely affect our business and operating results.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our operating results may suffer if our manufacturing capacity does not match the demand for our products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we cannot immediately adapt our production capacity and related cost structures to rapidly changing market conditions, when demand does not meet our expectations, our manufacturing capacity may exceed our production requirements. If during an economic downturn we had excess manufacturing capacity which could occur due to our plans to expand certain manufacturing capacities, then our fixed costs associated with excess manufacturing capacity would adversely affect our gross margins and operating results. If, during a general market upturn or an upturn in one of our segments, we cannot increase our manufacturing capacity to meet product demand, we may not be able to fulfill orders in a timely manner which could lead to order cancellations, contract breaches or indemnification obligations. This inability could materially and adversely limit our ability to improve our results. </span></div><div style="text-align:justify;text-indent:20.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dependence on contract manufacturing and outsourcing other portions of our supply chain, including logistics and third-party package delivery services, may adversely affect our ability to bring products to market and damage our reputation. Dependence on outsourced information technology and other administrative functions may impair our ability to operate effectively.</span></div><div style="text-align:justify;text-indent:20.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our efforts to streamline operations and to manage costs, we outsource aspects of our manufacturing processes and other functions and continue to evaluate additional outsourcing. If our contract manufacturers or other outsourcers fail to perform their obligations in a timely manner or at satisfactory quality levels, our ability to bring products to market and our reputation could suffer. For example, during a market upturn, our contract manufacturers may be unable to meet our demand requirements, which may preclude us from fulfilling our customers' orders on a timely basis. The ability of these manufacturers to perform is largely outside of our control. If one or more of the third-party package delivery providers experiences a significant disruption in services or institutes a significant price increase, we may have to seek alternative providers, our costs could increase, and the delivery of our products could be prevented or delayed. Additionally, changing or replacing our contract manufacturers, logistics providers or other outsourcers could cause disruptions or delays. In addition, we outsource significant portions of our information technology ("IT") and other administrative functions. Since IT is critical to our operations, any failure to perform on the part of our IT providers could impair our ability to operate effectively. In addition to the risks outlined above, problems with manufacturing or IT outsourcing could result in lower revenue and unexecuted efficiencies and impact our results of operations and our stock price. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we suffer a loss to our factories, facilities or distribution system due to catastrophe, our operations could be seriously harmed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our factories, facilities and distribution system are subject to catastrophic loss due to fire, flood, terrorism, public health crises, increasing severity or frequency of extreme weather events, or other climate-change related risks, including resource scarcity, rationing or unexpected costs from increases in fuel and raw material prices that may be caused by extreme weather conditions. For example, in the second quarter of fiscal year 2022, the outbreak of COVID-19 in China led to mandated shutdown of our facilities in Shanghai, which adversely impacted our business and results, and impacted our supply chain. In addition, several of our facilities could be subject to a catastrophic loss caused by earthquake due to their locations. Our production facilities, headquarters and laboratories in California, and our production facilities in Japan, are all located in areas </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with above-average seismic activity. In addition, our facilities in California are susceptible to extreme weather conditions such as drought, flooding and wildfires. If any of our facilities were to experience a catastrophic loss, it could disrupt our operations, delay production, shipments and revenue and result in large expenses to repair or replace the facility. If such a disruption were to occur, we could breach agreements, our reputation could be harmed, and our business and operating results could be adversely affected. In addition, because we have consolidated our manufacturing facilities and we may not have redundant manufacturing capability readily available, we are more likely to experience an interruption to our operations in the event of a catastrophe in any one location. Although we carry insurance for property damage and business interruption, we do not carry insurance or financial reserves for interruptions or potential losses arising from earthquakes or terrorism. Also, our third-party insurance coverage will vary from time to time in both type and amount depending on availability, cost and our decisions with respect to risk retention. Economic conditions and uncertainties in global markets may adversely affect the cost and other terms upon which we are able to obtain third-party insurance. If our third-party insurance coverage is adversely affected or to the extent we have elected to self-insure, we may be at a greater risk that our financial condition will be harmed by a catastrophic loss.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we experience a significant disruption in, or breach in security of, our information technology systems, or if we fail to implement new systems and software successfully, our business could be adversely affected.</span></div><div style="text-align:justify;text-indent:29.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on several centralized information technology systems throughout our company to provide products and services, keep financial records, process orders, manage inventory, process shipments to customers and operate other critical functions. Our information technology systems may be susceptible to damage, disruptions or shutdowns due to power outages, hardware failures, computer viruses, attacks by computer hackers, telecommunication failures, user errors, catastrophes or other unforeseen events. For example, in December 2020, it was widely reported that SolarWinds, an information technology company, was the subject of a cyberattack that created security vulnerabilities for thousands of its clients. We identified an impacted SolarWinds server and promptly took steps to contain and remediate the incidents. While we believe that there were no disruptions to our operations as a result of this attack, other similar attacks could have a significant negative impact on our systems and operations. Our information technology systems also may experience interruptions, delays or cessations of service or produce errors in connection with system integration, software upgrades or system migration work that takes place from time to time.  If we were to experience a prolonged system disruption in the information technology systems that involve our interactions with customers or suppliers, it could result in the loss of sales and customers and significant incremental costs, which could adversely affect our business. In addition, security breaches of our information technology systems could result in the misappropriation or unauthorized disclosure of confidential information belonging to us or to our employees, partners, customers or suppliers, which could result in our suffering significant financial or reputational damage.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial and Tax Risks</span></div><div style="text-align:justify;text-indent:20.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our retirement and post retirement pension plans are subject to financial market risks that could adversely affect our future results of operations and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have significant retirement and post retirement pension plan assets and obligations. The performance of the financial markets and interest rates impact our plan expenses and funding obligations. Significant decreases in market interest rates, decreases in the fair value of plan assets and investment losses on plan assets will increase our funding obligations and adversely impact our results of operations and cash flows.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in tax laws, unfavorable resolution of tax examinations, or exposure to additional tax liabilities could have a material adverse effect on our results of operations, financial condition and liquidity.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to taxes in the U.S., Singapore and various foreign jurisdictions. Governments in the jurisdictions in which we operate implement changes to tax laws and regulations periodically. Any implementation of tax laws that fundamentally change the taxation of corporations in the U.S. or Singapore could materially impact our effective tax rate and could have a significant adverse impact on our financial results.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Organization for Economic Co-operation and Development (OECD), an international association comprised of 38 countries, including the United States, has made changes and is contemplating additional changes to numerous long-standing tax principles. There can be no assurance that these changes and any contemplated changes if finalized, once adopted by countries, will not have an adverse impact on our provision for income taxes.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to examinations of our tax returns by tax authorities in various jurisdictions around the world. We regularly assess the likelihood of adverse outcomes resulting from ongoing tax examinations to determine the adequacy of our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provision for taxes. These assessments can require a high degree of judgment and estimation. Intercompany transactions associated with the sale of inventory, services, intellectual property and cost share arrangements are complex and affect our tax liabilities. The calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax laws and regulations in multiple jurisdictions. There can be no assurance that the outcomes from ongoing tax examinations will not have an adverse effect on our operating results and financial condition. A difference in the ultimate resolution of tax uncertainties from what is currently estimated could have an adverse effect on our financial results and condition.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If tax incentives change or cease to be in effect, our income taxes could increase significantly.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We benefit from tax incentives extended to our foreign subsidiaries to encourage investment or employment. Singapore has granted us tax incentives which require renewal at various times in the future. The incentives are conditioned on achieving various thresholds of investments and employment or specific types of income. Our taxes could increase if the incentives are not renewed upon expiration. If we cannot or do not wish to satisfy all or parts of the tax incentive conditions, we may lose the related tax incentive and could be required to refund tax incentives previously realized. As a result, our effective tax rate could be higher than it would have been had we maintained the benefits of the tax incentives.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have outstanding debt and may incur other debt in the future, which could adversely affect our financial condition, liquidity and results of operations.</span></div><div style="text-align:justify;text-indent:20.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are party to a $1.35&#160;billion five-year unsecured credit facility that will expire on March&#160;13, 2024 and a $600&#160;million term loan facility that matures on April 15, 2025.  Furthermore, we are permitted pursuant to the credit agreement to establish incremental facilities of up to $500 million.&#160;As of January&#160;31, 2023, we had no borrowings outstanding under the credit facility or the incremental facilities. On June 18, 2021, we increased the maximum amount of our commercial paper program to $1.35&#160;billion. As of  January&#160;31, 2023, we had borrowings of </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$238 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> outstanding under our U.S. commercial paper program and had a weighted average interest rate of </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.67 percent.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We also had outstanding an aggregate principal amount of $2.1 billion in senior unsecured notes and $600&#160;million outstanding under the term loan facility. We may borrow additional amounts in the future and use the proceeds from any future borrowing for general corporate purposes, future acquisitions, expansion of our business or repurchases of our outstanding shares of common stock.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our incurrence of this debt, and increases in our aggregate levels of debt, may adversely affect our operating results and financial condition by, among other things:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="padding-left:63pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increasing our vulnerability to downturns in our business, to competitive pressures and to adverse economic and industry conditions;&#160;</span></div><div style="padding-left:63pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">requiring the dedication of an increased portion of our expected cash flows from operations to service our indebtedness, thereby reducing the amount of expected cash flows available for other purposes, including capital expenditures, acquisitions, stock repurchases and dividends; and&#160;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limiting our flexibility in planning for or reacting to changes in our business and our industry.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our credit facility and our term loan facility each imposes restrictions on us, including restrictions on our ability to create liens on our assets and engage in certain types of sale and leaseback transactions and the ability of our subsidiaries to incur indebtedness, and requires us to maintain compliance with specified financial ratios. Our ability to comply with these ratios may be affected by events beyond our control. In addition, the indentures governing our senior notes contain covenants that may adversely affect our ability to incur certain liens or engage in certain types of sale and leaseback transactions. If we breach any of the covenants and do not obtain a waiver from the lenders or noteholders, then, subject to applicable cure periods, our outstanding indebtedness could be declared immediately due and payable.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We cannot assure that we will continue to pay dividends on our common stock.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the first quarter of fiscal year 2012, we have paid a quarterly dividend on our common stock. The timing, declaration, amount and payment of any future dividends fall within the discretion of our Board of Directors and will depend on many factors, including our available cash, estimated cash needs, earnings, financial condition, operating results, capital requirements, as well as limitations in our contractual agreements, applicable law, regulatory constraints, industry practice and other business considerations that our Board of Directors considers relevant. A change in our dividend program could have an adverse effect on the market price of our common stock.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adverse conditions in the global banking industry and credit markets may adversely impact the value of our cash investments or impair our liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January&#160;31, 2023, we had cash and cash equivalents of approximately $1.3 billion invested or held in a mix of money market funds, time deposit accounts and bank demand deposit accounts. Disruptions and volatility in the financial markets may, in some cases, result in an inability to access assets such as money market funds that traditionally have been viewed as highly liquid or hinder our ability to borrow money in the amounts, at interest rates or upon the more favorable terms and conditions that might be available under different economic circumstances. Any failure of our counterparty financial institutions or funds in which we have invested may adversely impact our cash and cash equivalent positions and, in turn, our operating results and financial condition.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_139"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;2.&#160; UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ISSUER PURCHASES OF EQUITY SECURITIES</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes information about the company&#8217;s purchases, based on trade date, of its equity securities registered pursuant to Section&#160;12 of the Exchange Act during the quarterly period ended January&#160;31, 2023.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:28.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.493%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.493%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.493%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares&#160;of&#160;Common</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock&#160;Purchased&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:700;line-height:100%">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Price&#160;Paid&#160;per&#160;Share<br/>of<br/>Common&#160;Stock&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Number&#160;of<br/>Shares&#160;of&#160;Common<br/>Stock&#160;Purchased&#160;as<br/>Part&#160;of&#160;Publicly<br/>Announced&#160;Plans&#160;or<br/>Programs&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:700;line-height:100%">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum<br/>Approximate&#160;Dollar<br/>Value&#160;of&#160;Shares&#160;of<br/>Common&#160;Stock&#160;that<br/>May&#160;Yet&#160;Be<br/>Purchased&#160;Under&#160;the<br/>Plans&#160;or&#160;Programs<br/>(in&#160;millions) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(d)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2021 Repurchase Program</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nov. 1, 2022 through Nov. 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dec. 1, 2022 through Dec&#160;31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jan. 1, 2023 through Jan. 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499,349&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499,349&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.68pt">On February 16, 2021 we announced that our board of directors had approved a new share repurchase program (the "2021 repurchase program") designed, among other things, to reduce or eliminate dilution resulting from issuance of stock under the company's employee equity incentive programs. The 2021 repurchase program authorizes the purchase of up to $2.0&#160;billion of our common stock at the company's discretion and has no fixed termination date. The 2021 repurchase program which became effective on February 18, 2021, replaced and terminated the 2019 repurchase program on that date. The 2021 repurchase program does not require the company to acquire a specific number of shares and may be suspended, amended or discontinued at any time. As of January&#160;31, 2023, all repurchased shares to date have been retired.</span></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.68pt">The weighted average price paid per share of common stock does not include the cost of commissions.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_142"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> ITEM 6. EXHIBITS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Exhibits:</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a-01312023xex101.htm">Letter of Terms and Conditions U.S. Indefinite Relocation and U.S. Domestic Relocation Agreement, each by and among Padraig McDonnell and the Company.*</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a-01312023xex311.htm">Certification of Chief Executive Officer pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a-01312023xex312.htm">Certification of Chief Financial Officer pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a-01312023xex321.htm">Certification of Chief Executive Officer pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a-01312023xex322.htm">Certification of Chief Financial Officer pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS XBRL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH XBRL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Schema Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL XBRL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Calculation Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB XBRL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Labels Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE XBRL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Presentation Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF XBRL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definition Linkbase Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Indicates management contract or compensatory plan, contract or arrangement.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><div id="ie1e46d0795a24ac2a4ed23d17765eb17_145"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ie1e46d0795a24ac2a4ed23d17765eb17_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AGILENT TECHNOLOGIES,&#160;INC.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:5.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.583%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.755%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Robert W. McMahon</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Robert W. McMahon</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Rodney Gonsalves</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rodney Gonsalves</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Corporate Controllership</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>a-01312023xex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i0aa533b950a444768220b58d8ea3dabf_1"></div><div style="min-height:33.84pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.929%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="padding-left:5.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 10.1</font></div><div style="padding-left:5.75pt"><img alt="image_0a.jpg" src="image_0a.jpg" style="height:48px;margin-bottom:5pt;vertical-align:text-bottom;width:227px"></div><div style="padding-left:5.75pt"><font><br></font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:45.214%"><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:14pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 February 2023</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:14pt;padding-right:1.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Padraig McDonnell </font></div><div style="padding-left:13.5pt;padding-right:1.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wilimngton, DE</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:14pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dear Padraig&#58;</font></div><div style="margin-top:4.6pt;padding-left:32pt"><font><br></font></div></div><div style="display:inline-block;max-width:9.570%;min-width:8.570%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:45.216%"><div style="text-indent:-31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:115%">Terms &#38; Conditions</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:100%">U.S. Indefinite Relocation</font></div></div></div><div style="margin-top:4.65pt;padding-left:14pt;padding-right:10.7pt;text-align:justify"><font><br></font></div><div style="padding-left:13.5pt;padding-right:10.7pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have the pleasure of confirming the terms and conditions which apply to your move from Wilmington, DE to Santa Clara, CA. This letter outlines the terms and conditions of your move for Agilent Technologies, Inc or any affiliated, subsidiary, or successor employer by which you are employed (&#8220;Agilent&#8221;). I understand your relocation will begin on or before 01 May 2023.</font></div><div style="padding-left:13.5pt"><font><br></font></div><div style="padding-left:13.5pt;padding-right:10.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agilent will assist you in your move from Wilmington, DE to Santa Clara, CA by providing you with relocation assistance per the US Indefinite Relocation, which includes the following provisions&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:50pt;padding-right:5.6pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.11pt;text-decoration:underline">Shipment of household goods&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Up to 20,000lbs from one primary residence, including shipment of two (max. 2) automobiles. Packing and unpacking, delivery to new location, normal appliance disconnections and connections. For internal relocations up to 2 days paid time off for packing of household goods&#59; up to 3 days paid time off for delivery and unpacking of HHG in destination location for internal relocations and New Hires. If necessary, Storage in Transit (SIT) up to a maximum of 30 days of household goods in the new location. The shipment of goods and 30 days of storage benefit is a taxable benefit and will be tax assisted. The amount of the benefit will be added to the employee&#8217;s W-2 as income.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:50pt;padding-right:10.85pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.11pt;text-decoration:underline">Final Travel&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Air first class travel one-way (or automobile travel reimbursement at the current mileage rate of $.655&#47;mile, maximum of 2 cars) for employee, spouse&#47;partner and dependent family members who permanently reside with the employee and who will be relocating to the new household. One night lodging and 1 day of per diem. This is a taxable benefit and will be tax assisted. The amount of the benefit will be added to the employee&#8217;s W-2 as income.</font></div><div><font><br></font></div><div style="padding-left:50pt;padding-right:10.85pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.67pt;text-decoration:underline">Temporary Living Accommodations&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Up to a maximum of 60 consecutive days</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Per Diem will be provided for the first 30 days. Two days of a rental car will be provided&#59; fuel will be included in the per diem. This is a taxable benefit and will be tax assisted. The amount of this benefit will be added to the employee&#8217;s W-2 as income.</font></div><div><font><br></font></div><div style="padding-left:50pt;padding-right:10.8pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.11pt;text-decoration:underline">Temporary Transportation&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rental of one automobile up to a maximum of seven (7) consecutive days, or until personal automobile arrives, whichever is sooner. Fuel will be the responsibility of the employee. This is a taxable benefit and will be tax assisted. The amount of this benefit will be added to the employee&#8217;s W-2 as income.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:50pt;padding-right:10.8pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.11pt;text-decoration:underline">Relocation allowance</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 month&#8217;s base salary (minus taxes) to be disbursed post arrival. This sum is intended to cover a variety of individual relocation expenses not specifically reimbursed such at pet transportation, driver license &#38; registration fees, utility hook-up charges, club membership, etc. This benefit is fully taxable, and taxes are deducted prior to payment through Agilent payroll.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:50pt;padding-right:11pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:11.9pt;text-decoration:underline">Destination Support&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Where available, you and your family will receive the services of a Destination Services provider in the destination location to assist you in finding housing to purchase or rent. This is a taxable benefit and will be tax assisted. The amount of this benefit will be added to the employee&#8217;s W-2 as income.</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:4.55pt;padding-right:5.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revised&#58; 08&#47;2020</font></div><div style="text-align:right"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:33.84pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.929%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div style="text-align:right"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:50pt;padding-right:10.95pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.11pt;text-decoration:underline">VIP Services&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Your relocation benefits will be coordinated by a Cartus Executive VIP Consultant that is specially trained on Agilent&#8217;s &#8220;high touch&#8221; service and are prepared to respond creatively and promptly to your requests and family needs.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:14pt;padding-right:6.65pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Agilent complies with the Sarbanes-Oxley Act of 2002. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This act prohibits companies with public stock or debt listed or traded in the U.S. from extending or arranging, directly or indirectly (including through a subsidiary), personal loans to directors or executive officers. This means that neither the Company nor the relocation provider may loan&#47;advance funds for any reason, e.g. home purchase down payments etc. to officers of the company. Advances of amounts that are not repayable by the employee may be permitted, but will be reviewed on a case-by-case basis.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:14pt;padding-right:5.95pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cartus will contact you to initiate the proper arrangements and will be available to answer any questions. The relocation element of the compensation package is contingent upon your execution of the attached Relocation Agreement and compliance with the terms of that Agreement. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">No substitutions or cash outs </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">for any of the provided relocation components are permitted. This relocation package is valid for 12 months from the effective date 01 May 2023.</font></div><div><font><br></font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:14pt;padding-right:5.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Padraig, I believe this fully outlines the issues discussed concerning your relocation to Santa Clara, CA. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Kindly acknowledge receipt and acceptance of the above terms by affixing your signature via DocuSign. The letter will then route to Cartus and your Cartus Consultant will initiate your relocation benefits.</font></div><div style="padding-right:5.75pt;text-align:justify"><font><br></font></div><div style="margin-top:0.15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">    </font><img alt="image_2a.jpg" src="image_2a.jpg" style="height:47px;margin-bottom:5pt;vertical-align:text-bottom;width:136px"></div><div style="margin-top:2.05pt;padding-left:11.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">  Mike McMullen</font></div><div style="margin-top:3.7pt;padding-left:14pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Hiring Manager</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:8.05pt;padding-left:14pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I AGREE TO THE TERMS AND CONDITIONS COVERING MY RELOCATION AS SET FORTH IN THIS</font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:47.948%"><div style="padding-left:14pt"><img alt="image_3a.jpg" src="image_3a.jpg" style="height:56px;margin-bottom:5pt;vertical-align:text-bottom;width:154px"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through"> </font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:line-through">Padraig McDonnell&#160;&#160;&#160;&#160;</font></div><div style="margin-top:4.8pt;padding-left:14.25pt"><font><br></font></div></div><div style="display:inline-block;max-width:4.103%;min-width:3.103%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:47.949%"><div style="padding-left:14.25pt"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">     14-Feb-2023</font></div><div style="margin-top:0.4pt"><font><br></font></div><div><font><br></font></div><div style="margin-top:0.4pt"><img alt="image_4.jpg" src="image_4.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:288px"></div><div style="margin-top:0.35pt;padding-left:14pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Date</font></div></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:14pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acceptance of the terms and conditions can be executed electronically, and an electronic signature will have the same effect as a wet ink signature.</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:14pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ENCL&#58;</font></div><div style="margin-top:0.05pt;padding-left:32pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.55pt">Relocation Agreement.</font></div><div><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:33.84pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.929%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-top:0.7pt;padding-left:1pt"><font><br></font></div></td></tr></table></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:157.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">U.S. Domestic Relocation Agreement</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:14pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:104%">Date&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:104%">14-Feb-2023</font></div><div style="padding-left:14pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Name&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:80%">Padraig McDonnell</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:14pt;padding-right:6.05pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I understand and agree that Agilent Technologies, Inc. or any affiliated, subsidiary, or successor employer by which I am employed (&#8220;Agilent&#8221;) may, in its sole discretion, require that I provide acceptable documentation of some or all of my relocation expenses before reimbursing me for those expenses.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:14pt;padding-right:5.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I further understand and agree that Agilent's obligation to make any relocation payment(s) is contingent upon my continued employment with the Company. I acknowledge that all relocation payments made to me or on my behalf during the 12 months following the relocation start date are in the nature of an advance, that is, I have not earned those payments until I have completed one year of employment in the new location. Thus, if I voluntarily terminate my employment prior to the last day of the twelfth month following the relocation start date, I agree to pay back 1&#47;12</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%">th </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">of all relocations payments advanced to me for each full month short of twelve.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:14pt;padding-right:5.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In the event of involuntary termination arising from a Workforce Management Program (WFM), no reimbursement is required. However, in the event that my employment is involuntarily terminated during the 12 months following the relocation start date for violation of Agilent policies or for performance reasons, I agree to repay Agilent or any subsidiary, affiliate or successor by which I am employed for the relocation costs Agilent advanced to me or on my behalf in accordance with the formula set forth above for voluntary terminations.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:14pt;padding-right:5.8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I hereby authorize Agilent or the subsidiary, affiliate or successor by which I am employed to withhold from my final paycheck any unearned relocation advance paid to me in accordance with the formula set forth above. I further agree to re-affirm this authorization in writing in the event that my employment is terminated, either voluntarily or involuntarily for reasons other than WFM, during the 12 months following the relocation start date. I understand that my final paycheck will pay me at least the US minimum wage. In the event the amount I owe Agilent or the subsidiary, affiliate or successor by which I am employed is greater than the amount withheld from my final paycheck, I agree to pay the balance in full to Agilent or the subsidiary, affiliate or successor by which I am employed within thirty (30) days of my termination date.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:14pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I understand that nothing stated in this letter alters the at-will status of employment.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:14pt;padding-right:11.5pt;text-align:justify"><font><br></font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:47.948%"><div style="margin-top:4.8pt;padding-left:266.3pt;text-indent:-252pt"><img alt="image_5a.jpg" src="image_5a.jpg" style="height:58px;margin-bottom:5pt;vertical-align:text-bottom;width:290px"></div><div style="margin-top:4.8pt;padding-left:14.25pt"><font><br></font></div></div><div style="display:inline-block;max-width:4.103%;min-width:3.103%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:47.949%"><div style="padding-left:14.25pt"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    14-Feb-2023</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.4pt"><img alt="image_4.jpg" src="image_4.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:288px"></div><div style="margin-top:0.35pt;padding-left:14pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</font></div></div></div><div style="padding-right:11.5pt;text-align:justify"><font><br></font></div><div style="padding-left:13.5pt;padding-right:11.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acceptance of the terms and conditions can be executed electronically and an electronic signature will   have the same effect as a wet ink signature.</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:9.25pt;padding-left:14pt;padding-right:10.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NOTE&#58; You are encouraged to seek tax advice from your personal tax advisor at your own expense to determine the impact of any relocation payments upon your individual tax liability. You are also encouraged to save all of your relocation expense receipts for tax purposes. The IRS provides tax information, forms and publications at no charge to the public at http&#58;&#47;&#47;www.irs.gov.</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>a-01312023xex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i3d122a619b704d019e7187a9f2bdc2c4_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit&#160;31.1</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">SECTION&#160;302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">I, Michael R. McMullen, certify that&#58;</font></div><div><font><br></font></div><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:1.5pt">I have reviewed this Form&#160;10-Q of Agilent Technologies,&#160;Inc.&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:1.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:1.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:1.5pt">The registrant&#8217;s other certifying officer(s)&#160;and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the registrant and have&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c)&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(d)&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:1.5pt">The registrant&#8217;s other certifying officer(s)&#160;and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.024%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.898%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.778%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#47;s&#47; Michael R. McMullen</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Michael R. McMullen</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director, President and Chief Executive Officer</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>a-01312023xex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i226cdc7b03f246ad8ad58779070746d4_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit&#160;31.2</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">SECTION&#160;302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">I, Robert W. McMahon, certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.25pt">I have reviewed this Form&#160;10-Q of Agilent Technologies,&#160;Inc.&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.25pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.25pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.25pt">The registrant&#8217;s other certifying officer(s)&#160;and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the registrant and have&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c)&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(d)&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.25pt">The registrant&#8217;s other certifying officer(s)&#160;and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.024%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.898%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.778%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#47;s&#47; Robert W. McMahon</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Robert W. McMahon</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Vice President and Chief Financial Officer</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>a-01312023xex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ife54b584ff2f45aa8fb180410a5ee31b_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit&#160;32.1</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">18 U.S.C. SECTION&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">AS ADOPTED PURSUANT TO SECTION&#160;906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Agilent Technologies,&#160;Inc. (the &#8220;Company&#8221;) on Form&#160;10-Q for the period ended January&#160;31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;),&#160;I, Michael R. McMullen, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;The Report fully complies with the requirements of Section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.024%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.898%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.778%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#47;s&#47; Michael R. McMullen</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Michael R. McMullen</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director, President and Chief Executive Officer</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>a-01312023xex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i37ce1ab96531477080b83f86e9c0c5e0_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit&#160;32.2</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">18 U.S.C. SECTION&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">AS ADOPTED PURSUANT TO SECTION&#160;906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Agilent Technologies,&#160;Inc. (the &#8220;Company&#8221;) on Form&#160;10-Q for the period ended January&#160;31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;),&#160;I, Robert W. McMahon, Senior Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;The Report fully complies with the requirements of Section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.024%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.143%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#47;s&#47; Robert W. McMahon</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Robert W. McMahon</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Vice President and Chief Financial Officer</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>a-20230131.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:bf6e4e81-d7a1-484d-a6c7-4a9890c9070b,g:1d2ec140-a31f-4aad-8309-92440730b1c7-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:a="http://www.agilent.com/20230131" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.agilent.com/20230131">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="a-20230131_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="a-20230131_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="a-20230131_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="a-20230131_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformation" roleURI="http://www.agilent.com/role/DocumentandEntityInformation">
        <link:definition>0000001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited" roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited">
        <link:definition>0000002 - Statement - CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited" roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited">
        <link:definition>0000003 - Statement - CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical" roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical">
        <link:definition>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS) (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited" roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited">
        <link:definition>0000005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETUnauditedParenthetical" roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnauditedParenthetical">
        <link:definition>0000006 - Statement - CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited" roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited">
        <link:definition>0000007 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY" roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY">
        <link:definition>0000008 - Statement - CONDENSED CONSOLIDATED STATEMENT OF EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATESTATEMENTOFEQUITYPARENTHETICAL" roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATESTATEMENTOFEQUITYPARENTHETICAL">
        <link:definition>0000009 - Statement - CONDENSED CONSOLIDATE STATEMENT OF EQUITY - (PARENTHETICAL)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNotes" roleURI="http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNotes">
        <link:definition>0000010 - Disclosure - OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NEWACCOUNTINGPRONOUNCEMENTSNotes" roleURI="http://www.agilent.com/role/NEWACCOUNTINGPRONOUNCEMENTSNotes">
        <link:definition>0000011 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUENotes" roleURI="http://www.agilent.com/role/REVENUENotes">
        <link:definition>0000012 - Disclosure - REVENUE (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONNotes" roleURI="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONNotes">
        <link:definition>0000013 - Disclosure - SHARE-BASED COMPENSATION (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESNotes" roleURI="http://www.agilent.com/role/INCOMETAXESNotes">
        <link:definition>0000014 - Disclosure - INCOME TAXES (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHARENotes" roleURI="http://www.agilent.com/role/NETINCOMEPERSHARENotes">
        <link:definition>0000015 - Disclosure - NET INCOME PER SHARE (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORYNotes" roleURI="http://www.agilent.com/role/INVENTORYNotes">
        <link:definition>0000016 - Disclosure - INVENTORY (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSNotes" roleURI="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNotes">
        <link:definition>0000017 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSNotes" roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSNotes">
        <link:definition>0000018 - Disclosure - FAIR VALUE MEASUREMENTS (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVESNotes" roleURI="http://www.agilent.com/role/DERIVATIVESNotes">
        <link:definition>0000019 - Disclosure - DERIVATIVES (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSNotes" roleURI="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSNotes">
        <link:definition>0000020 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WARRANTIESANDCONTINGENCIESNotes" roleURI="http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESNotes">
        <link:definition>0000021 - Disclosure - WARRANTIES AND CONTINGENCIES (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHORTTERMDEBTNotes" roleURI="http://www.agilent.com/role/SHORTTERMDEBTNotes">
        <link:definition>0000022 - Disclosure - SHORT-TERM DEBT (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LONGTERMDEBTNotes" roleURI="http://www.agilent.com/role/LONGTERMDEBTNotes">
        <link:definition>0000023 - Disclosure - LONG-TERM DEBT (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYNotes" roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYNotes">
        <link:definition>0000024 - Disclosure - STOCKHOLDERS' EQUITY (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONNotes" roleURI="http://www.agilent.com/role/SEGMENTINFORMATIONNotes">
        <link:definition>0000025 - Disclosure - SEGMENT INFORMATION (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>0000026 - Disclosure - OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>0000027 - Disclosure - OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NEWACCOUNTINGPRONOUNCEMENTSTables" roleURI="http://www.agilent.com/role/NEWACCOUNTINGPRONOUNCEMENTSTables">
        <link:definition>0000028 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUETables" roleURI="http://www.agilent.com/role/REVENUETables">
        <link:definition>0000029 - Disclosure - REVENUE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONTables" roleURI="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTables">
        <link:definition>0000030 - Disclosure - SHARE-BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHARETables" roleURI="http://www.agilent.com/role/NETINCOMEPERSHARETables">
        <link:definition>0000031 - Disclosure - NET INCOME PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORYTables" roleURI="http://www.agilent.com/role/INVENTORYTables">
        <link:definition>0000032 - Disclosure - INVENTORY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSTables" roleURI="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables">
        <link:definition>0000033 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSTables" roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSTables">
        <link:definition>0000034 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVESTables" roleURI="http://www.agilent.com/role/DERIVATIVESTables">
        <link:definition>0000035 - Disclosure - DERIVATIVES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSTables" roleURI="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSTables">
        <link:definition>0000036 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WARRANTIESANDCONTINGENCIESTable" roleURI="http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESTable">
        <link:definition>0000037 - Disclosure - WARRANTIES AND CONTINGENCIES (Table)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LONGTERMDEBTTables" roleURI="http://www.agilent.com/role/LONGTERMDEBTTables">
        <link:definition>0000038 - Disclosure - LONG-TERM DEBT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYTables" roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYTables">
        <link:definition>0000039 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONTables" roleURI="http://www.agilent.com/role/SEGMENTINFORMATIONTables">
        <link:definition>0000040 - Disclosure - SEGMENT INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" roleURI="http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails">
        <link:definition>0000041 - Disclosure - OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERevenuebyRegionDetails" roleURI="http://www.agilent.com/role/REVENUERevenuebyRegionDetails">
        <link:definition>0000042 - Disclosure - REVENUE- Revenue by Region (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERevenuebyEndMarketsDetails" roleURI="http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails">
        <link:definition>0000043 - Disclosure - REVENUE - Revenue by End Markets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERevenuebyTypeDetails" roleURI="http://www.agilent.com/role/REVENUERevenuebyTypeDetails">
        <link:definition>0000044 - Disclosure - REVENUE - Revenue by Type (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEContractAssetsandLiabilityDetails" roleURI="http://www.agilent.com/role/REVENUEContractAssetsandLiabilityDetails">
        <link:definition>0000045 - Disclosure - REVENUE - Contract Assets and Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERemainingPerformanceObligationDetails" roleURI="http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails">
        <link:definition>0000046 - Disclosure - REVENUE - Remaining Performance Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERemainingPerformanceObligationDetails_1" roleURI="http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails_1">
        <link:definition>0000046 - Disclosure - REVENUE - Remaining Performance Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONTextDetails" roleURI="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails">
        <link:definition>0000047 - Disclosure - SHARE-BASED COMPENSATION Text (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails" roleURI="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails">
        <link:definition>0000048 - Disclosure - SHARE-BASED COMPENSATION Allocated Share-based compensation expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails" roleURI="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails">
        <link:definition>0000049 - Disclosure - SHARE-BASED COMPENSATION Fair Value Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetails" roleURI="http://www.agilent.com/role/INCOMETAXESDetails">
        <link:definition>0000050 - Disclosure - INCOME TAXES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHAREDetails" roleURI="http://www.agilent.com/role/NETINCOMEPERSHAREDetails">
        <link:definition>0000051 - Disclosure - NET INCOME PER SHARE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORYDetails" roleURI="http://www.agilent.com/role/INVENTORYDetails">
        <link:definition>0000052 - Disclosure - INVENTORY (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails" roleURI="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails">
        <link:definition>0000053 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill Roll forward (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails" roleURI="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails">
        <link:definition>0000054 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Disclosures and Components of Purchased Other Intangibles (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails" roleURI="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails">
        <link:definition>0000055 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Textuals (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSEstimatedFutureAmortizationDetails" roleURI="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimatedFutureAmortizationDetails">
        <link:definition>0000056 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Estimated Future Amortization (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails" roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails">
        <link:definition>0000057 - Disclosure - FAIR VALUE MEASUREMENTS, Fair value of assets and liabilities measured on a recurring basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSEquitySecuritiesandInvestmentsDetails" roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSEquitySecuritiesandInvestmentsDetails">
        <link:definition>0000058 - Disclosure - FAIR VALUE MEASUREMENTS - Equity Securities and Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSContingentConsiderationDetails" roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails">
        <link:definition>0000059 - Disclosure - FAIR VALUE MEASUREMENTS, Contingent Consideration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingLevel3ContingentConsiderationLiabilityDetails" roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingLevel3ContingentConsiderationLiabilityDetails">
        <link:definition>0000060 - Disclosure - FAIR VALUE MEASUREMENTS - Reconciliation of Beginning and Ending Level 3 Contingent Consideration Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails" roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails">
        <link:definition>0000061 - Disclosure - FAIR VALUE MEASUREMENTS, Assets and Liabilities measured at Fair Value on a Non-Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSNonMarketableSecuritiesDetails" roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSNonMarketableSecuritiesDetails">
        <link:definition>0000062 - Disclosure - FAIR VALUE MEASUREMENTS, Non Marketable Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVESTextDetails" roleURI="http://www.agilent.com/role/DERIVATIVESTextDetails">
        <link:definition>0000063 - Disclosure - DERIVATIVES- Text (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVESForeignExchangeForwardContractsDetails" roleURI="http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails">
        <link:definition>0000064 - Disclosure - DERIVATIVES- Foreign Exchange Forward Contracts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails" roleURI="http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails">
        <link:definition>0000065 - Disclosure - DERIVATIVES, Fair value of derivative instruments and Consolidated Balance Sheet location (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails" roleURI="http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails">
        <link:definition>0000066 - Disclosure - DERIVATIVES, Effect of derivative instruments on Consolidated Statement of Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivitiesDetails" roleURI="http://www.agilent.com/role/DerivativeInstrumentsandHedgingActivitiesDetails">
        <link:definition>0000067 - Disclosure - Derivative Instruments and Hedging Activities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails" roleURI="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails">
        <link:definition>0000068 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS- Components of net periodic costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions" roleURI="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions">
        <link:definition>0000069 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Details) (Employer Contributions))</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WARRANTIESANDCONTINGENCIESDetails" roleURI="http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESDetails">
        <link:definition>0000070 - Disclosure - WARRANTIES AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHORTTERMDEBTCreditFacilityDetails" roleURI="http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails">
        <link:definition>0000071 - Disclosure - SHORT-TERM DEBT - Credit Facility (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LONGTERMDEBTDetails" roleURI="http://www.agilent.com/role/LONGTERMDEBTDetails">
        <link:definition>0000072 - Disclosure - LONG-TERM DEBT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LONGTERMDEBTTextDetails" roleURI="http://www.agilent.com/role/LONGTERMDEBTTextDetails">
        <link:definition>0000073 - Disclosure - LONG-TERM DEBT - Text (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYStockRepurchaseProgramDetails" roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails">
        <link:definition>0000074 - Disclosure - STOCKHOLDERS' EQUITY - Stock Repurchase Program (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYDividendsDetails" roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails">
        <link:definition>0000075 - Disclosure - STOCKHOLDER"S EQUITY - Dividends (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails" roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails">
        <link:definition>0000076 - Disclosure - STOCKHOLDER'S EQUITY - Accumulated Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails" roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails">
        <link:definition>0000077 - Disclosure - STOCKHOLDERS' EQUITY - Reclassifications out of accumulated comprehensive income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONProfitabilityDetails" roleURI="http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails">
        <link:definition>0000078 - Disclosure - SEGMENT INFORMATION - Profitability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONReconciliationofReportableResultsDetails" roleURI="http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails">
        <link:definition>0000079 - Disclosure - SEGMENT INFORMATION - Reconciliation of Reportable Results (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONSegmentAssetsDetails" roleURI="http://www.agilent.com/role/SEGMENTINFORMATIONSegmentAssetsDetails">
        <link:definition>0000080 - Disclosure - SEGMENT INFORMATION - Segment Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="a_NonInstrumentationandOtherMember" abstract="true" name="NonInstrumentationandOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="a_PharmaceuticalandBiopharmaceuticalMarketMember" abstract="true" name="PharmaceuticalandBiopharmaceuticalMarketMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_NumeratorAbstract" abstract="true" name="NumeratorAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="a_LtppMember" abstract="true" name="LtppMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_TermLoanMaturing2025Member" abstract="true" name="TermLoanMaturing2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_SeniorNotes2029Member" abstract="true" name="SeniorNotes2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_MeasurementInputRevenueVolatilityMember" abstract="true" name="MeasurementInputRevenueVolatilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_A2021RepurchaseProgramMember" abstract="true" name="A2021RepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_SeniorNotes2026Member" abstract="true" name="SeniorNotes2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_PercentageOfFaceAmountOfSeniorNoteInstrumentIssued" abstract="false" name="PercentageOfFaceAmountOfSeniorNoteInstrumentIssued" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="a_Taxrelatedtosharesissued" abstract="false" name="Taxrelatedtosharesissued" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="a_AgilentCrossLabMember" abstract="true" name="AgilentCrossLabMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock" abstract="false" name="EmployerContributionsAndExpectedEmployerContributionsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="a_SeniorNotes2022Member" abstract="true" name="SeniorNotes2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_EnvironmentalandForensicsMarketMember" abstract="true" name="EnvironmentalandForensicsMarketMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_PaymentOfAccruedAndUnpaidInterest" abstract="false" name="PaymentOfAccruedAndUnpaidInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="a_AdditionalIncrementalTermLoanFacilityMember" abstract="true" name="AdditionalIncrementalTermLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_DiagnosticsandClinicalMarketMember" abstract="true" name="DiagnosticsandClinicalMarketMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_ChemicalandEnergyMarketMember" abstract="true" name="ChemicalandEnergyMarketMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="a_SegmentTotalMember" abstract="true" name="SegmentTotalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_FoodMarketMember" abstract="true" name="FoodMarketMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_TransformationalPrograms" abstract="false" name="TransformationalPrograms" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="a_A5YrUnsecuredCreditFacilityMember" abstract="true" name="A5YrUnsecuredCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_RevenueComponentMember" abstract="true" name="RevenueComponentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_DocumentAndEntityInformationAbstract" abstract="true" name="DocumentAndEntityInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="a_InstrumentationMember" abstract="true" name="InstrumentationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="a_AcademiaandGovernmentMarketMember" abstract="true" name="AcademiaandGovernmentMarketMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_ResolutionBioscienceIncMember" abstract="true" name="ResolutionBioscienceIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_A2019RepurchaseProgramMember" abstract="true" name="A2019RepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_MeasurementInputAssetVolatilityMember" abstract="true" name="MeasurementInputAssetVolatilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_DenominatorsAbstract" abstract="true" name="DenominatorsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="a_BusinessCombinationContingentConsiderationFairValueMeasurementInput" abstract="false" name="BusinessCombinationContingentConsiderationFairValueMeasurementInput" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="a_SeniorNotes2030Member" abstract="true" name="SeniorNotes2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_LifeSciencesandAppliedMarketsMember" abstract="true" name="LifeSciencesandAppliedMarketsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_SeniorNotes2023Member" abstract="true" name="SeniorNotes2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_EndMarketsAxis" abstract="true" name="EndMarketsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="a_AmortizationAndDeferralsAbstract" abstract="true" name="AmortizationAndDeferralsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="a_BusinessCombinationsContingentConsiderationArrangements" abstract="false" name="BusinessCombinationsContingentConsiderationArrangements" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="a_AssetsLongLivedAbstract" abstract="true" name="AssetsLongLivedAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="a_EndMarketsDomain" abstract="true" name="EndMarketsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_LTPPRSUMember" abstract="true" name="LTPPRSUMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_DiagnosticsAndGenomicsMember" abstract="true" name="DiagnosticsAndGenomicsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_ThirdPartyTechnologyandLicensesMember" abstract="true" name="ThirdPartyTechnologyandLicensesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_A2023RepurchaseProgramMember" abstract="true" name="A2023RepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="a_SeniorNotes2031Member" abstract="true" name="SeniorNotes2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>a-20230131_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:bf6e4e81-d7a1-484d-a6c7-4a9890c9070b,g:1d2ec140-a31f-4aad-8309-92440730b1c7-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited" xlink:type="simple" xlink:href="a-20230131.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited"/>
  <link:calculationLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_49ef37f3-a62e-4b94-ad16-71caa6bbc57d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0cf5c303-f96a-4493-b709-8684c93772b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_49ef37f3-a62e-4b94-ad16-71caa6bbc57d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0cf5c303-f96a-4493-b709-8684c93772b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_d64ce63c-b58a-4287-aebe-40e661527219" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_49ef37f3-a62e-4b94-ad16-71caa6bbc57d" xlink:to="loc_us-gaap_CostsAndExpenses_d64ce63c-b58a-4287-aebe-40e661527219" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5ee518f3-a50d-4878-a013-5b88d09cb2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b906e8ba-48a1-4d76-979a-732f4a4c8429" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5ee518f3-a50d-4878-a013-5b88d09cb2d6" xlink:to="loc_us-gaap_OperatingIncomeLoss_b906e8ba-48a1-4d76-979a-732f4a4c8429" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_5628bbdb-ac5a-49fe-83b0-ea724dc6a0c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5ee518f3-a50d-4878-a013-5b88d09cb2d6" xlink:to="loc_us-gaap_InvestmentIncomeInterest_5628bbdb-ac5a-49fe-83b0-ea724dc6a0c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_77085d9f-4987-472a-9c22-b09275c94514" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5ee518f3-a50d-4878-a013-5b88d09cb2d6" xlink:to="loc_us-gaap_InterestExpense_77085d9f-4987-472a-9c22-b09275c94514" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_9a68f0b9-fa5a-4866-8a74-8437a6d91937" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5ee518f3-a50d-4878-a013-5b88d09cb2d6" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_9a68f0b9-fa5a-4866-8a74-8437a6d91937" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2f6ffe05-8c11-4104-9691-1f780e3e8398" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4c02df6c-7d05-4799-b6f8-c6053c5d7625" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_2f6ffe05-8c11-4104-9691-1f780e3e8398" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4c02df6c-7d05-4799-b6f8-c6053c5d7625" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_36780539-26b1-4fff-bffa-77651cd8326f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_2f6ffe05-8c11-4104-9691-1f780e3e8398" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_36780539-26b1-4fff-bffa-77651cd8326f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_6d585c70-eba5-4e1d-a051-a86efb4983b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_c3a18317-cf8e-4782-a360-3dd3a2d55f16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_6d585c70-eba5-4e1d-a051-a86efb4983b7" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_c3a18317-cf8e-4782-a360-3dd3a2d55f16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_2fcb3107-0e9b-4393-bf02-dd8ad5145e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_6d585c70-eba5-4e1d-a051-a86efb4983b7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_2fcb3107-0e9b-4393-bf02-dd8ad5145e4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e09b2cd6-3ded-4d68-b2cf-251ca0b9d319" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_6d585c70-eba5-4e1d-a051-a86efb4983b7" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e09b2cd6-3ded-4d68-b2cf-251ca0b9d319" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited" xlink:type="simple" xlink:href="a-20230131.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited"/>
  <link:calculationLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c7231ea0-af4a-4d4f-bf04-540127c7dc04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_5ee52d11-3a79-4e84-98bc-37d0f014ae1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c7231ea0-af4a-4d4f-bf04-540127c7dc04" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_5ee52d11-3a79-4e84-98bc-37d0f014ae1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_914af0ed-5bad-4597-a8d3-78e7dd646ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c7231ea0-af4a-4d4f-bf04-540127c7dc04" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_914af0ed-5bad-4597-a8d3-78e7dd646ae1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_378be41b-32df-4d2f-a059-336dc793c89c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c7231ea0-af4a-4d4f-bf04-540127c7dc04" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_378be41b-32df-4d2f-a059-336dc793c89c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_baacaf08-6f83-4d35-afdf-6db09ca3af01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c7231ea0-af4a-4d4f-bf04-540127c7dc04" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_baacaf08-6f83-4d35-afdf-6db09ca3af01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_df664f99-68dc-4d24-ac57-728706afdbf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d1bb7e3a-d6c7-4cba-bdaf-327fdf065ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_df664f99-68dc-4d24-ac57-728706afdbf8" xlink:to="loc_us-gaap_NetIncomeLoss_d1bb7e3a-d6c7-4cba-bdaf-327fdf065ec2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3fa6490f-9c6e-4c5a-9f23-ef4dc81a92bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_df664f99-68dc-4d24-ac57-728706afdbf8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3fa6490f-9c6e-4c5a-9f23-ef4dc81a92bd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited" xlink:type="simple" xlink:href="a-20230131.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"/>
  <link:calculationLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b79b506a-ebf0-4489-9126-dcd79943d023" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ef1f0dfa-64d4-4434-a5c2-6a85347bbecd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b79b506a-ebf0-4489-9126-dcd79943d023" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ef1f0dfa-64d4-4434-a5c2-6a85347bbecd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_99cd8e36-e2cf-4bc3-af02-2eb560e76644" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b79b506a-ebf0-4489-9126-dcd79943d023" xlink:to="loc_us-gaap_InventoryNet_99cd8e36-e2cf-4bc3-af02-2eb560e76644" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_3923a2cb-45a3-4c50-a20f-af595b83dd5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b79b506a-ebf0-4489-9126-dcd79943d023" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_3923a2cb-45a3-4c50-a20f-af595b83dd5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_7cbebc17-ebe6-4474-b7a2-43bda05fb720" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b79b506a-ebf0-4489-9126-dcd79943d023" xlink:to="loc_us-gaap_OtherAssetsCurrent_7cbebc17-ebe6-4474-b7a2-43bda05fb720" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e8f6e0d4-845c-4aff-aa49-8067bde1cda2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_04e37383-2a8b-4460-bdb1-245212985d01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e8f6e0d4-845c-4aff-aa49-8067bde1cda2" xlink:to="loc_us-gaap_PreferredStockValue_04e37383-2a8b-4460-bdb1-245212985d01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_e413642a-2c6b-4033-8d52-997e47ce9b54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e8f6e0d4-845c-4aff-aa49-8067bde1cda2" xlink:to="loc_us-gaap_CommonStockValue_e413642a-2c6b-4033-8d52-997e47ce9b54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_10de03a9-a1c0-4b31-8754-de3437959e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e8f6e0d4-845c-4aff-aa49-8067bde1cda2" xlink:to="loc_us-gaap_AdditionalPaidInCapital_10de03a9-a1c0-4b31-8754-de3437959e6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fd0596f5-14cc-4e45-a7a9-d07c7da188ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e8f6e0d4-845c-4aff-aa49-8067bde1cda2" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fd0596f5-14cc-4e45-a7a9-d07c7da188ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9ee91d9b-1576-4933-92b2-0027810764b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e8f6e0d4-845c-4aff-aa49-8067bde1cda2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9ee91d9b-1576-4933-92b2-0027810764b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_be980d01-41dd-4e0d-a957-a59f61b318f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_3741aa08-f073-465b-a9aa-d5b7f63fd95f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_be980d01-41dd-4e0d-a957-a59f61b318f8" xlink:to="loc_us-gaap_AccountsPayableCurrent_3741aa08-f073-465b-a9aa-d5b7f63fd95f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_5d414e19-7c21-48c2-851a-fff2ceeb0948" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_be980d01-41dd-4e0d-a957-a59f61b318f8" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_5d414e19-7c21-48c2-851a-fff2ceeb0948" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_fab8e204-1297-448b-89c1-c4bcd083e725" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_be980d01-41dd-4e0d-a957-a59f61b318f8" xlink:to="loc_us-gaap_DeferredRevenueCurrent_fab8e204-1297-448b-89c1-c4bcd083e725" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_b33b6528-308f-4a83-b042-cf2d2dfb07a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_be980d01-41dd-4e0d-a957-a59f61b318f8" xlink:to="loc_us-gaap_ShortTermBorrowings_b33b6528-308f-4a83-b042-cf2d2dfb07a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_48899521-1e41-4937-b83f-0792d5e99195" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_be980d01-41dd-4e0d-a957-a59f61b318f8" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_48899521-1e41-4937-b83f-0792d5e99195" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_8dc37f70-f9a2-41a7-be72-17f4e6bd8a71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_8d6f6f88-be57-4958-b1a8-aaaf9fa60a3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_8dc37f70-f9a2-41a7-be72-17f4e6bd8a71" xlink:to="loc_us-gaap_LiabilitiesCurrent_8d6f6f88-be57-4958-b1a8-aaaf9fa60a3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_92b71440-620d-491b-baa9-36a140a1cae9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_8dc37f70-f9a2-41a7-be72-17f4e6bd8a71" xlink:to="loc_us-gaap_LongTermDebt_92b71440-620d-491b-baa9-36a140a1cae9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_5192dc30-d33c-4145-8c14-025dc80cf747" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_8dc37f70-f9a2-41a7-be72-17f4e6bd8a71" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_5192dc30-d33c-4145-8c14-025dc80cf747" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_12780f83-02a5-4d69-973b-9d0639763129" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_8dc37f70-f9a2-41a7-be72-17f4e6bd8a71" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_12780f83-02a5-4d69-973b-9d0639763129" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_9d79974d-196c-4dae-98de-daceea48a607" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3e9e4381-c569-4b0b-9e4d-8117e1210662" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9d79974d-196c-4dae-98de-daceea48a607" xlink:to="loc_us-gaap_AssetsCurrent_3e9e4381-c569-4b0b-9e4d-8117e1210662" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_fbc0bd4a-a482-4c37-acae-1a0c3ad3bf90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9d79974d-196c-4dae-98de-daceea48a607" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_fbc0bd4a-a482-4c37-acae-1a0c3ad3bf90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f85453ee-b27e-46e2-bbb4-d3277875db3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9d79974d-196c-4dae-98de-daceea48a607" xlink:to="loc_us-gaap_Goodwill_f85453ee-b27e-46e2-bbb4-d3277875db3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3bacaecf-0d62-4a8a-be07-bc994288efa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9d79974d-196c-4dae-98de-daceea48a607" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3bacaecf-0d62-4a8a-be07-bc994288efa4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_504ce395-c4a9-4a66-ba0d-e3c87d4068a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9d79974d-196c-4dae-98de-daceea48a607" xlink:to="loc_us-gaap_LongTermInvestments_504ce395-c4a9-4a66-ba0d-e3c87d4068a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_6e156ae2-077b-410b-87cf-387ce2eaa43f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9d79974d-196c-4dae-98de-daceea48a607" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_6e156ae2-077b-410b-87cf-387ce2eaa43f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_24d80364-0a90-4c0e-b593-b43a4d5bf1e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_4c674dba-6608-455b-8f21-b2b104ea1c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_24d80364-0a90-4c0e-b593-b43a4d5bf1e5" xlink:to="loc_us-gaap_Liabilities_4c674dba-6608-455b-8f21-b2b104ea1c1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7db24bdd-f684-4ba0-b578-8ec7efd2a27f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_24d80364-0a90-4c0e-b593-b43a4d5bf1e5" xlink:to="loc_us-gaap_StockholdersEquity_7db24bdd-f684-4ba0-b578-8ec7efd2a27f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="a-20230131.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"/>
  <link:calculationLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4d964834-5453-47c5-8ff8-327c9c6b67d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_68dd2902-a638-469a-b1e7-427a4a53e504" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4d964834-5453-47c5-8ff8-327c9c6b67d7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_68dd2902-a638-469a-b1e7-427a4a53e504" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_913bcbd7-d4ac-4d3e-93ee-3d60d364470c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4d964834-5453-47c5-8ff8-327c9c6b67d7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_913bcbd7-d4ac-4d3e-93ee-3d60d364470c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_068ba165-90ad-4289-af0a-b6d3d9e5d11a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4d964834-5453-47c5-8ff8-327c9c6b67d7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_068ba165-90ad-4289-af0a-b6d3d9e5d11a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4d367402-9d76-4f6b-ae18-ad37f3a5de53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4d964834-5453-47c5-8ff8-327c9c6b67d7" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4d367402-9d76-4f6b-ae18-ad37f3a5de53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b32ce745-beff-4bf5-8fae-f367d1416391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0e9df334-b99f-48c4-9ec9-86ad29fe715c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b32ce745-beff-4bf5-8fae-f367d1416391" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0e9df334-b99f-48c4-9ec9-86ad29fe715c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_04a930b4-d46e-4e73-b3fc-47b79f8aafee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquitySecuritiesFvNi"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b32ce745-beff-4bf5-8fae-f367d1416391" xlink:to="loc_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_04a930b4-d46e-4e73-b3fc-47b79f8aafee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireNotesReceivable_11ab090d-09ff-4042-86e3-580746618cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireNotesReceivable"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b32ce745-beff-4bf5-8fae-f367d1416391" xlink:to="loc_us-gaap_PaymentsToAcquireNotesReceivable_11ab090d-09ff-4042-86e3-580746618cc6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_3cf35e1d-515e-4e53-ac60-79fd8019dde4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b32ce745-beff-4bf5-8fae-f367d1416391" xlink:to="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_3cf35e1d-515e-4e53-ac60-79fd8019dde4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi_50b8cc6c-71b4-4e2e-a31c-7c5b32f2757d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b32ce745-beff-4bf5-8fae-f367d1416391" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi_50b8cc6c-71b4-4e2e-a31c-7c5b32f2757d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_88519c53-03f8-4b8b-b73d-4ad494161feb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b32ce745-beff-4bf5-8fae-f367d1416391" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_88519c53-03f8-4b8b-b73d-4ad494161feb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8d34121-0beb-4ff6-8d85-ae32f2c26e16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_c715312b-4aeb-4419-8083-4d233c65d1f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8d34121-0beb-4ff6-8d85-ae32f2c26e16" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_c715312b-4aeb-4419-8083-4d233c65d1f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_6231ec0a-3e54-4a29-89dc-ac673b900b96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8d34121-0beb-4ff6-8d85-ae32f2c26e16" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_6231ec0a-3e54-4a29-89dc-ac673b900b96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfOrdinaryDividends_b37c6c51-ab34-48b6-b5cc-b19af99fd97c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfOrdinaryDividends"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8d34121-0beb-4ff6-8d85-ae32f2c26e16" xlink:to="loc_us-gaap_PaymentsOfOrdinaryDividends_b37c6c51-ab34-48b6-b5cc-b19af99fd97c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_2c4e0a6b-4ce1-4d38-9eb4-4e72a1e7b4c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8d34121-0beb-4ff6-8d85-ae32f2c26e16" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_2c4e0a6b-4ce1-4d38-9eb4-4e72a1e7b4c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_ef06cbcb-1e4c-4d5f-8f97-95dafe9e6743" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8d34121-0beb-4ff6-8d85-ae32f2c26e16" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_ef06cbcb-1e4c-4d5f-8f97-95dafe9e6743" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper_bfa5ebdf-0f14-49a6-bf20-f6471b78d335" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8d34121-0beb-4ff6-8d85-ae32f2c26e16" xlink:to="loc_us-gaap_RepaymentsOfCommercialPaper_bfa5ebdf-0f14-49a6-bf20-f6471b78d335" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_dbd2a3be-092e-4082-9ec4-eb859826dbe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8d34121-0beb-4ff6-8d85-ae32f2c26e16" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_dbd2a3be-092e-4082-9ec4-eb859826dbe0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3c85101-dac8-44a0-806c-c82489535911" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_55351d93-64c3-45ba-9a53-07431e3d8fed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3c85101-dac8-44a0-806c-c82489535911" xlink:to="loc_us-gaap_NetIncomeLoss_55351d93-64c3-45ba-9a53-07431e3d8fed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_4499d036-2fd5-48dc-94d5-dadbd3c8c462" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3c85101-dac8-44a0-806c-c82489535911" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_4499d036-2fd5-48dc-94d5-dadbd3c8c462" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ccc1b542-3acc-46e3-b319-7690008870e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3c85101-dac8-44a0-806c-c82489535911" xlink:to="loc_us-gaap_ShareBasedCompensation_ccc1b542-3acc-46e3-b319-7690008870e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9d67f004-7ec4-467a-a95c-d42bc55e7a13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3c85101-dac8-44a0-806c-c82489535911" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9d67f004-7ec4-467a-a95c-d42bc55e7a13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_7b89b3c2-735a-407e-9203-83b181c57065" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3c85101-dac8-44a0-806c-c82489535911" xlink:to="loc_us-gaap_InventoryWriteDown_7b89b3c2-735a-407e-9203-83b181c57065" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_bada3676-20ba-47ee-bf73-146f6680dc43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3c85101-dac8-44a0-806c-c82489535911" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_bada3676-20ba-47ee-bf73-146f6680dc43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3cd39994-0c5c-445a-ab4f-b8835ffc394f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3c85101-dac8-44a0-806c-c82489535911" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3cd39994-0c5c-445a-ab4f-b8835ffc394f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_855b31ac-1b84-4d61-b006-a2f4db28b96c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3c85101-dac8-44a0-806c-c82489535911" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_855b31ac-1b84-4d61-b006-a2f4db28b96c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_15b56dcb-fbfc-402e-9196-72581074be5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3c85101-dac8-44a0-806c-c82489535911" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_15b56dcb-fbfc-402e-9196-72581074be5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_89d38d19-def6-424e-9ad6-2b3592d9d2f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3c85101-dac8-44a0-806c-c82489535911" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_89d38d19-def6-424e-9ad6-2b3592d9d2f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_5a5be1d4-d35d-4e58-b980-af46b4df5a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3c85101-dac8-44a0-806c-c82489535911" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_5a5be1d4-d35d-4e58-b980-af46b4df5a3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_4d9589e0-537b-4a92-8c7b-d3048887f12a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3c85101-dac8-44a0-806c-c82489535911" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_4d9589e0-537b-4a92-8c7b-d3048887f12a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_e2b3b7d4-7af1-4919-8b74-7b325f0edc91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3c85101-dac8-44a0-806c-c82489535911" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_e2b3b7d4-7af1-4919-8b74-7b325f0edc91" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="simple" xlink:href="a-20230131.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"/>
  <link:calculationLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_da4e7407-adec-47c8-81ff-273dba6e96bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a74db6d0-ef31-4e3a-bc31-ab1821a7b3b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_da4e7407-adec-47c8-81ff-273dba6e96bd" xlink:to="loc_us-gaap_NetIncomeLoss_a74db6d0-ef31-4e3a-bc31-ab1821a7b3b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e8f058dd-e25a-49d4-9820-48bb2a1769a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_da4e7407-adec-47c8-81ff-273dba6e96bd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e8f058dd-e25a-49d4-9820-48bb2a1769a6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/NETINCOMEPERSHAREDetails" xlink:type="simple" xlink:href="a-20230131.xsd#NETINCOMEPERSHAREDetails"/>
  <link:calculationLink xlink:role="http://www.agilent.com/role/NETINCOMEPERSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_36e166ea-938c-4d77-b886-ab54ceccd223" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b4c425c4-b972-4ef9-871d-e97b928442c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_36e166ea-938c-4d77-b886-ab54ceccd223" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b4c425c4-b972-4ef9-871d-e97b928442c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_b5528280-f0b3-42ce-bfcd-29cc256554f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_36e166ea-938c-4d77-b886-ab54ceccd223" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_b5528280-f0b3-42ce-bfcd-29cc256554f7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/INVENTORYDetails" xlink:type="simple" xlink:href="a-20230131.xsd#INVENTORYDetails"/>
  <link:calculationLink xlink:role="http://www.agilent.com/role/INVENTORYDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_1fe24acd-d41b-4e91-b7e3-c5fbb99ee4c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_693f6a30-9c58-47bd-90fc-ca6b5faa5cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_1fe24acd-d41b-4e91-b7e3-c5fbb99ee4c4" xlink:to="loc_us-gaap_InventoryFinishedGoods_693f6a30-9c58-47bd-90fc-ca6b5faa5cfc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessAndRawMaterials_7c49db31-65c3-4839-8b48-a7ce51321a31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessAndRawMaterials"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_1fe24acd-d41b-4e91-b7e3-c5fbb99ee4c4" xlink:to="loc_us-gaap_InventoryWorkInProcessAndRawMaterials_7c49db31-65c3-4839-8b48-a7ce51321a31" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails" xlink:type="simple" xlink:href="a-20230131.xsd#FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"/>
  <link:calculationLink xlink:role="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_1a0bef69-e747-4cad-a6c5-6e187609f4d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_72ed54a6-147e-4c78-a081-ad817bb567ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_1a0bef69-e747-4cad-a6c5-6e187609f4d3" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_72ed54a6-147e-4c78-a081-ad817bb567ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_4485dd5d-9670-4296-9ecd-f433f3dedea3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_1a0bef69-e747-4cad-a6c5-6e187609f4d3" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_4485dd5d-9670-4296-9ecd-f433f3dedea3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_32e93196-79f2-48c6-933a-22187f686efd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_1a0bef69-e747-4cad-a6c5-6e187609f4d3" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_32e93196-79f2-48c6-933a-22187f686efd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_af83de9b-d905-42f8-8ced-668f14d327e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1dd079ea-e710-4f95-b9f9-42505232128a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_af83de9b-d905-42f8-8ced-668f14d327e9" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1dd079ea-e710-4f95-b9f9-42505232128a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_69db0759-69ba-4834-8298-68bf24ddcdc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_af83de9b-d905-42f8-8ced-668f14d327e9" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_69db0759-69ba-4834-8298-68bf24ddcdc6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_8bdb1392-07f5-40f7-ae5f-046143b988e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_af83de9b-d905-42f8-8ced-668f14d327e9" xlink:to="loc_us-gaap_TradingSecurities_8bdb1392-07f5-40f7-ae5f-046143b988e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_cd7e1a30-5296-4f9d-8a43-9d0910f7cf23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_af83de9b-d905-42f8-8ced-668f14d327e9" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_cd7e1a30-5296-4f9d-8a43-9d0910f7cf23" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails" xlink:type="simple" xlink:href="a-20230131.xsd#RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails"/>
  <link:calculationLink xlink:role="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_6a5af1a6-782a-42f8-bea3-b60f4bcb50f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_abee2221-166d-455b-9657-57e8e31d6365" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_6a5af1a6-782a-42f8-bea3-b60f4bcb50f2" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_abee2221-166d-455b-9657-57e8e31d6365" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_dcaa8d9f-d529-4558-b933-945c55ed7286" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_6a5af1a6-782a-42f8-bea3-b60f4bcb50f2" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_dcaa8d9f-d529-4558-b933-945c55ed7286" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_fd6b0e78-c0fe-45d5-bebb-cb4fd70cef98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_6a5af1a6-782a-42f8-bea3-b60f4bcb50f2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_fd6b0e78-c0fe-45d5-bebb-cb4fd70cef98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_a0f8d656-2351-431c-80a7-4334ca060e23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_6a5af1a6-782a-42f8-bea3-b60f4bcb50f2" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_a0f8d656-2351-431c-80a7-4334ca060e23" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>a-20230131_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:bf6e4e81-d7a1-484d-a6c7-4a9890c9070b,g:1d2ec140-a31f-4aad-8309-92440730b1c7-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited" xlink:type="simple" xlink:href="a-20230131.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited" xlink:type="extended" id="i279cef2f772e4b38b3891a07e451ff1d_CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1df0f763-6b55-47cc-b9d2-49f077dcf5ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_38c9f6a3-e14e-4484-b65a-bbc3e2991fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1df0f763-6b55-47cc-b9d2-49f077dcf5ab" xlink:to="loc_us-gaap_RevenuesAbstract_38c9f6a3-e14e-4484-b65a-bbc3e2991fa9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6af0f5a9-417a-468d-be7f-bb38ec1f3300" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_38c9f6a3-e14e-4484-b65a-bbc3e2991fa9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6af0f5a9-417a-468d-be7f-bb38ec1f3300" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_d04586b8-0b62-4ab1-83d3-7d7d4da34098" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1df0f763-6b55-47cc-b9d2-49f077dcf5ab" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_d04586b8-0b62-4ab1-83d3-7d7d4da34098" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_52f2be12-6009-4b46-b3e9-4b75089a707d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d04586b8-0b62-4ab1-83d3-7d7d4da34098" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_52f2be12-6009-4b46-b3e9-4b75089a707d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_48287831-4f98-43cb-8968-0027c844191a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d04586b8-0b62-4ab1-83d3-7d7d4da34098" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_48287831-4f98-43cb-8968-0027c844191a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_38d7b7ff-7c6a-498c-a782-a6194da5062c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d04586b8-0b62-4ab1-83d3-7d7d4da34098" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_38d7b7ff-7c6a-498c-a782-a6194da5062c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_f9121234-a641-4569-ac21-a43ecee130d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d04586b8-0b62-4ab1-83d3-7d7d4da34098" xlink:to="loc_us-gaap_CostsAndExpenses_f9121234-a641-4569-ac21-a43ecee130d5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ad739c92-c2de-42b1-ad73-ba62846f1c09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1df0f763-6b55-47cc-b9d2-49f077dcf5ab" xlink:to="loc_us-gaap_OperatingIncomeLoss_ad739c92-c2de-42b1-ad73-ba62846f1c09" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_fb55f476-da77-4392-b840-460fcd132b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1df0f763-6b55-47cc-b9d2-49f077dcf5ab" xlink:to="loc_us-gaap_InvestmentIncomeInterest_fb55f476-da77-4392-b840-460fcd132b6b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_efb47d94-53ce-4f09-aaac-8b83c4442bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1df0f763-6b55-47cc-b9d2-49f077dcf5ab" xlink:to="loc_us-gaap_InterestExpense_efb47d94-53ce-4f09-aaac-8b83c4442bb7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_26e5259c-c49a-4563-b515-5998053835d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1df0f763-6b55-47cc-b9d2-49f077dcf5ab" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_26e5259c-c49a-4563-b515-5998053835d3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c38937b2-c197-4fbe-91c0-48ab164fa9e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1df0f763-6b55-47cc-b9d2-49f077dcf5ab" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c38937b2-c197-4fbe-91c0-48ab164fa9e7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_25d0927b-25a8-4057-9b44-ec3e84189256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1df0f763-6b55-47cc-b9d2-49f077dcf5ab" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_25d0927b-25a8-4057-9b44-ec3e84189256" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e6017a56-29da-40df-938f-14028ddb2f23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1df0f763-6b55-47cc-b9d2-49f077dcf5ab" xlink:to="loc_us-gaap_NetIncomeLoss_e6017a56-29da-40df-938f-14028ddb2f23" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0db6d972-ebab-4f55-b19c-e88070ea3390" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1df0f763-6b55-47cc-b9d2-49f077dcf5ab" xlink:to="loc_us-gaap_EarningsPerShareAbstract_0db6d972-ebab-4f55-b19c-e88070ea3390" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_8d779394-df52-4535-b857-4fb22dccb520" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0db6d972-ebab-4f55-b19c-e88070ea3390" xlink:to="loc_us-gaap_EarningsPerShareBasic_8d779394-df52-4535-b857-4fb22dccb520" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_badc44ba-3bd1-442c-90f0-27417bf6db76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0db6d972-ebab-4f55-b19c-e88070ea3390" xlink:to="loc_us-gaap_EarningsPerShareDiluted_badc44ba-3bd1-442c-90f0-27417bf6db76" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5b457a00-4239-4350-a81f-ff70f5cdfa03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1df0f763-6b55-47cc-b9d2-49f077dcf5ab" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5b457a00-4239-4350-a81f-ff70f5cdfa03" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4e37c250-e5d4-4ba5-8450-8dd2b035d73b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5b457a00-4239-4350-a81f-ff70f5cdfa03" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4e37c250-e5d4-4ba5-8450-8dd2b035d73b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_934200e2-80b4-4523-9f74-e90e27a8ee0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5b457a00-4239-4350-a81f-ff70f5cdfa03" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_934200e2-80b4-4523-9f74-e90e27a8ee0c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9d9a6342-8e51-40db-9237-a01fee945973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1df0f763-6b55-47cc-b9d2-49f077dcf5ab" xlink:to="loc_us-gaap_StatementTable_9d9a6342-8e51-40db-9237-a01fee945973" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_3161e224-e5d1-4c31-af62-e6df308299d3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_9d9a6342-8e51-40db-9237-a01fee945973" xlink:to="loc_srt_ProductOrServiceAxis_3161e224-e5d1-4c31-af62-e6df308299d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3161e224-e5d1-4c31-af62-e6df308299d3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_3161e224-e5d1-4c31-af62-e6df308299d3" xlink:to="loc_srt_ProductsAndServicesDomain_3161e224-e5d1-4c31-af62-e6df308299d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b7081d99-b0be-47c2-9bd7-f96ff6329786" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_3161e224-e5d1-4c31-af62-e6df308299d3" xlink:to="loc_srt_ProductsAndServicesDomain_b7081d99-b0be-47c2-9bd7-f96ff6329786" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_33b8f347-4f21-43c9-bb71-5dc9f71b3b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b7081d99-b0be-47c2-9bd7-f96ff6329786" xlink:to="loc_us-gaap_ProductMember_33b8f347-4f21-43c9-bb71-5dc9f71b3b9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceOtherMember_84aef82e-6657-4589-af66-90b9e6d87725" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b7081d99-b0be-47c2-9bd7-f96ff6329786" xlink:to="loc_us-gaap_ServiceOtherMember_84aef82e-6657-4589-af66-90b9e6d87725" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_f0cdb1ac-048c-4f8b-bf1f-c009d6948d1c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_9d9a6342-8e51-40db-9237-a01fee945973" xlink:to="loc_srt_StatementScenarioAxis_f0cdb1ac-048c-4f8b-bf1f-c009d6948d1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_f0cdb1ac-048c-4f8b-bf1f-c009d6948d1c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_f0cdb1ac-048c-4f8b-bf1f-c009d6948d1c" xlink:to="loc_srt_ScenarioUnspecifiedDomain_f0cdb1ac-048c-4f8b-bf1f-c009d6948d1c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_04b3243e-ee1f-47aa-9a5f-f58beb881c8d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_f0cdb1ac-048c-4f8b-bf1f-c009d6948d1c" xlink:to="loc_srt_ScenarioUnspecifiedDomain_04b3243e-ee1f-47aa-9a5f-f58beb881c8d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited" xlink:type="simple" xlink:href="a-20230131.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited" xlink:type="extended" id="i10238f5c5d6847b6a580b0f250f8b790_CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_90612a17-c906-4751-90dc-0c79238989fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_125cb5fb-28a8-43bd-a807-8144c323bd0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_90612a17-c906-4751-90dc-0c79238989fd" xlink:to="loc_us-gaap_NetIncomeLoss_125cb5fb-28a8-43bd-a807-8144c323bd0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c20eec17-37d3-4c43-b6bc-9312095436ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_90612a17-c906-4751-90dc-0c79238989fd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c20eec17-37d3-4c43-b6bc-9312095436ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_49e5c6bf-6545-4867-afe1-258ecf51ca40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c20eec17-37d3-4c43-b6bc-9312095436ff" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_49e5c6bf-6545-4867-afe1-258ecf51ca40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_73e429f9-e28b-42c0-9474-473456e0e875" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c20eec17-37d3-4c43-b6bc-9312095436ff" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_73e429f9-e28b-42c0-9474-473456e0e875" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_01e92c03-962b-4678-b003-5dced9f7a583" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c20eec17-37d3-4c43-b6bc-9312095436ff" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_01e92c03-962b-4678-b003-5dced9f7a583" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_1ed22ed2-731e-4339-b6ab-33155c23c217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c20eec17-37d3-4c43-b6bc-9312095436ff" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_1ed22ed2-731e-4339-b6ab-33155c23c217" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_844cb2a6-a246-4757-ab3a-0642296b1b56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_1ed22ed2-731e-4339-b6ab-33155c23c217" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_844cb2a6-a246-4757-ab3a-0642296b1b56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_720bc882-08aa-45a4-a249-efff7fd2cc66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c20eec17-37d3-4c43-b6bc-9312095436ff" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_720bc882-08aa-45a4-a249-efff7fd2cc66" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2c001a9e-c069-410b-ad28-1fc3de3f2956" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_90612a17-c906-4751-90dc-0c79238989fd" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2c001a9e-c069-410b-ad28-1fc3de3f2956" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_51e1a69b-72e6-47ef-9808-8699c9e756e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_90612a17-c906-4751-90dc-0c79238989fd" xlink:to="loc_us-gaap_StatementTable_51e1a69b-72e6-47ef-9808-8699c9e756e1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_cf5d8c2c-8b66-47e1-bfd3-20e7d046dd42" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_51e1a69b-72e6-47ef-9808-8699c9e756e1" xlink:to="loc_srt_StatementScenarioAxis_cf5d8c2c-8b66-47e1-bfd3-20e7d046dd42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_cf5d8c2c-8b66-47e1-bfd3-20e7d046dd42_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_cf5d8c2c-8b66-47e1-bfd3-20e7d046dd42" xlink:to="loc_srt_ScenarioUnspecifiedDomain_cf5d8c2c-8b66-47e1-bfd3-20e7d046dd42_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_44b2ce29-c4b9-4652-b3b4-bc436cb36bfa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_cf5d8c2c-8b66-47e1-bfd3-20e7d046dd42" xlink:to="loc_srt_ScenarioUnspecifiedDomain_44b2ce29-c4b9-4652-b3b4-bc436cb36bfa" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical" xlink:type="simple" xlink:href="a-20230131.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical" xlink:type="extended" id="icfa0de2b75b240bfb3b7a90ad070e373_CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_64c85aa9-4b4a-4819-945b-c39b28bbbb69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_4a7ecfe9-e984-4f74-839e-b4da2ad24eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_64c85aa9-4b4a-4819-945b-c39b28bbbb69" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_4a7ecfe9-e984-4f74-839e-b4da2ad24eb2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_3f512c64-11ef-4aac-90b6-6e18886cc10c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_4a7ecfe9-e984-4f74-839e-b4da2ad24eb2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_3f512c64-11ef-4aac-90b6-6e18886cc10c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_16f297dc-f511-40a1-8477-c97803e5352b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_4a7ecfe9-e984-4f74-839e-b4da2ad24eb2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_16f297dc-f511-40a1-8477-c97803e5352b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_d2c53468-a2ef-4a1c-bb03-611550df361f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_4a7ecfe9-e984-4f74-839e-b4da2ad24eb2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_d2c53468-a2ef-4a1c-bb03-611550df361f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract_c25ab71d-1e34-443d-8210-20f586274da0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_4a7ecfe9-e984-4f74-839e-b4da2ad24eb2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract_c25ab71d-1e34-443d-8210-20f586274da0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_f3f46557-349d-44a7-a474-8359c6b5d71e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract_c25ab71d-1e34-443d-8210-20f586274da0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_f3f46557-349d-44a7-a474-8359c6b5d71e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_6dbbbc60-1895-41cc-9038-85b3d2b19758" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract_c25ab71d-1e34-443d-8210-20f586274da0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_6dbbbc60-1895-41cc-9038-85b3d2b19758" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9e4d788f-c7f5-41bf-9c78-a075b1c235d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_64c85aa9-4b4a-4819-945b-c39b28bbbb69" xlink:to="loc_us-gaap_StatementTable_9e4d788f-c7f5-41bf-9c78-a075b1c235d3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_a339cac4-b13f-4f5c-b6f0-d88d6d5d239c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_9e4d788f-c7f5-41bf-9c78-a075b1c235d3" xlink:to="loc_srt_StatementScenarioAxis_a339cac4-b13f-4f5c-b6f0-d88d6d5d239c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a339cac4-b13f-4f5c-b6f0-d88d6d5d239c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_a339cac4-b13f-4f5c-b6f0-d88d6d5d239c" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a339cac4-b13f-4f5c-b6f0-d88d6d5d239c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_368efda8-b1c9-4834-866d-1a028482fd06" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_a339cac4-b13f-4f5c-b6f0-d88d6d5d239c" xlink:to="loc_srt_ScenarioUnspecifiedDomain_368efda8-b1c9-4834-866d-1a028482fd06" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited" xlink:type="simple" xlink:href="a-20230131.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited" xlink:type="extended" id="i2b34f8a69ac54f97a71cb7774207096f_CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8adc52a9-558b-428f-8f1d-e6c08730ae07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_ea3115d0-a4bf-47f9-9ffa-9eaf81842da3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8adc52a9-558b-428f-8f1d-e6c08730ae07" xlink:to="loc_us-gaap_AssetsAbstract_ea3115d0-a4bf-47f9-9ffa-9eaf81842da3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_59f165aa-3f8b-4f8b-b40b-0d9bf00eaa74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_ea3115d0-a4bf-47f9-9ffa-9eaf81842da3" xlink:to="loc_us-gaap_AssetsCurrentAbstract_59f165aa-3f8b-4f8b-b40b-0d9bf00eaa74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_51d32c0d-f0a2-4f69-a745-822c10c5cfc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_59f165aa-3f8b-4f8b-b40b-0d9bf00eaa74" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_51d32c0d-f0a2-4f69-a745-822c10c5cfc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_8b181786-9d3a-4e3b-b56e-8f34f64f77ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_59f165aa-3f8b-4f8b-b40b-0d9bf00eaa74" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_8b181786-9d3a-4e3b-b56e-8f34f64f77ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_95bc328a-4b80-4c1a-9180-cf7398a4c5c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_59f165aa-3f8b-4f8b-b40b-0d9bf00eaa74" xlink:to="loc_us-gaap_InventoryNet_95bc328a-4b80-4c1a-9180-cf7398a4c5c7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_0090d6a0-43ed-420b-8b39-909072492108" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_59f165aa-3f8b-4f8b-b40b-0d9bf00eaa74" xlink:to="loc_us-gaap_OtherAssetsCurrent_0090d6a0-43ed-420b-8b39-909072492108" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_9e567368-e703-408b-8e71-030521d0ce86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_59f165aa-3f8b-4f8b-b40b-0d9bf00eaa74" xlink:to="loc_us-gaap_AssetsCurrent_9e567368-e703-408b-8e71-030521d0ce86" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_70905182-13a9-4fe3-a4b7-7ac770568351" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_ea3115d0-a4bf-47f9-9ffa-9eaf81842da3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_70905182-13a9-4fe3-a4b7-7ac770568351" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_98c71939-895d-4b6f-b431-b846d9dfaa1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_ea3115d0-a4bf-47f9-9ffa-9eaf81842da3" xlink:to="loc_us-gaap_Goodwill_98c71939-895d-4b6f-b431-b846d9dfaa1e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_83b2ecd0-4306-4c6d-818f-87290bc11866" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_ea3115d0-a4bf-47f9-9ffa-9eaf81842da3" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_83b2ecd0-4306-4c6d-818f-87290bc11866" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_6e541bce-e330-498d-9657-29a3383f59f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_ea3115d0-a4bf-47f9-9ffa-9eaf81842da3" xlink:to="loc_us-gaap_LongTermInvestments_6e541bce-e330-498d-9657-29a3383f59f2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_73a552b3-818b-4e61-bec5-bb0f1d75df70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_ea3115d0-a4bf-47f9-9ffa-9eaf81842da3" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_73a552b3-818b-4e61-bec5-bb0f1d75df70" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_0fa08507-8429-4125-af4d-e216aa9b13c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_ea3115d0-a4bf-47f9-9ffa-9eaf81842da3" xlink:to="loc_us-gaap_Assets_0fa08507-8429-4125-af4d-e216aa9b13c5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ed786591-bd73-4cd2-9766-8d4f3df8325e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8adc52a9-558b-428f-8f1d-e6c08730ae07" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ed786591-bd73-4cd2-9766-8d4f3df8325e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_9f8b1044-06e1-4e0c-8283-2b92b28ccd75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ed786591-bd73-4cd2-9766-8d4f3df8325e" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_9f8b1044-06e1-4e0c-8283-2b92b28ccd75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_862853c9-0ef9-460b-9535-6e75a82c3531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9f8b1044-06e1-4e0c-8283-2b92b28ccd75" xlink:to="loc_us-gaap_AccountsPayableCurrent_862853c9-0ef9-460b-9535-6e75a82c3531" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_44e02152-9cad-4742-b438-3fa0bfefde86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9f8b1044-06e1-4e0c-8283-2b92b28ccd75" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_44e02152-9cad-4742-b438-3fa0bfefde86" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_64b49e9a-fc40-412a-9418-6d858b370439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9f8b1044-06e1-4e0c-8283-2b92b28ccd75" xlink:to="loc_us-gaap_DeferredRevenueCurrent_64b49e9a-fc40-412a-9418-6d858b370439" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_2650c4ef-9652-4712-9c09-5b087fadc63f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9f8b1044-06e1-4e0c-8283-2b92b28ccd75" xlink:to="loc_us-gaap_ShortTermBorrowings_2650c4ef-9652-4712-9c09-5b087fadc63f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_0ceb4798-5f26-49f6-8a6a-a0e847a42b41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9f8b1044-06e1-4e0c-8283-2b92b28ccd75" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_0ceb4798-5f26-49f6-8a6a-a0e847a42b41" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_84d982f3-1ae8-4896-ba68-7e77fdf1faaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9f8b1044-06e1-4e0c-8283-2b92b28ccd75" xlink:to="loc_us-gaap_LiabilitiesCurrent_84d982f3-1ae8-4896-ba68-7e77fdf1faaf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f2386abe-f390-499d-bc33-36dca1bb0701" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9f8b1044-06e1-4e0c-8283-2b92b28ccd75" xlink:to="loc_us-gaap_LongTermDebt_f2386abe-f390-499d-bc33-36dca1bb0701" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_62325a60-cda8-423a-b3bb-b180f56376ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ed786591-bd73-4cd2-9766-8d4f3df8325e" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_62325a60-cda8-423a-b3bb-b180f56376ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_47bb135d-86a2-41de-aece-8b2f6e697b99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ed786591-bd73-4cd2-9766-8d4f3df8325e" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_47bb135d-86a2-41de-aece-8b2f6e697b99" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_53956531-dc3a-4060-a2d7-3a2057114125" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ed786591-bd73-4cd2-9766-8d4f3df8325e" xlink:to="loc_us-gaap_Liabilities_53956531-dc3a-4060-a2d7-3a2057114125" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_d58c9aa2-cd95-4d32-bbbd-208683ae5def" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ed786591-bd73-4cd2-9766-8d4f3df8325e" xlink:to="loc_us-gaap_CommitmentsAndContingencies_d58c9aa2-cd95-4d32-bbbd-208683ae5def" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d3b28441-0fbb-4827-ac07-a228e4d33b35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ed786591-bd73-4cd2-9766-8d4f3df8325e" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d3b28441-0fbb-4827-ac07-a228e4d33b35" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_db382817-3b15-45d6-9fdf-b3ebd89c633d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d3b28441-0fbb-4827-ac07-a228e4d33b35" xlink:to="loc_us-gaap_StockholdersEquityAbstract_db382817-3b15-45d6-9fdf-b3ebd89c633d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_df78e4ce-9358-484e-9256-6239c97ee332" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_db382817-3b15-45d6-9fdf-b3ebd89c633d" xlink:to="loc_us-gaap_PreferredStockValue_df78e4ce-9358-484e-9256-6239c97ee332" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_9efe2af5-3a14-48e9-ac55-9b4d5eeef4f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_db382817-3b15-45d6-9fdf-b3ebd89c633d" xlink:to="loc_us-gaap_CommonStockValue_9efe2af5-3a14-48e9-ac55-9b4d5eeef4f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_84ab1ca6-1d79-4144-8f4f-5bdcb9dbf591" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_db382817-3b15-45d6-9fdf-b3ebd89c633d" xlink:to="loc_us-gaap_AdditionalPaidInCapital_84ab1ca6-1d79-4144-8f4f-5bdcb9dbf591" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_50c59171-acfe-4e5c-9ddd-4c940e5410fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_db382817-3b15-45d6-9fdf-b3ebd89c633d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_50c59171-acfe-4e5c-9ddd-4c940e5410fa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_717bb95e-66f1-40ce-89ef-d2012e16994a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_db382817-3b15-45d6-9fdf-b3ebd89c633d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_717bb95e-66f1-40ce-89ef-d2012e16994a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d7058583-d782-4f3e-903d-d0f789142692" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_db382817-3b15-45d6-9fdf-b3ebd89c633d" xlink:to="loc_us-gaap_StockholdersEquity_d7058583-d782-4f3e-903d-d0f789142692" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_0b3876e0-c7a2-4118-b948-9e64b61ce944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ed786591-bd73-4cd2-9766-8d4f3df8325e" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_0b3876e0-c7a2-4118-b948-9e64b61ce944" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_81325213-0c81-4caf-8dd5-17ca2c01e24a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_8adc52a9-558b-428f-8f1d-e6c08730ae07" xlink:to="loc_us-gaap_StatementTable_81325213-0c81-4caf-8dd5-17ca2c01e24a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_d0254083-bf82-4b9d-b6b3-a19509c4d634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_81325213-0c81-4caf-8dd5-17ca2c01e24a" xlink:to="loc_us-gaap_StatementClassOfStockAxis_d0254083-bf82-4b9d-b6b3-a19509c4d634" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d0254083-bf82-4b9d-b6b3-a19509c4d634_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d0254083-bf82-4b9d-b6b3-a19509c4d634" xlink:to="loc_us-gaap_ClassOfStockDomain_d0254083-bf82-4b9d-b6b3-a19509c4d634_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_43f49287-a554-4fd4-b960-9cf07a2d5f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d0254083-bf82-4b9d-b6b3-a19509c4d634" xlink:to="loc_us-gaap_ClassOfStockDomain_43f49287-a554-4fd4-b960-9cf07a2d5f6d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="a-20230131.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited" xlink:type="extended" id="i4ae83141ba894420b06412eaa1cfa377_CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d62ea53d-abe5-482c-b228-7968cb1b880e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d931adfb-a70b-4245-94e3-d481992fbe7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d62ea53d-abe5-482c-b228-7968cb1b880e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d931adfb-a70b-4245-94e3-d481992fbe7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_38161c42-e8a0-434b-a032-cb0f8488966b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d931adfb-a70b-4245-94e3-d481992fbe7e" xlink:to="loc_us-gaap_NetIncomeLoss_38161c42-e8a0-434b-a032-cb0f8488966b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_970e534b-f8f4-4451-b53e-9b454117f22e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d931adfb-a70b-4245-94e3-d481992fbe7e" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_970e534b-f8f4-4451-b53e-9b454117f22e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_12205b69-a920-4a0b-816f-39f8b80153fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_970e534b-f8f4-4451-b53e-9b454117f22e" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_12205b69-a920-4a0b-816f-39f8b80153fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_d5ee5026-1bfc-4445-857a-fafd586cffcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_970e534b-f8f4-4451-b53e-9b454117f22e" xlink:to="loc_us-gaap_ShareBasedCompensation_d5ee5026-1bfc-4445-857a-fafd586cffcc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3aefa0b5-8b6f-4e3b-96ac-dc616275ad33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_970e534b-f8f4-4451-b53e-9b454117f22e" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3aefa0b5-8b6f-4e3b-96ac-dc616275ad33" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_1b9b05cb-5beb-47e0-8552-18bd5bc57daf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_970e534b-f8f4-4451-b53e-9b454117f22e" xlink:to="loc_us-gaap_InventoryWriteDown_1b9b05cb-5beb-47e0-8552-18bd5bc57daf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_a0e4a469-0e7e-4450-ad25-9670e569d078" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_970e534b-f8f4-4451-b53e-9b454117f22e" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_a0e4a469-0e7e-4450-ad25-9670e569d078" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_24e5280a-31d0-45e0-b1b5-b9d874870070" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_970e534b-f8f4-4451-b53e-9b454117f22e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_24e5280a-31d0-45e0-b1b5-b9d874870070" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_70241731-5918-4e8c-8d31-a27affc1cac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_970e534b-f8f4-4451-b53e-9b454117f22e" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_70241731-5918-4e8c-8d31-a27affc1cac7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca0f2a27-abff-4078-8adb-75be41891cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d931adfb-a70b-4245-94e3-d481992fbe7e" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca0f2a27-abff-4078-8adb-75be41891cf4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_bf0329ef-4d5f-459e-be8d-627eeb5d8a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca0f2a27-abff-4078-8adb-75be41891cf4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_bf0329ef-4d5f-459e-be8d-627eeb5d8a8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_c6cb4cab-1d41-4d40-bce7-2424ff3b6f45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca0f2a27-abff-4078-8adb-75be41891cf4" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_c6cb4cab-1d41-4d40-bce7-2424ff3b6f45" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_82b7aa12-54ca-464e-935c-a686e094a5f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca0f2a27-abff-4078-8adb-75be41891cf4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_82b7aa12-54ca-464e-935c-a686e094a5f5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_910e6c93-ea94-4f59-a094-14b2cf3fd7dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca0f2a27-abff-4078-8adb-75be41891cf4" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_910e6c93-ea94-4f59-a094-14b2cf3fd7dd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_0d1adbab-686e-45ff-8261-b1993ba06435" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca0f2a27-abff-4078-8adb-75be41891cf4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_0d1adbab-686e-45ff-8261-b1993ba06435" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dbe2c649-4af4-4831-99a2-823c6652a7aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d931adfb-a70b-4245-94e3-d481992fbe7e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dbe2c649-4af4-4831-99a2-823c6652a7aa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_520ae441-09b2-43a3-815d-bd145112ce8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d62ea53d-abe5-482c-b228-7968cb1b880e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_520ae441-09b2-43a3-815d-bd145112ce8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d12040a7-b477-4ee8-b896-fea8c59349bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_520ae441-09b2-43a3-815d-bd145112ce8d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d12040a7-b477-4ee8-b896-fea8c59349bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_51ed1aae-499d-4899-b3ca-36b6b7f97be3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_520ae441-09b2-43a3-815d-bd145112ce8d" xlink:to="loc_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_51ed1aae-499d-4899-b3ca-36b6b7f97be3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireNotesReceivable_e7678718-f7ff-488f-bad9-20a558c15aee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireNotesReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_520ae441-09b2-43a3-815d-bd145112ce8d" xlink:to="loc_us-gaap_PaymentsToAcquireNotesReceivable_e7678718-f7ff-488f-bad9-20a558c15aee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_3da44b79-ab3d-4e20-bdbf-6f2e32f6b469" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_520ae441-09b2-43a3-815d-bd145112ce8d" xlink:to="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_3da44b79-ab3d-4e20-bdbf-6f2e32f6b469" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi_31b0bf44-cd3d-4796-8950-5e9656a15e4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_520ae441-09b2-43a3-815d-bd145112ce8d" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi_31b0bf44-cd3d-4796-8950-5e9656a15e4d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_aa19cb1f-c858-4924-8c46-5a619984ebd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_520ae441-09b2-43a3-815d-bd145112ce8d" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_aa19cb1f-c858-4924-8c46-5a619984ebd6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ed7c0473-7916-45e4-b70a-1fad30538e89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d62ea53d-abe5-482c-b228-7968cb1b880e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ed7c0473-7916-45e4-b70a-1fad30538e89" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0cc7520b-d861-46f8-b1f1-036cda7930ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d62ea53d-abe5-482c-b228-7968cb1b880e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0cc7520b-d861-46f8-b1f1-036cda7930ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_741aa264-e51b-46f4-b853-3bd1d5671711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0cc7520b-d861-46f8-b1f1-036cda7930ad" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_741aa264-e51b-46f4-b853-3bd1d5671711" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1c16eb22-b923-4903-9963-95af5881e9cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0cc7520b-d861-46f8-b1f1-036cda7930ad" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1c16eb22-b923-4903-9963-95af5881e9cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfOrdinaryDividends_dd8745e8-1feb-459f-a2d2-6e5d496dc096" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfOrdinaryDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0cc7520b-d861-46f8-b1f1-036cda7930ad" xlink:to="loc_us-gaap_PaymentsOfOrdinaryDividends_dd8745e8-1feb-459f-a2d2-6e5d496dc096" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_c740ecf9-db12-4395-9091-76e216725216" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0cc7520b-d861-46f8-b1f1-036cda7930ad" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_c740ecf9-db12-4395-9091-76e216725216" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_45bb23de-fa95-4888-a1c7-1eb3e43d6290" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0cc7520b-d861-46f8-b1f1-036cda7930ad" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_45bb23de-fa95-4888-a1c7-1eb3e43d6290" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper_bb6de3cf-8692-462e-92f1-9e1343d82d50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0cc7520b-d861-46f8-b1f1-036cda7930ad" xlink:to="loc_us-gaap_RepaymentsOfCommercialPaper_bb6de3cf-8692-462e-92f1-9e1343d82d50" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_6ac6bf03-3808-487d-8a0f-3dc73d70b432" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0cc7520b-d861-46f8-b1f1-036cda7930ad" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_6ac6bf03-3808-487d-8a0f-3dc73d70b432" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ec163e42-6cca-432c-bcd4-84dfd875ad86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0cc7520b-d861-46f8-b1f1-036cda7930ad" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ec163e42-6cca-432c-bcd4-84dfd875ad86" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b084513d-abaf-40dd-86af-92c191f1669d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0cc7520b-d861-46f8-b1f1-036cda7930ad" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b084513d-abaf-40dd-86af-92c191f1669d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0e5765e3-a59d-4c2d-8550-548017e44678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d62ea53d-abe5-482c-b228-7968cb1b880e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0e5765e3-a59d-4c2d-8550-548017e44678" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_12059761-d3b8-4bb6-90f5-6b2d2e542451" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d62ea53d-abe5-482c-b228-7968cb1b880e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_12059761-d3b8-4bb6-90f5-6b2d2e542451" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_523542f8-1daa-48a2-a28b-1aa69e543b00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_cd2a2521-81c1-4880-bd0d-795967720bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d62ea53d-abe5-482c-b228-7968cb1b880e" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_cd2a2521-81c1-4880-bd0d-795967720bbb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_00ef1aa6-3740-424e-ad25-11f74a5f29b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_cd2a2521-81c1-4880-bd0d-795967720bbb" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_00ef1aa6-3740-424e-ad25-11f74a5f29b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_cf9b1cee-5698-490c-98a0-3680209a2a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_cd2a2521-81c1-4880-bd0d-795967720bbb" xlink:to="loc_us-gaap_InterestPaidNet_cf9b1cee-5698-490c-98a0-3680209a2a3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9ca2ebb3-3977-4a3b-8021-66c4878689e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_cd2a2521-81c1-4880-bd0d-795967720bbb" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9ca2ebb3-3977-4a3b-8021-66c4878689e6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_776c6862-a961-45a4-9bd2-8d6f3ba4724b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_d62ea53d-abe5-482c-b228-7968cb1b880e" xlink:to="loc_us-gaap_StatementTable_776c6862-a961-45a4-9bd2-8d6f3ba4724b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_648466fa-e98a-452d-b9f6-8a4563cfdb74" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_776c6862-a961-45a4-9bd2-8d6f3ba4724b" xlink:to="loc_srt_StatementScenarioAxis_648466fa-e98a-452d-b9f6-8a4563cfdb74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_648466fa-e98a-452d-b9f6-8a4563cfdb74_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_648466fa-e98a-452d-b9f6-8a4563cfdb74" xlink:to="loc_srt_ScenarioUnspecifiedDomain_648466fa-e98a-452d-b9f6-8a4563cfdb74_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_c5d9cf3d-9a6f-46e9-8640-5a1d758d3432" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_648466fa-e98a-452d-b9f6-8a4563cfdb74" xlink:to="loc_srt_ScenarioUnspecifiedDomain_c5d9cf3d-9a6f-46e9-8640-5a1d758d3432" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_bd5760b0-0103-4e03-bf3e-28582ede3f42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_776c6862-a961-45a4-9bd2-8d6f3ba4724b" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_bd5760b0-0103-4e03-bf3e-28582ede3f42" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_bd5760b0-0103-4e03-bf3e-28582ede3f42_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_bd5760b0-0103-4e03-bf3e-28582ede3f42" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_bd5760b0-0103-4e03-bf3e-28582ede3f42_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9ccee173-50f8-41b1-93bb-d40eefc5cd35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_bd5760b0-0103-4e03-bf3e-28582ede3f42" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9ccee173-50f8-41b1-93bb-d40eefc5cd35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_003e6b97-11f7-4809-9c39-5dd4bad9f472" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9ccee173-50f8-41b1-93bb-d40eefc5cd35" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_003e6b97-11f7-4809-9c39-5dd4bad9f472" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="simple" xlink:href="a-20230131.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="extended" id="i7de1f875f70f416d9753973e3b0644c2_CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_724728aa-3c57-4560-9466-d40b5118c9e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_8e3147f6-2248-49bf-be82-4200aeb20df2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_724728aa-3c57-4560-9466-d40b5118c9e2" xlink:to="loc_us-gaap_SharesIssued_8e3147f6-2248-49bf-be82-4200aeb20df2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c962c58b-6326-4848-b7f9-e8530b33d89a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_724728aa-3c57-4560-9466-d40b5118c9e2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c962c58b-6326-4848-b7f9-e8530b33d89a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_b8e140b8-0849-4263-88b4-0ca89a7c6b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_724728aa-3c57-4560-9466-d40b5118c9e2" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_b8e140b8-0849-4263-88b4-0ca89a7c6b4d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_71c6a567-2171-4c43-bfd4-31215c337726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_b8e140b8-0849-4263-88b4-0ca89a7c6b4d" xlink:to="loc_us-gaap_NetIncomeLoss_71c6a567-2171-4c43-bfd4-31215c337726" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_dfea7f4f-7a1b-4198-89d4-d9f2ab7e4244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_b8e140b8-0849-4263-88b4-0ca89a7c6b4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_dfea7f4f-7a1b-4198-89d4-d9f2ab7e4244" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_a7abb388-807a-475f-9278-de40946ee7a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_b8e140b8-0849-4263-88b4-0ca89a7c6b4d" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_a7abb388-807a-475f-9278-de40946ee7a3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_90403135-2057-4d44-8167-3b02f0f006a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_724728aa-3c57-4560-9466-d40b5118c9e2" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_90403135-2057-4d44-8167-3b02f0f006a0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_e247016c-a4c0-4165-8dbc-bbc864be6a18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_724728aa-3c57-4560-9466-d40b5118c9e2" xlink:to="loc_us-gaap_DividendsCommonStockCash_e247016c-a4c0-4165-8dbc-bbc864be6a18" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_7ff03e99-46bd-4baf-bddf-9a9c7afda6e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_724728aa-3c57-4560-9466-d40b5118c9e2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_7ff03e99-46bd-4baf-bddf-9a9c7afda6e7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_678e4212-3609-49fa-adbc-97e0847d7da9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_724728aa-3c57-4560-9466-d40b5118c9e2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_678e4212-3609-49fa-adbc-97e0847d7da9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_641f94d1-f911-42df-90bc-646a27108b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_724728aa-3c57-4560-9466-d40b5118c9e2" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_641f94d1-f911-42df-90bc-646a27108b7e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_8cd8b367-d69d-42ed-b0e7-55f6aeb427be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_724728aa-3c57-4560-9466-d40b5118c9e2" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_8cd8b367-d69d-42ed-b0e7-55f6aeb427be" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_5bf55ba1-f46e-469b-b5f1-a8a65ea6ddd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_724728aa-3c57-4560-9466-d40b5118c9e2" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_5bf55ba1-f46e-469b-b5f1-a8a65ea6ddd3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_9eabc616-f48c-4b55-a2bd-6c2888231443" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2753c729-0cc6-462e-9d59-850d4a8ac484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2cba3cd5-e19a-4efa-9031-41ac38b0da12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_724728aa-3c57-4560-9466-d40b5118c9e2" xlink:to="loc_us-gaap_StatementTable_2cba3cd5-e19a-4efa-9031-41ac38b0da12" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_b00501b7-0edc-47ee-ba93-718c63ee272f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2cba3cd5-e19a-4efa-9031-41ac38b0da12" xlink:to="loc_srt_RestatementAxis_b00501b7-0edc-47ee-ba93-718c63ee272f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_b00501b7-0edc-47ee-ba93-718c63ee272f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_b00501b7-0edc-47ee-ba93-718c63ee272f" xlink:to="loc_srt_RestatementDomain_b00501b7-0edc-47ee-ba93-718c63ee272f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_c8534878-76d9-4d73-9d1f-652b3c908d3e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_b00501b7-0edc-47ee-ba93-718c63ee272f" xlink:to="loc_srt_RestatementDomain_c8534878-76d9-4d73-9d1f-652b3c908d3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_1af7dd01-900a-48fa-91bd-824b6fe60806" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_c8534878-76d9-4d73-9d1f-652b3c908d3e" xlink:to="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_1af7dd01-900a-48fa-91bd-824b6fe60806" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e51bae26-8514-48b0-aade-0172f11b8e84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2cba3cd5-e19a-4efa-9031-41ac38b0da12" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e51bae26-8514-48b0-aade-0172f11b8e84" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e51bae26-8514-48b0-aade-0172f11b8e84_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e51bae26-8514-48b0-aade-0172f11b8e84" xlink:to="loc_us-gaap_EquityComponentDomain_e51bae26-8514-48b0-aade-0172f11b8e84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e14ace7b-cc55-40f5-9c17-a5fe3f6c2135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e51bae26-8514-48b0-aade-0172f11b8e84" xlink:to="loc_us-gaap_EquityComponentDomain_e14ace7b-cc55-40f5-9c17-a5fe3f6c2135" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d7dc5694-3d78-4c74-8977-20df53fcd1ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e14ace7b-cc55-40f5-9c17-a5fe3f6c2135" xlink:to="loc_us-gaap_CommonStockMember_d7dc5694-3d78-4c74-8977-20df53fcd1ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_8d54596b-1042-4ecb-afe1-465d02e14570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e14ace7b-cc55-40f5-9c17-a5fe3f6c2135" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_8d54596b-1042-4ecb-afe1-465d02e14570" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_f9715310-27ab-4858-885a-679a9e660025" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e14ace7b-cc55-40f5-9c17-a5fe3f6c2135" xlink:to="loc_us-gaap_RetainedEarningsMember_f9715310-27ab-4858-885a-679a9e660025" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_780832f8-0932-47fc-bc07-8c2218a1d315" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e14ace7b-cc55-40f5-9c17-a5fe3f6c2135" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_780832f8-0932-47fc-bc07-8c2218a1d315" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_befbc482-8e01-4e63-a587-a8952b0bf7d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e14ace7b-cc55-40f5-9c17-a5fe3f6c2135" xlink:to="loc_us-gaap_ParentMember_befbc482-8e01-4e63-a587-a8952b0bf7d9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_018664d2-e594-4772-9448-18f7e087cb23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e14ace7b-cc55-40f5-9c17-a5fe3f6c2135" xlink:to="loc_us-gaap_NoncontrollingInterestMember_018664d2-e594-4772-9448-18f7e087cb23" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b9095f6a-5b25-4c0a-a230-44f351dc70d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2cba3cd5-e19a-4efa-9031-41ac38b0da12" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b9095f6a-5b25-4c0a-a230-44f351dc70d0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b9095f6a-5b25-4c0a-a230-44f351dc70d0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b9095f6a-5b25-4c0a-a230-44f351dc70d0" xlink:to="loc_us-gaap_ClassOfStockDomain_b9095f6a-5b25-4c0a-a230-44f351dc70d0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_cc126ca3-764a-41e1-9ce2-657e5ffa3b35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b9095f6a-5b25-4c0a-a230-44f351dc70d0" xlink:to="loc_us-gaap_ClassOfStockDomain_cc126ca3-764a-41e1-9ce2-657e5ffa3b35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_b8f491a6-2f9d-424a-9296-ef868dde4e3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2cba3cd5-e19a-4efa-9031-41ac38b0da12" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_b8f491a6-2f9d-424a-9296-ef868dde4e3e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_b8f491a6-2f9d-424a-9296-ef868dde4e3e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_b8f491a6-2f9d-424a-9296-ef868dde4e3e" xlink:to="loc_us-gaap_TypeOfAdoptionMember_b8f491a6-2f9d-424a-9296-ef868dde4e3e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_fc804ac6-a523-4c22-9490-c3f2d40dea35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_b8f491a6-2f9d-424a-9296-ef868dde4e3e" xlink:to="loc_us-gaap_TypeOfAdoptionMember_fc804ac6-a523-4c22-9490-c3f2d40dea35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_cd356b69-e36d-4881-8566-e161aa962849" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2cba3cd5-e19a-4efa-9031-41ac38b0da12" xlink:to="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_cd356b69-e36d-4881-8566-e161aa962849" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingPrincipleMember_cd356b69-e36d-4881-8566-e161aa962849_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_cd356b69-e36d-4881-8566-e161aa962849" xlink:to="loc_us-gaap_ChangeInAccountingPrincipleMember_cd356b69-e36d-4881-8566-e161aa962849_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingPrincipleMember_7c4a442d-b3b1-48dd-8209-07a02530096d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_cd356b69-e36d-4881-8566-e161aa962849" xlink:to="loc_us-gaap_ChangeInAccountingPrincipleMember_7c4a442d-b3b1-48dd-8209-07a02530096d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_b95b5562-7f70-4e57-bd05-25e8e5c7a3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2cba3cd5-e19a-4efa-9031-41ac38b0da12" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_b95b5562-7f70-4e57-bd05-25e8e5c7a3b5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_b95b5562-7f70-4e57-bd05-25e8e5c7a3b5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_b95b5562-7f70-4e57-bd05-25e8e5c7a3b5" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_b95b5562-7f70-4e57-bd05-25e8e5c7a3b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_ec9f7967-4280-4b58-9720-09d1a98fcb1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_b95b5562-7f70-4e57-bd05-25e8e5c7a3b5" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_ec9f7967-4280-4b58-9720-09d1a98fcb1a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="a-20230131.xsd#STOCKHOLDERSEQUITYTables"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/STOCKHOLDERSEQUITYTables" xlink:type="extended" id="i57ded964470048fdaef562cf277990f7_STOCKHOLDERSEQUITYTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ded1fa53-e2d4-4fb5-b88f-ab719084028e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_f7c3573c-1d8f-47d6-b7df-658867ec2d24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ded1fa53-e2d4-4fb5-b88f-ab719084028e" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_f7c3573c-1d8f-47d6-b7df-658867ec2d24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_36287c7c-7f34-4a9e-84ec-470f271ce68a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ded1fa53-e2d4-4fb5-b88f-ab719084028e" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_36287c7c-7f34-4a9e-84ec-470f271ce68a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9f1d1a29-cb63-4bae-a92d-6e2e5575633d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ded1fa53-e2d4-4fb5-b88f-ab719084028e" xlink:to="loc_us-gaap_StatementTable_9f1d1a29-cb63-4bae-a92d-6e2e5575633d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_ae044564-841e-4a64-85be-7d2418889b6b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_9f1d1a29-cb63-4bae-a92d-6e2e5575633d" xlink:to="loc_srt_StatementScenarioAxis_ae044564-841e-4a64-85be-7d2418889b6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_ae044564-841e-4a64-85be-7d2418889b6b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_ae044564-841e-4a64-85be-7d2418889b6b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_ae044564-841e-4a64-85be-7d2418889b6b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_86b5937b-d1bf-45ad-86c6-5dfd4028fc8f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_ae044564-841e-4a64-85be-7d2418889b6b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_86b5937b-d1bf-45ad-86c6-5dfd4028fc8f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="simple" xlink:href="a-20230131.xsd#OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="extended" id="i338b5860577245afa12e637609e98ba5_OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_019346bf-004d-4318-8095-89dd86075682" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_b7f2e450-a520-4f24-8e01-d12f2cae6219" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_019346bf-004d-4318-8095-89dd86075682" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_b7f2e450-a520-4f24-8e01-d12f2cae6219" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7727ec6b-5770-493e-9aab-b30cb5ed9dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_b7f2e450-a520-4f24-8e01-d12f2cae6219" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7727ec6b-5770-493e-9aab-b30cb5ed9dbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_35dead14-ba40-4089-a16c-98e7697b6f01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_b7f2e450-a520-4f24-8e01-d12f2cae6219" xlink:to="loc_us-gaap_RestrictedCash_35dead14-ba40-4089-a16c-98e7697b6f01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_842269a8-2db9-4a2f-8497-85efc0254bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_b7f2e450-a520-4f24-8e01-d12f2cae6219" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_842269a8-2db9-4a2f-8497-85efc0254bd1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract_21881127-1dd7-4b5a-aeef-9c83d2eddab1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_019346bf-004d-4318-8095-89dd86075682" xlink:to="loc_us-gaap_LeasesOperatingAbstract_21881127-1dd7-4b5a-aeef-9c83d2eddab1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1a9c3070-63c8-4557-8a5c-09f2337548c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesOperatingAbstract_21881127-1dd7-4b5a-aeef-9c83d2eddab1" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1a9c3070-63c8-4557-8a5c-09f2337548c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_01c4ac96-73ba-4264-b994-344489768927" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesOperatingAbstract_21881127-1dd7-4b5a-aeef-9c83d2eddab1" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_01c4ac96-73ba-4264-b994-344489768927" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_6d3ecd9f-d5fb-468a-a07a-ee48a0ea1e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesOperatingAbstract_21881127-1dd7-4b5a-aeef-9c83d2eddab1" xlink:to="loc_us-gaap_OperatingLeaseLiability_6d3ecd9f-d5fb-468a-a07a-ee48a0ea1e5f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_9844239b-fbc1-4df1-aa7c-c2679a537526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesOperatingAbstract_21881127-1dd7-4b5a-aeef-9c83d2eddab1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_9844239b-fbc1-4df1-aa7c-c2679a537526" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_e6e622de-408b-4983-952a-21ccdbde31be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_019346bf-004d-4318-8095-89dd86075682" xlink:to="loc_us-gaap_FairValueDisclosuresAbstract_e6e622de-408b-4983-952a-21ccdbde31be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_31db0315-9d5b-4505-80b3-2995f93c71de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e6e622de-408b-4983-952a-21ccdbde31be" xlink:to="loc_us-gaap_DebtInstrumentFairValue_31db0315-9d5b-4505-80b3-2995f93c71de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_7257946f-e053-4316-ab31-9c1538f4b8d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e6e622de-408b-4983-952a-21ccdbde31be" xlink:to="loc_us-gaap_SeniorNotes_7257946f-e053-4316-ab31-9c1538f4b8d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_17a41372-d077-4da9-8255-54c1da6fe650" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_019346bf-004d-4318-8095-89dd86075682" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_17a41372-d077-4da9-8255-54c1da6fe650" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_8b94d4e1-a501-4328-9cee-33111c06df41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_17a41372-d077-4da9-8255-54c1da6fe650" xlink:to="loc_us-gaap_Assets_8b94d4e1-a501-4328-9cee-33111c06df41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_cf8f468b-e495-4669-aadd-592ecb79876f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_019346bf-004d-4318-8095-89dd86075682" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_cf8f468b-e495-4669-aadd-592ecb79876f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_a4632e8f-1454-49a5-bbe7-40b22424a660" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_cf8f468b-e495-4669-aadd-592ecb79876f" xlink:to="loc_srt_ConsolidatedEntitiesAxis_a4632e8f-1454-49a5-bbe7-40b22424a660" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_a4632e8f-1454-49a5-bbe7-40b22424a660_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_a4632e8f-1454-49a5-bbe7-40b22424a660" xlink:to="loc_srt_ConsolidatedEntitiesDomain_a4632e8f-1454-49a5-bbe7-40b22424a660_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_0d122b5d-a2b1-4bfc-8117-027ae1b6e0f8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_a4632e8f-1454-49a5-bbe7-40b22424a660" xlink:to="loc_srt_ConsolidatedEntitiesDomain_0d122b5d-a2b1-4bfc-8117-027ae1b6e0f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_808b4bd4-00bc-446a-9353-c9b7c1c48cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_0d122b5d-a2b1-4bfc-8117-027ae1b6e0f8" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_808b4bd4-00bc-446a-9353-c9b7c1c48cb5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PledgedStatusAxis_11078724-041a-4c4f-a041-fdad0860c98b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PledgedStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_cf8f468b-e495-4669-aadd-592ecb79876f" xlink:to="loc_us-gaap_PledgedStatusAxis_11078724-041a-4c4f-a041-fdad0860c98b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PledgedStatusDomain_11078724-041a-4c4f-a041-fdad0860c98b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PledgedStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PledgedStatusAxis_11078724-041a-4c4f-a041-fdad0860c98b" xlink:to="loc_us-gaap_PledgedStatusDomain_11078724-041a-4c4f-a041-fdad0860c98b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PledgedStatusDomain_9cb42a98-0849-4bea-9920-56d264a19691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PledgedStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PledgedStatusAxis_11078724-041a-4c4f-a041-fdad0860c98b" xlink:to="loc_us-gaap_PledgedStatusDomain_9cb42a98-0849-4bea-9920-56d264a19691" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecourseStatusAxis_548681e8-9065-4507-8c50-c199c75ae081" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RecourseStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_cf8f468b-e495-4669-aadd-592ecb79876f" xlink:to="loc_us-gaap_RecourseStatusAxis_548681e8-9065-4507-8c50-c199c75ae081" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecourseStatusDomain_548681e8-9065-4507-8c50-c199c75ae081_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RecourseStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RecourseStatusAxis_548681e8-9065-4507-8c50-c199c75ae081" xlink:to="loc_us-gaap_RecourseStatusDomain_548681e8-9065-4507-8c50-c199c75ae081_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecourseStatusDomain_c87098da-f57c-4819-86da-ee7f68d92389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RecourseStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RecourseStatusAxis_548681e8-9065-4507-8c50-c199c75ae081" xlink:to="loc_us-gaap_RecourseStatusDomain_c87098da-f57c-4819-86da-ee7f68d92389" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_43e740af-2d36-4348-b915-e6cdc4761cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_cf8f468b-e495-4669-aadd-592ecb79876f" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_43e740af-2d36-4348-b915-e6cdc4761cbf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_43e740af-2d36-4348-b915-e6cdc4761cbf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_43e740af-2d36-4348-b915-e6cdc4761cbf" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_43e740af-2d36-4348-b915-e6cdc4761cbf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a92aebca-9b97-4f77-b149-8a5360c62906" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_43e740af-2d36-4348-b915-e6cdc4761cbf" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a92aebca-9b97-4f77-b149-8a5360c62906" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_c57c397c-aea1-4d7e-b604-e9277dff6d20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a92aebca-9b97-4f77-b149-8a5360c62906" xlink:to="loc_us-gaap_OtherAssetsMember_c57c397c-aea1-4d7e-b604-e9277dff6d20" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_c4115ce7-9bee-41d6-a873-ba7dc0374e33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a92aebca-9b97-4f77-b149-8a5360c62906" xlink:to="loc_us-gaap_OtherLiabilitiesMember_c4115ce7-9bee-41d6-a873-ba7dc0374e33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_556e2fe6-d945-4e7c-a134-8002e11afa1a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_556e2fe6-d945-4e7c-a134-8002e11afa1a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_78f26323-895b-474d-b143-f5ddf9294ef4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_7957e371-0759-4ff7-978b-0d659c5c84ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cf789193-bd6f-455d-a224-e866e39d82c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_cf8f468b-e495-4669-aadd-592ecb79876f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cf789193-bd6f-455d-a224-e866e39d82c6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cf789193-bd6f-455d-a224-e866e39d82c6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cf789193-bd6f-455d-a224-e866e39d82c6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cf789193-bd6f-455d-a224-e866e39d82c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_54f9a246-c750-4788-8d5b-ee75cf3a8550" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cf789193-bd6f-455d-a224-e866e39d82c6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_54f9a246-c750-4788-8d5b-ee75cf3a8550" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3eaa9454-00b1-4c30-b7d7-0b737dbce06c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_54f9a246-c750-4788-8d5b-ee75cf3a8550" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3eaa9454-00b1-4c30-b7d7-0b737dbce06c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ca2f8e66-ad41-4b5f-b111-cf70212edbf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_cf8f468b-e495-4669-aadd-592ecb79876f" xlink:to="loc_us-gaap_DebtInstrumentAxis_ca2f8e66-ad41-4b5f-b111-cf70212edbf1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ca2f8e66-ad41-4b5f-b111-cf70212edbf1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_ca2f8e66-ad41-4b5f-b111-cf70212edbf1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ca2f8e66-ad41-4b5f-b111-cf70212edbf1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_754f1f99-0f1e-4024-be81-70c8cfc2de17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_ca2f8e66-ad41-4b5f-b111-cf70212edbf1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_754f1f99-0f1e-4024-be81-70c8cfc2de17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_ad412906-37f0-4845-bef7-99198e0353dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_754f1f99-0f1e-4024-be81-70c8cfc2de17" xlink:to="loc_us-gaap_SeniorNotesMember_ad412906-37f0-4845-bef7-99198e0353dd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/REVENUERevenuebyRegionDetails" xlink:type="simple" xlink:href="a-20230131.xsd#REVENUERevenuebyRegionDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/REVENUERevenuebyRegionDetails" xlink:type="extended" id="i64353036fbea456594f5f343d8cc016c_REVENUERevenuebyRegionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f0aee9cc-f37e-4ae3-86f6-e9f11797fc06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1cadf124-2e67-4234-b0b7-2abde1de4f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0aee9cc-f37e-4ae3-86f6-e9f11797fc06" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1cadf124-2e67-4234-b0b7-2abde1de4f6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_813b5a95-f1bf-491b-85d4-bcc4782f5d26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f0aee9cc-f37e-4ae3-86f6-e9f11797fc06" xlink:to="loc_us-gaap_StatementTable_813b5a95-f1bf-491b-85d4-bcc4782f5d26" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e8ee417e-59e1-4996-a6cd-7972e640d113" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_813b5a95-f1bf-491b-85d4-bcc4782f5d26" xlink:to="loc_srt_StatementGeographicalAxis_e8ee417e-59e1-4996-a6cd-7972e640d113" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e8ee417e-59e1-4996-a6cd-7972e640d113_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_e8ee417e-59e1-4996-a6cd-7972e640d113" xlink:to="loc_srt_SegmentGeographicalDomain_e8ee417e-59e1-4996-a6cd-7972e640d113_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2a4aa73c-efe2-4c1e-acb9-357ee21207a5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_e8ee417e-59e1-4996-a6cd-7972e640d113" xlink:to="loc_srt_SegmentGeographicalDomain_2a4aa73c-efe2-4c1e-acb9-357ee21207a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_e1146287-2d0f-470d-99d2-69a8189ed433" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2a4aa73c-efe2-4c1e-acb9-357ee21207a5" xlink:to="loc_srt_AmericasMember_e1146287-2d0f-470d-99d2-69a8189ed433" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_e5550abc-4446-4f84-858a-a08e75a6ada4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2a4aa73c-efe2-4c1e-acb9-357ee21207a5" xlink:to="loc_srt_EuropeMember_e5550abc-4446-4f84-858a-a08e75a6ada4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_1c66db60-aa15-4c15-be95-8c7ddf92586d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2a4aa73c-efe2-4c1e-acb9-357ee21207a5" xlink:to="loc_srt_AsiaPacificMember_1c66db60-aa15-4c15-be95-8c7ddf92586d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a49754b9-ac34-4141-b5b9-c21ff15a0d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_813b5a95-f1bf-491b-85d4-bcc4782f5d26" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a49754b9-ac34-4141-b5b9-c21ff15a0d3a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a49754b9-ac34-4141-b5b9-c21ff15a0d3a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a49754b9-ac34-4141-b5b9-c21ff15a0d3a" xlink:to="loc_us-gaap_SegmentDomain_a49754b9-ac34-4141-b5b9-c21ff15a0d3a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_de5059e1-cf6a-4623-8623-6991209875a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a49754b9-ac34-4141-b5b9-c21ff15a0d3a" xlink:to="loc_us-gaap_SegmentDomain_de5059e1-cf6a-4623-8623-6991209875a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_LifeSciencesandAppliedMarketsMember_c97c2060-3dd2-48c7-8a61-5f848dffae4b" xlink:href="a-20230131.xsd#a_LifeSciencesandAppliedMarketsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_de5059e1-cf6a-4623-8623-6991209875a4" xlink:to="loc_a_LifeSciencesandAppliedMarketsMember_c97c2060-3dd2-48c7-8a61-5f848dffae4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AgilentCrossLabMember_ef48a71d-c937-4c31-8202-6b27e4f02207" xlink:href="a-20230131.xsd#a_AgilentCrossLabMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_de5059e1-cf6a-4623-8623-6991209875a4" xlink:to="loc_a_AgilentCrossLabMember_ef48a71d-c937-4c31-8202-6b27e4f02207" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_DiagnosticsAndGenomicsMember_0a158e63-1585-4ef3-b629-7ce8f86bd40e" xlink:href="a-20230131.xsd#a_DiagnosticsAndGenomicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_de5059e1-cf6a-4623-8623-6991209875a4" xlink:to="loc_a_DiagnosticsAndGenomicsMember_0a158e63-1585-4ef3-b629-7ce8f86bd40e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails" xlink:type="simple" xlink:href="a-20230131.xsd#REVENUERevenuebyEndMarketsDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails" xlink:type="extended" id="i9e4d0c275e02407cb47211c3d813d732_REVENUERevenuebyEndMarketsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5938edb4-422c-4498-a301-ac50b87070a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f46a3c5d-f6e1-46e9-818e-0f3b12d62938" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5938edb4-422c-4498-a301-ac50b87070a7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f46a3c5d-f6e1-46e9-818e-0f3b12d62938" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_934e0a00-027b-4624-8b11-b3d1e8349cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_5938edb4-422c-4498-a301-ac50b87070a7" xlink:to="loc_us-gaap_StatementTable_934e0a00-027b-4624-8b11-b3d1e8349cb6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_EndMarketsAxis_4906d3a2-40f4-4c78-a30c-f7a2c6cc8097" xlink:href="a-20230131.xsd#a_EndMarketsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_934e0a00-027b-4624-8b11-b3d1e8349cb6" xlink:to="loc_a_EndMarketsAxis_4906d3a2-40f4-4c78-a30c-f7a2c6cc8097" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_EndMarketsDomain_4906d3a2-40f4-4c78-a30c-f7a2c6cc8097_default" xlink:href="a-20230131.xsd#a_EndMarketsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_a_EndMarketsAxis_4906d3a2-40f4-4c78-a30c-f7a2c6cc8097" xlink:to="loc_a_EndMarketsDomain_4906d3a2-40f4-4c78-a30c-f7a2c6cc8097_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_EndMarketsDomain_3b5eaf55-7fbf-4d01-bb08-a9000e976ab4" xlink:href="a-20230131.xsd#a_EndMarketsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_a_EndMarketsAxis_4906d3a2-40f4-4c78-a30c-f7a2c6cc8097" xlink:to="loc_a_EndMarketsDomain_3b5eaf55-7fbf-4d01-bb08-a9000e976ab4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_PharmaceuticalandBiopharmaceuticalMarketMember_808d25bb-d94b-424b-a4e0-bbc4485a8972" xlink:href="a-20230131.xsd#a_PharmaceuticalandBiopharmaceuticalMarketMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_a_EndMarketsDomain_3b5eaf55-7fbf-4d01-bb08-a9000e976ab4" xlink:to="loc_a_PharmaceuticalandBiopharmaceuticalMarketMember_808d25bb-d94b-424b-a4e0-bbc4485a8972" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ChemicalandEnergyMarketMember_ae8cbd86-ae44-45d7-8084-4026e1705113" xlink:href="a-20230131.xsd#a_ChemicalandEnergyMarketMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_a_EndMarketsDomain_3b5eaf55-7fbf-4d01-bb08-a9000e976ab4" xlink:to="loc_a_ChemicalandEnergyMarketMember_ae8cbd86-ae44-45d7-8084-4026e1705113" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_DiagnosticsandClinicalMarketMember_ca3037be-5cc9-46c5-b929-1b2f7cc71dee" xlink:href="a-20230131.xsd#a_DiagnosticsandClinicalMarketMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_a_EndMarketsDomain_3b5eaf55-7fbf-4d01-bb08-a9000e976ab4" xlink:to="loc_a_DiagnosticsandClinicalMarketMember_ca3037be-5cc9-46c5-b929-1b2f7cc71dee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_FoodMarketMember_bf256447-e979-47c8-a324-e7045520ca1c" xlink:href="a-20230131.xsd#a_FoodMarketMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_a_EndMarketsDomain_3b5eaf55-7fbf-4d01-bb08-a9000e976ab4" xlink:to="loc_a_FoodMarketMember_bf256447-e979-47c8-a324-e7045520ca1c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AcademiaandGovernmentMarketMember_f65eecde-36b7-4838-a806-b6f1c5b2d93b" xlink:href="a-20230131.xsd#a_AcademiaandGovernmentMarketMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_a_EndMarketsDomain_3b5eaf55-7fbf-4d01-bb08-a9000e976ab4" xlink:to="loc_a_AcademiaandGovernmentMarketMember_f65eecde-36b7-4838-a806-b6f1c5b2d93b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_EnvironmentalandForensicsMarketMember_11edafa2-190d-440c-aa04-649098ac5ef9" xlink:href="a-20230131.xsd#a_EnvironmentalandForensicsMarketMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_a_EndMarketsDomain_3b5eaf55-7fbf-4d01-bb08-a9000e976ab4" xlink:to="loc_a_EnvironmentalandForensicsMarketMember_11edafa2-190d-440c-aa04-649098ac5ef9" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/REVENUERevenuebyTypeDetails" xlink:type="simple" xlink:href="a-20230131.xsd#REVENUERevenuebyTypeDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/REVENUERevenuebyTypeDetails" xlink:type="extended" id="iabd86fb5d3ae4c488af1b885af28c1b0_REVENUERevenuebyTypeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7ccb66c3-b955-43f4-bf64-485f709ef6df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6a9c5787-a3a5-4eb5-a2c7-f0e18de29d19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7ccb66c3-b955-43f4-bf64-485f709ef6df" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6a9c5787-a3a5-4eb5-a2c7-f0e18de29d19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_40bdb16d-77d9-4378-ad5f-7475001122ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_7ccb66c3-b955-43f4-bf64-485f709ef6df" xlink:to="loc_us-gaap_StatementTable_40bdb16d-77d9-4378-ad5f-7475001122ff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_20c58009-3a44-4981-99c7-679fc24fa8bc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_40bdb16d-77d9-4378-ad5f-7475001122ff" xlink:to="loc_srt_ProductOrServiceAxis_20c58009-3a44-4981-99c7-679fc24fa8bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_20c58009-3a44-4981-99c7-679fc24fa8bc_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_20c58009-3a44-4981-99c7-679fc24fa8bc" xlink:to="loc_srt_ProductsAndServicesDomain_20c58009-3a44-4981-99c7-679fc24fa8bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_496a2a82-9934-4eaf-9704-c28c862675a2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_20c58009-3a44-4981-99c7-679fc24fa8bc" xlink:to="loc_srt_ProductsAndServicesDomain_496a2a82-9934-4eaf-9704-c28c862675a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_InstrumentationMember_428276fc-c9c4-4d08-9494-e25522d7edf0" xlink:href="a-20230131.xsd#a_InstrumentationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_496a2a82-9934-4eaf-9704-c28c862675a2" xlink:to="loc_a_InstrumentationMember_428276fc-c9c4-4d08-9494-e25522d7edf0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_NonInstrumentationandOtherMember_cf54daf0-9ced-4e11-a337-fa08443fd733" xlink:href="a-20230131.xsd#a_NonInstrumentationandOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_496a2a82-9934-4eaf-9704-c28c862675a2" xlink:to="loc_a_NonInstrumentationandOtherMember_cf54daf0-9ced-4e11-a337-fa08443fd733" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="a-20230131.xsd#REVENUERemainingPerformanceObligationDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails" xlink:type="extended" id="i55419e5402384256bde5fb80bd30f141_REVENUERemainingPerformanceObligationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e21897eb-90fe-4de8-8d95-a3690c7aa41a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_46977595-cca5-451d-8576-c75f92ce985f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e21897eb-90fe-4de8-8d95-a3690c7aa41a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_46977595-cca5-451d-8576-c75f92ce985f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_6491d675-524f-4502-aa50-5c0e75e15266" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e21897eb-90fe-4de8-8d95-a3690c7aa41a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_6491d675-524f-4502-aa50-5c0e75e15266" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_404dad8c-12aa-43d6-9831-531e5a327d18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e21897eb-90fe-4de8-8d95-a3690c7aa41a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_404dad8c-12aa-43d6-9831-531e5a327d18" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_7563af58-7349-4f37-851f-bf3c16aae417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_404dad8c-12aa-43d6-9831-531e5a327d18" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_7563af58-7349-4f37-851f-bf3c16aae417" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails_1" xlink:type="simple" xlink:href="a-20230131.xsd#REVENUERemainingPerformanceObligationDetails_1"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails_1" xlink:type="extended" id="ic59b90672a2e4bd987094c2c6794ccb1_REVENUERemainingPerformanceObligationDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e21897eb-90fe-4de8-8d95-a3690c7aa41a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_46977595-cca5-451d-8576-c75f92ce985f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e21897eb-90fe-4de8-8d95-a3690c7aa41a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_46977595-cca5-451d-8576-c75f92ce985f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_6491d675-524f-4502-aa50-5c0e75e15266" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e21897eb-90fe-4de8-8d95-a3690c7aa41a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_6491d675-524f-4502-aa50-5c0e75e15266" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_404dad8c-12aa-43d6-9831-531e5a327d18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e21897eb-90fe-4de8-8d95-a3690c7aa41a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_404dad8c-12aa-43d6-9831-531e5a327d18" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails" xlink:type="simple" xlink:href="a-20230131.xsd#SHAREBASEDCOMPENSATIONTextDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails" xlink:type="extended" id="ie7e3e229f7cc4178bc410a083c38c202_SHAREBASEDCOMPENSATIONTextDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8021c203-aad5-4150-b8fb-73819eb15f5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_f76c0f75-b355-4033-b36e-e0fa696ea9f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8021c203-aad5-4150-b8fb-73819eb15f5f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_f76c0f75-b355-4033-b36e-e0fa696ea9f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_ce93b2ae-c669-47e0-a0d7-cf1f809e66a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8021c203-aad5-4150-b8fb-73819eb15f5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_ce93b2ae-c669-47e0-a0d7-cf1f809e66a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_70794e0d-d4c8-4fb3-9bc7-ac1e40449054" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8021c203-aad5-4150-b8fb-73819eb15f5f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_70794e0d-d4c8-4fb3-9bc7-ac1e40449054" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_7a3a5d47-2199-41a6-b24c-d83e6b679a48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8021c203-aad5-4150-b8fb-73819eb15f5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_7a3a5d47-2199-41a6-b24c-d83e6b679a48" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_880f5414-fa51-4eff-b2fa-c28fda48242e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8021c203-aad5-4150-b8fb-73819eb15f5f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_880f5414-fa51-4eff-b2fa-c28fda48242e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_7c8af937-5c80-4249-802b-a2ce24c4c4da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8021c203-aad5-4150-b8fb-73819eb15f5f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_7c8af937-5c80-4249-802b-a2ce24c4c4da" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a1629c5-4da8-4fb5-8fb9-d41961510e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8021c203-aad5-4150-b8fb-73819eb15f5f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a1629c5-4da8-4fb5-8fb9-d41961510e6d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a7cdfd28-615d-48be-89a8-05b4e08bdcf2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a1629c5-4da8-4fb5-8fb9-d41961510e6d" xlink:to="loc_srt_RangeAxis_a7cdfd28-615d-48be-89a8-05b4e08bdcf2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a7cdfd28-615d-48be-89a8-05b4e08bdcf2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a7cdfd28-615d-48be-89a8-05b4e08bdcf2" xlink:to="loc_srt_RangeMember_a7cdfd28-615d-48be-89a8-05b4e08bdcf2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2eec3b8c-a9ee-41a3-abb3-ae4321ce18c7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a7cdfd28-615d-48be-89a8-05b4e08bdcf2" xlink:to="loc_srt_RangeMember_2eec3b8c-a9ee-41a3-abb3-ae4321ce18c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_853213eb-a32d-4bfb-92aa-a82bedb37000" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2eec3b8c-a9ee-41a3-abb3-ae4321ce18c7" xlink:to="loc_srt_MinimumMember_853213eb-a32d-4bfb-92aa-a82bedb37000" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b69d4c24-035b-40ec-9091-7ff5250adb27" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2eec3b8c-a9ee-41a3-abb3-ae4321ce18c7" xlink:to="loc_srt_MaximumMember_b69d4c24-035b-40ec-9091-7ff5250adb27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_50287a19-a4d0-4a80-b171-014904ae4311" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a1629c5-4da8-4fb5-8fb9-d41961510e6d" xlink:to="loc_us-gaap_AwardTypeAxis_50287a19-a4d0-4a80-b171-014904ae4311" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_50287a19-a4d0-4a80-b171-014904ae4311_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_50287a19-a4d0-4a80-b171-014904ae4311" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_50287a19-a4d0-4a80-b171-014904ae4311_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_920cf9da-886c-495b-91ae-fb1183695439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_50287a19-a4d0-4a80-b171-014904ae4311" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_920cf9da-886c-495b-91ae-fb1183695439" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_ac53f19e-2a05-4e5d-93a5-be03be29116a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_920cf9da-886c-495b-91ae-fb1183695439" xlink:to="loc_us-gaap_EmployeeStockMember_ac53f19e-2a05-4e5d-93a5-be03be29116a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_79172fae-82c7-4561-8d61-d7154bfdba83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_920cf9da-886c-495b-91ae-fb1183695439" xlink:to="loc_us-gaap_EmployeeStockOptionMember_79172fae-82c7-4561-8d61-d7154bfdba83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_caede6be-c079-413f-974a-a16709a02569" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_920cf9da-886c-495b-91ae-fb1183695439" xlink:to="loc_us-gaap_PerformanceSharesMember_caede6be-c079-413f-974a-a16709a02569" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_799b2db0-8804-4b90-ad5d-9f94834eb551" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_920cf9da-886c-495b-91ae-fb1183695439" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_799b2db0-8804-4b90-ad5d-9f94834eb551" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_78405677-577a-4834-9193-f9a5d91cb340" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a1629c5-4da8-4fb5-8fb9-d41961510e6d" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_78405677-577a-4834-9193-f9a5d91cb340" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_78405677-577a-4834-9193-f9a5d91cb340_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_78405677-577a-4834-9193-f9a5d91cb340" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_78405677-577a-4834-9193-f9a5d91cb340_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c94b1e00-fe16-4b27-bce3-28b395bc56cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_78405677-577a-4834-9193-f9a5d91cb340" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c94b1e00-fe16-4b27-bce3-28b395bc56cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_4bd9ac13-6400-4faf-ae08-8fcf1a027a37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c94b1e00-fe16-4b27-bce3-28b395bc56cb" xlink:to="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_4bd9ac13-6400-4faf-ae08-8fcf1a027a37" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails" xlink:type="simple" xlink:href="a-20230131.xsd#SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails" xlink:type="extended" id="id26165cf62c0425d8d82f94c3630fdf7_SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b9dbc7cc-9a24-4b93-bc90-9f6004352670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_0a907156-5a9e-4970-b8c9-8157fb6333fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b9dbc7cc-9a24-4b93-bc90-9f6004352670" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_0a907156-5a9e-4970-b8c9-8157fb6333fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e1406b34-e790-40a8-b9c8-430999e12419" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b9dbc7cc-9a24-4b93-bc90-9f6004352670" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e1406b34-e790-40a8-b9c8-430999e12419" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_094c8276-492e-4fb8-9581-aa5a2ceb528b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e1406b34-e790-40a8-b9c8-430999e12419" xlink:to="loc_us-gaap_AwardTypeAxis_094c8276-492e-4fb8-9581-aa5a2ceb528b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_094c8276-492e-4fb8-9581-aa5a2ceb528b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_094c8276-492e-4fb8-9581-aa5a2ceb528b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_094c8276-492e-4fb8-9581-aa5a2ceb528b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6e7031ae-f454-4803-9756-d9828cd8aef8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_094c8276-492e-4fb8-9581-aa5a2ceb528b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6e7031ae-f454-4803-9756-d9828cd8aef8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_LtppMember_2bd10df8-9cb2-40e9-b2cf-9a4b69ddd0ad" xlink:href="a-20230131.xsd#a_LtppMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6e7031ae-f454-4803-9756-d9828cd8aef8" xlink:to="loc_a_LtppMember_2bd10df8-9cb2-40e9-b2cf-9a4b69ddd0ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8e36135c-d7d7-4fcf-82e6-b8b7d6ababc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e1406b34-e790-40a8-b9c8-430999e12419" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8e36135c-d7d7-4fcf-82e6-b8b7d6ababc2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8e36135c-d7d7-4fcf-82e6-b8b7d6ababc2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8e36135c-d7d7-4fcf-82e6-b8b7d6ababc2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8e36135c-d7d7-4fcf-82e6-b8b7d6ababc2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5e27d58b-153d-4115-999b-9e9db38f7aac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8e36135c-d7d7-4fcf-82e6-b8b7d6ababc2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5e27d58b-153d-4115-999b-9e9db38f7aac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_916be886-7ad3-43b9-ab45-12d52f0d3ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5e27d58b-153d-4115-999b-9e9db38f7aac" xlink:to="loc_us-gaap_CostOfSalesMember_916be886-7ad3-43b9-ab45-12d52f0d3ef9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_53c557d8-20bd-467e-a439-879bdcdb3785" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5e27d58b-153d-4115-999b-9e9db38f7aac" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_53c557d8-20bd-467e-a439-879bdcdb3785" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_0f65010c-5cc2-48d4-b73f-eea88102984a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5e27d58b-153d-4115-999b-9e9db38f7aac" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_0f65010c-5cc2-48d4-b73f-eea88102984a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_eb531f84-e02f-4173-ba5f-84d9a525fb89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e1406b34-e790-40a8-b9c8-430999e12419" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_eb531f84-e02f-4173-ba5f-84d9a525fb89" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_eb531f84-e02f-4173-ba5f-84d9a525fb89_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_eb531f84-e02f-4173-ba5f-84d9a525fb89" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_eb531f84-e02f-4173-ba5f-84d9a525fb89_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c8d9ef5a-edb1-4a92-9369-4f66f25150a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_eb531f84-e02f-4173-ba5f-84d9a525fb89" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c8d9ef5a-edb1-4a92-9369-4f66f25150a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_d4b21c85-8a4e-4a73-af97-0ddd68ab7d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c8d9ef5a-edb1-4a92-9369-4f66f25150a1" xlink:to="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_d4b21c85-8a4e-4a73-af97-0ddd68ab7d5e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails" xlink:type="simple" xlink:href="a-20230131.xsd#SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails" xlink:type="extended" id="i50159a21a5c04d11aef9948deceba2ee_SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_046349fe-2a5d-4448-8e40-5670cbfbd456" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_abbd902e-4cc3-4e4a-8108-b5a32a7adfa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_046349fe-2a5d-4448-8e40-5670cbfbd456" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_abbd902e-4cc3-4e4a-8108-b5a32a7adfa1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_bf71b8bf-aea8-4ca6-9bc2-5605e18fae48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_046349fe-2a5d-4448-8e40-5670cbfbd456" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_bf71b8bf-aea8-4ca6-9bc2-5605e18fae48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_9854d29e-fdec-4a88-bc40-3db130dbc3ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_046349fe-2a5d-4448-8e40-5670cbfbd456" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_9854d29e-fdec-4a88-bc40-3db130dbc3ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_82e1253c-222d-4d0b-ac6d-d54de48935af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_046349fe-2a5d-4448-8e40-5670cbfbd456" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_82e1253c-222d-4d0b-ac6d-d54de48935af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_099c77b2-fa2f-4f1e-8cc9-e310bedf3a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_046349fe-2a5d-4448-8e40-5670cbfbd456" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_099c77b2-fa2f-4f1e-8cc9-e310bedf3a9b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum_a6e09fda-8e8f-40c9-a3b2-b207b776ceb7" xlink:href="a-20230131.xsd#a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_046349fe-2a5d-4448-8e40-5670cbfbd456" xlink:to="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum_a6e09fda-8e8f-40c9-a3b2-b207b776ceb7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum_65c7b078-7e23-4398-a021-19d9a6579566" xlink:href="a-20230131.xsd#a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_046349fe-2a5d-4448-8e40-5670cbfbd456" xlink:to="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum_65c7b078-7e23-4398-a021-19d9a6579566" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate_fcaf5e3d-947d-478a-845c-8599212cb717" xlink:href="a-20230131.xsd#a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_046349fe-2a5d-4448-8e40-5670cbfbd456" xlink:to="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate_fcaf5e3d-947d-478a-845c-8599212cb717" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions_601b5b49-5d98-4561-8c97-3fa3485d526e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_046349fe-2a5d-4448-8e40-5670cbfbd456" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions_601b5b49-5d98-4561-8c97-3fa3485d526e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_02517ab0-d501-44f0-ada1-5953c2807176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_046349fe-2a5d-4448-8e40-5670cbfbd456" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_02517ab0-d501-44f0-ada1-5953c2807176" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6a35a075-fe83-4b15-8c5e-fcb0e795c561" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_02517ab0-d501-44f0-ada1-5953c2807176" xlink:to="loc_us-gaap_AwardTypeAxis_6a35a075-fe83-4b15-8c5e-fcb0e795c561" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6a35a075-fe83-4b15-8c5e-fcb0e795c561_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6a35a075-fe83-4b15-8c5e-fcb0e795c561" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6a35a075-fe83-4b15-8c5e-fcb0e795c561_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_75618368-f005-4624-8815-ec68c4181815" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6a35a075-fe83-4b15-8c5e-fcb0e795c561" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_75618368-f005-4624-8815-ec68c4181815" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_8f56536d-5576-42fe-8e66-0213e6309ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_75618368-f005-4624-8815-ec68c4181815" xlink:to="loc_us-gaap_EmployeeStockOptionMember_8f56536d-5576-42fe-8e66-0213e6309ed0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_LtppMember_c266e1e6-aa4b-43ec-9775-4784621731ff" xlink:href="a-20230131.xsd#a_LtppMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_75618368-f005-4624-8815-ec68c4181815" xlink:to="loc_a_LtppMember_c266e1e6-aa4b-43ec-9775-4784621731ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_LTPPRSUMember_4e35d05a-1098-446e-bc68-3659e95d32ca" xlink:href="a-20230131.xsd#a_LTPPRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_75618368-f005-4624-8815-ec68c4181815" xlink:to="loc_a_LTPPRSUMember_4e35d05a-1098-446e-bc68-3659e95d32ca" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="a-20230131.xsd#INCOMETAXESDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/INCOMETAXESDetails" xlink:type="extended" id="iada5d06a15bb404cb57fb6b8dec0d2ac_INCOMETAXESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems_1da36a4b-0609-4532-9daa-e3a34dd22cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7199b455-64d8-48e2-b854-fd31859f2f43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_1da36a4b-0609-4532-9daa-e3a34dd22cf8" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7199b455-64d8-48e2-b854-fd31859f2f43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5ed34251-b3a2-4d5c-87b3-7481fc133a30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_1da36a4b-0609-4532-9daa-e3a34dd22cf8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5ed34251-b3a2-4d5c-87b3-7481fc133a30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_e18c9cf8-f9a5-4f0f-b73a-964df1cce259" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_1da36a4b-0609-4532-9daa-e3a34dd22cf8" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_e18c9cf8-f9a5-4f0f-b73a-964df1cce259" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherTaxExpenseBenefit_8412d9ff-8c08-4ad5-bb95-a3b6dc2dcd2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_1da36a4b-0609-4532-9daa-e3a34dd22cf8" xlink:to="loc_us-gaap_OtherTaxExpenseBenefit_8412d9ff-8c08-4ad5-bb95-a3b6dc2dcd2a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_48f2f794-8bb0-4259-bee2-9dfe5dac605b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_1da36a4b-0609-4532-9daa-e3a34dd22cf8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_48f2f794-8bb0-4259-bee2-9dfe5dac605b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_6fcda9c2-9b28-428e-9e9f-60d18dd2e97d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_1da36a4b-0609-4532-9daa-e3a34dd22cf8" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_6fcda9c2-9b28-428e-9e9f-60d18dd2e97d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_a3d03c55-82c9-4f73-b8d7-3909762c6a71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_1da36a4b-0609-4532-9daa-e3a34dd22cf8" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_a3d03c55-82c9-4f73-b8d7-3909762c6a71" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable_01d99ca7-6396-4d95-a235-04b9400feb0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_1da36a4b-0609-4532-9daa-e3a34dd22cf8" xlink:to="loc_us-gaap_IncomeTaxExaminationTable_01d99ca7-6396-4d95-a235-04b9400feb0b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_4f621c3b-5ca3-4bb6-90b7-1ebfab6d0494" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_01d99ca7-6396-4d95-a235-04b9400feb0b" xlink:to="loc_srt_StatementScenarioAxis_4f621c3b-5ca3-4bb6-90b7-1ebfab6d0494" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_4f621c3b-5ca3-4bb6-90b7-1ebfab6d0494_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_4f621c3b-5ca3-4bb6-90b7-1ebfab6d0494" xlink:to="loc_srt_ScenarioUnspecifiedDomain_4f621c3b-5ca3-4bb6-90b7-1ebfab6d0494_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_46c83bfa-d841-4517-94d4-6d27d893b9de" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_4f621c3b-5ca3-4bb6-90b7-1ebfab6d0494" xlink:to="loc_srt_ScenarioUnspecifiedDomain_46c83bfa-d841-4517-94d4-6d27d893b9de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_d0643152-2692-45f0-ba4c-8bcdb023aa40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_01d99ca7-6396-4d95-a235-04b9400feb0b" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_d0643152-2692-45f0-ba4c-8bcdb023aa40" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_d0643152-2692-45f0-ba4c-8bcdb023aa40_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_d0643152-2692-45f0-ba4c-8bcdb023aa40" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_d0643152-2692-45f0-ba4c-8bcdb023aa40_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_ae37ba08-df0a-403f-b4e5-1f170e6d0a58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_d0643152-2692-45f0-ba4c-8bcdb023aa40" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_ae37ba08-df0a-403f-b4e5-1f170e6d0a58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_71cad536-e10c-42e7-88a7-dde8967181d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_01d99ca7-6396-4d95-a235-04b9400feb0b" xlink:to="loc_us-gaap_TaxPeriodAxis_71cad536-e10c-42e7-88a7-dde8967181d5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_71cad536-e10c-42e7-88a7-dde8967181d5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_71cad536-e10c-42e7-88a7-dde8967181d5" xlink:to="loc_us-gaap_TaxPeriodDomain_71cad536-e10c-42e7-88a7-dde8967181d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_0e05e3c9-6bb2-41d0-9c4f-90aa0fd3984f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_71cad536-e10c-42e7-88a7-dde8967181d5" xlink:to="loc_us-gaap_TaxPeriodDomain_0e05e3c9-6bb2-41d0-9c4f-90aa0fd3984f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_8173f530-9ae2-40ee-b76c-ef829c007940" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_01d99ca7-6396-4d95-a235-04b9400feb0b" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_8173f530-9ae2-40ee-b76c-ef829c007940" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_8173f530-9ae2-40ee-b76c-ef829c007940_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_8173f530-9ae2-40ee-b76c-ef829c007940" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_8173f530-9ae2-40ee-b76c-ef829c007940_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_f24fbc46-a40a-4c8a-b7f7-5b7dae5e70a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_8173f530-9ae2-40ee-b76c-ef829c007940" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_f24fbc46-a40a-4c8a-b7f7-5b7dae5e70a5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/NETINCOMEPERSHAREDetails" xlink:type="simple" xlink:href="a-20230131.xsd#NETINCOMEPERSHAREDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/NETINCOMEPERSHAREDetails" xlink:type="extended" id="i91c0d139419d487f9dedfaef4470be13_NETINCOMEPERSHAREDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_63fccf48-bfa9-4495-88b1-c4bcc5aed476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_NumeratorAbstract_3c42b501-8624-454a-8378-d56cc80b0a27" xlink:href="a-20230131.xsd#a_NumeratorAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_63fccf48-bfa9-4495-88b1-c4bcc5aed476" xlink:to="loc_a_NumeratorAbstract_3c42b501-8624-454a-8378-d56cc80b0a27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_54d61497-bf18-44cd-99dc-511b00976808" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_a_NumeratorAbstract_3c42b501-8624-454a-8378-d56cc80b0a27" xlink:to="loc_us-gaap_NetIncomeLoss_54d61497-bf18-44cd-99dc-511b00976808" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_DenominatorsAbstract_f4d1e79b-380e-48be-b91b-efee56ca70a8" xlink:href="a-20230131.xsd#a_DenominatorsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_63fccf48-bfa9-4495-88b1-c4bcc5aed476" xlink:to="loc_a_DenominatorsAbstract_f4d1e79b-380e-48be-b91b-efee56ca70a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e4059ca6-3c93-4385-996d-5fe189d90bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_a_DenominatorsAbstract_f4d1e79b-380e-48be-b91b-efee56ca70a8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e4059ca6-3c93-4385-996d-5fe189d90bdc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_af154a44-bdf3-4277-9f46-1dcf08a5a983" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_a_DenominatorsAbstract_f4d1e79b-380e-48be-b91b-efee56ca70a8" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_af154a44-bdf3-4277-9f46-1dcf08a5a983" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d23e6f29-0926-4c97-b594-82afa05241a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_a_DenominatorsAbstract_f4d1e79b-380e-48be-b91b-efee56ca70a8" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d23e6f29-0926-4c97-b594-82afa05241a6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_98407524-c1fe-4287-b672-23d7e925b421" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_63fccf48-bfa9-4495-88b1-c4bcc5aed476" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_98407524-c1fe-4287-b672-23d7e925b421" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6186981f-872c-44e6-ab6c-434226a4f7bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_63fccf48-bfa9-4495-88b1-c4bcc5aed476" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6186981f-872c-44e6-ab6c-434226a4f7bd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0e7c1aa1-41c2-48d5-ab7b-43550bcb1902" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6186981f-872c-44e6-ab6c-434226a4f7bd" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0e7c1aa1-41c2-48d5-ab7b-43550bcb1902" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0e7c1aa1-41c2-48d5-ab7b-43550bcb1902_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0e7c1aa1-41c2-48d5-ab7b-43550bcb1902" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0e7c1aa1-41c2-48d5-ab7b-43550bcb1902_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ee8c9e17-70fc-41a3-8f99-7856cfe2b19b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0e7c1aa1-41c2-48d5-ab7b-43550bcb1902" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ee8c9e17-70fc-41a3-8f99-7856cfe2b19b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails" xlink:type="simple" xlink:href="a-20230131.xsd#GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails" xlink:type="extended" id="i3199cd4b38f846c4b114452f5d95859a_GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_cd33ec50-fde8-493a-9595-e8e61a15871a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_13340979-6ac7-4c8c-bafb-56df1ca966ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_cd33ec50-fde8-493a-9595-e8e61a15871a" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_13340979-6ac7-4c8c-bafb-56df1ca966ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_ccb3eaaf-01a9-4f29-91c7-a35ba56ccd2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_cd33ec50-fde8-493a-9595-e8e61a15871a" xlink:to="loc_us-gaap_GoodwillRollForward_ccb3eaaf-01a9-4f29-91c7-a35ba56ccd2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_c4a417ed-7684-4dbd-81ae-cb4beded168d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTransfers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_ccb3eaaf-01a9-4f29-91c7-a35ba56ccd2c" xlink:to="loc_us-gaap_GoodwillTransfers_c4a417ed-7684-4dbd-81ae-cb4beded168d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5e4bb75a-da80-4a72-b46c-83c2f76ea329" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_ccb3eaaf-01a9-4f29-91c7-a35ba56ccd2c" xlink:to="loc_us-gaap_Goodwill_5e4bb75a-da80-4a72-b46c-83c2f76ea329" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_09e74e34-d7db-420f-a2e4-ee2da1155834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_ccb3eaaf-01a9-4f29-91c7-a35ba56ccd2c" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_09e74e34-d7db-420f-a2e4-ee2da1155834" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_ef4ab1bf-bf8e-4585-9bd9-540c9484e8c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_ccb3eaaf-01a9-4f29-91c7-a35ba56ccd2c" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_ef4ab1bf-bf8e-4585-9bd9-540c9484e8c8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b7f3641a-9054-469a-a38a-4a4951384bfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_93bca2d8-5489-47db-b8f1-a5310c59bab9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_cd33ec50-fde8-493a-9595-e8e61a15871a" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_93bca2d8-5489-47db-b8f1-a5310c59bab9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b3ce5177-44cd-483e-9b09-d9f49140c050" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_93bca2d8-5489-47db-b8f1-a5310c59bab9" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b3ce5177-44cd-483e-9b09-d9f49140c050" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b3ce5177-44cd-483e-9b09-d9f49140c050_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b3ce5177-44cd-483e-9b09-d9f49140c050" xlink:to="loc_us-gaap_SegmentDomain_b3ce5177-44cd-483e-9b09-d9f49140c050_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_150fe108-06e9-467f-bdda-9cc4a6615fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b3ce5177-44cd-483e-9b09-d9f49140c050" xlink:to="loc_us-gaap_SegmentDomain_150fe108-06e9-467f-bdda-9cc4a6615fa6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_LifeSciencesandAppliedMarketsMember_c738d04e-9b24-4713-b84b-0b83a0085de2" xlink:href="a-20230131.xsd#a_LifeSciencesandAppliedMarketsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_150fe108-06e9-467f-bdda-9cc4a6615fa6" xlink:to="loc_a_LifeSciencesandAppliedMarketsMember_c738d04e-9b24-4713-b84b-0b83a0085de2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_DiagnosticsAndGenomicsMember_63193f3e-9289-40df-a364-1deaec484894" xlink:href="a-20230131.xsd#a_DiagnosticsAndGenomicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_150fe108-06e9-467f-bdda-9cc4a6615fa6" xlink:to="loc_a_DiagnosticsAndGenomicsMember_63193f3e-9289-40df-a364-1deaec484894" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AgilentCrossLabMember_3b11f172-9c41-4484-aa27-f12d7e1e79f4" xlink:href="a-20230131.xsd#a_AgilentCrossLabMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_150fe108-06e9-467f-bdda-9cc4a6615fa6" xlink:to="loc_a_AgilentCrossLabMember_3b11f172-9c41-4484-aa27-f12d7e1e79f4" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails" xlink:type="simple" xlink:href="a-20230131.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails" xlink:type="extended" id="id3b7f6b3f7144eb5bf00aeaa15f27c48_GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a7e2cec9-d864-4825-8980-5d843f83f1b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_e55bdb1d-6690-4460-a716-2ffb21ea3cea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a7e2cec9-d864-4825-8980-5d843f83f1b1" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_e55bdb1d-6690-4460-a716-2ffb21ea3cea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_9cf5398e-1ab1-457a-8599-14f93aed136d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a7e2cec9-d864-4825-8980-5d843f83f1b1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_9cf5398e-1ab1-457a-8599-14f93aed136d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d15192cc-1f2c-4b90-838e-c2ae6b9fc4e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_9cf5398e-1ab1-457a-8599-14f93aed136d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d15192cc-1f2c-4b90-838e-c2ae6b9fc4e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_b39b72d4-cb66-4f4f-8887-c039835748ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_9cf5398e-1ab1-457a-8599-14f93aed136d" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_b39b72d4-cb66-4f4f-8887-c039835748ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c32a9aea-7854-443f-a507-4dae04fb5464" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_9cf5398e-1ab1-457a-8599-14f93aed136d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c32a9aea-7854-443f-a507-4dae04fb5464" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_85f820ef-202a-411a-876e-8027ebd4b90f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_9cf5398e-1ab1-457a-8599-14f93aed136d" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_85f820ef-202a-411a-876e-8027ebd4b90f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f4d90abb-919d-410b-81f1-dc21c8912273" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_9cf5398e-1ab1-457a-8599-14f93aed136d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f4d90abb-919d-410b-81f1-dc21c8912273" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_bb14d1d2-0e26-48b4-82a8-1fd8d63f4717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a7e2cec9-d864-4825-8980-5d843f83f1b1" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_bb14d1d2-0e26-48b4-82a8-1fd8d63f4717" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_e9904a3a-451c-4911-9414-e24c1cabca0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_bb14d1d2-0e26-48b4-82a8-1fd8d63f4717" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_e9904a3a-451c-4911-9414-e24c1cabca0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a1184269-23a7-4958-ad30-4442088de7c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a7e2cec9-d864-4825-8980-5d843f83f1b1" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a1184269-23a7-4958-ad30-4442088de7c5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e586da5d-f8ae-4a43-9374-3899adf6f948" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a1184269-23a7-4958-ad30-4442088de7c5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e586da5d-f8ae-4a43-9374-3899adf6f948" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e586da5d-f8ae-4a43-9374-3899adf6f948_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e586da5d-f8ae-4a43-9374-3899adf6f948" xlink:to="loc_us-gaap_SegmentDomain_e586da5d-f8ae-4a43-9374-3899adf6f948_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_738fe835-91a7-4cc6-8658-009ec475c66b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e586da5d-f8ae-4a43-9374-3899adf6f948" xlink:to="loc_us-gaap_SegmentDomain_738fe835-91a7-4cc6-8658-009ec475c66b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7988cf4f-cf49-4058-b7ff-379cf547f175" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a1184269-23a7-4958-ad30-4442088de7c5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7988cf4f-cf49-4058-b7ff-379cf547f175" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7988cf4f-cf49-4058-b7ff-379cf547f175_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7988cf4f-cf49-4058-b7ff-379cf547f175" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7988cf4f-cf49-4058-b7ff-379cf547f175_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4005404b-3b27-4d29-8b68-9c8831d88cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7988cf4f-cf49-4058-b7ff-379cf547f175" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4005404b-3b27-4d29-8b68-9c8831d88cc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_c05b3a44-3376-4c98-b908-7e91ab933b96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4005404b-3b27-4d29-8b68-9c8831d88cc7" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_c05b3a44-3376-4c98-b908-7e91ab933b96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_40a91433-54b2-49e2-972e-caa5096f3c08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4005404b-3b27-4d29-8b68-9c8831d88cc7" xlink:to="loc_us-gaap_TrademarksMember_40a91433-54b2-49e2-972e-caa5096f3c08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_f578dcb0-53b6-409c-ae05-93ff167fc79f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4005404b-3b27-4d29-8b68-9c8831d88cc7" xlink:to="loc_us-gaap_CustomerRelationshipsMember_f578dcb0-53b6-409c-ae05-93ff167fc79f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_e889a9fb-ebc6-4dd8-9bdf-38074e23885c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4005404b-3b27-4d29-8b68-9c8831d88cc7" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_e889a9fb-ebc6-4dd8-9bdf-38074e23885c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ThirdPartyTechnologyandLicensesMember_7a55b7a2-c16b-4485-85e5-ee939b1ae799" xlink:href="a-20230131.xsd#a_ThirdPartyTechnologyandLicensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4005404b-3b27-4d29-8b68-9c8831d88cc7" xlink:to="loc_a_ThirdPartyTechnologyandLicensesMember_7a55b7a2-c16b-4485-85e5-ee939b1ae799" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_1c5cf302-5d9f-4040-8691-7a14255b6e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4005404b-3b27-4d29-8b68-9c8831d88cc7" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_1c5cf302-5d9f-4040-8691-7a14255b6e4a" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails" xlink:type="simple" xlink:href="a-20230131.xsd#GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails" xlink:type="extended" id="i7aeadf7883d0434696b283562248ae2c_GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4edd8bc6-c97a-4396-86bc-268e2ba1375f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_45968a97-f4b1-46f1-b422-59a8061d058b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4edd8bc6-c97a-4396-86bc-268e2ba1375f" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_45968a97-f4b1-46f1-b422-59a8061d058b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_9b4ba8e3-5a6d-4952-be96-e78c251c36c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4edd8bc6-c97a-4396-86bc-268e2ba1375f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_9b4ba8e3-5a6d-4952-be96-e78c251c36c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_cdb4223e-326e-4185-b140-850e1dcddae8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4edd8bc6-c97a-4396-86bc-268e2ba1375f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_cdb4223e-326e-4185-b140-850e1dcddae8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_168abfc0-f720-47c3-a75e-8430ad68d9c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4edd8bc6-c97a-4396-86bc-268e2ba1375f" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_168abfc0-f720-47c3-a75e-8430ad68d9c9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_deacf6d7-d3fa-4b7d-b36a-13ff74afe0cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4edd8bc6-c97a-4396-86bc-268e2ba1375f" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_deacf6d7-d3fa-4b7d-b36a-13ff74afe0cd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_1553c0b1-3ebd-4d57-8243-b1bf3a348ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4edd8bc6-c97a-4396-86bc-268e2ba1375f" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_1553c0b1-3ebd-4d57-8243-b1bf3a348ed6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb889e99-e97e-4b7d-90f6-1fd043a5b4a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4edd8bc6-c97a-4396-86bc-268e2ba1375f" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb889e99-e97e-4b7d-90f6-1fd043a5b4a5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_46e4260d-08b2-42ed-bdf7-9cacc0afa5b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb889e99-e97e-4b7d-90f6-1fd043a5b4a5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_46e4260d-08b2-42ed-bdf7-9cacc0afa5b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_46e4260d-08b2-42ed-bdf7-9cacc0afa5b9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_46e4260d-08b2-42ed-bdf7-9cacc0afa5b9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_46e4260d-08b2-42ed-bdf7-9cacc0afa5b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b92d9f60-45da-4097-8c10-4807d46aa3a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_46e4260d-08b2-42ed-bdf7-9cacc0afa5b9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b92d9f60-45da-4097-8c10-4807d46aa3a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ResolutionBioscienceIncMember_4ba386c1-18fe-41f1-ae85-bc91a53e9733" xlink:href="a-20230131.xsd#a_ResolutionBioscienceIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b92d9f60-45da-4097-8c10-4807d46aa3a7" xlink:to="loc_a_ResolutionBioscienceIncMember_4ba386c1-18fe-41f1-ae85-bc91a53e9733" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4aae9f8a-59ac-4641-81f0-982e3711cdf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb889e99-e97e-4b7d-90f6-1fd043a5b4a5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4aae9f8a-59ac-4641-81f0-982e3711cdf7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4aae9f8a-59ac-4641-81f0-982e3711cdf7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4aae9f8a-59ac-4641-81f0-982e3711cdf7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4aae9f8a-59ac-4641-81f0-982e3711cdf7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3eaa4c90-4a5d-4980-aaa0-8d36b5fbb5f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4aae9f8a-59ac-4641-81f0-982e3711cdf7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3eaa4c90-4a5d-4980-aaa0-8d36b5fbb5f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ThirdPartyTechnologyandLicensesMember_716cabe8-f381-4e8c-9b71-e849f137a80d" xlink:href="a-20230131.xsd#a_ThirdPartyTechnologyandLicensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3eaa4c90-4a5d-4980-aaa0-8d36b5fbb5f0" xlink:to="loc_a_ThirdPartyTechnologyandLicensesMember_716cabe8-f381-4e8c-9b71-e849f137a80d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d3d406ec-4902-4cf0-9dae-f16cd97a86ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb889e99-e97e-4b7d-90f6-1fd043a5b4a5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d3d406ec-4902-4cf0-9dae-f16cd97a86ba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d3d406ec-4902-4cf0-9dae-f16cd97a86ba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d3d406ec-4902-4cf0-9dae-f16cd97a86ba" xlink:to="loc_us-gaap_SegmentDomain_d3d406ec-4902-4cf0-9dae-f16cd97a86ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_47cfebda-6579-4a34-868d-7b43b8d57e25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d3d406ec-4902-4cf0-9dae-f16cd97a86ba" xlink:to="loc_us-gaap_SegmentDomain_47cfebda-6579-4a34-868d-7b43b8d57e25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_LifeSciencesandAppliedMarketsMember_5128cf24-be0f-4943-928d-137b54df36bf" xlink:href="a-20230131.xsd#a_LifeSciencesandAppliedMarketsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_47cfebda-6579-4a34-868d-7b43b8d57e25" xlink:to="loc_a_LifeSciencesandAppliedMarketsMember_5128cf24-be0f-4943-928d-137b54df36bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_DiagnosticsAndGenomicsMember_c9b0a672-7e83-4f1a-a365-b53e8c835411" xlink:href="a-20230131.xsd#a_DiagnosticsAndGenomicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_47cfebda-6579-4a34-868d-7b43b8d57e25" xlink:to="loc_a_DiagnosticsAndGenomicsMember_c9b0a672-7e83-4f1a-a365-b53e8c835411" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AgilentCrossLabMember_6b8947d8-3ca9-4417-a4b9-a4b1cee4a14b" xlink:href="a-20230131.xsd#a_AgilentCrossLabMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_47cfebda-6579-4a34-868d-7b43b8d57e25" xlink:to="loc_a_AgilentCrossLabMember_6b8947d8-3ca9-4417-a4b9-a4b1cee4a14b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7984b533-ca51-4c4a-878b-f0e3b9a22b99" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb889e99-e97e-4b7d-90f6-1fd043a5b4a5" xlink:to="loc_srt_RangeAxis_7984b533-ca51-4c4a-878b-f0e3b9a22b99" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7984b533-ca51-4c4a-878b-f0e3b9a22b99_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7984b533-ca51-4c4a-878b-f0e3b9a22b99" xlink:to="loc_srt_RangeMember_7984b533-ca51-4c4a-878b-f0e3b9a22b99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fe8283a9-6058-4759-989f-8e9e21a957bc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7984b533-ca51-4c4a-878b-f0e3b9a22b99" xlink:to="loc_srt_RangeMember_fe8283a9-6058-4759-989f-8e9e21a957bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_124ebfe7-34e3-49a0-ba05-56c4a900b2f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb889e99-e97e-4b7d-90f6-1fd043a5b4a5" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_124ebfe7-34e3-49a0-ba05-56c4a900b2f9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_124ebfe7-34e3-49a0-ba05-56c4a900b2f9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_124ebfe7-34e3-49a0-ba05-56c4a900b2f9" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_124ebfe7-34e3-49a0-ba05-56c4a900b2f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_db70bb36-c94a-403b-98d4-789885efa0cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_124ebfe7-34e3-49a0-ba05-56c4a900b2f9" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_db70bb36-c94a-403b-98d4-789885efa0cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_7c60efbb-f769-4551-a1c7-8ca34d2f04a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_db70bb36-c94a-403b-98d4-789885efa0cf" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_7c60efbb-f769-4551-a1c7-8ca34d2f04a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_95dd621c-aeff-49ab-b7f1-dfd10cd146c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_db70bb36-c94a-403b-98d4-789885efa0cf" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_95dd621c-aeff-49ab-b7f1-dfd10cd146c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillMember_604dbebb-8f61-4a22-845f-a25037445a9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_db70bb36-c94a-403b-98d4-789885efa0cf" xlink:to="loc_us-gaap_GoodwillMember_604dbebb-8f61-4a22-845f-a25037445a9e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_84777d73-dd99-40ef-9a33-f8b7a64f9621" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_db70bb36-c94a-403b-98d4-789885efa0cf" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_84777d73-dd99-40ef-9a33-f8b7a64f9621" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6efc5bad-b172-43ef-ba49-a061c1dd0ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb889e99-e97e-4b7d-90f6-1fd043a5b4a5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6efc5bad-b172-43ef-ba49-a061c1dd0ae2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6efc5bad-b172-43ef-ba49-a061c1dd0ae2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6efc5bad-b172-43ef-ba49-a061c1dd0ae2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6efc5bad-b172-43ef-ba49-a061c1dd0ae2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_339449c9-a4ce-4e2f-8f98-14cae2004217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6efc5bad-b172-43ef-ba49-a061c1dd0ae2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_339449c9-a4ce-4e2f-8f98-14cae2004217" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1884754d-cb32-4316-ba21-a24e70961e99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_339449c9-a4ce-4e2f-8f98-14cae2004217" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1884754d-cb32-4316-ba21-a24e70961e99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1a71ceb7-9320-4e00-b962-e418a7a8f1c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb889e99-e97e-4b7d-90f6-1fd043a5b4a5" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1a71ceb7-9320-4e00-b962-e418a7a8f1c8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_1a71ceb7-9320-4e00-b962-e418a7a8f1c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1a71ceb7-9320-4e00-b962-e418a7a8f1c8" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_1a71ceb7-9320-4e00-b962-e418a7a8f1c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_07d6ec15-2f01-4430-8402-7b06f47b0e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1a71ceb7-9320-4e00-b962-e418a7a8f1c8" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_07d6ec15-2f01-4430-8402-7b06f47b0e7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_5179e080-92f7-4c08-83c3-8653e19a7ae3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_07d6ec15-2f01-4430-8402-7b06f47b0e7c" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_5179e080-92f7-4c08-83c3-8653e19a7ae3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails" xlink:type="simple" xlink:href="a-20230131.xsd#FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails" xlink:type="extended" id="ia90ac8ab14be424c9e30ec8b31a1fe00_FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_bc517c9c-94a3-421e-b52b-77b7cdb1b690" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_d050d45f-ea86-4684-98d7-829004c34856" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_bc517c9c-94a3-421e-b52b-77b7cdb1b690" xlink:to="loc_us-gaap_AssetsCurrentAbstract_d050d45f-ea86-4684-98d7-829004c34856" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_5eb4eb20-83ac-48cd-8f2e-c058cdc915a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d050d45f-ea86-4684-98d7-829004c34856" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_5eb4eb20-83ac-48cd-8f2e-c058cdc915a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_0383bd87-29c3-4b86-ab44-3bda65fd0cab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d050d45f-ea86-4684-98d7-829004c34856" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_0383bd87-29c3-4b86-ab44-3bda65fd0cab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_09351d1f-3d7d-485b-bc2b-59db5c3b7dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d050d45f-ea86-4684-98d7-829004c34856" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_09351d1f-3d7d-485b-bc2b-59db5c3b7dc0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_839c9a01-b33e-4a5e-b59b-18ac1b8efac4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d050d45f-ea86-4684-98d7-829004c34856" xlink:to="loc_us-gaap_TradingSecurities_839c9a01-b33e-4a5e-b59b-18ac1b8efac4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_9e6e4e7f-f8ef-4115-ad72-01ab908e0a13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d050d45f-ea86-4684-98d7-829004c34856" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_9e6e4e7f-f8ef-4115-ad72-01ab908e0a13" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_ecc75e7c-a511-47f5-8fa5-6844878e92cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d050d45f-ea86-4684-98d7-829004c34856" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_ecc75e7c-a511-47f5-8fa5-6844878e92cd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_4b665f80-50fd-4e43-b0e8-57d68f1312b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_bc517c9c-94a3-421e-b52b-77b7cdb1b690" xlink:to="loc_us-gaap_LiabilitiesAbstract_4b665f80-50fd-4e43-b0e8-57d68f1312b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_e9ff949f-ff94-4c92-968b-d646d7fb4bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_4b665f80-50fd-4e43-b0e8-57d68f1312b0" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_e9ff949f-ff94-4c92-968b-d646d7fb4bbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_efac87b3-07c5-4de5-984c-a32b9c918fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_4b665f80-50fd-4e43-b0e8-57d68f1312b0" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_efac87b3-07c5-4de5-984c-a32b9c918fa8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_cd068813-f89c-4160-ac8a-345c983d3d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_4b665f80-50fd-4e43-b0e8-57d68f1312b0" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_cd068813-f89c-4160-ac8a-345c983d3d8f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_ff2e4982-f85d-461a-943b-1493fd43e5b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_4b665f80-50fd-4e43-b0e8-57d68f1312b0" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_ff2e4982-f85d-461a-943b-1493fd43e5b3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4f6aa856-3829-4c82-ae05-d6e04db9c8ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_bc517c9c-94a3-421e-b52b-77b7cdb1b690" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4f6aa856-3829-4c82-ae05-d6e04db9c8ed" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_01d19258-fe62-42a5-8aad-33e999759ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4f6aa856-3829-4c82-ae05-d6e04db9c8ed" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_01d19258-fe62-42a5-8aad-33e999759ee0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_01d19258-fe62-42a5-8aad-33e999759ee0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_01d19258-fe62-42a5-8aad-33e999759ee0" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_01d19258-fe62-42a5-8aad-33e999759ee0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_7af6a877-cfa7-4c25-9d64-23c1716850bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_01d19258-fe62-42a5-8aad-33e999759ee0" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_7af6a877-cfa7-4c25-9d64-23c1716850bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_be578c9a-a50b-481c-b72b-daf4e42c4609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_7af6a877-cfa7-4c25-9d64-23c1716850bb" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_be578c9a-a50b-481c-b72b-daf4e42c4609" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_c0c2b6bb-d846-4f47-968e-083415bf9210" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_7af6a877-cfa7-4c25-9d64-23c1716850bb" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_c0c2b6bb-d846-4f47-968e-083415bf9210" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2301a47b-d155-4765-8b75-497cd0ea1588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4f6aa856-3829-4c82-ae05-d6e04db9c8ed" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2301a47b-d155-4765-8b75-497cd0ea1588" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2301a47b-d155-4765-8b75-497cd0ea1588_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2301a47b-d155-4765-8b75-497cd0ea1588" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2301a47b-d155-4765-8b75-497cd0ea1588_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_72a09061-85c9-43d6-bbb2-e3a042b07fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2301a47b-d155-4765-8b75-497cd0ea1588" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_72a09061-85c9-43d6-bbb2-e3a042b07fcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_149577f2-f734-4372-929c-6e8620994d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_72a09061-85c9-43d6-bbb2-e3a042b07fcd" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_149577f2-f734-4372-929c-6e8620994d8a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_b617ac3d-850f-4028-8e76-fbd55e645c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_72a09061-85c9-43d6-bbb2-e3a042b07fcd" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_b617ac3d-850f-4028-8e76-fbd55e645c7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_9aa09973-9613-4f82-a4c3-73d7ad2ee0ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_72a09061-85c9-43d6-bbb2-e3a042b07fcd" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_9aa09973-9613-4f82-a4c3-73d7ad2ee0ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_b64172b0-5480-49af-a954-e4d96b38c019" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4f6aa856-3829-4c82-ae05-d6e04db9c8ed" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_b64172b0-5480-49af-a954-e4d96b38c019" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b64172b0-5480-49af-a954-e4d96b38c019_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b64172b0-5480-49af-a954-e4d96b38c019" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b64172b0-5480-49af-a954-e4d96b38c019_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_640ac2ce-1a5b-4f6e-b3ec-11d330da7eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b64172b0-5480-49af-a954-e4d96b38c019" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_640ac2ce-1a5b-4f6e-b3ec-11d330da7eb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_32bd2bbf-6ba6-424a-937a-efe8c47b1bd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_640ac2ce-1a5b-4f6e-b3ec-11d330da7eb0" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_32bd2bbf-6ba6-424a-937a-efe8c47b1bd9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_32266d61-c894-427f-83ba-fe42855bc9df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_640ac2ce-1a5b-4f6e-b3ec-11d330da7eb0" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_32266d61-c894-427f-83ba-fe42855bc9df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_2a68a538-bf5b-4988-9884-ec5f4b92719c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_640ac2ce-1a5b-4f6e-b3ec-11d330da7eb0" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_2a68a538-bf5b-4988-9884-ec5f4b92719c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_e0083339-3375-49fd-9e11-7ea11a79d6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_640ac2ce-1a5b-4f6e-b3ec-11d330da7eb0" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_e0083339-3375-49fd-9e11-7ea11a79d6d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3182e62a-c320-4fa0-a795-1fde7694fd12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4f6aa856-3829-4c82-ae05-d6e04db9c8ed" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3182e62a-c320-4fa0-a795-1fde7694fd12" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3182e62a-c320-4fa0-a795-1fde7694fd12_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3182e62a-c320-4fa0-a795-1fde7694fd12" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3182e62a-c320-4fa0-a795-1fde7694fd12_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_64f07390-0233-4d06-a0fd-62ea952d47da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3182e62a-c320-4fa0-a795-1fde7694fd12" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_64f07390-0233-4d06-a0fd-62ea952d47da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ResolutionBioscienceIncMember_0524fbf1-8fb4-4ec0-9005-cb3fef2069d3" xlink:href="a-20230131.xsd#a_ResolutionBioscienceIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_64f07390-0233-4d06-a0fd-62ea952d47da" xlink:to="loc_a_ResolutionBioscienceIncMember_0524fbf1-8fb4-4ec0-9005-cb3fef2069d3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails" xlink:type="simple" xlink:href="a-20230131.xsd#FAIRVALUEMEASUREMENTSContingentConsiderationDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails" xlink:type="extended" id="i6527942404674ba68cecd555fba4f34e_FAIRVALUEMEASUREMENTSContingentConsiderationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_fa98bc74-d87f-45bf-96c1-5d622c70a802" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_BusinessCombinationContingentConsiderationFairValueMeasurementInput_e637f1f0-7c0b-4197-8069-1c87ef071173" xlink:href="a-20230131.xsd#a_BusinessCombinationContingentConsiderationFairValueMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_fa98bc74-d87f-45bf-96c1-5d622c70a802" xlink:to="loc_a_BusinessCombinationContingentConsiderationFairValueMeasurementInput_e637f1f0-7c0b-4197-8069-1c87ef071173" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2b25fa80-784c-4192-8482-328eb4297223" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_fa98bc74-d87f-45bf-96c1-5d622c70a802" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2b25fa80-784c-4192-8482-328eb4297223" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_BusinessCombinationsContingentConsiderationArrangements_6d18870e-7691-4c02-8baa-0d189122be50" xlink:href="a-20230131.xsd#a_BusinessCombinationsContingentConsiderationArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_fa98bc74-d87f-45bf-96c1-5d622c70a802" xlink:to="loc_a_BusinessCombinationsContingentConsiderationArrangements_6d18870e-7691-4c02-8baa-0d189122be50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_44a2e2b8-748c-4500-903c-1b45c3205630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_fa98bc74-d87f-45bf-96c1-5d622c70a802" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_44a2e2b8-748c-4500-903c-1b45c3205630" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_ca34b7c4-81be-4ba8-bdca-1fe3c897a585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_fa98bc74-d87f-45bf-96c1-5d622c70a802" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_ca34b7c4-81be-4ba8-bdca-1fe3c897a585" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_4a0307e5-8784-450c-8c0c-2660dcdf7cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_fa98bc74-d87f-45bf-96c1-5d622c70a802" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_4a0307e5-8784-450c-8c0c-2660dcdf7cc6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_61e8e4e3-ae98-447c-9b16-2371bc2edde0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_4a0307e5-8784-450c-8c0c-2660dcdf7cc6" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_61e8e4e3-ae98-447c-9b16-2371bc2edde0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_61e8e4e3-ae98-447c-9b16-2371bc2edde0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_61e8e4e3-ae98-447c-9b16-2371bc2edde0" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_61e8e4e3-ae98-447c-9b16-2371bc2edde0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_430de3f0-13d2-438b-8883-7b57d1a9fc25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_61e8e4e3-ae98-447c-9b16-2371bc2edde0" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_430de3f0-13d2-438b-8883-7b57d1a9fc25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_MeasurementInputAssetVolatilityMember_4745b25d-d6ce-46cf-99db-0d7dfa4e3e57" xlink:href="a-20230131.xsd#a_MeasurementInputAssetVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_430de3f0-13d2-438b-8883-7b57d1a9fc25" xlink:to="loc_a_MeasurementInputAssetVolatilityMember_4745b25d-d6ce-46cf-99db-0d7dfa4e3e57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_MeasurementInputRevenueVolatilityMember_d410f783-c194-4ed1-a6b4-a79cb30e865d" xlink:href="a-20230131.xsd#a_MeasurementInputRevenueVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_430de3f0-13d2-438b-8883-7b57d1a9fc25" xlink:to="loc_a_MeasurementInputRevenueVolatilityMember_d410f783-c194-4ed1-a6b4-a79cb30e865d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a0cd06ec-2728-4463-9406-dcf5422a4a59" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_4a0307e5-8784-450c-8c0c-2660dcdf7cc6" xlink:to="loc_srt_RangeAxis_a0cd06ec-2728-4463-9406-dcf5422a4a59" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a0cd06ec-2728-4463-9406-dcf5422a4a59_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a0cd06ec-2728-4463-9406-dcf5422a4a59" xlink:to="loc_srt_RangeMember_a0cd06ec-2728-4463-9406-dcf5422a4a59_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fe19d175-92db-4408-b06e-f81695ffa0f0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a0cd06ec-2728-4463-9406-dcf5422a4a59" xlink:to="loc_srt_RangeMember_fe19d175-92db-4408-b06e-f81695ffa0f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8597322a-5dfe-420b-91aa-795d8f43a1ee" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fe19d175-92db-4408-b06e-f81695ffa0f0" xlink:to="loc_srt_MinimumMember_8597322a-5dfe-420b-91aa-795d8f43a1ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f3a8d9af-4f8d-409b-8569-6fd87dde64c9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fe19d175-92db-4408-b06e-f81695ffa0f0" xlink:to="loc_srt_MaximumMember_f3a8d9af-4f8d-409b-8569-6fd87dde64c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_85ea2f47-64aa-436a-b921-8b429f7fd83e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_4a0307e5-8784-450c-8c0c-2660dcdf7cc6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_85ea2f47-64aa-436a-b921-8b429f7fd83e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_85ea2f47-64aa-436a-b921-8b429f7fd83e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_85ea2f47-64aa-436a-b921-8b429f7fd83e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_85ea2f47-64aa-436a-b921-8b429f7fd83e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e20ef69d-d3fe-45e9-af39-97bef66beb71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_85ea2f47-64aa-436a-b921-8b429f7fd83e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e20ef69d-d3fe-45e9-af39-97bef66beb71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ResolutionBioscienceIncMember_247b6778-caa3-4462-a598-b3bb98d9dd5d" xlink:href="a-20230131.xsd#a_ResolutionBioscienceIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e20ef69d-d3fe-45e9-af39-97bef66beb71" xlink:to="loc_a_ResolutionBioscienceIncMember_247b6778-caa3-4462-a598-b3bb98d9dd5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8bc2d897-6bcd-4f71-8f79-ace25817129d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_4a0307e5-8784-450c-8c0c-2660dcdf7cc6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8bc2d897-6bcd-4f71-8f79-ace25817129d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8bc2d897-6bcd-4f71-8f79-ace25817129d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8bc2d897-6bcd-4f71-8f79-ace25817129d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8bc2d897-6bcd-4f71-8f79-ace25817129d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_44b1df12-684c-4bfd-8f02-afad67058a47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8bc2d897-6bcd-4f71-8f79-ace25817129d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_44b1df12-684c-4bfd-8f02-afad67058a47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_32631c88-2856-4948-8777-2029a7471df9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_44b1df12-684c-4bfd-8f02-afad67058a47" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_32631c88-2856-4948-8777-2029a7471df9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_347463e7-ada7-428c-a717-630aea5f4da5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_4a0307e5-8784-450c-8c0c-2660dcdf7cc6" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_347463e7-ada7-428c-a717-630aea5f4da5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_347463e7-ada7-428c-a717-630aea5f4da5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_347463e7-ada7-428c-a717-630aea5f4da5" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_347463e7-ada7-428c-a717-630aea5f4da5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_58ed73d7-079c-4874-83c5-4a26fe840eae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_347463e7-ada7-428c-a717-630aea5f4da5" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_58ed73d7-079c-4874-83c5-4a26fe840eae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_622b3470-5fd2-4c05-8709-5016df99fb0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_58ed73d7-079c-4874-83c5-4a26fe840eae" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_622b3470-5fd2-4c05-8709-5016df99fb0e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis_74afc693-cd17-4254-9e54-d496da0d8809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_4a0307e5-8784-450c-8c0c-2660dcdf7cc6" xlink:to="loc_us-gaap_OtherCommitmentsAxis_74afc693-cd17-4254-9e54-d496da0d8809" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_74afc693-cd17-4254-9e54-d496da0d8809_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherCommitmentsAxis_74afc693-cd17-4254-9e54-d496da0d8809" xlink:to="loc_us-gaap_OtherCommitmentsDomain_74afc693-cd17-4254-9e54-d496da0d8809_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_ad47f341-8c53-46a1-bda8-b1bef40a76e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherCommitmentsAxis_74afc693-cd17-4254-9e54-d496da0d8809" xlink:to="loc_us-gaap_OtherCommitmentsDomain_ad47f341-8c53-46a1-bda8-b1bef40a76e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_RevenueComponentMember_d4b9470a-49bf-4490-a865-be5892acf28e" xlink:href="a-20230131.xsd#a_RevenueComponentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_ad47f341-8c53-46a1-bda8-b1bef40a76e1" xlink:to="loc_a_RevenueComponentMember_d4b9470a-49bf-4490-a865-be5892acf28e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails" xlink:type="simple" xlink:href="a-20230131.xsd#FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails" xlink:type="extended" id="id95b25a857ab4d2a8f0532f053a5030c_FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c45d9ff0-f28c-4a7d-961d-40cd7a6dbf69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AssetsLongLivedAbstract_66bd4a7c-a1bf-41dd-b289-dfdfd6650880" xlink:href="a-20230131.xsd#a_AssetsLongLivedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c45d9ff0-f28c-4a7d-961d-40cd7a6dbf69" xlink:to="loc_a_AssetsLongLivedAbstract_66bd4a7c-a1bf-41dd-b289-dfdfd6650880" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_6650caae-6634-4775-b6be-8f3cf39bf856" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_a_AssetsLongLivedAbstract_66bd4a7c-a1bf-41dd-b289-dfdfd6650880" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_6650caae-6634-4775-b6be-8f3cf39bf856" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset_1ce41ff6-314c-4cf9-9fba-fb39e2d53e75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_a_AssetsLongLivedAbstract_66bd4a7c-a1bf-41dd-b289-dfdfd6650880" xlink:to="loc_us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset_1ce41ff6-314c-4cf9-9fba-fb39e2d53e75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure_2f2b8551-546b-469b-a856-f732b23dca79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_a_AssetsLongLivedAbstract_66bd4a7c-a1bf-41dd-b289-dfdfd6650880" xlink:to="loc_us-gaap_OtherAssetsFairValueDisclosure_2f2b8551-546b-469b-a856-f732b23dca79" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_3f632ae4-c062-48b3-bd8c-160f149fd606" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_a_AssetsLongLivedAbstract_66bd4a7c-a1bf-41dd-b289-dfdfd6650880" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_3f632ae4-c062-48b3-bd8c-160f149fd606" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f1376376-2562-487e-88d2-de16fab1612c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c45d9ff0-f28c-4a7d-961d-40cd7a6dbf69" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f1376376-2562-487e-88d2-de16fab1612c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2ddfcd99-5446-4b5f-bc12-e174f1e1a2a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f1376376-2562-487e-88d2-de16fab1612c" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2ddfcd99-5446-4b5f-bc12-e174f1e1a2a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_2ddfcd99-5446-4b5f-bc12-e174f1e1a2a8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2ddfcd99-5446-4b5f-bc12-e174f1e1a2a8" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_2ddfcd99-5446-4b5f-bc12-e174f1e1a2a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_31694529-3eda-4a67-a5f2-066352807fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2ddfcd99-5446-4b5f-bc12-e174f1e1a2a8" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_31694529-3eda-4a67-a5f2-066352807fc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_ee23d01b-ac21-4bf0-af11-172c6ad1f7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_31694529-3eda-4a67-a5f2-066352807fc1" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_ee23d01b-ac21-4bf0-af11-172c6ad1f7f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_b7dbb6dd-725d-49cb-9d39-5cc238f80387" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_31694529-3eda-4a67-a5f2-066352807fc1" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_b7dbb6dd-725d-49cb-9d39-5cc238f80387" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4f5b34ba-5550-44d2-9676-3f82f24dc813" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f1376376-2562-487e-88d2-de16fab1612c" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4f5b34ba-5550-44d2-9676-3f82f24dc813" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4f5b34ba-5550-44d2-9676-3f82f24dc813_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4f5b34ba-5550-44d2-9676-3f82f24dc813" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4f5b34ba-5550-44d2-9676-3f82f24dc813_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c39dade1-5668-4aca-9dbf-d40c103aacd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4f5b34ba-5550-44d2-9676-3f82f24dc813" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c39dade1-5668-4aca-9dbf-d40c103aacd9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_a5a09f9f-6259-495a-8a11-3ac9fbd1d166" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f1376376-2562-487e-88d2-de16fab1612c" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_a5a09f9f-6259-495a-8a11-3ac9fbd1d166" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_a5a09f9f-6259-495a-8a11-3ac9fbd1d166_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_a5a09f9f-6259-495a-8a11-3ac9fbd1d166" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_a5a09f9f-6259-495a-8a11-3ac9fbd1d166_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_8d913d43-1a22-4f02-98f4-d8f6a513f538" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_a5a09f9f-6259-495a-8a11-3ac9fbd1d166" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_8d913d43-1a22-4f02-98f4-d8f6a513f538" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_MeasurementInputAssetVolatilityMember_02fb86cc-acb1-4cfd-898b-07045521df44" xlink:href="a-20230131.xsd#a_MeasurementInputAssetVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_8d913d43-1a22-4f02-98f4-d8f6a513f538" xlink:to="loc_a_MeasurementInputAssetVolatilityMember_02fb86cc-acb1-4cfd-898b-07045521df44" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_MeasurementInputRevenueVolatilityMember_c6762e6a-fc06-478b-90c6-43b0a3da634e" xlink:href="a-20230131.xsd#a_MeasurementInputRevenueVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_8d913d43-1a22-4f02-98f4-d8f6a513f538" xlink:to="loc_a_MeasurementInputRevenueVolatilityMember_c6762e6a-fc06-478b-90c6-43b0a3da634e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1b950d3a-d3b4-4557-9b44-d1e224a351db" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f1376376-2562-487e-88d2-de16fab1612c" xlink:to="loc_srt_RangeAxis_1b950d3a-d3b4-4557-9b44-d1e224a351db" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1b950d3a-d3b4-4557-9b44-d1e224a351db_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1b950d3a-d3b4-4557-9b44-d1e224a351db" xlink:to="loc_srt_RangeMember_1b950d3a-d3b4-4557-9b44-d1e224a351db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5ab44180-0057-4984-bf1f-e313e6fc941c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1b950d3a-d3b4-4557-9b44-d1e224a351db" xlink:to="loc_srt_RangeMember_5ab44180-0057-4984-bf1f-e313e6fc941c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_21a9940e-cb97-4a43-b03b-014a0851af37" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5ab44180-0057-4984-bf1f-e313e6fc941c" xlink:to="loc_srt_MinimumMember_21a9940e-cb97-4a43-b03b-014a0851af37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_beed125a-b314-47ca-9a43-334ce57736fc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5ab44180-0057-4984-bf1f-e313e6fc941c" xlink:to="loc_srt_MaximumMember_beed125a-b314-47ca-9a43-334ce57736fc" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/DERIVATIVESTextDetails" xlink:type="simple" xlink:href="a-20230131.xsd#DERIVATIVESTextDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/DERIVATIVESTextDetails" xlink:type="extended" id="if4414f70f8bc400b9a1262347bd15a9f_DERIVATIVESTextDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_2bc3e7ce-24f2-4138-a6bf-c464bba53faf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentDetailAbstract_8437287f-916e-41ee-8801-c352844ad513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentDetailAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_2bc3e7ce-24f2-4138-a6bf-c464bba53faf" xlink:to="loc_us-gaap_DerivativeInstrumentDetailAbstract_8437287f-916e-41ee-8801-c352844ad513" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue_7a48aadb-761f-4990-90b8-a4a7d98af48b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNetLiabilityPositionAggregateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_8437287f-916e-41ee-8801-c352844ad513" xlink:to="loc_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue_7a48aadb-761f-4990-90b8-a4a7d98af48b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativesAbstract_6f079fce-a2b2-4fce-ace6-77a6746edcd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateDerivativesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_8437287f-916e-41ee-8801-c352844ad513" xlink:to="loc_us-gaap_InterestRateDerivativesAbstract_6f079fce-a2b2-4fce-ace6-77a6746edcd2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_05db7c1d-d764-4f0e-a4ff-153c0445c3f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateDerivativesAbstract_6f079fce-a2b2-4fce-ace6-77a6746edcd2" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_05db7c1d-d764-4f0e-a4ff-153c0445c3f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_2ad02e3f-b50f-44a4-8854-06c1c245524f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateDerivativesAbstract_6f079fce-a2b2-4fce-ace6-77a6746edcd2" xlink:to="loc_us-gaap_DerivativeNotionalAmount_2ad02e3f-b50f-44a4-8854-06c1c245524f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_bb3b3bcd-ee58-4bad-a39b-1e0319a57eea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateDerivativesAbstract_6f079fce-a2b2-4fce-ace6-77a6746edcd2" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_bb3b3bcd-ee58-4bad-a39b-1e0319a57eea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_1f98b57c-33f7-4cbf-bb09-a02527bef59b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_8437287f-916e-41ee-8801-c352844ad513" xlink:to="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_1f98b57c-33f7-4cbf-bb09-a02527bef59b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_990e5cce-6ede-44a5-bc0b-e103f81d440e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_1f98b57c-33f7-4cbf-bb09-a02527bef59b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_990e5cce-6ede-44a5-bc0b-e103f81d440e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_6f9534f2-8634-4b14-bb5e-99a39e2c93b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_2bc3e7ce-24f2-4138-a6bf-c464bba53faf" xlink:to="loc_us-gaap_DerivativeTable_6f9534f2-8634-4b14-bb5e-99a39e2c93b6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_29f9ba18-d820-4ad7-8bd0-9dee4342799f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_6f9534f2-8634-4b14-bb5e-99a39e2c93b6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_29f9ba18-d820-4ad7-8bd0-9dee4342799f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_29f9ba18-d820-4ad7-8bd0-9dee4342799f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_29f9ba18-d820-4ad7-8bd0-9dee4342799f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_29f9ba18-d820-4ad7-8bd0-9dee4342799f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_fe285ab8-6d7a-4d71-af00-217a8c3193de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_29f9ba18-d820-4ad7-8bd0-9dee4342799f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_fe285ab8-6d7a-4d71-af00-217a8c3193de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6cb523d1-14ec-4831-82b9-4effd21a8d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_fe285ab8-6d7a-4d71-af00-217a8c3193de" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6cb523d1-14ec-4831-82b9-4effd21a8d2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cc96c3d0-12a0-40ea-8572-318b3514ce40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_6f9534f2-8634-4b14-bb5e-99a39e2c93b6" xlink:to="loc_us-gaap_DebtInstrumentAxis_cc96c3d0-12a0-40ea-8572-318b3514ce40" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cc96c3d0-12a0-40ea-8572-318b3514ce40_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_cc96c3d0-12a0-40ea-8572-318b3514ce40" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cc96c3d0-12a0-40ea-8572-318b3514ce40_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_bc38e492-13f7-46d8-89a7-afbae6e8ec39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_cc96c3d0-12a0-40ea-8572-318b3514ce40" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_bc38e492-13f7-46d8-89a7-afbae6e8ec39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2022Member_3adf72c5-3898-41e4-ab0b-21a46f26154b" xlink:href="a-20230131.xsd#a_SeniorNotes2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bc38e492-13f7-46d8-89a7-afbae6e8ec39" xlink:to="loc_a_SeniorNotes2022Member_3adf72c5-3898-41e4-ab0b-21a46f26154b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2026Member_3065ca4c-8630-4305-880b-51a6b35c45bc" xlink:href="a-20230131.xsd#a_SeniorNotes2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bc38e492-13f7-46d8-89a7-afbae6e8ec39" xlink:to="loc_a_SeniorNotes2026Member_3065ca4c-8630-4305-880b-51a6b35c45bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2029Member_8c9ea29e-0834-4fda-86a5-9ea822ddf1f6" xlink:href="a-20230131.xsd#a_SeniorNotes2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bc38e492-13f7-46d8-89a7-afbae6e8ec39" xlink:to="loc_a_SeniorNotes2029Member_8c9ea29e-0834-4fda-86a5-9ea822ddf1f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a1490b10-35fa-496e-a3b1-170ff95cf26f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_6f9534f2-8634-4b14-bb5e-99a39e2c93b6" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a1490b10-35fa-496e-a3b1-170ff95cf26f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a1490b10-35fa-496e-a3b1-170ff95cf26f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a1490b10-35fa-496e-a3b1-170ff95cf26f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a1490b10-35fa-496e-a3b1-170ff95cf26f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_10d66351-b81a-4272-869e-0f1b3f187dca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a1490b10-35fa-496e-a3b1-170ff95cf26f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_10d66351-b81a-4272-869e-0f1b3f187dca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_bcf71108-e0c5-4e61-84cf-3e43b1ba846c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_10d66351-b81a-4272-869e-0f1b3f187dca" xlink:to="loc_us-gaap_InterestRateSwapMember_bcf71108-e0c5-4e61-84cf-3e43b1ba846c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember_3fd55753-a071-476d-915d-19d05a2ea211" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryLockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_10d66351-b81a-4272-869e-0f1b3f187dca" xlink:to="loc_us-gaap_TreasuryLockMember_3fd55753-a071-476d-915d-19d05a2ea211" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_a63f3cb2-cb5f-41f0-8df1-25adc74cd3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_10d66351-b81a-4272-869e-0f1b3f187dca" xlink:to="loc_us-gaap_ForeignExchangeContractMember_a63f3cb2-cb5f-41f0-8df1-25adc74cd3f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_a229b078-f763-4d96-b3a0-27426936d960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_6f9534f2-8634-4b14-bb5e-99a39e2c93b6" xlink:to="loc_us-gaap_HedgingDesignationAxis_a229b078-f763-4d96-b3a0-27426936d960" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a229b078-f763-4d96-b3a0-27426936d960_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_a229b078-f763-4d96-b3a0-27426936d960" xlink:to="loc_us-gaap_HedgingDesignationDomain_a229b078-f763-4d96-b3a0-27426936d960_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f9d913a3-b374-4b2f-9f35-6d98a797abe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_a229b078-f763-4d96-b3a0-27426936d960" xlink:to="loc_us-gaap_HedgingDesignationDomain_f9d913a3-b374-4b2f-9f35-6d98a797abe2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_67c4d160-36bc-4c96-8519-1ba690ea3ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_f9d913a3-b374-4b2f-9f35-6d98a797abe2" xlink:to="loc_us-gaap_NondesignatedMember_67c4d160-36bc-4c96-8519-1ba690ea3ca4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_efab03ee-f5d7-49c5-a716-9b68daba9bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_f9d913a3-b374-4b2f-9f35-6d98a797abe2" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_efab03ee-f5d7-49c5-a716-9b68daba9bc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_940c0378-0a57-48d6-8ad9-b1daebba2a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_6f9534f2-8634-4b14-bb5e-99a39e2c93b6" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_940c0378-0a57-48d6-8ad9-b1daebba2a2a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_940c0378-0a57-48d6-8ad9-b1daebba2a2a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_940c0378-0a57-48d6-8ad9-b1daebba2a2a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_940c0378-0a57-48d6-8ad9-b1daebba2a2a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_06b950ef-1bf3-47b6-bd2b-33e79ec457ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_940c0378-0a57-48d6-8ad9-b1daebba2a2a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_06b950ef-1bf3-47b6-bd2b-33e79ec457ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_62dceae4-b17a-473a-b743-92e8aba5c973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_06b950ef-1bf3-47b6-bd2b-33e79ec457ec" xlink:to="loc_us-gaap_CashFlowHedgingMember_62dceae4-b17a-473a-b743-92e8aba5c973" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_3d180562-c098-4867-8f2b-5393254b5077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_06b950ef-1bf3-47b6-bd2b-33e79ec457ec" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_3d180562-c098-4867-8f2b-5393254b5077" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_6f0ee95a-2ea6-47e7-b09c-91a4e7cbcf58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_6f9534f2-8634-4b14-bb5e-99a39e2c93b6" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_6f0ee95a-2ea6-47e7-b09c-91a4e7cbcf58" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6f0ee95a-2ea6-47e7-b09c-91a4e7cbcf58_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6f0ee95a-2ea6-47e7-b09c-91a4e7cbcf58" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6f0ee95a-2ea6-47e7-b09c-91a4e7cbcf58_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_da3a1753-21af-4435-984e-87863d7402d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6f0ee95a-2ea6-47e7-b09c-91a4e7cbcf58" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_da3a1753-21af-4435-984e-87863d7402d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_4a099e88-7b3e-4aff-86f5-b55df1777eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_da3a1753-21af-4435-984e-87863d7402d9" xlink:to="loc_us-gaap_CostOfSalesMember_4a099e88-7b3e-4aff-86f5-b55df1777eb8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails" xlink:type="simple" xlink:href="a-20230131.xsd#DERIVATIVESForeignExchangeForwardContractsDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails" xlink:type="extended" id="i11972a8318a44265b83129cc22fa8494_DERIVATIVESForeignExchangeForwardContractsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_93de76bb-796e-4092-b290-b10e075c8879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfForeignCurrencyDerivativesHeld_f909a0ba-e0ee-4deb-b4d3-b1da3a6b32de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfForeignCurrencyDerivativesHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_93de76bb-796e-4092-b290-b10e075c8879" xlink:to="loc_us-gaap_NumberOfForeignCurrencyDerivativesHeld_f909a0ba-e0ee-4deb-b4d3-b1da3a6b32de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_0e76e02f-bd5d-4691-a8f8-1df44bc8fdff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_93de76bb-796e-4092-b290-b10e075c8879" xlink:to="loc_us-gaap_DerivativeNotionalAmount_0e76e02f-bd5d-4691-a8f8-1df44bc8fdff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_6eaeb69b-487a-4c02-bb99-c9f404f2b67b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_93de76bb-796e-4092-b290-b10e075c8879" xlink:to="loc_us-gaap_DerivativeTable_6eaeb69b-487a-4c02-bb99-c9f404f2b67b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_7f490b60-519a-469b-ac4a-baa94de8295c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_6eaeb69b-487a-4c02-bb99-c9f404f2b67b" xlink:to="loc_us-gaap_PositionAxis_7f490b60-519a-469b-ac4a-baa94de8295c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_7f490b60-519a-469b-ac4a-baa94de8295c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PositionAxis_7f490b60-519a-469b-ac4a-baa94de8295c" xlink:to="loc_us-gaap_PositionDomain_7f490b60-519a-469b-ac4a-baa94de8295c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_9ca18f85-66e8-48a4-87ab-ab7a7454c78a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PositionAxis_7f490b60-519a-469b-ac4a-baa94de8295c" xlink:to="loc_us-gaap_PositionDomain_9ca18f85-66e8-48a4-87ab-ab7a7454c78a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_b75084a6-2f33-4fe2-b632-a933f7b760a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_9ca18f85-66e8-48a4-87ab-ab7a7454c78a" xlink:to="loc_us-gaap_ShortMember_b75084a6-2f33-4fe2-b632-a933f7b760a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_e807c88c-e870-42d4-86b0-58f949e380bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_9ca18f85-66e8-48a4-87ab-ab7a7454c78a" xlink:to="loc_us-gaap_LongMember_e807c88c-e870-42d4-86b0-58f949e380bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d0001185-e2f3-481a-9e20-513dd0e68034" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_6eaeb69b-487a-4c02-bb99-c9f404f2b67b" xlink:to="loc_us-gaap_HedgingDesignationAxis_d0001185-e2f3-481a-9e20-513dd0e68034" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d0001185-e2f3-481a-9e20-513dd0e68034_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_d0001185-e2f3-481a-9e20-513dd0e68034" xlink:to="loc_us-gaap_HedgingDesignationDomain_d0001185-e2f3-481a-9e20-513dd0e68034_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5d2d388a-a9fa-48ed-85bd-906fcff28fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_d0001185-e2f3-481a-9e20-513dd0e68034" xlink:to="loc_us-gaap_HedgingDesignationDomain_5d2d388a-a9fa-48ed-85bd-906fcff28fe5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_50aec329-55c7-4e33-8dd5-0f0fe452e5ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_5d2d388a-a9fa-48ed-85bd-906fcff28fe5" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_50aec329-55c7-4e33-8dd5-0f0fe452e5ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_9a988378-d1b6-41de-b39b-74a33aafc04a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_5d2d388a-a9fa-48ed-85bd-906fcff28fe5" xlink:to="loc_us-gaap_NondesignatedMember_9a988378-d1b6-41de-b39b-74a33aafc04a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dcb6be5f-be71-4072-b08e-0226581d9e23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_6eaeb69b-487a-4c02-bb99-c9f404f2b67b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dcb6be5f-be71-4072-b08e-0226581d9e23" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_dcb6be5f-be71-4072-b08e-0226581d9e23_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dcb6be5f-be71-4072-b08e-0226581d9e23" xlink:to="loc_us-gaap_HedgingRelationshipDomain_dcb6be5f-be71-4072-b08e-0226581d9e23_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_bc3e6b5e-229e-4ade-a5da-464faf45c997" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dcb6be5f-be71-4072-b08e-0226581d9e23" xlink:to="loc_us-gaap_HedgingRelationshipDomain_bc3e6b5e-229e-4ade-a5da-464faf45c997" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_c5e1a057-5580-43c0-902d-5c31539b3291" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_bc3e6b5e-229e-4ade-a5da-464faf45c997" xlink:to="loc_us-gaap_CashFlowHedgingMember_c5e1a057-5580-43c0-902d-5c31539b3291" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_84f91ebf-98f8-4b5b-a4d4-6e56cc074923" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_bc3e6b5e-229e-4ade-a5da-464faf45c997" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_84f91ebf-98f8-4b5b-a4d4-6e56cc074923" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_87062dc0-2f2b-4225-9cec-ec082e7d87d6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_6eaeb69b-487a-4c02-bb99-c9f404f2b67b" xlink:to="loc_srt_CurrencyAxis_87062dc0-2f2b-4225-9cec-ec082e7d87d6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_87062dc0-2f2b-4225-9cec-ec082e7d87d6_default" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_87062dc0-2f2b-4225-9cec-ec082e7d87d6" xlink:to="loc_currency_AllCurrenciesDomain_87062dc0-2f2b-4225-9cec-ec082e7d87d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_87062dc0-2f2b-4225-9cec-ec082e7d87d6" xlink:to="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_e61563e8-2c3d-4854-b27e-8fdf36a8779c" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_EUR_e61563e8-2c3d-4854-b27e-8fdf36a8779c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_GBP_1dbcd7bb-248b-4d8f-875f-8b5cedc5df64" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_GBP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_GBP_1dbcd7bb-248b-4d8f-875f-8b5cedc5df64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CAD_2c772452-e0fe-4cc8-8dc5-ac5bf12ef198" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_CAD_2c772452-e0fe-4cc8-8dc5-ac5bf12ef198" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AUD_8ca38c56-c5bb-4c70-ba63-be43147929e3" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AUD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_AUD_8ca38c56-c5bb-4c70-ba63-be43147929e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_MYR_91e87bac-d445-4df0-adb1-bc84f597857f" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_MYR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_MYR_91e87bac-d445-4df0-adb1-bc84f597857f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_11ef2d31-a2b3-460c-9972-2e4a6e7ef5b5" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_JPY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_JPY_11ef2d31-a2b3-460c-9972-2e4a6e7ef5b5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_DKK_b2214cee-fc8b-42ce-887f-6fc1fe1c2527" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_DKK"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_DKK_b2214cee-fc8b-42ce-887f-6fc1fe1c2527" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_KRW_3e5f7f13-f1e4-4279-a9f3-c54797faaca8" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_KRW"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_KRW_3e5f7f13-f1e4-4279-a9f3-c54797faaca8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SGD_bb8756d8-b6e6-4145-9c7a-f9df022aa34c" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_SGD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_SGD_bb8756d8-b6e6-4145-9c7a-f9df022aa34c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CHF_b0e32315-3411-454a-8a89-9c1475a3b1dd" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CHF"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_CHF_b0e32315-3411-454a-8a89-9c1475a3b1dd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CNY_296ae53e-e1b7-433a-883a-4493e0ccbafc" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CNY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_CNY_296ae53e-e1b7-433a-883a-4493e0ccbafc" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_PLN_d710a9af-29c6-471b-818c-001aef70d454" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_PLN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_PLN_d710a9af-29c6-471b-818c-001aef70d454" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SEK_a2bc97fc-d5a7-4a60-84dc-492103f78eb5" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_SEK"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_SEK_a2bc97fc-d5a7-4a60-84dc-492103f78eb5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_TWD_78e7de62-b2de-4732-b603-44cc08fe271b" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_TWD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_TWD_78e7de62-b2de-4732-b603-44cc08fe271b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_INR_2eeab7a9-eddd-4e12-a7f7-5f82fee48d23" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_INR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_INR_2eeab7a9-eddd-4e12-a7f7-5f82fee48d23" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_XXX_d5ad1c57-14cf-4277-ba7c-beb226837291" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_XXX"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_XXX_d5ad1c57-14cf-4277-ba7c-beb226837291" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_BRL_e72f5b65-03a8-4a63-a34a-83326ecf901e" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_BRL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_BRL_e72f5b65-03a8-4a63-a34a-83326ecf901e" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_THB_d1509a03-75cb-4c0a-9775-60f5bdc76a6a" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_THB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_THB_d1509a03-75cb-4c0a-9775-60f5bdc76a6a" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8ef28e43-0965-4916-b587-56ccb555e789" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_6eaeb69b-487a-4c02-bb99-c9f404f2b67b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8ef28e43-0965-4916-b587-56ccb555e789" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8ef28e43-0965-4916-b587-56ccb555e789_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8ef28e43-0965-4916-b587-56ccb555e789" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8ef28e43-0965-4916-b587-56ccb555e789_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3f4a8358-75cb-49fd-a57b-a57418a2723b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8ef28e43-0965-4916-b587-56ccb555e789" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3f4a8358-75cb-49fd-a57b-a57418a2723b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_601c1566-3c7e-4f4b-8ba0-ae8337e9fc84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3f4a8358-75cb-49fd-a57b-a57418a2723b" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_601c1566-3c7e-4f4b-8ba0-ae8337e9fc84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_971f0dda-2b9e-4e92-aa3d-2fa1cff74cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3f4a8358-75cb-49fd-a57b-a57418a2723b" xlink:to="loc_us-gaap_ForwardContractsMember_971f0dda-2b9e-4e92-aa3d-2fa1cff74cb0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails" xlink:type="simple" xlink:href="a-20230131.xsd#DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails" xlink:type="extended" id="if8f3600e3e8f48e3a3231246f436dbe1_DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_0f869b82-6277-40dc-a1e8-52f0301337c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNetAbstract_7c783173-93c6-4e08-83b5-58fa13d20f76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0f869b82-6277-40dc-a1e8-52f0301337c3" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNetAbstract_7c783173-93c6-4e08-83b5-58fa13d20f76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_1661e6b1-36e6-4faf-91ce-2866daf20d48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNetAbstract_7c783173-93c6-4e08-83b5-58fa13d20f76" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_1661e6b1-36e6-4faf-91ce-2866daf20d48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_1621b4eb-2df6-45b1-b6fa-3fb6f372c31c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNetAbstract_7c783173-93c6-4e08-83b5-58fa13d20f76" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_1621b4eb-2df6-45b1-b6fa-3fb6f372c31c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_8f8571ae-0dbe-4b31-980d-7320b6ae0450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_0f869b82-6277-40dc-a1e8-52f0301337c3" xlink:to="loc_us-gaap_DerivativeTable_8f8571ae-0dbe-4b31-980d-7320b6ae0450" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_088adda2-49a5-438a-9c8e-b4d4a081fff5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_8f8571ae-0dbe-4b31-980d-7320b6ae0450" xlink:to="loc_us-gaap_HedgingDesignationAxis_088adda2-49a5-438a-9c8e-b4d4a081fff5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_088adda2-49a5-438a-9c8e-b4d4a081fff5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_088adda2-49a5-438a-9c8e-b4d4a081fff5" xlink:to="loc_us-gaap_HedgingDesignationDomain_088adda2-49a5-438a-9c8e-b4d4a081fff5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5d3e3912-b9e3-4d88-9908-df0ddae4dbb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_088adda2-49a5-438a-9c8e-b4d4a081fff5" xlink:to="loc_us-gaap_HedgingDesignationDomain_5d3e3912-b9e3-4d88-9908-df0ddae4dbb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_85b79475-5152-409d-bece-754aef43dc5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_5d3e3912-b9e3-4d88-9908-df0ddae4dbb5" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_85b79475-5152-409d-bece-754aef43dc5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_e92a6a2c-9900-416d-9c25-9a07418b385e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_5d3e3912-b9e3-4d88-9908-df0ddae4dbb5" xlink:to="loc_us-gaap_NondesignatedMember_e92a6a2c-9900-416d-9c25-9a07418b385e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_49997d45-d012-4d5d-ae7c-e2013b50d984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_8f8571ae-0dbe-4b31-980d-7320b6ae0450" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_49997d45-d012-4d5d-ae7c-e2013b50d984" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_49997d45-d012-4d5d-ae7c-e2013b50d984_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_49997d45-d012-4d5d-ae7c-e2013b50d984" xlink:to="loc_us-gaap_HedgingRelationshipDomain_49997d45-d012-4d5d-ae7c-e2013b50d984_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_9dfe3053-4ea0-4e15-b333-ab52c933b53d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_49997d45-d012-4d5d-ae7c-e2013b50d984" xlink:to="loc_us-gaap_HedgingRelationshipDomain_9dfe3053-4ea0-4e15-b333-ab52c933b53d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_18c6194b-9c45-4132-be64-8660207c5be3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_9dfe3053-4ea0-4e15-b333-ab52c933b53d" xlink:to="loc_us-gaap_CashFlowHedgingMember_18c6194b-9c45-4132-be64-8660207c5be3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_f8f4c3e6-aaad-4930-a53a-448e6f4ef8ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_9dfe3053-4ea0-4e15-b333-ab52c933b53d" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_f8f4c3e6-aaad-4930-a53a-448e6f4ef8ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_eeb654f2-1593-4328-adee-d94e38de888d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_8f8571ae-0dbe-4b31-980d-7320b6ae0450" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_eeb654f2-1593-4328-adee-d94e38de888d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_eeb654f2-1593-4328-adee-d94e38de888d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_eeb654f2-1593-4328-adee-d94e38de888d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_eeb654f2-1593-4328-adee-d94e38de888d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a7fe962d-7b80-44a6-b830-174689602c33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_eeb654f2-1593-4328-adee-d94e38de888d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a7fe962d-7b80-44a6-b830-174689602c33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_859a79b2-9630-48ac-b310-133bd7aed300" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a7fe962d-7b80-44a6-b830-174689602c33" xlink:to="loc_us-gaap_ForeignExchangeContractMember_859a79b2-9630-48ac-b310-133bd7aed300" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_b65ee456-7ee9-47db-94f1-1adc731e990a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a7fe962d-7b80-44a6-b830-174689602c33" xlink:to="loc_us-gaap_InterestRateSwapMember_b65ee456-7ee9-47db-94f1-1adc731e990a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_74c26d17-c396-4f4e-8a96-5a1b03542fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_8f8571ae-0dbe-4b31-980d-7320b6ae0450" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_74c26d17-c396-4f4e-8a96-5a1b03542fbf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_74c26d17-c396-4f4e-8a96-5a1b03542fbf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_74c26d17-c396-4f4e-8a96-5a1b03542fbf" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_74c26d17-c396-4f4e-8a96-5a1b03542fbf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b606f63c-7edd-4ef9-b2db-3de8b22f7fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_74c26d17-c396-4f4e-8a96-5a1b03542fbf" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b606f63c-7edd-4ef9-b2db-3de8b22f7fbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_c9693561-997d-4425-93d1-2784315e3d20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b606f63c-7edd-4ef9-b2db-3de8b22f7fbd" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_c9693561-997d-4425-93d1-2784315e3d20" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_da4a65ba-a06d-40a5-bf68-05051e45d082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCurrentAssetsMember_c9693561-997d-4425-93d1-2784315e3d20" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_da4a65ba-a06d-40a5-bf68-05051e45d082" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails" xlink:type="simple" xlink:href="a-20230131.xsd#DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails" xlink:type="extended" id="i5a7099149e4743519c912d46bb9f9b68_DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_b7bbd356-7ac1-49a9-b04b-35900ff70aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_de57e240-8b34-4f19-aacb-f1b352fce0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b7bbd356-7ac1-49a9-b04b-35900ff70aa5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_de57e240-8b34-4f19-aacb-f1b352fce0a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_3d580188-a34e-4ed8-b084-ce743c93fcfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b7bbd356-7ac1-49a9-b04b-35900ff70aa5" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_3d580188-a34e-4ed8-b084-ce743c93fcfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_f2322768-c098-4edc-aa1f-7657f6224ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b7bbd356-7ac1-49a9-b04b-35900ff70aa5" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_f2322768-c098-4edc-aa1f-7657f6224ab3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_747c7183-b14d-4edd-a8d6-1195d9f30358" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b7bbd356-7ac1-49a9-b04b-35900ff70aa5" xlink:to="loc_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_747c7183-b14d-4edd-a8d6-1195d9f30358" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_61debfcc-33e5-4e4d-85b3-6f0d7da6fb20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b7bbd356-7ac1-49a9-b04b-35900ff70aa5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_61debfcc-33e5-4e4d-85b3-6f0d7da6fb20" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_0a8f4728-7f0f-4af9-af85-0949ddd77f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b7bbd356-7ac1-49a9-b04b-35900ff70aa5" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_0a8f4728-7f0f-4af9-af85-0949ddd77f1e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_eccab5d0-6738-4be7-a464-3c648661f51b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b7bbd356-7ac1-49a9-b04b-35900ff70aa5" xlink:to="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_eccab5d0-6738-4be7-a464-3c648661f51b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_d2e0914d-d184-4be8-9598-a8ec22ab34f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_b7bbd356-7ac1-49a9-b04b-35900ff70aa5" xlink:to="loc_us-gaap_DerivativeTable_d2e0914d-d184-4be8-9598-a8ec22ab34f4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_7e2ca9cd-d4f6-4061-adb8-35a2f4e9e743" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_d2e0914d-d184-4be8-9598-a8ec22ab34f4" xlink:to="loc_us-gaap_HedgingDesignationAxis_7e2ca9cd-d4f6-4061-adb8-35a2f4e9e743" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_7e2ca9cd-d4f6-4061-adb8-35a2f4e9e743_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_7e2ca9cd-d4f6-4061-adb8-35a2f4e9e743" xlink:to="loc_us-gaap_HedgingDesignationDomain_7e2ca9cd-d4f6-4061-adb8-35a2f4e9e743_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b7f2fdc0-8153-45cb-9937-3a696e75ac7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_7e2ca9cd-d4f6-4061-adb8-35a2f4e9e743" xlink:to="loc_us-gaap_HedgingDesignationDomain_b7f2fdc0-8153-45cb-9937-3a696e75ac7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_214933ed-72e7-4a76-9313-558e5e45afd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_b7f2fdc0-8153-45cb-9937-3a696e75ac7c" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_214933ed-72e7-4a76-9313-558e5e45afd9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_a254c171-59fc-40b3-a898-96c589be3c06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_b7f2fdc0-8153-45cb-9937-3a696e75ac7c" xlink:to="loc_us-gaap_NondesignatedMember_a254c171-59fc-40b3-a898-96c589be3c06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b52f0c59-7481-49e5-97ad-2ec813b1ff59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_d2e0914d-d184-4be8-9598-a8ec22ab34f4" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b52f0c59-7481-49e5-97ad-2ec813b1ff59" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_b52f0c59-7481-49e5-97ad-2ec813b1ff59_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b52f0c59-7481-49e5-97ad-2ec813b1ff59" xlink:to="loc_us-gaap_HedgingRelationshipDomain_b52f0c59-7481-49e5-97ad-2ec813b1ff59_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_4992944f-e650-4d76-8770-87ec476eb746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b52f0c59-7481-49e5-97ad-2ec813b1ff59" xlink:to="loc_us-gaap_HedgingRelationshipDomain_4992944f-e650-4d76-8770-87ec476eb746" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_dce57877-26d9-418c-acf9-d64e0d5d9063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_4992944f-e650-4d76-8770-87ec476eb746" xlink:to="loc_us-gaap_CashFlowHedgingMember_dce57877-26d9-418c-acf9-d64e0d5d9063" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_ab47b20b-02c3-44b5-82cc-ccfa1c82ffe1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_4992944f-e650-4d76-8770-87ec476eb746" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_ab47b20b-02c3-44b5-82cc-ccfa1c82ffe1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_413da1b1-303c-43c5-b34e-298945067d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_d2e0914d-d184-4be8-9598-a8ec22ab34f4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_413da1b1-303c-43c5-b34e-298945067d9a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_413da1b1-303c-43c5-b34e-298945067d9a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_413da1b1-303c-43c5-b34e-298945067d9a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_413da1b1-303c-43c5-b34e-298945067d9a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7ec12cff-14a2-4088-adb0-fa140f6e5c73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_413da1b1-303c-43c5-b34e-298945067d9a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7ec12cff-14a2-4088-adb0-fa140f6e5c73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_95da3d57-9fa3-4d2e-89e1-3bd819236049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7ec12cff-14a2-4088-adb0-fa140f6e5c73" xlink:to="loc_us-gaap_ForeignExchangeContractMember_95da3d57-9fa3-4d2e-89e1-3bd819236049" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_39d65710-ba5d-4c0e-94fb-e3ff2e1fd681" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_d2e0914d-d184-4be8-9598-a8ec22ab34f4" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_39d65710-ba5d-4c0e-94fb-e3ff2e1fd681" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_39d65710-ba5d-4c0e-94fb-e3ff2e1fd681_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_39d65710-ba5d-4c0e-94fb-e3ff2e1fd681" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_39d65710-ba5d-4c0e-94fb-e3ff2e1fd681_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bd9d1bc5-ed0c-455d-9475-7abad742ded2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_39d65710-ba5d-4c0e-94fb-e3ff2e1fd681" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bd9d1bc5-ed0c-455d-9475-7abad742ded2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_a37b5cd0-aca2-4f9d-9c96-b84adf69b337" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bd9d1bc5-ed0c-455d-9475-7abad742ded2" xlink:to="loc_us-gaap_InterestExpenseMember_a37b5cd0-aca2-4f9d-9c96-b84adf69b337" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_d29ba726-33da-4d35-a1a2-523164008231" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bd9d1bc5-ed0c-455d-9475-7abad742ded2" xlink:to="loc_us-gaap_CostOfSalesMember_d29ba726-33da-4d35-a1a2-523164008231" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_d723c25b-e6cf-4087-80af-45f8c3f7676c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bd9d1bc5-ed0c-455d-9475-7abad742ded2" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_d723c25b-e6cf-4087-80af-45f8c3f7676c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_b20fcb37-bf59-46fb-8f9d-d5ca78c6dd22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_d2e0914d-d184-4be8-9598-a8ec22ab34f4" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_b20fcb37-bf59-46fb-8f9d-d5ca78c6dd22" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b20fcb37-bf59-46fb-8f9d-d5ca78c6dd22_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b20fcb37-bf59-46fb-8f9d-d5ca78c6dd22" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b20fcb37-bf59-46fb-8f9d-d5ca78c6dd22_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6e63799c-bd36-499c-a9cf-b24b6055b70a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b20fcb37-bf59-46fb-8f9d-d5ca78c6dd22" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6e63799c-bd36-499c-a9cf-b24b6055b70a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_72a287de-1336-43c7-b543-a3adfa4a6932" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6e63799c-bd36-499c-a9cf-b24b6055b70a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_72a287de-1336-43c7-b543-a3adfa4a6932" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7509b270-c8b6-42bf-b7ab-98858e77f032" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_d2e0914d-d184-4be8-9598-a8ec22ab34f4" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7509b270-c8b6-42bf-b7ab-98858e77f032" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7509b270-c8b6-42bf-b7ab-98858e77f032_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7509b270-c8b6-42bf-b7ab-98858e77f032" xlink:to="loc_us-gaap_EquityComponentDomain_7509b270-c8b6-42bf-b7ab-98858e77f032_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_361cac1f-2280-43b4-ac91-cc63a2cf36bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7509b270-c8b6-42bf-b7ab-98858e77f032" xlink:to="loc_us-gaap_EquityComponentDomain_361cac1f-2280-43b4-ac91-cc63a2cf36bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_74dc9194-aaa5-4556-9533-b6e90a3ff165" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_361cac1f-2280-43b4-ac91-cc63a2cf36bf" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_74dc9194-aaa5-4556-9533-b6e90a3ff165" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/DerivativeInstrumentsandHedgingActivitiesDetails" xlink:type="simple" xlink:href="a-20230131.xsd#DerivativeInstrumentsandHedgingActivitiesDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/DerivativeInstrumentsandHedgingActivitiesDetails" xlink:type="extended" id="i5c91382e461f43ccad7b1ed6fd571a63_DerivativeInstrumentsandHedgingActivitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_e85141e5-e46f-40aa-9b93-98265ff4006f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_b824bd76-98ff-4a1f-a253-c47d71fb10af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_e85141e5-e46f-40aa-9b93-98265ff4006f" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_b824bd76-98ff-4a1f-a253-c47d71fb10af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_895fafde-8aff-4555-93c5-f1b036c8f468" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_e85141e5-e46f-40aa-9b93-98265ff4006f" xlink:to="loc_us-gaap_DerivativeTable_895fafde-8aff-4555-93c5-f1b036c8f468" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_58c050aa-9128-4b1b-993c-defe147981f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_895fafde-8aff-4555-93c5-f1b036c8f468" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_58c050aa-9128-4b1b-993c-defe147981f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_58c050aa-9128-4b1b-993c-defe147981f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_58c050aa-9128-4b1b-993c-defe147981f7" xlink:to="loc_us-gaap_HedgingRelationshipDomain_58c050aa-9128-4b1b-993c-defe147981f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_bf48b0fb-c154-4eda-9c4e-c9bc57f5c585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_58c050aa-9128-4b1b-993c-defe147981f7" xlink:to="loc_us-gaap_HedgingRelationshipDomain_bf48b0fb-c154-4eda-9c4e-c9bc57f5c585" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_0bf81c38-7558-4e45-a982-f235f58ca4f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_bf48b0fb-c154-4eda-9c4e-c9bc57f5c585" xlink:to="loc_us-gaap_CashFlowHedgingMember_0bf81c38-7558-4e45-a982-f235f58ca4f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_5ea5e998-3e83-4958-bc2a-f9e6f33c8e79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_895fafde-8aff-4555-93c5-f1b036c8f468" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_5ea5e998-3e83-4958-bc2a-f9e6f33c8e79" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5ea5e998-3e83-4958-bc2a-f9e6f33c8e79_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_5ea5e998-3e83-4958-bc2a-f9e6f33c8e79" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5ea5e998-3e83-4958-bc2a-f9e6f33c8e79_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b5e03330-310c-4602-ab1b-2cd8c80d3248" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_5ea5e998-3e83-4958-bc2a-f9e6f33c8e79" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b5e03330-310c-4602-ab1b-2cd8c80d3248" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_689b0b50-8e59-451c-8bac-b52cf1e86a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b5e03330-310c-4602-ab1b-2cd8c80d3248" xlink:to="loc_us-gaap_CostOfSalesMember_689b0b50-8e59-451c-8bac-b52cf1e86a2d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails" xlink:type="simple" xlink:href="a-20230131.xsd#RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails" xlink:type="extended" id="i83bf8cc4918941bda0679e37e87c6130_RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8d539313-d6ae-4100-b842-ce07e158cc1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_723816d9-5d5d-4b60-b630-dba2d1ff9a10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8d539313-d6ae-4100-b842-ce07e158cc1a" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_723816d9-5d5d-4b60-b630-dba2d1ff9a10" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_18b46e27-d4b5-4cfd-878e-f7b26b784d19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_723816d9-5d5d-4b60-b630-dba2d1ff9a10" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_18b46e27-d4b5-4cfd-878e-f7b26b784d19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_de164f36-98d3-47cc-867d-6008bb8d69fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_723816d9-5d5d-4b60-b630-dba2d1ff9a10" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_de164f36-98d3-47cc-867d-6008bb8d69fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_5583344e-0900-4342-83eb-029e309e3673" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_723816d9-5d5d-4b60-b630-dba2d1ff9a10" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_5583344e-0900-4342-83eb-029e309e3673" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AmortizationAndDeferralsAbstract_9504def3-1a85-499a-8e62-389bc42d0809" xlink:href="a-20230131.xsd#a_AmortizationAndDeferralsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_723816d9-5d5d-4b60-b630-dba2d1ff9a10" xlink:to="loc_a_AmortizationAndDeferralsAbstract_9504def3-1a85-499a-8e62-389bc42d0809" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_d3439e5c-874c-443e-a1d3-c0274f80e2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_a_AmortizationAndDeferralsAbstract_9504def3-1a85-499a-8e62-389bc42d0809" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_d3439e5c-874c-443e-a1d3-c0274f80e2bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_e7c09087-7cb1-4487-845a-2d490b556f59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_723816d9-5d5d-4b60-b630-dba2d1ff9a10" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_e7c09087-7cb1-4487-845a-2d490b556f59" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract_4819dd21-adcd-4dc6-91c8-20952c18506b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8d539313-d6ae-4100-b842-ce07e158cc1a" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract_4819dd21-adcd-4dc6-91c8-20952c18506b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_14f49e90-f96b-4aa0-972d-3d3057eff20f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract_4819dd21-adcd-4dc6-91c8-20952c18506b" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_14f49e90-f96b-4aa0-972d-3d3057eff20f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ce9f4323-e136-4ee0-ac96-afd0d22c7b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8d539313-d6ae-4100-b842-ce07e158cc1a" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ce9f4323-e136-4ee0-ac96-afd0d22c7b4e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_07ac8b37-bf17-4716-9518-40c4157cbbce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ce9f4323-e136-4ee0-ac96-afd0d22c7b4e" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_07ac8b37-bf17-4716-9518-40c4157cbbce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_07ac8b37-bf17-4716-9518-40c4157cbbce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_07ac8b37-bf17-4716-9518-40c4157cbbce" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_07ac8b37-bf17-4716-9518-40c4157cbbce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_b5c990c4-9a1a-4ce4-b59b-a895893f6bd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_07ac8b37-bf17-4716-9518-40c4157cbbce" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_b5c990c4-9a1a-4ce4-b59b-a895893f6bd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_624ba11c-49d8-4538-8123-59d3b53ac048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b5c990c4-9a1a-4ce4-b59b-a895893f6bd8" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_624ba11c-49d8-4538-8123-59d3b53ac048" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_1062e343-6acc-4af9-b5f4-ddb03fd03392" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b5c990c4-9a1a-4ce4-b59b-a895893f6bd8" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_1062e343-6acc-4af9-b5f4-ddb03fd03392" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPensionPlansDefinedBenefitMember_a1397afc-7539-4e5f-a408-b95033c55d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b5c990c4-9a1a-4ce4-b59b-a895893f6bd8" xlink:to="loc_us-gaap_OtherPensionPlansDefinedBenefitMember_a1397afc-7539-4e5f-a408-b95033c55d4c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_edd539f4-6fe6-49f6-a439-537ca61b3f76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ce9f4323-e136-4ee0-ac96-afd0d22c7b4e" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_edd539f4-6fe6-49f6-a439-537ca61b3f76" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_edd539f4-6fe6-49f6-a439-537ca61b3f76_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_edd539f4-6fe6-49f6-a439-537ca61b3f76" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_edd539f4-6fe6-49f6-a439-537ca61b3f76_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_b8e8378e-05c5-4ac7-9918-c7a517381408" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_edd539f4-6fe6-49f6-a439-537ca61b3f76" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_b8e8378e-05c5-4ac7-9918-c7a517381408" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_d417476c-389f-48b9-9617-030ce9d53d42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_b8e8378e-05c5-4ac7-9918-c7a517381408" xlink:to="loc_us-gaap_DomesticPlanMember_d417476c-389f-48b9-9617-030ce9d53d42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_39ff65b7-71a2-4e8b-9a77-a2597881f338" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_d417476c-389f-48b9-9617-030ce9d53d42" xlink:to="loc_country_US_39ff65b7-71a2-4e8b-9a77-a2597881f338" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_6f7425d7-d3de-4384-a469-05751f421415" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_b8e8378e-05c5-4ac7-9918-c7a517381408" xlink:to="loc_us-gaap_ForeignPlanMember_6f7425d7-d3de-4384-a469-05751f421415" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_49cddc31-1608-4f99-983d-9e05ec6e8078" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_DE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_6f7425d7-d3de-4384-a469-05751f421415" xlink:to="loc_country_DE_49cddc31-1608-4f99-983d-9e05ec6e8078" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_c8c8e6a6-5ab1-4b43-bc28-d95c1bf7fca5" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_6f7425d7-d3de-4384-a469-05751f421415" xlink:to="loc_country_GB_c8c8e6a6-5ab1-4b43-bc28-d95c1bf7fca5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_8215f8c9-d8dd-4d8c-bf44-2240cd4a6054" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_JP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_6f7425d7-d3de-4384-a469-05751f421415" xlink:to="loc_country_JP_8215f8c9-d8dd-4d8c-bf44-2240cd4a6054" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_NL_20b049d7-79db-42e2-8582-844146ff59fa" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_NL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_6f7425d7-d3de-4384-a469-05751f421415" xlink:to="loc_country_NL_20b049d7-79db-42e2-8582-844146ff59fa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_73cce696-9172-434c-9674-9960c6b635ea" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_6f7425d7-d3de-4384-a469-05751f421415" xlink:to="loc_country_CH_73cce696-9172-434c-9674-9960c6b635ea" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_3275d94d-9ce9-4cc7-9543-6fff0978f64d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ce9f4323-e136-4ee0-ac96-afd0d22c7b4e" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_3275d94d-9ce9-4cc7-9543-6fff0978f64d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_3275d94d-9ce9-4cc7-9543-6fff0978f64d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_3275d94d-9ce9-4cc7-9543-6fff0978f64d" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_3275d94d-9ce9-4cc7-9543-6fff0978f64d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_eb05ec20-c224-44b2-a08e-fbe788c280eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_3275d94d-9ce9-4cc7-9543-6fff0978f64d" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_eb05ec20-c224-44b2-a08e-fbe788c280eb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions" xlink:type="simple" xlink:href="a-20230131.xsd#RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions" xlink:type="extended" id="i6b3bff09a05841ca8735ace55b3c3a69_RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fcf5a777-9434-4e79-8c5e-67d15ff2201e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_ab8cf9d5-544e-4d18-83f1-5b2bc12605b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fcf5a777-9434-4e79-8c5e-67d15ff2201e" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_ab8cf9d5-544e-4d18-83f1-5b2bc12605b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_de586237-92dc-475c-b3c6-a1d79a338398" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fcf5a777-9434-4e79-8c5e-67d15ff2201e" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_de586237-92dc-475c-b3c6-a1d79a338398" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4c83f18d-6c48-4ba1-826d-e48254665ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fcf5a777-9434-4e79-8c5e-67d15ff2201e" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4c83f18d-6c48-4ba1-826d-e48254665ae4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_a39eabf2-a957-493b-9fc8-66fd85c0ad29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4c83f18d-6c48-4ba1-826d-e48254665ae4" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_a39eabf2-a957-493b-9fc8-66fd85c0ad29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_a39eabf2-a957-493b-9fc8-66fd85c0ad29_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_a39eabf2-a957-493b-9fc8-66fd85c0ad29" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_a39eabf2-a957-493b-9fc8-66fd85c0ad29_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_1679bb3c-56ab-4d24-aeee-3476e35e108b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_a39eabf2-a957-493b-9fc8-66fd85c0ad29" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_1679bb3c-56ab-4d24-aeee-3476e35e108b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_55432c6a-1d16-4d6c-b100-fdff30c49cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_1679bb3c-56ab-4d24-aeee-3476e35e108b" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_55432c6a-1d16-4d6c-b100-fdff30c49cc0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_57a16a16-a13a-4d28-93c1-6afdfbc0a49e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_1679bb3c-56ab-4d24-aeee-3476e35e108b" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_57a16a16-a13a-4d28-93c1-6afdfbc0a49e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_c94c4f6c-aad3-4a67-a4c0-72e76f3925bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4c83f18d-6c48-4ba1-826d-e48254665ae4" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_c94c4f6c-aad3-4a67-a4c0-72e76f3925bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_c94c4f6c-aad3-4a67-a4c0-72e76f3925bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_c94c4f6c-aad3-4a67-a4c0-72e76f3925bf" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_c94c4f6c-aad3-4a67-a4c0-72e76f3925bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_819add44-0afc-45e7-9432-d0f8a29c9545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_c94c4f6c-aad3-4a67-a4c0-72e76f3925bf" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_819add44-0afc-45e7-9432-d0f8a29c9545" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_2b9769d9-a077-48db-8d04-973c6a1fdecc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_819add44-0afc-45e7-9432-d0f8a29c9545" xlink:to="loc_us-gaap_DomesticPlanMember_2b9769d9-a077-48db-8d04-973c6a1fdecc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_9e42b8c5-d593-493d-bc84-974b1424a98a" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_2b9769d9-a077-48db-8d04-973c6a1fdecc" xlink:to="loc_country_US_9e42b8c5-d593-493d-bc84-974b1424a98a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_07070fa4-9423-4121-9436-f937acab65e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_819add44-0afc-45e7-9432-d0f8a29c9545" xlink:to="loc_us-gaap_ForeignPlanMember_07070fa4-9423-4121-9436-f937acab65e9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails" xlink:type="simple" xlink:href="a-20230131.xsd#SHORTTERMDEBTCreditFacilityDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails" xlink:type="extended" id="i504e3705285e46abbe76b73dc7939c80_SHORTTERMDEBTCreditFacilityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_7ccce990-4867-40b1-93cf-975dcb431ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInitiationDate1_619d6e57-d8a2-4d49-9642-5d15e1a50a46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInitiationDate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7ccce990-4867-40b1-93cf-975dcb431ea6" xlink:to="loc_us-gaap_LineOfCreditFacilityInitiationDate1_619d6e57-d8a2-4d49-9642-5d15e1a50a46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_30d27c05-83b1-4acc-8615-d653bb815552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7ccce990-4867-40b1-93cf-975dcb431ea6" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_30d27c05-83b1-4acc-8615-d653bb815552" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTerms_94a401bc-6ffe-4ac1-b7a5-2779087937f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7ccce990-4867-40b1-93cf-975dcb431ea6" xlink:to="loc_us-gaap_ShortTermDebtTerms_94a401bc-6ffe-4ac1-b7a5-2779087937f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationDate1_f2381b8b-1a6e-49ab-85c2-78504b49b3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityExpirationDate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7ccce990-4867-40b1-93cf-975dcb431ea6" xlink:to="loc_us-gaap_LineOfCreditFacilityExpirationDate1_f2381b8b-1a6e-49ab-85c2-78504b49b3ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_ae879390-f96b-48b9-9257-16b763b1b1fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7ccce990-4867-40b1-93cf-975dcb431ea6" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_ae879390-f96b-48b9-9257-16b763b1b1fe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate_a79888e6-be97-4c3c-ba54-ba773ec07966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7ccce990-4867-40b1-93cf-975dcb431ea6" xlink:to="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate_a79888e6-be97-4c3c-ba54-ba773ec07966" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper_17dce121-90eb-47cc-9525-7054c154e8bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7ccce990-4867-40b1-93cf-975dcb431ea6" xlink:to="loc_us-gaap_RepaymentsOfCommercialPaper_17dce121-90eb-47cc-9525-7054c154e8bc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_ae1562da-8903-427c-b045-d91ae51b843c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7ccce990-4867-40b1-93cf-975dcb431ea6" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_ae1562da-8903-427c-b045-d91ae51b843c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_ba619268-bfe8-4cc5-bd1c-782d05f523a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7ccce990-4867-40b1-93cf-975dcb431ea6" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_ba619268-bfe8-4cc5-bd1c-782d05f523a2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_e5ed97ea-f97a-41de-9d4c-f3caf978053f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_ba619268-bfe8-4cc5-bd1c-782d05f523a2" xlink:to="loc_us-gaap_CreditFacilityAxis_e5ed97ea-f97a-41de-9d4c-f3caf978053f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e5ed97ea-f97a-41de-9d4c-f3caf978053f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_e5ed97ea-f97a-41de-9d4c-f3caf978053f" xlink:to="loc_us-gaap_CreditFacilityDomain_e5ed97ea-f97a-41de-9d4c-f3caf978053f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_1b5c8d10-bc69-4702-a668-fe67e4f2c041" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_e5ed97ea-f97a-41de-9d4c-f3caf978053f" xlink:to="loc_us-gaap_CreditFacilityDomain_1b5c8d10-bc69-4702-a668-fe67e4f2c041" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_0c7d7bf6-96b9-46da-9f57-edd9135977dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_1b5c8d10-bc69-4702-a668-fe67e4f2c041" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_0c7d7bf6-96b9-46da-9f57-edd9135977dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_d1077bf7-9289-4f43-a7b6-7cbb86591635" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_1b5c8d10-bc69-4702-a668-fe67e4f2c041" xlink:to="loc_us-gaap_LineOfCreditMember_d1077bf7-9289-4f43-a7b6-7cbb86591635" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_2d6e014e-0926-483e-bc1a-b567ec3ceceb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_ba619268-bfe8-4cc5-bd1c-782d05f523a2" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_2d6e014e-0926-483e-bc1a-b567ec3ceceb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_2d6e014e-0926-483e-bc1a-b567ec3ceceb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_2d6e014e-0926-483e-bc1a-b567ec3ceceb" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_2d6e014e-0926-483e-bc1a-b567ec3ceceb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_7c3d1c87-b731-4d6c-ae0e-2908561898c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_2d6e014e-0926-483e-bc1a-b567ec3ceceb" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_7c3d1c87-b731-4d6c-ae0e-2908561898c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_30e0f9e7-11fa-4d4f-908c-ae5bffb220ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_ba619268-bfe8-4cc5-bd1c-782d05f523a2" xlink:to="loc_us-gaap_DebtInstrumentAxis_30e0f9e7-11fa-4d4f-908c-ae5bffb220ac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_30e0f9e7-11fa-4d4f-908c-ae5bffb220ac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_30e0f9e7-11fa-4d4f-908c-ae5bffb220ac" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_30e0f9e7-11fa-4d4f-908c-ae5bffb220ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d2a38da6-761e-4ca7-9ec2-23cdf4ad73e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_30e0f9e7-11fa-4d4f-908c-ae5bffb220ac" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d2a38da6-761e-4ca7-9ec2-23cdf4ad73e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_A5YrUnsecuredCreditFacilityMember_adc5ddac-3423-4b43-8d78-5dd8b17f20cd" xlink:href="a-20230131.xsd#a_A5YrUnsecuredCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d2a38da6-761e-4ca7-9ec2-23cdf4ad73e8" xlink:to="loc_a_A5YrUnsecuredCreditFacilityMember_adc5ddac-3423-4b43-8d78-5dd8b17f20cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AdditionalIncrementalTermLoanFacilityMember_a17d92f6-df85-458a-8c52-e4e9bb7bd741" xlink:href="a-20230131.xsd#a_AdditionalIncrementalTermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d2a38da6-761e-4ca7-9ec2-23cdf4ad73e8" xlink:to="loc_a_AdditionalIncrementalTermLoanFacilityMember_a17d92f6-df85-458a-8c52-e4e9bb7bd741" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_9d1896dc-a21b-4caa-a05f-a2ceb6de2566" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d2a38da6-761e-4ca7-9ec2-23cdf4ad73e8" xlink:to="loc_us-gaap_CommercialPaperMember_9d1896dc-a21b-4caa-a05f-a2ceb6de2566" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/LONGTERMDEBTDetails" xlink:type="simple" xlink:href="a-20230131.xsd#LONGTERMDEBTDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/LONGTERMDEBTDetails" xlink:type="extended" id="i197e5036e2474078b9622b383a2c447e_LONGTERMDEBTDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f122bf9e-68d2-4cd3-998f-be627e325b29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_8fab7c4f-876f-48cf-b624-2df993d7c318" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f122bf9e-68d2-4cd3-998f-be627e325b29" xlink:to="loc_us-gaap_LongTermDebt_8fab7c4f-876f-48cf-b624-2df993d7c318" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b736a7ee-507c-437a-abc3-2b8ed7d4f6fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f122bf9e-68d2-4cd3-998f-be627e325b29" xlink:to="loc_us-gaap_DebtInstrumentTable_b736a7ee-507c-437a-abc3-2b8ed7d4f6fc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_3f48a0d0-d86b-447d-86ad-547d8493563b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b736a7ee-507c-437a-abc3-2b8ed7d4f6fc" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_3f48a0d0-d86b-447d-86ad-547d8493563b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3f48a0d0-d86b-447d-86ad-547d8493563b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3f48a0d0-d86b-447d-86ad-547d8493563b" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3f48a0d0-d86b-447d-86ad-547d8493563b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_74eb9128-c00d-4f81-8193-2c135c9e33a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3f48a0d0-d86b-447d-86ad-547d8493563b" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_74eb9128-c00d-4f81-8193-2c135c9e33a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f9766491-c264-4773-8431-c900305890fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b736a7ee-507c-437a-abc3-2b8ed7d4f6fc" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f9766491-c264-4773-8431-c900305890fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_f9766491-c264-4773-8431-c900305890fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f9766491-c264-4773-8431-c900305890fa" xlink:to="loc_us-gaap_TypeOfAdoptionMember_f9766491-c264-4773-8431-c900305890fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_2b5fed2c-be30-4c31-b49b-3b81e4d28dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f9766491-c264-4773-8431-c900305890fa" xlink:to="loc_us-gaap_TypeOfAdoptionMember_2b5fed2c-be30-4c31-b49b-3b81e4d28dfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_62c38684-5309-46d8-82a4-7d9ce2af8e29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b736a7ee-507c-437a-abc3-2b8ed7d4f6fc" xlink:to="loc_us-gaap_DebtInstrumentAxis_62c38684-5309-46d8-82a4-7d9ce2af8e29" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_62c38684-5309-46d8-82a4-7d9ce2af8e29_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_62c38684-5309-46d8-82a4-7d9ce2af8e29" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_62c38684-5309-46d8-82a4-7d9ce2af8e29_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_971319f9-6b53-4df8-8e4c-fbcb21ce78ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_62c38684-5309-46d8-82a4-7d9ce2af8e29" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_971319f9-6b53-4df8-8e4c-fbcb21ce78ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2023Member_fd41e759-eb27-40b8-8b2d-938f5e059ddf" xlink:href="a-20230131.xsd#a_SeniorNotes2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_971319f9-6b53-4df8-8e4c-fbcb21ce78ad" xlink:to="loc_a_SeniorNotes2023Member_fd41e759-eb27-40b8-8b2d-938f5e059ddf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2026Member_4c35a03c-c5d3-41aa-9ec5-2435b098df69" xlink:href="a-20230131.xsd#a_SeniorNotes2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_971319f9-6b53-4df8-8e4c-fbcb21ce78ad" xlink:to="loc_a_SeniorNotes2026Member_4c35a03c-c5d3-41aa-9ec5-2435b098df69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2029Member_c0a61a93-b627-44f3-8f3f-0b22382235b1" xlink:href="a-20230131.xsd#a_SeniorNotes2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_971319f9-6b53-4df8-8e4c-fbcb21ce78ad" xlink:to="loc_a_SeniorNotes2029Member_c0a61a93-b627-44f3-8f3f-0b22382235b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2030Member_33511a39-72ed-4fa0-84f1-b85573ec673c" xlink:href="a-20230131.xsd#a_SeniorNotes2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_971319f9-6b53-4df8-8e4c-fbcb21ce78ad" xlink:to="loc_a_SeniorNotes2030Member_33511a39-72ed-4fa0-84f1-b85573ec673c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2031Member_be1a7c32-23d8-4da2-896c-40d58d8b8921" xlink:href="a-20230131.xsd#a_SeniorNotes2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_971319f9-6b53-4df8-8e4c-fbcb21ce78ad" xlink:to="loc_a_SeniorNotes2031Member_be1a7c32-23d8-4da2-896c-40d58d8b8921" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_e9e4115e-3fd5-4775-8419-25890057a6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_971319f9-6b53-4df8-8e4c-fbcb21ce78ad" xlink:to="loc_us-gaap_SeniorNotesMember_e9e4115e-3fd5-4775-8419-25890057a6c5" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/LONGTERMDEBTTextDetails" xlink:type="simple" xlink:href="a-20230131.xsd#LONGTERMDEBTTextDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/LONGTERMDEBTTextDetails" xlink:type="extended" id="i707ed44d10114c91b2cd7c0adb883693_LONGTERMDEBTTextDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIssuanceDate1_733a22ea-54ef-4ec4-8798-ce6cbcbabb5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentIssuanceDate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_us-gaap_DebtInstrumentIssuanceDate1_733a22ea-54ef-4ec4-8798-ce6cbcbabb5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_4e305092-7c36-4822-be95-07f934c834b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_4e305092-7c36-4822-be95-07f934c834b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_PercentageOfFaceAmountOfSeniorNoteInstrumentIssued_7f2a0d7c-fe5d-4ad9-bf8d-3dee76d0d216" xlink:href="a-20230131.xsd#a_PercentageOfFaceAmountOfSeniorNoteInstrumentIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_a_PercentageOfFaceAmountOfSeniorNoteInstrumentIssued_7f2a0d7c-fe5d-4ad9-bf8d-3dee76d0d216" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_8f2dd957-3067-4494-a816-a2709a5c5076" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_8f2dd957-3067-4494-a816-a2709a5c5076" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_39599002-119e-4a11-a614-1b0cf2c70c49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_39599002-119e-4a11-a614-1b0cf2c70c49" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_c7831e6c-2015-458a-af7b-aa7a37120582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_c7831e6c-2015-458a-af7b-aa7a37120582" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDateOfFirstRequiredPayment1_01c2754f-0015-40a7-bce8-cccb600f7e77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDateOfFirstRequiredPayment1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_us-gaap_DebtInstrumentDateOfFirstRequiredPayment1_01c2754f-0015-40a7-bce8-cccb600f7e77" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_e08b42ea-58b2-4943-bc6f-60ed15b69b75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_e08b42ea-58b2-4943-bc6f-60ed15b69b75" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarlyRepaymentOfSeniorDebt_38263190-0014-4258-86f7-27eb81c5bc80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarlyRepaymentOfSeniorDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_us-gaap_EarlyRepaymentOfSeniorDebt_38263190-0014-4258-86f7-27eb81c5bc80" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_5814457f-2b00-468b-9485-9781ab09ba5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_5814457f-2b00-468b-9485-9781ab09ba5f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_PaymentOfAccruedAndUnpaidInterest_d3511f2c-1dd3-40fa-9545-dfc0629071c1" xlink:href="a-20230131.xsd#a_PaymentOfAccruedAndUnpaidInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_a_PaymentOfAccruedAndUnpaidInterest_d3511f2c-1dd3-40fa-9545-dfc0629071c1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_2e917a8d-dad6-4fe9-9f7d-d37fcdcbe2b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_2e917a8d-dad6-4fe9-9f7d-d37fcdcbe2b5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest_c5bf897d-a54c-4140-b925-0011dfdc5f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest_c5bf897d-a54c-4140-b925-0011dfdc5f4a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_17d86a9c-cb94-4a82-b118-705aea4545d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_17d86a9c-cb94-4a82-b118-705aea4545d0" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_25e0a5e9-ea39-4893-ab25-82cd0fe4b63f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_25e0a5e9-ea39-4893-ab25-82cd0fe4b63f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_a034d2d3-c70a-4a82-852a-3d98e6793c79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_a034d2d3-c70a-4a82-852a-3d98e6793c79" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_500c78db-f604-42b1-8360-567b5de45bbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_us-gaap_LongTermDebt_500c78db-f604-42b1-8360-567b5de45bbd" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d1a46d5f-36ce-4f57-ace4-372f45f43460" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_us-gaap_DebtInstrumentTable_d1a46d5f-36ce-4f57-ace4-372f45f43460" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1b4af81f-7a27-40af-bc54-e7594f881f59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d1a46d5f-36ce-4f57-ace4-372f45f43460" xlink:to="loc_us-gaap_DebtInstrumentAxis_1b4af81f-7a27-40af-bc54-e7594f881f59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1b4af81f-7a27-40af-bc54-e7594f881f59_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1b4af81f-7a27-40af-bc54-e7594f881f59" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1b4af81f-7a27-40af-bc54-e7594f881f59_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9688b147-916f-42c8-b2ee-4852f5cd4d68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1b4af81f-7a27-40af-bc54-e7594f881f59" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9688b147-916f-42c8-b2ee-4852f5cd4d68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2022Member_8ccb66b1-5596-40a4-9f94-15b0be58a2f5" xlink:href="a-20230131.xsd#a_SeniorNotes2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9688b147-916f-42c8-b2ee-4852f5cd4d68" xlink:to="loc_a_SeniorNotes2022Member_8ccb66b1-5596-40a4-9f94-15b0be58a2f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2031Member_5ca52fbf-cb37-4d3b-97fb-98035260f0dd" xlink:href="a-20230131.xsd#a_SeniorNotes2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9688b147-916f-42c8-b2ee-4852f5cd4d68" xlink:to="loc_a_SeniorNotes2031Member_5ca52fbf-cb37-4d3b-97fb-98035260f0dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_TermLoanMaturing2025Member_d9b37f37-bd2b-4cb4-8d96-d755b58eede8" xlink:href="a-20230131.xsd#a_TermLoanMaturing2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9688b147-916f-42c8-b2ee-4852f5cd4d68" xlink:to="loc_a_TermLoanMaturing2025Member_d9b37f37-bd2b-4cb4-8d96-d755b58eede8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_d064fbfd-634b-4594-b4ba-dc15c8174d88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9688b147-916f-42c8-b2ee-4852f5cd4d68" xlink:to="loc_us-gaap_SeniorNotesMember_d064fbfd-634b-4594-b4ba-dc15c8174d88" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2023Member_e0184475-6ef5-4104-ad2c-2f8666b37660" xlink:href="a-20230131.xsd#a_SeniorNotes2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9688b147-916f-42c8-b2ee-4852f5cd4d68" xlink:to="loc_a_SeniorNotes2023Member_e0184475-6ef5-4104-ad2c-2f8666b37660" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_88fb75ef-5761-4b79-8bb9-cedd9ced11f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d1a46d5f-36ce-4f57-ace4-372f45f43460" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_88fb75ef-5761-4b79-8bb9-cedd9ced11f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_88fb75ef-5761-4b79-8bb9-cedd9ced11f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_88fb75ef-5761-4b79-8bb9-cedd9ced11f6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_88fb75ef-5761-4b79-8bb9-cedd9ced11f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_68ca0854-1f73-4709-92e0-aac1c29b3895" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_88fb75ef-5761-4b79-8bb9-cedd9ced11f6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_68ca0854-1f73-4709-92e0-aac1c29b3895" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_1f113280-5e8e-484d-9302-7f00068c6811" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d1a46d5f-36ce-4f57-ace4-372f45f43460" xlink:to="loc_us-gaap_VariableRateAxis_1f113280-5e8e-484d-9302-7f00068c6811" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_1f113280-5e8e-484d-9302-7f00068c6811_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_1f113280-5e8e-484d-9302-7f00068c6811" xlink:to="loc_us-gaap_VariableRateDomain_1f113280-5e8e-484d-9302-7f00068c6811_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_cc2ecc59-7d02-4c2c-9f79-64212e652f66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_1f113280-5e8e-484d-9302-7f00068c6811" xlink:to="loc_us-gaap_VariableRateDomain_cc2ecc59-7d02-4c2c-9f79-64212e652f66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_77bc6590-36ed-465a-a89f-dd3b4347d9c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d1a46d5f-36ce-4f57-ace4-372f45f43460" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_77bc6590-36ed-465a-a89f-dd3b4347d9c0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_77bc6590-36ed-465a-a89f-dd3b4347d9c0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_77bc6590-36ed-465a-a89f-dd3b4347d9c0" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_77bc6590-36ed-465a-a89f-dd3b4347d9c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_bd0810be-64e8-4b33-85a0-be6ee15bf11d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_77bc6590-36ed-465a-a89f-dd3b4347d9c0" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_bd0810be-64e8-4b33-85a0-be6ee15bf11d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_972b528b-314c-46be-8205-e753f8fc51fb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d1a46d5f-36ce-4f57-ace4-372f45f43460" xlink:to="loc_srt_RangeAxis_972b528b-314c-46be-8205-e753f8fc51fb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_972b528b-314c-46be-8205-e753f8fc51fb_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_972b528b-314c-46be-8205-e753f8fc51fb" xlink:to="loc_srt_RangeMember_972b528b-314c-46be-8205-e753f8fc51fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_175cf083-e6b5-4918-81f0-9e0265acbb25" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_972b528b-314c-46be-8205-e753f8fc51fb" xlink:to="loc_srt_RangeMember_175cf083-e6b5-4918-81f0-9e0265acbb25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_4dd415bd-4099-44a7-a8bc-0fe0de0bf5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d1a46d5f-36ce-4f57-ace4-372f45f43460" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_4dd415bd-4099-44a7-a8bc-0fe0de0bf5d6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_4dd415bd-4099-44a7-a8bc-0fe0de0bf5d6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4dd415bd-4099-44a7-a8bc-0fe0de0bf5d6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_4dd415bd-4099-44a7-a8bc-0fe0de0bf5d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0f6a98e7-5aa5-442e-bbe5-2b59d2c47cba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4dd415bd-4099-44a7-a8bc-0fe0de0bf5d6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0f6a98e7-5aa5-442e-bbe5-2b59d2c47cba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_4278e4e9-fefe-44d0-892d-2de3164d05e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_0f6a98e7-5aa5-442e-bbe5-2b59d2c47cba" xlink:to="loc_us-gaap_SubsequentEventMember_4278e4e9-fefe-44d0-892d-2de3164d05e2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails" xlink:type="simple" xlink:href="a-20230131.xsd#STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails" xlink:type="extended" id="ia9930fbefabf4e9589168e7361de92a2_STOCKHOLDERSEQUITYStockRepurchaseProgramDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_fd9a7f7a-e77f-4e60-a2e3-5351563d90d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_724a7794-47de-43ad-80ff-e7db0b4c4b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_fd9a7f7a-e77f-4e60-a2e3-5351563d90d8" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_724a7794-47de-43ad-80ff-e7db0b4c4b8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_686b8612-f8a1-4c9f-87ef-68b95d69e7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_fd9a7f7a-e77f-4e60-a2e3-5351563d90d8" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_686b8612-f8a1-4c9f-87ef-68b95d69e7a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_34426705-3229-41d6-b08a-c606291a95f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_fd9a7f7a-e77f-4e60-a2e3-5351563d90d8" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_34426705-3229-41d6-b08a-c606291a95f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_c7f4990f-8c28-4033-9f4f-98c20fba01a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_fd9a7f7a-e77f-4e60-a2e3-5351563d90d8" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_c7f4990f-8c28-4033-9f4f-98c20fba01a3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_9e1dad64-1d3f-4703-a800-6bfe73a51ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_fd9a7f7a-e77f-4e60-a2e3-5351563d90d8" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_9e1dad64-1d3f-4703-a800-6bfe73a51ca5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_233122a9-7edc-4b5d-b976-1a8fd9ae5572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_9e1dad64-1d3f-4703-a800-6bfe73a51ca5" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_233122a9-7edc-4b5d-b976-1a8fd9ae5572" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_233122a9-7edc-4b5d-b976-1a8fd9ae5572_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_233122a9-7edc-4b5d-b976-1a8fd9ae5572" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_233122a9-7edc-4b5d-b976-1a8fd9ae5572_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_580ec089-0f85-41a4-9d60-01b160ee2076" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_233122a9-7edc-4b5d-b976-1a8fd9ae5572" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_580ec089-0f85-41a4-9d60-01b160ee2076" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_54bc076b-c344-46c7-bbbc-711fdcac5f19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_9e1dad64-1d3f-4703-a800-6bfe73a51ca5" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_54bc076b-c344-46c7-bbbc-711fdcac5f19" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_54bc076b-c344-46c7-bbbc-711fdcac5f19_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_54bc076b-c344-46c7-bbbc-711fdcac5f19" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_54bc076b-c344-46c7-bbbc-711fdcac5f19_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_f7633779-d303-4fd3-b34b-33fe0995d3ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_54bc076b-c344-46c7-bbbc-711fdcac5f19" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_f7633779-d303-4fd3-b34b-33fe0995d3ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_A2019RepurchaseProgramMember_4d6768c4-5bb2-490a-80df-be05d34b98aa" xlink:href="a-20230131.xsd#a_A2019RepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_f7633779-d303-4fd3-b34b-33fe0995d3ae" xlink:to="loc_a_A2019RepurchaseProgramMember_4d6768c4-5bb2-490a-80df-be05d34b98aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_A2021RepurchaseProgramMember_ba1ae194-4b98-470d-bf27-25054518f68b" xlink:href="a-20230131.xsd#a_A2021RepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_f7633779-d303-4fd3-b34b-33fe0995d3ae" xlink:to="loc_a_A2021RepurchaseProgramMember_ba1ae194-4b98-470d-bf27-25054518f68b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_A2023RepurchaseProgramMember_cbe301ef-eda9-4ac5-91ae-d75ec58ec7af" xlink:href="a-20230131.xsd#a_A2023RepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_f7633779-d303-4fd3-b34b-33fe0995d3ae" xlink:to="loc_a_A2023RepurchaseProgramMember_cbe301ef-eda9-4ac5-91ae-d75ec58ec7af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_289b76d5-97e7-4a96-88ee-727c8a1ee697" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_9e1dad64-1d3f-4703-a800-6bfe73a51ca5" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_289b76d5-97e7-4a96-88ee-727c8a1ee697" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_289b76d5-97e7-4a96-88ee-727c8a1ee697_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_289b76d5-97e7-4a96-88ee-727c8a1ee697" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_289b76d5-97e7-4a96-88ee-727c8a1ee697_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_86814213-111e-4e88-9d96-ed9bad25f9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_289b76d5-97e7-4a96-88ee-727c8a1ee697" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_86814213-111e-4e88-9d96-ed9bad25f9a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_5d016200-fa94-4dae-8f2a-ef8474defd42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_86814213-111e-4e88-9d96-ed9bad25f9a8" xlink:to="loc_us-gaap_SubsequentEventMember_5d016200-fa94-4dae-8f2a-ef8474defd42" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails" xlink:type="simple" xlink:href="a-20230131.xsd#STOCKHOLDERSEQUITYDividendsDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails" xlink:type="extended" id="if2747f87ca894b1b83cbd5947cd29c32_STOCKHOLDERSEQUITYDividendsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableLineItems_128acdf2-f0f2-432e-ad48-8ee388f37fcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsAbstract_fc32ecdf-be65-445b-88cf-2fa8ebd29c51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_128acdf2-f0f2-432e-ad48-8ee388f37fcf" xlink:to="loc_us-gaap_PaymentsOfDividendsAbstract_fc32ecdf-be65-445b-88cf-2fa8ebd29c51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_d568dffb-3440-419e-918a-ca5cccb12097" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PaymentsOfDividendsAbstract_fc32ecdf-be65-445b-88cf-2fa8ebd29c51" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_d568dffb-3440-419e-918a-ca5cccb12097" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_63ab5895-7b1d-4878-8a84-ab48505f9f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PaymentsOfDividendsAbstract_fc32ecdf-be65-445b-88cf-2fa8ebd29c51" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_63ab5895-7b1d-4878-8a84-ab48505f9f9b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_94af5d8f-2351-491f-9e08-0a41a91112ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PaymentsOfDividendsAbstract_fc32ecdf-be65-445b-88cf-2fa8ebd29c51" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_94af5d8f-2351-491f-9e08-0a41a91112ab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockAbstract_1892dd5d-054e-4546-9039-92a619d6a740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_128acdf2-f0f2-432e-ad48-8ee388f37fcf" xlink:to="loc_us-gaap_DividendsCommonStockAbstract_1892dd5d-054e-4546-9039-92a619d6a740" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_3c89e7b6-7a24-4fc1-9350-88f8527dcb7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateDeclaredDayMonthAndYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsCommonStockAbstract_1892dd5d-054e-4546-9039-92a619d6a740" xlink:to="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_3c89e7b6-7a24-4fc1-9350-88f8527dcb7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_b74ecb1a-a1d2-4154-b088-dd15ccb8aec9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsCommonStockAbstract_1892dd5d-054e-4546-9039-92a619d6a740" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_b74ecb1a-a1d2-4154-b088-dd15ccb8aec9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_6339fe4e-962c-4d9b-9511-3b302a50db5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsCommonStockAbstract_1892dd5d-054e-4546-9039-92a619d6a740" xlink:to="loc_us-gaap_DividendsCommonStockCash_6339fe4e-962c-4d9b-9511-3b302a50db5b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_c7332f1d-9c5f-4a41-a7ce-9cf40a40e05b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendPayableDateToBePaidDayMonthAndYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsCommonStockAbstract_1892dd5d-054e-4546-9039-92a619d6a740" xlink:to="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_c7332f1d-9c5f-4a41-a7ce-9cf40a40e05b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_54012f9e-b27c-463b-94e7-2f4d674c6ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateOfRecordDayMonthAndYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsCommonStockAbstract_1892dd5d-054e-4546-9039-92a619d6a740" xlink:to="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_54012f9e-b27c-463b-94e7-2f4d674c6ce9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableTable_1504c0fd-e6ff-41b6-abbe-aa533d478edf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DividendsPayableLineItems_128acdf2-f0f2-432e-ad48-8ee388f37fcf" xlink:to="loc_us-gaap_DividendsPayableTable_1504c0fd-e6ff-41b6-abbe-aa533d478edf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_9669e31f-e18b-4257-8387-d394a0295d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DividendsPayableTable_1504c0fd-e6ff-41b6-abbe-aa533d478edf" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_9669e31f-e18b-4257-8387-d394a0295d2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_9669e31f-e18b-4257-8387-d394a0295d2b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9669e31f-e18b-4257-8387-d394a0295d2b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_9669e31f-e18b-4257-8387-d394a0295d2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5772e212-e1da-4e54-8b36-4fb7e286a29a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9669e31f-e18b-4257-8387-d394a0295d2b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5772e212-e1da-4e54-8b36-4fb7e286a29a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_faf1322c-21c6-4cdf-bf57-652aa56656d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_5772e212-e1da-4e54-8b36-4fb7e286a29a" xlink:to="loc_us-gaap_SubsequentEventMember_faf1322c-21c6-4cdf-bf57-652aa56656d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsAxis_53235955-3c3a-4438-8ef7-27cae209bd69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DividendsPayableTable_1504c0fd-e6ff-41b6-abbe-aa533d478edf" xlink:to="loc_us-gaap_DividendsAxis_53235955-3c3a-4438-8ef7-27cae209bd69" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDomain_53235955-3c3a-4438-8ef7-27cae209bd69_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DividendsAxis_53235955-3c3a-4438-8ef7-27cae209bd69" xlink:to="loc_us-gaap_DividendsDomain_53235955-3c3a-4438-8ef7-27cae209bd69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDomain_b048e6f5-7500-4d32-b2de-f6b02c486ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DividendsAxis_53235955-3c3a-4438-8ef7-27cae209bd69" xlink:to="loc_us-gaap_DividendsDomain_b048e6f5-7500-4d32-b2de-f6b02c486ab6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="a-20230131.xsd#STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended" id="ie0a73277238d4c7faf4f4eb279d24204_STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_0ae8101a-8f1a-4a22-97e4-af5f4a73f7ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_32574e60-7461-4899-b559-35fc77afd09d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0ae8101a-8f1a-4a22-97e4-af5f4a73f7ba" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_32574e60-7461-4899-b559-35fc77afd09d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_20f86709-3816-4ae4-9893-e21f36709421" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0ae8101a-8f1a-4a22-97e4-af5f4a73f7ba" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_20f86709-3816-4ae4-9893-e21f36709421" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_efa88e7b-4442-419d-a5a9-b44417240dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0ae8101a-8f1a-4a22-97e4-af5f4a73f7ba" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_efa88e7b-4442-419d-a5a9-b44417240dd3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_d8eb50bf-332e-4b17-b4ed-4163e70a725a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0ae8101a-8f1a-4a22-97e4-af5f4a73f7ba" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_d8eb50bf-332e-4b17-b4ed-4163e70a725a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_6a2bd93c-a101-4832-bf6b-438a2d9682b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0ae8101a-8f1a-4a22-97e4-af5f4a73f7ba" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_6a2bd93c-a101-4832-bf6b-438a2d9682b8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5ad3f1ff-3826-49f5-a790-fd2e9d58f0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0ae8101a-8f1a-4a22-97e4-af5f4a73f7ba" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5ad3f1ff-3826-49f5-a790-fd2e9d58f0e0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_29f61030-f154-436a-8d7e-324aa7824a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ade0052a-cf57-4fde-8ea7-374492dbaa3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0ae8101a-8f1a-4a22-97e4-af5f4a73f7ba" xlink:to="loc_us-gaap_StatementTable_ade0052a-cf57-4fde-8ea7-374492dbaa3c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_11db9437-563a-496d-9043-091d0d00eafc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ade0052a-cf57-4fde-8ea7-374492dbaa3c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_11db9437-563a-496d-9043-091d0d00eafc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_11db9437-563a-496d-9043-091d0d00eafc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_11db9437-563a-496d-9043-091d0d00eafc" xlink:to="loc_us-gaap_EquityComponentDomain_11db9437-563a-496d-9043-091d0d00eafc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_57020c5c-5ea8-4fbc-a18c-5d48dcc4facf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_11db9437-563a-496d-9043-091d0d00eafc" xlink:to="loc_us-gaap_EquityComponentDomain_57020c5c-5ea8-4fbc-a18c-5d48dcc4facf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_797f3a54-4a78-4638-8568-91638aa0bc6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_57020c5c-5ea8-4fbc-a18c-5d48dcc4facf" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_797f3a54-4a78-4638-8568-91638aa0bc6f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_e36349c8-b259-4b51-a56e-eefa63da5084" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_57020c5c-5ea8-4fbc-a18c-5d48dcc4facf" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_e36349c8-b259-4b51-a56e-eefa63da5084" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_e4ccbdad-300a-4c88-bad7-70cc7a93e3fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_57020c5c-5ea8-4fbc-a18c-5d48dcc4facf" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_e4ccbdad-300a-4c88-bad7-70cc7a93e3fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember_e764c4cd-b98f-4c76-868a-03c8672f3f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_57020c5c-5ea8-4fbc-a18c-5d48dcc4facf" xlink:to="loc_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember_e764c4cd-b98f-4c76-868a-03c8672f3f3c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_2a184749-6cae-4b78-b530-2c29211a7e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ade0052a-cf57-4fde-8ea7-374492dbaa3c" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_2a184749-6cae-4b78-b530-2c29211a7e5f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_2a184749-6cae-4b78-b530-2c29211a7e5f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_2a184749-6cae-4b78-b530-2c29211a7e5f" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_2a184749-6cae-4b78-b530-2c29211a7e5f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_5fda022e-bc67-483e-aecf-767573fd516f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_2a184749-6cae-4b78-b530-2c29211a7e5f" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_5fda022e-bc67-483e-aecf-767573fd516f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails" xlink:type="simple" xlink:href="a-20230131.xsd#STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails" xlink:type="extended" id="ia0fdbdf9a2a14f6893537ce3131616a9_STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db7ce1fd-0309-42b2-aa71-57c28dd56612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_c8e71069-6565-44b6-a7e7-6fc4133c3de8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db7ce1fd-0309-42b2-aa71-57c28dd56612" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_c8e71069-6565-44b6-a7e7-6fc4133c3de8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_46162a9e-fb86-4e8e-b587-45eeb20bae1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db7ce1fd-0309-42b2-aa71-57c28dd56612" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_46162a9e-fb86-4e8e-b587-45eeb20bae1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b2362f0f-5fd8-47e1-b54b-bbad56179e99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db7ce1fd-0309-42b2-aa71-57c28dd56612" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b2362f0f-5fd8-47e1-b54b-bbad56179e99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_66e4a260-ea2b-400c-89ca-9476f7214795" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db7ce1fd-0309-42b2-aa71-57c28dd56612" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_66e4a260-ea2b-400c-89ca-9476f7214795" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_cc6e645e-9350-4ab6-be74-db4b1b65d662" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db7ce1fd-0309-42b2-aa71-57c28dd56612" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_cc6e645e-9350-4ab6-be74-db4b1b65d662" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax_fb5e6a98-faaf-4dc9-ac35-6385fb0025ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db7ce1fd-0309-42b2-aa71-57c28dd56612" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax_fb5e6a98-faaf-4dc9-ac35-6385fb0025ab" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax_d82c2b09-24d3-4198-8722-89b3ea0d6d57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db7ce1fd-0309-42b2-aa71-57c28dd56612" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax_d82c2b09-24d3-4198-8722-89b3ea0d6d57" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_d3bfae0e-38fe-43a4-8b33-296320fdc6ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db7ce1fd-0309-42b2-aa71-57c28dd56612" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_d3bfae0e-38fe-43a4-8b33-296320fdc6ea" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_e75535ae-be38-43a7-a5cd-812e27965765" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db7ce1fd-0309-42b2-aa71-57c28dd56612" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_e75535ae-be38-43a7-a5cd-812e27965765" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_6ac1d60a-e93c-4988-992b-22b81511fc80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db7ce1fd-0309-42b2-aa71-57c28dd56612" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_6ac1d60a-e93c-4988-992b-22b81511fc80" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8b99aded-0e0d-4c07-8f51-250fa0524ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_6ac1d60a-e93c-4988-992b-22b81511fc80" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8b99aded-0e0d-4c07-8f51-250fa0524ad5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8b99aded-0e0d-4c07-8f51-250fa0524ad5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8b99aded-0e0d-4c07-8f51-250fa0524ad5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8b99aded-0e0d-4c07-8f51-250fa0524ad5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f1fa0988-c01b-4aa2-9837-ce3ab88b9b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8b99aded-0e0d-4c07-8f51-250fa0524ad5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f1fa0988-c01b-4aa2-9837-ce3ab88b9b4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_62c5ab66-1e43-4187-9631-1d14aa5d9bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f1fa0988-c01b-4aa2-9837-ce3ab88b9b4b" xlink:to="loc_us-gaap_CostOfSalesMember_62c5ab66-1e43-4187-9631-1d14aa5d9bf8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_933c23b0-249e-4ead-abe8-dd0f839ab10b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f1fa0988-c01b-4aa2-9837-ce3ab88b9b4b" xlink:to="loc_us-gaap_InterestExpenseMember_933c23b0-249e-4ead-abe8-dd0f839ab10b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_f0f9982f-8180-47a2-8bde-896e41880347" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_6ac1d60a-e93c-4988-992b-22b81511fc80" xlink:to="loc_srt_StatementScenarioAxis_f0f9982f-8180-47a2-8bde-896e41880347" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_f0f9982f-8180-47a2-8bde-896e41880347_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_f0f9982f-8180-47a2-8bde-896e41880347" xlink:to="loc_srt_ScenarioUnspecifiedDomain_f0f9982f-8180-47a2-8bde-896e41880347_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_919976c5-09e0-40ca-a25d-b27f248132b2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_f0f9982f-8180-47a2-8bde-896e41880347" xlink:to="loc_srt_ScenarioUnspecifiedDomain_919976c5-09e0-40ca-a25d-b27f248132b2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails" xlink:type="simple" xlink:href="a-20230131.xsd#SEGMENTINFORMATIONProfitabilityDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails" xlink:type="extended" id="i0f6aa25dceb64d35b4bea04a2d83e00b_SEGMENTINFORMATIONProfitabilityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_c859ffdd-2122-4f81-9769-719796c8f362" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dd853519-094e-42be-aa1e-b0b538da394a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c859ffdd-2122-4f81-9769-719796c8f362" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dd853519-094e-42be-aa1e-b0b538da394a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6e42cef2-b086-4df0-8e0d-4e05d74a24c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c859ffdd-2122-4f81-9769-719796c8f362" xlink:to="loc_us-gaap_OperatingIncomeLoss_6e42cef2-b086-4df0-8e0d-4e05d74a24c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c6b1ab8c-4e25-4e6e-a038-700986b9c82d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c859ffdd-2122-4f81-9769-719796c8f362" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c6b1ab8c-4e25-4e6e-a038-700986b9c82d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_723f4c3e-2643-4ee9-9034-3104c3e41644" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c6b1ab8c-4e25-4e6e-a038-700986b9c82d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_723f4c3e-2643-4ee9-9034-3104c3e41644" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_723f4c3e-2643-4ee9-9034-3104c3e41644_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_723f4c3e-2643-4ee9-9034-3104c3e41644" xlink:to="loc_us-gaap_SegmentDomain_723f4c3e-2643-4ee9-9034-3104c3e41644_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_960bb375-280b-44f7-9c8a-64e9b2dfbd1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_723f4c3e-2643-4ee9-9034-3104c3e41644" xlink:to="loc_us-gaap_SegmentDomain_960bb375-280b-44f7-9c8a-64e9b2dfbd1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_LifeSciencesandAppliedMarketsMember_55b7e2f0-71c0-41f0-8ef3-0e07946c902a" xlink:href="a-20230131.xsd#a_LifeSciencesandAppliedMarketsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_960bb375-280b-44f7-9c8a-64e9b2dfbd1a" xlink:to="loc_a_LifeSciencesandAppliedMarketsMember_55b7e2f0-71c0-41f0-8ef3-0e07946c902a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_DiagnosticsAndGenomicsMember_b57ccfb4-cf4e-460b-a8f6-f8d0fe132ae6" xlink:href="a-20230131.xsd#a_DiagnosticsAndGenomicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_960bb375-280b-44f7-9c8a-64e9b2dfbd1a" xlink:to="loc_a_DiagnosticsAndGenomicsMember_b57ccfb4-cf4e-460b-a8f6-f8d0fe132ae6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AgilentCrossLabMember_19ccab02-3e0d-4abf-8a12-aab772bfeb68" xlink:href="a-20230131.xsd#a_AgilentCrossLabMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_960bb375-280b-44f7-9c8a-64e9b2dfbd1a" xlink:to="loc_a_AgilentCrossLabMember_19ccab02-3e0d-4abf-8a12-aab772bfeb68" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SegmentTotalMember_1ae3ff23-97df-4f16-8a20-f1f23132ffc3" xlink:href="a-20230131.xsd#a_SegmentTotalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_960bb375-280b-44f7-9c8a-64e9b2dfbd1a" xlink:to="loc_a_SegmentTotalMember_1ae3ff23-97df-4f16-8a20-f1f23132ffc3" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails" xlink:type="simple" xlink:href="a-20230131.xsd#SEGMENTINFORMATIONReconciliationofReportableResultsDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails" xlink:type="extended" id="i726646d227214840b42e2df155a591f0_SEGMENTINFORMATIONReconciliationofReportableResultsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_60fcbbc2-d91f-43ef-9ada-1bf2a829231e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_b9428e6a-761c-46f9-bb14-29cba6857f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_60fcbbc2-d91f-43ef-9ada-1bf2a829231e" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_b9428e6a-761c-46f9-bb14-29cba6857f2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9eb4b84d-0ec7-4651-91c1-b003997320a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_b9428e6a-761c-46f9-bb14-29cba6857f2a" xlink:to="loc_us-gaap_OperatingIncomeLoss_9eb4b84d-0ec7-4651-91c1-b003997320a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_TransformationalPrograms_1f9396bd-7d14-4d4b-9be0-056b51e04ea5" xlink:href="a-20230131.xsd#a_TransformationalPrograms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_b9428e6a-761c-46f9-bb14-29cba6857f2a" xlink:to="loc_a_TransformationalPrograms_1f9396bd-7d14-4d4b-9be0-056b51e04ea5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_3bd01057-0919-4d00-9c8f-f1d0285f6747" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_b9428e6a-761c-46f9-bb14-29cba6857f2a" xlink:to="loc_us-gaap_AdjustmentForAmortization_3bd01057-0919-4d00-9c8f-f1d0285f6747" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_d6d6101e-1e96-478d-83cd-cb202a7e3a21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_b9428e6a-761c-46f9-bb14-29cba6857f2a" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_d6d6101e-1e96-478d-83cd-cb202a7e3a21" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_01298fc1-bf2f-420f-a6cb-b3c4e144162d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_b9428e6a-761c-46f9-bb14-29cba6857f2a" xlink:to="loc_us-gaap_AssetImpairmentCharges_01298fc1-bf2f-420f-a6cb-b3c4e144162d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_cb72d831-c6a9-42b7-9a22-f94a8ecc599d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_b9428e6a-761c-46f9-bb14-29cba6857f2a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_cb72d831-c6a9-42b7-9a22-f94a8ecc599d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_7cdb7df9-cb41-4e0b-98a7-8845284fa781" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessExitCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_b9428e6a-761c-46f9-bb14-29cba6857f2a" xlink:to="loc_us-gaap_BusinessExitCosts1_7cdb7df9-cb41-4e0b-98a7-8845284fa781" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonrecurringExpense_84d3e0b6-3453-44fc-9db2-4af6c60cf81c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonrecurringExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_b9428e6a-761c-46f9-bb14-29cba6857f2a" xlink:to="loc_us-gaap_OtherNonrecurringExpense_84d3e0b6-3453-44fc-9db2-4af6c60cf81c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_3b92a414-3aa4-4202-b784-eeeedb2c9707" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_b9428e6a-761c-46f9-bb14-29cba6857f2a" xlink:to="loc_us-gaap_InvestmentIncomeInterest_3b92a414-3aa4-4202-b784-eeeedb2c9707" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_5bbcfb34-6dd0-4e98-9c0f-fc7191740744" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_b9428e6a-761c-46f9-bb14-29cba6857f2a" xlink:to="loc_us-gaap_InterestExpense_5bbcfb34-6dd0-4e98-9c0f-fc7191740744" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_2b6a0798-ab78-466f-ae4b-eadde3b3c58c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_b9428e6a-761c-46f9-bb14-29cba6857f2a" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_2b6a0798-ab78-466f-ae4b-eadde3b3c58c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6f3ef87e-d4c1-4bb6-b2ac-372443528572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_b9428e6a-761c-46f9-bb14-29cba6857f2a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6f3ef87e-d4c1-4bb6-b2ac-372443528572" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e34a0044-303f-4329-92c8-790acf8fd3f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_60fcbbc2-d91f-43ef-9ada-1bf2a829231e" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e34a0044-303f-4329-92c8-790acf8fd3f8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_578a250c-5daa-4b64-9675-fe1f53d3bdef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e34a0044-303f-4329-92c8-790acf8fd3f8" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_578a250c-5daa-4b64-9675-fe1f53d3bdef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_578a250c-5daa-4b64-9675-fe1f53d3bdef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_578a250c-5daa-4b64-9675-fe1f53d3bdef" xlink:to="loc_us-gaap_SegmentDomain_578a250c-5daa-4b64-9675-fe1f53d3bdef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c7fff83b-7e7e-478c-aa54-95c9c7b4bc48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_578a250c-5daa-4b64-9675-fe1f53d3bdef" xlink:to="loc_us-gaap_SegmentDomain_c7fff83b-7e7e-478c-aa54-95c9c7b4bc48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SegmentTotalMember_4bc8195a-1f09-4d4a-92e2-1c5b55d4be39" xlink:href="a-20230131.xsd#a_SegmentTotalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c7fff83b-7e7e-478c-aa54-95c9c7b4bc48" xlink:to="loc_a_SegmentTotalMember_4bc8195a-1f09-4d4a-92e2-1c5b55d4be39" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_5ba14867-5fa6-4e1c-a799-bf3f442e25cf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e34a0044-303f-4329-92c8-790acf8fd3f8" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_5ba14867-5fa6-4e1c-a799-bf3f442e25cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_5ba14867-5fa6-4e1c-a799-bf3f442e25cf_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_5ba14867-5fa6-4e1c-a799-bf3f442e25cf" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_5ba14867-5fa6-4e1c-a799-bf3f442e25cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_8592bb7a-3e85-408e-b472-8b3e5f874fc7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_5ba14867-5fa6-4e1c-a799-bf3f442e25cf" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_8592bb7a-3e85-408e-b472-8b3e5f874fc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis_d95d0609-ceec-4f45-9dc6-8588916d314e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e34a0044-303f-4329-92c8-790acf8fd3f8" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsAxis_d95d0609-ceec-4f45-9dc6-8588916d314e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_d95d0609-ceec-4f45-9dc6-8588916d314e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_d95d0609-ceec-4f45-9dc6-8588916d314e" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_d95d0609-ceec-4f45-9dc6-8588916d314e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_c2c395d8-ee30-40c2-b370-f7ef012f9194" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_d95d0609-ceec-4f45-9dc6-8588916d314e" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_c2c395d8-ee30-40c2-b370-f7ef012f9194" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SEGMENTINFORMATIONSegmentAssetsDetails" xlink:type="simple" xlink:href="a-20230131.xsd#SEGMENTINFORMATIONSegmentAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.agilent.com/role/SEGMENTINFORMATIONSegmentAssetsDetails" xlink:type="extended" id="ib46ea1ddacea4fc8ad6eff846cf27367_SEGMENTINFORMATIONSegmentAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_91584b80-2e2f-4e2c-b850-1119c2fb7d75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_f13e8699-bb11-4b84-bf43-7d61bce763d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_91584b80-2e2f-4e2c-b850-1119c2fb7d75" xlink:to="loc_us-gaap_Assets_f13e8699-bb11-4b84-bf43-7d61bce763d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b7d1cb26-dbef-44c3-9872-32d4e22a9399" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_91584b80-2e2f-4e2c-b850-1119c2fb7d75" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b7d1cb26-dbef-44c3-9872-32d4e22a9399" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_43d70d90-6c88-45e2-bc7a-a054b4774b84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b7d1cb26-dbef-44c3-9872-32d4e22a9399" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_43d70d90-6c88-45e2-bc7a-a054b4774b84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_43d70d90-6c88-45e2-bc7a-a054b4774b84_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_43d70d90-6c88-45e2-bc7a-a054b4774b84" xlink:to="loc_us-gaap_SegmentDomain_43d70d90-6c88-45e2-bc7a-a054b4774b84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_07401666-7fa3-4e95-b378-c546f856af81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_43d70d90-6c88-45e2-bc7a-a054b4774b84" xlink:to="loc_us-gaap_SegmentDomain_07401666-7fa3-4e95-b378-c546f856af81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_LifeSciencesandAppliedMarketsMember_40aa1c8b-7e94-4a46-b529-3252e9577f5f" xlink:href="a-20230131.xsd#a_LifeSciencesandAppliedMarketsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_07401666-7fa3-4e95-b378-c546f856af81" xlink:to="loc_a_LifeSciencesandAppliedMarketsMember_40aa1c8b-7e94-4a46-b529-3252e9577f5f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_DiagnosticsAndGenomicsMember_4dd1b60e-faee-4d2d-927a-f48c01260d25" xlink:href="a-20230131.xsd#a_DiagnosticsAndGenomicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_07401666-7fa3-4e95-b378-c546f856af81" xlink:to="loc_a_DiagnosticsAndGenomicsMember_4dd1b60e-faee-4d2d-927a-f48c01260d25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AgilentCrossLabMember_69c1ad3f-39df-45c2-b1fa-0f31eba7a9b9" xlink:href="a-20230131.xsd#a_AgilentCrossLabMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_07401666-7fa3-4e95-b378-c546f856af81" xlink:to="loc_a_AgilentCrossLabMember_69c1ad3f-39df-45c2-b1fa-0f31eba7a9b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SegmentTotalMember_3978117d-0f5a-41cd-ad86-bed27638b51e" xlink:href="a-20230131.xsd#a_SegmentTotalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_07401666-7fa3-4e95-b378-c546f856af81" xlink:to="loc_a_SegmentTotalMember_3978117d-0f5a-41cd-ad86-bed27638b51e" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="2"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>a-20230131_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:bf6e4e81-d7a1-484d-a6c7-4a9890c9070b,g:1d2ec140-a31f-4aad-8309-92440730b1c7-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_ab009774-8925-423e-8be7-e2749f78f3f3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_9e60589c-5691-40d1-b666-f721760cd348_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_28bdf4b1-dd30-4297-b91e-478df193c4c8_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_GBP_39853076-946a-44cf-b16c-2973d0412715_terseLabel_en-US" xlink:label="lab_currency_GBP" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Pound</link:label>
    <link:label id="lab_currency_GBP_label_en-US" xlink:label="lab_currency_GBP" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United Kingdom, Pounds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_GBP" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_GBP"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_GBP" xlink:to="lab_currency_GBP" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_5a38d363-64bf-4a4e-9a1a-2d41d079fcca_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_657160c9-a36c-4753-af7a-0da7120fd1f4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_a_A2023RepurchaseProgramMember_8b9baa61-fbb4-46c6-8887-d3d089ab8d3f_terseLabel_en-US" xlink:label="lab_a_A2023RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Repurchase Program</link:label>
    <link:label id="lab_a_A2023RepurchaseProgramMember_label_en-US" xlink:label="lab_a_A2023RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Repurchase Program [Member]</link:label>
    <link:label id="lab_a_A2023RepurchaseProgramMember_documentation_en-US" xlink:label="lab_a_A2023RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_A2023RepurchaseProgramMember" xlink:href="a-20230131.xsd#a_A2023RepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_A2023RepurchaseProgramMember" xlink:to="lab_a_A2023RepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecurities_74e2139c-a1fd-4deb-9ddc-625273d12be6_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading securities</link:label>
    <link:label id="lab_us-gaap_TradingSecurities_label_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecurities" xlink:to="lab_us-gaap_TradingSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_a34cc989-df88-4d59-990e-46897ceb8feb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in actuarial net loss, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessExitCosts1_d1415fab-20f3-4d9c-8999-ea2c4b8406b0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business exit and divestiture costs</link:label>
    <link:label id="lab_us-gaap_BusinessExitCosts1_label_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Exit Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessExitCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessExitCosts1" xlink:to="lab_us-gaap_BusinessExitCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_f617528e-e22e-4526-905f-986c2510e65d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_65c90300-b180-404b-a22a-7c9c5b9d9edb_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_a_SeniorNotes2022Member_958dac29-c765-402a-a66f-28df3ac6441e_terseLabel_en-US" xlink:label="lab_a_SeniorNotes2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2022</link:label>
    <link:label id="lab_a_SeniorNotes2022Member_label_en-US" xlink:label="lab_a_SeniorNotes2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2022 [Member]</link:label>
    <link:label id="lab_a_SeniorNotes2022Member_documentation_en-US" xlink:label="lab_a_SeniorNotes2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bond that takes priority over other debt securities by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured ( general) creditors.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2022Member" xlink:href="a-20230131.xsd#a_SeniorNotes2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_SeniorNotes2022Member" xlink:to="lab_a_SeniorNotes2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_a_BusinessCombinationContingentConsiderationFairValueMeasurementInput_fd353c84-34f9-4ba8-bfb8-465387b063e1_terseLabel_en-US" xlink:label="lab_a_BusinessCombinationContingentConsiderationFairValueMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Liability Measurement Input</link:label>
    <link:label id="lab_a_BusinessCombinationContingentConsiderationFairValueMeasurementInput_label_en-US" xlink:label="lab_a_BusinessCombinationContingentConsiderationFairValueMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Fair Value Measurement Input</link:label>
    <link:label id="lab_a_BusinessCombinationContingentConsiderationFairValueMeasurementInput_documentation_en-US" xlink:label="lab_a_BusinessCombinationContingentConsiderationFairValueMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage input used to measure contingent consideration liability from business combination.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_BusinessCombinationContingentConsiderationFairValueMeasurementInput" xlink:href="a-20230131.xsd#a_BusinessCombinationContingentConsiderationFairValueMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_BusinessCombinationContingentConsiderationFairValueMeasurementInput" xlink:to="lab_a_BusinessCombinationContingentConsiderationFairValueMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_5c29cd6e-4491-4eaf-b865-2321af02c67a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_e021e890-370a-4e2e-83a1-a5821c7cc397_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate amount of cash dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_2b682a3c-1c7b-48a0-bbdb-739014ddae1d_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0eeb21e5-3e91-44b9-869c-86c03f913563_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity of credit facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_a1bfe7ce-3229-4a24-8e45-17624a2f5ab3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of net pension and post-retirement benefit costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_86acb51f-a879-43a1-9506-d4197e2a6e99_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_4001b3b6-ab32-4d51-854e-95fb1f7539dd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Senior Notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock_33e445b0-4e01-407e-922e-e208aeaa7650_terseLabel_en-US" xlink:label="lab_a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer Contributions and Expected Employer Contributions</link:label>
    <link:label id="lab_a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock_label_en-US" xlink:label="lab_a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer Contributions and Expected Employer Contributions [Table Text Block]</link:label>
    <link:label id="lab_a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock_documentation_en-US" xlink:label="lab_a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of amount of contributions received by defined benefit plan from employer which increases plan assets and amount of contribution expected to be received by defined benefit plan from employer in the remainder of current fiscal year.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock" xlink:href="a-20230131.xsd#a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock" xlink:to="lab_a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNetAbstract_cbe35e8e-994a-4427-8647-a9178d97852d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryNetAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNetAbstract" xlink:to="lab_us-gaap_InventoryNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_c2fee11d-092b-408e-9f56-7af14b7b9e5b_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_470af3b2-ac7f-4825-868f-1f944dadf308_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation, net of tax expense (benefit) of $(1) and $0</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_4d35814b-8ad8-40bc-ab81-bc27762ae4bc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_70acae9f-5644-4393-a9a6-8d9f44ff9a7a_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in-capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract_66cc4a8d-5143-4779-8f16-3d049f06faf5_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net defined benefit pension cost and post retirement plan costs, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTextBlock_0582bf92-8845-4c28-afc5-9bd3bd9eb92b_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SHORT-TERM DEBT</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTextBlock" xlink:to="lab_us-gaap_ShortTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyDisclosureAbstract_7af65c42-245e-435b-af42-b01cb50cfbee_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Disclosure</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyDisclosureAbstract" xlink:to="lab_us-gaap_StandardProductWarrantyDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_1d5ce08b-0e7f-4911-a89f-7f3e4ba0df09_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_8865ab80-dc8a-4498-9032-47a6e5b0dd4b_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_fc8bc5de-0c02-467c-9a53-57435e41db55_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed interest rate per annum</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_88d6653b-e987-43b4-b1a3-7a0672f9d4c0_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_a7e9abdd-d589-4a43-a488-c5e268d15c9f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of derivative instruments for foreign exchange contracts in the consolidated statement of operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_efeff1a8-5a66-4b6d-ba8e-c14fe43fe80c_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_de4c5bdd-c2dd-4f2e-9963-baf9830cb905_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets</link:label>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentAssetsMember" xlink:to="lab_us-gaap_OtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_a_NumeratorAbstract_5fba3f28-ccc0-4db2-a3f4-3f0961300964_terseLabel_en-US" xlink:label="lab_a_NumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_a_NumeratorAbstract_label_en-US" xlink:label="lab_a_NumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator [Abstract]</link:label>
    <link:label id="lab_a_NumeratorAbstract_documentation_en-US" xlink:label="lab_a_NumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_NumeratorAbstract" xlink:href="a-20230131.xsd#a_NumeratorAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_NumeratorAbstract" xlink:to="lab_a_NumeratorAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_7eb1bfd1-b564-40d1-85ef-b17492a49263_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net plan costs (benefits)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_eaeec3f1-13c1-435e-9197-2a4b7d05d664_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_c27df8fd-4cb7-47c7-8378-5fdcc1d88524_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments (foreign exchange contracts)</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contracts, Liability, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_37b435ef-56a1-46e1-824b-eb792500f11c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_83fb887f-639d-4c63-b1fe-a71dee7ac0d7_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_ec1e2d40-10b4-45ee-bc78-7a3b9fff34ef_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_59cf7c3f-020d-488c-afa0-e2a72dbca2d2_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_79f1edf7-eb00-44cb-a5ca-387e5c9dcda3_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Profit (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5e5e42f0-e0ca-483c-83bf-03e222c5caba_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from EPS Computation</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_f50b1678-543f-436e-8d35-dee03807af21_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7943c057-bd31-4d9b-bf4e-4ab3f79e5eaf_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive shares excluded from computation of dilutive earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_49888aa1-9953-45af-8360-f4a26bf6af5e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_a_A2019RepurchaseProgramMember_838dc296-746b-492c-a62f-cb93e95fe9f4_terseLabel_en-US" xlink:label="lab_a_A2019RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Repurchase Program [Member]</link:label>
    <link:label id="lab_a_A2019RepurchaseProgramMember_label_en-US" xlink:label="lab_a_A2019RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Repurchase Program [Member]</link:label>
    <link:label id="lab_a_A2019RepurchaseProgramMember_documentation_en-US" xlink:label="lab_a_A2019RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Repurchase Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_A2019RepurchaseProgramMember" xlink:href="a-20230131.xsd#a_A2019RepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_A2019RepurchaseProgramMember" xlink:to="lab_a_A2019RepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_f5cf67ee-c968-4efc-b91a-d5bd506fa795_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_111429be-4cdc-4cb6-b305-cdb8d67a84c9_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary, Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:to="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_a_Taxrelatedtosharesissued_fc376d1b-4f81-48b7-94e1-49dfd64738e4_terseLabel_en-US" xlink:label="lab_a_Taxrelatedtosharesissued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax related to shares issued</link:label>
    <link:label id="lab_a_Taxrelatedtosharesissued_label_en-US" xlink:label="lab_a_Taxrelatedtosharesissued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax related to shares issued</link:label>
    <link:label id="lab_a_Taxrelatedtosharesissued_documentation_en-US" xlink:label="lab_a_Taxrelatedtosharesissued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax related to shares issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_Taxrelatedtosharesissued" xlink:href="a-20230131.xsd#a_Taxrelatedtosharesissued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_Taxrelatedtosharesissued" xlink:to="lab_a_Taxrelatedtosharesissued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_d42c692e-e9db-416a-be46-d127ce90c927_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodDomain_85f971ba-4574-4632-a381-aba18aab3198_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodDomain_label_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodDomain" xlink:to="lab_us-gaap_TaxPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_a598d22d-671a-4bbf-9918-7815481fad45_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_a9ade0a5-1ee5-4084-9b70-fdf0d7165c00_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_27c8c7f8-0d8d-400f-8ee9-f4d04a2e23fd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_d33af468-0237-4916-aece-e84a3ec0864d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_ec83ff30-ecc1-4bdc-a2f6-51c62b889529_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_bac73f14-657a-4154-b160-77696b4ffeef_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets measured at fair value</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarlyRepaymentOfSeniorDebt_159e273e-3d9b-45f3-af5c-ee5a6ecbe965_terseLabel_en-US" xlink:label="lab_us-gaap_EarlyRepaymentOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Early Repayment of Senior Debt</link:label>
    <link:label id="lab_us-gaap_EarlyRepaymentOfSeniorDebt_label_en-US" xlink:label="lab_us-gaap_EarlyRepaymentOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Early Repayment of Senior Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarlyRepaymentOfSeniorDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarlyRepaymentOfSeniorDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarlyRepaymentOfSeniorDebt" xlink:to="lab_us-gaap_EarlyRepaymentOfSeniorDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_40806353-3deb-416f-bf55-8cabf50ae9fe_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_d3593952-6fc0-46d4-8a81-708301583b28_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of interest rate swap contracts terminated</link:label>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_label_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Interest Rate Derivatives Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:to="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_82b00ff9-d3aa-45d3-92b8-f9fb32f7b7e7_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_992a03c4-8487-45ad-8c27-3032048d1b53_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Assets (Unbilled Accounts Receivable)</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInitiationDate1_671f06d6-1754-419f-b5fa-306f53b88e90_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInitiationDate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initiation date of credit facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInitiationDate1_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInitiationDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Initiation Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInitiationDate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInitiationDate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInitiationDate1" xlink:to="lab_us-gaap_LineOfCreditFacilityInitiationDate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_fe225b49-5131-4edd-9c5c-df143e06c007_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_17516fb5-b04d-44a4-acf2-be591bfa325f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_67f243ff-d5b0-4e33-a3a2-743c48820e50_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_88aa247d-62f0-447a-a87c-4007fb94e8b9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecourseStatusDomain_4ff7adca-a860-443a-b3b0-db6261fab639_terseLabel_en-US" xlink:label="lab_us-gaap_RecourseStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recourse Status [Domain]</link:label>
    <link:label id="lab_us-gaap_RecourseStatusDomain_label_en-US" xlink:label="lab_us-gaap_RecourseStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recourse Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecourseStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RecourseStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecourseStatusDomain" xlink:to="lab_us-gaap_RecourseStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_1d258aaf-b4a5-4da1-a58d-b3a9f8917d40_verboseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_a_PercentageOfFaceAmountOfSeniorNoteInstrumentIssued_afc997f5-576f-40ca-8f27-2acda3addc57_terseLabel_en-US" xlink:label="lab_a_PercentageOfFaceAmountOfSeniorNoteInstrumentIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Face Amount Of Senior Note Instrument Issued</link:label>
    <link:label id="lab_a_PercentageOfFaceAmountOfSeniorNoteInstrumentIssued_label_en-US" xlink:label="lab_a_PercentageOfFaceAmountOfSeniorNoteInstrumentIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Face Amount Of Senior Note Instrument Issued</link:label>
    <link:label id="lab_a_PercentageOfFaceAmountOfSeniorNoteInstrumentIssued_documentation_en-US" xlink:label="lab_a_PercentageOfFaceAmountOfSeniorNoteInstrumentIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds obtained expressed as a percentage of debt instrument face value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_PercentageOfFaceAmountOfSeniorNoteInstrumentIssued" xlink:href="a-20230131.xsd#a_PercentageOfFaceAmountOfSeniorNoteInstrumentIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_PercentageOfFaceAmountOfSeniorNoteInstrumentIssued" xlink:to="lab_a_PercentageOfFaceAmountOfSeniorNoteInstrumentIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_a_DenominatorsAbstract_bd6ef03f-df3b-4ad1-a882-3017c85d3499_terseLabel_en-US" xlink:label="lab_a_DenominatorsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominators:</link:label>
    <link:label id="lab_a_DenominatorsAbstract_label_en-US" xlink:label="lab_a_DenominatorsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominators [Abstract]</link:label>
    <link:label id="lab_a_DenominatorsAbstract_documentation_en-US" xlink:label="lab_a_DenominatorsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominators [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_DenominatorsAbstract" xlink:href="a-20230131.xsd#a_DenominatorsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_DenominatorsAbstract" xlink:to="lab_a_DenominatorsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_a_AgilentCrossLabMember_fc667d3c-e05f-400e-b169-f215310c2f6f_terseLabel_en-US" xlink:label="lab_a_AgilentCrossLabMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agilent CrossLab</link:label>
    <link:label id="lab_a_AgilentCrossLabMember_label_en-US" xlink:label="lab_a_AgilentCrossLabMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agilent CrossLab [Member]</link:label>
    <link:label id="lab_a_AgilentCrossLabMember_documentation_en-US" xlink:label="lab_a_AgilentCrossLabMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agilent CrossLab [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_AgilentCrossLabMember" xlink:href="a-20230131.xsd#a_AgilentCrossLabMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_AgilentCrossLabMember" xlink:to="lab_a_AgilentCrossLabMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_6ca7704c-6f2b-4118-8fbc-9ddda0872b95_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_090914a5-8aa0-4d1a-a8ef-db97fa5c0244_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_f18da2b0-7590-4c23-a6bd-c44417ac1332_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_40956a9d-2fbe-4fef-8ee4-41fb6456a4b2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted Prices in Active Markets for Identical Assets (Level 1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PledgedStatusAxis_3ddf2085-62e7-48d9-b47b-a528148e45a1_terseLabel_en-US" xlink:label="lab_us-gaap_PledgedStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pledged Status [Axis]</link:label>
    <link:label id="lab_us-gaap_PledgedStatusAxis_label_en-US" xlink:label="lab_us-gaap_PledgedStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pledged Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PledgedStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PledgedStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PledgedStatusAxis" xlink:to="lab_us-gaap_PledgedStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate_b3bd8a1a-d6c7-4852-b097-b067bed1624a_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Interest Rate, at Point in Time</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_a_SeniorNotes2029Member_8f5270eb-80df-49e9-87d4-df88c566360b_terseLabel_en-US" xlink:label="lab_a_SeniorNotes2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2029</link:label>
    <link:label id="lab_a_SeniorNotes2029Member_label_en-US" xlink:label="lab_a_SeniorNotes2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2029 [Member]</link:label>
    <link:label id="lab_a_SeniorNotes2029Member_documentation_en-US" xlink:label="lab_a_SeniorNotes2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2029 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2029Member" xlink:href="a-20230131.xsd#a_SeniorNotes2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_SeniorNotes2029Member" xlink:to="lab_a_SeniorNotes2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_cd9671d2-2018-4367-8e0e-e5edebca35f1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [ESPP]</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_465881d4-ea34-4212-bc0b-177440947569_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentOperatingActivitiesDomain_032b7ff6-bd11-4af7-88cc-255a04048b07_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentOperatingActivitiesDomain_label_en-US" xlink:label="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain" xlink:to="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_fe7bbd11-fcc1-4797-a09d-257546a38d5c_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPensionPlansDefinedBenefitMember_2311cbaf-7846-45ba-8d74-e6f83dc9f99d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Pension Plan</link:label>
    <link:label id="lab_us-gaap_OtherPensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_c6177e5c-1883-4627-9479-46a8c219ef8f_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_43b411f7-1ee7-4d44-aee9-670f40ff60c0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_701b8e53-7d7b-4ec8-98d0-fd65ece50cd2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_90bc0697-a016-441e-a125-94724064be9e_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-Process R&amp;D</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_29425049-2477-443b-b9ce-b91c264d0a0f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AllCurrenciesDomain_6fd72ce1-d555-493f-b02e-f2166b375260_terseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_label_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain" xlink:to="lab_currency_AllCurrenciesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6a239010-5eed-402f-ba2e-5c0d0d78b553_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_bbd27f4a-1d46-4ab6-a954-f79c8a597e35_verboseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_70d779e8-a71d-47c8-a02d-2f0fece17f93_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected future employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsDomain_bbacc5ed-fc24-48fe-8664-3ae8062a38f5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsDomain_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsDomain" xlink:to="lab_us-gaap_OtherCommitmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockAbstract_f9a71b0b-bb1c-4fb6-a002-7cbced55cb3f_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockAbstract_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockAbstract" xlink:to="lab_us-gaap_DividendsCommonStockAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessAndRawMaterials_3403c368-fc95-43d9-9648-f5daec6152aa_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessAndRawMaterials" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchased parts and fabricated assemblies</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessAndRawMaterials_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessAndRawMaterials" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process and Raw Materials</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessAndRawMaterials" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessAndRawMaterials"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessAndRawMaterials" xlink:to="lab_us-gaap_InventoryWorkInProcessAndRawMaterials" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_c6b51bbd-c9ac-4414-8ae0-11c413edd4bb_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary [Member]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_b4052c56-6608-4588-8f86-62a165de3d46_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5bb3ebeb-3c8b-43f4-909a-fa4a088f4d50_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_02ac180f-899c-415d-a50c-c8a82788e3b6_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7a5ff566-19a9-4ada-a80e-ada3ad577f14_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from Investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_ff586555-7da9-4332-8c78-67aa746e1af9_verboseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement and post-retirement benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentIssuanceDate1_e731aee6-7bdf-4b73-ba79-1d248def56f0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentIssuanceDate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance date of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentIssuanceDate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentIssuanceDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Issuance Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIssuanceDate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentIssuanceDate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentIssuanceDate1" xlink:to="lab_us-gaap_DebtInstrumentIssuanceDate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PositionAxis_5ee2e2f6-c942-48a8-b753-f1066fcda424_terseLabel_en-US" xlink:label="lab_us-gaap_PositionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Axis]</link:label>
    <link:label id="lab_us-gaap_PositionAxis_label_en-US" xlink:label="lab_us-gaap_PositionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PositionAxis" xlink:to="lab_us-gaap_PositionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_68060e25-3e8a-4340-be9b-6823dfe8ee63_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_d2d5c76c-8104-489b-89f3-b0c34d75682b_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dec9d313-f2b8-47a3-ac30-f7faafdabf29_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_c11c3ebf-bdb4-40ea-9e17-36b5c1be7f23_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AUD_814686a8-48b6-4a43-9784-c916ab27dfb9_verboseLabel_en-US" xlink:label="lab_currency_AUD" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australian Dollar</link:label>
    <link:label id="lab_currency_AUD_label_en-US" xlink:label="lab_currency_AUD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australia, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AUD" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AUD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AUD" xlink:to="lab_currency_AUD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_6fbe40a9-ba64-4574-8a81-8e191be91b80_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_852be3e4-6ccd-4ba7-abb5-ace4fc846087_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_e2ae6d18-9f71-45cf-9ba8-e0a43ef4f96f_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_3c2793e6-bdd1-4101-b6e0-a35619ee8ac5_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LONG-TERM DEBT</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_803dd9ac-971d-4791-85b9-ac0f71480cec_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualPayments_0398b4a3-5735-4fa7-9831-c4e3c4155ec2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements made during the period</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual, Decrease for Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrualPayments" xlink:to="lab_us-gaap_StandardProductWarrantyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b2f7f3d2-1586-403c-846f-620904db0faf_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract_b8ef4685-1ab4-46a6-98bf-0c20624b405c_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Asset</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_f642edbd-baf3-41a5-9c7f-54fc5ddfad89_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_83bfa020-1e4f-493f-875e-65c4b0154849_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_1c7dfb0c-f546-42a0-ae9c-52a2dae3ac1b_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_6ae390b3-9634-4d1f-8396-13d90871f2a4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_a137633f-bc6a-4b73-a1c3-72a7de9c3d3d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in deferrals from customer cash advances, net of revenue recognized</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireNotesReceivable_0b227445-fa06-41bd-8ff1-c9161de762d7_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Loans Receivable</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireNotesReceivable_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireNotesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireNotesReceivable" xlink:to="lab_us-gaap_PaymentsToAcquireNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_a_EndMarketsAxis_d3ec2f04-222e-4104-b92f-8475dea20f6e_terseLabel_en-US" xlink:label="lab_a_EndMarketsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End Markets [Axis]</link:label>
    <link:label id="lab_a_EndMarketsAxis_label_en-US" xlink:label="lab_a_EndMarketsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End Markets [Axis]</link:label>
    <link:label id="lab_a_EndMarketsAxis_documentation_en-US" xlink:label="lab_a_EndMarketsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End Markets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_EndMarketsAxis" xlink:href="a-20230131.xsd#a_EndMarketsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_EndMarketsAxis" xlink:to="lab_a_EndMarketsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_349f4862-917c-46ae-9912-4e931fc71130_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchased Technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_adc56000-b78e-434d-a646-9fff102b8a6e_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recognized in accumulated other comprehensive&#160;loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_50ea23d5-74cb-46f3-a0d1-fb333f4147d3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_c8e44c08-1a27-4ed2-975b-a0ae9d62c347_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_35423262-1749-41ed-8f40-abc6e23446f6_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Liabilities and Changes in Balances</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_85ba98f8-35f5-428c-9b37-bd71ba652686_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationTable_d47fda1c-3b3f-42ee-970f-325609424b9e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationTable" xlink:to="lab_us-gaap_IncomeTaxExaminationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_23c99cd3-bf74-4527-aea7-27d243929909_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service benefit</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_09d33e72-835f-41f1-8de5-34d089563601_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_d72df7fb-1c91-4619-958d-154b6456275c_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_de557a5f-40a9-4901-b4b1-d29d59f05866_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_3ad05af3-3b3a-4c10-8457-e73132ffd030_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_8f02e090-63a1-4404-a6da-8261d2248e23_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_318d6249-4d01-4340-9136-3355f97dd627_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_793c10d0-fb71-49b8-bc00-3bf98c14eaba_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) by Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_76997675-8d87-42ab-8b8c-fe57c1773a0d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer Contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_0f4821a1-6ed8-4f92-a3db-33691fb3c3e4_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term investments (Equity securities with RDFV)</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ce0f2ae9-f4c8-4bd1-bf6f-22e601941aff_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_59088910-8262-4a48-a608-90327f7a23fc_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [LTPP]</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfCommercialPaper_323433d4-fad8-41aa-876b-c4db224236da_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of commercial paper</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfCommercialPaper" xlink:to="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_6bcdafa8-ad94-4f2e-ba78-2f8e827aea62_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_417fa103-2f1f-466c-94aa-587e891adca7_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance (in Shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_5e2ec2a0-e455-4435-b16c-597d89bbc546_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance (in Shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_32a9dbe0-3c8a-4b8e-b255-f96699aa7b30_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_02889ae7-44da-468c-8acb-84267560cdde_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermInvestments_a506502f-b9f0-4d2a-b943-c09569d84725_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_label_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermInvestments" xlink:to="lab_us-gaap_LongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_eadebe3d-311b-4d77-80dc-4dbfe4e97740_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase program authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_a86bfe8f-f0aa-438b-a649-5c3b8a0dc44f_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_2fc111ae-55dc-4c93-8391-bbf800fb8642_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_2eaad467-79fe-49c1-bb73-804b2d926969_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsAxis_92d2449e-c973-4a75-ae7f-0d8e2e8ba11d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Axis]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsAxis_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsAxis" xlink:to="lab_us-gaap_OtherCommitmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_162aba50-3935-4471-b2ce-ed823249a4eb_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dee0b517-aba3-4d1e-8473-ecc2432c91fd_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_86246fb4-7e3e-4ad8-9311-9f39a2acf8e0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before taxes, as reported</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_3cc349cf-77af-4a7d-941e-a791c0444d7d_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_d3759941-3ca8-4d12-840a-e2e4705db720_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_a605b25d-ba0d-4730-bf1f-44eabf2dbd10_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_JPY_8f802ab8-10e5-414c-8642-aa552f91c936_terseLabel_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japanese Yen</link:label>
    <link:label id="lab_currency_JPY_label_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Yen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_JPY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_JPY" xlink:to="lab_currency_JPY" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_41bd7232-2c75-422f-9cf8-942acfc5aa27_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost on benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForwardContractsMember_62de0074-b76e-479f-a7f7-d077d624dde5_terseLabel_en-US" xlink:label="lab_us-gaap_ForwardContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts USD</link:label>
    <link:label id="lab_us-gaap_ForwardContractsMember_label_en-US" xlink:label="lab_us-gaap_ForwardContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForwardContractsMember" xlink:to="lab_us-gaap_ForwardContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_47cc6689-aaaf-49d6-82d3-f7bf89b17bf2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1c70dd55-12da-4949-8a54-29741ef5cbe0_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumptions used to estimate fair value for LTPP</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_6e2926ee-3989-4618-89a8-fcf1a488d9d5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation liability</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Classified, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_bf74516e-56eb-4ee3-ab2d-0c4e07f6679d_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_65b96a52-0a69-4682-8ba9-b9fc650bc38d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recognized in accumulated other comprehensive loss - translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_31f67461-86a2-4629-bc96-8bd0ce545aa1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross fair values and balance sheet location of derivative instruments held in the consolidated balance sheet</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue_4da5f54f-7fc7-4065-af34-265a2575ba07_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate fair value of all derivative instruments with credit-risk-related contingent features that were in a net liability position</link:label>
    <link:label id="lab_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Net Liability Position, Aggregate Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNetLiabilityPositionAggregateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue" xlink:to="lab_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_31855356-b135-4e03-9ccd-a9877095f93e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_11abddbb-ee9a-4183-90d2-ef4866b6b257_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_c4d2d2c8-8ed5-44c6-90dc-bd0e3e321f25_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of other intangible assets during the period</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_35192cba-caa6-4d29-a30f-44d6fb4a959e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_053457c1-47ae-4a9f-b86f-29521cccb105_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_d97016e5-87c8-41a1-8cb2-1b3156ec7e25_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecourseStatusAxis_80fb9a23-ff84-43c2-a36a-a3bd882ce856_terseLabel_en-US" xlink:label="lab_us-gaap_RecourseStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recourse Status [Axis]</link:label>
    <link:label id="lab_us-gaap_RecourseStatusAxis_label_en-US" xlink:label="lab_us-gaap_RecourseStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recourse Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecourseStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RecourseStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecourseStatusAxis" xlink:to="lab_us-gaap_RecourseStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_5843bd53-2d5c-4574-9b42-4337df791fee_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherTaxExpenseBenefit_93a9e711-d832-4048-b9de-f8377f3317d6_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discrete tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_OtherTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_OtherTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherTaxExpenseBenefit" xlink:to="lab_us-gaap_OtherTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_b5a2b4a4-c3a6-4b67-a37e-5377832bc555_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit from Segments to Consolidated</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_84362434-9b71-4efb-b34e-14abd883987a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_84098b60-8e49-4ab7-8cd2-6f3663f65285_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_7080fdf0-4ac4-44af-bcb8-e197cbf5eeb2_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_e4864cc2-b601-4d1e-bad3-580fbeafcb0f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_6fc283de-0686-462f-afe7-36d8fc028925_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5599296b-c877-4096-b187-140288ff54fe_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_649be5f7-53dc-4a17-9e91-d11963cdcdcd_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_country_DE_1104b9fe-a7c7-4f60-ae8c-59b2a3c78a8d_terseLabel_en-US" xlink:label="lab_country_DE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GERMANY</link:label>
    <link:label id="lab_country_DE_label_en-US" xlink:label="lab_country_DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GERMANY</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_DE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_DE" xlink:to="lab_country_DE" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_da1b38d1-4232-4616-beaf-98ff0ddcc408_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_ed784a6f-a4aa-44ff-965e-9d90497deb01_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_b7b2f2ae-2779-4ac3-8dd3-114652f1e609_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_be5510ed-0d66-4647-8293-b1f4eb0d012b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_12eff45e-2db2-4928-a0cd-649b545ff24b_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess and obsolete inventory related charges</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_ed76e573-54bf-40a0-aa4e-f4ea949f3b60_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on derivative instruments, net of tax expense (benefit) of $(9) and $2</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_f70717f7-188e-40a0-9961-f49e13b6fe2b_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss reclassified from accumulated other comprehensive&#160;loss into Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_b3003a35-3c40-4f02-a3e1-357661a6b8cf_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLineItems_278ac21b-90bc-49ed-81bb-7695a5cb85fa_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems" xlink:to="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_04ff24ae-a4e1-4e24-b530-f6929f19461b_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_51d8032f-4db4-4bfd-a33a-dd124fefa341_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_34731bd6-e5a0-4293-88f1-3173725b0f88_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_48abd054-b659-4afe-af13-f4a32c3143ec_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c0cd7776-e474-4923-9198-a687950fb9fa_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_bf5ff9bb-18ea-4a35-a73c-173453bf5914_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_78d6f44e-8447-4985-b9ee-afb430fbdecb_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_6aa4d741-e22d-4ab5-8ce8-2f9962f4c274_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities and Other Long-Term Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesMember" xlink:to="lab_us-gaap_OtherLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_5d98a4b3-7bec-4b6b-a94d-638566a09e0c_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Principle, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Principle, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis" xlink:to="lab_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillMember_f40ecb08-5f43-4ece-a53f-4057e0b033bd_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillMember_label_en-US" xlink:label="lab_us-gaap_GoodwillMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillMember" xlink:to="lab_us-gaap_GoodwillMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_ef72ea6a-2f3b-496b-9348-974245bdabbb_terseLabel_en-US" xlink:label="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period Adjustment, Accounting Standards Update</link:label>
    <link:label id="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_label_en-US" xlink:label="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Accounting Standards Update, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:to="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualNoncurrent_9d48e935-cc55-4890-862c-79369b578e5d_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for warranties due after one year</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualNoncurrent_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrualNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrualNoncurrent" xlink:to="lab_us-gaap_StandardProductWarrantyAccrualNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOperatingActivitiesSegmentAxis_4d64c46e-c47a-4d5f-8d4c-858a3f75ced6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementOperatingActivitiesSegmentAxis_label_en-US" xlink:label="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:to="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_e38709a2-65fb-4efb-b418-1c1f3e1e5997_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_a_DiagnosticsandClinicalMarketMember_1eb08cae-7b31-45e2-91ea-b9362ae05bdc_terseLabel_en-US" xlink:label="lab_a_DiagnosticsandClinicalMarketMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics and Clinical</link:label>
    <link:label id="lab_a_DiagnosticsandClinicalMarketMember_label_en-US" xlink:label="lab_a_DiagnosticsandClinicalMarketMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics and Clinical Market [Member]</link:label>
    <link:label id="lab_a_DiagnosticsandClinicalMarketMember_documentation_en-US" xlink:label="lab_a_DiagnosticsandClinicalMarketMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics and Clinical Market [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_DiagnosticsandClinicalMarketMember" xlink:href="a-20230131.xsd#a_DiagnosticsandClinicalMarketMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_DiagnosticsandClinicalMarketMember" xlink:to="lab_a_DiagnosticsandClinicalMarketMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_b538740f-eb09-42b0-a055-d74e021ebfda_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_ccb54272-2a3e-4fa2-891e-22c403174b5f_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_8e3585af-0b37-4f80-9326-0cc24035bd78_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CH_a7134e04-c278-4e3a-ac2f-597ab89b56a8_terseLabel_en-US" xlink:label="lab_country_CH" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SWITZERLAND</link:label>
    <link:label id="lab_country_CH_label_en-US" xlink:label="lab_country_CH" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SWITZERLAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CH"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CH" xlink:to="lab_country_CH" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_92df44e0-a972-48ea-ad80-cd200483ac63_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_MYR_c1ec1a08-d273-4ac1-96e2-87fa86a00b1c_terseLabel_en-US" xlink:label="lab_currency_MYR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Malaysian Ringgit</link:label>
    <link:label id="lab_currency_MYR_label_en-US" xlink:label="lab_currency_MYR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Malaysia, Ringgits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_MYR" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_MYR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_MYR" xlink:to="lab_currency_MYR" xlink:type="arc" order="1"/>
    <link:label id="lab_a_AdditionalIncrementalTermLoanFacilityMember_3cce5851-b5c2-4a66-845c-f737deaad5e1_terseLabel_en-US" xlink:label="lab_a_AdditionalIncrementalTermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Incremental Term Loan Facility</link:label>
    <link:label id="lab_a_AdditionalIncrementalTermLoanFacilityMember_label_en-US" xlink:label="lab_a_AdditionalIncrementalTermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Incremental Term Loan Facility [Member]</link:label>
    <link:label id="lab_a_AdditionalIncrementalTermLoanFacilityMember_documentation_en-US" xlink:label="lab_a_AdditionalIncrementalTermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Incremental Term Loan Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_AdditionalIncrementalTermLoanFacilityMember" xlink:href="a-20230131.xsd#a_AdditionalIncrementalTermLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_AdditionalIncrementalTermLoanFacilityMember" xlink:to="lab_a_AdditionalIncrementalTermLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_fa865570-6431-464b-902a-e2edfb1fda1b_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_cb7058f5-e5fb-4d38-8790-c490726d5152_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents (money market funds)</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_a_FoodMarketMember_a6e68ebf-d128-4ad4-a384-933a6523c42c_terseLabel_en-US" xlink:label="lab_a_FoodMarketMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Food</link:label>
    <link:label id="lab_a_FoodMarketMember_label_en-US" xlink:label="lab_a_FoodMarketMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Food Market [Member]</link:label>
    <link:label id="lab_a_FoodMarketMember_documentation_en-US" xlink:label="lab_a_FoodMarketMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Food Market [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_FoodMarketMember" xlink:href="a-20230131.xsd#a_FoodMarketMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_FoodMarketMember" xlink:to="lab_a_FoodMarketMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_0f84ed33-ac80-4d26-af4e-82f01e0aee24_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_9af13f88-458b-490d-b8a8-0ebf648366fe_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_e5cd9d45-6c84-4cae-8418-83f1b03cf3fd_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c57fa62b-dad8-4cbe-88df-18c005f2da1b_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Contingent Consideration, Beginning Balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_d7f1fc09-a3b0-4368-973c-c0a55a4a00bd_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Contingent Consideration, Ending Balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_ad77abf1-2dcb-412f-adee-b5f6ae49c167_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_SEK_971026da-c6b4-41c8-b36f-687c5875869e_terseLabel_en-US" xlink:label="lab_currency_SEK" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swedish Krona</link:label>
    <link:label id="lab_currency_SEK_label_en-US" xlink:label="lab_currency_SEK" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sweden, Kronor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SEK" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_SEK"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_SEK" xlink:to="lab_currency_SEK" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_a51e2378-524d-46a2-be58-abc24bee8184_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in property, plant and equipment included in Accounts Payable and Accrued Liabilities increase (decrease)</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_c663bc5b-10c8-439a-93a1-373552752984_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteesAbstract_ae261af3-bf06-4c1f-825c-df550396e62f_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees</link:label>
    <link:label id="lab_us-gaap_GuaranteesAbstract_label_en-US" xlink:label="lab_us-gaap_GuaranteesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteesAbstract" xlink:to="lab_us-gaap_GuaranteesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_1f3b647c-1299-488f-9083-3ecc31584d8d_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_THB_0722989a-7306-402e-b757-3731eb907938_terseLabel_en-US" xlink:label="lab_currency_THB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thailand, Baht</link:label>
    <link:label id="lab_currency_THB_label_en-US" xlink:label="lab_currency_THB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thailand, Baht</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_THB" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_THB"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_THB" xlink:to="lab_currency_THB" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_a81cf681-ee2b-4e69-a028-caba3934c06f_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Declared Date of Record</link:label>
    <link:label id="lab_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_label_en-US" xlink:label="lab_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Date of Record</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateOfRecordDayMonthAndYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:to="lab_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_84a2c08d-ca0c-4959-a7ea-c03ac1875060_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets during the period</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_c3881ab5-7829-4b65-a096-9224b9ad0788_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_70ce0c7f-c5d4-4de5-8661-065b7b3bfded_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill balances and movements for each reportable segment during the period</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_55fbd752-a816-41c7-8e23-2bdabe835257_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest payments</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_d90e27af-0c69-476e-8475-dfe97cf3a036_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceOtherMember_8163f99c-1aaf-4b25-885c-ca6fd706d207_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service and Other</link:label>
    <link:label id="lab_us-gaap_ServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceOtherMember" xlink:to="lab_us-gaap_ServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_cbc7fdc1-236a-4394-baf0-6a9de494ff87_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_1a41dc87-a60d-4699-964e-bf4474fbe278_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_fa884f6b-177a-4e71-8fad-363316143ffb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions on Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNetAbstract_d421f292-3b07-40ed-b066-818a940a8a00_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Fair Value by Balance Sheet Location</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNetAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fair Value, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNetAbstract" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_ff37bef3-7087-4730-abdf-0bb47feed350_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholder's equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_14b925dc-28a9-4b30-a94c-97db8c5d3d1b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DERIVATIVES</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_a_LTPPRSUMember_5f844bf5-548f-4ad6-a74e-e9c89250e4a6_terseLabel_en-US" xlink:label="lab_a_LTPPRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LTPP &amp; RSU</link:label>
    <link:label id="lab_a_LTPPRSUMember_label_en-US" xlink:label="lab_a_LTPPRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LTPP &amp; RSU [Member]</link:label>
    <link:label id="lab_a_LTPPRSUMember_documentation_en-US" xlink:label="lab_a_LTPPRSUMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LTPP &amp; RSU [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_LTPPRSUMember" xlink:href="a-20230131.xsd#a_LTPPRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_LTPPRSUMember" xlink:to="lab_a_LTPPRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuePerformanceObligationAbstract_3d07cb38-63ce-4d78-857b-e397cb7a6c03_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuePerformanceObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenuePerformanceObligationAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuePerformanceObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuePerformanceObligationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuePerformanceObligationAbstract" xlink:to="lab_us-gaap_RevenuePerformanceObligationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_9deb3e62-82d0-42f4-846b-deb1ac4fcd9f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to contingent consideration (including measurement period adjustment)</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_00b8f126-5ad7-400c-9ab2-e93adba6ea9c_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_998e96e5-b759-4a1d-b698-703079b0dd7b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualCurrent_428fc998-94b6-4fb5-b867-ac4301101d73_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accruals for warranties due within one year</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualCurrent_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrualCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrualCurrent" xlink:to="lab_us-gaap_StandardProductWarrantyAccrualCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7ace8857-e2e3-4c7e-a0de-99206d326195_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_17c6f7fe-488a-495b-961c-c30d3d56f350_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_a_PharmaceuticalandBiopharmaceuticalMarketMember_79c42bb8-b5f3-40d1-8199-477c759541d0_terseLabel_en-US" xlink:label="lab_a_PharmaceuticalandBiopharmaceuticalMarketMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical and Biopharmaceutical</link:label>
    <link:label id="lab_a_PharmaceuticalandBiopharmaceuticalMarketMember_label_en-US" xlink:label="lab_a_PharmaceuticalandBiopharmaceuticalMarketMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical and Biopharmaceutical Market [Member]</link:label>
    <link:label id="lab_a_PharmaceuticalandBiopharmaceuticalMarketMember_documentation_en-US" xlink:label="lab_a_PharmaceuticalandBiopharmaceuticalMarketMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical and Biopharmaceutical Market [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_PharmaceuticalandBiopharmaceuticalMarketMember" xlink:href="a-20230131.xsd#a_PharmaceuticalandBiopharmaceuticalMarketMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_PharmaceuticalandBiopharmaceuticalMarketMember" xlink:to="lab_a_PharmaceuticalandBiopharmaceuticalMarketMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_3869f811-8737-4d31-a9a5-7d1026120c27_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_c6b17e7c-8805-47fc-90d7-e27b2224c5a1_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_fe911280-1139-49c2-b18a-93744377c5e8_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_c2e8b41d-a56a-400c-81d1-8ded466986ff_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_885e9d07-64dd-4731-98f6-17b5eefde3f7_verboseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Cash Dividends Declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_a_SeniorNotes2023Member_a909fcc8-19c9-4189-b5cf-5250712b2d19_terseLabel_en-US" xlink:label="lab_a_SeniorNotes2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2023</link:label>
    <link:label id="lab_a_SeniorNotes2023Member_label_en-US" xlink:label="lab_a_SeniorNotes2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2023 [Member]</link:label>
    <link:label id="lab_a_SeniorNotes2023Member_documentation_en-US" xlink:label="lab_a_SeniorNotes2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2023Member" xlink:href="a-20230131.xsd#a_SeniorNotes2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_SeniorNotes2023Member" xlink:to="lab_a_SeniorNotes2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_3d3265a3-4108-4fa5-9134-3e828a591534_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_806087ed-7f04-4b59-bbcf-86e20dbfe365_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_cd5c5046-1dfc-4854-abc2-110ef4efe08b_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocated share-based compensation expense disclosure</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_8cd7b032-893e-4acc-a4ef-1ce30e203bef_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based awards issued</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_de654544-85c0-4b86-8e4b-c5dcac67e385_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock repurchases</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_06771d13-1c51-4488-b785-a6430ab59a35_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest_ae8e538f-90a0-4ad7-a8fb-737187524831_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Increase, Accrued Interest</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Increase, Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:to="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_676b853e-3dcb-417b-90b0-b435819520e1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_49abc043-d3d2-42ef-a899-754ca5aead5d_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTransfers_10d0c9e6-a0f5-4fa8-8804-e8a1392fdf7a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill reassigned to segment</link:label>
    <link:label id="lab_us-gaap_GoodwillTransfers_label_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Transfers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTransfers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTransfers" xlink:to="lab_us-gaap_GoodwillTransfers" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_bb4b4613-fa00-47a6-bbd8-df7c6ba8adc4_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_786378de-43b3-4706-b3c0-345386670035_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_0969d459-8eec-4a77-8139-899bf09b8123_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_5d916037-87cb-4673-a78f-da3b37746f84_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonrecurringExpense_657c29fe-ebfb-4e63-b87b-7a5fab5ad9c2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonrecurringExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNonrecurringExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonrecurringExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonrecurring Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonrecurringExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonrecurringExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonrecurringExpense" xlink:to="lab_us-gaap_OtherNonrecurringExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_a_SeniorNotes2031Member_e16939e5-c6bb-4e6a-939a-e76325b89e8a_terseLabel_en-US" xlink:label="lab_a_SeniorNotes2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2031</link:label>
    <link:label id="lab_a_SeniorNotes2031Member_label_en-US" xlink:label="lab_a_SeniorNotes2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2031 [Member]</link:label>
    <link:label id="lab_a_SeniorNotes2031Member_documentation_en-US" xlink:label="lab_a_SeniorNotes2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2031Member" xlink:href="a-20230131.xsd#a_SeniorNotes2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_SeniorNotes2031Member" xlink:to="lab_a_SeniorNotes2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_3c4a1b5f-592d-4d1f-bed3-d8645ae5596e_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Realized Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_2b85e508-91cb-4f45-be36-636fcad80fba_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_af001fa7-60aa-4637-bc2a-91327adb02bb_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-Process R&amp;D</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_a_SeniorNotes2026Member_7a1c0002-d52e-49f5-a3a8-cb02f193e32c_terseLabel_en-US" xlink:label="lab_a_SeniorNotes2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2026</link:label>
    <link:label id="lab_a_SeniorNotes2026Member_label_en-US" xlink:label="lab_a_SeniorNotes2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2026 [Member]</link:label>
    <link:label id="lab_a_SeniorNotes2026Member_documentation_en-US" xlink:label="lab_a_SeniorNotes2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2026Member" xlink:href="a-20230131.xsd#a_SeniorNotes2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_SeniorNotes2026Member" xlink:to="lab_a_SeniorNotes2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_16fd3f4d-7f0a-40f2-b8ec-cfbde1c61dc6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value (included within SG&amp;A)</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_b9863273-6893-427e-ac66-fb4c6bdd5831_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_f3552aed-c0b7-4d12-bcb9-03b2b81d133a_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_e5ace4d7-a40b-481e-ba05-5cb74885de69_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement gain</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_abafca63-0f46-4bc1-9f9d-9507d65f9c0e_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3cc236c5-4474-468f-aa94-f87a1326d1ac_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_a1b7657a-6567-490f-913c-9cf8f01b812e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_3c0cb884-f682-4af0-bee4-3c1e8d4616c1_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_8ec6f9f0-2240-45d4-9ead-c0aa9d5d2cf7_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademark/Tradenames</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableTable_b2044440-014a-4909-9621-829691a302fa_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Table]</link:label>
    <link:label id="lab_us-gaap_DividendsPayableTable_label_en-US" xlink:label="lab_us-gaap_DividendsPayableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableTable" xlink:to="lab_us-gaap_DividendsPayableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_0df0bfcf-038f-4299-8d0a-93ea1863aae0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_a_A2021RepurchaseProgramMember_75a231f9-7dbb-4902-a9d2-b8c35e833e38_terseLabel_en-US" xlink:label="lab_a_A2021RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Repurchase Program [Member]</link:label>
    <link:label id="lab_a_A2021RepurchaseProgramMember_label_en-US" xlink:label="lab_a_A2021RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Repurchase Program [Member]</link:label>
    <link:label id="lab_a_A2021RepurchaseProgramMember_documentation_en-US" xlink:label="lab_a_A2021RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_A2021RepurchaseProgramMember" xlink:href="a-20230131.xsd#a_A2021RepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_A2021RepurchaseProgramMember" xlink:to="lab_a_A2021RepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_a_RevenueComponentMember_1ae08b42-097a-4434-ac6b-5367eeb314f5_terseLabel_en-US" xlink:label="lab_a_RevenueComponentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Component</link:label>
    <link:label id="lab_a_RevenueComponentMember_label_en-US" xlink:label="lab_a_RevenueComponentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Component [Member]</link:label>
    <link:label id="lab_a_RevenueComponentMember_documentation_en-US" xlink:label="lab_a_RevenueComponentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_RevenueComponentMember" xlink:href="a-20230131.xsd#a_RevenueComponentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_RevenueComponentMember" xlink:to="lab_a_RevenueComponentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_a44f2412-c869-49e0-bfae-0ec18ad7b15d_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_37ab64a3-3c8e-4a87-abc1-3ed12562396b_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignPlanMember_e922e106-75f5-4c30-9f84-fac5f2792941_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan</link:label>
    <link:label id="lab_us-gaap_ForeignPlanMember_label_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignPlanMember" xlink:to="lab_us-gaap_ForeignPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_GB_98b6ab5d-784b-4b8f-ad8c-f847ad721736_terseLabel_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED KINGDOM</link:label>
    <link:label id="lab_country_GB_label_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED KINGDOM</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_GB" xlink:to="lab_country_GB" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_62716133-0927-46a3-8ea1-66b01e891a26_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_599e6c02-734d-4ceb-8594-defedeeba730_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement Line Items</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_a_SeniorNotes2030Member_3b2fcd13-f4f2-42fd-a4ca-9cf1eab3173e_terseLabel_en-US" xlink:label="lab_a_SeniorNotes2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2030</link:label>
    <link:label id="lab_a_SeniorNotes2030Member_label_en-US" xlink:label="lab_a_SeniorNotes2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2030 [Member]</link:label>
    <link:label id="lab_a_SeniorNotes2030Member_documentation_en-US" xlink:label="lab_a_SeniorNotes2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2030Member" xlink:href="a-20230131.xsd#a_SeniorNotes2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_SeniorNotes2030Member" xlink:to="lab_a_SeniorNotes2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_00dd167b-0221-40dd-ad42-63e175fd1b64_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_5a78d2be-02e9-40f1-abcd-d999fbb4f86c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt interest payment frequency</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Frequency of Periodic Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:to="lab_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_f8717d99-9732-4e27-b9d6-d1f3b39275ac_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_bda902a0-280d-4276-b382-11daf7ad0dba_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_9c3f783f-5cfe-443a-aeae-f555c8c9447e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_1eaf26c6-474f-40d6-a257-0e1b206be508_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_5f695eec-fd48-44d4-923c-71b7d111744b_verboseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_CAD_1137661c-c079-4573-919f-9ef46a97d38b_terseLabel_en-US" xlink:label="lab_currency_CAD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Dollar</link:label>
    <link:label id="lab_currency_CAD_label_en-US" xlink:label="lab_currency_CAD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CAD" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_CAD" xlink:to="lab_currency_CAD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_7057a200-5c14-479e-ba8e-45ffd8ca383d_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW ACCOUNTING PRONOUNCEMENTS</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3d130d05-1534-4a80-b090-931e0b811db6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_1e3793a3-3117-4f2c-b732-cdda0c690251_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_46a06a02-b44c-41cd-ae44-35378e3de73d_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_3be2f15f-f5cc-4a6d-b8b3-01a7f4492dd7_terseLabel_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_label_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:to="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3cf19b6c-b043-44e9-bd12-fcc5be60cab5_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0677ce5b-522b-46ef-9f28-ca8ab8809f84_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_3975d275-e0e3-4b91-bbe3-3f1d7507a541_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified out of accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, before Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_8ef2f407-e0ed-4ef2-9a03-50845f478965_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedge</link:label>
    <link:label id="lab_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_label_en-US" xlink:label="lab_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Net Investment Hedge Activity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract" xlink:to="lab_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BankAcceptancesExecuted_07879392-fdf2-4748-98aa-9c4979dc109f_terseLabel_en-US" xlink:label="lab_us-gaap_BankAcceptancesExecuted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees</link:label>
    <link:label id="lab_us-gaap_BankAcceptancesExecuted_label_en-US" xlink:label="lab_us-gaap_BankAcceptancesExecuted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Acceptances Executed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankAcceptancesExecuted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BankAcceptancesExecuted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BankAcceptancesExecuted" xlink:to="lab_us-gaap_BankAcceptancesExecuted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_1e09783e-f3d9-438d-9ce3-b7e9b01d7f04_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentDateOfFirstRequiredPayment1_980f31d2-4731-49fe-ba77-766fdd606a04_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Date interest payment commenced</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentDateOfFirstRequiredPayment1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Date of First Required Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDateOfFirstRequiredPayment1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" xlink:to="lab_us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_8baf90ee-7a37-4610-9032-3d9566e303c3_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_59b6d059-7ab7-4907-a8c9-2f792fd3ec5c_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_27bfbe26-5429-4d0a-b365-d27167018467_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_0e4c2408-f273-4684-b3fc-116bdddb9545_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_90a13daf-663a-4182-942e-666d5cfb594b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_INR_9ad9c04a-5f61-4ea1-849b-427115f03c1a_terseLabel_en-US" xlink:label="lab_currency_INR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">India, Rupees</link:label>
    <link:label id="lab_currency_INR_label_en-US" xlink:label="lab_currency_INR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">India, Rupees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_INR" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_INR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_INR" xlink:to="lab_currency_INR" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_KRW_ae3735a7-ab64-41b6-b8a2-1f70b179d181_terseLabel_en-US" xlink:label="lab_currency_KRW" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Korean Won</link:label>
    <link:label id="lab_currency_KRW_label_en-US" xlink:label="lab_currency_KRW" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Korea (South), Won</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_KRW" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_KRW"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_KRW" xlink:to="lab_currency_KRW" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_6b48d060-c2b5-41ff-8b8a-475b71ac6940_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-marketable equity securities carrying amount</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PositionDomain_cb193f57-f7c5-410e-8439-ac6d2a51b5e2_terseLabel_en-US" xlink:label="lab_us-gaap_PositionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Domain]</link:label>
    <link:label id="lab_us-gaap_PositionDomain_label_en-US" xlink:label="lab_us-gaap_PositionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PositionDomain" xlink:to="lab_us-gaap_PositionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_d6876f11-431c-40a9-947d-c8634ad5d6cf_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_aa28ef3d-17a1-42ed-9475-4312dbc940fe_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_c4e3efe7-0342-49f4-aca3-523b124f8315_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_ed778f5a-0d4d-4cea-ae52-16bce315ff96_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_5aeae253-4769-4a0c-8018-fff0f8e0e86f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_89e05b24-2e41-45d4-983f-5deea40ca203_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard Product Warranty Accrual</link:label>
    <link:label id="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard Product Warranty Accrual [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:to="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_3d278676-f1e2-4e9e-b7eb-5ffe1fc1db8f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:to="lab_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_4710dbe8-00e3-44ad-b2de-2f51c681e77d_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities measured at fair value</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_d575161f-a373-4079-acd4-e123e6096ae0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial net loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_6cfdae81-4506-434f-b4c4-6e5297c621e4_terseLabel_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Domain]</link:label>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_label_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:to="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6d6c9c09-8dc7-4522-885c-2332cdda8f8e_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_608427d6-0bee-4d3a-92d1-f74beecf05e8_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND OTHER INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_34d45ee1-4b73-4059-87df-630baf5d833b_periodStartLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_9525ac39-5bfe-4d10-ab7a-e036c92ffb04_periodEndLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance at end of period</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrual" xlink:to="lab_us-gaap_StandardProductWarrantyAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_7fe7acff-4dcd-4fa8-920f-ea49d1bb8ce7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_8f2107d0-ae64-48b5-804a-93389a1ec217_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision (benefit) for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_449730d4-4891-4191-bf0b-ece29f69eaf5_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_392b84fe-2ded-4d39-9072-33ee8f6d7fb0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Service Credits</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_5074c2d2-b2f4-49dd-a86e-0c13e543b116_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard warranty</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Warranty Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_cbb5340c-21bb-4a05-a7c0-5f5d3f329e0c_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_6e889520-6723-498a-8eb3-e13cf73ed5cc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_38e66bc8-3b0f-4392-b9ad-271e6409f7d2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_b3bc6206-6367-43bc-b23c-12d3ebb627a5_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets Held-for-use</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_b7b4f3e4-9450-471e-aca0-d1473e5bcb0c_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_a0f70fc4-dd20-4b95-9d6a-80ff0a424cb3_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_38951fdc-cf2f-4dc8-a410-ad4f26fab960_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_fde9092b-2919-4c5b-9b18-9f34bbb1ae1b_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_a_BusinessCombinationsContingentConsiderationArrangements_4ee244a7-d97b-48c6-ad09-61e372afbace_terseLabel_en-US" xlink:label="lab_a_BusinessCombinationsContingentConsiderationArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration maximum earn-out period</link:label>
    <link:label id="lab_a_BusinessCombinationsContingentConsiderationArrangements_label_en-US" xlink:label="lab_a_BusinessCombinationsContingentConsiderationArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">business combinations, contingent consideration, arrangements</link:label>
    <link:label id="lab_a_BusinessCombinationsContingentConsiderationArrangements_documentation_en-US" xlink:label="lab_a_BusinessCombinationsContingentConsiderationArrangements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum earn-out period for settlement of contingent consideration payment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_BusinessCombinationsContingentConsiderationArrangements" xlink:href="a-20230131.xsd#a_BusinessCombinationsContingentConsiderationArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_BusinessCombinationsContingentConsiderationArrangements" xlink:to="lab_a_BusinessCombinationsContingentConsiderationArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_c9ea39c8-c9f0-4319-ad78-9a84ee898275_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_27bf213f-267a-4a47-8c89-58c264b95e7b_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bf8da24e-633c-4a86-8cd8-12f40b277038_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted average shares</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_539a4c58-f3ab-4bf2-baf0-ebebbb254625_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVENTORY</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_70f030b6-5535-4517-93c7-b79053510cd2_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net defined benefit pension cost and post retirement plan costs:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_2f1450b6-a369-412a-ad3b-b0545951b79e_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives liabilities fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_910413f3-72d4-41fc-af5d-6fa5af364636_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_1cd86688-a113-4fe2-9dd6-4b84d234e0a2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of New Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_f9fd4cce-bfce-409c-87c0-d4f24f1cd1c2_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_89b9c44b-9d23-465c-bde7-1b682184abdd_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends paid per common share</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_c1a4ee52-5ccd-468f-88e5-6452e4a4367b_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock; $0.01 par value; 2 billion shares authorized; 296 million shares at January 31, 2023 and 295 million shares at October 31, 2022, issued and outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_a_SegmentTotalMember_e7fcc58b-f63c-4357-bf90-8219e97f3376_terseLabel_en-US" xlink:label="lab_a_SegmentTotalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Total</link:label>
    <link:label id="lab_a_SegmentTotalMember_label_en-US" xlink:label="lab_a_SegmentTotalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Total [Member]</link:label>
    <link:label id="lab_a_SegmentTotalMember_documentation_en-US" xlink:label="lab_a_SegmentTotalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reportable amounts associated with all reporting segments included in a reconciliation from segment reporting to consolidated income from operations, before taxes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_SegmentTotalMember" xlink:href="a-20230131.xsd#a_SegmentTotalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_SegmentTotalMember" xlink:to="lab_a_SegmentTotalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_48eec1f9-3105-4a5f-ba7e-392e1188b0e8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_655c7500-ce2a-4cf5-b5a3-1c6a851fd1a3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_3ff05a2a-4002-4d6c-9f3b-b0eb7afcc866_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfForeignCurrencyDerivativesHeld_66d0606a-5d53-45b2-b37e-fd26f6b78ad5_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfForeignCurrencyDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of foreign exchange forward contracts (in units)</link:label>
    <link:label id="lab_us-gaap_NumberOfForeignCurrencyDerivativesHeld_label_en-US" xlink:label="lab_us-gaap_NumberOfForeignCurrencyDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Foreign Currency Derivatives Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfForeignCurrencyDerivativesHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfForeignCurrencyDerivativesHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfForeignCurrencyDerivativesHeld" xlink:to="lab_us-gaap_NumberOfForeignCurrencyDerivativesHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTerms_3c4e39df-c3e0-4877-82f8-5c6c80e78ee6_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit faciity terms (in years)</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTerms_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTerms" xlink:to="lab_us-gaap_ShortTermDebtTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_8796fa21-cad4-4085-884e-3dfdffada47d_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtLineItems" xlink:to="lab_us-gaap_ShortTermDebtLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_d0ad7630-5b87-40c9-86fe-27009da490f1_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_a_ChemicalandEnergyMarketMember_ad19ca1a-e3c4-4e78-98bc-73fa7bb6bf4a_terseLabel_en-US" xlink:label="lab_a_ChemicalandEnergyMarketMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chemical and Advanced Materials</link:label>
    <link:label id="lab_a_ChemicalandEnergyMarketMember_label_en-US" xlink:label="lab_a_ChemicalandEnergyMarketMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chemical and Energy Market [Member]</link:label>
    <link:label id="lab_a_ChemicalandEnergyMarketMember_documentation_en-US" xlink:label="lab_a_ChemicalandEnergyMarketMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chemical and Energy Market [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_ChemicalandEnergyMarketMember" xlink:href="a-20230131.xsd#a_ChemicalandEnergyMarketMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_ChemicalandEnergyMarketMember" xlink:to="lab_a_ChemicalandEnergyMarketMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_fa0571f1-aca8-400d-a2ea-17bb31465b38_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Assets And Liabilities Measured On Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_3cc8f03d-a632-4f8f-b75a-e8b65cf9bdd1_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gain to be reclassified within next Twelve Months</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock_5a4e36a8-fbf5-488f-a7b5-26283de06ce5_terseLabel_en-US" xlink:label="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions And Methodology [Text Block]</link:label>
    <link:label id="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock_label_en-US" xlink:label="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions And Methodology [Text Block]</link:label>
    <link:label id="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock_documentation_en-US" xlink:label="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, and long-term performance plan grants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock" xlink:href="a-20230131.xsd#a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock" xlink:to="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_ee5eec6e-9e79-4529-aac1-82c283fee5c6_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_33bdace5-2f52-4504-b910-7fe0b462c40b_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Finite-lived</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Finite-Lived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_e61d4270-3c83-4844-8b08-cc1580791571_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3e3401b5-469e-40e3-a8db-8419e6db4841_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_56cd91e4-ff46-44eb-b329-012b8274e024_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7cbfaf7b-59f3-4217-a46d-a0a4e92fdce4_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, restricted cash and restricted cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_a_DiagnosticsAndGenomicsMember_0e9145f3-5da2-4c65-8a07-c70b359b215b_terseLabel_en-US" xlink:label="lab_a_DiagnosticsAndGenomicsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics and Genomics</link:label>
    <link:label id="lab_a_DiagnosticsAndGenomicsMember_label_en-US" xlink:label="lab_a_DiagnosticsAndGenomicsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics and Genomics [Member]</link:label>
    <link:label id="lab_a_DiagnosticsAndGenomicsMember_documentation_en-US" xlink:label="lab_a_DiagnosticsAndGenomicsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics and Genomics segment includes; DNA mutation detection; genotyping; gene copy number determination; identification of gene rearrangements; DNA methylation profiling; gene expression profiling; and automated gel electrophoresis-based sample analysis systems.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_DiagnosticsAndGenomicsMember" xlink:href="a-20230131.xsd#a_DiagnosticsAndGenomicsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_DiagnosticsAndGenomicsMember" xlink:to="lab_a_DiagnosticsAndGenomicsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_32d433fc-5aeb-4451-8288-5f8980846e43_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WARRANTIES AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_d7d40852-95e3-4625-a4f7-60a476d64ff7_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_236ac699-be2b-4c10-a33b-0ec46ee28fe5_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4138f802-14db-40e7-9462-00c6c6468e6d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_a_EndMarketsDomain_91f2a9f3-a83b-4088-af1e-2c92d91829a9_terseLabel_en-US" xlink:label="lab_a_EndMarketsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End Markets [Domain]</link:label>
    <link:label id="lab_a_EndMarketsDomain_label_en-US" xlink:label="lab_a_EndMarketsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End Markets [Domain]</link:label>
    <link:label id="lab_a_EndMarketsDomain_documentation_en-US" xlink:label="lab_a_EndMarketsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for End Markets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_EndMarketsDomain" xlink:href="a-20230131.xsd#a_EndMarketsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_EndMarketsDomain" xlink:to="lab_a_EndMarketsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInAccountingPrincipleMember_f57f1160-4a74-41ca-b734-5905234787e1_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInAccountingPrincipleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Principle, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ChangeInAccountingPrincipleMember_label_en-US" xlink:label="lab_us-gaap_ChangeInAccountingPrincipleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Principle, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingPrincipleMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInAccountingPrincipleMember" xlink:to="lab_us-gaap_ChangeInAccountingPrincipleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_ff3ef4c6-f1e0-48f1-a787-b31270d1073c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PledgedStatusDomain_77179aae-5bd2-4f6a-a4fd-1999ae90e0bd_terseLabel_en-US" xlink:label="lab_us-gaap_PledgedStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pledged Status [Domain]</link:label>
    <link:label id="lab_us-gaap_PledgedStatusDomain_label_en-US" xlink:label="lab_us-gaap_PledgedStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pledged Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PledgedStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PledgedStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PledgedStatusDomain" xlink:to="lab_us-gaap_PledgedStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_a_AssetsLongLivedAbstract_b49b4ef5-4cb5-40ba-9d69-e9dcae71e7ca_terseLabel_en-US" xlink:label="lab_a_AssetsLongLivedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:label id="lab_a_AssetsLongLivedAbstract_label_en-US" xlink:label="lab_a_AssetsLongLivedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Long Lived [Abstract]</link:label>
    <link:label id="lab_a_AssetsLongLivedAbstract_documentation_en-US" xlink:label="lab_a_AssetsLongLivedAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Long Lived [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_AssetsLongLivedAbstract" xlink:href="a-20230131.xsd#a_AssetsLongLivedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_AssetsLongLivedAbstract" xlink:to="lab_a_AssetsLongLivedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_ec3086eb-bc96-4db7-870c-38cc7465a198_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified into earnings related to derivative instruments, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAbstract_3f63338d-9e5d-44c0-b830-55c933408d0d_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAbstract_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAbstract" xlink:to="lab_us-gaap_RestrictedCashAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_6ec25689-893c-4cf5-85de-74aef9d6a3aa_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Stockholder's Equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_50860f8e-934d-4d71-93c4-a859f11a48b2_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_a14d0e06-a1f9-41d9-9cab-a4ba8a4f8059_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and integration costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_1cff2d93-1a2d-46b7-909e-f9ca27345b2c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_1ba21a63-3903-4c84-a6cd-2a181d99310b_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement and Other Comprehensive Income (Loss) Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_ab78a152-96c6-40b1-9e3e-e5719658401b_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_eca4268b-d1ea-4941-a7a4-97afd1fb3b78_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation impact on other intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_bae01475-6206-41cb-979f-c47686f79a96_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5104dafd-907c-4906-8ad8-2605b948a539_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_1e23048e-0370-48a3-a6e2-8f3873fabd34_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_cfcf7c60-97b8-47f5-8f7b-9fddc328e34f_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_3fb6e530-783b-4eb4-aaac-561e3b2361f8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate face amount of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_53fa5e07-5787-441f-ae23-2105cf0ecdc4_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0f049275-b9f3-49b6-b23c-bb752c046d60_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_e43a38b1-8be0-44f8-9baf-0c3ece223abe_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_1947c3b2-2183-4d76-96b0-82b460c1181e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill arising from acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_3b41b7cc-7a44-4504-b60b-3b97b43d8bf2_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_75d8039c-c753-4eac-a41a-bcff9e09739c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_75189125-cf71-4ebf-bae9-e7bd95c915c2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Profitability and Segment Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateDerivativesAbstract_1374b1a0-5f33-4de7-809b-0205541ff877_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateDerivativesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Terminated Derivative Contracts</link:label>
    <link:label id="lab_us-gaap_InterestRateDerivativesAbstract_label_en-US" xlink:label="lab_us-gaap_InterestRateDerivativesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Derivatives [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateDerivativesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateDerivativesAbstract" xlink:to="lab_us-gaap_InterestRateDerivativesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_ec00acab-9b22-465a-80c1-00b54834ef8a_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived assets Held for sale</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets to be Disposed of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_c8d2d624-7aeb-43d3-8671-47088ce8be80_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0e8b7dbe-8a44-4d86-87ac-f7c7930a9314_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_61efb913-04e7-4723-a599-d331e81415b3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_9468e8f7-c92c-45dc-a2da-61e873012fac_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee compensation and benefits</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_a_PaymentOfAccruedAndUnpaidInterest_d19f41dd-7380-453a-ad90-7f9f211d1d77_terseLabel_en-US" xlink:label="lab_a_PaymentOfAccruedAndUnpaidInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of accrued and unpaid interest</link:label>
    <link:label id="lab_a_PaymentOfAccruedAndUnpaidInterest_label_en-US" xlink:label="lab_a_PaymentOfAccruedAndUnpaidInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of accrued and unpaid interest</link:label>
    <link:label id="lab_a_PaymentOfAccruedAndUnpaidInterest_documentation_en-US" xlink:label="lab_a_PaymentOfAccruedAndUnpaidInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of accrued and unpaid interest on early redemption of senior notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_PaymentOfAccruedAndUnpaidInterest" xlink:href="a-20230131.xsd#a_PaymentOfAccruedAndUnpaidInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_PaymentOfAccruedAndUnpaidInterest" xlink:to="lab_a_PaymentOfAccruedAndUnpaidInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_201ba2a7-edac-45d8-a2f4-a95df65ff193_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_13b9735d-8458-4fef-9d7d-245b8d06e76f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price of Common Stock, Percent of FMV</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_CNY_645bff53-73a7-4083-be55-69d2abc35075_terseLabel_en-US" xlink:label="lab_currency_CNY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chinese Yuan Renminbi</link:label>
    <link:label id="lab_currency_CNY_label_en-US" xlink:label="lab_currency_CNY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">China, Yuan Renminbi</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CNY" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CNY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_CNY" xlink:to="lab_currency_CNY" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_cc5fd789-4937-495b-ab65-bac2bb2e78bc_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation impact</link:label>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_country_JP_95acbf59-3c8c-4fbf-97c9-36c405c33470_terseLabel_en-US" xlink:label="lab_country_JP" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JAPAN</link:label>
    <link:label id="lab_country_JP_label_en-US" xlink:label="lab_country_JP" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JAPAN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_JP"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_JP" xlink:to="lab_country_JP" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_ef65019c-a247-4803-acd3-df67d1fc35cf_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableAmountPerShare_2145d4d4-c33f-4e31-bacb-986bc4d65593_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Amount Per Share</link:label>
    <link:label id="lab_us-gaap_DividendsPayableAmountPerShare_label_en-US" xlink:label="lab_us-gaap_DividendsPayableAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Amount Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableAmountPerShare" xlink:to="lab_us-gaap_DividendsPayableAmountPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_adc187cf-8452-48f6-88ab-46257519fce5_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accruals for warranties including change in estimate</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual, Increase for Warranties Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrualWarrantiesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:to="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_cfc1d402-86d8-40f2-b6fa-8d533118ef48_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_7b15e823-7070-426d-bbff-44d191bde9af_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_3bf1691e-92e8-460a-937d-e7f8be0f8d58_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in actuarial net loss, net of tax expense of $0 and $2</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_299861a4-3b18-4476-9c96-cc724a2cb8d9_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_53bafda5-c0f4-442b-bc10-b6fc623a1b73_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6d231c37-761b-4a7f-b70d-afb3e5cc6d86_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate Movements</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_0bba98cf-9333-46a0-ad40-8019dd0d140e_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CurrencyAxis_feef2004-0feb-4b7a-88e0-38ef51142210_terseLabel_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:label id="lab_srt_CurrencyAxis_label_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis" xlink:to="lab_srt_CurrencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_077e9d98-32a4-4084-8456-4f56075a0a6e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_739c350d-0531-4041-96d5-181c2a62a2ae_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of estimated future amortization expense of finite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_f82065aa-096c-444b-8117-904df5a9c139_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Addition to other intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_SGD_63051709-3d8f-46e3-8136-f0d11a3168a2_terseLabel_en-US" xlink:label="lab_currency_SGD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Singapore Dollar</link:label>
    <link:label id="lab_currency_SGD_label_en-US" xlink:label="lab_currency_SGD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Singapore, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SGD" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_SGD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_SGD" xlink:to="lab_currency_SGD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_f579f978-6ee2-4b87-814c-1cd2cb75b39e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticPlanMember_e0b73baf-c7b2-40e9-a6b5-ebad7ce4772c_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan</link:label>
    <link:label id="lab_us-gaap_DomesticPlanMember_label_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticPlanMember" xlink:to="lab_us-gaap_DomesticPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_e919df69-f0f5-4711-9787-f33cc453e54c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Arrangement - Maximum</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_4075d6a4-5d99-4c72-9523-00262d3bdaa4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Volatility of Agilent shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityAbstract_5f59c4f1-bdf6-47f6-9190-2c1f61148eb1_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_a_TransformationalPrograms_5ae8ac85-bb2c-4da8-a2b3-45bd133acd5a_negatedLabel_en-US" xlink:label="lab_a_TransformationalPrograms" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transformational initiatives</link:label>
    <link:label id="lab_a_TransformationalPrograms_label_en-US" xlink:label="lab_a_TransformationalPrograms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transformational Programs</link:label>
    <link:label id="lab_a_TransformationalPrograms_documentation_en-US" xlink:label="lab_a_TransformationalPrograms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The charge against earnings in the period, comprised of costs associated with restructuring activities not otherwise specified in the taxonomy that are not part of a specific plan as required by GAAP.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_TransformationalPrograms" xlink:href="a-20230131.xsd#a_TransformationalPrograms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_TransformationalPrograms" xlink:to="lab_a_TransformationalPrograms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_2a802dc7-cc05-4a1a-9a4f-059d7e331863_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_6949271f-a42d-433e-bbfc-9209602866e5_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_0188d96b-61da-42f3-810f-96c3b399b513_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_f5db4055-02ea-4647-8067-04d257d2b41c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_12691521-f702-4063-a606-31d4a6ea75a2_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_9642e99f-fc1b-4821-9503-8004191adaf8_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_dc3b54c0-d899-4d44-b5b7-0390164a12be_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_CHF_9d918c7d-1283-40d3-bc7b-8d4fca648354_terseLabel_en-US" xlink:label="lab_currency_CHF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swiss Franc</link:label>
    <link:label id="lab_currency_CHF_label_en-US" xlink:label="lab_currency_CHF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Switzerland, Francs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CHF" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CHF"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_CHF" xlink:to="lab_currency_CHF" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ac2409f7-8c7c-4deb-ba0d-65d5daa850df_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_d56f3f2e-6b46-46fb-b28b-b77eba2f2836_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_aa2a82c7-8915-43fa-b353-59a47d3f9da2_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3c5dbfa0-33bc-4762-99bf-8817f9120d7f_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8fb13098-5850-413a-a31e-7ee44dca82ca_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_fc803705-cda9-4417-9b3d-de90984a3bb9_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities acquired in business combinations</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_1167bf97-15e0-4284-a632-9362b5553039_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount outstanding on credit facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Fair Value of Amount Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:to="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortMember_8eb241d5-8543-4415-b722-4c096e02f033_terseLabel_en-US" xlink:label="lab_us-gaap_ShortMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sell</link:label>
    <link:label id="lab_us-gaap_ShortMember_label_en-US" xlink:label="lab_us-gaap_ShortMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortMember" xlink:to="lab_us-gaap_ShortMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PublicUtilitiesInventoryTypeDomain_38887988-0eb4-44bd-942c-f9a83cf66bf1_terseLabel_en-US" xlink:label="lab_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_PublicUtilitiesInventoryTypeDomain_label_en-US" xlink:label="lab_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:to="lab_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_109156d9-249e-44d5-b3f9-12058fc85717_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_39f0bf7f-210d-4c8c-a9cf-b426af38a338_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_56ddf6a0-b167-46d4-b479-643f668eeddf_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased and retired during period, (Value)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_bec6dd0f-0017-4ce6-8717-898140f147a0_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_c79db801-3524-4221-aa39-1e2e56308c50_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenue deferred in the period</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_15fd957e-de3c-4f5a-b514-13ff77b5436c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (gain) loss on equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_b3f0261a-34a3-46af-b320-ed3711fd4305_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_4c4b769a-f91e-473b-ad0e-4760281df81e_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_a1d7bd87-a42c-40d1-bcb7-51a83f1caff3_verboseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDate_8efa0348-9b8b-4f2c-a33f-c769ee779c4d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity date of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDate_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentMaturityDate" xlink:to="lab_us-gaap_DebtInstrumentMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_004c86cd-5f66-4429-a311-ef504e0873b4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax paid, net</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_18e3e42f-8d8a-4fc2-bf12-21be20d84186_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on derivative instruments, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_4e087bef-f0e4-4497-b1a9-4b3b4948eb19_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), tax, parenthetical disclosures</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax, Parenthetical Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_a_ResolutionBioscienceIncMember_f44deba8-3a33-437d-8ce3-ab9ff055f68e_terseLabel_en-US" xlink:label="lab_a_ResolutionBioscienceIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Resolution Bioscience, Inc.</link:label>
    <link:label id="lab_a_ResolutionBioscienceIncMember_label_en-US" xlink:label="lab_a_ResolutionBioscienceIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Resolution Bioscience, Inc. [Member]</link:label>
    <link:label id="lab_a_ResolutionBioscienceIncMember_documentation_en-US" xlink:label="lab_a_ResolutionBioscienceIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Resolution Bioscience, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_ResolutionBioscienceIncMember" xlink:href="a-20230131.xsd#a_ResolutionBioscienceIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_ResolutionBioscienceIncMember" xlink:to="lab_a_ResolutionBioscienceIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_a80e328f-b54c-4e58-8893-ed1dad127487_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized that was included in the contract liability balance at the beginning of the period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableLineItems_7095a2c4-479c-45af-b1c4-8cec18c87ca0_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Line Items]</link:label>
    <link:label id="lab_us-gaap_DividendsPayableLineItems_label_en-US" xlink:label="lab_us-gaap_DividendsPayableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableLineItems" xlink:to="lab_us-gaap_DividendsPayableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_a7920228-fc91-4a76-b64b-d90bac314604_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_6d9c8932-534a-4385-9146-2665823c4504_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of non-controlling interest increase (decrease)</link:label>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:to="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_3e64cb96-cce6-4ed8-90aa-45cd5a687eac_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember_c994f216-2b8e-43b2-9321-13a06277b7a7_terseLabel_en-US" xlink:label="lab_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains (Losses) on Derivatives</link:label>
    <link:label id="lab_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember_label_en-US" xlink:label="lab_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Derivative Qualifying as Hedge, Excluded Component, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember" xlink:to="lab_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_2a1597d8-19c1-406f-b354-5f4032cc12be_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_85dce183-6f2a-4887-b2c9-1656d43ae9e9_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotes_63cdb3ac-2f72-48e5-a283-a0b015ceef36_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value of Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotes_label_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotes" xlink:to="lab_us-gaap_SeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_d36c9919-fe17-4cfa-ae45-ad5e72ef7639_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Declared per share</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_5eb495e5-88b8-4f3e-a2a2-5c44486ae0d5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Declared. per share</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_fd0d42e2-7fe2-42b7-8ba5-a0cfeb51e7a3_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenue:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_2bece6bd-3e8b-47b9-8497-403e30688f41_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_005fd3f8-93be-47ae-8c3a-62c3cc571cbd_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_2f3f43fa-a863-4823-b57c-0b6025e5d091_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining performance obligation expected timing of satisfaction period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease_eb205e30-460b-4f25-8c15-7524af6097a2_terseLabel_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Translation and Other Adjustment</link:label>
    <link:label id="lab_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation Adjustment Functional to Reporting Currency, Net of Tax, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" xlink:to="lab_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_7607046d-3d74-4921-a338-8e53e8e4cbb0_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_b883afb8-2198-469c-9710-60d3b5209759_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity</link:label>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Variable Interest Entity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:to="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_5605b396-b888-47fc-8b2f-c5099c60a30f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_bc1e66d4-85e8-4aeb-9ee9-3099bd05e318_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased and retired during period, (Shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongMember_908596c9-e663-4121-8dfd-8578bde211cc_terseLabel_en-US" xlink:label="lab_us-gaap_LongMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buy</link:label>
    <link:label id="lab_us-gaap_LongMember_label_en-US" xlink:label="lab_us-gaap_LongMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongMember" xlink:to="lab_us-gaap_LongMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_18a18abe-c18d-4f81-a331-a2b7238ae7e0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable,net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_5fc6686e-124b-4fa3-8782-1c0059f21fce_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_e6d1ab2b-389a-4ba9-b8af-6a4d037593ca_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cd4a43fd-98cd-4dbd-812e-408d23442a25_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsFairValueDisclosure_881fd1db-a31d-44cf-9cb4-a7c1ed45e1a1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of impaired long-lived assets held for use</link:label>
    <link:label id="lab_us-gaap_OtherAssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_OtherAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsFairValueDisclosure" xlink:to="lab_us-gaap_OtherAssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_a_InstrumentationMember_b5480be8-66a0-458d-927c-4dc223567954_terseLabel_en-US" xlink:label="lab_a_InstrumentationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instrumentation</link:label>
    <link:label id="lab_a_InstrumentationMember_label_en-US" xlink:label="lab_a_InstrumentationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instrumentation [Member]</link:label>
    <link:label id="lab_a_InstrumentationMember_documentation_en-US" xlink:label="lab_a_InstrumentationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instrumentation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_InstrumentationMember" xlink:href="a-20230131.xsd#a_InstrumentationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_InstrumentationMember" xlink:to="lab_a_InstrumentationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_5702c415-ac15-456c-a038-daef9a3b5061_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_d737f90c-e7e8-4f6f-b327-9eb3c6b0751d_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_DKK_30e8764a-1cde-4956-804c-8d55a79fdf86_terseLabel_en-US" xlink:label="lab_currency_DKK" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Danish Krone</link:label>
    <link:label id="lab_currency_DKK_label_en-US" xlink:label="lab_currency_DKK" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denmark, Kroner</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_DKK" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_DKK"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_DKK" xlink:to="lab_currency_DKK" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForErrorCorrectionDomain_32e4c4e3-934a-45c6-8f17-743c40574e35_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForErrorCorrectionDomain_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:to="lab_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_84881763-3dd3-46b7-8051-861dfc58f257_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total costs and expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_4ad89f8e-fde7-4426-af86-a0512f3f5060_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_c5150d3e-f2e8-4150-99e6-34027790e3a4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_70f2d664-3227-4c22-8bf2-ad81ebc7bea5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_a40c25bb-b90e-44a6-86fe-497c5a9f273d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based awards issued, net of tax (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_21087961-a60a-4847-8013-eee7bcfdc704_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_a_A5YrUnsecuredCreditFacilityMember_e48cbcaa-b53a-4e42-a14f-8f499399b5be_terseLabel_en-US" xlink:label="lab_a_A5YrUnsecuredCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5 yr Unsecured Credit Facility</link:label>
    <link:label id="lab_a_A5YrUnsecuredCreditFacilityMember_label_en-US" xlink:label="lab_a_A5YrUnsecuredCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5 yr Unsecured Credit Facility [Member]</link:label>
    <link:label id="lab_a_A5YrUnsecuredCreditFacilityMember_documentation_en-US" xlink:label="lab_a_A5YrUnsecuredCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5 yr Unsecured Credit Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_A5YrUnsecuredCreditFacilityMember" xlink:href="a-20230131.xsd#a_A5YrUnsecuredCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_A5YrUnsecuredCreditFacilityMember" xlink:to="lab_a_A5YrUnsecuredCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_8c8614ef-065c-450a-940d-b3346e4df364_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_0d66a17d-0c43-48b0-afd5-a3ca1bf3efb8_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEGMENT INFORMATION</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_fa1418c6-7bbd-4d58-b992-15e20ab3af09_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_97e1a0a8-6ac2-471d-ba11-9fdd6fe141a0_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess tax benefit from stock based compensation</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax_5bddd14c-1f8d-4293-87a4-2783978c35e8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax on actuarial net loss and prior service benefit reclassified</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_aa6a04c9-c7d3-414f-a890-79ca573ff39e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recognized</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_39035a67-ad71-424a-aabf-9da773be49dd_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_country_NL_cf35b6c2-c39a-42dc-b0b6-6b5eb382aef7_terseLabel_en-US" xlink:label="lab_country_NL" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NETHERLANDS</link:label>
    <link:label id="lab_country_NL_label_en-US" xlink:label="lab_country_NL" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NETHERLANDS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_NL" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_NL"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_NL" xlink:to="lab_country_NL" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_31afd9f3-95b7-4d67-be45-6721cf265a7c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fe45bf8d-3ab1-4e8f-a5c5-511d529d03e7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_a7e13a43-5cd6-4af8-b69e-c719f8e438e0_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d168ae0d-1b93-4f85-8a9d-15c3e892d6ca_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares used in computing net income per share:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_a_DocumentAndEntityInformationAbstract_d72ab5b3-d728-497a-b0fa-d252ee0caa09_terseLabel_en-US" xlink:label="lab_a_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
    <link:label id="lab_a_DocumentAndEntityInformationAbstract_label_en-US" xlink:label="lab_a_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
    <link:label id="lab_a_DocumentAndEntityInformationAbstract_documentation_en-US" xlink:label="lab_a_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_DocumentAndEntityInformationAbstract" xlink:href="a-20230131.xsd#a_DocumentAndEntityInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_DocumentAndEntityInformationAbstract" xlink:to="lab_a_DocumentAndEntityInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions_781e3cd3-48eb-4a5a-b8c8-2d64f1bb29b5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post-vest holding restriction discount for all executive awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_9a14c711-144c-4385-8f1c-82cfb2ddc5a5_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_11fe8955-0012-497f-bd27-c5268bce2df9_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_89070ad3-b174-41f2-a1fb-b39e3ab61784_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_2568a148-14c3-4c61-8b95-4b462a57835a_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_2a950eb1-508d-4d4e-b300-5d23bbb9be13_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfInvestments_1b3f682b-7f5d-4288-b0c9-488d9c7ffaa3_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Investments</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfInvestments_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other than Temporary Impairment Losses, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfInvestments" xlink:to="lab_us-gaap_ImpairmentOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_PLN_b8203473-fef0-45d1-bd65-8fb2dceb490d_terseLabel_en-US" xlink:label="lab_currency_PLN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Polish Zloty</link:label>
    <link:label id="lab_currency_PLN_label_en-US" xlink:label="lab_currency_PLN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Poland, Zlotych</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_PLN" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_PLN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_PLN" xlink:to="lab_currency_PLN" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_d1690843-240f-446a-aba8-5653431e2293_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate_7a07c9e3-2e31-4d3f-a6bf-7d23dc07d99f_verboseLabel_en-US" xlink:label="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pair-wise correlation with selected peers (in hundredths)</link:label>
    <link:label id="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate_label_en-US" xlink:label="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Peer Company Shares Price Wise Correlationy Rate</link:label>
    <link:label id="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate_documentation_en-US" xlink:label="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The measure of the percentage amount of share price correlation during the period with a selected group of peer companies. Pair-wise correlations with selected peers is calculated as the correlation between each pair and the sum of correlations divided by the number of pairs to produce the average correlation between each pair.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate" xlink:href="a-20230131.xsd#a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate" xlink:to="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_8930f508-e641-4d2b-866d-5cd94b4ef50a_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_f2309b8b-a633-4316-8499-f03a35e55bdc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_0e9d9a86-ad4e-4d73-88d4-172b17dd9fe4_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0605b613-75de-48be-8cdf-7137912171c9_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_08b52499-916e-4ac1-82db-e58ef3e8643c_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5a996c52-308c-4d78-90b5-a75d6bbcdce2_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted-average shares</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_8e939c09-3056-44c0-8186-5d6aa545d13e_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_446a351a-1975-44ac-accc-ad52fb8be065_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_ed065fe5-a41c-40fb-b0d8-dabff5b223e4_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies (Note 9 and 12)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_3f09bbae-dcda-4f52-b5eb-40fd3338d8cb_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_fb3cf5bc-98d6-4dd7-938a-6a925142022a_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_1774e01e-9357-4bbf-872e-11522368f298_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_6066acf1-e070-430b-a9cc-a3e0e3c03e97_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock; $0.01 par value; 125 million shares authorized; none issued and outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_BRL_fff8c81e-e6fb-413c-8caa-2b2775ff7747_terseLabel_en-US" xlink:label="lab_currency_BRL" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brazil, Brazil Real</link:label>
    <link:label id="lab_currency_BRL_label_en-US" xlink:label="lab_currency_BRL" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brazil, Brazil Real</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_BRL" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_BRL"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_BRL" xlink:to="lab_currency_BRL" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_298e7bb5-f991-407c-85c3-1319bc2f9a4a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount reclassified into earnings related to derivative instruments, net of tax benefit of $(2) and $(1)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_29098db4-a621-4019-8a59-94d068b816c4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on derivatives after reclassification and after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_6f22b4c9-c6c0-473e-92b1-ee08adf38ea2_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAbstract_b687db8f-5351-4dc2-ac51-2fa9679e2e3a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3c82a8a5-10ba-4c0c-9264-0d39d22b7ba4_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_81e6a875-bb49-4ae2-96ec-fd050aaba79f_terseLabel_en-US" xlink:label="lab_us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Date of Declared Dividends</link:label>
    <link:label id="lab_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_label_en-US" xlink:label="lab_us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Date to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendPayableDateToBePaidDayMonthAndYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:to="lab_us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_f6d9ab36-3abb-441d-a85d-03cda5162f5c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost - benefits earned during the period</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_17a25ceb-c97d-410d-a6c1-de7be84c29f7_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Date Dividends Declared</link:label>
    <link:label id="lab_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_label_en-US" xlink:label="lab_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Date Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateDeclaredDayMonthAndYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear" xlink:to="lab_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsDomain_b76ad7f6-3068-42c0-a1e8-c9e0bf2702cf_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends [Domain]</link:label>
    <link:label id="lab_us-gaap_DividendsDomain_label_en-US" xlink:label="lab_us-gaap_DividendsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsDomain" xlink:to="lab_us-gaap_DividendsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_612fca3e-1d97-43ce-8b91-997cb87731b2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_b7413141-2981-4f72-8fb2-a9a39e7a642b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_2696c992-ed78-40d8-9f40-8a9ba696f911_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Unobservable Inputs (Level 3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_b902c5bf-603d-4c0c-bd12-a60c27332b9f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_0ad09aec-b07d-4e49-a669-00ba9dcf8bca_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_a_NonInstrumentationandOtherMember_69b1666f-3cf5-414a-b5f0-5e730233ef9a_terseLabel_en-US" xlink:label="lab_a_NonInstrumentationandOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Instrumentation and Other</link:label>
    <link:label id="lab_a_NonInstrumentationandOtherMember_label_en-US" xlink:label="lab_a_NonInstrumentationandOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Instrumentation and Other [Member]</link:label>
    <link:label id="lab_a_NonInstrumentationandOtherMember_documentation_en-US" xlink:label="lab_a_NonInstrumentationandOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Instrumentation and Other[Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_NonInstrumentationandOtherMember" xlink:href="a-20230131.xsd#a_NonInstrumentationandOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_NonInstrumentationandOtherMember" xlink:to="lab_a_NonInstrumentationandOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1d25b3bf-5980-4633-a18b-718c0dac9778_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SHARE-BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrderOrProductionBacklogMember_3c4df965-f113-434e-9081-1cf0783e9bed_terseLabel_en-US" xlink:label="lab_us-gaap_OrderOrProductionBacklogMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Backlog</link:label>
    <link:label id="lab_us-gaap_OrderOrProductionBacklogMember_label_en-US" xlink:label="lab_us-gaap_OrderOrProductionBacklogMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Order or Production Backlog [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrderOrProductionBacklogMember" xlink:to="lab_us-gaap_OrderOrProductionBacklogMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_b0bd5a3a-1d74-47cb-b41e-cf79d7c47b47_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial Losses</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_89fb1b3f-610b-4ecc-ba54-568957fb7d12_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_3ebc8d8a-29e8-4b2d-98f6-f68edab70821_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_5175fded-d8a3-4907-84f7-8434e6c25cd6_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling Interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6416261f-c40d-4728-af97-130ac3a91b96_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_TWD_8d15131e-7cde-4577-9d40-55a372ca0ea6_terseLabel_en-US" xlink:label="lab_currency_TWD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taiwan, New Dollars</link:label>
    <link:label id="lab_currency_TWD_label_en-US" xlink:label="lab_currency_TWD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taiwan, New Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_TWD" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_TWD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_TWD" xlink:to="lab_currency_TWD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_a31b1cb7-9ea0-4eaa-a771-c8efd01fcfeb_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial losses</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_9e6224b8-b3b9-44e4-9538-33f51e4039a8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of taxes related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_598e4c7f-a53b-4a07-b64c-bcaa39219cea_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Award, Tax</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_259e7362-cce0-429b-abcd-87e0706dc455_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_a_ThirdPartyTechnologyandLicensesMember_95f39404-e5f8-4070-94f2-9f5732bc631c_terseLabel_en-US" xlink:label="lab_a_ThirdPartyTechnologyandLicensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third-Party Technology and Licenses</link:label>
    <link:label id="lab_a_ThirdPartyTechnologyandLicensesMember_label_en-US" xlink:label="lab_a_ThirdPartyTechnologyandLicensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third-Party Technology and Licenses [Member]</link:label>
    <link:label id="lab_a_ThirdPartyTechnologyandLicensesMember_documentation_en-US" xlink:label="lab_a_ThirdPartyTechnologyandLicensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third-Party Technology and Licenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_ThirdPartyTechnologyandLicensesMember" xlink:href="a-20230131.xsd#a_ThirdPartyTechnologyandLicensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_ThirdPartyTechnologyandLicensesMember" xlink:to="lab_a_ThirdPartyTechnologyandLicensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_a_LifeSciencesandAppliedMarketsMember_9c4affa6-501b-4f7a-a83b-235dc4a57ab7_terseLabel_en-US" xlink:label="lab_a_LifeSciencesandAppliedMarketsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Sciences and Applied Markets</link:label>
    <link:label id="lab_a_LifeSciencesandAppliedMarketsMember_label_en-US" xlink:label="lab_a_LifeSciencesandAppliedMarketsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Sciences and Applied Markets [Member]</link:label>
    <link:label id="lab_a_LifeSciencesandAppliedMarketsMember_documentation_en-US" xlink:label="lab_a_LifeSciencesandAppliedMarketsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Sciences and Applied Markets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_LifeSciencesandAppliedMarketsMember" xlink:href="a-20230131.xsd#a_LifeSciencesandAppliedMarketsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_LifeSciencesandAppliedMarketsMember" xlink:to="lab_a_LifeSciencesandAppliedMarketsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_0532b4e8-d940-4746-b82b-7275ca72724d_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_a7a68d17-356c-475f-af23-2ef2722489d7_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Roll Forward</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_72312337-84a5-4722-9792-9b54df140e22_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining authorized repurchase amount under share repurchase program</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a39d2169-2701-4e4d-9dff-e1be282aea9e_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential common shares - stock options and other employee stock plans</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_5b43605e-5603-4a40-a8dc-bac5e9e28b17_verboseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_a65e24ae-30f6-48dc-b161-655593b00c60_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_a_MeasurementInputAssetVolatilityMember_93b7d507-ce58-4316-83b8-e0e32afb748a_terseLabel_en-US" xlink:label="lab_a_MeasurementInputAssetVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Asset Volatility</link:label>
    <link:label id="lab_a_MeasurementInputAssetVolatilityMember_label_en-US" xlink:label="lab_a_MeasurementInputAssetVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Asset Volatility [Member]</link:label>
    <link:label id="lab_a_MeasurementInputAssetVolatilityMember_documentation_en-US" xlink:label="lab_a_MeasurementInputAssetVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Asset Volatility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_MeasurementInputAssetVolatilityMember" xlink:href="a-20230131.xsd#a_MeasurementInputAssetVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_MeasurementInputAssetVolatilityMember" xlink:to="lab_a_MeasurementInputAssetVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_4e38a21b-057f-459b-83c1-8bb1f5173a4d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions of businesses and intangible assets, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable_70091968-1b1c-43fe-9903-d520000f302e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment in exchange for convertible note</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Collection of Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:to="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_ae1d025a-4f3c-48e7-a182-a33e8dcbee04_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Other Observable Inputs (Level 2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_6e51ed4d-238c-49cb-acf3-6b9805f1b610_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Allocation of Recognized Period Costs</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_045b15c5-fac0-4c14-b0c1-7bcac33828b6_verboseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of segment results to total enterprise results</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax_4be89963-b347-4d16-93b0-f89141eec465_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial net loss and prior service benefit reclassified, before tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_3886d035-058d-423e-8cd9-cfa55cf7b508_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_75306493-5fe6-493b-a103-3ea9ffc18dfe_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_875db0c8-1d0d-4c71-99c0-2d585f55dad1_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_a5a4bfb2-569f-4840-8eef-119bce449450_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Book Value</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_4def177e-1765-48e6-bdb1-85d0bc036439_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_69e7c3c7-ef37-49c0-8104-a32d5ab2ef6c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_fb611444-8714-48f3-81e2-420079438bdf_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_a_TermLoanMaturing2025Member_81610c3f-5014-4139-abce-d54f299c19e2_terseLabel_en-US" xlink:label="lab_a_TermLoanMaturing2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Maturing 2025</link:label>
    <link:label id="lab_a_TermLoanMaturing2025Member_label_en-US" xlink:label="lab_a_TermLoanMaturing2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Maturing 2025 [Member]</link:label>
    <link:label id="lab_a_TermLoanMaturing2025Member_documentation_en-US" xlink:label="lab_a_TermLoanMaturing2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Maturing 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_TermLoanMaturing2025Member" xlink:href="a-20230131.xsd#a_TermLoanMaturing2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_TermLoanMaturing2025Member" xlink:to="lab_a_TermLoanMaturing2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_cab68820-c776-420d-a95f-d8f5a7bf500f_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_ef67538e-67f1-46ca-b32a-406b9986bacc_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_a_MeasurementInputRevenueVolatilityMember_559ec760-9278-4fb0-bfc4-faca6078074a_terseLabel_en-US" xlink:label="lab_a_MeasurementInputRevenueVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Revenue Volatility</link:label>
    <link:label id="lab_a_MeasurementInputRevenueVolatilityMember_label_en-US" xlink:label="lab_a_MeasurementInputRevenueVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Revenue Volatility [Member]</link:label>
    <link:label id="lab_a_MeasurementInputRevenueVolatilityMember_documentation_en-US" xlink:label="lab_a_MeasurementInputRevenueVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Revenue Volatility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_MeasurementInputRevenueVolatilityMember" xlink:href="a-20230131.xsd#a_MeasurementInputRevenueVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_MeasurementInputRevenueVolatilityMember" xlink:to="lab_a_MeasurementInputRevenueVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_a1705bd6-c150-4478-aaa1-5c9f9b82ef64_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_44a95f09-ec77-4ca3-a243-5fecaee43051_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation capitalized in inventory</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum_ce72f99c-d2cb-45a8-9d4f-6298515b71c3_terseLabel_en-US" xlink:label="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Volatility of selected peer-company shares - Maximum</link:label>
    <link:label id="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum_label_en-US" xlink:label="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Peer Company Shares Volatility Rate Range Maximum</link:label>
    <link:label id="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum_documentation_en-US" xlink:label="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The measure of the percentage amount by which a share price fluctuates during a period for peer companies - maximum range. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum" xlink:href="a-20230131.xsd#a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum" xlink:to="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_76d4bdb8-8b0d-4e37-8f08-b2ea94ba7dea_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_02cd2386-3ddc-44d9-a15e-38fab3380b44_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining performance obligation amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_037445d0-06df-4745-a463-e1ef4868317d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in net prior service benefit, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_d92502ed-c605-46ec-9600-a4c535d5d521_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum contractual term, Expiration Period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_3cd758c0-56a4-4422-bb38-320ef19985bb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregated notional amounts by currency and designation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_297482ab-b958-4f68-b110-021011f7d6ab_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_84748887-b6b6-410a-a0d6-c2d43c392ce0_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsDomain_1b6fcc4e-fbca-4b8a-a420-cd3772c78c9e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:to="lab_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AmericasMember_fb4c536b-53ca-4395-94da-9f00ba90a828_terseLabel_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas</link:label>
    <link:label id="lab_srt_AmericasMember_label_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AmericasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AmericasMember" xlink:to="lab_srt_AmericasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_4e403649-4b0e-4787-b6a2-5c879e3b17c4_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets related to business combinations</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_91f008e2-ff5b-4000-a1f2-fa86a3f90c69_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase program</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_30cffa04-01d9-4b10-8765-826a36e7621e_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives asset fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum_4564d381-510c-4852-880b-f378daf2d641_terseLabel_en-US" xlink:label="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Volatility of selected peer-company shares - Minimum</link:label>
    <link:label id="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum_label_en-US" xlink:label="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Peer Company Shares Volatility Rate Range Minimum</link:label>
    <link:label id="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum_documentation_en-US" xlink:label="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The measure of the percentage amount by which a share price fluctuates during a period for peer companies - minimum range. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum" xlink:href="a-20230131.xsd#a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum" xlink:to="lab_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_cd0f9b07-443e-4b5c-9c5c-9bf81c8875a7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_cfadbf52-9507-47c6-badc-344564b65d88_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_f7d12d01-1e11-438d-96ae-6984a175be2f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_bc08c0b2-8725-4f7f-aa3b-f2315457c11a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liability ending balance as of October 31, 2022</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_17e10219-dfaf-41a3-aa01-5f4bae79e7bb_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liability ending balance as of January 31, 2023</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentDetailAbstract_8bc89a79-e3bf-4b14-8781-39e1376b02ff_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentDetailAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentDetailAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentDetailAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument Detail [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentDetailAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentDetailAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentDetailAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_3caf405f-74c7-4138-a81e-3e712445f191_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of IPR&amp;D</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_1d2d8c49-a8c0-453c-ac11-ca24da0a8e77_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_d736cb51-440e-47ed-9aef-8c67175c78aa_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_bb699820-7fac-4e90-b9ad-c8b321017c4e_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_ea355437-05c6-4d0c-853b-92248d790735_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_XXX_eb33ded0-50b7-46f4-90d6-1bc3c1c6fe1e_terseLabel_en-US" xlink:label="lab_currency_XXX" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_currency_XXX_label_en-US" xlink:label="lab_currency_XXX" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">No currency</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_XXX" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_XXX"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_XXX" xlink:to="lab_currency_XXX" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_d77cfe4a-aaf7-4589-ba50-4fd5043bb958_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_c1307823-d628-44a9-ac3a-e9b2b487cc72_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c24fa0a5-2e89-4193-b1ce-b905290e440d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_bf3ee35b-6fe1-445d-bebf-4cb312d32fd2_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) reclassified from accumulated other comprehensive&#160;loss into cost of sales</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_0de694f8-ead6-4a39-b3e7-f406399b893c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_800334f5-e95d-4b3f-89bd-8df8a13028e8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining Gain (Loss) Reclassification from Accumulated OCI to be amortized to Income,</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_fc347045-2544-4446-9876-502e8dd31686_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_682fcf17-44dc-425a-9223-b4c4d11d230a_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_6fbac47c-2680-4ba1-a9c9-3595c72f8b34_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_1e309204-88aa-4b85-8817-afce029a0be3_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVENTORY</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_12317fc2-9da4-412f-9c06-7d14bf34393a_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Senior Notes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_772b8a56-7e08-4abe-b2c9-30d2964245a0_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_43841f21-c99b-4fab-85e3-f7375ac4379b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial net loss and prior service benefit reclassified, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_8579a0e6-c52d-410b-97b2-408b8b2cbe10_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments (foreign exchange contracts)</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contract, Asset, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_a2ffac20-c948-4d26-9cf7-4302cd828ca6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP plan purchase price (in hundredths)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Discount from Market Price, Purchase Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi_abfea241-f988-4741-8474-5bb2d0809124_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of equity securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi" xlink:to="lab_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_60a2c18c-d8c6-47c1-82e6-836174b7dd8b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_84fabb02-acf9-4ece-8b67-759544d539e3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_78c0a8b1-55e9-47c8-856e-2b562ee7dd3a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsAbstract_1305717f-62bb-42fd-bc65-dcad49db6f34_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsAbstract_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsAbstract" xlink:to="lab_us-gaap_PaymentsOfDividendsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_195456fe-6fdd-4a02-b784-763be8113174_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_9eed53f8-5b19-459d-b44a-6136debd541f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_dc3f5417-75fb-4f0c-9250-018d3ad618b8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire equity securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" xlink:to="lab_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_39e21922-224b-4f07-8cf0-afb69d2f135d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_d28d9c44-9fc5-443d-9892-104b296e344d_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_3d939d74-ee9f-4d49-b217-f04eecc78d7b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Reclassified from AOCI into cost of sales [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:to="lab_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_45abd8ea-f828-4936-ae26-5391501c48ee_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_a_EnvironmentalandForensicsMarketMember_580f24e1-2a32-4fd0-8bbe-84f78a7602d3_terseLabel_en-US" xlink:label="lab_a_EnvironmentalandForensicsMarketMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental and Forensics</link:label>
    <link:label id="lab_a_EnvironmentalandForensicsMarketMember_label_en-US" xlink:label="lab_a_EnvironmentalandForensicsMarketMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental and Forensics Market [Member]</link:label>
    <link:label id="lab_a_EnvironmentalandForensicsMarketMember_documentation_en-US" xlink:label="lab_a_EnvironmentalandForensicsMarketMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental and Forensics Market [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_EnvironmentalandForensicsMarketMember" xlink:href="a-20230131.xsd#a_EnvironmentalandForensicsMarketMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_EnvironmentalandForensicsMarketMember" xlink:to="lab_a_EnvironmentalandForensicsMarketMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_f71756a4-050f-4b43-8ab8-f8487c0fd385_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_6b42cf4e-0e14-471f-8c94-10335d69b300_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsAxis_7625112b-5b5d-4ba1-8210-ab200a1a586e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:to="lab_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_e7c0c596-dd29-4448-a5d4-a1eacb1faaec_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsAbstract_2677bd77-aca6-425f-a06e-494dc637a60d_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends [Abstract]</link:label>
    <link:label id="lab_us-gaap_DividendsAbstract_label_en-US" xlink:label="lab_us-gaap_DividendsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsAbstract" xlink:to="lab_us-gaap_DividendsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_fc1270d3-50b1-4191-9534-71992e408b2b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_e7474d4f-d5ad-40c4-afe5-374ee63355ef_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_304b29ad-d787-40f3-9c09-2a4649900865_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_a_AcademiaandGovernmentMarketMember_b77c4bdd-9627-47a6-9f8f-8a00acf9e901_terseLabel_en-US" xlink:label="lab_a_AcademiaandGovernmentMarketMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Academia and Government</link:label>
    <link:label id="lab_a_AcademiaandGovernmentMarketMember_label_en-US" xlink:label="lab_a_AcademiaandGovernmentMarketMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Academia and Government Market [Member]</link:label>
    <link:label id="lab_a_AcademiaandGovernmentMarketMember_documentation_en-US" xlink:label="lab_a_AcademiaandGovernmentMarketMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Academia and Government Market [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_AcademiaandGovernmentMarketMember" xlink:href="a-20230131.xsd#a_AcademiaandGovernmentMarketMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_AcademiaandGovernmentMarketMember" xlink:to="lab_a_AcademiaandGovernmentMarketMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_e13f1e18-6533-4fd8-94c4-70338dfde797_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_6313fc93-d286-478f-89be-fa9f567c2cc8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_cc9208be-f4a1-426d-8a96-fcf722fb96a2_terseLabel_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Axis]</link:label>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_label_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:to="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6d402545-f448-43f0-867d-aefed311b5ef_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ed46d859-0ed9-4ec2-a55d-3e98c2577939_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityExpirationDate1_9105c469-d30f-40fd-8b99-e113e2147599_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityExpirationDate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration date of credit facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityExpirationDate1_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityExpirationDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationDate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityExpirationDate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityExpirationDate1" xlink:to="lab_us-gaap_LineOfCreditFacilityExpirationDate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract_f549b873-3207-4242-bb0a-c60f3cb99457_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Curtailments and Settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Settlement and Curtailment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodAxis_f619d14f-5af7-4035-9a9d-94506331a374_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodAxis_label_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodAxis" xlink:to="lab_us-gaap_TaxPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_d9c93093-9bd2-450b-8670-7e76b8199910_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_a7208a55-60b1-4c65-87a4-5416caf6749a_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_47c9655d-e202-4509-81c3-3c8f04ec9937_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_6dbd42f7-6775-4c81-91ef-0cc261ae060d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_8e15acbb-9cc1-4331-bf9e-b2cd9726c3ec_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_fc3abc02-f8c1-4b67-91bd-7fe0845f7099_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_EUR_102dc3bd-ba3d-4c66-a5f3-654e5af9c3e5_terseLabel_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro</link:label>
    <link:label id="lab_currency_EUR_label_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_EUR" xlink:to="lab_currency_EUR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_a4becdcf-b289-4965-91d2-9bf5f8da8a3c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfOrdinaryDividends_d5b91728-0a6c-4835-98a5-54c9cbd17a1c_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfOrdinaryDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of dividends</link:label>
    <link:label id="lab_us-gaap_PaymentsOfOrdinaryDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfOrdinaryDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfOrdinaryDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfOrdinaryDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfOrdinaryDividends" xlink:to="lab_us-gaap_PaymentsOfOrdinaryDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsAxis_ceebdede-3b9f-4da2-a672-a76e8acea916_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends [Axis]</link:label>
    <link:label id="lab_us-gaap_DividendsAxis_label_en-US" xlink:label="lab_us-gaap_DividendsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsAxis" xlink:to="lab_us-gaap_DividendsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_20d6ce9b-ab8d-44a2-afd7-b8360677298e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_97b2196b-f1db-45c6-a18d-c0ea7f8f1480_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_5cd5a144-44d0-4f53-acec-b4c924860ed3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recognized in accumulated other comprehensive&#160;loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestmentsTextBlock_d4b4d544-636b-4101-bad1-515063accb4b_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Securities</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestmentsTextBlock" xlink:to="lab_us-gaap_GainLossOnInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowingsAbstract_ebbfa0c8-f175-46f7-afc8-16948f51f50b_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowingsAbstract_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowingsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract" xlink:to="lab_us-gaap_ShortTermBorrowingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_44712c10-654f-4256-8d54-4451419aee44_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_56ebe4bd-590c-4a11-9dfb-80ff826ac9fb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesOperatingAbstract_8058fb1e-875f-49c6-95bc-ceaab588a215_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesOperatingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_LeasesOperatingAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesOperatingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Operating [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesOperatingAbstract" xlink:to="lab_us-gaap_LeasesOperatingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_f771fb7d-6d86-49b5-82e6-65ba5a7f6a37_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Senior Debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Senior Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:to="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_7eb97c32-b876-434d-8763-3a707bb1a8a8_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset_7687ab02-3f80-4b9d-bdb3-9dff28d22842_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of impaired long-lived assets held for use</link:label>
    <link:label id="lab_us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset_label_en-US" xlink:label="lab_us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impaired Assets to be Disposed of by Method Other than Sale, Carrying Value of Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset" xlink:to="lab_us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_acd47d8a-110e-41fc-8e5a-113630897685_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper_6544f153-1bbd-4da4-ac65-c1ff9397c939_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Commercial Paper</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_1d0a3baf-3aef-42bc-98c3-95514b6b1319_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_a_AmortizationAndDeferralsAbstract_4924fb2e-423b-49eb-ad55-d657c2facfb0_terseLabel_en-US" xlink:label="lab_a_AmortizationAndDeferralsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization:</link:label>
    <link:label id="lab_a_AmortizationAndDeferralsAbstract_label_en-US" xlink:label="lab_a_AmortizationAndDeferralsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization and deferrals [Abstract]</link:label>
    <link:label id="lab_a_AmortizationAndDeferralsAbstract_documentation_en-US" xlink:label="lab_a_AmortizationAndDeferralsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization and deferrals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_AmortizationAndDeferralsAbstract" xlink:href="a-20230131.xsd#a_AmortizationAndDeferralsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_AmortizationAndDeferralsAbstract" xlink:to="lab_a_AmortizationAndDeferralsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b6f9561f-9ddf-4c70-99ec-f9f34831e9e7_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryLockMember_29376d05-b467-4851-b02b-e57a6e777046_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryLockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Lock [Member]</link:label>
    <link:label id="lab_us-gaap_TreasuryLockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryLockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Lock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryLockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryLockMember" xlink:to="lab_us-gaap_TreasuryLockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_b332b830-c33c-43d8-af91-9f485974cf35_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_e058cbae-240b-4627-ae33-b44b9c9ae42f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_c0f95ff4-4f88-49b4-a3f4-70bb7ec7b144_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of the numerators and denominators of the basic and diluted net income per share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_1ede593b-e7ce-405a-8b9f-ec08034afce1_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_37c4e5fa-8eb9-44f2-90db-a421b5bffbbb_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Products and Services</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_82703dfe-3537-471b-983f-84fc6a8497f4_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Products and Services</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_ae7225dd-df54-48ff-a2ab-b713cf834f5e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Overview and Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_a8033c1d-93ae-443e-9938-aabf9897b2f1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_a_LtppMember_c5cb712d-ce3f-433e-a5fb-a617285e6f2f_terseLabel_en-US" xlink:label="lab_a_LtppMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LTPP</link:label>
    <link:label id="lab_a_LtppMember_label_en-US" xlink:label="lab_a_LtppMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LTPP [Member]</link:label>
    <link:label id="lab_a_LtppMember_documentation_en-US" xlink:label="lab_a_LtppMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Performance Plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_a_LtppMember" xlink:href="a-20230131.xsd#a_LtppMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_a_LtppMember" xlink:to="lab_a_LtppMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>a-20230131_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:bf6e4e81-d7a1-484d-a6c7-4a9890c9070b,g:1d2ec140-a31f-4aad-8309-92440730b1c7-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.agilent.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="a-20230131.xsd#DocumentandEntityInformation"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/DocumentandEntityInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_a_DocumentAndEntityInformationAbstract_a9df6db6-d6ce-42f3-ba60-7175e1cd16cf" xlink:href="a-20230131.xsd#a_DocumentAndEntityInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_e2d05bc2-0b78-4f5e-bdb1-46814fc6d7c7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_a9df6db6-d6ce-42f3-ba60-7175e1cd16cf" xlink:to="loc_dei_EntityRegistrantName_e2d05bc2-0b78-4f5e-bdb1-46814fc6d7c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_15d2d33f-fc99-4e00-9fd0-fdffe835687a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_a9df6db6-d6ce-42f3-ba60-7175e1cd16cf" xlink:to="loc_dei_DocumentType_15d2d33f-fc99-4e00-9fd0-fdffe835687a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_d1debab0-d883-43a8-9e67-8841696ddcad" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_a9df6db6-d6ce-42f3-ba60-7175e1cd16cf" xlink:to="loc_dei_DocumentFiscalPeriodFocus_d1debab0-d883-43a8-9e67-8841696ddcad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_5583fec3-bad5-47d7-a20e-7f4cd2333c61" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_a9df6db6-d6ce-42f3-ba60-7175e1cd16cf" xlink:to="loc_dei_DocumentPeriodEndDate_5583fec3-bad5-47d7-a20e-7f4cd2333c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_d7dd0a04-5ab6-40bd-9599-7ba577ed4496" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_a9df6db6-d6ce-42f3-ba60-7175e1cd16cf" xlink:to="loc_dei_CurrentFiscalYearEndDate_d7dd0a04-5ab6-40bd-9599-7ba577ed4496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_b3603895-3e16-4a8c-b2c0-17a3d49b64cf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_a9df6db6-d6ce-42f3-ba60-7175e1cd16cf" xlink:to="loc_dei_DocumentFiscalYearFocus_b3603895-3e16-4a8c-b2c0-17a3d49b64cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_034d6e88-71cb-450b-8f94-89974865ebc0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_a9df6db6-d6ce-42f3-ba60-7175e1cd16cf" xlink:to="loc_dei_AmendmentFlag_034d6e88-71cb-450b-8f94-89974865ebc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_500483bd-d1a9-498f-9507-a8c5e516beed" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_a9df6db6-d6ce-42f3-ba60-7175e1cd16cf" xlink:to="loc_dei_DocumentQuarterlyReport_500483bd-d1a9-498f-9507-a8c5e516beed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_c0679501-4efe-434d-b31b-c8fdea99ff6a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_a9df6db6-d6ce-42f3-ba60-7175e1cd16cf" xlink:to="loc_dei_DocumentTransitionReport_c0679501-4efe-434d-b31b-c8fdea99ff6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_50b204a5-3ff8-404b-872f-6d06d70b77d3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_a9df6db6-d6ce-42f3-ba60-7175e1cd16cf" xlink:to="loc_dei_EntityCentralIndexKey_50b204a5-3ff8-404b-872f-6d06d70b77d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_8e1fd11a-08f8-489d-b049-32f2208195e7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_a9df6db6-d6ce-42f3-ba60-7175e1cd16cf" xlink:to="loc_dei_EntityFileNumber_8e1fd11a-08f8-489d-b049-32f2208195e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_d5d6a962-89a2-4e12-a442-31bdee4448b9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_a9df6db6-d6ce-42f3-ba60-7175e1cd16cf" xlink:to="loc_dei_EntityIncorporationStateCountryCode_d5d6a962-89a2-4e12-a442-31bdee4448b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_650afef9-4bfc-45fc-9c2d-b36d0748f4eb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_a9df6db6-d6ce-42f3-ba60-7175e1cd16cf" xlink:to="loc_dei_EntityTaxIdentificationNumber_650afef9-4bfc-45fc-9c2d-b36d0748f4eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_07760b53-dc25-4db6-b4af-a65dcfd1619c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_a9df6db6-d6ce-42f3-ba60-7175e1cd16cf" xlink:to="loc_dei_EntityAddressAddressLine1_07760b53-dc25-4db6-b4af-a65dcfd1619c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_38fbf9e2-bfcd-45f2-beca-7b15baccd7f0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_a9df6db6-d6ce-42f3-ba60-7175e1cd16cf" xlink:to="loc_dei_EntityAddressCityOrTown_38fbf9e2-bfcd-45f2-beca-7b15baccd7f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_d2b7e520-417e-43b3-8a68-e00ef038bf16" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_a9df6db6-d6ce-42f3-ba60-7175e1cd16cf" xlink:to="loc_dei_EntityAddressStateOrProvince_d2b7e520-417e-43b3-8a68-e00ef038bf16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_97c84552-15ae-4891-b468-68f0ec5b0cf0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_a9df6db6-d6ce-42f3-ba60-7175e1cd16cf" xlink:to="loc_dei_EntityAddressPostalZipCode_97c84552-15ae-4891-b468-68f0ec5b0cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_a84cae8a-c46d-4853-891a-026ab06ac345" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_a9df6db6-d6ce-42f3-ba60-7175e1cd16cf" xlink:to="loc_dei_CityAreaCode_a84cae8a-c46d-4853-891a-026ab06ac345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_74c84c05-2b86-44c1-89db-5aa2c4176c8e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_a9df6db6-d6ce-42f3-ba60-7175e1cd16cf" xlink:to="loc_dei_LocalPhoneNumber_74c84c05-2b86-44c1-89db-5aa2c4176c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_fbff529d-dcbf-4bd0-ac95-9f8ff520366a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_a9df6db6-d6ce-42f3-ba60-7175e1cd16cf" xlink:to="loc_dei_Security12bTitle_fbff529d-dcbf-4bd0-ac95-9f8ff520366a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_9a2da8d9-d565-4549-8738-76c8242626d5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_a9df6db6-d6ce-42f3-ba60-7175e1cd16cf" xlink:to="loc_dei_TradingSymbol_9a2da8d9-d565-4549-8738-76c8242626d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_c73ad599-f3ab-4642-8027-92458d2cb8b8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_a9df6db6-d6ce-42f3-ba60-7175e1cd16cf" xlink:to="loc_dei_SecurityExchangeName_c73ad599-f3ab-4642-8027-92458d2cb8b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_2ac61def-ef7f-4d5c-8f59-73298cf38d03" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_a9df6db6-d6ce-42f3-ba60-7175e1cd16cf" xlink:to="loc_dei_EntityCurrentReportingStatus_2ac61def-ef7f-4d5c-8f59-73298cf38d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_021009a8-12a1-4c39-8174-6b452a9ad5cf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_a9df6db6-d6ce-42f3-ba60-7175e1cd16cf" xlink:to="loc_dei_EntityInteractiveDataCurrent_021009a8-12a1-4c39-8174-6b452a9ad5cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_186fcc9d-d4ee-4693-b3b6-6ae4bc2253bf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_a9df6db6-d6ce-42f3-ba60-7175e1cd16cf" xlink:to="loc_dei_EntityFilerCategory_186fcc9d-d4ee-4693-b3b6-6ae4bc2253bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_d54a0dd5-92d1-4531-bba8-3315f8cb6e91" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_a9df6db6-d6ce-42f3-ba60-7175e1cd16cf" xlink:to="loc_dei_EntitySmallBusiness_d54a0dd5-92d1-4531-bba8-3315f8cb6e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_37808b31-0e8b-4ea3-9724-9732e465c509" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_a9df6db6-d6ce-42f3-ba60-7175e1cd16cf" xlink:to="loc_dei_EntityEmergingGrowthCompany_37808b31-0e8b-4ea3-9724-9732e465c509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_e990c9b7-be99-4ac7-8958-9554c48db847" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_a9df6db6-d6ce-42f3-ba60-7175e1cd16cf" xlink:to="loc_dei_EntityShellCompany_e990c9b7-be99-4ac7-8958-9554c48db847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_54506780-9fa2-439c-8361-7e75cdaa4cca" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DocumentAndEntityInformationAbstract_a9df6db6-d6ce-42f3-ba60-7175e1cd16cf" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_54506780-9fa2-439c-8361-7e75cdaa4cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited" xlink:type="simple" xlink:href="a-20230131.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_b1b13bf8-bb05-4008-abfc-e8416b064a18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9d9a6342-8e51-40db-9237-a01fee945973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b1b13bf8-bb05-4008-abfc-e8416b064a18" xlink:to="loc_us-gaap_StatementTable_9d9a6342-8e51-40db-9237-a01fee945973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_3161e224-e5d1-4c31-af62-e6df308299d3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9d9a6342-8e51-40db-9237-a01fee945973" xlink:to="loc_srt_ProductOrServiceAxis_3161e224-e5d1-4c31-af62-e6df308299d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b7081d99-b0be-47c2-9bd7-f96ff6329786" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_3161e224-e5d1-4c31-af62-e6df308299d3" xlink:to="loc_srt_ProductsAndServicesDomain_b7081d99-b0be-47c2-9bd7-f96ff6329786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_33b8f347-4f21-43c9-bb71-5dc9f71b3b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b7081d99-b0be-47c2-9bd7-f96ff6329786" xlink:to="loc_us-gaap_ProductMember_33b8f347-4f21-43c9-bb71-5dc9f71b3b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceOtherMember_84aef82e-6657-4589-af66-90b9e6d87725" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b7081d99-b0be-47c2-9bd7-f96ff6329786" xlink:to="loc_us-gaap_ServiceOtherMember_84aef82e-6657-4589-af66-90b9e6d87725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_f0cdb1ac-048c-4f8b-bf1f-c009d6948d1c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9d9a6342-8e51-40db-9237-a01fee945973" xlink:to="loc_srt_StatementScenarioAxis_f0cdb1ac-048c-4f8b-bf1f-c009d6948d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_04b3243e-ee1f-47aa-9a5f-f58beb881c8d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_f0cdb1ac-048c-4f8b-bf1f-c009d6948d1c" xlink:to="loc_srt_ScenarioUnspecifiedDomain_04b3243e-ee1f-47aa-9a5f-f58beb881c8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1df0f763-6b55-47cc-b9d2-49f077dcf5ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9d9a6342-8e51-40db-9237-a01fee945973" xlink:to="loc_us-gaap_StatementLineItems_1df0f763-6b55-47cc-b9d2-49f077dcf5ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_38c9f6a3-e14e-4484-b65a-bbc3e2991fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1df0f763-6b55-47cc-b9d2-49f077dcf5ab" xlink:to="loc_us-gaap_RevenuesAbstract_38c9f6a3-e14e-4484-b65a-bbc3e2991fa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6af0f5a9-417a-468d-be7f-bb38ec1f3300" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_38c9f6a3-e14e-4484-b65a-bbc3e2991fa9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6af0f5a9-417a-468d-be7f-bb38ec1f3300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_d04586b8-0b62-4ab1-83d3-7d7d4da34098" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1df0f763-6b55-47cc-b9d2-49f077dcf5ab" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_d04586b8-0b62-4ab1-83d3-7d7d4da34098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_52f2be12-6009-4b46-b3e9-4b75089a707d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d04586b8-0b62-4ab1-83d3-7d7d4da34098" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_52f2be12-6009-4b46-b3e9-4b75089a707d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_48287831-4f98-43cb-8968-0027c844191a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d04586b8-0b62-4ab1-83d3-7d7d4da34098" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_48287831-4f98-43cb-8968-0027c844191a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_38d7b7ff-7c6a-498c-a782-a6194da5062c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d04586b8-0b62-4ab1-83d3-7d7d4da34098" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_38d7b7ff-7c6a-498c-a782-a6194da5062c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_f9121234-a641-4569-ac21-a43ecee130d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_d04586b8-0b62-4ab1-83d3-7d7d4da34098" xlink:to="loc_us-gaap_CostsAndExpenses_f9121234-a641-4569-ac21-a43ecee130d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ad739c92-c2de-42b1-ad73-ba62846f1c09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1df0f763-6b55-47cc-b9d2-49f077dcf5ab" xlink:to="loc_us-gaap_OperatingIncomeLoss_ad739c92-c2de-42b1-ad73-ba62846f1c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_fb55f476-da77-4392-b840-460fcd132b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1df0f763-6b55-47cc-b9d2-49f077dcf5ab" xlink:to="loc_us-gaap_InvestmentIncomeInterest_fb55f476-da77-4392-b840-460fcd132b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_efb47d94-53ce-4f09-aaac-8b83c4442bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1df0f763-6b55-47cc-b9d2-49f077dcf5ab" xlink:to="loc_us-gaap_InterestExpense_efb47d94-53ce-4f09-aaac-8b83c4442bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_26e5259c-c49a-4563-b515-5998053835d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1df0f763-6b55-47cc-b9d2-49f077dcf5ab" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_26e5259c-c49a-4563-b515-5998053835d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c38937b2-c197-4fbe-91c0-48ab164fa9e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1df0f763-6b55-47cc-b9d2-49f077dcf5ab" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c38937b2-c197-4fbe-91c0-48ab164fa9e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_25d0927b-25a8-4057-9b44-ec3e84189256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1df0f763-6b55-47cc-b9d2-49f077dcf5ab" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_25d0927b-25a8-4057-9b44-ec3e84189256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e6017a56-29da-40df-938f-14028ddb2f23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1df0f763-6b55-47cc-b9d2-49f077dcf5ab" xlink:to="loc_us-gaap_NetIncomeLoss_e6017a56-29da-40df-938f-14028ddb2f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0db6d972-ebab-4f55-b19c-e88070ea3390" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1df0f763-6b55-47cc-b9d2-49f077dcf5ab" xlink:to="loc_us-gaap_EarningsPerShareAbstract_0db6d972-ebab-4f55-b19c-e88070ea3390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_8d779394-df52-4535-b857-4fb22dccb520" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0db6d972-ebab-4f55-b19c-e88070ea3390" xlink:to="loc_us-gaap_EarningsPerShareBasic_8d779394-df52-4535-b857-4fb22dccb520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_badc44ba-3bd1-442c-90f0-27417bf6db76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0db6d972-ebab-4f55-b19c-e88070ea3390" xlink:to="loc_us-gaap_EarningsPerShareDiluted_badc44ba-3bd1-442c-90f0-27417bf6db76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5b457a00-4239-4350-a81f-ff70f5cdfa03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1df0f763-6b55-47cc-b9d2-49f077dcf5ab" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5b457a00-4239-4350-a81f-ff70f5cdfa03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4e37c250-e5d4-4ba5-8450-8dd2b035d73b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5b457a00-4239-4350-a81f-ff70f5cdfa03" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4e37c250-e5d4-4ba5-8450-8dd2b035d73b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_934200e2-80b4-4523-9f74-e90e27a8ee0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5b457a00-4239-4350-a81f-ff70f5cdfa03" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_934200e2-80b4-4523-9f74-e90e27a8ee0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited" xlink:type="simple" xlink:href="a-20230131.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7bdfc7ec-d96a-4b63-895a-2b7d5813b45b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_51e1a69b-72e6-47ef-9808-8699c9e756e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7bdfc7ec-d96a-4b63-895a-2b7d5813b45b" xlink:to="loc_us-gaap_StatementTable_51e1a69b-72e6-47ef-9808-8699c9e756e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_cf5d8c2c-8b66-47e1-bfd3-20e7d046dd42" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_51e1a69b-72e6-47ef-9808-8699c9e756e1" xlink:to="loc_srt_StatementScenarioAxis_cf5d8c2c-8b66-47e1-bfd3-20e7d046dd42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_44b2ce29-c4b9-4652-b3b4-bc436cb36bfa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_cf5d8c2c-8b66-47e1-bfd3-20e7d046dd42" xlink:to="loc_srt_ScenarioUnspecifiedDomain_44b2ce29-c4b9-4652-b3b4-bc436cb36bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_90612a17-c906-4751-90dc-0c79238989fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_51e1a69b-72e6-47ef-9808-8699c9e756e1" xlink:to="loc_us-gaap_StatementLineItems_90612a17-c906-4751-90dc-0c79238989fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_125cb5fb-28a8-43bd-a807-8144c323bd0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_90612a17-c906-4751-90dc-0c79238989fd" xlink:to="loc_us-gaap_NetIncomeLoss_125cb5fb-28a8-43bd-a807-8144c323bd0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c20eec17-37d3-4c43-b6bc-9312095436ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_90612a17-c906-4751-90dc-0c79238989fd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c20eec17-37d3-4c43-b6bc-9312095436ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_49e5c6bf-6545-4867-afe1-258ecf51ca40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c20eec17-37d3-4c43-b6bc-9312095436ff" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_49e5c6bf-6545-4867-afe1-258ecf51ca40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_73e429f9-e28b-42c0-9474-473456e0e875" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c20eec17-37d3-4c43-b6bc-9312095436ff" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_73e429f9-e28b-42c0-9474-473456e0e875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_01e92c03-962b-4678-b003-5dced9f7a583" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c20eec17-37d3-4c43-b6bc-9312095436ff" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_01e92c03-962b-4678-b003-5dced9f7a583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_1ed22ed2-731e-4339-b6ab-33155c23c217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c20eec17-37d3-4c43-b6bc-9312095436ff" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_1ed22ed2-731e-4339-b6ab-33155c23c217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_844cb2a6-a246-4757-ab3a-0642296b1b56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_1ed22ed2-731e-4339-b6ab-33155c23c217" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_844cb2a6-a246-4757-ab3a-0642296b1b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_720bc882-08aa-45a4-a249-efff7fd2cc66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c20eec17-37d3-4c43-b6bc-9312095436ff" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_720bc882-08aa-45a4-a249-efff7fd2cc66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2c001a9e-c069-410b-ad28-1fc3de3f2956" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_90612a17-c906-4751-90dc-0c79238989fd" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2c001a9e-c069-410b-ad28-1fc3de3f2956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical" xlink:type="simple" xlink:href="a-20230131.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_032fad54-8b09-44f3-a999-d2484b2137ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9e4d788f-c7f5-41bf-9c78-a075b1c235d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_032fad54-8b09-44f3-a999-d2484b2137ab" xlink:to="loc_us-gaap_StatementTable_9e4d788f-c7f5-41bf-9c78-a075b1c235d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_a339cac4-b13f-4f5c-b6f0-d88d6d5d239c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9e4d788f-c7f5-41bf-9c78-a075b1c235d3" xlink:to="loc_srt_StatementScenarioAxis_a339cac4-b13f-4f5c-b6f0-d88d6d5d239c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_368efda8-b1c9-4834-866d-1a028482fd06" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_a339cac4-b13f-4f5c-b6f0-d88d6d5d239c" xlink:to="loc_srt_ScenarioUnspecifiedDomain_368efda8-b1c9-4834-866d-1a028482fd06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_64c85aa9-4b4a-4819-945b-c39b28bbbb69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9e4d788f-c7f5-41bf-9c78-a075b1c235d3" xlink:to="loc_us-gaap_StatementLineItems_64c85aa9-4b4a-4819-945b-c39b28bbbb69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_4a7ecfe9-e984-4f74-839e-b4da2ad24eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_64c85aa9-4b4a-4819-945b-c39b28bbbb69" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_4a7ecfe9-e984-4f74-839e-b4da2ad24eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_3f512c64-11ef-4aac-90b6-6e18886cc10c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_4a7ecfe9-e984-4f74-839e-b4da2ad24eb2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_3f512c64-11ef-4aac-90b6-6e18886cc10c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_16f297dc-f511-40a1-8477-c97803e5352b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_4a7ecfe9-e984-4f74-839e-b4da2ad24eb2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_16f297dc-f511-40a1-8477-c97803e5352b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_d2c53468-a2ef-4a1c-bb03-611550df361f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_4a7ecfe9-e984-4f74-839e-b4da2ad24eb2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_d2c53468-a2ef-4a1c-bb03-611550df361f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract_c25ab71d-1e34-443d-8210-20f586274da0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_4a7ecfe9-e984-4f74-839e-b4da2ad24eb2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract_c25ab71d-1e34-443d-8210-20f586274da0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_f3f46557-349d-44a7-a474-8359c6b5d71e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract_c25ab71d-1e34-443d-8210-20f586274da0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_f3f46557-349d-44a7-a474-8359c6b5d71e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_6dbbbc60-1895-41cc-9038-85b3d2b19758" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract_c25ab71d-1e34-443d-8210-20f586274da0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_6dbbbc60-1895-41cc-9038-85b3d2b19758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited" xlink:type="simple" xlink:href="a-20230131.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_b4570e65-42a0-43ef-b179-c093a51a1df4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_81325213-0c81-4caf-8dd5-17ca2c01e24a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b4570e65-42a0-43ef-b179-c093a51a1df4" xlink:to="loc_us-gaap_StatementTable_81325213-0c81-4caf-8dd5-17ca2c01e24a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_d0254083-bf82-4b9d-b6b3-a19509c4d634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_81325213-0c81-4caf-8dd5-17ca2c01e24a" xlink:to="loc_us-gaap_StatementClassOfStockAxis_d0254083-bf82-4b9d-b6b3-a19509c4d634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_43f49287-a554-4fd4-b960-9cf07a2d5f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d0254083-bf82-4b9d-b6b3-a19509c4d634" xlink:to="loc_us-gaap_ClassOfStockDomain_43f49287-a554-4fd4-b960-9cf07a2d5f6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8adc52a9-558b-428f-8f1d-e6c08730ae07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_81325213-0c81-4caf-8dd5-17ca2c01e24a" xlink:to="loc_us-gaap_StatementLineItems_8adc52a9-558b-428f-8f1d-e6c08730ae07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_ea3115d0-a4bf-47f9-9ffa-9eaf81842da3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8adc52a9-558b-428f-8f1d-e6c08730ae07" xlink:to="loc_us-gaap_AssetsAbstract_ea3115d0-a4bf-47f9-9ffa-9eaf81842da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_59f165aa-3f8b-4f8b-b40b-0d9bf00eaa74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ea3115d0-a4bf-47f9-9ffa-9eaf81842da3" xlink:to="loc_us-gaap_AssetsCurrentAbstract_59f165aa-3f8b-4f8b-b40b-0d9bf00eaa74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_51d32c0d-f0a2-4f69-a745-822c10c5cfc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_59f165aa-3f8b-4f8b-b40b-0d9bf00eaa74" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_51d32c0d-f0a2-4f69-a745-822c10c5cfc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_8b181786-9d3a-4e3b-b56e-8f34f64f77ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_59f165aa-3f8b-4f8b-b40b-0d9bf00eaa74" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_8b181786-9d3a-4e3b-b56e-8f34f64f77ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_95bc328a-4b80-4c1a-9180-cf7398a4c5c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_59f165aa-3f8b-4f8b-b40b-0d9bf00eaa74" xlink:to="loc_us-gaap_InventoryNet_95bc328a-4b80-4c1a-9180-cf7398a4c5c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_0090d6a0-43ed-420b-8b39-909072492108" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_59f165aa-3f8b-4f8b-b40b-0d9bf00eaa74" xlink:to="loc_us-gaap_OtherAssetsCurrent_0090d6a0-43ed-420b-8b39-909072492108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_9e567368-e703-408b-8e71-030521d0ce86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_59f165aa-3f8b-4f8b-b40b-0d9bf00eaa74" xlink:to="loc_us-gaap_AssetsCurrent_9e567368-e703-408b-8e71-030521d0ce86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_70905182-13a9-4fe3-a4b7-7ac770568351" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ea3115d0-a4bf-47f9-9ffa-9eaf81842da3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_70905182-13a9-4fe3-a4b7-7ac770568351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_98c71939-895d-4b6f-b431-b846d9dfaa1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ea3115d0-a4bf-47f9-9ffa-9eaf81842da3" xlink:to="loc_us-gaap_Goodwill_98c71939-895d-4b6f-b431-b846d9dfaa1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_83b2ecd0-4306-4c6d-818f-87290bc11866" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ea3115d0-a4bf-47f9-9ffa-9eaf81842da3" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_83b2ecd0-4306-4c6d-818f-87290bc11866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_6e541bce-e330-498d-9657-29a3383f59f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ea3115d0-a4bf-47f9-9ffa-9eaf81842da3" xlink:to="loc_us-gaap_LongTermInvestments_6e541bce-e330-498d-9657-29a3383f59f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_73a552b3-818b-4e61-bec5-bb0f1d75df70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ea3115d0-a4bf-47f9-9ffa-9eaf81842da3" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_73a552b3-818b-4e61-bec5-bb0f1d75df70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_0fa08507-8429-4125-af4d-e216aa9b13c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ea3115d0-a4bf-47f9-9ffa-9eaf81842da3" xlink:to="loc_us-gaap_Assets_0fa08507-8429-4125-af4d-e216aa9b13c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ed786591-bd73-4cd2-9766-8d4f3df8325e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8adc52a9-558b-428f-8f1d-e6c08730ae07" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ed786591-bd73-4cd2-9766-8d4f3df8325e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_9f8b1044-06e1-4e0c-8283-2b92b28ccd75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ed786591-bd73-4cd2-9766-8d4f3df8325e" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_9f8b1044-06e1-4e0c-8283-2b92b28ccd75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_862853c9-0ef9-460b-9535-6e75a82c3531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9f8b1044-06e1-4e0c-8283-2b92b28ccd75" xlink:to="loc_us-gaap_AccountsPayableCurrent_862853c9-0ef9-460b-9535-6e75a82c3531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_44e02152-9cad-4742-b438-3fa0bfefde86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9f8b1044-06e1-4e0c-8283-2b92b28ccd75" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_44e02152-9cad-4742-b438-3fa0bfefde86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_64b49e9a-fc40-412a-9418-6d858b370439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9f8b1044-06e1-4e0c-8283-2b92b28ccd75" xlink:to="loc_us-gaap_DeferredRevenueCurrent_64b49e9a-fc40-412a-9418-6d858b370439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_2650c4ef-9652-4712-9c09-5b087fadc63f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9f8b1044-06e1-4e0c-8283-2b92b28ccd75" xlink:to="loc_us-gaap_ShortTermBorrowings_2650c4ef-9652-4712-9c09-5b087fadc63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_0ceb4798-5f26-49f6-8a6a-a0e847a42b41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9f8b1044-06e1-4e0c-8283-2b92b28ccd75" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_0ceb4798-5f26-49f6-8a6a-a0e847a42b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_84d982f3-1ae8-4896-ba68-7e77fdf1faaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9f8b1044-06e1-4e0c-8283-2b92b28ccd75" xlink:to="loc_us-gaap_LiabilitiesCurrent_84d982f3-1ae8-4896-ba68-7e77fdf1faaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f2386abe-f390-499d-bc33-36dca1bb0701" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9f8b1044-06e1-4e0c-8283-2b92b28ccd75" xlink:to="loc_us-gaap_LongTermDebt_f2386abe-f390-499d-bc33-36dca1bb0701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_62325a60-cda8-423a-b3bb-b180f56376ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ed786591-bd73-4cd2-9766-8d4f3df8325e" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_62325a60-cda8-423a-b3bb-b180f56376ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_47bb135d-86a2-41de-aece-8b2f6e697b99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ed786591-bd73-4cd2-9766-8d4f3df8325e" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_47bb135d-86a2-41de-aece-8b2f6e697b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_53956531-dc3a-4060-a2d7-3a2057114125" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ed786591-bd73-4cd2-9766-8d4f3df8325e" xlink:to="loc_us-gaap_Liabilities_53956531-dc3a-4060-a2d7-3a2057114125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_d58c9aa2-cd95-4d32-bbbd-208683ae5def" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ed786591-bd73-4cd2-9766-8d4f3df8325e" xlink:to="loc_us-gaap_CommitmentsAndContingencies_d58c9aa2-cd95-4d32-bbbd-208683ae5def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d3b28441-0fbb-4827-ac07-a228e4d33b35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ed786591-bd73-4cd2-9766-8d4f3df8325e" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d3b28441-0fbb-4827-ac07-a228e4d33b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_db382817-3b15-45d6-9fdf-b3ebd89c633d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d3b28441-0fbb-4827-ac07-a228e4d33b35" xlink:to="loc_us-gaap_StockholdersEquityAbstract_db382817-3b15-45d6-9fdf-b3ebd89c633d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_df78e4ce-9358-484e-9256-6239c97ee332" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_db382817-3b15-45d6-9fdf-b3ebd89c633d" xlink:to="loc_us-gaap_PreferredStockValue_df78e4ce-9358-484e-9256-6239c97ee332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_9efe2af5-3a14-48e9-ac55-9b4d5eeef4f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_db382817-3b15-45d6-9fdf-b3ebd89c633d" xlink:to="loc_us-gaap_CommonStockValue_9efe2af5-3a14-48e9-ac55-9b4d5eeef4f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_84ab1ca6-1d79-4144-8f4f-5bdcb9dbf591" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_db382817-3b15-45d6-9fdf-b3ebd89c633d" xlink:to="loc_us-gaap_AdditionalPaidInCapital_84ab1ca6-1d79-4144-8f4f-5bdcb9dbf591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_50c59171-acfe-4e5c-9ddd-4c940e5410fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_db382817-3b15-45d6-9fdf-b3ebd89c633d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_50c59171-acfe-4e5c-9ddd-4c940e5410fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_717bb95e-66f1-40ce-89ef-d2012e16994a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_db382817-3b15-45d6-9fdf-b3ebd89c633d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_717bb95e-66f1-40ce-89ef-d2012e16994a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d7058583-d782-4f3e-903d-d0f789142692" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_db382817-3b15-45d6-9fdf-b3ebd89c633d" xlink:to="loc_us-gaap_StockholdersEquity_d7058583-d782-4f3e-903d-d0f789142692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_0b3876e0-c7a2-4118-b948-9e64b61ce944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ed786591-bd73-4cd2-9766-8d4f3df8325e" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_0b3876e0-c7a2-4118-b948-9e64b61ce944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnauditedParenthetical" xlink:type="simple" xlink:href="a-20230131.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_8cdda734-3b37-48ef-ad0a-a776dfaee192" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_205bcefd-85d5-4660-a42e-f7189374e0b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8cdda734-3b37-48ef-ad0a-a776dfaee192" xlink:to="loc_us-gaap_StockholdersEquityAbstract_205bcefd-85d5-4660-a42e-f7189374e0b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_6acbab55-ef5a-45df-9f2c-cf7805d2fc1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_205bcefd-85d5-4660-a42e-f7189374e0b6" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_6acbab55-ef5a-45df-9f2c-cf7805d2fc1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_4ab74de8-268a-4e86-90f1-5c674de7d5e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_205bcefd-85d5-4660-a42e-f7189374e0b6" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_4ab74de8-268a-4e86-90f1-5c674de7d5e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_652f22e4-8f43-4029-8c89-793a20a30b15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_205bcefd-85d5-4660-a42e-f7189374e0b6" xlink:to="loc_us-gaap_PreferredStockSharesIssued_652f22e4-8f43-4029-8c89-793a20a30b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_5dfcb6ef-83eb-4f27-b245-ef5b75db046f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_205bcefd-85d5-4660-a42e-f7189374e0b6" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_5dfcb6ef-83eb-4f27-b245-ef5b75db046f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_d62e64ce-89ca-4255-877f-e245e7a13729" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_205bcefd-85d5-4660-a42e-f7189374e0b6" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_d62e64ce-89ca-4255-877f-e245e7a13729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_d02af5c4-773e-474b-8dfe-d67971cf8014" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_205bcefd-85d5-4660-a42e-f7189374e0b6" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_d02af5c4-773e-474b-8dfe-d67971cf8014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_7234f016-497b-49e6-ba5f-a020f5c93861" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_205bcefd-85d5-4660-a42e-f7189374e0b6" xlink:to="loc_us-gaap_CommonStockSharesIssued_7234f016-497b-49e6-ba5f-a020f5c93861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_c146c33b-a1b8-4f01-a694-2baa03bb06cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_205bcefd-85d5-4660-a42e-f7189374e0b6" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_c146c33b-a1b8-4f01-a694-2baa03bb06cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="a-20230131.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_5a4e1cf9-cdc3-43fa-a9ba-745ff18d2028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_776c6862-a961-45a4-9bd2-8d6f3ba4724b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5a4e1cf9-cdc3-43fa-a9ba-745ff18d2028" xlink:to="loc_us-gaap_StatementTable_776c6862-a961-45a4-9bd2-8d6f3ba4724b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_648466fa-e98a-452d-b9f6-8a4563cfdb74" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_776c6862-a961-45a4-9bd2-8d6f3ba4724b" xlink:to="loc_srt_StatementScenarioAxis_648466fa-e98a-452d-b9f6-8a4563cfdb74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_c5d9cf3d-9a6f-46e9-8640-5a1d758d3432" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_648466fa-e98a-452d-b9f6-8a4563cfdb74" xlink:to="loc_srt_ScenarioUnspecifiedDomain_c5d9cf3d-9a6f-46e9-8640-5a1d758d3432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_bd5760b0-0103-4e03-bf3e-28582ede3f42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_776c6862-a961-45a4-9bd2-8d6f3ba4724b" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_bd5760b0-0103-4e03-bf3e-28582ede3f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9ccee173-50f8-41b1-93bb-d40eefc5cd35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_bd5760b0-0103-4e03-bf3e-28582ede3f42" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9ccee173-50f8-41b1-93bb-d40eefc5cd35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_003e6b97-11f7-4809-9c39-5dd4bad9f472" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9ccee173-50f8-41b1-93bb-d40eefc5cd35" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_003e6b97-11f7-4809-9c39-5dd4bad9f472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d62ea53d-abe5-482c-b228-7968cb1b880e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_776c6862-a961-45a4-9bd2-8d6f3ba4724b" xlink:to="loc_us-gaap_StatementLineItems_d62ea53d-abe5-482c-b228-7968cb1b880e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d931adfb-a70b-4245-94e3-d481992fbe7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d62ea53d-abe5-482c-b228-7968cb1b880e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d931adfb-a70b-4245-94e3-d481992fbe7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_38161c42-e8a0-434b-a032-cb0f8488966b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d931adfb-a70b-4245-94e3-d481992fbe7e" xlink:to="loc_us-gaap_NetIncomeLoss_38161c42-e8a0-434b-a032-cb0f8488966b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_970e534b-f8f4-4451-b53e-9b454117f22e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d931adfb-a70b-4245-94e3-d481992fbe7e" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_970e534b-f8f4-4451-b53e-9b454117f22e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_12205b69-a920-4a0b-816f-39f8b80153fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_970e534b-f8f4-4451-b53e-9b454117f22e" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_12205b69-a920-4a0b-816f-39f8b80153fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_d5ee5026-1bfc-4445-857a-fafd586cffcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_970e534b-f8f4-4451-b53e-9b454117f22e" xlink:to="loc_us-gaap_ShareBasedCompensation_d5ee5026-1bfc-4445-857a-fafd586cffcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3aefa0b5-8b6f-4e3b-96ac-dc616275ad33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_970e534b-f8f4-4451-b53e-9b454117f22e" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3aefa0b5-8b6f-4e3b-96ac-dc616275ad33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_1b9b05cb-5beb-47e0-8552-18bd5bc57daf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_970e534b-f8f4-4451-b53e-9b454117f22e" xlink:to="loc_us-gaap_InventoryWriteDown_1b9b05cb-5beb-47e0-8552-18bd5bc57daf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_a0e4a469-0e7e-4450-ad25-9670e569d078" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_970e534b-f8f4-4451-b53e-9b454117f22e" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_a0e4a469-0e7e-4450-ad25-9670e569d078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_24e5280a-31d0-45e0-b1b5-b9d874870070" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_970e534b-f8f4-4451-b53e-9b454117f22e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_24e5280a-31d0-45e0-b1b5-b9d874870070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_70241731-5918-4e8c-8d31-a27affc1cac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_970e534b-f8f4-4451-b53e-9b454117f22e" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_70241731-5918-4e8c-8d31-a27affc1cac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca0f2a27-abff-4078-8adb-75be41891cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d931adfb-a70b-4245-94e3-d481992fbe7e" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca0f2a27-abff-4078-8adb-75be41891cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_bf0329ef-4d5f-459e-be8d-627eeb5d8a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca0f2a27-abff-4078-8adb-75be41891cf4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_bf0329ef-4d5f-459e-be8d-627eeb5d8a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_c6cb4cab-1d41-4d40-bce7-2424ff3b6f45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca0f2a27-abff-4078-8adb-75be41891cf4" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_c6cb4cab-1d41-4d40-bce7-2424ff3b6f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_82b7aa12-54ca-464e-935c-a686e094a5f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca0f2a27-abff-4078-8adb-75be41891cf4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_82b7aa12-54ca-464e-935c-a686e094a5f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_910e6c93-ea94-4f59-a094-14b2cf3fd7dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca0f2a27-abff-4078-8adb-75be41891cf4" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_910e6c93-ea94-4f59-a094-14b2cf3fd7dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_0d1adbab-686e-45ff-8261-b1993ba06435" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ca0f2a27-abff-4078-8adb-75be41891cf4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_0d1adbab-686e-45ff-8261-b1993ba06435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dbe2c649-4af4-4831-99a2-823c6652a7aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d931adfb-a70b-4245-94e3-d481992fbe7e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dbe2c649-4af4-4831-99a2-823c6652a7aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_520ae441-09b2-43a3-815d-bd145112ce8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d62ea53d-abe5-482c-b228-7968cb1b880e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_520ae441-09b2-43a3-815d-bd145112ce8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d12040a7-b477-4ee8-b896-fea8c59349bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_520ae441-09b2-43a3-815d-bd145112ce8d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d12040a7-b477-4ee8-b896-fea8c59349bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_51ed1aae-499d-4899-b3ca-36b6b7f97be3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_520ae441-09b2-43a3-815d-bd145112ce8d" xlink:to="loc_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_51ed1aae-499d-4899-b3ca-36b6b7f97be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireNotesReceivable_e7678718-f7ff-488f-bad9-20a558c15aee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireNotesReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_520ae441-09b2-43a3-815d-bd145112ce8d" xlink:to="loc_us-gaap_PaymentsToAcquireNotesReceivable_e7678718-f7ff-488f-bad9-20a558c15aee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_3da44b79-ab3d-4e20-bdbf-6f2e32f6b469" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_520ae441-09b2-43a3-815d-bd145112ce8d" xlink:to="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_3da44b79-ab3d-4e20-bdbf-6f2e32f6b469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi_31b0bf44-cd3d-4796-8950-5e9656a15e4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_520ae441-09b2-43a3-815d-bd145112ce8d" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi_31b0bf44-cd3d-4796-8950-5e9656a15e4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_aa19cb1f-c858-4924-8c46-5a619984ebd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_520ae441-09b2-43a3-815d-bd145112ce8d" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_aa19cb1f-c858-4924-8c46-5a619984ebd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ed7c0473-7916-45e4-b70a-1fad30538e89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d62ea53d-abe5-482c-b228-7968cb1b880e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ed7c0473-7916-45e4-b70a-1fad30538e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0cc7520b-d861-46f8-b1f1-036cda7930ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d62ea53d-abe5-482c-b228-7968cb1b880e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0cc7520b-d861-46f8-b1f1-036cda7930ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_741aa264-e51b-46f4-b853-3bd1d5671711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0cc7520b-d861-46f8-b1f1-036cda7930ad" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_741aa264-e51b-46f4-b853-3bd1d5671711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1c16eb22-b923-4903-9963-95af5881e9cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0cc7520b-d861-46f8-b1f1-036cda7930ad" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1c16eb22-b923-4903-9963-95af5881e9cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfOrdinaryDividends_dd8745e8-1feb-459f-a2d2-6e5d496dc096" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfOrdinaryDividends"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0cc7520b-d861-46f8-b1f1-036cda7930ad" xlink:to="loc_us-gaap_PaymentsOfOrdinaryDividends_dd8745e8-1feb-459f-a2d2-6e5d496dc096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_c740ecf9-db12-4395-9091-76e216725216" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0cc7520b-d861-46f8-b1f1-036cda7930ad" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_c740ecf9-db12-4395-9091-76e216725216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_45bb23de-fa95-4888-a1c7-1eb3e43d6290" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0cc7520b-d861-46f8-b1f1-036cda7930ad" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_45bb23de-fa95-4888-a1c7-1eb3e43d6290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper_bb6de3cf-8692-462e-92f1-9e1343d82d50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0cc7520b-d861-46f8-b1f1-036cda7930ad" xlink:to="loc_us-gaap_RepaymentsOfCommercialPaper_bb6de3cf-8692-462e-92f1-9e1343d82d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_6ac6bf03-3808-487d-8a0f-3dc73d70b432" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0cc7520b-d861-46f8-b1f1-036cda7930ad" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_6ac6bf03-3808-487d-8a0f-3dc73d70b432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ec163e42-6cca-432c-bcd4-84dfd875ad86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0cc7520b-d861-46f8-b1f1-036cda7930ad" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ec163e42-6cca-432c-bcd4-84dfd875ad86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b084513d-abaf-40dd-86af-92c191f1669d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0cc7520b-d861-46f8-b1f1-036cda7930ad" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b084513d-abaf-40dd-86af-92c191f1669d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0e5765e3-a59d-4c2d-8550-548017e44678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d62ea53d-abe5-482c-b228-7968cb1b880e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0e5765e3-a59d-4c2d-8550-548017e44678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_12059761-d3b8-4bb6-90f5-6b2d2e542451" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d62ea53d-abe5-482c-b228-7968cb1b880e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_12059761-d3b8-4bb6-90f5-6b2d2e542451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_523542f8-1daa-48a2-a28b-1aa69e543b00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d62ea53d-abe5-482c-b228-7968cb1b880e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_523542f8-1daa-48a2-a28b-1aa69e543b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_cd2a2521-81c1-4880-bd0d-795967720bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d62ea53d-abe5-482c-b228-7968cb1b880e" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_cd2a2521-81c1-4880-bd0d-795967720bbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_00ef1aa6-3740-424e-ad25-11f74a5f29b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_cd2a2521-81c1-4880-bd0d-795967720bbb" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_00ef1aa6-3740-424e-ad25-11f74a5f29b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_cf9b1cee-5698-490c-98a0-3680209a2a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_cd2a2521-81c1-4880-bd0d-795967720bbb" xlink:to="loc_us-gaap_InterestPaidNet_cf9b1cee-5698-490c-98a0-3680209a2a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9ca2ebb3-3977-4a3b-8021-66c4878689e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_cd2a2521-81c1-4880-bd0d-795967720bbb" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9ca2ebb3-3977-4a3b-8021-66c4878689e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="simple" xlink:href="a-20230131.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_9b37dd96-5c1d-45e9-9547-6795eb3a05f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2cba3cd5-e19a-4efa-9031-41ac38b0da12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_9b37dd96-5c1d-45e9-9547-6795eb3a05f6" xlink:to="loc_us-gaap_StatementTable_2cba3cd5-e19a-4efa-9031-41ac38b0da12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_b00501b7-0edc-47ee-ba93-718c63ee272f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2cba3cd5-e19a-4efa-9031-41ac38b0da12" xlink:to="loc_srt_RestatementAxis_b00501b7-0edc-47ee-ba93-718c63ee272f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_c8534878-76d9-4d73-9d1f-652b3c908d3e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_b00501b7-0edc-47ee-ba93-718c63ee272f" xlink:to="loc_srt_RestatementDomain_c8534878-76d9-4d73-9d1f-652b3c908d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_1af7dd01-900a-48fa-91bd-824b6fe60806" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_c8534878-76d9-4d73-9d1f-652b3c908d3e" xlink:to="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_1af7dd01-900a-48fa-91bd-824b6fe60806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e51bae26-8514-48b0-aade-0172f11b8e84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2cba3cd5-e19a-4efa-9031-41ac38b0da12" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e51bae26-8514-48b0-aade-0172f11b8e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e14ace7b-cc55-40f5-9c17-a5fe3f6c2135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e51bae26-8514-48b0-aade-0172f11b8e84" xlink:to="loc_us-gaap_EquityComponentDomain_e14ace7b-cc55-40f5-9c17-a5fe3f6c2135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d7dc5694-3d78-4c74-8977-20df53fcd1ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e14ace7b-cc55-40f5-9c17-a5fe3f6c2135" xlink:to="loc_us-gaap_CommonStockMember_d7dc5694-3d78-4c74-8977-20df53fcd1ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_8d54596b-1042-4ecb-afe1-465d02e14570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e14ace7b-cc55-40f5-9c17-a5fe3f6c2135" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_8d54596b-1042-4ecb-afe1-465d02e14570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_f9715310-27ab-4858-885a-679a9e660025" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e14ace7b-cc55-40f5-9c17-a5fe3f6c2135" xlink:to="loc_us-gaap_RetainedEarningsMember_f9715310-27ab-4858-885a-679a9e660025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_780832f8-0932-47fc-bc07-8c2218a1d315" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e14ace7b-cc55-40f5-9c17-a5fe3f6c2135" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_780832f8-0932-47fc-bc07-8c2218a1d315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_befbc482-8e01-4e63-a587-a8952b0bf7d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e14ace7b-cc55-40f5-9c17-a5fe3f6c2135" xlink:to="loc_us-gaap_ParentMember_befbc482-8e01-4e63-a587-a8952b0bf7d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_018664d2-e594-4772-9448-18f7e087cb23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e14ace7b-cc55-40f5-9c17-a5fe3f6c2135" xlink:to="loc_us-gaap_NoncontrollingInterestMember_018664d2-e594-4772-9448-18f7e087cb23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b9095f6a-5b25-4c0a-a230-44f351dc70d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2cba3cd5-e19a-4efa-9031-41ac38b0da12" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b9095f6a-5b25-4c0a-a230-44f351dc70d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_cc126ca3-764a-41e1-9ce2-657e5ffa3b35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b9095f6a-5b25-4c0a-a230-44f351dc70d0" xlink:to="loc_us-gaap_ClassOfStockDomain_cc126ca3-764a-41e1-9ce2-657e5ffa3b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_b8f491a6-2f9d-424a-9296-ef868dde4e3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2cba3cd5-e19a-4efa-9031-41ac38b0da12" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_b8f491a6-2f9d-424a-9296-ef868dde4e3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_fc804ac6-a523-4c22-9490-c3f2d40dea35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_b8f491a6-2f9d-424a-9296-ef868dde4e3e" xlink:to="loc_us-gaap_TypeOfAdoptionMember_fc804ac6-a523-4c22-9490-c3f2d40dea35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_cd356b69-e36d-4881-8566-e161aa962849" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2cba3cd5-e19a-4efa-9031-41ac38b0da12" xlink:to="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_cd356b69-e36d-4881-8566-e161aa962849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingPrincipleMember_7c4a442d-b3b1-48dd-8209-07a02530096d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_cd356b69-e36d-4881-8566-e161aa962849" xlink:to="loc_us-gaap_ChangeInAccountingPrincipleMember_7c4a442d-b3b1-48dd-8209-07a02530096d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_b95b5562-7f70-4e57-bd05-25e8e5c7a3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2cba3cd5-e19a-4efa-9031-41ac38b0da12" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_b95b5562-7f70-4e57-bd05-25e8e5c7a3b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_ec9f7967-4280-4b58-9720-09d1a98fcb1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_b95b5562-7f70-4e57-bd05-25e8e5c7a3b5" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_ec9f7967-4280-4b58-9720-09d1a98fcb1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_724728aa-3c57-4560-9466-d40b5118c9e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2cba3cd5-e19a-4efa-9031-41ac38b0da12" xlink:to="loc_us-gaap_StatementLineItems_724728aa-3c57-4560-9466-d40b5118c9e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_8e3147f6-2248-49bf-be82-4200aeb20df2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_724728aa-3c57-4560-9466-d40b5118c9e2" xlink:to="loc_us-gaap_SharesIssued_8e3147f6-2248-49bf-be82-4200aeb20df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c962c58b-6326-4848-b7f9-e8530b33d89a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_724728aa-3c57-4560-9466-d40b5118c9e2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c962c58b-6326-4848-b7f9-e8530b33d89a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_b8e140b8-0849-4263-88b4-0ca89a7c6b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_724728aa-3c57-4560-9466-d40b5118c9e2" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_b8e140b8-0849-4263-88b4-0ca89a7c6b4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_71c6a567-2171-4c43-bfd4-31215c337726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_b8e140b8-0849-4263-88b4-0ca89a7c6b4d" xlink:to="loc_us-gaap_NetIncomeLoss_71c6a567-2171-4c43-bfd4-31215c337726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_dfea7f4f-7a1b-4198-89d4-d9f2ab7e4244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_b8e140b8-0849-4263-88b4-0ca89a7c6b4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_dfea7f4f-7a1b-4198-89d4-d9f2ab7e4244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_a7abb388-807a-475f-9278-de40946ee7a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_b8e140b8-0849-4263-88b4-0ca89a7c6b4d" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_a7abb388-807a-475f-9278-de40946ee7a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_90403135-2057-4d44-8167-3b02f0f006a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_724728aa-3c57-4560-9466-d40b5118c9e2" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_90403135-2057-4d44-8167-3b02f0f006a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_e247016c-a4c0-4165-8dbc-bbc864be6a18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_724728aa-3c57-4560-9466-d40b5118c9e2" xlink:to="loc_us-gaap_DividendsCommonStockCash_e247016c-a4c0-4165-8dbc-bbc864be6a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_7ff03e99-46bd-4baf-bddf-9a9c7afda6e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_724728aa-3c57-4560-9466-d40b5118c9e2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_7ff03e99-46bd-4baf-bddf-9a9c7afda6e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_678e4212-3609-49fa-adbc-97e0847d7da9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_724728aa-3c57-4560-9466-d40b5118c9e2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_678e4212-3609-49fa-adbc-97e0847d7da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_641f94d1-f911-42df-90bc-646a27108b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_724728aa-3c57-4560-9466-d40b5118c9e2" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_641f94d1-f911-42df-90bc-646a27108b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_8cd8b367-d69d-42ed-b0e7-55f6aeb427be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_724728aa-3c57-4560-9466-d40b5118c9e2" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_8cd8b367-d69d-42ed-b0e7-55f6aeb427be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_5bf55ba1-f46e-469b-b5f1-a8a65ea6ddd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_724728aa-3c57-4560-9466-d40b5118c9e2" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_5bf55ba1-f46e-469b-b5f1-a8a65ea6ddd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_9eabc616-f48c-4b55-a2bd-6c2888231443" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_724728aa-3c57-4560-9466-d40b5118c9e2" xlink:to="loc_us-gaap_SharesIssued_9eabc616-f48c-4b55-a2bd-6c2888231443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2753c729-0cc6-462e-9d59-850d4a8ac484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_724728aa-3c57-4560-9466-d40b5118c9e2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2753c729-0cc6-462e-9d59-850d4a8ac484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/CONDENSEDCONSOLIDATESTATEMENTOFEQUITYPARENTHETICAL" xlink:type="simple" xlink:href="a-20230131.xsd#CONDENSEDCONSOLIDATESTATEMENTOFEQUITYPARENTHETICAL"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/CONDENSEDCONSOLIDATESTATEMENTOFEQUITYPARENTHETICAL" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_c84cd20e-b44e-4a25-8b41-7ee1a523b4b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_9ca91de4-de39-4aac-98ec-0aa1964c09b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_c84cd20e-b44e-4a25-8b41-7ee1a523b4b5" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_9ca91de4-de39-4aac-98ec-0aa1964c09b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_679627bd-4ef6-4099-bcdc-404d79b8d0b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_c84cd20e-b44e-4a25-8b41-7ee1a523b4b5" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_679627bd-4ef6-4099-bcdc-404d79b8d0b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_Taxrelatedtosharesissued_16f65d6d-c763-4ed9-b55d-29a6ade97f97" xlink:href="a-20230131.xsd#a_Taxrelatedtosharesissued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_c84cd20e-b44e-4a25-8b41-7ee1a523b4b5" xlink:to="loc_a_Taxrelatedtosharesissued_16f65d6d-c763-4ed9-b55d-29a6ade97f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_db7dd008-5700-4e79-9850-17985252e4c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_c84cd20e-b44e-4a25-8b41-7ee1a523b4b5" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_db7dd008-5700-4e79-9850-17985252e4c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_856e1205-251b-45a6-8e08-65822144352b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_c84cd20e-b44e-4a25-8b41-7ee1a523b4b5" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_856e1205-251b-45a6-8e08-65822144352b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNotes" xlink:type="simple" xlink:href="a-20230131.xsd#OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNotes"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f261e4c3-fe7a-4535-854e-3da0cc7eaff8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_6c0be2bb-8162-4441-adcb-a21ff0be4135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f261e4c3-fe7a-4535-854e-3da0cc7eaff8" xlink:to="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_6c0be2bb-8162-4441-adcb-a21ff0be4135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/NEWACCOUNTINGPRONOUNCEMENTSNotes" xlink:type="simple" xlink:href="a-20230131.xsd#NEWACCOUNTINGPRONOUNCEMENTSNotes"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/NEWACCOUNTINGPRONOUNCEMENTSNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_d5b71f10-f617-47b3-8695-f1f8caabb40a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6a775ba9-0c28-438d-9083-0b96803fc5e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_d5b71f10-f617-47b3-8695-f1f8caabb40a" xlink:to="loc_us-gaap_AccountingPoliciesAbstract_6a775ba9-0c28-438d-9083-0b96803fc5e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_c0f35781-b191-45a1-94d7-d581f86c72d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6a775ba9-0c28-438d-9083-0b96803fc5e9" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_c0f35781-b191-45a1-94d7-d581f86c72d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/REVENUENotes" xlink:type="simple" xlink:href="a-20230131.xsd#REVENUENotes"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/REVENUENotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_69129373-fd61-4817-b033-43a42fc92e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_72f324cc-0804-48f3-b205-08b4fe00d33a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_69129373-fd61-4817-b033-43a42fc92e5d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_72f324cc-0804-48f3-b205-08b4fe00d33a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONNotes" xlink:type="simple" xlink:href="a-20230131.xsd#SHAREBASEDCOMPENSATIONNotes"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_37be90d9-4c39-4468-9550-439e50f071db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_cd324595-ef3b-4828-873e-8a0c7d61d062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_37be90d9-4c39-4468-9550-439e50f071db" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_cd324595-ef3b-4828-873e-8a0c7d61d062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/INCOMETAXESNotes" xlink:type="simple" xlink:href="a-20230131.xsd#INCOMETAXESNotes"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/INCOMETAXESNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9746e230-09f9-45f1-a1f5-9dff6f0c2eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_ea0e2431-e1cb-4d52-a76c-a7e407fe3619" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9746e230-09f9-45f1-a1f5-9dff6f0c2eb5" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_ea0e2431-e1cb-4d52-a76c-a7e407fe3619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/NETINCOMEPERSHARENotes" xlink:type="simple" xlink:href="a-20230131.xsd#NETINCOMEPERSHARENotes"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/NETINCOMEPERSHARENotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_9a575025-84db-4548-ad80-de494bbb1e47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_d079ca44-2198-486e-bae7-70043e2db39d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9a575025-84db-4548-ad80-de494bbb1e47" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_d079ca44-2198-486e-bae7-70043e2db39d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/INVENTORYNotes" xlink:type="simple" xlink:href="a-20230131.xsd#INVENTORYNotes"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/INVENTORYNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_d009b31a-b036-4e1e-badb-92eb026731f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_0e0f521b-4537-42ab-bf09-341a55434185" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_d009b31a-b036-4e1e-badb-92eb026731f0" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_0e0f521b-4537-42ab-bf09-341a55434185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNotes" xlink:type="simple" xlink:href="a-20230131.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNotes"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_35a45511-5e45-4844-aba1-1ec54bdf6815" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_e32ba9cd-6780-4bf8-bca0-43768b3bea66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_35a45511-5e45-4844-aba1-1ec54bdf6815" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_e32ba9cd-6780-4bf8-bca0-43768b3bea66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSNotes" xlink:type="simple" xlink:href="a-20230131.xsd#FAIRVALUEMEASUREMENTSNotes"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_04ea4142-46a3-4c10-bfe4-0408828389af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_e59f0d71-b302-49e5-8920-e4b240e24d28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_04ea4142-46a3-4c10-bfe4-0408828389af" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_e59f0d71-b302-49e5-8920-e4b240e24d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/DERIVATIVESNotes" xlink:type="simple" xlink:href="a-20230131.xsd#DERIVATIVESNotes"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/DERIVATIVESNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_06a99af0-50c9-4525-9579-52f89fadaffe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_ae6d3459-b447-4252-923a-527fe4ad55da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_06a99af0-50c9-4525-9579-52f89fadaffe" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_ae6d3459-b447-4252-923a-527fe4ad55da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSNotes" xlink:type="simple" xlink:href="a-20230131.xsd#RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSNotes"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_ef8d03c0-fc04-41e8-80ef-0074e04fa7c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_7855e7be-9af6-420f-b587-10a8f8f918f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_ef8d03c0-fc04-41e8-80ef-0074e04fa7c7" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_7855e7be-9af6-420f-b587-10a8f8f918f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESNotes" xlink:type="simple" xlink:href="a-20230131.xsd#WARRANTIESANDCONTINGENCIESNotes"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d1696885-e3ad-437d-8b39-db208e672cbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_fa98b22a-4592-490c-9e0e-92cb1aa96076" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d1696885-e3ad-437d-8b39-db208e672cbe" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_fa98b22a-4592-490c-9e0e-92cb1aa96076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SHORTTERMDEBTNotes" xlink:type="simple" xlink:href="a-20230131.xsd#SHORTTERMDEBTNotes"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/SHORTTERMDEBTNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowingsAbstract_e6903528-861b-494a-9b7a-e8e9a945a872" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowingsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTextBlock_914f3a77-2936-4060-9426-78b5292d2134" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermBorrowingsAbstract_e6903528-861b-494a-9b7a-e8e9a945a872" xlink:to="loc_us-gaap_ShortTermDebtTextBlock_914f3a77-2936-4060-9426-78b5292d2134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/LONGTERMDEBTNotes" xlink:type="simple" xlink:href="a-20230131.xsd#LONGTERMDEBTNotes"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/LONGTERMDEBTNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_31855977-de56-4430-b980-489b9244a119" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_7a61f167-fcdf-4c52-b9f2-b3e0d2a9e352" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_31855977-de56-4430-b980-489b9244a119" xlink:to="loc_us-gaap_LongTermDebtTextBlock_7a61f167-fcdf-4c52-b9f2-b3e0d2a9e352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYNotes" xlink:type="simple" xlink:href="a-20230131.xsd#STOCKHOLDERSEQUITYNotes"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/STOCKHOLDERSEQUITYNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_d8e337d4-e1d2-4c53-9ce1-99ebe0e6425a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1ac9e508-6106-4b5d-9fa4-1d2bd3a124a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_d8e337d4-e1d2-4c53-9ce1-99ebe0e6425a" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1ac9e508-6106-4b5d-9fa4-1d2bd3a124a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SEGMENTINFORMATIONNotes" xlink:type="simple" xlink:href="a-20230131.xsd#SEGMENTINFORMATIONNotes"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/SEGMENTINFORMATIONNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_b9bdee39-2303-4582-a2a0-53b2c694f5dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_0943d6f7-79a0-418b-b533-19d111eb6cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b9bdee39-2303-4582-a2a0-53b2c694f5dd" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_0943d6f7-79a0-418b-b533-19d111eb6cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="a-20230131.xsd#OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a15492c4-78fa-48fe-93cb-2cd7a403fb9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_4ca618fb-1a50-445a-8424-e638c68e6428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a15492c4-78fa-48fe-93cb-2cd7a403fb9e" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_4ca618fb-1a50-445a-8424-e638c68e6428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_d23eebfb-5bd6-4566-8402-4acae0c3a451" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a15492c4-78fa-48fe-93cb-2cd7a403fb9e" xlink:to="loc_us-gaap_UseOfEstimates_d23eebfb-5bd6-4566-8402-4acae0c3a451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_60fa72f7-0ea4-4fb3-b1d6-101abfd202fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a15492c4-78fa-48fe-93cb-2cd7a403fb9e" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_60fa72f7-0ea4-4fb3-b1d6-101abfd202fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_04158fb2-a0ec-4709-8712-d545607d4120" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a15492c4-78fa-48fe-93cb-2cd7a403fb9e" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_04158fb2-a0ec-4709-8712-d545607d4120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_67b7fc8a-3935-4e73-98da-8572b58ace89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a15492c4-78fa-48fe-93cb-2cd7a403fb9e" xlink:to="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_67b7fc8a-3935-4e73-98da-8572b58ace89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_eb8941e4-ca05-44c1-b458-faf9df4629c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a15492c4-78fa-48fe-93cb-2cd7a403fb9e" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_eb8941e4-ca05-44c1-b458-faf9df4629c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="a-20230131.xsd#OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAbstract_48dc7163-1a9e-4579-8e0b-3f3bd29a5f63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_ee2a031c-0380-4bfe-9cdf-a226b4d63925" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAbstract_48dc7163-1a9e-4579-8e0b-3f3bd29a5f63" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_ee2a031c-0380-4bfe-9cdf-a226b4d63925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/NEWACCOUNTINGPRONOUNCEMENTSTables" xlink:type="simple" xlink:href="a-20230131.xsd#NEWACCOUNTINGPRONOUNCEMENTSTables"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/NEWACCOUNTINGPRONOUNCEMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_100d3201-cdc1-4549-b15f-ddde8abaa137" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_9528f68a-9799-4665-b127-3f6212c33dad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_100d3201-cdc1-4549-b15f-ddde8abaa137" xlink:to="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_9528f68a-9799-4665-b127-3f6212c33dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5254f468-5979-4ec9-97c2-5e16568b6d94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_100d3201-cdc1-4549-b15f-ddde8abaa137" xlink:to="loc_us-gaap_AccountingPoliciesAbstract_5254f468-5979-4ec9-97c2-5e16568b6d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_21683e50-66bd-4b22-8a5b-df749ae8c016" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5254f468-5979-4ec9-97c2-5e16568b6d94" xlink:to="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_21683e50-66bd-4b22-8a5b-df749ae8c016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/REVENUETables" xlink:type="simple" xlink:href="a-20230131.xsd#REVENUETables"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/REVENUETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1693c9d4-69da-4675-8398-996980fb7c27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_ca8c4625-7ba0-4a95-82a1-486954b04b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1693c9d4-69da-4675-8398-996980fb7c27" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_ca8c4625-7ba0-4a95-82a1-486954b04b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_d7fcbbad-e3bd-4e5c-a127-5e1630ec7587" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1693c9d4-69da-4675-8398-996980fb7c27" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_d7fcbbad-e3bd-4e5c-a127-5e1630ec7587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="a-20230131.xsd#SHAREBASEDCOMPENSATIONTables"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_e8a8addc-d553-4e3d-86d0-1aa0f6a9ce46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_54912dc0-720f-454f-959e-32f9b27dce0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_e8a8addc-d553-4e3d-86d0-1aa0f6a9ce46" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_54912dc0-720f-454f-959e-32f9b27dce0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock_6dc2c018-4b4a-47c3-9162-07ac91b7cce2" xlink:href="a-20230131.xsd#a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_e8a8addc-d553-4e3d-86d0-1aa0f6a9ce46" xlink:to="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock_6dc2c018-4b4a-47c3-9162-07ac91b7cce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_518e561c-396c-4567-b569-c631dcdeaf7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_e8a8addc-d553-4e3d-86d0-1aa0f6a9ce46" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_518e561c-396c-4567-b569-c631dcdeaf7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/NETINCOMEPERSHARETables" xlink:type="simple" xlink:href="a-20230131.xsd#NETINCOMEPERSHARETables"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/NETINCOMEPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_56edb8b1-e2b9-4c8a-bb04-52b2e7e93885" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_94a6c8a2-9021-48e6-b882-5cb0e16b35fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_56edb8b1-e2b9-4c8a-bb04-52b2e7e93885" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_94a6c8a2-9021-48e6-b882-5cb0e16b35fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/INVENTORYTables" xlink:type="simple" xlink:href="a-20230131.xsd#INVENTORYTables"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/INVENTORYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_d42a4b42-9d65-4194-9117-fa47abde1c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_9af1559d-e9fd-4073-b56c-1f9edc735489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_d42a4b42-9d65-4194-9117-fa47abde1c8e" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_9af1559d-e9fd-4073-b56c-1f9edc735489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="a-20230131.xsd#GOODWILLANDOTHERINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9b743c93-66ca-47ba-9597-fff769302e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_3b3079bd-5e82-47cc-b53e-01e0f7d10118" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9b743c93-66ca-47ba-9597-fff769302e5f" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_3b3079bd-5e82-47cc-b53e-01e0f7d10118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_849e27e9-aa16-492b-b9e8-dd991963ae22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9b743c93-66ca-47ba-9597-fff769302e5f" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_849e27e9-aa16-492b-b9e8-dd991963ae22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_18483a38-5aae-44f4-a414-81092d406d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9b743c93-66ca-47ba-9597-fff769302e5f" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_18483a38-5aae-44f4-a414-81092d406d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="a-20230131.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_d715cff5-1604-4255-8340-e2ed34d0cc05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_7aaf3724-b8d8-4b6d-b30d-829f70462d92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d715cff5-1604-4255-8340-e2ed34d0cc05" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_7aaf3724-b8d8-4b6d-b30d-829f70462d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsTextBlock_a46e37bb-459e-44a8-85c0-1d87d6b86178" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestmentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d715cff5-1604-4255-8340-e2ed34d0cc05" xlink:to="loc_us-gaap_GainLossOnInvestmentsTextBlock_a46e37bb-459e-44a8-85c0-1d87d6b86178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_ff8d3049-841a-4ac3-8e46-3932533808d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d715cff5-1604-4255-8340-e2ed34d0cc05" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_ff8d3049-841a-4ac3-8e46-3932533808d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/DERIVATIVESTables" xlink:type="simple" xlink:href="a-20230131.xsd#DERIVATIVESTables"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/DERIVATIVESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_36e6c8b1-0f27-429b-b872-9b2ddcc2120c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_370cf78b-b074-4925-af89-7b2822db84ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_36e6c8b1-0f27-429b-b872-9b2ddcc2120c" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_370cf78b-b074-4925-af89-7b2822db84ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_838e74a8-84a2-4022-b8e6-813ec6e5ec90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_36e6c8b1-0f27-429b-b872-9b2ddcc2120c" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_838e74a8-84a2-4022-b8e6-813ec6e5ec90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_68ff1ffc-09a8-4287-963f-f798628fb8f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_36e6c8b1-0f27-429b-b872-9b2ddcc2120c" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_68ff1ffc-09a8-4287-963f-f798628fb8f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSTables" xlink:type="simple" xlink:href="a-20230131.xsd#RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSTables"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_39c3fdac-acc8-4745-ab80-9ece00fd4ae0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_2c2f81f8-76db-493a-af0b-311391175f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_39c3fdac-acc8-4745-ab80-9ece00fd4ae0" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_2c2f81f8-76db-493a-af0b-311391175f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_d6080a96-4695-43e7-b7ef-ff11ef8e6e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_2c2f81f8-76db-493a-af0b-311391175f7e" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_d6080a96-4695-43e7-b7ef-ff11ef8e6e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock_4c9d40e6-bd4c-40c6-91f7-610232066099" xlink:href="a-20230131.xsd#a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_39c3fdac-acc8-4745-ab80-9ece00fd4ae0" xlink:to="loc_a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock_4c9d40e6-bd4c-40c6-91f7-610232066099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESTable" xlink:type="simple" xlink:href="a-20230131.xsd#WARRANTIESANDCONTINGENCIESTable"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESTable" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2839c5c4-d6ac-4c9f-8d0a-dcb094f7573a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_b86f0290-e1d8-4ff6-a400-02db8f61aa89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2839c5c4-d6ac-4c9f-8d0a-dcb094f7573a" xlink:to="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_b86f0290-e1d8-4ff6-a400-02db8f61aa89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/LONGTERMDEBTTables" xlink:type="simple" xlink:href="a-20230131.xsd#LONGTERMDEBTTables"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/LONGTERMDEBTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_53f2b708-7932-4cc1-8edd-24523dd11614" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_d1fea2fa-7aeb-4b21-8fe9-dc2c8e18e19d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_53f2b708-7932-4cc1-8edd-24523dd11614" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_d1fea2fa-7aeb-4b21-8fe9-dc2c8e18e19d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="a-20230131.xsd#STOCKHOLDERSEQUITYTables"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/STOCKHOLDERSEQUITYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_710ced06-70e0-4ad1-9f12-43e46a11eefd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9f1d1a29-cb63-4bae-a92d-6e2e5575633d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_710ced06-70e0-4ad1-9f12-43e46a11eefd" xlink:to="loc_us-gaap_StatementTable_9f1d1a29-cb63-4bae-a92d-6e2e5575633d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_ae044564-841e-4a64-85be-7d2418889b6b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9f1d1a29-cb63-4bae-a92d-6e2e5575633d" xlink:to="loc_srt_StatementScenarioAxis_ae044564-841e-4a64-85be-7d2418889b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_86b5937b-d1bf-45ad-86c6-5dfd4028fc8f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_ae044564-841e-4a64-85be-7d2418889b6b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_86b5937b-d1bf-45ad-86c6-5dfd4028fc8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ded1fa53-e2d4-4fb5-b88f-ab719084028e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9f1d1a29-cb63-4bae-a92d-6e2e5575633d" xlink:to="loc_us-gaap_StatementLineItems_ded1fa53-e2d4-4fb5-b88f-ab719084028e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_f7c3573c-1d8f-47d6-b7df-658867ec2d24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ded1fa53-e2d4-4fb5-b88f-ab719084028e" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_f7c3573c-1d8f-47d6-b7df-658867ec2d24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_36287c7c-7f34-4a9e-84ec-470f271ce68a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ded1fa53-e2d4-4fb5-b88f-ab719084028e" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_36287c7c-7f34-4a9e-84ec-470f271ce68a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="a-20230131.xsd#SEGMENTINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/SEGMENTINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_da97ecd5-f551-4be6-930a-d85645850df5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_aebd4321-056e-479a-b592-3f634e6aa18c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_da97ecd5-f551-4be6-930a-d85645850df5" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_aebd4321-056e-479a-b592-3f634e6aa18c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_3ee16152-f089-4e37-bef5-f096a34b9393" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_da97ecd5-f551-4be6-930a-d85645850df5" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_3ee16152-f089-4e37-bef5-f096a34b9393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="simple" xlink:href="a-20230131.xsd#OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6a7c8505-6578-4fa0-9add-072281f287f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_cf8f468b-e495-4669-aadd-592ecb79876f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6a7c8505-6578-4fa0-9add-072281f287f4" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_cf8f468b-e495-4669-aadd-592ecb79876f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_a4632e8f-1454-49a5-bbe7-40b22424a660" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_cf8f468b-e495-4669-aadd-592ecb79876f" xlink:to="loc_srt_ConsolidatedEntitiesAxis_a4632e8f-1454-49a5-bbe7-40b22424a660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_0d122b5d-a2b1-4bfc-8117-027ae1b6e0f8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_a4632e8f-1454-49a5-bbe7-40b22424a660" xlink:to="loc_srt_ConsolidatedEntitiesDomain_0d122b5d-a2b1-4bfc-8117-027ae1b6e0f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_808b4bd4-00bc-446a-9353-c9b7c1c48cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_0d122b5d-a2b1-4bfc-8117-027ae1b6e0f8" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_808b4bd4-00bc-446a-9353-c9b7c1c48cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PledgedStatusAxis_11078724-041a-4c4f-a041-fdad0860c98b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PledgedStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_cf8f468b-e495-4669-aadd-592ecb79876f" xlink:to="loc_us-gaap_PledgedStatusAxis_11078724-041a-4c4f-a041-fdad0860c98b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PledgedStatusDomain_9cb42a98-0849-4bea-9920-56d264a19691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PledgedStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PledgedStatusAxis_11078724-041a-4c4f-a041-fdad0860c98b" xlink:to="loc_us-gaap_PledgedStatusDomain_9cb42a98-0849-4bea-9920-56d264a19691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecourseStatusAxis_548681e8-9065-4507-8c50-c199c75ae081" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RecourseStatusAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_cf8f468b-e495-4669-aadd-592ecb79876f" xlink:to="loc_us-gaap_RecourseStatusAxis_548681e8-9065-4507-8c50-c199c75ae081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecourseStatusDomain_c87098da-f57c-4819-86da-ee7f68d92389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RecourseStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RecourseStatusAxis_548681e8-9065-4507-8c50-c199c75ae081" xlink:to="loc_us-gaap_RecourseStatusDomain_c87098da-f57c-4819-86da-ee7f68d92389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_43e740af-2d36-4348-b915-e6cdc4761cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_cf8f468b-e495-4669-aadd-592ecb79876f" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_43e740af-2d36-4348-b915-e6cdc4761cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a92aebca-9b97-4f77-b149-8a5360c62906" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_43e740af-2d36-4348-b915-e6cdc4761cbf" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a92aebca-9b97-4f77-b149-8a5360c62906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_c57c397c-aea1-4d7e-b604-e9277dff6d20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a92aebca-9b97-4f77-b149-8a5360c62906" xlink:to="loc_us-gaap_OtherAssetsMember_c57c397c-aea1-4d7e-b604-e9277dff6d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_c4115ce7-9bee-41d6-a873-ba7dc0374e33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a92aebca-9b97-4f77-b149-8a5360c62906" xlink:to="loc_us-gaap_OtherLiabilitiesMember_c4115ce7-9bee-41d6-a873-ba7dc0374e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_556e2fe6-d945-4e7c-a134-8002e11afa1a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_78f26323-895b-474d-b143-f5ddf9294ef4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_7957e371-0759-4ff7-978b-0d659c5c84ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cf789193-bd6f-455d-a224-e866e39d82c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_cf8f468b-e495-4669-aadd-592ecb79876f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cf789193-bd6f-455d-a224-e866e39d82c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_54f9a246-c750-4788-8d5b-ee75cf3a8550" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cf789193-bd6f-455d-a224-e866e39d82c6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_54f9a246-c750-4788-8d5b-ee75cf3a8550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3eaa9454-00b1-4c30-b7d7-0b737dbce06c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_54f9a246-c750-4788-8d5b-ee75cf3a8550" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3eaa9454-00b1-4c30-b7d7-0b737dbce06c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ca2f8e66-ad41-4b5f-b111-cf70212edbf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_cf8f468b-e495-4669-aadd-592ecb79876f" xlink:to="loc_us-gaap_DebtInstrumentAxis_ca2f8e66-ad41-4b5f-b111-cf70212edbf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_754f1f99-0f1e-4024-be81-70c8cfc2de17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_ca2f8e66-ad41-4b5f-b111-cf70212edbf1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_754f1f99-0f1e-4024-be81-70c8cfc2de17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_ad412906-37f0-4845-bef7-99198e0353dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_754f1f99-0f1e-4024-be81-70c8cfc2de17" xlink:to="loc_us-gaap_SeniorNotesMember_ad412906-37f0-4845-bef7-99198e0353dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_019346bf-004d-4318-8095-89dd86075682" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_cf8f468b-e495-4669-aadd-592ecb79876f" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_019346bf-004d-4318-8095-89dd86075682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_b7f2e450-a520-4f24-8e01-d12f2cae6219" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_019346bf-004d-4318-8095-89dd86075682" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_b7f2e450-a520-4f24-8e01-d12f2cae6219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7727ec6b-5770-493e-9aab-b30cb5ed9dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_b7f2e450-a520-4f24-8e01-d12f2cae6219" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7727ec6b-5770-493e-9aab-b30cb5ed9dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_35dead14-ba40-4089-a16c-98e7697b6f01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_b7f2e450-a520-4f24-8e01-d12f2cae6219" xlink:to="loc_us-gaap_RestrictedCash_35dead14-ba40-4089-a16c-98e7697b6f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_842269a8-2db9-4a2f-8497-85efc0254bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_b7f2e450-a520-4f24-8e01-d12f2cae6219" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_842269a8-2db9-4a2f-8497-85efc0254bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract_21881127-1dd7-4b5a-aeef-9c83d2eddab1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_019346bf-004d-4318-8095-89dd86075682" xlink:to="loc_us-gaap_LeasesOperatingAbstract_21881127-1dd7-4b5a-aeef-9c83d2eddab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1a9c3070-63c8-4557-8a5c-09f2337548c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_21881127-1dd7-4b5a-aeef-9c83d2eddab1" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1a9c3070-63c8-4557-8a5c-09f2337548c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_01c4ac96-73ba-4264-b994-344489768927" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_21881127-1dd7-4b5a-aeef-9c83d2eddab1" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_01c4ac96-73ba-4264-b994-344489768927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_6d3ecd9f-d5fb-468a-a07a-ee48a0ea1e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_21881127-1dd7-4b5a-aeef-9c83d2eddab1" xlink:to="loc_us-gaap_OperatingLeaseLiability_6d3ecd9f-d5fb-468a-a07a-ee48a0ea1e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_9844239b-fbc1-4df1-aa7c-c2679a537526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_21881127-1dd7-4b5a-aeef-9c83d2eddab1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_9844239b-fbc1-4df1-aa7c-c2679a537526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_e6e622de-408b-4983-952a-21ccdbde31be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_019346bf-004d-4318-8095-89dd86075682" xlink:to="loc_us-gaap_FairValueDisclosuresAbstract_e6e622de-408b-4983-952a-21ccdbde31be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_31db0315-9d5b-4505-80b3-2995f93c71de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e6e622de-408b-4983-952a-21ccdbde31be" xlink:to="loc_us-gaap_DebtInstrumentFairValue_31db0315-9d5b-4505-80b3-2995f93c71de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_7257946f-e053-4316-ab31-9c1538f4b8d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e6e622de-408b-4983-952a-21ccdbde31be" xlink:to="loc_us-gaap_SeniorNotes_7257946f-e053-4316-ab31-9c1538f4b8d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_17a41372-d077-4da9-8255-54c1da6fe650" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_019346bf-004d-4318-8095-89dd86075682" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_17a41372-d077-4da9-8255-54c1da6fe650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_8b94d4e1-a501-4328-9cee-33111c06df41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_17a41372-d077-4da9-8255-54c1da6fe650" xlink:to="loc_us-gaap_Assets_8b94d4e1-a501-4328-9cee-33111c06df41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/REVENUERevenuebyRegionDetails" xlink:type="simple" xlink:href="a-20230131.xsd#REVENUERevenuebyRegionDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/REVENUERevenuebyRegionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_13a038f4-d409-4d54-b1a6-9f60e979ab8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_813b5a95-f1bf-491b-85d4-bcc4782f5d26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_13a038f4-d409-4d54-b1a6-9f60e979ab8c" xlink:to="loc_us-gaap_StatementTable_813b5a95-f1bf-491b-85d4-bcc4782f5d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e8ee417e-59e1-4996-a6cd-7972e640d113" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_813b5a95-f1bf-491b-85d4-bcc4782f5d26" xlink:to="loc_srt_StatementGeographicalAxis_e8ee417e-59e1-4996-a6cd-7972e640d113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2a4aa73c-efe2-4c1e-acb9-357ee21207a5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_e8ee417e-59e1-4996-a6cd-7972e640d113" xlink:to="loc_srt_SegmentGeographicalDomain_2a4aa73c-efe2-4c1e-acb9-357ee21207a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_e1146287-2d0f-470d-99d2-69a8189ed433" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AmericasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2a4aa73c-efe2-4c1e-acb9-357ee21207a5" xlink:to="loc_srt_AmericasMember_e1146287-2d0f-470d-99d2-69a8189ed433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_e5550abc-4446-4f84-858a-a08e75a6ada4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2a4aa73c-efe2-4c1e-acb9-357ee21207a5" xlink:to="loc_srt_EuropeMember_e5550abc-4446-4f84-858a-a08e75a6ada4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_1c66db60-aa15-4c15-be95-8c7ddf92586d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2a4aa73c-efe2-4c1e-acb9-357ee21207a5" xlink:to="loc_srt_AsiaPacificMember_1c66db60-aa15-4c15-be95-8c7ddf92586d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a49754b9-ac34-4141-b5b9-c21ff15a0d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_813b5a95-f1bf-491b-85d4-bcc4782f5d26" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a49754b9-ac34-4141-b5b9-c21ff15a0d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_de5059e1-cf6a-4623-8623-6991209875a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a49754b9-ac34-4141-b5b9-c21ff15a0d3a" xlink:to="loc_us-gaap_SegmentDomain_de5059e1-cf6a-4623-8623-6991209875a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_LifeSciencesandAppliedMarketsMember_c97c2060-3dd2-48c7-8a61-5f848dffae4b" xlink:href="a-20230131.xsd#a_LifeSciencesandAppliedMarketsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_de5059e1-cf6a-4623-8623-6991209875a4" xlink:to="loc_a_LifeSciencesandAppliedMarketsMember_c97c2060-3dd2-48c7-8a61-5f848dffae4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AgilentCrossLabMember_ef48a71d-c937-4c31-8202-6b27e4f02207" xlink:href="a-20230131.xsd#a_AgilentCrossLabMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_de5059e1-cf6a-4623-8623-6991209875a4" xlink:to="loc_a_AgilentCrossLabMember_ef48a71d-c937-4c31-8202-6b27e4f02207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_DiagnosticsAndGenomicsMember_0a158e63-1585-4ef3-b629-7ce8f86bd40e" xlink:href="a-20230131.xsd#a_DiagnosticsAndGenomicsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_de5059e1-cf6a-4623-8623-6991209875a4" xlink:to="loc_a_DiagnosticsAndGenomicsMember_0a158e63-1585-4ef3-b629-7ce8f86bd40e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f0aee9cc-f37e-4ae3-86f6-e9f11797fc06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_813b5a95-f1bf-491b-85d4-bcc4782f5d26" xlink:to="loc_us-gaap_StatementLineItems_f0aee9cc-f37e-4ae3-86f6-e9f11797fc06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1cadf124-2e67-4234-b0b7-2abde1de4f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0aee9cc-f37e-4ae3-86f6-e9f11797fc06" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1cadf124-2e67-4234-b0b7-2abde1de4f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails" xlink:type="simple" xlink:href="a-20230131.xsd#REVENUERevenuebyEndMarketsDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1bf0c8e0-8f36-4586-9be0-4e6b77609df7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_934e0a00-027b-4624-8b11-b3d1e8349cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1bf0c8e0-8f36-4586-9be0-4e6b77609df7" xlink:to="loc_us-gaap_StatementTable_934e0a00-027b-4624-8b11-b3d1e8349cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_EndMarketsAxis_4906d3a2-40f4-4c78-a30c-f7a2c6cc8097" xlink:href="a-20230131.xsd#a_EndMarketsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_934e0a00-027b-4624-8b11-b3d1e8349cb6" xlink:to="loc_a_EndMarketsAxis_4906d3a2-40f4-4c78-a30c-f7a2c6cc8097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_EndMarketsDomain_3b5eaf55-7fbf-4d01-bb08-a9000e976ab4" xlink:href="a-20230131.xsd#a_EndMarketsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_EndMarketsAxis_4906d3a2-40f4-4c78-a30c-f7a2c6cc8097" xlink:to="loc_a_EndMarketsDomain_3b5eaf55-7fbf-4d01-bb08-a9000e976ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_PharmaceuticalandBiopharmaceuticalMarketMember_808d25bb-d94b-424b-a4e0-bbc4485a8972" xlink:href="a-20230131.xsd#a_PharmaceuticalandBiopharmaceuticalMarketMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_EndMarketsDomain_3b5eaf55-7fbf-4d01-bb08-a9000e976ab4" xlink:to="loc_a_PharmaceuticalandBiopharmaceuticalMarketMember_808d25bb-d94b-424b-a4e0-bbc4485a8972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ChemicalandEnergyMarketMember_ae8cbd86-ae44-45d7-8084-4026e1705113" xlink:href="a-20230131.xsd#a_ChemicalandEnergyMarketMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_EndMarketsDomain_3b5eaf55-7fbf-4d01-bb08-a9000e976ab4" xlink:to="loc_a_ChemicalandEnergyMarketMember_ae8cbd86-ae44-45d7-8084-4026e1705113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_DiagnosticsandClinicalMarketMember_ca3037be-5cc9-46c5-b929-1b2f7cc71dee" xlink:href="a-20230131.xsd#a_DiagnosticsandClinicalMarketMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_EndMarketsDomain_3b5eaf55-7fbf-4d01-bb08-a9000e976ab4" xlink:to="loc_a_DiagnosticsandClinicalMarketMember_ca3037be-5cc9-46c5-b929-1b2f7cc71dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_FoodMarketMember_bf256447-e979-47c8-a324-e7045520ca1c" xlink:href="a-20230131.xsd#a_FoodMarketMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_EndMarketsDomain_3b5eaf55-7fbf-4d01-bb08-a9000e976ab4" xlink:to="loc_a_FoodMarketMember_bf256447-e979-47c8-a324-e7045520ca1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AcademiaandGovernmentMarketMember_f65eecde-36b7-4838-a806-b6f1c5b2d93b" xlink:href="a-20230131.xsd#a_AcademiaandGovernmentMarketMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_EndMarketsDomain_3b5eaf55-7fbf-4d01-bb08-a9000e976ab4" xlink:to="loc_a_AcademiaandGovernmentMarketMember_f65eecde-36b7-4838-a806-b6f1c5b2d93b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_EnvironmentalandForensicsMarketMember_11edafa2-190d-440c-aa04-649098ac5ef9" xlink:href="a-20230131.xsd#a_EnvironmentalandForensicsMarketMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_EndMarketsDomain_3b5eaf55-7fbf-4d01-bb08-a9000e976ab4" xlink:to="loc_a_EnvironmentalandForensicsMarketMember_11edafa2-190d-440c-aa04-649098ac5ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5938edb4-422c-4498-a301-ac50b87070a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_934e0a00-027b-4624-8b11-b3d1e8349cb6" xlink:to="loc_us-gaap_StatementLineItems_5938edb4-422c-4498-a301-ac50b87070a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f46a3c5d-f6e1-46e9-818e-0f3b12d62938" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5938edb4-422c-4498-a301-ac50b87070a7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f46a3c5d-f6e1-46e9-818e-0f3b12d62938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/REVENUERevenuebyTypeDetails" xlink:type="simple" xlink:href="a-20230131.xsd#REVENUERevenuebyTypeDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/REVENUERevenuebyTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e8929a3c-38f2-4bef-8995-b686f2d7b2f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_40bdb16d-77d9-4378-ad5f-7475001122ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e8929a3c-38f2-4bef-8995-b686f2d7b2f9" xlink:to="loc_us-gaap_StatementTable_40bdb16d-77d9-4378-ad5f-7475001122ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_20c58009-3a44-4981-99c7-679fc24fa8bc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_40bdb16d-77d9-4378-ad5f-7475001122ff" xlink:to="loc_srt_ProductOrServiceAxis_20c58009-3a44-4981-99c7-679fc24fa8bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_496a2a82-9934-4eaf-9704-c28c862675a2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_20c58009-3a44-4981-99c7-679fc24fa8bc" xlink:to="loc_srt_ProductsAndServicesDomain_496a2a82-9934-4eaf-9704-c28c862675a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_InstrumentationMember_428276fc-c9c4-4d08-9494-e25522d7edf0" xlink:href="a-20230131.xsd#a_InstrumentationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_496a2a82-9934-4eaf-9704-c28c862675a2" xlink:to="loc_a_InstrumentationMember_428276fc-c9c4-4d08-9494-e25522d7edf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_NonInstrumentationandOtherMember_cf54daf0-9ced-4e11-a337-fa08443fd733" xlink:href="a-20230131.xsd#a_NonInstrumentationandOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_496a2a82-9934-4eaf-9704-c28c862675a2" xlink:to="loc_a_NonInstrumentationandOtherMember_cf54daf0-9ced-4e11-a337-fa08443fd733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7ccb66c3-b955-43f4-bf64-485f709ef6df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_40bdb16d-77d9-4378-ad5f-7475001122ff" xlink:to="loc_us-gaap_StatementLineItems_7ccb66c3-b955-43f4-bf64-485f709ef6df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6a9c5787-a3a5-4eb5-a2c7-f0e18de29d19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7ccb66c3-b955-43f4-bf64-485f709ef6df" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6a9c5787-a3a5-4eb5-a2c7-f0e18de29d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/REVENUEContractAssetsandLiabilityDetails" xlink:type="simple" xlink:href="a-20230131.xsd#REVENUEContractAssetsandLiabilityDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/REVENUEContractAssetsandLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_85e3fa72-8973-4ff0-93f4-b3e2af6580b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract_d26c7c82-d517-4e6e-aa5e-32aff9ec290a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_85e3fa72-8973-4ff0-93f4-b3e2af6580b4" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract_d26c7c82-d517-4e6e-aa5e-32aff9ec290a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_f8ba7567-f415-4c89-aba0-8f3a4daa971e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract_d26c7c82-d517-4e6e-aa5e-32aff9ec290a" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_f8ba7567-f415-4c89-aba0-8f3a4daa971e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityAbstract_3b987f9f-e036-4dd1-a49c-1576a1e0225c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_85e3fa72-8973-4ff0-93f4-b3e2af6580b4" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityAbstract_3b987f9f-e036-4dd1-a49c-1576a1e0225c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_6989ac87-720e-4efd-b91f-88f51f9ea48c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract_3b987f9f-e036-4dd1-a49c-1576a1e0225c" xlink:to="loc_us-gaap_ContractWithCustomerLiability_6989ac87-720e-4efd-b91f-88f51f9ea48c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_9972f62f-fbda-4dd3-8b94-4b504654ccda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract_3b987f9f-e036-4dd1-a49c-1576a1e0225c" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_9972f62f-fbda-4dd3-8b94-4b504654ccda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_d3a18adc-c496-451c-b45e-63bc40e799f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract_3b987f9f-e036-4dd1-a49c-1576a1e0225c" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_d3a18adc-c496-451c-b45e-63bc40e799f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_cafd872b-689d-4350-a33c-d8034ab1d0d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract_3b987f9f-e036-4dd1-a49c-1576a1e0225c" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_cafd872b-689d-4350-a33c-d8034ab1d0d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_f61bf07a-3be5-4de8-8d76-3ed0c5ae5417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract_3b987f9f-e036-4dd1-a49c-1576a1e0225c" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_f61bf07a-3be5-4de8-8d76-3ed0c5ae5417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease_ed00e158-b2da-4648-aa4d-ade45f5a7fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract_3b987f9f-e036-4dd1-a49c-1576a1e0225c" xlink:to="loc_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease_ed00e158-b2da-4648-aa4d-ade45f5a7fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_d41d2045-b26f-469b-ae83-b980d5354ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract_3b987f9f-e036-4dd1-a49c-1576a1e0225c" xlink:to="loc_us-gaap_ContractWithCustomerLiability_d41d2045-b26f-469b-ae83-b980d5354ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="a-20230131.xsd#REVENUERemainingPerformanceObligationDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationAbstract_9e7a74d5-bce8-42c7-b719-fb70afad5a93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuePerformanceObligationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_404dad8c-12aa-43d6-9831-531e5a327d18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuePerformanceObligationAbstract_9e7a74d5-bce8-42c7-b719-fb70afad5a93" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_404dad8c-12aa-43d6-9831-531e5a327d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_7563af58-7349-4f37-851f-bf3c16aae417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_404dad8c-12aa-43d6-9831-531e5a327d18" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_7563af58-7349-4f37-851f-bf3c16aae417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e21897eb-90fe-4de8-8d95-a3690c7aa41a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_404dad8c-12aa-43d6-9831-531e5a327d18" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e21897eb-90fe-4de8-8d95-a3690c7aa41a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_46977595-cca5-451d-8576-c75f92ce985f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e21897eb-90fe-4de8-8d95-a3690c7aa41a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_46977595-cca5-451d-8576-c75f92ce985f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_6491d675-524f-4502-aa50-5c0e75e15266" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e21897eb-90fe-4de8-8d95-a3690c7aa41a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_6491d675-524f-4502-aa50-5c0e75e15266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails_1" xlink:type="simple" xlink:href="a-20230131.xsd#REVENUERemainingPerformanceObligationDetails_1"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails" xlink:type="simple" xlink:href="a-20230131.xsd#SHAREBASEDCOMPENSATIONTextDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_87d36bc3-93dd-46df-a4c9-c92cf60843e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a1629c5-4da8-4fb5-8fb9-d41961510e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_87d36bc3-93dd-46df-a4c9-c92cf60843e2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a1629c5-4da8-4fb5-8fb9-d41961510e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a7cdfd28-615d-48be-89a8-05b4e08bdcf2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a1629c5-4da8-4fb5-8fb9-d41961510e6d" xlink:to="loc_srt_RangeAxis_a7cdfd28-615d-48be-89a8-05b4e08bdcf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2eec3b8c-a9ee-41a3-abb3-ae4321ce18c7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a7cdfd28-615d-48be-89a8-05b4e08bdcf2" xlink:to="loc_srt_RangeMember_2eec3b8c-a9ee-41a3-abb3-ae4321ce18c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_853213eb-a32d-4bfb-92aa-a82bedb37000" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2eec3b8c-a9ee-41a3-abb3-ae4321ce18c7" xlink:to="loc_srt_MinimumMember_853213eb-a32d-4bfb-92aa-a82bedb37000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b69d4c24-035b-40ec-9091-7ff5250adb27" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2eec3b8c-a9ee-41a3-abb3-ae4321ce18c7" xlink:to="loc_srt_MaximumMember_b69d4c24-035b-40ec-9091-7ff5250adb27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_50287a19-a4d0-4a80-b171-014904ae4311" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a1629c5-4da8-4fb5-8fb9-d41961510e6d" xlink:to="loc_us-gaap_AwardTypeAxis_50287a19-a4d0-4a80-b171-014904ae4311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_920cf9da-886c-495b-91ae-fb1183695439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_50287a19-a4d0-4a80-b171-014904ae4311" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_920cf9da-886c-495b-91ae-fb1183695439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_ac53f19e-2a05-4e5d-93a5-be03be29116a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_920cf9da-886c-495b-91ae-fb1183695439" xlink:to="loc_us-gaap_EmployeeStockMember_ac53f19e-2a05-4e5d-93a5-be03be29116a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_79172fae-82c7-4561-8d61-d7154bfdba83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_920cf9da-886c-495b-91ae-fb1183695439" xlink:to="loc_us-gaap_EmployeeStockOptionMember_79172fae-82c7-4561-8d61-d7154bfdba83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_caede6be-c079-413f-974a-a16709a02569" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_920cf9da-886c-495b-91ae-fb1183695439" xlink:to="loc_us-gaap_PerformanceSharesMember_caede6be-c079-413f-974a-a16709a02569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_799b2db0-8804-4b90-ad5d-9f94834eb551" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_920cf9da-886c-495b-91ae-fb1183695439" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_799b2db0-8804-4b90-ad5d-9f94834eb551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_78405677-577a-4834-9193-f9a5d91cb340" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a1629c5-4da8-4fb5-8fb9-d41961510e6d" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_78405677-577a-4834-9193-f9a5d91cb340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c94b1e00-fe16-4b27-bce3-28b395bc56cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_78405677-577a-4834-9193-f9a5d91cb340" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c94b1e00-fe16-4b27-bce3-28b395bc56cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_4bd9ac13-6400-4faf-ae08-8fcf1a027a37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c94b1e00-fe16-4b27-bce3-28b395bc56cb" xlink:to="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_4bd9ac13-6400-4faf-ae08-8fcf1a027a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8021c203-aad5-4150-b8fb-73819eb15f5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a1629c5-4da8-4fb5-8fb9-d41961510e6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8021c203-aad5-4150-b8fb-73819eb15f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_f76c0f75-b355-4033-b36e-e0fa696ea9f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8021c203-aad5-4150-b8fb-73819eb15f5f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_f76c0f75-b355-4033-b36e-e0fa696ea9f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_ce93b2ae-c669-47e0-a0d7-cf1f809e66a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8021c203-aad5-4150-b8fb-73819eb15f5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_ce93b2ae-c669-47e0-a0d7-cf1f809e66a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_70794e0d-d4c8-4fb3-9bc7-ac1e40449054" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8021c203-aad5-4150-b8fb-73819eb15f5f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_70794e0d-d4c8-4fb3-9bc7-ac1e40449054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_7a3a5d47-2199-41a6-b24c-d83e6b679a48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8021c203-aad5-4150-b8fb-73819eb15f5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_7a3a5d47-2199-41a6-b24c-d83e6b679a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_880f5414-fa51-4eff-b2fa-c28fda48242e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8021c203-aad5-4150-b8fb-73819eb15f5f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_880f5414-fa51-4eff-b2fa-c28fda48242e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_7c8af937-5c80-4249-802b-a2ce24c4c4da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8021c203-aad5-4150-b8fb-73819eb15f5f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_7c8af937-5c80-4249-802b-a2ce24c4c4da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails" xlink:type="simple" xlink:href="a-20230131.xsd#SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_37f3dc66-0446-4af2-b243-0344f06cb9e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e1406b34-e790-40a8-b9c8-430999e12419" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_37f3dc66-0446-4af2-b243-0344f06cb9e2" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e1406b34-e790-40a8-b9c8-430999e12419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_094c8276-492e-4fb8-9581-aa5a2ceb528b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e1406b34-e790-40a8-b9c8-430999e12419" xlink:to="loc_us-gaap_AwardTypeAxis_094c8276-492e-4fb8-9581-aa5a2ceb528b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6e7031ae-f454-4803-9756-d9828cd8aef8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_094c8276-492e-4fb8-9581-aa5a2ceb528b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6e7031ae-f454-4803-9756-d9828cd8aef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_LtppMember_2bd10df8-9cb2-40e9-b2cf-9a4b69ddd0ad" xlink:href="a-20230131.xsd#a_LtppMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6e7031ae-f454-4803-9756-d9828cd8aef8" xlink:to="loc_a_LtppMember_2bd10df8-9cb2-40e9-b2cf-9a4b69ddd0ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8e36135c-d7d7-4fcf-82e6-b8b7d6ababc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e1406b34-e790-40a8-b9c8-430999e12419" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8e36135c-d7d7-4fcf-82e6-b8b7d6ababc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5e27d58b-153d-4115-999b-9e9db38f7aac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8e36135c-d7d7-4fcf-82e6-b8b7d6ababc2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5e27d58b-153d-4115-999b-9e9db38f7aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_916be886-7ad3-43b9-ab45-12d52f0d3ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5e27d58b-153d-4115-999b-9e9db38f7aac" xlink:to="loc_us-gaap_CostOfSalesMember_916be886-7ad3-43b9-ab45-12d52f0d3ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_53c557d8-20bd-467e-a439-879bdcdb3785" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5e27d58b-153d-4115-999b-9e9db38f7aac" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_53c557d8-20bd-467e-a439-879bdcdb3785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_0f65010c-5cc2-48d4-b73f-eea88102984a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5e27d58b-153d-4115-999b-9e9db38f7aac" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_0f65010c-5cc2-48d4-b73f-eea88102984a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_eb531f84-e02f-4173-ba5f-84d9a525fb89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e1406b34-e790-40a8-b9c8-430999e12419" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_eb531f84-e02f-4173-ba5f-84d9a525fb89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c8d9ef5a-edb1-4a92-9369-4f66f25150a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_eb531f84-e02f-4173-ba5f-84d9a525fb89" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c8d9ef5a-edb1-4a92-9369-4f66f25150a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_d4b21c85-8a4e-4a73-af97-0ddd68ab7d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c8d9ef5a-edb1-4a92-9369-4f66f25150a1" xlink:to="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_d4b21c85-8a4e-4a73-af97-0ddd68ab7d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b9dbc7cc-9a24-4b93-bc90-9f6004352670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e1406b34-e790-40a8-b9c8-430999e12419" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b9dbc7cc-9a24-4b93-bc90-9f6004352670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_0a907156-5a9e-4970-b8c9-8157fb6333fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b9dbc7cc-9a24-4b93-bc90-9f6004352670" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_0a907156-5a9e-4970-b8c9-8157fb6333fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails" xlink:type="simple" xlink:href="a-20230131.xsd#SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_8a73f0d5-ab50-4487-adf0-149456358755" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_02517ab0-d501-44f0-ada1-5953c2807176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_8a73f0d5-ab50-4487-adf0-149456358755" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_02517ab0-d501-44f0-ada1-5953c2807176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6a35a075-fe83-4b15-8c5e-fcb0e795c561" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_02517ab0-d501-44f0-ada1-5953c2807176" xlink:to="loc_us-gaap_AwardTypeAxis_6a35a075-fe83-4b15-8c5e-fcb0e795c561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_75618368-f005-4624-8815-ec68c4181815" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6a35a075-fe83-4b15-8c5e-fcb0e795c561" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_75618368-f005-4624-8815-ec68c4181815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_8f56536d-5576-42fe-8e66-0213e6309ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_75618368-f005-4624-8815-ec68c4181815" xlink:to="loc_us-gaap_EmployeeStockOptionMember_8f56536d-5576-42fe-8e66-0213e6309ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_LtppMember_c266e1e6-aa4b-43ec-9775-4784621731ff" xlink:href="a-20230131.xsd#a_LtppMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_75618368-f005-4624-8815-ec68c4181815" xlink:to="loc_a_LtppMember_c266e1e6-aa4b-43ec-9775-4784621731ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_LTPPRSUMember_4e35d05a-1098-446e-bc68-3659e95d32ca" xlink:href="a-20230131.xsd#a_LTPPRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_75618368-f005-4624-8815-ec68c4181815" xlink:to="loc_a_LTPPRSUMember_4e35d05a-1098-446e-bc68-3659e95d32ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_046349fe-2a5d-4448-8e40-5670cbfbd456" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_02517ab0-d501-44f0-ada1-5953c2807176" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_046349fe-2a5d-4448-8e40-5670cbfbd456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_abbd902e-4cc3-4e4a-8108-b5a32a7adfa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_046349fe-2a5d-4448-8e40-5670cbfbd456" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_abbd902e-4cc3-4e4a-8108-b5a32a7adfa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_bf71b8bf-aea8-4ca6-9bc2-5605e18fae48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_046349fe-2a5d-4448-8e40-5670cbfbd456" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_bf71b8bf-aea8-4ca6-9bc2-5605e18fae48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_9854d29e-fdec-4a88-bc40-3db130dbc3ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_046349fe-2a5d-4448-8e40-5670cbfbd456" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_9854d29e-fdec-4a88-bc40-3db130dbc3ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_82e1253c-222d-4d0b-ac6d-d54de48935af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_046349fe-2a5d-4448-8e40-5670cbfbd456" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_82e1253c-222d-4d0b-ac6d-d54de48935af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_099c77b2-fa2f-4f1e-8cc9-e310bedf3a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_046349fe-2a5d-4448-8e40-5670cbfbd456" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_099c77b2-fa2f-4f1e-8cc9-e310bedf3a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum_a6e09fda-8e8f-40c9-a3b2-b207b776ceb7" xlink:href="a-20230131.xsd#a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_046349fe-2a5d-4448-8e40-5670cbfbd456" xlink:to="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum_a6e09fda-8e8f-40c9-a3b2-b207b776ceb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum_65c7b078-7e23-4398-a021-19d9a6579566" xlink:href="a-20230131.xsd#a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_046349fe-2a5d-4448-8e40-5670cbfbd456" xlink:to="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum_65c7b078-7e23-4398-a021-19d9a6579566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate_fcaf5e3d-947d-478a-845c-8599212cb717" xlink:href="a-20230131.xsd#a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_046349fe-2a5d-4448-8e40-5670cbfbd456" xlink:to="loc_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate_fcaf5e3d-947d-478a-845c-8599212cb717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions_601b5b49-5d98-4561-8c97-3fa3485d526e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_046349fe-2a5d-4448-8e40-5670cbfbd456" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions_601b5b49-5d98-4561-8c97-3fa3485d526e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="a-20230131.xsd#INCOMETAXESDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/INCOMETAXESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f2837918-2a38-48f1-b0c3-844fd0bc2353" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable_01d99ca7-6396-4d95-a235-04b9400feb0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f2837918-2a38-48f1-b0c3-844fd0bc2353" xlink:to="loc_us-gaap_IncomeTaxExaminationTable_01d99ca7-6396-4d95-a235-04b9400feb0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_4f621c3b-5ca3-4bb6-90b7-1ebfab6d0494" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_01d99ca7-6396-4d95-a235-04b9400feb0b" xlink:to="loc_srt_StatementScenarioAxis_4f621c3b-5ca3-4bb6-90b7-1ebfab6d0494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_46c83bfa-d841-4517-94d4-6d27d893b9de" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_4f621c3b-5ca3-4bb6-90b7-1ebfab6d0494" xlink:to="loc_srt_ScenarioUnspecifiedDomain_46c83bfa-d841-4517-94d4-6d27d893b9de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_d0643152-2692-45f0-ba4c-8bcdb023aa40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_01d99ca7-6396-4d95-a235-04b9400feb0b" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_d0643152-2692-45f0-ba4c-8bcdb023aa40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_ae37ba08-df0a-403f-b4e5-1f170e6d0a58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_d0643152-2692-45f0-ba4c-8bcdb023aa40" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_ae37ba08-df0a-403f-b4e5-1f170e6d0a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_71cad536-e10c-42e7-88a7-dde8967181d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_01d99ca7-6396-4d95-a235-04b9400feb0b" xlink:to="loc_us-gaap_TaxPeriodAxis_71cad536-e10c-42e7-88a7-dde8967181d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_0e05e3c9-6bb2-41d0-9c4f-90aa0fd3984f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_71cad536-e10c-42e7-88a7-dde8967181d5" xlink:to="loc_us-gaap_TaxPeriodDomain_0e05e3c9-6bb2-41d0-9c4f-90aa0fd3984f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_8173f530-9ae2-40ee-b76c-ef829c007940" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_01d99ca7-6396-4d95-a235-04b9400feb0b" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_8173f530-9ae2-40ee-b76c-ef829c007940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_f24fbc46-a40a-4c8a-b7f7-5b7dae5e70a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_8173f530-9ae2-40ee-b76c-ef829c007940" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_f24fbc46-a40a-4c8a-b7f7-5b7dae5e70a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems_1da36a4b-0609-4532-9daa-e3a34dd22cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_01d99ca7-6396-4d95-a235-04b9400feb0b" xlink:to="loc_us-gaap_IncomeTaxExaminationLineItems_1da36a4b-0609-4532-9daa-e3a34dd22cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7199b455-64d8-48e2-b854-fd31859f2f43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_1da36a4b-0609-4532-9daa-e3a34dd22cf8" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7199b455-64d8-48e2-b854-fd31859f2f43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5ed34251-b3a2-4d5c-87b3-7481fc133a30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_1da36a4b-0609-4532-9daa-e3a34dd22cf8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5ed34251-b3a2-4d5c-87b3-7481fc133a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_e18c9cf8-f9a5-4f0f-b73a-964df1cce259" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_1da36a4b-0609-4532-9daa-e3a34dd22cf8" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_e18c9cf8-f9a5-4f0f-b73a-964df1cce259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherTaxExpenseBenefit_8412d9ff-8c08-4ad5-bb95-a3b6dc2dcd2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_1da36a4b-0609-4532-9daa-e3a34dd22cf8" xlink:to="loc_us-gaap_OtherTaxExpenseBenefit_8412d9ff-8c08-4ad5-bb95-a3b6dc2dcd2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_48f2f794-8bb0-4259-bee2-9dfe5dac605b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_1da36a4b-0609-4532-9daa-e3a34dd22cf8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_48f2f794-8bb0-4259-bee2-9dfe5dac605b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_6fcda9c2-9b28-428e-9e9f-60d18dd2e97d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_1da36a4b-0609-4532-9daa-e3a34dd22cf8" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_6fcda9c2-9b28-428e-9e9f-60d18dd2e97d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_a3d03c55-82c9-4f73-b8d7-3909762c6a71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_1da36a4b-0609-4532-9daa-e3a34dd22cf8" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_a3d03c55-82c9-4f73-b8d7-3909762c6a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/NETINCOMEPERSHAREDetails" xlink:type="simple" xlink:href="a-20230131.xsd#NETINCOMEPERSHAREDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/NETINCOMEPERSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_3d3d6df8-ef90-44c5-9390-6e8df4aca94c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6186981f-872c-44e6-ab6c-434226a4f7bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3d3d6df8-ef90-44c5-9390-6e8df4aca94c" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6186981f-872c-44e6-ab6c-434226a4f7bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0e7c1aa1-41c2-48d5-ab7b-43550bcb1902" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6186981f-872c-44e6-ab6c-434226a4f7bd" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0e7c1aa1-41c2-48d5-ab7b-43550bcb1902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ee8c9e17-70fc-41a3-8f99-7856cfe2b19b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0e7c1aa1-41c2-48d5-ab7b-43550bcb1902" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ee8c9e17-70fc-41a3-8f99-7856cfe2b19b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_63fccf48-bfa9-4495-88b1-c4bcc5aed476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6186981f-872c-44e6-ab6c-434226a4f7bd" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_63fccf48-bfa9-4495-88b1-c4bcc5aed476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_NumeratorAbstract_3c42b501-8624-454a-8378-d56cc80b0a27" xlink:href="a-20230131.xsd#a_NumeratorAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_63fccf48-bfa9-4495-88b1-c4bcc5aed476" xlink:to="loc_a_NumeratorAbstract_3c42b501-8624-454a-8378-d56cc80b0a27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_54d61497-bf18-44cd-99dc-511b00976808" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_NumeratorAbstract_3c42b501-8624-454a-8378-d56cc80b0a27" xlink:to="loc_us-gaap_NetIncomeLoss_54d61497-bf18-44cd-99dc-511b00976808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_DenominatorsAbstract_f4d1e79b-380e-48be-b91b-efee56ca70a8" xlink:href="a-20230131.xsd#a_DenominatorsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_63fccf48-bfa9-4495-88b1-c4bcc5aed476" xlink:to="loc_a_DenominatorsAbstract_f4d1e79b-380e-48be-b91b-efee56ca70a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e4059ca6-3c93-4385-996d-5fe189d90bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DenominatorsAbstract_f4d1e79b-380e-48be-b91b-efee56ca70a8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e4059ca6-3c93-4385-996d-5fe189d90bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_af154a44-bdf3-4277-9f46-1dcf08a5a983" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DenominatorsAbstract_f4d1e79b-380e-48be-b91b-efee56ca70a8" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_af154a44-bdf3-4277-9f46-1dcf08a5a983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d23e6f29-0926-4c97-b594-82afa05241a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_DenominatorsAbstract_f4d1e79b-380e-48be-b91b-efee56ca70a8" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d23e6f29-0926-4c97-b594-82afa05241a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_98407524-c1fe-4287-b672-23d7e925b421" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_63fccf48-bfa9-4495-88b1-c4bcc5aed476" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_98407524-c1fe-4287-b672-23d7e925b421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/INVENTORYDetails" xlink:type="simple" xlink:href="a-20230131.xsd#INVENTORYDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/INVENTORYDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_51d79bb0-4945-4bf5-86f1-a12ee404ac10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_90d902d2-26a8-4bc8-b5f2-bd8deedba09c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_51d79bb0-4945-4bf5-86f1-a12ee404ac10" xlink:to="loc_us-gaap_InventoryFinishedGoods_90d902d2-26a8-4bc8-b5f2-bd8deedba09c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessAndRawMaterials_bbbdfc05-b092-45c5-8557-e2c9e2f2e579" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessAndRawMaterials"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_51d79bb0-4945-4bf5-86f1-a12ee404ac10" xlink:to="loc_us-gaap_InventoryWorkInProcessAndRawMaterials_bbbdfc05-b092-45c5-8557-e2c9e2f2e579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_db0a5136-2d58-4255-b5b5-dc20a9f910fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_51d79bb0-4945-4bf5-86f1-a12ee404ac10" xlink:to="loc_us-gaap_InventoryNet_db0a5136-2d58-4255-b5b5-dc20a9f910fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails" xlink:type="simple" xlink:href="a-20230131.xsd#GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_382da0d2-ce9a-4a40-b7b5-060542c675d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_93bca2d8-5489-47db-b8f1-a5310c59bab9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_382da0d2-ce9a-4a40-b7b5-060542c675d2" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_93bca2d8-5489-47db-b8f1-a5310c59bab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b3ce5177-44cd-483e-9b09-d9f49140c050" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_93bca2d8-5489-47db-b8f1-a5310c59bab9" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b3ce5177-44cd-483e-9b09-d9f49140c050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_150fe108-06e9-467f-bdda-9cc4a6615fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b3ce5177-44cd-483e-9b09-d9f49140c050" xlink:to="loc_us-gaap_SegmentDomain_150fe108-06e9-467f-bdda-9cc4a6615fa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_LifeSciencesandAppliedMarketsMember_c738d04e-9b24-4713-b84b-0b83a0085de2" xlink:href="a-20230131.xsd#a_LifeSciencesandAppliedMarketsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_150fe108-06e9-467f-bdda-9cc4a6615fa6" xlink:to="loc_a_LifeSciencesandAppliedMarketsMember_c738d04e-9b24-4713-b84b-0b83a0085de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_DiagnosticsAndGenomicsMember_63193f3e-9289-40df-a364-1deaec484894" xlink:href="a-20230131.xsd#a_DiagnosticsAndGenomicsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_150fe108-06e9-467f-bdda-9cc4a6615fa6" xlink:to="loc_a_DiagnosticsAndGenomicsMember_63193f3e-9289-40df-a364-1deaec484894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AgilentCrossLabMember_3b11f172-9c41-4484-aa27-f12d7e1e79f4" xlink:href="a-20230131.xsd#a_AgilentCrossLabMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_150fe108-06e9-467f-bdda-9cc4a6615fa6" xlink:to="loc_a_AgilentCrossLabMember_3b11f172-9c41-4484-aa27-f12d7e1e79f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_cd33ec50-fde8-493a-9595-e8e61a15871a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_93bca2d8-5489-47db-b8f1-a5310c59bab9" xlink:to="loc_us-gaap_GoodwillLineItems_cd33ec50-fde8-493a-9595-e8e61a15871a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_13340979-6ac7-4c8c-bafb-56df1ca966ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_cd33ec50-fde8-493a-9595-e8e61a15871a" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_13340979-6ac7-4c8c-bafb-56df1ca966ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_ccb3eaaf-01a9-4f29-91c7-a35ba56ccd2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_cd33ec50-fde8-493a-9595-e8e61a15871a" xlink:to="loc_us-gaap_GoodwillRollForward_ccb3eaaf-01a9-4f29-91c7-a35ba56ccd2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_c4a417ed-7684-4dbd-81ae-cb4beded168d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTransfers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_ccb3eaaf-01a9-4f29-91c7-a35ba56ccd2c" xlink:to="loc_us-gaap_GoodwillTransfers_c4a417ed-7684-4dbd-81ae-cb4beded168d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5e4bb75a-da80-4a72-b46c-83c2f76ea329" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_ccb3eaaf-01a9-4f29-91c7-a35ba56ccd2c" xlink:to="loc_us-gaap_Goodwill_5e4bb75a-da80-4a72-b46c-83c2f76ea329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_09e74e34-d7db-420f-a2e4-ee2da1155834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_ccb3eaaf-01a9-4f29-91c7-a35ba56ccd2c" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_09e74e34-d7db-420f-a2e4-ee2da1155834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_ef4ab1bf-bf8e-4585-9bd9-540c9484e8c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_ccb3eaaf-01a9-4f29-91c7-a35ba56ccd2c" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_ef4ab1bf-bf8e-4585-9bd9-540c9484e8c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b7f3641a-9054-469a-a38a-4a4951384bfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_ccb3eaaf-01a9-4f29-91c7-a35ba56ccd2c" xlink:to="loc_us-gaap_Goodwill_b7f3641a-9054-469a-a38a-4a4951384bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails" xlink:type="simple" xlink:href="a-20230131.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_61f19430-d1a5-4657-b7df-8e4634790a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a1184269-23a7-4958-ad30-4442088de7c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_61f19430-d1a5-4657-b7df-8e4634790a5d" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a1184269-23a7-4958-ad30-4442088de7c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e586da5d-f8ae-4a43-9374-3899adf6f948" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a1184269-23a7-4958-ad30-4442088de7c5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e586da5d-f8ae-4a43-9374-3899adf6f948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_738fe835-91a7-4cc6-8658-009ec475c66b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e586da5d-f8ae-4a43-9374-3899adf6f948" xlink:to="loc_us-gaap_SegmentDomain_738fe835-91a7-4cc6-8658-009ec475c66b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7988cf4f-cf49-4058-b7ff-379cf547f175" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a1184269-23a7-4958-ad30-4442088de7c5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7988cf4f-cf49-4058-b7ff-379cf547f175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4005404b-3b27-4d29-8b68-9c8831d88cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7988cf4f-cf49-4058-b7ff-379cf547f175" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4005404b-3b27-4d29-8b68-9c8831d88cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_c05b3a44-3376-4c98-b908-7e91ab933b96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4005404b-3b27-4d29-8b68-9c8831d88cc7" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_c05b3a44-3376-4c98-b908-7e91ab933b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_40a91433-54b2-49e2-972e-caa5096f3c08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4005404b-3b27-4d29-8b68-9c8831d88cc7" xlink:to="loc_us-gaap_TrademarksMember_40a91433-54b2-49e2-972e-caa5096f3c08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_f578dcb0-53b6-409c-ae05-93ff167fc79f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4005404b-3b27-4d29-8b68-9c8831d88cc7" xlink:to="loc_us-gaap_CustomerRelationshipsMember_f578dcb0-53b6-409c-ae05-93ff167fc79f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_e889a9fb-ebc6-4dd8-9bdf-38074e23885c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4005404b-3b27-4d29-8b68-9c8831d88cc7" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_e889a9fb-ebc6-4dd8-9bdf-38074e23885c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ThirdPartyTechnologyandLicensesMember_7a55b7a2-c16b-4485-85e5-ee939b1ae799" xlink:href="a-20230131.xsd#a_ThirdPartyTechnologyandLicensesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4005404b-3b27-4d29-8b68-9c8831d88cc7" xlink:to="loc_a_ThirdPartyTechnologyandLicensesMember_7a55b7a2-c16b-4485-85e5-ee939b1ae799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_1c5cf302-5d9f-4040-8691-7a14255b6e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4005404b-3b27-4d29-8b68-9c8831d88cc7" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_1c5cf302-5d9f-4040-8691-7a14255b6e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a7e2cec9-d864-4825-8980-5d843f83f1b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a1184269-23a7-4958-ad30-4442088de7c5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a7e2cec9-d864-4825-8980-5d843f83f1b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_e55bdb1d-6690-4460-a716-2ffb21ea3cea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a7e2cec9-d864-4825-8980-5d843f83f1b1" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_e55bdb1d-6690-4460-a716-2ffb21ea3cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_9cf5398e-1ab1-457a-8599-14f93aed136d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a7e2cec9-d864-4825-8980-5d843f83f1b1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_9cf5398e-1ab1-457a-8599-14f93aed136d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d15192cc-1f2c-4b90-838e-c2ae6b9fc4e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_9cf5398e-1ab1-457a-8599-14f93aed136d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d15192cc-1f2c-4b90-838e-c2ae6b9fc4e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_b39b72d4-cb66-4f4f-8887-c039835748ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_9cf5398e-1ab1-457a-8599-14f93aed136d" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_b39b72d4-cb66-4f4f-8887-c039835748ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c32a9aea-7854-443f-a507-4dae04fb5464" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_9cf5398e-1ab1-457a-8599-14f93aed136d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c32a9aea-7854-443f-a507-4dae04fb5464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_85f820ef-202a-411a-876e-8027ebd4b90f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_9cf5398e-1ab1-457a-8599-14f93aed136d" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_85f820ef-202a-411a-876e-8027ebd4b90f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f4d90abb-919d-410b-81f1-dc21c8912273" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_9cf5398e-1ab1-457a-8599-14f93aed136d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f4d90abb-919d-410b-81f1-dc21c8912273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_bb14d1d2-0e26-48b4-82a8-1fd8d63f4717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a7e2cec9-d864-4825-8980-5d843f83f1b1" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_bb14d1d2-0e26-48b4-82a8-1fd8d63f4717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_e9904a3a-451c-4911-9414-e24c1cabca0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_bb14d1d2-0e26-48b4-82a8-1fd8d63f4717" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_e9904a3a-451c-4911-9414-e24c1cabca0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails" xlink:type="simple" xlink:href="a-20230131.xsd#GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_619acbd7-bd05-4614-918f-c9d14eac51ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb889e99-e97e-4b7d-90f6-1fd043a5b4a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_619acbd7-bd05-4614-918f-c9d14eac51ba" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb889e99-e97e-4b7d-90f6-1fd043a5b4a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_46e4260d-08b2-42ed-bdf7-9cacc0afa5b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb889e99-e97e-4b7d-90f6-1fd043a5b4a5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_46e4260d-08b2-42ed-bdf7-9cacc0afa5b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b92d9f60-45da-4097-8c10-4807d46aa3a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_46e4260d-08b2-42ed-bdf7-9cacc0afa5b9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b92d9f60-45da-4097-8c10-4807d46aa3a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ResolutionBioscienceIncMember_4ba386c1-18fe-41f1-ae85-bc91a53e9733" xlink:href="a-20230131.xsd#a_ResolutionBioscienceIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b92d9f60-45da-4097-8c10-4807d46aa3a7" xlink:to="loc_a_ResolutionBioscienceIncMember_4ba386c1-18fe-41f1-ae85-bc91a53e9733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4aae9f8a-59ac-4641-81f0-982e3711cdf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb889e99-e97e-4b7d-90f6-1fd043a5b4a5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4aae9f8a-59ac-4641-81f0-982e3711cdf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3eaa4c90-4a5d-4980-aaa0-8d36b5fbb5f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4aae9f8a-59ac-4641-81f0-982e3711cdf7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3eaa4c90-4a5d-4980-aaa0-8d36b5fbb5f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ThirdPartyTechnologyandLicensesMember_716cabe8-f381-4e8c-9b71-e849f137a80d" xlink:href="a-20230131.xsd#a_ThirdPartyTechnologyandLicensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3eaa4c90-4a5d-4980-aaa0-8d36b5fbb5f0" xlink:to="loc_a_ThirdPartyTechnologyandLicensesMember_716cabe8-f381-4e8c-9b71-e849f137a80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d3d406ec-4902-4cf0-9dae-f16cd97a86ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb889e99-e97e-4b7d-90f6-1fd043a5b4a5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d3d406ec-4902-4cf0-9dae-f16cd97a86ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_47cfebda-6579-4a34-868d-7b43b8d57e25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d3d406ec-4902-4cf0-9dae-f16cd97a86ba" xlink:to="loc_us-gaap_SegmentDomain_47cfebda-6579-4a34-868d-7b43b8d57e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_LifeSciencesandAppliedMarketsMember_5128cf24-be0f-4943-928d-137b54df36bf" xlink:href="a-20230131.xsd#a_LifeSciencesandAppliedMarketsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_47cfebda-6579-4a34-868d-7b43b8d57e25" xlink:to="loc_a_LifeSciencesandAppliedMarketsMember_5128cf24-be0f-4943-928d-137b54df36bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_DiagnosticsAndGenomicsMember_c9b0a672-7e83-4f1a-a365-b53e8c835411" xlink:href="a-20230131.xsd#a_DiagnosticsAndGenomicsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_47cfebda-6579-4a34-868d-7b43b8d57e25" xlink:to="loc_a_DiagnosticsAndGenomicsMember_c9b0a672-7e83-4f1a-a365-b53e8c835411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AgilentCrossLabMember_6b8947d8-3ca9-4417-a4b9-a4b1cee4a14b" xlink:href="a-20230131.xsd#a_AgilentCrossLabMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_47cfebda-6579-4a34-868d-7b43b8d57e25" xlink:to="loc_a_AgilentCrossLabMember_6b8947d8-3ca9-4417-a4b9-a4b1cee4a14b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7984b533-ca51-4c4a-878b-f0e3b9a22b99" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb889e99-e97e-4b7d-90f6-1fd043a5b4a5" xlink:to="loc_srt_RangeAxis_7984b533-ca51-4c4a-878b-f0e3b9a22b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fe8283a9-6058-4759-989f-8e9e21a957bc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7984b533-ca51-4c4a-878b-f0e3b9a22b99" xlink:to="loc_srt_RangeMember_fe8283a9-6058-4759-989f-8e9e21a957bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_124ebfe7-34e3-49a0-ba05-56c4a900b2f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb889e99-e97e-4b7d-90f6-1fd043a5b4a5" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_124ebfe7-34e3-49a0-ba05-56c4a900b2f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_db70bb36-c94a-403b-98d4-789885efa0cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_124ebfe7-34e3-49a0-ba05-56c4a900b2f9" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_db70bb36-c94a-403b-98d4-789885efa0cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_7c60efbb-f769-4551-a1c7-8ca34d2f04a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_db70bb36-c94a-403b-98d4-789885efa0cf" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_7c60efbb-f769-4551-a1c7-8ca34d2f04a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_95dd621c-aeff-49ab-b7f1-dfd10cd146c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_db70bb36-c94a-403b-98d4-789885efa0cf" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_95dd621c-aeff-49ab-b7f1-dfd10cd146c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillMember_604dbebb-8f61-4a22-845f-a25037445a9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_db70bb36-c94a-403b-98d4-789885efa0cf" xlink:to="loc_us-gaap_GoodwillMember_604dbebb-8f61-4a22-845f-a25037445a9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_84777d73-dd99-40ef-9a33-f8b7a64f9621" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_db70bb36-c94a-403b-98d4-789885efa0cf" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_84777d73-dd99-40ef-9a33-f8b7a64f9621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6efc5bad-b172-43ef-ba49-a061c1dd0ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb889e99-e97e-4b7d-90f6-1fd043a5b4a5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6efc5bad-b172-43ef-ba49-a061c1dd0ae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_339449c9-a4ce-4e2f-8f98-14cae2004217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6efc5bad-b172-43ef-ba49-a061c1dd0ae2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_339449c9-a4ce-4e2f-8f98-14cae2004217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1884754d-cb32-4316-ba21-a24e70961e99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_339449c9-a4ce-4e2f-8f98-14cae2004217" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1884754d-cb32-4316-ba21-a24e70961e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1a71ceb7-9320-4e00-b962-e418a7a8f1c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb889e99-e97e-4b7d-90f6-1fd043a5b4a5" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1a71ceb7-9320-4e00-b962-e418a7a8f1c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_07d6ec15-2f01-4430-8402-7b06f47b0e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1a71ceb7-9320-4e00-b962-e418a7a8f1c8" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_07d6ec15-2f01-4430-8402-7b06f47b0e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_5179e080-92f7-4c08-83c3-8653e19a7ae3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_07d6ec15-2f01-4430-8402-7b06f47b0e7c" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_5179e080-92f7-4c08-83c3-8653e19a7ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4edd8bc6-c97a-4396-86bc-268e2ba1375f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb889e99-e97e-4b7d-90f6-1fd043a5b4a5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4edd8bc6-c97a-4396-86bc-268e2ba1375f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_45968a97-f4b1-46f1-b422-59a8061d058b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4edd8bc6-c97a-4396-86bc-268e2ba1375f" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_45968a97-f4b1-46f1-b422-59a8061d058b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_9b4ba8e3-5a6d-4952-be96-e78c251c36c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4edd8bc6-c97a-4396-86bc-268e2ba1375f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_9b4ba8e3-5a6d-4952-be96-e78c251c36c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_cdb4223e-326e-4185-b140-850e1dcddae8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4edd8bc6-c97a-4396-86bc-268e2ba1375f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_cdb4223e-326e-4185-b140-850e1dcddae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_168abfc0-f720-47c3-a75e-8430ad68d9c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4edd8bc6-c97a-4396-86bc-268e2ba1375f" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_168abfc0-f720-47c3-a75e-8430ad68d9c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_deacf6d7-d3fa-4b7d-b36a-13ff74afe0cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4edd8bc6-c97a-4396-86bc-268e2ba1375f" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_deacf6d7-d3fa-4b7d-b36a-13ff74afe0cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_1553c0b1-3ebd-4d57-8243-b1bf3a348ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4edd8bc6-c97a-4396-86bc-268e2ba1375f" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_1553c0b1-3ebd-4d57-8243-b1bf3a348ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimatedFutureAmortizationDetails" xlink:type="simple" xlink:href="a-20230131.xsd#GOODWILLANDOTHERINTANGIBLEASSETSEstimatedFutureAmortizationDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimatedFutureAmortizationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5b7fae1f-434e-472c-9df4-5486b47dc11b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_3bc2226e-e3e3-4d9c-98cb-7f805e72806c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5b7fae1f-434e-472c-9df4-5486b47dc11b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_3bc2226e-e3e3-4d9c-98cb-7f805e72806c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_6bb2051f-6b4e-4198-9dbb-a5d3df580046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5b7fae1f-434e-472c-9df4-5486b47dc11b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_6bb2051f-6b4e-4198-9dbb-a5d3df580046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_692339d9-8929-406f-b366-3c47536926d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5b7fae1f-434e-472c-9df4-5486b47dc11b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_692339d9-8929-406f-b366-3c47536926d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_820cedf9-eeff-4e59-84db-fa7ff98509a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5b7fae1f-434e-472c-9df4-5486b47dc11b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_820cedf9-eeff-4e59-84db-fa7ff98509a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_9750d261-d66b-4609-bb4f-be153c9b4780" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5b7fae1f-434e-472c-9df4-5486b47dc11b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_9750d261-d66b-4609-bb4f-be153c9b4780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_77a45ff9-a03b-4951-8670-5552ee7c74cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5b7fae1f-434e-472c-9df4-5486b47dc11b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_77a45ff9-a03b-4951-8670-5552ee7c74cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_dbfeccbf-96bc-4dc4-a15b-0716929f40f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5b7fae1f-434e-472c-9df4-5486b47dc11b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_dbfeccbf-96bc-4dc4-a15b-0716929f40f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails" xlink:type="simple" xlink:href="a-20230131.xsd#FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b2182cbd-411a-42c0-b3bd-80cdbd4cac50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4f6aa856-3829-4c82-ae05-d6e04db9c8ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b2182cbd-411a-42c0-b3bd-80cdbd4cac50" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4f6aa856-3829-4c82-ae05-d6e04db9c8ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_01d19258-fe62-42a5-8aad-33e999759ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4f6aa856-3829-4c82-ae05-d6e04db9c8ed" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_01d19258-fe62-42a5-8aad-33e999759ee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_7af6a877-cfa7-4c25-9d64-23c1716850bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_01d19258-fe62-42a5-8aad-33e999759ee0" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_7af6a877-cfa7-4c25-9d64-23c1716850bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_be578c9a-a50b-481c-b72b-daf4e42c4609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_7af6a877-cfa7-4c25-9d64-23c1716850bb" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_be578c9a-a50b-481c-b72b-daf4e42c4609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_c0c2b6bb-d846-4f47-968e-083415bf9210" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_7af6a877-cfa7-4c25-9d64-23c1716850bb" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_c0c2b6bb-d846-4f47-968e-083415bf9210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2301a47b-d155-4765-8b75-497cd0ea1588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4f6aa856-3829-4c82-ae05-d6e04db9c8ed" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2301a47b-d155-4765-8b75-497cd0ea1588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_72a09061-85c9-43d6-bbb2-e3a042b07fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2301a47b-d155-4765-8b75-497cd0ea1588" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_72a09061-85c9-43d6-bbb2-e3a042b07fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_149577f2-f734-4372-929c-6e8620994d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_72a09061-85c9-43d6-bbb2-e3a042b07fcd" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_149577f2-f734-4372-929c-6e8620994d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_b617ac3d-850f-4028-8e76-fbd55e645c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_72a09061-85c9-43d6-bbb2-e3a042b07fcd" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_b617ac3d-850f-4028-8e76-fbd55e645c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_9aa09973-9613-4f82-a4c3-73d7ad2ee0ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_72a09061-85c9-43d6-bbb2-e3a042b07fcd" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_9aa09973-9613-4f82-a4c3-73d7ad2ee0ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_b64172b0-5480-49af-a954-e4d96b38c019" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4f6aa856-3829-4c82-ae05-d6e04db9c8ed" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_b64172b0-5480-49af-a954-e4d96b38c019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_640ac2ce-1a5b-4f6e-b3ec-11d330da7eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b64172b0-5480-49af-a954-e4d96b38c019" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_640ac2ce-1a5b-4f6e-b3ec-11d330da7eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_32bd2bbf-6ba6-424a-937a-efe8c47b1bd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_640ac2ce-1a5b-4f6e-b3ec-11d330da7eb0" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_32bd2bbf-6ba6-424a-937a-efe8c47b1bd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_32266d61-c894-427f-83ba-fe42855bc9df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_640ac2ce-1a5b-4f6e-b3ec-11d330da7eb0" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_32266d61-c894-427f-83ba-fe42855bc9df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_2a68a538-bf5b-4988-9884-ec5f4b92719c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_640ac2ce-1a5b-4f6e-b3ec-11d330da7eb0" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_2a68a538-bf5b-4988-9884-ec5f4b92719c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_e0083339-3375-49fd-9e11-7ea11a79d6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_640ac2ce-1a5b-4f6e-b3ec-11d330da7eb0" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_e0083339-3375-49fd-9e11-7ea11a79d6d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3182e62a-c320-4fa0-a795-1fde7694fd12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4f6aa856-3829-4c82-ae05-d6e04db9c8ed" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3182e62a-c320-4fa0-a795-1fde7694fd12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_64f07390-0233-4d06-a0fd-62ea952d47da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3182e62a-c320-4fa0-a795-1fde7694fd12" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_64f07390-0233-4d06-a0fd-62ea952d47da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ResolutionBioscienceIncMember_0524fbf1-8fb4-4ec0-9005-cb3fef2069d3" xlink:href="a-20230131.xsd#a_ResolutionBioscienceIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_64f07390-0233-4d06-a0fd-62ea952d47da" xlink:to="loc_a_ResolutionBioscienceIncMember_0524fbf1-8fb4-4ec0-9005-cb3fef2069d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_bc517c9c-94a3-421e-b52b-77b7cdb1b690" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4f6aa856-3829-4c82-ae05-d6e04db9c8ed" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_bc517c9c-94a3-421e-b52b-77b7cdb1b690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_d050d45f-ea86-4684-98d7-829004c34856" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_bc517c9c-94a3-421e-b52b-77b7cdb1b690" xlink:to="loc_us-gaap_AssetsCurrentAbstract_d050d45f-ea86-4684-98d7-829004c34856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_5eb4eb20-83ac-48cd-8f2e-c058cdc915a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d050d45f-ea86-4684-98d7-829004c34856" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_5eb4eb20-83ac-48cd-8f2e-c058cdc915a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_0383bd87-29c3-4b86-ab44-3bda65fd0cab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d050d45f-ea86-4684-98d7-829004c34856" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_0383bd87-29c3-4b86-ab44-3bda65fd0cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_09351d1f-3d7d-485b-bc2b-59db5c3b7dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d050d45f-ea86-4684-98d7-829004c34856" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_09351d1f-3d7d-485b-bc2b-59db5c3b7dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_839c9a01-b33e-4a5e-b59b-18ac1b8efac4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d050d45f-ea86-4684-98d7-829004c34856" xlink:to="loc_us-gaap_TradingSecurities_839c9a01-b33e-4a5e-b59b-18ac1b8efac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_9e6e4e7f-f8ef-4115-ad72-01ab908e0a13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d050d45f-ea86-4684-98d7-829004c34856" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_9e6e4e7f-f8ef-4115-ad72-01ab908e0a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_ecc75e7c-a511-47f5-8fa5-6844878e92cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d050d45f-ea86-4684-98d7-829004c34856" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_ecc75e7c-a511-47f5-8fa5-6844878e92cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_4b665f80-50fd-4e43-b0e8-57d68f1312b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_bc517c9c-94a3-421e-b52b-77b7cdb1b690" xlink:to="loc_us-gaap_LiabilitiesAbstract_4b665f80-50fd-4e43-b0e8-57d68f1312b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_e9ff949f-ff94-4c92-968b-d646d7fb4bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4b665f80-50fd-4e43-b0e8-57d68f1312b0" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_e9ff949f-ff94-4c92-968b-d646d7fb4bbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_efac87b3-07c5-4de5-984c-a32b9c918fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4b665f80-50fd-4e43-b0e8-57d68f1312b0" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_efac87b3-07c5-4de5-984c-a32b9c918fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_cd068813-f89c-4160-ac8a-345c983d3d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4b665f80-50fd-4e43-b0e8-57d68f1312b0" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_cd068813-f89c-4160-ac8a-345c983d3d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_ff2e4982-f85d-461a-943b-1493fd43e5b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4b665f80-50fd-4e43-b0e8-57d68f1312b0" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_ff2e4982-f85d-461a-943b-1493fd43e5b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSEquitySecuritiesandInvestmentsDetails" xlink:type="simple" xlink:href="a-20230131.xsd#FAIRVALUEMEASUREMENTSEquitySecuritiesandInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSEquitySecuritiesandInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_9390cb2c-1602-4593-9395-2320d218378c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_b5d3574f-0c4c-4fe1-9a74-0a4eac633436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9390cb2c-1602-4593-9395-2320d218378c" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_b5d3574f-0c4c-4fe1-9a74-0a4eac633436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_0a1c286b-4389-47d7-95e0-75b74050918d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9390cb2c-1602-4593-9395-2320d218378c" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_0a1c286b-4389-47d7-95e0-75b74050918d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_92065855-8b9c-4aa7-9f70-14db764fdb99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9390cb2c-1602-4593-9395-2320d218378c" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_92065855-8b9c-4aa7-9f70-14db764fdb99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfInvestments_a95f4d30-34a6-42b2-b74d-05c7169bdf06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9390cb2c-1602-4593-9395-2320d218378c" xlink:to="loc_us-gaap_ImpairmentOfInvestments_a95f4d30-34a6-42b2-b74d-05c7169bdf06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails" xlink:type="simple" xlink:href="a-20230131.xsd#FAIRVALUEMEASUREMENTSContingentConsiderationDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_48b56a52-c559-4de4-b98f-81f915b0bd07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_4a0307e5-8784-450c-8c0c-2660dcdf7cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_48b56a52-c559-4de4-b98f-81f915b0bd07" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_4a0307e5-8784-450c-8c0c-2660dcdf7cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_61e8e4e3-ae98-447c-9b16-2371bc2edde0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_4a0307e5-8784-450c-8c0c-2660dcdf7cc6" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_61e8e4e3-ae98-447c-9b16-2371bc2edde0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_430de3f0-13d2-438b-8883-7b57d1a9fc25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_61e8e4e3-ae98-447c-9b16-2371bc2edde0" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_430de3f0-13d2-438b-8883-7b57d1a9fc25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_MeasurementInputAssetVolatilityMember_4745b25d-d6ce-46cf-99db-0d7dfa4e3e57" xlink:href="a-20230131.xsd#a_MeasurementInputAssetVolatilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_430de3f0-13d2-438b-8883-7b57d1a9fc25" xlink:to="loc_a_MeasurementInputAssetVolatilityMember_4745b25d-d6ce-46cf-99db-0d7dfa4e3e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_MeasurementInputRevenueVolatilityMember_d410f783-c194-4ed1-a6b4-a79cb30e865d" xlink:href="a-20230131.xsd#a_MeasurementInputRevenueVolatilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_430de3f0-13d2-438b-8883-7b57d1a9fc25" xlink:to="loc_a_MeasurementInputRevenueVolatilityMember_d410f783-c194-4ed1-a6b4-a79cb30e865d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a0cd06ec-2728-4463-9406-dcf5422a4a59" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_4a0307e5-8784-450c-8c0c-2660dcdf7cc6" xlink:to="loc_srt_RangeAxis_a0cd06ec-2728-4463-9406-dcf5422a4a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fe19d175-92db-4408-b06e-f81695ffa0f0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a0cd06ec-2728-4463-9406-dcf5422a4a59" xlink:to="loc_srt_RangeMember_fe19d175-92db-4408-b06e-f81695ffa0f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8597322a-5dfe-420b-91aa-795d8f43a1ee" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fe19d175-92db-4408-b06e-f81695ffa0f0" xlink:to="loc_srt_MinimumMember_8597322a-5dfe-420b-91aa-795d8f43a1ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f3a8d9af-4f8d-409b-8569-6fd87dde64c9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fe19d175-92db-4408-b06e-f81695ffa0f0" xlink:to="loc_srt_MaximumMember_f3a8d9af-4f8d-409b-8569-6fd87dde64c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_85ea2f47-64aa-436a-b921-8b429f7fd83e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_4a0307e5-8784-450c-8c0c-2660dcdf7cc6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_85ea2f47-64aa-436a-b921-8b429f7fd83e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e20ef69d-d3fe-45e9-af39-97bef66beb71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_85ea2f47-64aa-436a-b921-8b429f7fd83e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e20ef69d-d3fe-45e9-af39-97bef66beb71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_ResolutionBioscienceIncMember_247b6778-caa3-4462-a598-b3bb98d9dd5d" xlink:href="a-20230131.xsd#a_ResolutionBioscienceIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e20ef69d-d3fe-45e9-af39-97bef66beb71" xlink:to="loc_a_ResolutionBioscienceIncMember_247b6778-caa3-4462-a598-b3bb98d9dd5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8bc2d897-6bcd-4f71-8f79-ace25817129d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_4a0307e5-8784-450c-8c0c-2660dcdf7cc6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8bc2d897-6bcd-4f71-8f79-ace25817129d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_44b1df12-684c-4bfd-8f02-afad67058a47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8bc2d897-6bcd-4f71-8f79-ace25817129d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_44b1df12-684c-4bfd-8f02-afad67058a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_32631c88-2856-4948-8777-2029a7471df9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_44b1df12-684c-4bfd-8f02-afad67058a47" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_32631c88-2856-4948-8777-2029a7471df9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_347463e7-ada7-428c-a717-630aea5f4da5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_4a0307e5-8784-450c-8c0c-2660dcdf7cc6" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_347463e7-ada7-428c-a717-630aea5f4da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_58ed73d7-079c-4874-83c5-4a26fe840eae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_347463e7-ada7-428c-a717-630aea5f4da5" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_58ed73d7-079c-4874-83c5-4a26fe840eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_622b3470-5fd2-4c05-8709-5016df99fb0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_58ed73d7-079c-4874-83c5-4a26fe840eae" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_622b3470-5fd2-4c05-8709-5016df99fb0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis_74afc693-cd17-4254-9e54-d496da0d8809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_4a0307e5-8784-450c-8c0c-2660dcdf7cc6" xlink:to="loc_us-gaap_OtherCommitmentsAxis_74afc693-cd17-4254-9e54-d496da0d8809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_ad47f341-8c53-46a1-bda8-b1bef40a76e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsAxis_74afc693-cd17-4254-9e54-d496da0d8809" xlink:to="loc_us-gaap_OtherCommitmentsDomain_ad47f341-8c53-46a1-bda8-b1bef40a76e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_RevenueComponentMember_d4b9470a-49bf-4490-a865-be5892acf28e" xlink:href="a-20230131.xsd#a_RevenueComponentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_ad47f341-8c53-46a1-bda8-b1bef40a76e1" xlink:to="loc_a_RevenueComponentMember_d4b9470a-49bf-4490-a865-be5892acf28e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_fa98bc74-d87f-45bf-96c1-5d622c70a802" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_4a0307e5-8784-450c-8c0c-2660dcdf7cc6" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_fa98bc74-d87f-45bf-96c1-5d622c70a802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_BusinessCombinationContingentConsiderationFairValueMeasurementInput_e637f1f0-7c0b-4197-8069-1c87ef071173" xlink:href="a-20230131.xsd#a_BusinessCombinationContingentConsiderationFairValueMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_fa98bc74-d87f-45bf-96c1-5d622c70a802" xlink:to="loc_a_BusinessCombinationContingentConsiderationFairValueMeasurementInput_e637f1f0-7c0b-4197-8069-1c87ef071173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2b25fa80-784c-4192-8482-328eb4297223" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_fa98bc74-d87f-45bf-96c1-5d622c70a802" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2b25fa80-784c-4192-8482-328eb4297223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_BusinessCombinationsContingentConsiderationArrangements_6d18870e-7691-4c02-8baa-0d189122be50" xlink:href="a-20230131.xsd#a_BusinessCombinationsContingentConsiderationArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_fa98bc74-d87f-45bf-96c1-5d622c70a802" xlink:to="loc_a_BusinessCombinationsContingentConsiderationArrangements_6d18870e-7691-4c02-8baa-0d189122be50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_44a2e2b8-748c-4500-903c-1b45c3205630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_fa98bc74-d87f-45bf-96c1-5d622c70a802" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_44a2e2b8-748c-4500-903c-1b45c3205630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_ca34b7c4-81be-4ba8-bdca-1fe3c897a585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_fa98bc74-d87f-45bf-96c1-5d622c70a802" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_ca34b7c4-81be-4ba8-bdca-1fe3c897a585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingLevel3ContingentConsiderationLiabilityDetails" xlink:type="simple" xlink:href="a-20230131.xsd#FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingLevel3ContingentConsiderationLiabilityDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingLevel3ContingentConsiderationLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b472cd52-fd77-4540-8805-ec3195cfdcbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_57f6aae6-fd3b-46fa-a936-265c4bf52e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b472cd52-fd77-4540-8805-ec3195cfdcbc" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_57f6aae6-fd3b-46fa-a936-265c4bf52e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_4f9f508c-e1d9-44b1-b9ee-dcb1b8091b39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b472cd52-fd77-4540-8805-ec3195cfdcbc" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_4f9f508c-e1d9-44b1-b9ee-dcb1b8091b39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_ea2b98e2-d09b-44ae-b0d2-d8734d765a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b472cd52-fd77-4540-8805-ec3195cfdcbc" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_ea2b98e2-d09b-44ae-b0d2-d8734d765a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_d61477d1-91bb-43f2-88ac-b77811099b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b472cd52-fd77-4540-8805-ec3195cfdcbc" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_d61477d1-91bb-43f2-88ac-b77811099b9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_5be3f3f2-b1a5-469c-8c80-d01987d98460" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b472cd52-fd77-4540-8805-ec3195cfdcbc" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_5be3f3f2-b1a5-469c-8c80-d01987d98460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails" xlink:type="simple" xlink:href="a-20230131.xsd#FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b4ec25f3-9f6f-4043-90c4-e7aeb505bf03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f1376376-2562-487e-88d2-de16fab1612c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b4ec25f3-9f6f-4043-90c4-e7aeb505bf03" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f1376376-2562-487e-88d2-de16fab1612c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2ddfcd99-5446-4b5f-bc12-e174f1e1a2a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f1376376-2562-487e-88d2-de16fab1612c" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2ddfcd99-5446-4b5f-bc12-e174f1e1a2a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_31694529-3eda-4a67-a5f2-066352807fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2ddfcd99-5446-4b5f-bc12-e174f1e1a2a8" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_31694529-3eda-4a67-a5f2-066352807fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_ee23d01b-ac21-4bf0-af11-172c6ad1f7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_31694529-3eda-4a67-a5f2-066352807fc1" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_ee23d01b-ac21-4bf0-af11-172c6ad1f7f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_b7dbb6dd-725d-49cb-9d39-5cc238f80387" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_31694529-3eda-4a67-a5f2-066352807fc1" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_b7dbb6dd-725d-49cb-9d39-5cc238f80387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4f5b34ba-5550-44d2-9676-3f82f24dc813" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f1376376-2562-487e-88d2-de16fab1612c" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4f5b34ba-5550-44d2-9676-3f82f24dc813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c39dade1-5668-4aca-9dbf-d40c103aacd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4f5b34ba-5550-44d2-9676-3f82f24dc813" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c39dade1-5668-4aca-9dbf-d40c103aacd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_a5a09f9f-6259-495a-8a11-3ac9fbd1d166" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f1376376-2562-487e-88d2-de16fab1612c" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_a5a09f9f-6259-495a-8a11-3ac9fbd1d166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_8d913d43-1a22-4f02-98f4-d8f6a513f538" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_a5a09f9f-6259-495a-8a11-3ac9fbd1d166" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_8d913d43-1a22-4f02-98f4-d8f6a513f538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_MeasurementInputAssetVolatilityMember_02fb86cc-acb1-4cfd-898b-07045521df44" xlink:href="a-20230131.xsd#a_MeasurementInputAssetVolatilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_8d913d43-1a22-4f02-98f4-d8f6a513f538" xlink:to="loc_a_MeasurementInputAssetVolatilityMember_02fb86cc-acb1-4cfd-898b-07045521df44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_MeasurementInputRevenueVolatilityMember_c6762e6a-fc06-478b-90c6-43b0a3da634e" xlink:href="a-20230131.xsd#a_MeasurementInputRevenueVolatilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_8d913d43-1a22-4f02-98f4-d8f6a513f538" xlink:to="loc_a_MeasurementInputRevenueVolatilityMember_c6762e6a-fc06-478b-90c6-43b0a3da634e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1b950d3a-d3b4-4557-9b44-d1e224a351db" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f1376376-2562-487e-88d2-de16fab1612c" xlink:to="loc_srt_RangeAxis_1b950d3a-d3b4-4557-9b44-d1e224a351db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5ab44180-0057-4984-bf1f-e313e6fc941c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1b950d3a-d3b4-4557-9b44-d1e224a351db" xlink:to="loc_srt_RangeMember_5ab44180-0057-4984-bf1f-e313e6fc941c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_21a9940e-cb97-4a43-b03b-014a0851af37" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5ab44180-0057-4984-bf1f-e313e6fc941c" xlink:to="loc_srt_MinimumMember_21a9940e-cb97-4a43-b03b-014a0851af37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_beed125a-b314-47ca-9a43-334ce57736fc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5ab44180-0057-4984-bf1f-e313e6fc941c" xlink:to="loc_srt_MaximumMember_beed125a-b314-47ca-9a43-334ce57736fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c45d9ff0-f28c-4a7d-961d-40cd7a6dbf69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f1376376-2562-487e-88d2-de16fab1612c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c45d9ff0-f28c-4a7d-961d-40cd7a6dbf69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AssetsLongLivedAbstract_66bd4a7c-a1bf-41dd-b289-dfdfd6650880" xlink:href="a-20230131.xsd#a_AssetsLongLivedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c45d9ff0-f28c-4a7d-961d-40cd7a6dbf69" xlink:to="loc_a_AssetsLongLivedAbstract_66bd4a7c-a1bf-41dd-b289-dfdfd6650880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_6650caae-6634-4775-b6be-8f3cf39bf856" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_AssetsLongLivedAbstract_66bd4a7c-a1bf-41dd-b289-dfdfd6650880" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_6650caae-6634-4775-b6be-8f3cf39bf856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset_1ce41ff6-314c-4cf9-9fba-fb39e2d53e75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_AssetsLongLivedAbstract_66bd4a7c-a1bf-41dd-b289-dfdfd6650880" xlink:to="loc_us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset_1ce41ff6-314c-4cf9-9fba-fb39e2d53e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure_2f2b8551-546b-469b-a856-f732b23dca79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_AssetsLongLivedAbstract_66bd4a7c-a1bf-41dd-b289-dfdfd6650880" xlink:to="loc_us-gaap_OtherAssetsFairValueDisclosure_2f2b8551-546b-469b-a856-f732b23dca79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_3f632ae4-c062-48b3-bd8c-160f149fd606" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_AssetsLongLivedAbstract_66bd4a7c-a1bf-41dd-b289-dfdfd6650880" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_3f632ae4-c062-48b3-bd8c-160f149fd606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSNonMarketableSecuritiesDetails" xlink:type="simple" xlink:href="a-20230131.xsd#FAIRVALUEMEASUREMENTSNonMarketableSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/FAIRVALUEMEASUREMENTSNonMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1e315aa9-40c7-4b0a-ba9c-3f2a7b547e59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_d1149e78-ae5e-435f-b5da-008b16c67250" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1e315aa9-40c7-4b0a-ba9c-3f2a7b547e59" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_d1149e78-ae5e-435f-b5da-008b16c67250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_53ff34e7-bc8f-4113-a279-79f5a96e86ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1e315aa9-40c7-4b0a-ba9c-3f2a7b547e59" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_53ff34e7-bc8f-4113-a279-79f5a96e86ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_023b6b1e-3479-4e04-9066-8313eda7deaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1e315aa9-40c7-4b0a-ba9c-3f2a7b547e59" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_023b6b1e-3479-4e04-9066-8313eda7deaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_a3362688-2847-4330-92bf-f2b530a69076" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1e315aa9-40c7-4b0a-ba9c-3f2a7b547e59" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_a3362688-2847-4330-92bf-f2b530a69076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_03c9937d-0f61-4fa6-9d86-50a00a19c65e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1e315aa9-40c7-4b0a-ba9c-3f2a7b547e59" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_03c9937d-0f61-4fa6-9d86-50a00a19c65e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_2207879e-48cc-4e01-8a33-344455268e23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1e315aa9-40c7-4b0a-ba9c-3f2a7b547e59" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_2207879e-48cc-4e01-8a33-344455268e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/DERIVATIVESTextDetails" xlink:type="simple" xlink:href="a-20230131.xsd#DERIVATIVESTextDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/DERIVATIVESTextDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_735e8891-f1d2-4dbe-a717-87c65166d4cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_6f9534f2-8634-4b14-bb5e-99a39e2c93b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_735e8891-f1d2-4dbe-a717-87c65166d4cc" xlink:to="loc_us-gaap_DerivativeTable_6f9534f2-8634-4b14-bb5e-99a39e2c93b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_29f9ba18-d820-4ad7-8bd0-9dee4342799f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_6f9534f2-8634-4b14-bb5e-99a39e2c93b6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_29f9ba18-d820-4ad7-8bd0-9dee4342799f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_fe285ab8-6d7a-4d71-af00-217a8c3193de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_29f9ba18-d820-4ad7-8bd0-9dee4342799f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_fe285ab8-6d7a-4d71-af00-217a8c3193de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6cb523d1-14ec-4831-82b9-4effd21a8d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_fe285ab8-6d7a-4d71-af00-217a8c3193de" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6cb523d1-14ec-4831-82b9-4effd21a8d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cc96c3d0-12a0-40ea-8572-318b3514ce40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_6f9534f2-8634-4b14-bb5e-99a39e2c93b6" xlink:to="loc_us-gaap_DebtInstrumentAxis_cc96c3d0-12a0-40ea-8572-318b3514ce40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_bc38e492-13f7-46d8-89a7-afbae6e8ec39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_cc96c3d0-12a0-40ea-8572-318b3514ce40" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_bc38e492-13f7-46d8-89a7-afbae6e8ec39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2022Member_3adf72c5-3898-41e4-ab0b-21a46f26154b" xlink:href="a-20230131.xsd#a_SeniorNotes2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bc38e492-13f7-46d8-89a7-afbae6e8ec39" xlink:to="loc_a_SeniorNotes2022Member_3adf72c5-3898-41e4-ab0b-21a46f26154b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2026Member_3065ca4c-8630-4305-880b-51a6b35c45bc" xlink:href="a-20230131.xsd#a_SeniorNotes2026Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bc38e492-13f7-46d8-89a7-afbae6e8ec39" xlink:to="loc_a_SeniorNotes2026Member_3065ca4c-8630-4305-880b-51a6b35c45bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2029Member_8c9ea29e-0834-4fda-86a5-9ea822ddf1f6" xlink:href="a-20230131.xsd#a_SeniorNotes2029Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bc38e492-13f7-46d8-89a7-afbae6e8ec39" xlink:to="loc_a_SeniorNotes2029Member_8c9ea29e-0834-4fda-86a5-9ea822ddf1f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a1490b10-35fa-496e-a3b1-170ff95cf26f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_6f9534f2-8634-4b14-bb5e-99a39e2c93b6" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a1490b10-35fa-496e-a3b1-170ff95cf26f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_10d66351-b81a-4272-869e-0f1b3f187dca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a1490b10-35fa-496e-a3b1-170ff95cf26f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_10d66351-b81a-4272-869e-0f1b3f187dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_bcf71108-e0c5-4e61-84cf-3e43b1ba846c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_10d66351-b81a-4272-869e-0f1b3f187dca" xlink:to="loc_us-gaap_InterestRateSwapMember_bcf71108-e0c5-4e61-84cf-3e43b1ba846c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember_3fd55753-a071-476d-915d-19d05a2ea211" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryLockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_10d66351-b81a-4272-869e-0f1b3f187dca" xlink:to="loc_us-gaap_TreasuryLockMember_3fd55753-a071-476d-915d-19d05a2ea211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_a63f3cb2-cb5f-41f0-8df1-25adc74cd3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_10d66351-b81a-4272-869e-0f1b3f187dca" xlink:to="loc_us-gaap_ForeignExchangeContractMember_a63f3cb2-cb5f-41f0-8df1-25adc74cd3f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_a229b078-f763-4d96-b3a0-27426936d960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_6f9534f2-8634-4b14-bb5e-99a39e2c93b6" xlink:to="loc_us-gaap_HedgingDesignationAxis_a229b078-f763-4d96-b3a0-27426936d960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f9d913a3-b374-4b2f-9f35-6d98a797abe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_a229b078-f763-4d96-b3a0-27426936d960" xlink:to="loc_us-gaap_HedgingDesignationDomain_f9d913a3-b374-4b2f-9f35-6d98a797abe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_67c4d160-36bc-4c96-8519-1ba690ea3ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_f9d913a3-b374-4b2f-9f35-6d98a797abe2" xlink:to="loc_us-gaap_NondesignatedMember_67c4d160-36bc-4c96-8519-1ba690ea3ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_efab03ee-f5d7-49c5-a716-9b68daba9bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_f9d913a3-b374-4b2f-9f35-6d98a797abe2" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_efab03ee-f5d7-49c5-a716-9b68daba9bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_940c0378-0a57-48d6-8ad9-b1daebba2a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_6f9534f2-8634-4b14-bb5e-99a39e2c93b6" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_940c0378-0a57-48d6-8ad9-b1daebba2a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_06b950ef-1bf3-47b6-bd2b-33e79ec457ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_940c0378-0a57-48d6-8ad9-b1daebba2a2a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_06b950ef-1bf3-47b6-bd2b-33e79ec457ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_62dceae4-b17a-473a-b743-92e8aba5c973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_06b950ef-1bf3-47b6-bd2b-33e79ec457ec" xlink:to="loc_us-gaap_CashFlowHedgingMember_62dceae4-b17a-473a-b743-92e8aba5c973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_3d180562-c098-4867-8f2b-5393254b5077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_06b950ef-1bf3-47b6-bd2b-33e79ec457ec" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_3d180562-c098-4867-8f2b-5393254b5077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_6f0ee95a-2ea6-47e7-b09c-91a4e7cbcf58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_6f9534f2-8634-4b14-bb5e-99a39e2c93b6" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_6f0ee95a-2ea6-47e7-b09c-91a4e7cbcf58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_da3a1753-21af-4435-984e-87863d7402d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6f0ee95a-2ea6-47e7-b09c-91a4e7cbcf58" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_da3a1753-21af-4435-984e-87863d7402d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_4a099e88-7b3e-4aff-86f5-b55df1777eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_da3a1753-21af-4435-984e-87863d7402d9" xlink:to="loc_us-gaap_CostOfSalesMember_4a099e88-7b3e-4aff-86f5-b55df1777eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_2bc3e7ce-24f2-4138-a6bf-c464bba53faf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_6f9534f2-8634-4b14-bb5e-99a39e2c93b6" xlink:to="loc_us-gaap_DerivativeLineItems_2bc3e7ce-24f2-4138-a6bf-c464bba53faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentDetailAbstract_8437287f-916e-41ee-8801-c352844ad513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentDetailAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_2bc3e7ce-24f2-4138-a6bf-c464bba53faf" xlink:to="loc_us-gaap_DerivativeInstrumentDetailAbstract_8437287f-916e-41ee-8801-c352844ad513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue_7a48aadb-761f-4990-90b8-a4a7d98af48b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNetLiabilityPositionAggregateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_8437287f-916e-41ee-8801-c352844ad513" xlink:to="loc_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue_7a48aadb-761f-4990-90b8-a4a7d98af48b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativesAbstract_6f079fce-a2b2-4fce-ace6-77a6746edcd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateDerivativesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_8437287f-916e-41ee-8801-c352844ad513" xlink:to="loc_us-gaap_InterestRateDerivativesAbstract_6f079fce-a2b2-4fce-ace6-77a6746edcd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_05db7c1d-d764-4f0e-a4ff-153c0445c3f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateDerivativesAbstract_6f079fce-a2b2-4fce-ace6-77a6746edcd2" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_05db7c1d-d764-4f0e-a4ff-153c0445c3f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_2ad02e3f-b50f-44a4-8854-06c1c245524f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateDerivativesAbstract_6f079fce-a2b2-4fce-ace6-77a6746edcd2" xlink:to="loc_us-gaap_DerivativeNotionalAmount_2ad02e3f-b50f-44a4-8854-06c1c245524f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_bb3b3bcd-ee58-4bad-a39b-1e0319a57eea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateDerivativesAbstract_6f079fce-a2b2-4fce-ace6-77a6746edcd2" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_bb3b3bcd-ee58-4bad-a39b-1e0319a57eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_1f98b57c-33f7-4cbf-bb09-a02527bef59b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_8437287f-916e-41ee-8801-c352844ad513" xlink:to="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_1f98b57c-33f7-4cbf-bb09-a02527bef59b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_990e5cce-6ede-44a5-bc0b-e103f81d440e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract_1f98b57c-33f7-4cbf-bb09-a02527bef59b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_990e5cce-6ede-44a5-bc0b-e103f81d440e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails" xlink:type="simple" xlink:href="a-20230131.xsd#DERIVATIVESForeignExchangeForwardContractsDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5c2e4321-c7d6-4d20-b309-38bf8008ad6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_6eaeb69b-487a-4c02-bb99-c9f404f2b67b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5c2e4321-c7d6-4d20-b309-38bf8008ad6e" xlink:to="loc_us-gaap_DerivativeTable_6eaeb69b-487a-4c02-bb99-c9f404f2b67b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_7f490b60-519a-469b-ac4a-baa94de8295c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_6eaeb69b-487a-4c02-bb99-c9f404f2b67b" xlink:to="loc_us-gaap_PositionAxis_7f490b60-519a-469b-ac4a-baa94de8295c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_9ca18f85-66e8-48a4-87ab-ab7a7454c78a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionAxis_7f490b60-519a-469b-ac4a-baa94de8295c" xlink:to="loc_us-gaap_PositionDomain_9ca18f85-66e8-48a4-87ab-ab7a7454c78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_b75084a6-2f33-4fe2-b632-a933f7b760a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_9ca18f85-66e8-48a4-87ab-ab7a7454c78a" xlink:to="loc_us-gaap_ShortMember_b75084a6-2f33-4fe2-b632-a933f7b760a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_e807c88c-e870-42d4-86b0-58f949e380bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_9ca18f85-66e8-48a4-87ab-ab7a7454c78a" xlink:to="loc_us-gaap_LongMember_e807c88c-e870-42d4-86b0-58f949e380bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d0001185-e2f3-481a-9e20-513dd0e68034" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_6eaeb69b-487a-4c02-bb99-c9f404f2b67b" xlink:to="loc_us-gaap_HedgingDesignationAxis_d0001185-e2f3-481a-9e20-513dd0e68034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5d2d388a-a9fa-48ed-85bd-906fcff28fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_d0001185-e2f3-481a-9e20-513dd0e68034" xlink:to="loc_us-gaap_HedgingDesignationDomain_5d2d388a-a9fa-48ed-85bd-906fcff28fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_50aec329-55c7-4e33-8dd5-0f0fe452e5ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_5d2d388a-a9fa-48ed-85bd-906fcff28fe5" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_50aec329-55c7-4e33-8dd5-0f0fe452e5ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_9a988378-d1b6-41de-b39b-74a33aafc04a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_5d2d388a-a9fa-48ed-85bd-906fcff28fe5" xlink:to="loc_us-gaap_NondesignatedMember_9a988378-d1b6-41de-b39b-74a33aafc04a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dcb6be5f-be71-4072-b08e-0226581d9e23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_6eaeb69b-487a-4c02-bb99-c9f404f2b67b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dcb6be5f-be71-4072-b08e-0226581d9e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_bc3e6b5e-229e-4ade-a5da-464faf45c997" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dcb6be5f-be71-4072-b08e-0226581d9e23" xlink:to="loc_us-gaap_HedgingRelationshipDomain_bc3e6b5e-229e-4ade-a5da-464faf45c997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_c5e1a057-5580-43c0-902d-5c31539b3291" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_bc3e6b5e-229e-4ade-a5da-464faf45c997" xlink:to="loc_us-gaap_CashFlowHedgingMember_c5e1a057-5580-43c0-902d-5c31539b3291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_84f91ebf-98f8-4b5b-a4d4-6e56cc074923" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_bc3e6b5e-229e-4ade-a5da-464faf45c997" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_84f91ebf-98f8-4b5b-a4d4-6e56cc074923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_87062dc0-2f2b-4225-9cec-ec082e7d87d6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_6eaeb69b-487a-4c02-bb99-c9f404f2b67b" xlink:to="loc_srt_CurrencyAxis_87062dc0-2f2b-4225-9cec-ec082e7d87d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_87062dc0-2f2b-4225-9cec-ec082e7d87d6" xlink:to="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_e61563e8-2c3d-4854-b27e-8fdf36a8779c" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_EUR_e61563e8-2c3d-4854-b27e-8fdf36a8779c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_GBP_1dbcd7bb-248b-4d8f-875f-8b5cedc5df64" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_GBP"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_GBP_1dbcd7bb-248b-4d8f-875f-8b5cedc5df64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CAD_2c772452-e0fe-4cc8-8dc5-ac5bf12ef198" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_CAD_2c772452-e0fe-4cc8-8dc5-ac5bf12ef198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AUD_8ca38c56-c5bb-4c70-ba63-be43147929e3" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AUD"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_AUD_8ca38c56-c5bb-4c70-ba63-be43147929e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_MYR_91e87bac-d445-4df0-adb1-bc84f597857f" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_MYR"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_MYR_91e87bac-d445-4df0-adb1-bc84f597857f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_11ef2d31-a2b3-460c-9972-2e4a6e7ef5b5" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_JPY"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_JPY_11ef2d31-a2b3-460c-9972-2e4a6e7ef5b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_DKK_b2214cee-fc8b-42ce-887f-6fc1fe1c2527" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_DKK"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_DKK_b2214cee-fc8b-42ce-887f-6fc1fe1c2527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_KRW_3e5f7f13-f1e4-4279-a9f3-c54797faaca8" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_KRW"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_KRW_3e5f7f13-f1e4-4279-a9f3-c54797faaca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SGD_bb8756d8-b6e6-4145-9c7a-f9df022aa34c" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_SGD"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_SGD_bb8756d8-b6e6-4145-9c7a-f9df022aa34c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CHF_b0e32315-3411-454a-8a89-9c1475a3b1dd" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CHF"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_CHF_b0e32315-3411-454a-8a89-9c1475a3b1dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CNY_296ae53e-e1b7-433a-883a-4493e0ccbafc" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CNY"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_CNY_296ae53e-e1b7-433a-883a-4493e0ccbafc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_PLN_d710a9af-29c6-471b-818c-001aef70d454" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_PLN"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_PLN_d710a9af-29c6-471b-818c-001aef70d454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SEK_a2bc97fc-d5a7-4a60-84dc-492103f78eb5" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_SEK"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_SEK_a2bc97fc-d5a7-4a60-84dc-492103f78eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_TWD_78e7de62-b2de-4732-b603-44cc08fe271b" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_TWD"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_TWD_78e7de62-b2de-4732-b603-44cc08fe271b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_INR_2eeab7a9-eddd-4e12-a7f7-5f82fee48d23" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_INR"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_INR_2eeab7a9-eddd-4e12-a7f7-5f82fee48d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_XXX_d5ad1c57-14cf-4277-ba7c-beb226837291" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_XXX"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_XXX_d5ad1c57-14cf-4277-ba7c-beb226837291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_BRL_e72f5b65-03a8-4a63-a34a-83326ecf901e" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_BRL"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_BRL_e72f5b65-03a8-4a63-a34a-83326ecf901e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_THB_d1509a03-75cb-4c0a-9775-60f5bdc76a6a" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_THB"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_6771226a-2e29-4f28-b69e-3d2ef36ea73c" xlink:to="loc_currency_THB_d1509a03-75cb-4c0a-9775-60f5bdc76a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8ef28e43-0965-4916-b587-56ccb555e789" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_6eaeb69b-487a-4c02-bb99-c9f404f2b67b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8ef28e43-0965-4916-b587-56ccb555e789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3f4a8358-75cb-49fd-a57b-a57418a2723b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8ef28e43-0965-4916-b587-56ccb555e789" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3f4a8358-75cb-49fd-a57b-a57418a2723b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_601c1566-3c7e-4f4b-8ba0-ae8337e9fc84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3f4a8358-75cb-49fd-a57b-a57418a2723b" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_601c1566-3c7e-4f4b-8ba0-ae8337e9fc84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_971f0dda-2b9e-4e92-aa3d-2fa1cff74cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3f4a8358-75cb-49fd-a57b-a57418a2723b" xlink:to="loc_us-gaap_ForwardContractsMember_971f0dda-2b9e-4e92-aa3d-2fa1cff74cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_93de76bb-796e-4092-b290-b10e075c8879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_6eaeb69b-487a-4c02-bb99-c9f404f2b67b" xlink:to="loc_us-gaap_DerivativeLineItems_93de76bb-796e-4092-b290-b10e075c8879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfForeignCurrencyDerivativesHeld_f909a0ba-e0ee-4deb-b4d3-b1da3a6b32de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfForeignCurrencyDerivativesHeld"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_93de76bb-796e-4092-b290-b10e075c8879" xlink:to="loc_us-gaap_NumberOfForeignCurrencyDerivativesHeld_f909a0ba-e0ee-4deb-b4d3-b1da3a6b32de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_0e76e02f-bd5d-4691-a8f8-1df44bc8fdff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_93de76bb-796e-4092-b290-b10e075c8879" xlink:to="loc_us-gaap_DerivativeNotionalAmount_0e76e02f-bd5d-4691-a8f8-1df44bc8fdff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails" xlink:type="simple" xlink:href="a-20230131.xsd#DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_15fdb3e2-9b86-43dc-a4e8-4768becfe064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_8f8571ae-0dbe-4b31-980d-7320b6ae0450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_15fdb3e2-9b86-43dc-a4e8-4768becfe064" xlink:to="loc_us-gaap_DerivativeTable_8f8571ae-0dbe-4b31-980d-7320b6ae0450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_088adda2-49a5-438a-9c8e-b4d4a081fff5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_8f8571ae-0dbe-4b31-980d-7320b6ae0450" xlink:to="loc_us-gaap_HedgingDesignationAxis_088adda2-49a5-438a-9c8e-b4d4a081fff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5d3e3912-b9e3-4d88-9908-df0ddae4dbb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_088adda2-49a5-438a-9c8e-b4d4a081fff5" xlink:to="loc_us-gaap_HedgingDesignationDomain_5d3e3912-b9e3-4d88-9908-df0ddae4dbb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_85b79475-5152-409d-bece-754aef43dc5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_5d3e3912-b9e3-4d88-9908-df0ddae4dbb5" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_85b79475-5152-409d-bece-754aef43dc5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_e92a6a2c-9900-416d-9c25-9a07418b385e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_5d3e3912-b9e3-4d88-9908-df0ddae4dbb5" xlink:to="loc_us-gaap_NondesignatedMember_e92a6a2c-9900-416d-9c25-9a07418b385e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_49997d45-d012-4d5d-ae7c-e2013b50d984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_8f8571ae-0dbe-4b31-980d-7320b6ae0450" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_49997d45-d012-4d5d-ae7c-e2013b50d984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_9dfe3053-4ea0-4e15-b333-ab52c933b53d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_49997d45-d012-4d5d-ae7c-e2013b50d984" xlink:to="loc_us-gaap_HedgingRelationshipDomain_9dfe3053-4ea0-4e15-b333-ab52c933b53d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_18c6194b-9c45-4132-be64-8660207c5be3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_9dfe3053-4ea0-4e15-b333-ab52c933b53d" xlink:to="loc_us-gaap_CashFlowHedgingMember_18c6194b-9c45-4132-be64-8660207c5be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_f8f4c3e6-aaad-4930-a53a-448e6f4ef8ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_9dfe3053-4ea0-4e15-b333-ab52c933b53d" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_f8f4c3e6-aaad-4930-a53a-448e6f4ef8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_eeb654f2-1593-4328-adee-d94e38de888d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_8f8571ae-0dbe-4b31-980d-7320b6ae0450" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_eeb654f2-1593-4328-adee-d94e38de888d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a7fe962d-7b80-44a6-b830-174689602c33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_eeb654f2-1593-4328-adee-d94e38de888d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a7fe962d-7b80-44a6-b830-174689602c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_859a79b2-9630-48ac-b310-133bd7aed300" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a7fe962d-7b80-44a6-b830-174689602c33" xlink:to="loc_us-gaap_ForeignExchangeContractMember_859a79b2-9630-48ac-b310-133bd7aed300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_b65ee456-7ee9-47db-94f1-1adc731e990a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a7fe962d-7b80-44a6-b830-174689602c33" xlink:to="loc_us-gaap_InterestRateSwapMember_b65ee456-7ee9-47db-94f1-1adc731e990a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_74c26d17-c396-4f4e-8a96-5a1b03542fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_8f8571ae-0dbe-4b31-980d-7320b6ae0450" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_74c26d17-c396-4f4e-8a96-5a1b03542fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b606f63c-7edd-4ef9-b2db-3de8b22f7fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_74c26d17-c396-4f4e-8a96-5a1b03542fbf" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b606f63c-7edd-4ef9-b2db-3de8b22f7fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_c9693561-997d-4425-93d1-2784315e3d20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b606f63c-7edd-4ef9-b2db-3de8b22f7fbd" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_c9693561-997d-4425-93d1-2784315e3d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_da4a65ba-a06d-40a5-bf68-05051e45d082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCurrentAssetsMember_c9693561-997d-4425-93d1-2784315e3d20" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_da4a65ba-a06d-40a5-bf68-05051e45d082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_0f869b82-6277-40dc-a1e8-52f0301337c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_8f8571ae-0dbe-4b31-980d-7320b6ae0450" xlink:to="loc_us-gaap_DerivativeLineItems_0f869b82-6277-40dc-a1e8-52f0301337c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNetAbstract_7c783173-93c6-4e08-83b5-58fa13d20f76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0f869b82-6277-40dc-a1e8-52f0301337c3" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNetAbstract_7c783173-93c6-4e08-83b5-58fa13d20f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_1661e6b1-36e6-4faf-91ce-2866daf20d48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNetAbstract_7c783173-93c6-4e08-83b5-58fa13d20f76" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_1661e6b1-36e6-4faf-91ce-2866daf20d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_1621b4eb-2df6-45b1-b6fa-3fb6f372c31c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNetAbstract_7c783173-93c6-4e08-83b5-58fa13d20f76" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_1621b4eb-2df6-45b1-b6fa-3fb6f372c31c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails" xlink:type="simple" xlink:href="a-20230131.xsd#DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5926aba7-4363-4ca9-b889-9bc5a5ee75e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_d2e0914d-d184-4be8-9598-a8ec22ab34f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5926aba7-4363-4ca9-b889-9bc5a5ee75e3" xlink:to="loc_us-gaap_DerivativeTable_d2e0914d-d184-4be8-9598-a8ec22ab34f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_7e2ca9cd-d4f6-4061-adb8-35a2f4e9e743" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d2e0914d-d184-4be8-9598-a8ec22ab34f4" xlink:to="loc_us-gaap_HedgingDesignationAxis_7e2ca9cd-d4f6-4061-adb8-35a2f4e9e743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b7f2fdc0-8153-45cb-9937-3a696e75ac7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_7e2ca9cd-d4f6-4061-adb8-35a2f4e9e743" xlink:to="loc_us-gaap_HedgingDesignationDomain_b7f2fdc0-8153-45cb-9937-3a696e75ac7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_214933ed-72e7-4a76-9313-558e5e45afd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_b7f2fdc0-8153-45cb-9937-3a696e75ac7c" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_214933ed-72e7-4a76-9313-558e5e45afd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_a254c171-59fc-40b3-a898-96c589be3c06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_b7f2fdc0-8153-45cb-9937-3a696e75ac7c" xlink:to="loc_us-gaap_NondesignatedMember_a254c171-59fc-40b3-a898-96c589be3c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b52f0c59-7481-49e5-97ad-2ec813b1ff59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d2e0914d-d184-4be8-9598-a8ec22ab34f4" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b52f0c59-7481-49e5-97ad-2ec813b1ff59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_4992944f-e650-4d76-8770-87ec476eb746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b52f0c59-7481-49e5-97ad-2ec813b1ff59" xlink:to="loc_us-gaap_HedgingRelationshipDomain_4992944f-e650-4d76-8770-87ec476eb746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_dce57877-26d9-418c-acf9-d64e0d5d9063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_4992944f-e650-4d76-8770-87ec476eb746" xlink:to="loc_us-gaap_CashFlowHedgingMember_dce57877-26d9-418c-acf9-d64e0d5d9063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_ab47b20b-02c3-44b5-82cc-ccfa1c82ffe1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_4992944f-e650-4d76-8770-87ec476eb746" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_ab47b20b-02c3-44b5-82cc-ccfa1c82ffe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_413da1b1-303c-43c5-b34e-298945067d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d2e0914d-d184-4be8-9598-a8ec22ab34f4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_413da1b1-303c-43c5-b34e-298945067d9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7ec12cff-14a2-4088-adb0-fa140f6e5c73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_413da1b1-303c-43c5-b34e-298945067d9a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7ec12cff-14a2-4088-adb0-fa140f6e5c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_95da3d57-9fa3-4d2e-89e1-3bd819236049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7ec12cff-14a2-4088-adb0-fa140f6e5c73" xlink:to="loc_us-gaap_ForeignExchangeContractMember_95da3d57-9fa3-4d2e-89e1-3bd819236049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_39d65710-ba5d-4c0e-94fb-e3ff2e1fd681" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d2e0914d-d184-4be8-9598-a8ec22ab34f4" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_39d65710-ba5d-4c0e-94fb-e3ff2e1fd681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bd9d1bc5-ed0c-455d-9475-7abad742ded2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_39d65710-ba5d-4c0e-94fb-e3ff2e1fd681" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bd9d1bc5-ed0c-455d-9475-7abad742ded2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_a37b5cd0-aca2-4f9d-9c96-b84adf69b337" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bd9d1bc5-ed0c-455d-9475-7abad742ded2" xlink:to="loc_us-gaap_InterestExpenseMember_a37b5cd0-aca2-4f9d-9c96-b84adf69b337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_d29ba726-33da-4d35-a1a2-523164008231" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bd9d1bc5-ed0c-455d-9475-7abad742ded2" xlink:to="loc_us-gaap_CostOfSalesMember_d29ba726-33da-4d35-a1a2-523164008231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_d723c25b-e6cf-4087-80af-45f8c3f7676c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bd9d1bc5-ed0c-455d-9475-7abad742ded2" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_d723c25b-e6cf-4087-80af-45f8c3f7676c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_b20fcb37-bf59-46fb-8f9d-d5ca78c6dd22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d2e0914d-d184-4be8-9598-a8ec22ab34f4" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_b20fcb37-bf59-46fb-8f9d-d5ca78c6dd22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6e63799c-bd36-499c-a9cf-b24b6055b70a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b20fcb37-bf59-46fb-8f9d-d5ca78c6dd22" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6e63799c-bd36-499c-a9cf-b24b6055b70a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_72a287de-1336-43c7-b543-a3adfa4a6932" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6e63799c-bd36-499c-a9cf-b24b6055b70a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_72a287de-1336-43c7-b543-a3adfa4a6932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7509b270-c8b6-42bf-b7ab-98858e77f032" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d2e0914d-d184-4be8-9598-a8ec22ab34f4" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7509b270-c8b6-42bf-b7ab-98858e77f032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_361cac1f-2280-43b4-ac91-cc63a2cf36bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7509b270-c8b6-42bf-b7ab-98858e77f032" xlink:to="loc_us-gaap_EquityComponentDomain_361cac1f-2280-43b4-ac91-cc63a2cf36bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_74dc9194-aaa5-4556-9533-b6e90a3ff165" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_361cac1f-2280-43b4-ac91-cc63a2cf36bf" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_74dc9194-aaa5-4556-9533-b6e90a3ff165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_b7bbd356-7ac1-49a9-b04b-35900ff70aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d2e0914d-d184-4be8-9598-a8ec22ab34f4" xlink:to="loc_us-gaap_DerivativeLineItems_b7bbd356-7ac1-49a9-b04b-35900ff70aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_de57e240-8b34-4f19-aacb-f1b352fce0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b7bbd356-7ac1-49a9-b04b-35900ff70aa5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_de57e240-8b34-4f19-aacb-f1b352fce0a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_3d580188-a34e-4ed8-b084-ce743c93fcfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b7bbd356-7ac1-49a9-b04b-35900ff70aa5" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet_3d580188-a34e-4ed8-b084-ce743c93fcfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_f2322768-c098-4edc-aa1f-7657f6224ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b7bbd356-7ac1-49a9-b04b-35900ff70aa5" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_f2322768-c098-4edc-aa1f-7657f6224ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_747c7183-b14d-4edd-a8d6-1195d9f30358" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b7bbd356-7ac1-49a9-b04b-35900ff70aa5" xlink:to="loc_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_747c7183-b14d-4edd-a8d6-1195d9f30358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_61debfcc-33e5-4e4d-85b3-6f0d7da6fb20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b7bbd356-7ac1-49a9-b04b-35900ff70aa5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_61debfcc-33e5-4e4d-85b3-6f0d7da6fb20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_0a8f4728-7f0f-4af9-af85-0949ddd77f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b7bbd356-7ac1-49a9-b04b-35900ff70aa5" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_0a8f4728-7f0f-4af9-af85-0949ddd77f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_eccab5d0-6738-4be7-a464-3c648661f51b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b7bbd356-7ac1-49a9-b04b-35900ff70aa5" xlink:to="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_eccab5d0-6738-4be7-a464-3c648661f51b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/DerivativeInstrumentsandHedgingActivitiesDetails" xlink:type="simple" xlink:href="a-20230131.xsd#DerivativeInstrumentsandHedgingActivitiesDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/DerivativeInstrumentsandHedgingActivitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_759f72ae-2b42-459d-86bc-4f2cc173e3ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_895fafde-8aff-4555-93c5-f1b036c8f468" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_759f72ae-2b42-459d-86bc-4f2cc173e3ab" xlink:to="loc_us-gaap_DerivativeTable_895fafde-8aff-4555-93c5-f1b036c8f468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_58c050aa-9128-4b1b-993c-defe147981f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_895fafde-8aff-4555-93c5-f1b036c8f468" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_58c050aa-9128-4b1b-993c-defe147981f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_bf48b0fb-c154-4eda-9c4e-c9bc57f5c585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_58c050aa-9128-4b1b-993c-defe147981f7" xlink:to="loc_us-gaap_HedgingRelationshipDomain_bf48b0fb-c154-4eda-9c4e-c9bc57f5c585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_0bf81c38-7558-4e45-a982-f235f58ca4f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_bf48b0fb-c154-4eda-9c4e-c9bc57f5c585" xlink:to="loc_us-gaap_CashFlowHedgingMember_0bf81c38-7558-4e45-a982-f235f58ca4f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_5ea5e998-3e83-4958-bc2a-f9e6f33c8e79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_895fafde-8aff-4555-93c5-f1b036c8f468" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_5ea5e998-3e83-4958-bc2a-f9e6f33c8e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b5e03330-310c-4602-ab1b-2cd8c80d3248" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_5ea5e998-3e83-4958-bc2a-f9e6f33c8e79" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b5e03330-310c-4602-ab1b-2cd8c80d3248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_689b0b50-8e59-451c-8bac-b52cf1e86a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b5e03330-310c-4602-ab1b-2cd8c80d3248" xlink:to="loc_us-gaap_CostOfSalesMember_689b0b50-8e59-451c-8bac-b52cf1e86a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_e85141e5-e46f-40aa-9b93-98265ff4006f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_895fafde-8aff-4555-93c5-f1b036c8f468" xlink:to="loc_us-gaap_DerivativeLineItems_e85141e5-e46f-40aa-9b93-98265ff4006f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_b824bd76-98ff-4a1f-a253-c47d71fb10af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_e85141e5-e46f-40aa-9b93-98265ff4006f" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_b824bd76-98ff-4a1f-a253-c47d71fb10af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails" xlink:type="simple" xlink:href="a-20230131.xsd#RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ce9f4323-e136-4ee0-ac96-afd0d22c7b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_07ac8b37-bf17-4716-9518-40c4157cbbce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ce9f4323-e136-4ee0-ac96-afd0d22c7b4e" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_07ac8b37-bf17-4716-9518-40c4157cbbce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_b5c990c4-9a1a-4ce4-b59b-a895893f6bd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_07ac8b37-bf17-4716-9518-40c4157cbbce" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_b5c990c4-9a1a-4ce4-b59b-a895893f6bd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_624ba11c-49d8-4538-8123-59d3b53ac048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b5c990c4-9a1a-4ce4-b59b-a895893f6bd8" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_624ba11c-49d8-4538-8123-59d3b53ac048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_1062e343-6acc-4af9-b5f4-ddb03fd03392" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b5c990c4-9a1a-4ce4-b59b-a895893f6bd8" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_1062e343-6acc-4af9-b5f4-ddb03fd03392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPensionPlansDefinedBenefitMember_a1397afc-7539-4e5f-a408-b95033c55d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b5c990c4-9a1a-4ce4-b59b-a895893f6bd8" xlink:to="loc_us-gaap_OtherPensionPlansDefinedBenefitMember_a1397afc-7539-4e5f-a408-b95033c55d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_edd539f4-6fe6-49f6-a439-537ca61b3f76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ce9f4323-e136-4ee0-ac96-afd0d22c7b4e" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_edd539f4-6fe6-49f6-a439-537ca61b3f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_b8e8378e-05c5-4ac7-9918-c7a517381408" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_edd539f4-6fe6-49f6-a439-537ca61b3f76" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_b8e8378e-05c5-4ac7-9918-c7a517381408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_d417476c-389f-48b9-9617-030ce9d53d42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_b8e8378e-05c5-4ac7-9918-c7a517381408" xlink:to="loc_us-gaap_DomesticPlanMember_d417476c-389f-48b9-9617-030ce9d53d42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_39ff65b7-71a2-4e8b-9a77-a2597881f338" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_d417476c-389f-48b9-9617-030ce9d53d42" xlink:to="loc_country_US_39ff65b7-71a2-4e8b-9a77-a2597881f338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_6f7425d7-d3de-4384-a469-05751f421415" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_b8e8378e-05c5-4ac7-9918-c7a517381408" xlink:to="loc_us-gaap_ForeignPlanMember_6f7425d7-d3de-4384-a469-05751f421415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_49cddc31-1608-4f99-983d-9e05ec6e8078" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_DE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_6f7425d7-d3de-4384-a469-05751f421415" xlink:to="loc_country_DE_49cddc31-1608-4f99-983d-9e05ec6e8078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_c8c8e6a6-5ab1-4b43-bc28-d95c1bf7fca5" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_6f7425d7-d3de-4384-a469-05751f421415" xlink:to="loc_country_GB_c8c8e6a6-5ab1-4b43-bc28-d95c1bf7fca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_8215f8c9-d8dd-4d8c-bf44-2240cd4a6054" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_JP"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_6f7425d7-d3de-4384-a469-05751f421415" xlink:to="loc_country_JP_8215f8c9-d8dd-4d8c-bf44-2240cd4a6054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_NL_20b049d7-79db-42e2-8582-844146ff59fa" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_NL"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_6f7425d7-d3de-4384-a469-05751f421415" xlink:to="loc_country_NL_20b049d7-79db-42e2-8582-844146ff59fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_73cce696-9172-434c-9674-9960c6b635ea" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CH"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_6f7425d7-d3de-4384-a469-05751f421415" xlink:to="loc_country_CH_73cce696-9172-434c-9674-9960c6b635ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_3275d94d-9ce9-4cc7-9543-6fff0978f64d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ce9f4323-e136-4ee0-ac96-afd0d22c7b4e" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_3275d94d-9ce9-4cc7-9543-6fff0978f64d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_eb05ec20-c224-44b2-a08e-fbe788c280eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_3275d94d-9ce9-4cc7-9543-6fff0978f64d" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_eb05ec20-c224-44b2-a08e-fbe788c280eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8d539313-d6ae-4100-b842-ce07e158cc1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ce9f4323-e136-4ee0-ac96-afd0d22c7b4e" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8d539313-d6ae-4100-b842-ce07e158cc1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_723816d9-5d5d-4b60-b630-dba2d1ff9a10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8d539313-d6ae-4100-b842-ce07e158cc1a" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_723816d9-5d5d-4b60-b630-dba2d1ff9a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_18b46e27-d4b5-4cfd-878e-f7b26b784d19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_723816d9-5d5d-4b60-b630-dba2d1ff9a10" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_18b46e27-d4b5-4cfd-878e-f7b26b784d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_de164f36-98d3-47cc-867d-6008bb8d69fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_723816d9-5d5d-4b60-b630-dba2d1ff9a10" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_de164f36-98d3-47cc-867d-6008bb8d69fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_5583344e-0900-4342-83eb-029e309e3673" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_723816d9-5d5d-4b60-b630-dba2d1ff9a10" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_5583344e-0900-4342-83eb-029e309e3673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AmortizationAndDeferralsAbstract_9504def3-1a85-499a-8e62-389bc42d0809" xlink:href="a-20230131.xsd#a_AmortizationAndDeferralsAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_723816d9-5d5d-4b60-b630-dba2d1ff9a10" xlink:to="loc_a_AmortizationAndDeferralsAbstract_9504def3-1a85-499a-8e62-389bc42d0809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_d3439e5c-874c-443e-a1d3-c0274f80e2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_a_AmortizationAndDeferralsAbstract_9504def3-1a85-499a-8e62-389bc42d0809" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_d3439e5c-874c-443e-a1d3-c0274f80e2bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_e7c09087-7cb1-4487-845a-2d490b556f59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_723816d9-5d5d-4b60-b630-dba2d1ff9a10" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_e7c09087-7cb1-4487-845a-2d490b556f59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract_4819dd21-adcd-4dc6-91c8-20952c18506b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8d539313-d6ae-4100-b842-ce07e158cc1a" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract_4819dd21-adcd-4dc6-91c8-20952c18506b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_14f49e90-f96b-4aa0-972d-3d3057eff20f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract_4819dd21-adcd-4dc6-91c8-20952c18506b" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_14f49e90-f96b-4aa0-972d-3d3057eff20f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions" xlink:type="simple" xlink:href="a-20230131.xsd#RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_880fbafd-6867-4a50-b875-40f734e43255" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4c83f18d-6c48-4ba1-826d-e48254665ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract_880fbafd-6867-4a50-b875-40f734e43255" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4c83f18d-6c48-4ba1-826d-e48254665ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_a39eabf2-a957-493b-9fc8-66fd85c0ad29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4c83f18d-6c48-4ba1-826d-e48254665ae4" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_a39eabf2-a957-493b-9fc8-66fd85c0ad29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_1679bb3c-56ab-4d24-aeee-3476e35e108b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_a39eabf2-a957-493b-9fc8-66fd85c0ad29" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_1679bb3c-56ab-4d24-aeee-3476e35e108b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_55432c6a-1d16-4d6c-b100-fdff30c49cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_1679bb3c-56ab-4d24-aeee-3476e35e108b" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_55432c6a-1d16-4d6c-b100-fdff30c49cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_57a16a16-a13a-4d28-93c1-6afdfbc0a49e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_1679bb3c-56ab-4d24-aeee-3476e35e108b" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_57a16a16-a13a-4d28-93c1-6afdfbc0a49e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_c94c4f6c-aad3-4a67-a4c0-72e76f3925bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4c83f18d-6c48-4ba1-826d-e48254665ae4" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_c94c4f6c-aad3-4a67-a4c0-72e76f3925bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_819add44-0afc-45e7-9432-d0f8a29c9545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_c94c4f6c-aad3-4a67-a4c0-72e76f3925bf" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_819add44-0afc-45e7-9432-d0f8a29c9545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_2b9769d9-a077-48db-8d04-973c6a1fdecc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_819add44-0afc-45e7-9432-d0f8a29c9545" xlink:to="loc_us-gaap_DomesticPlanMember_2b9769d9-a077-48db-8d04-973c6a1fdecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_9e42b8c5-d593-493d-bc84-974b1424a98a" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_2b9769d9-a077-48db-8d04-973c6a1fdecc" xlink:to="loc_country_US_9e42b8c5-d593-493d-bc84-974b1424a98a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_07070fa4-9423-4121-9436-f937acab65e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_819add44-0afc-45e7-9432-d0f8a29c9545" xlink:to="loc_us-gaap_ForeignPlanMember_07070fa4-9423-4121-9436-f937acab65e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fcf5a777-9434-4e79-8c5e-67d15ff2201e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4c83f18d-6c48-4ba1-826d-e48254665ae4" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fcf5a777-9434-4e79-8c5e-67d15ff2201e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_ab8cf9d5-544e-4d18-83f1-5b2bc12605b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fcf5a777-9434-4e79-8c5e-67d15ff2201e" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_ab8cf9d5-544e-4d18-83f1-5b2bc12605b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_de586237-92dc-475c-b3c6-a1d79a338398" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fcf5a777-9434-4e79-8c5e-67d15ff2201e" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_de586237-92dc-475c-b3c6-a1d79a338398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="a-20230131.xsd#WARRANTIESANDCONTINGENCIESDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c619ce82-99a4-4ed4-ba0a-b6998d98b215" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_75a70e33-067a-43c0-905f-c40416c26ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c619ce82-99a4-4ed4-ba0a-b6998d98b215" xlink:to="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_75a70e33-067a-43c0-905f-c40416c26ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_8ef9a5cc-c36c-4573-8e55-61cb42377290" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_75a70e33-067a-43c0-905f-c40416c26ae4" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_8ef9a5cc-c36c-4573-8e55-61cb42377290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_9c75bab1-4487-4fa4-8ce8-f2b494bd3b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrualWarrantiesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_75a70e33-067a-43c0-905f-c40416c26ae4" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_9c75bab1-4487-4fa4-8ce8-f2b494bd3b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualPayments_fce51334-d01e-4b92-8d8f-d3aba4d69158" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrualPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_75a70e33-067a-43c0-905f-c40416c26ae4" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualPayments_fce51334-d01e-4b92-8d8f-d3aba4d69158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_87671850-f2c8-4eb8-affa-822cb5897086" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_75a70e33-067a-43c0-905f-c40416c26ae4" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_87671850-f2c8-4eb8-affa-822cb5897086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyDisclosureAbstract_1ffe74ca-1b49-4034-b8fa-0678c1a1f064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c619ce82-99a4-4ed4-ba0a-b6998d98b215" xlink:to="loc_us-gaap_StandardProductWarrantyDisclosureAbstract_1ffe74ca-1b49-4034-b8fa-0678c1a1f064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualCurrent_95459882-cb6c-4797-a9a6-c8fb1a3133eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrualCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StandardProductWarrantyDisclosureAbstract_1ffe74ca-1b49-4034-b8fa-0678c1a1f064" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualCurrent_95459882-cb6c-4797-a9a6-c8fb1a3133eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualNoncurrent_0c3c3466-b7de-47d1-a9da-65971a1ad815" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrualNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StandardProductWarrantyDisclosureAbstract_1ffe74ca-1b49-4034-b8fa-0678c1a1f064" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualNoncurrent_0c3c3466-b7de-47d1-a9da-65971a1ad815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesAbstract_9fc6af7a-dfa3-4bf0-9522-74b690a8cbc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c619ce82-99a4-4ed4-ba0a-b6998d98b215" xlink:to="loc_us-gaap_GuaranteesAbstract_9fc6af7a-dfa3-4bf0-9522-74b690a8cbc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankAcceptancesExecuted_679738bd-1bcf-4706-ad7c-2bd8ff437d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BankAcceptancesExecuted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteesAbstract_9fc6af7a-dfa3-4bf0-9522-74b690a8cbc8" xlink:to="loc_us-gaap_BankAcceptancesExecuted_679738bd-1bcf-4706-ad7c-2bd8ff437d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails" xlink:type="simple" xlink:href="a-20230131.xsd#SHORTTERMDEBTCreditFacilityDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1ae5fd56-9dbe-44e2-9778-6ef726c25494" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_ba619268-bfe8-4cc5-bd1c-782d05f523a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1ae5fd56-9dbe-44e2-9778-6ef726c25494" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_ba619268-bfe8-4cc5-bd1c-782d05f523a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_e5ed97ea-f97a-41de-9d4c-f3caf978053f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_ba619268-bfe8-4cc5-bd1c-782d05f523a2" xlink:to="loc_us-gaap_CreditFacilityAxis_e5ed97ea-f97a-41de-9d4c-f3caf978053f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_1b5c8d10-bc69-4702-a668-fe67e4f2c041" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_e5ed97ea-f97a-41de-9d4c-f3caf978053f" xlink:to="loc_us-gaap_CreditFacilityDomain_1b5c8d10-bc69-4702-a668-fe67e4f2c041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_0c7d7bf6-96b9-46da-9f57-edd9135977dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_1b5c8d10-bc69-4702-a668-fe67e4f2c041" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_0c7d7bf6-96b9-46da-9f57-edd9135977dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_d1077bf7-9289-4f43-a7b6-7cbb86591635" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_1b5c8d10-bc69-4702-a668-fe67e4f2c041" xlink:to="loc_us-gaap_LineOfCreditMember_d1077bf7-9289-4f43-a7b6-7cbb86591635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_2d6e014e-0926-483e-bc1a-b567ec3ceceb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_ba619268-bfe8-4cc5-bd1c-782d05f523a2" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_2d6e014e-0926-483e-bc1a-b567ec3ceceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_7c3d1c87-b731-4d6c-ae0e-2908561898c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_2d6e014e-0926-483e-bc1a-b567ec3ceceb" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_7c3d1c87-b731-4d6c-ae0e-2908561898c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_30e0f9e7-11fa-4d4f-908c-ae5bffb220ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_ba619268-bfe8-4cc5-bd1c-782d05f523a2" xlink:to="loc_us-gaap_DebtInstrumentAxis_30e0f9e7-11fa-4d4f-908c-ae5bffb220ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d2a38da6-761e-4ca7-9ec2-23cdf4ad73e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_30e0f9e7-11fa-4d4f-908c-ae5bffb220ac" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d2a38da6-761e-4ca7-9ec2-23cdf4ad73e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_A5YrUnsecuredCreditFacilityMember_adc5ddac-3423-4b43-8d78-5dd8b17f20cd" xlink:href="a-20230131.xsd#a_A5YrUnsecuredCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d2a38da6-761e-4ca7-9ec2-23cdf4ad73e8" xlink:to="loc_a_A5YrUnsecuredCreditFacilityMember_adc5ddac-3423-4b43-8d78-5dd8b17f20cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AdditionalIncrementalTermLoanFacilityMember_a17d92f6-df85-458a-8c52-e4e9bb7bd741" xlink:href="a-20230131.xsd#a_AdditionalIncrementalTermLoanFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d2a38da6-761e-4ca7-9ec2-23cdf4ad73e8" xlink:to="loc_a_AdditionalIncrementalTermLoanFacilityMember_a17d92f6-df85-458a-8c52-e4e9bb7bd741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_9d1896dc-a21b-4caa-a05f-a2ceb6de2566" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d2a38da6-761e-4ca7-9ec2-23cdf4ad73e8" xlink:to="loc_us-gaap_CommercialPaperMember_9d1896dc-a21b-4caa-a05f-a2ceb6de2566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_7ccce990-4867-40b1-93cf-975dcb431ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_ba619268-bfe8-4cc5-bd1c-782d05f523a2" xlink:to="loc_us-gaap_ShortTermDebtLineItems_7ccce990-4867-40b1-93cf-975dcb431ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInitiationDate1_619d6e57-d8a2-4d49-9642-5d15e1a50a46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInitiationDate1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7ccce990-4867-40b1-93cf-975dcb431ea6" xlink:to="loc_us-gaap_LineOfCreditFacilityInitiationDate1_619d6e57-d8a2-4d49-9642-5d15e1a50a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_30d27c05-83b1-4acc-8615-d653bb815552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7ccce990-4867-40b1-93cf-975dcb431ea6" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_30d27c05-83b1-4acc-8615-d653bb815552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTerms_94a401bc-6ffe-4ac1-b7a5-2779087937f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTerms"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7ccce990-4867-40b1-93cf-975dcb431ea6" xlink:to="loc_us-gaap_ShortTermDebtTerms_94a401bc-6ffe-4ac1-b7a5-2779087937f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationDate1_f2381b8b-1a6e-49ab-85c2-78504b49b3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityExpirationDate1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7ccce990-4867-40b1-93cf-975dcb431ea6" xlink:to="loc_us-gaap_LineOfCreditFacilityExpirationDate1_f2381b8b-1a6e-49ab-85c2-78504b49b3ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_ae879390-f96b-48b9-9257-16b763b1b1fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7ccce990-4867-40b1-93cf-975dcb431ea6" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_ae879390-f96b-48b9-9257-16b763b1b1fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate_a79888e6-be97-4c3c-ba54-ba773ec07966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7ccce990-4867-40b1-93cf-975dcb431ea6" xlink:to="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate_a79888e6-be97-4c3c-ba54-ba773ec07966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper_17dce121-90eb-47cc-9525-7054c154e8bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7ccce990-4867-40b1-93cf-975dcb431ea6" xlink:to="loc_us-gaap_RepaymentsOfCommercialPaper_17dce121-90eb-47cc-9525-7054c154e8bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_ae1562da-8903-427c-b045-d91ae51b843c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7ccce990-4867-40b1-93cf-975dcb431ea6" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_ae1562da-8903-427c-b045-d91ae51b843c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/LONGTERMDEBTDetails" xlink:type="simple" xlink:href="a-20230131.xsd#LONGTERMDEBTDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/LONGTERMDEBTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_bbbd62ef-d11c-474f-86d6-1fd370777c18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b736a7ee-507c-437a-abc3-2b8ed7d4f6fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bbbd62ef-d11c-474f-86d6-1fd370777c18" xlink:to="loc_us-gaap_DebtInstrumentTable_b736a7ee-507c-437a-abc3-2b8ed7d4f6fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_3f48a0d0-d86b-447d-86ad-547d8493563b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b736a7ee-507c-437a-abc3-2b8ed7d4f6fc" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_3f48a0d0-d86b-447d-86ad-547d8493563b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_74eb9128-c00d-4f81-8193-2c135c9e33a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3f48a0d0-d86b-447d-86ad-547d8493563b" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_74eb9128-c00d-4f81-8193-2c135c9e33a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f9766491-c264-4773-8431-c900305890fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b736a7ee-507c-437a-abc3-2b8ed7d4f6fc" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f9766491-c264-4773-8431-c900305890fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_2b5fed2c-be30-4c31-b49b-3b81e4d28dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f9766491-c264-4773-8431-c900305890fa" xlink:to="loc_us-gaap_TypeOfAdoptionMember_2b5fed2c-be30-4c31-b49b-3b81e4d28dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_62c38684-5309-46d8-82a4-7d9ce2af8e29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b736a7ee-507c-437a-abc3-2b8ed7d4f6fc" xlink:to="loc_us-gaap_DebtInstrumentAxis_62c38684-5309-46d8-82a4-7d9ce2af8e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_971319f9-6b53-4df8-8e4c-fbcb21ce78ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_62c38684-5309-46d8-82a4-7d9ce2af8e29" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_971319f9-6b53-4df8-8e4c-fbcb21ce78ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2023Member_fd41e759-eb27-40b8-8b2d-938f5e059ddf" xlink:href="a-20230131.xsd#a_SeniorNotes2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_971319f9-6b53-4df8-8e4c-fbcb21ce78ad" xlink:to="loc_a_SeniorNotes2023Member_fd41e759-eb27-40b8-8b2d-938f5e059ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2026Member_4c35a03c-c5d3-41aa-9ec5-2435b098df69" xlink:href="a-20230131.xsd#a_SeniorNotes2026Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_971319f9-6b53-4df8-8e4c-fbcb21ce78ad" xlink:to="loc_a_SeniorNotes2026Member_4c35a03c-c5d3-41aa-9ec5-2435b098df69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2029Member_c0a61a93-b627-44f3-8f3f-0b22382235b1" xlink:href="a-20230131.xsd#a_SeniorNotes2029Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_971319f9-6b53-4df8-8e4c-fbcb21ce78ad" xlink:to="loc_a_SeniorNotes2029Member_c0a61a93-b627-44f3-8f3f-0b22382235b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2030Member_33511a39-72ed-4fa0-84f1-b85573ec673c" xlink:href="a-20230131.xsd#a_SeniorNotes2030Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_971319f9-6b53-4df8-8e4c-fbcb21ce78ad" xlink:to="loc_a_SeniorNotes2030Member_33511a39-72ed-4fa0-84f1-b85573ec673c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2031Member_be1a7c32-23d8-4da2-896c-40d58d8b8921" xlink:href="a-20230131.xsd#a_SeniorNotes2031Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_971319f9-6b53-4df8-8e4c-fbcb21ce78ad" xlink:to="loc_a_SeniorNotes2031Member_be1a7c32-23d8-4da2-896c-40d58d8b8921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_e9e4115e-3fd5-4775-8419-25890057a6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_971319f9-6b53-4df8-8e4c-fbcb21ce78ad" xlink:to="loc_us-gaap_SeniorNotesMember_e9e4115e-3fd5-4775-8419-25890057a6c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f122bf9e-68d2-4cd3-998f-be627e325b29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b736a7ee-507c-437a-abc3-2b8ed7d4f6fc" xlink:to="loc_us-gaap_DebtInstrumentLineItems_f122bf9e-68d2-4cd3-998f-be627e325b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_8fab7c4f-876f-48cf-b624-2df993d7c318" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f122bf9e-68d2-4cd3-998f-be627e325b29" xlink:to="loc_us-gaap_LongTermDebt_8fab7c4f-876f-48cf-b624-2df993d7c318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/LONGTERMDEBTTextDetails" xlink:type="simple" xlink:href="a-20230131.xsd#LONGTERMDEBTTextDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/LONGTERMDEBTTextDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_7498510d-f45f-44d6-95cd-ef077fafdbba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d1a46d5f-36ce-4f57-ace4-372f45f43460" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_7498510d-f45f-44d6-95cd-ef077fafdbba" xlink:to="loc_us-gaap_DebtInstrumentTable_d1a46d5f-36ce-4f57-ace4-372f45f43460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1b4af81f-7a27-40af-bc54-e7594f881f59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d1a46d5f-36ce-4f57-ace4-372f45f43460" xlink:to="loc_us-gaap_DebtInstrumentAxis_1b4af81f-7a27-40af-bc54-e7594f881f59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9688b147-916f-42c8-b2ee-4852f5cd4d68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1b4af81f-7a27-40af-bc54-e7594f881f59" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9688b147-916f-42c8-b2ee-4852f5cd4d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2022Member_8ccb66b1-5596-40a4-9f94-15b0be58a2f5" xlink:href="a-20230131.xsd#a_SeniorNotes2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9688b147-916f-42c8-b2ee-4852f5cd4d68" xlink:to="loc_a_SeniorNotes2022Member_8ccb66b1-5596-40a4-9f94-15b0be58a2f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2031Member_5ca52fbf-cb37-4d3b-97fb-98035260f0dd" xlink:href="a-20230131.xsd#a_SeniorNotes2031Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9688b147-916f-42c8-b2ee-4852f5cd4d68" xlink:to="loc_a_SeniorNotes2031Member_5ca52fbf-cb37-4d3b-97fb-98035260f0dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_TermLoanMaturing2025Member_d9b37f37-bd2b-4cb4-8d96-d755b58eede8" xlink:href="a-20230131.xsd#a_TermLoanMaturing2025Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9688b147-916f-42c8-b2ee-4852f5cd4d68" xlink:to="loc_a_TermLoanMaturing2025Member_d9b37f37-bd2b-4cb4-8d96-d755b58eede8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_d064fbfd-634b-4594-b4ba-dc15c8174d88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9688b147-916f-42c8-b2ee-4852f5cd4d68" xlink:to="loc_us-gaap_SeniorNotesMember_d064fbfd-634b-4594-b4ba-dc15c8174d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SeniorNotes2023Member_e0184475-6ef5-4104-ad2c-2f8666b37660" xlink:href="a-20230131.xsd#a_SeniorNotes2023Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9688b147-916f-42c8-b2ee-4852f5cd4d68" xlink:to="loc_a_SeniorNotes2023Member_e0184475-6ef5-4104-ad2c-2f8666b37660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_88fb75ef-5761-4b79-8bb9-cedd9ced11f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d1a46d5f-36ce-4f57-ace4-372f45f43460" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_88fb75ef-5761-4b79-8bb9-cedd9ced11f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_68ca0854-1f73-4709-92e0-aac1c29b3895" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_88fb75ef-5761-4b79-8bb9-cedd9ced11f6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_68ca0854-1f73-4709-92e0-aac1c29b3895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_1f113280-5e8e-484d-9302-7f00068c6811" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d1a46d5f-36ce-4f57-ace4-372f45f43460" xlink:to="loc_us-gaap_VariableRateAxis_1f113280-5e8e-484d-9302-7f00068c6811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_cc2ecc59-7d02-4c2c-9f79-64212e652f66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_1f113280-5e8e-484d-9302-7f00068c6811" xlink:to="loc_us-gaap_VariableRateDomain_cc2ecc59-7d02-4c2c-9f79-64212e652f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_77bc6590-36ed-465a-a89f-dd3b4347d9c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d1a46d5f-36ce-4f57-ace4-372f45f43460" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_77bc6590-36ed-465a-a89f-dd3b4347d9c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_bd0810be-64e8-4b33-85a0-be6ee15bf11d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_77bc6590-36ed-465a-a89f-dd3b4347d9c0" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_bd0810be-64e8-4b33-85a0-be6ee15bf11d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_972b528b-314c-46be-8205-e753f8fc51fb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d1a46d5f-36ce-4f57-ace4-372f45f43460" xlink:to="loc_srt_RangeAxis_972b528b-314c-46be-8205-e753f8fc51fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_175cf083-e6b5-4918-81f0-9e0265acbb25" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_972b528b-314c-46be-8205-e753f8fc51fb" xlink:to="loc_srt_RangeMember_175cf083-e6b5-4918-81f0-9e0265acbb25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_4dd415bd-4099-44a7-a8bc-0fe0de0bf5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d1a46d5f-36ce-4f57-ace4-372f45f43460" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_4dd415bd-4099-44a7-a8bc-0fe0de0bf5d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0f6a98e7-5aa5-442e-bbe5-2b59d2c47cba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4dd415bd-4099-44a7-a8bc-0fe0de0bf5d6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0f6a98e7-5aa5-442e-bbe5-2b59d2c47cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_4278e4e9-fefe-44d0-892d-2de3164d05e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_0f6a98e7-5aa5-442e-bbe5-2b59d2c47cba" xlink:to="loc_us-gaap_SubsequentEventMember_4278e4e9-fefe-44d0-892d-2de3164d05e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d1a46d5f-36ce-4f57-ace4-372f45f43460" xlink:to="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIssuanceDate1_733a22ea-54ef-4ec4-8798-ce6cbcbabb5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentIssuanceDate1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_us-gaap_DebtInstrumentIssuanceDate1_733a22ea-54ef-4ec4-8798-ce6cbcbabb5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_4e305092-7c36-4822-be95-07f934c834b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_4e305092-7c36-4822-be95-07f934c834b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_PercentageOfFaceAmountOfSeniorNoteInstrumentIssued_7f2a0d7c-fe5d-4ad9-bf8d-3dee76d0d216" xlink:href="a-20230131.xsd#a_PercentageOfFaceAmountOfSeniorNoteInstrumentIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_a_PercentageOfFaceAmountOfSeniorNoteInstrumentIssued_7f2a0d7c-fe5d-4ad9-bf8d-3dee76d0d216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_8f2dd957-3067-4494-a816-a2709a5c5076" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_8f2dd957-3067-4494-a816-a2709a5c5076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_39599002-119e-4a11-a614-1b0cf2c70c49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_39599002-119e-4a11-a614-1b0cf2c70c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_c7831e6c-2015-458a-af7b-aa7a37120582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_c7831e6c-2015-458a-af7b-aa7a37120582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDateOfFirstRequiredPayment1_01c2754f-0015-40a7-bce8-cccb600f7e77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDateOfFirstRequiredPayment1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_us-gaap_DebtInstrumentDateOfFirstRequiredPayment1_01c2754f-0015-40a7-bce8-cccb600f7e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_e08b42ea-58b2-4943-bc6f-60ed15b69b75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_e08b42ea-58b2-4943-bc6f-60ed15b69b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarlyRepaymentOfSeniorDebt_38263190-0014-4258-86f7-27eb81c5bc80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarlyRepaymentOfSeniorDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_us-gaap_EarlyRepaymentOfSeniorDebt_38263190-0014-4258-86f7-27eb81c5bc80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_5814457f-2b00-468b-9485-9781ab09ba5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_5814457f-2b00-468b-9485-9781ab09ba5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_PaymentOfAccruedAndUnpaidInterest_d3511f2c-1dd3-40fa-9545-dfc0629071c1" xlink:href="a-20230131.xsd#a_PaymentOfAccruedAndUnpaidInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_a_PaymentOfAccruedAndUnpaidInterest_d3511f2c-1dd3-40fa-9545-dfc0629071c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_2e917a8d-dad6-4fe9-9f7d-d37fcdcbe2b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_2e917a8d-dad6-4fe9-9f7d-d37fcdcbe2b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest_c5bf897d-a54c-4140-b925-0011dfdc5f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest_c5bf897d-a54c-4140-b925-0011dfdc5f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_17d86a9c-cb94-4a82-b118-705aea4545d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_17d86a9c-cb94-4a82-b118-705aea4545d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_25e0a5e9-ea39-4893-ab25-82cd0fe4b63f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_25e0a5e9-ea39-4893-ab25-82cd0fe4b63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_a034d2d3-c70a-4a82-852a-3d98e6793c79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_a034d2d3-c70a-4a82-852a-3d98e6793c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_500c78db-f604-42b1-8360-567b5de45bbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_19977e3e-445f-4b26-b694-c2addea0006d" xlink:to="loc_us-gaap_LongTermDebt_500c78db-f604-42b1-8360-567b5de45bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails" xlink:type="simple" xlink:href="a-20230131.xsd#STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_2393f361-ec88-4e9e-99a3-2f06d20b4034" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_9e1dad64-1d3f-4703-a800-6bfe73a51ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_2393f361-ec88-4e9e-99a3-2f06d20b4034" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_9e1dad64-1d3f-4703-a800-6bfe73a51ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_233122a9-7edc-4b5d-b976-1a8fd9ae5572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_9e1dad64-1d3f-4703-a800-6bfe73a51ca5" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_233122a9-7edc-4b5d-b976-1a8fd9ae5572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_580ec089-0f85-41a4-9d60-01b160ee2076" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_233122a9-7edc-4b5d-b976-1a8fd9ae5572" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_580ec089-0f85-41a4-9d60-01b160ee2076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_54bc076b-c344-46c7-bbbc-711fdcac5f19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_9e1dad64-1d3f-4703-a800-6bfe73a51ca5" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_54bc076b-c344-46c7-bbbc-711fdcac5f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_f7633779-d303-4fd3-b34b-33fe0995d3ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_54bc076b-c344-46c7-bbbc-711fdcac5f19" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_f7633779-d303-4fd3-b34b-33fe0995d3ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_A2019RepurchaseProgramMember_4d6768c4-5bb2-490a-80df-be05d34b98aa" xlink:href="a-20230131.xsd#a_A2019RepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_f7633779-d303-4fd3-b34b-33fe0995d3ae" xlink:to="loc_a_A2019RepurchaseProgramMember_4d6768c4-5bb2-490a-80df-be05d34b98aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_A2021RepurchaseProgramMember_ba1ae194-4b98-470d-bf27-25054518f68b" xlink:href="a-20230131.xsd#a_A2021RepurchaseProgramMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_f7633779-d303-4fd3-b34b-33fe0995d3ae" xlink:to="loc_a_A2021RepurchaseProgramMember_ba1ae194-4b98-470d-bf27-25054518f68b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_A2023RepurchaseProgramMember_cbe301ef-eda9-4ac5-91ae-d75ec58ec7af" xlink:href="a-20230131.xsd#a_A2023RepurchaseProgramMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_f7633779-d303-4fd3-b34b-33fe0995d3ae" xlink:to="loc_a_A2023RepurchaseProgramMember_cbe301ef-eda9-4ac5-91ae-d75ec58ec7af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_289b76d5-97e7-4a96-88ee-727c8a1ee697" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_9e1dad64-1d3f-4703-a800-6bfe73a51ca5" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_289b76d5-97e7-4a96-88ee-727c8a1ee697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_86814213-111e-4e88-9d96-ed9bad25f9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_289b76d5-97e7-4a96-88ee-727c8a1ee697" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_86814213-111e-4e88-9d96-ed9bad25f9a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_5d016200-fa94-4dae-8f2a-ef8474defd42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_86814213-111e-4e88-9d96-ed9bad25f9a8" xlink:to="loc_us-gaap_SubsequentEventMember_5d016200-fa94-4dae-8f2a-ef8474defd42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_fd9a7f7a-e77f-4e60-a2e3-5351563d90d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_9e1dad64-1d3f-4703-a800-6bfe73a51ca5" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_fd9a7f7a-e77f-4e60-a2e3-5351563d90d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_724a7794-47de-43ad-80ff-e7db0b4c4b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_fd9a7f7a-e77f-4e60-a2e3-5351563d90d8" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_724a7794-47de-43ad-80ff-e7db0b4c4b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_686b8612-f8a1-4c9f-87ef-68b95d69e7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_fd9a7f7a-e77f-4e60-a2e3-5351563d90d8" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_686b8612-f8a1-4c9f-87ef-68b95d69e7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_34426705-3229-41d6-b08a-c606291a95f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_fd9a7f7a-e77f-4e60-a2e3-5351563d90d8" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_34426705-3229-41d6-b08a-c606291a95f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_c7f4990f-8c28-4033-9f4f-98c20fba01a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_fd9a7f7a-e77f-4e60-a2e3-5351563d90d8" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_c7f4990f-8c28-4033-9f4f-98c20fba01a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails" xlink:type="simple" xlink:href="a-20230131.xsd#STOCKHOLDERSEQUITYDividendsDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsAbstract_47196136-a2bf-4e42-a44c-aee5e8b45d84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableTable_1504c0fd-e6ff-41b6-abbe-aa533d478edf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsAbstract_47196136-a2bf-4e42-a44c-aee5e8b45d84" xlink:to="loc_us-gaap_DividendsPayableTable_1504c0fd-e6ff-41b6-abbe-aa533d478edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_9669e31f-e18b-4257-8387-d394a0295d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_1504c0fd-e6ff-41b6-abbe-aa533d478edf" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_9669e31f-e18b-4257-8387-d394a0295d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5772e212-e1da-4e54-8b36-4fb7e286a29a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9669e31f-e18b-4257-8387-d394a0295d2b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5772e212-e1da-4e54-8b36-4fb7e286a29a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_faf1322c-21c6-4cdf-bf57-652aa56656d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_5772e212-e1da-4e54-8b36-4fb7e286a29a" xlink:to="loc_us-gaap_SubsequentEventMember_faf1322c-21c6-4cdf-bf57-652aa56656d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsAxis_53235955-3c3a-4438-8ef7-27cae209bd69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_1504c0fd-e6ff-41b6-abbe-aa533d478edf" xlink:to="loc_us-gaap_DividendsAxis_53235955-3c3a-4438-8ef7-27cae209bd69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDomain_b048e6f5-7500-4d32-b2de-f6b02c486ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsAxis_53235955-3c3a-4438-8ef7-27cae209bd69" xlink:to="loc_us-gaap_DividendsDomain_b048e6f5-7500-4d32-b2de-f6b02c486ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableLineItems_128acdf2-f0f2-432e-ad48-8ee388f37fcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_1504c0fd-e6ff-41b6-abbe-aa533d478edf" xlink:to="loc_us-gaap_DividendsPayableLineItems_128acdf2-f0f2-432e-ad48-8ee388f37fcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsAbstract_fc32ecdf-be65-445b-88cf-2fa8ebd29c51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_128acdf2-f0f2-432e-ad48-8ee388f37fcf" xlink:to="loc_us-gaap_PaymentsOfDividendsAbstract_fc32ecdf-be65-445b-88cf-2fa8ebd29c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_d568dffb-3440-419e-918a-ca5cccb12097" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PaymentsOfDividendsAbstract_fc32ecdf-be65-445b-88cf-2fa8ebd29c51" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_d568dffb-3440-419e-918a-ca5cccb12097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_63ab5895-7b1d-4878-8a84-ab48505f9f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PaymentsOfDividendsAbstract_fc32ecdf-be65-445b-88cf-2fa8ebd29c51" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_63ab5895-7b1d-4878-8a84-ab48505f9f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_94af5d8f-2351-491f-9e08-0a41a91112ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PaymentsOfDividendsAbstract_fc32ecdf-be65-445b-88cf-2fa8ebd29c51" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_94af5d8f-2351-491f-9e08-0a41a91112ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockAbstract_1892dd5d-054e-4546-9039-92a619d6a740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_128acdf2-f0f2-432e-ad48-8ee388f37fcf" xlink:to="loc_us-gaap_DividendsCommonStockAbstract_1892dd5d-054e-4546-9039-92a619d6a740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_3c89e7b6-7a24-4fc1-9350-88f8527dcb7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateDeclaredDayMonthAndYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsCommonStockAbstract_1892dd5d-054e-4546-9039-92a619d6a740" xlink:to="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_3c89e7b6-7a24-4fc1-9350-88f8527dcb7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_b74ecb1a-a1d2-4154-b088-dd15ccb8aec9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsCommonStockAbstract_1892dd5d-054e-4546-9039-92a619d6a740" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_b74ecb1a-a1d2-4154-b088-dd15ccb8aec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_6339fe4e-962c-4d9b-9511-3b302a50db5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsCommonStockAbstract_1892dd5d-054e-4546-9039-92a619d6a740" xlink:to="loc_us-gaap_DividendsCommonStockCash_6339fe4e-962c-4d9b-9511-3b302a50db5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_c7332f1d-9c5f-4a41-a7ce-9cf40a40e05b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendPayableDateToBePaidDayMonthAndYear"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsCommonStockAbstract_1892dd5d-054e-4546-9039-92a619d6a740" xlink:to="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_c7332f1d-9c5f-4a41-a7ce-9cf40a40e05b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_54012f9e-b27c-463b-94e7-2f4d674c6ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateOfRecordDayMonthAndYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsCommonStockAbstract_1892dd5d-054e-4546-9039-92a619d6a740" xlink:to="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_54012f9e-b27c-463b-94e7-2f4d674c6ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="a-20230131.xsd#STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_73e8be07-bc31-41a1-97b9-67270068917d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ade0052a-cf57-4fde-8ea7-374492dbaa3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_73e8be07-bc31-41a1-97b9-67270068917d" xlink:to="loc_us-gaap_StatementTable_ade0052a-cf57-4fde-8ea7-374492dbaa3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_11db9437-563a-496d-9043-091d0d00eafc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ade0052a-cf57-4fde-8ea7-374492dbaa3c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_11db9437-563a-496d-9043-091d0d00eafc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_57020c5c-5ea8-4fbc-a18c-5d48dcc4facf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_11db9437-563a-496d-9043-091d0d00eafc" xlink:to="loc_us-gaap_EquityComponentDomain_57020c5c-5ea8-4fbc-a18c-5d48dcc4facf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_797f3a54-4a78-4638-8568-91638aa0bc6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_57020c5c-5ea8-4fbc-a18c-5d48dcc4facf" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_797f3a54-4a78-4638-8568-91638aa0bc6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_e36349c8-b259-4b51-a56e-eefa63da5084" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_57020c5c-5ea8-4fbc-a18c-5d48dcc4facf" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_e36349c8-b259-4b51-a56e-eefa63da5084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_e4ccbdad-300a-4c88-bad7-70cc7a93e3fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_57020c5c-5ea8-4fbc-a18c-5d48dcc4facf" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_e4ccbdad-300a-4c88-bad7-70cc7a93e3fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember_e764c4cd-b98f-4c76-868a-03c8672f3f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_57020c5c-5ea8-4fbc-a18c-5d48dcc4facf" xlink:to="loc_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember_e764c4cd-b98f-4c76-868a-03c8672f3f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_2a184749-6cae-4b78-b530-2c29211a7e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ade0052a-cf57-4fde-8ea7-374492dbaa3c" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_2a184749-6cae-4b78-b530-2c29211a7e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_5fda022e-bc67-483e-aecf-767573fd516f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_2a184749-6cae-4b78-b530-2c29211a7e5f" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_5fda022e-bc67-483e-aecf-767573fd516f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_0ae8101a-8f1a-4a22-97e4-af5f4a73f7ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ade0052a-cf57-4fde-8ea7-374492dbaa3c" xlink:to="loc_us-gaap_StatementLineItems_0ae8101a-8f1a-4a22-97e4-af5f4a73f7ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_32574e60-7461-4899-b559-35fc77afd09d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0ae8101a-8f1a-4a22-97e4-af5f4a73f7ba" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_32574e60-7461-4899-b559-35fc77afd09d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_20f86709-3816-4ae4-9893-e21f36709421" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0ae8101a-8f1a-4a22-97e4-af5f4a73f7ba" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_20f86709-3816-4ae4-9893-e21f36709421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_efa88e7b-4442-419d-a5a9-b44417240dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0ae8101a-8f1a-4a22-97e4-af5f4a73f7ba" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_efa88e7b-4442-419d-a5a9-b44417240dd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_d8eb50bf-332e-4b17-b4ed-4163e70a725a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0ae8101a-8f1a-4a22-97e4-af5f4a73f7ba" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_d8eb50bf-332e-4b17-b4ed-4163e70a725a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_6a2bd93c-a101-4832-bf6b-438a2d9682b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0ae8101a-8f1a-4a22-97e4-af5f4a73f7ba" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_6a2bd93c-a101-4832-bf6b-438a2d9682b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5ad3f1ff-3826-49f5-a790-fd2e9d58f0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0ae8101a-8f1a-4a22-97e4-af5f4a73f7ba" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5ad3f1ff-3826-49f5-a790-fd2e9d58f0e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_29f61030-f154-436a-8d7e-324aa7824a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0ae8101a-8f1a-4a22-97e4-af5f4a73f7ba" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_29f61030-f154-436a-8d7e-324aa7824a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails" xlink:type="simple" xlink:href="a-20230131.xsd#STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_da35885a-e2be-427c-bd0d-b31b63d56177" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_6ac1d60a-e93c-4988-992b-22b81511fc80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_da35885a-e2be-427c-bd0d-b31b63d56177" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_6ac1d60a-e93c-4988-992b-22b81511fc80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8b99aded-0e0d-4c07-8f51-250fa0524ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_6ac1d60a-e93c-4988-992b-22b81511fc80" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8b99aded-0e0d-4c07-8f51-250fa0524ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f1fa0988-c01b-4aa2-9837-ce3ab88b9b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8b99aded-0e0d-4c07-8f51-250fa0524ad5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f1fa0988-c01b-4aa2-9837-ce3ab88b9b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_62c5ab66-1e43-4187-9631-1d14aa5d9bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f1fa0988-c01b-4aa2-9837-ce3ab88b9b4b" xlink:to="loc_us-gaap_CostOfSalesMember_62c5ab66-1e43-4187-9631-1d14aa5d9bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_933c23b0-249e-4ead-abe8-dd0f839ab10b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f1fa0988-c01b-4aa2-9837-ce3ab88b9b4b" xlink:to="loc_us-gaap_InterestExpenseMember_933c23b0-249e-4ead-abe8-dd0f839ab10b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_f0f9982f-8180-47a2-8bde-896e41880347" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_6ac1d60a-e93c-4988-992b-22b81511fc80" xlink:to="loc_srt_StatementScenarioAxis_f0f9982f-8180-47a2-8bde-896e41880347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_919976c5-09e0-40ca-a25d-b27f248132b2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_f0f9982f-8180-47a2-8bde-896e41880347" xlink:to="loc_srt_ScenarioUnspecifiedDomain_919976c5-09e0-40ca-a25d-b27f248132b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db7ce1fd-0309-42b2-aa71-57c28dd56612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_6ac1d60a-e93c-4988-992b-22b81511fc80" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db7ce1fd-0309-42b2-aa71-57c28dd56612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_c8e71069-6565-44b6-a7e7-6fc4133c3de8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db7ce1fd-0309-42b2-aa71-57c28dd56612" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_c8e71069-6565-44b6-a7e7-6fc4133c3de8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_46162a9e-fb86-4e8e-b587-45eeb20bae1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db7ce1fd-0309-42b2-aa71-57c28dd56612" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_46162a9e-fb86-4e8e-b587-45eeb20bae1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b2362f0f-5fd8-47e1-b54b-bbad56179e99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db7ce1fd-0309-42b2-aa71-57c28dd56612" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b2362f0f-5fd8-47e1-b54b-bbad56179e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_66e4a260-ea2b-400c-89ca-9476f7214795" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db7ce1fd-0309-42b2-aa71-57c28dd56612" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_66e4a260-ea2b-400c-89ca-9476f7214795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_cc6e645e-9350-4ab6-be74-db4b1b65d662" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db7ce1fd-0309-42b2-aa71-57c28dd56612" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_cc6e645e-9350-4ab6-be74-db4b1b65d662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax_fb5e6a98-faaf-4dc9-ac35-6385fb0025ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db7ce1fd-0309-42b2-aa71-57c28dd56612" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax_fb5e6a98-faaf-4dc9-ac35-6385fb0025ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax_d82c2b09-24d3-4198-8722-89b3ea0d6d57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db7ce1fd-0309-42b2-aa71-57c28dd56612" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax_d82c2b09-24d3-4198-8722-89b3ea0d6d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_d3bfae0e-38fe-43a4-8b33-296320fdc6ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db7ce1fd-0309-42b2-aa71-57c28dd56612" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_d3bfae0e-38fe-43a4-8b33-296320fdc6ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_e75535ae-be38-43a7-a5cd-812e27965765" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_db7ce1fd-0309-42b2-aa71-57c28dd56612" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_e75535ae-be38-43a7-a5cd-812e27965765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails" xlink:type="simple" xlink:href="a-20230131.xsd#SEGMENTINFORMATIONProfitabilityDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_6721a45e-3c46-40f5-9491-d40b90939480" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_c5955e65-71c8-4c40-b142-8de73ceb77f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_6721a45e-3c46-40f5-9491-d40b90939480" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_c5955e65-71c8-4c40-b142-8de73ceb77f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_ce99994c-d9ff-46e9-a68a-14212ba21199" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_c5955e65-71c8-4c40-b142-8de73ceb77f5" xlink:to="loc_us-gaap_NumberOfOperatingSegments_ce99994c-d9ff-46e9-a68a-14212ba21199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c6b1ab8c-4e25-4e6e-a038-700986b9c82d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_6721a45e-3c46-40f5-9491-d40b90939480" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c6b1ab8c-4e25-4e6e-a038-700986b9c82d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_723f4c3e-2643-4ee9-9034-3104c3e41644" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c6b1ab8c-4e25-4e6e-a038-700986b9c82d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_723f4c3e-2643-4ee9-9034-3104c3e41644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_960bb375-280b-44f7-9c8a-64e9b2dfbd1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_723f4c3e-2643-4ee9-9034-3104c3e41644" xlink:to="loc_us-gaap_SegmentDomain_960bb375-280b-44f7-9c8a-64e9b2dfbd1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_LifeSciencesandAppliedMarketsMember_55b7e2f0-71c0-41f0-8ef3-0e07946c902a" xlink:href="a-20230131.xsd#a_LifeSciencesandAppliedMarketsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_960bb375-280b-44f7-9c8a-64e9b2dfbd1a" xlink:to="loc_a_LifeSciencesandAppliedMarketsMember_55b7e2f0-71c0-41f0-8ef3-0e07946c902a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_DiagnosticsAndGenomicsMember_b57ccfb4-cf4e-460b-a8f6-f8d0fe132ae6" xlink:href="a-20230131.xsd#a_DiagnosticsAndGenomicsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_960bb375-280b-44f7-9c8a-64e9b2dfbd1a" xlink:to="loc_a_DiagnosticsAndGenomicsMember_b57ccfb4-cf4e-460b-a8f6-f8d0fe132ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AgilentCrossLabMember_19ccab02-3e0d-4abf-8a12-aab772bfeb68" xlink:href="a-20230131.xsd#a_AgilentCrossLabMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_960bb375-280b-44f7-9c8a-64e9b2dfbd1a" xlink:to="loc_a_AgilentCrossLabMember_19ccab02-3e0d-4abf-8a12-aab772bfeb68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SegmentTotalMember_1ae3ff23-97df-4f16-8a20-f1f23132ffc3" xlink:href="a-20230131.xsd#a_SegmentTotalMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_960bb375-280b-44f7-9c8a-64e9b2dfbd1a" xlink:to="loc_a_SegmentTotalMember_1ae3ff23-97df-4f16-8a20-f1f23132ffc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_c859ffdd-2122-4f81-9769-719796c8f362" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c6b1ab8c-4e25-4e6e-a038-700986b9c82d" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_c859ffdd-2122-4f81-9769-719796c8f362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dd853519-094e-42be-aa1e-b0b538da394a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c859ffdd-2122-4f81-9769-719796c8f362" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dd853519-094e-42be-aa1e-b0b538da394a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6e42cef2-b086-4df0-8e0d-4e05d74a24c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c859ffdd-2122-4f81-9769-719796c8f362" xlink:to="loc_us-gaap_OperatingIncomeLoss_6e42cef2-b086-4df0-8e0d-4e05d74a24c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails" xlink:type="simple" xlink:href="a-20230131.xsd#SEGMENTINFORMATIONReconciliationofReportableResultsDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_21bbe24d-f4dd-4f65-9f16-1baa44bc0c24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e34a0044-303f-4329-92c8-790acf8fd3f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_21bbe24d-f4dd-4f65-9f16-1baa44bc0c24" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e34a0044-303f-4329-92c8-790acf8fd3f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_578a250c-5daa-4b64-9675-fe1f53d3bdef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e34a0044-303f-4329-92c8-790acf8fd3f8" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_578a250c-5daa-4b64-9675-fe1f53d3bdef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c7fff83b-7e7e-478c-aa54-95c9c7b4bc48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_578a250c-5daa-4b64-9675-fe1f53d3bdef" xlink:to="loc_us-gaap_SegmentDomain_c7fff83b-7e7e-478c-aa54-95c9c7b4bc48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SegmentTotalMember_4bc8195a-1f09-4d4a-92e2-1c5b55d4be39" xlink:href="a-20230131.xsd#a_SegmentTotalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c7fff83b-7e7e-478c-aa54-95c9c7b4bc48" xlink:to="loc_a_SegmentTotalMember_4bc8195a-1f09-4d4a-92e2-1c5b55d4be39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_5ba14867-5fa6-4e1c-a799-bf3f442e25cf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e34a0044-303f-4329-92c8-790acf8fd3f8" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_5ba14867-5fa6-4e1c-a799-bf3f442e25cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_8592bb7a-3e85-408e-b472-8b3e5f874fc7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_5ba14867-5fa6-4e1c-a799-bf3f442e25cf" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_8592bb7a-3e85-408e-b472-8b3e5f874fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis_d95d0609-ceec-4f45-9dc6-8588916d314e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e34a0044-303f-4329-92c8-790acf8fd3f8" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsAxis_d95d0609-ceec-4f45-9dc6-8588916d314e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_c2c395d8-ee30-40c2-b370-f7ef012f9194" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_d95d0609-ceec-4f45-9dc6-8588916d314e" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_c2c395d8-ee30-40c2-b370-f7ef012f9194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_60fcbbc2-d91f-43ef-9ada-1bf2a829231e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e34a0044-303f-4329-92c8-790acf8fd3f8" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_60fcbbc2-d91f-43ef-9ada-1bf2a829231e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_b9428e6a-761c-46f9-bb14-29cba6857f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_60fcbbc2-d91f-43ef-9ada-1bf2a829231e" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_b9428e6a-761c-46f9-bb14-29cba6857f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9eb4b84d-0ec7-4651-91c1-b003997320a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_b9428e6a-761c-46f9-bb14-29cba6857f2a" xlink:to="loc_us-gaap_OperatingIncomeLoss_9eb4b84d-0ec7-4651-91c1-b003997320a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_TransformationalPrograms_1f9396bd-7d14-4d4b-9be0-056b51e04ea5" xlink:href="a-20230131.xsd#a_TransformationalPrograms"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_b9428e6a-761c-46f9-bb14-29cba6857f2a" xlink:to="loc_a_TransformationalPrograms_1f9396bd-7d14-4d4b-9be0-056b51e04ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_3bd01057-0919-4d00-9c8f-f1d0285f6747" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_b9428e6a-761c-46f9-bb14-29cba6857f2a" xlink:to="loc_us-gaap_AdjustmentForAmortization_3bd01057-0919-4d00-9c8f-f1d0285f6747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_d6d6101e-1e96-478d-83cd-cb202a7e3a21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_b9428e6a-761c-46f9-bb14-29cba6857f2a" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_d6d6101e-1e96-478d-83cd-cb202a7e3a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_01298fc1-bf2f-420f-a6cb-b3c4e144162d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_b9428e6a-761c-46f9-bb14-29cba6857f2a" xlink:to="loc_us-gaap_AssetImpairmentCharges_01298fc1-bf2f-420f-a6cb-b3c4e144162d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_cb72d831-c6a9-42b7-9a22-f94a8ecc599d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_b9428e6a-761c-46f9-bb14-29cba6857f2a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_cb72d831-c6a9-42b7-9a22-f94a8ecc599d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_7cdb7df9-cb41-4e0b-98a7-8845284fa781" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessExitCosts1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_b9428e6a-761c-46f9-bb14-29cba6857f2a" xlink:to="loc_us-gaap_BusinessExitCosts1_7cdb7df9-cb41-4e0b-98a7-8845284fa781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonrecurringExpense_84d3e0b6-3453-44fc-9db2-4af6c60cf81c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonrecurringExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_b9428e6a-761c-46f9-bb14-29cba6857f2a" xlink:to="loc_us-gaap_OtherNonrecurringExpense_84d3e0b6-3453-44fc-9db2-4af6c60cf81c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_3b92a414-3aa4-4202-b784-eeeedb2c9707" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_b9428e6a-761c-46f9-bb14-29cba6857f2a" xlink:to="loc_us-gaap_InvestmentIncomeInterest_3b92a414-3aa4-4202-b784-eeeedb2c9707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_5bbcfb34-6dd0-4e98-9c0f-fc7191740744" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_b9428e6a-761c-46f9-bb14-29cba6857f2a" xlink:to="loc_us-gaap_InterestExpense_5bbcfb34-6dd0-4e98-9c0f-fc7191740744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_2b6a0798-ab78-466f-ae4b-eadde3b3c58c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_b9428e6a-761c-46f9-bb14-29cba6857f2a" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_2b6a0798-ab78-466f-ae4b-eadde3b3c58c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6f3ef87e-d4c1-4bb6-b2ac-372443528572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_b9428e6a-761c-46f9-bb14-29cba6857f2a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6f3ef87e-d4c1-4bb6-b2ac-372443528572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.agilent.com/role/SEGMENTINFORMATIONSegmentAssetsDetails" xlink:type="simple" xlink:href="a-20230131.xsd#SEGMENTINFORMATIONSegmentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.agilent.com/role/SEGMENTINFORMATIONSegmentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_febe1a5e-1c42-44f3-92ff-36b6f4be1ced" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b7d1cb26-dbef-44c3-9872-32d4e22a9399" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_febe1a5e-1c42-44f3-92ff-36b6f4be1ced" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b7d1cb26-dbef-44c3-9872-32d4e22a9399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_43d70d90-6c88-45e2-bc7a-a054b4774b84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b7d1cb26-dbef-44c3-9872-32d4e22a9399" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_43d70d90-6c88-45e2-bc7a-a054b4774b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_07401666-7fa3-4e95-b378-c546f856af81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_43d70d90-6c88-45e2-bc7a-a054b4774b84" xlink:to="loc_us-gaap_SegmentDomain_07401666-7fa3-4e95-b378-c546f856af81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_LifeSciencesandAppliedMarketsMember_40aa1c8b-7e94-4a46-b529-3252e9577f5f" xlink:href="a-20230131.xsd#a_LifeSciencesandAppliedMarketsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_07401666-7fa3-4e95-b378-c546f856af81" xlink:to="loc_a_LifeSciencesandAppliedMarketsMember_40aa1c8b-7e94-4a46-b529-3252e9577f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_DiagnosticsAndGenomicsMember_4dd1b60e-faee-4d2d-927a-f48c01260d25" xlink:href="a-20230131.xsd#a_DiagnosticsAndGenomicsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_07401666-7fa3-4e95-b378-c546f856af81" xlink:to="loc_a_DiagnosticsAndGenomicsMember_4dd1b60e-faee-4d2d-927a-f48c01260d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_AgilentCrossLabMember_69c1ad3f-39df-45c2-b1fa-0f31eba7a9b9" xlink:href="a-20230131.xsd#a_AgilentCrossLabMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_07401666-7fa3-4e95-b378-c546f856af81" xlink:to="loc_a_AgilentCrossLabMember_69c1ad3f-39df-45c2-b1fa-0f31eba7a9b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_a_SegmentTotalMember_3978117d-0f5a-41cd-ad86-bed27638b51e" xlink:href="a-20230131.xsd#a_SegmentTotalMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_07401666-7fa3-4e95-b378-c546f856af81" xlink:to="loc_a_SegmentTotalMember_3978117d-0f5a-41cd-ad86-bed27638b51e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_91584b80-2e2f-4e2c-b850-1119c2fb7d75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b7d1cb26-dbef-44c3-9872-32d4e22a9399" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_91584b80-2e2f-4e2c-b850-1119c2fb7d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_f13e8699-bb11-4b84-bf43-7d61bce763d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_91584b80-2e2f-4e2c-b850-1119c2fb7d75" xlink:to="loc_us-gaap_Assets_f13e8699-bb11-4b84-bf43-7d61bce763d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>image_0a.jpg
<TEXT>
begin 644 image_0a.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !N @8# 2(  A$! Q$!_\0
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M,;22.L:*,LS'  ]S0 ^BD!# $$$'H12T %(1D8I:CN [02",A9"IVDC(![4
M<]X)\!:=X"BU2/3I+F1=1OI=0F^TR^81(^,A?0<?7U)KI:\F^ FA?$71(=>'
MC^_^VM+<*UGF82D#YM[ CHI^7"]L'@5ZS7;C8.&(E&513?\ ,M4]/Z1YF6SC
M4PD)1I.DM?=:LUJ]UY[_ #"BBBN(],**9Y\8F$7F+YI&X)D;L>N*?0 4444
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ME!*!WR=S#N  3CN0*F\4? CP9XQ\7P>)=4TH7&J1%"S"1E2;;]W>H.&Q@#W
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M7E]Q/7 ?''XB2?"[X=:AKMM EQ>J4AMTDSL\QS@%L=AR<=\8[UW]>=?%K4?
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M1TQAAC!61J#3L?9?_!)GQ]_PD7P"UCPU+)NN/#NK.$3/W8)U\Q?SD$]>+?\
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MLXM:\0_96\&_M2:[\+VN?@_K+V/A+[=,AB6]M81]H 7>=LGS="O/2@:V(/\
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MYQT  M_M;_L?:M^QU>>$M6L/%<FM0:DTGE7T%N;.:UN8MK<8=NH;*L"#\I]
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M@/\ DL7C?_L K_Z41U],?M01K'_P3/E08*KX;T,#\);3%?,__!(#_DL7C?\
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MMW5?A;X2USP'%X*U#0+*[\)Q0Q6Z:1+%FW6.(J8U"^BE%Q]!0*Y^;7_!'O\
MY*/\0O\ L%6__HXU\Y?MT_\ )VWQ+_["*_\ HF.OVB^'OP,\ ?">]N[OP=X3
MTSPY<W<8BGEL(!&TJ Y /J >:QO%'[+?PE\:Z_>ZWKO@#0]5U>]?S+B\N;4-
M)*V ,L>_ 'Y4#OK<^9?^"J__ ":SX._[&"T_]([FL3_@CS_R3WXB?]A2V_\
M135]O>._A;X2^)VA6VC>*] LM?TJVE6>&TOH@\:2*K*K >H5F'XFH_AY\)/!
MOPFM+RU\'>'+#PY;WCK)<1V$0C65@, GU(!H%?2Q^*WQ,T'5?V4?VOI;JZL)
M"FA>(DUBQ1AM%U:"?S8RIZ89/E)[$,.H->B_M]_MC^&_VH(O!VF^$[#4K33M
M)\^YN9-3B2-Y)I BA557;A0K<YY+>W/ZN?$SX*^!OC'8PVGC3POIWB&.'/DO
M=Q?O8L]=D@PZY[X(S7$>#?V*O@EX!UB'5=&^'FF)?PL'BFNVDN_+8<AE$SN
M1V(&10.YQW_!.WX5ZC\*_P!E[28M7MGLM2UNXFUF6VE7:\:R!5B##L3'&C8[
M;L5^6W[%/_)UOPQ_[#$?\C7[S$ C';I7EGAK]ECX1^#M>L=:T3X?:'IFK64@
MFMKRWM0LD3CHRGL:!)GR?_P5R^%6H^(?!/A#QSI]K)<6^@S3V>H&-<F.*;88
MY&]%#QE2?605XS^S#^W]X?\ @C^S%JW@/4]+U.Y\26OVS^QY+5$-N_G99?,8
MN"NV1F)PIXQCFOUCOK&VU.SGM+RWBNK6=#'+!,@=)%(P593P01V->$ZG^P9\
M!-6U)KZ?X;Z=',S;BMM-/!%G_KFDBH![ 8H"Y^<G_!,;X5:CXX_:4TWQ&+60
MZ+X7AFO+FY*G9YKQO%#'G^\2Y;'I&:ZW_@K)\,-3T3XV:7XV6UD?1-;TZ*V-
MV%RB7,.Y6C)[$IY9&>OS8^Z:_4SP3X \-_#?0HM&\+:'8Z!I<9++:V$"Q(6/
M5C@<L>Y.2?6OC[]NG]LK5?@'XXM/!EY\.]$\7^&]5TU+U7UDL\<K>8ZNA0J5
M.THI_P"!"@=]3Y/\??ML:M\6OV0K7X4VOA2Y%WI-E9Q:QK2RAX/L=M)&L3E<
M95F<0 Y.,],[ACM/^"0'_)8?&_\ V 5_]*(Z[SXZ?'/X.:W^P/J2^$K;PIX9
M\2^*8;&.X\-^'XH()HKI;B*297C0!]J"-\.PP1MP?F%<M_P1[\/7LOCSQ_KH
MB8:=!IL%D92.#*\N\*#W($9)^H]: Z'EO_!4?_D[+4O^P59?^@&OO_4?AM=?
M%W_@G?H?A.P3S=0O_ FF-:1GC?/':PRQ+[9>-1GWKU7QQ^SE\,OB7KTFM^*?
M!&CZ[JSQK$UY>VX>0JHPHSZ"NZT71K'P[HUCI.FVL=EIMC;QVMM;0KA(HD4*
MB*.P"@ ?2@5S\2_V)/VC+/\ 92^,>IW_ (HTZ_DTF]LI-,OX+:(?:+>02*RM
ML<KDJR%2"00&/<8,OQ5^//C[]J#]I.^D^'NH^)--M]>O(;32M'MK^6+8BQK&
M&=8WVIG89&/1<MDX&:_6#XD?LE_"+XM:O)JOBGP+INH:I+S+>Q;[::4^KO$R
MES[MFM?X7?L\?#?X+O+)X+\(:;H=S*NQ[N*,R7#+_=,KEGQ[9Q0.Y\L_\%%4
M^(?PK^!'P^U#P=XIU[3H="D73M6O=,O989)@T*)'+,RL"1OC(RW\4@[FO"O@
M3_P4 T+1?V<_&/@SXJ-K_C/Q#>_:EM9+UOM:744L2JL3R2/E KACT. <C)XK
M]5M4TJRUO3KBPU&T@O[&X0Q36US&LD<J'@JRL""#Z&O"=0_8(^ >I7YO)?AQ
MIZ2EMQ6WN+B&//\ US20*![8Q0(_(O\ 9R_9I\7_ +2&O:I8>&(O*CTZV$]Q
M>S96%26"K&6Z;FRQ ]$;THK]U?!7@'PW\.-"BT;POH=CH.EQDLMK80+$A8]6
M.!RQQR3DFB@&S?HHK$\:ZEJ^D>%]0O-!TT:OJT4>ZWLF<()6R,C)]!D^^,5<
M(.I)0773M^)E4J*E"525[)7T5WIV2U;\D<%\=OC-J'PCE\.+8Z$^LC4[AHGP
MQ&W;MPBX!^=MQQ_NG@UZ%?\ AC1==NK2^U#1[*]O+;#0375LDDD)Z_*Q!*\^
ME6],EN+O3+.6]MQ:W;Q(\UN&#>4Y ++D=<'(S5NNJ=:$:<(4X\LXWO)/XK[>
M2LM--SAIX>I*K4J5I\].7*XQ<5[MEKYN[UUV$ P,5E>+/$4'A'PQJNMW*/+!
MI]M)<O&GWF"J3@>YQBM:H+^QM]4L;BSNX4N+6XC:*6)QE71AAE(]""17+!Q4
MDYJZZ^AVU5-TY*F[2L[>O0\2^ 7[2;_&/Q!J6D7>D)IEU!";J%H93(K1A@I#
M9 ^8%EY[Y/ Q7NE<-\._@UX3^&%S>S^'M/-M/=\2222M(P4'(0%B<+G\^,YP
M*[FO0S&IA*N(<L%!QIZ63_'J_P SRLGI8^A@XPS.HIU=;M;6OIT7Y(S-<\,:
M/XFCBCU?2K+58XFWQI>VZ3!&]0&!P:\V^-/QEO?A+J?A>PL/#[:I%J<QB8H2
MNT J B  Y<[N ?3\O7*:RAL9&<=*PPU>%.I%UX<\%?W;M;K_ #U.G&8:I6I2
M6&J>SJ.WO))O1]GOI=>5Q0<@'I2US5QK/B"/Q_:Z9%HJR>&Y+)II=6\X QSA
MB!'LZGC!S_M>QKI:YYP<+7ZJ^]_^&]#KIU8U.9)/1VU37W7W7FM HHHK,V"B
MBB@ HHHH *\]^-?P&\%_M ^%UT'QII0U"VB<RV\\;F.>VDQC='(.5XZCD'C(
M.*]"HH ^&E_X)%_"D:@)3XF\6M:;L_9_M%MG'IN\C^E?5GP@^"WA#X$^$H_#
MG@W28]+T\.99&W%Y9Y" #)(YY9N!UZ  # &*[FB@=PHHHH$%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %>;?'+]GGP/\ M$>'(='\::4;Q+9C):W<#F*YM6( )C<=,X&5.5.!
MD' KTFB@#X:@_P""1?PICU 2R>)O%LMH&S]G-Q; D>A80YKZS^%'PB\*?!/P
MA;^&?!^DQZ3I43&0HI+/+(<;I)'.2[' Y)Z  8  KLJ* "BBB@ HHHH ****
M "BBB@ HHHH **** "F3(98716*,RD!AU'O3Z0\ T >4_ 7X1:U\*8=>36-?
M_MLZA<K+$ 7(3&[+G=_$V1G']T<FO5ZX/X3^/-0\=VWB*34+6VMFTW6+C3HA
M;,Q#)'MP6W=^>WY"N\KT,PG7GB9RQ/QZ7M;LNVFQY&4T\+2P5.&#O[/6U[M[
MN^^N]PHHHKSSUPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image_2a.jpg
<TEXT>
begin 644 image_2a.jpg
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M0? R0CGR@^<.GCHG%Q(E*"DMKWSBFG]Z%?9[/WF"S/A64?3D\K']*G+KI(7
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MNCPXOB X.3LX-CLX,COX;>&]^(I[[RKN18.Y%( I ^.R ]_F!T06?<C_UCN
MH]%HC+F511IIBC(6]R9\R^:-T\4,BD](U>"@@_N'5ZE?_^K%QQ2=/$7%564F
M7S#=L8[U1 2?C*+H3<O-SY\-BJF$ZFU@17UB M^9_B[4[<0>2_#A*L@G !8Z
MO$*B"Y>"U<#]^^WW[]^U?[^)IH:BI(@ -U@RBRQ8B-ZPW?K(Q=L/D],+QL9_
M=..@$L?'NAJ^%24^]G"RUEJIM$R,'X40%)%8ODY]L[ZYJ=7N?7OWZJU?OX:7
M1YJ+DQO&*22^:(VZJ?5AM[#XW/[)J7'*%"@6%?D9/A<.6&Q:+B\M#"#X@"4&
MP%:W$X$I35WSE2+SE8>;I8CQ:D"2'^"1D5]@>%CW^HN(S]4S::KS/@6?WVVS
M:>%*:3ZH8(<C$3Q\TK+R:]=O-32Q/G3B]&57UQM>=]T#[@4_?A(6'IZ9G]\\
M.#3&8)+_*!6$@:F>BK+XAS8F.C^- M"W=PS,*<L=(O1#2L&<HE,H$Z/9G][>
MN79XM]&F%;+"_$A..">2AU=,466SI:V]S3[H4AH8F:]0W+Q 9L5R/F$% !!G
ME52+U4TUS[UPC:ZJ:AN>(H\S>RMQI9'N3K;" GS3>8GQ\ZC+RYIN4M8S-M38
MM\_8WFZOO:V!EL9*<3$14"Y9S3 BBY66;-QS^>[SJF_=X]!; ":3C*,/E.'J
M(B*\CN[<M'K-0G%^;H2@J.3J#3HZ9O86N^U!M+=L6+9 4$1,$"&^0'+M)H/]
M)Z[=>YI>5$ZC_VC!(0QW=]6DIT?</6]KI"0M)L//PPGC$))8N%1IJ[JNA=E.
M&[L]5CMUU^U8Q[M-27"SLMCR)0)\O'#HQ8>H@I2*I=?CJ'$JC76!_F>@$1]A
M[I?VR.M,=\_DX04DI1%22T0$ERT56J6EIF>_SWZ?W5X[&VO-+9NE)"5 7X!S
M\PF(RVXQ/W+*-SXJHZYW"#_86E/TRNWA2:T=JHNAJ49@?#!.22N;8YDEE016
M>]0,[949.4\ONSKH*BZ3!I!\@-0J017SJR$ON\8(1";T'P:NZTM34F#L#8N=
M6U:R;I04 "B:[KZ67%(_.#4U\]:0#1LV?RM_KU),DJ@#(Q,5#=VODLMO/4PY
M<>?=SJL1)M?"#*Z':EQ\I'@J"'W"#WW&#^WLIW T8)5]T*J]_JMM?-;8!:QU
M?+3NX#-%^U!%FU EQ_O*)WW7'_95V>>ONO^!ZLF7&YS?;#C\5-7&7\71;_U)
M'^6C04KV&,6]SQ4=GJT[C%F[/W@M&&2OW^I]0:OV/5*P?:E@$X&V>8BV\5&P
M]5&PN[MJ;_ JF]#5>\/6'GBZ[N!#1?L@19N[2@X!RL=#UA_&K-\7KF+_0N5$
MB*KS7=7#=U5M[ZHX/% Y$;[^6)BR/49I;XBB0\"Z(SYK#P2MM7UX.3BMNK&;
M1"+1?S[6(>B@4HS'1;^<JQ33W3/?0-TS_T(IF-0I^N27K)0[9L8& +",M2.W
MK)+0Y@,';CTKKFN9FJ(PF4.#@U6W7,Y(B B@$%Q@E9Z3FQ<A*KM,1=/IXK5W
M[V+?O0N-B_,_=WK/ZB4+4!P<<!A8Y>=%BB[G6Z)UU?-!=^_ =%;$T;ZN\J2<
M\)O'K+<)\'+#P9(' !8L1>OM/G+JUKT@3'AT9*2+_3Y+,1%%!)< #"SDD5PH
M4;E5&Z_[/Z\;GNJ;A+I,5N1]]CE_V&+C*GEI44@I5A@ !FXG'J0T=?^J%$1\
M^FN/FSM%MJ\!)/@![@7RDB8'-=V>A^54S:09;<SY]O)TQ'&5[>M8*@5-9 66
M09Q<7 @DDAN%0O$)BP@O7B:U3E5%:YNYA:5G<$C6]Y9.&IWPQ^Z6A*&I[MJR
M=\]L3/2F+S[(#GM'3$Y9Z1!A$%0*)GV*,C$QW/70QT4-+24M!$<AP#.$ P"_
MF,3*/?M//7H5]S+Z74S<N\N7+ZU=O0H)YX3#.+A^]&X!%FTVU;P2YOJNJJIC
M9(I$8/;4XXKCW4_MGU$**!8GI_@"F6V'#YV)C?6-??/F793;A=.&*Y?+ 8
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M+163D\[W7L36UGZNJZZJJTQZC?$\MLMZX_+EK!9^ . $ /B>_2<^%-1WC%#
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M;'$%U&_87(_.KVB;G*#0YLX^1"-.4>:/^% T.+#'/?'%_Z 4Y+K<]%OF)EL
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M78=*;OVKP([K@(DK8'(;4@V=8&"+/[#1&]#T!@SO0$( :H&!+Z#A#R@% )M
MAW !#%T!(P](&O3] >T@0,L'LA#02,Q< ,OK@/D5P/@2H',)$I%MEP'CJX#9
M+<#B+F "&DP@L!4\MKN I@>@=PLP H\*S#00T D!U (!)3] PQ<P\ %VW &,
MP=SO EH!@$8 L-4;T+X%:+D 6M=M7-_FEW5-CM-IE#E5.VCVS%^6#4/Q"6TP
M..#HGO@Z]4O_OU(*4EUNVB]*L4@5V')\IWM$?GW;M[HJ[_-'-)<(R DC81P
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M[C#_B9G9=E,3G0WK5XD)"TRG1 F);["]XOBRZ75Q!W:X*RTAW'*;AA ,X.8
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M7R&LJ:XN]OGS9X^>O/J8F53=5-W>/SPZ,4FD,* 1'QD^SHX6ZBOEI80!3AY
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M&8R>.;]_,AX[WEV>'GO?TEA[)I35OB,Q635-6$@I.IKJ[E\Y9+086"D$P&$
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MM]"3E5[, >/GA"/ *AI:6]G@S%U,?-O@&)GU3*3B>W"-L8U)YZ\?T5HLPR/
M!ZUM*;-LE:[-L3/>CYY&OLL'HV5GYGW^%!;B=NF MK'ZPL62O%P(A,@"V25*
M&SS]@_KZL=,'B.MOKOD8\,9]A[W^<E$>3FY.7AB'Y%KE[>=<_",24]^G9^5D
M9R6\>OS"V_F@E:ZLE!@'%X*+5U@*K6I]-22X:#2O@TB@,#IJBE)";KC9ZFQ&
MRTYW"031,C#W"'X=]3XO)3,GXU-B]&.OP(M[+715A87YN>!<'# ._@4KY(U.
MFKM&16?7LXYEDLD<3/OT<O\> _E%PD+\W!PP3FX!<4'I%0:['&X_#'N5E/HI
M(^OGI<J.BXI\$N"W?_>N13+2, XN&(Q'0&RYFLG9_9YI41E-(WC2%*%_JJ>X
M+#[8QF3VQ0>H% ]RRHI82L%DT!AD' [;_,#/9>.Z13)B/-P(3@%AZ16*>MNM
MG=U]GZ1GYW_.^9R;E_H:<^NF@ZJ5&J^\%&NI>19RJJ:Z3F$>KZLAI8!6(BW%
ME;YP=YI]\0$JQ9V$Q'(&HW=N*P4>B^^NR(A]8&6L,Q/*:M_AF.SJID$2CD0?
M[&K^^-3CEO5Z@W4+^!%<<!0O0EQZK:;!61>_B'>9R2G9>;FY<:&!F"OV!XW4
MEDB++%@D9VGG>.?1B\RR*AR=/OT+Z6TJSGIQP>^8NKZ*-#<<Q@43Y !D-VGM
MN>'[)"(A]6-Z5G9F6G+TL\C[+OOV[!"1D>#@9LU&_G-Q<Z^'_\:R8:!2?'SA
MZK)KD;ZB$#]KJ5$$-T):3FZ+L;GCI9OWGK[(R<D%?]K9GY-"0ZZ=W+56<R4@
M*P)Z#K>PK.K2C8X7O%_6M/106-TH?@ Z14\EI>SY:W<'M=5R,U=I&F[19<(K
M#7>?\OY44(>G3/ULVIB%C,,.?<UKR(QX^_R>&X2?F]NCZ-B,YFXL:6XN;-BP
M^3OY5TI!IS.QHX27&95V=Z/4CH<*;P^&Z_C"]#T! T] WY?;Z+ZZ4]21P+3
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M[V8= DY&2IB3DS-JU"CX ZJ9,&'"+TS29&5E#55$<]AU'WS[]DU65A9.3#M
M"CQZ] CVW@=P8M*WC8F)86)B@C_H#7IZ>MAC%T;.%?7%O__^"QF;F)C 1K0
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M5U?_Y1D+P.K5JZD/*@PGIJY9_]Y;PL>/'\-&U%%<7 RY @-HV*@+[N[ND#W
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M/PDK*W_]W!/85[\#UEZC/=)T8!6M &T'YT<*],E"@OD'3#]@_ $#"?H?T/T
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MTY=/#5<8=LFJD]&C1_^V1?5PW@,5T8#T6H;#=$5/'X?OWF8X9X:TL! 7J$5
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M0G%6L?U!>R#QR9("2&0A 2$)40EN+F[PEQDJ,W;OW;W_T/Z-EAMUE^G*R,D
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MG5L )S"*;10'(P>0%(9+#8'-[:NW/5P]S-:8C1N'28H^>?_^/1AOK%^_'M1
M<A%Q<'"L6[<N,C(R+2V-INU.KUXE^OL=76EL(BW5N4$,QX[3-]8_%GKLV>MG
M5378WET,&$1I8P I(+<?HN>+Z'DB>FXFGF$):4-V;!CER8?@Y^=?L&"!E975
ME2M77KUZE9Z>7EI:VMS<W-345%%100Z<Y^/CLV3)$E;67EY(4Y@U:U8_2^U
M$[QX";S[#@!T RN.55!,<+;F[+,A9\$H,_1\J):Z%D52@*[:Q[6711AP!GT#
MAJW@<AH:&@CUA+K:^J;&7XQR 115UY"Z7>'DX#188F!O8^]DYQ1X-/#&M1N?
M/G[J^8X)-"*AH:&4<)QCY<=V=X-H:FL>"3P2^S*VN P==H#R!/T<9$,&C"#-
MS,PR,S.A+'H%W$>@!2=/GMS5 VS4G:Z6U-A3R;!>47M'.[&!6%E=>?SX<>7Q
MR@P( ^@"0=<X67&RT4+TY$:(DN(2>VM[ 78!-@8V6B4%J*A %,(>NZ"MHPV^
MS)_UXJ,@O\#/QT]UIJJ,I PS@(D95&P\!YZ?B9\?X6='V$%YKC%9$QT5_?CN
M8Q\O'W"_ADI2H N,.M 7@@W$AMKJ6O"LH>$@T?WS?<8(&?F\>/'"S=UMZ;*E
MXN+BY"+BXN+:_,_FY\^>?_OZK:^(-;WR\-[#G5MV@ELC)"!$=L7)Q6F^R?QN
MS-W/.9_KB?5P HR_'D1ITS'22:3^R,(CI//-'4U<;R:D#MDF4LJ3/QP("POW
M/R9[\/"!GIX>G Q!>+AX.+DY1RN,7FRX^/*URZ!9.7_^O*:ZIIBH& Z'$Q$6
M,= W\'+U@I/1TJK6$^H+B@I2TU)?Q24]?QR?FY4+^Z+:&[A&$1$1./$/^/CX
M%NDM\CKL%1X6GIJ2"C1955555E;6DR=/W-W=]?7UV=F[O=$'5]?UOX"%BQ:>
M/G<ZZ7T2Y3TK:%MGS/AYVA $Z(95554='1UC8F*^?/E265G9VMH*_LW(R #J
M,"0DY-]__U565N[U=4/W*X.!K0>RIY[ANR+0 Q44%KQY]\;.WDY^C#QYC3VH
M1>,5QR]9N 2V)LU2V!ZRY>7A!;TG15+45 ^\EH+,X<.'88]=\/+V>O?Q74DI
M>H[N8(#]DH"-AHAOW[XY.SG+R\D+\@LR,C*R,K/R<?$)<@GR,//@$!P+PL*$
M,&VPV)#P,N%%W N_(WYFJX;LQ0=9]]?6U*9^2GUPYT'BR\2O>5]KZFKZWWTS
MPKEW[][6;5MGS9XE(-@YL\O-S;U]^_9W;]^!NM=SR-$/41%1F]9MFCYI.C^>
M'R&M#>?AX=F];W?*EY2*ZHK^MSUC_)T@2O\$RED<QQL&(#I'T+44<VU-'*XE
M)/\!DI'-B8$  (  241!5$),3&S %7;W[]_O>9 C0  O@.?#3YX^>>V&M6$1
M84!2!)\/GJ<^3UA4F W'!I3*,OUE'JZ]Q*^$,^B;LHJR=Y_>1=V[%Q1XWM_]
M9$)L/.R+%F] (O3<0_AK@ $T]!?]I?J7KUY.24NIKOEY$#:!0.AK\<I@Z')-
MO0!;#V1/$\-T12TM+<DIR3=OW]S\[V;*/0*U2$%106MA+U,CZ%H*>VL. 0Y&
M-D;R6HK;MVX#24'EX9!E965 B\!.20!Q>2+HQ)5;5]*^#'8'!.R:!&PT1&3G
M9%M96?'B>4&AT=/3L[.PB_"(@!_P"WJB!,+(BK!NV;KE8^;'U\FOCP8<-3,Q
M&Z<P-)*BK;6-4$\H+BB.NAWEN-\Q."@X\4UB?G$^@4C#VX&1QM7K5_67ZX\>
M,YJ3JS/,#- !>_?M_9+Q!3S@-)WN$78K;+71Z@D*$WBY>1&2I !US,G)J:ZN
M#C;%P""!*&TB'V[NA>@Z(_,=D7GV)HXW$U)&NJ18L&!!41'ZXK\OT"%F9L;)
M4R=GSYX-)R8UOD*CA-0UU7?OW?W@T0,@*<Z=/P<DA8BH"%E2@,&]JZLKG(RZ
M5K6AL:&BJN+9BV>>/IX;-VTR-C0U7K;JJ.]1V!=UWBB4EY>#JX9=T XS$]PA
M+5NN?^/FE2]?4FMJ?TJ*[Z3W!<[.SCUW&0R&KOY[ EL/9$\KPW%%8$3[(N&%
M=X"W@;&!L$AG #%65E89:9E9,WO9L ,DA8VM#2<O)R-+IZ2@:9;B>Q_GOP F
M3IBXTG3ESCT[P\/#2XI+ZNOJ^PGRW0_IZ>FP:P19LF0);#=$9&=G[]FSAX.#
M=,X.'1TO%Z^\I#SX ;\ A8%CQ>&Y\:!'3,])_Y#ZX?B)XT/RXH/\OJ.TI#3Z
M8;2?MY_E9DO=^;H6ZRR<W9QO1]S.^9H#)_@3("_K"3X7/'O.;'Y!?A96%G3?
M)R/"(\AC?<@Z/R^_@=C0SVOBGERZ>$E'6T=20I*=G9V\N9>?G]_)&9,4&'V"
M*&TXCB[/-'9!%A]$M&T1=2<3I]M#*"D^?_[LX>$Q<^9,4!V[-%"_SNC1HR]=
MN@1GTX.L[*RH^U'[#^Z?,+%SK7)7> 5XQ<3$])?HN[JX/G_VG"PIU-35R))B
ME/"HQ?J+G5U[.2$"SJ8'P%5E5>67["\G3I^8KS5?4$B0#\\O+B:QSFP=[(L*
M;Q# >5!0$'BJ84>T )H&Z"^&!DO#PZYF9Z75U763%&124E(&/[@'WWG[]NWO
MW[^'O7<'3D9[$5'#T%X1D *1]R.W66U3G:^*Y\>3/V5F9A8=)3I1 3X=%"%+
M"AL;+BXN)B8F<"^T%FC=NGFKNJJ:^I?<,3$QL%/R"!+/-VK4J)DJ,P]['/[T
MX5-Q83%-_0>%@ !XKQ,# \/PG1&5E96U<^=.%F86(/7 50CQ"TV;, W\@%]
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MRNTKX,^^_MP_!-"(OKZ^>P_N;=RVD9Z'GIR.''X#A@2#H<7(Z<@=/7YTH'L
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MVI^WW[Q^TV>?C_R2Z4I3()D[UNUH?=B:$9>A**-(2D[*P<.AJ:^9FIZ*I13
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M9^CCX6,(""RM;7*N7W\Y\')A.<O(.L\4</_#O_@6&,EUB0BEL K"Z.W%&!W
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M(4@M!(Z&FH8!7@&1?I&ZZKH0V8LN$35;91:?&M_6A<LQ42I]\=)%=75U5(!
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M6'FI<G!$\+VR>R]Z<4OT_A0@@< GAH>&#X4=@B^._C8Z&CK5):KVR^RE1*2
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MHQ,H!7;]4E9!ULO?*[L@NZ5S]FH6<^ KI2!%*(66ME;R\>3ZYOJAD9_O;>$
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MH[.K<^?.KY1"7D7>-\PWOS@?G"CN@)]AFE+035,*0T/#"Q<OO!QX.9^]+1R
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M[Q1YH;1Q,9WX&'D]4M]4#X[*:-G7KVZSW";K2E9R<C($TQ!_$!(0@NG_*:6
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M4U,SXU1&_\O^!?@Y>,W>_EZD+L)!/^Q6%!4UE9*RDLM:E_,7?IB>F7$Z0]M
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M-_='R8]^.G4*6$MP_"7Y)6'^87;+[)9J+Y65EYTI.I.7AU=66G:#U88==CO
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M?W]_0V-#3GZ.[SE?0PM#CR"/XO)Q[&MO[VH'>W?J_*D%2@N(.P11OWS1\M#
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MSO&^D?^0-V\S0\/.;]AD-7/6YT1&V+#'!9=@86Z1\30# MF?6W%&T<Q^XKE
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M\$W_??B1Z'XG_51U5:?/F@X!#5AGT,40G+&SL?/P\'!R<8+-!?$^>3B!//0
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M,1@4$KF"  H,@\-1:,S/^W0!8%!+L+GFD?9L#Z>#=+14W$I@??=4O]R&C_V
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M7[\O!<*@H)/=V:VO3H1>4=W)SZJAKA.2DEX^.#((642C4;FWPT_JLRNIBC&
MCZFX)&\D*<8@8V_+\B-LK;4IJ*C-3MK'OOY4VCT^!8$25F C4"C@];6N*H#[
M=AJ]4E=?<_/404/Z;31*=I<.9=6E-TV,+'T?C/*-VI>9H78:EH*;^>G(6-FW
MN_I&=$R@II=Q1$E!Y+^ OY44WS,RLYSQMOM*RKO]83G:;JEBY\(9#KAM-?,@
MTPH"*86#E'U!*FX@%7^0:B1([3I(+9K9_(:&8_JI^.RHW(H7M3WYM;WYM?T%
M^-174--3^+ZCL**ML+*KH+*OH*J_X/U@P?N!@NK>@NKN@@_=!35=!1]["VH'
M\*D.2'V%=9V%=6T%M<#?^PH^]A=\',3_UO04U*SEQZ>^@NH!? +L5/4"E@LK
M.@LJ>@O*!PHJ!@LJA_!GJ>HN>-^U=HH>?/Z:P8*:@36#/84?.PMK.PMJ>_$E
MQ)]Q$#AI05U7 ?#'C]U 80IK^@L_#!16 V?I:>B>F%N$ :KC9TFQ,7A)D5EP
MS?ZSI B-BQM<JEI8^4E2 "\J) X-[6E\4?30T<O)2D%;2\'$+B@]^\,H9'@1
M 61O?964<5GX@@&UJ.2ZI"",I1ANJ,WUN.PN+ZS.P0A(BD,.#D6#@P,XW,;]
MVU^S)BF^;<B]+BFZIJ$S?R<IVNH_1+F?-9/G%N*@)2,CN^3@U#$PC,!_F H'
M@TP-M)2^>1I[\M@^:E8N=:,CKD%/L@I;!D;FH3.#7:_B7H8:'3<6IO[JI?B'
MD@*Q,#7;];$^.RGF,'@?![FZD!B/C-DYG_C*SOX%' Y0!%CX KSSS6Q16-B%
MW0)<["P[N 04%7<:&.@8&YM]P03/+BU514E>-GY.5F%9/7ESQ]"4O)YQ" 0!
M=)ZXLM)2"PL+<G)F6H9]V_F2_8.J)WXE*9;Z<*/%+VYY&JI)L7!+ZE](=7Z!
M+>C ?1W<HE?F8#.?6BINN1\SYR8CD]<[8!20&_ZRLV-\:3T#"C8S_#[^8Y*:
MRSZA'2S,"CJ6@??RRH;FAI=^FH\A  >T';*SZN7#JT<N&TLK2 AM%U-T#+[Y
MH1\YO+"ZT6)PW)J7 B\IM"FI>#AY^%2U+[E[O?@M^06%^2^+:S\US,Q^WB<-
M#EM\GA%E;RNLI27*(*E.):#)S;]31EA&7573T,3$V,04P SXS\3$0$==49)+
MG)=>0E9%4NNH9^3=FJZ1&3AJ!3^;A<&AE^&+@Q^*(Y/]%4\=49+1-K0\[_6H
MO&9R=16*#P)%/;L3?L: 745-C!$O*5(VDA3?-N3>LI5"Q<CB0DA\Y*V'C[)S
M":OQ$X5%K]Y^:JL=7AJ:7UD!+CD.N!R#[<VY+N?V\#/32AM:JKG'!F25M@Q,
MX.??OJZ1QF'A2S/SD]WY=Z]=,)969B-AHP2QLG,2)061_R;^C:2 (E"]XY"J
M]O'\#P/W7G5>2'PF<R64T<YCBZ4'R,@+!/8%&0:"],-!.M$@K4B01O!6O6 V
MJTCAH[&*5](,_1X9^F49^N6"?7/!/D_!'H_ 5]+ 9Q/ YV^#+SX!V^> KSP'
M.^:"G1Z#G1^ W>Z!/>Z"/1^#K^:!O9^!??/ OIE@W]M@GV2P]SWPU6SPU5SP
MU>=@KQRP9P;8_1X^O^L#L',FV/$9V"$/?#D'?.DQ^,)M\#G@%!G@,[G@\\_
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MVA1DI++:%H?][R07UG6/CDV,MF?=BW8XM=O T(A=6,O&/NQN>6_C#&X&_MD
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M?]P%1W%Y0F*B$(<]!*UKS;^=>&JGM:&JOK[^UN.7+SYO*(2@OG7;% 3D_WM
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M/7O6##YZ2U>$)#]XW3W2@__JE_$D= QLZ$U2PV6' (=Q2>%=55O+Y">"'2\
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M! 0$! 0$Y < 2@H0$! 0$!"0'P H*4! 0$! 0$!^ /\#:K39"O+H''\
(245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>image_3a.jpg
<TEXT>
begin 644 image_3a.jpg
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MOMAQY!8V.5W'ZKU7,7W;>0Q=>Q(FLYV@-\(.6OTV0LER+63,UT"BQT8(+'=
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MB;9-52B8EQ4*DZ8](!AS$$;[7^'TR\0OZE@X8L(M?A_RQ>+W/B1,'$B8/*!
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M]O'#$R\?!+P-1U)Z)O**OC[ [A,Q)%P\X.-CBU&C3$JT9YTVO6$Y_RQLSD;
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M?="C)9$^3=)FI66@JDEDJ6$+-&G1!F;T&,Q,8=:Z!9HWTH=6355(2TN3GVD
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MK8*FIB8+#2PE*85V9NVP=<M61$1$P.^>'_X\\R>F3)\"_0;Z;.\)_;DF39K
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MSC8F,?OI1[DWC9LTQN[=NV/ GF%9?Y5@XDS:W,,'#T4]BGXF3(+X7+Q^_5I
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M**7LKB0E^#P$'@G$H&&#4-VJNG2#XTH.RA0K@R%=AF#3PDV(./=M=C1/G5$
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MT&/F\N7+.'\^#->O1^+>_<<*B'VM )<8!;6D5$5XD/_^[G<YW$GCXXO_S'5
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M)X\Q=^Y<E"U3-A:0:'Y2DH*??I!#6PH'FA]$QG-XG^'8NF(KKEW2K\%@0H(
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MQT\DGHZA5OHY8%ZE:A6AD7"^A(D\A]'K6=?#C)DS$OT;)R0(/-W=W9'9*+,
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M!#]4J+IP[0*N1UX72L>;9V_PQ[O$ZWA_S3@9<A+.@YU1ME19';ZT.J/CX.B
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MTV28G4DS78:9R%'H@14Z I,^0_J@9MV:TBTA(&C2L G&NH_%T:"C.N_%Y(%
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M34@263 _K&VLX3K:%9/\)J%7]UZH;U4?10H6$6#,!)M@I6?/GC@4>"C!WUN
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M^>J7C/B "8LJQ8L6AYVMG2BWO7V3N&LD*#EW_!Q6SU^-MJW:2B=.YBQ__EF
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M)2.A:>3Q7<L%<S/>M6\7G$<YHU:#6LB6XP-E@@\\*RY&F8PPQ'F(#C#AG^/
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MVMDYY'41A)"FTW]P?TR?.QTVC6WDMV;UCG1&5B\I:QY?!!X.1 O[%DB9.J6
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MIX^?XM#>0YCB,T4ZF*1)"M!(^;.L%=*;2&E@:[YUF]8Q10*MV1;^M^R<D,Y
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MA(:&:O**]WP1,#E]\K3,G357UPE]5YR#GV3Z1 J5*J3?B0;MF3-G2L&"?[J
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MF(PR@,EG!C#YZOG A/NZ9>,6Z1;03>7TTWZ25L\]*-G8%$R>.%F#?"J3T/H
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M:M>JK5DE=7!_ZVT%4C3A#^P_4!<^U0YK&9\>FM"04%5%P=@IMN)*3';;^/^
M$S9!RNB)-2BW7[A^0=9L72.M_%O))VD_T0J/RK_RF48@2Y S;<HT>7C_H?*H
MN:\X_P;V"Y3R5<NK>51<@33<T4)%"VDO!]2 I!@[=^S4W@SXJ@1DUL]GGL"]
MINF431B* -+1R").GC!9N<N)U7/$ADJ6D6H=M"E *9LNUP'7F*!TY8J5Z@9M
M'5S#Z=.G5;:U=.G2SP4F*+[0''SEZI4$E;SM@,E3V5ZM'KWS;H* R8%]>PP
MW5)R97.4CU.ET/?@GC-O 5X ZT(%"TF:3]+8,F'O)M/YW[QI<UF[<JV:SI$U
M-]<D\TCIC_=NJ=&?L[.S3;@BQ8=2M'@QF62 ,-K?R9\G;;TS8>/K1P8P.60
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M>7/G53 "/2/])^DEQ?LI[()%^I;@9V_<L5$N7[^<,&!2UP F62S Y&E%(S[
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MLN?1TG1<E2;S!3\:H\W'7SZ6'W]XL;E9?*^)S!_!HW\W?W'*[R2ITJ:*J=@
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M9LHQ:%(?C6F35+TG0\8,>CUP9UDXT\.GR^.;C[6O!;YZ>'BXN!9VC:%PL3'
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M-("DN1DJ3]5J554RE2"!C9!#%C47O" (<LSWSN2428J5*R8]^_>4/?OW:%!
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MF3GA_3A@,1\D.+5N3*:I(29K:-3#OR9(9D,#F%2N7%F-N* KP</EY\F,<3@
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MDY5+5^H<,ON[ !J()\&R 5RKA/#3SW IX**5G55K5]G6TM[]VH\S?/AP%2/
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MG1@064OC)4J64 43JBQD<?A=N*21T9$J8>Q>TUU[(EBH;)* HK%CQFJ&%$J
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MU/141,=%X^+EBQ@T<!"*%RV.HD6*9E=Z9Z*D:8NF&#MQ+"Y?O8SW'T0A58%
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M(=&(3TK_5<<N$ @$ H% (! (_B-(/O]_T I(2GHF=IWS0N=Q#BBM/0O%].=
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M<!^$^YS"5H=Y,-+HA.:R35&G<4LT;JV&GKT'Y#EOFD6O65\692K70LV&S=B
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MMM8<4U2K0JM]4]1IUPT])YCCD/MM1,1G()&L2G.=<T9&,M+38W#UTDF,,#5
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M%K&A]_'LUF[,GSH0=:M50-NN/6$TTPEV>Z_CX<MWO&]]_KJ(\+\,[Q.SX;I
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M2D8:V:FBKSV]R^Z58A!MU)E6;=M0O6D'9J[?SO.0.,)2?YQQR$VRTE-(CXO
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M,0_"[TI&*MEQ8F#YX07;5BV@5>-ZU&G:%@6#<?1;N(M+CJ]EX61_7B:4%)M
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M8_[Y)UQ[Y4]<\K?PLM_ 1$JPV%& R7#&CS\@VL<_SW:(B? AY-UU[$ZN8/P
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MBTYSS\7W;T<+E(M<Y"*7_]_E_RJ8R"3[VRQ*5G9.IN\O6K",Z_^6YI;U/:L
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MV:8=K5NVH&%=!93*%J-"\8H4+:*(?C\S#M@]QB<^C9CTO_,V/@=,7@DP623
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MCN)^LK__0MQ7/OCZ1LC:]XM(LS 9"='$AW\4SV0W6;L]=WO#_VGO;E80!((
M +__,W;K%ATZ!75P#?*W,%U=822^#[K)SLQN*PZ(>SI?Z\OM7C^>ZU]W S@*
MC<E?2>TG-ZO^P,K<5Z66AV[&JMZ'/9;\MN;4UM8=PIER'I;VRKF:SCD-\_WS
MFD*E^>?D-*ZA--92N*&>W#6<'6Q[[FWLW/!%ZU"Z#V?V7LZ<KZ]KYWO'$*V/
MU^WEZ6W5-+%[[ZLTGL>T\?_7Y[TBMZ]Z9N?V8ZW3_/TR3<SGRG( CD9C @
MA-.8    X30F  ! .(T)   03F,"  "$TY@   #A-"8  $ XC0D  !!.8P(
8 (1[ 50L[#6%823:     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image_4.jpg
<TEXT>
begin 644 image_4.jpg
MB5!.1PT*&@H    -24A$4@  !=T    %" (    _G-)-    /4E$051X7NW8
M,0$ , R L/HWS?X):)_D1 (S     *RK_@0   #  E\&    X(8O P   '##
<EP$   "X43U4W [R\972[0    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>image_5a.jpg
<TEXT>
begin 644 image_5a.jpg
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M\2#PU'K&=[?'2%_WBUCOV*4+IV[<(%;$DR:E>$E/PN?Q%<[NG,NX?FVH5*P
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M5ERZCWM8"J')&60F11'S\A)/C\]G?)]6%+(R0U7'%!WKBM1HW9O9+@>Y\3B
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MNA30^M?X-1/,)ACZ,>;V$6YM^9H5W]:D886\ACXTP<C$%AN'PGPR>#3KSMW
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M[:*4RV>-G87A'#"<!\:F-H9SR)5*-3^G^X!5;-AZ@9#@1SR^=Y5K!U>S;-)
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MDK!XW1_O$"&$$$(((8000HA_B?\:UJNC)B.B$_&]&L2B;1?H-'HK#HUG8M7
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M3YT\ULHF%_F*U*5R[7X,&CJ)18M\&/[EIS0J5P!GPWXY6)M1R*44_2?-8FO
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MS2[6TZ\'#!C &=J<=9Z+0$EVI-G>-/=I?Z:J,FJ:3-G?E+'_K07[+XGUU,.
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M4 ?L.;@'$9$1O.]]#K+!.>G_?[&^64ZQGO9XJL;8O7TW(B,BD?X\/4_C0=>
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M$#1LT1#F5N9"()*TS)4G%RK:5,3H":,1?3Y:[ JH;M05J&RCBOM2W"4$C I
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MEE5XH?GGK>:?QT\?"UG<HG4+F)7X=Y3UTI7R_"7BSL1AU=)5:->ZG10VE+G
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M^K L;8D>W7I(%X.NCT,!O^?P6DX,G(@FKDUD?8AG?8%\FGM'%?B/\)>NF[2
M:Y#%'Y^N/I+#P0*D!,QJ[BTJ6:]"A0H5*E2H4*%"A8JT0,^B4PC,.DR%?I,
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M/Y&6=NMRUBB8KZ 0E22(Z=5-)2PM,&[>OJGUSB=(>-"^HE>O7J+NHWHR:==
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MX2.EL&!0R$#(65YSCN&V;=MBR[8M0GJ2R$UY3%S+^/M7KEU!V.$PA*P,P=C
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MXZ<PT'.@J-U)F) \*J!? #4L:\"CCP?V[-@CI C;N"?,F@!'9T<AT#5RD58
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MXG???B?!DU01FAB9P*RXF;3^Y\J32PBJCAT[8MK4:6*W0PN*N/@X(1 ]!GC
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M$!X>GOR]XG/H]%)04%!04%!04%!0^&>A,^TXY;6RW@^ZN@R7'0Z=K1><1Z]
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M<3$6+9HUQYC18\3F@O8G:27E^-E4+%^\<%$* ]8UK44YJ9=33SH06G=H#9\
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MGS]_?FK4K,&TZ=.X<?L&L7&Q*)2*;WR&@B (@B (@B (@B (@@ ZNR\&LOS
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MCQ\<%Y+'?CYY[>=0L-E\*K=?2>.!FYG^^UDN/0@B."J.Y+0L5&K-NRM(A?\
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M(<A7KU[CPH4;7+GZ4)DW+PD+BWFK3.6Y&1NNM,<+KR?WN'G#!9<;-WG\PI=
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2I65ZNSP+     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915922781792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Feb. 24, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_a_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AGILENT TECHNOLOGIES,&#160;INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--10-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001090872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-15405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">77-0518772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5301 Stevens Creek Blvd.,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Santa Clara,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">95051<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(800)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">227-9770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295,701,853<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Document and Entity Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>a_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915925407984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (Unaudited) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Net revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 1,756<span></span>
</td>
<td class="nump">$ 1,674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenue</a></td>
<td class="nump">788<span></span>
</td>
<td class="nump">764<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">123<span></span>
</td>
<td class="nump">117<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">419<span></span>
</td>
<td class="nump">417<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total costs and expenses</a></td>
<td class="nump">1,330<span></span>
</td>
<td class="nump">1,298<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">426<span></span>
</td>
<td class="nump">376<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(25)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before taxes</a></td>
<td class="nump">410<span></span>
</td>
<td class="nump">319<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 352<span></span>
</td>
<td class="nump">$ 283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic</a></td>
<td class="nump">$ 1.19<span></span>
</td>
<td class="nump">$ 0.94<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted</a></td>
<td class="nump">$ 1.19<span></span>
</td>
<td class="nump">$ 0.93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares used in computing net income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic</a></td>
<td class="nump">296<span></span>
</td>
<td class="nump">301<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted</a></td>
<td class="nump">297<span></span>
</td>
<td class="nump">303<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Net revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 1,323<span></span>
</td>
<td class="nump">$ 1,263<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenue</a></td>
<td class="nump">556<span></span>
</td>
<td class="nump">545<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceOtherMember', window );">Service and Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Net revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">433<span></span>
</td>
<td class="nump">411<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenue</a></td>
<td class="nump">$ 232<span></span>
</td>
<td class="nump">$ 219<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915926314864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 352<span></span>
</td>
<td class="nump">$ 283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Unrealized gain (loss) on derivative instruments, net of tax expense (benefit) of $(9) and $2</a></td>
<td class="num">(22)<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount reclassified into earnings related to derivative instruments, net of tax benefit of $(2) and $(1)</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Foreign currency translation, net of tax expense (benefit) of $(1) and $0</a></td>
<td class="nump">91<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Net defined benefit pension cost and post retirement plan costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax', window );">Change in actuarial net loss, net of tax expense of $0 and $2</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">67<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Total comprehensive income</a></td>
<td class="nump">$ 419<span></span>
</td>
<td class="nump">$ 267<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915923471792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS) (Unaudited) (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract', window );"><strong>Other comprehensive income (loss), tax, parenthetical disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax', window );">Unrealized gain (loss) on derivative instruments, tax</a></td>
<td class="num">$ (9)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax', window );">Amounts reclassified into earnings related to derivative instruments, tax</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Foreign currency translation, tax</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract', window );"><strong>Net defined benefit pension cost and post retirement plan costs, tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax', window );">Change in actuarial net loss, tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30755-110894<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915922912048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="nump">$ 1,053<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">1,459<span></span>
</td>
<td class="nump">1,405<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">1,111<span></span>
</td>
<td class="nump">1,038<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">258<span></span>
</td>
<td class="nump">282<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">4,078<span></span>
</td>
<td class="nump">3,778<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">1,147<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">3,983<span></span>
</td>
<td class="nump">3,952<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets, net</a></td>
<td class="nump">810<span></span>
</td>
<td class="nump">821<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">188<span></span>
</td>
<td class="nump">195<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">713<span></span>
</td>
<td class="nump">686<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">10,919<span></span>
</td>
<td class="nump">10,532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">540<span></span>
</td>
<td class="nump">580<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee compensation and benefits</a></td>
<td class="nump">296<span></span>
</td>
<td class="nump">455<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">521<span></span>
</td>
<td class="nump">461<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt</a></td>
<td class="nump">238<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent', window );">Other accrued liabilities</a></td>
<td class="nump">341<span></span>
</td>
<td class="nump">329<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,936<span></span>
</td>
<td class="nump">1,861<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">2,733<span></span>
</td>
<td class="nump">2,733<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Retirement and post-retirement benefits</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">542<span></span>
</td>
<td class="nump">536<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">5,310<span></span>
</td>
<td class="nump">5,227<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (Note 9 and 12)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock; $0.01 par value; 125 million shares authorized; none issued and outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock; $0.01 par value; 2 billion shares authorized; 296 million shares at January 31, 2023 and 295 million shares at October 31, 2022, issued and outstanding</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="nump">5,345<span></span>
</td>
<td class="nump">5,325<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">541<span></span>
</td>
<td class="nump">324<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(280)<span></span>
</td>
<td class="num">(347)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholder's equity</a></td>
<td class="nump">5,609<span></span>
</td>
<td class="nump">5,305<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 10,919<span></span>
</td>
<td class="nump">$ 10,532<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915922699632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited) (Parenthetical) - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">125,000<span></span>
</td>
<td class="nump">125,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">296,000<span></span>
</td>
<td class="nump">295,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">296,000<span></span>
</td>
<td class="nump">295,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915925589808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 352<span></span>
</td>
<td class="nump">$ 283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred taxes</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Excess and obsolete inventory related charges</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Net (gain) loss on equity securities</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent consideration</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash expense, net</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable,net</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(69)<span></span>
</td>
<td class="num">(54)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(27)<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Employee compensation and benefits</a></td>
<td class="num">(174)<span></span>
</td>
<td class="num">(210)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other assets and liabilities</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">296<span></span>
</td>
<td class="nump">255<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Investments in property, plant and equipment</a></td>
<td class="num">(76)<span></span>
</td>
<td class="num">(75)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi', window );">Payments to acquire equity securities</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireNotesReceivable', window );">Proceeds from Sale of Loans Receivable</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfNotesReceivable', window );">Payment in exchange for convertible note</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi', window );">Proceeds from sale of equity securities</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions of businesses and intangible assets, net of cash acquired</a></td>
<td class="num">(30)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(104)<span></span>
</td>
<td class="num">(79)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Issuance of common stock under employee stock plans</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payment of taxes related to net share settlement of equity awards</a></td>
<td class="num">(51)<span></span>
</td>
<td class="num">(63)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfOrdinaryDividends', window );">Payment of dividends</a></td>
<td class="num">(67)<span></span>
</td>
<td class="num">(63)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment for Contingent Consideration</a></td>
<td class="num">(62)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommercialPaper', window );">Proceeds from Commercial Paper</a></td>
<td class="nump">527<span></span>
</td>
<td class="nump">240<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfCommercialPaper', window );">Repayments of commercial paper</a></td>
<td class="num">(324)<span></span>
</td>
<td class="num">(240)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Treasury stock repurchases</a></td>
<td class="num">(75)<span></span>
</td>
<td class="num">(447)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(546)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of Exchange Rate Movements</a></td>
<td class="nump">22<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="nump">197<span></span>
</td>
<td class="num">(374)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">1,056<span></span>
</td>
<td class="nump">1,490<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">1,253<span></span>
</td>
<td class="nump">1,116<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income tax paid, net</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest payments</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property, Plant and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Net change in property, plant and equipment included in Accounts Payable and Accrued Liabilities increase (decrease)</a></td>
<td class="num">$ (20)<span></span>
</td>
<td class="num">$ (7)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfOrdinaryDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of ordinary dividends to common shareholders, preferred shareholders and noncontrolling interests, generally out of earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfOrdinaryDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123583714&amp;loc=SL75117360-209713<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3444-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollectionOfNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollectionOfNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowing by issuing commercial paper.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3444-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123583714&amp;loc=SL75117360-209713<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow due to repaying amounts borrowed by issuing commercial paper.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915922984368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENT OF EQUITY - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Total Stockholder's Equity</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning Balance (in Shares) at Oct. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">302,208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Oct. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 5,320<span></span>
</td>
<td class="nump">$ 348<span></span>
</td>
<td class="num">$ (282)<span></span>
</td>
<td class="nump">$ 5,389<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>Components of comprehensive income, net of tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">267<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based awards issued, net of tax (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based awards issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Stock Repurchased and Retired During Period, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,907)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Stock Repurchased and Retired During Period, Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="num">(409)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(447)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (in Shares) at Jan. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Jan. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">5,290<span></span>
</td>
<td class="nump">159<span></span>
</td>
<td class="num">(298)<span></span>
</td>
<td class="nump">5,154<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning Balance (in Shares) at Oct. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Oct. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">5,325<span></span>
</td>
<td class="nump">324<span></span>
</td>
<td class="num">(347)<span></span>
</td>
<td class="nump">5,305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>Components of comprehensive income, net of tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">352<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">352<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">352<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">$ 67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">419<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based awards issued, net of tax (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based awards issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Stock Repurchased and Retired During Period, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(499)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Stock Repurchased and Retired During Period, Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(68)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(75)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (in Shares) at Jan. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295,821<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Jan. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 5,345<span></span>
</td>
<td class="nump">$ 541<span></span>
</td>
<td class="num">$ (280)<span></span>
</td>
<td class="nump">$ 5,609<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139916008771616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATE STATEMENT OF EQUITY - (PARENTHETICAL) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends Declared per share</a></td>
<td class="nump">$ 0.225<span></span>
</td>
<td class="nump">$ 0.210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Share-based Award, Tax</a></td>
<td class="nump">$ 51<span></span>
</td>
<td class="nump">$ 63<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915924386064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Overview. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agilent Technologies, Inc. ("we," "Agilent" or the "company"), incorporated in Delaware in May 1999, is a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year-end is October&#160;31, and our fiscal quarters end on January&#160;31, April&#160;30 and July&#160;31. Unless otherwise stated, these dates refer to our fiscal year and fiscal quarters.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We have prepared the accompanying financial data for the three months ended January&#160;31, 2023 and 2022 pursuant to the rules&#160;and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles (&#8220;GAAP&#8221;) in the U.S. have been condensed or omitted pursuant to such rules&#160;and regulations. The October&#160;31, 2022 condensed balance sheet data was derived from audited financial statements but does not include all the disclosures required in audited financial statements by U.S. GAAP. The accompanying financial data and information should be read in conjunction with our Annual Report on Form 10-K for the fiscal year ended October&#160;31, 2022.  </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying condensed consolidated financial statements contain all normal and recurring adjustments necessary for a fair statement of our condensed consolidated balance sheet as of January&#160;31, 2023 and October&#160;31, 2022, condensed consolidated statement of comprehensive income (loss) for the three months ended January&#160;31, 2023 and 2022, condensed consolidated statement of operations for the three months ended January&#160;31, 2023 and 2022, condensed consolidated statement of cash flows for the three months ended January&#160;31, 2023 and 2022 and condensed consolidated statement of equity for the three months ended January&#160;31, 2023 and 2022.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The preparation of condensed consolidated financial statements in accordance with GAAP in the U.S. requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Although these estimates are based on management&#8217;s best knowledge of current events and actions that may impact the company in the future, actual results may be different from the estimates. Our critical accounting policies are those that affect our financial statements materially and involve difficult, subjective or complex judgments by management. Those policies are revenue recognition, valuation of goodwill and purchased intangible assets,  inventory valuation, retirement and post-retirement benefit plan assumptions and accounting for income taxes.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash and Restricted Cash Equivalents. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash and restricted cash equivalents are included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows.  A reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheet follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.863%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,053&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,253&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,056&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January&#160;31, 2023 and October&#160;31, 2022, operating lease right-of-use assets where we are the lessee were  $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDQ4Mw_0923d8a4-45b0-4175-952d-a7c717b81666">155&#160;million</span> and $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDQ5MA_9b066508-1908-4248-884a-1df299c2bc14">150&#160;million</span>, respectively, and were included within other assets in the accompanying condensed consolidated balance sheet. The associated operating lease liabilities were $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDY1Mg_3682f298-9ca7-4d01-a434-54ee5feb1306">159&#160;million</span> and $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDY1OQ_fa7b70f1-0cec-4130-bca6-58ec8ae1e703">152&#160;million</span> as of January&#160;31, 2023 and October&#160;31, 2022, respectively, and were included in other accrued liabilities and other long-term liabilities in the accompanying condensed consolidated balance sheet. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Interest Entities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We make a determination upon entering into an arrangement whether an entity in which we have made an investment is considered a Variable Interest Entity (&#8220;VIE&#8221;). We evaluate our investments in privately held companies on an ongoing basis. We have determined that as of January&#160;31, 2023 and October&#160;31, 2022, there were no VIEs required to be consolidated in our consolidated financial statements because we do not have a controlling financial interest in </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any of the VIEs in which we have invested nor are we the primary beneficiary. We account for these investments under either the equity method or as equity investments without readily determinable fair value ("RDFV"), depending on the circumstances. We periodically reassess whether we are the primary beneficiary of a VIE. The reassessment process considers whether we have acquired the power to direct the most significant activities of the VIE through changes in governing documents or other circumstances. We also reconsider whether entities previously determined not to be VIEs have become VIEs and vice-versa, based on changes in facts and circumstances including changes in contractual arrangements and capital structure.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January&#160;31, 2023 and October&#160;31, 2022, the total carrying value of investments and loans in privately held companies considered as VIEs was $71 million and $87 million respectively. The maximum exposure is equal to the carrying value because we do not have future funding commitments. The investments are included on the long-term investments line and the loans on the other current assets and other assets lines (depending upon tenure of loan) on the condensed consolidated balance sheet.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value of Financial Instruments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The carrying values of certain of our financial instruments including cash and cash equivalents, accounts receivable, accounts payable, accrued compensation and other accrued liabilities approximate fair value because of their short maturities. The fair value of long-term equity investments which are readily determinable, and which are not accounted under the equity method are reported at fair value using quoted market prices for those securities when available with gains and losses included in net income. The fair value of long-term equity investments which are not readily determinable, and which are not accounted under the equity method are reported at cost with adjustments for observable changes in prices or impairments included in net income. As of January&#160;31, 2023 and October&#160;31, 2022, the fair value of the term loans approximates its carrying value.  As of January&#160;31, 2023, the fair value of our senior notes was $1,859&#160;million with a carrying value of $2,133 million. This compares to the fair value of our senior notes of $1,754&#160;million with a carrying value of $2,133 million as of October&#160;31, 2022. The change in the fair value compared to carrying value in the three months ended January&#160;31, 2023 is primarily due to decreased market interest rates. The fair value was calculated from quoted prices which are primarily Level 1 inputs under the accounting guidance. The fair value of foreign currency contracts used for hedging purposes is estimated internally by using inputs tied to active markets. These inputs, for example, interest rate yield curves, foreign exchange rates, and forward and spot prices for currencies are observable in the market or&#160;can be corroborated by observable market data for substantially the full term of the assets or liabilities. See also Note&#160;9, "Fair Value Measurements" for additional information on the fair value of financial instruments and contingent consideration.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI https://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139916007302864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NEW ACCOUNTING PRONOUNCEMENTS (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">NEW ACCOUNTING PRONOUNCEMENTS</a></td>
<td class="text">NEW ACCOUNTING PRONOUNCEMENTS<div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In November 2021, the FASB issued updates to increase the transparency in the annual disclosure requirements relating to government assistance received by business entities in Topic 832, Government Assistance. The guidance requires certain disclosures about transactions with a government that are accounted for by applying a grant or contribution model. On November 1, 2022, we adopted this guidance which did not have a material impact on our condensed consolidated financial statements and disclosures. </span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no additions to the new accounting pronouncements not yet adopted as described in our Annual Report on Form 10-K for the fiscal year ended October&#160;31, 2022.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other amendments to GAAP in the U.S. that have been issued by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on our condensed consolidated financial statements upon adoption.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI https://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31137-122693<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=SL108384541-122693<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (f)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915924119584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue from Contract with Customer</a></td>
<td class="text">REVENUE <div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the company&#8217;s total revenue and segment revenue disaggregated by geographical region: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.859%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.953%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:16.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.953%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended January 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Sciences and Applied Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agilent CrossLab<br/></span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diagnostics and Genomics<br/></span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Sciences and Applied Markets</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agilent CrossLab<br/></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diagnostics and Genomics<br/></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Revenue by Region</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,756&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the company&#8217;s total revenue disaggregated by end markets and by revenue type:</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.169%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Revenue by End Markets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical and Biopharmaceutical</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chemicals and Advanced Materials</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics and Clinical</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Food</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Academia and Government</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Environmental and Forensics</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,756&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,674&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Revenue by Type</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instrumentation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">759&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">691&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-instrumentation and other</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,756&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,674&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue by region is based on the ship to location of the customer. Revenue by end market is determined by the market indicator of the customer and by customer type. Instrumentation revenue includes sales from instruments, remarketed instruments and third-party products. Non-instrumentation and other revenue include sales from contract and per incident services, our companion diagnostics and our nucleic acid solutions businesses as well as sales from spare parts, consumables, reagents, vacuum pumps, subscriptions, software licenses and associated services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Balances</span></div><div><span><br/></span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract assets (unbilled accounts receivable) primarily relate to the company's right to consideration for work completed but not billed at the reporting date. The unbilled receivables are reclassified to trade receivables when billed to customers. Contract assets are generally classified as current assets and are included in "Accounts receivable, net" in the condensed consolidated balance sheet. The balances of contract assets as of January&#160;31, 2023 and October&#160;31, 2022 were $276 million and $275 million, respectively. </span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Liabilities</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about contract liabilities (deferred revenue) and the significant changes in the balances during the three months ended January&#160;31, 2023: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:78.078%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contract <br/>Liabilities</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance as of October 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue deferred in the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized that was included in the contract liability balance at the beginning of the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(196)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in deferrals from customer cash advances, net of revenue recognized</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation and other adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance as of January 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended January&#160;31, 2022 revenue recognized that was included in the contract liability balance at October&#160;31, 2021 was $191 million.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily relate to multiple element arrangements for which billing has occurred but transfer of control of all elements to the customer has either partially or not occurred at the balance sheet date. This includes cash received from customers for products and related installation and services in advance of the transfer of control. Contract liabilities are classified as either current in deferred revenue or long-term in other long-term liabilities in the condensed consolidated balance sheet based on the timing of when we expect to complete our performance obligation.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Costs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incremental costs of obtaining a contract with a customer are recognized as an asset if we expect the benefit of those costs to be longer than one year. We have determined that certain sales incentive programs meet the requirements to be capitalized. The change in total capitalized costs to obtain a contract was immaterial during the three months ended January&#160;31, 2023 and was included in other current and long-term assets on the condensed consolidated balance sheet. We have applied the practical expedient to expense costs as incurred for costs to obtain a contract with a customer when the amortization period would have been one year or less. These costs include the company's internal sales force compensation program, as we have determined that annual compensation is commensurate with annual sales activities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transaction Price Allocated to the Remaining Performance Obligations   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have applied the practical expedient in ASC 606-10-50-14 and have not disclosed information about transaction price allocated to remaining performance obligations that have original expected durations of one year or less.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div>The estimated revenue expected to be recognized for remaining performance obligations that have an original term of more than one year, as of January&#160;31, 2023, was $378 million, the majority of which is expected to be recognized over the next 12 months. Remaining performance obligations primarily include extended warranty, customer manufacturing contracts, software maintenance contracts and revenue associated with lease arrangements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915922641632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-Based Payment Arrangement, Noncash Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">SHARE-BASED COMPENSATION</a></td>
<td class="text">SHARE-BASED COMPENSATION<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for share-based awards in accordance with the provisions of the authoritative accounting guidance which requires the measurement and recognition of compensation expense for all share-based payment awards made to our employees and directors including employee stock options, restricted stock units, employee stock purchases made under our employee stock purchase plan and performance share awards granted to selected members of our senior management under the long-term performance plan (&#8220;LTPP&#8221;) based on estimated fair values. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have two LTPP performance stock award programs, which are administered under the 2018 Stock Plan, for our executive officers and other key employees. Participants in our LTPP Total Stockholders&#8217; Return (&#8220;TSR&#8221;) and LTPP Earnings Per Share (&#8220;EPS&#8221;) programs are entitled to receive shares of the company's stock after the end of a three-year period, if specified performance targets for the programs are met. The LTPP-TSR awards are generally designed to meet the criteria of a </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">performance award with the performance metrics and peer group comparison based on the TSR set at the beginning of the performance period. The LTPP-EPS awards are based on the company&#8217;s EPS performance over a three-year period. The performance targets for the LTPP-EPS for year 2 and year 3 of the performance period are set in the first quarter of year 2 and year 3, respectively. All LTPP awards are subject to a one-year post-vest holding period.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final LTPP award may vary from 0 percent to 200 percent of the target award. We consider the dilutive impact of these programs in our diluted net income per share calculation only to the extent that the performance conditions are expected to be met. Restricted stock units generally vest, with some exceptions, at a rate of 25 percent per year over a period of four years from the date of grant.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal year 2021, we resumed granting stock options. Stock options granted under the 2018 Stock Plan may be either "incentive stock options", as defined in Section 422 of the Internal Revenue Code, or non-statutory. Options generally vest at a rate of 25 percent per year over a period of four years from the date of grant with a maximum contractual term of ten years. The exercise price for stock options is generally not less than 100 percent of the fair market value of our common stock on the date the stock award is granted. We issue new shares of common stock when employee stock options are exercised. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact on our results for share-based compensation was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products and services</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At January&#160;31, 2023 and October&#160;31, 2022, no share-based compensation was capitalized within inventory. </span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                                               </span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following assumptions were used to estimate the fair value of awards granted.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.654%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.159%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Option Plans:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average risk-free interest rate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average volatility</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LTPP:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility of Agilent shares</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility of selected peer-company shares</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22%-84%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23%-81%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pair-wise correlation with selected peers</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Post-vest holding restriction discount for all executive awards</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of share-based awards for our employee stock option awards was estimated using the Black-Scholes option pricing model. Shares granted under the LTPP (TSR) were valued using a Monte Carlo simulation model. The Monte Carlo simulation fair value model requires the use of highly subjective and complex assumptions, including the price volatility of the underlying stock. &#160;For the volatility of our LTPP (TSR) grants, we used our own historical stock price volatility.&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ESPP allows eligible employees to purchase shares of our common stock at 85 percent of the price at purchase and uses the purchase date to establish the fair market value. </span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use historical volatility to estimate the expected stock price volatility assumption for employee stock option awards. In reaching the conclusion, we have considered many factors including the extent to which our options are currently traded and our ability to find traded options in the current market with similar terms and prices to the options we are valuing. In estimating the expected life of our options granted, we considered the historical option exercise behavior of our executives, which we believe is representative of future behavior.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of restricted stock units and LTPP (EPS) awards is determined based on the market price of our common stock on the date of grant adjusted for expected dividend yield. The compensation cost for LTPP (EPS) reflects the cost of awards that are probable to vest at the end of the performance period. </span></div>All LTPP awards granted to our senior management employees have a one-year post-vest holding restriction. The estimated discount associated with post-vest holding restrictions is calculated using the Finnerty model. The model calculates the potential lost value if the employees were able to sell the shares during the lack of marketability period, instead of being required to hold the shares. The model used the same historical stock price volatility and dividend yield assumption used for the Monte Carlo simulation model and an expected dividend yield to compute the discount.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915924110176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES <div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended January&#160;31, 2023, our income tax expense was $58 million with an effective tax rate of 14.1 percent. Our effective tax rate increased in 2023 compared to 2022, primarily due to the mandatory capitalization of research and development expenses, which became effective for Agilent in the first quarter of 2023, due to a change in tax law from the Tax Cuts and Jobs Act of 2017. For the three months ended January 31, 2023, our effective tax rate and the resulting provision for income taxes were also impacted by the excess tax benefits from stock-based compensation of $12&#160;million along with the expiration of various foreign statutes of limitations which resulted in the recognition of previously unrecognized tax benefits of $7&#160;million.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended January&#160;31, 2022, our income tax expense was $36 million with an effective tax rate of 11.3 percent. The income taxes for the three months ended January&#160;31, 2022 include the excess tax benefits from stock-based compensation of $16&#160;million. For the three months ended January&#160;31, 2022, our effective tax rate and the resulting provision for income taxes were also impacted by the expiration of various foreign statutes of limitations which resulted in the recognition of previously unrecognized tax benefits of $8&#160;million.  </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In the U.S., tax years remain open back to the year 2018 for federal income tax purposes and for significant states. In other major jurisdictions where the company conducts business, the tax years generally remain open back to the year 2013.  </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With these jurisdictions and the U.S., it is reasonably possible there could be significant changes to our unrecognized tax benefits in the next twelve months due to either the expiration of a statute of limitation or a tax audit settlement which will be partially offset by an anticipated tax liability related to unremitted foreign earnings, where applicable. Given the number of years and numerous matters that remain subject to examination in various tax jurisdictions, management is unable to estimate the range of possible changes to the balance of our unrecognized tax benefits.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915924165088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">NET INCOME PER SHARE</a></td>
<td class="text">NET INCOME PER SHARE<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the numerator and denominator of the basic and diluted net income per share computations for the periods presented below:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.894%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.675%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average shares</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potential common shares&#8212; stock&#160;options and other employee stock plans</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average shares</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The dilutive effect of share-based awards is reflected in diluted net income per share by application of the treasury stock method, which includes consideration of unamortized share-based compensation expense and the dilutive effect of in-the-money options and non-vested restricted stock units. Under the treasury stock method, the amount the employee must pay for exercising stock options and unamortized share-based compensation expense collectively are assumed proceeds to be used to repurchase hypothetical shares. An increase in the fair market value of the company's common stock can result in a greater dilutive effect from potentially dilutive awards.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We exclude stock options with exercise prices greater than the average market price of our common stock from the calculation of diluted earnings per share because their effect would be anti-dilutive. In addition, we exclude from the calculation of diluted earnings per share stock options, ESPP, LTPP and restricted stock awards whose combined exercise price and unamortized fair value were greater than the average market price of our common stock because their effect would also be anti-dilutive. &#160; </span></div>For the three months ended January&#160;31, 2023 and 2022, potential common shares excluded from the calculation of diluted earnings per share were not material.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915924113408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORY (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventory, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORY</a></td>
<td class="text">INVENTORY<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory as of January&#160;31, 2023 and October&#160;31, 2022 consisted of the following:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.218%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">555&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased parts and fabricated assemblies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,111&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,038&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915924055008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND OTHER INTANGIBLE ASSETS</a></td>
<td class="text">GOODWILL AND OTHER INTANGIBLE ASSETS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents goodwill balances and the movements for each of our reportable segments during the three months ended January&#160;31, 2023:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:50.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.070%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Sciences and Applied Markets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diagnostics and Genomics</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agilent CrossLab</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of October 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,953&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,952&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill arising from acquisitions and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of January 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,755&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,965&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,983&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The component parts of other intangible assets as of January&#160;31, 2023 and October&#160;31, 2022 are shown in the table below:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other&#160;Intangible&#160;Assets</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net&#160;Book<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of October 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased technology</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademark/Tradename</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Backlog</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third-party technology and licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortizable intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">811&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-Process R&amp;D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,159&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">821&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of January 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased technology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,761&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,096&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademark/Tradename</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Backlog</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third-party technology and licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,179&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,379&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-Process R&amp;D</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,189&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,379&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">810&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended January&#160;31, 2023, we recorded additions to goodwill of $11 million and to other intangible assets of $23 million in our diagnostics and genomics segment related to the acquisition of one business. During the three months ended January&#160;31, 2023, other intangible assets in total increased $2 million due to the impact of foreign currency translation. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, for U.S. federal tax purposes, goodwill from asset purchases is amortizable; however, any goodwill created as part of a stock acquisition is not deductible.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each quarter we review the events and circumstances to determine if impairment of indefinite-lived intangible assets and goodwill is indicated. During the three months ended January&#160;31, 2023 and 2022 we did not identify any triggering events or circumstances which would indicate an impairment of goodwill or indefinite-lived intangible assets. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense of intangible assets was $36 million and $51 million for the three months ended January&#160;31, 2023 and 2022, respectively. </span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future amortization expense related to existing finite-lived purchased intangible assets for the remainder of fiscal year 2023 and for each of the next five fiscal years and thereafter is estimated below:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:90.859%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.941%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated future amortization expense:</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915924149152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text">FAIR VALUE MEASUREMENTS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The authoritative guidance defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, we consider the principal or most advantageous market and assumptions that market participants would use when pricing the asset or liability.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Hierarchy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The guidance establishes a fair value hierarchy that prioritizes the use of inputs used in valuation techniques into three levels. A financial instrument&#8217;s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. There are three levels of inputs that may be used to measure fair value:</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- applies to assets or liabilities for which there are inputs other than quoted prices included within level 1 that are observable, either directly or indirectly, for the asset or liability such as: quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in less active markets; or other inputs that can be derived principally from, or corroborated by, observable market data.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis as of January&#160;31, 2023 were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement at January 31, 2023 Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">in&#160;Active</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Markets&#160;for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Identical&#160;Assets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Observable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;3)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents (money market funds)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments (foreign exchange contracts)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments (foreign exchange contracts) </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis as of October&#160;31, 2022 were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement at October 31, 2022 Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">in&#160;Active</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Markets&#160;for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Identical&#160;Assets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Observable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;3)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents (money market funds)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments (foreign exchange contracts)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments (foreign exchange contracts)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our money market funds and trading securities are generally valued using quoted market prices and therefore are classified within level&#160;1 of the fair value hierarchy. Our derivative financial instruments are classified within level 2, as there is not an active market for each hedge contract, but the inputs used to calculate the value of the instruments are tied to active </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">markets.  Our deferred compensation liability is classified as level&#160;2 because, although the values are not directly based on quoted market prices, the inputs used in the calculations are observable. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other investments represent shares we own in a special fund that targets underlying investments of approximately 40 percent in debt securities and 60 percent in equity securities. These shares have been classified as level 2 because, although the shares of the fund are not traded on any active stock exchange, each of the individual underlying securities are or can be derived from and hence we have a readily determinable value for the underlying securities, from which we are able to determine the fair market value for the special fund itself. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trading securities, which are comprised of mutual funds, bonds and other similar instruments, other investments and deferred compensation liability are reported at fair value, with gains or losses resulting from changes in fair value recognized currently in net income. Certain derivative instruments are reported at fair value, with unrealized gains and losses, net of tax, included in accumulated other comprehensive income (loss) within stockholders' equity. Realized gains and losses from the sale of these instruments are recorded in net income.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains and losses reflected in other income (expense), net for our equity investments with readily determinable fair value ("RDFV") and equity investments without RDFV are summarized below:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.651%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss recognized during the period on equity securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net loss on equity securities sold during the period</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (gain) loss on equity securities </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The fair value of the contingent consideration liability relates to milestone payments in connection with the acquisition of advanced artificial intelligence technology in February 2022 and the acquisition of Resolution Bioscience in April 2021.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Resolution Bioscience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The fair value of the potential future milestone payments, which is set to certain revenue and technical targets, was based on (i) the probability of achieving the relevant revenue targets and technical milestones and (ii) the timing of achieving such milestones, which are significant unobservable inputs, and has been classified as Level 3. We used the Monte Carlo simulation approach to estimate the fair value of the revenue component which resulted in a fair value of zero. A change in any of these unobservable inputs can significantly change the fair value of the contingent consideration. As of January&#160;31, 2023, the expected maximum earn-out period for the contingent payments does not exceed 1.9 years and potential future payments will not exceed $80&#160;million. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent consideration liability is our only recurring Level 3 asset or liability.  A summary of the Level 3 activity follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:82.135%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:6.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.989%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to contingent consideration (including measurement period adjustment)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value (included within selling, general and administrative expenses)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the contingent consideration liability as of January&#160;31, 2023, was estimated to be $3 million of which $2 million was recorded in other accrued liabilities and $1 million was recorded in other long-term liabilities on the condensed consolidated balance sheet. During the three months ended January&#160;31, 2023, we made a contingent consideration payment of $65&#160;million related to the achievement of a certain technical milestone associated with our acquisition of Resolution Bioscience.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of Investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> There were no impairments of investments for the three months ended January&#160;31, 2023 and 2022.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended January&#160;31, 2023 and 2022 , there were no impairments of long-lived assets held and used or long-lived assets held for sale. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-Marketable Equity Securities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended January&#160;31, 2023 and 2022, there were no impairments or unrealized gain (loss) adjustments to the carrying value of non-marketable securities without readily determinable fair value based on an observable market transaction.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January&#160;31, 2023, the cumulative net gain (loss) on our non-marketable equity securities without readily determinable fair values was comprised of a $35&#160;million gain and no losses, and the carrying amount was $126&#160;million. As of January&#160;31, 2022, the cumulative net gain (loss) on our non-marketable equity securities without readily determinable fair values was comprised of a $30&#160;million gain and no losses, and the carrying amount was $125&#160;million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair values for the non-marketable securities included in long-term investments on the condensed consolidated balance sheet were measured using Level 3 inputs because they are primarily equity stock issued by private companies without quoted market prices. To estimate the fair value of our non-marketable securities, we use the measurement alternative to record these investments at cost and adjust for impairments and observable price changes (orderly transactions for the identical or a similar security from the same issuer) as and when they occur.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915924333328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVES (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">DERIVATIVES</a></td>
<td class="text">DERIVATIVES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to foreign currency exchange rate fluctuations and interest rate changes in the normal course of our business. As part of our risk management strategy, we use derivative instruments, primarily forward contracts and purchased options to hedge economic and/or accounting exposures resulting from changes in foreign currency exchange rates.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flow Hedges</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into foreign exchange contracts to hedge our forecasted operational cash flow exposures resulting from changes in foreign currency exchange rates. These foreign exchange contracts, carried at fair value, have maturities between one and twelve months. These derivative instruments are designated and qualify as cash flow hedges under the criteria prescribed in the authoritative guidance and are assessed for effectiveness against the underlying exposure every reporting period. For open contracts as of January&#160;31, 2023, changes in the time value of the foreign exchange contract are excluded from the assessment of hedge effectiveness and are recognized in cost of sales over the life of the foreign exchange contract. The changes in fair value of the effective portion of the derivative instrument are recognized in accumulated other comprehensive income (loss). Amounts associated with cash flow hedges are reclassified to cost of sales in the condensed consolidated statement of operations when the forecasted transaction occurs. If it becomes probable that the forecasted transaction will not occur, the hedge relationship will be de-designated and amounts accumulated in other comprehensive income (loss) will be reclassified to other income (expense), net in the current period. Changes in the fair value of the ineffective portion of derivative instruments are recognized in other income (expense), net in the condensed consolidated statement of operations in the current period. We record the premium paid (time value) of an option on the date of purchase as an asset. For options designated as cash flow hedges, changes in the time value are excluded from the assessment of hedge effectiveness and are recognized in cost of sales over the life of the option contract. For the three months ended January&#160;31, 2023 and 2022, ineffectiveness and gains and losses recognized in other income (expense), net due to de-designation of cash flow hedge contracts were not significant.  </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, Agilent executed three forward-starting pay fixed/receive variable interest rate swaps for the notional amount of $300 million in connection with future interest payments to be made on our 2026 senior notes issued on September 15, 2016. These derivative instruments were designated and qualified as cash flow hedges under the criteria prescribed in the authoritative guidance. The swap arrangements were terminated on September 15, 2016 with a payment of $10 million, and we recognized this as a deferred loss in accumulated other comprehensive income (loss) which is being amortized to interest expense over the life of the 2026 senior notes. The remaining loss to be amortized related to the interest rate swap agreements at January&#160;31, 2023 was $3 million. </span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, Agilent executed treasury lock agreements for $250 million in connection with future interest payments to be made on our 2029 senior notes issued on September 16, 2019. We designated the treasury lock as a cash flow hedge. The treasury lock contracts were terminated on September 6, 2019, and we recognized a deferred loss of $6&#160;million in accumulated other comprehensive income (loss) which is being amortized to interest expense over the life of the 2029 senior notes. The remaining loss to be amortized related to the treasury lock agreements at January&#160;31, 2023 was $4 million. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Hedges </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into foreign exchange contracts to hedge net investments in foreign operations to mitigate the risk of adverse movements in exchange rates. These foreign exchange contracts are carried at fair value and are designated and qualify as net investment hedges under the criteria prescribed in the authoritative guidance. Changes in fair value of the effective portion of the derivative instrument are recognized in accumulated other comprehensive income (loss)- translation adjustment and are assessed for effectiveness against the underlying exposure every reporting period. If the company&#8217;s net investment changes during the year, the hedge relationship will be assessed and de-designated if the hedge notional amount is outside of prescribed tolerance with a gain/loss reclassified from other comprehensive income (loss) to other income (expense) in the current period. For the three months ended January&#160;31, 2023, ineffectiveness and the resultant effect of any gains or losses recognized in other income (expense) due to de-designation of the hedge contracts were not significant.  </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Hedges</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we enter into foreign exchange contracts to hedge monetary assets and liabilities that are denominated in currencies other than the functional currency of our subsidiaries. These foreign exchange contracts are carried at fair value and do not qualify for hedge accounting treatment and are not designated as hedging instruments. Changes in value of the derivative instruments are recognized in other income (expense), net in the condensed consolidated statement of operations, in the current period, along with the offsetting foreign currency gain or loss on the underlying assets or liabilities.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our use of derivative instruments exposes us to credit risk to the extent that the counterparties may be unable to meet the terms of the agreement. We do, however, seek to mitigate such risks by limiting our counterparties to major financial institutions which are selected based on their credit ratings and other factors.&#160;We have established policies and procedures for mitigating credit risk that include establishing counterparty credit limits, monitoring credit exposures, and continually assessing the creditworthiness of counterparties.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of our derivative agreements contain threshold limits to the net liability position with counterparties and are dependent on our corporate credit rating determined by the major credit rating agencies. The counterparties to the derivative instruments may request collateralization, in accordance with derivative agreements, on derivative instruments in net liability positions.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate fair value of all derivative instruments with credit-risk-related contingent features that were in a net liability position as of January&#160;31, 2023, was $23&#160;million. The credit-risk-related contingent features underlying these agreements had not been triggered as of January&#160;31, 2023.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were 270 foreign exchange forward contracts open as of January&#160;31, 2023, and designated as cash flow hedges. There were 189 foreign exchange forward contracts open as of January&#160;31, 2023, and not designated as hedging instruments. There were 3 foreign exchange forward contracts open as of January&#160;31, 2023, and designated as a net investment hedge.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The aggregated notional amounts by currency and designation as of January&#160;31, 2023, were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:44.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.786%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.080%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.258%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives&#160;<br/>Designated as <br/>Cash&#160;Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives <br/>Designated as <br/>Net Investment Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives <br/>Not Designated as&#160;<br/>Hedging Instruments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Forward<br/>Contracts USD</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Forward<br/>Contracts USD</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Forward<br/>Contracts USD</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Buy/(Sell)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Buy/(Sell)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Buy/(Sell)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">British Pound</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canadian Dollar</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japanese Yen</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danish Krone</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Korean Won</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore Dollar</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chinese Yuan Renminbi</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taiwan Dollar</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indian Rupee</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Totals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(434)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Derivative instruments are subject to master netting arrangements and are disclosed gross in the balance sheet in accordance with the authoritative guidance. The gross fair values and balance sheet location of derivative instruments held in the condensed consolidated balance sheet as of January&#160;31, 2023, and October&#160;31, 2022, were as follows:</span></div><div style="margin-top:5pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:29.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.875%"/><td style="width:0.1%"/></tr><tr><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;text-indent:-31.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Values&#160;of&#160;Derivative&#160;Instruments</span></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset&#160;Derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability&#160;Derivatives</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;Sheet&#160;Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;Sheet&#160;Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31,<br/>2022</span></td></tr><tr><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of derivative instruments for foreign exchange contracts designated as hedging instruments and not designated as hedging instruments in our condensed consolidated statement of operations were as follows:</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.356%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.944%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Cash Flow Hedges</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in accumulated other comprehensive&#160;loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) reclassified from accumulated other comprehensive&#160;loss into cost of sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTItNS0xLTEtNjg3NTE_9acfeb89-7d88-4046-b4c7-cb2eb4fcaa42">6</span>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTItNy0xLTEtNjg3NTE_4ec61448-9de2-40a0-8dd4-e126176d3a29">3</span>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on time value of forward contracts recorded in cost of sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTctNS0xLTEtNjg3NTE_e833622d-040d-4809-bc1d-d9369471a833">2</span>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTctNy0xLTEtNjg3NTE_ae37cd7a-d092-478d-9c12-235792651f19">&#8212;</span>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Net Investment Hedges</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in accumulated other comprehensive loss - translation adjustment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in other income (expense)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMjUtNS0xLTEtNjg3NTE_7bdf9258-4aa3-411c-b03c-7da3efd96a29">(13)</span></span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMjUtNy0xLTEtNjg3NTE_295a067e-a8da-4362-a6e5-55ad7d16f169">(3)</span></span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At January&#160;31, 2023, the amount of existing net gain that is expected to be reclassified from accumulated other comprehensive income (loss) is $14 million. Within the next twelve months it is estimated that $19 million of loss included within the net amount of accumulated other comprehensive income (loss) will be reclassified to cost of sales in respect of cash flow hedges.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915924304928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS</a></td>
<td class="text">RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS<div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Components of net periodic costs (benefits).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For the three months ended January&#160;31, 2023 and 2022, our net pension and post retirement benefit costs (benefits) were comprised of the following:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:42.365%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.715%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:42.365%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.715%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended January 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S. <br/>Pension&#160;Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S.<br/>Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.&#160;Post&#160;Retirement<br/>Benefit&#160;Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost&#8212;benefits earned during the period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial losses (gains)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net plan costs (benefits)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The service cost component is recorded in cost of sales and operating expenses in the condensed consolidated statement of operations. All other cost components are recorded in other income (expense), net in the condensed consolidated statement of operations.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employer contributions and expected future employer contributions for the remainder of the year were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.771%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.729%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employer Contributions</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For Remainder of Year</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. defined benefit plans</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. defined benefit plans</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915923992800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>WARRANTIES AND CONTINGENCIES (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">WARRANTIES AND CONTINGENCIES</a></td>
<td class="text">WARRANTIES AND CONTINGENCIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warranties</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue for standard warranty costs based on historical trends in actual warranty charges over the past 12 months. The accrual is reviewed regularly and periodically adjusted to reflect changes in warranty cost over the period. The standard warranty accrual balances are held in other accrued and other long-term liabilities on our condensed consolidated balance sheet. Our standard warranty terms typically extend to one year from the date of delivery, depending on the product.  </span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the standard warranty accrual activity is shown in the table below:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard warranty accrual, beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals for warranties including change in estimates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements made during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard warranty accrual, ending balance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals for warranties due within one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals for warranties due after one year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard warranty accrual, ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Bank Guarantees</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Guarantees consist primarily of outstanding standby letters of credit and bank guarantees and were approximately $37 million as of both January&#160;31, 2023 and October&#160;31, 2022, respectively. A standby letter of credit is a guarantee of payment issued by a bank on behalf of us that is used as payment of last resort should we fail to fulfill a contractual commitment with a third party. A bank guarantee is a promise from a bank or other lending institution that if we default on a loan, the bank will cover the loss.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in lawsuits, claims, investigations and proceedings, including, but not limited to, intellectual property, commercial, real estate, environmental and employment matters, which arise in the ordinary course of business. There are no matters pending that we currently believe are reasonably possible of having a material impact to our business, condensed consolidated financial condition, results of operations or cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915924239936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHORT-TERM DEBT (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowingsAbstract', window );"><strong>Short-Term Debt [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTextBlock', window );">SHORT-TERM DEBT</a></td>
<td class="text">SHORT-TERM DEBT<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Facilities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 13, 2019, we entered into a credit agreement with a group of financial institutions which, as amended, provided for a $1 billion five-year unsecured credit facility that will expire on March 13, 2024 and incremental term loan facilities in an aggregate amount of up to $500 million.&#160;On April 21, 2021, we entered into an incremental assumption agreement, pursuant to which the aggregate amount available for borrowing under the revolving credit facility was increased to $1.35&#160;billion and the aggregate amount available for incremental facilities was refreshed to remain at $500&#160;million. As of </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January&#160;31, 2023, we had no borrowings outstanding under the credit facility and no borrowings under the incremental facilities. We were in compliance with the covenants for the credit facility during the three months ended January&#160;31, 2023.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercial Paper</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our U.S. commercial paper program, the company may issue and sell unsecured, short-term promissory notes in the aggregate principal amount not to exceed $1.35&#160;billion with up to 397-day maturities. At any point in time, the company intends to maintain available commitments under its revolving credit facility in an amount at least equal to the amount of the commercial paper notes outstanding. Amounts available under the program may be borrowed, repaid and re-borrowed from time to time. The proceeds from issuances under the program may be used for general corporate purposes. During the three months ended January&#160;31, 2023, we borrowed $527 million and repaid $324 million. As </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January&#160;31, 2023</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we had borrowings of $238 million outstanding under our U.S. commercial paper program and had a weighted average annual interest rate of 4.67 percent.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for short-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915924111408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LONG-TERM DEBT (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">LONG-TERM DEBT</a></td>
<td class="text">LONG-TERM DEBT<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Term Loan Facility</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 15, 2022, we entered into a term loan agreement with a group of financial institutions, which provided for a $600&#160;million delayed draw term loan that will mature on April 15, 2025. As of January&#160;31, 2023, we had $600&#160;million borrowings outstanding under the term loan facility and had a weighted average interest rate of 5.40 percent. Loans under the term loan agreement bear interest, at our option, either at: (i) the alternate base rate, as defined in the term loan agreement, plus the applicable margin for such loans or (ii) adjusted term SOFR, as defined in the term loan agreement, plus the applicable margin for such loans. The term loan agreement contains customary representations and warranties as well as customary affirmative and negative covenants. We were in compliance with the covenants for the term loan during the three months ended January&#160;31, 2023.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Notes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the company&#8217;s long-term senior notes:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.469%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.471%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized <br/>Principal</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Principal</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2031 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Senior Notes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,133&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,133&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>All outstanding notes listed above are unsecured and rank equally in right of payment with all of Agilent&#8217;s other senior unsecured indebtedness. There have been no other changes to the principal, maturity, interest rates and interest payment terms of the Agilent senior notes, detailed in the table above, in the three months ended January&#160;31, 2023, as compared to the senior notes described in our Annual Report on Form 10-K for the fiscal year ended October&#160;31, 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915924165088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS EQUITY</a></td>
<td class="text">STOCKHOLDERS' EQUITY <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Repurchase Program </span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 16, 2021 we announced that our board of directors had approved a new share repurchase program (the "2021 repurchase program") designed, among other things, to reduce or eliminate dilution resulting from issuance of stock under the company's employee equity incentive programs. The 2021 repurchase program authorizes the purchase of up to $2.0&#160;billion of our common stock at the company's discretion and has no fixed termination date. The 2021 repurchase program which became effective on February 18, 2021, replaced and terminated the 2019 repurchase program on that date. The 2021 repurchase </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">program does not require the company to acquire a specific number of shares and may be suspended, amended or discontinued at any time. During the three months ended January&#160;31, 2023, we repurchased and retired 499,000 shares for $75 million under this authorization. During the three months ended January&#160;31, 2022, we repurchased and retired 2.9 million shares for $447 million under this authorization. As of January&#160;31, 2023, we had remaining authorization to repurchase up to approximately $363 million of our common stock under the 2021 repurchase program. On March 1, 2023, the 2021 repurchase program was terminated and the remaining authorization of $339&#160;million expired.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 9, 2023, we announced that our board of directors had approved a share repurchase program (the "2023 repurchase program") designed, among other things, to reduce or eliminate dilution resulting from issuance of stock under the company's employee equity incentive programs. The 2023 repurchase program authorizes the purchase of up to $2.0&#160;billion of our common stock at the company's discretion and has no fixed termination date. The 2023 repurchase program does not require the company to acquire a specific number of shares and may be suspended, amended or discontinued at any time. The 2023 repurchase program commenced on March 1, 2023, and also terminated and replaced the 2021 repurchase program.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Dividends on Shares of Common Stock</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended January&#160;31, 2023, we paid cash dividends of $0.225 per common share or $67 million  on the company's common stock. During the three months ended January&#160;31, 2022, we paid cash dividends of  $0.210 per common share or $63 million on the company's common stock. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 22, 2023, our board of directors declared a quarterly dividend of $0.225 per share of common stock or approximately $67&#160;million which will be paid on April 26, 2023 to all shareholders of record at the close of business on April 4, 2023. The timing and amounts of any future dividends are subject to determination and approval by our board of directors.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Income (Loss)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in accumulated other comprehensive income (loss) by component and related tax effects were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.126%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.113%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.848%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.697%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.848%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.848%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.857%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net defined benefit pension cost and post retirement plan costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended January 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prior service credits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Actuarial Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized gains (losses) on derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of October 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(347)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified out of accumulated other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of January 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(244)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(280)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reclassifications out of accumulated other comprehensive income (loss) for the three months ended January&#160;31, 2023 and 2022 were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center;text-indent:4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:33.504%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.973%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.973%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.731%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Details about accumulated other <br/>comprehensive income (loss) components</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amounts Reclassified from <br/>other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affected line item in<br/>statement of operations</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="12" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain on derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTItNi0xLTEtNjg3NTE_c88580f0-1f89-414b-85e7-775437129012">6</span>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTItOC0xLTEtNjg3NTE_f8a759f4-726e-4284-aa80-54ef5c1c9cc9">3</span>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before income tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net of income tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net defined benefit pension cost and post retirement plan costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial net gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before income tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Provision) benefit for income tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net of income tax</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications for the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts in parentheses indicate reductions to income and increases to other comprehensive income (loss).</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reclassifications out of accumulated other comprehensive income (loss) of actuarial net gain (loss) in respect of retirement plans and post retirement pension plans are included in the computation of net periodic cost (see Note 11, "Retirement Plans and Post Retirement Pension Plans").</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915924129776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT INFORMATION</a></td>
<td class="text">SEGMENT INFORMATION<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Description of segments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  We are a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow.  </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to have three business segments comprised of life sciences and applied markets, diagnostics and genomics and Agilent CrossLab, each of which continues to comprise a reportable segment. The three operating segments were determined based primarily on how the chief operating decision maker views and evaluates our operations. Operating results are regularly reviewed by the chief operating decision maker to make decisions about resources to be allocated to the segment and to assess its performance. Other factors, including market separation and customer specific applications, go-to-market channels, products and services and manufacturing are considered in determining the formation of these operating segments.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A description of our three reportable segments is as follows:</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our life sciences and applied markets business provides application-focused solutions that include instruments, consumables and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. Key product categories include: liquid chromatography ("LC") systems and components; liquid chromatography mass spectrometry ("LCMS") systems; gas chromatography ("GC") systems and components; gas chromatography mass spectrometry ("GCMS") systems; inductively coupled plasma mass spectrometry ("ICP-MS") instruments; atomic absorption ("AA") instruments; microwave plasma-atomic emission spectrometry ("MP-AES") instruments; inductively coupled plasma optical emission spectrometry ("ICP-OES") instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software for sample tracking; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps and measurement technologies. Our consumables portfolio is designed to improve customer outcomes. Most of the portfolio is vendor neutral, meaning Agilent can serve and supply customers regardless of their instrument purchase </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">choices. Solutions range from chemistries to supplies. Key product categories in consumables include GC and LC columns, sample preparation products, custom chemistries, and a large selection of laboratory instrument supplies.  </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our diagnostics and genomics business is comprised of six areas of activity providing active pharmaceutical ingredients ("APIs") for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables, which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level.&#160;First, our genomics business includes arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, as well as next generation sequencing ("NGS") target enrichment and genetic data management and interpretation support software. This business also includes solutions that enable clinical labs to identify DNA variants associated with genetic disease and help direct cancer therapy. Second, our nucleic acid solutions business is a contract and development manufacturing organization that provides services related to and the production of synthesized oligonucleotides under pharmaceutical good manufacturing practices ("GMP") conditions for use as API in a class of drugs that utilize nucleic acid molecules for disease therapy. Third, our pathology solutions business is focused on product offerings for cancer diagnostics and anatomic pathology workflows. The broad portfolio of offerings includes immunohistochemistry ("IHC"), in situ hybridization ("ISH"), hematoxylin and eosin ("H&amp;E") staining and special staining. Fourth, we also collaborate with a number of major pharmaceutical companies to develop new potential tissue and liquid-based pharmacodiagnostics, also known as companion diagnostics, which may be used to identify patients most likely to benefit from a specific targeted therapy. Fifth, the reagent partnership business provides clinical flow cytometry reagents for routine cancer diagnostics. This business also provides bulk antibodies as raw materials and associated assay development services to IVD manufacturers, biotechnology and pharmaceutical companies. Finally, our biomolecular analysis business provides complete workflow solutions, including instruments, consumables and software, for quality control analysis of nucleic acid samples. Samples are analyzed using quantitative and qualitative techniques to ensure accuracy in further genomics analysis techniques including NGS, utilized in clinical and life science research applications.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Agilent CrossLab business spans the entire lab with its extensive services portfolio, which is designed to improve customer outcomes.  The majority of the portfolio is vendor neutral, meaning we can serve and supply customers regardless of their instrument purchase choices.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The services portfolio include repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting and various other custom services to support the customers' laboratory operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Custom services are tailored to meet the specific application needs of various industries and to keep instruments fully operational and compliant with the respective industry requirements.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant portion of the segments' expenses arise from shared services and infrastructure that we have historically provided to the segments in order to realize economies of scale and to efficiently use resources. These expenses, collectively called corporate charges, include legal, accounting, tax, real estate, insurance services, information technology services, treasury, order administration, other corporate infrastructure expenses, costs of centralized research and development and joint sales and marketing costs. Charges are allocated to the segments, and the allocations have been determined on a basis that we consider to be a reasonable reflection of the utilization of services provided to or benefits received by the segments. In addition, we do not allocate asset impairments, amortization of acquisition-related intangible assets, change in the fair value of acquisition-related contingent consideration, acquisition and integration costs, transformational initiatives expenses, business exit and divestiture costs and certain other charges to the operating margin for each segment because management does not include this information in its measurement of the performance of the operating segments. Transformational initiatives include expenses associated with targeted cost reduction activities such as manufacturing transfers, site consolidations, legal entity and other business reorganizations, in-sourcing or outsourcing of activities. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables reflect the results of our reportable segments under our management reporting system. The performance of each segment is measured based on several metrics, including segment income from operations. These results are used, in part, by the chief operating decision maker in evaluating the performance of, and in allocating resources to, each of the segments.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The profitability of each of the segments is measured after excluding items such as transformational initiatives, acquisition and integration costs, amortization of intangible assets related to business combinations, interest income, interest expense and other items as noted in the reconciliations below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.429%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Revenue:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences and Applied Markets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics and Genomics</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agilent CrossLab</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,756&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Income From Operations:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences and Applied Markets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics and Genomics</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agilent CrossLab</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment income from operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles segment income from operations to Agilent&#8217;s total enterprise income before taxes:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.429%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment income from operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transformational initiatives</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets related to business combinations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration costs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before taxes, as reported</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-indent:4.5pt"><span><br/></span></div><div style="padding-left:9pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) For the three months ended January&#160;31, 2023 and 2022, other income (expense), net includes net (gains) losses on the fair value of equity securities.</span></div><div style="padding-left:9pt;text-indent:4.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects segment assets under our management reporting system. Segment assets include allocations of corporate assets, goodwill, net other intangibles and other assets. Unallocated assets primarily consist of cash, cash equivalents, short-term and long-term investments, deferred tax assets, right-of-use assets and other assets. &#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences and Applied Markets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,004&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics and Genomics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agilent CrossLab</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,486&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,313&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915922982400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Overview and Basis of Presentation</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Overview. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agilent Technologies, Inc. ("we," "Agilent" or the "company"), incorporated in Delaware in May 1999, is a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year-end is October&#160;31, and our fiscal quarters end on January&#160;31, April&#160;30 and July&#160;31. Unless otherwise stated, these dates refer to our fiscal year and fiscal quarters.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We have prepared the accompanying financial data for the three months ended January&#160;31, 2023 and 2022 pursuant to the rules&#160;and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles (&#8220;GAAP&#8221;) in the U.S. have been condensed or omitted pursuant to such rules&#160;and regulations. The October&#160;31, 2022 condensed balance sheet data was derived from audited financial statements but does not include all the disclosures required in audited financial statements by U.S. GAAP. The accompanying financial data and information should be read in conjunction with our Annual Report on Form 10-K for the fiscal year ended October&#160;31, 2022.  </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying condensed consolidated financial statements contain all normal and recurring adjustments necessary for a fair statement of our condensed consolidated balance sheet as of January&#160;31, 2023 and October&#160;31, 2022, condensed consolidated statement of comprehensive income (loss) for the three months ended January&#160;31, 2023 and 2022, condensed consolidated statement of operations for the three months ended January&#160;31, 2023 and 2022, condensed consolidated statement of cash flows for the three months ended January&#160;31, 2023 and 2022 and condensed consolidated statement of equity for the three months ended January&#160;31, 2023 and 2022.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The preparation of condensed consolidated financial statements in accordance with GAAP in the U.S. requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Although these estimates are based on management&#8217;s best knowledge of current events and actions that may impact the company in the future, actual results may be different from the estimates. Our critical accounting policies are those that affect our financial statements materially and involve difficult, subjective or complex judgments by management. Those policies are revenue recognition, valuation of goodwill and purchased intangible assets,  inventory valuation, retirement and post-retirement benefit plan assumptions and accounting for income taxes.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash and Restricted Cash Equivalents</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash and Restricted Cash Equivalents. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash and restricted cash equivalents are included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows.  A reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheet follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.863%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,053&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,253&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,056&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text">Leases. As of January&#160;31, 2023 and October&#160;31, 2022, operating lease right-of-use assets where we are the lessee were  $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDQ4Mw_0923d8a4-45b0-4175-952d-a7c717b81666">155&#160;million</span> and $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDQ5MA_9b066508-1908-4248-884a-1df299c2bc14">150&#160;million</span>, respectively, and were included within other assets in the accompanying condensed consolidated balance sheet. The associated operating lease liabilities were $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDY1Mg_3682f298-9ca7-4d01-a434-54ee5feb1306">159&#160;million</span> and $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDY1OQ_fa7b70f1-0cec-4130-bca6-58ec8ae1e703">152&#160;million</span> as of January&#160;31, 2023 and October&#160;31, 2022, respectively, and were included in other accrued liabilities and other long-term liabilities in the accompanying condensed consolidated balance sheet.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationVariableInterestEntityPolicy', window );">Variable Interest Entity</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Interest Entities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We make a determination upon entering into an arrangement whether an entity in which we have made an investment is considered a Variable Interest Entity (&#8220;VIE&#8221;). We evaluate our investments in privately held companies on an ongoing basis. We have determined that as of January&#160;31, 2023 and October&#160;31, 2022, there were no VIEs required to be consolidated in our consolidated financial statements because we do not have a controlling financial interest in </span><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any of the VIEs in which we have invested nor are we the primary beneficiary. We account for these investments under either the equity method or as equity investments without readily determinable fair value ("RDFV"), depending on the circumstances. We periodically reassess whether we are the primary beneficiary of a VIE. The reassessment process considers whether we have acquired the power to direct the most significant activities of the VIE through changes in governing documents or other circumstances. We also reconsider whether entities previously determined not to be VIEs have become VIEs and vice-versa, based on changes in facts and circumstances including changes in contractual arrangements and capital structure.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January&#160;31, 2023 and October&#160;31, 2022, the total carrying value of investments and loans in privately held companies considered as VIEs was $71 million and $87 million respectively. The maximum exposure is equal to the carrying value because we do not have future funding commitments. The investments are included on the long-term investments line and the loans on the other current assets and other assets lines (depending upon tenure of loan) on the condensed consolidated balance sheet.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value of Financial Instruments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The carrying values of certain of our financial instruments including cash and cash equivalents, accounts receivable, accounts payable, accrued compensation and other accrued liabilities approximate fair value because of their short maturities. The fair value of long-term equity investments which are readily determinable, and which are not accounted under the equity method are reported at fair value using quoted market prices for those securities when available with gains and losses included in net income. The fair value of long-term equity investments which are not readily determinable, and which are not accounted under the equity method are reported at cost with adjustments for observable changes in prices or impairments included in net income. As of January&#160;31, 2023 and October&#160;31, 2022, the fair value of the term loans approximates its carrying value.  As of January&#160;31, 2023, the fair value of our senior notes was $1,859&#160;million with a carrying value of $2,133 million. This compares to the fair value of our senior notes of $1,754&#160;million with a carrying value of $2,133 million as of October&#160;31, 2022. The change in the fair value compared to carrying value in the three months ended January&#160;31, 2023 is primarily due to decreased market interest rates. The fair value was calculated from quoted prices which are primarily Level 1 inputs under the accounting guidance. The fair value of foreign currency contracts used for hedging purposes is estimated internally by using inputs tied to active markets. These inputs, for example, interest rate yield curves, foreign exchange rates, and forward and spot prices for currencies are observable in the market or&#160;can be corroborated by observable market data for substantially the full term of the assets or liabilities. See also Note&#160;9, "Fair Value Measurements" for additional information on the fair value of financial instruments and contingent consideration.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationVariableInterestEntityPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5728-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2AA<br> -Subparagraph a<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759068-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationVariableInterestEntityPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915924149152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAbstract', window );"><strong>Restricted Cash [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock', window );">Restrictions on Cash and Cash Equivalents</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash and Restricted Cash Equivalents. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash and restricted cash equivalents are included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows.  A reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheet follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.863%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,053&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,253&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,056&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915924131872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the company&#8217;s total revenue and segment revenue disaggregated by geographical region: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.859%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.953%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:16.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.953%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended January 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Sciences and Applied Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agilent CrossLab<br/></span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diagnostics and Genomics<br/></span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Sciences and Applied Markets</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agilent CrossLab<br/></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diagnostics and Genomics<br/></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Revenue by Region</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,756&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the company&#8217;s total revenue disaggregated by end markets and by revenue type:</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.169%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Revenue by End Markets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical and Biopharmaceutical</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chemicals and Advanced Materials</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics and Clinical</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Food</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Academia and Government</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Environmental and Forensics</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,756&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,674&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Revenue by Type</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instrumentation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">759&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">691&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-instrumentation and other</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,756&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,674&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Contract Liabilities and Changes in Balances</a></td>
<td class="text"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about contract liabilities (deferred revenue) and the significant changes in the balances during the three months ended January&#160;31, 2023: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:78.078%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contract <br/>Liabilities</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance as of October 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue deferred in the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized that was included in the contract liability balance at the beginning of the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(196)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in deferrals from customer cash advances, net of revenue recognized</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation and other adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance as of January 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915924221296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-Based Payment Arrangement, Noncash Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Allocated share-based compensation expense disclosure</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact on our results for share-based compensation was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products and services</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock', window );">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions And Methodology [Text Block]</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following assumptions were used to estimate the fair value of awards granted.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.654%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.159%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Option Plans:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average risk-free interest rate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average volatility</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LTPP:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility of Agilent shares</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility of selected peer-company shares</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22%-84%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23%-81%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pair-wise correlation with selected peers</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Post-vest holding restriction discount for all executive awards</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, and long-term performance plan grants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>a_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915922641632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Reconciliation of the numerators and denominators of the basic and diluted net income per share</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the numerator and denominator of the basic and diluted net income per share computations for the periods presented below:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.894%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.675%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average shares</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potential common shares&#8212; stock&#160;options and other employee stock plans</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average shares</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915924182976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORY (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventory, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">INVENTORY</a></td>
<td class="text">INVENTORY<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory as of January&#160;31, 2023 and October&#160;31, 2022 consisted of the following:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.218%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">555&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased parts and fabricated assemblies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,111&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,038&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915924354672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Goodwill balances and movements for each reportable segment during the period</a></td>
<td class="text"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents goodwill balances and the movements for each of our reportable segments during the three months ended January&#160;31, 2023:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:50.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.070%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Sciences and Applied Markets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diagnostics and Genomics</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agilent CrossLab</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of October 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,953&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,952&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill arising from acquisitions and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of January 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,755&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,965&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,983&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Components of other intangible assets during the period</a></td>
<td class="text"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The component parts of other intangible assets as of January&#160;31, 2023 and October&#160;31, 2022 are shown in the table below:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other&#160;Intangible&#160;Assets</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net&#160;Book<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of October 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased technology</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademark/Tradename</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Backlog</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third-party technology and licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortizable intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">811&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-Process R&amp;D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,159&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">821&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of January 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased technology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,761&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,096&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademark/Tradename</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Backlog</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third-party technology and licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,179&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,379&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-Process R&amp;D</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,189&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,379&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">810&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of estimated future amortization expense of finite-lived intangible assets</a></td>
<td class="text"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future amortization expense related to existing finite-lived purchased intangible assets for the remainder of fiscal year 2023 and for each of the next five fiscal years and thereafter is estimated below:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:90.859%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.941%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated future amortization expense:</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915922784640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Fair Value Assets And Liabilities Measured On Recurring Basis</a></td>
<td class="text"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis as of January&#160;31, 2023 were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement at January 31, 2023 Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">in&#160;Active</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Markets&#160;for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Identical&#160;Assets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Observable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;3)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents (money market funds)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments (foreign exchange contracts)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments (foreign exchange contracts) </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis as of October&#160;31, 2022 were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement at October 31, 2022 Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">in&#160;Active</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Markets&#160;for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Identical&#160;Assets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Observable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Level&#160;3)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents (money market funds)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments (foreign exchange contracts)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments (foreign exchange contracts)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestmentsTextBlock', window );">Gain (Loss) on Securities</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains and losses reflected in other income (expense), net for our equity investments with readily determinable fair value ("RDFV") and equity investments without RDFV are summarized below:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.651%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss recognized during the period on equity securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net loss on equity securities sold during the period</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (gain) loss on equity securities </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent consideration liability is our only recurring Level 3 asset or liability.  A summary of the Level 3 activity follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:82.135%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:6.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.989%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to contingent consideration (including measurement period adjustment)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value (included within selling, general and administrative expenses)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of realized and unrealized gain (loss) on investment in security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915924424224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Aggregated notional amounts by currency and designation</a></td>
<td class="text">The aggregated notional amounts by currency and designation as of January&#160;31, 2023, were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:44.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.786%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.080%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.258%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives&#160;<br/>Designated as <br/>Cash&#160;Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives <br/>Designated as <br/>Net Investment Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives <br/>Not Designated as&#160;<br/>Hedging Instruments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Forward<br/>Contracts USD</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Forward<br/>Contracts USD</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Forward<br/>Contracts USD</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Buy/(Sell)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Buy/(Sell)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Buy/(Sell)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">British Pound</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canadian Dollar</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japanese Yen</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danish Krone</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Korean Won</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore Dollar</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chinese Yuan Renminbi</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taiwan Dollar</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indian Rupee</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Totals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(434)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Gross fair values and balance sheet location of derivative instruments held in the consolidated balance sheet</a></td>
<td class="text">Derivative instruments are subject to master netting arrangements and are disclosed gross in the balance sheet in accordance with the authoritative guidance. The gross fair values and balance sheet location of derivative instruments held in the condensed consolidated balance sheet as of January&#160;31, 2023, and October&#160;31, 2022, were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:29.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.875%"/><td style="width:0.1%"/></tr><tr><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;text-indent:-31.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Values&#160;of&#160;Derivative&#160;Instruments</span></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset&#160;Derivatives</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability&#160;Derivatives</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;Sheet&#160;Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;Sheet&#160;Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31,<br/>2022</span></td></tr><tr><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Effect of derivative instruments for foreign exchange contracts in the consolidated statement of operations</a></td>
<td class="text">The effects of derivative instruments for foreign exchange contracts designated as hedging instruments and not designated as hedging instruments in our condensed consolidated statement of operations were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.356%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.944%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Cash Flow Hedges</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in accumulated other comprehensive&#160;loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) reclassified from accumulated other comprehensive&#160;loss into cost of sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTItNS0xLTEtNjg3NTE_9acfeb89-7d88-4046-b4c7-cb2eb4fcaa42">6</span>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTItNy0xLTEtNjg3NTE_4ec61448-9de2-40a0-8dd4-e126176d3a29">3</span>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on time value of forward contracts recorded in cost of sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTctNS0xLTEtNjg3NTE_e833622d-040d-4809-bc1d-d9369471a833">2</span>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTctNy0xLTEtNjg3NTE_ae37cd7a-d092-478d-9c12-235792651f19">&#8212;</span>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Net Investment Hedges</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in accumulated other comprehensive loss - translation adjustment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in other income (expense)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMjUtNS0xLTEtNjg3NTE_7bdf9258-4aa3-411c-b03c-7da3efd96a29">(13)</span></span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMjUtNy0xLTEtNjg3NTE_295a067e-a8da-4362-a6e5-55ad7d16f169">(3)</span></span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41678-113959<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41641-113959<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915922778736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Defined Benefit Plan, Net Periodic Benefit Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock', window );">Schedule of net pension and post-retirement benefit costs</a></td>
<td class="text"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Components of net periodic costs (benefits).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For the three months ended January&#160;31, 2023 and 2022, our net pension and post retirement benefit costs (benefits) were comprised of the following:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:42.365%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.715%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:42.365%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.715%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended January 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S. <br/>Pension&#160;Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S.<br/>Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.&#160;Post&#160;Retirement<br/>Benefit&#160;Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost&#8212;benefits earned during the period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial losses (gains)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net plan costs (benefits)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The service cost component is recorded in cost of sales and operating expenses in the condensed consolidated statement of operations. All other cost components are recorded in other income (expense), net in the condensed consolidated statement of operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock', window );">Employer Contributions and Expected Employer Contributions</a></td>
<td class="text"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employer contributions and expected future employer contributions for the remainder of the year were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.771%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.729%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employer Contributions</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For Remainder of Year</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. defined benefit plans</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. defined benefit plans</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of amount of contributions received by defined benefit plan from employer which increases plan assets and amount of contribution expected to be received by defined benefit plan from employer in the remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>a_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2439-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2410-114920<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915924229360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>WARRANTIES AND CONTINGENCIES (Table)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock', window );">Standard warranty</a></td>
<td class="text"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the standard warranty accrual activity is shown in the table below:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard warranty accrual, beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals for warranties including change in estimates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements made during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard warranty accrual, ending balance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals for warranties due within one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals for warranties due after one year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard warranty accrual, ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915924369840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LONG-TERM DEBT (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Senior Notes</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the company&#8217;s long-term senior notes:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.469%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.471%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized <br/>Principal</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Principal</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2031 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Senior Notes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,133&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,133&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915924175680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in accumulated other comprehensive income (loss) by component and related tax effects were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.126%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.113%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.848%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.697%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.848%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.848%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.857%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net defined benefit pension cost and post retirement plan costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended January 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prior service credits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Actuarial Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized gains (losses) on derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of October 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(347)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified out of accumulated other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of January 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(244)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(280)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock', window );">Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reclassifications out of accumulated other comprehensive income (loss) for the three months ended January&#160;31, 2023 and 2022 were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center;text-indent:4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:33.504%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.973%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.973%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.731%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Details about accumulated other <br/>comprehensive income (loss) components</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amounts Reclassified from <br/>other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affected line item in<br/>statement of operations</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="12" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain on derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTItNi0xLTEtNjg3NTE_c88580f0-1f89-414b-85e7-775437129012">6</span>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTItOC0xLTEtNjg3NTE_f8a759f4-726e-4284-aa80-54ef5c1c9cc9">3</span>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before income tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net of income tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net defined benefit pension cost and post retirement plan costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial net gain (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before income tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Provision) benefit for income tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net of income tax</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications for the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915928549840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jan. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Segment Profitability and Segment Assets</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The profitability of each of the segments is measured after excluding items such as transformational initiatives, acquisition and integration costs, amortization of intangible assets related to business combinations, interest income, interest expense and other items as noted in the reconciliations below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.429%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Revenue:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences and Applied Markets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics and Genomics</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agilent CrossLab</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,756&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Income From Operations:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences and Applied Markets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics and Genomics</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agilent CrossLab</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment income from operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects segment assets under our management reporting system. Segment assets include allocations of corporate assets, goodwill, net other intangibles and other assets. Unallocated assets primarily consist of cash, cash equivalents, short-term and long-term investments, deferred tax assets, right-of-use assets and other assets. &#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences and Applied Markets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,004&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics and Genomics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agilent CrossLab</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,486&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,313&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Reconciliation of segment results to total enterprise results</a></td>
<td class="text"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles segment income from operations to Agilent&#8217;s total enterprise income before taxes:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.429%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment income from operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transformational initiatives</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets related to business combinations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration costs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before taxes, as reported</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-indent:4.5pt"><span><br/></span></div><div style="padding-left:9pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) For the three months ended January&#160;31, 2023 and 2022, other income (expense), net includes net (gains) losses on the fair value of equity securities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915926396336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="nump">$ 1,053<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted Cash</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, restricted cash and restricted cash equivalents</a></td>
<td class="nump">1,253<span></span>
</td>
<td class="nump">1,056<span></span>
</td>
<td class="nump">$ 1,116<span></span>
</td>
<td class="nump">$ 1,490<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesOperatingAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-Use Asset</a></td>
<td class="nump">$ 155<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other assets<span></span>
</td>
<td class="text">Other assets<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="nump">$ 159<span></span>
</td>
<td class="nump">$ 152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList', window );">Operating Lease Liability, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other accrued liabilities, Other long-term liabilities<span></span>
</td>
<td class="text">Other accrued liabilities, Other long-term liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value of Financial Instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Carrying Value of Senior Notes</a></td>
<td class="nump">$ 2,133<span></span>
</td>
<td class="nump">$ 2,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract', window );"><strong>Variable Interest Entity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">10,919<span></span>
</td>
<td class="nump">10,532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Prices in Active Markets for Identical Assets (Level 1) | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value of Financial Instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair Value of Senior Notes</a></td>
<td class="nump">1,859<span></span>
</td>
<td class="nump">1,754<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember', window );">Variable Interest Entity, Not Primary Beneficiary [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract', window );"><strong>Variable Interest Entity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOperatingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOperatingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915925430688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE- Revenue by Region (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 1,756<span></span>
</td>
<td class="nump">$ 1,674<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=a_LifeSciencesandAppliedMarketsMember', window );">Life Sciences and Applied Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">1,033<span></span>
</td>
<td class="nump">976<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=a_AgilentCrossLabMember', window );">Agilent CrossLab</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">381<span></span>
</td>
<td class="nump">359<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=a_DiagnosticsAndGenomicsMember', window );">Diagnostics and Genomics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">342<span></span>
</td>
<td class="nump">339<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AmericasMember', window );">Americas</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">687<span></span>
</td>
<td class="nump">637<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AmericasMember', window );">Americas | Life Sciences and Applied Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">332<span></span>
</td>
<td class="nump">317<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AmericasMember', window );">Americas | Agilent CrossLab</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">154<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AmericasMember', window );">Americas | Diagnostics and Genomics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">201<span></span>
</td>
<td class="nump">188<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">456<span></span>
</td>
<td class="nump">451<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe | Life Sciences and Applied Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">259<span></span>
</td>
<td class="nump">252<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe | Agilent CrossLab</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">98<span></span>
</td>
<td class="nump">98<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe | Diagnostics and Genomics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">101<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">613<span></span>
</td>
<td class="nump">586<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific | Life Sciences and Applied Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">442<span></span>
</td>
<td class="nump">407<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific | Agilent CrossLab</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">129<span></span>
</td>
<td class="nump">129<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific | Diagnostics and Genomics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=a_LifeSciencesandAppliedMarketsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=a_LifeSciencesandAppliedMarketsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=a_AgilentCrossLabMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=a_AgilentCrossLabMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=a_DiagnosticsAndGenomicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=a_DiagnosticsAndGenomicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915925751600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE - Revenue by End Markets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 1,756<span></span>
</td>
<td class="nump">$ 1,674<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_a_EndMarketsAxis=a_PharmaceuticalandBiopharmaceuticalMarketMember', window );">Pharmaceutical and Biopharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">639<span></span>
</td>
<td class="nump">602<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_a_EndMarketsAxis=a_ChemicalandEnergyMarketMember', window );">Chemical and Advanced Materials</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">406<span></span>
</td>
<td class="nump">373<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_a_EndMarketsAxis=a_DiagnosticsandClinicalMarketMember', window );">Diagnostics and Clinical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">239<span></span>
</td>
<td class="nump">243<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_a_EndMarketsAxis=a_FoodMarketMember', window );">Food</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">160<span></span>
</td>
<td class="nump">158<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_a_EndMarketsAxis=a_AcademiaandGovernmentMarketMember', window );">Academia and Government</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_a_EndMarketsAxis=a_EnvironmentalandForensicsMarketMember', window );">Environmental and Forensics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 166<span></span>
</td>
<td class="nump">$ 157<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_EndMarketsAxis=a_PharmaceuticalandBiopharmaceuticalMarketMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_EndMarketsAxis=a_PharmaceuticalandBiopharmaceuticalMarketMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_EndMarketsAxis=a_ChemicalandEnergyMarketMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_EndMarketsAxis=a_ChemicalandEnergyMarketMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_EndMarketsAxis=a_DiagnosticsandClinicalMarketMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_EndMarketsAxis=a_DiagnosticsandClinicalMarketMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_EndMarketsAxis=a_FoodMarketMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_EndMarketsAxis=a_FoodMarketMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_EndMarketsAxis=a_AcademiaandGovernmentMarketMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_EndMarketsAxis=a_AcademiaandGovernmentMarketMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_EndMarketsAxis=a_EnvironmentalandForensicsMarketMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_EndMarketsAxis=a_EnvironmentalandForensicsMarketMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915919705824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE - Revenue by Type (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 1,756<span></span>
</td>
<td class="nump">$ 1,674<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=a_InstrumentationMember', window );">Instrumentation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">759<span></span>
</td>
<td class="nump">691<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=a_NonInstrumentationandOtherMember', window );">Non-Instrumentation and Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 997<span></span>
</td>
<td class="nump">$ 983<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=a_InstrumentationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=a_InstrumentationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=a_NonInstrumentationandOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=a_NonInstrumentationandOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915922970960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE - Contract Assets and Liability (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract', window );"><strong>Contract Asset</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract Assets (Unbilled Accounts Receivable)</a></td>
<td class="nump">$ 276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityAbstract', window );"><strong>Contract Liability</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liability ending balance as of October 31, 2022</a></td>
<td class="nump">557<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Net revenue deferred in the period</a></td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized that was included in the contract liability balance at the beginning of the period</a></td>
<td class="num">(196)<span></span>
</td>
<td class="num">$ (191)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Change in deferrals from customer cash advances, net of revenue recognized</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease', window );">Currency Translation and Other Adjustment</a></td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liability ending balance as of January 31, 2023</a></td>
<td class="nump">$ 623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126938201&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cumulative translation adjustment, after tax, from translating foreign currency financial statements into the reporting currency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915919694688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>REVENUE - Remaining Performance Obligation (Details) - Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-31<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jan. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligation expected timing of satisfaction period</a></td>
<td class="text">12 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligation amount</a></td>
<td class="nump">$ 378<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-31">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-31</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915922873248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION Text (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate', window );">ESPP plan purchase price (in hundredths)</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PublicUtilitiesInventoryTypeDomain', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1', window );">Share-based compensation capitalized in inventory</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting Period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Maximum contractual term, Expiration Period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Exercise Price of Common Stock, Percent of FMV</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting Period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Performance Shares [LTPP]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Performance Shares [LTPP]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount rate from fair value on purchase date that participants pay for shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost expensed and capitalized for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PublicUtilitiesInventoryTypeDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PublicUtilitiesInventoryTypeDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915925784768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION Allocated Share-based compensation expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Products and Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, General and Administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 26<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915922678144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION Fair Value Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Weighted average risk-free interest rate</a></td>
<td class="nump">3.90%<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Weighted average volatility</a></td>
<td class="nump">28.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected Life</a></td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=a_LtppMember', window );">LTPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility of Agilent shares</a></td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">29.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum', window );">Volatility of selected peer-company shares - Minimum</a></td>
<td class="nump">22.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum', window );">Volatility of selected peer-company shares - Maximum</a></td>
<td class="nump">84.00%<span></span>
</td>
<td class="nump">81.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate', window );">Pair-wise correlation with selected peers (in hundredths)</a></td>
<td class="nump">42.00%<span></span>
</td>
<td class="nump">41.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=a_LTPPRSUMember', window );">LTPP &amp; RSU</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions', window );">Post-vest holding restriction discount for all executive awards</a></td>
<td class="nump">7.10%<span></span>
</td>
<td class="nump">6.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The measure of the percentage amount of share price correlation during the period with a selected group of peer companies. Pair-wise correlations with selected peers is calculated as the correlation between each pair and the sum of correlations divided by the number of pairs to produce the average correlation between each pair.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>a_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The measure of the percentage amount by which a share price fluctuates during a period for peer companies - maximum range. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>a_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The measure of the percentage amount by which a share price fluctuates during a period for peer companies - minimum range. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>a_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restrictions on equity-based instruments during the vesting period, such as the inability to transfer unvested awards, are not taken into account in estimating the fair value of the award. However, restrictions that remain in effect after an award is vested, such as the inability to transfer or hedge vested options or a prohibition on the sale of outstanding vested shares (or other type of equity) for a period of time, affect the estimate of an award's fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=a_LtppMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=a_LtppMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=a_LTPPRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=a_LTPPRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915927881184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLineItems', window );"><strong>Income Tax Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision (benefit) for income taxes</a></td>
<td class="nump">$ 58<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">14.10%<span></span>
</td>
<td class="nump">11.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</a></td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Share-based Payment Arrangement, Expense, Tax Benefit</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139916008779392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE (Details) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_a_NumeratorAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 352<span></span>
</td>
<td class="nump">$ 283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_a_DenominatorsAbstract', window );"><strong>Denominators:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted-average shares</a></td>
<td class="nump">296<span></span>
</td>
<td class="nump">301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Potential common shares - stock options and other employee stock plans</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average shares</a></td>
<td class="nump">297<span></span>
</td>
<td class="nump">303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive shares excluded from computation of dilutive earnings per share (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_DenominatorsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Denominators [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_DenominatorsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>a_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_NumeratorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Numerator [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_NumeratorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>a_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915922981296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORY (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventory, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">$ 589<span></span>
</td>
<td class="nump">$ 555<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessAndRawMaterials', window );">Purchased parts and fabricated assemblies</a></td>
<td class="nump">522<span></span>
</td>
<td class="nump">483<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">$ 1,111<span></span>
</td>
<td class="nump">$ 1,038<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessAndRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate carrying amount as of the balance sheet date of items held by the entity which are partially completed at the time of measurement and unprocessed items that will go through the production process and become part of the final product. Includes supplies used directly or indirectly in the manufacturing or production process. This element may be used when the reporting entity combines work in process and raw materials into an aggregate amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessAndRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915918301824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill Roll forward (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill Roll Forward</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill beginning balance</a></td>
<td class="nump">3,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency translation impact</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill arising from acquisitions</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill ending balance</a></td>
<td class="nump">3,983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=a_LifeSciencesandAppliedMarketsMember', window );">Life Sciences and Applied Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill Roll Forward</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill beginning balance</a></td>
<td class="nump">1,743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency translation impact</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill arising from acquisitions</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill ending balance</a></td>
<td class="nump">1,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=a_DiagnosticsAndGenomicsMember', window );">Diagnostics and Genomics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill Roll Forward</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill beginning balance</a></td>
<td class="nump">1,953<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency translation impact</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill arising from acquisitions</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill ending balance</a></td>
<td class="nump">1,965<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=a_AgilentCrossLabMember', window );">Agilent CrossLab</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill Roll Forward</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill beginning balance</a></td>
<td class="nump">256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency translation impact</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill arising from acquisitions</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill ending balance</a></td>
<td class="nump">$ 263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=a_LifeSciencesandAppliedMarketsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=a_LifeSciencesandAppliedMarketsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=a_DiagnosticsAndGenomicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=a_DiagnosticsAndGenomicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=a_AgilentCrossLabMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=a_AgilentCrossLabMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915925720800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS Disclosures and Components of Purchased Other Intangibles (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 2,179<span></span>
</td>
<td class="nump">$ 2,149<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Total Intangible Assets</a></td>
<td class="nump">2,189<span></span>
</td>
<td class="nump">2,159<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">1,379<span></span>
</td>
<td class="nump">1,338<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Book Value</a></td>
<td class="nump">810<span></span>
</td>
<td class="nump">821<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">800<span></span>
</td>
<td class="nump">811<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Purchased Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">1,761<span></span>
</td>
<td class="nump">1,733<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">1,096<span></span>
</td>
<td class="nump">1,068<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Book Value</a></td>
<td class="nump">665<span></span>
</td>
<td class="nump">665<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademark/Tradenames</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">196<span></span>
</td>
<td class="nump">196<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">152<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Book Value</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">181<span></span>
</td>
<td class="nump">180<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Book Value</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember', window );">Backlog</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Book Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=a_ThirdPartyTechnologyandLicensesMember', window );">Third-Party Technology and Licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Book Value</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-Process R&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract', window );"><strong>Indefinite-Lived Intangible Assets (Excluding Goodwill)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">In-Process R&amp;D</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=a_ThirdPartyTechnologyandLicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=a_ThirdPartyTechnologyandLicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915922681200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS Textuals (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions to goodwill</a></td>
<td class="nump">$ 11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease', window );">Addition to other intangible assets</a></td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss', window );">Foreign currency translation impact on other intangible assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of IPR&amp;D</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets during the period</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=a_LifeSciencesandAppliedMarketsMember', window );">Life Sciences and Applied Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions to goodwill</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=a_DiagnosticsAndGenomicsMember', window );">Diagnostics and Genomics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions to goodwill</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=a_AgilentCrossLabMember', window );">Agilent CrossLab</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions to goodwill</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in carrying value of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=a_LifeSciencesandAppliedMarketsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=a_LifeSciencesandAppliedMarketsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=a_DiagnosticsAndGenomicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=a_DiagnosticsAndGenomicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=a_AgilentCrossLabMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=a_AgilentCrossLabMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139916008792784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS - Estimated Future Amortization (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jan. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Remainder of 2023</a></td>
<td class="nump">$ 109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2024</a></td>
<td class="nump">129<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2025</a></td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2026</a></td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2027</a></td>
<td class="nump">73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2028</a></td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">$ 243<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915918048960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS, Fair value of assets and liabilities measured on a recurring basis (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent Consideration</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
<td class="nump">$ 92<span></span>
</td>
<td class="nump">$ 89<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">723<span></span>
</td>
<td class="nump">577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents (money market funds)</a></td>
<td class="nump">652<span></span>
</td>
<td class="nump">492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Derivative instruments (foreign exchange contracts)</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Trading securities</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Derivative instruments (foreign exchange contracts)</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent Consideration</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liability</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent Consideration</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">688<span></span>
</td>
<td class="nump">523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents (money market funds)</a></td>
<td class="nump">652<span></span>
</td>
<td class="nump">492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Derivative instruments (foreign exchange contracts)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Trading securities</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Derivative instruments (foreign exchange contracts)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent Consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent Consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">64<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents (money market funds)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Derivative instruments (foreign exchange contracts)</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Trading securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Derivative instruments (foreign exchange contracts)</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent Consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liability</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent Consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents (money market funds)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Derivative instruments (foreign exchange contracts)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Trading securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Derivative instruments (foreign exchange contracts)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Other accrued liabilities | Resolution Bioscience, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent Consideration</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Other long-term liabilities | Resolution Bioscience, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent Consideration</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=a_ResolutionBioscienceIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=a_ResolutionBioscienceIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915926313056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Equity Securities and Investments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Net (gain) loss on equity securities</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss', window );">Equity Securities, FV-NI, Realized Gain (Loss)</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Unrealized gain (loss) on equity securities</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfInvestments', window );">Impairment of Investments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8A<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=SL6284422-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915918412896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS, Contingent Consideration (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair Value of contingent consideration</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
<td class="nump">$ 92<span></span>
</td>
<td class="nump">$ 89<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=a_ResolutionBioscienceIncMember', window );">Resolution Bioscience, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_a_BusinessCombinationsContingentConsiderationArrangements', window );">Contingent Consideration maximum earn-out period</a></td>
<td class="text">1 year 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent Consideration Arrangement - Maximum</a></td>
<td class="nump">$ 80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=a_ResolutionBioscienceIncMember', window );">Resolution Bioscience, Inc. | Significant Unobservable Inputs (Level 3) | Fair Value, Measurements, Recurring | Revenue Component</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair Value of contingent consideration</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_BusinessCombinationsContingentConsiderationArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum earn-out period for settlement of contingent consideration payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_BusinessCombinationsContingentConsiderationArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>a_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=a_ResolutionBioscienceIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=a_ResolutionBioscienceIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=a_RevenueComponentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=a_RevenueComponentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915925592240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Reconciliation of Beginning and Ending Level 3 Contingent Consideration Liability (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair Value Contingent Consideration, Beginning Balance</a></td>
<td class="nump">$ 67<span></span>
</td>
<td class="nump">$ 89<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3', window );">Additions to contingent consideration (including measurement period adjustment)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</a></td>
<td class="num">(65)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Change in fair value (included within SG&amp;A)</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair Value Contingent Consideration, Ending Balance</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 92<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as a liability into level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915923462880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS, Assets and Liabilities measured at Fair Value on a Non-Recurring Basis (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_a_AssetsLongLivedAbstract', window );"><strong>Long-Lived Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of Long-Lived Assets Held-for-use</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Impairment of Long-Lived assets Held for sale</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_AssetsLongLivedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets Long Lived [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_AssetsLongLivedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>a_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915925639632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS, Non Marketable Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount', window );">Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount', window );">Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount', window );">Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount', window );">Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Non-marketable equity securities carrying amount</a></td>
<td class="nump">$ 126<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from downward price adjustment on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative loss from downward price adjustment on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain from upward price adjustment on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative gain from upward price adjustment on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915925622032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVES- Text (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 06, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 15, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 16, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 01, 2016 </div>
<div>USD ($) </div>
<div>contracts</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue', window );">Aggregate fair value of all derivative instruments with credit-risk-related contingent features that were in a net liability position</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=a_SeniorNotes2026Member', window );">Senior Notes 2026 | Interest Rate Swap | Derivatives Designated as Hedging Instrument | Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateDerivativesAbstract', window );"><strong>Terminated Derivative Contracts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of interest rate swap contracts terminated | contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Remaining Gain (Loss) Reclassification from Accumulated OCI to be amortized to Income,</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=a_SeniorNotes2029Member', window );">Senior Notes 2029 | Treasury Lock [Member] | Derivatives Designated as Hedging Instrument | Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateDerivativesAbstract', window );"><strong>Terminated Derivative Contracts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Remaining Gain (Loss) Reclassification from Accumulated OCI to be amortized to Income,</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentDetailAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentDetailAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated value of gains (losses), net anticipated to be transferred in the future from accumulated other comprehensive income into earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80845-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNetLiabilityPositionAggregateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value amounts of derivative instruments that contain credit-risk-related contingent features that are in a net liability position at the end of the reporting period. For nonderivative instruments that are designated and qualify as hedging instruments, the fair value amounts are the carrying value of the nonderivative hedging instrument, including the adjustment for the foreign currency transaction gain (loss) on that instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4H<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624258-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNetLiabilityPositionAggregateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateDerivativesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateDerivativesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfInterestRateDerivativesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of interest rate derivative instruments held by the entity at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfInterestRateDerivativesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=a_SeniorNotes2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=a_SeniorNotes2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=a_SeniorNotes2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=a_SeniorNotes2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915918484320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVES- Foreign Exchange Forward Contracts (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jan. 31, 2023 </div>
<div>USD ($) </div>
<div>contracts</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives Designated as Hedging Instrument | Cash Flow Hedging | Foreign Exchange Forward</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfForeignCurrencyDerivativesHeld', window );">Number of foreign exchange forward contracts (in units) | contracts</a></td>
<td class="nump">270<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives Designated as Hedging Instrument | Net Investment Hedging [Member] | Foreign Exchange Forward</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfForeignCurrencyDerivativesHeld', window );">Number of foreign exchange forward contracts (in units) | contracts</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives Not Designated as Hedging Instruments | Foreign Exchange Forward</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfForeignCurrencyDerivativesHeld', window );">Number of foreign exchange forward contracts (in units) | contracts</a></td>
<td class="nump">189<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Designated as Hedging Instrument | Cash Flow Hedging | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">$ 434<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Designated as Hedging Instrument | Cash Flow Hedging | Euro | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">83<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Designated as Hedging Instrument | Cash Flow Hedging | British Pound | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Designated as Hedging Instrument | Cash Flow Hedging | Canadian Dollar | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Designated as Hedging Instrument | Cash Flow Hedging | Japanese Yen | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Designated as Hedging Instrument | Cash Flow Hedging | Korean Won | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Designated as Hedging Instrument | Cash Flow Hedging | Chinese Yuan Renminbi | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Designated as Hedging Instrument | Net Investment Hedging [Member] | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Designated as Hedging Instrument | Net Investment Hedging [Member] | Euro | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Not Designated as Hedging Instruments | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">152<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Not Designated as Hedging Instruments | Canadian Dollar | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Not Designated as Hedging Instruments | Japanese Yen | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Not Designated as Hedging Instruments | Korean Won | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Not Designated as Hedging Instruments | Chinese Yuan Renminbi | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Not Designated as Hedging Instruments | Taiwan, New Dollars | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_ShortMember', window );">Sell | Derivatives Not Designated as Hedging Instruments | India, Rupees | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_LongMember', window );">Buy | Derivatives Designated as Hedging Instrument | Cash Flow Hedging | Singapore Dollar | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_LongMember', window );">Buy | Derivatives Designated as Hedging Instrument | Cash Flow Hedging | Other | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_LongMember', window );">Buy | Derivatives Not Designated as Hedging Instruments | Euro | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_LongMember', window );">Buy | Derivatives Not Designated as Hedging Instruments | British Pound | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_LongMember', window );">Buy | Derivatives Not Designated as Hedging Instruments | Danish Krone | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_LongMember', window );">Buy | Derivatives Not Designated as Hedging Instruments | Singapore Dollar | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PositionAxis=us-gaap_LongMember', window );">Buy | Derivatives Not Designated as Hedging Instruments | Other | Forward Contracts USD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">$ 5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfForeignCurrencyDerivativesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of foreign currency exchange rate derivatives held by the entity at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfForeignCurrencyDerivativesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_ShortMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_ShortMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_GBP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_GBP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CAD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CAD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_JPY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_JPY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_KRW">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_KRW</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CNY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CNY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_TWD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_TWD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_INR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_INR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_LongMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_LongMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_SGD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_SGD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_XXX">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_XXX</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_DKK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_DKK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915918267968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVES, Fair value of derivative instruments and Consolidated Balance Sheet location (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNetAbstract', window );"><strong>Derivative Fair Value by Balance Sheet Location</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivatives asset fair value</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivatives liabilities fair value</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives Designated as Hedging Instruments | Cash Flow Hedging | Foreign Exchange Contracts | Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNetAbstract', window );"><strong>Derivative Fair Value by Balance Sheet Location</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivatives asset fair value</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives Designated as Hedging Instruments | Cash Flow Hedging | Foreign Exchange Contracts | Other Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNetAbstract', window );"><strong>Derivative Fair Value by Balance Sheet Location</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivatives liabilities fair value</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives Designated as Hedging Instruments | Net Investment Hedging [Member] | Foreign Exchange Contracts | Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNetAbstract', window );"><strong>Derivative Fair Value by Balance Sheet Location</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivatives asset fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives Designated as Hedging Instruments | Net Investment Hedging [Member] | Foreign Exchange Contracts | Other Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNetAbstract', window );"><strong>Derivative Fair Value by Balance Sheet Location</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivatives liabilities fair value</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives Not Designated as Hedging Instruments | Foreign Exchange Contracts | Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNetAbstract', window );"><strong>Derivative Fair Value by Balance Sheet Location</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivatives asset fair value</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives Not Designated as Hedging Instruments | Foreign Exchange Contracts | Other Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNetAbstract', window );"><strong>Derivative Fair Value by Balance Sheet Location</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivatives liabilities fair value</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915922940640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVES, Effect of derivative instruments on Consolidated Statement of Operations (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Gain (loss) reclassified from accumulated other comprehensive&#160;loss into cost of sales</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Gain (Loss) Reclassified from AOCI into cost of sales [Extensible Enumeration]</a></td>
<td class="text">Cost of revenue<span></span>
</td>
<td class="text">Cost of revenue<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives Designated as Hedging Instrument | Cash Flow Hedging | Foreign Exchange Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Gain (loss) reclassified from accumulated other comprehensive&#160;loss into cost of sales</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Gain (Loss) Reclassified from AOCI into cost of sales [Extensible Enumeration]</a></td>
<td class="text">Cost of revenue<span></span>
</td>
<td class="text">Cost of revenue<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain (loss) recognized</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Cost of revenue<span></span>
</td>
<td class="text">Cost of revenue<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives Designated as Hedging Instrument | Cash Flow Hedging | Foreign Exchange Contracts | Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) recognized in accumulated other comprehensive&#160;loss</a></td>
<td class="num">$ (31)<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives Designated as Hedging Instrument | Net Investment Hedging [Member] | Foreign Exchange Contracts | Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) recognized in accumulated other comprehensive loss - translation adjustment</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives Not Designated as Hedging Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain (loss) recognized</a></td>
<td class="num">$ (13)<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Other income (expense), net<span></span>
</td>
<td class="text">Other income (expense), net<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes gain (loss) from derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes gain (loss) from effective portion of derivative instrument reclassified from accumulated other comprehensive income (AOCI) into income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624177-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624177-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139916008761168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities (Details) - Cash Flow Hedging<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jan. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Net gain to be reclassified within next Twelve Months</a></td>
<td class="nump">$ 14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cost of Products and Services</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Net gain to be reclassified within next Twelve Months</a></td>
<td class="nump">$ 19<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915925657488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS- Components of net periodic costs (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Defined Benefit Plan, Net Periodic Benefit Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost - benefits earned during the period</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost on benefit obligation</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_a_AmortizationAndDeferralsAbstract', window );"><strong>Amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Actuarial losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Total net plan costs (benefits)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan | Foreign Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Defined Benefit Plan, Net Periodic Benefit Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost - benefits earned during the period</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost on benefit obligation</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_a_AmortizationAndDeferralsAbstract', window );"><strong>Amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Actuarial losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Total net plan costs (benefits)</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Postretirement Benefits Plan | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Defined Benefit Plan, Net Periodic Benefit Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost - benefits earned during the period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost on benefit obligation</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_a_AmortizationAndDeferralsAbstract', window );"><strong>Amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Actuarial losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Total net plan costs (benefits)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_AmortizationAndDeferralsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization and deferrals [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_AmortizationAndDeferralsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>a_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915925295200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Details) (Employer Contributions)) - Pension Plan - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer Contributions</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear', window );">Expected future employer contributions</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Foreign Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer Contributions</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear', window );">Expected future employer contributions</a></td>
<td class="nump">$ 11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution expected to be received by defined benefit plan from employer in remainder of current fiscal year. Excludes contribution previously paid by employer in current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915925249568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>WARRANTIES AND CONTINGENCIES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward', window );"><strong>Movement in Standard Product Warranty Accrual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Beginning balance</a></td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued', window );">Accruals for warranties including change in estimate</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualPayments', window );">Settlements made during the period</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Ending balance at end of period</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyDisclosureAbstract', window );"><strong>Standard Product Warranty Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualCurrent', window );">Accruals for warranties due within one year</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualNoncurrent', window );">Accrual for warranties due after one year</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteesAbstract', window );"><strong>Guarantees</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BankAcceptancesExecuted', window );">Guarantees</a></td>
<td class="nump">$ 37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BankAcceptancesExecuted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the financial institution's obligation to pay the holder of the customer's draft which the financial institution has guaranteed (i.e., Banker's Acceptance).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.14)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BankAcceptancesExecuted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInStandardProductWarrantyAccrualRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1),(c)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the aggregate standard product warranty liability that is expected to be paid within one year or the normal operating cycle, if longer. Does not include the balance for the extended product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the aggregate standard product warranty liability that is expected to be paid after one year or beyond the normal operating cycle, if longer. Does not include the balance for the extended product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the standard product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard product warranty. Excludes extended product warranties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualWarrantiesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915918455968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHORT-TERM DEBT - Credit Facility (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 13, 2019</div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jun. 18, 2021</div></th>
<th class="th"><div>Apr. 21, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfCommercialPaper', window );">Repayments of commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (324)<span></span>
</td>
<td class="num">$ (240)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommercialPaper', window );">Proceeds from Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">527<span></span>
</td>
<td class="nump">$ 240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit [Member] | 5 yr Unsecured Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInitiationDate1', window );">Initiation date of credit facility</a></td>
<td class="text">Mar. 13,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity of credit facility</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTerms', window );">Credit faciity terms (in years)</a></td>
<td class="text">five<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Expiration date of credit facility</a></td>
<td class="text">Mar. 13,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Amount outstanding on credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit [Member] | Additional Incremental Term Loan Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity of credit facility</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Amount outstanding on credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit [Member] | Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity of credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Amount outstanding on credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtWeightedAverageInterestRate', window );">Weighted Average Interest Rate, at Point in Time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.67%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the credit facility terminates, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the amount outstanding under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInitiationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the credit facility first became available, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInitiationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowing by issuing commercial paper.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow due to repaying amounts borrowed by issuing commercial paper.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the short-term debt arrangement, and disclosures pertaining to the underlying arrangements, including repayment terms, interest rates, restrictions on assets and activities, debt covenants, and other matters important to users of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of short-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=a_A5YrUnsecuredCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=a_A5YrUnsecuredCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=a_AdditionalIncrementalTermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=a_AdditionalIncrementalTermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915925423200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LONG-TERM DEBT (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 2,733<span></span>
</td>
<td class="nump">$ 2,733<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=a_SeniorNotes2026Member', window );">Senior Notes 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">299<span></span>
</td>
<td class="nump">299<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=a_SeniorNotes2029Member', window );">Senior Notes 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">495<span></span>
</td>
<td class="nump">495<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=a_SeniorNotes2030Member', window );">Senior Notes 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">496<span></span>
</td>
<td class="nump">496<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=a_SeniorNotes2031Member', window );">Senior Notes 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">843<span></span>
</td>
<td class="nump">843<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 2,133<span></span>
</td>
<td class="nump">$ 2,133<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=a_SeniorNotes2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=a_SeniorNotes2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=a_SeniorNotes2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=a_SeniorNotes2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=a_SeniorNotes2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=a_SeniorNotes2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=a_SeniorNotes2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=a_SeniorNotes2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915922938672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LONG-TERM DEBT - Text (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Apr. 15, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 2,733<span></span>
</td>
<td class="nump">$ 2,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=a_SeniorNotes2031Member', window );">Senior Notes 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 843<span></span>
</td>
<td class="nump">843<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=a_TermLoanMaturing2025Member', window );">Term Loan Maturing 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity of credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Long-Term Debt, Weighted Average Interest Rate, at Point in Time</a></td>
<td class="nump">5.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 2,133<span></span>
</td>
<td class="nump">$ 2,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=a_SeniorNotes2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=a_SeniorNotes2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=a_TermLoanMaturing2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=a_TermLoanMaturing2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915919968304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Stock Repurchase Program (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Mar. 01, 2023</div></th>
<th class="th"><div>Jan. 09, 2023</div></th>
<th class="th"><div>Feb. 18, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=a_A2021RepurchaseProgramMember', window );">2021 Repurchase Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Share repurchase program</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Share repurchase program authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Shares repurchased and retired during period, (Shares)</a></td>
<td class="nump">499,000<span></span>
</td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Shares repurchased and retired during period, (Value)</a></td>
<td class="nump">$ 75<span></span>
</td>
<td class="nump">$ 447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining authorized repurchase amount under share repurchase program</a></td>
<td class="nump">$ 363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=a_A2021RepurchaseProgramMember', window );">2021 Repurchase Program [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Share repurchase program</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining authorized repurchase amount under share repurchase program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=a_A2023RepurchaseProgramMember', window );">2023 Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Share repurchase program</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Share repurchase program authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=a_A2021RepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=a_A2021RepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=a_A2023RepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=a_A2023RepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915927981184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDER"S EQUITY - Dividends (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 22, 2023</div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsAbstract', window );"><strong>Dividends Paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Cash dividends paid per common share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.225<span></span>
</td>
<td class="nump">$ 0.210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Aggregate amount of cash dividends paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
<td class="nump">$ 63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockAbstract', window );"><strong>Dividends Declared</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends Declared. per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.225<span></span>
</td>
<td class="nump">$ 0.210<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockAbstract', window );"><strong>Dividends Declared</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear', window );">Date Dividends Declared</a></td>
<td class="text">Feb. 22,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends Declared. per share</a></td>
<td class="nump">$ 0.225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Aggregate Cash Dividends Declared</a></td>
<td class="nump">$ 67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendPayableDateToBePaidDayMonthAndYear', window );">Payment Date of Declared Dividends</a></td>
<td class="text">Apr. 26,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear', window );">Dividends Declared Date of Record</a></td>
<td class="text">Apr.  04,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendPayableDateToBePaidDayMonthAndYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the declared dividend will be paid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendPayableDateToBePaidDayMonthAndYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the dividend to be paid was declared, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableDateDeclaredDayMonthAndYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the holder must own the stock to be entitled to the dividend, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableDateOfRecordDayMonthAndYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915919907168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDER'S EQUITY - Accumulated Other Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning Balance</a></td>
<td class="num">$ (347)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Amounts reclassified out of accumulated other comprehensive income (loss)</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Tax expense (benefit)</a></td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">67<span></span>
</td>
<td class="num">$ (16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending Balance</a></td>
<td class="num">(280)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning Balance</a></td>
<td class="num">(335)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Amounts reclassified out of accumulated other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Tax expense (benefit)</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending Balance</a></td>
<td class="num">(244)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember', window );">Prior Service Credits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning Balance</a></td>
<td class="nump">123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Amounts reclassified out of accumulated other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Tax expense (benefit)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending Balance</a></td>
<td class="nump">123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember', window );">Actuarial Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning Balance</a></td>
<td class="num">(155)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Amounts reclassified out of accumulated other comprehensive income (loss)</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Tax expense (benefit)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending Balance</a></td>
<td class="num">(153)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember', window );">Unrealized Gains (Losses) on Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning Balance</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(31)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Amounts reclassified out of accumulated other comprehensive income (loss)</a></td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Tax expense (benefit)</a></td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(26)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending Balance</a></td>
<td class="num">$ (6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915923030464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Reclassifications out of accumulated comprehensive income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Unrealized gain (loss) on derivatives</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax', window );">Amounts reclassified into earnings related to derivative instruments, tax</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Unrealized gain (loss) on derivatives after reclassification and after Tax</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Actuarial net loss</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax', window );">Actuarial net loss and prior service benefit reclassified, before tax</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax', window );">Tax on actuarial net loss and prior service benefit reclassified</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax', window );">Actuarial net loss and prior service benefit reclassified, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624177-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net period benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax (expense) benefit for reclassification adjustment from accumulated other comprehensive (income) loss of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915925649984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION - Profitability (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Reporting Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 1,756<span></span>
</td>
<td class="nump">$ 1,674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">426<span></span>
</td>
<td class="nump">376<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=a_LifeSciencesandAppliedMarketsMember', window );">Life Sciences and Applied Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">1,033<span></span>
</td>
<td class="nump">976<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">314<span></span>
</td>
<td class="nump">282<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=a_DiagnosticsAndGenomicsMember', window );">Diagnostics and Genomics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">342<span></span>
</td>
<td class="nump">339<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=a_AgilentCrossLabMember', window );">Agilent CrossLab</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">381<span></span>
</td>
<td class="nump">359<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">103<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=a_SegmentTotalMember', window );">Segment Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">1,756<span></span>
</td>
<td class="nump">1,674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">$ 476<span></span>
</td>
<td class="nump">$ 441<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=a_LifeSciencesandAppliedMarketsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=a_LifeSciencesandAppliedMarketsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=a_DiagnosticsAndGenomicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=a_DiagnosticsAndGenomicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=a_AgilentCrossLabMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=a_AgilentCrossLabMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=a_SegmentTotalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=a_SegmentTotalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915919736960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION - Reconciliation of Reportable Results (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit from Segments to Consolidated</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">$ 426<span></span>
</td>
<td class="nump">$ 376<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_a_TransformationalPrograms', window );">Transformational initiatives</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization of intangible assets related to business combinations</a></td>
<td class="num">(36)<span></span>
</td>
<td class="num">(51)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition and integration costs</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Change in fair value of contingent consideration</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonrecurringExpense', window );">Other</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(25)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before taxes, as reported</a></td>
<td class="nump">410<span></span>
</td>
<td class="nump">319<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=a_SegmentTotalMember', window );">Segment Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit from Segments to Consolidated</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">$ 476<span></span>
</td>
<td class="nump">$ 441<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_a_TransformationalPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings in the period, comprised of costs associated with restructuring activities not otherwise specified in the taxonomy that are not part of a specific plan as required by GAAP.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">a_TransformationalPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>a_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonrecurringExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense that is infrequent in occurrence or unusual in nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=114868883&amp;loc=SL114871943-224233<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonrecurringExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=a_SegmentTotalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=a_SegmentTotalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139915918319856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SEGMENT INFORMATION - Segment Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">$ 10,919<span></span>
</td>
<td class="nump">$ 10,532<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=a_LifeSciencesandAppliedMarketsMember', window );">Life Sciences and Applied Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">4,004<span></span>
</td>
<td class="nump">3,955<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=a_DiagnosticsAndGenomicsMember', window );">Diagnostics and Genomics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">3,520<span></span>
</td>
<td class="nump">3,489<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=a_AgilentCrossLabMember', window );">Agilent CrossLab</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">962<span></span>
</td>
<td class="nump">869<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=a_SegmentTotalMember', window );">Segment Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">$ 8,486<span></span>
</td>
<td class="nump">$ 8,313<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=a_LifeSciencesandAppliedMarketsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=a_LifeSciencesandAppliedMarketsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=a_DiagnosticsAndGenomicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=a_DiagnosticsAndGenomicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=a_AgilentCrossLabMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=a_AgilentCrossLabMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=a_SegmentTotalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=a_SegmentTotalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>a-20230131_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:a="http://www.agilent.com/20230131"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:currency="http://xbrl.sec.gov/currency/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="a-20230131.xsd" xlink:type="simple"/>
    <context id="i70d639bf42ac431baa789730eb29b398_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="if251c72c968c42798ed7df06399c339f_I20230224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
        </entity>
        <period>
            <instant>2023-02-24</instant>
        </period>
    </context>
    <context id="i3259791ee7e54e039e20c225742b0b34_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i3782575b566e410fbbe25167e7d79c3c_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i748dc3491f9645c98ca706c3c99c1306_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="ifebdb786506c4e9eb46de7ebfb8b03f5_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i658253fffabe4343b44569144474388f_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i728f596925ae44e9bfb99f953f600ea9_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i56485a537aba4a7691bd4bf959f3eaad_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i7452fced71814cff84c1f48750a63bfa_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i09a604512a0e4676affadfea2edad573_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i47cbf7fc4b914e59bbe1b08345963c45_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i03309ce0ed5f4d9e91d12ef6e9a11409_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="id92438986c5e4e49b96bc1f9a2f4db1b_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i086d2c8106374131912a8bbf8b1f0389_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i606776969cda4cf3b6e3577e3c4bed44_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i159c212a281a41ca83ae4c377dbc7ac2_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="ibc9a621efe2543f482d33c51bc9d5416_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i444f3ab3feb249a4b04e665424135f76_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i1e544c079add458db2a18a80383a6e7b_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i0045b371692f47b18ee58c78620f8429_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="icc75cb8136f54543a29bfc1d00dfeb94_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="ibe3a97d20a2e44a1b4614a44d8406d81_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i3e763681f4b045fa9fce2449566d8e3d_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i17235fbc23384d9f8362cd810ffa1a21_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i222c7e31873d4892afc0e691da9b4bce_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i0dd61afa70ad4f12b65e7f736904b893_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i7a4a359dc74949868e019c988906b5d0_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="ice97c2676fc846c99090bf80caa8297f_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="id29a4ca3e0874d32842cabb48c356b30_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i8325ec83b30f404fae1f872f8bcb4f30_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="ie66c1641c23d4e3d9b549e52e10a56c8_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i871f3a85672446d38dfc792b021eed04_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ia9a62a47fae946da9a3700c66ce2854b_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i164344fd739541659db977e6b67ac77f_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i10a00291ab2f4d61adf4c24df618cf71_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ia26e13aca129490c96e3ddb74f2dddfc_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i353beb6720a24469809c0d404c4182ea_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i2b33cacf7b234159b6c800d566d9d055_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i5eb4ff2fb6b34aa4b034790d18900784_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="ibdb13e13506245be95833ade22aa694e_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="ia8dcd748ed474187bf0b21aa9aafa830_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="ida8131692d1643f8a5dc1d105f4fcc7f_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i0bf212d52a5c43fc80953fcd23626126_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i3680858c584e48c0ab29a7b1c6e0b029_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i67000e3aa16f48a6b186edcc2d77662d_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i33f78913651a47bb92a2c9900a5966db_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i2befebaadc5845d4b2d401527b04cfaa_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i6d7d677f290d463982d78a58cc084bf7_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i2ebb4d48c62249409808fe3659039d91_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="if7f2de7d06eb471e9bfd5e643f5764f0_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i6d893a60dca04278bdac0cdc1e4d7989_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i4a7f1e005ab74d76ae872de230a40733_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ibb3d192ff70c43558d2066769b7f1110_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i5f9fc291277d49d591b89a8b399ecfc2_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="ic6b3e33e9f0d48d49e7efcf7b7ef2aca_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="if298d324aaf84d769b2e82d2d4124e2c_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i046a05a9e0514062bf9a677859974cf0_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i01fc9bcc3b254bf39b375532b23a0c12_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i4d0d7a31803341648e3a045e2165534e_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i8ec12050ee6648a19d1b871251909434_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i69383333245348d09b86b40f341453b8_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="iefc8abdb47254b4cb32b27b0c6fea825_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="ie6d69f7e74f34f0195f00e307ab8c80e_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i87246a3249384b37a1500f923b627ee8_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i73b7b9de08cd4437b818bb9e0f9b4ee8_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i352bfe2a93f947e1bcd491c49559ee2d_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i4eeadafeeecb428dbb6170dd77089aaf_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ie7b2543146dc41dd86c44c7ecf447270_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i433f969b78854ee3a4db35ffe5965afe_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i90bc58b4dc464d058d4f7d56e61e2e21_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i6d83c1345e874e8fabdab7fd0ec051b6_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i405a137dbfd148ab9797e53157dcb87b_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="ibfc4fdb619ed43958b648563fb2ca526_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i23ae7b4eb6644b20adf956a785dc7849_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="if846265414d142bd8d679b7776dae8eb_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i2a91b9cb9e834ebdae96fd116f3b54bb_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="a:EndMarketsAxis">a:PharmaceuticalandBiopharmaceuticalMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i3806cb502c9f457482e587434ee21a3a_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="a:EndMarketsAxis">a:PharmaceuticalandBiopharmaceuticalMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ief1e084458524e819f6e6ec4ad38798d_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="a:EndMarketsAxis">a:ChemicalandEnergyMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="ib1c59e046fef4e9a882ae2d9736f805c_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="a:EndMarketsAxis">a:ChemicalandEnergyMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i8a907fa8237046bc9803dec7949c9487_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="a:EndMarketsAxis">a:DiagnosticsandClinicalMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="ifac394aa55dd4cd78340931392cbac84_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="a:EndMarketsAxis">a:DiagnosticsandClinicalMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i918e15743a054525a9ccefdb3ad5a96e_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="a:EndMarketsAxis">a:FoodMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i62c28467676b4ec4bb9ab059f9e3ace4_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="a:EndMarketsAxis">a:FoodMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i3149e70ed5cc4cf09a5de74e7be57b1c_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="a:EndMarketsAxis">a:AcademiaandGovernmentMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i791084f532a9497884a77723bd002cab_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="a:EndMarketsAxis">a:AcademiaandGovernmentMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i4e0adf97a40a40168240f072cee0a25e_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="a:EndMarketsAxis">a:EnvironmentalandForensicsMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="id4cf935018ca4152b0524665cd240808_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="a:EndMarketsAxis">a:EnvironmentalandForensicsMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="id4192156e4404414ad46fd4d9c955d45_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">a:InstrumentationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="iad9f52901e11433ca11e2fd403c4973f_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">a:InstrumentationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i912f785ffd524583ab9332e174a0fd40_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">a:NonInstrumentationandOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="if7ae14d8d8fd4f5bab3bf7785fc6ec16_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">a:NonInstrumentationandOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i760e2fe91a2a4c6185fc11aef9ce399f_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-31</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="iaa92731b48d9431b9c71e61f579b2e2d_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i48899fe9fcfe40b0a73c87a1ed2a0395_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="ie790d592078944d5b3d633d03546cc1d_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i2bafa1d058fc442f80a7b778bd3869ed_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i2339426bfd7e4abe87998a6a1ba2cd4a_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="if327b7d783dc44e792963c335ca5a65b_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i39c3cd014db248d291455e64255569d7_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i6eca4fc7ce75413ab4ea045884e10a1e_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i43fcff5de6e1452bbd0a529d852367d6_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i94553cf9a1f84b418346d9811212fd96_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i959ba1e365cb46fa9d6a0d02c602c418_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i86cd4d87f14b4de7b2d3da170bbf7106_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ic8c2f25497504473b732d53cf9c153d0_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i290a2031fda542169028caab109d3e44_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i7776701abc9e4dfd9513b31afb36fc5d_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PublicUtilitiesInventoryTypeDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i20cb6e7201dd4408b86351630d0bad5a_D20211101-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PublicUtilitiesInventoryTypeDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i3152ba76c1df417987d29128ff805a81_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">a:LtppMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="ia93bc1b9aa474f94bdf99722444eb9d8_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">a:LtppMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i09873915b6ae475892e5c9a10735d4d2_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">a:LTPPRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="ib61c5c9996464615b2178256d5815306_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">a:LTPPRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i14749e019f0c4a78a5749fbc0e9602a5_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i4c417edb3d704da7925a02009feeff69_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="ibdb82786efda42a99e13832f0a499c71_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i9e0c874f1a2f4b52bde701c5d0c5f04a_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:LifeSciencesandAppliedMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="ic29288e8bc2e49b7b040c7b53788b074_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:DiagnosticsAndGenomicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i39cb63aace124a70b0cf20f2781b5388_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:AgilentCrossLabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i8aff20c1669045879c48618f094be7f4_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i78c9af0b8c6542c9804e6ef220ea2418_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="ie41bd8ebbf7b4eb68a78111db1b20475_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="ib3aadc25089b4d77a8b3cba419d06996_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="ia533acfa2c5343c2a822b9e8c8ada803_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">a:ThirdPartyTechnologyandLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="if6f781359e43434dbbae2d8573466196_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="iaecdfae8339144e08ca120f755566194_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="if38c838bd72546ecb1b03552dfe899cf_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i8d9e00fde0b04942843ffcf15477e77f_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="ic775993ecc604246b97b951a0ebb69f7_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i20a5d3b2a23247998eeb29965ed5cdec_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">a:ThirdPartyTechnologyandLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="id63c0b222b0f4e9591e1e1ec87de74b7_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i437d3b6251fa4606a05df57d58d3c73c_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i6f3778491b9842b0b3c469f4bf304247_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i771947e8e65142a1a1ce68ffba8ff0b3_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i3b2eea0376824cb7ae764ad375383f52_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i171aadf8a79b4a8faa50f9b31b327f84_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="ia1682ba3d772453aaed03af1031bb843_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i109ec2cab42849fbbaba1a368387a380_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i010b31c6afda45549d3eba9b0bb42875_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="ibaaa0ef2c25948abb1a1d1b853e18ed6_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="ie7ced5b567134408b99ecb1dcf4ae051_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="ic76a06664a9c458885914a4582301f23_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="ib0a5d971f1eb44de8d7f86aad8db9e29_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i82e671a18849495b8fb217e22b89ec5e_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i3bb56a780b484db596a8537265a00ae7_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i75a58a1a2e104511a28697e212909d94_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i520e8d9623a54c38ad726102ce099ef0_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i5b44dbcd02a9484b8ddc79b3a7fab6d0_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">a:ResolutionBioscienceIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="ia0bae153c6ff4111936aa0ad12293d37_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="id6ceec45342244868b46e5292ec40d82_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i6a2fd80baf9f425780781f01120bc35f_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i26efb771671d46d386db8ba65c21d53e_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i3a38492613ee42308d5ca58cb82e54ef_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">a:ResolutionBioscienceIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="ia8a78ace67c24152ae9bf94ef8fff79d_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i3c10ebdbbadb4b66aa09bafa9c10e706_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i1e5a6aeaf4184c46acacaeb8daab5f0e_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="icd7fc31a934145e0b639ded81bd2a4d4_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i7721625bbc374f08999fc25fad1ac438_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i3d7c15a459fa45b195a04ab621f88594_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i02170c8657d54b96b0528a195ed9a6cd_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i281883c980b344c399e2833cbe9f3289_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="ibeffa87382834b81853275826f27932c_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="ie9dec0e06e6d42a3a1fc2593ab243f89_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i3c48d568a480440bbe49a9dd5591a169_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i5163f85023154e9ab98ef3ed85fa7d48_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i1c579659bdb34d54a78c87a9d2a18b6d_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="id54402bbdc8b44b3b749044437d33713_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i1ec93e8012ad48e49930d3765f4c1246_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i4c8f6a78e1ad4a9396e91d5d4207fb18_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="ia7281c10e5fb4984b926202c8a6449b4_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">a:ResolutionBioscienceIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i1b9a47671ca446ada8a588e63d75db26_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="ie6200f5bde164b3aacc0816f6518870b_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i58623f61e4ac46a6a1223beba978e707_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i8b98c020f64f40bca09058f4ab716c9c_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="ibef8720eccc140e49ee2951305a773c9_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">a:ResolutionBioscienceIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i0cb8b86211c5442c9bef1b1297e7aefb_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">a:ResolutionBioscienceIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">a:RevenueComponentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i78c42080d0f14678bc601c2d0167baec_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">a:ResolutionBioscienceIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i16a365fe29a5430f9bd225bf44aa6737_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">a:ResolutionBioscienceIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="ib98f34fc7f8142658a397ac37f6164c3_I20160201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-02-01</instant>
        </period>
    </context>
    <context id="i324659d1cb1d46c89cd0b89529d4034d_D20160914-20160915">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-09-14</startDate>
            <endDate>2016-09-15</endDate>
        </period>
    </context>
    <context id="i78d62c946c8542959b4e01f2cf974dd8_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="ia8fcf2a391464f039d40d132dd664e20_I20190816">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-16</instant>
        </period>
    </context>
    <context id="i904b39b3a0a541d89b9c91d944f3526e_D20190906-20190906">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-06</startDate>
            <endDate>2019-09-06</endDate>
        </period>
    </context>
    <context id="i3c598168990b490090f5881a47627e8c_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i6368af5356e443e2b1bcf93e16e6d501_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="ia16943661c8e4bc59b6314507abbb36d_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i1cb76a4102ed49558e2227ab243ac8fd_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i70fa0d9850894ce2bd08150dce5dd880_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="if0d17d231ad5405b9ae739955f35f425_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i4bd82f3839e44ab192c48ef9a1870c15_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i17dde9e7368e4020ab08f6c0f4846ca7_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="idf03d71e237844c9ab4a9ebd0faa3359_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i5aafc014163f40529f30fefed7819d7b_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i71cd31f9f70b417fb1bb4b7d5392f0b2_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i3775203ec49249b4ab76f5cf6f2294ee_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="ib5ed8a5ca0774169b7f944d0bc113de9_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="ic52474b3fc2c44c7bec341cd3919960f_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:DKK</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="ia08df4cafe1540658c021ebd7e9ffadf_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:KRW</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i61cfdf67052b485b9591582a21abe8d0_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:KRW</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i295d08acf58449ef98033f4386430180_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i33d60a29c4894eb3bbb33a68e4118838_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i52e8713c120048e69a3901dd8044bd07_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i16cf2f8e131444838a3d586870b9b6c9_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i7ef13b82dfee4eb7bbf8c4421b6feda3_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:TWD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i23a1060162f147c9b80ea9c15caa11f8_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:INR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="idfcbd73a2af54018a2f5aeb70c0a2d56_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XXX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="ia52b02295eb54f4498499beee0165955_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XXX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="ie806c5c691284655bfd5c99810e88955_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="ic9849f16147a4c6a8af2c15f51852e70_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i601ab9e19dde4d31bfab5c2b2c29aaef_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i6d83ab74cb7347a5997c114b0ed5304e_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i57b59664cd454e6cbc394cafcff6db66_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i5b2775a8204c459cb7fac69d437dc90c_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="iecb19970c8c74e3ea1d87896cfeb7d28_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i4660a8668a594fbaae707aa7558ab4e3_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i3443903b09984986b9027f5937e42b78_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i87421f1569744288b0e82400d83000e1_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="iaab05383499649d68262077bbecf0617_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i22ad5bff85274efd9620a8216896b106_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="ie15965d2e28741fe8be38f4bf8c301ec_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i48143490c5ee44a2abd1901822b86a71_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i873674ebcbd7473eb35b8c4112bc01f3_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i69c58982edd04b3c8b9b1a661fa43077_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i446051e3e67a4f3eb24fc2a9fc021f9f_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ibe16525b780846f0a8256296b5fb0f87_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i359eb8716c884382914b552c36e4c9cc_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ia1a503ae15114ad2ab5911699cb1de9d_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i68beea4ee84a417ab91740679bcbab4d_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i1e03d76a6cd14445b069223cf851a0fb_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i2fb1f98c73934300bcb2677be16791c7_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ia7aac091b08c48afba3a0408369ffcc4_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i34dcb13592ff484696f17ceb6e02417d_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i125675019576446bbc7947a564d0c89f_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i9e99b539b79445c1b5eceb9da39435cd_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i1c2a35f6169348d4bb4fe4e665306d51_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="ifbcda6d0b469429ca1598f0fa2ebb7d7_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ie73c662f34154fc49f2f4456e56cd10c_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i73728e1faa1e4efda17c4a3ca7016e37_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i5a4bcfb758684d2488eda427cdb6b25d_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="ia940a16a97b2481b975ec28bbbb5866c_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i2ef13658ecf745f787fde75342d47896_D20190313-20190313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:A5YrUnsecuredCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-13</startDate>
            <endDate>2019-03-13</endDate>
        </period>
    </context>
    <context id="iafd490bd02de47189afdbcca947d8d74_I20190313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:A5YrUnsecuredCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-13</instant>
        </period>
    </context>
    <context id="i152367a04c424a7ba2d724aaa1763fdc_I20190313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:AdditionalIncrementalTermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-13</instant>
        </period>
    </context>
    <context id="i6bdea77493e34375a99fd1155e7a9865_I20210421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:A5YrUnsecuredCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-21</instant>
        </period>
    </context>
    <context id="i2f2d43ce269b4254baf2999a8865ea28_I20210421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:AdditionalIncrementalTermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-21</instant>
        </period>
    </context>
    <context id="i2bdca111b15343188d0db9a98448ac9d_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:A5YrUnsecuredCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="id9fc0ac763d44a1cb45cc9609a903602_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:AdditionalIncrementalTermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i6a69ec0f4903459fb41ff3b295fb9cb3_I20210618">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-18</instant>
        </period>
    </context>
    <context id="idfa1651ae6144d3fa003dba82a34e213_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i00a9160afdad455eb4f9ec0885e50ae0_I20220415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:TermLoanMaturing2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-15</instant>
        </period>
    </context>
    <context id="i08d40d57102743d89263c457fb2d9f57_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:TermLoanMaturing2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i10c0cb7fda60466cb455e2be4d15041f_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i0b64ba8cd1f3436782785cc805950f95_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i350ed86205aa4b80911ef00f731a2abd_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i783cb7ee1875433c87db62ff80483811_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i2079ee6072754438b4665c88d5465e25_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i7455386a3c3948c1a56733c226910fac_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i3d34be775eb5486e9dd8f335cc3b5197_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i8992aace108544bd92848aeb54b66881_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">a:SeniorNotes2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i5d6a03bdbe0143bda21e2c1075865b76_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i9cad5754c77d481a8d01dd8905da7bb4_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i09d3df9f558a4787b3d731f7b3eab7d8_I20210218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">a:A2021RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-18</instant>
        </period>
    </context>
    <context id="ie3f5a8f5de1849ddac4ff626ed31a5af_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">a:A2021RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="idd4e332392a048ae990d8d227847d292_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">a:A2021RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="id4f8c2b1ca13416f801985533f043e3e_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">a:A2021RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="ib27fcdd7d55f4e51b96ab02b41cb16f3_I20230301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">a:A2021RepurchaseProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-01</instant>
        </period>
    </context>
    <context id="i2e36614039e441fc844c3eebaa2a03df_I20230109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">a:A2023RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-09</instant>
        </period>
    </context>
    <context id="i5cee235c15894fc79e55ebd92dddd62f_D20230222-20230222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-22</startDate>
            <endDate>2023-02-22</endDate>
        </period>
    </context>
    <context id="i9a78f97293c94b7a9a3259156a44fa2e_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="if9481c6bfaca4632a77a30f531bb71a6_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="id8f1f6f3136049d4be156f4751093caf_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="ie3afa252a57540f291b6c76329807920_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i019e110038214039b7e2ec2a8a8e7c57_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i6a083ba0b32e485283552d0ac7ca6ea6_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="id3b66509fec04f3dbca28ec34bb295c1_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i408570a1fe564491867039bfbb606643_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i3d54a60dc4d4494fbe0eee8846f953cb_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="if9f56afb4f9643e593d0341fc1aa9b85_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i251d1854299d4023ad580a36c8fdb3f4_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i4876675b17484a69a10e8f4181f8a034_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i899550b909f344acbdc4d7dab570fb1d_D20221101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:SegmentTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i0e1195fba3dd4542a09cd93dc4067241_D20211101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:SegmentTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ia34e53066283455d9839cece675eac92_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:SegmentTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i927186f756bc4f41b7276527c4ebea8a_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">a:SegmentTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="contracts">
        <measure>a:contracts</measure>
    </unit>
    <unit id="rate">
        <measure>utr:Rate</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180L2ZyYWc6NTJhNjc0Y2I0NjE0NDAzODllZGI5M2FiMzFkZTBkN2UvdGFibGU6NTEwYzc2ZTkwY2IwNGY2ZWEzY2JlZjIxODAxMDI0MTAvdGFibGVyYW5nZTo1MTBjNzZlOTBjYjA0ZjZlYTNjYmVmMjE4MDEwMjQxMF8xLTEtMS0xLTY4NzUx_55e042b2-1d6f-451c-8111-ca34c8601edf">0001090872</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180L2ZyYWc6NTJhNjc0Y2I0NjE0NDAzODllZGI5M2FiMzFkZTBkN2UvdGFibGU6NTEwYzc2ZTkwY2IwNGY2ZWEzY2JlZjIxODAxMDI0MTAvdGFibGVyYW5nZTo1MTBjNzZlOTBjYjA0ZjZlYTNjYmVmMjE4MDEwMjQxMF8zLTEtMS0xLTY4NzUx_98941c90-5b0d-47bf-97d3-125520a992c5">--10-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180L2ZyYWc6NTJhNjc0Y2I0NjE0NDAzODllZGI5M2FiMzFkZTBkN2UvdGFibGU6NTEwYzc2ZTkwY2IwNGY2ZWEzY2JlZjIxODAxMDI0MTAvdGFibGVyYW5nZTo1MTBjNzZlOTBjYjA0ZjZlYTNjYmVmMjE4MDEwMjQxMF80LTEtMS0xLTY4NzUx_bf0b790e-c908-446b-a509-303589d9c30f">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180L2ZyYWc6NTJhNjc0Y2I0NjE0NDAzODllZGI5M2FiMzFkZTBkN2UvdGFibGU6NTEwYzc2ZTkwY2IwNGY2ZWEzY2JlZjIxODAxMDI0MTAvdGFibGVyYW5nZTo1MTBjNzZlOTBjYjA0ZjZlYTNjYmVmMjE4MDEwMjQxMF81LTEtMS0xLTY4NzUx_9c972be1-4837-4bfc-9955-e9b8ca129063">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180L2ZyYWc6NTJhNjc0Y2I0NjE0NDAzODllZGI5M2FiMzFkZTBkN2UvdGFibGU6NTEwYzc2ZTkwY2IwNGY2ZWEzY2JlZjIxODAxMDI0MTAvdGFibGVyYW5nZTo1MTBjNzZlOTBjYjA0ZjZlYTNjYmVmMjE4MDEwMjQxMF82LTEtMS0xLTY4NzUx_3d73745a-1cac-49a7-82e4-15110369823a">false</dei:AmendmentFlag>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDQ4Mw_0923d8a4-45b0-4175-952d-a7c717b81666">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDQ5MA_9b066508-1908-4248-884a-1df299c2bc14">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDY1Mg_3682f298-9ca7-4d01-a434-54ee5feb1306">http://fasb.org/us-gaap/2022#OtherAccruedLiabilitiesCurrentAndNoncurrent http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDY1OQ_fa7b70f1-0cec-4130-bca6-58ec8ae1e703">http://fasb.org/us-gaap/2022#OtherAccruedLiabilitiesCurrentAndNoncurrent http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList>
    <us-gaap:DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="ibe16525b780846f0a8256296b5fb0f87_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTItNS0xLTEtNjg3NTE_9acfeb89-7d88-4046-b4c7-cb2eb4fcaa42">http://fasb.org/us-gaap/2022#CostOfGoodsAndServicesSold</us-gaap:DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="i359eb8716c884382914b552c36e4c9cc_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTItNy0xLTEtNjg3NTE_4ec61448-9de2-40a0-8dd4-e126176d3a29">http://fasb.org/us-gaap/2022#CostOfGoodsAndServicesSold</us-gaap:DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="ibe16525b780846f0a8256296b5fb0f87_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTctNS0xLTEtNjg3NTE_e833622d-040d-4809-bc1d-d9369471a833">http://fasb.org/us-gaap/2022#CostOfGoodsAndServicesSold</us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="i359eb8716c884382914b552c36e4c9cc_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTctNy0xLTEtNjg3NTE_ae37cd7a-d092-478d-9c12-235792651f19">http://fasb.org/us-gaap/2022#CostOfGoodsAndServicesSold</us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="i1e03d76a6cd14445b069223cf851a0fb_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMjUtNS0xLTEtNjg3NTE_7bdf9258-4aa3-411c-b03c-7da3efd96a29">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="i2fb1f98c73934300bcb2677be16791c7_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMjUtNy0xLTEtNjg3NTE_295a067e-a8da-4362-a6e5-55ad7d16f169">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTItNi0xLTEtNjg3NTE_c88580f0-1f89-414b-85e7-775437129012">http://fasb.org/us-gaap/2022#CostOfGoodsAndServicesSold</us-gaap:DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTItOC0xLTEtNjg3NTE_f8a759f4-726e-4284-aa80-54ef5c1c9cc9">http://fasb.org/us-gaap/2022#CostOfGoodsAndServicesSold</us-gaap:DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <dei:DocumentType
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGV4dHJlZ2lvbjphZjljOGUwYmYzM2M0ZGU4YTc3ZjVjNDMwYzc5MjBmZl8yMjU3_947ca818-54da-417a-8ef2-9e05dda3f654">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGV4dHJlZ2lvbjphZjljOGUwYmYzM2M0ZGU4YTc3ZjVjNDMwYzc5MjBmZl8yMjU4_8f061253-5076-4c1f-add2-dc6d1e9a2522">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGV4dHJlZ2lvbjphZjljOGUwYmYzM2M0ZGU4YTc3ZjVjNDMwYzc5MjBmZl8yMjU_a9f98e13-bcdf-4c40-91cb-f37184fd7f6a">2023-01-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGV4dHJlZ2lvbjphZjljOGUwYmYzM2M0ZGU4YTc3ZjVjNDMwYzc5MjBmZl8yMjQ3_49d4bc5e-185c-4762-ae43-699ddab10570">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGV4dHJlZ2lvbjphZjljOGUwYmYzM2M0ZGU4YTc3ZjVjNDMwYzc5MjBmZl8yMjQ2_41bedeb2-958f-4dad-9967-254c724e9925">001-15405</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGV4dHJlZ2lvbjphZjljOGUwYmYzM2M0ZGU4YTc3ZjVjNDMwYzc5MjBmZl8yMjUz_6dcebc1d-cf38-4646-aa6f-516783b9f41a">AGILENT TECHNOLOGIES,&#160;INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGFibGU6YzllNWM3YzNlZTY2NDRjMTgwYjE4MjA2NTZjN2QyYjUvdGFibGVyYW5nZTpjOWU1YzdjM2VlNjY0NGMxODBiMTgyMDY1NmM3ZDJiNV8wLTEtMS0xLTY4NzUx_716bd30e-6a82-4ab8-8f2c-b31b04f0e0b2">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGFibGU6YzllNWM3YzNlZTY2NDRjMTgwYjE4MjA2NTZjN2QyYjUvdGFibGVyYW5nZTpjOWU1YzdjM2VlNjY0NGMxODBiMTgyMDY1NmM3ZDJiNV8wLTUtMS0xLTY4NzUx_186ae85b-d68c-4e80-ac6a-1fb5466ee52f">77-0518772</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGV4dHJlZ2lvbjphZjljOGUwYmYzM2M0ZGU4YTc3ZjVjNDMwYzc5MjBmZl8yMjU0_8aae352b-0248-4d87-9cea-a8104432a76a">5301 Stevens Creek Blvd.,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGV4dHJlZ2lvbjphZjljOGUwYmYzM2M0ZGU4YTc3ZjVjNDMwYzc5MjBmZl8yMjU1_02638fc6-a641-4e26-8505-f7ed3951a5a1">Santa Clara,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGV4dHJlZ2lvbjphZjljOGUwYmYzM2M0ZGU4YTc3ZjVjNDMwYzc5MjBmZl8yMjQ5_ebaf4b18-9de5-4d70-b879-1e783ee22c5c">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGV4dHJlZ2lvbjphZjljOGUwYmYzM2M0ZGU4YTc3ZjVjNDMwYzc5MjBmZl8yMjQ4_0aeb38d8-d827-4b1f-a197-e2b67c5f386c">95051</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGV4dHJlZ2lvbjphZjljOGUwYmYzM2M0ZGU4YTc3ZjVjNDMwYzc5MjBmZl8yMjUw_0b3a28b1-11d8-423c-a83a-dcee91293369">(800)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGV4dHJlZ2lvbjphZjljOGUwYmYzM2M0ZGU4YTc3ZjVjNDMwYzc5MjBmZl8yMjU5_8af9881f-d7f1-4ebb-a029-ab38eafbc529">227-9770</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGFibGU6NDE1NDY2NzkwNzQ3NGUwMWE1ZWZmMjU1YTBjZGM3ZjAvdGFibGVyYW5nZTo0MTU0NjY3OTA3NDc0ZTAxYTVlZmYyNTVhMGNkYzdmMF8xLTAtMS0xLTY4NzUx_055af4a1-4d18-479f-8b43-48814692c95c">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGFibGU6NDE1NDY2NzkwNzQ3NGUwMWE1ZWZmMjU1YTBjZGM3ZjAvdGFibGVyYW5nZTo0MTU0NjY3OTA3NDc0ZTAxYTVlZmYyNTVhMGNkYzdmMF8xLTMtMS0xLTY4NzUx_05fbfa73-2aac-4fc4-a1e7-6166edcd6724">A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGFibGU6NDE1NDY2NzkwNzQ3NGUwMWE1ZWZmMjU1YTBjZGM3ZjAvdGFibGVyYW5nZTo0MTU0NjY3OTA3NDc0ZTAxYTVlZmYyNTVhMGNkYzdmMF8xLTctMS0xLTY4NzUx_c4d94495-4123-4e81-b824-1a6778edb780">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGV4dHJlZ2lvbjphZjljOGUwYmYzM2M0ZGU4YTc3ZjVjNDMwYzc5MjBmZl8yMjUx_d7aae156-c0b1-4e37-836a-54c6c81cd3fa">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGV4dHJlZ2lvbjphZjljOGUwYmYzM2M0ZGU4YTc3ZjVjNDMwYzc5MjBmZl8yMjUy_369a649e-2749-41ae-88a4-104b1e7611a5">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGFibGU6ZjkwMmVmZGJiODA1NDEwNmE3OThlZjcyMzI2MWY2YWUvdGFibGVyYW5nZTpmOTAyZWZkYmI4MDU0MTA2YTc5OGVmNzIzMjYxZjZhZV8wLTAtMS0xLTY4NzUx_55ddd14c-0fe0-499e-a8b0-54bfe6d3cdaa">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGFibGU6ZjkwMmVmZGJiODA1NDEwNmE3OThlZjcyMzI2MWY2YWUvdGFibGVyYW5nZTpmOTAyZWZkYmI4MDU0MTA2YTc5OGVmNzIzMjYxZjZhZV8xLTEtMS0xLTY4NzUx_1cd2107f-e6e1-453c-a113-8cec64d0a323">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGFibGU6ZjkwMmVmZGJiODA1NDEwNmE3OThlZjcyMzI2MWY2YWUvdGFibGVyYW5nZTpmOTAyZWZkYmI4MDU0MTA2YTc5OGVmNzIzMjYxZjZhZV8xLTctMS0xLTY4NzUx_115c3527-b8ef-4361-b970-0814ab336835">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGV4dHJlZ2lvbjphZjljOGUwYmYzM2M0ZGU4YTc3ZjVjNDMwYzc5MjBmZl8yMjU2_3ef3a74e-4609-4ff4-b203-2664326ba8e8">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="if251c72c968c42798ed7df06399c339f_I20230224"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xL2ZyYWc6YWY5YzhlMGJmMzNjNGRlOGE3N2Y1YzQzMGM3OTIwZmYvdGV4dHJlZ2lvbjphZjljOGUwYmYzM2M0ZGU4YTc3ZjVjNDMwYzc5MjBmZl8yMTgx_85767295-9f92-4e7a-b35a-a16b56a084c6"
      unitRef="shares">295701853</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3259791ee7e54e039e20c225742b0b34_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfNC01LTEtMS02ODc1MQ_dbd7f14f-4e3d-4058-909f-363e931ca3e1"
      unitRef="usd">1323000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3782575b566e410fbbe25167e7d79c3c_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfNC03LTEtMS02ODc1MQ_efd1dcc9-b725-4987-9bb7-249e620e113c"
      unitRef="usd">1263000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i748dc3491f9645c98ca706c3c99c1306_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfNS01LTEtMS02ODc1MQ_a6b0d6d1-f24c-4e5a-ab13-167809d1d6d4"
      unitRef="usd">433000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifebdb786506c4e9eb46de7ebfb8b03f5_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfNS03LTEtMS02ODc1MQ_8eda11f1-1d46-4bce-bd9c-1e30bc0c5a6b"
      unitRef="usd">411000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfNi01LTEtMS02ODc1MQ_727f2f48-7f2e-4fb4-8ffb-1f8d3a5c4d9c"
      unitRef="usd">1756000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfNi03LTEtMS02ODc1MQ_2fa035eb-f26e-4b8d-94d0-40b415de9b20"
      unitRef="usd">1674000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i3259791ee7e54e039e20c225742b0b34_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfOC01LTEtMS02ODc1MQ_bc211eb1-8167-4e2e-b8fa-7c04056cba46"
      unitRef="usd">556000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i3782575b566e410fbbe25167e7d79c3c_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfOC03LTEtMS02ODc1MQ_f628db12-b917-4f08-aa97-bf7ed30fa82e"
      unitRef="usd">545000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i748dc3491f9645c98ca706c3c99c1306_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfOS01LTEtMS02ODc1MQ_8cfcc55e-1059-4eab-b0f9-5388aa37125d"
      unitRef="usd">232000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ifebdb786506c4e9eb46de7ebfb8b03f5_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfOS03LTEtMS02ODc1MQ_c6feb77b-b6d2-46ff-ba92-7001c4b20fa0"
      unitRef="usd">219000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTAtNS0xLTEtNjg3NTE_71274a60-f836-4ec7-acdd-6a16bff45d68"
      unitRef="usd">788000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTAtNy0xLTEtNjg3NTE_303a202d-ff0e-4998-8382-145361d078ff"
      unitRef="usd">764000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTEtNS0xLTEtNjg3NTE_911506da-5588-437e-a15e-d8038c27a8b9"
      unitRef="usd">123000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTEtNy0xLTEtNjg3NTE_b9301d04-608b-4c19-be5b-88cf37fe3571"
      unitRef="usd">117000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTItNS0xLTEtNjg3NTE_3d6c648d-12f0-4ff2-b8bb-0f845955174b"
      unitRef="usd">419000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTItNy0xLTEtNjg3NTE_c0b10c05-3388-461e-bd5e-86ee07f9e4cf"
      unitRef="usd">417000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTMtNS0xLTEtNjg3NTE_5a34e1b6-ffff-4362-b23a-0cc2e2b53c97"
      unitRef="usd">1330000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTMtNy0xLTEtNjg3NTE_2c791f5c-ae3d-4b26-a8c6-e5e79ad271f4"
      unitRef="usd">1298000000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTQtNS0xLTEtNjg3NTE_474bb262-e390-4faf-8196-5c06eb43b72d"
      unitRef="usd">426000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTQtNy0xLTEtNjg3NTE_84fd7457-6479-4024-9c60-20dc38577757"
      unitRef="usd">376000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTUtNS0xLTEtNjg3NTE_1615350a-6d77-43e3-bbd8-9d9359e7b5c1"
      unitRef="usd">9000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTUtNy0xLTEtNjg3NTE_9e144256-cfdf-44ed-8520-d179e2019cec"
      unitRef="usd">1000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTYtNS0xLTEtNjg3NTE_350b57ce-c3a1-4a75-b4a7-29fffc0f4632"
      unitRef="usd">25000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTYtNy0xLTEtNjg3NTE_f78be576-9a67-4edd-b240-45c499ad57d1"
      unitRef="usd">21000000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTctNS0xLTEtNjg3NTE_4dde0977-3384-4202-9641-26fb5b0f3fad"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTctNy0xLTEtNjg3NTE_9a81c65b-033b-43c4-91ec-446905e872f2"
      unitRef="usd">-37000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTgtNS0xLTEtNjg3NTE_06491e30-1662-48e3-8804-d9dfad5e6999"
      unitRef="usd">410000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTgtNy0xLTEtNjg3NTE_8b42a7d1-a892-42b2-a9ff-690f9b5e3eb3"
      unitRef="usd">319000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTktNS0xLTEtNjg3NTE_e05bc500-d25e-443f-9245-193ab8cadb91"
      unitRef="usd">58000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMTktNy0xLTEtNjg3NTE_f66d3aa7-b68e-4724-b45d-7d63a631e8d3"
      unitRef="usd">36000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMjAtNS0xLTEtNjg3NTE_ba028988-b791-490f-8698-39ac025c762f"
      unitRef="usd">352000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMjAtNy0xLTEtNjg3NTE_a49ae587-b9fc-4b64-9f0d-7d7faad565fe"
      unitRef="usd">283000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMjMtNS0xLTEtNjg3NTE_ac774593-dddb-416e-8157-2fb338a31be7"
      unitRef="usdPerShare">1.19</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMjMtNy0xLTEtNjg3NTE_6945fc11-e36b-4bd7-9303-e3488a6ec88f"
      unitRef="usdPerShare">0.94</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMjQtNS0xLTEtNjg3NTE_5340e610-7228-4d25-8b04-155ff679328d"
      unitRef="usdPerShare">1.19</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMjQtNy0xLTEtNjg3NTE_664cdffe-c259-4c7a-80b5-ed50135d0e2c"
      unitRef="usdPerShare">0.93</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMjctNS0xLTEtNjg3NTE_92218217-bb95-45f2-aef2-eccc34ee3c40"
      unitRef="shares">296000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMjctNy0xLTEtNjg3NTE_5e448ea6-ad21-404a-ad7f-82bd47d65677"
      unitRef="shares">301000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMjgtNS0xLTEtNjg3NTE_d2c6175c-a53e-44da-a448-8f391e27a694"
      unitRef="shares">297000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xNi9mcmFnOjRmOGJmMGI1ZDY5NjQxOWNhYjc3ODc3YTQ2OGQ3MWMxL3RhYmxlOjlmNzI0NTFmYzZlOTQyOWNhMjczNTFlMjc1NzlkOGFjL3RhYmxlcmFuZ2U6OWY3MjQ1MWZjNmU5NDI5Y2EyNzM1MWUyNzU3OWQ4YWNfMjgtNy0xLTEtNjg3NTE_90e3a438-04b1-4040-802c-220fefdc4bda"
      unitRef="shares">303000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfNC01LTEtMS02ODc1MQ_910fdead-b464-410b-b253-1577c93b2347"
      unitRef="usd">352000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfNC03LTEtMS02ODc1MQ_0679f287-1f00-4e6b-87d2-c3c32d4494c1"
      unitRef="usd">283000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfOC0wLTEtMS02ODc1MS90ZXh0cmVnaW9uOjljMTdjZTc1YjI5ZjQxOTFiNjAzZTg0ZWMzNTExODE5Xzk0_95c937fe-77c6-4f6d-95b1-c066e2490918"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfOC0wLTEtMS02ODc1MS90ZXh0cmVnaW9uOjljMTdjZTc1YjI5ZjQxOTFiNjAzZTg0ZWMzNTExODE5XzEwMQ_1a1164cf-20f9-469d-8656-c600b4b43cc0"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfOC01LTEtMS02ODc1MQ_559afccd-1796-4291-a937-6b53d9890fb6"
      unitRef="usd">-22000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfOC03LTEtMS02ODc1MQ_594b7920-e0dc-42a4-8e8a-f25de51b8977"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfOS0wLTEtMS02ODc1MS90ZXh0cmVnaW9uOjI5YTE1NDE3NmM2NDQ1ZGZiZTQ2ZTg3Yjg4YWQ0YzU0XzExNQ_2242305c-b0c1-4f27-b00b-f7310eff21cc"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfOS0wLTEtMS02ODc1MS90ZXh0cmVnaW9uOjI5YTE1NDE3NmM2NDQ1ZGZiZTQ2ZTg3Yjg4YWQ0YzU0XzEyMg_484e0342-ee8d-4722-aaf3-3d6ba4f4fef4"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfOS01LTEtMS02ODc1MQ_b481566e-d2f3-4d20-a88a-71d06343686d"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfOS03LTEtMS02ODc1MQ_9474039c-07ce-4234-9d1e-0f4ca0ef6919"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfMTAtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjo2YWY4NTNhMWY3OGM0YjQwOTk4MmViNTUxMGQ2OTZmNF82NA_33aa68f4-fc2a-469c-8eb5-de92bc451822"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfMTAtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjo2YWY4NTNhMWY3OGM0YjQwOTk4MmViNTUxMGQ2OTZmNF83MQ_d9f5c029-5ae5-4e50-bf9e-6a7efbfc3b37"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfMTAtNS0xLTEtNjg3NTE_f8ff8196-fea2-4e81-9eb6-883042af7d72"
      unitRef="usd">91000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfMTAtNy0xLTEtNjg3NTE_346ef4eb-2dc8-4a04-952c-a48d8e8d378c"
      unitRef="usd">-27000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfMTItMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjpjNWRjZTQ3ZmU1NmY0MjZiYWNjOTkxODg4MTk2ZjI2MV82NA_09eace8a-55f0-4554-8914-8ddf12a8c7e3"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfMTItMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjpjNWRjZTQ3ZmU1NmY0MjZiYWNjOTkxODg4MTk2ZjI2MV83MQ_cf0bc464-7a40-40ee-bac7-12bee58bcb63"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfMTItNS0xLTEtNjg3NTE_ebc1042f-5cb1-433c-8ce8-f22a84ad1c4d"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfMTItNy0xLTEtNjg3NTE_763b0c92-add4-429b-afc9-ec86b6cf2467"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfMTQtNS0xLTEtNjg3NTE_01e7a032-9e0c-4533-a8d6-3292acd4c204"
      unitRef="usd">67000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfMTQtNy0xLTEtNjg3NTE_db892b2b-b84b-4168-a2f2-054c8d704f06"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfMTUtNS0xLTEtNjg3NTE_895f1be4-6fe1-4338-8883-d97d822697f1"
      unitRef="usd">419000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18xOS9mcmFnOmVjNTQwN2UxZGU2MzRjM2U4OTQzNjI5Mjc2OTYzM2Q2L3RhYmxlOjc2MGU5NjJmY2RiNjRhYTBiNmFiMWQwYWI4MDY3ZTY5L3RhYmxlcmFuZ2U6NzYwZTk2MmZjZGI2NGFhMGI2YWIxZDBhYjgwNjdlNjlfMTUtNy0xLTEtNjg3NTE_8ea0934a-0114-43a7-8eb2-f7f0fa309f6c"
      unitRef="usd">267000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMy0xLTEtMS02ODc1MQ_47469734-a4df-44d9-974e-4e889cc06a80"
      unitRef="usd">1250000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMy0zLTEtMS02ODc1MQ_85bd2d4b-a46b-403e-815b-3c56e61a517e"
      unitRef="usd">1053000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfNS0xLTEtMS02ODc1MQ_2905457e-bc23-430b-9272-c7b6f146a82c"
      unitRef="usd">1459000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfNS0zLTEtMS02ODc1MQ_c1e6fd7c-7cf8-4b37-836e-b2366960f240"
      unitRef="usd">1405000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfNi0xLTEtMS02ODc1MQ_606cf30e-560e-4c1e-a6e0-e2e2a4c3292a"
      unitRef="usd">1111000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfNi0zLTEtMS02ODc1MQ_1530526f-97fe-45bf-bfa9-b7fa35ef5de3"
      unitRef="usd">1038000000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfNy0xLTEtMS02ODc1MQ_efb93ac0-8a70-4d1b-bb54-861185f1d05b"
      unitRef="usd">258000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfNy0zLTEtMS02ODc1MQ_eea09050-dfc8-4abe-9015-59f71bfcdd4c"
      unitRef="usd">282000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfOC0xLTEtMS02ODc1MQ_8cf65efa-fe58-43d6-8c60-061b5e85d87d"
      unitRef="usd">4078000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfOC0zLTEtMS02ODc1MQ_257f9d40-623e-47c6-9ac0-8e76ac84a3f2"
      unitRef="usd">3778000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfOS0xLTEtMS02ODc1MQ_fd722165-2386-4706-8b64-c04989d759e9"
      unitRef="usd">1147000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfOS0zLTEtMS02ODc1MQ_f9a79d50-a7dc-475a-9482-0f2a6e9cc9fa"
      unitRef="usd">1100000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMTAtMS0xLTEtNjg3NTE_40526df2-13e1-4151-87a5-4812659c1cff"
      unitRef="usd">3983000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMTAtMy0xLTEtNjg3NTE_f6d8f747-8840-44db-9d90-e699cf3e1288"
      unitRef="usd">3952000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMTEtMS0xLTEtNjg3NTE_1b7bdd87-8cb8-4d36-9d85-11ee40f970cc"
      unitRef="usd">810000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMTEtMy0xLTEtNjg3NTE_8cee4afe-3522-4728-81c4-4a3bd7b5bb64"
      unitRef="usd">821000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:LongTermInvestments
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMTItMS0xLTEtNjg3NTE_be3bd701-661b-496c-89c4-79bb82e28a94"
      unitRef="usd">188000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMTItMy0xLTEtNjg3NTE_192588b6-7992-40ae-999a-3d642ffbe1c9"
      unitRef="usd">195000000</us-gaap:LongTermInvestments>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMTMtMS0xLTEtNjg3NTE_2a455952-451a-416a-82d6-02ecc500b5c2"
      unitRef="usd">713000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMTMtMy0xLTEtNjg3NTE_4e44b883-d26f-47e3-a659-aca79f065009"
      unitRef="usd">686000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMTQtMS0xLTEtNjg3NTE_c99bba14-be76-4fe4-94cf-296d12368f5b"
      unitRef="usd">10919000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMTQtMy0xLTEtNjg3NTE_714d9813-a3d3-4b57-b0d7-bb1de61cbf44"
      unitRef="usd">10532000000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMTctMS0xLTEtNjg3NTE_ce2535d2-fe66-4f9b-806b-cdd63017c890"
      unitRef="usd">540000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMTctMy0xLTEtNjg3NTE_b0be02fa-b2df-43a6-bbc4-b2df665de6e3"
      unitRef="usd">580000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMTgtMS0xLTEtNjg3NTE_ce5badd4-117c-46b3-93b5-f99a395577d2"
      unitRef="usd">296000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMTgtMy0xLTEtNjg3NTE_2f15be13-4df0-4c07-9561-6cc8e7de0291"
      unitRef="usd">455000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMTktMS0xLTEtNjg3NTE_239f7a83-08ce-4014-8e61-4c3c0bbd1e06"
      unitRef="usd">521000000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMTktMy0xLTEtNjg3NTE_8340675f-0782-4c39-9d90-e4d1a48cf572"
      unitRef="usd">461000000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:ShortTermBorrowings
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMjAtMS0xLTEtNjg3NTE_9b33fedd-83b8-4b66-9cc3-03e6a5641a37"
      unitRef="usd">238000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMjAtMy0xLTEtNjg3NTE_765979c8-39b6-4710-acbc-fe380a0f09f3"
      unitRef="usd">36000000</us-gaap:ShortTermBorrowings>
    <us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMjEtMS0xLTEtNjg3NTE_fb245dd7-dd4e-4cbf-8c7d-b0fcbe9ec278"
      unitRef="usd">341000000</us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMjEtMy0xLTEtNjg3NTE_f48720e1-b2b7-459f-a2bb-16a9b52b8d96"
      unitRef="usd">329000000</us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMjItMS0xLTEtNjg3NTE_a3a8f99d-44e4-4bb7-a4ee-61a60a416dec"
      unitRef="usd">1936000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMjItMy0xLTEtNjg3NTE_ea2fb413-b883-4360-8c56-91fd2960f935"
      unitRef="usd">1861000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebt
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMjMtMS0xLTEtNjg3NTE_cd2fbe5c-374c-4a11-b47c-fca9ee89a274"
      unitRef="usd">2733000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMjMtMy0xLTEtNjg3NTE_76fbda24-9b27-4e5c-b338-d1c5cfc2b991"
      unitRef="usd">2733000000</us-gaap:LongTermDebt>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMjQtMS0xLTEtNjg3NTE_415441d6-060c-4cfb-b648-b2db3cb91c6c"
      unitRef="usd">99000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMjQtMy0xLTEtNjg3NTE_07de2aea-91bb-4efa-aef3-9925f7860143"
      unitRef="usd">97000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMjUtMS0xLTEtNjg3NTE_d6376176-d91c-4fc9-908c-06f89d8f15fa"
      unitRef="usd">542000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMjUtMy0xLTEtNjg3NTE_7613abdd-15ce-42b1-8ae1-8325050bb793"
      unitRef="usd">536000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMjYtMS0xLTEtNjg3NTE_fca6ff98-dd48-4d5d-a039-d082418c8703"
      unitRef="usd">5310000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMjYtMy0xLTEtNjg3NTE_1a50aff7-7be5-4571-9a12-8b9bba3c32da"
      unitRef="usd">5227000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMjctMS0xLTEtNjg3NTE_ac1b29d6-b15b-48ca-871b-c6845dc71970"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMjctMy0xLTEtNjg3NTE_57410165-fc99-443c-96cd-d25e6d524274"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzAtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjpjZjZkMjFlN2NlY2E0YTk4YTA4OTAxMDkyZDY5ODA0NF8yMQ_29739779-367a-4ac5-b809-7d3968b55a51"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzAtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjpjZjZkMjFlN2NlY2E0YTk4YTA4OTAxMDkyZDY5ODA0NF8yMQ_db02a6d9-5ecc-4680-8ca7-d95003640cd1"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzAtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjpjZjZkMjFlN2NlY2E0YTk4YTA4OTAxMDkyZDY5ODA0NF8zNQ_db188dbf-93cd-4422-8549-c0b13744633f"
      unitRef="shares">125000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzAtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjpjZjZkMjFlN2NlY2E0YTk4YTA4OTAxMDkyZDY5ODA0NF8zNQ_e9d3efc6-9d7e-4ca5-9eb6-bded1db98374"
      unitRef="shares">125000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzAtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjpjZjZkMjFlN2NlY2E0YTk4YTA4OTAxMDkyZDY5ODA0NF81Nw_2df65bb9-fd19-4528-80a1-800debbb7ffe"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzAtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjpjZjZkMjFlN2NlY2E0YTk4YTA4OTAxMDkyZDY5ODA0NF81Nw_44eb064f-7771-41de-aea0-f8a9435a6610"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzAtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjpjZjZkMjFlN2NlY2E0YTk4YTA4OTAxMDkyZDY5ODA0NF81Nw_4aa6c8c2-9f4e-404c-849f-746b8b5f0191"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzAtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjpjZjZkMjFlN2NlY2E0YTk4YTA4OTAxMDkyZDY5ODA0NF81Nw_89902682-37f3-4e23-ae42-5cdefa9bde46"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzAtMS0xLTEtNjg3NTE_108aaf00-4748-481e-bab0-226fa02b9af7"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzAtMy0xLTEtNjg3NTE_ce4fd96a-351e-45c4-a8f7-c34425e59b04"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzEtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjo2NWZjMTc2YjNmOWE0ZTc2OWExZjBiZGNjMTAxMTY2NV8xOA_1a1100fc-f65d-49e2-80d7-9ff643e5bf56"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzEtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjo2NWZjMTc2YjNmOWE0ZTc2OWExZjBiZGNjMTAxMTY2NV8xOA_9c23ac19-d6a2-4fae-b2bd-039ab7d1d4f2"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzEtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjo2NWZjMTc2YjNmOWE0ZTc2OWExZjBiZGNjMTAxMTY2NV8zMg_dff96aa8-2384-4fad-9942-39ec4f16d9b4"
      unitRef="shares">2000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzEtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjo2NWZjMTc2YjNmOWE0ZTc2OWExZjBiZGNjMTAxMTY2NV8zMg_e435afbd-6e5e-465f-b0c1-3e8178c69ad8"
      unitRef="shares">2000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzEtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjo2NWZjMTc2YjNmOWE0ZTc2OWExZjBiZGNjMTAxMTY2NV81NA_34ab76ce-12eb-46e6-9154-aadfcdf3667a"
      unitRef="shares">296000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzEtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjo2NWZjMTc2YjNmOWE0ZTc2OWExZjBiZGNjMTAxMTY2NV81NA_a957abb1-11e9-40df-ba4b-1e918640547c"
      unitRef="shares">296000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzEtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjo2NWZjMTc2YjNmOWE0ZTc2OWExZjBiZGNjMTAxMTY2NV83NA_e671b854-2301-4a5a-89fe-d64642e2aab6"
      unitRef="shares">295000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzEtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjo2NWZjMTc2YjNmOWE0ZTc2OWExZjBiZGNjMTAxMTY2NV83NA_f31fcde1-4e42-45e6-a173-ee922ad693f5"
      unitRef="shares">295000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzEtMS0xLTEtNjg3NTE_a63bd5fa-ed24-4366-bc7f-1b1a87cd759f"
      unitRef="usd">3000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzEtMy0xLTEtNjg3NTE_d4ce826a-f230-4c15-a3ac-6ed9dcde6bb6"
      unitRef="usd">3000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzItMS0xLTEtNjg3NTE_2e0ed95d-1078-494f-b8e1-1fde4aae2a08"
      unitRef="usd">5345000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzItMy0xLTEtNjg3NTE_c168a57f-4bf2-4e3d-a973-340cf73c5c68"
      unitRef="usd">5325000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzMtMS0xLTEtNjg3NTE_8842cd1e-7a7b-408b-862b-7b97124d667c"
      unitRef="usd">541000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzMtMy0xLTEtNjg3NTE_d139869a-c936-4401-a475-4c9baa794244"
      unitRef="usd">324000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzQtMS0xLTEtNjg3NTE_51e5fa5c-c515-483b-8ee3-41cc0534b349"
      unitRef="usd">-280000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzQtMy0xLTEtNjg3NTE_2e2761d7-72ac-4f8d-b72d-4494a47d59f5"
      unitRef="usd">-347000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzUtMS0xLTEtNjg3NTE_cceec090-8e62-4ecc-bf64-2bc56415c704"
      unitRef="usd">5609000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzUtMy0xLTEtNjg3NTE_185d5491-dd1c-446d-b897-031ec45db6ee"
      unitRef="usd">5305000000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzgtMS0xLTEtNjg3NTE_67f7d4aa-83b3-400a-a034-72e48b294107"
      unitRef="usd">10919000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yMi9mcmFnOjQ2NTc3OTk4ZjE1YzQ1ZDI5NzYxMWJmNzAxODIyOGUxL3RhYmxlOmE5YzE2OWM4N2E4NzQzMzRiYzY0YjgzM2UyNmQ0YTliL3RhYmxlcmFuZ2U6YTljMTY5Yzg3YTg3NDMzNGJjNjRiODMzZTI2ZDRhOWJfMzgtMy0xLTEtNjg3NTE_5b64cb20-41ec-4043-803f-69047a7dfeb8"
      unitRef="usd">10532000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNC0xLTEtMS02ODc1MQ_910fdead-b464-410b-b253-1577c93b2347"
      unitRef="usd">352000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNC0zLTEtMS02ODc1MQ_0679f287-1f00-4e6b-87d2-c3c32d4494c1"
      unitRef="usd">283000000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNi0xLTEtMS02ODc1MQ_56beae9d-3012-45c8-b8a5-4432de8ec1dc"
      unitRef="usd">67000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNi0zLTEtMS02ODc1MQ_f13c8b42-1ce9-4cfe-bb89-b23fe6235eb2"
      unitRef="usd">82000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfOC0xLTEtMS02ODc1MQ_5c1908f1-5895-426f-8ec1-484cc3b7cd8a"
      unitRef="usd">44000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfOC0zLTEtMS02ODc1MQ_207a7ab3-e8f3-470c-9a5b-5521660723c7"
      unitRef="usd">44000000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfOS0xLTEtMS02ODc1MQ_5b013f4f-3a98-4007-b07b-02d2558dafcf"
      unitRef="usd">4000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfOS0zLTEtMS02ODc1MQ_5d7aa810-c522-4238-8b2d-7e2c33460e3d"
      unitRef="usd">24000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:InventoryWriteDown
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMTAtMS0xLTEtNjg3NTE_a00be058-6315-430f-b57a-f9923d302189"
      unitRef="usd">7000000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMTAtMy0xLTEtNjg3NTE_6b5e1abd-aec2-49ea-a45f-95edb6205049"
      unitRef="usd">5000000</us-gaap:InventoryWriteDown>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMTItMS0xLTEtNjg3NTE_745156a0-1c12-4ba2-bc1a-d735294b4278"
      unitRef="usd">-10000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMTItMy0xLTEtNjg3NTE_4f0970ed-717a-473e-a38d-11f285d50722"
      unitRef="usd">-47000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMTQtMS0xLTEtNjg3NTE_d26e3f01-846d-4719-a855-f391bb7736e7"
      unitRef="usd">1000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMTQtMy0xLTEtNjg3NTE_e6d6eaa2-6c2e-4822-9ea1-ca0e34046d1f"
      unitRef="usd">3000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMTUtMS0xLTEtNjg3NTE_f37fe4bf-cb3e-461b-b732-e9d9d8fe5231"
      unitRef="usd">-1000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMTUtMy0xLTEtNjg3NTE_a220889e-370f-432f-9cd5-901dd5ed9704"
      unitRef="usd">0</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMTctMS0xLTEtNjg3NTE_8b6d2650-643c-401d-9989-5394545ad91a"
      unitRef="usd">5000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMTctMy0xLTEtNjg3NTE_8ac6280a-dfcc-4b23-beaf-030fe4b9af68"
      unitRef="usd">46000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMTgtMS0xLTEtNjg3NTE_7e48ecb1-e50b-4729-9c13-404291ebb7e7"
      unitRef="usd">69000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMTgtMy0xLTEtNjg3NTE_04586015-8b63-42c5-bd02-7dae3168594e"
      unitRef="usd">54000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMTktMS0xLTEtNjg3NTE_b70b92c0-efe9-47d9-91c3-fdf443866556"
      unitRef="usd">-27000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMTktMy0xLTEtNjg3NTE_1f5ffb07-707e-4974-b061-f8b7edc00164"
      unitRef="usd">37000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMjAtMS0xLTEtNjg3NTE_6908062f-ee49-4e15-9942-ebfa6973d45a"
      unitRef="usd">-174000000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMjAtMy0xLTEtNjg3NTE_128324ac-c5f9-4c64-a383-d048065ef143"
      unitRef="usd">-210000000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMjEtMS0xLTEtNjg3NTE_8d1ea933-51b3-401a-b612-19a5429dabbc"
      unitRef="usd">-85000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMjEtMy0xLTEtNjg3NTE_1774593b-6cbd-4a37-9653-0e0cddd62e89"
      unitRef="usd">-40000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMjItMS0xLTEtNjg3NTE_edc43c4e-0b2a-423d-9590-a78cb725e4a1"
      unitRef="usd">296000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMjItMy0xLTEtNjg3NTE_95342381-81ce-416c-afdd-06626b254a66"
      unitRef="usd">255000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMjUtMS0xLTEtNjg3NTE_0a7b8d52-dc19-4b23-a4a2-448f0dc47ee8"
      unitRef="usd">76000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMjUtMy0xLTEtNjg3NTE_4e301d21-5844-4bbf-9704-6557fca00f38"
      unitRef="usd">75000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireEquitySecuritiesFvNi
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMzAtMS0xLTEtNjg3NTE_4b5559e9-cdcf-4cac-9d88-349219d50a5d"
      unitRef="usd">1000000</us-gaap:PaymentsToAcquireEquitySecuritiesFvNi>
    <us-gaap:PaymentsToAcquireEquitySecuritiesFvNi
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMzAtMy0xLTEtNjg3NTE_45c40405-d41f-446d-afe3-8c0d2bb663ad"
      unitRef="usd">3000000</us-gaap:PaymentsToAcquireEquitySecuritiesFvNi>
    <us-gaap:PaymentsToAcquireNotesReceivable
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMzEtMS0xLTEtNjg3NTE_61ecab0d-f780-44a5-8891-8e99bcf04138"
      unitRef="usd">3000000</us-gaap:PaymentsToAcquireNotesReceivable>
    <us-gaap:PaymentsToAcquireNotesReceivable
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMzEtMy0xLTEtNjg3NTE_a33cda4f-d6cf-42ad-9766-101af8cdb297"
      unitRef="usd">1000000</us-gaap:PaymentsToAcquireNotesReceivable>
    <us-gaap:ProceedsFromCollectionOfNotesReceivable
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMzMtMS0xLTEtODkyNTk_ca16301b-98d6-4206-a987-6ea72489ae58"
      unitRef="usd">2000000</us-gaap:ProceedsFromCollectionOfNotesReceivable>
    <us-gaap:ProceedsFromCollectionOfNotesReceivable
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMzMtMy0xLTEtODkyNTk_4b6ad9bc-df07-4334-921d-c47a83367726"
      unitRef="usd">0</us-gaap:ProceedsFromCollectionOfNotesReceivable>
    <us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMzMtMS0xLTEtNjg3NTE_ab5ca0b8-fac4-41fe-bf70-692b3b3fce29"
      unitRef="usd">4000000</us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi>
    <us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMzMtMy0xLTEtNjg3NTE_b9a6715e-1c9b-41a5-8fc6-6277570cdf6c"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMzYtMS0xLTEtNjg3NTE_e2ee5ab2-8162-49c7-8e51-3e1a563bb27f"
      unitRef="usd">30000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMzYtMy0xLTEtNjg3NTE_b30bb8d6-cd5b-4e2c-87f3-d8687049c5c1"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMzctMS0xLTEtNjg3NTE_4b69f7c3-fcc3-436f-8c8c-0b89250568e7"
      unitRef="usd">-104000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfMzctMy0xLTEtNjg3NTE_bd79250e-3317-4b9a-8dc2-82d26b238a5a"
      unitRef="usd">-79000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNDAtMS0xLTEtNjg3NTE_b3f54da6-e896-4363-b1cd-785bc85e5dc7"
      unitRef="usd">35000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNDAtMy0xLTEtNjg3NTE_1df4b6f2-1d70-4c40-8bef-33335f8f36ae"
      unitRef="usd">27000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNDEtMS0xLTEtNjg3NTE_643b20fa-24de-491f-9b36-d8b3cae95a1e"
      unitRef="usd">51000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNDEtMy0xLTEtNjg3NTE_eedc64fa-c463-472d-bafa-423b4ad57e82"
      unitRef="usd">63000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsOfOrdinaryDividends
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNDItMS0xLTEtNjg3NTE_edfb94b1-da55-491c-9100-efc49653b1fd"
      unitRef="usd">67000000</us-gaap:PaymentsOfOrdinaryDividends>
    <us-gaap:PaymentsOfOrdinaryDividends
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNDItMy0xLTEtNjg3NTE_564086cc-735c-49ed-a79b-25dcaba95bde"
      unitRef="usd">63000000</us-gaap:PaymentsOfOrdinaryDividends>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNTItMS0xLTEtOTExNzc_4e93f77c-8237-4886-bd0a-3e73a854337c"
      unitRef="usd">62000000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNTItMy0xLTEtOTExNzc_6f26cc32-e608-4ad5-9b01-cae556c6a330"
      unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommercialPaper
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNTEtMS0xLTEtNjg3NTE_c207effd-d804-4855-9b52-eead5aea539f"
      unitRef="usd">527000000</us-gaap:ProceedsFromIssuanceOfCommercialPaper>
    <us-gaap:ProceedsFromIssuanceOfCommercialPaper
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNTEtMy0xLTEtNjg3NTE_f97e1779-2b14-4a64-8121-5fb6523e0382"
      unitRef="usd">240000000</us-gaap:ProceedsFromIssuanceOfCommercialPaper>
    <us-gaap:RepaymentsOfCommercialPaper
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNTItMS0xLTEtNjg3NTE_296bac56-4129-4ee8-a5c7-8a7057da52cf"
      unitRef="usd">324000000</us-gaap:RepaymentsOfCommercialPaper>
    <us-gaap:RepaymentsOfCommercialPaper
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNTItMy0xLTEtNjg3NTE_1316d207-6365-4170-8ed7-5ffefb1a568f"
      unitRef="usd">240000000</us-gaap:RepaymentsOfCommercialPaper>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNTQtMS0xLTEtNjg3NTE_df55dc64-5ab5-4ecd-9f47-e7c51caefc7b"
      unitRef="usd">75000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNTQtMy0xLTEtNjg3NTE_b7c2a40a-277c-45f0-9cd3-0a300a6f6b69"
      unitRef="usd">447000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNTUtMS0xLTEtNjg3NTE_6332dc66-5c68-42f3-8497-e14ff7d281d4"
      unitRef="usd">-17000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNTUtMy0xLTEtNjg3NTE_88048ac5-4161-4d2e-af4c-b3b54a0924ed"
      unitRef="usd">-546000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNTctMS0xLTEtNjg3NTE_69bdc788-69a2-4950-88c3-3505868d9068"
      unitRef="usd">22000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNTctMy0xLTEtNjg3NTE_2033fbcf-5e29-46f1-9ae7-6f9290a13a20"
      unitRef="usd">-4000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNTktMS0xLTEtNjg3NTE_1cc7f200-d87d-4735-bf65-49afe351cad1"
      unitRef="usd">197000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNTktMy0xLTEtNjg3NTE_a6b4b201-1ad6-451c-beb6-795838459772"
      unitRef="usd">-374000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNjEtMS0xLTEtNjg3NTE_78a23759-3a78-481e-b951-1c703c57ca44"
      unitRef="usd">1056000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i56485a537aba4a7691bd4bf959f3eaad_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNjEtMy0xLTEtNjg3NTE_73f82754-d8a5-4d50-bd2a-602eb1a6ebc3"
      unitRef="usd">1490000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNjItMS0xLTEtNjg3NTE_e31de443-86cf-4a9e-9c52-90f00813c7d5"
      unitRef="usd">1253000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7452fced71814cff84c1f48750a63bfa_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNjItMy0xLTEtNjg3NTE_0b69abe5-c8b1-4e25-a11c-a0d425dbbee4"
      unitRef="usd">1116000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNjUtMS0xLTEtNjg3NTE_fe6320e6-7312-468e-993e-712d2a30c144"
      unitRef="usd">17000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNjUtMy0xLTEtNjg3NTE_8f6cd71a-31df-4119-867c-322a01acf9be"
      unitRef="usd">22000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNjYtMS0xLTEtNjg3NTE_18e3bf14-a567-4b4c-b2d3-96377e8dca87"
      unitRef="usd">15000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNjYtMy0xLTEtNjg3NTE_02190026-4edf-428c-8165-16ceceba5d2e"
      unitRef="usd">18000000</us-gaap:InterestPaidNet>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i09a604512a0e4676affadfea2edad573_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNjctMS0xLTEtNjg3NTE_864ac823-9899-4fd0-839f-99be4840dbc5"
      unitRef="usd">-20000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i47cbf7fc4b914e59bbe1b08345963c45_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yNS9mcmFnOjU5ZmEwOGIzM2FkZDRkYTQ4OGE4MzBmZjQxMDQ1YzhiL3RhYmxlOjE2MmU1YjAwOTk5YjQ1ZGViZjQyMDE3YjNiY2VkMjNiL3RhYmxlcmFuZ2U6MTYyZTViMDA5OTliNDVkZWJmNDIwMTdiM2JjZWQyM2JfNjctMy0xLTEtNjg3NTE_a1946410-04d0-4dc4-9d3b-24d2454f72ee"
      unitRef="usd">-7000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:SharesIssued
      contextRef="i03309ce0ed5f4d9e91d12ef6e9a11409_I20221031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMy0xLTEtMS02ODc1MQ_479996e5-a393-48f8-af43-d8609fec375c"
      unitRef="shares">295259000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i03309ce0ed5f4d9e91d12ef6e9a11409_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMy0zLTEtMS02ODc1MQ_e1a92dc2-1df5-4609-90a6-341c1132ef28"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id92438986c5e4e49b96bc1f9a2f4db1b_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMy01LTEtMS02ODc1MQ_aeb09286-eded-4df0-aef6-30c6c4d4cf53"
      unitRef="usd">5325000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i086d2c8106374131912a8bbf8b1f0389_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMy03LTEtMS02ODc1MQ_fa029e94-d859-42f3-a89d-933ae15c4744"
      unitRef="usd">324000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i606776969cda4cf3b6e3577e3c4bed44_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMy05LTEtMS02ODc1MQ_091837cf-a5fb-454e-b8f7-bde877319c6f"
      unitRef="usd">-347000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i159c212a281a41ca83ae4c377dbc7ac2_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMy0xMS0xLTEtNjg3NTE_a31d0009-a859-4401-a3f6-e855c3082870"
      unitRef="usd">5305000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ibc9a621efe2543f482d33c51bc9d5416_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfNi03LTEtMS02ODc1MQ_08c1aaf3-4881-4920-8154-c1675ae0f2dc"
      unitRef="usd">352000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i444f3ab3feb249a4b04e665424135f76_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfNi0xMS0xLTEtNjg3NTE_30c825f3-a324-42d5-a45a-221e32933ce6"
      unitRef="usd">352000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1e544c079add458db2a18a80383a6e7b_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfNy05LTEtMS02ODc1MQ_63ee16a7-c98c-451b-b11d-32ebc4e92d14"
      unitRef="usd">67000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i444f3ab3feb249a4b04e665424135f76_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfNy0xMS0xLTEtNjg3NTE_30e8c152-5024-4ca1-95fb-0723284a51ef"
      unitRef="usd">67000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i444f3ab3feb249a4b04e665424135f76_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfOC0xMS0xLTEtNjg3NTE_c123b553-a0cf-4021-8f74-4ff3a5a2cebf"
      unitRef="usd">419000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTAtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjpkMTdkOTJhMWUzMjI0ZGNhYWFiM2I5OWJmNDEwODA0Ml8yOQ_06ab9f14-d5c8-4fc2-a5ff-6f18c84664f2"
      unitRef="usdPerShare">0.225</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="ibc9a621efe2543f482d33c51bc9d5416_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTAtNy0xLTEtNjg3NTE_f4b876bd-4444-434c-b5c1-c6228e255667"
      unitRef="usd">67000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i444f3ab3feb249a4b04e665424135f76_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTAtMTEtMS0xLTY4NzUx_1db080d8-a92a-45e2-8db6-74a30393a26e"
      unitRef="usd">67000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTEtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjpiMDEwMzJkZDNhYjE0YTY2YTc5YTc2ODNjZmY1NDQ4MV80NQ_f04e7c74-5410-43b7-b810-462242eb2ebd"
      unitRef="usd">51000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i0045b371692f47b18ee58c78620f8429_D20221101-20230131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTEtMS0xLTEtNjg3NTE_f6e1bb4a-2de3-49ac-bdc5-3577c63b61c6"
      unitRef="shares">1061000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="icc75cb8136f54543a29bfc1d00dfeb94_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTEtNS0xLTEtNjg3NTE_6c77fde7-55cc-4502-ac0b-6d3df3dbbaf2"
      unitRef="usd">-17000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i444f3ab3feb249a4b04e665424135f76_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTEtMTEtMS0xLTY4NzUx_1eb2818e-ebb5-4bc4-9b32-d7e33c18163b"
      unitRef="usd">-17000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i0045b371692f47b18ee58c78620f8429_D20221101-20230131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTItMS0xLTEtNjg3NTE_2db123af-2a66-487d-9cf7-3ab749896311"
      unitRef="shares">499000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="icc75cb8136f54543a29bfc1d00dfeb94_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTItNS0xLTEtNjg3NTE_d82c8a95-bec7-435a-8490-58044f353b51"
      unitRef="usd">7000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ibc9a621efe2543f482d33c51bc9d5416_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTItNy0xLTEtNjg3NTE_490db7a8-cb80-4d7e-831d-ae2b8e42dc1e"
      unitRef="usd">68000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i444f3ab3feb249a4b04e665424135f76_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTItMTEtMS0xLTY4NzUx_d7fa5e93-f478-4a83-ae91-b23958aea5ca"
      unitRef="usd">75000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="icc75cb8136f54543a29bfc1d00dfeb94_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTMtNS0xLTEtNjg3NTE_fb4791c0-7190-426b-97bb-28c105d356fe"
      unitRef="usd">44000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i444f3ab3feb249a4b04e665424135f76_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTMtMTEtMS0xLTY4NzUx_147e8769-63e5-485d-89e7-6de6879392fd"
      unitRef="usd">44000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesIssued
      contextRef="ibe3a97d20a2e44a1b4614a44d8406d81_I20230131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTQtMS0xLTEtNjg3NTE_603d69a0-de78-4e2c-b482-d0d90ef65b56"
      unitRef="shares">295821000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibe3a97d20a2e44a1b4614a44d8406d81_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTQtMy0xLTEtNjg3NTE_d9892fd0-6848-4a44-b039-fd0637cd96d5"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3e763681f4b045fa9fce2449566d8e3d_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTQtNS0xLTEtNjg3NTE_1659cdf0-5b1c-4ef2-a53e-0f83ea6c4641"
      unitRef="usd">5345000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i17235fbc23384d9f8362cd810ffa1a21_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTQtNy0xLTEtNjg3NTE_f7a5a708-b5cc-4c4b-8614-2c44f70037cd"
      unitRef="usd">541000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i222c7e31873d4892afc0e691da9b4bce_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTQtOS0xLTEtNjg3NTE_e64a59c3-b37d-4293-bb59-2fb3ef344625"
      unitRef="usd">-280000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0dd61afa70ad4f12b65e7f736904b893_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjBlZTZkM2Y0ZGIzZjRhYzA4ODY1NWMyNzk2YWI2M2VlL3RhYmxlcmFuZ2U6MGVlNmQzZjRkYjNmNGFjMDg4NjU1YzI3OTZhYjYzZWVfMTQtMTEtMS0xLTY4NzUx_2db58d48-6d75-43f5-99c2-7e29e6617f2b"
      unitRef="usd">5609000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i7a4a359dc74949868e019c988906b5d0_I20211031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfNC0xLTEtMS02ODc1MQ_71158e48-341c-418a-836e-130f11342a30"
      unitRef="shares">302208000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7a4a359dc74949868e019c988906b5d0_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfNC0zLTEtMS02ODc1MQ_0c97a1dd-f322-42b2-b603-26fb46d187cd"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ice97c2676fc846c99090bf80caa8297f_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfNC01LTEtMS02ODc1MQ_e6b0a05b-3ce5-4ebb-ba03-e70e3cf89432"
      unitRef="usd">5320000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id29a4ca3e0874d32842cabb48c356b30_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfNC03LTEtMS02ODc1MQ_4145ba17-d604-48da-9934-3f4fe97d846e"
      unitRef="usd">348000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8325ec83b30f404fae1f872f8bcb4f30_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfNC05LTEtMS02ODc1MQ_aa70a40d-a316-4d22-aae5-8b3d1cf4ec54"
      unitRef="usd">-282000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie66c1641c23d4e3d9b549e52e10a56c8_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfNC0xMS0xLTEtNjg3NTE_dbcc3efc-c492-411e-abd6-65206ba51299"
      unitRef="usd">5389000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i871f3a85672446d38dfc792b021eed04_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfNy03LTEtMS02ODc1MQ_3f9b4a16-5e72-4d9b-a277-84af7a7f2840"
      unitRef="usd">283000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia9a62a47fae946da9a3700c66ce2854b_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfNy0xMS0xLTEtNjg3NTE_8cb3915e-e921-4096-8422-8240ca57e927"
      unitRef="usd">283000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i164344fd739541659db977e6b67ac77f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfOC05LTEtMS02ODc1MQ_e3c32b9f-499c-476d-9597-4eabaa4ae55d"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia9a62a47fae946da9a3700c66ce2854b_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfOC0xMS0xLTEtNjg3NTE_2bda0a1d-8f24-437b-b73a-9ca80a356cc9"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ia9a62a47fae946da9a3700c66ce2854b_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfOS0xMS0xLTEtNjg3NTE_9a48a24f-b7e2-42dd-9db2-caa90211cf2f"
      unitRef="usd">267000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTEtMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjo2Y2YxMTNhYWMxMzU0YWQ4YWZlNWQxODZjY2YwYzljOF8yOQ_fa975bd9-1428-4f4c-b6d0-073bb87c95c8"
      unitRef="usdPerShare">0.210</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i871f3a85672446d38dfc792b021eed04_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTEtNy0xLTEtNjg3NTE_4ea7f518-df5c-4449-a610-41299c9b2a7f"
      unitRef="usd">63000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ia9a62a47fae946da9a3700c66ce2854b_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTEtMTEtMS0xLTY4NzUx_9e765d99-35ba-40cb-afae-0fb2d7825d5f"
      unitRef="usd">63000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTItMC0xLTEtNjg3NTEvdGV4dHJlZ2lvbjozNDU0YTM2YzZlZWY0YTFlOWUyNGIzNWVhYjVkZWU3MF80NQ_bab09a52-9aa4-436c-b65a-27be8c8c1fe2"
      unitRef="usd">63000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i10a00291ab2f4d61adf4c24df618cf71_D20211101-20220131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTItMS0xLTEtNjg3NTE_d8a16b06-e6b7-4173-9239-536708c0399a"
      unitRef="shares">972000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ia26e13aca129490c96e3ddb74f2dddfc_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTItNS0xLTEtNjg3NTE_9d1ff831-94ec-4794-a3c8-5c28bf4ebbf8"
      unitRef="usd">-36000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ia9a62a47fae946da9a3700c66ce2854b_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTItMTEtMS0xLTY4NzUx_6c463968-4109-4504-92c2-8b5751da765d"
      unitRef="usd">-36000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i10a00291ab2f4d61adf4c24df618cf71_D20211101-20220131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTMtMS0xLTEtNjg3NTE_15f2fd3f-af4e-4fe2-a94e-e95aeb3493e2"
      unitRef="shares">2907000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ia26e13aca129490c96e3ddb74f2dddfc_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTMtNS0xLTEtNjg3NTE_a5ca5398-8a84-498d-af40-adb937927c1a"
      unitRef="usd">38000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i871f3a85672446d38dfc792b021eed04_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTMtNy0xLTEtNjg3NTE_35181897-0e59-4a9c-960e-9a45ab72eaae"
      unitRef="usd">409000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ia9a62a47fae946da9a3700c66ce2854b_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTMtMTEtMS0xLTY4NzUx_593e18a4-5139-4fe8-8672-206249e010fa"
      unitRef="usd">447000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia26e13aca129490c96e3ddb74f2dddfc_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTQtNS0xLTEtNjg3NTE_56c6f30e-2675-4e78-a879-18949e1b2e44"
      unitRef="usd">44000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia9a62a47fae946da9a3700c66ce2854b_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTQtMTEtMS0xLTY4NzUx_0bcb9d6f-4691-4647-9656-4711fd11892d"
      unitRef="usd">44000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesIssued
      contextRef="i353beb6720a24469809c0d404c4182ea_I20220131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTUtMS0xLTEtNjg3NTE_8f140df5-45fa-490e-a7f4-71111613adce"
      unitRef="shares">300273000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i353beb6720a24469809c0d404c4182ea_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTUtMy0xLTEtNjg3NTE_8371d486-46b9-4be3-9155-4f61a3e1933c"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2b33cacf7b234159b6c800d566d9d055_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTUtNS0xLTEtNjg3NTE_9aa5488e-dc6c-44bd-aa55-530d2986f611"
      unitRef="usd">5290000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5eb4ff2fb6b34aa4b034790d18900784_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTUtNy0xLTEtNjg3NTE_cc6d2f53-df13-4e00-b9f9-cb2f6e1e7193"
      unitRef="usd">159000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibdb13e13506245be95833ade22aa694e_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTUtOS0xLTEtNjg3NTE_8643a4f5-84cb-41df-96e6-1095131d1034"
      unitRef="usd">-298000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia8dcd748ed474187bf0b21aa9aafa830_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18yOC9mcmFnOjk3ZTY1ZWE4YzRjZjRmYTM4ZmY2ZDI3ZDI5OTFiYTMxL3RhYmxlOjNhYWQ4N2I2NjFhYTQ1MzJhNWYxMjNjN2MzYjdkMzVkL3RhYmxlcmFuZ2U6M2FhZDg3YjY2MWFhNDUzMmE1ZjEyM2M3YzNiN2QzNWRfMTUtMTEtMS0xLTY4NzUx_3b91e11c-ac9f-4058-adb1-fbef99aa8d30"
      unitRef="usd">5154000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfODMzOQ_a7ef7add-0727-43b8-ac18-e46836594551">OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Overview. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Agilent Technologies, Inc. ("we," "Agilent" or the "company"), incorporated in Delaware in May 1999, is a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our fiscal year-end is October&#160;31, and our fiscal quarters end on January&#160;31, April&#160;30 and July&#160;31. Unless otherwise stated, these dates refer to our fiscal year and fiscal quarters.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. We have prepared the accompanying financial data for the three months ended January&#160;31, 2023 and 2022 pursuant to the rules&#160;and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles (&#x201c;GAAP&#x201d;) in the U.S. have been condensed or omitted pursuant to such rules&#160;and regulations. The October&#160;31, 2022 condensed balance sheet data was derived from audited financial statements but does not include all the disclosures required in audited financial statements by U.S. GAAP. The accompanying financial data and information should be read in conjunction with our Annual Report on Form 10-K for the fiscal year ended October&#160;31, 2022.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the opinion of management, the accompanying condensed consolidated financial statements contain all normal and recurring adjustments necessary for a fair statement of our condensed consolidated balance sheet as of January&#160;31, 2023 and October&#160;31, 2022, condensed consolidated statement of comprehensive income (loss) for the three months ended January&#160;31, 2023 and 2022, condensed consolidated statement of operations for the three months ended January&#160;31, 2023 and 2022, condensed consolidated statement of cash flows for the three months ended January&#160;31, 2023 and 2022 and condensed consolidated statement of equity for the three months ended January&#160;31, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Use of Estimates.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The preparation of condensed consolidated financial statements in accordance with GAAP in the U.S. requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Although these estimates are based on management&#x2019;s best knowledge of current events and actions that may impact the company in the future, actual results may be different from the estimates. Our critical accounting policies are those that affect our financial statements materially and involve difficult, subjective or complex judgments by management. Those policies are revenue recognition, valuation of goodwill and purchased intangible assets,  inventory valuation, retirement and post-retirement benefit plan assumptions and accounting for income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Cash and Restricted Cash Equivalents. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash and restricted cash equivalents are included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows.  A reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheet follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.863%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash included in other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of January&#160;31, 2023 and October&#160;31, 2022, operating lease right-of-use assets where we are the lessee were  $&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDQ4Mw_0923d8a4-45b0-4175-952d-a7c717b81666"&gt;155&#160;million&lt;/span&gt; and $&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDQ5MA_9b066508-1908-4248-884a-1df299c2bc14"&gt;150&#160;million&lt;/span&gt;, respectively, and were included within other assets in the accompanying condensed consolidated balance sheet. The associated operating lease liabilities were $&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDY1Mg_3682f298-9ca7-4d01-a434-54ee5feb1306"&gt;159&#160;million&lt;/span&gt; and $&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDY1OQ_fa7b70f1-0cec-4130-bca6-58ec8ae1e703"&gt;152&#160;million&lt;/span&gt; as of January&#160;31, 2023 and October&#160;31, 2022, respectively, and were included in other accrued liabilities and other long-term liabilities in the accompanying condensed consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Interest Entities. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We make a determination upon entering into an arrangement whether an entity in which we have made an investment is considered a Variable Interest Entity (&#x201c;VIE&#x201d;). We evaluate our investments in privately held companies on an ongoing basis. We have determined that as of January&#160;31, 2023 and October&#160;31, 2022, there were no VIEs required to be consolidated in our consolidated financial statements because we do not have a controlling financial interest in &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;any of the VIEs in which we have invested nor are we the primary beneficiary. We account for these investments under either the equity method or as equity investments without readily determinable fair value ("RDFV"), depending on the circumstances. We periodically reassess whether we are the primary beneficiary of a VIE. The reassessment process considers whether we have acquired the power to direct the most significant activities of the VIE through changes in governing documents or other circumstances. We also reconsider whether entities previously determined not to be VIEs have become VIEs and vice-versa, based on changes in facts and circumstances including changes in contractual arrangements and capital structure.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of January&#160;31, 2023 and October&#160;31, 2022, the total carrying value of investments and loans in privately held companies considered as VIEs was $71 million and $87 million respectively. The maximum exposure is equal to the carrying value because we do not have future funding commitments. The investments are included on the long-term investments line and the loans on the other current assets and other assets lines (depending upon tenure of loan) on the condensed consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value of Financial Instruments.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The carrying values of certain of our financial instruments including cash and cash equivalents, accounts receivable, accounts payable, accrued compensation and other accrued liabilities approximate fair value because of their short maturities. The fair value of long-term equity investments which are readily determinable, and which are not accounted under the equity method are reported at fair value using quoted market prices for those securities when available with gains and losses included in net income. The fair value of long-term equity investments which are not readily determinable, and which are not accounted under the equity method are reported at cost with adjustments for observable changes in prices or impairments included in net income. As of January&#160;31, 2023 and October&#160;31, 2022, the fair value of the term loans approximates its carrying value.  As of January&#160;31, 2023, the fair value of our senior notes was $1,859&#160;million with a carrying value of $2,133 million. This compares to the fair value of our senior notes of $1,754&#160;million with a carrying value of $2,133 million as of October&#160;31, 2022. The change in the fair value compared to carrying value in the three months ended January&#160;31, 2023 is primarily due to decreased market interest rates. The fair value was calculated from quoted prices which are primarily Level 1 inputs under the accounting guidance. The fair value of foreign currency contracts used for hedging purposes is estimated internally by using inputs tied to active markets. These inputs, for example, interest rate yield curves, foreign exchange rates, and forward and spot prices for currencies are observable in the market or&#160;can be corroborated by observable market data for substantially the full term of the assets or liabilities. See also Note&#160;9, "Fair Value Measurements" for additional information on the fair value of financial instruments and contingent consideration.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfODMxMg_9c881089-a94b-43d6-8527-c17b4a983d85">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Overview. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Agilent Technologies, Inc. ("we," "Agilent" or the "company"), incorporated in Delaware in May 1999, is a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our fiscal year-end is October&#160;31, and our fiscal quarters end on January&#160;31, April&#160;30 and July&#160;31. Unless otherwise stated, these dates refer to our fiscal year and fiscal quarters.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. We have prepared the accompanying financial data for the three months ended January&#160;31, 2023 and 2022 pursuant to the rules&#160;and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles (&#x201c;GAAP&#x201d;) in the U.S. have been condensed or omitted pursuant to such rules&#160;and regulations. The October&#160;31, 2022 condensed balance sheet data was derived from audited financial statements but does not include all the disclosures required in audited financial statements by U.S. GAAP. The accompanying financial data and information should be read in conjunction with our Annual Report on Form 10-K for the fiscal year ended October&#160;31, 2022.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the opinion of management, the accompanying condensed consolidated financial statements contain all normal and recurring adjustments necessary for a fair statement of our condensed consolidated balance sheet as of January&#160;31, 2023 and October&#160;31, 2022, condensed consolidated statement of comprehensive income (loss) for the three months ended January&#160;31, 2023 and 2022, condensed consolidated statement of operations for the three months ended January&#160;31, 2023 and 2022, condensed consolidated statement of cash flows for the three months ended January&#160;31, 2023 and 2022 and condensed consolidated statement of equity for the three months ended January&#160;31, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfODM0MQ_78141f3d-7482-4a26-b80d-b8907b2b9f8c">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Use of Estimates.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The preparation of condensed consolidated financial statements in accordance with GAAP in the U.S. requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Although these estimates are based on management&#x2019;s best knowledge of current events and actions that may impact the company in the future, actual results may be different from the estimates. Our critical accounting policies are those that affect our financial statements materially and involve difficult, subjective or complex judgments by management. Those policies are revenue recognition, valuation of goodwill and purchased intangible assets,  inventory valuation, retirement and post-retirement benefit plan assumptions and accounting for income taxes.&lt;/span&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfODMwOQ_7d94de1c-8b6c-4db3-8dd0-9a6d1cd4382c">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Cash and Restricted Cash Equivalents. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash and restricted cash equivalents are included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows.  A reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheet follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.863%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash included in other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfODMwOQ_e5a9d672-54c5-4c30-a42b-8e22d87d0a98">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Cash and Restricted Cash Equivalents. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash and restricted cash equivalents are included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows.  A reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheet follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.863%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash included in other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RhYmxlOjI5M2RhOTkxZWIxMjRiMDM5NWZkMmZmMmVlZWIwYzEwL3RhYmxlcmFuZ2U6MjkzZGE5OTFlYjEyNGIwMzk1ZmQyZmYyZWVlYjBjMTBfMy0xLTEtMS02ODc1MQ_42ce68c7-38e0-4008-bef3-7abed1b71157"
      unitRef="usd">1250000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RhYmxlOjI5M2RhOTkxZWIxMjRiMDM5NWZkMmZmMmVlZWIwYzEwL3RhYmxlcmFuZ2U6MjkzZGE5OTFlYjEyNGIwMzk1ZmQyZmYyZWVlYjBjMTBfMy0zLTEtMS02ODc1MQ_02d22644-05b4-4f78-8d1e-3b762115378c"
      unitRef="usd">1053000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RhYmxlOjI5M2RhOTkxZWIxMjRiMDM5NWZkMmZmMmVlZWIwYzEwL3RhYmxlcmFuZ2U6MjkzZGE5OTFlYjEyNGIwMzk1ZmQyZmYyZWVlYjBjMTBfNC0xLTEtMS02ODc1MQ_5904d265-a581-41ed-a50c-b281434d65c4"
      unitRef="usd">3000000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RhYmxlOjI5M2RhOTkxZWIxMjRiMDM5NWZkMmZmMmVlZWIwYzEwL3RhYmxlcmFuZ2U6MjkzZGE5OTFlYjEyNGIwMzk1ZmQyZmYyZWVlYjBjMTBfNC0zLTEtMS02ODc1MQ_4fc2dd9e-ec09-435b-b48c-26923bd8e03f"
      unitRef="usd">3000000</us-gaap:RestrictedCash>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RhYmxlOjI5M2RhOTkxZWIxMjRiMDM5NWZkMmZmMmVlZWIwYzEwL3RhYmxlcmFuZ2U6MjkzZGE5OTFlYjEyNGIwMzk1ZmQyZmYyZWVlYjBjMTBfNS0xLTEtMS02ODc1MQ_f15e8118-6526-4e9c-a616-c8d3f1334ff5"
      unitRef="usd">1253000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RhYmxlOjI5M2RhOTkxZWIxMjRiMDM5NWZkMmZmMmVlZWIwYzEwL3RhYmxlcmFuZ2U6MjkzZGE5OTFlYjEyNGIwMzk1ZmQyZmYyZWVlYjBjMTBfNS0zLTEtMS02ODc1MQ_313624df-febc-4db8-b5d2-a9d0eab27f24"
      unitRef="usd">1056000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfODMzMA_56b4aefa-c1cf-49c4-81f3-1aac778ea314">Leases. As of January&#160;31, 2023 and October&#160;31, 2022, operating lease right-of-use assets where we are the lessee were  $&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDQ4Mw_0923d8a4-45b0-4175-952d-a7c717b81666"&gt;155&#160;million&lt;/span&gt; and $&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDQ5MA_9b066508-1908-4248-884a-1df299c2bc14"&gt;150&#160;million&lt;/span&gt;, respectively, and were included within other assets in the accompanying condensed consolidated balance sheet. The associated operating lease liabilities were $&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDY1Mg_3682f298-9ca7-4d01-a434-54ee5feb1306"&gt;159&#160;million&lt;/span&gt; and $&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDY1OQ_fa7b70f1-0cec-4130-bca6-58ec8ae1e703"&gt;152&#160;million&lt;/span&gt; as of January&#160;31, 2023 and October&#160;31, 2022, respectively, and were included in other accrued liabilities and other long-term liabilities in the accompanying condensed consolidated balance sheet.</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDQ4Mw_530d430b-2d80-4e9b-8136-eaa4f472ed48"
      unitRef="usd">155000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDQ5MA_7b07a319-7063-4dea-930d-99483d0dea7c"
      unitRef="usd">150000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDY1Mg_a6684bb3-22fc-476c-b14f-a37002042d30"
      unitRef="usd">159000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNDY1OQ_8d4b1411-98cc-499c-a0c1-34e76eabf794"
      unitRef="usd">152000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:ConsolidationVariableInterestEntityPolicy
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfODMyMA_668ed0d1-96b1-41ee-ab3f-155e97969c42">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Interest Entities. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We make a determination upon entering into an arrangement whether an entity in which we have made an investment is considered a Variable Interest Entity (&#x201c;VIE&#x201d;). We evaluate our investments in privately held companies on an ongoing basis. We have determined that as of January&#160;31, 2023 and October&#160;31, 2022, there were no VIEs required to be consolidated in our consolidated financial statements because we do not have a controlling financial interest in &lt;/span&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;any of the VIEs in which we have invested nor are we the primary beneficiary. We account for these investments under either the equity method or as equity investments without readily determinable fair value ("RDFV"), depending on the circumstances. We periodically reassess whether we are the primary beneficiary of a VIE. The reassessment process considers whether we have acquired the power to direct the most significant activities of the VIE through changes in governing documents or other circumstances. We also reconsider whether entities previously determined not to be VIEs have become VIEs and vice-versa, based on changes in facts and circumstances including changes in contractual arrangements and capital structure.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of January&#160;31, 2023 and October&#160;31, 2022, the total carrying value of investments and loans in privately held companies considered as VIEs was $71 million and $87 million respectively. The maximum exposure is equal to the carrying value because we do not have future funding commitments. The investments are included on the long-term investments line and the loans on the other current assets and other assets lines (depending upon tenure of loan) on the condensed consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationVariableInterestEntityPolicy>
    <us-gaap:Assets
      contextRef="ida8131692d1643f8a5dc1d105f4fcc7f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNjEzNA_4ca8669a-8f2a-47b6-9159-47aca950bf57"
      unitRef="usd">71000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i0bf212d52a5c43fc80953fcd23626126_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNjE0MQ_79c882d2-6bdc-4612-b0a9-3731367c7ea3"
      unitRef="usd">87000000</us-gaap:Assets>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfODMyMQ_f660f1e7-7153-4568-9b49-9fca92199806">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value of Financial Instruments.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The carrying values of certain of our financial instruments including cash and cash equivalents, accounts receivable, accounts payable, accrued compensation and other accrued liabilities approximate fair value because of their short maturities. The fair value of long-term equity investments which are readily determinable, and which are not accounted under the equity method are reported at fair value using quoted market prices for those securities when available with gains and losses included in net income. The fair value of long-term equity investments which are not readily determinable, and which are not accounted under the equity method are reported at cost with adjustments for observable changes in prices or impairments included in net income. As of January&#160;31, 2023 and October&#160;31, 2022, the fair value of the term loans approximates its carrying value.  As of January&#160;31, 2023, the fair value of our senior notes was $1,859&#160;million with a carrying value of $2,133 million. This compares to the fair value of our senior notes of $1,754&#160;million with a carrying value of $2,133 million as of October&#160;31, 2022. The change in the fair value compared to carrying value in the three months ended January&#160;31, 2023 is primarily due to decreased market interest rates. The fair value was calculated from quoted prices which are primarily Level 1 inputs under the accounting guidance. The fair value of foreign currency contracts used for hedging purposes is estimated internally by using inputs tied to active markets. These inputs, for example, interest rate yield curves, foreign exchange rates, and forward and spot prices for currencies are observable in the market or&#160;can be corroborated by observable market data for substantially the full term of the assets or liabilities. See also Note&#160;9, "Fair Value Measurements" for additional information on the fair value of financial instruments and contingent consideration.&lt;/span&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i3680858c584e48c0ab29a7b1c6e0b029_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNzM4NQ_e1dc6f21-cd0a-4584-8ea6-c759ccd415b3"
      unitRef="usd">1859000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:SeniorNotes
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNTQ5NzU1ODIzNTcz_796b0f5b-b5a1-43c7-bcdb-23d7f96fed99"
      unitRef="usd">2133000000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i67000e3aa16f48a6b186edcc2d77662d_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNzQ4MQ_7766f0b1-c239-4d3d-aba1-f7180b759bd3"
      unitRef="usd">1754000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:SeniorNotes
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNC9mcmFnOmQ1MzM5MDZlZTM4MTRjNzU4ZjhjM2M3YTc5ODJlYTE2L3RleHRyZWdpb246ZDUzMzkwNmVlMzgxNGM3NThmOGMzYzdhNzk4MmVhMTZfNzUwOQ_d7b0a961-ea9f-4ad1-8e94-9362ddf93ae0"
      unitRef="usd">2133000000</us-gaap:SeniorNotes>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN18zNy9mcmFnOmY1Njg5OTcxODQ3NDRiZjVhZWEyMTUxZDRiMDI1YjFjL3RleHRyZWdpb246ZjU2ODk5NzE4NDc0NGJmNWFlYTIxNTFkNGIwMjViMWNfMTcwOQ_c673c1e3-f5f9-4b3e-b27c-946a4b746145">NEW ACCOUNTING PRONOUNCEMENTS&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In November 2021, the FASB issued updates to increase the transparency in the annual disclosure requirements relating to government assistance received by business entities in Topic 832, Government Assistance. The guidance requires certain disclosures about transactions with a government that are accounted for by applying a grant or contribution model. On November 1, 2022, we adopted this guidance which did not have a material impact on our condensed consolidated financial statements and disclosures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no additions to the new accounting pronouncements not yet adopted as described in our Annual Report on Form 10-K for the fiscal year ended October&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other amendments to GAAP in the U.S. that have been issued by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on our condensed consolidated financial statements upon adoption.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RleHRyZWdpb246NWY0NzVmZjhlODdiNGMzNDgyNWYyYmMyMzY0MWRlYjRfMzc2NQ_2c5224ed-6b9a-43e2-b255-66778ca11c48">REVENUE &lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the company&#x2019;s total revenue and segment revenue disaggregated by geographical region: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended January 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Life Sciences and Applied Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Agilent CrossLab&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Diagnostics and Genomics&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Life Sciences and Applied Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Agilent CrossLab&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Diagnostics and Genomics&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Revenue by Region&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the company&#x2019;s total revenue disaggregated by end markets and by revenue type:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.169%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Revenue by End Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmaceutical and Biopharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Chemicals and Advanced Materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics and Clinical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Food&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Academia and Government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Environmental and Forensics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Revenue by Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instrumentation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-instrumentation and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue by region is based on the ship to location of the customer. Revenue by end market is determined by the market indicator of the customer and by customer type. Instrumentation revenue includes sales from instruments, remarketed instruments and third-party products. Non-instrumentation and other revenue include sales from contract and per incident services, our companion diagnostics and our nucleic acid solutions businesses as well as sales from spare parts, consumables, reagents, vacuum pumps, subscriptions, software licenses and associated services.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract assets (unbilled accounts receivable) primarily relate to the company's right to consideration for work completed but not billed at the reporting date. The unbilled receivables are reclassified to trade receivables when billed to customers. Contract assets are generally classified as current assets and are included in "Accounts receivable, net" in the condensed consolidated balance sheet. The balances of contract assets as of January&#160;31, 2023 and October&#160;31, 2022 were $276 million and $275 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about contract liabilities (deferred revenue) and the significant changes in the balances during the three months ended January&#160;31, 2023: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.078%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contract &lt;br/&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance as of October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue deferred in the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue recognized that was included in the contract liability balance at the beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in deferrals from customer cash advances, net of revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance as of January 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended January&#160;31, 2022 revenue recognized that was included in the contract liability balance at October&#160;31, 2021 was $191 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities primarily relate to multiple element arrangements for which billing has occurred but transfer of control of all elements to the customer has either partially or not occurred at the balance sheet date. This includes cash received from customers for products and related installation and services in advance of the transfer of control. Contract liabilities are classified as either current in deferred revenue or long-term in other long-term liabilities in the condensed consolidated balance sheet based on the timing of when we expect to complete our performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Incremental costs of obtaining a contract with a customer are recognized as an asset if we expect the benefit of those costs to be longer than one year. We have determined that certain sales incentive programs meet the requirements to be capitalized. The change in total capitalized costs to obtain a contract was immaterial during the three months ended January&#160;31, 2023 and was included in other current and long-term assets on the condensed consolidated balance sheet. We have applied the practical expedient to expense costs as incurred for costs to obtain a contract with a customer when the amortization period would have been one year or less. These costs include the company's internal sales force compensation program, as we have determined that annual compensation is commensurate with annual sales activities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Transaction Price Allocated to the Remaining Performance Obligations   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have applied the practical expedient in ASC 606-10-50-14 and have not disclosed information about transaction price allocated to remaining performance obligations that have original expected durations of one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;The estimated revenue expected to be recognized for remaining performance obligations that have an original term of more than one year, as of January&#160;31, 2023, was $378 million, the majority of which is expected to be recognized over the next 12 months. Remaining performance obligations primarily include extended warranty, customer manufacturing contracts, software maintenance contracts and revenue associated with lease arrangements.</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RleHRyZWdpb246NWY0NzVmZjhlODdiNGMzNDgyNWYyYmMyMzY0MWRlYjRfMzc2Nw_43c94cf6-16d4-419c-8a4d-22e0cb323a6d">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the company&#x2019;s total revenue and segment revenue disaggregated by geographical region: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended January 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Life Sciences and Applied Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Agilent CrossLab&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Diagnostics and Genomics&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Life Sciences and Applied Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Agilent CrossLab&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Diagnostics and Genomics&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Revenue by Region&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the company&#x2019;s total revenue disaggregated by end markets and by revenue type:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.169%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Revenue by End Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmaceutical and Biopharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Chemicals and Advanced Materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics and Clinical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Food&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Academia and Government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Environmental and Forensics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Revenue by Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instrumentation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-instrumentation and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i33f78913651a47bb92a2c9900a5966db_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfNi0xLTEtMS02ODc1MQ_00d5d249-b988-4b0e-b358-f009eb4d12ca"
      unitRef="usd">332000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2befebaadc5845d4b2d401527b04cfaa_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfNi0zLTEtMS02ODc1MQ_acdec1e2-b666-4b2a-855a-444d9f5b73be"
      unitRef="usd">154000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d7d677f290d463982d78a58cc084bf7_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfNi01LTEtMS02ODc1MQ_e378a825-eac9-4260-b257-fc96bb3fa982"
      unitRef="usd">201000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2ebb4d48c62249409808fe3659039d91_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfNi03LTEtMS02ODc1MQ_6d41eb21-ddb6-44a5-841c-370e04284bd0"
      unitRef="usd">687000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if7f2de7d06eb471e9bfd5e643f5764f0_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfNi05LTEtMS02ODc1MQ_c857853e-708f-4488-b97d-4ee94234fe8f"
      unitRef="usd">317000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d893a60dca04278bdac0cdc1e4d7989_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfNi0xMS0xLTEtNjg3NTE_a561723a-b649-4d92-8f1e-d73004a1bc0a"
      unitRef="usd">132000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a7f1e005ab74d76ae872de230a40733_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfNi0xMy0xLTEtNjg3NTE_55a11f01-c35b-4802-9b18-fc85609a2dce"
      unitRef="usd">188000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibb3d192ff70c43558d2066769b7f1110_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfNi0xNS0xLTEtNjg3NTE_d5841d52-bd2c-4e31-9b0e-79593dc680ca"
      unitRef="usd">637000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5f9fc291277d49d591b89a8b399ecfc2_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfNy0xLTEtMS02ODc1MQ_0c97850c-e949-4f25-8b19-f7e00f85a9e4"
      unitRef="usd">259000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic6b3e33e9f0d48d49e7efcf7b7ef2aca_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfNy0zLTEtMS02ODc1MQ_0358be2c-11d6-4e8f-bff9-37e156d6f3a5"
      unitRef="usd">98000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if298d324aaf84d769b2e82d2d4124e2c_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfNy01LTEtMS02ODc1MQ_5ece248e-3b37-4f96-b3bd-03fbeffd7e78"
      unitRef="usd">99000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i046a05a9e0514062bf9a677859974cf0_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfNy03LTEtMS02ODc1MQ_c32c74e2-6ce9-4085-9570-b37e3aec8472"
      unitRef="usd">456000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i01fc9bcc3b254bf39b375532b23a0c12_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfNy05LTEtMS02ODc1MQ_d31cc401-f3eb-4a31-8617-10913928e693"
      unitRef="usd">252000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4d0d7a31803341648e3a045e2165534e_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfNy0xMS0xLTEtNjg3NTE_f8b333f5-3441-4aa9-bee2-b35392757585"
      unitRef="usd">98000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8ec12050ee6648a19d1b871251909434_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfNy0xMy0xLTEtNjg3NTE_0cf534bb-3d0a-443d-9c3b-cc86ee1946b1"
      unitRef="usd">101000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i69383333245348d09b86b40f341453b8_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfNy0xNS0xLTEtNjg3NTE_b28d60e9-5317-4526-b0c5-910c0a53851e"
      unitRef="usd">451000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iefc8abdb47254b4cb32b27b0c6fea825_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfOC0xLTEtMS02ODc1MQ_46b75504-078c-4fc0-ba36-1756d77ddc20"
      unitRef="usd">442000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie6d69f7e74f34f0195f00e307ab8c80e_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfOC0zLTEtMS02ODc1MQ_0e47b7f2-2a3b-42e7-a67b-5327c3d304b7"
      unitRef="usd">129000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i87246a3249384b37a1500f923b627ee8_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfOC01LTEtMS02ODc1MQ_f59c168c-7eae-4aa4-91c7-437d51178783"
      unitRef="usd">42000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i73b7b9de08cd4437b818bb9e0f9b4ee8_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfOC03LTEtMS02ODc1MQ_044052cd-9296-45ca-995c-2bccdf04dd3d"
      unitRef="usd">613000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i352bfe2a93f947e1bcd491c49559ee2d_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfOC05LTEtMS02ODc1MQ_0caf27a0-b9d7-4166-88f2-6af91cf9f6c9"
      unitRef="usd">407000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4eeadafeeecb428dbb6170dd77089aaf_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfOC0xMS0xLTEtNjg3NTE_c39ea66e-751d-4629-81af-a88326f92ac4"
      unitRef="usd">129000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie7b2543146dc41dd86c44c7ecf447270_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfOC0xMy0xLTEtNjg3NTE_cb37ef5b-c297-473e-9047-8f576cca5c2a"
      unitRef="usd">50000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i433f969b78854ee3a4db35ffe5965afe_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfOC0xNS0xLTEtNjg3NTE_8be25fe6-a205-4504-a675-991b1a66be9b"
      unitRef="usd">586000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i90bc58b4dc464d058d4f7d56e61e2e21_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfOS0xLTEtMS02ODc1MQ_aa57af29-c4d7-43b5-a412-0dcc37dff10f"
      unitRef="usd">1033000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d83c1345e874e8fabdab7fd0ec051b6_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfOS0zLTEtMS02ODc1MQ_bbd883a8-c3b2-4fec-a71b-07fc0baaef7a"
      unitRef="usd">381000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i405a137dbfd148ab9797e53157dcb87b_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfOS01LTEtMS02ODc1MQ_4195ef91-eac1-49ef-9cc6-e955c95dfd13"
      unitRef="usd">342000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfOS03LTEtMS02ODc1MQ_2fbe4881-536e-4243-b20c-12d656481ad7"
      unitRef="usd">1756000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibfc4fdb619ed43958b648563fb2ca526_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfOS05LTEtMS02ODc1MQ_99b8f271-578e-49cc-965d-40b72d4d9cc9"
      unitRef="usd">976000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i23ae7b4eb6644b20adf956a785dc7849_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfOS0xMS0xLTEtNjg3NTE_0e7dff88-06f5-4f3d-9b94-5d4bd1fa4c43"
      unitRef="usd">359000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if846265414d142bd8d679b7776dae8eb_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfOS0xMy0xLTEtNjg3NTE_27c53acf-3332-4f9c-88de-dfa91fb1ae70"
      unitRef="usd">339000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjlhZTUzYjE3MDM0ZDQ4YTNhM2I5YjQ4MzI0OTliZDk2L3RhYmxlcmFuZ2U6OWFlNTNiMTcwMzRkNDhhM2EzYjliNDgzMjQ5OWJkOTZfOS0xNS0xLTEtNjg3NTE_e7b31a4b-ca3a-4cc5-85e1-a94a8267c2b8"
      unitRef="usd">1674000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2a91b9cb9e834ebdae96fd116f3b54bb_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfNS01LTEtMS02ODc1MQ_2eba7f9e-1877-4c74-af56-83e9f6ec9409"
      unitRef="usd">639000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3806cb502c9f457482e587434ee21a3a_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfNS03LTEtMS02ODc1MQ_401eb23c-3c49-4229-84a6-7cf48d1e3ad1"
      unitRef="usd">602000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ief1e084458524e819f6e6ec4ad38798d_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfNi01LTEtMS02ODc1MQ_80164378-ea60-4b94-a435-b39f0cde886d"
      unitRef="usd">406000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib1c59e046fef4e9a882ae2d9736f805c_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfNi03LTEtMS02ODc1MQ_7a178855-9e37-45cb-9610-fe66582e849f"
      unitRef="usd">373000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8a907fa8237046bc9803dec7949c9487_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfNy01LTEtMS02ODc1MQ_b3588b0b-ddfa-4500-ad27-dc03a7da8973"
      unitRef="usd">239000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifac394aa55dd4cd78340931392cbac84_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfNy03LTEtMS02ODc1MQ_f12bc4c2-fc89-4e57-8eae-d628668b1911"
      unitRef="usd">243000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i918e15743a054525a9ccefdb3ad5a96e_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfOC01LTEtMS02ODc1MQ_4459edce-5582-470a-9b1d-9cb189e89644"
      unitRef="usd">160000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i62c28467676b4ec4bb9ab059f9e3ace4_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfOC03LTEtMS02ODc1MQ_e19a638b-dbb8-4781-bc08-ffd699ad4040"
      unitRef="usd">158000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3149e70ed5cc4cf09a5de74e7be57b1c_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfOS01LTEtMS02ODc1MQ_b3f62eec-d47f-4eed-861e-2eab7b9ad3d6"
      unitRef="usd">146000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i791084f532a9497884a77723bd002cab_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfOS03LTEtMS02ODc1MQ_8cad11de-c3c7-49c2-87c1-752e745d6234"
      unitRef="usd">141000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e0adf97a40a40168240f072cee0a25e_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfMTAtNS0xLTEtNjg3NTE_ba6817ad-a0cd-474e-88c3-d7af60e1b3a9"
      unitRef="usd">166000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id4cf935018ca4152b0524665cd240808_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfMTAtNy0xLTEtNjg3NTE_b7bf066b-2d7e-4482-a300-299647e9e8eb"
      unitRef="usd">157000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfMTEtNS0xLTEtNjg3NTE_329595dd-f3dd-47b7-8439-95cc79fb3054"
      unitRef="usd">1756000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfMTEtNy0xLTEtNjg3NTE_7771792f-4b04-424e-98a9-a15fdcd08c67"
      unitRef="usd">1674000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id4192156e4404414ad46fd4d9c955d45_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfMTQtNS0xLTEtNjg3NTE_78d41f71-756e-4362-8080-ece25099834b"
      unitRef="usd">759000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iad9f52901e11433ca11e2fd403c4973f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfMTQtNy0xLTEtNjg3NTE_4632c07b-c123-4b64-a287-12364a3c8b7c"
      unitRef="usd">691000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i912f785ffd524583ab9332e174a0fd40_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfMTUtNS0xLTEtNjg3NTE_75c3af77-bdf9-4b59-a7fa-701cd7718486"
      unitRef="usd">997000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if7ae14d8d8fd4f5bab3bf7785fc6ec16_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfMTUtNy0xLTEtNjg3NTE_adfc06e1-2378-4d7b-bf15-22c0f93d434d"
      unitRef="usd">983000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfMTYtNS0xLTEtNjg3NTE_4f2a84c3-7239-47ed-9ff6-f5af502d3d2a"
      unitRef="usd">1756000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOmFjZTM4Y2IyMDEzMzQwZmY4ODMzYzBiYTA0ZmYzYTQyL3RhYmxlcmFuZ2U6YWNlMzhjYjIwMTMzNDBmZjg4MzNjMGJhMDRmZjNhNDJfMTYtNy0xLTEtNjg3NTE_7347f346-e8c9-4cff-aae8-bbea834e763b"
      unitRef="usd">1674000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RleHRyZWdpb246NWY0NzVmZjhlODdiNGMzNDgyNWYyYmMyMzY0MWRlYjRfMTMwNQ_019aa969-be6e-4b84-875e-b9ef533ca340"
      unitRef="usd">276000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RleHRyZWdpb246NWY0NzVmZjhlODdiNGMzNDgyNWYyYmMyMzY0MWRlYjRfMTMxMg_8e2ebb49-eb5b-451e-9ef8-e84f5fd4a264"
      unitRef="usd">275000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RleHRyZWdpb246NWY0NzVmZjhlODdiNGMzNDgyNWYyYmMyMzY0MWRlYjRfMzc2NA_e98ccd39-e769-4510-aa07-58b7c2708e25">&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about contract liabilities (deferred revenue) and the significant changes in the balances during the three months ended January&#160;31, 2023: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.078%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contract &lt;br/&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance as of October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue deferred in the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue recognized that was included in the contract liability balance at the beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in deferrals from customer cash advances, net of revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance as of January 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjU0ZDMzYzk3ZjFkODQ3M2NiNjJlNzYxZmNkMDlhYzk5L3RhYmxlcmFuZ2U6NTRkMzNjOTdmMWQ4NDczY2I2MmU3NjFmY2QwOWFjOTlfMy0yLTEtMS02ODc1MQ_4e17eaac-9761-4a08-b6d4-fb7fbc199197"
      unitRef="usd">557000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjU0ZDMzYzk3ZjFkODQ3M2NiNjJlNzYxZmNkMDlhYzk5L3RhYmxlcmFuZ2U6NTRkMzNjOTdmMWQ4NDczY2I2MmU3NjFmY2QwOWFjOTlfNC0yLTEtMS02ODc1MQ_5d493449-a3ed-4f85-80bd-d6d131f52e57"
      unitRef="usd">246000000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjU0ZDMzYzk3ZjFkODQ3M2NiNjJlNzYxZmNkMDlhYzk5L3RhYmxlcmFuZ2U6NTRkMzNjOTdmMWQ4NDczY2I2MmU3NjFmY2QwOWFjOTlfNS0yLTEtMS02ODc1MQ_c54a0a50-2187-444f-9430-9222fd39512b"
      unitRef="usd">-196000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjU0ZDMzYzk3ZjFkODQ3M2NiNjJlNzYxZmNkMDlhYzk5L3RhYmxlcmFuZ2U6NTRkMzNjOTdmMWQ4NDczY2I2MmU3NjFmY2QwOWFjOTlfNi0yLTEtMS02ODc1MQ_ed95b411-1062-40f9-92b0-1ebae2d8df7b"
      unitRef="usd">-5000000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjU0ZDMzYzk3ZjFkODQ3M2NiNjJlNzYxZmNkMDlhYzk5L3RhYmxlcmFuZ2U6NTRkMzNjOTdmMWQ4NDczY2I2MmU3NjFmY2QwOWFjOTlfOC0yLTEtMS02ODc1MQ_874f901a-2215-44ce-8e12-92156440796a"
      unitRef="usd">21000000</us-gaap:TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RhYmxlOjU0ZDMzYzk3ZjFkODQ3M2NiNjJlNzYxZmNkMDlhYzk5L3RhYmxlcmFuZ2U6NTRkMzNjOTdmMWQ4NDczY2I2MmU3NjFmY2QwOWFjOTlfOS0yLTEtMS02ODc1MQ_ff618d6f-1d70-42a4-afc6-c962ae7db4ca"
      unitRef="usd">623000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RleHRyZWdpb246NWY0NzVmZjhlODdiNGMzNDgyNWYyYmMyMzY0MWRlYjRfMTYzMQ_30efee7e-f2fe-49b9-b56d-d554d7d6cb13"
      unitRef="usd">-191000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i760e2fe91a2a4c6185fc11aef9ce399f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RleHRyZWdpb246NWY0NzVmZjhlODdiNGMzNDgyNWYyYmMyMzY0MWRlYjRfMzUwMw_6661da46-19a3-439e-b7ab-4ff2a5533c6a"
      unitRef="usd">378000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i760e2fe91a2a4c6185fc11aef9ce399f_I20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180MC9mcmFnOjVmNDc1ZmY4ZTg3YjRjMzQ4MjVmMmJjMjM2NDFkZWI0L3RleHRyZWdpb246NWY0NzVmZjhlODdiNGMzNDgyNWYyYmMyMzY0MWRlYjRfMzU3Mg_9a0d29d1-a162-4ed3-b849-ef8ded502b19">P12M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfNDg1OA_acea732b-29de-4136-bc8f-de5467f77c35">SHARE-BASED COMPENSATION&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for share-based awards in accordance with the provisions of the authoritative accounting guidance which requires the measurement and recognition of compensation expense for all share-based payment awards made to our employees and directors including employee stock options, restricted stock units, employee stock purchases made under our employee stock purchase plan and performance share awards granted to selected members of our senior management under the long-term performance plan (&#x201c;LTPP&#x201d;) based on estimated fair values. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have two LTPP performance stock award programs, which are administered under the 2018 Stock Plan, for our executive officers and other key employees. Participants in our LTPP Total Stockholders&#x2019; Return (&#x201c;TSR&#x201d;) and LTPP Earnings Per Share (&#x201c;EPS&#x201d;) programs are entitled to receive shares of the company's stock after the end of a three-year period, if specified performance targets for the programs are met. The LTPP-TSR awards are generally designed to meet the criteria of a &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;performance award with the performance metrics and peer group comparison based on the TSR set at the beginning of the performance period. The LTPP-EPS awards are based on the company&#x2019;s EPS performance over a three-year period. The performance targets for the LTPP-EPS for year 2 and year 3 of the performance period are set in the first quarter of year 2 and year 3, respectively. All LTPP awards are subject to a one-year post-vest holding period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The final LTPP award may vary from 0 percent to 200 percent of the target award. We consider the dilutive impact of these programs in our diluted net income per share calculation only to the extent that the performance conditions are expected to be met. Restricted stock units generally vest, with some exceptions, at a rate of 25 percent per year over a period of four years from the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In fiscal year 2021, we resumed granting stock options. Stock options granted under the 2018 Stock Plan may be either "incentive stock options", as defined in Section 422 of the Internal Revenue Code, or non-statutory. Options generally vest at a rate of 25 percent per year over a period of four years from the date of grant with a maximum contractual term of ten years. The exercise price for stock options is generally not less than 100 percent of the fair market value of our common stock on the date the stock award is granted. We issue new shares of common stock when employee stock options are exercised. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The impact on our results for share-based compensation was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products and services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At January&#160;31, 2023 and October&#160;31, 2022, no share-based compensation was capitalized within inventory. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;                                               &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following assumptions were used to estimate the fair value of awards granted.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock Option Plans:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LTPP:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility of Agilent shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility of selected peer-company shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22%-84%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23%-81%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pair-wise correlation with selected peers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Post-vest holding restriction discount for all executive awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of share-based awards for our employee stock option awards was estimated using the Black-Scholes option pricing model. Shares granted under the LTPP (TSR) were valued using a Monte Carlo simulation model. The Monte Carlo simulation fair value model requires the use of highly subjective and complex assumptions, including the price volatility of the underlying stock. &#160;For the volatility of our LTPP (TSR) grants, we used our own historical stock price volatility.&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ESPP allows eligible employees to purchase shares of our common stock at 85 percent of the price at purchase and uses the purchase date to establish the fair market value. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use historical volatility to estimate the expected stock price volatility assumption for employee stock option awards. In reaching the conclusion, we have considered many factors including the extent to which our options are currently traded and our ability to find traded options in the current market with similar terms and prices to the options we are valuing. In estimating the expected life of our options granted, we considered the historical option exercise behavior of our executives, which we believe is representative of future behavior.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of restricted stock units and LTPP (EPS) awards is determined based on the market price of our common stock on the date of grant adjusted for expected dividend yield. The compensation cost for LTPP (EPS) reflects the cost of awards that are probable to vest at the end of the performance period. &lt;/span&gt;&lt;/div&gt;All LTPP awards granted to our senior management employees have a one-year post-vest holding restriction. The estimated discount associated with post-vest holding restrictions is calculated using the Finnerty model. The model calculates the potential lost value if the employees were able to sell the shares during the lack of marketability period, instead of being required to hold the shares. The model used the same historical stock price volatility and dividend yield assumption used for the Monte Carlo simulation model and an expected dividend yield to compute the discount.</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="iaa92731b48d9431b9c71e61f579b2e2d_D20211101-20220131"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMTU0MA_155031f8-3263-4f91-9ee1-059b7baa8823"
      unitRef="number">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="iaa92731b48d9431b9c71e61f579b2e2d_D20211101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMTU0MA_1c67ecd0-dc2a-4bcf-b4b0-051485ea3164"
      unitRef="number">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i48899fe9fcfe40b0a73c87a1ed2a0395_D20221101-20230131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMTU0MA_53848418-47ce-4d2d-9b0f-39164d53cf48"
      unitRef="number">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i48899fe9fcfe40b0a73c87a1ed2a0395_D20221101-20230131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMTU0MA_cc2dbcb0-0e44-46a9-978e-98dec3be4c07"
      unitRef="number">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="ie790d592078944d5b3d633d03546cc1d_D20221101-20230131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMTU0Ng_28f7ddf9-cc91-48ee-826d-7fee505a2e7c"
      unitRef="number">2</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="ie790d592078944d5b3d633d03546cc1d_D20221101-20230131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMTU0Ng_3c26083c-3f3e-4744-9d8c-d72092964f00"
      unitRef="number">2</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i2bafa1d058fc442f80a7b778bd3869ed_D20211101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMTU0Ng_703e7d62-c485-4ff4-896a-04b97c4980e3"
      unitRef="number">2</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i2bafa1d058fc442f80a7b778bd3869ed_D20211101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMTU0Ng_a2ea2a61-d41d-4ae6-bd55-a42657e20eaf"
      unitRef="number">2</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i2339426bfd7e4abe87998a6a1ba2cd4a_D20211101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMTgxNw_31744297-7efb-4e1b-bde1-6f1958be4163"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i2339426bfd7e4abe87998a6a1ba2cd4a_D20211101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMTgxNw_a5837d0d-8fd4-4bc6-a692-bd2fca189f76"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="if327b7d783dc44e792963c335ca5a65b_D20221101-20230131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMTgxNw_ba046ce4-ba7a-4c89-afbf-31fc5253ab34"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="if327b7d783dc44e792963c335ca5a65b_D20221101-20230131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMTgxNw_d8c41463-17db-4cac-941a-91f666111acc"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i2339426bfd7e4abe87998a6a1ba2cd4a_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMTg0Ng_6a3a3508-e679-401a-b890-18c041c9fd31">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i2339426bfd7e4abe87998a6a1ba2cd4a_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMTg0Ng_a29a5664-cc74-4a1c-bb6d-b5a36cee946a">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="if327b7d783dc44e792963c335ca5a65b_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMTg0Ng_a3d82439-c038-4ac5-bbfe-eee9b3013b35">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="if327b7d783dc44e792963c335ca5a65b_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMTg0Ng_d846a980-2ad2-4e2c-9cd1-1271cf817404">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i39c3cd014db248d291455e64255569d7_D20221101-20230131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjEyOQ_6380e208-63c3-44dc-ac42-8b5f35c9abe7"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i39c3cd014db248d291455e64255569d7_D20221101-20230131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjEyOQ_91256123-4e1f-4a35-b34d-eaf09e7d94d9"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i6eca4fc7ce75413ab4ea045884e10a1e_D20211101-20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjEyOQ_b7efe269-9353-485c-973d-2ba72214c1e4"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i6eca4fc7ce75413ab4ea045884e10a1e_D20211101-20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjEyOQ_e2f5b106-2171-48d9-84b3-30a1ad60d135"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i6eca4fc7ce75413ab4ea045884e10a1e_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjE1OA_405362ea-3481-40a3-b9d8-0c4a80f273dd">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i6eca4fc7ce75413ab4ea045884e10a1e_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjE1OA_4db32ca8-fc3e-473b-948b-ff3402040103">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i39c3cd014db248d291455e64255569d7_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjE1OA_cabb3b46-7ce2-4969-84b6-e9600e119a6d">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i39c3cd014db248d291455e64255569d7_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjE1OA_d92afdcd-3d8e-445c-946a-1db528d6e746">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i6eca4fc7ce75413ab4ea045884e10a1e_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjIxOQ_2bd27c45-ff72-42f0-96eb-9c84a08a4967">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i39c3cd014db248d291455e64255569d7_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjIxOQ_60f2074f-7b49-45bd-aa80-80bf47fee770">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i39c3cd014db248d291455e64255569d7_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjIxOQ_a2d420df-fc7b-4997-a6bd-9428259a4704">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i6eca4fc7ce75413ab4ea045884e10a1e_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjIxOQ_e8eeba1d-2136-4b26-ac32-c3d6e4d100d7">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i39c3cd014db248d291455e64255569d7_D20221101-20230131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjI4Nw_00f5546e-e2bd-45f4-9180-c20d8b053b44"
      unitRef="number">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i39c3cd014db248d291455e64255569d7_D20221101-20230131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjI4Nw_6339c774-d70e-4f83-9486-064713696c9b"
      unitRef="number">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i6eca4fc7ce75413ab4ea045884e10a1e_D20211101-20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjI4Nw_c4416827-55fc-4500-808c-223e1dec7e2e"
      unitRef="number">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i6eca4fc7ce75413ab4ea045884e10a1e_D20211101-20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjI4Nw_d5e116fc-87df-420d-96ef-32faf198065d"
      unitRef="number">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfNDg3Ng_450bfc06-5e97-42fc-9165-cbf7fd427a9b">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The impact on our results for share-based compensation was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products and services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i43fcff5de6e1452bbd0a529d852367d6_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmU2NTYyOWI1YjY4ZTQyZTE4Njc5YjQ0MDEzZTY1ODJmL3RhYmxlcmFuZ2U6ZTY1NjI5YjViNjhlNDJlMTg2NzliNDQwMTNlNjU4MmZfNC01LTEtMS02ODc1MQ_bec47b0c-fab7-482a-80bc-32001b25da1e"
      unitRef="usd">13000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i94553cf9a1f84b418346d9811212fd96_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmU2NTYyOWI1YjY4ZTQyZTE4Njc5YjQ0MDEzZTY1ODJmL3RhYmxlcmFuZ2U6ZTY1NjI5YjViNjhlNDJlMTg2NzliNDQwMTNlNjU4MmZfNC03LTEtMS02ODc1MQ_e96aacab-adb6-424f-b7ac-23888682cd4a"
      unitRef="usd">11000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i959ba1e365cb46fa9d6a0d02c602c418_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmU2NTYyOWI1YjY4ZTQyZTE4Njc5YjQ0MDEzZTY1ODJmL3RhYmxlcmFuZ2U6ZTY1NjI5YjViNjhlNDJlMTg2NzliNDQwMTNlNjU4MmZfNS01LTEtMS02ODc1MQ_da9d08c5-717b-42cf-8b63-8f25d80ba9ce"
      unitRef="usd">5000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i86cd4d87f14b4de7b2d3da170bbf7106_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmU2NTYyOWI1YjY4ZTQyZTE4Njc5YjQ0MDEzZTY1ODJmL3RhYmxlcmFuZ2U6ZTY1NjI5YjViNjhlNDJlMTg2NzliNDQwMTNlNjU4MmZfNS03LTEtMS02ODc1MQ_fb619b46-17f5-404a-922f-a7cce7d1df9c"
      unitRef="usd">6000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic8c2f25497504473b732d53cf9c153d0_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmU2NTYyOWI1YjY4ZTQyZTE4Njc5YjQ0MDEzZTY1ODJmL3RhYmxlcmFuZ2U6ZTY1NjI5YjViNjhlNDJlMTg2NzliNDQwMTNlNjU4MmZfNi01LTEtMS02ODc1MQ_671a4ada-7724-4a31-8f1e-355b0ab18610"
      unitRef="usd">26000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i290a2031fda542169028caab109d3e44_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmU2NTYyOWI1YjY4ZTQyZTE4Njc5YjQ0MDEzZTY1ODJmL3RhYmxlcmFuZ2U6ZTY1NjI5YjViNjhlNDJlMTg2NzliNDQwMTNlNjU4MmZfNi03LTEtMS02ODc1MQ_66747176-8544-49e1-b533-93e09e42a45c"
      unitRef="usd">28000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmU2NTYyOWI1YjY4ZTQyZTE4Njc5YjQ0MDEzZTY1ODJmL3RhYmxlcmFuZ2U6ZTY1NjI5YjViNjhlNDJlMTg2NzliNDQwMTNlNjU4MmZfNy01LTEtMS02ODc1MQ_ac179141-b35e-4fba-bc61-824063e88676"
      unitRef="usd">44000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmU2NTYyOWI1YjY4ZTQyZTE4Njc5YjQ0MDEzZTY1ODJmL3RhYmxlcmFuZ2U6ZTY1NjI5YjViNjhlNDJlMTg2NzliNDQwMTNlNjU4MmZfNy03LTEtMS02ODc1MQ_7915f8f1-e907-4a22-a061-0b4463f88a44"
      unitRef="usd">45000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="i7776701abc9e4dfd9513b31afb36fc5d_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjU0OA_b8d9eb4b-021a-43b2-aed5-fe9ff8f02be1"
      unitRef="usd">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="i20cb6e7201dd4408b86351630d0bad5a_D20211101-20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMjU0OA_e9fd2a0e-1df6-4f0d-b2db-9fe81f9e4681"
      unitRef="usd">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfNDg4NQ_699cfb03-d6f1-426f-b21c-3a359e34b631">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following assumptions were used to estimate the fair value of awards granted.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock Option Plans:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LTPP:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility of Agilent shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility of selected peer-company shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22%-84%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23%-81%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pair-wise correlation with selected peers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Post-vest holding restriction discount for all executive awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i39c3cd014db248d291455e64255569d7_D20221101-20230131"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfNC01LTEtMS02ODc1MQ_e02541a5-e2fd-4298-b556-4d8380f74d9f"
      unitRef="number">0.039</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i6eca4fc7ce75413ab4ea045884e10a1e_D20211101-20220131"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfNC03LTEtMS02ODc1MQ_de686f3b-d17f-4595-986b-4b33046ba30c"
      unitRef="number">0.013</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i39c3cd014db248d291455e64255569d7_D20221101-20230131"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfNS01LTEtMS02ODc1MQ_ed07dfcc-7208-430b-9abe-309bb83e3494"
      unitRef="number">0.006</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i6eca4fc7ce75413ab4ea045884e10a1e_D20211101-20220131"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfNS03LTEtMS02ODc1MQ_522c6180-d283-4e03-b726-e303e67ca851"
      unitRef="number">0.005</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i39c3cd014db248d291455e64255569d7_D20221101-20230131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfNi01LTEtMS02ODc1MQ_84b05cd5-3fcf-4493-98b0-858c427f2de6"
      unitRef="number">0.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i6eca4fc7ce75413ab4ea045884e10a1e_D20211101-20220131"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfNi03LTEtMS02ODc1MQ_b2eea4f6-5b99-4c7f-aac2-d4ac3288bf17"
      unitRef="number">0.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i39c3cd014db248d291455e64255569d7_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfNy01LTEtMS02ODc1MQ_400ba1e6-939c-4ac6-8d07-f7b64cd75cd5">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i6eca4fc7ce75413ab4ea045884e10a1e_D20211101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfNy03LTEtMS02ODc1MQ_c0318956-fa3f-41a5-8b89-aef1d46c4a63">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i3152ba76c1df417987d29128ff805a81_D20221101-20230131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfOS01LTEtMS02ODc1MQ_98843f48-d506-47e0-80c6-e9f93627286f"
      unitRef="number">0.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ia93bc1b9aa474f94bdf99722444eb9d8_D20211101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfOS03LTEtMS02ODc1MQ_2d86ff4b-4ebc-453e-9361-354372a9ace5"
      unitRef="number">0.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum
      contextRef="i3152ba76c1df417987d29128ff805a81_D20221101-20230131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfMTAtNS0xLTEtNjg3NTEvdGV4dHJlZ2lvbjo1ZGFlZWFmOGFmZjg0MGE1OWZkZDJhNWMxYjNiZDcyY180_0eb9776d-0723-4897-8ee8-2d3bde800f39"
      unitRef="number">0.22</a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum>
    <a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum
      contextRef="i3152ba76c1df417987d29128ff805a81_D20221101-20230131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfMTAtNS0xLTEtNjg3NTEvdGV4dHJlZ2lvbjo1ZGFlZWFmOGFmZjg0MGE1OWZkZDJhNWMxYjNiZDcyY183_1bae18b4-801b-4f42-b632-4b13fe9e81b7"
      unitRef="number">0.84</a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum>
    <a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum
      contextRef="ia93bc1b9aa474f94bdf99722444eb9d8_D20211101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfMTAtNy0xLTEtNjg3NTEvdGV4dHJlZ2lvbjo1MDU2OWM3Y2ZhNTQ0ZjU4OTkwY2ZiN2Y2YTk3NTdjOF80_6035b378-a199-47a7-89d0-fcbfc38b835e"
      unitRef="number">0.23</a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum>
    <a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum
      contextRef="ia93bc1b9aa474f94bdf99722444eb9d8_D20211101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfMTAtNy0xLTEtNjg3NTEvdGV4dHJlZ2lvbjo1MDU2OWM3Y2ZhNTQ0ZjU4OTkwY2ZiN2Y2YTk3NTdjOF83_6bb2c6db-8664-468d-b123-d29a2b4b21d3"
      unitRef="number">0.81</a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum>
    <a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate
      contextRef="i3152ba76c1df417987d29128ff805a81_D20221101-20230131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfMTEtNS0xLTEtNjg3NTE_32b358c4-2183-467a-a50f-01d67a640af7"
      unitRef="number">0.42</a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate>
    <a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate
      contextRef="ia93bc1b9aa474f94bdf99722444eb9d8_D20211101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfMTEtNy0xLTEtNjg3NTE_6631c384-413b-408c-86c3-08248cf2a94d"
      unitRef="number">0.41</a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions
      contextRef="i09873915b6ae475892e5c9a10735d4d2_D20221101-20230131"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfMTMtNS0xLTEtNjg3NTE_9d2cd15a-2d88-4dc1-9c1d-d84fa61148e6"
      unitRef="number">0.071</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions
      contextRef="ib61c5c9996464615b2178256d5815306_D20211101-20220131"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RhYmxlOmZlNzdlNDIzMjczNDQ1YWE5Njc2OTkzMmQ5OWIzY2Y2L3RhYmxlcmFuZ2U6ZmU3N2U0MjMyNzM0NDVhYTk2NzY5OTMyZDk5YjNjZjZfMTMtNy0xLTEtNjg3NTE_61fd766c-7f61-48d0-84ee-5150c044f37b"
      unitRef="number">0.065</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMzMwNw_0186dc59-ded5-4e1f-aeb3-051dc08d4b12"
      unitRef="number">0.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMzMwNw_62cdfbf7-9fd3-41d0-9499-f7a0e2d756bf"
      unitRef="number">0.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMzMwNw_84670f4c-191c-4962-abc8-c9d7c2c134f7"
      unitRef="number">0.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180My9mcmFnOjkwMDRjNmMzOTAzZTQ4NGVhM2UwMzQwYzJlOGYwMmFmL3RleHRyZWdpb246OTAwNGM2YzM5MDNlNDg0ZWEzZTAzNDBjMmU4ZjAyYWZfMzMwNw_f3ab9ddb-1ea2-43a9-a6b4-d4fc20f1484f"
      unitRef="number">0.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180Ni9mcmFnOmI1MTg5MWRkMjhjNzQ0MTdhNGVhMDcyOWM1ZGVmYWQwL3RleHRyZWdpb246YjUxODkxZGQyOGM3NDQxN2E0ZWEwNzI5YzVkZWZhZDBfMjI0MA_8eb451d6-3b77-4c37-95b9-5dc851d4a7f0">INCOME TAXES &lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended January&#160;31, 2023, our income tax expense was $58 million with an effective tax rate of 14.1 percent. Our effective tax rate increased in 2023 compared to 2022, primarily due to the mandatory capitalization of research and development expenses, which became effective for Agilent in the first quarter of 2023, due to a change in tax law from the Tax Cuts and Jobs Act of 2017. For the three months ended January 31, 2023, our effective tax rate and the resulting provision for income taxes were also impacted by the excess tax benefits from stock-based compensation of $12&#160;million along with the expiration of various foreign statutes of limitations which resulted in the recognition of previously unrecognized tax benefits of $7&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended January&#160;31, 2022, our income tax expense was $36 million with an effective tax rate of 11.3 percent. The income taxes for the three months ended January&#160;31, 2022 include the excess tax benefits from stock-based compensation of $16&#160;million. For the three months ended January&#160;31, 2022, our effective tax rate and the resulting provision for income taxes were also impacted by the expiration of various foreign statutes of limitations which resulted in the recognition of previously unrecognized tax benefits of $8&#160;million.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In the U.S., tax years remain open back to the year 2018 for federal income tax purposes and for significant states. In other major jurisdictions where the company conducts business, the tax years generally remain open back to the year 2013.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With these jurisdictions and the U.S., it is reasonably possible there could be significant changes to our unrecognized tax benefits in the next twelve months due to either the expiration of a statute of limitation or a tax audit settlement which will be partially offset by an anticipated tax liability related to unremitted foreign earnings, where applicable. Given the number of years and numerous matters that remain subject to examination in various tax jurisdictions, management is unable to estimate the range of possible changes to the balance of our unrecognized tax benefits.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180Ni9mcmFnOmI1MTg5MWRkMjhjNzQ0MTdhNGVhMDcyOWM1ZGVmYWQwL3RleHRyZWdpb246YjUxODkxZGQyOGM3NDQxN2E0ZWEwNzI5YzVkZWZhZDBfMTE5_e05bc500-d25e-443f-9245-193ab8cadb91"
      unitRef="usd">58000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180Ni9mcmFnOmI1MTg5MWRkMjhjNzQ0MTdhNGVhMDcyOWM1ZGVmYWQwL3RleHRyZWdpb246YjUxODkxZGQyOGM3NDQxN2E0ZWEwNzI5YzVkZWZhZDBfMTUy_d466ef6c-f123-4673-9662-69600f249dcb"
      unitRef="number">0.141</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180Ni9mcmFnOmI1MTg5MWRkMjhjNzQ0MTdhNGVhMDcyOWM1ZGVmYWQwL3RleHRyZWdpb246YjUxODkxZGQyOGM3NDQxN2E0ZWEwNzI5YzVkZWZhZDBfOTg5NTYwNDY1MzkxOA_88a70279-47aa-4116-8021-87cbd302d190"
      unitRef="usd">12000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180Ni9mcmFnOmI1MTg5MWRkMjhjNzQ0MTdhNGVhMDcyOWM1ZGVmYWQwL3RleHRyZWdpb246YjUxODkxZGQyOGM3NDQxN2E0ZWEwNzI5YzVkZWZhZDBfOTg5NTYwNDY1Mzk2NA_4b163d0c-85ad-4944-9b10-fbc907f68f70"
      unitRef="usd">7000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180Ni9mcmFnOmI1MTg5MWRkMjhjNzQ0MTdhNGVhMDcyOWM1ZGVmYWQwL3RleHRyZWdpb246YjUxODkxZGQyOGM3NDQxN2E0ZWEwNzI5YzVkZWZhZDBfOTIx_c70124fb-443a-4533-9ab0-e9de281b30cf"
      unitRef="usd">36000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180Ni9mcmFnOmI1MTg5MWRkMjhjNzQ0MTdhNGVhMDcyOWM1ZGVmYWQwL3RleHRyZWdpb246YjUxODkxZGQyOGM3NDQxN2E0ZWEwNzI5YzVkZWZhZDBfOTU0_e708da18-bdff-4914-b993-0e7249bee8c2"
      unitRef="number">0.113</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180Ni9mcmFnOmI1MTg5MWRkMjhjNzQ0MTdhNGVhMDcyOWM1ZGVmYWQwL3RleHRyZWdpb246YjUxODkxZGQyOGM3NDQxN2E0ZWEwNzI5YzVkZWZhZDBfMTEyMQ_c10babd4-b849-4548-a42c-2f30e4a3b07a"
      unitRef="usd">16000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180Ni9mcmFnOmI1MTg5MWRkMjhjNzQ0MTdhNGVhMDcyOWM1ZGVmYWQwL3RleHRyZWdpb246YjUxODkxZGQyOGM3NDQxN2E0ZWEwNzI5YzVkZWZhZDBfMTM3OA_f59fb40e-f86f-44fc-b5b9-2bd1f32f425f"
      unitRef="usd">8000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180OS9mcmFnOmViNWFkNjYxZDRkZjRmNTdiNjYzZmY4MGI3YmI2ZmJiL3RleHRyZWdpb246ZWI1YWQ2NjFkNGRmNGY1N2I2NjNmZjgwYjdiYjZmYmJfMTUxNw_62eb8c33-a1dd-41df-906c-7c671452c68c">NET INCOME PER SHARE&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of the numerator and denominator of the basic and diluted net income per share computations for the periods presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted-average shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Potential common shares&#x2014; stock&#160;options and other employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted-average shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The dilutive effect of share-based awards is reflected in diluted net income per share by application of the treasury stock method, which includes consideration of unamortized share-based compensation expense and the dilutive effect of in-the-money options and non-vested restricted stock units. Under the treasury stock method, the amount the employee must pay for exercising stock options and unamortized share-based compensation expense collectively are assumed proceeds to be used to repurchase hypothetical shares. An increase in the fair market value of the company's common stock can result in a greater dilutive effect from potentially dilutive awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We exclude stock options with exercise prices greater than the average market price of our common stock from the calculation of diluted earnings per share because their effect would be anti-dilutive. In addition, we exclude from the calculation of diluted earnings per share stock options, ESPP, LTPP and restricted stock awards whose combined exercise price and unamortized fair value were greater than the average market price of our common stock because their effect would also be anti-dilutive. &#160; &lt;/span&gt;&lt;/div&gt;For the three months ended January&#160;31, 2023 and 2022, potential common shares excluded from the calculation of diluted earnings per share were not material.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180OS9mcmFnOmViNWFkNjYxZDRkZjRmNTdiNjYzZmY4MGI3YmI2ZmJiL3RleHRyZWdpb246ZWI1YWQ2NjFkNGRmNGY1N2I2NjNmZjgwYjdiYjZmYmJfMTUwNA_0b6b0a82-0a9f-4f87-9e9c-df55483b57bc">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of the numerator and denominator of the basic and diluted net income per share computations for the periods presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted-average shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Potential common shares&#x2014; stock&#160;options and other employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted-average shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180OS9mcmFnOmViNWFkNjYxZDRkZjRmNTdiNjYzZmY4MGI3YmI2ZmJiL3RhYmxlOjdkYTc1NjcwY2I0NDRiOTg5MGE4ZWNhZDJhMWY3MmFkL3RhYmxlcmFuZ2U6N2RhNzU2NzBjYjQ0NGI5ODkwYThlY2FkMmExZjcyYWRfNS01LTEtMS02ODc1MQ_910fdead-b464-410b-b253-1577c93b2347"
      unitRef="usd">352000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180OS9mcmFnOmViNWFkNjYxZDRkZjRmNTdiNjYzZmY4MGI3YmI2ZmJiL3RhYmxlOjdkYTc1NjcwY2I0NDRiOTg5MGE4ZWNhZDJhMWY3MmFkL3RhYmxlcmFuZ2U6N2RhNzU2NzBjYjQ0NGI5ODkwYThlY2FkMmExZjcyYWRfNS03LTEtMS02ODc1MQ_0679f287-1f00-4e6b-87d2-c3c32d4494c1"
      unitRef="usd">283000000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180OS9mcmFnOmViNWFkNjYxZDRkZjRmNTdiNjYzZmY4MGI3YmI2ZmJiL3RhYmxlOjdkYTc1NjcwY2I0NDRiOTg5MGE4ZWNhZDJhMWY3MmFkL3RhYmxlcmFuZ2U6N2RhNzU2NzBjYjQ0NGI5ODkwYThlY2FkMmExZjcyYWRfNy01LTEtMS02ODc1MQ_92218217-bb95-45f2-aef2-eccc34ee3c40"
      unitRef="shares">296000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180OS9mcmFnOmViNWFkNjYxZDRkZjRmNTdiNjYzZmY4MGI3YmI2ZmJiL3RhYmxlOjdkYTc1NjcwY2I0NDRiOTg5MGE4ZWNhZDJhMWY3MmFkL3RhYmxlcmFuZ2U6N2RhNzU2NzBjYjQ0NGI5ODkwYThlY2FkMmExZjcyYWRfNy03LTEtMS02ODc1MQ_5e448ea6-ad21-404a-ad7f-82bd47d65677"
      unitRef="shares">301000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180OS9mcmFnOmViNWFkNjYxZDRkZjRmNTdiNjYzZmY4MGI3YmI2ZmJiL3RhYmxlOjdkYTc1NjcwY2I0NDRiOTg5MGE4ZWNhZDJhMWY3MmFkL3RhYmxlcmFuZ2U6N2RhNzU2NzBjYjQ0NGI5ODkwYThlY2FkMmExZjcyYWRfOC01LTEtMS02ODc1MQ_aaa9c69e-97c5-4bb1-b3d5-a82916d9af1d"
      unitRef="shares">1000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180OS9mcmFnOmViNWFkNjYxZDRkZjRmNTdiNjYzZmY4MGI3YmI2ZmJiL3RhYmxlOjdkYTc1NjcwY2I0NDRiOTg5MGE4ZWNhZDJhMWY3MmFkL3RhYmxlcmFuZ2U6N2RhNzU2NzBjYjQ0NGI5ODkwYThlY2FkMmExZjcyYWRfOC03LTEtMS02ODc1MQ_ded51ae7-f2ac-4ad9-ad48-b53cf07de3d4"
      unitRef="shares">2000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180OS9mcmFnOmViNWFkNjYxZDRkZjRmNTdiNjYzZmY4MGI3YmI2ZmJiL3RhYmxlOjdkYTc1NjcwY2I0NDRiOTg5MGE4ZWNhZDJhMWY3MmFkL3RhYmxlcmFuZ2U6N2RhNzU2NzBjYjQ0NGI5ODkwYThlY2FkMmExZjcyYWRfOS01LTEtMS02ODc1MQ_03321a63-421f-435a-bc55-122f70ba4f99"
      unitRef="shares">297000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180OS9mcmFnOmViNWFkNjYxZDRkZjRmNTdiNjYzZmY4MGI3YmI2ZmJiL3RhYmxlOjdkYTc1NjcwY2I0NDRiOTg5MGE4ZWNhZDJhMWY3MmFkL3RhYmxlcmFuZ2U6N2RhNzU2NzBjYjQ0NGI5ODkwYThlY2FkMmExZjcyYWRfOS03LTEtMS02ODc1MQ_2e5eb595-7a0c-4289-98da-6b8b58a597ed"
      unitRef="shares">303000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180OS9mcmFnOmViNWFkNjYxZDRkZjRmNTdiNjYzZmY4MGI3YmI2ZmJiL3RleHRyZWdpb246ZWI1YWQ2NjFkNGRmNGY1N2I2NjNmZjgwYjdiYjZmYmJfMTQ4Nw_22da2b2f-3096-4071-9fb0-22f4ebd83364"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180OS9mcmFnOmViNWFkNjYxZDRkZjRmNTdiNjYzZmY4MGI3YmI2ZmJiL3RleHRyZWdpb246ZWI1YWQ2NjFkNGRmNGY1N2I2NjNmZjgwYjdiYjZmYmJfMTQ4Nw_4e1d2ee0-6f62-4be7-8615-012642e5ae6c"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180OS9mcmFnOmViNWFkNjYxZDRkZjRmNTdiNjYzZmY4MGI3YmI2ZmJiL3RleHRyZWdpb246ZWI1YWQ2NjFkNGRmNGY1N2I2NjNmZjgwYjdiYjZmYmJfMTQ4Nw_5cdbb5d1-5105-4046-a4cc-39824610dacd"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN180OS9mcmFnOmViNWFkNjYxZDRkZjRmNTdiNjYzZmY4MGI3YmI2ZmJiL3RleHRyZWdpb246ZWI1YWQ2NjFkNGRmNGY1N2I2NjNmZjgwYjdiYjZmYmJfMTQ4Nw_8cd32326-e8eb-4f79-b747-a21a6975b34c"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181Mi9mcmFnOmVjMjJmOWJiZjU3YTRmY2RiMGMzMDc2Njk2MGU4ODNhL3RleHRyZWdpb246ZWMyMmY5YmJmNTdhNGZjZGIwYzMwNzY2OTYwZTg4M2FfOTA_4745fcdc-7f05-495e-bcf2-f666e55ff384">INVENTORY&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory as of January&#160;31, 2023 and October&#160;31, 2022 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.218%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased parts and fabricated assemblies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181Mi9mcmFnOmVjMjJmOWJiZjU3YTRmY2RiMGMzMDc2Njk2MGU4ODNhL3RleHRyZWdpb246ZWMyMmY5YmJmNTdhNGZjZGIwYzMwNzY2OTYwZTg4M2FfOTI_88954154-dadf-4c69-973f-10e777e77e9f">INVENTORY&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory as of January&#160;31, 2023 and October&#160;31, 2022 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.218%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased parts and fabricated assemblies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoods
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181Mi9mcmFnOmVjMjJmOWJiZjU3YTRmY2RiMGMzMDc2Njk2MGU4ODNhL3RhYmxlOjg2NWU0OTE0MmNiYTQyYjE5ZjA0OWIzYzgxZjU4MjM5L3RhYmxlcmFuZ2U6ODY1ZTQ5MTQyY2JhNDJiMTlmMDQ5YjNjODFmNTgyMzlfMi0xLTEtMS02ODc1MQ_2fd2cc28-f2ef-4ae6-9e41-0a6163cce0f2"
      unitRef="usd">589000000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181Mi9mcmFnOmVjMjJmOWJiZjU3YTRmY2RiMGMzMDc2Njk2MGU4ODNhL3RhYmxlOjg2NWU0OTE0MmNiYTQyYjE5ZjA0OWIzYzgxZjU4MjM5L3RhYmxlcmFuZ2U6ODY1ZTQ5MTQyY2JhNDJiMTlmMDQ5YjNjODFmNTgyMzlfMi0zLTEtMS02ODc1MQ_74f10f18-1f77-4c8a-8bb3-3df887f3c63a"
      unitRef="usd">555000000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryWorkInProcessAndRawMaterials
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181Mi9mcmFnOmVjMjJmOWJiZjU3YTRmY2RiMGMzMDc2Njk2MGU4ODNhL3RhYmxlOjg2NWU0OTE0MmNiYTQyYjE5ZjA0OWIzYzgxZjU4MjM5L3RhYmxlcmFuZ2U6ODY1ZTQ5MTQyY2JhNDJiMTlmMDQ5YjNjODFmNTgyMzlfMy0xLTEtMS02ODc1MQ_329bf70c-146a-4a9c-9401-486cc8ce5945"
      unitRef="usd">522000000</us-gaap:InventoryWorkInProcessAndRawMaterials>
    <us-gaap:InventoryWorkInProcessAndRawMaterials
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181Mi9mcmFnOmVjMjJmOWJiZjU3YTRmY2RiMGMzMDc2Njk2MGU4ODNhL3RhYmxlOjg2NWU0OTE0MmNiYTQyYjE5ZjA0OWIzYzgxZjU4MjM5L3RhYmxlcmFuZ2U6ODY1ZTQ5MTQyY2JhNDJiMTlmMDQ5YjNjODFmNTgyMzlfMy0zLTEtMS02ODc1MQ_7a3c5665-45e9-4507-a7b0-29d1e01e9b49"
      unitRef="usd">483000000</us-gaap:InventoryWorkInProcessAndRawMaterials>
    <us-gaap:InventoryNet
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181Mi9mcmFnOmVjMjJmOWJiZjU3YTRmY2RiMGMzMDc2Njk2MGU4ODNhL3RhYmxlOjg2NWU0OTE0MmNiYTQyYjE5ZjA0OWIzYzgxZjU4MjM5L3RhYmxlcmFuZ2U6ODY1ZTQ5MTQyY2JhNDJiMTlmMDQ5YjNjODFmNTgyMzlfNC0xLTEtMS02ODc1MQ_30842b6a-6b6c-41ee-80ea-cb6658643af0"
      unitRef="usd">1111000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181Mi9mcmFnOmVjMjJmOWJiZjU3YTRmY2RiMGMzMDc2Njk2MGU4ODNhL3RhYmxlOjg2NWU0OTE0MmNiYTQyYjE5ZjA0OWIzYzgxZjU4MjM5L3RhYmxlcmFuZ2U6ODY1ZTQ5MTQyY2JhNDJiMTlmMDQ5YjNjODFmNTgyMzlfNC0zLTEtMS02ODc1MQ_f489376c-0b4b-4746-9691-89f9083a013a"
      unitRef="usd">1038000000</us-gaap:InventoryNet>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RleHRyZWdpb246NTg5M2FjZGJiMjliNGIwNWI1YzdhNGQ5YTY0NTZjOTNfMjg1OQ_5aedb331-c81b-4774-a4be-75319f7726c5">GOODWILL AND OTHER INTANGIBLE ASSETS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents goodwill balances and the movements for each of our reportable segments during the three months ended January&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.512%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.070%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Life Sciences and Applied Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Diagnostics and Genomics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Agilent CrossLab&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill as of October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation impact&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill arising from acquisitions and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill as of January 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The component parts of other intangible assets as of January&#160;31, 2023 and October&#160;31, 2022 are shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&#160;Intangible&#160;Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&#160;Book&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased technology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademark/Tradename&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Third-party technology and licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-Process R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of January 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased technology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademark/Tradename&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Third-party technology and licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-Process R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended January&#160;31, 2023, we recorded additions to goodwill of $11 million and to other intangible assets of $23 million in our diagnostics and genomics segment related to the acquisition of one business. During the three months ended January&#160;31, 2023, other intangible assets in total increased $2 million due to the impact of foreign currency translation. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In general, for U.S. federal tax purposes, goodwill from asset purchases is amortizable; however, any goodwill created as part of a stock acquisition is not deductible.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each quarter we review the events and circumstances to determine if impairment of indefinite-lived intangible assets and goodwill is indicated. During the three months ended January&#160;31, 2023 and 2022 we did not identify any triggering events or circumstances which would indicate an impairment of goodwill or indefinite-lived intangible assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense of intangible assets was $36 million and $51 million for the three months ended January&#160;31, 2023 and 2022, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future amortization expense related to existing finite-lived purchased intangible assets for the remainder of fiscal year 2023 and for each of the next five fiscal years and thereafter is estimated below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:90.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.941%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Estimated future amortization expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RleHRyZWdpb246NTg5M2FjZGJiMjliNGIwNWI1YzdhNGQ5YTY0NTZjOTNfMjg1Mw_4548a5be-f51c-4f39-b20b-4514b1217a04">&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents goodwill balances and the movements for each of our reportable segments during the three months ended January&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.512%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.070%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Life Sciences and Applied Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Diagnostics and Genomics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Agilent CrossLab&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill as of October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation impact&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill arising from acquisitions and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill as of January 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i14749e019f0c4a78a5749fbc0e9602a5_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjFlNGFlMDBmZTg3MDQwOTdhMWU5NjNmYzE5MzNiMmEyL3RhYmxlcmFuZ2U6MWU0YWUwMGZlODcwNDA5N2ExZTk2M2ZjMTkzM2IyYTJfMi0xLTEtMS02ODc1MQ_220fa5e9-25c0-4370-86c3-f450ed705879"
      unitRef="usd">1743000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4c417edb3d704da7925a02009feeff69_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjFlNGFlMDBmZTg3MDQwOTdhMWU5NjNmYzE5MzNiMmEyL3RhYmxlcmFuZ2U6MWU0YWUwMGZlODcwNDA5N2ExZTk2M2ZjMTkzM2IyYTJfMi0zLTEtMS02ODc1MQ_cdc2dcdc-a598-4816-90b1-485e0bff0d20"
      unitRef="usd">1953000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ibdb82786efda42a99e13832f0a499c71_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjFlNGFlMDBmZTg3MDQwOTdhMWU5NjNmYzE5MzNiMmEyL3RhYmxlcmFuZ2U6MWU0YWUwMGZlODcwNDA5N2ExZTk2M2ZjMTkzM2IyYTJfMi01LTEtMS02ODc1MQ_4d4026a2-d070-47e8-a535-acacf2a42bc9"
      unitRef="usd">256000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjFlNGFlMDBmZTg3MDQwOTdhMWU5NjNmYzE5MzNiMmEyL3RhYmxlcmFuZ2U6MWU0YWUwMGZlODcwNDA5N2ExZTk2M2ZjMTkzM2IyYTJfMi03LTEtMS02ODc1MQ_d9017a67-59aa-4091-9a6f-502f19746fbc"
      unitRef="usd">3952000000</us-gaap:Goodwill>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i90bc58b4dc464d058d4f7d56e61e2e21_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjFlNGFlMDBmZTg3MDQwOTdhMWU5NjNmYzE5MzNiMmEyL3RhYmxlcmFuZ2U6MWU0YWUwMGZlODcwNDA5N2ExZTk2M2ZjMTkzM2IyYTJfMy0xLTEtMS02ODc1MQ_c4c7250a-edd3-45c6-9a72-65c253c7d1f7"
      unitRef="usd">12000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i405a137dbfd148ab9797e53157dcb87b_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjFlNGFlMDBmZTg3MDQwOTdhMWU5NjNmYzE5MzNiMmEyL3RhYmxlcmFuZ2U6MWU0YWUwMGZlODcwNDA5N2ExZTk2M2ZjMTkzM2IyYTJfMy0zLTEtMS02ODc1MQ_1c0d6bba-20fc-4726-bfb0-c65eed32060b"
      unitRef="usd">1000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i6d83c1345e874e8fabdab7fd0ec051b6_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjFlNGFlMDBmZTg3MDQwOTdhMWU5NjNmYzE5MzNiMmEyL3RhYmxlcmFuZ2U6MWU0YWUwMGZlODcwNDA5N2ExZTk2M2ZjMTkzM2IyYTJfMy01LTEtMS02ODc1MQ_5f28e64b-f141-4b8c-b3a1-5697c8bfb0d5"
      unitRef="usd">7000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjFlNGFlMDBmZTg3MDQwOTdhMWU5NjNmYzE5MzNiMmEyL3RhYmxlcmFuZ2U6MWU0YWUwMGZlODcwNDA5N2ExZTk2M2ZjMTkzM2IyYTJfMy03LTEtMS02ODc1MQ_72bb07af-4bc6-4c56-a1a2-230285b37bf3"
      unitRef="usd">20000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i90bc58b4dc464d058d4f7d56e61e2e21_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjFlNGFlMDBmZTg3MDQwOTdhMWU5NjNmYzE5MzNiMmEyL3RhYmxlcmFuZ2U6MWU0YWUwMGZlODcwNDA5N2ExZTk2M2ZjMTkzM2IyYTJfNC0xLTEtMS02ODc1MQ_4e7e446e-a3eb-4112-9a3c-b566a1aba9f8"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i405a137dbfd148ab9797e53157dcb87b_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjFlNGFlMDBmZTg3MDQwOTdhMWU5NjNmYzE5MzNiMmEyL3RhYmxlcmFuZ2U6MWU0YWUwMGZlODcwNDA5N2ExZTk2M2ZjMTkzM2IyYTJfNC0zLTEtMS02ODc1MQ_9b22615c-9f75-4002-a7ae-f994ea024a9a"
      unitRef="usd">11000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i6d83c1345e874e8fabdab7fd0ec051b6_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjFlNGFlMDBmZTg3MDQwOTdhMWU5NjNmYzE5MzNiMmEyL3RhYmxlcmFuZ2U6MWU0YWUwMGZlODcwNDA5N2ExZTk2M2ZjMTkzM2IyYTJfNC01LTEtMS02ODc1MQ_40aa4f8d-caa4-4675-985f-14ed0c3086be"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjFlNGFlMDBmZTg3MDQwOTdhMWU5NjNmYzE5MzNiMmEyL3RhYmxlcmFuZ2U6MWU0YWUwMGZlODcwNDA5N2ExZTk2M2ZjMTkzM2IyYTJfNC03LTEtMS02ODc1MQ_a1af71ad-3f88-490b-81a4-c7f346cc238f"
      unitRef="usd">11000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:Goodwill
      contextRef="i9e0c874f1a2f4b52bde701c5d0c5f04a_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjFlNGFlMDBmZTg3MDQwOTdhMWU5NjNmYzE5MzNiMmEyL3RhYmxlcmFuZ2U6MWU0YWUwMGZlODcwNDA5N2ExZTk2M2ZjMTkzM2IyYTJfNS0xLTEtMS02ODc1MQ_005b61fb-8e0a-461a-84fe-198c15361ac4"
      unitRef="usd">1755000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic29288e8bc2e49b7b040c7b53788b074_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjFlNGFlMDBmZTg3MDQwOTdhMWU5NjNmYzE5MzNiMmEyL3RhYmxlcmFuZ2U6MWU0YWUwMGZlODcwNDA5N2ExZTk2M2ZjMTkzM2IyYTJfNS0zLTEtMS02ODc1MQ_6c033982-8310-49b2-b3e0-d2092c1d0642"
      unitRef="usd">1965000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i39cb63aace124a70b0cf20f2781b5388_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjFlNGFlMDBmZTg3MDQwOTdhMWU5NjNmYzE5MzNiMmEyL3RhYmxlcmFuZ2U6MWU0YWUwMGZlODcwNDA5N2ExZTk2M2ZjMTkzM2IyYTJfNS01LTEtMS02ODc1MQ_5010bcdf-59ca-47ac-af22-5fe0ff9fe924"
      unitRef="usd">263000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjFlNGFlMDBmZTg3MDQwOTdhMWU5NjNmYzE5MzNiMmEyL3RhYmxlcmFuZ2U6MWU0YWUwMGZlODcwNDA5N2ExZTk2M2ZjMTkzM2IyYTJfNS03LTEtMS02ODc1MQ_03b55f7a-aba5-4fba-906f-63ba0cf3c377"
      unitRef="usd">3983000000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RleHRyZWdpb246NTg5M2FjZGJiMjliNGIwNWI1YzdhNGQ5YTY0NTZjOTNfMjg0OQ_f3a389ed-80ab-4c05-b9f1-050481df2cd4">&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The component parts of other intangible assets as of January&#160;31, 2023 and October&#160;31, 2022 are shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&#160;Intangible&#160;Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&#160;Book&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased technology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademark/Tradename&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Third-party technology and licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-Process R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of January 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased technology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademark/Tradename&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Third-party technology and licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-Process R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8aff20c1669045879c48618f094be7f4_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfNC0xLTEtMS02ODc1MQ_88844eba-d57b-4fe7-bde6-b769ddf747e0"
      unitRef="usd">1733000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8aff20c1669045879c48618f094be7f4_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfNC0zLTEtMS02ODc1MQ_68391552-848a-4299-acca-fed57ec913c1"
      unitRef="usd">1068000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i8aff20c1669045879c48618f094be7f4_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfNC01LTEtMS02ODc1MQ_fc05b3b0-92bd-4f3c-9288-6a75b317ccd4"
      unitRef="usd">665000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i78c9af0b8c6542c9804e6ef220ea2418_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfNS0xLTEtMS02ODc1MQ_f1013f5f-b7d8-4f00-90df-1b802885531d"
      unitRef="usd">196000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i78c9af0b8c6542c9804e6ef220ea2418_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfNS0zLTEtMS02ODc1MQ_4eb047cc-bf11-4452-bb4f-8702cae0c92e"
      unitRef="usd">148000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i78c9af0b8c6542c9804e6ef220ea2418_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfNS01LTEtMS02ODc1MQ_bb6324a3-a5c0-4278-9fa5-d6a09b19318e"
      unitRef="usd">48000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie41bd8ebbf7b4eb68a78111db1b20475_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfNi0xLTEtMS02ODc1MQ_3d535d36-f454-4947-893a-de16b71ea2c1"
      unitRef="usd">180000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie41bd8ebbf7b4eb68a78111db1b20475_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfNi0zLTEtMS02ODc1MQ_bf0ccd17-dc7d-4d7e-9b89-67a68a984409"
      unitRef="usd">105000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ie41bd8ebbf7b4eb68a78111db1b20475_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfNi01LTEtMS02ODc1MQ_b3d0dca8-cdf3-4f11-a206-d2239ffa7584"
      unitRef="usd">75000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib3aadc25089b4d77a8b3cba419d06996_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfNy0xLTEtMS02ODc1MQ_0dd3a8e2-5df0-4f97-9d3b-38f79637767d"
      unitRef="usd">8000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib3aadc25089b4d77a8b3cba419d06996_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfNy0zLTEtMS02ODc1MQ_dd6a5b25-ff7a-4965-9f1f-45cc31e6cfe2"
      unitRef="usd">8000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ib3aadc25089b4d77a8b3cba419d06996_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfNy01LTEtMS02ODc1MQ_8ba29057-fdd5-4aed-864b-e0b0fbc0356d"
      unitRef="usd">0</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia533acfa2c5343c2a822b9e8c8ada803_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfOC0xLTEtMS02ODc1MQ_daac5168-5ac2-40fe-af5b-13b113d75894"
      unitRef="usd">32000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia533acfa2c5343c2a822b9e8c8ada803_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfOC0zLTEtMS02ODc1MQ_5ca8d238-ed2f-42f0-9140-7892dd5e72cb"
      unitRef="usd">9000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ia533acfa2c5343c2a822b9e8c8ada803_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfOC01LTEtMS02ODc1MQ_6177b902-60d4-4eeb-aa98-303526e2c556"
      unitRef="usd">23000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfOS0xLTEtMS02ODc1MQ_188784b5-2566-4666-8eb4-0e4643a75078"
      unitRef="usd">2149000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfOS0zLTEtMS02ODc1MQ_ef7053a2-fe02-4081-8bf9-84303301d2a2"
      unitRef="usd">1338000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfOS01LTEtMS02ODc1MQ_2d35d61b-f98d-4901-907b-c078213c3b72"
      unitRef="usd">811000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="if6f781359e43434dbbae2d8573466196_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTAtMS0xLTEtNjg3NTE_0ff7d37d-02d4-442a-b6c9-2e3a4316332f"
      unitRef="usd">10000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="if6f781359e43434dbbae2d8573466196_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTAtNS0xLTEtNjg3NTE_38ab3e8a-be40-4ebc-b63c-d187d8896e4e"
      unitRef="usd">10000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTEtMS0xLTEtNjg3NTE_8240c05a-4829-4625-833d-5b5cbeeef911"
      unitRef="usd">2159000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTEtMy0xLTEtNjg3NTE_584db2dc-3bd9-4a77-84d3-48b1f15957f7"
      unitRef="usd">1338000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTEtNS0xLTEtNjg3NTE_6b614a80-0d86-4224-b3c0-76aae476f54e"
      unitRef="usd">821000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iaecdfae8339144e08ca120f755566194_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTMtMS0xLTEtNjg3NTE_5d560e14-2a5a-4eeb-9656-83418b6005b8"
      unitRef="usd">1761000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iaecdfae8339144e08ca120f755566194_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTMtMy0xLTEtNjg3NTE_f9bd8faa-eb41-4384-a0dc-17bf54c6267d"
      unitRef="usd">1096000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iaecdfae8339144e08ca120f755566194_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTMtNS0xLTEtNjg3NTE_ba798977-a854-4f0d-adbe-c3b2c21d64a9"
      unitRef="usd">665000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if38c838bd72546ecb1b03552dfe899cf_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTQtMS0xLTEtNjg3NTE_0d33ed08-eea0-4177-8774-b9bdaade2b10"
      unitRef="usd">196000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if38c838bd72546ecb1b03552dfe899cf_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTQtMy0xLTEtNjg3NTE_a367ab5f-201f-4873-8253-1fcd0c0367ff"
      unitRef="usd">152000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="if38c838bd72546ecb1b03552dfe899cf_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTQtNS0xLTEtNjg3NTE_d8fa1e09-0a84-41ab-ae6f-23e630fbaac0"
      unitRef="usd">44000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8d9e00fde0b04942843ffcf15477e77f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTUtMS0xLTEtNjg3NTE_2c8cbc05-2646-49c5-8684-2976a0764899"
      unitRef="usd">181000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8d9e00fde0b04942843ffcf15477e77f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTUtMy0xLTEtNjg3NTE_45d1020a-9886-4f10-915d-3b88666b6ef1"
      unitRef="usd">113000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i8d9e00fde0b04942843ffcf15477e77f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTUtNS0xLTEtNjg3NTE_ccef5634-eea1-416d-8f8e-887a43439d22"
      unitRef="usd">68000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic775993ecc604246b97b951a0ebb69f7_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTYtMS0xLTEtNjg3NTE_553585bd-8a96-4958-9321-49dd304d5fc1"
      unitRef="usd">8000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic775993ecc604246b97b951a0ebb69f7_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTYtMy0xLTEtNjg3NTE_a0db7e3e-f74f-4d91-bcdd-500a882b5cba"
      unitRef="usd">8000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic775993ecc604246b97b951a0ebb69f7_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTYtNS0xLTEtNjg3NTE_1437aeaa-ac65-4265-b260-1afdd445f0c4"
      unitRef="usd">0</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i20a5d3b2a23247998eeb29965ed5cdec_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTctMS0xLTEtNjg3NTE_d3cc7fc8-a78e-40cf-bdec-98d90adfd189"
      unitRef="usd">33000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i20a5d3b2a23247998eeb29965ed5cdec_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTctMy0xLTEtNjg3NTE_23e3067f-b2c5-429a-827d-100c0b20eb1b"
      unitRef="usd">10000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i20a5d3b2a23247998eeb29965ed5cdec_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTctNS0xLTEtNjg3NTE_a320623f-d3b3-4670-b9ca-bedf58726a0a"
      unitRef="usd">23000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTgtMS0xLTEtNjg3NTE_873faad6-bcde-4e93-8835-740319ae159e"
      unitRef="usd">2179000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTgtMy0xLTEtNjg3NTE_2c6f5e79-937e-43cf-8218-34b46c96b110"
      unitRef="usd">1379000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTgtNS0xLTEtNjg3NTE_cd7f617a-fd64-4115-86c2-64a4772889cd"
      unitRef="usd">800000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="id63c0b222b0f4e9591e1e1ec87de74b7_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTktMS0xLTEtNjg3NTE_5b157b67-f8c6-4dd4-96a4-2dab719eb3ae"
      unitRef="usd">10000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="id63c0b222b0f4e9591e1e1ec87de74b7_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMTktNS0xLTEtNjg3NTE_9a48714c-8fcc-4f41-b49a-2d588dc0baed"
      unitRef="usd">10000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMjAtMS0xLTEtNjg3NTE_633f0a18-9331-49ab-ac2d-e32e80916a80"
      unitRef="usd">2189000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMjAtMy0xLTEtNjg3NTE_7074bbfe-ecdc-4a6e-be8f-b36263701f64"
      unitRef="usd">1379000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjdkN2NhMDYwODAzZjRlMDY5OWVjYTZlYTBjMmMxNjU4L3RhYmxlcmFuZ2U6N2Q3Y2EwNjA4MDNmNGUwNjk5ZWNhNmVhMGMyYzE2NThfMjAtNS0xLTEtNjg3NTE_0c1013c6-1f91-4663-8d8b-e8358d0e3db0"
      unitRef="usd">810000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RleHRyZWdpb246NTg5M2FjZGJiMjliNGIwNWI1YzdhNGQ5YTY0NTZjOTNfMjE5OTAyMzI2MDM5NQ_415b3961-d4d8-4f8e-984e-3c1c0aebc7ea"
      unitRef="usd">11000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RleHRyZWdpb246NTg5M2FjZGJiMjliNGIwNWI1YzdhNGQ5YTY0NTZjOTNfMTcwOA_4a1c64eb-564f-42c9-b3f9-a5a0966fedc1"
      unitRef="usd">23000000</us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease>
    <us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RleHRyZWdpb246NTg5M2FjZGJiMjliNGIwNWI1YzdhNGQ5YTY0NTZjOTNfMTg4OA_5ab20a56-e944-4efc-afcb-5a450f4184b7"
      unitRef="usd">2000000</us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RleHRyZWdpb246NTg5M2FjZGJiMjliNGIwNWI1YzdhNGQ5YTY0NTZjOTNfMjMwMg_795d6d73-2b96-4a28-a51e-ff4dcac1f4c4"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RleHRyZWdpb246NTg5M2FjZGJiMjliNGIwNWI1YzdhNGQ5YTY0NTZjOTNfMjMwMg_826cb311-5bf2-4abb-9075-080d0964d9e8"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RleHRyZWdpb246NTg5M2FjZGJiMjliNGIwNWI1YzdhNGQ5YTY0NTZjOTNfMjMwMg_9974c00b-3a92-43ce-9ac4-1d140f9abf51"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RleHRyZWdpb246NTg5M2FjZGJiMjliNGIwNWI1YzdhNGQ5YTY0NTZjOTNfMjMwMg_e4e9c7ff-fa30-4f96-a62a-3f9126ec470f"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RleHRyZWdpb246NTg5M2FjZGJiMjliNGIwNWI1YzdhNGQ5YTY0NTZjOTNfMjQ5NQ_98ec33f0-9300-4556-8928-dfd9c81abeab"
      unitRef="usd">36000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RleHRyZWdpb246NTg5M2FjZGJiMjliNGIwNWI1YzdhNGQ5YTY0NTZjOTNfMjU5Mw_28b945c0-a889-40b9-8854-78b8ed2eccbc"
      unitRef="usd">51000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RleHRyZWdpb246NTg5M2FjZGJiMjliNGIwNWI1YzdhNGQ5YTY0NTZjOTNfMjg2Mg_c7977ce2-d0dc-48e6-bba4-8131b4314246">&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future amortization expense related to existing finite-lived purchased intangible assets for the remainder of fiscal year 2023 and for each of the next five fiscal years and thereafter is estimated below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:90.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.941%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Estimated future amortization expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjM3YTkyOWQ3MmNkNDQxMzBiNjg5MjVlMWIwMGQ3ODE0L3RhYmxlcmFuZ2U6MzdhOTI5ZDcyY2Q0NDEzMGI2ODkyNWUxYjAwZDc4MTRfMi0xLTEtMS02ODc1MQ_c6e2de66-6792-48c2-8015-783f8e396b61"
      unitRef="usd">109000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjM3YTkyOWQ3MmNkNDQxMzBiNjg5MjVlMWIwMGQ3ODE0L3RhYmxlcmFuZ2U6MzdhOTI5ZDcyY2Q0NDEzMGI2ODkyNWUxYjAwZDc4MTRfMy0xLTEtMS02ODc1MQ_07e3e3df-cba3-4197-84af-d6f265f1c57b"
      unitRef="usd">129000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjM3YTkyOWQ3MmNkNDQxMzBiNjg5MjVlMWIwMGQ3ODE0L3RhYmxlcmFuZ2U6MzdhOTI5ZDcyY2Q0NDEzMGI2ODkyNWUxYjAwZDc4MTRfNC0xLTEtMS02ODc1MQ_db41c779-569a-4e97-98dd-7ed0b2e19e10"
      unitRef="usd">104000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjM3YTkyOWQ3MmNkNDQxMzBiNjg5MjVlMWIwMGQ3ODE0L3RhYmxlcmFuZ2U6MzdhOTI5ZDcyY2Q0NDEzMGI2ODkyNWUxYjAwZDc4MTRfNS0xLTEtMS02ODc1MQ_3497a34a-c1f0-4504-8f0c-824f4f3fad38"
      unitRef="usd">75000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjM3YTkyOWQ3MmNkNDQxMzBiNjg5MjVlMWIwMGQ3ODE0L3RhYmxlcmFuZ2U6MzdhOTI5ZDcyY2Q0NDEzMGI2ODkyNWUxYjAwZDc4MTRfNi0xLTEtMS02ODc1MQ_b29bd7c7-5ad7-43c1-8ee3-728334daeb3a"
      unitRef="usd">73000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjM3YTkyOWQ3MmNkNDQxMzBiNjg5MjVlMWIwMGQ3ODE0L3RhYmxlcmFuZ2U6MzdhOTI5ZDcyY2Q0NDEzMGI2ODkyNWUxYjAwZDc4MTRfNy0xLTEtMS02ODc1MQ_d5818ab3-6fcb-41e5-97ff-52519a93304a"
      unitRef="usd">67000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181NS9mcmFnOjU4OTNhY2RiYjI5YjRiMDViNWM3YTRkOWE2NDU2YzkzL3RhYmxlOjM3YTkyOWQ3MmNkNDQxMzBiNjg5MjVlMWIwMGQ3ODE0L3RhYmxlcmFuZ2U6MzdhOTI5ZDcyY2Q0NDEzMGI2ODkyNWUxYjAwZDc4MTRfOC0xLTEtMS02ODc1MQ_b3c94576-89bd-4398-84f4-3388adaf7bd2"
      unitRef="usd">243000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfODI0Ng_ccb8bd80-a241-43d3-b6b6-97135fde17e6">FAIR VALUE MEASUREMENTS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The authoritative guidance defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, we consider the principal or most advantageous market and assumptions that market participants would use when pricing the asset or liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:2.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Hierarchy&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The guidance establishes a fair value hierarchy that prioritizes the use of inputs used in valuation techniques into three levels. A financial instrument&#x2019;s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. There are three levels of inputs that may be used to measure fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;- applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;- applies to assets or liabilities for which there are inputs other than quoted prices included within level 1 that are observable, either directly or indirectly, for the asset or liability such as: quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in less active markets; or other inputs that can be derived principally from, or corroborated by, observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;- applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities measured at fair value on a recurring basis as of January&#160;31, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurement at January 31, 2023 Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;in&#160;Active&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Markets&#160;for&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Identical&#160;Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Observable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Inputs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Inputs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents (money market funds)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments (foreign exchange contracts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments (foreign exchange contracts) &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities measured at fair value on a recurring basis as of October&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurement at October 31, 2022 Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;in&#160;Active&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Markets&#160;for&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Identical&#160;Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Observable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Inputs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Inputs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents (money market funds)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments (foreign exchange contracts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments (foreign exchange contracts)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our money market funds and trading securities are generally valued using quoted market prices and therefore are classified within level&#160;1 of the fair value hierarchy. Our derivative financial instruments are classified within level 2, as there is not an active market for each hedge contract, but the inputs used to calculate the value of the instruments are tied to active &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;markets.  Our deferred compensation liability is classified as level&#160;2 because, although the values are not directly based on quoted market prices, the inputs used in the calculations are observable. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other investments represent shares we own in a special fund that targets underlying investments of approximately 40 percent in debt securities and 60 percent in equity securities. These shares have been classified as level 2 because, although the shares of the fund are not traded on any active stock exchange, each of the individual underlying securities are or can be derived from and hence we have a readily determinable value for the underlying securities, from which we are able to determine the fair market value for the special fund itself. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trading securities, which are comprised of mutual funds, bonds and other similar instruments, other investments and deferred compensation liability are reported at fair value, with gains or losses resulting from changes in fair value recognized currently in net income. Certain derivative instruments are reported at fair value, with unrealized gains and losses, net of tax, included in accumulated other comprehensive income (loss) within stockholders' equity. Realized gains and losses from the sale of these instruments are recorded in net income.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains and losses reflected in other income (expense), net for our equity investments with readily determinable fair value ("RDFV") and equity investments without RDFV are summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss recognized during the period on equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Net loss on equity securities sold during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized (gain) loss on equity securities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingent Consideration.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The fair value of the contingent consideration liability relates to milestone payments in connection with the acquisition of advanced artificial intelligence technology in February 2022 and the acquisition of Resolution Bioscience in April 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Resolution Bioscience&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The fair value of the potential future milestone payments, which is set to certain revenue and technical targets, was based on (i) the probability of achieving the relevant revenue targets and technical milestones and (ii) the timing of achieving such milestones, which are significant unobservable inputs, and has been classified as Level 3. We used the Monte Carlo simulation approach to estimate the fair value of the revenue component which resulted in a fair value of zero. A change in any of these unobservable inputs can significantly change the fair value of the contingent consideration. As of January&#160;31, 2023, the expected maximum earn-out period for the contingent payments does not exceed 1.9 years and potential future payments will not exceed $80&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The contingent consideration liability is our only recurring Level 3 asset or liability.  A summary of the Level 3 activity follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions to contingent consideration (including measurement period adjustment)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value (included within selling, general and administrative expenses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the contingent consideration liability as of January&#160;31, 2023, was estimated to be $3 million of which $2 million was recorded in other accrued liabilities and $1 million was recorded in other long-term liabilities on the condensed consolidated balance sheet. During the three months ended January&#160;31, 2023, we made a contingent consideration payment of $65&#160;million related to the achievement of a certain technical milestone associated with our acquisition of Resolution Bioscience.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Impairment of Investments.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; There were no impairments of investments for the three months ended January&#160;31, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended January&#160;31, 2023 and 2022 , there were no impairments of long-lived assets held and used or long-lived assets held for sale. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Non-Marketable Equity Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended January&#160;31, 2023 and 2022, there were no impairments or unrealized gain (loss) adjustments to the carrying value of non-marketable securities without readily determinable fair value based on an observable market transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of January&#160;31, 2023, the cumulative net gain (loss) on our non-marketable equity securities without readily determinable fair values was comprised of a $35&#160;million gain and no losses, and the carrying amount was $126&#160;million. As of January&#160;31, 2022, the cumulative net gain (loss) on our non-marketable equity securities without readily determinable fair values was comprised of a $30&#160;million gain and no losses, and the carrying amount was $125&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair values for the non-marketable securities included in long-term investments on the condensed consolidated balance sheet were measured using Level 3 inputs because they are primarily equity stock issued by private companies without quoted market prices. To estimate the fair value of our non-marketable securities, we use the measurement alternative to record these investments at cost and adjust for impairments and observable price changes (orderly transactions for the identical or a similar security from the same issuer) as and when they occur.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfODI0OA_d0fa77ad-cd8d-46b9-b1bd-d5312b42248c">&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities measured at fair value on a recurring basis as of January&#160;31, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurement at January 31, 2023 Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;in&#160;Active&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Markets&#160;for&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Identical&#160;Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Observable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Inputs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Inputs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents (money market funds)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments (foreign exchange contracts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments (foreign exchange contracts) &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities measured at fair value on a recurring basis as of October&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurement at October 31, 2022 Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;in&#160;Active&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Markets&#160;for&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Identical&#160;Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Observable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Inputs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Inputs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Level&#160;3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents (money market funds)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments (foreign exchange contracts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments (foreign exchange contracts)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i437d3b6251fa4606a05df57d58d3c73c_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfNS0xLTEtMS02ODc1MQ_cb5c15ad-8ee8-4b39-b338-bc42a94373d9"
      unitRef="usd">652000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i6f3778491b9842b0b3c469f4bf304247_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfNS0zLTEtMS02ODc1MQ_cfab7357-b2f1-4074-9e7e-5b91ec9283e1"
      unitRef="usd">652000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i771947e8e65142a1a1ce68ffba8ff0b3_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfNS01LTEtMS02ODc1MQ_386c67fc-9803-401a-b3db-43ad41d793e5"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i3b2eea0376824cb7ae764ad375383f52_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfNS03LTEtMS02ODc1MQ_ad0bdbb3-4206-4591-82ca-e050a3bb03a2"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i437d3b6251fa4606a05df57d58d3c73c_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfNi0xLTEtMS02ODc1MQ_e617f50d-2aca-430f-9efa-9bdca3a77fcc"
      unitRef="usd">8000000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i6f3778491b9842b0b3c469f4bf304247_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfNi0zLTEtMS02ODc1MQ_3d4bca4d-f017-4d7d-9956-e8f08e89bb77"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i771947e8e65142a1a1ce68ffba8ff0b3_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfNi01LTEtMS02ODc1MQ_01ad7117-ae55-4299-be97-6cc0ecf6d7cf"
      unitRef="usd">8000000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i3b2eea0376824cb7ae764ad375383f52_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfNi03LTEtMS02ODc1MQ_be282a31-d7b0-450a-9134-f7dc2206e5e2"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:TradingSecurities
      contextRef="i171aadf8a79b4a8faa50f9b31b327f84_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfOS0xLTEtMS02ODc1MQ_00cc1042-fa59-4657-8c2f-9ef8b02f5c2b"
      unitRef="usd">36000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="ia1682ba3d772453aaed03af1031bb843_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfOS0zLTEtMS02ODc1MQ_ffa0fcac-79f7-44c5-8ff8-399e2e1e4a5f"
      unitRef="usd">36000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i109ec2cab42849fbbaba1a368387a380_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfOS01LTEtMS02ODc1MQ_a3e6e54d-7bfe-42a9-8254-355119dc2d23"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i010b31c6afda45549d3eba9b0bb42875_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfOS03LTEtMS02ODc1MQ_eca523b7-8291-446d-b256-e92b442fec98"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i171aadf8a79b4a8faa50f9b31b327f84_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTAtMS0xLTEtNjg3NTE_c0b255fc-99ed-426a-98cc-3b297ec888ba"
      unitRef="usd">27000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ia1682ba3d772453aaed03af1031bb843_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTAtMy0xLTEtNjg3NTE_07490c7a-aae1-4178-bfe6-ea78be215aa7"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i109ec2cab42849fbbaba1a368387a380_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTAtNS0xLTEtNjg3NTE_b9fa34e8-f6c5-49a0-896b-d9f96a02224b"
      unitRef="usd">27000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i010b31c6afda45549d3eba9b0bb42875_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTAtNy0xLTEtNjg3NTE_1b84a55d-3b9c-4be3-83b1-9068f17534da"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ibaaa0ef2c25948abb1a1d1b853e18ed6_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTItMS0xLTEtNjg3NTE_990c6835-ceac-45dc-9295-79fcff436f17"
      unitRef="usd">723000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ie7ced5b567134408b99ecb1dcf4ae051_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTItMy0xLTEtNjg3NTE_6c2c1991-70c7-46f6-b8ad-e3ddfeb90824"
      unitRef="usd">688000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic76a06664a9c458885914a4582301f23_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTItNS0xLTEtNjg3NTE_75a7c671-78aa-4169-b34b-0447c8771307"
      unitRef="usd">35000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib0a5d971f1eb44de8d7f86aad8db9e29_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTItNy0xLTEtNjg3NTE_9e216aa4-c7f3-4cdf-92c2-3ce0769da7dc"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i82e671a18849495b8fb217e22b89ec5e_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTUtMS0xLTEtNjg3NTE_bfe6b0fd-9e38-44c8-9c9b-32605b641775"
      unitRef="usd">28000000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i3bb56a780b484db596a8537265a00ae7_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTUtMy0xLTEtNjg3NTE_522810f8-5828-44d9-8b5f-f2a8824d8896"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i75a58a1a2e104511a28697e212909d94_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTUtNS0xLTEtNjg3NTE_b98656d5-e787-48ae-9178-606e62f6206f"
      unitRef="usd">28000000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i520e8d9623a54c38ad726102ce099ef0_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTUtNy0xLTEtNjg3NTE_44d503f3-9b82-442d-b98a-e01190bfe06a"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i82e671a18849495b8fb217e22b89ec5e_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTYtMS0xLTEtNjg3NTE_b91b7740-b723-4ea8-9559-ceb6c8647b26"
      unitRef="usd">2000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i3bb56a780b484db596a8537265a00ae7_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTYtMy0xLTEtNjg3NTE_87a38941-c1d1-4502-a6cd-cbda230fc68a"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i75a58a1a2e104511a28697e212909d94_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTYtNS0xLTEtNjg3NTE_3b9b3721-1ebc-4777-82e7-a7cab4f2adca"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i5b44dbcd02a9484b8ddc79b3a7fab6d0_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTYtNy0xLTEtNjg3NTE_d713423d-1fb1-47e0-94c1-be727dea7db4"
      unitRef="usd">2000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="ia0bae153c6ff4111936aa0ad12293d37_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTgtMS0xLTEtNjg3NTE_4e3af26a-44f7-41dc-bf13-75175c95337a"
      unitRef="usd">36000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="id6ceec45342244868b46e5292ec40d82_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTgtMy0xLTEtNjg3NTE_8124fb4a-fe8a-4923-b8ab-f5a8da97a335"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i6a2fd80baf9f425780781f01120bc35f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTgtNS0xLTEtNjg3NTE_88db8f2a-6e2a-447a-aedd-44964e5863fa"
      unitRef="usd">36000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i26efb771671d46d386db8ba65c21d53e_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTgtNy0xLTEtNjg3NTE_2af9fdd8-0d77-4981-9593-c8886a1f93fe"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ia0bae153c6ff4111936aa0ad12293d37_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTktMS0xLTEtNjg3NTE_f21c05bd-77f7-4b19-aa39-14b51d55f776"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="id6ceec45342244868b46e5292ec40d82_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTktMy0xLTEtNjg3NTE_daae4483-bce8-4066-a8b3-1ae484f59f0c"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i6a2fd80baf9f425780781f01120bc35f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTktNS0xLTEtNjg3NTE_e352c083-822e-406c-bbf8-7c42ec82024b"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i3a38492613ee42308d5ca58cb82e54ef_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMTktNy0xLTEtNjg3NTE_88415547-fc07-479c-8ffd-14c71f619713"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ibaaa0ef2c25948abb1a1d1b853e18ed6_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMjAtMS0xLTEtNjg3NTE_538b137d-f450-4179-8160-816c2a86ecf4"
      unitRef="usd">67000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ie7ced5b567134408b99ecb1dcf4ae051_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMjAtMy0xLTEtNjg3NTE_b4f93799-983b-42e7-a5eb-38c5cbb71238"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ic76a06664a9c458885914a4582301f23_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMjAtNS0xLTEtNjg3NTE_2c040d1a-3454-45c8-8fcc-3a6f0ff643ec"
      unitRef="usd">64000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ib0a5d971f1eb44de8d7f86aad8db9e29_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjgzZGIwMWE0OTJkMDQ2YzY5MWY3ODhkNzAxZjg4YWZhL3RhYmxlcmFuZ2U6ODNkYjAxYTQ5MmQwNDZjNjkxZjc4OGQ3MDFmODhhZmFfMjAtNy0xLTEtNjg3NTE_bee0256b-120c-4788-9109-9ea1d33f24b8"
      unitRef="usd">3000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ia8a78ace67c24152ae9bf94ef8fff79d_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfNS0xLTEtMS02ODc1MQ_998d5128-bdd1-41f1-9353-30673179b466"
      unitRef="usd">492000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i3c10ebdbbadb4b66aa09bafa9c10e706_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfNS0zLTEtMS02ODc1MQ_8a8db8bc-e4a0-411e-b99c-51082a937c6f"
      unitRef="usd">492000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i1e5a6aeaf4184c46acacaeb8daab5f0e_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfNS01LTEtMS02ODc1MQ_c90e7b61-22a7-4a65-9464-c9d8c7e9bcfc"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="icd7fc31a934145e0b639ded81bd2a4d4_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfNS03LTEtMS02ODc1MQ_e64fafc4-f1d9-4946-bb49-83a55dc02bc9"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ia8a78ace67c24152ae9bf94ef8fff79d_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfNi0xLTEtMS02ODc1MQ_fc0f06eb-dd9f-4eaf-9d33-88d737d563c7"
      unitRef="usd">31000000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i3c10ebdbbadb4b66aa09bafa9c10e706_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfNi0zLTEtMS02ODc1MQ_76259344-5ed5-43c3-af35-f37244736b7e"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i1e5a6aeaf4184c46acacaeb8daab5f0e_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfNi01LTEtMS02ODc1MQ_18edb8c0-35d2-4341-be2f-262ebc4490ac"
      unitRef="usd">31000000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="icd7fc31a934145e0b639ded81bd2a4d4_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfNi03LTEtMS02ODc1MQ_d0fbea8b-45fb-4426-9431-3ae014c803d1"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:TradingSecurities
      contextRef="i7721625bbc374f08999fc25fad1ac438_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfOS0xLTEtMS02ODc1MQ_e1bc69ed-fad9-4ac2-9b4f-5d4bdfb7bdbe"
      unitRef="usd">31000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i3d7c15a459fa45b195a04ab621f88594_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfOS0zLTEtMS02ODc1MQ_85777412-8705-48ee-9372-0ead162faac4"
      unitRef="usd">31000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i02170c8657d54b96b0528a195ed9a6cd_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfOS01LTEtMS02ODc1MQ_24ec68d5-ed33-46b5-bd72-40805fe65a68"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i281883c980b344c399e2833cbe9f3289_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfOS03LTEtMS02ODc1MQ_c05d0c28-ea79-45c4-ae7e-9009245a128a"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i7721625bbc374f08999fc25fad1ac438_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTAtMS0xLTEtNjg3NTE_5a725580-ee25-4a9a-b3c1-4bcf218da54b"
      unitRef="usd">23000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i3d7c15a459fa45b195a04ab621f88594_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTAtMy0xLTEtNjg3NTE_4efebe19-964b-4751-b7cb-b71d56d83854"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i02170c8657d54b96b0528a195ed9a6cd_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTAtNS0xLTEtNjg3NTE_0b98e729-abd1-4e55-a8d3-88929ab0df95"
      unitRef="usd">23000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i281883c980b344c399e2833cbe9f3289_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTAtNy0xLTEtNjg3NTE_2156799c-5691-4d39-979c-922a9a7e35bf"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ibeffa87382834b81853275826f27932c_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTEtMS0xLTEtNjg3NTE_0d48aeac-becf-4314-9d06-1b961965e6fa"
      unitRef="usd">577000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ie9dec0e06e6d42a3a1fc2593ab243f89_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTEtMy0xLTEtNjg3NTE_58fd0f3a-557b-4e18-b648-7f67ca26ac58"
      unitRef="usd">523000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i3c48d568a480440bbe49a9dd5591a169_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTEtNS0xLTEtNjg3NTE_245aa663-eaaa-46bc-b419-c1a44c271123"
      unitRef="usd">54000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5163f85023154e9ab98ef3ed85fa7d48_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTEtNy0xLTEtNjg3NTE_6aa6d1b7-9b86-4e00-b6e8-bd47bfa00fce"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i1c579659bdb34d54a78c87a9d2a18b6d_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTQtMS0xLTEtNjg3NTE_f5722a82-22b1-41d8-ae8d-f9b3595e9feb"
      unitRef="usd">5000000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="id54402bbdc8b44b3b749044437d33713_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTQtMy0xLTEtNjg3NTE_4526251d-edbd-4f95-a331-41b0ab751be0"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i1ec93e8012ad48e49930d3765f4c1246_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTQtNS0xLTEtNjg3NTE_dd823ea1-3fe6-4a54-866f-bf4e00378c19"
      unitRef="usd">5000000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i4c8f6a78e1ad4a9396e91d5d4207fb18_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTQtNy0xLTEtNjg3NTE_38fb1706-5316-4679-b276-d75262271ca9"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i1c579659bdb34d54a78c87a9d2a18b6d_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTUtMS0xLTEtNjg3NTE_32772517-39a2-4b02-a81e-1648d94c274e"
      unitRef="usd">66000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="id54402bbdc8b44b3b749044437d33713_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTUtMy0xLTEtNjg3NTE_767607f3-999f-4a26-9add-940ba47904e3"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i1ec93e8012ad48e49930d3765f4c1246_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTUtNS0xLTEtNjg3NTE_13923686-76c9-45f3-abb4-f87994818c19"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ia7281c10e5fb4984b926202c8a6449b4_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTUtNy0xLTEtNjg3NTE_b94414f1-4f9c-49f5-a12c-be008e03fea3"
      unitRef="usd">66000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i1b9a47671ca446ada8a588e63d75db26_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTctMS0xLTEtNjg3NTE_1f7d6f22-6c34-4048-a510-fcba233a7334"
      unitRef="usd">31000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="ie6200f5bde164b3aacc0816f6518870b_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTctMy0xLTEtNjg3NTE_829e5282-5496-4812-8441-f2a0980de062"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i58623f61e4ac46a6a1223beba978e707_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTctNS0xLTEtNjg3NTE_725c71ca-cbbf-4272-bd3c-9f730775a9bb"
      unitRef="usd">31000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i8b98c020f64f40bca09058f4ab716c9c_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTctNy0xLTEtNjg3NTE_6bfe2267-4f6a-4262-a216-40af80c2550d"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i1b9a47671ca446ada8a588e63d75db26_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTgtMS0xLTEtNjg3NTE_6c5a075b-c77f-49f2-80c3-3574bf82f637"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ie6200f5bde164b3aacc0816f6518870b_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTgtMy0xLTEtNjg3NTE_c965a86b-cb1c-4ec3-9a0e-f2f59306559e"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i58623f61e4ac46a6a1223beba978e707_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTgtNS0xLTEtNjg3NTE_1116a077-d6fa-439d-833d-bb44bcc5d9db"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ibef8720eccc140e49ee2951305a773c9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTgtNy0xLTEtNjg3NTE_d07431a4-73c1-4585-82de-69c26ae0048a"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ibeffa87382834b81853275826f27932c_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTktMS0xLTEtNjg3NTE_135d99af-d8a3-4ef7-a94b-0d4b92b4efe3"
      unitRef="usd">103000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ie9dec0e06e6d42a3a1fc2593ab243f89_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTktMy0xLTEtNjg3NTE_898bb00b-beb7-49b7-baab-4b380251575c"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i3c48d568a480440bbe49a9dd5591a169_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTktNS0xLTEtNjg3NTE_d0d9b35a-acf5-4ee2-8848-d01d1f1abe9f"
      unitRef="usd">36000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i5163f85023154e9ab98ef3ed85fa7d48_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOjhjN2VmODBiZTJiNjQxZTE5MmMwODlkMmZiZTYwYjNhL3RhYmxlcmFuZ2U6OGM3ZWY4MGJlMmI2NDFlMTkyYzA4OWQyZmJlNjBiM2FfMTktNy0xLTEtNjg3NTE_e830dcc9-1513-444b-8c78-2a865e732543"
      unitRef="usd">67000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:GainLossOnInvestmentsTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfODIzMw_ceab05a6-1f1b-4f4f-9aed-a0e42cb6c475">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains and losses reflected in other income (expense), net for our equity investments with readily determinable fair value ("RDFV") and equity investments without RDFV are summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss recognized during the period on equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Net loss on equity securities sold during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized (gain) loss on equity securities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GainLossOnInvestmentsTextBlock>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOmQzNjAzYTYzYTNkODQ4NGM5ODI3NGMwMjI3ZTdiMDdiL3RhYmxlcmFuZ2U6ZDM2MDNhNjNhM2Q4NDg0Yzk4Mjc0YzAyMjdlN2IwN2JfNS01LTEtMS02ODc1MQ_44d5ebc2-9fe5-4b71-a1f6-335ab7e96f57"
      unitRef="usd">-10000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOmQzNjAzYTYzYTNkODQ4NGM5ODI3NGMwMjI3ZTdiMDdiL3RhYmxlcmFuZ2U6ZDM2MDNhNjNhM2Q4NDg0Yzk4Mjc0YzAyMjdlN2IwN2JfNS03LTEtMS02ODc1MQ_7ee79f0f-95fc-44b5-bbf7-fd4be04f9950"
      unitRef="usd">-47000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOmQzNjAzYTYzYTNkODQ4NGM5ODI3NGMwMjI3ZTdiMDdiL3RhYmxlcmFuZ2U6ZDM2MDNhNjNhM2Q4NDg0Yzk4Mjc0YzAyMjdlN2IwN2JfNi01LTEtMS02ODc1MQ_526f163b-e7c2-4e99-8823-6c4b96344d56"
      unitRef="usd">11000000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOmQzNjAzYTYzYTNkODQ4NGM5ODI3NGMwMjI3ZTdiMDdiL3RhYmxlcmFuZ2U6ZDM2MDNhNjNhM2Q4NDg0Yzk4Mjc0YzAyMjdlN2IwN2JfNi03LTEtMS02ODc1MQ_6b58362f-bd22-4895-95ee-1048983cd8e9"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOmQzNjAzYTYzYTNkODQ4NGM5ODI3NGMwMjI3ZTdiMDdiL3RhYmxlcmFuZ2U6ZDM2MDNhNjNhM2Q4NDg0Yzk4Mjc0YzAyMjdlN2IwN2JfNy01LTEtMS02ODc1MQ_f8961e5b-67fd-4453-8fe5-93810c08a5dd"
      unitRef="usd">-1000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOmQzNjAzYTYzYTNkODQ4NGM5ODI3NGMwMjI3ZTdiMDdiL3RhYmxlcmFuZ2U6ZDM2MDNhNjNhM2Q4NDg0Yzk4Mjc0YzAyMjdlN2IwN2JfNy03LTEtMS02ODc1MQ_e3a546d9-f2f6-474d-ab4a-6b55ac21d809"
      unitRef="usd">47000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i0cb8b86211c5442c9bef1b1297e7aefb_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNTIxNQ_97bea071-0e60-44aa-b524-825f261c4d9b"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <a:BusinessCombinationsContingentConsiderationArrangements
      contextRef="i78c42080d0f14678bc601c2d0167baec_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNTY2MA_6fd21bab-a3c0-43c5-9036-38c6bcca4137">P1Y10M24D</a:BusinessCombinationsContingentConsiderationArrangements>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i16a365fe29a5430f9bd225bf44aa6737_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNTcwOQ_6ad201e8-3da1-42dc-8fd0-3194790c7870"
      unitRef="usd">80000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfODIzNA_52d31ddc-e44c-45ed-bf80-4eecdd8e1966">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The contingent consideration liability is our only recurring Level 3 asset or liability.  A summary of the Level 3 activity follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions to contingent consideration (including measurement period adjustment)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value (included within selling, general and administrative expenses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOmUzYjY0MzQzMGIxYjQwMjQ5MjU1M2YxMDljZDk3NzlhL3RhYmxlcmFuZ2U6ZTNiNjQzNDMwYjFiNDAyNDkyNTUzZjEwOWNkOTc3OWFfNC01LTEtMS02ODc1MQ_9ea6a489-ded4-44e2-a05e-e7b7b3e2e17c"
      unitRef="usd">67000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i56485a537aba4a7691bd4bf959f3eaad_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOmUzYjY0MzQzMGIxYjQwMjQ5MjU1M2YxMDljZDk3NzlhL3RhYmxlcmFuZ2U6ZTNiNjQzNDMwYjFiNDAyNDkyNTUzZjEwOWNkOTc3OWFfNC03LTEtMS02ODc1MQ_802209e9-9494-429c-bb81-b93137d473e0"
      unitRef="usd">89000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOmUzYjY0MzQzMGIxYjQwMjQ5MjU1M2YxMDljZDk3NzlhL3RhYmxlcmFuZ2U6ZTNiNjQzNDMwYjFiNDAyNDkyNTUzZjEwOWNkOTc3OWFfNS01LTEtMS02ODc1MQ_aa72ef69-4ecd-4798-a68b-ec9848e7c57c"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOmUzYjY0MzQzMGIxYjQwMjQ5MjU1M2YxMDljZDk3NzlhL3RhYmxlcmFuZ2U6ZTNiNjQzNDMwYjFiNDAyNDkyNTUzZjEwOWNkOTc3OWFfNS03LTEtMS02ODc1MQ_14a06069-9ba1-495f-852b-f274c9141e27"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOmUzYjY0MzQzMGIxYjQwMjQ5MjU1M2YxMDljZDk3NzlhL3RhYmxlcmFuZ2U6ZTNiNjQzNDMwYjFiNDAyNDkyNTUzZjEwOWNkOTc3OWFfNi01LTEtMS05MjA5Mg_9b54a04d-adbc-427d-a0c9-5219f6b6d891"
      unitRef="usd">-65000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOmUzYjY0MzQzMGIxYjQwMjQ5MjU1M2YxMDljZDk3NzlhL3RhYmxlcmFuZ2U6ZTNiNjQzNDMwYjFiNDAyNDkyNTUzZjEwOWNkOTc3OWFfNi03LTEtMS05MjA5Mg_54c5a5a3-6c84-4283-b038-5572421c4a54"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOmUzYjY0MzQzMGIxYjQwMjQ5MjU1M2YxMDljZDk3NzlhL3RhYmxlcmFuZ2U6ZTNiNjQzNDMwYjFiNDAyNDkyNTUzZjEwOWNkOTc3OWFfNi01LTEtMS02ODc1MQ_62ebb3a1-033a-4337-b8bc-7102f827cc8c"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOmUzYjY0MzQzMGIxYjQwMjQ5MjU1M2YxMDljZDk3NzlhL3RhYmxlcmFuZ2U6ZTNiNjQzNDMwYjFiNDAyNDkyNTUzZjEwOWNkOTc3OWFfNi03LTEtMS02ODc1MQ_fe3c4c52-2613-45dd-ae1b-fe9e191cb84e"
      unitRef="usd">3000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOmUzYjY0MzQzMGIxYjQwMjQ5MjU1M2YxMDljZDk3NzlhL3RhYmxlcmFuZ2U6ZTNiNjQzNDMwYjFiNDAyNDkyNTUzZjEwOWNkOTc3OWFfNy01LTEtMS02ODc1MQ_835d4578-e56a-4621-909b-cf3adb89112e"
      unitRef="usd">3000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i7452fced71814cff84c1f48750a63bfa_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RhYmxlOmUzYjY0MzQzMGIxYjQwMjQ5MjU1M2YxMDljZDk3NzlhL3RhYmxlcmFuZ2U6ZTNiNjQzNDMwYjFiNDAyNDkyNTUzZjEwOWNkOTc3OWFfNy03LTEtMS02ODc1MQ_08bf5e3a-fa54-4333-98ed-85af3200e208"
      unitRef="usd">92000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNTk0NA_2b5ec3dc-9b96-471b-8d08-cfa80adc738b"
      unitRef="usd">3000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i5b44dbcd02a9484b8ddc79b3a7fab6d0_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNTk1Ng_d713423d-1fb1-47e0-94c1-be727dea7db4"
      unitRef="usd">2000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i3a38492613ee42308d5ca58cb82e54ef_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNjAwNQ_88415547-fc07-479c-8ffd-14c71f619713"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNTQ5NzU1ODI1NzQ2_9b54a04d-adbc-427d-a0c9-5219f6b6d891"
      unitRef="usd">-65000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:ImpairmentOfInvestments
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNjM0NA_5894d0f2-9874-4e37-88da-6075ae6e383f"
      unitRef="usd">0</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNjM0NA_956ae9b0-ff2c-4259-b698-25e27e49c278"
      unitRef="usd">0</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNjM0NA_ab949d26-8fc7-4837-8752-1febc5ebba2d"
      unitRef="usd">0</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNjM0NA_cadb0055-34cf-4fcd-ae3d-aa78f89dd63a"
      unitRef="usd">0</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNjUyMg_2311adbb-7524-4f51-8e4a-220c295eba79"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNjUyMg_4b98fc8a-e8ce-4864-a0ba-a51c0c2b1219"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNjUyMg_df622140-3874-43d2-9a18-314c67222f98"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNjUyMg_e73f120d-0429-44ed-a730-05e05c53c5d5"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNjk5OA_41f2f088-8cb8-4b1c-b6af-cf6a991f5bdd"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNjk5OA_57e505d5-e33c-4cd3-850c-e88606d5354c"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNjk5OA_950aa537-e2c1-43e1-9a3b-fd518d7831bd"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNjk5OA_9e6bdd6b-7973-448b-94a2-bc078bf98cc9"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNjk5OA_d6eabc87-ec45-426b-96ce-57f0b34afe44"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfNjk5OA_f3ea6c8c-ad68-4213-aa9c-66d0727c7bed"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfMjE5OTAyMzI2NDU1MA_eb257cd2-2fd6-4f0c-9a06-6bad0d180404"
      unitRef="usd">35000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfMjE5OTAyMzI2NDg0OA_a4841470-e57f-4be6-82da-512c22cb7aa5"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfMjE5OTAyMzI2NDg2MQ_048e9dbf-050d-4205-942d-31f78f7ddbd0"
      unitRef="usd">126000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount
      contextRef="i7452fced71814cff84c1f48750a63bfa_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfMjE5OTAyMzI2NDY4OQ_2d06db08-e22c-4990-9c08-d5eb4e9cfdcf"
      unitRef="usd">30000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount
      contextRef="i7452fced71814cff84c1f48750a63bfa_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfMjE5OTAyMzI2NDcxNg_8cf44bfb-3d85-453b-bcdc-2949687dd874"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i7452fced71814cff84c1f48750a63bfa_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN181OC9mcmFnOjNlMjQ0MjgyNjgzMDRlZGI4N2QwZDk0OTIxZWQ2OTE0L3RleHRyZWdpb246M2UyNDQyODI2ODMwNGVkYjg3ZDBkOTQ5MjFlZDY5MTRfMjE5OTAyMzI2NDc0Mw_e361bb9e-513a-48b9-b3f4-8916c76ca429"
      unitRef="usd">125000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfNzg3Mg_d670ed29-e5f1-461d-a724-2b483fe7a88c">DERIVATIVES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are exposed to foreign currency exchange rate fluctuations and interest rate changes in the normal course of our business. As part of our risk management strategy, we use derivative instruments, primarily forward contracts and purchased options to hedge economic and/or accounting exposures resulting from changes in foreign currency exchange rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into foreign exchange contracts to hedge our forecasted operational cash flow exposures resulting from changes in foreign currency exchange rates. These foreign exchange contracts, carried at fair value, have maturities between one and twelve months. These derivative instruments are designated and qualify as cash flow hedges under the criteria prescribed in the authoritative guidance and are assessed for effectiveness against the underlying exposure every reporting period. For open contracts as of January&#160;31, 2023, changes in the time value of the foreign exchange contract are excluded from the assessment of hedge effectiveness and are recognized in cost of sales over the life of the foreign exchange contract. The changes in fair value of the effective portion of the derivative instrument are recognized in accumulated other comprehensive income (loss). Amounts associated with cash flow hedges are reclassified to cost of sales in the condensed consolidated statement of operations when the forecasted transaction occurs. If it becomes probable that the forecasted transaction will not occur, the hedge relationship will be de-designated and amounts accumulated in other comprehensive income (loss) will be reclassified to other income (expense), net in the current period. Changes in the fair value of the ineffective portion of derivative instruments are recognized in other income (expense), net in the condensed consolidated statement of operations in the current period. We record the premium paid (time value) of an option on the date of purchase as an asset. For options designated as cash flow hedges, changes in the time value are excluded from the assessment of hedge effectiveness and are recognized in cost of sales over the life of the option contract. For the three months ended January&#160;31, 2023 and 2022, ineffectiveness and gains and losses recognized in other income (expense), net due to de-designation of cash flow hedge contracts were not significant.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2016, Agilent executed three forward-starting pay fixed/receive variable interest rate swaps for the notional amount of $300 million in connection with future interest payments to be made on our 2026 senior notes issued on September 15, 2016. These derivative instruments were designated and qualified as cash flow hedges under the criteria prescribed in the authoritative guidance. The swap arrangements were terminated on September 15, 2016 with a payment of $10 million, and we recognized this as a deferred loss in accumulated other comprehensive income (loss) which is being amortized to interest expense over the life of the 2026 senior notes. The remaining loss to be amortized related to the interest rate swap agreements at January&#160;31, 2023 was $3 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2019, Agilent executed treasury lock agreements for $250 million in connection with future interest payments to be made on our 2029 senior notes issued on September 16, 2019. We designated the treasury lock as a cash flow hedge. The treasury lock contracts were terminated on September 6, 2019, and we recognized a deferred loss of $6&#160;million in accumulated other comprehensive income (loss) which is being amortized to interest expense over the life of the 2029 senior notes. The remaining loss to be amortized related to the treasury lock agreements at January&#160;31, 2023 was $4 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Investment Hedges &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into foreign exchange contracts to hedge net investments in foreign operations to mitigate the risk of adverse movements in exchange rates. These foreign exchange contracts are carried at fair value and are designated and qualify as net investment hedges under the criteria prescribed in the authoritative guidance. Changes in fair value of the effective portion of the derivative instrument are recognized in accumulated other comprehensive income (loss)- translation adjustment and are assessed for effectiveness against the underlying exposure every reporting period. If the company&#x2019;s net investment changes during the year, the hedge relationship will be assessed and de-designated if the hedge notional amount is outside of prescribed tolerance with a gain/loss reclassified from other comprehensive income (loss) to other income (expense) in the current period. For the three months ended January&#160;31, 2023, ineffectiveness and the resultant effect of any gains or losses recognized in other income (expense) due to de-designation of the hedge contracts were not significant.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, we enter into foreign exchange contracts to hedge monetary assets and liabilities that are denominated in currencies other than the functional currency of our subsidiaries. These foreign exchange contracts are carried at fair value and do not qualify for hedge accounting treatment and are not designated as hedging instruments. Changes in value of the derivative instruments are recognized in other income (expense), net in the condensed consolidated statement of operations, in the current period, along with the offsetting foreign currency gain or loss on the underlying assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our use of derivative instruments exposes us to credit risk to the extent that the counterparties may be unable to meet the terms of the agreement. We do, however, seek to mitigate such risks by limiting our counterparties to major financial institutions which are selected based on their credit ratings and other factors.&#160;We have established policies and procedures for mitigating credit risk that include establishing counterparty credit limits, monitoring credit exposures, and continually assessing the creditworthiness of counterparties.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A number of our derivative agreements contain threshold limits to the net liability position with counterparties and are dependent on our corporate credit rating determined by the major credit rating agencies. The counterparties to the derivative instruments may request collateralization, in accordance with derivative agreements, on derivative instruments in net liability positions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate fair value of all derivative instruments with credit-risk-related contingent features that were in a net liability position as of January&#160;31, 2023, was $23&#160;million. The credit-risk-related contingent features underlying these agreements had not been triggered as of January&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were 270 foreign exchange forward contracts open as of January&#160;31, 2023, and designated as cash flow hedges. There were 189 foreign exchange forward contracts open as of January&#160;31, 2023, and not designated as hedging instruments. There were 3 foreign exchange forward contracts open as of January&#160;31, 2023, and designated as a net investment hedge.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The aggregated notional amounts by currency and designation as of January&#160;31, 2023, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives&#160;&lt;br/&gt;Designated as &lt;br/&gt;Cash&#160;Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives &lt;br/&gt;Designated as &lt;br/&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives &lt;br/&gt;Not Designated as&#160;&lt;br/&gt;Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Forward&lt;br/&gt;Contracts USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Forward&lt;br/&gt;Contracts USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Forward&lt;br/&gt;Contracts USD&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Buy/(Sell)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Buy/(Sell)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Buy/(Sell)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;British Pound&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canadian Dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japanese Yen&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Danish Krone&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Korean Won&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Singapore Dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Chinese Yuan Renminbi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Taiwan Dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indian Rupee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(434)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Derivative instruments are subject to master netting arrangements and are disclosed gross in the balance sheet in accordance with the authoritative guidance. The gross fair values and balance sheet location of derivative instruments held in the condensed consolidated balance sheet as of January&#160;31, 2023, and October&#160;31, 2022, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.875%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;text-indent:-31.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Values&#160;of&#160;Derivative&#160;Instruments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset&#160;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability&#160;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;Sheet&#160;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;Sheet&#160;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effects of derivative instruments for foreign exchange contracts designated as hedging instruments and not designated as hedging instruments in our condensed consolidated statement of operations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.944%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) recognized in accumulated other comprehensive&#160;loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) reclassified from accumulated other comprehensive&#160;loss into cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTItNS0xLTEtNjg3NTE_9acfeb89-7d88-4046-b4c7-cb2eb4fcaa42"&gt;6&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTItNy0xLTEtNjg3NTE_4ec61448-9de2-40a0-8dd4-e126176d3a29"&gt;3&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) on time value of forward contracts recorded in cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTctNS0xLTEtNjg3NTE_e833622d-040d-4809-bc1d-d9369471a833"&gt;2&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTctNy0xLTEtNjg3NTE_ae37cd7a-d092-478d-9c12-235792651f19"&gt;&#x2014;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) recognized in accumulated other comprehensive loss - translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) recognized in other income (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMjUtNS0xLTEtNjg3NTE_7bdf9258-4aa3-411c-b03c-7da3efd96a29"&gt;(13)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMjUtNy0xLTEtNjg3NTE_295a067e-a8da-4362-a6e5-55ad7d16f169"&gt;(3)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At January&#160;31, 2023, the amount of existing net gain that is expected to be reclassified from accumulated other comprehensive income (loss) is $14 million. Within the next twelve months it is estimated that $19 million of loss included within the net amount of accumulated other comprehensive income (loss) will be reclassified to cost of sales in respect of cash flow hedges.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="ib98f34fc7f8142658a397ac37f6164c3_I20160201"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfMjM5Nw_0ea2514d-7edc-473c-8abb-3f85b87ee979"
      unitRef="contracts">3</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib98f34fc7f8142658a397ac37f6164c3_I20160201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfMjQ5MQ_cd235bc1-0dc3-4fe5-8968-5bc912a73df4"
      unitRef="usd">300000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i324659d1cb1d46c89cd0b89529d4034d_D20160914-20160915"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfMjgyMg_05148ec3-0f7f-45cb-afae-7b56119b0dfa"
      unitRef="usd">10000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i78d62c946c8542959b4e01f2cf974dd8_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfMzA5Mg_3956902c-974f-426e-8785-f26412cfe923"
      unitRef="usd">3000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia8fcf2a391464f039d40d132dd664e20_I20190816"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfMzE2MA_c8477611-c133-465e-b685-56bdadd1a51c"
      unitRef="usd">250000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i904b39b3a0a541d89b9c91d944f3526e_D20190906-20190906"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfMzQzMA_11def5fa-7293-43bf-ac0e-52dea9ad649b"
      unitRef="usd">6000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i3c598168990b490090f5881a47627e8c_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfMzY1Mg_9efc4da7-7b65-425a-a0aa-6a713bb5ae3a"
      unitRef="usd">4000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeNetLiabilityPositionAggregateFairValue
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfNjQ0NQ_7bd0e96c-6d0c-43ce-a01a-70b018847452"
      unitRef="usd">23000000</us-gaap:DerivativeNetLiabilityPositionAggregateFairValue>
    <us-gaap:NumberOfForeignCurrencyDerivativesHeld
      contextRef="i6368af5356e443e2b1bcf93e16e6d501_I20230131"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfNjU3Ng_1d2eb610-5287-4925-aff7-98eee5a7cc7c"
      unitRef="contracts">270</us-gaap:NumberOfForeignCurrencyDerivativesHeld>
    <us-gaap:NumberOfForeignCurrencyDerivativesHeld
      contextRef="ia16943661c8e4bc59b6314507abbb36d_I20230131"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfNjY3NQ_ea7376ae-d362-4d1e-afac-b67d5deb242e"
      unitRef="contracts">189</us-gaap:NumberOfForeignCurrencyDerivativesHeld>
    <us-gaap:NumberOfForeignCurrencyDerivativesHeld
      contextRef="i1cb76a4102ed49558e2227ab243ac8fd_I20230131"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfNjc4MQ_859f7a2d-2ecf-4f77-9695-64a8ae076918"
      unitRef="contracts">3</us-gaap:NumberOfForeignCurrencyDerivativesHeld>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfNzg4Ng_d1d21467-77e8-416c-8112-02d5b86abfc3">The aggregated notional amounts by currency and designation as of January&#160;31, 2023, were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives&#160;&lt;br/&gt;Designated as &lt;br/&gt;Cash&#160;Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives &lt;br/&gt;Designated as &lt;br/&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives &lt;br/&gt;Not Designated as&#160;&lt;br/&gt;Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Forward&lt;br/&gt;Contracts USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Forward&lt;br/&gt;Contracts USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Forward&lt;br/&gt;Contracts USD&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Buy/(Sell)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Buy/(Sell)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Buy/(Sell)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;British Pound&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canadian Dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japanese Yen&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Danish Krone&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Korean Won&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Singapore Dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Chinese Yuan Renminbi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Taiwan Dollar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indian Rupee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(434)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i70fa0d9850894ce2bd08150dce5dd880_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfNC0yLTEtMS02ODc1MQ_20052d65-6758-4cd2-8bb6-f38bd2f83551"
      unitRef="usd">83000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if0d17d231ad5405b9ae739955f35f425_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfNC02LTEtMS02ODc1MQ_4050b229-c81c-47e3-8b11-06550abf2380"
      unitRef="usd">10000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4bd82f3839e44ab192c48ef9a1870c15_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfNC04LTEtMS02ODc1MQ_94d7f3d1-2c71-41a1-ae86-5a7a8a2d5d6b"
      unitRef="usd">25000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i17dde9e7368e4020ab08f6c0f4846ca7_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfNS0yLTEtMS02ODc1MQ_d66a7361-5493-4310-8c92-f1e7d8800d1c"
      unitRef="usd">67000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="idf03d71e237844c9ab4a9ebd0faa3359_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfNS04LTEtMS02ODc1MQ_ec44c34f-92ae-4beb-9991-6b54e710aa7f"
      unitRef="usd">6000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5aafc014163f40529f30fefed7819d7b_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfNi0yLTEtMS02ODc1MQ_3e31e83b-e48f-450a-a70c-25794ce4107b"
      unitRef="usd">54000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i71cd31f9f70b417fb1bb4b7d5392f0b2_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfNi04LTEtMS02ODc1MQ_2c4ca607-423c-4057-9e25-42dbc0b5680b"
      unitRef="usd">24000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i3775203ec49249b4ab76f5cf6f2294ee_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfOS0yLTEtMS02ODc1MQ_bb2caa1b-fec4-4614-9ab8-34575c687ab2"
      unitRef="usd">89000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib5ed8a5ca0774169b7f944d0bc113de9_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfOS04LTEtMS02ODc1MQ_029b75bb-db99-42f3-9be5-ebc0af8bfdd8"
      unitRef="usd">46000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic52474b3fc2c44c7bec341cd3919960f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfMTAtOC0xLTEtNjg3NTE_6f90cfb4-d86e-45c6-8bd4-d930248164be"
      unitRef="usd">22000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia08df4cafe1540658c021ebd7e9ffadf_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfMTEtMi0xLTEtNjg3NTE_45dc43f7-5d0f-4eca-bfb2-883363c02338"
      unitRef="usd">77000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i61cfdf67052b485b9591582a21abe8d0_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfMTEtOC0xLTEtNjg3NTE_76d91763-cc5c-47c2-a6b1-90779d2336cc"
      unitRef="usd">7000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i295d08acf58449ef98033f4386430180_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfMTItMi0xLTEtNjg3NTE_ad01c851-7355-4b85-ba6a-b695fe74c7b1"
      unitRef="usd">22000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i33d60a29c4894eb3bbb33a68e4118838_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfMTItOC0xLTEtNjg3NTE_89372417-9b9e-405a-8650-964efbfb1366"
      unitRef="usd">14000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i52e8713c120048e69a3901dd8044bd07_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfMTQtMi0xLTEtNjg3NTE_1a6f4722-4b5b-4202-9eae-18bbd36805d5"
      unitRef="usd">90000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i16cf2f8e131444838a3d586870b9b6c9_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfMTQtOC0xLTEtNjg3NTE_c3a86099-22e7-46f2-97a1-5692425f869f"
      unitRef="usd">126000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7ef13b82dfee4eb7bbf8c4421b6feda3_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfMTctOC0xLTEtNjg3NTE_d240d731-7504-4922-852a-93e463f1b8a6"
      unitRef="usd">10000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i23a1060162f147c9b80ea9c15caa11f8_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfMTgtOC0xLTEtNjg3NTE_0bf6bddd-3789-4514-83b0-971ee69114a1"
      unitRef="usd">11000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="idfcbd73a2af54018a2f5aeb70c0a2d56_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfMjEtMi0xLTEtNjg3NTE_3b35a8e4-772f-480e-8caf-f684874dd7a9"
      unitRef="usd">4000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia52b02295eb54f4498499beee0165955_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfMjEtOC0xLTEtNjg3NTE_8da55acf-61f0-4841-9e9d-156c23239e8d"
      unitRef="usd">5000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ie806c5c691284655bfd5c99810e88955_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfMjItMi0xLTEtNjg3NTE_b1c0e425-ef32-4d5b-90cc-37f2dceb7f74"
      unitRef="usd">434000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic9849f16147a4c6a8af2c15f51852e70_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfMjItNi0xLTEtNjg3NTE_23db4ca1-6862-4b19-a605-d62fea201080"
      unitRef="usd">10000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i601ab9e19dde4d31bfab5c2b2c29aaef_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOmM1Yzk3ZDhmN2U1MjRhYWY4YmQ5YzM2ODE5ZWQ0YmI2L3RhYmxlcmFuZ2U6YzVjOTdkOGY3ZTUyNGFhZjhiZDljMzY4MTllZDRiYjZfMjItOC0xLTEtNjg3NTE_d2f2a130-5f8f-4269-80f1-707c5450633c"
      unitRef="usd">152000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfNzg3Nw_71df566a-58e6-476a-bf74-21c6f21a5a76">Derivative instruments are subject to master netting arrangements and are disclosed gross in the balance sheet in accordance with the authoritative guidance. The gross fair values and balance sheet location of derivative instruments held in the condensed consolidated balance sheet as of January&#160;31, 2023, and October&#160;31, 2022, were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.875%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;text-indent:-31.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Values&#160;of&#160;Derivative&#160;Instruments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset&#160;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability&#160;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;Sheet&#160;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;Sheet&#160;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i6d83ab74cb7347a5997c114b0ed5304e_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjhkODMzMGNjNWViYzQ4M2M5ZDRkZTg4NDBmY2E1NDBhL3RhYmxlcmFuZ2U6OGQ4MzMwY2M1ZWJjNDgzYzlkNGRlODg0MGZjYTU0MGFfOC0yLTEtMS02ODc1MQ_d6c87233-13a1-4a19-a0ae-d6520b78083e"
      unitRef="usd">3000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i57b59664cd454e6cbc394cafcff6db66_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjhkODMzMGNjNWViYzQ4M2M5ZDRkZTg4NDBmY2E1NDBhL3RhYmxlcmFuZ2U6OGQ4MzMwY2M1ZWJjNDgzYzlkNGRlODg0MGZjYTU0MGFfOC00LTEtMS02ODc1MQ_1c1e309e-d419-4d51-b949-08c95dee1dbf"
      unitRef="usd">23000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i5b2775a8204c459cb7fac69d437dc90c_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjhkODMzMGNjNWViYzQ4M2M5ZDRkZTg4NDBmY2E1NDBhL3RhYmxlcmFuZ2U6OGQ4MzMwY2M1ZWJjNDgzYzlkNGRlODg0MGZjYTU0MGFfOC04LTEtMS02ODc1MQ_3a93136f-59bd-4378-9f2f-a3be1b7cdb7b"
      unitRef="usd">19000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="iecb19970c8c74e3ea1d87896cfeb7d28_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjhkODMzMGNjNWViYzQ4M2M5ZDRkZTg4NDBmY2E1NDBhL3RhYmxlcmFuZ2U6OGQ4MzMwY2M1ZWJjNDgzYzlkNGRlODg0MGZjYTU0MGFfOC0xMC0xLTEtNjg3NTE_4160d018-31d9-4284-bbee-8dc9cd48d741"
      unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i4660a8668a594fbaae707aa7558ab4e3_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjhkODMzMGNjNWViYzQ4M2M5ZDRkZTg4NDBmY2E1NDBhL3RhYmxlcmFuZ2U6OGQ4MzMwY2M1ZWJjNDgzYzlkNGRlODg0MGZjYTU0MGFfMTItMi0xLTEtNjg3NTE_46b246f8-f234-4517-a50e-c624969870a3"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i3443903b09984986b9027f5937e42b78_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjhkODMzMGNjNWViYzQ4M2M5ZDRkZTg4NDBmY2E1NDBhL3RhYmxlcmFuZ2U6OGQ4MzMwY2M1ZWJjNDgzYzlkNGRlODg0MGZjYTU0MGFfMTItNC0xLTEtNjg3NTE_8d163229-51ee-49dd-b2b7-52c169574a5f"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i87421f1569744288b0e82400d83000e1_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjhkODMzMGNjNWViYzQ4M2M5ZDRkZTg4NDBmY2E1NDBhL3RhYmxlcmFuZ2U6OGQ4MzMwY2M1ZWJjNDgzYzlkNGRlODg0MGZjYTU0MGFfMTItOC0xLTEtNjg3NTE_e98ef60a-fca3-4b2d-93fa-eb3cb986b691"
      unitRef="usd">1000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="iaab05383499649d68262077bbecf0617_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjhkODMzMGNjNWViYzQ4M2M5ZDRkZTg4NDBmY2E1NDBhL3RhYmxlcmFuZ2U6OGQ4MzMwY2M1ZWJjNDgzYzlkNGRlODg0MGZjYTU0MGFfMTItMTAtMS0xLTY4NzUx_8b69875a-4d8e-4ecf-9ec0-7ef9c8392868"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i22ad5bff85274efd9620a8216896b106_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjhkODMzMGNjNWViYzQ4M2M5ZDRkZTg4NDBmY2E1NDBhL3RhYmxlcmFuZ2U6OGQ4MzMwY2M1ZWJjNDgzYzlkNGRlODg0MGZjYTU0MGFfMTctMi0xLTEtNjg3NTE_4257520a-5b90-4da7-a32d-ebed296fef7a"
      unitRef="usd">5000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ie15965d2e28741fe8be38f4bf8c301ec_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjhkODMzMGNjNWViYzQ4M2M5ZDRkZTg4NDBmY2E1NDBhL3RhYmxlcmFuZ2U6OGQ4MzMwY2M1ZWJjNDgzYzlkNGRlODg0MGZjYTU0MGFfMTctNC0xLTEtNjg3NTE_1d39a2d6-0666-46e5-a3ef-0175ca2a477c"
      unitRef="usd">8000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i48143490c5ee44a2abd1901822b86a71_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjhkODMzMGNjNWViYzQ4M2M5ZDRkZTg4NDBmY2E1NDBhL3RhYmxlcmFuZ2U6OGQ4MzMwY2M1ZWJjNDgzYzlkNGRlODg0MGZjYTU0MGFfMTctOC0xLTEtNjg3NTE_dd32d09c-d5a7-4851-ba30-3b88d9d93010"
      unitRef="usd">8000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i873674ebcbd7473eb35b8c4112bc01f3_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjhkODMzMGNjNWViYzQ4M2M5ZDRkZTg4NDBmY2E1NDBhL3RhYmxlcmFuZ2U6OGQ4MzMwY2M1ZWJjNDgzYzlkNGRlODg0MGZjYTU0MGFfMTctMTAtMS0xLTY4NzUx_45a5909c-3c46-4704-8567-717a4cd0a3cb"
      unitRef="usd">3000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjhkODMzMGNjNWViYzQ4M2M5ZDRkZTg4NDBmY2E1NDBhL3RhYmxlcmFuZ2U6OGQ4MzMwY2M1ZWJjNDgzYzlkNGRlODg0MGZjYTU0MGFfMTgtMi0xLTEtNjg3NTE_a55a4e2a-365e-4387-b977-03abaa3a2aae"
      unitRef="usd">8000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjhkODMzMGNjNWViYzQ4M2M5ZDRkZTg4NDBmY2E1NDBhL3RhYmxlcmFuZ2U6OGQ4MzMwY2M1ZWJjNDgzYzlkNGRlODg0MGZjYTU0MGFfMTgtNC0xLTEtNjg3NTE_fbfcab47-09c2-419a-bee6-24949c499f13"
      unitRef="usd">31000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjhkODMzMGNjNWViYzQ4M2M5ZDRkZTg4NDBmY2E1NDBhL3RhYmxlcmFuZ2U6OGQ4MzMwY2M1ZWJjNDgzYzlkNGRlODg0MGZjYTU0MGFfMTgtOC0xLTEtNjg3NTE_1ed5af3d-4045-4c02-8c7f-2ea90330d961"
      unitRef="usd">28000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjhkODMzMGNjNWViYzQ4M2M5ZDRkZTg4NDBmY2E1NDBhL3RhYmxlcmFuZ2U6OGQ4MzMwY2M1ZWJjNDgzYzlkNGRlODg0MGZjYTU0MGFfMTgtMTAtMS0xLTY4NzUx_d5715830-a185-4f8d-ae7e-f4b6af6de733"
      unitRef="usd">5000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfNzg4Mg_d268799b-abdc-43fe-91d5-e2555f977b23">The effects of derivative instruments for foreign exchange contracts designated as hedging instruments and not designated as hedging instruments in our condensed consolidated statement of operations were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.944%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) recognized in accumulated other comprehensive&#160;loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) reclassified from accumulated other comprehensive&#160;loss into cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTItNS0xLTEtNjg3NTE_9acfeb89-7d88-4046-b4c7-cb2eb4fcaa42"&gt;6&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTItNy0xLTEtNjg3NTE_4ec61448-9de2-40a0-8dd4-e126176d3a29"&gt;3&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) on time value of forward contracts recorded in cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTctNS0xLTEtNjg3NTE_e833622d-040d-4809-bc1d-d9369471a833"&gt;2&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTctNy0xLTEtNjg3NTE_ae37cd7a-d092-478d-9c12-235792651f19"&gt;&#x2014;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) recognized in accumulated other comprehensive loss - translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) recognized in other income (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMjUtNS0xLTEtNjg3NTE_7bdf9258-4aa3-411c-b03c-7da3efd96a29"&gt;(13)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMjUtNy0xLTEtNjg3NTE_295a067e-a8da-4362-a6e5-55ad7d16f169"&gt;(3)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i69c58982edd04b3c8b9b1a661fa43077_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTAtNS0xLTEtNjg3NTE_76b79b65-d061-49ae-869f-831bff19746b"
      unitRef="usd">-31000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i446051e3e67a4f3eb24fc2a9fc021f9f_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTAtNy0xLTEtNjg3NTE_83828d7a-fbc0-4872-822c-65f3a0d97bf6"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="ibe16525b780846f0a8256296b5fb0f87_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTItNS0xLTEtNjg3NTE_b4df5c84-d980-4b48-8f4d-82d138dd4ec7"
      unitRef="usd">6000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i359eb8716c884382914b552c36e4c9cc_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTItNy0xLTEtNjg3NTE_4ee1a9f9-0462-4e03-9fcc-bc50c623fb3b"
      unitRef="usd">3000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ibe16525b780846f0a8256296b5fb0f87_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTctNS0xLTEtNjg3NTE_1472c1fa-54ce-4f5d-8846-cde686551779"
      unitRef="usd">2000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i359eb8716c884382914b552c36e4c9cc_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMTctNy0xLTEtNjg3NTE_2991a36d-def5-4bf7-8e70-e6c1498717bc"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ia1a503ae15114ad2ab5911699cb1de9d_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMjEtNS0xLTEtNjg3NTE_5788f57b-a3cd-4d62-85a8-dcb40ed19280"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i68beea4ee84a417ab91740679bcbab4d_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMjEtNy0xLTEtNjg3NTE_fec02099-0bc4-4a06-bdc4-17edcbe73231"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i1e03d76a6cd14445b069223cf851a0fb_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMjUtNS0xLTEtNjg3NTE_c467ed55-5e28-4742-970a-24ba5b65b71c"
      unitRef="usd">-13000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i2fb1f98c73934300bcb2677be16791c7_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RhYmxlOjQ3ZmY0NWIxNTFjMTRmZTNhZGMwZWQ3NjZhNWY3MGYwL3RhYmxlcmFuZ2U6NDdmZjQ1YjE1MWMxNGZlM2FkYzBlZDc2NmE1ZjcwZjBfMjUtNy0xLTEtNjg3NTE_d759c8b5-c83d-4a47-a21f-ead407b8441a"
      unitRef="usd">-3000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="ia7aac091b08c48afba3a0408369ffcc4_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfNzYzNg_c08a00d0-48e1-4ed1-ac13-a61a69a10151"
      unitRef="usd">14000000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="i34dcb13592ff484696f17ceb6e02417d_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182MS9mcmFnOjhmYjYxZDFlMjU1MTQ3MDA4N2VjM2Y3MjgzM2I1Nzc0L3RleHRyZWdpb246OGZiNjFkMWUyNTUxNDcwMDg3ZWMzZjcyODMzYjU3NzRfNzY5MQ_1aff736f-1bc1-4b70-900e-60fe9a782740"
      unitRef="usd">19000000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RleHRyZWdpb246YjQxMzQ5ZjQ3NTQ4NDUwZmI1MjBjOTAyNmE5OTkzYzlfNjI5_602637e0-cadf-49f0-8dc6-5e4d2be52616">RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Components of net periodic costs (benefits).&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; For the three months ended January&#160;31, 2023 and 2022, our net pension and post retirement benefit costs (benefits) were comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.365%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.365%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended January 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S. &lt;br/&gt;Pension&#160;Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-U.S.&lt;br/&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S.&#160;Post&#160;Retirement&lt;br/&gt;Benefit&#160;Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&#x2014;benefits earned during the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost on benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial losses (gains)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net plan costs (benefits)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The service cost component is recorded in cost of sales and operating expenses in the condensed consolidated statement of operations. All other cost components are recorded in other income (expense), net in the condensed consolidated statement of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Employer contributions and expected future employer contributions for the remainder of the year were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employer Contributions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For Remainder of Year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. defined benefit plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. defined benefit plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RleHRyZWdpb246YjQxMzQ5ZjQ3NTQ4NDUwZmI1MjBjOTAyNmE5OTkzYzlfNjMy_72b7c827-619b-4f7b-9cac-ad9ea46e40f9">&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Components of net periodic costs (benefits).&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; For the three months ended January&#160;31, 2023 and 2022, our net pension and post retirement benefit costs (benefits) were comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.365%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.365%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended January 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S. &lt;br/&gt;Pension&#160;Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-U.S.&lt;br/&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S.&#160;Post&#160;Retirement&lt;br/&gt;Benefit&#160;Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&#x2014;benefits earned during the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost on benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial losses (gains)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net plan costs (benefits)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The service cost component is recorded in cost of sales and operating expenses in the condensed consolidated statement of operations. All other cost components are recorded in other income (expense), net in the condensed consolidated statement of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i125675019576446bbc7947a564d0c89f_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfNi0xLTEtMS02ODc1MQ_664c6728-5478-4f20-82ed-24f01dba256f"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i9e99b539b79445c1b5eceb9da39435cd_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfNi0zLTEtMS02ODc1MQ_43152f85-f504-45f2-9944-33db7e0816c6"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i1c2a35f6169348d4bb4fe4e665306d51_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfNi01LTEtMS02ODc1MQ_ab2ee66b-693e-4ace-8c47-5acfae73699e"
      unitRef="usd">6000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ifbcda6d0b469429ca1598f0fa2ebb7d7_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfNi03LTEtMS02ODc1MQ_d162703d-eda9-4e6b-94c1-32c7f7656006"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ie73c662f34154fc49f2f4456e56cd10c_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfNi05LTEtMS02ODc1MQ_7b04c26f-6bdf-4ace-a8d5-4b5211b614d2"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i73728e1faa1e4efda17c4a3ca7016e37_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfNi0xMS0xLTEtNjg3NTE_21733960-725f-472a-8109-c550191bea50"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i125675019576446bbc7947a564d0c89f_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfNy0xLTEtMS02ODc1MQ_00834122-b85a-43f6-a21e-abc5b7d3f6ac"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i9e99b539b79445c1b5eceb9da39435cd_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfNy0zLTEtMS02ODc1MQ_2d00651f-1f2a-47e4-ae1e-da96eb9e5062"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i1c2a35f6169348d4bb4fe4e665306d51_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfNy01LTEtMS02ODc1MQ_f80a6b2c-7f4b-4cae-b6d6-1f4412b64543"
      unitRef="usd">6000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ifbcda6d0b469429ca1598f0fa2ebb7d7_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfNy03LTEtMS02ODc1MQ_fe81858e-468e-4114-a95f-d3a7829654a0"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ie73c662f34154fc49f2f4456e56cd10c_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfNy05LTEtMS02ODc1MQ_0dcb5737-c9ac-4935-b953-69c97781dfad"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i73728e1faa1e4efda17c4a3ca7016e37_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfNy0xMS0xLTEtNjg3NTE_c4471324-f970-4d21-981f-a48a53feb0d4"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i125675019576446bbc7947a564d0c89f_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfOC0xLTEtMS02ODc1MQ_ed29a0fa-a8b1-4cd1-99f5-573e75d16e56"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i9e99b539b79445c1b5eceb9da39435cd_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfOC0zLTEtMS02ODc1MQ_3037c4ef-858b-41c7-9b26-dfdef39766b4"
      unitRef="usd">6000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i1c2a35f6169348d4bb4fe4e665306d51_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfOC01LTEtMS02ODc1MQ_e31d10b8-eec9-4fea-ba30-bd4c195b3075"
      unitRef="usd">9000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ifbcda6d0b469429ca1598f0fa2ebb7d7_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfOC03LTEtMS02ODc1MQ_a486f936-f56c-4afc-9aef-c19b5613f160"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ie73c662f34154fc49f2f4456e56cd10c_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfOC05LTEtMS02ODc1MQ_cea40f5f-b7cf-417c-8728-5818443f143e"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i73728e1faa1e4efda17c4a3ca7016e37_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfOC0xMS0xLTEtNjg3NTE_d8e3b0bc-e0f2-4f84-8780-ff10b9f6738c"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i125675019576446bbc7947a564d0c89f_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfMTAtMS0xLTEtNjg3NTE_c91ca5cc-2e98-4254-b7ed-f1e1f8afecd5"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i9e99b539b79445c1b5eceb9da39435cd_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfMTAtMy0xLTEtNjg3NTE_5f2df949-f880-4c91-8f14-e347ab2f8db5"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i1c2a35f6169348d4bb4fe4e665306d51_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfMTAtNS0xLTEtNjg3NTE_450443c6-6a19-441c-9761-2da445c8fa8d"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ifbcda6d0b469429ca1598f0fa2ebb7d7_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfMTAtNy0xLTEtNjg3NTE_fcf4ee8a-cd07-451b-8fae-8a322e797631"
      unitRef="usd">-6000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ie73c662f34154fc49f2f4456e56cd10c_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfMTAtOS0xLTEtNjg3NTE_3b78563b-7708-4a6e-85ba-8548c5a9a5a6"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i73728e1faa1e4efda17c4a3ca7016e37_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfMTAtMTEtMS0xLTY4NzUx_3abc16c9-7335-48d4-bf0e-701595537bd5"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i125675019576446bbc7947a564d0c89f_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfMTItMS0xLTEtNjg3NTE_c9911ba5-9bd6-49ce-acc4-77f7366ad641"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i9e99b539b79445c1b5eceb9da39435cd_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfMTItMy0xLTEtNjg3NTE_15845724-113c-4b89-aaa0-0c6729935885"
      unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i1c2a35f6169348d4bb4fe4e665306d51_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfMTItNS0xLTEtNjg3NTE_f82bb36d-6778-40dd-aa32-f52632dc83ce"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ifbcda6d0b469429ca1598f0fa2ebb7d7_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfMTItNy0xLTEtNjg3NTE_4efdfca3-4f41-4e54-b0f9-086eafbac9d5"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ie73c662f34154fc49f2f4456e56cd10c_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfMTItOS0xLTEtNjg3NTE_d1bb1723-886e-48ee-92c8-2e99c3a0f18e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i73728e1faa1e4efda17c4a3ca7016e37_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjBlOThkNTUzODQ0ZDQwOGZiZjQxODgwM2RjMDM0NmYyL3RhYmxlcmFuZ2U6MGU5OGQ1NTM4NDRkNDA4ZmJmNDE4ODAzZGMwMzQ2ZjJfMTItMTEtMS0xLTY4NzUx_2267c458-3245-4954-8827-cd9227c1d753"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <a:EmployerContributionsAndExpectedEmployerContributionsTableTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RleHRyZWdpb246YjQxMzQ5ZjQ3NTQ4NDUwZmI1MjBjOTAyNmE5OTkzYzlfNjM1_37aa043a-26cc-477b-a986-340d4c4c4a7f">&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Employer contributions and expected future employer contributions for the remainder of the year were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employer Contributions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For Remainder of Year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. defined benefit plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. defined benefit plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</a:EmployerContributionsAndExpectedEmployerContributionsTableTextBlock>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i125675019576446bbc7947a564d0c89f_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjFmZjY1N2ZlM2E2YjQxMWI5MTBjNDMwYmY1NWZmMDY3L3RhYmxlcmFuZ2U6MWZmNjU3ZmUzYTZiNDExYjkxMGM0MzBiZjU1ZmYwNjdfNC01LTEtMS02ODc1MQ_ff15ab19-83d7-4ece-874c-69362aa77612"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i9e99b539b79445c1b5eceb9da39435cd_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjFmZjY1N2ZlM2E2YjQxMWI5MTBjNDMwYmY1NWZmMDY3L3RhYmxlcmFuZ2U6MWZmNjU3ZmUzYTZiNDExYjkxMGM0MzBiZjU1ZmYwNjdfNC03LTEtMS02ODc1MQ_99d96017-4748-40c5-bf9e-68911e397e46"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear
      contextRef="i5a4bcfb758684d2488eda427cdb6b25d_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjFmZjY1N2ZlM2E2YjQxMWI5MTBjNDMwYmY1NWZmMDY3L3RhYmxlcmFuZ2U6MWZmNjU3ZmUzYTZiNDExYjkxMGM0MzBiZjU1ZmYwNjdfNC0xMC0xLTEtNjg3NTE_f7867d63-05ee-410b-9fd2-fef79d0c7e8c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i1c2a35f6169348d4bb4fe4e665306d51_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjFmZjY1N2ZlM2E2YjQxMWI5MTBjNDMwYmY1NWZmMDY3L3RhYmxlcmFuZ2U6MWZmNjU3ZmUzYTZiNDExYjkxMGM0MzBiZjU1ZmYwNjdfNS01LTEtMS02ODc1MQ_9150af22-2bb8-4c45-83a2-70aa5e180611"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="ifbcda6d0b469429ca1598f0fa2ebb7d7_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjFmZjY1N2ZlM2E2YjQxMWI5MTBjNDMwYmY1NWZmMDY3L3RhYmxlcmFuZ2U6MWZmNjU3ZmUzYTZiNDExYjkxMGM0MzBiZjU1ZmYwNjdfNS03LTEtMS02ODc1MQ_dd1010f4-1acf-48e7-aaca-1dfae2c2dc18"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear
      contextRef="ia940a16a97b2481b975ec28bbbb5866c_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182NC9mcmFnOmI0MTM0OWY0NzU0ODQ1MGZiNTIwYzkwMjZhOTk5M2M5L3RhYmxlOjFmZjY1N2ZlM2E2YjQxMWI5MTBjNDMwYmY1NWZmMDY3L3RhYmxlcmFuZ2U6MWZmNjU3ZmUzYTZiNDExYjkxMGM0MzBiZjU1ZmYwNjdfNS0xMC0xLTEtNjg3NTE_62f314ad-6c7c-428c-a339-b71135d090d2"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RleHRyZWdpb246MGE5MWQzMmZiNzJjNDQ1NmFlYTZiNjhmOWQxNzE2ZjlfMTU5OA_59ad54ea-cb0e-426e-aa06-2b9ed8668537">WARRANTIES AND CONTINGENCIES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Warranties&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We accrue for standard warranty costs based on historical trends in actual warranty charges over the past 12 months. The accrual is reviewed regularly and periodically adjusted to reflect changes in warranty cost over the period. The standard warranty accrual balances are held in other accrued and other long-term liabilities on our condensed consolidated balance sheet. Our standard warranty terms typically extend to one year from the date of delivery, depending on the product.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the standard warranty accrual activity is shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Standard warranty accrual, beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accruals for warranties including change in estimates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements made during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Standard warranty accrual, ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accruals for warranties due within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accruals for warranties due after one year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Standard warranty accrual, ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Bank Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Guarantees consist primarily of outstanding standby letters of credit and bank guarantees and were approximately $37 million as of both January&#160;31, 2023 and October&#160;31, 2022, respectively. A standby letter of credit is a guarantee of payment issued by a bank on behalf of us that is used as payment of last resort should we fail to fulfill a contractual commitment with a third party. A bank guarantee is a promise from a bank or other lending institution that if we default on a loan, the bank will cover the loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are involved in lawsuits, claims, investigations and proceedings, including, but not limited to, intellectual property, commercial, real estate, environmental and employment matters, which arise in the ordinary course of business. There are no matters pending that we currently believe are reasonably possible of having a material impact to our business, condensed consolidated financial condition, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RleHRyZWdpb246MGE5MWQzMmZiNzJjNDQ1NmFlYTZiNjhmOWQxNzE2ZjlfMTU4MQ_a5079a71-deeb-4a95-bc3e-729c40cb6b3a">&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the standard warranty accrual activity is shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Standard warranty accrual, beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accruals for warranties including change in estimates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements made during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Standard warranty accrual, ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accruals for warranties due within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accruals for warranties due after one year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Standard warranty accrual, ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RhYmxlOmQzNzFjMzE3YjdmNTQ2OWM4ODE4ZWFlOTRiOWM3MDJlL3RhYmxlcmFuZ2U6ZDM3MWMzMTdiN2Y1NDY5Yzg4MThlYWU5NGI5YzcwMmVfNC0xLTEtMS02ODc1MQ_0db4c967-a632-4430-baec-8359189569bc"
      unitRef="usd">30000000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="i56485a537aba4a7691bd4bf959f3eaad_I20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RhYmxlOmQzNzFjMzE3YjdmNTQ2OWM4ODE4ZWFlOTRiOWM3MDJlL3RhYmxlcmFuZ2U6ZDM3MWMzMTdiN2Y1NDY5Yzg4MThlYWU5NGI5YzcwMmVfNC0zLTEtMS02ODc1MQ_875a0863-135b-479a-a097-0bc83b1d86b9"
      unitRef="usd">30000000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrualWarrantiesIssued
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RhYmxlOmQzNzFjMzE3YjdmNTQ2OWM4ODE4ZWFlOTRiOWM3MDJlL3RhYmxlcmFuZ2U6ZDM3MWMzMTdiN2Y1NDY5Yzg4MThlYWU5NGI5YzcwMmVfNS0xLTEtMS02ODc1MQ_d61e48d9-13cb-46b9-aca8-f7fd05fb0e1d"
      unitRef="usd">11000000</us-gaap:StandardProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:StandardProductWarrantyAccrualWarrantiesIssued
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RhYmxlOmQzNzFjMzE3YjdmNTQ2OWM4ODE4ZWFlOTRiOWM3MDJlL3RhYmxlcmFuZ2U6ZDM3MWMzMTdiN2Y1NDY5Yzg4MThlYWU5NGI5YzcwMmVfNS0zLTEtMS02ODc1MQ_4e83c5a4-d801-4e9a-9197-27d44908b305"
      unitRef="usd">13000000</us-gaap:StandardProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:StandardProductWarrantyAccrualPayments
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RhYmxlOmQzNzFjMzE3YjdmNTQ2OWM4ODE4ZWFlOTRiOWM3MDJlL3RhYmxlcmFuZ2U6ZDM3MWMzMTdiN2Y1NDY5Yzg4MThlYWU5NGI5YzcwMmVfNi0xLTEtMS02ODc1MQ_6c703b06-0a91-44af-91ea-411cd32b0710"
      unitRef="usd">13000000</us-gaap:StandardProductWarrantyAccrualPayments>
    <us-gaap:StandardProductWarrantyAccrualPayments
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RhYmxlOmQzNzFjMzE3YjdmNTQ2OWM4ODE4ZWFlOTRiOWM3MDJlL3RhYmxlcmFuZ2U6ZDM3MWMzMTdiN2Y1NDY5Yzg4MThlYWU5NGI5YzcwMmVfNi0zLTEtMS02ODc1MQ_03e97a7b-0cb6-4808-bddb-5b417a4e6ab5"
      unitRef="usd">13000000</us-gaap:StandardProductWarrantyAccrualPayments>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RhYmxlOmQzNzFjMzE3YjdmNTQ2OWM4ODE4ZWFlOTRiOWM3MDJlL3RhYmxlcmFuZ2U6ZDM3MWMzMTdiN2Y1NDY5Yzg4MThlYWU5NGI5YzcwMmVfNy0xLTEtMS02ODc1MQ_1a316801-4dfd-4dd1-8129-1a510b9617a7"
      unitRef="usd">28000000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="i7452fced71814cff84c1f48750a63bfa_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RhYmxlOmQzNzFjMzE3YjdmNTQ2OWM4ODE4ZWFlOTRiOWM3MDJlL3RhYmxlcmFuZ2U6ZDM3MWMzMTdiN2Y1NDY5Yzg4MThlYWU5NGI5YzcwMmVfNy0zLTEtMS02ODc1MQ_ffc9a5e9-29f5-428b-9575-8931cbc66b46"
      unitRef="usd">30000000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrualCurrent
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RhYmxlOmQzNzFjMzE3YjdmNTQ2OWM4ODE4ZWFlOTRiOWM3MDJlL3RhYmxlcmFuZ2U6ZDM3MWMzMTdiN2Y1NDY5Yzg4MThlYWU5NGI5YzcwMmVfOS0xLTEtMS02ODc1MQ_8fd8b3b9-0401-496b-9a4d-785e7335456b"
      unitRef="usd">28000000</us-gaap:StandardProductWarrantyAccrualCurrent>
    <us-gaap:StandardProductWarrantyAccrualCurrent
      contextRef="i7452fced71814cff84c1f48750a63bfa_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RhYmxlOmQzNzFjMzE3YjdmNTQ2OWM4ODE4ZWFlOTRiOWM3MDJlL3RhYmxlcmFuZ2U6ZDM3MWMzMTdiN2Y1NDY5Yzg4MThlYWU5NGI5YzcwMmVfOS0zLTEtMS02ODc1MQ_960d3629-ef65-4d34-8f4a-a09cb324c983"
      unitRef="usd">29000000</us-gaap:StandardProductWarrantyAccrualCurrent>
    <us-gaap:StandardProductWarrantyAccrualNoncurrent
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RhYmxlOmQzNzFjMzE3YjdmNTQ2OWM4ODE4ZWFlOTRiOWM3MDJlL3RhYmxlcmFuZ2U6ZDM3MWMzMTdiN2Y1NDY5Yzg4MThlYWU5NGI5YzcwMmVfMTAtMS0xLTEtNjg3NTE_64c059de-0771-4a49-bf6a-56cef1cf16dc"
      unitRef="usd">0</us-gaap:StandardProductWarrantyAccrualNoncurrent>
    <us-gaap:StandardProductWarrantyAccrualNoncurrent
      contextRef="i7452fced71814cff84c1f48750a63bfa_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RhYmxlOmQzNzFjMzE3YjdmNTQ2OWM4ODE4ZWFlOTRiOWM3MDJlL3RhYmxlcmFuZ2U6ZDM3MWMzMTdiN2Y1NDY5Yzg4MThlYWU5NGI5YzcwMmVfMTAtMy0xLTEtNjg3NTE_a1ad60be-36b2-4a09-82ab-faafee90ba96"
      unitRef="usd">1000000</us-gaap:StandardProductWarrantyAccrualNoncurrent>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RhYmxlOmQzNzFjMzE3YjdmNTQ2OWM4ODE4ZWFlOTRiOWM3MDJlL3RhYmxlcmFuZ2U6ZDM3MWMzMTdiN2Y1NDY5Yzg4MThlYWU5NGI5YzcwMmVfMTEtMS0xLTEtNjg3NTE_6146ed37-e288-46ca-aba1-41a417bfb887"
      unitRef="usd">28000000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="i7452fced71814cff84c1f48750a63bfa_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RhYmxlOmQzNzFjMzE3YjdmNTQ2OWM4ODE4ZWFlOTRiOWM3MDJlL3RhYmxlcmFuZ2U6ZDM3MWMzMTdiN2Y1NDY5Yzg4MThlYWU5NGI5YzcwMmVfMTEtMy0xLTEtNjg3NTE_1c07d5e0-b373-4626-8537-4fb2eac3088c"
      unitRef="usd">30000000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:BankAcceptancesExecuted
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RleHRyZWdpb246MGE5MWQzMmZiNzJjNDQ1NmFlYTZiNjhmOWQxNzE2ZjlfNzY1_8019368b-da68-4527-a05e-a0aae258eacd"
      unitRef="usd">37000000</us-gaap:BankAcceptancesExecuted>
    <us-gaap:BankAcceptancesExecuted
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN182Ny9mcmFnOjBhOTFkMzJmYjcyYzQ0NTZhZWE2YjY4ZjlkMTcxNmY5L3RleHRyZWdpb246MGE5MWQzMmZiNzJjNDQ1NmFlYTZiNjhmOWQxNzE2ZjlfNzY1_8089b217-dabe-4f28-8291-a149e58eb520"
      unitRef="usd">37000000</us-gaap:BankAcceptancesExecuted>
    <us-gaap:ShortTermDebtTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183MC9mcmFnOjg3MTEyNGQ1ZGE5NjRlM2ZhNjljYWUyNzdmMmUxOTE0L3RleHRyZWdpb246ODcxMTI0ZDVkYTk2NGUzZmE2OWNhZTI3N2YyZTE5MTRfMTYwNQ_1155dbe3-f324-4aee-aeae-de3a5a4b59d3">SHORT-TERM DEBT&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 13, 2019, we entered into a credit agreement with a group of financial institutions which, as amended, provided for a $1 billion five-year unsecured credit facility that will expire on March 13, 2024 and incremental term loan facilities in an aggregate amount of up to $500 million.&#160;On April 21, 2021, we entered into an incremental assumption agreement, pursuant to which the aggregate amount available for borrowing under the revolving credit facility was increased to $1.35&#160;billion and the aggregate amount available for incremental facilities was refreshed to remain at $500&#160;million. As of &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;January&#160;31, 2023, we had no borrowings outstanding under the credit facility and no borrowings under the incremental facilities. We were in compliance with the covenants for the credit facility during the three months ended January&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Commercial Paper&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under our U.S. commercial paper program, the company may issue and sell unsecured, short-term promissory notes in the aggregate principal amount not to exceed $1.35&#160;billion with up to 397-day maturities. At any point in time, the company intends to maintain available commitments under its revolving credit facility in an amount at least equal to the amount of the commercial paper notes outstanding. Amounts available under the program may be borrowed, repaid and re-borrowed from time to time. The proceeds from issuances under the program may be used for general corporate purposes. During the three months ended January&#160;31, 2023, we borrowed $527 million and repaid $324 million. As &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;January&#160;31, 2023&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we had borrowings of $238 million outstanding under our U.S. commercial paper program and had a weighted average annual interest rate of 4.67 percent.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShortTermDebtTextBlock>
    <us-gaap:LineOfCreditFacilityInitiationDate1
      contextRef="i2ef13658ecf745f787fde75342d47896_D20190313-20190313"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183MC9mcmFnOjg3MTEyNGQ1ZGE5NjRlM2ZhNjljYWUyNzdmMmUxOTE0L3RleHRyZWdpb246ODcxMTI0ZDVkYTk2NGUzZmE2OWNhZTI3N2YyZTE5MTRfNTI_1a6d6a3f-6653-4961-9934-23028a15718e">2019-03-13</us-gaap:LineOfCreditFacilityInitiationDate1>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="iafd490bd02de47189afdbcca947d8d74_I20190313"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183MC9mcmFnOjg3MTEyNGQ1ZGE5NjRlM2ZhNjljYWUyNzdmMmUxOTE0L3RleHRyZWdpb246ODcxMTI0ZDVkYTk2NGUzZmE2OWNhZTI3N2YyZTE5MTRfMTY0_9b975601-5af2-4bbc-9420-c31f88ee72e6"
      unitRef="usd">1000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ShortTermDebtTerms
      contextRef="i2ef13658ecf745f787fde75342d47896_D20190313-20190313"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183MC9mcmFnOjg3MTEyNGQ1ZGE5NjRlM2ZhNjljYWUyNzdmMmUxOTE0L3RleHRyZWdpb246ODcxMTI0ZDVkYTk2NGUzZmE2OWNhZTI3N2YyZTE5MTRfMTYwMQ_bc224339-aaf8-4811-b5f6-758760cc05b8">five</us-gaap:ShortTermDebtTerms>
    <us-gaap:LineOfCreditFacilityExpirationDate1
      contextRef="i2ef13658ecf745f787fde75342d47896_D20190313-20190313"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183MC9mcmFnOjg3MTEyNGQ1ZGE5NjRlM2ZhNjljYWUyNzdmMmUxOTE0L3RleHRyZWdpb246ODcxMTI0ZDVkYTk2NGUzZmE2OWNhZTI3N2YyZTE5MTRfMjIz_6326ab37-b45e-4855-81cd-69ec235e2f51">2024-03-13</us-gaap:LineOfCreditFacilityExpirationDate1>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i152367a04c424a7ba2d724aaa1763fdc_I20190313"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183MC9mcmFnOjg3MTEyNGQ1ZGE5NjRlM2ZhNjljYWUyNzdmMmUxOTE0L3RleHRyZWdpb246ODcxMTI0ZDVkYTk2NGUzZmE2OWNhZTI3N2YyZTE5MTRfMjk1_2745f324-5923-476c-96b6-524ddfe223fb"
      unitRef="usd">500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i6bdea77493e34375a99fd1155e7a9865_I20210421"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183MC9mcmFnOjg3MTEyNGQ1ZGE5NjRlM2ZhNjljYWUyNzdmMmUxOTE0L3RleHRyZWdpb246ODcxMTI0ZDVkYTk2NGUzZmE2OWNhZTI3N2YyZTE5MTRfNDg3_30ba4d28-b65e-4b75-a182-e79d7f0f5fb6"
      unitRef="usd">1350000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i2f2d43ce269b4254baf2999a8865ea28_I20210421"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183MC9mcmFnOjg3MTEyNGQ1ZGE5NjRlM2ZhNjljYWUyNzdmMmUxOTE0L3RleHRyZWdpb246ODcxMTI0ZDVkYTk2NGUzZmE2OWNhZTI3N2YyZTE5MTRfNTc5_9decf906-59ea-4111-a623-2e0f3906c728"
      unitRef="usd">500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="i2bdca111b15343188d0db9a98448ac9d_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183MC9mcmFnOjg3MTEyNGQ1ZGE5NjRlM2ZhNjljYWUyNzdmMmUxOTE0L3RleHRyZWdpb246ODcxMTI0ZDVkYTk2NGUzZmE2OWNhZTI3N2YyZTE5MTRfNjAw_7928ddf2-0186-4908-82ba-32a9d6c6fa63"
      unitRef="usd">0</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="id9fc0ac763d44a1cb45cc9609a903602_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183MC9mcmFnOjg3MTEyNGQ1ZGE5NjRlM2ZhNjljYWUyNzdmMmUxOTE0L3RleHRyZWdpb246ODcxMTI0ZDVkYTk2NGUzZmE2OWNhZTI3N2YyZTE5MTRfNjU2_e5843ed5-062f-4865-8921-6b8dc33a651a"
      unitRef="usd">0</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i6a69ec0f4903459fb41ff3b295fb9cb3_I20210618"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183MC9mcmFnOjg3MTEyNGQ1ZGE5NjRlM2ZhNjljYWUyNzdmMmUxOTE0L3RleHRyZWdpb246ODcxMTI0ZDVkYTk2NGUzZmE2OWNhZTI3N2YyZTE5MTRfOTc5_e1e551c3-e2cf-4b0d-9d0d-7129ed9c8a96"
      unitRef="usd">1350000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromIssuanceOfCommercialPaper
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183MC9mcmFnOjg3MTEyNGQ1ZGE5NjRlM2ZhNjljYWUyNzdmMmUxOTE0L3RleHRyZWdpb246ODcxMTI0ZDVkYTk2NGUzZmE2OWNhZTI3N2YyZTE5MTRfMTQzOA_c207effd-d804-4855-9b52-eead5aea539f"
      unitRef="usd">527000000</us-gaap:ProceedsFromIssuanceOfCommercialPaper>
    <us-gaap:RepaymentsOfCommercialPaper
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183MC9mcmFnOjg3MTEyNGQ1ZGE5NjRlM2ZhNjljYWUyNzdmMmUxOTE0L3RleHRyZWdpb246ODcxMTI0ZDVkYTk2NGUzZmE2OWNhZTI3N2YyZTE5MTRfMTQ1Mg_296bac56-4129-4ee8-a5c7-8a7057da52cf"
      unitRef="usd">324000000</us-gaap:RepaymentsOfCommercialPaper>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="idfa1651ae6144d3fa003dba82a34e213_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183MC9mcmFnOjg3MTEyNGQ1ZGE5NjRlM2ZhNjljYWUyNzdmMmUxOTE0L3RleHRyZWdpb246ODcxMTI0ZDVkYTk2NGUzZmE2OWNhZTI3N2YyZTE5MTRfNTQ5NzU1ODE1NTAy_e47d2d03-bd98-42c4-9450-952ac2f6ebfd"
      unitRef="usd">238000000</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:ShortTermDebtWeightedAverageInterestRate
      contextRef="idfa1651ae6144d3fa003dba82a34e213_I20230131"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183MC9mcmFnOjg3MTEyNGQ1ZGE5NjRlM2ZhNjljYWUyNzdmMmUxOTE0L3RleHRyZWdpb246ODcxMTI0ZDVkYTk2NGUzZmE2OWNhZTI3N2YyZTE5MTRfMTU5NA_98cfd5c7-1937-4511-b0cf-deec50a0cdd6"
      unitRef="rate">0.0467</us-gaap:ShortTermDebtWeightedAverageInterestRate>
    <us-gaap:LongTermDebtTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183My9mcmFnOjhmNjQzZDU2Y2UwMTQzY2RiNTg3MmIyNTlkZDY5ZWU2L3RleHRyZWdpb246OGY2NDNkNTZjZTAxNDNjZGI1ODcyYjI1OWRkNjllZTZfMTk2NQ_ad072fc1-2093-4b43-a80a-1218e85790ab">LONG-TERM DEBT&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Term Loan Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 15, 2022, we entered into a term loan agreement with a group of financial institutions, which provided for a $600&#160;million delayed draw term loan that will mature on April 15, 2025. As of January&#160;31, 2023, we had $600&#160;million borrowings outstanding under the term loan facility and had a weighted average interest rate of 5.40 percent. Loans under the term loan agreement bear interest, at our option, either at: (i) the alternate base rate, as defined in the term loan agreement, plus the applicable margin for such loans or (ii) adjusted term SOFR, as defined in the term loan agreement, plus the applicable margin for such loans. The term loan agreement contains customary representations and warranties as well as customary affirmative and negative covenants. We were in compliance with the covenants for the term loan during the three months ended January&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the company&#x2019;s long-term senior notes:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.471%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized &lt;br/&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2031 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;All outstanding notes listed above are unsecured and rank equally in right of payment with all of Agilent&#x2019;s other senior unsecured indebtedness. There have been no other changes to the principal, maturity, interest rates and interest payment terms of the Agilent senior notes, detailed in the table above, in the three months ended January&#160;31, 2023, as compared to the senior notes described in our Annual Report on Form 10-K for the fiscal year ended October&#160;31, 2022.</us-gaap:LongTermDebtTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i00a9160afdad455eb4f9ec0885e50ae0_I20220415"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183My9mcmFnOjhmNjQzZDU2Y2UwMTQzY2RiNTg3MmIyNTlkZDY5ZWU2L3RleHRyZWdpb246OGY2NDNkNTZjZTAxNDNjZGI1ODcyYjI1OWRkNjllZTZfNTQ5NzU1ODE3NTYx_8c302ac9-925f-4e1c-90c6-2d80ed1662d1"
      unitRef="usd">600000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LongTermDebt
      contextRef="i08d40d57102743d89263c457fb2d9f57_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183My9mcmFnOjhmNjQzZDU2Y2UwMTQzY2RiNTg3MmIyNTlkZDY5ZWU2L3RleHRyZWdpb246OGY2NDNkNTZjZTAxNDNjZGI1ODcyYjI1OWRkNjllZTZfNTQ5NzU1ODE3NjQy_e5fe513e-ca01-4bdb-b5ef-6254f606c20f"
      unitRef="usd">600000000</us-gaap:LongTermDebt>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="i08d40d57102743d89263c457fb2d9f57_I20230131"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183My9mcmFnOjhmNjQzZDU2Y2UwMTQzY2RiNTg3MmIyNTlkZDY5ZWU2L3RleHRyZWdpb246OGY2NDNkNTZjZTAxNDNjZGI1ODcyYjI1OWRkNjllZTZfNTQ5NzU1ODE3NzQy_5beec9f4-5464-41b3-93e8-978771d10338"
      unitRef="number">0.054</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183My9mcmFnOjhmNjQzZDU2Y2UwMTQzY2RiNTg3MmIyNTlkZDY5ZWU2L3RleHRyZWdpb246OGY2NDNkNTZjZTAxNDNjZGI1ODcyYjI1OWRkNjllZTZfMTk1NA_4f70b975-42d2-4448-a143-68b9e7763e4e">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the company&#x2019;s long-term senior notes:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.471%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized &lt;br/&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2031 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i10c0cb7fda60466cb455e2be4d15041f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183My9mcmFnOjhmNjQzZDU2Y2UwMTQzY2RiNTg3MmIyNTlkZDY5ZWU2L3RhYmxlOjk5ODBhNGJiZGVmNjQzMzM5NTRmYWIyODVmMmVmYmJkL3RhYmxlcmFuZ2U6OTk4MGE0YmJkZWY2NDMzMzk1NGZhYjI4NWYyZWZiYmRfNC0xLTEtMS02ODc1MQ_b5c3f01c-1949-403b-9d29-a5502f460571"
      unitRef="usd">299000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i0b64ba8cd1f3436782785cc805950f95_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183My9mcmFnOjhmNjQzZDU2Y2UwMTQzY2RiNTg3MmIyNTlkZDY5ZWU2L3RhYmxlOjk5ODBhNGJiZGVmNjQzMzM5NTRmYWIyODVmMmVmYmJkL3RhYmxlcmFuZ2U6OTk4MGE0YmJkZWY2NDMzMzk1NGZhYjI4NWYyZWZiYmRfNC0zLTEtMS02ODc1MQ_f857a9cf-dc76-44d4-9be8-e7715ba3b68a"
      unitRef="usd">299000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i350ed86205aa4b80911ef00f731a2abd_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183My9mcmFnOjhmNjQzZDU2Y2UwMTQzY2RiNTg3MmIyNTlkZDY5ZWU2L3RhYmxlOjk5ODBhNGJiZGVmNjQzMzM5NTRmYWIyODVmMmVmYmJkL3RhYmxlcmFuZ2U6OTk4MGE0YmJkZWY2NDMzMzk1NGZhYjI4NWYyZWZiYmRfNS0xLTEtMS02ODc1MQ_677e6a28-bd7c-4878-9652-6ea0b0529e9a"
      unitRef="usd">495000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i783cb7ee1875433c87db62ff80483811_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183My9mcmFnOjhmNjQzZDU2Y2UwMTQzY2RiNTg3MmIyNTlkZDY5ZWU2L3RhYmxlOjk5ODBhNGJiZGVmNjQzMzM5NTRmYWIyODVmMmVmYmJkL3RhYmxlcmFuZ2U6OTk4MGE0YmJkZWY2NDMzMzk1NGZhYjI4NWYyZWZiYmRfNS0zLTEtMS02ODc1MQ_695e5916-ac4f-4fe2-8126-67c227992886"
      unitRef="usd">495000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i2079ee6072754438b4665c88d5465e25_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183My9mcmFnOjhmNjQzZDU2Y2UwMTQzY2RiNTg3MmIyNTlkZDY5ZWU2L3RhYmxlOjk5ODBhNGJiZGVmNjQzMzM5NTRmYWIyODVmMmVmYmJkL3RhYmxlcmFuZ2U6OTk4MGE0YmJkZWY2NDMzMzk1NGZhYjI4NWYyZWZiYmRfNi0xLTEtMS02ODc1MQ_385076a1-c8a2-4c4c-802f-6c601bc7b4fe"
      unitRef="usd">496000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i7455386a3c3948c1a56733c226910fac_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183My9mcmFnOjhmNjQzZDU2Y2UwMTQzY2RiNTg3MmIyNTlkZDY5ZWU2L3RhYmxlOjk5ODBhNGJiZGVmNjQzMzM5NTRmYWIyODVmMmVmYmJkL3RhYmxlcmFuZ2U6OTk4MGE0YmJkZWY2NDMzMzk1NGZhYjI4NWYyZWZiYmRfNi0zLTEtMS02ODc1MQ_7b25b847-c9b1-4a63-9088-07e05d9377c9"
      unitRef="usd">496000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i3d34be775eb5486e9dd8f335cc3b5197_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183My9mcmFnOjhmNjQzZDU2Y2UwMTQzY2RiNTg3MmIyNTlkZDY5ZWU2L3RhYmxlOjk5ODBhNGJiZGVmNjQzMzM5NTRmYWIyODVmMmVmYmJkL3RhYmxlcmFuZ2U6OTk4MGE0YmJkZWY2NDMzMzk1NGZhYjI4NWYyZWZiYmRfNy0xLTEtMS02ODc1MQ_61e8609d-fd4a-4413-9084-615226e3fbb8"
      unitRef="usd">843000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i8992aace108544bd92848aeb54b66881_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183My9mcmFnOjhmNjQzZDU2Y2UwMTQzY2RiNTg3MmIyNTlkZDY5ZWU2L3RhYmxlOjk5ODBhNGJiZGVmNjQzMzM5NTRmYWIyODVmMmVmYmJkL3RhYmxlcmFuZ2U6OTk4MGE0YmJkZWY2NDMzMzk1NGZhYjI4NWYyZWZiYmRfNy0zLTEtMS02ODc1MQ_74be7108-077d-470d-8a2d-545e4fac77b6"
      unitRef="usd">843000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i5d6a03bdbe0143bda21e2c1075865b76_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183My9mcmFnOjhmNjQzZDU2Y2UwMTQzY2RiNTg3MmIyNTlkZDY5ZWU2L3RhYmxlOjk5ODBhNGJiZGVmNjQzMzM5NTRmYWIyODVmMmVmYmJkL3RhYmxlcmFuZ2U6OTk4MGE0YmJkZWY2NDMzMzk1NGZhYjI4NWYyZWZiYmRfOC0xLTEtMS02ODc1MQ_2ffb53f4-aaa2-47f1-867b-2ac536470e33"
      unitRef="usd">2133000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i9cad5754c77d481a8d01dd8905da7bb4_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183My9mcmFnOjhmNjQzZDU2Y2UwMTQzY2RiNTg3MmIyNTlkZDY5ZWU2L3RhYmxlOjk5ODBhNGJiZGVmNjQzMzM5NTRmYWIyODVmMmVmYmJkL3RhYmxlcmFuZ2U6OTk4MGE0YmJkZWY2NDMzMzk1NGZhYjI4NWYyZWZiYmRfOC0zLTEtMS02ODc1MQ_64d2a4fd-ed5b-4984-8fe4-4e69e2143622"
      unitRef="usd">2133000000</us-gaap:LongTermDebt>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfMzMzNA_f3f14c7a-d6af-43d5-9eb7-3c36e2109cde">STOCKHOLDERS' EQUITY &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Repurchase Program &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 16, 2021 we announced that our board of directors had approved a new share repurchase program (the "2021 repurchase program") designed, among other things, to reduce or eliminate dilution resulting from issuance of stock under the company's employee equity incentive programs. The 2021 repurchase program authorizes the purchase of up to $2.0&#160;billion of our common stock at the company's discretion and has no fixed termination date. The 2021 repurchase program which became effective on February 18, 2021, replaced and terminated the 2019 repurchase program on that date. The 2021 repurchase &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;program does not require the company to acquire a specific number of shares and may be suspended, amended or discontinued at any time. During the three months ended January&#160;31, 2023, we repurchased and retired 499,000 shares for $75 million under this authorization. During the three months ended January&#160;31, 2022, we repurchased and retired 2.9 million shares for $447 million under this authorization. As of January&#160;31, 2023, we had remaining authorization to repurchase up to approximately $363 million of our common stock under the 2021 repurchase program. On March 1, 2023, the 2021 repurchase program was terminated and the remaining authorization of $339&#160;million expired.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 9, 2023, we announced that our board of directors had approved a share repurchase program (the "2023 repurchase program") designed, among other things, to reduce or eliminate dilution resulting from issuance of stock under the company's employee equity incentive programs. The 2023 repurchase program authorizes the purchase of up to $2.0&#160;billion of our common stock at the company's discretion and has no fixed termination date. The 2023 repurchase program does not require the company to acquire a specific number of shares and may be suspended, amended or discontinued at any time. The 2023 repurchase program commenced on March 1, 2023, and also terminated and replaced the 2021 repurchase program.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash Dividends on Shares of Common Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended January&#160;31, 2023, we paid cash dividends of $0.225 per common share or $67 million  on the company's common stock. During the three months ended January&#160;31, 2022, we paid cash dividends of  $0.210 per common share or $63 million on the company's common stock. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 22, 2023, our board of directors declared a quarterly dividend of $0.225 per share of common stock or approximately $67&#160;million which will be paid on April 26, 2023 to all shareholders of record at the close of business on April 4, 2023. The timing and amounts of any future dividends are subject to determination and approval by our board of directors.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accumulated Other Comprehensive Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in accumulated other comprehensive income (loss) by component and related tax effects were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.126%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.848%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.848%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.848%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.857%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net defined benefit pension cost and post retirement plan costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended January 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Prior service credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Actuarial Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized gains (losses) on derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(335)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified out of accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of January 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(153)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(280)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reclassifications out of accumulated other comprehensive income (loss) for the three months ended January&#160;31, 2023 and 2022 were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:4.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.504%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.731%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Details about accumulated other &lt;br/&gt;comprehensive income (loss) components&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amounts Reclassified from &lt;br/&gt;other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Affected line item in&lt;br/&gt;statement of operations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="12" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gain on derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTItNi0xLTEtNjg3NTE_c88580f0-1f89-414b-85e7-775437129012"&gt;6&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTItOC0xLTEtNjg3NTE_f8a759f4-726e-4284-aa80-54ef5c1c9cc9"&gt;3&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total before income tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net of income tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net defined benefit pension cost and post retirement plan costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial net gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total before income tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Provision) benefit for income tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net of income tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reclassifications for the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts in parentheses indicate reductions to income and increases to other comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reclassifications out of accumulated other comprehensive income (loss) of actuarial net gain (loss) in respect of retirement plans and post retirement pension plans are included in the computation of net periodic cost (see Note 11, "Retirement Plans and Post Retirement Pension Plans").&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i09d3df9f558a4787b3d731f7b3eab7d8_I20210218"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfMTMxOQ_ad1678cc-2872-4149-9006-fa49cfb7c3c5"
      unitRef="usd">2000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="ie3f5a8f5de1849ddac4ff626ed31a5af_D20221101-20230131"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfMTc1Nw_9d9f11ff-1524-409b-9deb-65f0ce4cdb33"
      unitRef="shares">499000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ie3f5a8f5de1849ddac4ff626ed31a5af_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfMTc3MQ_493f57d2-0b79-4cdf-9952-b7c13d01ff90"
      unitRef="usd">75000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="idd4e332392a048ae990d8d227847d292_D20211101-20220131"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfMTkxNQ_0f4c7dd8-77e8-45b4-9075-9cbee764762f"
      unitRef="shares">2900000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="idd4e332392a048ae990d8d227847d292_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfMTkyOQ_966ea73d-f5ae-470f-881d-cdb9438f26d6"
      unitRef="usd">447000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="id4f8c2b1ca13416f801985533f043e3e_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfMjA0OA_be6c53d7-141f-44e0-8e85-9595cf198fa6"
      unitRef="usd">363000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="ib27fcdd7d55f4e51b96ab02b41cb16f3_I20230301"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfMjE5OTAyMzI2MTkyOA_ebabced1-55cf-4fa6-96e5-a892a2d57727"
      unitRef="usd">339000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i2e36614039e441fc844c3eebaa2a03df_I20230109"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfMjE5OTAyMzI2MTM2MQ_2ab093b7-bc48-4462-86b3-07b1f19255f5"
      unitRef="usd">2000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfMjIwOA_6ebf8aad-f458-4321-9766-2fdf71942174"
      unitRef="usdPerShare">0.225</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfMjIzMQ_b7e3d26a-443e-4fbd-b6fd-126145404050"
      unitRef="usd">67000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfMjM5OQ_07d155d7-5e98-4057-96b1-2b3e1d8e84fa"
      unitRef="usdPerShare">0.210</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfMjQyMg_c8af8470-5ae3-450c-b932-af9c112f6315"
      unitRef="usd">63000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:DividendsPayableDateDeclaredDayMonthAndYear
      contextRef="i5cee235c15894fc79e55ebd92dddd62f_D20230222-20230222"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfNTQ5NzU1ODIyMDAy_dc2bead5-dade-4093-9321-71f9cbf5df74">2023-02-22</us-gaap:DividendsPayableDateDeclaredDayMonthAndYear>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i5cee235c15894fc79e55ebd92dddd62f_D20230222-20230222"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfNTQ5NzU1ODIxOTUx_33d83298-802d-42a0-923d-f83fe5eb8231"
      unitRef="usdPerShare">0.225</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i5cee235c15894fc79e55ebd92dddd62f_D20230222-20230222"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfNTQ5NzU1ODIxOTYx_db5d7693-630d-436a-a948-27615e70b331"
      unitRef="usd">67000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendPayableDateToBePaidDayMonthAndYear
      contextRef="i5cee235c15894fc79e55ebd92dddd62f_D20230222-20230222"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfNTQ5NzU1ODIyMDIx_ad6cfeb6-a3c7-4e1d-b718-636915856ba9">2023-04-26</us-gaap:DividendPayableDateToBePaidDayMonthAndYear>
    <us-gaap:DividendsPayableDateOfRecordDayMonthAndYear
      contextRef="i5cee235c15894fc79e55ebd92dddd62f_D20230222-20230222"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfNTQ5NzU1ODIyMDM3_46009cc8-86bb-4bcb-88a1-bf3a53bf5157">2023-04-04</us-gaap:DividendsPayableDateOfRecordDayMonthAndYear>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfMzMyNg_d7fa7dc1-2adc-48be-989b-e8721f52d1cc">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in accumulated other comprehensive income (loss) by component and related tax effects were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.126%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.848%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.848%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.848%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.857%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net defined benefit pension cost and post retirement plan costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended January 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Prior service credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Actuarial Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized gains (losses) on derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of October 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(335)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified out of accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of January 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(153)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(280)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9a78f97293c94b7a9a3259156a44fa2e_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMTctNC0xLTEtNjg3NTE_98c443ad-7a56-4c9b-8aff-ddc93eac572e"
      unitRef="usd">-335000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="if9481c6bfaca4632a77a30f531bb71a6_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMTctNi0xLTEtNjg3NTE_17a0c56c-4c97-4878-977b-85b6d78a299f"
      unitRef="usd">123000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id8f1f6f3136049d4be156f4751093caf_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMTctOC0xLTEtNjg3NTE_f63869da-8b21-447b-84bc-67681c9030eb"
      unitRef="usd">-155000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ie3afa252a57540f291b6c76329807920_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMTctMTAtMS0xLTY4NzUx_d48d7090-9595-4230-a7f8-0aa18ac10f1f"
      unitRef="usd">20000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i728f596925ae44e9bfb99f953f600ea9_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMTctMTItMS0xLTY4NzUx_e5bc1c6c-cc56-4ae2-89cf-7fa4f8ee99fa"
      unitRef="usd">-347000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i019e110038214039b7e2ec2a8a8e7c57_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMTktNC0xLTEtNjg3NTE_7624db94-3c88-4dbd-ae4b-6f383b3a86bb"
      unitRef="usd">90000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i6a083ba0b32e485283552d0ac7ca6ea6_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMTktNi0xLTEtNjg3NTE_ccddc823-25b6-41ac-8541-5e45b691f296"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="id3b66509fec04f3dbca28ec34bb295c1_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMTktOC0xLTEtNjg3NTE_33d42a73-c448-4e7f-a0f1-5cb9c6b7649b"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i408570a1fe564491867039bfbb606643_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMTktMTAtMS0xLTY4NzUx_0b548ad4-0613-44bf-9f34-fb513fa298d4"
      unitRef="usd">-31000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMTktMTItMS0xLTY4NzUx_78943a97-0ccb-4361-aa28-f06c95a014b3"
      unitRef="usd">62000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i019e110038214039b7e2ec2a8a8e7c57_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjEtNC0xLTEtNjg3NTE_47416801-3b93-4ccf-9e39-d4dd4608f382"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i6a083ba0b32e485283552d0ac7ca6ea6_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjEtNi0xLTEtNjg3NTE_4ec9c9a6-5743-4919-8ece-d61da0c581ad"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="id3b66509fec04f3dbca28ec34bb295c1_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjEtOC0xLTEtNjg3NTE_400a0100-b2c2-438a-a261-97bcf1a53ec5"
      unitRef="usd">-1000000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i408570a1fe564491867039bfbb606643_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjEtMTAtMS0xLTY4NzUx_48bfc078-a919-4bec-b0ef-bf293be9482b"
      unitRef="usd">-6000000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjEtMTItMS0xLTY4NzUx_faa4620f-9193-4959-8720-ee88a6559884"
      unitRef="usd">-7000000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i019e110038214039b7e2ec2a8a8e7c57_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjMtNC0xLTEtNjg3NTE_105c9024-3c36-49cf-8311-49b09a49906e"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i6a083ba0b32e485283552d0ac7ca6ea6_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjMtNi0xLTEtNjg3NTE_c0a1e90c-0d06-4110-8722-2615adbaa25e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="id3b66509fec04f3dbca28ec34bb295c1_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjMtOC0xLTEtNjg3NTE_6e8fc3e6-0cd6-4d75-9497-90dc536a23a2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i408570a1fe564491867039bfbb606643_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjMtMTAtMS0xLTY4NzUx_82f2aba1-346e-4e1f-91a3-dc3288eed0c9"
      unitRef="usd">-11000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjMtMTItMS0xLTY4NzUx_30bc5163-836f-4be6-9359-ebdc64b6ddea"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i019e110038214039b7e2ec2a8a8e7c57_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjUtNC0xLTEtNjg3NTE_ca5f29e8-ee7f-4beb-b6ca-bf42d552716b"
      unitRef="usd">91000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6a083ba0b32e485283552d0ac7ca6ea6_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjUtNi0xLTEtNjg3NTE_87345522-fafe-4c7d-9c89-552bfa5aae24"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id3b66509fec04f3dbca28ec34bb295c1_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjUtOC0xLTEtNjg3NTE_4c33e16e-9aea-46c9-81f1-0f2f6daf70ed"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i408570a1fe564491867039bfbb606643_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjUtMTAtMS0xLTY4NzUx_e2988399-c1a5-4ef4-9b5d-ccc570b3403d"
      unitRef="usd">-26000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjUtMTItMS0xLTY4NzUx_d126d6dc-ffe2-464f-a1ad-776964a2a8ce"
      unitRef="usd">67000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i3d54a60dc4d4494fbe0eee8846f953cb_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjctNC0xLTEtNjg3NTE_dc7e8db6-4d74-4807-ae2c-d908007cf6b2"
      unitRef="usd">-244000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="if9f56afb4f9643e593d0341fc1aa9b85_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjctNi0xLTEtNjg3NTE_a3a3984e-c2e5-427b-8eb1-4b740ae256f0"
      unitRef="usd">123000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i251d1854299d4023ad580a36c8fdb3f4_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjctOC0xLTEtNjg3NTE_a324b0bd-5f6c-4f1d-acf8-4d1d194e26a7"
      unitRef="usd">-153000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4876675b17484a69a10e8f4181f8a034_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjctMTAtMS0xLTY4NzUx_fe373432-abae-4c3f-b264-9620bc83c0f7"
      unitRef="usd">-6000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i658253fffabe4343b44569144474388f_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjhmYzRlOWEzMWQxZjQzZDM5Y2Y3MjljMTJlOGNlZTI0L3RhYmxlcmFuZ2U6OGZjNGU5YTMxZDFmNDNkMzljZjcyOWMxMmU4Y2VlMjRfMjctMTItMS0xLTY4NzUx_cdb50692-0d0c-46fe-bf6f-0684da29cb69"
      unitRef="usd">-280000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RleHRyZWdpb246ZWFmYTUxZTlhMzE2NGI3ZGE1ZmE3N2RkZWNkMzcyMWNfMzMzMA_58bc72d4-7f7b-4c1e-926f-c5d3712a0023">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reclassifications out of accumulated other comprehensive income (loss) for the three months ended January&#160;31, 2023 and 2022 were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:4.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.504%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.731%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Details about accumulated other &lt;br/&gt;comprehensive income (loss) components&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amounts Reclassified from &lt;br/&gt;other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Affected line item in&lt;br/&gt;statement of operations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="12" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gain on derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTItNi0xLTEtNjg3NTE_c88580f0-1f89-414b-85e7-775437129012"&gt;6&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTItOC0xLTEtNjg3NTE_f8a759f4-726e-4284-aa80-54ef5c1c9cc9"&gt;3&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total before income tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net of income tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net defined benefit pension cost and post retirement plan costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial net gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total before income tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Provision) benefit for income tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net of income tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reclassifications for the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTItNi0xLTEtNjg3NTE_8835540f-f237-412d-9e5c-08d13d7145a5"
      unitRef="usd">6000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTItOC0xLTEtNjg3NTE_d86647ec-d370-45b3-a632-ca1cdcd80121"
      unitRef="usd">3000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTQtNi0xLTEtNjg3NTE_2bdc009c-2406-4d88-a493-0bb0ecc4fbb7"
      unitRef="usd">6000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTQtOC0xLTEtNjg3NTE_2a212bd8-1a39-4d60-9a74-dd9e084166d9"
      unitRef="usd">3000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTUtNi0xLTEtNjg3NTE_7cf3f667-9f13-47f8-95d1-f2ee952c9475"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTUtOC0xLTEtNjg3NTE_3056f079-55fb-4eb2-a250-1bb3cc4b827f"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTYtNi0xLTEtNjg3NTE_b8101626-ec68-4339-819d-b1dbd00baa4c"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTYtOC0xLTEtNjg3NTE_f2f077b3-aa57-4dac-be7e-168da47b21d1"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTktNi0xLTEtNjg3NTE_9d479cdf-5c95-4cce-ab78-764b3afb300d"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMTktOC0xLTEtNjg3NTE_c446a000-771a-45b6-a078-99c130b7dfe3"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMjEtNi0xLTEtNjg3NTE_bf88be26-3d34-4103-bb2c-f012ad7ce3df"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMjEtOC0xLTEtNjg3NTE_c29ac514-09b9-4c59-ab61-f0a7bec695cb"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMjItNi0xLTEtNjg3NTE_27a8743e-88e2-4b0e-94f7-5a9c397fe196"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMjItOC0xLTEtNjg3NTE_e1aff65d-323a-41d0-a0f5-fadd64b0fdec"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMjMtNi0xLTEtNjg3NTE_509f77b2-366c-41fd-a7bc-37e3659949f8"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMjMtOC0xLTEtNjg3NTE_67479d95-5d3c-4f2e-884c-c0c045ddb75c"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMjUtNi0xLTEtNjg3NTE_c4bd6e94-93f6-4612-b124-1b99fbcd19d5"
      unitRef="usd">4000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183Ni9mcmFnOmVhZmE1MWU5YTMxNjRiN2RhNWZhNzdkZGVjZDM3MjFjL3RhYmxlOjIzNDAwYTM1YzNiMzQ5NmFiYmQyMjMzNWM0ZmQ3ZDJiL3RhYmxlcmFuZ2U6MjM0MDBhMzVjM2IzNDk2YWJiZDIyMzM1YzRmZDdkMmJfMjUtOC0xLTEtNjg3NTE_08245795-bf8d-4bac-8fdf-eee99cb69075"
      unitRef="usd">-3000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RleHRyZWdpb246NDE1MGJiNmMyODBmNDZkNmI5ZGRkYTEwY2QxOTZkY2JfOTE2OQ_25053f9a-6e09-4ea4-ac7c-4e27603856f4">SEGMENT INFORMATION&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Description of segments.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  We are a global leader in life sciences, diagnostics and applied chemical markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We continue to have three business segments comprised of life sciences and applied markets, diagnostics and genomics and Agilent CrossLab, each of which continues to comprise a reportable segment. The three operating segments were determined based primarily on how the chief operating decision maker views and evaluates our operations. Operating results are regularly reviewed by the chief operating decision maker to make decisions about resources to be allocated to the segment and to assess its performance. Other factors, including market separation and customer specific applications, go-to-market channels, products and services and manufacturing are considered in determining the formation of these operating segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A description of our three reportable segments is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our life sciences and applied markets business provides application-focused solutions that include instruments, consumables and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. Key product categories include: liquid chromatography ("LC") systems and components; liquid chromatography mass spectrometry ("LCMS") systems; gas chromatography ("GC") systems and components; gas chromatography mass spectrometry ("GCMS") systems; inductively coupled plasma mass spectrometry ("ICP-MS") instruments; atomic absorption ("AA") instruments; microwave plasma-atomic emission spectrometry ("MP-AES") instruments; inductively coupled plasma optical emission spectrometry ("ICP-OES") instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software for sample tracking; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps and measurement technologies. Our consumables portfolio is designed to improve customer outcomes. Most of the portfolio is vendor neutral, meaning Agilent can serve and supply customers regardless of their instrument purchase &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;choices. Solutions range from chemistries to supplies. Key product categories in consumables include GC and LC columns, sample preparation products, custom chemistries, and a large selection of laboratory instrument supplies.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our diagnostics and genomics business is comprised of six areas of activity providing active pharmaceutical ingredients ("APIs") for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables, which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level.&#160;First, our genomics business includes arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, as well as next generation sequencing ("NGS") target enrichment and genetic data management and interpretation support software. This business also includes solutions that enable clinical labs to identify DNA variants associated with genetic disease and help direct cancer therapy. Second, our nucleic acid solutions business is a contract and development manufacturing organization that provides services related to and the production of synthesized oligonucleotides under pharmaceutical good manufacturing practices ("GMP") conditions for use as API in a class of drugs that utilize nucleic acid molecules for disease therapy. Third, our pathology solutions business is focused on product offerings for cancer diagnostics and anatomic pathology workflows. The broad portfolio of offerings includes immunohistochemistry ("IHC"), in situ hybridization ("ISH"), hematoxylin and eosin ("H&amp;amp;E") staining and special staining. Fourth, we also collaborate with a number of major pharmaceutical companies to develop new potential tissue and liquid-based pharmacodiagnostics, also known as companion diagnostics, which may be used to identify patients most likely to benefit from a specific targeted therapy. Fifth, the reagent partnership business provides clinical flow cytometry reagents for routine cancer diagnostics. This business also provides bulk antibodies as raw materials and associated assay development services to IVD manufacturers, biotechnology and pharmaceutical companies. Finally, our biomolecular analysis business provides complete workflow solutions, including instruments, consumables and software, for quality control analysis of nucleic acid samples. Samples are analyzed using quantitative and qualitative techniques to ensure accuracy in further genomics analysis techniques including NGS, utilized in clinical and life science research applications.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Agilent CrossLab business spans the entire lab with its extensive services portfolio, which is designed to improve customer outcomes.  The majority of the portfolio is vendor neutral, meaning we can serve and supply customers regardless of their instrument purchase choices.  &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The services portfolio include repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting and various other custom services to support the customers' laboratory operations.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  Custom services are tailored to meet the specific application needs of various industries and to keep instruments fully operational and compliant with the respective industry requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A significant portion of the segments' expenses arise from shared services and infrastructure that we have historically provided to the segments in order to realize economies of scale and to efficiently use resources. These expenses, collectively called corporate charges, include legal, accounting, tax, real estate, insurance services, information technology services, treasury, order administration, other corporate infrastructure expenses, costs of centralized research and development and joint sales and marketing costs. Charges are allocated to the segments, and the allocations have been determined on a basis that we consider to be a reasonable reflection of the utilization of services provided to or benefits received by the segments. In addition, we do not allocate asset impairments, amortization of acquisition-related intangible assets, change in the fair value of acquisition-related contingent consideration, acquisition and integration costs, transformational initiatives expenses, business exit and divestiture costs and certain other charges to the operating margin for each segment because management does not include this information in its measurement of the performance of the operating segments. Transformational initiatives include expenses associated with targeted cost reduction activities such as manufacturing transfers, site consolidations, legal entity and other business reorganizations, in-sourcing or outsourcing of activities. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables reflect the results of our reportable segments under our management reporting system. The performance of each segment is measured based on several metrics, including segment income from operations. These results are used, in part, by the chief operating decision maker in evaluating the performance of, and in allocating resources to, each of the segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The profitability of each of the segments is measured after excluding items such as transformational initiatives, acquisition and integration costs, amortization of intangible assets related to business combinations, interest income, interest expense and other items as noted in the reconciliations below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life Sciences and Applied Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics and Genomics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agilent CrossLab&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment Income From Operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life Sciences and Applied Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics and Genomics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agilent CrossLab&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment income from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles segment income from operations to Agilent&#x2019;s total enterprise income before taxes:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment income from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transformational initiatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets related to business combinations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition and integration costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense), net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before taxes, as reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) For the three months ended January&#160;31, 2023 and 2022, other income (expense), net includes net (gains) losses on the fair value of equity securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reflects segment assets under our management reporting system. Segment assets include allocations of corporate assets, goodwill, net other intangibles and other assets. Unallocated assets primarily consist of cash, cash equivalents, short-term and long-term investments, deferred tax assets, right-of-use assets and other assets. &#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life Sciences and Applied Markets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics and Genomics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agilent CrossLab&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RleHRyZWdpb246NDE1MGJiNmMyODBmNDZkNmI5ZGRkYTEwY2QxOTZkY2JfMTIyOA_199c20eb-95bd-4d93-9075-6183d147bc32"
      unitRef="number">3</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfOperatingSegments
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RleHRyZWdpb246NDE1MGJiNmMyODBmNDZkNmI5ZGRkYTEwY2QxOTZkY2JfMTIyOA_baaedd7f-df6f-42ce-beb3-88d0269e3e97"
      unitRef="number">3</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RleHRyZWdpb246NDE1MGJiNmMyODBmNDZkNmI5ZGRkYTEwY2QxOTZkY2JfMTIyOA_c5416e8c-902a-4e7f-acce-8004e3d5e892"
      unitRef="number">3</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfOperatingSegments
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RleHRyZWdpb246NDE1MGJiNmMyODBmNDZkNmI5ZGRkYTEwY2QxOTZkY2JfMTIyOA_f1a4f9aa-9f37-4874-bbe7-63a4ea4f2239"
      unitRef="number">3</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RleHRyZWdpb246NDE1MGJiNmMyODBmNDZkNmI5ZGRkYTEwY2QxOTZkY2JfOTE1Mg_ef82e198-f0a3-4ee3-a0da-4e314f8a09b1">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The profitability of each of the segments is measured after excluding items such as transformational initiatives, acquisition and integration costs, amortization of intangible assets related to business combinations, interest income, interest expense and other items as noted in the reconciliations below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life Sciences and Applied Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics and Genomics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agilent CrossLab&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment Income From Operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life Sciences and Applied Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics and Genomics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agilent CrossLab&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment income from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reflects segment assets under our management reporting system. Segment assets include allocations of corporate assets, goodwill, net other intangibles and other assets. Unallocated assets primarily consist of cash, cash equivalents, short-term and long-term investments, deferred tax assets, right-of-use assets and other assets. &#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life Sciences and Applied Markets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics and Genomics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agilent CrossLab&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i90bc58b4dc464d058d4f7d56e61e2e21_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjUyMTlkNTJlNmM0MjRlMDk5OGI3YjY4MTc2YWY3MDNiL3RhYmxlcmFuZ2U6NTIxOWQ1MmU2YzQyNGUwOTk4YjdiNjgxNzZhZjcwM2JfNS01LTEtMS02ODc1MQ_602289a6-9ca9-4c13-ace3-b55e7159a82a"
      unitRef="usd">1033000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibfc4fdb619ed43958b648563fb2ca526_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjUyMTlkNTJlNmM0MjRlMDk5OGI3YjY4MTc2YWY3MDNiL3RhYmxlcmFuZ2U6NTIxOWQ1MmU2YzQyNGUwOTk4YjdiNjgxNzZhZjcwM2JfNS03LTEtMS02ODc1MQ_25f8d12c-fda2-4d16-b31f-e7d99c00ca48"
      unitRef="usd">976000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i405a137dbfd148ab9797e53157dcb87b_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjUyMTlkNTJlNmM0MjRlMDk5OGI3YjY4MTc2YWY3MDNiL3RhYmxlcmFuZ2U6NTIxOWQ1MmU2YzQyNGUwOTk4YjdiNjgxNzZhZjcwM2JfNi01LTEtMS02ODc1MQ_4004987c-f20f-4c0e-8e53-55dd9e423358"
      unitRef="usd">342000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if846265414d142bd8d679b7776dae8eb_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjUyMTlkNTJlNmM0MjRlMDk5OGI3YjY4MTc2YWY3MDNiL3RhYmxlcmFuZ2U6NTIxOWQ1MmU2YzQyNGUwOTk4YjdiNjgxNzZhZjcwM2JfNi03LTEtMS02ODc1MQ_65d20ef7-88aa-4c27-91da-87f3a8f536df"
      unitRef="usd">339000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d83c1345e874e8fabdab7fd0ec051b6_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjUyMTlkNTJlNmM0MjRlMDk5OGI3YjY4MTc2YWY3MDNiL3RhYmxlcmFuZ2U6NTIxOWQ1MmU2YzQyNGUwOTk4YjdiNjgxNzZhZjcwM2JfNy01LTEtMS02ODc1MQ_637cd99c-02f0-43c4-8f67-3866b2521ff4"
      unitRef="usd">381000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i23ae7b4eb6644b20adf956a785dc7849_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjUyMTlkNTJlNmM0MjRlMDk5OGI3YjY4MTc2YWY3MDNiL3RhYmxlcmFuZ2U6NTIxOWQ1MmU2YzQyNGUwOTk4YjdiNjgxNzZhZjcwM2JfNy03LTEtMS02ODc1MQ_447de2b5-9def-4a5a-ad3b-41dab750c330"
      unitRef="usd">359000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i899550b909f344acbdc4d7dab570fb1d_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjUyMTlkNTJlNmM0MjRlMDk5OGI3YjY4MTc2YWY3MDNiL3RhYmxlcmFuZ2U6NTIxOWQ1MmU2YzQyNGUwOTk4YjdiNjgxNzZhZjcwM2JfOC01LTEtMS02ODc1MQ_52453162-4b94-487a-a350-1755c8fa55b0"
      unitRef="usd">1756000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0e1195fba3dd4542a09cd93dc4067241_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjUyMTlkNTJlNmM0MjRlMDk5OGI3YjY4MTc2YWY3MDNiL3RhYmxlcmFuZ2U6NTIxOWQ1MmU2YzQyNGUwOTk4YjdiNjgxNzZhZjcwM2JfOC03LTEtMS02ODc1MQ_5f3f320d-0c46-4c28-849b-812d087a1cf1"
      unitRef="usd">1674000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i90bc58b4dc464d058d4f7d56e61e2e21_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjUyMTlkNTJlNmM0MjRlMDk5OGI3YjY4MTc2YWY3MDNiL3RhYmxlcmFuZ2U6NTIxOWQ1MmU2YzQyNGUwOTk4YjdiNjgxNzZhZjcwM2JfMTEtNS0xLTEtNjg3NTE_767bba40-d45c-48de-a960-b1edde558c9f"
      unitRef="usd">314000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibfc4fdb619ed43958b648563fb2ca526_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjUyMTlkNTJlNmM0MjRlMDk5OGI3YjY4MTc2YWY3MDNiL3RhYmxlcmFuZ2U6NTIxOWQ1MmU2YzQyNGUwOTk4YjdiNjgxNzZhZjcwM2JfMTEtNy0xLTEtNjg3NTE_aca57ce2-3beb-4663-b5f8-69b38ea8e9a7"
      unitRef="usd">282000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i405a137dbfd148ab9797e53157dcb87b_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjUyMTlkNTJlNmM0MjRlMDk5OGI3YjY4MTc2YWY3MDNiL3RhYmxlcmFuZ2U6NTIxOWQ1MmU2YzQyNGUwOTk4YjdiNjgxNzZhZjcwM2JfMTItNS0xLTEtNjg3NTE_4a8d49d7-1093-4911-af64-150c48b2b153"
      unitRef="usd">59000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if846265414d142bd8d679b7776dae8eb_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjUyMTlkNTJlNmM0MjRlMDk5OGI3YjY4MTc2YWY3MDNiL3RhYmxlcmFuZ2U6NTIxOWQ1MmU2YzQyNGUwOTk4YjdiNjgxNzZhZjcwM2JfMTItNy0xLTEtNjg3NTE_b28ad539-6ac4-4b4f-813c-c009aa14ae55"
      unitRef="usd">68000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6d83c1345e874e8fabdab7fd0ec051b6_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjUyMTlkNTJlNmM0MjRlMDk5OGI3YjY4MTc2YWY3MDNiL3RhYmxlcmFuZ2U6NTIxOWQ1MmU2YzQyNGUwOTk4YjdiNjgxNzZhZjcwM2JfMTMtNS0xLTEtNjg3NTE_548fc901-d89b-4fcc-b90a-c062ea6812be"
      unitRef="usd">103000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i23ae7b4eb6644b20adf956a785dc7849_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjUyMTlkNTJlNmM0MjRlMDk5OGI3YjY4MTc2YWY3MDNiL3RhYmxlcmFuZ2U6NTIxOWQ1MmU2YzQyNGUwOTk4YjdiNjgxNzZhZjcwM2JfMTMtNy0xLTEtNjg3NTE_89ef56f2-21b3-4798-83a5-02e575e5cced"
      unitRef="usd">91000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i899550b909f344acbdc4d7dab570fb1d_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjUyMTlkNTJlNmM0MjRlMDk5OGI3YjY4MTc2YWY3MDNiL3RhYmxlcmFuZ2U6NTIxOWQ1MmU2YzQyNGUwOTk4YjdiNjgxNzZhZjcwM2JfMTQtNS0xLTEtNjg3NTE_06a56d5b-b4ed-47ac-aac7-b4ed01c32e98"
      unitRef="usd">476000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0e1195fba3dd4542a09cd93dc4067241_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjUyMTlkNTJlNmM0MjRlMDk5OGI3YjY4MTc2YWY3MDNiL3RhYmxlcmFuZ2U6NTIxOWQ1MmU2YzQyNGUwOTk4YjdiNjgxNzZhZjcwM2JfMTQtNy0xLTEtNjg3NTE_e20ed75c-04c8-4e48-9823-f0a14c2099d4"
      unitRef="usd">441000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RleHRyZWdpb246NDE1MGJiNmMyODBmNDZkNmI5ZGRkYTEwY2QxOTZkY2JfOTE3Nw_0d63d122-8418-40cc-94b4-ca7bf11cdbcb">&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles segment income from operations to Agilent&#x2019;s total enterprise income before taxes:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment income from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transformational initiatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets related to business combinations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition and integration costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense), net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before taxes, as reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) For the three months ended January&#160;31, 2023 and 2022, other income (expense), net includes net (gains) losses on the fair value of equity securities.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:OperatingIncomeLoss
      contextRef="i899550b909f344acbdc4d7dab570fb1d_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfNC01LTEtMS02ODc1MQ_67468402-515c-4319-bcb9-684c6d1c01d6"
      unitRef="usd">476000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0e1195fba3dd4542a09cd93dc4067241_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfNC03LTEtMS02ODc1MQ_8fc0b411-8f05-4237-baa3-b62b863148d1"
      unitRef="usd">441000000</us-gaap:OperatingIncomeLoss>
    <a:TransformationalPrograms
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfNS01LTEtMS02ODc1MQ_0574b593-0ec3-4043-ac0d-fd0e9619f50d"
      unitRef="usd">7000000</a:TransformationalPrograms>
    <a:TransformationalPrograms
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfNS03LTEtMS02ODc1MQ_647461b5-9020-4f30-a3ff-0fc5c1e21b76"
      unitRef="usd">4000000</a:TransformationalPrograms>
    <us-gaap:AdjustmentForAmortization
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfNi01LTEtMS02ODc1MQ_1fc90913-1a27-4ed3-81c4-e19fee483d09"
      unitRef="usd">36000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfNi03LTEtMS02ODc1MQ_bf2ad4be-24b0-4a16-b759-ff7165c19ca3"
      unitRef="usd">51000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfNy01LTEtMS02ODc1MQ_b62d725b-fc64-4d42-b823-24c2c82b9922"
      unitRef="usd">2000000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfNy03LTEtMS02ODc1MQ_d773e464-8a64-498a-8bf5-522d78be4257"
      unitRef="usd">7000000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfOS01LTEtMS02ODc1MQ_17d8fc12-7320-4897-b078-6d97ce8f91cd"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfOS03LTEtMS02ODc1MQ_121fa7b2-132f-4dbe-afda-2351be131e98"
      unitRef="usd">3000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:OtherNonrecurringExpense
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfMTUtNS0xLTEtNjg3NTE_277b3046-736a-4b10-8758-21f2f07be238"
      unitRef="usd">4000000</us-gaap:OtherNonrecurringExpense>
    <us-gaap:OtherNonrecurringExpense
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfMTUtNy0xLTEtNjg3NTE_564413e9-15dc-4c6f-a7e6-46f2c7da2071"
      unitRef="usd">0</us-gaap:OtherNonrecurringExpense>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfMTYtNS0xLTEtNjg3NTE_1615350a-6d77-43e3-bbd8-9d9359e7b5c1"
      unitRef="usd">9000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfMTYtNy0xLTEtNjg3NTE_9e144256-cfdf-44ed-8520-d179e2019cec"
      unitRef="usd">1000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfMTctNS0xLTEtNjg3NTE_350b57ce-c3a1-4a75-b4a7-29fffc0f4632"
      unitRef="usd">25000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfMTctNy0xLTEtNjg3NTE_f78be576-9a67-4edd-b240-45c499ad57d1"
      unitRef="usd">21000000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfMTgtNS0xLTEtNjg3NTE_4dde0977-3384-4202-9641-26fb5b0f3fad"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfMTgtNy0xLTEtNjg3NTE_9a81c65b-033b-43c4-91ec-446905e872f2"
      unitRef="usd">-37000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i70d639bf42ac431baa789730eb29b398_D20221101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfMTktNS0xLTEtNjg3NTE_849a7012-463c-48b4-8c2b-63e238b51f6f"
      unitRef="usd">410000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib808477c48624d6eab8344fe246a9e83_D20211101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjk0M2UxMTgxZDFlNzRmN2M5Mzg4ZmE4ZGRjZmY1ODUyL3RhYmxlcmFuZ2U6OTQzZTExODFkMWU3NGY3YzkzODhmYThkZGNmZjU4NTJfMTktNy0xLTEtNjg3NTE_2bc7d2d6-b534-434f-9ddd-384d1d48875e"
      unitRef="usd">319000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:Assets
      contextRef="i9e0c874f1a2f4b52bde701c5d0c5f04a_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjM0ODQ2YWIyYjk2OTQ3ZGJiYWEzYTkyNDBkZTE3ZjNmL3RhYmxlcmFuZ2U6MzQ4NDZhYjJiOTY5NDdkYmJhYTNhOTI0MGRlMTdmM2ZfMy0xLTEtMS02ODc1MQ_a9a2fdc4-6567-48d4-9215-8bc1eaf1c22b"
      unitRef="usd">4004000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i14749e019f0c4a78a5749fbc0e9602a5_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjM0ODQ2YWIyYjk2OTQ3ZGJiYWEzYTkyNDBkZTE3ZjNmL3RhYmxlcmFuZ2U6MzQ4NDZhYjJiOTY5NDdkYmJhYTNhOTI0MGRlMTdmM2ZfMy0zLTEtMS02ODc1MQ_f59bf4d3-bf9e-47d7-a0aa-41dcc7ce2703"
      unitRef="usd">3955000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ic29288e8bc2e49b7b040c7b53788b074_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjM0ODQ2YWIyYjk2OTQ3ZGJiYWEzYTkyNDBkZTE3ZjNmL3RhYmxlcmFuZ2U6MzQ4NDZhYjJiOTY5NDdkYmJhYTNhOTI0MGRlMTdmM2ZfNC0xLTEtMS02ODc1MQ_5903ea2c-3640-4ec7-a420-ee2627c2ffa8"
      unitRef="usd">3520000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i4c417edb3d704da7925a02009feeff69_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjM0ODQ2YWIyYjk2OTQ3ZGJiYWEzYTkyNDBkZTE3ZjNmL3RhYmxlcmFuZ2U6MzQ4NDZhYjJiOTY5NDdkYmJhYTNhOTI0MGRlMTdmM2ZfNC0zLTEtMS02ODc1MQ_35d8cff0-8888-4df7-a6d8-dee5eb86b082"
      unitRef="usd">3489000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i39cb63aace124a70b0cf20f2781b5388_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjM0ODQ2YWIyYjk2OTQ3ZGJiYWEzYTkyNDBkZTE3ZjNmL3RhYmxlcmFuZ2U6MzQ4NDZhYjJiOTY5NDdkYmJhYTNhOTI0MGRlMTdmM2ZfNS0xLTEtMS02ODc1MQ_99d272c3-2878-4d44-b0c5-97e6f74a9dd6"
      unitRef="usd">962000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ibdb82786efda42a99e13832f0a499c71_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjM0ODQ2YWIyYjk2OTQ3ZGJiYWEzYTkyNDBkZTE3ZjNmL3RhYmxlcmFuZ2U6MzQ4NDZhYjJiOTY5NDdkYmJhYTNhOTI0MGRlMTdmM2ZfNS0zLTEtMS02ODc1MQ_bb0a6c15-a08b-444f-b4c7-5da83c856693"
      unitRef="usd">869000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia34e53066283455d9839cece675eac92_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjM0ODQ2YWIyYjk2OTQ3ZGJiYWEzYTkyNDBkZTE3ZjNmL3RhYmxlcmFuZ2U6MzQ4NDZhYjJiOTY5NDdkYmJhYTNhOTI0MGRlMTdmM2ZfNi0xLTEtMS02ODc1MQ_38f70046-ef9b-4ff4-b9c3-f0e6209aa5ca"
      unitRef="usd">8486000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i927186f756bc4f41b7276527c4ebea8a_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxZTQ2ZDA3OTVhMjRhYzJhNGVkMjNkMTc3NjVlYjE3L3NlYzplMWU0NmQwNzk1YTI0YWMyYTRlZDIzZDE3NzY1ZWIxN183OS9mcmFnOjQxNTBiYjZjMjgwZjQ2ZDZiOWRkZGExMGNkMTk2ZGNiL3RhYmxlOjM0ODQ2YWIyYjk2OTQ3ZGJiYWEzYTkyNDBkZTE3ZjNmL3RhYmxlcmFuZ2U6MzQ4NDZhYjJiOTY5NDdkYmJhYTNhOTI0MGRlMTdmM2ZfNi0zLTEtMS02ODc1MQ_a62f562a-db28-49a6-8b1a-6bc579e63c16"
      unitRef="usd">8313000000</us-gaap:Assets>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>97
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MWZS?CCT\JBYGZ8?847YHG,#Z,]]),)]'^ [<RHDK5G&>POBPTOBPHXR/6;N
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MUI&QBJ/]W-&^R7K949V?J;*;**N4LY\YPX$[Z>W+^#5"[K"?"U5P#7)< V,
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MSJ<.HPCW@6\P"D>V"M81RW<C:[GF0M4E+*$K<WW5V8,#K7;I1H&M/G1\\MV
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M9[!!L ;P_5Q*L[NP/U"]CS7^/U!+ P04    " "-EF)6.4@NNT@'  !).@
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ML^]FI[:RC\]_FSQC&2]1?H>6G>DBR<0]>XTRL:(17W+Z0]?E#F270\)\2%@
M"0LA81$0K),^[CY]7.,HO12IL4L376JX2L*2B32$YD9^WXA#P@)7^2U0:A]"
M.HS,#COQ\?;Q\8SQV:T"=,,:O4S%:N"5+FR>4H\A]J2P&=WV#1LD+("$A2=T
M160NTPG;>!^VL3%LNR77<V9C([?O; P)\R%A 20LA(1%8W40>V-]-DSVV3 Q
M9L.<EBL4)P])S,23DGA07J9B>1SKPF\$]0T_),R'A 43I9,]>6:&]!<9_75B
M.MW'=&J,:?V$,ZQ$D!C11UJ(N"9EN67QX0"OGX5V#\O:B=KHHF^TITH;IV-I
M!>I#.@P@82$D+ *"=1(#6ZVB8CTO-;2BB)'5-P= :7Y#Z_PRVM*O9P#J,@2E
M14\TH!O? \4,F^-;*2GHAFVVQ7*UBW(6BWN>B$D=^=NB>NB]9D62B\E@IX1H
M(V_TTCOR6&TJF5IC:0( =1J TD)06@1%ZR9)*XMALR[6*TF^T'2K?0 S.^F=
M(Y T'ZM:V]">R+.#II!C3:7?>M"*15J?SI$U'&[U+&P6M ZG]6IE+Y;UM-*.
MM7$#U;% :7Y#.^P>QY'#!NDQ!*5%YOIW@]NJ:-BHLLR"+#9HV'_1;"];$FV\
M046TAM95L2TREM5+4*\!*"T$I450M&YVM"(9-JMD4G:<E!&0RM(<JTJ<D@RJ
M^N2*!8 \L-52V%6F8[606$M(4WND<XC=8R.Q%;RP6?'JM:&D[WI(!6F.57F(
M3%TB=YH/ZC4 I86@M B*UDV05EK#9FWMR8TE?5* "FL-S3@>52')M8DKCT>U
ME$T<>3RJA8:V,Y;'H\ZAY1X9CZUVA2?_\P83!A6U0&D^*"T I86@M B*UDVC
M5B[#9KW,O-&$5?'*=B7Q:F[VT#ORH%K8*0T(05U&3[CLGN9HQ2MB%J^>M>'4
M, ^G0T^:GN9FOWVC!TH+0&DA454GN3<B<YEN[%IABIB%J>?O.IG!O0_A0-)\
M4%H 2@M!:1%1-3P''SD?0@X.:)F5J!Z[3V92[S0 E9M :0%1-2)YC(:@'B.S
MQVYL6TV*G*Y)/7L7RNRC=]15>09;'I8/X$'Z#$!I(2@M@J)U,Z05MHA9V.JU
M&65F]<X$T,-@1!7%AE@:L@&HRQ"4%CW1@&Y\6VF*F*4IH,THLY?>D=<(2,Y4
M5DQ ?0:@M!"4%D'1NCG22FK$+*G![$69G?1.$= #:$1SADN9&S1E//D<+VBU
M(FVUCB@RI!7 B%D Z[,194;U#AKH@3*B"E;*1A2HQQ"4%IGKWPUN*[<1\UFQ
MTS>B;&V\0;4VHIZ;(E-W0I35'*B*!DH+06D1%*V;':V*1LPJFGDC2I\1H(?,
M&II)^-84<6U'%KYUI1PLS\9JH2&96+*6HD%YEOS</#IX1ZYZR?(3+>Z3K$0I
MNQ-FUINQR/)B]][B[H;GF_JUN:\YY_FZOEPQ&K.B*B"^O\MS_NNF>A-O__;H
M[#]02P,$%     @ C99B5BY)<'ZR @  =@8  !@   !X;"]W;W)K<VAE971S
M+W-H965T.2YX;6RM55UOFS 4_2M7K-I6J0T$DJSJ$J1\5<W4M%E)-TW3'ARX
M"58!4]M)VG\_VQ"69C3:PU[ OK[G^)R+?>EN&7\4,:*$YS3)1,^*I<PO;5N$
M,:9$-%B.F5I9,IX2J:9\98N<(XD,*$ULUW$Z=DIH9OE=$YMQO\O6,J$9SCB(
M=9H2_C+ A&U[5M/:!>[I*I8Z8/O=G*PP0/F0S[B:V15+1%/,!&49<%SVK'[S
M<MC6^2;A&\6MV!N#=K)@[%%/)E'/<K0@3#"4FH&HUP:'F"2:2,EX*CFM:DL-
MW!_OV*^,=^5E000.6?*=1C+N61<61+@DZT3>L^TUEGZ,P) EPCQA6^8Z%H1K
M(5E:@I6"E&;%FSR7==@#*)YZ@%L"W$- ZPV 5P(\8[109FR-B"1^E[,M<)VM
MV/3 U,:@E1N:Z:\82*Y6J<))?WAW.QK?!N,1J%%P=S,9]>=C".;J.1W?SN'N
M"L9?'R;S'W .'V?]>Q6['L\GP_[-J8H\!"/X>'(*)T SF-(D45]&=&VIA&EZ
M.RQ%# H1[ALB/)BR3,8"QEF$T6N\K0Q5KMR=JX%[E/ +R1K@-<_ =5RO1L_P
MW^'N$3E>563/\'EO\ 622%1'7P);0B!9^!BS)$(N/L#X:4WE"_SL+X3DZDS_
MJJM>P=ZJ9]?W_%+D),2>I2ZR0+Y!RW__KMEQ/M=9_T]DKPK1J@K1.L;NC^B&
M1IA% D88)H1C!#FJGA*K89WQ@NW"L.E^M/&=ANNVN_9FWU%M5K-*>J6T72EM
M'U4::$GGND%$T-\2'IW!G#S7:2QX.GN[MYL' O].Z7@'\NR]*YPB7YG.)B!D
MZTP6Y[Z*5LVS;WK&07R@FFK1 __0%!UY2OB*9@(27"I*I_%)R>)%ERLFDN6F
M42R85&W'#&/U8T"N$]3ZDC&YF^@-JE^-_QM02P,$%     @ C99B5KU=FL!S
M#   ,B(  !D   !X;"]W;W)K<VAE971S+W-H965T,3 N>&ULM5II;QLY$OTK
MA"88)( LZX@GMP'%<68].SY@.QDL%ON!ZJ8D)MW-#LF6K'^_KXKL0[;LL6=W
M$"#N@RQ6%:M>/5;K_=K8[VZIE!<W>5:X#[VE]^7;_7V7+%4NW<"4JL";N;&Y
M]+BUBWU76B53GI1G^^/A\)?]7.JB=_B>GUW8P_>F\IDNU(45KLIS:3<?56;6
M'WJC7OW@4B^6GA[L'[XOY4)=*?^EO+"XVV^DI#I7A=.F$%;-/_2FH[<?7])X
M'O!5J[7K7 NR9&;,=[HY23_TAJ20RE3B28+$GY4Z4EE&@J#&CRBSURQ)$[O7
MM?3/;#MLF4FGCDSVAT[]\D/O=4^D:BZKS%^:]3]4M.> Y"4F<_R_6,>QPYY(
M*N=-'B=#@UP7X:^\B7YXS(1QG#!FO<-"K.4GZ>7A>VO6PM)H2*,+-I5G0SE=
MT*9<>8NW&O/\X?G7X\NO)\=_],7'Z=7)E3C_+"XNCZ^.SZZGUR?G9V)Z]DE<
M?3D]G5[^B]Y=G?QZ=O+YY&AZ=BVF1T?G7\ZN3\Y^%1?GOY\<G1Q?B>=GQBOW
MXOV^AVZTPGX2]?@8]!C?H\=$G)K"+YTX+E*5;L_?ATV-8>/:L(_C!P7^)HN!
MF(SZ8CP<3QZ0-VD<-6%YDWOD39/$5(77Q4)<F$PG6CGQ[^G,>8O ^L\N@X.\
ME[OE4;*]=:5,U(<>LLDINU*]PY]_&OTR?/> MB\;;5\^)+W9UB?NWRXS'K?0
M_RE^SE=P!#)O(*8+G:G"BVN5+ N3F04<WA<G13(0SWMKU>^)7AS2$\8*OU2B
MEYB\E,6F]Z(O=)$86QHKO4IQ(SZI3*ZE571]*C=B].;-&XQR0HI%9F8R$QD@
M35EZG^FY$@X[7"2T9JKEHC#.ZP2CBU3(LLPTI!(^Z@0S@6;?E<?(TIJ53BE$
M>$PB&7CF!GF,\<YD%3UP4%9ZTC"K4E((,50!YTB",W-/:N**'('U><D$LZI<
MSC+<SZ.UF*!A3R9G9*6Q&\:_.5!V(,XK*^;:D7(;)>V>@@S8>IYX,X.-E!8D
MUK3#?E32>F6=H*%0&NF#)QL>.BVMSL1DR'-^JS)Z.A!?"FCCA($N=JT=/.;)
MV7U2#G<I;AS!-M;SIKL4:<2B;BT]$!^E@Y9F+BXH(PH?_#<0?RBQE"L%_ZH2
MSDG9?IG$[29_SW4ABT1#&M:5C8_\TBHE\H LBI!ERS""!M8$%V-15M95$B$'
M=6FRK;+H?JL652;#WD$[>OEE<#405RJIK/8Z#CN^29:R6"AQ9/)<.ZY;SW_^
MZ?5X/'QW=7S$5Z-W+P;B2%F/>HFM#U65RQ,YQ!A? $ 1<B[)C*O@!E'0D Q.
MCP'#X=S:RU[GZ&G=HPOVCDTQ1J&@^*58J$)9%H,WJJ2LD"VB88,AK21[:X5_
MG4XO:HU)8&,T[\1,J8*B,D5YABBXV^3:D]2N%UV5+'>[<2"N(:\;C[P%K41D
M)"L?F EOZEHZU%N+(@Y/69,+6:6:EMSIC%F%:8;]U^8:',"&=/UKU8]*UUY[
M4.(F.( \$_1_* 3)X.[^NJ6I,MB%N +0T&(P]EM5!'+">T0Y,BT0GIFX5, N
M3XE(W$.,AGO_;(*ZFT8AIF_[<0"<Y*&FU 6)1]#FL@#)(DOZ=].G]3LA#<I;
M*N]U T9P\)(O0VS&S44N6,:^]!MX2QA<*$"8HWPC[9&84MM6&.E%1M^S_'8,
M2,Z]G>E[V_[^?1*W5B;[K5H2P5PI+ABY$L\1%N[%7P*0QZT*.FTCE/Q]BR32
M+065@K^V2%US_G0=2AV_^4MKH("@2D#&,2IK3L4BY%0 L9 SO$F/C\P=L$>Y
MNH5>,=M=)Q\(J7+Y'16UUB24>8>26W8*MIS/<90(R9,3<A)V4)H&['@@D'=J
MRVMTDY"0'TXX;16CXP;,PN!6-;AEJ7$LL$P]U W"B8D*RUM)JTT5B_*6!3,%
MSD+("6,#!CE3$*$ T\H\L&FQC(6[XP70"U*!"4'K+ZH*HU?O2*;SXGMAUIE*
M%[R7! &D.%9J3>RX, ?STC XNC$:7V_0O/(541^\)@S$+N%HY7C2C# ;_F?I
M#/Y,@=K0(<:34"TFKW0K6\W5R1C8Z=369@9:LF-W2*S5H6 RDJ],M@I*Z 1J
M@:!5LV^*SY14_LB43-V(;U6Z:,I%ZS.*;5I[2QU+;JKH;V(6A28_];&%6=5$
M_\*8=*VS@+"HK. 7CJ/-@V=H[![M,5-/*(AEB 4V OH03!210XD%@,3N=9[-
MP GFVHL2,+L5+'5H1A]2>D=X]/*&O'T)SR, *;:/"&IHPNUGQT@TZ$*^V)J0
MU!/LK6>JG2 "4X]\AS.YF79G[!H0SC[$)F:D+X7&3"UT4>!NS\SW*$=,RK.!
M2ITGWG@*EYC-*-'K@F*=!-R#ITB7=JT6I?"^O\.*'59&<OFHDC<W&:WY=@M%
M;Q6[24#LY\BA')%"^_>BW90[*CT3H_[X8,A_AP>3.QO3)9D-BB#"Q 3_KME=
M3S VK#:)J_TB?E>$:/#A4VIYK)C8V(RF"TN-%MI$G*IJ[1 #B)BUBFF.8Q%H
MAZ(GN,?J!P>U=W ][%R_Z5R/F^NOP%$"1_ HP #!W#%2@8@^'T:X6DB04;S,
M@1X<!E6)_Q2-)U61HD906EE+1P(.)"@9/,KCJ'#"R>NE!DE>QQ-.+HFE%IS.
M@4/1N8U"1(/Z$FF_3[=-P]QQ'&^/&M!6!410#':M8*Z7(/XKO +*+5661D#6
MH<Q(RH6%(6MF=#!KSV&UX7P2DT^D9CYN%?XKC("R'0H>BM-61K25]4_JZ4PE
MDB("KDP-LW[653)AM<BD;9*N:^\1:T -BN<ZUN?.M@2O8>6"6&R(-,]D15,K
M,R(IY-H->RF"9TV,G-KR>U50HT%I#@:N8X%&Y0@/PX<I.#0^Z\XC'#0XUM !
M0F/+FOBC:&!F33L-#MN[_/3Y*W5!4E4"\,CPB&J)MDF5PVO4VF!5 Q)2V81$
MH@6.3O5UJ'8R:H>MY#1)+@O4K9[-85M:0]2_B=TMF6%GDGK72;I9AT9!BD>1
M'N2H5\)IE$:L1T=*;N&&\W:[7<0ZF;Z$PS?OWL*LE"7T1R@DH;?"9U1>_ZX/
M9.9,0'56M=%4Q:0G4KHB8M5Q.@>#CQ'+41,/QEPG^0$S,IVH/2CC9+_E4AU-
MY[ I]GBZ:D4<YK-9.Y@C.;*C#K#$^;+4GE/"5@D1J2?"+!/X"/#6,B,-X001
MW2BDV9F1Q</XT84L%]Q!Y_=GKT8-R)*@9Z]?-??(QC(0JFP3 BJ7-SJO<F*Y
M?%@G+$1>0,6ZBFYK>@\$!%Z)/R$5$NK.!&/",EO6=8E'3)H,,+A'N[XUDCJA
M;$,80@Z)XV.812X<*Q3WV[H%E>8[\;Q-42X@'HS0LL])Y(LF;Q]!%P;B,V'
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MJX;*U?W4>%Y>5)I;4+MR#0&MP&AB=4@V34V'+-*= GZIT@7W+BJ+ND<AUC:
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M#;9! -]7!A.IWP0#^[^7V;]02P,$%     @ C99B5CZ-UDS5"    A<  !D
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MZ&P^'<2!OKT)MN*OG$L;P$_^N5&8N1UMP/.5M:&](07=9^_K_P!02P,$%
M  @ C99B5K(G^Q6>"0  3Q@  !D   !X;"]W;W)K<VAE971S+W-H965T,3,N
M>&ULM5G;<ANY$?T5%'>UL:O$NR0KMJ0JR=;6.A7;+-'9?4CE 9P!2:PP QK
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MT)AOH"I$+M)9Q_$X2S35-IV=+2"P82T[G1#=&]_NB2D1GM Z!J2%!<FU(I:
M;1C-0@$\^B:0M#7=J#F.;VF1T8I8ND<8^ -1F;[8$.&J<#;>*TJ,Z< W 5I\
M^.O(_A#]!F>EM\U7)&*7A!H3S,Z)+>$;L^J_L:>&^<G\S\JS491Q-9AY9U!%
M^SOC.B-20B(M$YU:4O/W*1TC:TEV\X&#0@D6LY!4T(AT36=;1_>7SJR'/@T.
M6Q]Y"X4S%7W*!HN@41*_]S9/FZ_EU_$C\7YY_-3^!4<RC80Q:@G1T>#=:0_S
MG#]?QYM@-_S)>&%#L 5?KA6RW=$"O%]:&^H;VJ#Y'\+5?P!02P,$%     @
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M'\*8(S=^>U)2[V-E'^SR^AF7VNC]%;N0#;CQ5L8<6Y"UEKBDZ OD87<E$98
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MNZ.$;/N^:B?>5/%-,S<>+Z0X+/ D91L,L+XP$&PW"1OTC]S)?U!+ P04
M" "-EF)6+[H>M'\"  !_!0  &0   'AL+W=O<FMS:&5E=',O<VAE970Q-BYX
M;6Q]5.]/VS 0_5=.&9I 0N17VW5=6XDRT)A$J6!CFJ9]<)-+8^'8F>U0^.]W
M=MI0I-(OML^^]_S.]O-XK?2C*1$M/%="FDE06EN/PM!D)5;,G*D:):T42E?,
M4JA7H:DULMR#*A$F430(*\9E,!W[N86>CE5C!9>XT&":JF+Z989"K2=!'&PG
M[OBJM&XBG(YKML)[M#_KA:8H[%AR7J$T7$G06$R"\W@TZ[E\G_# <6UVQN J
M62KUZ(+K?!)$3A *S*QC8-0]X04*X8A(QK\-9]!MZ8"[XRW[E:^=:EDR@Q=*
M_.*Y+2?!,( <"]8(>Z?6WW!33]_Q94H8W\*ZS4T& 62-L:K:@$E!Q67;L^?-
M.>P AM$[@&0#2+SN=B.O\BNS;#K6:@W:91.;&_A2/9K$<>DNY=YJ6N6$L]/K
M^</E_,?MW6\XGBN+YF0<6J)UBV&VH9BU%,D[%"G<*&E+ Y<RQ_PM/B0YG:9D
MJVF6'"3\SN09I/$I)%&2'N!+NQI3SY>^5Z-\0FF5?CF%.3WS/^=+8S4]A[_[
M:FVI>ONIG$5&IF893@+R@$']A,'TXX=X$'TY(+37">T=8G^]C'W"#D+W"WN]
MW.X(@!E0!= 1-^3![I2!R1QN,ZN6J+>3"62*S&<LY@YB2X1""7(QEZO1&X9=
MX#&7]$Z%(,N9$[CBDM/CS&&E5&[@"/K#SZ[M]V'1Z*PD/^50,VV-5U"PI>89
M<SLR8[!:"HX&^B2E-TQWBCB"^#2.8]]'Z1#VG7VX8XH*]<I;WU!-C;2M/[K9
M[G<Y;TWUFMY^33=,K[@T(+ @:'3VJ1^ ;NW>!E;5WF)+9<FP?EC2#XG:)=!Z
MH<A;F\!MT/VYT_]02P,$%     @ C99B5D5G8R U!@  @@\  !D   !X;"]W
M;W)K<VAE971S+W-H965T,3<N>&ULG5=M4]LX$/XK.SFFT\[0)+:3$"@P$PIM
MN:'  +U^N+D/BJTD.FS)E60"]^OO6=EY*1"NW,#$DJU=/?OLBU;[<V-OW4Q*
M3_=%KMU!:^9]N=?IN'0F"^':II0:7R;&%L)C:J<=5UHILB!4Y)VXVQUT"J%T
MZW _O+NTA_NF\KG2\M*2JXI"V(<CF9OY02MJ+5Y<J>G,\XO.X7XIIO):^F_E
MI<6LL]22J4)JIXPF*R<'K5&T=]3C]6'!'TK.W=J8V)*Q,;<\.<T.6ET&)'.9
M>M8@\+B3'V6>LR+ ^-'H;"VW9,'U\4+[IV [;!D+)S^:_+O*_.R@-6Q1)B>B
MROV5F7^1C3U]UI>:W(5?FM=K^TF+TLIY4S3"0% H73_%?</#FL"PNT$@;@3B
M@+O>** \%EX<[ELS)\NKH8T'P=0@#7!*LU.NO<57!3E_^/GBXOC[Z=D9C<Z/
MZ>+FR\D5G9[?C,X_GQZ=G=#H^OKDYIK>GALOW;O]CL>.+-=)&^U'M?9X@_:$
MOAKM9XY.=":SG^4[0+J$&R_@'L4O*OQ=Z#8ET3;%W3AY05^R-#\)^I)-YAN3
MS56>D] 9G6HO]%2-<TDCYZ1W=*Q<FAM764E_CL;.6P317\_14._2>WX73JP]
M5XI4'K20.4[:.]DZ?/-;-.A^>,&&WM*&WDO:?\F%SV%^4>OSF'\I6FYFDB8F
M1[HK/24OF,^@0H/1Z8+PL<B%3J4+S'N(%.9.%F$-2@U)D<[(3,A4%KE?&EOK
M<7):K\DJ&[1#T,^L9/$0:)(#C1 F%4K,,E+VZ$Q-)%VG2B[W')5EKK#VJ["W
MM:_%5!OG55I__RRU*7@RFJH<>])':YP[$V.Z,5[D]%9I)&2>H[:X=[0*),>P
M+U)OQM(N ,2T1='V3B\)S]T^/^/^ +\)9C&AP*!\:"2\M4#X0(@T[7(1"I<J
MX 9/44P1[4#;VEY6.69A8DV!^O:CPI1%:@-$]C?J1TW7F]^&<11_H"A:'SX"
M_9BU&G2_7X,>\#,>)#7H81+\G)JB-)K9*87U08N!3RRI52Z).I<V[,%(G[ E
MD'!N9N8P7M<^#MX?\QFR1Q=AAZ?9^ID=1*,TK8H*W,&WYSC5CG B/'+6Z'D?
M758VG:'"(QYE.M,F-].'FH.DYJ([&.(Y !,W5F0X'>UM)XRT*"1%NP.*>D/"
M_\=0N"6';NU$-U.EHVC8I:C;IYT^'8GT%OIIB+^%1VYFRF;OF<B'=03,4*Y2
M'(2(W"2F70)M=0R* HFA_@GD/&4\WHYZNX"=)-@%[C[5[R^M0?P[NGHCBO+#
M,="LXJ';*-UBP?YNL)A%MP@+&LZ>N&\S9X.HYFQW\%^<(0%ZO<V<10C5A$#]
M_^8L8>-^G;2=0!I^A]WNJT@;-J3M\'.(;\>OJE+;-)>P/C66OXHL:Y+9FU79
MA ^VX,HFENOB:3;F'*^&W8O52 *NI]FC2C==5+JFNM8>D$$S0U^K+"'!-3*Q
M0N$!)^U7F[@)*B=Z8%+I%-TE1]16O$2>57*!IBF' #)YH6JVX3@V3%J1;X<3
MY5O[NDT3F?$;U)-[*BM;&L3']HK=NI R(/X: AO(W'K(?"#4)7DG[3:X>UB)
M,FCF#&6.HY'Q"4)$I[<_\0=EVGCTC5F%?A3ZVG3"1]T/T.1!3(B .^YFV5;L
MP]6;G90JB[KF?'UH@HM,8CTZ0C R":0H&YR'C16XGRBMO'R?H^?-GJO&[/<%
M=L7T9RIE U[KT: IE$] SU06S%-(;Z\F#X$B;]5T*H/.QAYXXV=SYC,%#N:F
MRK,E$L@^,FN5!/873&S3J/%:(%[>EUP-:GH>LS&'U[:2P4]IM=5?I1G'SVOY
MV(8C72G#K2-_:-.GRG,?*9X#M99P\EXA,_E07[>N7);9I^ 7X*SD2QCB.^0&
M.E?$^8,4=@5KO;%B"2WO/5;>R?7ERXX, 3WAD$1T2$ J L+F"#Y9OIAL-FOO
MT;%[M0YPT6!T=WG8XV$<AJ'=Z/9XR"<'SDJ,=GB4\"B<P#O<?"SPH?2BL7JN
MD>ZLW8MPLDS#[<^A::FTKZ](R[?+"^:HOE>MEM>W4W2)4X5:G,L)1+OMG7Z+
M;'WCJR?>E.&6-38>QU@8SG!)EI87X/O$X [53'B#Y;7[\%]02P,$%     @
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MWAF9[?+MAI1,)-)Y;;2%S/]5AXRSU]O2OV\4C,A[?)2N>=:Z79K4KE\$Q/O
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M_N>Y(JJXR!"D!PN56545 Q1#DF<Y*S)77 RZ30#4\G!2YBL")!>]Q_H\A2D
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MT@+<'QGCJR_$H'[G]OR_4$L#!!0    ( (V68E8GK2$\' 0  "0*   9
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M^QISOQK=+ISKWF'CYLY0[_S[Q)#7"FG+2[S>K9] T_+F_TI>OI\>F=Y138#
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MWKX>D.]NP]U'=$VZ@:*8<9]-KQ7^0+"7!9@O'>Z9_8<$V/XEN?@?4$L#!!0
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M<3^B:N!TO62K!Y6J70-254IF8J&0 FM7I,,Y<35E2072--N39%'D_U$G(MB
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M:&5E=#(U+GAM;+5::W/;MA+]*QBUTSHS\DNR'3M.,N,ZC[HW3C))VGZX<S]
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M<SGV\42I)C]-IY,+.H#1KHN%=(*;CJ;)HLX$PF_5-&N,:86 SUT_U.-*%C_
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M,=S9^G?CU-TP"CY]7X\#Y$E>:DI=$'DX;2X+8""2I/\P?%J]4Z9!Z4GEHVK
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MI:XW0)WOZ3+9\!Y_W_(G)E!:<XKX6>C3Q)_OC$OUW':4]?)X,=L'Z&<V/ 0
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M^<=U +H6Z7IBU<8+XTI9DED_+.E>0^T<:+U0RNXG+D%[4PY^ E!+ P04
M" "-EF)6$@'5->0$  #5"P  &0   'AL+W=O<FMS:&5E=',O<VAE970R."YX
M;6RM5FMOVS84_2L7;E$D0%;KY5>:&'#<=.N0=D&:=A^&?: E6N(JD1I).<U^
M_0XI67$:QT"Q?3 M/N[AN?<>7O+L3NFOIN#<TK>JE.9\4%A;GPZ')BUXQ<QK
M57.)F;72%;/HZGQH:LU9YHVJ<A@%P7A8,2$'\S,_=JWG9ZJQI9#\6I-IJHKI
M^PM>JKOS03C8#MR(O+!N8#@_JUG./W'[N;[6Z U[E$Q47!JA)&F^/A\LPM.+
MD5OO%WP1_,[L?)/S9*745]=YGYT/ D>(ESRU#H'A;\.7O"P=$&C\W6$.^BV=
MX>[W%OV=]QV^K)CA2U7^+C);G ^F \KXFC6EO5%WO_#.'T\P5:7Q+=VU:Y/)
M@-+&6%5UQF!0"=G^LV]=''8,IL$S!E%G$'G>[4:>Y5MFV?Q,JSO2;C70W(=W
MU5N#G) N*9^LQJR G9W?7'ZY_/CYDHYNV:KDYOAL:('JYH9IAW#1(D3/(,3T
M04E;&+J4&<\>VP_!IJ<4;2E=1 <!?V7R-<7A"45!%!_ BWL78X\7/^<BWW#9
M<%IK5=$27#6D@##;@I8^P%S3'XN5\>-_[@M BY_LQW?'YM34+.7G YP+P_6&
M#^:O7H3CX,T!]DG//CF$/G\K#,MSS7/F5:S6U/FSC^A!J/U$;PM$1I4XG$+F
M9)T*R,]*:\AB,E55S>3]JQ?3*)R\P9BRK,1Y;(/*9$:&YSBFMA_+'BCSC%;W
ME'.5:U87(O66.1PYI=M"<_Y(.X3,-Z@,??)=$]&56'/ZE HN4V[\AHNZ+@76
M?V#Z*P?-12Y*1V"IE3%7;$5O!<NE,E:DK<'/7*K*=6X]^?\?\4A(G,ZRA&?F
M>)LAY_J-]Y86$!F\-_22XCA"&XX2M%$0HAU/)VX\=&W8SDZG;CR>T&6C48 I
M&LUH-J79C)+1&+W(]4)8)Z.0%D8PNF:I6(N4DB2B,,*ZB,9A3$DP\=U10*/I
MN&.+#4Z".':;3AV!./&;GDR _9)F$]?&V-&1G?F9\22A_ZB4)ZK@"&/5Q=N%
M%$/;M?:^YC^@D&>C#Z,^I=<%0Q5/>6.]#-V.%T+5CT==T)W'XR"B)>X_-]@I
M)-LPR,7A6>32#2?!F.))_$0;2QP\CQ8!*TIB>J=41J@'R/J4%BG+ ,Q:&:D-
MU]*?GC 9XQ>"\T9HY<<ZFKA^W"T(]'",-:/)3AK;E+4)VG'\%@&D]Q(UK?%
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M:?!Z E'K]A'9=JRJ_<-MI2SBXC\+O+NY=@LPOU;*;CMN@_XE/_\74$L#!!0
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MS\Q67\/'17L>KA:W</-PMUS<K\+UMX=[^+AF&X'ZT\0W%,8:^]$!<EY#!N]
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MIBPYU@\K^B)1NP1:+Y6RF\!MT'^ZL_]02P,$%     @ C99B5@.>,?@>!0
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MX3" ,.C#H ]3EMZB?ACBWS:DYKDPV2<B\F$7 3$D18KM'%,OCF $2%N=1*S
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M/@^P YCZ(EY/G"[]Y7>A'>:E'^;X[<(-;<#UI=9N.Z$#FJ^A\=]02P,$%
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M,<6CMN@XO? /R9EV^"SUS90S+'H2P/FYUF[5(0/5?Q;&_P%02P,$%     @
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MH#+*^]@/KA>I%F[][R]1K_T+QU .J$V:9T!_VC^BYLW;X4&\>8%]8GKM1K#
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MP*>VD!4D.K9_O-MU=C?4<#<7W+%(;#BXC99D6<ZW9>5Y^>BU_&MD%/P;1Q?
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MT6%%=-A)U*3")&DE>+*/E428):<,MZ:H$^ZE*>H)K!'YJ(I\].KU/.I3K)[
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M>VQ-95+7IZI1FD.RS&..JD0^4I.V+8S;/TV.->J8DMUKWF]^S^LS$=Z1K/@
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M("1SO([%/=W\(+N"<H,!C7G^%VQVL9X#@C47--DE2P=)E&[_X^==(_828.-
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M[6O$[8F@J_Q-W ,5<@^9'RX)#@G+ N3W<TK%ZTGV<J]XF=O_#U!+ P04
M" "-EF)6RA6AW_\#  #I$0  &0   'AL+W=O<FMS:&5E=',O<VAE970U-"YX
M;6RUF-ENVSH0AE]EH%,4+=!&B]>DM@ O:>K"61"G[34MT381B=0AZ3@]3W](
M29&\R&QBJ#>V%L[/_Z-&XI"]#>./8H6QA.<XHJ)OK:1,+FQ;!"L<(W'&$DS5
MG07C,9+JE"]MD7",PC0HCFS/<=IVC BU_%YZ[8[[/;:6$:'XCH-8QS'BOX<X
M8IN^Y5HO%^[)<B7U!=OO)6B)9UC^2.ZX.K,+E9#$F K"*'"\Z%L#]V+D=G5
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M;%\A.Y$L29?F<R;50C\]7&$48JX;J/L+QN3+B>Z@V-WQ_P=02P,$%     @
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MK@FE+*[P8J)%YF[!E=#F3G7#Q+QZ4%H#L[\60K],[ '5.VKX$U!+ P04
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M+H#N+Y6RSP/W@*;!C/X&4$L#!!0    ( (V68E9PX.SGVP0  (L:   9
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M9EB-Z:\7Y,V_#RJHQ@0XI;FIEP<%(0D@Z>%5%;/?*"*ED?;0>"M24/(-,WD
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MT<5=#J$,@8HODC0DF"I2R"ZU4/,!4TL(:/'S?/M0"%2Z=FP(V(3Y-F%#F[#
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MT480YH!LYQPHR;HXF\P%R1B0C/7J;+(CSF;--H(!L)@96/:*Z+*Y- =E._&
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M(LQU@'J_8$P^W^@#YOP?"J/_ %!+ P04    " "-EF)6C1! Q*<$  !2%P
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M-SH<(JF[DH[BD2U=%ESI0L@V-[I6!6$6Z/D5YVK?,1MDU6_W-U!+ P04
M" "-EF)6NV3R9:P#   F#P  &0   'AL+W=O<FMS:&5E=',O<VAE970V.2YX
M;6RM5VUOVS80_BN$5@PML$9OCNUDM@#;RKH.2!K$Z_*9D<X648KT2,IN_OU(
M25%D668RPU]LDKI[>,^CXXDWV7'Q0V8 "OW,*9-3)U-J<^VZ,LD@Q_*";X#I
M)RLN<JST5*Q=N1& T](IIV[@>4,WQX0YT:1<NQ?1A!>*$@;W LDBS[%XG@/E
MNZGC.R\+#V2=*;/@1I,-7L,2U/?-O= SMT%)20Y,$LZ0@-74F?G7L1\8A]+B
M'P([V1HC0^6)\Q]F\C6=.IZ)""@DRD!@_;>%!5!JD'0<_]:@3K.G<6R/7]#_
M*,EK,D]8PH+31Y*J;.J,'93""A=4/?#=GU 3NC1X":>R_$6[RG88.B@II.)Y
M[:PCR FK_O'/6HB6@\;I=PAJAZ#K,#CB$-8.X7L=!K7#H%2FHE+J$&.%HXG@
M.R2,M48S@U+,TEO3)\R\]Z42^BG1?BIZG#T\S.[^_GJS1+.[&"V^Z?'=EYN[
MA5GY&(/"A,I/Z#/ZOHS1QP^?T =$&+HEE.JW)B>NTC$8)#>I]YM7^P5']@O1
M+6<JD^B&I9#N^[LZ]H9 \$)@'E@!_\+L H7^;RCP@K GGL7[W8,>]]CN_BU1
MQ]SWV(3-ZPA+O/ (WBW?@CY5RHB\5)BE6*3H7O"T2!1ZQ$)@II[1+$E$@6F?
M^A7\H!_>%)%KN<$)3!U=)22(+3C1K[_X0^_W/NG."1:?"6Q/UD$CZ\"&'LUA
M31@C;*UK!,4L@3[I*HAA"6'*Y38*O8F[;0ORMDEL#>1$FI<-S4LKS3HO)-+?
M [2KLH6 U,F4T"(U]),,LS68[ *IB"Z;O4I4NURV:/I^1XD>D["CA#76$Y48
M-DH,K4KH[Y6BY4F2NEJF@-)"&/XJ [0!07C:QWMX0.ISE]7B'3:Q-;83F8\:
MYB,K<UU76WF.L$+ 4L17%MJC TK!N,/ZT.0@\:UAG4AZW) >6\OF\5(9$YE0
M+@O1F^CC<U;+<X+%9P+;4_.J4?/JI#*2%J!O)RK3U8,S0,^ 19^H5V^G4X_)
M52>=K"&>*(#OO=Z*O/=(T*< 7BD05@%J[#:][H>D-FE_23H5-K9'>*H"K7NA
M;SU27PIL6 /T7_+\<YZ<LZ+%YT+;%RYX%2ZPILX;P@6'5XA1-SFL&_QO.:P[
M5B3=5@.1@UB7C9A$"2^8JJ[BS6K3[,W*%J>S/O>O%U7+]@I3=9"W6.@[F$04
M5AK2NQCIXR&JIJR:*+XIVY0GKG334PXSW<B", ;Z^8IS]3(Q&S2M<?0?4$L#
M!!0    ( (V68E8Q5PU6;@4  *HG   9    >&PO=V]R:W-H965T<R]S:&5E
M=#<P+GAM;+6:6V^C.!2 _XJ5':TZTK3<DC3MII': )JN)MHH;7<>5OO@@I-8
M SAK.[U(^^/7!@HAI6Z8GGUIN9W/QA]@^\3C1\9_B#4A$CVE228N>FLI-^>6
M):(U2;$X81N2J3-+QE,LU2Y?66+#"8[SH#2Q7-L>6BFF66\RSH_-^63,MC*A
M&9ES)+9IBOGS%4G8XT7/Z;T<6-#56NH#UF2\P2MR0^3=9L[5GE518IJ23%"6
M(4Z6%[U+YSQT\X#\BC\I>10[VTC?RCUC/_3.=7S1LW6-2$(BJ1%8_7L@4Y(D
MFJ3J\4\)[55EZL#=[1=ZF-^\NIE[+,B4)=]I+-<7O5$/Q62)MXE<L,>OI+RA
M@>9%+!'Y7_187#M4%T=;(5E:!JL:I#0K_N.GLB%V A2G/< M ]Q# [PRP-L/
MZ+\1T"\#^H<&#,J P:$!PS)@F+=]T5AY2_M8XLF8LT?$]=6*IC=R77FT:F":
MZ2?K1G)UEJHX.;GY^L?B]O@V6,R0'US=HF,TY22F$H4XH@F5S^C()Q+31'Q6
MY^YN?'3TZ3/ZA&B&9C1)U,,AQI94%=$X*RH+G1:%NF\4ZJ$9R^1:H""+2=R,
MM]0-5'?AOMS%E6L$SC _08[W!;FV<]96'W/X[S@[09ZCPUVO)=P_/-QM"0_>
M"=^J<&>4ASLMX:$Y_'*C[MUUVL(;;>E53X27\[RWGH@UX_)8$IXBG]S+E@I=
M%8!^.T!_"\_%!D?DHJ<^=H+P!]*;_/J+,[1_:U,#"?,A80$D+ 2"-93V*Z5]
M$WVR(!O\K+H#*1!;HHBE*>$1Q0G:X WA;8:-O*Z&"]@PA^F>[F%R[+G]L?6P
M:Z[E(K=O-R\*(*L5 L$:1@:5D8'1R)RSB)!8H"5G*9K61N9O&3'RNAHI8(.=
MQAZXIWM"!J^$O/8!6:D0"-;P,:Q\#(T^OJE]_6Z4G=]?,Y+>$_XW^A<-T#-'
M=YD@T5:=V^\=VTP92^IJ"A+F0\("2%@(!&NX/ZW<GWZTPSN%5 H)\R%A 20L
M!((UE(XJI2/CZWR=44EQ/G6)L<S?[*AX<9>&%]?,K,:8;PXRC?%=Q4+" DA8
M" 1KB#VKQ)Z](^&)IML4W3.N(FFV0A%6A>EYRF&.SU[U:HYM[W5K4V,=NHJ$
MA 60L+"E+;Q!W18-08Y=3RAMHZ)I+4%KT=]5@8[4?/&98"X^MTEYA[BD#Z1U
MDFD,Z^H)E!: TD(H6E/I3H[ ,0H(GC:4=_Z<O@/=_9[JV4"+7R.@LU](6@!*
M"Z%H3;]N[=<UJKA,V3:3B&VED#B+]6=5J3Y$L9';=6!4TG:G)7M?9A^TP "4
M%D+1FA+KM(UC3"$8IC"7L3J@7EXUO;S.E%6="5#;MWK$^XWAS#B;,9?:63%H
MM@>4%H#20BA:\VFH,SY._Z.3&@<TR0-*\T%I 2@MA*(US=:9(\><.OKP$-AY
MG=D9O!H"FRO162<D+0"EA>\T1]-2G4]RS FEG^]20=-')<W8I8)FA4!I(12M
M*;%.##G&)(6A2STD8VN&=S8)FC8"I06@M!"*UI1>IXZ<T8=[3LA\RA24YH/2
M E!:"$5KFJUS1\[_G#PR\SM[!TTS@=("YYW<4.D3J,SF;_YUILDUYX5^NH\U
M<[MZ+&F-7\J\T5XO"UID $H+H6A-C75VR34G@K[GJW](C"X?",<KHB:IZNM+
MA$0++,D7A"6:,ZI$TPS=TK0M%7AE+J*ST7+-C+T[;#JQ^\/]WTA!BPU :2$4
MK;!J[2PQ4B.?5;X83*!(OX'%.IWJ:+7@[#)?9K5W?.J<^\6RL1I3K&*;8;ZB
MF4 )62JD?7*J1JV\6!A6[$BVR1<RW3,I69IOK@F."=<7J/-+QN3+CBZ@6IXW
M^0]02P,$%     @ C99B5J/P#34\ P  11$  !D   !X;"]W;W)K<VAE971S
M+W-H965T-S$N>&ULK5AK;YLP%/TK%JNF5EH+!O*@2Y#6I-LZ]:6FW3X[B9.@
M LYL)^G^_6R@@!-*@N(OB0WW'-_#/<C7]#:$OK(%QAR\16',^L:"\^6E:;+)
M D>(79 ECL6=&:$1XF)*YR9;4HRF"2@*3=NRVF:$@MCP>\FU1^KWR(J'08P?
M*6"K*$+TWQ4.R:9O0./]PE,P7W!YP?1[2S3'(\Q?EH]4S,R<91I$.&8!B0'%
ML[[Q#5X.8%<"DHC? =ZPTAA(*6-"7N7D9MHW+)D1#O&$2PHD_M9X@,-0,HD\
M_F:D1KZF!);'[^S?$_%"S!@Q/"#AGV#*%WVC:X IGJ%5R)_(YB?.!+4DWX2$
M+/D%FS36]0PP63%.H@PL,HB"./U';]F#* &@^P' S@#VH0 G SB)T#2S1-80
M<>3W*-D *J,%FQPDSR9!"S5!+,LXXE3<#02.^[</]S_.GZ^?[L#P^NH9G XQ
M1T'(SL Y>!D-P>G)&3@!00SN@C 4CYWU3"Y6E5ASDJUPE:Y@?[#"+Q1?  =^
M ;9E.Q7P03W\8<)SN*W"3:$U%VSG@NV$S_F ;XC''-S$C-.5<".OTI,2N-4$
M\KVZ9$LTP7U#O#@,TS4V_,^?8-OZ6J5.$YFBU<FU.G7L_BV)Y^<<TT@8>UPI
M-<6W$[Q\X]>^W7%$E=9E"7N"E-3</#6W-K41C@-"P3WAF,G2MJNRJZ5H6@A-
M9(K:5JZV=:SI6CJU:B)3M+9SK>TC39?B6V4_>=Z6Y^ICE,0Z>6*=1I;SJG*K
MI6A:!DUDBMINKK9[K.6Z.K5J(E.T>KE6[TC+>3MV<KW6EN7J8Y3$H%5LKU83
MTSE6Y09:R]&T$KK85,6EA@(>:[R,09=>36RJWJ*?@+5;^ 'FRPA49[6WW+<G
M2$VN: !@?0>P;3]8F5\M1^-R:&)3%1=]!72/MI_6OD(7FZJWZ"Q@[69^B/U:
M.\[JNML]WIX@-;FB%8#UO4#9?I6IU<(;5T(3FRJV:"]@YVCG:6TO=+&I>HL&
M ];NZ8<XK[M[<H [QXM]46EZ9NF,*S\PW"$Z#V(&0CP3,.NB(ZQ+TS-[.N%D
MF1Q[QX2+0W0R7& TQ50&B/LS(ER93>1).O]RXO\'4$L#!!0    ( (V68E;[
MF8D=G@,  +L2   9    >&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;*U8:W/:
M.!3]*QIO9Z>=2? +$Y(%SR117SM)FTGH]K,P%]#4MEA)0/+O]\IV'=PX7BCZ
M@B59YTCG6%=<:;05\H=: FCRF*6Y&CM+K5<7KJN2)61,]<0*<GPS%S)C&JMR
MX:J5!#8K0%GJ!IXW<#/&<R<>%6UW,AZ)M4YY#G>2J'66,?ET!:G8CAW?^=EP
MSQ=+;1K<>+1B"W@ _6UU)['FUBPSGD&NN,B)A/G8N?0OJ-\W@*+'/QRV:J=,
MC)2I$#],Y?-L['AF1I!"H@T%P\<&KB%-#1/.X]^*U*G'-,#=\D_V#X5X%#-E
M"JY%^IW/]'+L#!TR@SE;I_I>;#]!)2@R?(E(5?%+MF7?0>209*VTR"HPSB#C
M>?EDCY41.P 4V@X(*D"P+R"L .&^@'X%**QV2RF%#Y1I%H^DV!)I>B.;*11F
M%FB4SW/SW1^TQ+<<<3J^^?KEX^GD_?TMH>^O)N243.!1D[<4-..I>H<-WQXH
M>?OF'7E#>$YN>9KBYU(C5^/@AL)-JH&NRH&"5P;ZF^4]$OHG)/""L 5^W0W_
MFN@:'K3 :3?\<B5[Q(_:X"XZ5ML6U+8%!5_X"A^%J2:?<Z7E&H- M]E1$O3;
M"4PX7Z@52V#L8+PJD!MPXC__\ ?>7VWFV"2CEL@:QH6U<6$7>WPC\L6I!IEA
M<$Y;?2OQ@P)O=JU-')R%N&(VNW[LTXEVSN0W=?9KG?U.G0^0<R')%Z%!X:(+
M_3:IG12'+A&;9-026<.ZJ+8N.C:V(IO&V22CEL@:Q@UJXP9'QM;@1=@,^[^&
M5MDGZNI#.^?QFRK/:I5GG2HG1N"-8/AGQ/1:\GQA-O6H36XGT:'+Q"89M436
M,'!8&S@\-KZ&-HVS248MD36,.Z^-.^]<>;?LD6?KC$R%1*19> G#P;A^(F).
M$@DSKLD<&U)L:K.UD_Y06VV2T?,7&\/ \^J@;[CE>\^II??_^U$1KF;)G9#O
M11(.,W*Y 8F'"ER$N%N!TN2>:3@A3),[P7-M$LT)'BY:D\QR2/.HI^KUO*C_
MRR[6/;5#[;'%UC1R)T?WC]S8*X+7/F#E2><H!WMBB:WIR7,"[G>FJ8T$J]41
MJ_FW539JBZUIW7,*[H?'_@'XEG+GRCV;;-066].]Y\3>[\[L]PC&_LO3B?_B
M"+-7+]H]F4/%NCL7!>9:YY;)!<\526&.]%[O#-,^6=Z4E!4M5L7=P51H+;*B
MN 0V VDZX/NYP/BK*N8ZHKZOBO\#4$L#!!0    ( (V68E;V(6Z=,P0  (H;
M   9    >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;,69?X^;-AB OXK%JNU.
MZL+/_+HED7H!U&Z+>DUZG:9I?SC!">@ 4V.2;MJ'KPT<@1RAB?I*^R<!XO?Q
M:S^. 7MRH.PI]0GAZ$L4QNE4\3E/[E0UW?@DPFF/)B06OVPIBS 7IVRGI@DC
MV,N#HE U-&V@1CB(E=DDO_; 9A.:\3"(R0-#:19%F/US3T)ZF"JZ\GQA&>Q\
M+B^HLTF"=V1%^&/RP,296E&\(")Q&M 8,;*=*F_T.U>W9$!>XE- #FGM&,FF
MK"E]DB?OO*FBR8Q(2#9<(K#XVI,Y"4-)$GE\+J%*5:<,K!\_T]V\\:(Q:YR2
M.0W_"#SN3Y61@CRRQ5G(E_3PEI0-ZDO>AH9I_HD.95E-09LLY30J@T4&41 7
MW_A+V1&U ,%I#S#* .,TP#H38)8!YJ4!5AE@71K0+P/ZEP8,RH!!WO=%9^4]
M;6..9Q-&#XC)TH(F#W)=>;3HX""6(VO%F?@U$'%\MOKX?O[;V_>_V\YR]1-R
M/CR^^_@G^AFM.-T\H25),K;QA3CTP.B.X0C=V(3C($QO1:''E8UN7MVB5RB(
MT2((0S%4THG*15H2KF[*%.Z+%(PS*9AH06/NI\B)/>(UXU71G*I-QG.;[HU.
MX*\X[B%3?XT,S3!;\IE?'FZTA-O=X0O,>D@[7[MS0>W:^&RXVQWNDG4/Z:,\
M7._H2[,:'V;.L\[P)*9M'/RU(-&:L+_;='<2Y51YER9X0Z:*F M3PO9$F?WX
M@S[0?FES!0FS(6$.),P%@C4<6Y5C*Z>;Y^8 'S,B;A.5Y*20W.;6@G0+";,A
M80XDS 6"-=SV*[?]SO_O.;<(9]RG+/B7> A'-(MYF^U.]K6V(6$V),R!A+D%
M;)##Y'/=7LRAFC91]RT6!Y7%P;<MIC6-0EKLB7,>,''L92R(=R@A+*#>:W13
M%+]M,UK4TZ]E9XW']?P*5R^+&;+4:3F[,^UK-4#"7"!80]>PTC6$U/4)AQEI
MM35\,9:&_1-3+XM8UO#$4F>VUUJ"A+E L(:E465IU&EI2>2;ES11FPMK,V4Q
M+:),/)6*5[$K[I&C%TK,@7FBK3.U:R=#2)@#"7.!8 V_X\KO^+L>7=%_:)6M
M4_(Y(T*SLY>?78^UG;5=>S.$A-F0, <2Y@+!&OYU[?ANJX$]V)8H(+V@-!N4
MYH#27"A:4W%M^4+_?R;Q[GJO'@^0-+ND->XPYKAYAW% JW2A:$W-QE&S\:VY
MW&R9RUO%=9*N%@=)LT%I#BC-A:(U#1_7F703;JX&76$"I=F@- >4YD+1FHJ/
MRTQZYTK'=ZY%=,.OE@ZZ]@1*<TK:V26$4B;HLI):VT*("-OEFSTIVD@;Q<I[
M=;7:4'J3;Z.<7+_7[^;%MM 14^Q2+3#;!7&*0K(52*TW["N(%1L_Q0FG2;Y1
ML::<TR@_] D6-VY90/R^I90_G\@*JNVWV5=02P,$%     @ C99B5@TM,SC(
M P  C!(  !D   !X;"]W;W)K<VAE971S+W-H965T-S0N>&ULK5A=;]LV%/TK
MA%8,+=!9'[;E)+,%)%:*=EM0+VXV#,,>:.G:$BJ)*DG;[;\?2<FRE4B,#?#%
M(BF>0YY#7OJ*TSVA7UD"P-'W/"O8S$HX+V]LFT4)Y)@-2 F%>+,F-,=<5.G&
M9B4%'"M0GMF>X_AVCM/""J:J;4&#*=GR+"U@01';YCFF/^X@(_N9Y5J'AL=T
MDW#98 ?3$F]@"?RI7%!1LQN6.,VA8"DI$(7US+IU;T)W) &JQU\I[-E)&4DI
M*T*^RLJG>&8Y<D:00<0E!1:/'<PARR23F,>WFM1JQI3 T_*!_8,2+\2L,(,Y
MR?Y.8Y[,K"L+Q;#&VXP_DOU'J 6-)5]$,J9^T;[NZU@HVC).\AHL9I"G1?7$
MWVLC3@"NWP/P:H#W'##N 0QKP/ Y8-0#&-4 9;5=25$^A)CC8$K)'E'96[#)
M@C)3H87\M)#KON14O$T%C@?++Y_GOW_\_$=X_V@MT?V?3Y^^_(-^06&Z2V,H
M8H;>AL!QFK%WHO5I&:*W;]ZA-\A&+,$4&$H+]%2DG+T7C:+\D&:96$XVM;F8
MG!S"CNJ)S*N)>#T3&:('4O"$H?LBAKB-MX6H1IEW4';G:0D_P&J /.\]\AQO
MV#4?/?PW7 S0T.V%A^?#/8V:8;-.0\4W[.$[+L@"IW''?.XJ_*@;+X^/&U;B
M"&:6.!\8T!U8P<\_N;[S:Y<W)LE"0V0MWT:-;R,=>S#'+$%Q8UXIS$,E4!21
M/!?'CMK%76YJ62]ULR*[4F3R(-X%SL#SQE-[=VI39R^WZ=22/V[DC[7R;S<;
M"AO, >&<; N.R!I%+RWI<D!+?*D#%9E_HLV?/)/?T678+=YOQ/MGQDP(4286
MNE.G;U*G2;+0$%G+NTGCW42[<5YZ-U!QTQLP6KI+;9R<%3"=O7H"YJK1?:75
MO=RN&'S;@@B5^YW\_?<!\A70_[HT:ZDNU6R2+#1$UK+PNK'PVD#879OTSB19
M:(BLY9WK'/,Q1Q]X\K ^S\)7F)H$J#<#TA-<ZILIMK9Q)XFL:_;$JOE>.67F
M^F$O-LD06]LD[VB2=V8^H!*C,_>9]^J_]UP_[L4N&6)KNW3,M5UM2AHL\(]<
MGOTJ%D7&=##GZ%>G37K2VY**</1UX6@TZS;%UO;PF'>[^L3[Y=9J['R$B-#N
MG:;G5!8B9Z3ST&3B'IIBJSRT3S[3<Z ;==W!Q*>(2,RK[]JFM;E2N547"<_:
MY_*J17W^'VFJ>YH'3#=IP5 &:T'I#"8BJZ;5U4=5X:14EP$KPCG)53$!' .5
M'<3[-2'\4)$#-!=0P?]02P,$%     @ C99B5ENEEPE6!0  C2$  !D   !X
M;"]W;W)K<VAE971S+W-H965T-S4N>&ULQ9IK<^(V%(;_BL;=:3<S34 2ER0%
M9@))NVDWDS0D[?2C8@1HUI:H+"#;7U_Y$@LL1[ &MU_ -M8YY]7EG ?+O;60
M7Z(YI0J\A@&/^MY<J<5EHQ'Y<QJ2Z$PL*->_3(4,B=*G<M:(%I*22=(H#!JH
MV>PT0L*X-^@EUQ[DH">6*F"</D@0+<.0R*]#&HAUWX/>VX5'-INK^$)CT%N0
M&1U3];QXD/JLD5N9L)#RB D.))WVO2MX.<*=N$%RQQ^,KJ.-8Q!+>1'B2WQR
M.^E[S3@B&E!?Q2:(_EK1$0V"V)*.X^_,J)?[C!MN'K]9_SD1K\6\D(B.1/ G
MFZAYWSOWP(1.R3)0CV+]B6:"VK$]7P11\@G6V;U-#_C+2(DP:ZPC"!E/O\EK
MUA$;#;2=\@8H:X"*#5KO-,!9 YP(32-+9%T3108]*=9 QG=K:_%!TC=):ZV&
M\7@8QTKJ7YENIP;CI_O1;Y_N/U_?//XP!C>_/]\^_05.P97O+\-E0!2=@'LU
MIQ*,1*CGR3P>P!4%M]P7(04?KZDB+(A.=)/G\37X^.$$? ",@SL6!'J4HEY#
MZ2!C5PT_"VB8!H3>"0B#.\'5/ (W?$(GV^T;6ERN$+TI'"*GP5\)/P,8_@A0
M$^&2>$;[-T>.<'#>X3BQUWK'WI#.&.>,S\"0!(3[M*R+4A.=Q$2\$%>#4]SJ
M]AJKS;B=?N+E?QDMB$_[GAZWB,H5]0;??P<[S9\<*EJYBI9313HG_*TYP;(Y
M$8A(3X@7JG,,U2O=#T@4L2GSB7IO1J2^VAMR.Z@@UAE.1;'M7&S;*?8J%$NN
MH@TM>E7HE C$5*<ALU#$KDXIT]ZVM)\6!]H9747MG5Q[QZG]B;P"^JJ+1J1%
MO%!.ITR5ZNC8.F!Q$)VN*@KIYD*ZA\W8,E%=>V(6!Z=K+U78R>_9"O4\#_7<
M&:K.?#ORP[G=V>B\68C,Z:1B;U_D$BZ<$G2)U064@]%22LK]K^!)$AX%20HH
M$^2TMG^LJ? C&=L2#INFH#8/3_"9C:T1Q+A=&$&WIZI*-M  _H=)/G.V*?FB
M.&7= 545C(Q@]/\E^LSWIGY+OC.\JO(-F4 WFNR=ZS,[V\F^J*4./(&&3^"!
M@%*JRP:1"TM7'20"#8I -XOLK@VPA"A0JU6440=40$,5T(T5#Y()"<;:+O,I
M&$DZ8:H\:QR)&3+5=1 (- @"W0RR7VFPH0/&?URVA\_IJ*H0 RC032A'K@PV
MSEB9L0Z8@89FH!MGZBT,%[OEUX$TR" -<B/-WH4!V5A3E.)V556*81IT(-.4
MRK+1Q9)5![D@0R[(32Z[RP*R\<-.*VXO5548 $%N +GRU9)(1@+P60\%+4T6
M;A/?6A".96U;L*$4Y*:4O0H"LJGD%+:+_Q7<GJHJ,5R"W%QRW(J ;(:QIFH=
M (,,P" WP-1:$5#9PY2B_CI0!AF406Z4V;\DV#ACY<XZ8 89F$$'PDRI+)M9
MBD^[W&ZKRC+,@MS,LD=)L,%#)Q9KH=7!'MBP!W:SQS.7E 3L'[V6?B&,1^!C
M6AM.@.#@FDJV(O%&4&D:<9O^UEIQ+&O;'6'(!;O)9;^- YM44'&YN?U4U6%0
M!;M1Y;B5 MM8<XJ+N=(=457%&SL^.["FSEJ!2Y[%=(KZZZ <;"@'NREG[UJ!
MRTC'&LPZ0 <;T,$'@DZIL+)G,M8HU4$TV! -=A/-[GJ1&>@XI]I1L:2QL;$=
M4CE+]OLCW?MZ/:4[P/G5_)V"JV0GO7!]""]'Z9L!QDSZHL(=D;.XK 1TJDTV
MS[IZ%&2Z]Y^>*+%(ML]?A%(B3 [GE$RHC&_0OT^%4&\GL8/\#8S!OU!+ P04
M    " "-EF)6/ADEI:@#  "L"P  &0   'AL+W=O<FMS:&5E=',O<VAE970W
M-BYX;6RU5MMRXS8,_16.NM-F9^+H9CN7VIIQ['0VW:9)XZ2=/C(29+%+D2Y)
MV>E^?4%)5GR1U>WMQ19)X/ < "0Q6DOU26< AKSF7.BQDQFSO')='6>04WTF
MER!P)94JIP:':N'JI0*:E$XY=P//&[HY9<*)1N7<@XI&LC"<"7A01!=Y3M4?
MU\#E>NSXSF;BD2TR8R?<:+2D"YB#>5X^*!RY#4K"<A":24$4I&-GXE]-_=*A
MM/B9P5IO?1,KY47*3W9PFXP=SS("#K&Q$!3_5C %SBT2\OB]!G6:/:WC]O<&
M_;M2/(IYH1JFDO_"$I.-G0N'))#2@IM'N?X M:"!Q8LEU^4O6=>VGD/B0AN9
MU\[((&>B^J>O=2"V'!"GW2&H'8)]A_X1A[!V"$NA%;-2UHP:&HV47!-EK1'-
M?I2Q*;U1#1,VC7.C<)6AGXGF3_?3CQ_N?YC=/,Z_(3<_/=\^_4IZY!%B3K5F
M*8NI#;<F6 )$IACVN,@+3@TD))8YEDYF<[H"P@2.@9S,P%#&]7M$>9[/R,F[
M]^0=+I([QKE%&KD&>=O=W;CF>%UQ#(YP#,F=%";3Y$8DD.SZNZBW$1UL1%\'
MG8#?4W%&0O^4!%X0MO"9?KE[T$$G;'(0EGCA$;S]8)-)\AMF'@^+V81]LA7V
M>Y.!(M.=X-]6P4??&2BVHO9LM$:Z8M)O9V+OC"N]I#&,'037H%;@1%]_Y0^]
M;]O"]!^![02MWP2MWX4>/0N\M3C[C %9X&U%3KC46'08@:0[ A7LL(2UE]PJ
M&H[<U;:L0XNPL=CA.FBX#CJY3G)9"*/QVMLD&EDS820!J@03"[M4)1?GWOBC
MC3:JL(6@3XFAKVUZJJT'6VQ[P9Z@%A._7=&P433\]]$G-#58J6J_O*E(ZJ6G
M=DG# [[]/46'%D&[H/-&T'EWBF)34,4H)P+?3JNFC=CYP;;^'K%#B]ZPG=E%
MP^SB;S(K [A43.)SC*>*Q4!>0$#*S$Z%G>(LOO-PK' N_E+,H<4Q,9>-F,M.
M,9AP4CW>_TQ3FX[+KNJNA!R:'*E_WWM[-[W_*RW6 >_T(VFI]]TFZ^W):3'I
M#8X(VFH$_$Y!!Z]0JF3^A0_/*9D62MGWZ@&/OT2-/U8:CQSPFLJPXX2WF/3V
MKV%WJ^_)02W*=E!C7X*W;=4--+--RSDI&ZV]^6O;BI;]U!M,U<?>4;7 6YAP
M2!'2.SO'H*NJ-:P&1B[+[NI%&NS5RL\,VVE0U@#74RG-9F W:!KTZ$]02P,$
M%     @ C99B5B2H+94J!   LQ0  !D   !X;"]W;W)K<VAE971S+W-H965T
M-S<N>&ULK5AMC]HX$/XK5JXZM=)U$SN\[@$2RVY[G,IVM6SO/IMD &L3F[,-
MM/_^G!<2 B9;U'R!.)EY_#SV3&;BP5[(5[4&T.A[''$U=-9:;VY=5P5KB*FZ
M$1O@YLE2R)AJ,Y0K5VTDT#!UBB.7>%['C2GCSFB0WGN2HX'8ZHAQ>))(;>.8
MRA]W$(G]T,'.X<8S6ZUU<L,=#39T!7/0WS9/THS< B5D,7#%!$<2ED-GC&\G
MQ$\<4HM_&.S5T35*I"R$>$T&TW#H> DCB"#0"00U?SN80!0E2(;'?SFH4\R9
M.!Y?'] _I>*-F 55,!'1ORS4ZZ'3<U (2[J-]+/8_P6YH':"%XA(I;]HG]EV
M/ <%6Z5%G#L;!C'CV3_]GB_$D0,A%QQ([D!^UL'/'=*5<S-FJ:Q[JNEH(,4>
MR<3:H"47Z=JDWD8-X\DVSK4T3YGQTZ/YP^?9P^,+FCY^^OH\&[],OSZBC^A)
MBB73=,$BIG^@]_>@*8O4!_0.,8YF+(K,#JB!JPV!!,8-\LGNLLG(A<E\-!-<
MKQ5ZX"&$57_7$"_8DP/[.U(+^#?E-\C'?R#B$1]]F]^C]^\^6'A-?AZ&V&$J
M]/QB<?T4U[^TN+ R$:_1,VR$U(ROT)1GF6?6S[9\&5S+#I=D]*W:T "&CDE9
M!7('SNCWWW#'^].FN2&PBO)6H;Q5ASYZW,8+D$@LD7GA2)IJ5]EJ6.,F0VNG
M:,F;9S?R!^[N6$V=185BNZ#8;G9SVDUN3D-@%>6=0GFG?G-,=9"P [X%F\[,
MN7.TTKC;[IQLA\6HTVW9=Z1;\.K6\IKR0,2 EE+$A["Y\)KIG@5#BYPR/+?Q
MNQT[P5Y!L%=+\ M; IH'#'@ "E$>HO%F$S$(T8S*5["'=BWDM6'3$%A%?;]0
MWV\V8?I-*F\(K*(<>V65]'XE97+OXV##GG_Z"K-8]2^%)#XJX+BAK,F!*BF!
M6Z<DSXU(CUP@24J2I);D/:,K+I1F098WGX&+V RL-&NAKHV;IM"JPLL. #?<
M N!&>X"FT*KJRRX O]$&O)$VEJ+>(J<!:3'R^Q<"LBS^N+;"7I,U[;/YV_U3
MCN<VG=X%BF65QO5E>KQB41(Z$RF4^D(75G*U$%='2T-H5<%E^<?=AG.EMI^X
M6GU#:%7U96^!ZYN+MW*E=YX&/7P:AQ:C]J5<*>L^KBVNU^1*WU8'3TF>&_6Q
MG2,I"S2I+]"'V'D1FD8V:O7^U\9*4VA5M67-)[C93"&U/<35ZAM"JZHOFPE2
MWTR\D2FY=R4(SS]@;%87OV!(6>]);46](E=RH.-/J%;WC*7%J'6:+.[1\4\,
M<I6>BBD4B"W7V5E*<;<X>1NGYTTG]^_P[20[/RMALN,\\WVS8ERA")8&TKOI
MFG63V0E9-M!BDQXR+836(DXOUT!#D(F!>;X40A\&R03%.>7H?U!+ P04
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MK[Z3ZO%R;[D]_KK\.HDXKZXXU_<5P_-?4$L#!!0    ( (V68E;=)VL+& (
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M4')O<',O8V]R92YX;6Q02P$"% ,4    " "-EF)6F5R<(Q &  "<)P  $P
M            @ '+ 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (
M (V68E8#UN@ZVP4   0?   8              " @0P(  !X;"]W;W)K<VAE
M971S+W-H965T,2YX;6Q02P$"% ,4    " "-EF)6Q^A(YF8%   J&@  &
M            @($=#@  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#
M%     @ C99B5K@XLH?) P  I0L  !@              ("!N1,  'AL+W=O
M<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( (V68E8%Z8^09@,  &,)
M   8              " @;@7  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q0
M2P$"% ,4    " "-EF)6.EE=@SD&   M&@  &               @(%4&P
M>&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ C99B5HP_MVL-
M P  +@H  !@              ("!PR$  'AL+W=O<FMS:&5E=',O<VAE970V
M+GAM;%!+ 0(4 Q0    ( (V68E;]W(C&,0@  )LE   8              "
M@08E  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " "-EF)6
M.4@NNT@'  !).@  &               @(%M+0  >&PO=V]R:W-H965T<R]S
M:&5E=#@N>&UL4$L! A0#%     @ C99B5BY)<'ZR @  =@8  !@
M     ("!ZS0  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    (
M (V68E:]79K <PP  #(B   9              " @=,W  !X;"]W;W)K<VAE
M971S+W-H965T,3 N>&UL4$L! A0#%     @ C99B5MV&0[WV P  R0@  !D
M             ("!?40  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"
M% ,4    " "-EF)6/HW63-4(   "%P  &0              @(&J2   >&PO
M=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( (V68E:R)_L5G@D
M $\8   9              " @;91  !X;"]W;W)K<VAE971S+W-H965T,3,N
M>&UL4$L! A0#%     @ C99B5@_UQX('!0  ^ P  !D              ("!
MBUL  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " "-EF)6
M-6363I($  #P"@  &0              @(')8   >&PO=V]R:W-H965T<R]S
M:&5E=#$U+GAM;%!+ 0(4 Q0    ( (V68E8ONAZT?P(  '\%   9
M      " @9)E  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%
M  @ C99B5D5G8R U!@  @@\  !D              ("!2&@  'AL+W=O<FMS
M:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " "-EF)64HK7QN\,  #0*0
M&0              @(&T;@  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+
M 0(4 Q0    ( (V68E:X/%W1DPP  '\K   9              " @=I[  !X
M;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ C99B5B>M(3P<
M!   ) H  !D              ("!I(@  'AL+W=O<FMS:&5E=',O<VAE970R
M,"YX;6Q02P$"% ,4    " "-EF)6=Z-:*),%  ">#   &0
M@('WC   >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( (V6
M8E93P:@?Q00  &D+   9              " @<&2  !X;"]W;W)K<VAE971S
M+W-H965T,C(N>&UL4$L! A0#%     @ C99B5BR\"IH9!   60D  !D
M         ("!O9<  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4
M    " "-EF)63ZW&C) '  "J%@  &0              @($-G   >&PO=V]R
M:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( (V68E:#*/+NB0\  )(J
M   9              " @=2C  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL
M4$L! A0#%     @ C99B5N0@9'O,#   JR0  !D              ("!E+,
M 'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " "-EF)6%0H^
MT"D#   U!P  &0              @(&7P   >&PO=V]R:W-H965T<R]S:&5E
M=#(W+GAM;%!+ 0(4 Q0    ( (V68E82 =4UY 0  -4+   9
M  " @??#  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @
MC99B5ASB[7,0!    0D  !D              ("!$LD  'AL+W=O<FMS:&5E
M=',O<VAE970R.2YX;6Q02P$"% ,4    " "-EF)6BK!U#.X"  "?!@  &0
M            @(%9S0  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4
M Q0    ( (V68E;B]+A(?P(  ( %   9              " @7[0  !X;"]W
M;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ C99B5@.>,?@>!0
M&0T  !D              ("!--,  'AL+W=O<FMS:&5E=',O<VAE970S,BYX
M;6Q02P$"% ,4    " "-EF)6B_CUA*@%  "9$0  &0              @(&)
MV   >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( (V68E93
M?)SG@04  &40   9              " @6C>  !X;"]W;W)K<VAE971S+W-H
M965T,S0N>&UL4$L! A0#%     @ C99B5MX>2-(K!   @PH  !D
M     ("!(.0  'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( (V68E9:IK!S?@4  %(@   9              "
M@4[X  !X;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ C99B
M5@X!/3JW!   9AP  !D              ("! _X  'AL+W=O<FMS:&5E=',O
M<VAE970T,2YX;6Q02P$"% ,4    " "-EF)6JV=[^'(#   '#@  &0
M        @('Q @$ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0
M   ( (V68E:B9,:CFP(  +8'   9              " @9H& 0!X;"]W;W)K
M<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @ C99B5MSU=\W9 P  5@\
M !D              ("!; D! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q0
M2P$"% ,4    " "-EF)6*GUN!F4"  "M!0  &0              @(%\#0$
M>&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    ( (V68E:0ZA?0
MZ 0  /0=   9              " @1@0 0!X;"]W;W)K<VAE971S+W-H965T
M-#8N>&UL4$L! A0#%     @ C99B5O5@E+MH P  C X  !D
M ("!-Q4! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q02P$"% ,4    " "-
MEF)6HGA>:3X$   /$0  &0              @('6& $ >&PO=V]R:W-H965T
M<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( (V68E:59+SH_P(  .L'   9
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M970U,RYX;6Q02P$"% ,4    " "-EF)6RA6AW_\#  #I$0  &0
M    @('&, $ >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    (
M (V68E;%7&P-I0(  .(&   9              " @?PT 0!X;"]W;W)K<VAE
M971S+W-H965T-34N>&UL4$L! A0#%     @ C99B5M Z 5<8#   Y(H  !D
M             ("!V#<! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"
M% ,4    " "-EF)6] C2"O "  #C!P  &0              @($G1 $ >&PO
M=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    ( (V68E97G;X!Y@,
M #83   9              " @4Y' 0!X;"]W;W)K<VAE971S+W-H965T-3@N
M>&UL4$L! A0#%     @ C99B5KE-7Y]@ P  4PD  !D              ("!
M:TL! 'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6Q02P$"% ,4    " "-EF)6
ME1D5DZ$"  "G!@  &0              @($"3P$ >&PO=V]R:W-H965T<R]S
M:&5E=#8P+GAM;%!+ 0(4 Q0    ( (V68E:X8%F4+P,  &P*   9
M      " @=I1 0!X;"]W;W)K<VAE971S+W-H965T-C$N>&UL4$L! A0#%
M  @ C99B5G#@[.?;!   BQH  !D              ("!0%4! 'AL+W=O<FMS
M:&5E=',O<VAE970V,BYX;6Q02P$"% ,4    " "-EF)66?6C:^<&  #E.0
M&0              @(%26@$ >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+
M 0(4 Q0    ( (V68E:RD:F%(P0  %P8   9              " @7!A 0!X
M;"]W;W)K<VAE971S+W-H965T-C0N>&UL4$L! A0#%     @ C99B5HT00,2G
M!   4A<  !D              ("!RF4! 'AL+W=O<FMS:&5E=',O<VAE970V
M-2YX;6Q02P$"% ,4    " "-EF)6%!CQV8<"  #!!@  &0
M@(&H:@$ >&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    ( (V6
M8E8-\'!LJP0  $(7   9              " @69M 0!X;"]W;W)K<VAE971S
M+W-H965T-C<N>&UL4$L! A0#%     @ C99B5I0>F<T" P  "0L  !D
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M=#<R+GAM;%!+ 0(4 Q0    ( (V68E;V(6Z=,P0  (H;   9
M  " @5&& 0!X;"]W;W)K<VAE971S+W-H965T-S,N>&UL4$L! A0#%     @
MC99B5@TM,SC( P  C!(  !D              ("!NXH! 'AL+W=O<FMS:&5E
M=',O<VAE970W-"YX;6Q02P$"% ,4    " "-EF)66Z67"58%  "-(0  &0
M            @(&ZC@$ >&PO=V]R:W-H965T<R]S:&5E=#<U+GAM;%!+ 0(4
M Q0    ( (V68E8^&26EJ ,  *P+   9              " @4>4 0!X;"]W
M;W)K<VAE971S+W-H965T-S8N>&UL4$L! A0#%     @ C99B5B2H+94J!
MLQ0  !D              ("!)I@! 'AL+W=O<FMS:&5E=',O<VAE970W-RYX
M;6Q02P$"% ,4    " "-EF)6^0)J+Q$$  "2#@  &0              @(&'
MG $ >&PO=V]R:W-H965T<R]S:&5E=#<X+GAM;%!+ 0(4 Q0    ( (V68E8J
MIUOS2 ,  !</   9              " @<^@ 0!X;"]W;W)K<VAE971S+W-H
M965T-SDN>&UL4$L! A0#%     @ C99B5E"T&S\H P  2A(   T
M     ( !3J0! 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " "-EF)6EXJ[',
M   3 @  "P              @ &AIP$ 7W)E;',O+G)E;'-02P$"% ,4
M" "-EF)6L]AI D$&  !L-   #P              @ &*J $ >&PO=V]R:V)O
M;VLN>&UL4$L! A0#%     @ C99B5KM)TM]B @  M"X  !H
M ( !^*X! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @
MC99B5MTG:PL8 @  A2T  !,              ( !DK$! %M#;VYT96YT7U1Y
><&5S72YX;6Q02P4&     %< 5P#8%P  V[,!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>285</ContextCount>
  <ElementCount>318</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>96</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/DocumentandEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS) (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS) (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnauditedParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - CONDENSED CONSOLIDATED STATEMENT OF EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENT OF EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Statement - CONDENSED CONSOLIDATE STATEMENT OF EQUITY - (PARENTHETICAL)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/CONDENSEDCONSOLIDATESTATEMENTOFEQUITYPARENTHETICAL</Role>
      <ShortName>CONDENSED CONSOLIDATE STATEMENT OF EQUITY - (PARENTHETICAL)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNotes</Role>
      <ShortName>OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.agilent.com/role/NEWACCOUNTINGPRONOUNCEMENTSNotes</Role>
      <ShortName>NEW ACCOUNTING PRONOUNCEMENTS (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - REVENUE (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.agilent.com/role/REVENUENotes</Role>
      <ShortName>REVENUE (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - SHARE-BASED COMPENSATION (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.agilent.com/role/SHAREBASEDCOMPENSATIONNotes</Role>
      <ShortName>SHARE-BASED COMPENSATION (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - INCOME TAXES (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.agilent.com/role/INCOMETAXESNotes</Role>
      <ShortName>INCOME TAXES (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - NET INCOME PER SHARE (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.agilent.com/role/NETINCOMEPERSHARENotes</Role>
      <ShortName>NET INCOME PER SHARE (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - INVENTORY (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.agilent.com/role/INVENTORYNotes</Role>
      <ShortName>INVENTORY (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNotes</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - FAIR VALUE MEASUREMENTS (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.agilent.com/role/FAIRVALUEMEASUREMENTSNotes</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - DERIVATIVES (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.agilent.com/role/DERIVATIVESNotes</Role>
      <ShortName>DERIVATIVES (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSNotes</Role>
      <ShortName>RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - WARRANTIES AND CONTINGENCIES (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESNotes</Role>
      <ShortName>WARRANTIES AND CONTINGENCIES (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - SHORT-TERM DEBT (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.agilent.com/role/SHORTTERMDEBTNotes</Role>
      <ShortName>SHORT-TERM DEBT (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - LONG-TERM DEBT (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.agilent.com/role/LONGTERMDEBTNotes</Role>
      <ShortName>LONG-TERM DEBT (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - STOCKHOLDERS' EQUITY (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.agilent.com/role/STOCKHOLDERSEQUITYNotes</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - SEGMENT INFORMATION (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.agilent.com/role/SEGMENTINFORMATIONNotes</Role>
      <ShortName>SEGMENT INFORMATION (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNotes</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - REVENUE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/REVENUETables</Role>
      <ShortName>REVENUE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.agilent.com/role/REVENUENotes</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - SHARE-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTables</Role>
      <ShortName>SHARE-BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.agilent.com/role/SHAREBASEDCOMPENSATIONNotes</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - NET INCOME PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/NETINCOMEPERSHARETables</Role>
      <ShortName>NET INCOME PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.agilent.com/role/NETINCOMEPERSHARENotes</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - INVENTORY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/INVENTORYTables</Role>
      <ShortName>INVENTORY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.agilent.com/role/INVENTORYNotes</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNotes</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/FAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.agilent.com/role/FAIRVALUEMEASUREMENTSNotes</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - DERIVATIVES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/DERIVATIVESTables</Role>
      <ShortName>DERIVATIVES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.agilent.com/role/DERIVATIVESNotes</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSTables</Role>
      <ShortName>RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSNotes</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - WARRANTIES AND CONTINGENCIES (Table)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESTable</Role>
      <ShortName>WARRANTIES AND CONTINGENCIES (Table)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESNotes</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - LONG-TERM DEBT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/LONGTERMDEBTTables</Role>
      <ShortName>LONG-TERM DEBT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.agilent.com/role/LONGTERMDEBTNotes</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/STOCKHOLDERSEQUITYTables</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.agilent.com/role/STOCKHOLDERSEQUITYNotes</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - SEGMENT INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/SEGMENTINFORMATIONTables</Role>
      <ShortName>SEGMENT INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.agilent.com/role/SEGMENTINFORMATIONNotes</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails</Role>
      <ShortName>OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - REVENUE- Revenue by Region (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/REVENUERevenuebyRegionDetails</Role>
      <ShortName>REVENUE- Revenue by Region (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - REVENUE - Revenue by End Markets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails</Role>
      <ShortName>REVENUE - Revenue by End Markets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - REVENUE - Revenue by Type (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/REVENUERevenuebyTypeDetails</Role>
      <ShortName>REVENUE - Revenue by Type (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - REVENUE - Contract Assets and Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/REVENUEContractAssetsandLiabilityDetails</Role>
      <ShortName>REVENUE - Contract Assets and Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - REVENUE - Remaining Performance Obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails</Role>
      <ShortName>REVENUE - Remaining Performance Obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - SHARE-BASED COMPENSATION Text (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION Text (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - SHARE-BASED COMPENSATION Allocated Share-based compensation expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION Allocated Share-based compensation expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - SHARE-BASED COMPENSATION Fair Value Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION Fair Value Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/INCOMETAXESDetails</Role>
      <ShortName>INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.agilent.com/role/INCOMETAXESNotes</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - NET INCOME PER SHARE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/NETINCOMEPERSHAREDetails</Role>
      <ShortName>NET INCOME PER SHARE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.agilent.com/role/NETINCOMEPERSHARETables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - INVENTORY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/INVENTORYDetails</Role>
      <ShortName>INVENTORY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.agilent.com/role/INVENTORYTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill Roll forward (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill Roll forward (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Disclosures and Components of Purchased Other Intangibles (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS Disclosures and Components of Purchased Other Intangibles (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Textuals (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS Textuals (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Estimated Future Amortization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimatedFutureAmortizationDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS - Estimated Future Amortization (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - FAIR VALUE MEASUREMENTS, Fair value of assets and liabilities measured on a recurring basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS, Fair value of assets and liabilities measured on a recurring basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - FAIR VALUE MEASUREMENTS - Equity Securities and Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/FAIRVALUEMEASUREMENTSEquitySecuritiesandInvestmentsDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Equity Securities and Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - FAIR VALUE MEASUREMENTS, Contingent Consideration (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS, Contingent Consideration (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - FAIR VALUE MEASUREMENTS - Reconciliation of Beginning and Ending Level 3 Contingent Consideration Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingLevel3ContingentConsiderationLiabilityDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Reconciliation of Beginning and Ending Level 3 Contingent Consideration Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - FAIR VALUE MEASUREMENTS, Assets and Liabilities measured at Fair Value on a Non-Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS, Assets and Liabilities measured at Fair Value on a Non-Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - FAIR VALUE MEASUREMENTS, Non Marketable Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/FAIRVALUEMEASUREMENTSNonMarketableSecuritiesDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS, Non Marketable Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - DERIVATIVES- Text (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/DERIVATIVESTextDetails</Role>
      <ShortName>DERIVATIVES- Text (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - DERIVATIVES- Foreign Exchange Forward Contracts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails</Role>
      <ShortName>DERIVATIVES- Foreign Exchange Forward Contracts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - DERIVATIVES, Fair value of derivative instruments and Consolidated Balance Sheet location (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails</Role>
      <ShortName>DERIVATIVES, Fair value of derivative instruments and Consolidated Balance Sheet location (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - DERIVATIVES, Effect of derivative instruments on Consolidated Statement of Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails</Role>
      <ShortName>DERIVATIVES, Effect of derivative instruments on Consolidated Statement of Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - Derivative Instruments and Hedging Activities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/DerivativeInstrumentsandHedgingActivitiesDetails</Role>
      <ShortName>Derivative Instruments and Hedging Activities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS- Components of net periodic costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails</Role>
      <ShortName>RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS- Components of net periodic costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Details) (Employer Contributions))</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions</Role>
      <ShortName>RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Details) (Employer Contributions))</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - WARRANTIES AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESDetails</Role>
      <ShortName>WARRANTIES AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESTable</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - SHORT-TERM DEBT - Credit Facility (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails</Role>
      <ShortName>SHORT-TERM DEBT - Credit Facility (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - LONG-TERM DEBT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/LONGTERMDEBTDetails</Role>
      <ShortName>LONG-TERM DEBT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.agilent.com/role/LONGTERMDEBTTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - LONG-TERM DEBT - Text (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/LONGTERMDEBTTextDetails</Role>
      <ShortName>LONG-TERM DEBT - Text (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - STOCKHOLDERS' EQUITY - Stock Repurchase Program (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Stock Repurchase Program (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - STOCKHOLDER"S EQUITY - Dividends (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails</Role>
      <ShortName>STOCKHOLDER"S EQUITY - Dividends (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - STOCKHOLDER'S EQUITY - Accumulated Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails</Role>
      <ShortName>STOCKHOLDER'S EQUITY - Accumulated Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000077 - Disclosure - STOCKHOLDERS' EQUITY - Reclassifications out of accumulated comprehensive income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Reclassifications out of accumulated comprehensive income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0000078 - Disclosure - SEGMENT INFORMATION - Profitability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails</Role>
      <ShortName>SEGMENT INFORMATION - Profitability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0000079 - Disclosure - SEGMENT INFORMATION - Reconciliation of Reportable Results (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails</Role>
      <ShortName>SEGMENT INFORMATION - Reconciliation of Reportable Results (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="a-20230131.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0000080 - Disclosure - SEGMENT INFORMATION - Segment Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com/role/SEGMENTINFORMATIONSegmentAssetsDetails</Role>
      <ShortName>SEGMENT INFORMATION - Segment Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="a-20230131.htm">a-20230131.htm</File>
    <File>a-01312023xex101.htm</File>
    <File>a-01312023xex311.htm</File>
    <File>a-01312023xex312.htm</File>
    <File>a-01312023xex321.htm</File>
    <File>a-01312023xex322.htm</File>
    <File>a-20230131.xsd</File>
    <File>a-20230131_cal.xml</File>
    <File>a-20230131_def.xml</File>
    <File>a-20230131_lab.xml</File>
    <File>a-20230131_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="939">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>102
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "a-20230131.htm": {
   "axisCustom": 1,
   "axisStandard": 26,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 939,
    "http://xbrl.sec.gov/dei/2022": 29
   },
   "contextCount": 285,
   "dts": {
    "calculationLink": {
     "local": [
      "a-20230131_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "a-20230131_def.xml"
     ]
    },
    "inline": {
     "local": [
      "a-20230131.htm"
     ]
    },
    "labelLink": {
     "local": [
      "a-20230131_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "a-20230131_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "a-20230131.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 684,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 12,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 17
   },
   "keyCustom": 7,
   "keyStandard": 311,
   "memberCustom": 26,
   "memberStandard": 70,
   "nsprefix": "a",
   "nsuri": "http://www.agilent.com/20230131",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.agilent.com/role/DocumentandEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Notes)",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNotes",
     "shortName": "OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS (Notes)",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.agilent.com/role/NEWACCOUNTINGPRONOUNCEMENTSNotes",
     "shortName": "NEW ACCOUNTING PRONOUNCEMENTS (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - REVENUE (Notes)",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.agilent.com/role/REVENUENotes",
     "shortName": "REVENUE (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - SHARE-BASED COMPENSATION (Notes)",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONNotes",
     "shortName": "SHARE-BASED COMPENSATION (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - INCOME TAXES (Notes)",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.agilent.com/role/INCOMETAXESNotes",
     "shortName": "INCOME TAXES (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - NET INCOME PER SHARE (Notes)",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.agilent.com/role/NETINCOMEPERSHARENotes",
     "shortName": "NET INCOME PER SHARE (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - INVENTORY (Notes)",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.agilent.com/role/INVENTORYNotes",
     "shortName": "INVENTORY (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Notes)",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNotes",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - FAIR VALUE MEASUREMENTS (Notes)",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSNotes",
     "shortName": "FAIR VALUE MEASUREMENTS (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - DERIVATIVES (Notes)",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.agilent.com/role/DERIVATIVESNotes",
     "shortName": "DERIVATIVES (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (Unaudited)",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Notes)",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSNotes",
     "shortName": "RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - WARRANTIES AND CONTINGENCIES (Notes)",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESNotes",
     "shortName": "WARRANTIES AND CONTINGENCIES (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - SHORT-TERM DEBT (Notes)",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.agilent.com/role/SHORTTERMDEBTNotes",
     "shortName": "SHORT-TERM DEBT (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - LONG-TERM DEBT (Notes)",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.agilent.com/role/LONGTERMDEBTNotes",
     "shortName": "LONG-TERM DEBT (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - STOCKHOLDERS' EQUITY (Notes)",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.agilent.com/role/STOCKHOLDERSEQUITYNotes",
     "shortName": "STOCKHOLDERS' EQUITY (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - SEGMENT INFORMATION (Notes)",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://www.agilent.com/role/SEGMENTINFORMATIONNotes",
     "shortName": "SEGMENT INFORMATION (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "menuCat": "Policies",
     "order": "26",
     "role": "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables",
     "shortName": "OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - REVENUE (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.agilent.com/role/REVENUETables",
     "shortName": "REVENUE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - SHARE-BASED COMPENSATION (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTables",
     "shortName": "SHARE-BASED COMPENSATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (Unaudited)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - NET INCOME PER SHARE (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.agilent.com/role/NETINCOMEPERSHARETables",
     "shortName": "NET INCOME PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - INVENTORY (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.agilent.com/role/INVENTORYTables",
     "shortName": "INVENTORY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSTables",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - DERIVATIVES (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.agilent.com/role/DERIVATIVESTables",
     "shortName": "DERIVATIVES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSTables",
     "shortName": "RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - WARRANTIES AND CONTINGENCIES (Table)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESTable",
     "shortName": "WARRANTIES AND CONTINGENCIES (Table)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - LONG-TERM DEBT (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://www.agilent.com/role/LONGTERMDEBTTables",
     "shortName": "LONG-TERM DEBT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - STOCKHOLDERS' EQUITY (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://www.agilent.com/role/STOCKHOLDERSEQUITYTables",
     "shortName": "STOCKHOLDERS' EQUITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - SEGMENT INFORMATION (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://www.agilent.com/role/SEGMENTINFORMATIONTables",
     "shortName": "SEGMENT INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS) (Unaudited) (Parenthetical)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical",
     "shortName": "CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS) (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i658253fffabe4343b44569144474388f_I20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
     "shortName": "OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i658253fffabe4343b44569144474388f_I20230131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestrictedCash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - REVENUE- Revenue by Region (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.agilent.com/role/REVENUERevenuebyRegionDetails",
     "shortName": "REVENUE- Revenue by Region (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i2ebb4d48c62249409808fe3659039d91_D20221101-20230131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - REVENUE - Revenue by End Markets (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails",
     "shortName": "REVENUE - Revenue by End Markets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i2a91b9cb9e834ebdae96fd116f3b54bb_D20221101-20230131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - REVENUE - Revenue by Type (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.agilent.com/role/REVENUERevenuebyTypeDetails",
     "shortName": "REVENUE - Revenue by Type (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "id4192156e4404414ad46fd4d9c955d45_D20221101-20230131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i658253fffabe4343b44569144474388f_I20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - REVENUE - Contract Assets and Liability (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.agilent.com/role/REVENUEContractAssetsandLiabilityDetails",
     "shortName": "REVENUE - Contract Assets and Liability (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i658253fffabe4343b44569144474388f_I20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i760e2fe91a2a4c6185fc11aef9ce399f_I20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - REVENUE - Remaining Performance Obligation (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails",
     "shortName": "REVENUE - Remaining Performance Obligation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i760e2fe91a2a4c6185fc11aef9ce399f_I20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - SHARE-BASED COMPENSATION Text (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails",
     "shortName": "SHARE-BASED COMPENSATION Text (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - SHARE-BASED COMPENSATION Allocated Share-based compensation expense (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails",
     "shortName": "SHARE-BASED COMPENSATION Allocated Share-based compensation expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i39c3cd014db248d291455e64255569d7_D20221101-20230131",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - SHARE-BASED COMPENSATION Fair Value Assumptions (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails",
     "shortName": "SHARE-BASED COMPENSATION Fair Value Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "a:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i39c3cd014db248d291455e64255569d7_D20221101-20230131",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - INCOME TAXES (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.agilent.com/role/INCOMETAXESDetails",
     "shortName": "INCOME TAXES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i658253fffabe4343b44569144474388f_I20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i658253fffabe4343b44569144474388f_I20230131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - NET INCOME PER SHARE (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.agilent.com/role/NETINCOMEPERSHAREDetails",
     "shortName": "NET INCOME PER SHARE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i658253fffabe4343b44569144474388f_I20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - INVENTORY (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.agilent.com/role/INVENTORYDetails",
     "shortName": "INVENTORY (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i658253fffabe4343b44569144474388f_I20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill Roll forward (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill Roll forward (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i658253fffabe4343b44569144474388f_I20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Disclosures and Components of Purchased Other Intangibles (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS Disclosures and Components of Purchased Other Intangibles (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i658253fffabe4343b44569144474388f_I20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Textuals (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS Textuals (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i658253fffabe4343b44569144474388f_I20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Estimated Future Amortization (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimatedFutureAmortizationDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Estimated Future Amortization (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i658253fffabe4343b44569144474388f_I20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i658253fffabe4343b44569144474388f_I20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - FAIR VALUE MEASUREMENTS, Fair value of assets and liabilities measured on a recurring basis (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails",
     "shortName": "FAIR VALUE MEASUREMENTS, Fair value of assets and liabilities measured on a recurring basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "ibaaa0ef2c25948abb1a1d1b853e18ed6_I20230131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiGainLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - FAIR VALUE MEASUREMENTS - Equity Securities and Investments (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSEquitySecuritiesandInvestmentsDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - Equity Securities and Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:GainLossOnInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiRealizedGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i658253fffabe4343b44569144474388f_I20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - FAIR VALUE MEASUREMENTS, Contingent Consideration (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails",
     "shortName": "FAIR VALUE MEASUREMENTS, Contingent Consideration (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i78c42080d0f14678bc601c2d0167baec_D20221101-20230131",
      "decimals": null,
      "lang": "en-US",
      "name": "a:BusinessCombinationsContingentConsiderationArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i728f596925ae44e9bfb99f953f600ea9_I20221031",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - FAIR VALUE MEASUREMENTS - Reconciliation of Beginning and Ending Level 3 Contingent Consideration Liability (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingLevel3ContingentConsiderationLiabilityDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - Reconciliation of Beginning and Ending Level 3 Contingent Consideration Liability (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i658253fffabe4343b44569144474388f_I20230131",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited) (Parenthetical)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnauditedParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i658253fffabe4343b44569144474388f_I20230131",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf",
       "us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - FAIR VALUE MEASUREMENTS, Assets and Liabilities measured at Fair Value on a Non-Recurring Basis (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
     "shortName": "FAIR VALUE MEASUREMENTS, Assets and Liabilities measured at Fair Value on a Non-Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf",
       "us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount",
       "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - FAIR VALUE MEASUREMENTS, Non Marketable Securities (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSNonMarketableSecuritiesDetails",
     "shortName": "FAIR VALUE MEASUREMENTS, Non Marketable Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount",
       "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i658253fffabe4343b44569144474388f_I20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNetLiabilityPositionAggregateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - DERIVATIVES- Text (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.agilent.com/role/DERIVATIVESTextDetails",
     "shortName": "DERIVATIVES- Text (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i658253fffabe4343b44569144474388f_I20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNetLiabilityPositionAggregateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i6368af5356e443e2b1bcf93e16e6d501_I20230131",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfForeignCurrencyDerivativesHeld",
      "reportCount": 1,
      "unique": true,
      "unitRef": "contracts",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - DERIVATIVES- Foreign Exchange Forward Contracts (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails",
     "shortName": "DERIVATIVES- Foreign Exchange Forward Contracts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i6368af5356e443e2b1bcf93e16e6d501_I20230131",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfForeignCurrencyDerivativesHeld",
      "reportCount": 1,
      "unique": true,
      "unitRef": "contracts",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i658253fffabe4343b44569144474388f_I20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - DERIVATIVES, Fair value of derivative instruments and Consolidated Balance Sheet location (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
     "shortName": "DERIVATIVES, Fair value of derivative instruments and Consolidated Balance Sheet location (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i658253fffabe4343b44569144474388f_I20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - DERIVATIVES, Effect of derivative instruments on Consolidated Statement of Operations (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
     "shortName": "DERIVATIVES, Effect of derivative instruments on Consolidated Statement of Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "ibe16525b780846f0a8256296b5fb0f87_D20221101-20230131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "ia7aac091b08c48afba3a0408369ffcc4_D20221101-20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - Derivative Instruments and Hedging Activities (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.agilent.com/role/DerivativeInstrumentsandHedgingActivitiesDetails",
     "shortName": "Derivative Instruments and Hedging Activities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "ia7aac091b08c48afba3a0408369ffcc4_D20221101-20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i125675019576446bbc7947a564d0c89f_D20221101-20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS- Components of net periodic costs (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails",
     "shortName": "RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS- Components of net periodic costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i125675019576446bbc7947a564d0c89f_D20221101-20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "a:EmployerContributionsAndExpectedEmployerContributionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i125675019576446bbc7947a564d0c89f_D20221101-20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Details) (Employer Contributions))",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions",
     "shortName": "RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS (Details) (Employer Contributions))",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "a:EmployerContributionsAndExpectedEmployerContributionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i125675019576446bbc7947a564d0c89f_D20221101-20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i728f596925ae44e9bfb99f953f600ea9_I20221031",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StandardProductWarrantyAccrual",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - WARRANTIES AND CONTINGENCIES (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESDetails",
     "shortName": "WARRANTIES AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i728f596925ae44e9bfb99f953f600ea9_I20221031",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StandardProductWarrantyAccrual",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RepaymentsOfCommercialPaper",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - SHORT-TERM DEBT - Credit Facility (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails",
     "shortName": "SHORT-TERM DEBT - Credit Facility (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i2ef13658ecf745f787fde75342d47896_D20190313-20190313",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityInitiationDate1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i658253fffabe4343b44569144474388f_I20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - LONG-TERM DEBT (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.agilent.com/role/LONGTERMDEBTDetails",
     "shortName": "LONG-TERM DEBT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i10c0cb7fda60466cb455e2be4d15041f_I20230131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i658253fffabe4343b44569144474388f_I20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - LONG-TERM DEBT - Text (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.agilent.com/role/LONGTERMDEBTTextDetails",
     "shortName": "LONG-TERM DEBT - Text (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i00a9160afdad455eb4f9ec0885e50ae0_I20220415",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i09d3df9f558a4787b3d731f7b3eab7d8_I20210218",
      "decimals": "-7",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - STOCKHOLDERS' EQUITY - Stock Repurchase Program (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Stock Repurchase Program (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i09d3df9f558a4787b3d731f7b3eab7d8_I20210218",
      "decimals": "-7",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - STOCKHOLDER\"S EQUITY - Dividends (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails",
     "shortName": "STOCKHOLDER\"S EQUITY - Dividends (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i728f596925ae44e9bfb99f953f600ea9_I20221031",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - STOCKHOLDER'S EQUITY - Accumulated Other Comprehensive Income (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails",
     "shortName": "STOCKHOLDER'S EQUITY - Accumulated Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - STOCKHOLDERS' EQUITY - Reclassifications out of accumulated comprehensive income (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Reclassifications out of accumulated comprehensive income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:NumberOfOperatingSegments",
       "us-gaap:NumberOfOperatingSegments",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000078 - Disclosure - SEGMENT INFORMATION - Profitability (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails",
     "shortName": "SEGMENT INFORMATION - Profitability (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:NumberOfOperatingSegments",
       "us-gaap:NumberOfOperatingSegments",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000079 - Disclosure - SEGMENT INFORMATION - Reconciliation of Reportable Results (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails",
     "shortName": "SEGMENT INFORMATION - Reconciliation of Reportable Results (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "a:TransformationalPrograms",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i658253fffabe4343b44569144474388f_I20230131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000080 - Disclosure - SEGMENT INFORMATION - Segment Assets (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://www.agilent.com/role/SEGMENTINFORMATIONSegmentAssetsDetails",
     "shortName": "SEGMENT INFORMATION - Segment Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i9e0c874f1a2f4b52bde701c5d0c5f04a_I20230131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i7a4a359dc74949868e019c988906b5d0_I20211031",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - CONDENSED CONSOLIDATED STATEMENT OF EQUITY",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENT OF EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i7a4a359dc74949868e019c988906b5d0_I20211031",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a-20230131.htm",
      "contextRef": "i70d639bf42ac431baa789730eb29b398_D20221101-20230131",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000009 - Statement - CONDENSED CONSOLIDATE STATEMENT OF EQUITY - (PARENTHETICAL)",
     "menuCat": "Statements",
     "order": "9",
     "role": "http://www.agilent.com/role/CONDENSEDCONSOLIDATESTATEMENTOFEQUITYPARENTHETICAL",
     "shortName": "CONDENSED CONSOLIDATE STATEMENT OF EQUITY - (PARENTHETICAL)",
     "subGroupType": "",
     "uniqueAnchor": null
    }
   },
   "segmentCount": 96,
   "tag": {
    "a_A2019RepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 Repurchase Program [Member]",
        "label": "2019 Repurchase Program [Member]",
        "terseLabel": "2019 Repurchase Program [Member]"
       }
      }
     },
     "localname": "A2019RepurchaseProgramMember",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_A2021RepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Repurchase Program",
        "label": "2021 Repurchase Program [Member]",
        "terseLabel": "2021 Repurchase Program [Member]"
       }
      }
     },
     "localname": "A2021RepurchaseProgramMember",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_A2023RepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2023 Repurchase Program",
        "label": "2023 Repurchase Program [Member]",
        "terseLabel": "2023 Repurchase Program"
       }
      }
     },
     "localname": "A2023RepurchaseProgramMember",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_A5YrUnsecuredCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5 yr Unsecured Credit Facility",
        "label": "5 yr Unsecured Credit Facility [Member]",
        "terseLabel": "5 yr Unsecured Credit Facility"
       }
      }
     },
     "localname": "A5YrUnsecuredCreditFacilityMember",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_AcademiaandGovernmentMarketMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Academia and Government Market [Member]",
        "label": "Academia and Government Market [Member]",
        "terseLabel": "Academia and Government"
       }
      }
     },
     "localname": "AcademiaandGovernmentMarketMember",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_AdditionalIncrementalTermLoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Incremental Term Loan Facility",
        "label": "Additional Incremental Term Loan Facility [Member]",
        "terseLabel": "Additional Incremental Term Loan Facility"
       }
      }
     },
     "localname": "AdditionalIncrementalTermLoanFacilityMember",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_AgilentCrossLabMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agilent CrossLab [Member]",
        "label": "Agilent CrossLab [Member]",
        "terseLabel": "Agilent CrossLab"
       }
      }
     },
     "localname": "AgilentCrossLabMember",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails",
      "http://www.agilent.com/role/REVENUERevenuebyRegionDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONSegmentAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_AmortizationAndDeferralsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization and deferrals [Abstract]",
        "label": "Amortization and deferrals [Abstract]",
        "terseLabel": "Amortization:"
       }
      }
     },
     "localname": "AmortizationAndDeferralsAbstract",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "a_AssetsLongLivedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets Long Lived [Abstract]",
        "label": "Assets Long Lived [Abstract]",
        "terseLabel": "Long-Lived Assets"
       }
      }
     },
     "localname": "AssetsLongLivedAbstract",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "a_BusinessCombinationContingentConsiderationFairValueMeasurementInput": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination Contingent Consideration Fair Value Measurement Input",
        "terseLabel": "Business Combination Contingent Consideration Liability Measurement Input"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationFairValueMeasurementInput",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "a_BusinessCombinationsContingentConsiderationArrangements": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum earn-out period for settlement of contingent consideration payment.",
        "label": "business combinations, contingent consideration, arrangements",
        "terseLabel": "Contingent Consideration maximum earn-out period"
       }
      }
     },
     "localname": "BusinessCombinationsContingentConsiderationArrangements",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "a_ChemicalandEnergyMarketMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Chemical and Energy Market [Member]",
        "label": "Chemical and Energy Market [Member]",
        "terseLabel": "Chemical and Advanced Materials"
       }
      }
     },
     "localname": "ChemicalandEnergyMarketMember",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_DenominatorsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Denominators [Abstract]",
        "label": "Denominators [Abstract]",
        "terseLabel": "Denominators:"
       }
      }
     },
     "localname": "DenominatorsAbstract",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/NETINCOMEPERSHAREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "a_DiagnosticsAndGenomicsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diagnostics and Genomics segment includes; DNA mutation detection; genotyping; gene copy number determination; identification of gene rearrangements; DNA methylation profiling; gene expression profiling; and automated gel electrophoresis-based sample analysis systems.",
        "label": "Diagnostics and Genomics [Member]",
        "terseLabel": "Diagnostics and Genomics"
       }
      }
     },
     "localname": "DiagnosticsAndGenomicsMember",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails",
      "http://www.agilent.com/role/REVENUERevenuebyRegionDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONSegmentAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_DiagnosticsandClinicalMarketMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diagnostics and Clinical Market [Member]",
        "label": "Diagnostics and Clinical Market [Member]",
        "terseLabel": "Diagnostics and Clinical"
       }
      }
     },
     "localname": "DiagnosticsandClinicalMarketMember",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Document and Entity Information [Abstract]",
        "label": "Document and Entity Information [Abstract]",
        "terseLabel": "Document and Entity Information [Abstract]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://www.agilent.com/20230131",
     "xbrltype": "stringItemType"
    },
    "a_EmployerContributionsAndExpectedEmployerContributionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of amount of contributions received by defined benefit plan from employer which increases plan assets and amount of contribution expected to be received by defined benefit plan from employer in the remainder of current fiscal year.",
        "label": "Employer Contributions and Expected Employer Contributions [Table Text Block]",
        "terseLabel": "Employer Contributions and Expected Employer Contributions"
       }
      }
     },
     "localname": "EmployerContributionsAndExpectedEmployerContributionsTableTextBlock",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "a_EndMarketsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End Markets [Axis]",
        "label": "End Markets [Axis]",
        "terseLabel": "End Markets [Axis]"
       }
      }
     },
     "localname": "EndMarketsAxis",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "a_EndMarketsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for End Markets [Axis]",
        "label": "End Markets [Domain]",
        "terseLabel": "End Markets [Domain]"
       }
      }
     },
     "localname": "EndMarketsDomain",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_EnvironmentalandForensicsMarketMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Environmental and Forensics Market [Member]",
        "label": "Environmental and Forensics Market [Member]",
        "terseLabel": "Environmental and Forensics"
       }
      }
     },
     "localname": "EnvironmentalandForensicsMarketMember",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_FoodMarketMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Food Market [Member]",
        "label": "Food Market [Member]",
        "terseLabel": "Food"
       }
      }
     },
     "localname": "FoodMarketMember",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_InstrumentationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrumentation [Member]",
        "label": "Instrumentation [Member]",
        "terseLabel": "Instrumentation"
       }
      }
     },
     "localname": "InstrumentationMember",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/REVENUERevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_LTPPRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "LTPP &amp; RSU [Member]",
        "label": "LTPP &amp; RSU [Member]",
        "terseLabel": "LTPP &amp; RSU"
       }
      }
     },
     "localname": "LTPPRSUMember",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_LifeSciencesandAppliedMarketsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Life Sciences and Applied Markets [Member]",
        "label": "Life Sciences and Applied Markets [Member]",
        "terseLabel": "Life Sciences and Applied Markets"
       }
      }
     },
     "localname": "LifeSciencesandAppliedMarketsMember",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails",
      "http://www.agilent.com/role/REVENUERevenuebyRegionDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONSegmentAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_LtppMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long Term Performance Plan.",
        "label": "LTPP [Member]",
        "terseLabel": "LTPP"
       }
      }
     },
     "localname": "LtppMember",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_MeasurementInputAssetVolatilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Asset Volatility",
        "label": "Measurement Input, Asset Volatility [Member]",
        "terseLabel": "Measurement Input, Asset Volatility"
       }
      }
     },
     "localname": "MeasurementInputAssetVolatilityMember",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_MeasurementInputRevenueVolatilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Revenue Volatility",
        "label": "Measurement Input, Revenue Volatility [Member]",
        "terseLabel": "Measurement Input, Revenue Volatility"
       }
      }
     },
     "localname": "MeasurementInputRevenueVolatilityMember",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_NonInstrumentationandOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Instrumentation and Other[Member]",
        "label": "Non-Instrumentation and Other [Member]",
        "terseLabel": "Non-Instrumentation and Other"
       }
      }
     },
     "localname": "NonInstrumentationandOtherMember",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/REVENUERevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_NumeratorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Numerator [Abstract]",
        "label": "Numerator [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NumeratorAbstract",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/NETINCOMEPERSHAREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "a_PaymentOfAccruedAndUnpaidInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment of accrued and unpaid interest on early redemption of senior notes.",
        "label": "Payment of accrued and unpaid interest",
        "terseLabel": "Payment of accrued and unpaid interest"
       }
      }
     },
     "localname": "PaymentOfAccruedAndUnpaidInterest",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "a_PercentageOfFaceAmountOfSeniorNoteInstrumentIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds obtained expressed as a percentage of debt instrument face value.",
        "label": "Percentage Of Face Amount Of Senior Note Instrument Issued",
        "terseLabel": "Percentage Of Face Amount Of Senior Note Instrument Issued"
       }
      }
     },
     "localname": "PercentageOfFaceAmountOfSeniorNoteInstrumentIssued",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "a_PharmaceuticalandBiopharmaceuticalMarketMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmaceutical and Biopharmaceutical Market [Member]",
        "label": "Pharmaceutical and Biopharmaceutical Market [Member]",
        "terseLabel": "Pharmaceutical and Biopharmaceutical"
       }
      }
     },
     "localname": "PharmaceuticalandBiopharmaceuticalMarketMember",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_ResolutionBioscienceIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Resolution Bioscience, Inc.",
        "label": "Resolution Bioscience, Inc. [Member]",
        "terseLabel": "Resolution Bioscience, Inc."
       }
      }
     },
     "localname": "ResolutionBioscienceIncMember",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_RevenueComponentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue Component",
        "label": "Revenue Component [Member]",
        "terseLabel": "Revenue Component"
       }
      }
     },
     "localname": "RevenueComponentMember",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_SegmentTotalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reportable amounts associated with all reporting segments included in a reconciliation from segment reporting to consolidated income from operations, before taxes.",
        "label": "Segment Total [Member]",
        "terseLabel": "Segment Total"
       }
      }
     },
     "localname": "SegmentTotalMember",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONSegmentAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_SeniorNotes2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured ( general) creditors.",
        "label": "Senior Notes 2022 [Member]",
        "terseLabel": "Senior Notes 2022"
       }
      }
     },
     "localname": "SeniorNotes2022Member",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTextDetails",
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_SeniorNotes2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2023 [Member]",
        "label": "Senior Notes 2023 [Member]",
        "terseLabel": "Senior Notes 2023"
       }
      }
     },
     "localname": "SeniorNotes2023Member",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTDetails",
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_SeniorNotes2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2026",
        "label": "Senior Notes 2026 [Member]",
        "terseLabel": "Senior Notes 2026"
       }
      }
     },
     "localname": "SeniorNotes2026Member",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTextDetails",
      "http://www.agilent.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_SeniorNotes2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2029 [Member]",
        "label": "Senior Notes 2029 [Member]",
        "terseLabel": "Senior Notes 2029"
       }
      }
     },
     "localname": "SeniorNotes2029Member",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTextDetails",
      "http://www.agilent.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_SeniorNotes2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2030",
        "label": "Senior Notes 2030 [Member]",
        "terseLabel": "Senior Notes 2030"
       }
      }
     },
     "localname": "SeniorNotes2030Member",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_SeniorNotes2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2031",
        "label": "Senior Notes 2031 [Member]",
        "terseLabel": "Senior Notes 2031"
       }
      }
     },
     "localname": "SeniorNotes2031Member",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTDetails",
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, and long-term performance plan grants.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions And Methodology [Text Block]",
        "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions And Methodology [Text Block]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyTextBlock",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The measure of the percentage amount of share price correlation during the period with a selected group of peer companies. Pair-wise correlations with selected peers is calculated as the correlation between each pair and the sum of correlations divided by the number of pairs to produce the average correlation between each pair.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Peer Company Shares Price Wise Correlationy Rate",
        "verboseLabel": "Pair-wise correlation with selected peers (in hundredths)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesPriceWiseCorrelationyRate",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The measure of the percentage amount by which a share price fluctuates during a period for peer companies - maximum range. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Peer Company Shares Volatility Rate Range Maximum",
        "terseLabel": "Volatility of selected peer-company shares - Maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMaximum",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "a_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The measure of the percentage amount by which a share price fluctuates during a period for peer companies - minimum range. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Peer Company Shares Volatility Rate Range Minimum",
        "terseLabel": "Volatility of selected peer-company shares - Minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPeerCompanySharesVolatilityRateRangeMinimum",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "a_Taxrelatedtosharesissued": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax related to shares issued",
        "label": "Tax related to shares issued",
        "terseLabel": "Tax related to shares issued"
       }
      }
     },
     "localname": "Taxrelatedtosharesissued",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATESTATEMENTOFEQUITYPARENTHETICAL"
     ],
     "xbrltype": "monetaryItemType"
    },
    "a_TermLoanMaturing2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Maturing 2025",
        "label": "Term Loan Maturing 2025 [Member]",
        "terseLabel": "Term Loan Maturing 2025"
       }
      }
     },
     "localname": "TermLoanMaturing2025Member",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_ThirdPartyTechnologyandLicensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third-Party Technology and Licenses [Member]",
        "label": "Third-Party Technology and Licenses [Member]",
        "terseLabel": "Third-Party Technology and Licenses"
       }
      }
     },
     "localname": "ThirdPartyTechnologyandLicensesMember",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "a_TransformationalPrograms": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The charge against earnings in the period, comprised of costs associated with restructuring activities not otherwise specified in the taxonomy that are not part of a specific plan as required by GAAP.",
        "label": "Transformational Programs",
        "negatedLabel": "Transformational initiatives"
       }
      }
     },
     "localname": "TransformationalPrograms",
     "nsuri": "http://www.agilent.com/20230131",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "country_CH": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SWITZERLAND",
        "terseLabel": "SWITZERLAND"
       }
      }
     },
     "localname": "CH",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_DE": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GERMANY",
        "terseLabel": "GERMANY"
       }
      }
     },
     "localname": "DE",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_GB": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED KINGDOM",
        "terseLabel": "UNITED KINGDOM"
       }
      }
     },
     "localname": "GB",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_JP": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "JAPAN",
        "terseLabel": "JAPAN"
       }
      }
     },
     "localname": "JP",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_NL": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NETHERLANDS",
        "terseLabel": "NETHERLANDS"
       }
      }
     },
     "localname": "NL",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails",
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AUD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Australia, Dollars",
        "verboseLabel": "Australian Dollar"
       }
      }
     },
     "localname": "AUD",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Currencies [Domain]",
        "terseLabel": "All Currencies [Domain]"
       }
      }
     },
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_BRL": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Brazil, Brazil Real",
        "terseLabel": "Brazil, Brazil Real"
       }
      }
     },
     "localname": "BRL",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_CAD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Canada, Dollars",
        "terseLabel": "Canadian Dollar"
       }
      }
     },
     "localname": "CAD",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_CHF": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Switzerland, Francs",
        "terseLabel": "Swiss Franc"
       }
      }
     },
     "localname": "CHF",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_CNY": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "China, Yuan Renminbi",
        "terseLabel": "Chinese Yuan Renminbi"
       }
      }
     },
     "localname": "CNY",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_DKK": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Denmark, Kroner",
        "terseLabel": "Danish Krone"
       }
      }
     },
     "localname": "DKK",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_EUR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euro Member Countries, Euro",
        "terseLabel": "Euro"
       }
      }
     },
     "localname": "EUR",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_GBP": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United Kingdom, Pounds",
        "terseLabel": "British Pound"
       }
      }
     },
     "localname": "GBP",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_INR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "India, Rupees",
        "terseLabel": "India, Rupees"
       }
      }
     },
     "localname": "INR",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_JPY": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Japan, Yen",
        "terseLabel": "Japanese Yen"
       }
      }
     },
     "localname": "JPY",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_KRW": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Korea (South), Won",
        "terseLabel": "Korean Won"
       }
      }
     },
     "localname": "KRW",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_MYR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Malaysia, Ringgits",
        "terseLabel": "Malaysian Ringgit"
       }
      }
     },
     "localname": "MYR",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_PLN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Poland, Zlotych",
        "terseLabel": "Polish Zloty"
       }
      }
     },
     "localname": "PLN",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_SEK": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sweden, Kronor",
        "terseLabel": "Swedish Krona"
       }
      }
     },
     "localname": "SEK",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_SGD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Singapore, Dollars",
        "terseLabel": "Singapore Dollar"
       }
      }
     },
     "localname": "SGD",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_THB": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Thailand, Baht",
        "terseLabel": "Thailand, Baht"
       }
      }
     },
     "localname": "THB",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_TWD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taiwan, New Dollars",
        "terseLabel": "Taiwan, New Dollars"
       }
      }
     },
     "localname": "TWD",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_XXX": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "No currency",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "XXX",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r834"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r835"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r836"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r831"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r833"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.agilent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_AmericasMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Americas [Member]",
        "terseLabel": "Americas"
       }
      }
     },
     "localname": "AmericasMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.agilent.com/role/REVENUERevenuebyRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia Pacific [Member]",
        "terseLabel": "Asia Pacific"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.agilent.com/role/REVENUERevenuebyRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r296",
      "r640",
      "r641",
      "r642",
      "r643",
      "r730",
      "r788",
      "r882",
      "r885",
      "r886"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r296",
      "r640",
      "r641",
      "r642",
      "r643",
      "r730",
      "r788",
      "r882",
      "r885",
      "r886"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]",
        "terseLabel": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.agilent.com/role/REVENUERevenuebyRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r423",
      "r424",
      "r425",
      "r426",
      "r566",
      "r739",
      "r764",
      "r790",
      "r791",
      "r807",
      "r821",
      "r830",
      "r887",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r423",
      "r424",
      "r425",
      "r426",
      "r566",
      "r739",
      "r764",
      "r790",
      "r791",
      "r807",
      "r821",
      "r830",
      "r887",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r371",
      "r741",
      "r809",
      "r828",
      "r879",
      "r880",
      "r889",
      "r920"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
      "http://www.agilent.com/role/REVENUERevenuebyTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r371",
      "r741",
      "r809",
      "r828",
      "r879",
      "r880",
      "r889",
      "r920"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
      "http://www.agilent.com/role/REVENUERevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r423",
      "r424",
      "r425",
      "r426",
      "r514",
      "r566",
      "r597",
      "r598",
      "r599",
      "r735",
      "r739",
      "r764",
      "r790",
      "r791",
      "r807",
      "r821",
      "r830",
      "r878",
      "r887",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails",
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r423",
      "r424",
      "r425",
      "r426",
      "r514",
      "r566",
      "r597",
      "r598",
      "r599",
      "r735",
      "r739",
      "r764",
      "r790",
      "r791",
      "r807",
      "r821",
      "r830",
      "r878",
      "r887",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails",
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis": {
     "auth_ref": [
      "r789",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name of Property [Axis]",
        "terseLabel": "Name of Property [Axis]"
       }
      }
     },
     "localname": "RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain": {
     "auth_ref": [
      "r789",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name of Property [Domain]",
        "terseLabel": "Name of Property [Domain]"
       }
      }
     },
     "localname": "RealEstateAndAccumulatedDepreciationNameOfPropertyDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r243",
      "r297",
      "r298",
      "r299",
      "r302",
      "r303",
      "r307",
      "r308",
      "r309",
      "r310",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r334",
      "r395",
      "r396",
      "r620",
      "r658",
      "r663",
      "r664",
      "r665",
      "r715",
      "r727",
      "r728",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]",
        "terseLabel": "Revision of Prior Period [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r243",
      "r297",
      "r298",
      "r299",
      "r302",
      "r303",
      "r307",
      "r308",
      "r309",
      "r310",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r334",
      "r395",
      "r396",
      "r620",
      "r658",
      "r663",
      "r664",
      "r665",
      "r715",
      "r727",
      "r728",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]",
        "terseLabel": "Revision of Prior Period [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember": {
     "auth_ref": [
      "r243",
      "r302",
      "r303",
      "r310",
      "r317",
      "r395",
      "r396",
      "r620",
      "r658",
      "r665",
      "r715",
      "r727",
      "r728",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period, Accounting Standards Update, Adjustment [Member]",
        "terseLabel": "Revision of Prior Period Adjustment, Accounting Standards Update"
       }
      }
     },
     "localname": "RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r317",
      "r567",
      "r838",
      "r860"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
      "http://www.agilent.com/role/INCOMETAXESDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r372",
      "r373",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r810",
      "r829",
      "r889"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.agilent.com/role/REVENUERevenuebyRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r372",
      "r373",
      "r777",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r810",
      "r829",
      "r889"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.agilent.com/role/REVENUERevenuebyRegionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r317",
      "r567",
      "r838",
      "r839",
      "r860"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
      "http://www.agilent.com/role/INCOMETAXESDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/NEWACCOUNTINGPRONOUNCEMENTSNotes",
      "http://www.agilent.com/role/NEWACCOUNTINGPRONOUNCEMENTSTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r17",
      "r827"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r377",
      "r378"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "verboseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesMember": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.",
        "label": "Accrued Liabilities [Member]",
        "terseLabel": "Other Accrued Liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember": {
     "auth_ref": [
      "r36",
      "r41",
      "r158",
      "r278",
      "r279",
      "r846"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to prior service cost (credit) component of defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member]",
        "terseLabel": "Prior Service Credits"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember": {
     "auth_ref": [
      "r35",
      "r41",
      "r158",
      "r278",
      "r279",
      "r846"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]",
        "terseLabel": "Actuarial Losses"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r38",
      "r40",
      "r41",
      "r260",
      "r757",
      "r772",
      "r776"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "verboseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r37",
      "r41",
      "r158",
      "r728",
      "r767",
      "r768",
      "r846",
      "r847",
      "r848",
      "r857",
      "r858",
      "r859"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)",
        "verboseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r32",
      "r41",
      "r158",
      "r278",
      "r279",
      "r700",
      "r701",
      "r702",
      "r703",
      "r706",
      "r846"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r9",
      "r827"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in-capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r606",
      "r607",
      "r608",
      "r857",
      "r858",
      "r859",
      "r904"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r65",
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "negatedLabel": "Amortization of intangible assets related to business combinations"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis": {
     "auth_ref": [
      "r302",
      "r303",
      "r304",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of change in accounting principle. Excludes change from amendment to accounting standards.",
        "label": "Change in Accounting Principle, Type [Axis]",
        "terseLabel": "Change in Accounting Principle, Type [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForChangeInAccountingPrincipleAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsForErrorCorrectionDomain": {
     "auth_ref": [
      "r307",
      "r308",
      "r309",
      "r312",
      "r313",
      "r315",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of error correction.",
        "label": "Error Correction, Type [Domain]",
        "terseLabel": "Error Correction, Type [Domain]"
       }
      }
     },
     "localname": "AdjustmentsForErrorCorrectionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r302",
      "r303",
      "r304",
      "r306",
      "r317",
      "r379",
      "r380",
      "r389",
      "r390",
      "r391",
      "r392",
      "r395",
      "r396",
      "r606",
      "r607",
      "r608",
      "r617",
      "r618",
      "r619",
      "r620",
      "r636",
      "r637",
      "r638",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r692",
      "r693",
      "r708",
      "r709",
      "r712",
      "r713",
      "r714",
      "r715",
      "r722",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r743",
      "r744",
      "r745",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Accounting Standards Update [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.agilent.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r140",
      "r141",
      "r571"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r602"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r65",
      "r91",
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "verboseLabel": "Amortization of intangible assets during the period"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive shares excluded from computation of dilutive earnings per share (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/NETINCOMEPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/NETINCOMEPERSHAREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from EPS Computation"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/NETINCOMEPERSHAREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/NETINCOMEPERSHAREDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember": {
     "auth_ref": [
      "r269",
      "r278",
      "r279",
      "r650",
      "r846"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from increase (decrease) in value of excluded component of derivative hedge, attributable to parent.",
        "label": "AOCI, Derivative Qualifying as Hedge, Excluded Component, Parent [Member]",
        "terseLabel": "Unrealized Gains (Losses) on Derivatives"
       }
      }
     },
     "localname": "AociDerivativeQualifyingAsHedgeExcludedComponentParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r65",
      "r101"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "negatedTerseLabel": "Asset Impairment"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r211",
      "r227",
      "r255",
      "r292",
      "r355",
      "r361",
      "r367",
      "r388",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r640",
      "r642",
      "r682",
      "r827",
      "r883",
      "r884",
      "r909"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited",
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONSegmentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r248",
      "r263",
      "r292",
      "r388",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r640",
      "r642",
      "r682",
      "r827",
      "r883",
      "r884",
      "r909"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Assets",
        "verboseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r196"
     ],
     "calculation": {
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets measured at fair value"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited",
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails",
      "http://www.agilent.com/role/LONGTERMDEBTDetails",
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r178",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited",
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails",
      "http://www.agilent.com/role/LONGTERMDEBTDetails",
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BankAcceptancesExecuted": {
     "auth_ref": [
      "r215"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the financial institution's obligation to pay the holder of the customer's draft which the financial institution has guaranteed (i.e., Banker's Acceptance).",
        "label": "Bank Acceptances Executed",
        "terseLabel": "Guarantees"
       }
      }
     },
     "localname": "BankAcceptancesExecuted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r635",
      "r815",
      "r818"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r148",
      "r149",
      "r635",
      "r815",
      "r818"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r147"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "negatedLabel": "Acquisition and integration costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r639",
      "r849"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Change in fair value of contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r154"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Contingent Consideration Arrangement - Maximum"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "auth_ref": [
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "terseLabel": "Business Combination, Contingent Consideration, Liability, Measurement Input"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r0",
      "r72",
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "terseLabel": "Overview and Basis of Presentation"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessExitCosts1": {
     "auth_ref": [
      "r65"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Business Exit Costs",
        "negatedTerseLabel": "Business exit and divestiture costs"
       }
      }
     },
     "localname": "BusinessExitCosts1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r67",
      "r250",
      "r793"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited",
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash equivalents (money market funds)"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r68",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Restricted Cash and Restricted Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r62",
      "r67",
      "r71"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period",
        "terseLabel": "Cash, cash equivalents, restricted cash and restricted cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited",
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]",
        "terseLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r62",
      "r203"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "auth_ref": [
      "r194"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months",
        "terseLabel": "Net gain to be reclassified within next Twelve Months"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DerivativeInstrumentsandHedgingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails",
      "http://www.agilent.com/role/DerivativeInstrumentsandHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangeInAccountingPrincipleMember": {
     "auth_ref": [
      "r302",
      "r303",
      "r304",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in accounting principle. Excludes change from amendment to accounting standards.",
        "label": "Change in Accounting Principle, Type [Domain]",
        "terseLabel": "Change in Accounting Principle, Type [Domain]"
       }
      }
     },
     "localname": "ChangeInAccountingPrincipleMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r257",
      "r258",
      "r259",
      "r292",
      "r322",
      "r326",
      "r328",
      "r330",
      "r337",
      "r338",
      "r388",
      "r427",
      "r429",
      "r430",
      "r431",
      "r434",
      "r435",
      "r455",
      "r456",
      "r458",
      "r462",
      "r468",
      "r682",
      "r792",
      "r837",
      "r852",
      "r861"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r121",
      "r122",
      "r123",
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]",
        "terseLabel": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r28",
      "r218",
      "r234"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and Contingencies (Note 9 and 12)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r105",
      "r421",
      "r422",
      "r778",
      "r881"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "WARRANTIES AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareCashPaid": {
     "auth_ref": [
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Cash Paid",
        "terseLabel": "Cash dividends paid per common share"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareCashPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends Declared. per share",
        "verboseLabel": "Dividends Declared per share"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATESTATEMENTOFEQUITYPARENTHETICAL",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r857",
      "r858",
      "r904"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common Stock, Shares, Issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r8",
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common Stock, Shares, Outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r8",
      "r827"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock; $0.01 par value; 2 billion shares authorized; 296 million shares at January 31, 2023 and 295 million shares at October 31, 2022, issued and outstanding"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r43",
      "r274",
      "r276",
      "r283",
      "r753",
      "r760"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Total comprehensive income, net of tax"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]",
        "terseLabel": "Components of comprehensive income, net of tax"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r157",
      "r168",
      "r274",
      "r276",
      "r282",
      "r752",
      "r759"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationVariableInterestEntityPolicy": {
     "auth_ref": [
      "r159",
      "r161",
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).",
        "label": "Consolidation, Variable Interest Entity, Policy [Policy Text Block]",
        "terseLabel": "Variable Interest Entity"
       }
      }
     },
     "localname": "ConsolidationVariableInterestEntityPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Abstract]",
        "terseLabel": "Contract Asset"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/REVENUEContractAssetsandLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r888"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Contract Liabilities and Changes in Balances"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/REVENUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "auth_ref": [
      "r470",
      "r472",
      "r485"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "terseLabel": "Contract Assets (Unbilled Accounts Receivable)"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/REVENUEContractAssetsandLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r470",
      "r471",
      "r485"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "periodEndLabel": "Contract liability ending balance as of January 31, 2023",
        "periodStartLabel": "Contract liability ending balance as of October 31, 2022"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/REVENUEContractAssetsandLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer, Liability [Abstract]",
        "terseLabel": "Contract Liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/REVENUEContractAssetsandLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination": {
     "auth_ref": [
      "r808"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from business combination.",
        "label": "Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination",
        "terseLabel": "Contract liabilities acquired in business combinations"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/REVENUEContractAssetsandLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r486"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Revenue recognized that was included in the contract liability balance at the beginning of the period"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/REVENUEContractAssetsandLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r48",
      "r741"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Products and Services",
        "verboseLabel": "Cost of Products and Services"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails",
      "http://www.agilent.com/role/DerivativeInstrumentsandHedgingActivitiesDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total costs and expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "verboseLabel": "Costs and expenses:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r3",
      "r4",
      "r5",
      "r212",
      "r213",
      "r226",
      "r296",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r711",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r853"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTextDetails",
      "http://www.agilent.com/role/LONGTERMDEBTDetails",
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails",
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r5",
      "r213",
      "r226",
      "r453"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Long-term Debt, Gross"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentDateOfFirstRequiredPayment1": {
     "auth_ref": [
      "r26",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the debt agreement requires the first payment to be made, in YYYY-MM-DD format.",
        "label": "Debt Instrument, Date of First Required Payment",
        "terseLabel": "Date interest payment commenced"
       }
      }
     },
     "localname": "DebtInstrumentDateOfFirstRequiredPayment1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r205",
      "r207",
      "r436",
      "r711",
      "r803",
      "r804"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Aggregate face amount of debt"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r444",
      "r681",
      "r803",
      "r804"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Fair Value of Senior Notes"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFrequencyOfPeriodicPayment": {
     "auth_ref": [
      "r26",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the frequency of periodic payments (monthly, quarterly, annual).",
        "label": "Debt Instrument, Frequency of Periodic Payment",
        "terseLabel": "Debt interest payment frequency"
       }
      }
     },
     "localname": "DebtInstrumentFrequencyOfPeriodicPayment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentIncreaseAccruedInterest": {
     "auth_ref": [
      "r853"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period.",
        "label": "Debt Instrument, Increase, Accrued Interest",
        "terseLabel": "Debt Instrument, Increase, Accrued Interest"
       }
      }
     },
     "localname": "DebtInstrumentIncreaseAccruedInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r24",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Fixed interest rate per annum"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentIssuanceDate1": {
     "auth_ref": [
      "r25",
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the debt instrument was issued, in YYYY-MM-DD format.",
        "label": "Debt Instrument, Issuance Date",
        "terseLabel": "Issuance date of debt"
       }
      }
     },
     "localname": "DebtInstrumentIssuanceDate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTDetails",
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "auth_ref": [
      "r264",
      "r802",
      "r905"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.",
        "label": "Debt Instrument, Maturity Date",
        "terseLabel": "Maturity date of debt"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r26",
      "r296",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r711",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r853"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTextDetails",
      "http://www.agilent.com/role/LONGTERMDEBTDetails",
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails",
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r26",
      "r116",
      "r117",
      "r118",
      "r119",
      "r204",
      "r205",
      "r207",
      "r225",
      "r296",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r711",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r853"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTDetails",
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).",
        "label": "Deferred Compensation Liability, Classified, Noncurrent",
        "terseLabel": "Deferred compensation liability"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityClassifiedNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r65",
      "r145",
      "r616",
      "r626",
      "r627",
      "r855"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r842"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "verboseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r491",
      "r530",
      "r555",
      "r813",
      "r814"
     ],
     "calculation": {
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedLabel": "Actuarial losses"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r507",
      "r517",
      "r559",
      "r811",
      "r812",
      "r813",
      "r814"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Employer Contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails",
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear": {
     "auth_ref": [
      "r559",
      "r814"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in remainder of current fiscal year. Excludes contribution previously paid by employer in current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year",
        "terseLabel": "Expected future employer contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r491",
      "r529",
      "r554",
      "r813",
      "r814"
     ],
     "calculation": {
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r491",
      "r496",
      "r528",
      "r553",
      "r813",
      "r814"
     ],
     "calculation": {
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "verboseLabel": "Interest cost on benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r526",
      "r551",
      "r813",
      "r814"
     ],
     "calculation": {
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Total net plan costs (benefits)"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]",
        "terseLabel": "Defined Benefit Plan, Net Periodic Benefit Cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails",
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": {
     "auth_ref": [
      "r492",
      "r533",
      "r558"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement",
        "terseLabel": "Settlement gain"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r494",
      "r527",
      "r552",
      "r813",
      "r814"
     ],
     "calculation": {
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost - benefits earned during the period"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsAndCurtailmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Settlement and Curtailment [Abstract]",
        "terseLabel": "Curtailments and Settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsAndCurtailmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r65",
      "r350"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r30",
      "r180",
      "r208",
      "r265",
      "r796"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset",
        "verboseLabel": "Derivatives asset fair value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r30",
      "r180",
      "r208",
      "r265",
      "r796"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset",
        "verboseLabel": "Derivatives liabilities fair value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative, Fair Value, Net [Abstract]",
        "terseLabel": "Derivative Fair Value by Balance Sheet Location"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r902"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Gain (loss) recognized"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": {
     "auth_ref": [
      "r902"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of income or comprehensive income that includes gain (loss) from derivative.",
        "label": "Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "terseLabel": "Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]"
       }
      }
     },
     "localname": "DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_DerivativeInstrumentDetailAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instrument Detail [Abstract]",
        "verboseLabel": "Derivative Instruments and Hedging Activities Disclosure"
       }
      }
     },
     "localname": "DerivativeInstrumentDetailAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": {
     "auth_ref": [
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of income or comprehensive income that includes gain (loss) from effective portion of derivative instrument reclassified from accumulated other comprehensive income (AOCI) into income.",
        "label": "Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "terseLabel": "Gain (Loss) Reclassified from AOCI into cost of sales [Extensible Enumeration]"
       }
      }
     },
     "localname": "DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r179",
      "r181",
      "r185",
      "r187",
      "r796"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r195",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "DERIVATIVES"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r176",
      "r179",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails",
      "http://www.agilent.com/role/DerivativeInstrumentsandHedgingActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred": {
     "auth_ref": [
      "r651"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated value of gains (losses), net anticipated to be transferred in the future from accumulated other comprehensive income into earnings.",
        "label": "Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred",
        "terseLabel": "Remaining Gain (Loss) Reclassification from Accumulated OCI to be amortized to Income,"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": {
     "auth_ref": [
      "r184",
      "r186"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net",
        "terseLabel": "Unrealized gain (loss) on derivatives",
        "verboseLabel": "Gain (loss) reclassified from accumulated other comprehensive\u00a0loss into cost of sales"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails",
      "http://www.agilent.com/role/DerivativeInstrumentsandHedgingActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNetLiabilityPositionAggregateFairValue": {
     "auth_ref": [
      "r188"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate fair value amounts of derivative instruments that contain credit-risk-related contingent features that are in a net liability position at the end of the reporting period. For nonderivative instruments that are designated and qualify as hedging instruments, the fair value amounts are the carrying value of the nonderivative hedging instrument, including the adjustment for the foreign currency transaction gain (loss) on that instrument.",
        "label": "Derivative, Net Liability Position, Aggregate Fair Value",
        "terseLabel": "Aggregate fair value of all derivative instruments with credit-risk-related contingent features that were in a net liability position"
       }
      }
     },
     "localname": "DerivativeNetLiabilityPositionAggregateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r900",
      "r901"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, Notional Amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r170",
      "r172",
      "r173",
      "r176",
      "r177",
      "r183",
      "r185",
      "r189",
      "r190",
      "r192",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails",
      "http://www.agilent.com/role/DerivativeInstrumentsandHedgingActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives Designated as Hedging Instrument",
        "verboseLabel": "Derivatives Designated as Hedging Instruments"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Purchased Technology"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r889"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/REVENUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r574",
      "r603",
      "r604",
      "r605",
      "r609",
      "r822"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "SHARE-BASED COMPENSATION"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendPayableDateToBePaidDayMonthAndYear": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the declared dividend will be paid, in YYYY-MM-DD format.",
        "label": "Dividends Payable, Date to be Paid",
        "terseLabel": "Payment Date of Declared Dividends"
       }
      }
     },
     "localname": "DividendPayableDateToBePaidDayMonthAndYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DividendsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends [Abstract]",
        "terseLabel": "Dividends [Abstract]"
       }
      }
     },
     "localname": "DividendsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about distribution of earnings to shareholders including, but not limited to, cash, property or capital stock.",
        "label": "Dividends [Axis]",
        "terseLabel": "Dividends [Axis]"
       }
      }
     },
     "localname": "DividendsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsCommonStockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends, Common Stock [Abstract]",
        "terseLabel": "Dividends Declared"
       }
      }
     },
     "localname": "DividendsCommonStockAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r120"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "terseLabel": "Cash dividends declared",
        "verboseLabel": "Aggregate Cash Dividends Declared"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Distributions of earnings to shareholders including but not limited to cash, property or capital stock.",
        "label": "Dividends [Domain]",
        "terseLabel": "Dividends [Domain]"
       }
      }
     },
     "localname": "DividendsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsPayableAmountPerShare": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date.",
        "label": "Dividends Payable, Amount Per Share",
        "terseLabel": "Dividends Payable, Amount Per Share"
       }
      }
     },
     "localname": "DividendsPayableAmountPerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DividendsPayableDateDeclaredDayMonthAndYear": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the dividend to be paid was declared, in YYYY-MM-DD format.",
        "label": "Dividends Payable, Date Declared",
        "terseLabel": "Date Dividends Declared"
       }
      }
     },
     "localname": "DividendsPayableDateDeclaredDayMonthAndYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DividendsPayableDateOfRecordDayMonthAndYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the holder must own the stock to be entitled to the dividend, in YYYY-MM-DD format.",
        "label": "Dividends Payable, Date of Record",
        "terseLabel": "Dividends Declared Date of Record"
       }
      }
     },
     "localname": "DividendsPayableDateOfRecordDayMonthAndYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DividendsPayableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Dividends Payable [Line Items]",
        "terseLabel": "Dividends Payable [Line Items]"
       }
      }
     },
     "localname": "DividendsPayableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsPayableTable": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table that contains information regarding dividends that have been declared but not paid as of the financial reporting date. This information may contain the amount, amount per share, declared date, and date to be paid.",
        "label": "Dividends Payable [Table]",
        "terseLabel": "Dividends Payable [Table]"
       }
      }
     },
     "localname": "DividendsPayableTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DomesticPlanMember": {
     "auth_ref": [
      "r892",
      "r893",
      "r894"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Domestic Plan [Member]",
        "terseLabel": "Domestic Plan"
       }
      }
     },
     "localname": "DomesticPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails",
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarlyRepaymentOfSeniorDebt": {
     "auth_ref": [
      "r60"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the extinguishment of long-term borrowing, with the highest claim on the assets of the entity in case of bankruptcy or liquidation, before its maturity.",
        "label": "Early Repayment of Senior Debt",
        "terseLabel": "Early Repayment of Senior Debt"
       }
      }
     },
     "localname": "EarlyRepaymentOfSeniorDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income per share"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r284",
      "r307",
      "r308",
      "r310",
      "r311",
      "r312",
      "r320",
      "r322",
      "r328",
      "r329",
      "r330",
      "r334",
      "r664",
      "r665",
      "r754",
      "r761",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r284",
      "r307",
      "r308",
      "r310",
      "r311",
      "r312",
      "r322",
      "r328",
      "r329",
      "r330",
      "r334",
      "r664",
      "r665",
      "r754",
      "r761",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r331",
      "r332",
      "r333",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "NET INCOME PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/NETINCOMEPERSHARENotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r697"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of Exchange Rate Movements"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "auth_ref": [
      "r896",
      "r898"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount",
        "terseLabel": "Excess tax benefit from stock based compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "verboseLabel": "Employee compensation and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Employee Service Share-based Compensation, Allocation of Recognized Period Costs"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r602"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Share-based Payment Arrangement, Expense, Tax Benefit"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employee Stock [ESPP]"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Share-based Payment Arrangement, Option [Member]"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "terseLabel": "Share repurchase program"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r115",
      "r242",
      "r277",
      "r278",
      "r279",
      "r297",
      "r298",
      "r299",
      "r303",
      "r313",
      "r316",
      "r336",
      "r392",
      "r469",
      "r606",
      "r607",
      "r608",
      "r619",
      "r620",
      "r663",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r706",
      "r728",
      "r767",
      "r768",
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r256",
      "r680",
      "r795"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Short term investments (Equity securities with RDFV)"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiGainLoss": {
     "auth_ref": [
      "r864"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Gain (Loss)",
        "negatedTerseLabel": "Net (gain) loss on equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSEquitySecuritiesandInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiRealizedGainLoss": {
     "auth_ref": [
      "r762",
      "r864"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Realized Gain (Loss)",
        "terseLabel": "Equity Securities, FV-NI, Realized Gain (Loss)"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiRealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSEquitySecuritiesandInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": {
     "auth_ref": [
      "r762",
      "r864"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)",
        "terseLabel": "Unrealized gain (loss) on equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSEquitySecuritiesandInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r385"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Non-marketable equity securities carrying amount"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSNonMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount": {
     "auth_ref": [
      "r386"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from downward price adjustment on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount",
        "terseLabel": "Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSNonMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount": {
     "auth_ref": [
      "r386"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative loss from downward price adjustment on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount",
        "terseLabel": "Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSNonMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount": {
     "auth_ref": [
      "r386"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount",
        "terseLabel": "Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSNonMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount": {
     "auth_ref": [
      "r387"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain from upward price adjustment on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount",
        "terseLabel": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSNonMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount": {
     "auth_ref": [
      "r387"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative gain from upward price adjustment on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount",
        "terseLabel": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSNonMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis": {
     "auth_ref": [
      "r307",
      "r308",
      "r309",
      "r312",
      "r313",
      "r315",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of error correction.",
        "label": "Error Correction, Type [Axis]",
        "terseLabel": "Error Correction, Type [Axis]"
       }
      }
     },
     "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "verboseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r670",
      "r671",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "auth_ref": [
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r444",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r671",
      "r732",
      "r733",
      "r734",
      "r803",
      "r804",
      "r811",
      "r812",
      "r813"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails",
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r670",
      "r671",
      "r673",
      "r674",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r444",
      "r517",
      "r522",
      "r671",
      "r732",
      "r811",
      "r812",
      "r813"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted Prices in Active Markets for Identical Assets (Level 1)"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails",
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r444",
      "r517",
      "r522",
      "r671",
      "r733",
      "r803",
      "r804",
      "r811",
      "r812",
      "r813"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant Other Observable Inputs (Level 2)"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r444",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r671",
      "r734",
      "r803",
      "r804",
      "r811",
      "r812",
      "r813"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Significant Unobservable Inputs (Level 3)"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r198",
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3": {
     "auth_ref": [
      "r675"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of financial instrument classified as a liability into level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3",
        "terseLabel": "Additions to contingent consideration (including measurement period adjustment)"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingLevel3ContingentConsiderationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease": {
     "auth_ref": [
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)",
        "negatedLabel": "Change in fair value of contingent consideration",
        "terseLabel": "Change in fair value (included within SG&amp;A)"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingLevel3ContingentConsiderationLiabilityDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r199"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "terseLabel": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingLevel3ContingentConsiderationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r198"
     ],
     "calculation": {
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Fair Value Contingent Consideration, Ending Balance",
        "periodStartLabel": "Fair Value Contingent Consideration, Beginning Balance",
        "terseLabel": "Contingent Consideration",
        "verboseLabel": "Fair Value of contingent consideration"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingLevel3ContingentConsiderationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r444",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r732",
      "r733",
      "r734",
      "r803",
      "r804",
      "r811",
      "r812",
      "r813"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails",
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "auth_ref": [
      "r670",
      "r671",
      "r673",
      "r674",
      "r676",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.",
        "label": "Fair Value, Nonrecurring [Member]",
        "terseLabel": "Fair Value, Nonrecurring"
       }
      }
     },
     "localname": "FairValueMeasurementsNonrecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r677",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Measurements, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r201",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r253",
      "r414"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimatedFutureAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r97"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimatedFutureAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimatedFutureAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r97"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2028"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimatedFutureAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r97"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimatedFutureAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r97"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimatedFutureAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r97"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimatedFutureAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r412",
      "r413",
      "r414",
      "r415",
      "r742",
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "verboseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation impact on other intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r95",
      "r749"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r92",
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r95",
      "r742"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Finite-Lived Intangible Assets, Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net [Abstract]",
        "terseLabel": "Finite-Lived Intangible Assets, Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in carrying value of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Period Increase (Decrease)",
        "terseLabel": "Addition to other intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyContractAssetFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.",
        "label": "Foreign Currency Contract, Asset, Fair Value Disclosure",
        "terseLabel": "Derivative instruments (foreign exchange contracts)"
       }
      }
     },
     "localname": "ForeignCurrencyContractAssetFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.",
        "label": "Foreign Currency Contracts, Liability, Fair Value Disclosure",
        "terseLabel": "Derivative instruments (foreign exchange contracts)"
       }
      }
     },
     "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r796",
      "r811",
      "r826"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign Exchange Contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign Exchange Forward"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignPlanMember": {
     "auth_ref": [
      "r892",
      "r893",
      "r894"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Foreign Plan [Member]",
        "terseLabel": "Foreign Plan"
       }
      }
     },
     "localname": "ForeignPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails",
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForwardContractsMember": {
     "auth_ref": [
      "r903"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts negotiated between two parties to purchase and sell a specific quantity of a financial instrument, foreign currency, or commodity at a price specified at origination of the contract, with delivery and settlement at a specified future date.",
        "label": "Forward Contracts [Member]",
        "terseLabel": "Forward Contracts USD"
       }
      }
     },
     "localname": "ForwardContractsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnInvestmentsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of realized and unrealized gain (loss) on investment in security.",
        "label": "Gain (Loss) on Securities [Table Text Block]",
        "terseLabel": "Gain (Loss) on Securities"
       }
      }
     },
     "localname": "GainLossOnInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r65",
      "r112",
      "r113"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r252",
      "r399",
      "r750",
      "r801",
      "r827",
      "r866",
      "r873"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill ending balance",
        "periodStartLabel": "Goodwill beginning balance",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r402",
      "r801"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill arising from acquisitions",
        "verboseLabel": "Additions to goodwill"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND OTHER INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r65",
      "r400",
      "r405",
      "r411",
      "r801"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill impairment"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill [Member]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill Roll Forward"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTransfers": {
     "auth_ref": [
      "r872"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Transfers",
        "terseLabel": "Goodwill reassigned to segment"
       }
      }
     },
     "localname": "GoodwillTransfers",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r146",
      "r874"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Translation and Purchase Accounting Adjustments",
        "terseLabel": "Foreign currency translation impact"
       }
      }
     },
     "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Guarantees [Abstract]",
        "terseLabel": "Guarantees"
       }
      }
     },
     "localname": "GuaranteesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r176",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails",
      "http://www.agilent.com/role/DerivativeInstrumentsandHedgingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset": {
     "auth_ref": [
      "r100",
      "r104"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount on the books of the entity of the impaired asset to be disposed of by a method other than sale.",
        "label": "Impaired Assets to be Disposed of by Method Other than Sale, Carrying Value of Asset",
        "terseLabel": "Carrying value of impaired long-lived assets held for use"
       }
      }
     },
     "localname": "ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "auth_ref": [
      "r850",
      "r877"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.",
        "label": "Impairment of Intangible Assets, Finite-Lived",
        "terseLabel": "Impairment of Intangible Assets, Finite-lived"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r850",
      "r877"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)",
        "terseLabel": "Impairment of IPR&amp;D"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfInvestments": {
     "auth_ref": [
      "r383"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.",
        "label": "Other than Temporary Impairment Losses, Investments",
        "terseLabel": "Impairment of Investments"
       }
      }
     },
     "localname": "ImpairmentOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSEquitySecuritiesandInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "auth_ref": [
      "r65",
      "r101",
      "r103"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).",
        "label": "Impairment, Long-Lived Asset, Held-for-Use",
        "terseLabel": "Impairment of Long-Lived Assets Held-for-use"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": {
     "auth_ref": [
      "r65",
      "r100"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.",
        "label": "Impairment of Long-Lived Assets to be Disposed of",
        "terseLabel": "Impairment of Long-Lived assets Held for sale"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In-Process R&amp;D"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r45",
      "r209",
      "r220",
      "r238",
      "r355",
      "r360",
      "r366",
      "r369",
      "r755",
      "r800"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income before taxes, as reported",
        "totalLabel": "Income before taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r416",
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]",
        "verboseLabel": "Derivative Instruments, Gain (Loss) by Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails",
      "http://www.agilent.com/role/DerivativeInstrumentsandHedgingActivitiesDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]",
        "verboseLabel": "Income Statement and Other Comprehensive Income (Loss) Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails",
      "http://www.agilent.com/role/DerivativeInstrumentsandHedgingActivitiesDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r294",
      "r612",
      "r614",
      "r615",
      "r624",
      "r628",
      "r632",
      "r633",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/INCOMETAXESNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Examination [Line Items]",
        "terseLabel": "Income Tax Disclosure"
       }
      }
     },
     "localname": "IncomeTaxExaminationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExaminationTable": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A summary of income tax examinations that an enterprise is currently subject to or that have been completed in the current period typically including a description of the examination, the jurisdiction conducting the examination, the tax year(s) under examination, the likelihood of an unfavorable settlement, the range of possible losses, the liability recorded, the Increase or Decrease in the liability from the prior period, and any penalties and interest that have been incurred or accrued.",
        "label": "Income Tax Examination [Table]",
        "terseLabel": "Income Tax Examination [Table]"
       }
      }
     },
     "localname": "IncomeTaxExaminationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r295",
      "r315",
      "r316",
      "r353",
      "r610",
      "r625",
      "r630",
      "r763"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes",
        "verboseLabel": "Provision (benefit) for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
      "http://www.agilent.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r898"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r69"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income tax paid, net"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r64"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Net change in property, plant and equipment included in Accounts Payable and Accrued Liabilities increase (decrease)"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable,net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r740",
      "r849"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Net revenue deferred in the period"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/REVENUEContractAssetsandLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r797"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Change in deferrals from customer cash advances, net of revenue recognized"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/REVENUEContractAssetsandLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "terseLabel": "Employee compensation and benefits"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedTerseLabel": "Other assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r323",
      "r324",
      "r325",
      "r330",
      "r573"
     ],
     "calculation": {
      "http://www.agilent.com/role/NETINCOMEPERSHAREDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Potential common shares - stock options and other employee stock plans"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/NETINCOMEPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r98"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "In-Process R&amp;D"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract]",
        "terseLabel": "Indefinite-Lived Intangible Assets (Excluding Goodwill)"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [
      "r252"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Total Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r90",
      "r93"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Net Book Value",
        "verboseLabel": "Other intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r206",
      "r222",
      "r280",
      "r349",
      "r710"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest Expense"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r286",
      "r289",
      "r290"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest payments"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet": {
     "auth_ref": [
      "r184"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net gains or losses on interest rate cash flow hedges reclassified during the period to earnings from accumulated other comprehensive income upon the hedged transaction affecting earnings.",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net",
        "terseLabel": "Loss reclassified from accumulated other comprehensive\u00a0loss into Interest expense"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateDerivativesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Rate Derivatives [Abstract]",
        "terseLabel": "Terminated Derivative Contracts"
       }
      }
     },
     "localname": "InterestRateDerivativesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r825"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "verboseLabel": "INVENTORY"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/INVENTORYNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r843"
     ],
     "calculation": {
      "http://www.agilent.com/role/INVENTORYDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/INVENTORYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r261",
      "r794",
      "r827"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.agilent.com/role/INVENTORYDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "totalLabel": "Inventory",
        "verboseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited",
      "http://www.agilent.com/role/INVENTORYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Net [Abstract]",
        "terseLabel": "Inventory, Net [Abstract]"
       }
      }
     },
     "localname": "InventoryNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryWorkInProcessAndRawMaterials": {
     "auth_ref": [
      "r845"
     ],
     "calculation": {
      "http://www.agilent.com/role/INVENTORYDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate carrying amount as of the balance sheet date of items held by the entity which are partially completed at the time of measurement and unprocessed items that will go through the production process and become part of the final product. Includes supplies used directly or indirectly in the manufacturing or production process. This element may be used when the reporting entity combines work in process and raw materials into an aggregate amount.",
        "label": "Inventory, Work in Process and Raw Materials",
        "verboseLabel": "Purchased parts and fabricated assemblies"
       }
      }
     },
     "localname": "InventoryWorkInProcessAndRawMaterials",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/INVENTORYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r397"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "terseLabel": "Excess and obsolete inventory related charges"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r50",
      "r348"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "verboseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r670"
     ],
     "calculation": {
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Other investments"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeasesOperatingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases, Operating [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "LeasesOperatingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r21",
      "r292",
      "r388",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r641",
      "r642",
      "r643",
      "r682",
      "r799",
      "r883",
      "r909",
      "r910"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r13",
      "r214",
      "r232",
      "r827",
      "r854",
      "r865",
      "r906"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r23",
      "r249",
      "r292",
      "r388",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r641",
      "r642",
      "r643",
      "r682",
      "r827",
      "r883",
      "r909",
      "r910"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "verboseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r196"
     ],
     "calculation": {
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Liabilities, Fair Value Disclosure",
        "totalLabel": "Total liabilities measured at fair value"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityExpirationDate1": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the credit facility terminates, in YYYY-MM-DD format.",
        "label": "Line of Credit Facility, Expiration Date",
        "terseLabel": "Expiration date of credit facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityExpirationDate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding": {
     "auth_ref": [
      "r681"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the amount outstanding under the credit facility.",
        "label": "Line of Credit Facility, Fair Value of Amount Outstanding",
        "terseLabel": "Amount outstanding on credit facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityFairValueOfAmountOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails",
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityInitiationDate1": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the credit facility first became available, in YYYY-MM-DD format.",
        "label": "Line of Credit Facility, Initiation Date",
        "terseLabel": "Initiation date of credit facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityInitiationDate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r19"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity of credit facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails",
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit [Member]"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates an ownership position in, or purchase of, a security.",
        "label": "Long [Member]",
        "terseLabel": "Buy"
       }
      }
     },
     "localname": "LongMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r5",
      "r213",
      "r229",
      "r443",
      "r454",
      "r803",
      "r804"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited",
      "http://www.agilent.com/role/LONGTERMDEBTDetails",
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-Term Debt [Text Block]",
        "terseLabel": "LONG-TERM DEBT"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermInvestments": {
     "auth_ref": [
      "r251"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).",
        "label": "Long-Term Investments",
        "verboseLabel": "Long-term investments"
       }
      }
     },
     "localname": "LongTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r26",
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermDebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.",
        "label": "Long-Term Debt, Weighted Average Interest Rate, at Point in Time",
        "terseLabel": "Long-Term Debt, Weighted Average Interest Rate, at Point in Time"
       }
      }
     },
     "localname": "LongtermDebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterestPeriodIncreaseDecrease": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.",
        "label": "Noncontrolling Interest, Period Increase (Decrease)",
        "terseLabel": "Purchase of non-controlling interest increase (decrease)"
       }
      }
     },
     "localname": "MinorityInterestPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MovementInStandardProductWarrantyAccrualRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Movement in Standard Product Warranty Accrual [Roll Forward]",
        "terseLabel": "Movement in Standard Product Warranty Accrual"
       }
      }
     },
     "localname": "MovementInStandardProductWarrantyAccrualRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r288"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r288"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from Investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r62",
      "r63",
      "r66"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r46",
      "r66",
      "r221",
      "r237",
      "r247",
      "r272",
      "r275",
      "r279",
      "r292",
      "r302",
      "r307",
      "r308",
      "r310",
      "r311",
      "r315",
      "r316",
      "r327",
      "r355",
      "r360",
      "r366",
      "r369",
      "r388",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r665",
      "r682",
      "r800",
      "r883"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
      "http://www.agilent.com/role/NETINCOMEPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging [Member]"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "Accounting Standards Update and Change in Accounting Principle [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r245",
      "r300",
      "r301",
      "r304",
      "r305",
      "r317",
      "r318",
      "r319",
      "r381",
      "r382",
      "r393",
      "r394",
      "r621",
      "r622",
      "r623",
      "r661",
      "r667",
      "r668",
      "r669",
      "r689",
      "r690",
      "r691",
      "r716",
      "r717",
      "r723",
      "r729",
      "r746",
      "r747",
      "r748",
      "r771",
      "r772",
      "r773",
      "r774",
      "r776"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "NEW ACCOUNTING PRONOUNCEMENTS"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/NEWACCOUNTINGPRONOUNCEMENTSNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r155",
      "r469",
      "r857",
      "r858",
      "r859"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non-controlling Interest"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives Not Designated as Hedging Instruments",
        "verboseLabel": "Not Designated as Hedging Instruments"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails",
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfForeignCurrencyDerivativesHeld": {
     "auth_ref": [
      "r171",
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of foreign currency exchange rate derivatives held by the entity at the reporting date.",
        "label": "Number of Foreign Currency Derivatives Held",
        "terseLabel": "Number of foreign exchange forward contracts (in units)"
       }
      }
     },
     "localname": "NumberOfForeignCurrencyDerivativesHeld",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfInterestRateDerivativesHeld": {
     "auth_ref": [
      "r171",
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of interest rate derivative instruments held by the entity at the reporting date.",
        "label": "Number of Interest Rate Derivatives Held",
        "terseLabel": "Number of interest rate swap contracts terminated"
       }
      }
     },
     "localname": "NumberOfInterestRateDerivativesHeld",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r863"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "verboseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r355",
      "r360",
      "r366",
      "r369",
      "r800"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Income from operations",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
      "http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r719"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes operating lease liability.",
        "label": "Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease Liability, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r718"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Right-of-Use Asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.",
        "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OrderOrProductionBacklogMember": {
     "auth_ref": [
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Orders, production or production backlog arising from contracts such as purchase or sales orders acquired in a business combination.",
        "label": "Order or Production Backlog [Member]",
        "terseLabel": "Backlog"
       }
      }
     },
     "localname": "OrderOrProductionBacklogMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r72",
      "r75",
      "r82",
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.",
        "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
        "terseLabel": "OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r216",
      "r235"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other.",
        "label": "Other Accrued Liabilities",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r262",
      "r827"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "verboseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of other assets.",
        "label": "Other Assets, Fair Value Disclosure",
        "terseLabel": "Fair value of impaired long-lived assets held for use"
       }
      }
     },
     "localname": "OtherAssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesmeasuredatFairValueonaNonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r178",
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r254"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of other commitment.",
        "label": "Other Commitments [Axis]",
        "terseLabel": "Other Commitments [Axis]"
       }
      }
     },
     "localname": "OtherCommitmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other future obligation.",
        "label": "Other Commitments [Domain]",
        "terseLabel": "Other Commitments [Domain]"
       }
      }
     },
     "localname": "OtherCommitmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax [Abstract]",
        "verboseLabel": "Net defined benefit pension cost and post retirement plan costs:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r35",
      "r38",
      "r534"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax",
        "verboseLabel": "Change in actuarial net loss, net of tax expense of $0 and $2"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax": {
     "auth_ref": [
      "r39"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax",
        "terseLabel": "Change in actuarial net loss, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax [Abstract]",
        "verboseLabel": "Net defined benefit pension cost and post retirement plan costs, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r33",
      "r38",
      "r694",
      "r695",
      "r698"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Foreign currency translation, net of tax expense (benefit) of $(1) and $0"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax": {
     "auth_ref": [
      "r38",
      "r42",
      "r271",
      "r534"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax",
        "terseLabel": "Prior service benefit"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax": {
     "auth_ref": [
      "r39"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax (expense) benefit of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, Tax",
        "terseLabel": "Change in net prior service benefit, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": {
     "auth_ref": [
      "r41",
      "r278",
      "r699",
      "r701",
      "r706",
      "r846"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": {
     "auth_ref": [
      "r268"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax",
        "terseLabel": "Amounts reclassified into earnings related to derivative instruments, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r266",
      "r267"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Unrealized gain (loss) on derivative instruments, net of tax expense (benefit) of $(9) and $2"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r266",
      "r267",
      "r644",
      "r645",
      "r649"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications",
        "verboseLabel": "Gain (loss) recognized in accumulated other comprehensive\u00a0loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax": {
     "auth_ref": [
      "r268"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax",
        "terseLabel": "Unrealized gain (loss) on derivative instruments, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r267",
      "r270"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedTerseLabel": "Amount reclassified into earnings related to derivative instruments, net of tax benefit of $(2) and $(1)",
        "terseLabel": "Unrealized gain (loss) on derivatives after reclassification and after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": {
     "auth_ref": [
      "r31",
      "r39",
      "r696",
      "r705"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax",
        "verboseLabel": "Foreign currency translation, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r646"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Gain (loss) recognized in accumulated other comprehensive loss - translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r44",
      "r115",
      "r273",
      "r276",
      "r281",
      "r699",
      "r704",
      "r706",
      "r751",
      "r758",
      "r846",
      "r847"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income (loss)",
        "totalLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "verboseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax": {
     "auth_ref": [
      "r38",
      "r42",
      "r271",
      "r891"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net period benefit cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, before Tax",
        "terseLabel": "Actuarial net loss and prior service benefit reclassified, before tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax": {
     "auth_ref": [
      "r38",
      "r42",
      "r271",
      "r534"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax",
        "negatedTerseLabel": "Actuarial net loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax": {
     "auth_ref": [
      "r38",
      "r42",
      "r128",
      "r271"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax",
        "terseLabel": "Actuarial net loss and prior service benefit reclassified, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax": {
     "auth_ref": [
      "r39",
      "r157"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax (expense) benefit for reclassification adjustment from accumulated other comprehensive (income) loss of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, Tax",
        "terseLabel": "Tax on actuarial net loss and prior service benefit reclassified"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTax": {
     "auth_ref": [
      "r39",
      "r277",
      "r281",
      "r610",
      "r629",
      "r631",
      "r699",
      "r702",
      "r706",
      "r751",
      "r758"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Tax",
        "terseLabel": "Tax expense (benefit)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Tax, Parenthetical Disclosure [Abstract]",
        "terseLabel": "Other comprehensive income (loss), tax, parenthetical disclosures"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r34",
      "r38",
      "r193"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax",
        "terseLabel": "Gain (loss) recognized in accumulated other comprehensive\u00a0loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentAssetsMember": {
     "auth_ref": [
      "r178",
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current assets.",
        "label": "Other Current Assets [Member]",
        "terseLabel": "Other Current Assets"
       }
      }
     },
     "localname": "OtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESFairvalueofderivativeinstrumentsandConsolidatedBalanceSheetlocationDetails",
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other Intangible Assets"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesMember": {
     "auth_ref": [
      "r178",
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other liabilities.",
        "label": "Other Liabilities [Member]",
        "terseLabel": "Other Accrued Liabilities and Other Long-Term Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other non-cash expense, net"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net",
        "verboseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other income (expense)"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonrecurringExpense": {
     "auth_ref": [
      "r52"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other expense that is infrequent in occurrence or unusual in nature.",
        "label": "Other Nonrecurring Expense",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "OtherNonrecurringExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPensionPlansDefinedBenefitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide retirement benefits, classified as other. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Other Pension Plan [Member]",
        "terseLabel": "Other Pension Plan"
       }
      }
     },
     "localname": "OtherPensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r127",
      "r489",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r538",
      "r539",
      "r541",
      "r544",
      "r547",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r563",
      "r564",
      "r565",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "terseLabel": "Other Postretirement Benefits Plan"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails",
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherTaxExpenseBenefit": {
     "auth_ref": [
      "r293",
      "r897",
      "r899"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other income tax expense (benefit).",
        "label": "Other Tax Expense (Benefit)",
        "verboseLabel": "Discrete tax expense (benefit)"
       }
      }
     },
     "localname": "OtherTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total Stockholder's Equity"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "negatedTerseLabel": "Payment for Contingent Consideration"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Treasury stock repurchases"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments of Dividends [Abstract]",
        "terseLabel": "Dividends Paid"
       }
      }
     },
     "localname": "PaymentsOfDividendsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r59"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "verboseLabel": "Aggregate amount of cash dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfOrdinaryDividends": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of ordinary dividends to common shareholders, preferred shareholders and noncontrolling interests, generally out of earnings.",
        "label": "Payments of Ordinary Dividends",
        "negatedLabel": "Payment of dividends"
       }
      }
     },
     "localname": "PaymentsOfOrdinaryDividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r285"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedTerseLabel": "Payment of taxes related to net share settlement of equity awards",
        "terseLabel": "Share-based Award, Tax"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATESTATEMENTOFEQUITYPARENTHETICAL"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Acquisitions of businesses and intangible assets, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquitySecuritiesFvNi": {
     "auth_ref": [
      "r287",
      "r384"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity.",
        "label": "Payments to Acquire Equity Securities, FV-NI",
        "negatedTerseLabel": "Payments to acquire equity securities"
       }
      }
     },
     "localname": "PaymentsToAcquireEquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireNotesReceivable": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.",
        "label": "Payments to Acquire Notes Receivable",
        "terseLabel": "Proceeds from Sale of Loans Receivable"
       }
      }
     },
     "localname": "PaymentsToAcquireNotesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Investments in property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r514",
      "r516",
      "r522",
      "r540",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r561",
      "r562",
      "r563",
      "r569",
      "r813"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "RETIREMENT PLANS AND POST RETIREMENT PENSION PLANS"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "auth_ref": [
      "r6",
      "r489",
      "r490",
      "r513",
      "r813"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "verboseLabel": "Retirement and post-retirement benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r126",
      "r489",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r538",
      "r539",
      "r541",
      "r544",
      "r547",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r563",
      "r564",
      "r568",
      "r813",
      "r814",
      "r818",
      "r819",
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension Plan"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails",
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares [LTPP]"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PledgedStatusAxis": {
     "auth_ref": [
      "r640",
      "r824"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by pledged or not pledged status of asset owned by entity.",
        "label": "Pledged Status [Axis]",
        "terseLabel": "Pledged Status [Axis]"
       }
      }
     },
     "localname": "PledgedStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PledgedStatusDomain": {
     "auth_ref": [
      "r640",
      "r824"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pledged or not pledged status of asset owned by entity.",
        "label": "Pledged Status [Domain]",
        "terseLabel": "Pledged Status [Domain]"
       }
      }
     },
     "localname": "PledgedStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PositionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by position taken for a security.",
        "label": "Position [Axis]",
        "terseLabel": "Position [Axis]"
       }
      }
     },
     "localname": "PositionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PositionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates position taken for a security.",
        "label": "Position [Domain]",
        "terseLabel": "Position [Domain]"
       }
      }
     },
     "localname": "PositionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r7",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r7",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred Stock, Shares Issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r7",
      "r827"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "verboseLabel": "Preferred stock; $0.01 par value; 125 million shares authorized; none issued and outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromCollectionOfNotesReceivable": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation.",
        "label": "Proceeds from Collection of Notes Receivable",
        "terseLabel": "Payment in exchange for convertible note"
       }
      }
     },
     "localname": "ProceedsFromCollectionOfNotesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommercialPaper": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from borrowing by issuing commercial paper.",
        "label": "Proceeds from Issuance of Commercial Paper",
        "terseLabel": "Proceeds from Commercial Paper"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited",
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r57",
      "r138"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Issuance of common stock under employee stock plans"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi": {
     "auth_ref": [
      "r287",
      "r384"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity.",
        "label": "Proceeds from Sale of Equity Securities, FV-NI",
        "terseLabel": "Proceeds from sale of equity securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfEquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Product"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment [Member]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r102",
      "r233",
      "r756",
      "r827"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "verboseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PublicUtilitiesInventoryTypeDomain": {
     "auth_ref": [
      "r844"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property that is held for sale in the ordinary course of business, in process of production for such sale or is to be currently consumed in the production of goods or services to be available for sale.",
        "label": "Inventory [Domain]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "PublicUtilitiesInventoryTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]",
        "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r41",
      "r44",
      "r278",
      "r699",
      "r703",
      "r706",
      "r846"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "terseLabel": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent": {
     "auth_ref": [
      "r41"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, before Tax, Attributable to Parent",
        "terseLabel": "Amounts reclassified out of accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYReclassificationsoutofaccumulatedcomprehensiveincomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]",
        "terseLabel": "Reconciliation of Operating Profit from Segments to Consolidated"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r85",
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "verboseLabel": "Reconciliation of segment results to total enterprise results"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RecourseStatusAxis": {
     "auth_ref": [
      "r641",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by recourse or nonrecourse status of liability.",
        "label": "Recourse Status [Axis]",
        "terseLabel": "Recourse Status [Axis]"
       }
      }
     },
     "localname": "RecourseStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RecourseStatusDomain": {
     "auth_ref": [
      "r641",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recourse or nonrecourse status of liability.",
        "label": "Recourse Status [Domain]",
        "terseLabel": "Recourse Status [Domain]"
       }
      }
     },
     "localname": "RecourseStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RepaymentsOfCommercialPaper": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow due to repaying amounts borrowed by issuing commercial paper.",
        "label": "Repayments of Commercial Paper",
        "negatedTerseLabel": "Repayments of commercial paper"
       }
      }
     },
     "localname": "RepaymentsOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited",
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfSeniorDebt": {
     "auth_ref": [
      "r60"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.",
        "label": "Repayments of Senior Debt",
        "terseLabel": "Repayments of Senior Debt"
       }
      }
     },
     "localname": "RepaymentsOfSeniorDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r142",
      "r239",
      "r917"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "verboseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r840",
      "r851",
      "r918",
      "r919"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "terseLabel": "Restricted Cash"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Cash [Abstract]",
        "terseLabel": "Restricted Cash [Abstract]"
       }
      }
     },
     "localname": "RestrictedCashAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r10",
      "r120",
      "r231",
      "r771",
      "r776",
      "r827"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r242",
      "r297",
      "r298",
      "r299",
      "r303",
      "r313",
      "r316",
      "r392",
      "r606",
      "r607",
      "r608",
      "r619",
      "r620",
      "r663",
      "r767",
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationAxis": {
     "auth_ref": [
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r541",
      "r544",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r892",
      "r893",
      "r894"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Axis]",
        "terseLabel": "Retirement Plan Sponsor Location [Axis]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails",
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationDomain": {
     "auth_ref": [
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r541",
      "r544",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r892",
      "r893",
      "r894"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Domain]",
        "terseLabel": "Retirement Plan Sponsor Location [Domain]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails",
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r126",
      "r127",
      "r489",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r538",
      "r539",
      "r541",
      "r544",
      "r547",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r563",
      "r564",
      "r565",
      "r568",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails",
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r126",
      "r127",
      "r489",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r538",
      "r539",
      "r541",
      "r544",
      "r547",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r563",
      "r564",
      "r565",
      "r568",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails",
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r346",
      "r347",
      "r359",
      "r364",
      "r365",
      "r371",
      "r372",
      "r375",
      "r483",
      "r484",
      "r741"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
      "http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails",
      "http://www.agilent.com/role/REVENUERevenuebyRegionDetails",
      "http://www.agilent.com/role/REVENUERevenuebyTypeDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r481",
      "r482",
      "r487",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue from Contract with Customer"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/REVENUENotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuePerformanceObligationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue, Performance Obligation [Abstract]",
        "terseLabel": "Revenue, Performance Obligation [Abstract]"
       }
      }
     },
     "localname": "RevenuePerformanceObligationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r479"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Remaining performance obligation amount"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Remaining performance obligation expected timing of satisfaction period"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/REVENUERemainingPerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Net revenue:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r41",
      "r907",
      "r908"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/NETINCOMEPERSHAREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r26",
      "r116",
      "r117",
      "r118",
      "r119",
      "r204",
      "r205",
      "r207",
      "r225",
      "r803",
      "r805",
      "r856"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "verboseLabel": "Schedule of Senior Notes"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r129",
      "r130",
      "r131",
      "r132",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSDetailsEmployerContributions"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock": {
     "auth_ref": [
      "r129",
      "r130",
      "r131",
      "r132",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table Text Block]",
        "terseLabel": "Schedule of net pension and post-retirement benefit costs"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r179",
      "r185",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Effect of derivative instruments for foreign exchange contracts in the consolidated statement of operations"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Gross fair values and balance sheet location of derivative instruments held in the consolidated balance sheet"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
     "auth_ref": [
      "r170",
      "r172",
      "r173",
      "r176",
      "r177",
      "r183",
      "r185",
      "r189",
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Schedule of Derivative Instruments [Table Text Block]",
        "terseLabel": "Aggregated notional amounts by currency and designation"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r862"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Reconciliation of the numerators and denominators of the basic and diluted net income per share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/NETINCOMEPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r136",
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "verboseLabel": "Allocated share-based compensation expense disclosure"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r670",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r92",
      "r94",
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r92",
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "verboseLabel": "Components of other intangible assets during the period"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r801"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r801",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Goodwill balances and movements for each reportable segment during the period"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r1",
      "r14",
      "r15",
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "verboseLabel": "INVENTORY"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/INVENTORYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r73",
      "r74",
      "r77",
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table Text Block]",
        "terseLabel": "Summary of New Accounting Pronouncements"
       }
      }
     },
     "localname": "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/NEWACCOUNTINGPRONOUNCEMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": {
     "auth_ref": [
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.",
        "label": "Schedule of Product Warranty Liability [Table Text Block]",
        "verboseLabel": "Standard warranty"
       }
      }
     },
     "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESTable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": {
     "auth_ref": [
      "r71",
      "r210",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.",
        "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Restrictions on Cash and Cash Equivalents"
       }
      }
     },
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r83",
      "r84",
      "r86",
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONSegmentAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r83",
      "r84",
      "r86",
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Segment Profitability and Segment Assets"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r570",
      "r572",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "verboseLabel": "Assumptions used to estimate fair value for LTPP"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-Term Debt [Table]",
        "terseLabel": "Schedule of Short-term Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "auth_ref": [
      "r160",
      "r162",
      "r164",
      "r165",
      "r166",
      "r640",
      "r641",
      "r642",
      "r643",
      "r736",
      "r737",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table]",
        "terseLabel": "Schedule of Variable Interest Entities [Table]"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of estimated future amortization expense of finite-lived intangible assets"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r343",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r369",
      "r375",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r419",
      "r420",
      "r801",
      "r920"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails",
      "http://www.agilent.com/role/REVENUERevenuebyRegionDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONSegmentAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentOperatingActivitiesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operations of an entity including continuing and discontinued operations.",
        "label": "Operating Activities [Domain]",
        "terseLabel": "Operating Activities [Domain]"
       }
      }
     },
     "localname": "SegmentOperatingActivitiesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r343",
      "r344",
      "r345",
      "r355",
      "r358",
      "r363",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r374",
      "r375",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "SEGMENT INFORMATION"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONSegmentAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationProfitLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information, Profit (Loss) [Abstract]",
        "terseLabel": "Segment Reporting Information"
       }
      }
     },
     "localname": "SegmentReportingInformationProfitLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "verboseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, General and Administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeniorNotes": {
     "auth_ref": [
      "r217",
      "r236"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.",
        "label": "Senior Notes",
        "terseLabel": "Carrying Value of Senior Notes"
       }
      }
     },
     "localname": "SeniorNotes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTDetails",
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails",
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceOtherMember": {
     "auth_ref": [
      "r890"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, financial service, and other financial service, classified as other.",
        "label": "Service, Other [Member]",
        "terseLabel": "Service and Other"
       }
      }
     },
     "localname": "ServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Noncash Expense [Abstract]",
        "terseLabel": "Share-based Payment Arrangement, Noncash Expense [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r822"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount rate from fair value on purchase date that participants pay for shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Discount from Market Price, Purchase Date",
        "terseLabel": "ESPP plan purchase price (in hundredths)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions": {
     "auth_ref": [
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restrictions on equity-based instruments during the vesting period, such as the inability to transfer unvested awards, are not taken into account in estimating the fair value of the award. However, restrictions that remain in effect after an award is vested, such as the inability to transfer or hedge vested options or a prohibition on the sale of outstanding vested shares (or other type of equity) for a period of time, affect the estimate of an award's fair value.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions",
        "terseLabel": "Post-vest holding restriction discount for all executive awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Volatility of Agilent shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Weighted average risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "auth_ref": [
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "terseLabel": "Weighted average volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONAllocatedSharebasedcompensationexpenseDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails",
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r895"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Vesting percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1": {
     "auth_ref": [
      "r601"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost expensed and capitalized for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount",
        "terseLabel": "Share-based compensation capitalized in inventory"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r823"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Maximum contractual term, Expiration Period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected Life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Exercise Price of Common Stock, Percent of FMV"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHAREBASEDCOMPENSATIONTextDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Ending Balance (in Shares)",
        "periodStartLabel": "Beginning Balance (in Shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates the sale of a borrowed security or written option.",
        "label": "Short [Member]",
        "terseLabel": "Sell"
       }
      }
     },
     "localname": "ShortMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r2",
      "r212",
      "r228",
      "r827"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-Term Debt",
        "terseLabel": "Short-term debt"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermBorrowingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt [Abstract]",
        "terseLabel": "Short-term Debt [Abstract]"
       }
      }
     },
     "localname": "ShortTermBorrowingsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Short-Term Debt [Line Items]",
        "terseLabel": "Short-term Debt"
       }
      }
     },
     "localname": "ShortTermDebtLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTerms": {
     "auth_ref": [
      "r841"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the short-term debt arrangement, and disclosures pertaining to the underlying arrangements, including repayment terms, interest rates, restrictions on assets and activities, debt covenants, and other matters important to users of the financial statements.",
        "label": "Short-Term Debt, Terms",
        "terseLabel": "Credit faciity terms (in years)"
       }
      }
     },
     "localname": "ShortTermDebtTerms",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTextBlock": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for short-term debt.",
        "label": "Short-Term Debt [Text Block]",
        "terseLabel": "SHORT-TERM DEBT"
       }
      }
     },
     "localname": "ShortTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-Term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-Term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermDebtWeightedAverageInterestRate": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of short-term debt outstanding calculated at point in time.",
        "label": "Short-Term Debt, Weighted Average Interest Rate, at Point in Time",
        "terseLabel": "Weighted Average Interest Rate, at Point in Time"
       }
      }
     },
     "localname": "ShortTermDebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SHORTTERMDEBTCreditFacilityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_StandardProductWarrantyAccrual": {
     "auth_ref": [
      "r108"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.",
        "label": "Standard Product Warranty Accrual",
        "periodEndLabel": "Ending balance at end of period",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrual",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyAccrualCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability that is expected to be paid within one year or the normal operating cycle, if longer. Does not include the balance for the extended product warranty liability.",
        "label": "Standard Product Warranty Accrual, Current",
        "terseLabel": "Accruals for warranties due within one year"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrualCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyAccrualNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability that is expected to be paid after one year or beyond the normal operating cycle, if longer. Does not include the balance for the extended product warranty liability.",
        "label": "Standard Product Warranty Accrual, Noncurrent",
        "terseLabel": "Accrual for warranties due after one year"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrualNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyAccrualPayments": {
     "auth_ref": [
      "r106"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the standard product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard product warranty. Excludes extended product warranties.",
        "label": "Standard Product Warranty Accrual, Decrease for Payments",
        "negatedTerseLabel": "Settlements made during the period"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyAccrualWarrantiesIssued": {
     "auth_ref": [
      "r107"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties.",
        "label": "Standard Product Warranty Accrual, Increase for Warranties Issued",
        "terseLabel": "Accruals for warranties including change in estimate"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrualWarrantiesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Standard Product Warranty Disclosure [Abstract]",
        "terseLabel": "Standard Product Warranty Disclosure"
       }
      }
     },
     "localname": "StandardProductWarrantyDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/WARRANTIESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r246",
      "r343",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r369",
      "r375",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r417",
      "r419",
      "r420",
      "r801",
      "r920"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails",
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTextualsDetails",
      "http://www.agilent.com/role/REVENUERevenuebyRegionDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONProfitabilityDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails",
      "http://www.agilent.com/role/SEGMENTINFORMATIONSegmentAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r257",
      "r258",
      "r259",
      "r292",
      "r322",
      "r326",
      "r328",
      "r330",
      "r337",
      "r338",
      "r388",
      "r427",
      "r429",
      "r430",
      "r431",
      "r434",
      "r435",
      "r455",
      "r456",
      "r458",
      "r462",
      "r468",
      "r682",
      "r792",
      "r837",
      "r852",
      "r861"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r29",
      "r115",
      "r242",
      "r277",
      "r278",
      "r279",
      "r297",
      "r298",
      "r299",
      "r303",
      "r313",
      "r316",
      "r336",
      "r392",
      "r469",
      "r606",
      "r607",
      "r608",
      "r619",
      "r620",
      "r663",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r706",
      "r728",
      "r767",
      "r768",
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.agilent.com/role/DERIVATIVESEffectofderivativeinstrumentsonConsolidatedStatementofOperationsDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement Line Items"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
      "http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails",
      "http://www.agilent.com/role/REVENUERevenuebyRegionDetails",
      "http://www.agilent.com/role/REVENUERevenuebyTypeDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOperatingActivitiesSegmentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by continuing and discontinuing operations.",
        "label": "Operating Activities [Axis]",
        "terseLabel": "Operating Activities [Axis]"
       }
      }
     },
     "localname": "StatementOperatingActivitiesSegmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/RETIREMENTPLANSANDPOSTRETIREMENTPENSIONPLANSComponentsofnetperiodiccostsDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r297",
      "r298",
      "r299",
      "r336",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCOMPREHENSIVEINCOMEUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
      "http://www.agilent.com/role/REVENUERevenuebyEndMarketsDetails",
      "http://www.agilent.com/role/REVENUERevenuebyRegionDetails",
      "http://www.agilent.com/role/REVENUERevenuebyTypeDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r7",
      "r8",
      "r115",
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Share-based awards issued, net of tax (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r7",
      "r8",
      "r120",
      "r134"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Share-based awards issued"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Share repurchase program authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Remaining authorized repurchase amount under share repurchase program"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "auth_ref": [
      "r7",
      "r8",
      "r115",
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased and retired during the period.",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "negatedTerseLabel": "Stock Repurchased and Retired During Period, Shares",
        "terseLabel": "Shares repurchased and retired during period, (Shares)"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATESTATEMENTOFEQUITYPARENTHETICAL",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "auth_ref": [
      "r7",
      "r8",
      "r115",
      "r120"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).",
        "label": "Stock Repurchased and Retired During Period, Value",
        "negatedTerseLabel": "Stock Repurchased and Retired During Period, Value",
        "terseLabel": "Shares repurchased and retired during period, (Value)"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATESTATEMENTOFEQUITYPARENTHETICAL",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r8",
      "r11",
      "r12",
      "r88",
      "r827",
      "r854",
      "r865",
      "r906"
     ],
     "calculation": {
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total stockholder's equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "verboseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited",
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnauditedParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r155",
      "r156",
      "r167",
      "r242",
      "r243",
      "r278",
      "r297",
      "r298",
      "r299",
      "r303",
      "r313",
      "r392",
      "r469",
      "r606",
      "r607",
      "r608",
      "r619",
      "r620",
      "r663",
      "r699",
      "r700",
      "r706",
      "r728",
      "r768",
      "r769",
      "r854",
      "r865",
      "r906"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r125",
      "r291",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r469",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCKHOLDERS EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsegmentsConsolidationItemsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments.",
        "label": "Subsegments Consolidation Items [Axis]",
        "terseLabel": "Subsegments Consolidation Items [Axis]"
       }
      }
     },
     "localname": "SubsegmentsConsolidationItemsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsConsolidationItemsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments.",
        "label": "Subsegments Consolidation Items [Domain]",
        "terseLabel": "Subsegments Consolidation Items [Domain]"
       }
      }
     },
     "localname": "SubsegmentsConsolidationItemsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/SEGMENTINFORMATIONReconciliationofReportableResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r707",
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r707",
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r707",
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYDividendsDetails",
      "http://www.agilent.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SummaryOfNetInvestmentHedgeActivityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Net Investment Hedge Activity [Abstract]",
        "terseLabel": "Net Investment Hedge"
       }
      }
     },
     "localname": "SummaryOfNetInvestmentHedgeActivityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about the period subject to enacted tax laws.",
        "label": "Tax Period [Axis]",
        "terseLabel": "Tax Period [Axis]"
       }
      }
     },
     "localname": "TaxPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified tax period.",
        "label": "Tax Period [Domain]",
        "terseLabel": "Tax Period [Domain]"
       }
      }
     },
     "localname": "TaxPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademark/Tradenames"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDisclosuresandComponentsofPurchasedOtherIntangiblesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradingSecurities": {
     "auth_ref": [
      "r219",
      "r256",
      "r795"
     ],
     "calculation": {
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI",
        "terseLabel": "Trading securities"
       }
      }
     },
     "localname": "TradingSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/FAIRVALUEMEASUREMENTSFairvalueofassetsandliabilitiesmeasuredonarecurringbasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease": {
     "auth_ref": [
      "r38",
      "r907"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cumulative translation adjustment, after tax, from translating foreign currency financial statements into the reporting currency.",
        "label": "Translation Adjustment Functional to Reporting Currency, Net of Tax, Period Increase (Decrease)",
        "terseLabel": "Currency Translation and Other Adjustment"
       }
      }
     },
     "localname": "TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/REVENUEContractAssetsandLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryLockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customized agreement that fixes the yield or price on a specified treasury security for a specific period.",
        "label": "Treasury Lock [Member]",
        "terseLabel": "Treasury Lock [Member]"
       }
      }
     },
     "localname": "TreasuryLockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/DERIVATIVESTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r302",
      "r303",
      "r304",
      "r306",
      "r317",
      "r379",
      "r380",
      "r389",
      "r390",
      "r391",
      "r392",
      "r395",
      "r396",
      "r606",
      "r607",
      "r608",
      "r617",
      "r618",
      "r619",
      "r620",
      "r636",
      "r637",
      "r638",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r692",
      "r693",
      "r708",
      "r709",
      "r712",
      "r713",
      "r714",
      "r715",
      "r722",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r743",
      "r744",
      "r745",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Accounting Standards Update [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.agilent.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r613"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "terseLabel": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r79",
      "r80",
      "r81",
      "r339",
      "r340",
      "r341",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Variable Interest Entity [Line Items]",
        "terseLabel": "Variable Interest Entity [Line Items]"
       }
      }
     },
     "localname": "VariableInterestEntityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Interest Entity, Not Primary Beneficiary, Disclosures [Abstract]",
        "terseLabel": "Variable Interest Entity"
       }
      }
     },
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Not Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Not Primary Beneficiary [Member]"
       }
      }
     },
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/OVERVIEWBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/LONGTERMDEBTTextDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r321",
      "r330"
     ],
     "calculation": {
      "http://www.agilent.com/role/NETINCOMEPERSHAREDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Diluted weighted average shares",
        "verboseLabel": "Diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
      "http://www.agilent.com/role/NETINCOMEPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average shares used in computing net income per share:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r320",
      "r330"
     ],
     "calculation": {
      "http://www.agilent.com/role/NETINCOMEPERSHAREDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic weighted-average shares",
        "verboseLabel": "Basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.agilent.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFOPERATIONSUnaudited",
      "http://www.agilent.com/role/NETINCOMEPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 6
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2611-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(2))",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(3))",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1),(c)(5)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2AA",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759068-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6228884-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624258-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121558989&loc=d3e80720-113993",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.14)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.16)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3444-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "https://asc.fasb.org/topic&trid=2122394",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=SL6284422-111562",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=123583714&loc=SL75117360-209713",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e39076-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e7008-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80784-113994",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80845-113994",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28129-110885",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "https://asc.fasb.org/topic&trid=2122394",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(d))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e725-108305",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e765-108305",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 5))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r792": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r831": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r832": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r833": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r834": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r835": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r836": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117546-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "740",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126970579&loc=d3e23163-113944",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r904": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r905": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r906": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r907": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r908": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r909": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r910": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r911": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r912": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r913": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r914": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r915": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r916": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r917": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r918": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r919": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r920": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r921": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r922": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r923": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r924": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r925": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r926": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r927": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r928": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>103
<FILENAME>0001090872-23-000005-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001090872-23-000005-xbrl.zip
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M?29YJV:E/*P!!RB-I##W-:9KKOL\$:;^Y2X24W8<D)/5;C;;+Y%G)O>0 PQ
M/>KD-P0R3PJ8TZP/(206SX-;1BT#?0M!)7J*^!68JY0YIB9&ZKP 01?./<6Z
MH(;8=.AZ)B3XQL@EU$-0?-N^;\G((T->ZFE[5[O/DD4*UHM,YEY6VN!8HI '
M-8! &1[VOF\LZ'&4BD3 @GR#U FM<HJ=&CZ#5LA@X8W'?$JSD??%PS%U<@Q
M9QG*PN/K( (&@VW1&#; $8_%O0L>JDF2A[O&Q<X = Y=GJ-SV)XVV+$;WX4)
MY'Q[J%'\, > $CAU'OQTMEJ)</8I;1]+2]V _<R6:I=C*29._CD+ +1Z?UK'
MWYC<D*M*8VM=TMA[R$1NU"!Z-4I("N!IE &,JX!$V#.'796N%J(5ED,<!PM'
MRW+D5$2#%)\E9B(<8Y#J<[T]-[/L)2)1=!QY!A")\:S'@UOJD3$$%" -G\Q
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MD1@+^_I5[:AZVJB5ZYM6/Z*]S9WV>D/W,3( %'#].%;V!E>CX;MAKSL:7EZ
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MK[O)*AHBT!] 6[;H[=)$"A37*FV63,&] )5Q+*SE_"OY9JR BV [$V"?4W(
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M99$57"?8UZ23],N*2:K[EE*[_58X#TFM"C/;ZQS&V[?D=L9^S=8Z?%ZOU<;
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MW9[.M9_!^X;@^5O!XSFVF@4Q_0U;G2*XG.);X_U-9 G7O:[ XM9!;&HRR3)
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MT,C*D)"-DU(?;A6I;#1!HI3H,T6SCH"$%G-)QJ!_!,1Z'*3&S?4AD/ N2:$
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M=2E&6%%-6XN0B+L 6<L7@X\X[)=[K:[J6<\I@,A:4L"OO'5.@;56R) 8*]N
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M7RC,L[7UVH?4/N1G!]YX3))GGRT+BI>J2R&H8).67F06*K U]$)L_8JI^LK
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MY>!H'7.GC^DI]NG#2HXD>O0^:.D#P4?IR(-&LE4^@?1*ZEBE$*[&T2)CCRA
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M8DXP_&4/89K<S<,N9.!&<T##E4HR V,R!7 "I$+!*U Z]KYBX)?LP$F_,P7
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M(U-9IA!!.(Q2A9)N'JM4FZJBGGCQ&%#,:<N 9]1&*<^=L<7LYQ ,,T;)%<3
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MPJB1.UU,#>AVZ8RRUK*,^?SGI%-&?,:#1L"+$^C&H^F@S^4BN<'PRT5R%X-
M7XP=77+QM3@N!+TLDFLD.DIA2SGU>(@1)T$,%XW)>O!1XS>Z*>E<8W1"U'UT
M."@YY[-%8>-#&'_]*I_@:GM+8Z<77[S-/WYO0#\U?A-?O'(@]:63PA&]4+EH
M<CY=69IR<;-)C;))2R8MA=&XX5DCP=GHX941P-N>OGMV,BS5/:?+8 LU&,/X
M9%1)V_-+0\:G[Y,%*%O8-",+9<A8VJ:3!II:11,=CTEF>/!D#T=?VXGK1FSG
MO'#ZIFLT+TIW+,?H=7MPF[-?/[-L=7%243^\=';Q-O]BV=,/6?YB_<CP]3KC
M,=E+[)(!' [ZA=UUSQI(3.^LL5E('\3)O/$ZC&&ZEO,KG_#Y'E_."FR?='':
M*L5TL?C;>' RK0;?V&GN-GXK!^T_A10/+TX8'W8F2XN.R]*BV_8-TT9?6GL<
M_>-N;?D7/5LZ]L*TWS];?O9>&@]&>6P*JSR10<"F<T \D*E X9KA'/1?V/+;
ML5@WJWYQJQ;KIDU82C]RJSUSTV9=L>6+[IF_GA^NI@<A>PV-+OE$;$",Y$&&
M9=N!B3T=%JI][:\-4N'FM0=&/7(]])3AC."2W>U15YR5Z(+N1D2\N-^#QL%P
M\&E\.#OZD.(,;*2RV<&D;L0D\ZGD_@AZS^\T;G*8_W-VVM^>\-VFS<XK<<6#
M[S3P05DW^]D?<A&:8C9/_F5<]/#O>$>)7?5WRDS<[22[]P^=EC\UQ\X?ZEN8
M8U</N9W_>M4RO3K_V7 N'W(F[G475 P%Q$5N>9)]6$SQ?1E>_5RI9?B,;.[!
M8'AVS>CJY*2)-8X7)U5ZH'7_Z,.G5N]M;__%GYVM]37>7M_XU.YMT'F'W?VC
M>-8ZWQ2M=WMB[]TWB_YZ6[MK9_OO]C_L]395:_T-:^VN"2+5>NO%VU[[?/.\
M=;1WNG^T?[@_6?3WU;RBUBDEKF*3961-Y8EJ@PNLJ57(:)*,">#!DY?7>\H[
M7.5[?<[<5#&6H-X=NX9N7U2*O^TEOW>X./IFMF'M6YC4L/AZW.C68;%\/J-]
M';6OL?'KV%@E8K'SO5CJG@/EU@G7I.-G>^^L8AG5.R5:I]_43^$Q"<YL;J)!
MWE2ZK#'A7#9=Q&A48B"%_-LRK+?A.Q9^:B7LTL;UHS>U5;I=JS3K]A>37G\V
M&S*KK=.O6J>O\FTXUU%J89O!86XJ:7@S>,N:S'$%04KCI+XEZ_0CB31B>295
M-_-?C#J7-:37CI5W\G43K9/I56+$_<%D=O1DA).SZ$6GNS!<4_9X,)P\JUOV
M>VU\ZM"CRU!XG]YM4,C3Q\YHPK#[T(]%X8EWE_IHY>2RFUV"81HURHK\3OK>
M@BWY&_SCVH'H.AG@IR>0YCV]]].S:?=V)NLGYK!&A]CM7LXV_4;ZFJ9[9]]P
MYN9J\L >CFH%NI. IHAMA1G#+V56B/<2LP2KL*D,\TV5LVH&P613&*.D, $<
MNGEM"S'7O(I;VASBAK6:[R2'80FR!.>RF<1W;/Y-:H4LWE,TUDJNP/0-GV,8
MEFV5IM^$FNZM]/NW7"Y=R1![/DGB(C)UTN],3=OH$(8X>G#5W&6A>;0B>N.B
M$M8[3#9E1B;01RE]OMA26PCU@%Q/[/2@._K7 W9-#O!D^=<D&7YG\J"MD_&$
M[A'ON[JS5O^DUTR#R6:YY7;$T"D"Q<E-[Y<IW#TX?>^T-59XW?39BZ9""\T@
M-32!FZ -,*>B>?"$3OC=,OZ[TY>;:LWD^Z0QE6OQ_G&Z!&]T[1*\0M^GY_[>
M&'R6S?=S.V8;/HN'MJ1>' ^F8<#C(99LR8_XS1[0GY,\)@$3^WP)A-&@>S+^
M]I+O*^77>QW?;/=J^V!VS>'P<^1W@,TP1/C0A#S&X6/H?H*ST8-']1;7\VK+
MK6UQO1CS^[<;.'RE,8MIY>[:TY<;95^G9UOM76KNMUMN+V6-TJLI8XM($+/3
M>A<_O/T">T@PGG_2E7THQ/QW"=#^H;N%;1WL0W/#K*N?GQFL?,GU12]3O;.W
MJB5UR]N&3][J%1&8"4.:EF+[D0HA/RB[:0F017 =MD1<YZ_;<G.NPUF1W7!\
MP1P>7L-SYJ9UM>3F+;GGEQ,8F_UI^$IWNTT1WHWA_%XNT T-Y\^6:?C9Z>;O
M=T>-YQ_#L_P.=F_#@RPS@FO#ND@@R@=/-L?8NYBVNE67^*5YJ84W)^$]&Y3!
M\3+!3Y\FUG^23_O964X*\D\+4_SVI@\GJ4/'_W%7<J[=R&T#H'8C]0O5UO4V
ME,M\U[I>VM0R:KYUC-.G7#=N7AO5)6G+C\G]%XWJG>5&UX;@+@#A;V8(2G[1
M$ _IM%(%I^Q*V\/&;R\'H]$5NK6(C/5&;996 86JYGKU"]4F?O[*)<1W3?Q3
MZ%(DC8V=0\1QS?!61=JZ-J7U"]6F]!:42]^0+</HL/&\._A4A\TK(W=3A\TU
M("X!X6YF"#;^<](9G]5&8%5D;FMF5;]0;5#GKUR2E[I)8VK3>-#X@7G?VK2N
MBO1=;5KKE*%% ]&)+U.&1)TRM/BV_)CP6M"'@XEKN-SW?KTSBB>C45F>6NI3
MK_6A>S;J3-8P?O8HQ>5,"X^4<[9Q=-(=CRZW\:FGP5</*<+7#J=V.(M&(B^[
M+W[V.++V.(MORP]*[W6I*-493Y:I3[P'_="=?2_.ISL8G91%\VMA<#)NM&#X
M <>-[<[H0^U,5@8$2M3>I/8FBX>B_=*;J-J;++XM/RB]4J=B2+*9>))7PT'$
M5)Q'[2I61L)WZBIJW9S7:I2KZZOK!=:+;LL/RFYK4O:R7EU=>XEJX%75:]]J
MT[D$4*S74%=<>B_Q +K32&*R?70=2JR.;&LG43N)98"BN>(DUFHOL?BV_*#X
MRG1$XSG$\6!8.XC5$6OM(&H'L0Q0]%,'T:@SJI:@+3\HN#?]:>5_');5#="=
MEG^?KFPHNRB=##OC#O[_[+UK4QM)UBW\5Q3,O,_ICG"Z\WYQSR$" _;084FV
MD>T#7QQY-<)"XI&$#?SZ-[,D,); 1J@$)2DGI@'K6I69:^7:._=E=&#Q85 4
MVQY;&WDG69U5P')2Z6KM)#\$.W^^CH2\>W[4-NV409#Y:<GYB::<]SGS,Y<=
MSDLZ<VQC<S^.JQZ>]?WB3U17:%_)1XS56.Q+##SVRVS6J4ZU]^II]AA]G&Y9
M&J,^"J6CX7X]:' 9S:12U>S<3>KQKV5AW:0F.! DPGM!^!4+COO^@?3(PM?M
M5*N/8MV^W7K?JNT]3NF^VZ[@[Y^&!C^G1=F+(F\+_UU[M=?8:FSO;;VI[35>
M-=_7MUI[S4;%NT[=$^IDXQ'OX/:YWVOMUFOH>6KGM;/;V-_=27_M-]_L[6RU
MXC]^#/Y^*SY03QV_:G]\:&Q]V(GOW/ES->:!;]R"U\??56Z?H5G[PE7M^N]8
M6=?K*363:[[=?5_@>KJ=7-5NYX]VMQ8_MI.20)_5_+GUI\,?72YK^B2UG1],
M Z-R]W&S3GYEKG49F_M%>?4<CB36K-W]A'R.);MOO[Q;#*NK>^CV"CE5C5?>
M^_;E<TGO[@CXJVZ!OWZ.D;N_\Z$]"-.UTC)[$-ZCNE=Y<Z:6LPE=*XIR7ZO'
MUQT-:KM1*;O:3]Z&-6SWN/9KXA_=/=/]BQI!S_):J"#[W_+*A_9OJ][B2WWI
MRVI8=X\-8*4&#L\"5Z/MUR_]J*4=&%^AM=Z'\.!V?X^L6XN;;OAAK>^_^>Z9
M?[%*<+YK;AZZ7 N'_E(>;/QVF=X'Y.LXG#/#/Q3_F[SM6OHM1F<,56:"M_V>
M.[,W@@RJBNU?FW3WFA986P9N_O?D5,QTBT\%M_O=VW_:YVD"7_6U+4J9G77;
MP_?I=.-LX#;BK'?3U1</M EF2BCDO?",>DB4Q]!BS 3%!AI"/^^DG1LAB$#2
M/A 1M%%SWK9/=&?P?S< WZAU]8E/'PV^:'WZXOUHOWO5[YT4)0SB)7QJ#X^V
MSP9Q/'Q_]]QVSM(X;@T&/O[?M?3Y1FV4C!LOYWSXHGMV ERO.*5)7Q)79AS5
M^ 7QFPIWKB,?+\Q.[]L;_/[; :F?N>/=;X>OU7'SY,/Y8>L=/MS9(LW6QZ/Z
M\?NC@\M_CAJO/WZM'S>^UEN6-(X_=@Z.=\D;TN@<7)YVZI\^P,;)N^^-RZ_H
MH+4'#S[5+PY:[SN'.WN7ASN[I'%Y@ X_[9TWD#QOM-6)/7G5;1Z_/VF^_N>D
M_GH/'>X<L,;QN_/FI\;1P;$ES1U+#N(U-%^_(_5/]?,W)%[#R7FG>=PY:5SN
MP4;KU<G!Y6&GV7IWD=Y3/[:7\;%._(T:EYVOS=>OCJ_>$[_K[!!_X,U/\2Z/
MWZ'ZI\/CQLD'UMC98P=X]Z)Q68^/?8B_/Y#FIW?TX%,C-+8A>M/:'=;W(8[7
M@NKO/COC1$ T .J) Q0R"114 1!.O"+(:N+1QB9Z1I*P_7G=W+$-/H2B9P#,
M3#OEQ%=.[K:9ME:5MH2,',4,X]Q3!(,Q'C/$A1=.*$ML05OHBK9PIJVJTQ:9
MH"T?''+6*F $9H J*8 R1@!,E><8>H2(3;2%>95HJR2C=EE4[;[O?VO;<<A_
M+Q766%9]>_U*/-MDW;II+#6S"BJ=)52AH#AE5DFK!>214I6RB$#^.((PD^?]
MR7-_2O-I;J#C#H& J8W"CVF@#2(@;I 2JDBLW*52A61NZOP%?2U*\=W7O[+V
M0 [>.",D9Q&]U"MO*'?1RC/!2 -)8(\CD3*09P'RI J2WFF$ @+(40ZHL1X8
MIRQ GD!CH641Z1'("%4(R&5Z]I"JN )J]8:Z4^O^\/.OM  :S]2]_=*K1ZHB
M[JM$F4"QMI0@H[602A#H#5:&*)G=94O%N.TIZ22P"#A0">(O#V@P%,@0#$!!
M.J*9I9%^D]TI4IY9*7;G+*<\3^E+RPQQ+X8P$DHJA*628^JXUT822H/'E&OE
M)<F>J25CB$E-AH.&A'D3C2L>&<)(!Q1U$%!H*&+.*X-A8@@NZ+(PQ#K$8FSW
M!L.1H\J?GZ:F<H.U",E8\C"!)XBZ6/(16[/ B@3KE(AWNN0!%K.HJ]464*5'
M)*0ET@RO>STWV.JZJS.+_5['92DT@Q1J3L<6&!OGP1L$).("4!\M)B.#!L)"
M"AFW1E.>*@:592HMJ36TXG@M^R@^X[4LO$Z:+H%CZ0S"P"@4\1J@!%HK 4P0
MWA$8M,1Q3V*450BO:W:D?J5G!OEH?>68LO2C]<R4Y3#E] FZM,%:QCQ D*FH
M;+0!!@8%&)%2:R(09FYC$Q-<H8.W?()>]1/TC->R\#JI;"R/DR5$1"EW&% >
M C!:82 @1)8:'+4-C'A%JD)X7<.#<IN<L"LM9/(!6.E'Y)DU2V'->FMKV-B'
MYXDY&\=?2*.U^SGJ&$$UAR!(PJ/,L0)HZQS@&G$3 F6.RXU-(>6RG&3EL^ZE
M/NO.4"\/ZA<_0YU HN,D.! "]( J)8$D$@-$&>'(02%#B%#GZW9HO2R.H?=^
MX'7?'A4.(>>_^4[O],1WARNMIM;"S%Q 3.%HJ40*W?FQ4'9'80^92&<BTMTI
MS:008I [#1B3$E B/-"(>> D)-)BH:51&YMH_G3:[!JJ+F87$.67,5LB9B?$
MCU&1-AVD@$-I +5( >.9 5+:0$3PA(F4!(]$A3"[9H$\^[X3'_SRK/;%=WU?
M=PJ=H]U)N]L>#/M%S?B5ECIK$2M0NM09KYK7HS43R7/KIQ63^?,A_+DWI7F(
MXY93Z0#" 0(: @9&&@-@D)0IQI"@11[:W.[U'.A37?"6KGDR>!<#W@GQ8Z%!
MT$(&"$D&"T<IB30:+))[#T50GMJ0P#NW^*EHU,\RG8W]E*"PTGIGUAJ'J\>G
M"SDH2W[S,7$.<AI8>;1:G])$3!/JD>$@D1Z@A$=-A(D&T%KLL6'$*E$45B.P
M)*NR,J=G);J)UAC_"SD]R_A?&/XG9!6V0J' +-!%846#.=#2<N"9%TH[+%"@
M184R-??I^6/AOR274Z7%UE[7]DY\+?1[)[7>J1_U@5MMJ94#%4J76LW1RNE^
M&2VG-[W!(!/J3(3Z;DI044%-9%$,/%')R:0#D$AQP"SDWE!B!';13L6Y\$;&
M^&/(J8SQ$C ^(9HD#4Y0)@"G0@$*,07*<AAGQ%DBF1""1:.)B*7!^#J4SMA+
MS63\8%AK%T!8::VT%M$+I<NAO>ZWN#Y2Q,*(*Z]63.;+F?CRPY0F0APQPJ &
MW D!*/$$&.,D4$X1IKPPS**-S2IEM>10HZKKF@S6LL Z(6Z41Y1BQH$-+@!*
MO0.280@<$JF("5+6I]J!%0+K>CA\QNIE?*RVTO)E>0,1_GA:_3):(SGDX"%,
M># =+\2@8<)Z8(E&@&K!@(D_ 59Q=5H8*"=X8Q-/UQGY,T<*K0) %Z!9,D#G
M NB$5 E"&L\$!TH7E;N< P93""BS5"GMF' HY<M7 Z#KX&1IIAH_8P]+[8^Q
M5OGS6:HMO]**92ULN/+/G])J:?2ZO9]]U-?T>//@/[3/HR5RZ?N]3)LST::=
M/J)RSD,E1 JEI(#&N0**TSAI/!AF8"!!NU2556*$_ZZ0G9>=,A54.(-XP_&O
M6:&=(3P;A">=-%HBRYD!D! #*+$4*.0MH)0KR+P4..!T C6'\LD.FH=$Y!@?
M-RU?&^KS%8]\SD?U"_#?7)W07[7):'?/XO@UKP.\7A:K:_2Z5EIBN^?#OHY3
MT.[J_L7>T)\,(N>FJ^SWBJR4[!5_$.%^F=),D%.5^I4!Q#D&5'H"I(04..6B
M6F*>*Z52^LG<4=(YK&<5N6(!KJ3,%97ABLGP(!.W!.$0T%)%KL & ZU" %&:
M!668)]Z0*,Y*RS/-X4$E@/EMO_>M/4@PCK"Y\F"MOHQ;7COWZ95:9-6Q/?O2
M=WUH9^:<C3F_3JDL#YFQ#$+@,//1F"4!*$P90(K$'=-J9Q3:V&1EI:)DIU0%
MP;H@J93!.C=8)T_?.'<D4BDP7$:P"DR!H<P!$<E6<X*\=$GFS!T$G1U1,T&M
MX9<]Q'FQ=F3E)NS?"]/[,\"CXIM"Z0HNHB0GQ#QL*SB>KL!M-,1220F,4 C0
M:.<"R94$1&D+,;."XQ"W C9WHY$E\XYE)LM,MFAYFYEL+B:;$+6:*NV9C*)6
M!0NHX12H ).H%4%KQS@+4:I@.7==W$?VW5U=R-6RQ05/E6V\5EQ8SG*O-R:&
MQ*%WO3/3\5,S4T:+YGD^XP%7N5XV4.W4Q[5_I/M^M1NEW_>8[BD_8ZW*X;W4
M@[9=UB4WMP>R<M-Q?VEZVRTNK_I\Z_O[B?W*M:?QI C=U?UN'*W!U=<5J_]:
MC,(L1N\A1J>+\VDK!&6* .>< 11Q#R1B N!@")$ZSIM/Q?F>5ZHA8$DJ*%/0
MBE/0G(9PIJ#%4-"$/<P59<$B!#SAD8*,$T 12.(_J92:>RMEV-B$S]7<';>J
M=\RS'$)SI]TY&WJW<E+SOCFFE9N0F;V@J\WSBY::X_6?F7XFII\N7,@(A9XC
M" 3&$E"'&9 &4H 8"X$+1;!TY8C-ZB6]9Q):<1):M-C,)/1 $IJ4FYQ:%X('
M%C,%J!4:2&@8\([%.6$.>FP+N5G6^4L^8GFZ(Y:J'**L[3')I^(?WM5TO"K]
MQ8\.2@:ULT%\K-V-]WUR>I:2=U/]AO4^4'GB*-M[3>?M#/A41S]+.F+YD*IR
MX,SY+3^IW!%)+SI \FIOV!IM#8VS$^/[S5"HW4'S;#@8ZFX:TI_=K#GLZ#ZZ
M=[HDBXIS(S$2P!C% &4! ^WC#V^M)=1[8BG<V,2J2L'T.?.E?!B7'AV88;Q0
M&$^8K\Q3*KWF0#N, (54Q[]$ !(;1X7CC(O4& "N8/7<Y1 \2WY8<B^NO*_/
M<MFY\K$DSWC-3%%F9LN9V'*ZIHK#EB.1>L\QDK)]763+R)] !J*0QT)S19/H
MJ5)+WUQE=WE%3P9R64">K$8'/=&42 "I*60/!!)B"^)<!1^<I<;I)'LJY[3_
M:ZA-Q\??KOUM\S_QQ]57W_@LZU-=G,<'$K[%0575RVP=^9JVR5VLNQ>%O[@W
MC)\><5:+%]..5_:EKSNU4]T?UGJA-CSR Y\XP*5\_,2&W2+Q12=?=&AW==>V
MX\LC/H<^=?@8/)]Y!#;_8_I_;=[YMO'54_Q<L'B'I[U!.ZW'%WW?T</V-__W
M][8;'EVQV8TWCA;1"_CC+=K$:X^\<N=;JC))Y.?1N/DS76W!?!YYRAT4BFE,
MM<6:>H>)0T)PY@T2GY':N'K3T?6)UVDD66#Z7G\%.L0;?*$[W_7%8..OG\;A
MI-V]NB"JGJ=AGQRQ.\<EA(6-RX@VXF[2&]7->A'IQO?3J^(UZ<I<2^VHG_;*
M?_U^AJ*!V4JLEH"6ZH(E_/SG+[UYV^P_Z2H5MZ[2K==[;W8;K5IK=_N_C>:;
MYNN]W?UG(QK<:VS/3@2/??W;S<;.;F-_=Z<6_]IOOMG;V6K%?^RWXJ]ZNK'F
MJ_A,_>W[W?_&E^U]W*W%VVK6=VM_O&GN[_]9^?O[H]VMQ8_MI!)S2W"U'[KZ
MS+7COC)]K??:*$YT_TODK91@QWY6W=?W56B('_M#D9 7[Z^C3P?^Q=4??U]9
M].UN<97%F_X>?_IX4TE?,*%9BN\;/3UF2\6?0R0288Y]-N,O'G/I\X)+)X34
MZ#F)GG/%[GP:/D?_7V4<';^ZLHGG&)?WO:=[#Q5_+@A]T*<^S;7>;U9_X^E;
M2.C);S]43;WT%@MWA+7',7'E[X@%CA1OW_M:/;[N:%#;C=NTJ\URC+Q,42+W
M#BO(J^(?W3W3_8L:0<_R:GA2!_HLD2PSE&"H]O)+;N[[A/_<YX;7;>#P;8"=
M<!?P7T1T+DW@9MD3?(_/6>A7KD-QXB6JZ9<3?=<VT7<]:_8U]\>'-B<?CQNM
M^!X<O^_U!UR_?']<QQ]HL_7NLG&\Q^K'%C=;!Y=U_ [_.+2QN/[Z VL<_W-R
M@-^W&^G:6B_;C9-7[?JG=]\//NW1^LX!.6P=L,E#FW@-WP];7W']Y/#X\/4>
M;KQ^=52/O^-[S@]W7AX=''_YWCAVG<9Q)S2V(4H'-O5]B)L[%M7??58(!N>U
M X9R"BB"!AC,"$!,"*N(P82*4DKV52_B+#/.BC+.FM366Q+&(1., [E0 4L!
M4( 04,\-D,)A8(DEV%&JJ$6EE-:K7G!<I<ECU+,U'=[V_9'O#MK?_'4'UTY<
M]W]6/]%G.>NA/4)-M6I',5;YE7E@GV9@2[?7;QSFC3\"I->G<Q-6X.@I./=#
MM^_C=5YZ5_NBV]TQT=:BO''Q [\5,2B1A ?#_ED1 %-TT"Y"9_1Y;=Q6N_:'
M&76R^#,]\>]9^KZ68)K]JN_K]LV]Y(> VM:#HU>=WO?_>O?%OXZWG1X<M2E[
M[VU'#P;M$&<P77Q+GV>Y-8/<:F[#[S_)K7T%#__?$;0G'[OZDSIK'G>.ZRUW
M?-BRZ"!>ZV&**&R]BM>S=7G8^@(//]4O&ZW=\^;.+OM_EU_A9\6B$2B"!U%.
M<T #=T Q@X"%G$<]K:!"<F-SNA3(GS7==;5_/Z5HSTMP!9;@[O=H,2"-$*<V
MQ(D/"E"N')"<<6 YA(8:2JQ-67%3BW BU.GI][R<*E=VY_+*[V!;*1 R<\C,
M'#+IIV1,Z6"M TBHN!%AA8"..Q/@AA&GI(+!\,@!TR3P))W.,]"K[M++\'Y2
M>$\Z!9FB1B@,@8?.1GAK"J27&@3,G&?(1%(7&YM52GM_;)=@)>W7K9-XA\-!
MK7\-BZ)BT+!7\^/*:+4BE2(^&A^[ATT[-F67V9(M*"%;$7-2Q/[OK(@]=M#:
M18UT;R=UW-AYAPY?'[:+<6M](?&SZ,&G=_#@\@.,5L1YX]UGC&F<>&:!@19%
M4Q:+^!<T( B"8&0%C*R]S8H8F[*SK,82=JN\&E=W-5[4OWRFDGI(* ;>2Y>Z
MIF*@=2" .&XT#7&Q!+JQ.5T@XL^E-6K7.Q7ZD3>S.5DCR]QR6&/2BC54(L:Y
M!PY'K%,7!:^64>8*Y" GE'#)W<;F= W]^QNQN<9!A8']]%9L!G8YP)ZT7Q45
M%!)E 1361_N54* <\@ &:G54EUREC.EYO%/E%RI>[Z/75[U^_&>W9L_Z?=^U
M%[5A/WY:IT#%2ARSCF]P>WQ_K1^WM^6.SP;#9'QGY,^&_'IK:UC?_JGJR3?W
M^B-U__VG<X@[W\QQ+[[O@#9:C:/ZIP/2?%V'!\?OOC=;7VG]Y&.[T?IP7G_]
M+E[_X4GCE<2-K<^$:,UEH"!8K-/AE@72&P:<5]A8RI#$^%9#H-HGK'GU57[U
MD;AO.168A5@!ICT#U#,(3% ><"U\,,$20\3&)LQ'JVMWXO)H1NAM3#&ZO*VN
MN\$;UQZM?GL0AWWGK!]_OHWCT',-/VR&S":SL\ED*;X@0Y!(<1"\QI$.) +*
M&PZD)# NA""<B)N1JE+=T@S\"EJI,\K53 %/2 $31?P(Y3Y0;P!V5@*J8;1D
M&;9 4^FDEXX(F8Y)IHMQ/DF@19E5B\6H"%R5<S12 K"+1FC7N^NCTF2=)D3;
MWF!8V 2GZ8^^'[;[1=6\6M1*HV<'.8.CNI^1G3*I:MJ1[GY)T0&U2"IGNI_*
M/R973 J+O]4IDUPQ512U.R.0OAQA]&U$X"!B]T-\<R].QZ5WO]C*\BXVZRZV
M]QNS^/2X\>G]<1PG<GCR 35.#F#]^+!]\*EQ'$WC\^;.%UJ/WW5XO(?K'PNG
M#%1>VQ1_Q%B @#)&@50H_G N(*RE%9[<9A97UR>3%^32+LCDI[$!&ILR](6F
M<4%"[T'<$01 V'C/I+&&DQP"OS+FVJIM:=DZ>R"-3#IHO+$(4AP LZG$.B$6
MR+A1@8#CKD2U0Y:ZVW@@^V=6!O!+(1DRX!\*^ EWC.#$0*LPB&N:IKP7 W2P
M"G@KN>$VQ%D7&YMSMT9Y/)=,]3+1E^65N0C)8##E9*S<S"TT/N[.LH@KON<]
M:D1LWKL>M'>]FQ*K$'FA(<% >6@!980 +1T'!*LXCXY:#.G&)B^KK]?]P+%$
MT; KA?9JGT!FW,^#^PG-ZHQ4V& #C*0&4,0ET#A@ !FUT@E( ^0;FV@ZFW/F
M:-C%0GX=2@JW>D/=N55P+:'2FK/@YW@UC=NPD+AJ7.\L-76YFH9[5SI?T7*A
M)0Y0M3>KIY2FM^Q.5SM3_%?G+(WAV^2!Z76WAL-^VYP5381:O4:OFZZLW^O$
M&_JREXKK^\$P[V8S[68?IE2L5"P@XRG@P1<N5PFDE 0X)9S$F"L1T,8F1=-%
ML![F@RD/9!6OKYSI-M/MTWN_,]T^,=U.& _2:Z@(U0 B1"/=:I'R83 ((L"@
M"52!I_C#^;T&E:';VUL0WZLMX0/;WE:E%>WC]PO.78'OF I:1E?@E*F6NP(_
M_K7DKL#+W17XY=:;K<;V;FW_O[N[K<K?Q,W6O\]J_MSZN/%%CJY]TYTS7X1
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M&51S)V=FA\$#' 8YL>+1$RM21Y <O/T ;JE/;?Y84\84B[3"D$XM!#60V'$
ML;>606B8Q1N; LU]@I ] M6%Z *2*S)$'P[1B>V?QCDQ12.TE'%)A2= <Z:
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M\0A</'?^5D5="<N306NGXZYSG[*GK;AURTEG3LHJBZNFJW%IHF50RH&XN5!
M320L3;T''&D.-44\#G1J'Z!*,WB6)=LT _]Q*WEEX"\6^!,BQ6L<#$4$%+4^
M*.$P6A>, X6"PXK#H A+P)?SGWCD9,Q%% )]\!'(6MA-95< W8FCG0FI/$*:
M+@UF720DSRP@@EI -8KV$Q46!*N5]U)I+.C&)GXF2"X.ML+ +;LR: 9NZ<"=
M.C )QFE,@3)8 )H@; B1P"'+;+ XSA^J'G#7(:W\O1^V^_[$CWN;GO8&0]#_
M\5C.OGBT+J>^.XA?M=5UA1_V;9R('_.P$R>AZ]W+T6RD!HJ#&\90]LL^D*BF
M2VM1Q"A%J=HHAU%AV&" X52F5#%#K%'(<KNQJ<HJJ[6DOHS51G1I_4XSHI\"
MT1/2 PKGL?8:*&1,E!Y! ^T# 2K.;Q"20T1)1/3<'8RK%ZM1:=TQ"M#H7+LJ
M<HC&8X=H9+J9GVX^3 D(QXG@2'#@HE8 -%@%%)0VZHD@E9,!L=1KF=&YR]=E
M!T5U<5IJ1$;&:2DXG?)((**-<P"QE&^%#0)2^_B#8 89-$:H5!-B_B/-ZODC
MEBP (P=>5$4VW&"B["XMCYP.IL,ZK>8A*)G".E-35.: AD0!!R6F2%HI8"*G
M9V3^MJ@YXF(5$;^ B(N,^%(1/]E033.H0Q! &,\ 90(!I1$&TJ12_\02[)+9
M\ SCLAP5.=2BC**\O9.3]JBG8'%\DD 8K]UW;41,[8]&;QA_J>(IA/\LJ1[V
MW=-UQ9:+D0;G@_:+;KOS?S>&_3,_R10W1F*KZ[9OCD.FA'M0PG2A3&V1P<IQ
M8! S@$JK@13( ,LE9<X*I 1,6)M@@RI4&"]SA<ZRE>45NM@5.K%I,4$11)R!
M8)4"E!(+%+<..,P\=PS3(ASGCA6Z#H?K(P/6_^]9>WB1B[7G8NVY6/M=93N&
M/?OUJ->)&\C@?_XE,1)_SP6;WTO)95@$3[")+_F(/?:FXMK?KCY[_!$@O?X%
M+R#W1&!ZV[\JBC=(L/J[]N]?R:VWOK]_I/N^%)\AGHJ!N+J6 N%O=;_9WQ^F
M<I4?=>?,__CNL?L 9B7V>R5VN36L;_^DQ+ZYUQ^I^^\_G4/<^6:.3X\/CP_C
M>+SJ-' < [P;O_,K/6AMT69KZ[R^\_7B<.> -7>V8.-5O.=WG[$21 FA .%"
M ZHM T9"!80CBDO#F&;HUZ+]CE7T,#]47D5+N8J<@5ASIP#S-E4WEBE=2 O@
M%(.0< JMBZL(/H?3V4)3#]1.=;_V+<WNW[4[U]T@S?J@'-<G^?6:*Q;88.ML
M>-3K1RIVV1M:T85XV4@+$4GI3 "*V)2UBC&0C"I@H4%$4,H)";^@LUN7U0//
MT/*R6IUEY94C/E@.E!.IV(IF0'G#@7'>(6>4),G=@?!T.>AI>HNRKY,6W6BM
MU?3U"IB5[A:Y+IMGP\%0=Y.L_7EAAO:Y=^#2]WMYSWVZ-8D:WS^G#B;,& 6"
M0PI0AB604*/X SIOC!$A^%FI;I$[Z-Y@<#9)<WDU564UQ=DVD-, A! (4.0\
MT%Y#$*16E##-.8)5VCCS:JKT:M*:6VDQ4"$5)X/4 DE57%R4FVA4!HC4KZS*
M1^>FO-U5?DE)I2#F$@,B @'48Q()BF+ K/-!JZC$*-_8C,O)_UZ#W4.EM0M^
M*8[O>S\61TT/:__H[IGN7XQ<D 0]JR42*U[8M,.>\?V?GL&U:R^E:W_+.5<+
MS*+\"=>%>^BW6,[FU#VQ/!&@@*#4.D (XAQ)0"7RP&@# <8\:(B-TD$D+[W$
M"/]=H?2JG#!9T6C##-X%@O=BLA4=#4YQ#0B+N*7,4J!E$, 22C'S3!E(JPC>
MQXXJK.0)7PIE2LZCAQ_OE70P,[J0?"I3'E)W?R.9>[CQZ3!^GL4'QXV3YJ==
M>!C_CK_/#X]?M@]?-^)S43JW#G#CHSQO;GU&&L5%$RP(G#E E<= 0B>B418X
M)9Z9P/B#SO9*.B'.2ZCR2TA93+1%"CBN,:!!^U2VV %(E#;"(4<#7OS!7EF.
MI!L+[F''+RJOPL=>A9?U+Y]="%&O: DPD32M0@>4BK8_4=[2@+A3ACZ5.RFO
MJ>5<4SYYM4.D,NY95,&<!6"@18!XB82T7&DG-S:G<_6G:<U4[4!O:DG>YBS/
M)\R568ZHL?69T+B?<NL!PM[$Y>A3K5T6+3/M@G6!<"[T4YV_3*VG.]WE>5%5
M:E%IQ80V!@&$O (4NLAQFAH0_X4DIY!186]O.O_[L(5?.<(KLA/G95K]94KB
M,O5<(",CV24R E0S#:0*/MH<E%/LL=;F5W;JXRZJO)=6?CT%@N*>Z>-22@>$
ME,6]5"-!@/<*8^VX(H$EVGM(M-;PCE.^V\\+YSC[6XMJ266=_=U Z?CL("-P
M-@1.9B!S8AP+&GB':>K_P(&Q(@!DD);".L%4V-BL4L7F7,FLHD=[&9OS8G/B
M_,Y1ZR7F&H1(C8!:Q( FV@+NG7)QW^,FR:4J87/-.M%OQ:M.(ZX[M5/==J#=
M!5:?MH>ZDVNI+UH)_!C[MW'H][K;HX'/>KT\1IIN$X<]C-S#'$!02$ 5#<#(
MJ+]1<)YJ'2TX*(NB971:<N=@H)7!<%F*(6/X,3 \&16$N-0L2GQJ0C2:/7%
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MP$!A ,0.,R:=#C9$YJF0/94=(577"!FRI4)V4BPP)[26" ++,(ZZGD@@#79
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M[^=0DL=U\;P\&\3K&0RV>R>FW2U&?_MZ5K9O3LI6OY]FL<@N&$WH7G?K),[
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MI+0$$ :9Y-(IR%,_S;D;:N:CM;64<1GR%8#\A-[#D)!@; #,IY-T'A!0V@O
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M10$'@V.2P@FYLD:-> $ZU3UE8;\_'GKD8Y5'!HM%0]U_/1XAW(  %@E$SXD
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MLB'4IN52M&P(M6FY%"T;0FU:+D7+)O#XF05R-F-MQKI,8WT.@<>B"3QNFBX
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MEEX:3>7FFLK;.4>.D%XF!M8?E4H@'I5&5BN#P$ $/84X&CG/BDH3"+E<3-]
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M>)"]#A58S-_B$%H>]GO?VUFJUFU\C6"IYT?9!"VF'WPP@,':81YA9Q3R@ 9
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M+YSZ*+57B.F($1"&1BXFAA3L;"!.$2+4RAIY0<6=$_?<E%T>.1=X WL-[,W
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M962M*)<6S .P$[ACRA*!<3*4.4E5C+IAY,5CY-G#\"2,)Q*$L8HV9H\=!\O
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ME$(N) , *PRR*EFD,/%!*:*YEBMKQMPY%J&)OEY<3D[*1L*##AKX-@EG'7-
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M9-_#(LKY0ZEN@(++CIXGRV[+LE>_C;JNW>D NUCO00#"1_WH8_M[9L;? 69
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M'+89 &NE#QAF'!DXB67T=K!?V?"].')+=$O&OOX<K#;JX9)BX+RBN#'6_\<
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MZG1BL_P^>+Z\Y^3[L?N@!M2I;&=%#^SD$^,SSI/5><ESCF9TN?I3R"62R&7
MR@A+N?5 UC%0%HA24D1'U!?.5GZ%+GFIN.*K556C_/S/![Y8OU%K3J-^W$FO
MIA3V=[6GIYCL[_=A6__,_I W]KALS\)<LC^>,.6WH^V-=U];!]L_=W;7?\([
M.;QC?YL"[OY\>P3O[.S\]>EH^^#UP2Q30OLC8$3ZZ>>VV-YH=8 A\>>/F]#'
M>L[T^77[X /__'7]^-/'SPF^(SOK7ZR/5C'J$'!F1)PPB9S7"<2<X%(EI3P3
ML]DCJ+=6,Z^DX9('#1M%N2>P2U0Y$ IT]E+^^_]9?[>)_ERO4WULO]ELO5_?
MW=IIS1V%S&9AF-=[KG[UV:$R+2WUP=$(&I/$U +\!^FDHAH3;.C*([+*S)G6
M315K7I+]/)ZY,\Y65Q3'068K5/L9+2!GJ+VGT*(?"G@6;*QMHM[W]F!B9A0'
MP&BXGU6 DJEHTFL&Y+U1>_QPT0O&?II!K38 S([Z8T]U@>.B(DQRC9ZQUR<^
MBSS0[(Z>'NQAC0*301_D9';9?S'J5_'@L-,[CN.LE@%>[8>]_L3=D <X:0&+
M#_A1]29Y,6&00Z#GD@&S?),U6OA\IOWAJ._W;4Z;65Y;J@R?>?-,N^JP8[N3
M5*$GXJ_,9C+^O2SB:KUI$#NU#G40#USV@&>K#CH?Q&Z[5V2?K074^,5Y54_=
M2--O**_][?_\EZ84__'W[ILWY5?RQ^^GCN530R/9=K_Z;CNC.)C-A75;VKZC
M3^"Q^:182\.C7I67[NS6E>TM6W?BEWPQIO:RJ0%TR_8 -@06]G27*":Z>E^>
M?0-;\Z(0=J&;']&/"A?U4FK[O.FG\8S?XO$I2:]6;_)YBV_#DA0/6GF^#+!4
M&*F[W^]UX)V#O-U$_0'J%VA*IY2P^_[="2'DUY2G-VT_*VB#[!2JBK ]:;_Y
MYOU)^Q,O;&Z0/;/#SL2%48YO:JH^@8A3K]YXR7(JK_)-SAV<3YEJARHJ+HO:
MB?@BNY=S8K;Z!&9ZW8>VOQ?'IUIC3#H=S<$D)62>#X))3GCK;+;*$/-!;SWH
M$U>R!QC+KMYZ2#=P/SS+!&ZD2>#6)'!K$K@5O?9*/75&KR6**&-H!'V8<RNR
M'<U]%%9%HK27YR5P^T4GJI?R_#0*UW+O5#&<^@HPN#_)<'X8 >IS=-=A+0;Z
M[0$LVIDC[0S2^3SQDENBI\I,$0Y3" ]B:1KASW0\ECMC 3BH<MLSKH?LC3I'
M]M3=7R9R3EZ=/RA/TC+;\BN[>.!EC.7LM!YA:O<'P^I_1R#-Z["$N;YF\Y.N
M@P9<1/74I <C]W4< F"SZW8\%S"8T7=0[:JL"(S=+GEVC5I7<KH5U_?I4H)*
M?0R:;_^X#CVYT*O='65]?+;6M 4+EA''=3#9_6&\(@ %22@#F$##%8%G;-87
M4E2O0LO3GI#U4[?4G\>G3<:ND/4\B_+CGZS/=_?>Y1D/0)/+R 9R^'H.<42?
MF2=E>_<#WE[_0H3 C"2-&)4,\60(,C$2A(5QREFK-667A#0_!%G0ABP>GRR\
M5-$'C(*G%G'G$W+<82 +PK6(EI&<8?IF9,&U-B9%DWR*'#ML%?-:61(#M9@9
M<<65J88L'I\L!--<<Z(15SXB'FA QN&$F %Z"(+YQ'5#%L^.++RGP?D,#Y%S
ME*/.D5$Z(J-AA9B+W&.ULH;G#E5O\4'6YOPXK.MF=!:5P4$8BI4V'(C5L2 9
M"Y@)+KTGH:&SQ::SUMX7JI,*N6"[]Z"G< WVBZ8R()5B%%A8&I6_*?PT9+'T
M9,$\E5@SCUAB()448) )VJ.@*#;42)XPOBE94&>3)0$+G3SG-&F02TXI[0+3
MTL1&AUU\LE"8114D11Y4UASBPY$VTB+,G5&>&XWCC4V;ABR6GBQ 2EAJ)4&!
MDX"XC1*Y( 2RG$JA(L71II4UBN]779G<Q2D>M=KU4D+8)]7/RK>AW:E/PMH'
MASG\O'YH,'76,S[S*@UC*(F5VEW?.RB>MO&I*FRO'XVO!O6ZG>-)[',)*AK6
MP9"S?KH<<M^NHY'*X=;94+9RNO3NW//AJ<.E['1[4;M&!WE$\8>/D\/E')1>
ME;ASF-,-68XQ UOC4E"16Q>U,D9;:8G+OF=N&Y9;9);;^]$Z^L((R&1J%%(Q
M.<0C<<!RD2"9B!$:[ ,B;X[$#5DL.UE8H9D*.""= L].)HFL-!1H@R9OB39)
MR9N216(4!')0F@40T*#<@_['/&/"6V&E<(TZO_!DX2P&TRMRY*RRB'MMD$TN
M(4:2%U0PZ]B-?8\-62P]68!%QPF7#!$50(CXG Z>$XL,23FLGQ";+Y#0^91X
M=U';LE95WRBJ#TW'YYFG2LRY8<&WDDWG$-B?5Q/8GY<1V&4A_4>]?AC$[O.C
MI6P#2,LL$UBC*)5!/*?Y<MI@1+3'G'B3 NS(I275FBU>\"VVU%@A)4?>*U N
M+/'(.1F0$Y:!=(F&YZL^EVWQK61&L\6_<(M9T)0S@SQF&K;8"]CB%%&$W75Y
M/QP3S18O]18'_?^S]ZY+;25)V^BM*-CO^^V>"!=3YT/W%T30!GOHL*2VP>T-
M?QQU!&$A,3H8XZO?66M)("0P" 1(L&9B/("DI3ID/I69E?EDODW2&%$;<O45
MA4/?!X((5<0G#7XE!ELPY9A(/J;[L\49\_U>9L$4L9A1L*)(3E^.Y*'G)-*H
MI5:V/T>96G"TO<GL [W8AX4+Y2+E7*LK-07KHWSOT:\7>?XW)H47R4@NCEEG
MUBX),*X\=ZVHSPTQ%8P'K4YM-Y8^ *=T'&C;&1,IC'LYO.V&^*:DZ>F@_L .
MAH-N[WR]UAP/[DH<ZR$!*V8\\P$3'D#H=:"&<"&BY%0((4U0M_@:.XUWE;?Q
MC,!SO'W>_/A5,HTC!0LQGP>(\^"1]9PB[42"X\& R:?F=4(KP7@!@F$(%9)0
MEL.8"8P.!D8'XP%%F[")*A@>S+R"(:.W/'GEHQ*<,.MXM)@+K>$[L"7QEEAF
M)1C+(!A.Q12I-,@P =*A16Y7QP*BSBK0:NY)G#ML50G&"Q",2)-P!$M$B<I9
M*\$@S1U##';0!HD#R6[*4@2N[B5OE3_T-+*4"]\Y%DS2:!'C&F0)6X:<"1IA
MSZW&B0+@A%^[O-46+_L6!\>HMQHE7V0S,8<,UPZEQ#BFF&."V:^W^%YV9K7%
M3[?%WCK'')<(M) B;F1Q(D@436XZ3(BQ\A8MKK9XR;<X&&I3\ &QH$&+>;8&
MN;2(!">H#C(J+I\@<#5FL#RQ/UHGPY,+.J#A!/_94YP6][$XMW^<MDIROU+*
M*B&;$+*='V!94A>H\ES V:  1VC"R,@(YX77N4FV!6113X,CU?X^QOY*L.BP
MX@DIQPWBP@5DP<S+38(3STGO2N%J?U=W?RT-G.*0P-13#NP HY"5L,F&4TV%
ML5QA_C36?+6_C[&_44=8-A+ \V<2<4<ELIY1Y!D8 #P0C /@\R!V%F,#E 7\
M\4?L^5:1-)RY=@NBJRO7,*W)RXY,WINI<DL"U)6-9_\]8ILJ:)\+(KV3;J>X
M6!I%J:H0U4V"RAMG7S%.0G 94023 @Z:Q)&!T2 /Z*0=%KDQU0K?=E32\2#I
MD SV4BF.@L+@RR3-<D1"(BRY F STANWPI'M2CH>)!V><R(U54B(Y $[<+9/
MM4>4LDA@D52DL9*.URH=041") B&5F#G9FLWNZ@),9IL(D9C*<+:!GF<:JN"
MUO'$]K[%0<GN.*:3],4NCNVBSF7<)/\P27#8NLA:*:JU6OW^,+-XGTU0_5UY
M5M$@Y'J&S5%A56F<A6MH)I>BW\#CDAWO^J,8AFW0H^W1&NV6?:MN"$:6?2+@
MIV:Z;#-7>AL%,?(KID%FC<.O +8N>2R1B. Z<@IJ9H@4R+ND$KB6RL+!/$5K
MO!H)9]F1&1=!EB6/.=6L/>(BF^3"O4*:FSLSV/P>$)RS_N]+HF*W4"8#0!VV
M.D4[SS)5L&B\><F5633[A+&V[6D__C[^X8_0ZI^V[?GOK4[QC<6'_A@]:T2P
MF2DEIQI]%OM;OGS)-KF.2\;)4>_HT3>/7EXO7IIJ7EJ^ILBZ,>;&E_$ZF7SM
MFB[,XSD Y,1'?N>O1C;UFF W3_E7G_S54A&R+LF=EVH)!DOIG1Y[2\_QF[II
M/VB';WVHF7GK-1VU2^++I^D<K6^C*,4EZ.7V:O6RO=IVT?_A2N_@:JT7M]83
M+>/OL\;/VZ']3C.\OOGT\X+PPZ3V:F/LV=;7\_3%7F[IS/;S'7;N3A.N%O;J
MPM)*WY]>WPE=S6/BMU:G7-=1^Z_^O^:1'F?]MTP"W0EH-%[O8TSI5SKSA&)U
MJ_>"R^[!_2*@<J4/];C=])**VQQ;, V/\VP=KJW"!O[/]";--<7)J?7R4Y=J
M;G-T8>0L^91$B#(2+JAS 5M!3="",JF"O.4^:K8=XT5SV>N#5]ME Y_E:;EX
MOQC5T?[)CS:,C3;V]L^;7W;(_G'NN_?Q_&!OFS>.O=@__HCK6SE.M4^:6W]=
M? :^:WA /\O\]\;Q#KSOGU;C^*C=V/JK7=\[I(V?[59CZ^-9?:_1;AQ_YO63
M@]1XB\F'O>U!?1?3YI8G]8]?7?1<.>Q!?IQ"7%.;TU\\8A1CXJ@(E@ $$#83
M#+[^/)P3F6MSZD"%1!42W8I$AHM,E6PL29H[3C3C,AA-""4T!2-ON=VJD.AI
MD(A-(5$TTEIO';+!2<0I3[EYK$>4::VE+F@_R@9!2X-$<]NGJ?C/2MFGGV(_
MVEYN/I8;WL7OL=T]S;>W*VB:3JW^C9X[G6\'KST<5AM!A7%P[C,IO.,R61.D
MQ0%3+^%_ *B5+;<$"+H[8\L%V"BLO4"*Y'Q7ZA/23C*D$]AQ8-59XT%G9@LA
MYP30ZT'L44VY2G/OJ+E:PC$9M$H$+)\0E:.!@0FOL'-)$5S9/LNAN=.V3W*2
MF%RQ1E02B&-ND:$T(:O 6E&!A&3\VH9<(LU]#:&YW=B&/QZ^&>=S%R;0N/]J
MK^C!N8)6T"UN\9VP]*XN\DICJ=>>PLG)C1*8YT)AQ6C1A,=X(EC E16T!%C:
MFK&"I"*6VV"14C0S$S("!A")B GAL'5$2X+7-NB#P73Y(EJ5ZE[0AQIL:6Z\
M%ZS@E$B#J?86-A^;P"+GE1FT%*H[;09)J3CX+A)ID1M=F4B0$XPAPR(VD5/+
M1>8@UDNDNJ\A!%1V?[\Q*S26PK^"IM M;N5MG[N:U\% @D)WF'-+YT[L>&GW
M"XM?H!=S--TKS;\ZFI[V:#J?L2JM)\H0#@<2$[E(SUGDO 33DG(L6=1:YF8:
MG"_(15^<YCQS:*["T I#%XZA3F/-E?)<2\J#C-9IQGF*-+-91\TJ\WXI,'3:
MO < %0E\<10-5N"94XHL!@S%CG/)DM8VE\'S15U0/#^&%L[!OXO2H7%ATC3'
MQ+)63<U%O/[48]\<U$8%!N4L&'F32=-9$:!M^D'7Q=Z55^B;F[DWKC'1E)(*
M$^L\.)TA!2-RKP-BDV,R>7%;S]I9>+EW=?3DVW.BZ%4FN-]3ZT<,Z&?L=5<=
MFAY0!_T9-S>_.AU,=-PAP'V+.', +3$(E!N? ^1@ZB*9+X*$O9-1P=D1 N=8
M.RV9()+A@)T-8KH!#<&5##RW#,!6YY[V$9&0))CH."!'@T,F14T2J++4( .=
M[AT*W7]9 >OM:6L T/@37LS\?ZU.K=7Y#MM5-#Q8342MS?>?IRAJM_>GT'QG
M6[U_,B'!9K\_/"GY 38[H1X'1]T *WIX_HHKVWGCXU=IC$\.,Q0DF&.<R@2J
M0CS*;;M,9-S)O ^K6ME>UJ?G?BGV<O]K9[$7:\-^V74WTZN>C!DI"AZ+"P*+
M@IGBDI=B!=O)O-R">+$N!5^-@OA[EL[_LFX<)BC4JA2YY\'>K2+_.0JO;WOG
MBM9=+V.-^PM=ZJK$?;EA];X%W2LA?,]3P?XR%FZN"O67D<A8$*65K?B*3H 3
MW$W+JJL+2'&\K]0^Y=W(G?;OSD!\_Y2Q5[Z<"TKC*6X)5!'(66I ^%+\ L:A
MA5'9PUCKM?K?4,JV8RLC=F[1F;MSOFB4N#T3ZRF/KX?>DCX&231;6%.;ZR)R
MGT#FWH'([8PD[A,(W,H3NH[N6 _:C9^AW8#GUH_]S\;61[+_95LTCCUM[GW[
M63_Y*)I?=G[NTWTZ<\=Z\IDUZ&=</ZZ?-W[6<6/KGZ/]O6\4QB::>_7S@ZUO
M8O^X<7QP?&T]?\14<&(%BC0%Q*G1R,%>(QXTTS@I'DQ:VV#K9B;H_;_W.E^J
MRJPGHUVNM''IM7$ZXR%$J65B#@6B$N+""&2T=(@[QC"7SC+LUS;(^H/I-193
MV?4<*O2_C^&-K8H=MM7ZW@JQ$VKGK=@.+]K:NMUMKJRMQ\3WG,/FP>0?BUR%
M[W/C^VS%?0Q8A>0]4KF7/6?8H=RZ'C%LG-,L,F[XV@9>GRTVNY^U516 O1!K
MJ]+&!6CCM+4E*/4R]U4*5#/$(V;(*2I19)A%J;S5@F1M?'""Z6+JQU;0VGIA
M4:_OW38H<;LU.'_1IE<5Z+K-]**/"O9CN=LLQ>Z?"ZFK4']NU)^M]]?<8>&#
M0)F %'%N&/C8#B,MM.=4)0I.^+5%PU7 ZU6;8)56+E(KIVTQ1V.$O9=(.&,0
M]RHA:SU%@><6K5J[1-0B6#BJP-=*FF)C_Z?6;J67?<MX>]QK^41S65N>_\J3
MWHN]$W)MC^S<_+D"\=M!?+;H':0C\X!*9&#7$2"W1#I@A9)RDON@LMFUMB$N
M'>IQ6>.XX?;S)JR\&)U[SC;TE<X]KLY-&TX>,Z*-D"!E#-R9?)6OG3;(QD0"
MEYY;R>ZJ<Z^!G.C#WM]_O^QLQKMZG,_YC%=FOEXZB[EB;/.PU<YMD<NFQ2]:
M%E_#+2X1U%DE/0F)$V6TRD8NU2EI+*PFSQI*')^\5;3B_H=N<_8>UX IQ1+7
M* @L$5<1(XW!VHTF&2:IHEKFK+G9WA./>XW[RC71&N8\<<9:KG@RW(5DC**4
M<QZ="?J6\&&EB2N@B=/F+PV@:HD[!%L,+J=@$9Q/21 3G"EJC?417$YZ6_KJ
M*[O9O&J/]&.[#*Z=QJ*2^P1&=/X:K),'NB_7%_>7,+H2@+DHTV7!U!M_@QB^
M+:6P^%#_*F9^RL^LMSJMD^%)A9_SX&=];W/0V,4_,H8VC@]98V_[>WC_#P__
M^:M]0-O?W7&7'+Q_US[X\NZD^?[=R<'Q(:Z_WR;-+P??#K9@K;[4?\"S6@=;
M_GP?YOP5P[FJE P(*\H0UT8A':-&-# 7HL8X,0/H2V?1%[T>2;4_*DE]9DEE
M7XFSD6C'P4XG8"PD3I&3C"+N"$O11$V<6MO0LWRL_WN5%^6YHRBO[HQ:E%%?
MG5$KI/GGO];\^M9GVOQ29_OTX*BQ]Q$?''_F,(8S^+W5@.^'9\/GPG'S'9Q1
M$C/AF-+(DIQ9H"R<429@E+Q+GFFGF0##D<Z6U,Q[1JVRI%9GU+-+*OLJG:->
M!H>TE!QQJ0-R!.PJ,'4L==Q1$AB<4;^**EV>4:\LPOXW2#XZ:_4C3+;7B^T1
M_6)K<'35O7W9#NTK"/*MBB?P=Z_EXQ<0R+>7\EB%_.X!LMO3CL!71AW+R;J(
MDERW(95%5N"$, GPL^38)K#E^35>9Q5]KPSU2C$7IYA7K9^O4C(")C78+H2!
MDXVU!U/&,X0UY=HG:@T/H)BW78N-3)>QN%]PE9;DHX_F>Z_NL?^*,CZ6VPCM
M]@?H>R9#.NJV\ZAKF1D#\*: 3]AA#Q,<Y/RWFFVW:_%'],/<%7;$(5R9IJM]
M F(P1IDAPDD;N1+:T"B\L00K)@(/]%GK^;=&TO>NV\MBFJ44]N'3I7SVJ_-O
MOO.O/F.8FD!](,(B&K1&/'B"#/@I*&B>K"2$ZUQ:IM:KO) GU4LGB0=%-$9R
M^"_H)R5*4R&#T$2P6YO<5WJY<GHY;9>2%)24'JDD">(Z8*1YC$@0@3WF/#'E
MUC;D-87^UQBF+[,_TS-W8+C246&RF\JHNT(VF;K#7BV>G+:[YS%W'\@4M=V2
MHG;TIMQL9=RH(=2&_6R Y7X-?[8!]="N!Z,,ACWZS"EL5W[#23?$]GJM] W'
M71P 4$+L%1_.^>*UW_9V/_VK[ A1C'+\=%M0I\?:6]MK=VO]ULEP%'@</37/
M[89W3$RY>#.8BO\=MO(8\K<.^\5*',$ZM<]K_:$[CKZT%#MEAYEV_#'9K>)-
MK=7Q[6$83SG/;I*O(#^L>&Z>5_L\OZU8P?5:*3> /L7K5S^15WQB_L7BP%>=
MC?IBY)>[9QT8)3RKE\^&T;9,?_MZ^24+$]&-_^MZ_]Y845G?WH4%M;GC"$@K
M#+*5FVF,Y;J?FXV<#GO^"*1_E((UW@G8]I-N9[3$=G!SA[)K#\$']I%=7'+D
MQ8'7ZY[4;>];'!01F;]'D]XJ(C&3':M@.BAT!V@TF)4_#N_?M^IG_:QQ]A43
M+8,7!A8D",0C2<A&QQ 6)'BL W>$SFLB5=+Q4J1#@@N27%+(I, 0)V#K&&X,
M2LKB2(,2TJ6Y#>B']4^MI&-II$-SJ7#B'A%#/.)&4F2=U\B;H#SUA/%\=5))
MQ^N4CL2L,R$X1**EB#-KD)6.H\"3IS@1KCE@AYYUD^[QA]II[.7(PM@R+6U&
M,&LNK)]LZH*=61K$%W\-11>VHB,;^&&M_M%E2[:38L]+HWJZL6+^^BRUK<[0
ME@-Z#,MS9.QQ6B9,G';[K?QEOY?W3-_C94NS_[V:FS=JB(8O/V)=O]L>#F[^
MR!*D\Q4V+:%3*SWQ[]'%)<ZI/027KA?M-V03#/9WVSZSY_VU?U]M-=?JC!_.
MS7I>PN69_4Q_F+*U\/N=#]N-O=K>]MO_-)H?FN]WMG??U'8:;^_4"/!9A]YH
M[FWOUO::M;?-QM9V8W=[*_^TV_RPL[6Y![^\VVEL-M[N;'ZH[>[!'^HPS=W:
M;Y\;FY^W=N#U?]50[;>WI4K%\*\[-3*],M^[>W%+]K&++J:3@%(>&$0190R-
MU%O.K7":&^ZCL"H2I;WTY=%9K-AF/H2,5"9H%Z@,!2^993YRKA*URBOIR(U"
MOV2.[9<R9#$1"9B()$SWSXQC,I_KHP43<8TB[O.KF,]Z;:=3 U3Q1^/(!ZRO
M;P_[\)8B4'%DOQ=_Z[="[,%7GN32I@1G4+?7GXJ9P$KF\PA&>W;4\D=E>&/4
M#!3,C9H?]GKPAC9,J&=SI[Q\0.4W67<QSP1;,7YY_-E6IQQ8^?'Q*56FIK5@
M+VRO!O)VTB^>5RQ&$07(G^E>]"(M1I!/-AAM,>G1BEX.?H(@:1PQ&']\%-4J
M%F1B+?+G)G9LM+#Q!QS,.9'.15B\5@Z\E4^[N*[,(:!BA<[RF]JM"$O<ZL,V
MG/9B'Z98''7Y4VDX&/8N'[2(WJ@K'?JY#$Y>#7B.;XDO5"(;W*4\E.&W[;]W
M_S6.<L)*AY@%!KXBU,HH:;<4L9%HE0IU7=1H]+["AH+7"[FHV9"7*@\J*]M8
MCL(5JODRE'FEM;7O]LNK[(DA]F+*N9;]D2;V!Q,-<@='8-QE*3[M=5W101:$
MO+@LA[\7(IS5:60,QEYAIW=\\7.K&Y['GEM><;K^^+G].-ELM\L-N]JV..]%
MEA90WZSQ,#Q;^EH3D<D"2BW(4$29.J9V^JMLAU)@+@7^(OD!P+WK6\7?"@C\
MY5,*:0=L\CEJ?B6F_Z[5Z<0>@.Y$I+V,HU^\?>0X=#.JMP#?VED>2YUKE6)V
M.;<BM#\6RGZ$1<JOC^*O8=@;?VV^2<A"6FK:&/A+$<TQ>- C6TBQB^54BIA^
ML;QY>A-/G1QRV64ZOP2.\.WA] (8KNKGY)E9/"V- OJ_NI\HGF,[-^E\'G36
M^.'HV!YOX?JL\LW3Q?X6S2OD.)+(9<#*"$NY]=3R&"@+1"DIHB/J*Y=K$Q]Z
M'A44X\N3V7\?J<7].$*RTX%]B7OV1XYX@%C#(;LL#>H;K5'DXF2'U/<.1?W+
M)WCNT7'CYT=<WPM'1?1BRY\WO]3)P?M_3O:_?#R;CESL'W_^T=SZ]N/@_<?S
MYOLZ:VQ]_-&@VSEZ 6/8$?L___EV\.7@Z&#KSU0_WL'US:\Z.BY(D(@YI1#W
M3"$CG$$B> U_YU8E/&U[2Q K^)15W#L.DJ9!P!S'B5O"K(QXNJ$].'7-^G9M
M;_/_ [=IYN)W6I!OEO)KD?O6P:S(N32^2!P4C:7!\LB-I6/16'K4 +G4$$;>
MU+)XORF.G58AT+6!_5& 40>LSWR9^S\W!B*'_;#8&PPD;U2R[7)$?\9.3*W!
MW2*(\K6IX=ZV^!JQ<%[@W$]!1,0Y2\A0+A QS#KM;7 &+! QRZQ= T%L7]3K
MY!,II=%]=Q:)WLA<?=(KK9FLG^WQF"X$(R>-CP(@<-@WP0JPHX2=E0@R/[V,
M?#[_&KB4,4F/4JYLXU(Q9*2D2!J)<:+<!._6-@B_)D=N'#%>KS6S-SHK(H B
MO5CX0^!RYSTMS!<[LK_R;K_)MA38;H![8-7%L9L-J <N4;=W#L;C:6L P/JS
MA.;2-P-CUQ^51A>XNNWN:6D8E[!PX0R[Z+/U=CFN;(*-J=Y&,8#4ZH$-^E^
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M@T33QN97[HAD 7NDA0V(&\Z1<02CY+S!*DF=%$BT^K5 O^KPZ)Q^ UV8W_#
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M:W9T1&5ZN1EZO8<$_N_,4O+R<$I1G821A@H;.8_&)6=,,H(EB7&TIJJ^7CH
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M#PC,>Y6\1E;IB#CV"3G8$&1T,-B&%(@V:QNLB@Q6REHY DN@OE.. &618:E
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MC+WE:1"S(N!$IIL;:.FE2AX9C1F $[%@(06'.+.!DZ ,BR*[@9H2^D<%4!5
MK0A ,4=CM)@IJ2GW3MFH)+>!*<$T2X)6 +6D ,6F ,H&[()S@$T42\2%(4A3
M;U'$ EOF'&:6+B- +?+"8NG#9%N9V*:D5[PD.^O7?@.5@+?E7NC^R'8."^+
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M8\<X]\R82#5CWD63&-6F2.XC2^YTO,YC$;"G&D6K3+Y?A",;%>A<C WEPA(
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M\JO5TR/)?(/!@]5JA/57UEYG")] >D#V"55"*Q>]!9 &R.\,=WN'.[NG -W
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M"W.BGG$;- Z.0P#/@7"ID%)1(T[ ^=>$4(1I$$Y+ZY)GT\QG-#;<AX2Y3EP
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M;T##:\ET=_YZ2#(5#GM$#KL&GQ8"@FZVRK\:A[59Z.?LM3:_?ARYP_<B6,]
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ML-KFY5T$I?3(*+!U+VUZN,2"1!:ELCRQZ"A/GEJ3/*8DF52C%AFC%KV^#*.
MU:."U?'4A:E,4QV41<EYC+A6%&E*/9(B,8N#42[)Q6KJ4V(XBQ+#66X7><K[
M&($+.!RIW]N_N0<"[LJP!Q\.ZM2V 8#1,CHE=ZQ,>LK:_:(E+KAVGWPI#.)1
M^Q?:;8<0NZ^+@KQ206Z<L^:-]2DZ;9 *6N>*1HD<]PIY1Z,#4\A:3F<RJ%PD
M4E#AE,::RY0[: M)C70B.9ST3=S RRJS+LC5_GL"V=X#L*V=XMK6VXT-P*[&
M^GI7YQ+#&/_I]?,*6D^F[<+CL8[C(0FO.0I&@VWEN$8Z\0 &5B!,A\"C5RMO
MY#G;:@1-MZOG6J)ZUJ(U%FEM16O<1?2GW"H0;4DX"+P)D8+6L!AE@4>14$F4
M#,Q2,Y/68,* %E)$>JTY^&R&<"<$]4Q&[HWW,[OA16LL+.M$8DTR"$P-8)V(
M&3+)>^2\P%Y2EAR[L,7EHVN-XIB7K)7E>K(0MA!VN9Y\QAD"8!\-8>SJ9VX]
MDF-MJ=<_LOUPFMI2)Q'T0Y-"L.P1N7+>]I3.VXIO=5L#V9\+JT3-F*0T@(&,
M ^(:&["-24#!,&FX(E;G_CB+$9$;.U1;W=._%2?I[CQ N**>)(L$]Q'Q) ("
MOU@B'Z+44@BB%/C7=$Y.4DFW*/!?X/^Q1'\J/F(C4SYG+ 1L*.)*!V0\H8@R
MH0R5@B2R,*&U2^&_[I23^[[\&KY.[5\QH-^QWRMJX8Z\08TAEDFP!6(2B+ND
MD(X*HR@]X0;V6#F?2]DT)?3/Q5,.(^]N_*Z3UD\U]-]?DOJBN3[+D*J_0.G^
MCZW69RR: ORK-KH_XV!8]X,JE5,+/L8S2PLKE5/+.,8SCHO.5#E5U2F+J *.
M[@XZ3;L[&W(KO S&2\C@Q4]^0G[R+-54EEB!F8U$$,)MH-8)0X@TQCL2H@GW
M4TT%QLNI[5*J%.[%K]M[=R[<)Y3622B'+/,!\2 ITL)J%+SC. 9BJ,8K;TI%
M58&N):BHDMK%:'F,FEM.E'6&*(ZE,LX[ZWB8:T55 :R' :RI0%2*'E-L#,+.
M<\0MEL@%^(VH")@5%:.PJ<MT3_'BI4(LRY,EJ+<T7N0">:(+HLBO[XIXH^[P
MRQ@Z68;8W'+&]X:]@X6+FS2QDG9M-U4OXJ^#?(G!.?=A"=BVU.3\_^Q]:4];
MR;;V7]E"KW2[I12GYB%]%(D.)(>^;=-)R(G@2U0CF'C@>@B!7_^NVMMFL('8
MQ("!W>?> /8>:ECK64.M8:$IKKA540<.W%4G_SQ;E\6%9*C0H(Y;AC@A'CG,
M/%+!LIB"D65.SB(^*!(Q"TI:Z4-N1RH<EH92YI,6Q.+D[NZ#JB/([IL:/)=@
MBPF!1*1 $HI39!2VB')GA9/"*>+7WI!9$^U"*-P==NK$S%H(U$+@0=A^)D)(
M6 R<CZP.%G$F*;(R @H(&U0@,A&YH!"@R9%DM%?,,,XP=MY1J50.*E:&>#6'
M.Z\6 H]$#4$)X[43R.O<KMIRA2PE"44;.%9.<T[L=6ZZQY0!/VF7^L (5;8E
MG*O/Y,^[*2[<NVV%.C-N#(MQLZ+*A<O(JR+K?*\*,"P+VP%B*-.1XH\6#+U[
M4'3CL#C(YNCPT Z+UJ#(-J?/+I1AKW!Q\9)$Y\9K9=["$__?(L>IREJ/#7%8
M>ZYM<I99S+%FTJ3D/5\X!^+:4FZ[O3_CY=SR+ZWA8:N[>Q+;WV/54>MJ:&QW
MU$&A-T3C%SUUO/N%QI)[9\V#KQYKBW'(==HB03P&@JPG#"08L=)8V!Q!0&?E
M,WA5C#NXK!?5BI=$V87-+X;EVA>=<O&+5D6)0*&=DLQ*VER$C!@/WA$F#$V)
M:RX-"%3EHY,14T[4/*?R-1G=)QF)QH>OQ*:DF$R(. ]DY!1&!N.()$[16*6I
MXODTW=Q(1AG(QK7/?'N4$RY/+I/5\!+>+09:)_#\&?";+J^6W77].,AHF3_S
MN0A_RD7X#\M0TJDFS]<V#E^J>"I)*)+(9< *U$O*K:<6N).R0)22(CJBODJ^
M=NFFQQ%2A*P717'/383_R3M;'B27Y]+_P-;UX[#5+]N__AF[,;6&@\W6P,.6
MC_HKTRNX^7;,BYUMW-AMX)TOH)*>?<8[FQ]((_/8[O;)WMFWDP:HHSN[WT2#
M-L0T+^X=??C1./L@0"4%]?(#;VY^/MGO;)/&T9]'.[L;IZ"."K@7P+R=FD?;
MXJO$5#(5,?(V),1-RF5BO$0B\D!=%%02.=TI&'.P-!+W)@7&01@X39DG7GH1
M%.$T3G<*_KBUN_VQ[!1>_//W1O-3L='<+/[9^;1;7/YFJ_EI>Z=977&7)KQW
M8Y]K.^_^?()7%\0*$1FCQ&F90/Q$RS4C(@>&&9^TO4@&>HBVV0F8+HRI_)\V
M\.H%I0]>+JDW3K\JZI0'T8(D,0[QI!PRWGID@X$=DY'C9*9)=Y6T__FS'$JH
MS>$XO6[9&1MD5):)Q_#H7BC);P"?_N;&4/C[N<!Z%-/M7:]?BNUAV=9VK ?&
MLJWMM09-V1(\L\2KLM]W-;,2\<MOCK.DOL#[8CS+F4E7G;]+7:"5NX7#(N51
M5'W LXD\ SJ/LSY7 W(>MN.W,>M"EDV<%VWXS>DZD^+&K^_:<%JM*W(_S;'G
M:V-=C[4>ZW,>ZWP<>WU F;@EGFR!V)'ZTB=_Z;U&<M9AHO4BU%?6+%9?^42I
MJ[YR]:^L">"%7UD3P N_LB: %WYE30 O_,J: %[XE34!O/ KKP9ZWG+V[F-W
M&/MP6WT\]:3<_?58Z[$^I;'^RO$4JX^GZDMOH0]=TT=]Z3QZ[\\??W'M6 4:
M*S4YX6;0:[="D<.&;BNX42E4#Y,$J.>JN+%;1F=5L>W%UN7HK(*15U?2D.9<
MO\?-ZIQKTM<70SJ?DYG>YV'O^$EO\N?U3^M%&24[CJ&N%J ,(YVC$L7/5^%&
MGGEV2]GL=5%>SLNK6=0+>3>:')-A;S"L?OMX'MY9+N\XVODF8GTQ>#0' 3VY
M[<\1O\N:\#R5BVX1V/E1SVIAZ1P+6Z]=390U43Z1M:N)\D&(\N4H%,]1H_BM
M-39KQKG$@]\7V=QY*VNL=+&B3['_O>5S]E/6J,M>5).\J"+:?A>,^S#JYR(1
M.26JRAO[I?I&=0FGQR[AM$!-.2JD$I@8H23GTCFO#%=62!ZPUR;=H1GI=$[J
MF/[> OFM?">Z.^:JCBL+_=G>V3W\UMS]? ;7X_W-#R>Y7,+^T8<?.YL')PWZ
M\:BQV8"Q[)U.5Q9JO/\L=MY_(,W=!F]N?OS6W-S@^YV_.LW-+;ZSN7&6JQ,U
MSF#>1W^E9JNJ*M3XA.G.IB>-#U^EY%XJJI'@2B.>*$::PMI2GC )SL(FIYL;
MT2U8!;PN,%>CTP.ADXG&.,&, U#BPA,GHH_.!,L,9\(OWKN@1J<'0*>S*73B
MC B:M$!)8(ZX2!09V$_$6' J8DVDES4ZU>BT$G-;1'?RU#*1))&&<1VX<SQ%
M'J44#,L@R+)UIQJ%%D$A,H5"UM$(>^,0[%9$W/J(M.<*">N3C8I)8^+:&UGC
M3XT_3P1_DO/!RH =EX93XRT11B><+(W.J3!/*=@:?^X-?]@4_@0BJ<(LH!BL
M02 F'#+<$\2H5TE)(3$&+4C7^%/CSQ/!'Q":7DJ:&">")\]-H@G,-!E%[E"
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M/H"'O&;>93'OM+\\-WC'223DE$^@-"N/=%EI01/-.? N9_$ZYUO-N\^"=Q_
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M+L>-I$BYM"9JMG $=<W"]\G"TWH&ARWRPG(4-,[-^D#/, 3T#*H"YP9KQ[
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M_0CF]MY)\\-70H0(+C*4&.6(VPBJ8[01-#)F<\-K80*;;J1"HHZ46DTT*(A
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M= R?D&:$P&\.&\N-P3)>YQVHW7_/AGD?-)V@SAA8(B]/9PQ@2Z+!'N& <\8
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M/N^\1+!BKXK_&]GRMVJ(7=L^/8M5=,_AZ: T@?,7K@5+=U#^":,]SJ<B&=/
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M%K-QB/9S]KU%:](X<(=<L D0Q,0,)!1:<[<@%;VF?"%/Z<("E1C:*//QYA^
M)@UBE7:BEK8 T^J.LIQ @C[#E F17DKM!3,-__XC"5$?8TJK$9>YR(]HK+9V
M(< @U)0UP1;2L86_R%?(K*$S=CF/JU$H>+.#%U1A5N""BGQ0(1T(T2P1MF_*
M@XJ7#&<0JDKA&BCY>05_0,I)Y1IEE\?AB(O DR)80KN$I?C"_".+PT^T.,F+
M74IV#2(7I(+:YACIH9R=>< UQ V)KFQ8 "B+AR&NGD; <QF1-U+Z;P(83\-
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MZ[^,S^-?S-_^^M?LZN,O]]>WW^S?_O##JS^&WZ_^^GWT^Q_>_6?SG\'53<?
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M./O96G93;<Y:Z^>A:BAU_\I/0ZE[IM1%'<@-3.;;+M=-VP4=B&%/7*<[T(/
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M9L"0 _')8_-(7!)? TN@7%$D[A;]"W.81?(P O">*<2<8L^A9!@#OQ?II1)
M2_M$J$< (6 VL4R['4XCE4T;"RR1= H;FK"9!BS,3Y UT2D1 25%"876XA<9
M_)X%,_HY"H$\?7PP3Z@EJN<CL&F&(Y%2.X0UIT)HI,EX;A+!H7(BYZBR'<%P
M8"!D=LPCG)3'%,._O7)&X%1Q&(0*YS)8GX1=-@6J(*X$5C%0.UC/VA3E6!@O
M,#%BM<A]Q3\G,,2(92CZQB L*J>HL)P2U0$ <*3J)$!;&Z;R")%N2C0A0'H
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M=%;MLHM: <8#<H7W+>V/J3\LRS(PT"K&DTIB@PC6%@G\TI<G*BN4&;+;EGY
MD)%"3V',6 ="9'IYBEJK,"VHE6P!=$)6ER52KU;,4\D!%;J3R"DM FE;RNM(
M>6UDW\#!?:] PYU5 (<'AG//+4==*LK<:Y'TADG],25P%,G:+>DL*J)70>#G
M>N6W:CI[]01:E83OQ<3VTANUE-Q> %G",$B*WMDYMKDG[$MY!>?!6*O&HL/
M%+@L8T$?/A=T9X/U%[HE0JROS5'<X565-6&7+27UH>NMK96<@Z@<4!\V6* O
M#CX"11*,6D\F7%?J-<RKME74=L$BYW?B$D]4-LE KP80MK7S""N #$<RL+F<
M"H]<,)HDKJ!&P=!<U-:_Q<E]Q/VA<-G+(AJ()\6Q5&@+C51Y1UTU<R41"U]Y
M:S'565JVA<51YC@72]V315ES+_G#"6?Q$K;.4%+X' Y-'7N!V&& 62 %PV1S
M'RNPRH_&S*_@016IA"D#KU+NJ6!32&:P+&!#I=DDW2?H<9@[-UP?C4X<*Z@<
M<8F$-&J!KC.9^%Y2LK!=TX*$)2ZMW(Y:8&6X*/R&;F,D?,\CUH[#5YBI&%>2
M\#+?K2'F/2UU?F ?/G7^O%)6!X?\,E?=HLFA?_+:;SC7KD /T<R6)A4W'+EJ
M-,P7%)$JG0H1VD8!HEI)4F06I_I@^9(3\P]N2'=.K9/'50#;A0Q@.WGK\8#A
M%=.BD!JE1F92DZ+B.IDJ1C-.8IZC8[2B D>A*$Q4%*D2ER8H\N#C)),Q7*6D
M7*K.Q+]+>9<*#1 3S(4>IOR0,F>UK/(EBC\0X>-?PMM+[M2#!3WN(73Y5WRW
M7.\&L"*5A %G&XK:(4O+HFODF?!:T]6)_$)X0\LOW)FX2"O\\$L80*YT4.,\
MK&15S6:CHD[;+!KFPHCWF8H0D*KW8Y_!R"(E#Y,KU;<$/3I*7 9GWJB:34QB
M0YH'9 2A<IG(6HJRW@">IGI'7!^$@"?TMJHK@CL?D;E1DH@""WTC*Z]IV0@K
MYQ':TZU!H?SA79M/\>8Q*VK%H/$A"CS"[N6ND8HDTH/IG(5^R*C\&RK!6"02
M+#URWI.54ZD$Y6+A'UJHGU0-M(QB1R,L:J="+4.\/*6",W>ACX"/*!54@6NU
ME"UDZWR=F16[=SGE>*\JZ*8*WZ@[W85J;BM(%L\<S]3#ZQ(T]RED:O$,6H\Q
M)N'Y6+&:ZDK$":]8!,%>732 =D['(.Y0".S:6QD4HJ5)%!%FWO/HCNL"+P46
M_4"'@V:E($.:3/)*"<!L$466*()64M[@R$._E3GKWW-R/B'.X742V1QD:_FJ
MRARI15C>,DFI%J$L=18(6ZRHBD8W5WS%"BA)^%YL@VY&1.U,]59!L%1H4"6Z
MR@MZBD\)LV]B@2O 3#RJ8JB3>\T'B#+!CA2&5NJTK2OD51>QOYD69G0Z:]4P
MJ1E8O8-5!U'N8'* E [A[4JH'6;I&#XO\S1JA2CSZ$)%W<OK2BHD[R':3S+^
MH_K'3WZ832(V^S&,:53ZZ"=1[%35I<<+NH4B\H1#XG%Y=]?NB/L[V9%)SBP?
MM^G10F%\\:SGM W'7ONXTS:JSU9T^E![B!.ZJZO'FQMOO]^V.^:FN]_B6==:
M/^=#7^YMK<\.U9??OP$?]C8#P"/-R1::-QRH$<QC[*ZS0@J]!'4--H&3"*)X
M&4CU-X+4+5F GX4%^)XLP!<%6^\XP?8;&$4"R= D%O\J?[L@W6\.C@UMO3[:
M4B'#EM%Z47!5&HIMTHQG;;_7+<<YBC,A?M=09@VUSY-&.W2B;G P>Z97:0TM
M#W52@#4/A/%;G,=1@50H@[OPR T@46_6,SA!UO,6 ^=%<DWV0_U)97L6N*>>
MVK5N;%JICO;C*0GX;1O>UGB,TX#/UL04T/^M[.SIU+\__1?9;.=8:6J;8SFU
M%LZKMECO)LQ&RS*M+?ON/D!?S]5T?&'*C9N.-SA72YPS>[7#N9>1E8_@\1/$
MVZ$T_@W/O/M?VUAOFRK(QR+3;ZJ]3R@5XUBE>_&FN=UAK>2Z]6--MK4M8WH
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M#V"J!(GO@ 6QV"0\45P0%SEW?BU40\%,ISW#T4UCLA%Q!, _=,()/D@:(G)
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M E%62%:$5; ,/'_-F^52NU>2B# I30!FR(J7,&HEERH&=Z?1-ZJ*ZP*H. G
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M.*:FPEU3X:YF&M%)'_QA*MQ)M7]YJ),";%,!KRX5\%X3EQJ<()>JE@<\@E*
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M6Y22^'*A>H69  V<.;P,@@DV4D%@Q<X0#=DW;%]\QX2D@HU&205MYQM+RU#
M$??A58;-EP%G[SG[%DL0LW@&^I#BETTSVR,)[QNTS=Y@U_"^3N]9PKLV;K9Z
M9([#C9K".L_3P':WDWKYM1[\_#?>OV&T36>S2,0COS ]TJBF)KRO">]K"*$)
M[VO"^^JG$9WTP3<-;)OPO;J M&E@6V]DJD<DW)-!TS2PW?*>NVE@6Z^ A*:!
M[</';/?;W:8_Z5X0^401Q&D0Y"@XW8F$7AE8#__5]:!INM<VW6N/NYGHMB&R
M]>LEVN#;,>';MN7PZX=O!],+CK)33K=I7=NTKFW2MA[88KWYM6,=?0Y-@W!'
MA7#;=GJL'\(UGH.F=6W3NG:?COHC[DSJM#M-9]*](/*)(DBWZ6U\%)SN1 QR
MLVE<VS2N;<RB8S.+C$YCB#<8]Z(W0\=?KZ<QQ+=B,?:K+I_RM*:PE9(8R_4F
MMJDW\L3FM%@.0U2R$'GPLC6::+QWET33L6AUD\/X/!>]1[VRH@>6-<!:&J+=
MCB^7D;4>ZPU9[<#6VKBM6[4;HN;S"'.D9QHV"Q3U8:)D& *.>+('*G:G>8F"
M+*^RZ5I_?=.UIGW::;=/JPL'?M8>R]V="E@];]]G;+2UINESTX!W9S1ZJ1[*
M]>[P_'!/\0:]=D:OY^SOO *YGEBV;@6$3KO<V,KCV94_@R:*!)0"4<;KM&G1
MUE(IS,.*]BX*\8 )2)7%X+RB!!3HLN'UJZXMN*^>TN5IO3',N9;7]M8MK\UR
M@+WUO'Z<(\]ATSK&O*E)]9RL></&RZ9QMM'TSXYXJ[G3A\NK\ZN+R_-/VL7U
MU;O+V\OKJUI4N7J06A9<<5N>[> YJ9Q&W+PZUZ?PSVGHJ\)J%VQ"Y=M S4ZF
M0*SK:W5MO,6CY8B_<LWE40B,B0KD>2P35@?] [NTWC$LP(=E+/$7H3^B"V>!
M1[6$2DDE\&;(9Y@HO.=)6*N*>S0V:!)AKN%B9*V\# ;)@EF+.!V#1QR5"F1!
M,8!)R^]Y=%<P/AS"Y3/@J2U:<U0<;K6M;$MS$Y"1PRAQB;.1*87-FW-5,D]T
M(E85^((DBJCXWX_:?9)2%4*U=FJ/VRK^)%$*\TU3=#L51?>8!Y,+#PS\G.6)
M]PUK@<INS0J @!0AG#F-!]M)@:=.8<S$!>10D 09, YSN0M@X+$73J3.CCV2
M8=H<6/9,>+- ;/C<S07\12OCU0#!ALB)%]+AD?J L*LT,'[5BL$UP"((L?LT
MR,&BI"1VE :!MZX$KR@!ZY-,7$<W).*-EMGM%%(>!JWJT_"TT[6J3^&3:R]/
M7%5.24YIOFH+Z%?LMXX< OE.#B.3+0+_Q=*]5!#7XVG.J-!GGN5,:%Q(&@A/
MP'7T,J?)=#A"I(]5A4LZKPJ1 KG= 8E$,SWFPR07Y )D&F= J:2, 8<B,KL/
M,PZ6]=0;S3T'OA)@(<R6X&P^1V:!5#H![8^%D302:&Y4"^5'#S&R*J- XD]#
MN922Y$5=T1K8R(:%OM<#"/[56(-=:R[PB+]@L55?7$^4UMHY]B6GXJ8[[]=H
MF\^ZX6?4T Y#S497G@N17A@'(';GM FLQ%N<"]TMO3$'O8)!/JE6>G5.,KZZ
MW:6!J\X-8"?$>36M6/&$A:+0=RB,M9Q]YYDJ1+_5E1F;@/W^'>PSY#<@!YQB
M*=4ESTU#DR]8C0^N^YK8 XA^I7Q%85&GN+4U+%O4$&$1B/WNRH4OOF9W-EKR
MSMALT\U90XG;ND2VQ !0[),I:C8I]S@(2W0.3-'50.>-!_T .M"+A S+!+T2
M?]^Q6?;?_Z=O&LY/TF=1%>]OS][=7)_]\*">AI3F=#4?!EIV9O;D@_4#P!IN
M1Q67#:P,YJ11%SPJHW B%.V8L[0H$2^KQ?\) X/JWM8N2^]<BT8J?37SXTUC
MH%,L05[".:MX!<L^!:@ZQ%,OXJ$'AP/\@6Y_24%0QDE+W+"/D.EH41(/N33U
M0+6@$N%X5C,8HBVD)1V3X'$P'6@6,\&'>X,]LN$"%[KV9KAP62R&SBR)]9%J
MQF&8SF,'.;\"HV,]>O(+5V7E0950B?!RCBJICSD*"%F@79B,JF ZSLM!0<RY
M##  S 4+UQ=J+)X@UH&BNO<D!J<I5:4'JQPKO6N[4R@8B2O(TUPM9X1P4VH2
MOF@YFYW+P97. [)/Y U\/(F2&1Q.<=!DR)&;(N9!B TB0N4:F3\+PUG&_3U0
ME&EL)FN!M85"Q8HP-*?$=0:&2\GP[E@:$B()%P2ZM_'&L/!!5.)TWA@5;4!,
M,[_0-V9'QOC-OV4NL$9<LKBZF I'.>VPPG99/,>4\?T[Y@G8%^#>AT'TTBBU
M#WHZ@'5.5FKH3M%@7M!L2XR <T/VY@-58,,.21_:)&+BXHI\=EL1 :*D5'5A
M8!;':"47:Q%F,N E"E5$;S+'Y?4,SJ/"JY R@%+&U*9'. R4UHP"<IK1+["K
M/T0#H":.JQK'-6CBN&JQE@/$<1T(Y>;,6#9&E6K>$Z;]*D):O%RU!1+,:<GJ
M-C9C3OXT55<%*4?%$&".P$,F]"IMUKIZ^GX1&CI9"]F>O'S/>I=YFGZ%PE\V
ME><1%N>QZ-TS.D]0@A=N4^*-ID4=V1E4]=1%#5E0ME!*M[.^YC5QJU3$<:^D
M!8B5DH91WAGBV^=@>S'M[R&8D/[A7?D'=4KAH0GC(L2K$W0-Y[,6\6+1@A-O
M2$10K+ [G#UYB-\XW8WP @R_3"B]V.3-EWBVM.25*T:%="DPAYH'PLLH>D!P
M ?0D5CS@WY$1@+1I>$0&)DS^ ?:"#5&_M4"VPXDQ/R%$5DU BGZ',%LR!8W7
M%_ZA>RXNK5Q>(9LWCCFGOP?3E 0MK=&GU<%Y3U'N"A&)K? \7$DE1E%N96X;
M+OE2<"PVH7:)V=JU_P,[X-&*E4C'Y>8)7L>ONI8O4$#$*HGXQ&)OB]9)IS-G
MD+:U&W2X2\B7YXKWC_@Y!XH)474"8%"_OF F&W^&8W>:9G1M5YK)91X+3A\G
M.4 0 Q)@I&]Q<A]K4W@M4MW^Y+&#59Y-7?1SRL L:B+*<][6#N]N.4QDSX9B
M_X.XQ7_=8O^@:N62Y ^*(ZF(X)V2S-;=D2U)_953"E_SPQ</!7\_3M@_4:7O
MUXBR;]&U-P5I=4.A5%_+4*H]G<T3M:.#GC/ZN@!/C4J$&8K:8<K&&IOFHR2%
MP42[Z.(YH/9T(ERPJCR0JR*7A:S#P#-L1TT 9R( C\@LGOT/6,!AYF&HC?1M
MXV52#.I ^!UID*=C(#EZZ#,44^]*>WEK7QX*^G)CONRSBT$^OF8/!BV K9:-
MF!+T596-AF@/.J7:77W1M@O^@6%#&>H2(*(Q&I"<*+!4D+P*@+2=MG:^_DJ)
M5!*\$A<N >(WU8\1VI43$N!?4#^L7AG\M>H<U,+XN@-O:]>Q]IGRQ8IE/? Z
M,5)U7A*XI5=C>0MDQ5B#>9\]:"IX&GMR?!PU)99J]:"U5K/&4W43EI* \0%T
MY*0BU"%TP"P.)E!UU9&]Q0,Z(QI9?GKV@^;S#*##_7E7&"!S/,2[7T1"T,(Y
MQJZ!]BI.'I8AS @DA&F4%_>/899-E1M\$05+;E!<>J%90V9'<2TDEI6)B_,U
MBZX)EWIHA7[",]+7931>=2(1X2Q^AG,#/A(&8-?$T[$KW(*2ZS!J-D[*?C;-
MZ.Z!#DEP03@.7&YA0[*<6FCCM?##2T,0<,*N9(GT*0X[RI)%&H=A(B80<CTK
MJ0,]UTH+>:?BM0]N=1W0'?,464[<D,+6YN/?2:YTVJ9).=(%41,'1%'=JTAJ
M' O?-3IKWK76275YRU>RARKS(,'Y@;MIN7Q<KR"C-1S;YUY$5@=3(3WHP9&;
M6MB37& PS[$PPV%> ^@Y\\*UXBYP)>S@U_-)&D9RE3T)9.1"F#Z!$XV2"+@T
MP37%NR&_X(U1(OAJD:HP/YHM!A,<)T?I,!1,9"RB2!**9]:"*;I6*@>(F\NF
M[A_RBL7G5?9* Y!D8Q&&*ZT&Y^&=G+5B-A<D"8;H/KK [ )?)F=H7T2DQ1XV
M^9IX4,EZWO3FG+I>"6=O#LY%1$O%3X\S,F^$*5+DV$-R*'(-<NZ-8DPHPN$Y
M$'C,5^;9+#CZ,?-,*E]_#Y/,"U&8 SL2L8+5U<H5M4 '+W>0R=PE9$.H8V!,
M)(79XMZ0RRXD9^U,9GM#G'J1F<@_^R \YJ%4TVY '<WU6^!AVCON;D-K1^GK
M.62RE=19Q08,"ZG5& CW/N6W49X;!J')3$$V!((7=SU(4 R#7\%( $(J<[;"
M&/:8RWL1DJ M(HZQU+F+R$9*,=3>&)HR*P+0%72Z()C&&?>F.+^<N+A4$=<C
M*)&%Y5OHW=4]F+8*D!.I.[ J%(E:E+#B?B84N0+P QO"KH9HB E!6[%\NJ7[
MHBTFN)826S,%;S-60"N>FQFXT'0\$;)8@:^%9A8:=R2PA9I![&UQ*0PSE2@\
M!*'E)FE*J9$50S#E=TET1]<]"Z"B8F!%J"S,TX1*57#?[C2A4K58R^L)E7IC
MM*WNG">E53C]'J'\*D.I,# 1R1" J342)"Y\AVAPK+A-W<1_&B<EEYE/\:CX
MGA88#>YA_KORW=4+IZ P"A<(Q?U1%)*CBZ2*L!/O. B4O'*!O#"IO[T:NKN1
M8[9/TJ=R@=ZKE*3V%P9*ZO:JUA.M&/-Y(]<>W/PO(G 0;()?VC=MX<D3L)@@
M+)0GKC7G;407(KIEN2SU!'I(H:NTP/Q'S954#?AZ#"]B:DJ<Y&5>8DGGE7H"
M@N+1PPDDS+][G.K9+#(+01U",[$&CNXS7 _&>@B2.A=.2U%T%*>CG.SJZK%H
M 3H,,$L&V 093B6?J50[D 0<D@&V3K^0VI-D5ZI6!,=(C,)<*Q0JN8QY$ O(
M5)@,;$+Z.LIEE;Q$.5VE'U?P&X1[RLFX%,Y57?V^G*$N/"LPC$=907-.]FS]
M1$42EBK:!E)L@H*,O.6@^B#T=S6+B]6^Z5;R@:2?F$QFRRRB\HB'/U!?RS3,
MKCEX1J))@GECYQ"$NQ*6AP1*(3RKDA.3?ZQ^>:&X)$D?Y3SRV@0]G&)Z]#+<
M 0(.N4JO**J0$#+"G':[YZC"5XVX6RP^E,3#G?P*S^3#._1UJ3!DC6ZKO!]8
M,/M+JWE;RU_%VBU:^[T%K10+/[,9YMRF[+XR7VGGDXCCA:M<K;>[F3Z[/.&C
MZNV2JV#V$"4ND6"W;7<*$MPY0N9(''Z/I61BPA= "J0HC]%&\$8LQ@JD*LQ6
MZ4 MI<E0.:@*1+.5U9;HC#*E5YP/PX@<PI7CS'@<)NF\[K5K*#N%IE7'P]Q'
MGGEIZ(H@-V3EYX(C?^6@&5!2VX<$T,CHZ/];F#!!F*&#FCQ<8OJ:5A>J%=<6
MA3/6;D5V6="Q.\B/5F^^S\*IWL%<R^@+I:X+%X&XS4-*@E%EG;*B&JU*(Z;"
M.V^,A3 B4H7?&%:9BD&>!<3E9T'Q(FJ_W(.(N"EN>Q@E._-\1D$<*@N_4BON
M\I9^QJ6H)@)2V&#2V2*$5.H9(P"I*'D<D:!4C#\/)LN:!Q/+Q*O2",S*RJ\2
M@*V.O?Q)#>$H'$_W9-L ^.ZD6;,20#"(!.Q"?L%<I6.9E4MUD.>LH1B3>7%P
MC,BOWGZ3C!;&=!ETE-+5.>D8F/8P)A$@XXWFBNBI1:M:A".LXR %0M%, F.+
M,@4DJC:V<J:Y0@]"8*$Q/L,"K"BX1.$/&;Y#MXA*&P*K$<Q'S M0()J*,*ID
MHL(./;0N(XJ'\$;<G\KL?>8C3UG>ETC&2 2F%($"HHP%B$O$CT2B"""-W(7+
M$=HBK(BVFTKW&HA<$8)626(HA'!1Y&)_"*GRJ:J5TJK(*24QK)W*2E;D,6F2
MY1PB$.)7KDY#;J/@;7$2ZP*RY"08@A2'W7%.9>$J,ZX7IEL+CE,((!+"% N?
M"#=5)7M7%F"AQ/_UD42K3UW>@FM8\*(WQ_\6XX JG*E<15E9J[H@=0V?*3\2
M<(PW@P7!51T0PSQE- ",I*ZDGK*Q^=43/B)[G<9,IATQSYNF(GIH@NXQ3[8#
MF%MV$4$$DB6"PZ)X0U@WR9FV]H_D'GD9*+XY1A2@^$EP G3E99E(<!J)$"(L
MKIA,(Y_"& &],-81+Q$K:C52WS3&P"-XC',A+(KR)Y+^5A1SE<EO/)01JUQ<
ML!:AQWAA!"JZL'$P=#5G11E&1I.P*;H',Y[G$?&R!PVTA4CG-X:Q$'N%LO(!
M9!7'7A@2Y$BAZH^RW#HB@+05A"$:BBU2(BKL)(IDU=8[N5L!$N)(R(!6,(ZF
M>]"ZJU1C_56JOT7E<+NH'-Y<P)["!>QA*KQ?WK[_K('N\*]?SJ]N+V_/;R__
M_5X[OWJ'/WQ2?[^[O+GX='WSR]?W-]KYWZ]_N=4^GW_]W_>WVM?+F_]=0_E'
M%E9T4.^B%)0@0A(9? **)+P0ETT+^'<AM83C+ VS;RB>4,:)ZRM2RJG0X%P9
M;M1AT66$,I\>RT#[E84UBW1OO##F<:+"\,-B'92.*$4>D\HIZ!%((JBZJL5*
M"P2UZ- /T: 2=]B@T ^YBL@5$7]1<I\];3)4^H=R[P@V&!<-#;KXFQ?:U&'D
MCHF8Q6DJX(U+$?>(R_#-5"D].&'@K&1HP$I(>H!UD7']'HT8,$+"3!8EH[Y$
M? C+RL.(TD0P+?Q.%&N:=_ZF4WE(I94N[2 \!]C*/<8=*]M ),0(""K%;066
MB!UE96P W6**8M+4)(,29H8LE'68(U":5"?#!-4S%7LN.-X,WUX8=>EC^45E
MH\6B:<'2MAT3#N M(>5YB*U(='-9)*X5%U!A:8?4GJ14<B3H85P_(2M49LX7
ME?/I1W&32TJO.)5'#X4L.=1EI[+.%FR'3JB\PKQ-I-Y'\%6%"(0_@2Q4FA#4
M*N',C\"HQ<("8#/*TMD!70A7(FQ5>\G%75.QH'L!.L(]<>&@WBI0MX1ZF3I%
MBB-@LUC@BK:2I&W++BGBVCDKKJ K!<)?9:V@PR?+5KKIJ!X69,RO8H05AIIA
M>7?RI5'G'BJD&J:B+>A,@]]\1$45-5[<&>@J]$$]$L4-E0R1MHVPUI8HLS*]
M&%"["SF54+Y+D(CH:DC%-A1X2"7ER\LT@=FT_ ?0FPF_77FKP-SDCHM #634
MPJFBYD#T!^MJ+GFE:Q4-CW"QW4K_(^4]$SV/,&:L[!X"FR+;R4^BB*79+F%5
ME0RC>6L9@RT2\M)%<QV,>!!PV<%(VJVK.7]%?E7[;R GQ/*Y(EM2'0 P.AX/
M\Y'ZN[*K%B4?EIY=!0EW5O:%K#1:V_*VB'BUQR)BK((]E2V:2JXD-9I'MHEK
M8NA@5H<@?6B/?0:C2ZA6#I :PM$&<"F< 0K*5*EYK)556?*DK/J(:P@]$18D
MWZ$FO.2 I+=%F8:G="MIV.CNRK4LDBF2E3EY/>[$136+9EF8B:AS2B#31K,)
M*IW4;D<SY&UXP2M\K*K)"T2MDN("CDE7B])_*LQ+QK"N5+ 66-HCM_:$>VH/
M>*/E">>>]'_!0N=V(_MW5&0_><=00R*_,2L=QHKIQ,H_[6,;/M)&LR0*?=%+
M::GS3$NR&7$)4>FRA-ZP(@\)I4S*1W@0=URY,Y.T(D%>I[9QT#JX*%!)+Z]8
MH?/1&J1&5JI^C<,,\ 78I,O!SA)NW/(3V;E1Y++-%"9AH$B&X8\BL[V,61!U
MD&6]YE3=8Q6C464-NE82]S"(*JWEKD5E9YE*<&FEQ%EY1T(W:7[%DJ"6.XOR
M/5D2060FJ^4OQ%X4EU$$G<5F.2JOE4(LRT@@#.,\> C#:7/HA6,2SF64^LDB
M(PY8F (:1M.BCEJ)IX0A&S#DY>7S)>:\M EMB_4+KBWU.1%6'(X+SJU,.7GM
MN69#\Y1-.]O2@[^IF]HYJX>/TVYC#\O;K]>?;LB_^>7K]<7[=^C2/ D'9IV*
MV[U'A"O,Q7=AAJG\Z&=#+WB:1()/?\' <A^UGB9G]9G3-H@M32<8@)(I_V+A
M(*0NNO^_O2]M;N/(LOTK%7X=T_9$D>8BR9(5,Q$T1=OL9UEZHFS/?"P ":!:
MA2IT+:30O_[EW3)OU@(NH@2(Q$1,M$4 M>1R\R[GGJ/C>Z;&M#$>-5^&@I.G
M\]1,H[./9MQ@8NS-=)J.0:L)%$KQLY^=6\B?,;P4Q-II93";"SF9H R#[ YT
MYXE?+F.]7)9NN5!B@U-L+/E[ 4TEE,0^$S_\A(+*PQ?'3YB)2'_TS7?1NR8S
MT@B;[!T^_7;T'?TSJ>A_.>Y3>CA,MP<-5^[NJ6"6]J.?O =@K;QQ^R"^Z]#1
ML-F!X+YYY=K?9*!*-<C@?]BC20+>!,X.E ZHN3D?JO.+)G/,.U!(:'(YMHK[
M7A.B)&:C9,P$("=(<87^$4H>C'&QPN#.DI)@JI 7<E.O!H!/NXNST\W#0;?)
M$I_ZC-$YG/B0+V0C3+5\/R\$9[*CO+/&GQGB+5 SE<XCQEZ>H+&>(!]CES)!
M.FDE&:IU"4?6T((Z&#N)D!-$LP#M8%"<P**% ])DZ0?8@;CE6S^(;_>H/:'-
MS;?8K3?FHT23'-T+FN3X8(<FV:%)/CG2>GOR[GUT?AZA].'1R^C-^U_/WD7G
MO__\YMWKD_?G;W[?\ECKIKOE>$N"VL/]Z+>S7TY^HVCV[-7Y[[\\C'!V\[G0
M-(=.;JKY9<E5U:2H:9TEZ0(A&Z@S,$N\HC4W2A-WJ?./XVC44+,ZHD#1DZ:F
MK2PS5*WR,A&^MS5&]"N ^NT)'-OC_3(MBUPX<@"F@SRFS.]?U]BD0-#-!( I
M4I8KP'$&DM=N0X$@WQ/R1O@J$:H12(1P912@8F0R8!-C&8ABY*3U^C"X]D;6
MY:"$74]N2L/UXZ&J@LN=#I05[EXSN,:?N*D9>+8M9N"$^980D!?]?'+Z_LV[
MAV$(OH2606=D?WABG_LGZ29!EC6"=:7CZ!U PV[FN!Y\'HWUPVN#P?ZE\OXS
MTQ#<\G$@;_#FS_-7>X<O(OM $[.PHXM2OY0"A[8QM!=(/9Q/G&@-]5@!.2C!
M],"@"B+.9%S:Y&R2MS']%@21=GT&!T'NU$N-YO:CH.C$R#IM1M]' 5]L<NYL
M .MX1U3\]IZ- $F:9=;T9WH0J6*(O5P%STF;3'+9C#*87GNHV7^-X8@*@(]F
MF>("X*.4EX,',LE*(9@,/T)EAYK:V-Q"FB>\6  K)PL&@9,V_HT1<,<%%D&=
M4/ =U*H12HKP0>F,<UV/*XC:T[S:OY;8X[/S:+P&H!8J)I?$SJ<S<G_DZ&M<
MU(1W 1$>V!?V3PN4IS!^:/]%S6#V^C&]5#4W&8#!;%R'/7+\9^L(3,U5#*#
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MLF6]2R@AC:O+(M?'O=\'?\W3#*KHE4-T^K6*N=#2V,,]IR5U590?Z)BWZ[3
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M*!?(E@.Q$Y._@SNRGDNXX=RUD:&0UQA]@@D,!U;W&VLEAQD[GSYJX/O$&!#
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M_LN=".L,A@C#"I<[F8FV^&4W88(RHHWSQH5! ]-"[5A(RHK%*(-"Q:=E3!^
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M!'4G_/DP;-@UWD]/*3ATQV(JF@*G!?*(6S\)W!Z8]I,Q(R?^V/^_^]9S2T?
M'XY_]7-#,0/>RZZ.>3I*N7! 5].2KX$[4J!23I*AQQQZZAUDI.?;[2.!?0-7
MPATGKW)"5>A3SD(I$ MW__4-S7YTX4Y[[I>3E)%K@@.*L8I??U'DD* /TZW*
M ^ NY#A@70'TO+!1<]X)J;"Q\F/?(/0B]J,_TT(&PAW5:P[AH//)"#B7-U3L
MXV8WH'$8-[6[WZ"8(BXK?Z9@#^B\=@AUBAS;V!& ID@QO)' %=PO;#VRSAHW
ML&OUT9K:)Q506<DP4"FK7TJDI6HB::P./@WJXTS4<-73G!H("J(-G&!#$FE0
M4RQLPRZ17=99D^$I$W$CUHS+"\ !-"7^%!?>@-R$DUB>&9)>9B6I2UPJ3'#T
MJ?J9#\%B4B-O8$MD@LS'6 A<5'^;JT#4I)N"<!HO_@3[))^ALXY]5/99726Q
MU5<SG'_K29NW'K(H*2Y:F,D*R3$N>VQ 8+=.4(.3>FVM86PZ-X&@UCX&^"6*
M=[IK/G!G>AN"81)4'23$5'N'GQ3S^?QDX:<^QT/Y0%(Y7X@77C'=@W&UX8X5
M4A9@G)0E*L"%TF@!N$0G=T:L>:256P*V%7YWXIRRX0#+\?@_^\HN)3GAZ V&
MU'-CM;)@OC5.WU4**]!3%U/R9B8)4*ZC!P\IX%C))-GPV$SL/"$[EIQ_?0LA
MZ M3'$7M928'!D*]!OK#8\KJ\HI:%!/ HK4?4X\*Q?#!6NX$?947G_?03H6A
M6BL<W4-4Q-^B2\O=X@$<,ES7-W%NEY+E9C/*@>>O??:2.?@*&USF'>VL)C-<
M[:7]0G6E?)*4=K6.[(I!96+1Z@C5N2[<%]\$"5A%5^47DV?N=U+%VI7]^=4)
M*8ZA<]'>K9!"XS0T/7);RE$J>)GK^8P2QR(0[IS0IS =::4M6$E;5A+[JY-0
M1Z@E4A>&$\PSR24CJC>)SR[QC<H]RDH@[U+13>BY[Q3+.J'JLJEYY=T54+05
MZ)1-HJE]'^4:\I)P#?3.?.S#NE> =ZXE$?ZK+R?]VM@'CB[XLEPCP#P=96)?
M _H*;O8?R6+YDO^93MPO;KNZVH6C&[ULMXU[=/W;W_[)HJZ32QX>]-I#JEMU
M2/;4'_:D4]E7.F*"\5IKB,Z7IJRA<(<2PTHK', ,"2C ]@CKVGLN"AJW_L;4
M+@=#:YG8\'AIV#%T7H^/Z/6H^ ('H#+0OF-\[EQ I<SGGH$A=KZ@*D>"MB$R
M-WP >7=Z@/D=[UL:RNY;,S<A)@SF,<V8: #N1!_1O5PYW0Z@Z2<FNZ*VDR@S
M-:SWEPXI183<F+>G9 14;*$0U?BPUPNZ,4!$X.$1UB\HZ=-)0L22F4OS?WHI
M0URIP_7XEUT%)NWBOZ2Z!#@+384LMB[R@=Q0-6]J[+SWJQ;QY;YS0A@Q7#RA
M##*Y>^I>_AXDGW99C(.0AK2AJ+6'%(AU'V\H*E*,8',J"-,$%\<X,TG)69R2
MI#(O$XIY9/_"U^W?2!B@,NF_,86 #\3Q4<N>X#L6OCZKIL\1@J@8J<.JS/$
M''_PB([$M&U(5L*<Q">CW1J8NAOB0<+Y%[Q?"!*S[@\=F54 Z.OB>$-^Y"YR
M?QUX-S 8BCM>O9?)+].RH#"7D-(8Q@= 7A_.=P(-;<F%?#&!M$',M6^\J/5S
MRUJ2/Q0HM6N8<?0AAW7,3JK]H7WX/].Z+*)7:3++[3BEXZ!<#E_#:OG!2_CV
MGZ]4[9RP7Y0"K2):X3B?RO"(#*R/0H44@+STZ!+O/G%W=\B-LP8:@^S)^D>>
M*BJK^_4GCF[D3T2?Y^:W21NU(UFPYJTL4-IB($#HB\9)C.W%4T+4Z"4A1ZMN
ML;=36N\)GKXI+TV:99@)] <S5?_AN7AAA!,/*8^%T<A?6)Y,,OK:'BI'!T='
M=C&W.=G8?U!7:JL:]Q">NC7S1W@4IT[-W3XQP[U\&FB&/'@TGAP_V@OH>W^!
MV.E1%I*?[PK)6_$L&Q>0V++,P 6<RGWY614 > 2+HAC1IEG20$'B$> T'^W9
M:B_$Y;5/2A)\>KO:PXCT^R<,?34*)(ER"2GI<2*13CL%#F<7/7#9>FZ0;Q_0
M!06EZ@45'"M,4QS2&,&M(%)Q3:XA4TZ0V=<UXC/O$-KS6$$!3\@#_E9\KK<G
MXF\IY-5[7$H7;BFYRK+ #Y'4VWF?E/;$:*$.I4;IDKH*3:?ZVAMT@_O^V! Q
M_*:J6W%X,)Q=8BAHX)2I"*Y!W$(RF'ZZV,.T)[NB2YYC3J:#^76H1HX&!0!2
MUL%];S (@BT0[ G3*K>9"5?NHN*B6&\6GO\"0,[LFX#S3LTA!A;096JN_'*Q
M*X"X]^VM?$-%_YLMLP0P[[@N\8<05N>X!M3K*1M$]4+(3KMR<:Z9#QD JC,H
MT,8AJ93^/8%L6JUMD8R*QG6QNZDCITO7HYT*S% B YQ<2,7[E(=2Z*EZW4>6
MD0D3[.U6(?VT,?,0[@$#@2Q2\2G#9PD'R)!$:S@680&K!F#HVGZ"/GR$_3W@
M(,7D((:C M,'[(-4VB2DBW2]^X<@$&U_$3 "=9.L19E)W9ZH:*16"MJR$;;4
MUE2;5+"0786AIX#E2?* :P&+>JT^%[T&51U<@!6D6=H##'I$O258I"X1YBVU
M?=E3 DCF]5X*CLD^-/V#$KQVG/'$#=M+8L*)L0_&&3$_!P[^GB)T<"F<JB[/
MC= L1Z(RU.T")K(A:]&/DI(^0H03(?*8,H^:L)B>0K7<)1,D)^?0E3%5CK V
M"*F[R(Y.@PBSV,J=N2NO9SEV,5W=C*<3+T-+AF_72<6B+.:"._&9T<%QT13E
MU!#Q#:5:@7PC#A*F4P?ATTE1Z!$DH+^I*C;$ZE>X1KCNT;_3\'P8?',D%."G
M!F(DSWY%-YD(NXWZ-=1X$1B53COP$6[L1YR^W2C^1KV0@A9J;+P!F, 6VUE=
M+U5C/"G"9'%O^[$0=V&A'#PN5 )8LK(69(E&*UVP4? WAKLI9B&,#('PYYI)
M>4! C;^,YYB@WN\>S&!/ WG(+BJ)1V*=(($F;O* <A'))I(!6BS2FF.IF\T%
MSUP5?5N4+:[^*T=.AS:0?H"V\CM&VN)&$QPCGB+<PP85*8=I;K>BH:4G0T ]
M2WV(8XTW'A&2.::6]SCZD(X_C)(Q<X-/[7?L,&=)ND!/#PV=+E]ZWVXI4&E"
M=-D]5%>.:@&!P@K5K'L<_2^I>\F:+HPE[.: OC^@N^8PB;H@N>/1E^1L^&>@
MU0L#2A?7J39%+)/XU(FJJ]\![TUQCRBG %J;AY![HR30#1L:/3&_N,O<W"1(
M6CII<;"P<(1!!8=U'U@:CZS#=7/JRA[+IEQ*R<Q5ZK#&)O_HB/IPR8^@>];T
MP* Y3@+JCN.H\9*8JDHDZIF$<';&NW.['\8*$S,KC5%5./<Z4F^#4F&6F9E/
M6HF0B:O%8>=#"Z="T\'N#Z,].Z785H6W-QHF]ZUO\N(@J8,,/_,B@^0%S'B3
MN@=T=4"*7+"FV_5&:,'60%]!H6J^Y_X0-GQHOH2A7O;,L<3XEX3 =6HZ8 TL
M#_H%@Z&!,1_@NO ^< OASH#V6V;^H:JM!MX&EM"OXC3GHMR5L#M0:999,<G:
M>5P:*N )F8E3=43X&4+!N5%4/E)(.G+;X(04E0 NJ(;@8%P^?;_B<27Q1GR^
M?IZE84'48/'U'>[;D1K=,H<IS#O"@9PX5QPMW3*II+V"I*04]%(<3[W1]3Y3
M'(*/*48]98 4$UFFY%K@2E8TE< %B>#@C"(63$;#:4G#S%@%F@@,7D;6D0+@
M33A+^__Q?PZ?';P,^D/@4HYLT1!06>9BU8XE/4Y$W])NP(I3Z83Q\"^C2354
MC.MOD HH=0WA(W$&%<!JDTVMFV<F\B+G+BM-J2P9N@0.*VY>H,M2/I1D(&OF
MUM1BHVK\]0@X 2"!-JG1#*KCSHH21%?L:'LB,4MK0[,T(XI,*??\^C:V+S/>
MCZ-?S17@H?;> K]$.8G.4%O1GF8F^A;"= .5H_:73JG/^CO<?!<IV+"*489V
MQ<&K^M_^:5T3N\X)29A%%^0_T^V_DX%UY/LTO+=<G75K -@KF<C!#78B9CA1
M^ZMPOZN4Z(0PKFVHKZH"KH2)2SA,J*T!YI;3G3R1] ON_:\9W6 "RQ60V:(,
M< D1GQ"(JJ5M3[MYFAG9)TA>?)50@@'<*W?4K&- 13_,RWZO,:+ EYRO^O81
M*="-W5/[744MJ!.BOFD]#6ZO:V[H?T1\J2EL@(:9M8 YL>6$4/DK-ZKZ5;?X
MJ-6V<OM"[4V922XG";K*#U$X=WIH8;V$[[-($#OH+%N[:43D^_15KM/,NR4L
M^E&",%[L0!A;\2P;!V$\U"I,3Y]'>(CTI>1)#4Z3 G14F51@J#AD Z(1=93D
MS%F^!56R37.$D>>&.-P4Z\AC-/]M,3\[J"8IQ_,.LI]+SD828YZXOK_^PH6=
M-=QB&IBK>&7P$3LE]OXN_4#7P1WJB._M<9?[C\"64\K)*"C7J)]Y'UPB+M4F
M[KJLD:<95BT21Q$H5X7@W7M?^]J<QK7G&V88D+&((/R>O2C(XW2(7)V_E:GV
MI4K'_6%0Z9R?_<B[L>QX$DD!R:9"GS$5=<99"EZ0=)@Z?BCP;WBCDF>(/W10
M9=4::#27P\3.'D*ABW8O?SAV_=T>0^J&B^2#I_\4^D2'>O! 5!CM<%<,+7Q,
MY;18GH'662[>YG'NH<$7[+[P'ZF\O'V41HCMO41"&::+KJDWWG*MW8A+ O-Y
ML4KF^6D(JZ.71AQ1CD(<T80._#I$+T'M<("2HL4BX_-12$*S0&4CAIRPE]IJ
MG(^Y&;D)'=ME4U9-DDM#JV!CBE*/2%NO-6P)['89>W7"3FWQ2]>JMLQ%>!_(
M;")M*11:?,H44RM3V(2>9[Y7OJ3%%,J C] KD/0W13/0Y ,7=50,4+\RPL,B
M%65HHV$3X  ZKA?D,;L4/Z/2"C,_P_^BSLKP;&H>F)[6)M<IR=-MUDVV]0/M
M@Y#Y3>R67[&F9 T6GJHIQ+A8+0ONY,(T$57Q2"L2A6,A>X__FU1I)5IHU1*$
MG7"-N!7CR0=!8HFKG:*STO>$;L\/BY!.B+R:K+\6PX2QL79ZGGM]3OA2DWOQ
M *XJ=N^KGMF[R1,OSZ+X).%SD*MT<IU>9;I7K^6$IW/PWC)UC-Z .VO""(RV
M";R6R+"@867S?FE<ZQUF'ZG+E$5F8,*=0W-ICSP,Q A "Z2H]@!' F]3+BHM
MG#4.W(^&22:Y=37$!G(:[=J)BZ4,W9N0UWSAQ%/&%"X@B^Q!S\DL :8GTCM2
M/K9NSQ)?9<UVV8_>-$-+T"F0:V>PJ0P)JJ(V4\GB1 CB-"7.+YZ,N9D5=9KP
MQSPM<7M3);=9$9@%:[V2AP.@TR8%,30D>V!(5H/+?*SXJSW!.^-HE6B3?).<
M,<T:'ZPD=+9:+=JH4IASBC 1#J QTOT$ K+8C'I9E'U+\,N78K;^C'<FOAA:
MNX'@'9_E6O(&-E*YXFYBDT\&Q FH#U-@MWQH/*+2V!NOHNR4[$!L#.0&<4;$
MG89QA\9%*,#[DR= UOCS"$ 2"*: _< R/UH$"H]EV<J2"UAWCNO[\/$*AGNY
MDH^1TAMP-@P408;ORHQ+5(-7_#":!1L.4X6LQ*2#<_I00FWFY [LX53! 0+2
M=^WQ$%\CD"N3#M_!%<P_"\2#1*3,KV,'WO3KO*WI,*2A^JB=3V0H8F%Q6C%J
MP?@U DLF:#25Q@6* G6.),N**];<U&I+Z,3. 97#+JE=T%DZ04?-[BU[3^_-
M=E<NGOQN[;;*0 ._Z:SV=5XFWT9>1%" 326R\F$E1VF&32[MGR!,?LS+2'2_
MN-)=K3E*F-Y3<J3AR;+>N*FCK)V1 R^!O0^F N7JK F=:6Q&4L<HN7V#EL1C
M:@DIS<X1WR*XLG^9&Q@S:^/''\AK9^<&EC1UPJ3EN%FXWDI^W_&\*,A5Q.4)
MR14CMZ,78V8^=([IL4ILR$H@"0@9EGK0NY5:*17!6T*3 $SOTD,$6YMLQ661
M3CJ#3?$!'118RKUV:"!YL!)/'GX(H#:5NN [ZY.4N8367%286K2V+,^5?=N%
MS'63>S\6PU92Y'!-2IYU51\MF Y-[5%F8U]#8ZB'AT1]T \.A/WZBB\9)"^Y
M(00RDI0SAE _=KB6X1%,*W'2<1?B1%9*7!1M,[VP N^C@;.&KF$%PF1@H6R!
M@=LRA[RG+B=B%N.B7!8(?R64)'%. +0 ^80@.3*VDPV+@D1:@QQLJXK'1!$J
MH^VA"E3((W*A=9UL7_\!TQIJ+ V@&]<(@%P/'!!D-=E,&I9U[3-4[T!*FFRZ
MITH@6K:F@XJ_.#O%'_W^OQ=G@<OLYMZ)A(4S2_9O<&'L,!UJNI\>[# =6_$L
MCT>A(2SPH5DHB#HK:"GQAINZZRLS8( "644P#=@)08&.ZQO"3+4@S_-55ZL'
M:VZ(U!2&XE;F$*MJ)D_&;6:&@8;06'I U&F"I00O+PV_="ERHA!P9,.(HZNZ
M!,58%7 64!N^N']\ M.)NCSV(.N<8Y)V[I FW4ZY]SYA\5^9"O ;J3O8E?QI
M@K\/U8L[=SVPUOWG&#)0JJ9*#Y>7VJ+M56TWQB+CAJAI#^9!L_NIZ#49SU/K
MZ&.$!+@*,_6:J'%?P#(Q&52? H[P$-+@2F7,-/@IG,D/0P5>=Q<TM1W*?[=X
M0#3XBE.P3/!!+6H>*ZSUR<5B VRG9.RP^S1>NP;0<+;*45G"+7BR)O1:P%O-
MR@()&,H9R*8O,+%!S4'1B2/,9Z+3>K4$/%HHJ:ZY,:3]7-:1*U;JW#.5%QU"
M!I-W:2XG51^D1X)BZC&WH;E["J*6H@. RH?8[E>G 3>H)(;#G>C3R1X[1$++
M.$)26 R%EPLDWY_;A>!( ;622KB3#6'HAG<H8LKM83Y.E]0HL<I-.5.R)3*H
MG$5PNR],$[0Q*X,\H%N5FMXR8_VF5WT@9";I;K]Q8IT&6 63PA!%T2*IQW.N
M&?>*(CRFZM9/G#OT"<YT07TGQ-N?+ ,1#5CJ;D1#CK(*,8D-<@@10B!9IA.R
M'A2M<PK,HR=CTICD:? 39%BY(_0EU\PM+ +S<6S,I/VP 1,F"F$(1C>R,4]>
M+" A4USE]HHYV?L)7@E-;N^]]+ZFWD_&H(@])R-%BBIB[GNOE1HA4R(HW$<>
MQV[OSC5/-&QC].$Q9&CLJ,1N6*3#7":K6>+(D"87_T,$J9@ W,PXNE!K2 N4
M##RUL*4*ERFM@@[NEL\"[KD3H4[DB05$"?EH2'J@YD4ZJ$DC; SA1.:"#T=6
M ^F#\=RPI,I@WQ^$06FEB*$E]>O5MG(]_)@Z;GMP?'!K(;_]X;S/(^[N?84E
M=H/D;;F?JR["'J#;4%=*'6E?6SA)>R\ZE0=E Z)I)E28Q\F0FK81?WOE($+4
MH->[Q=0DC\0K\GI#M(N(2:*'=@ E&=3[RDMAL.]UEEM -J;,#U'"4R&2)WB(
MC973LJ,NQ[P,RF7:CA;S#88)%8,XF!UG:D>]9B5@#N],&RF-$XN!(9IKM%EN
MYJSQ7AHF+;D.!4\3Z6=.N+1\\BC)&NSV\-)8:MT[PJ>>;2(X=[R#>SBEQ<!\
M6PP1U7W./<:5BI6@6E9-42]OY;QK:MCL" RNW0LM[HV #2KDAG?G4G >Q>O>
MVA?T^.QP_@0[&B%UN*^1+4L#)L(XPAX^=*1"[:+MO\LQ5*B18O@KI,QD&)S4
M4?B :O"A; = (J@'<RM*H::TR&B*0]@O$HJNLUH,8;"W\MPJ50O(P)$*HWP=
M<AB/0KM!ZZ;N_ 1X>WP^T)W4).]7$ E(DG&G"?9F\V/(=%4.Q^\O(L!<]_!M
MH*;+;'A0.31*6[]S!9KB80SL?$W$Q +_CYN\WL42J\/ CUKOOM$L*G[P*O<P
M[3)Y8!."86P=4P.&_MMOSM]_\]T-[/U^=)'"\7'^'I;3&/IWH"V,/5*=@DJ4
MJ*%:A(6TPWLS:*_EA\.)D=_P1-'CX!@;J%;9U!E"WI*1=8:0\]/NT04C;5IY
M$WP*?<IW*^97QG,H4NK:? 2.T59.31B?A')_6$D9W8:Z&'^@Q?X)+MI#C<(I
M4<,1=P*H!9>-I).!](X"69F 3I:8TB1HLNYV8C\LEO-07]#W3$&[H"F9X^'V
M<G!?NW_R9G!@N235&=EVL=R-L UU<;IXZ*<I0$NF65%,D,^RM+>H%K' %+BQ
M;0R<'YZG$O9A97=<R>@]EGH=H]VV(P;'JET@"5HLM->DK,LT"]3BN,<MCI(\
M0..@/72!C$75."G'6">C1<&& ?;YDJ0JZ53!XUH.%?1@IHVA4EZ97'EV"=S5
M#*U@/P$M.K'QM1[?)RI:3@GG$2O(($S $2IK@A=,TPI,[\HD)6J#$%F6M6%8
MJ<;RZ)L_SU_M';Z :YS.;4P99=)8F4^8&,P+-?&NDAFWO[F D;,!C<NXMJIC
MG $)<HML[F)E!OEK.D)J'5\XR:@IWGZ*/MKGI&>9J8&U S2WP_3!J'Z=M/2Y
M5X+B]<I2Q; 0)SS&C$"VIT>9T([ <;0;UQYD>9KXXDF_Q)7]\C\2NXECEN#,
MZ!&HM(I:,SLL1H#%.-QA,;;B61X/%H,PU^ >[B5@@69@9^VY9*T*ZS:M>C#@
MX1[W!D'XC:&W+96RTJ"9=SQ8$R*)Y]-1,DY7:3:!0Y,2R8I25]W]BCD'?>#5
M9QOC*)7F/JT,IWUUC"F4&;,6>9XN/;&W=GN52XQ=*5H8W49!Z+9+/$0U+7[B
M%;X)O;6.".4M,+\=*ZY_S)CZSD*.[#JAO,-.>X.\OMJUMKV[7X>\KSC;DW!I
M.4PJNXR_!K%N>_#F[0PCI*D=^5PR2>%Y!!_L)#4Q( <AYFS5GO.<.!<4?VG+
MN0VH((!70KO">!S!^K*!OQR2^P%?'JFWI[DP%4\+1X^VDE0CO*]2%_./$ZLF
MG/:%"MV4#RPFY273?>@KL%"]4&7!FD8*DQ0=1/3&_*%/+1SB8,)[5 4MG+!'
M41X!FP/A!;#;\!+ZAZ;M1FD8(=3BK%<,JDH6 -'F%BWT$W.9,IS'F&I4LAZM
MF>6F)K0XS)"/.P;02*7!=X-A/Y,ZD3(4 4Y*S YK)E*FJNK/&#N:"A_74Z]C
MLRP4\2FZ)VROJ$^L?ZQ<!O":D1R4>>?P',6C:[>G3$9?( G,Z1Y>T6A.$&A=
MB&:(2RMIQ!Q7=A^G \YDP%+>8Q5W)>_^8#LX2P9S>!AFL8'&C)XUW92$C->E
MF2HA7BS:TAXI!#O8S '01*VL6!73^HI.UG9C7HOA_RY\'0\>F:0Z.R7* B_?
M_J^]R&#A1R9 096D$Q*."LCG<>=:K^9J'($24&#;01^H<B)(G-..I;3A=)?\
M-[P' GD%ASWS)[J1.%^2D"I)^>;:->C9H0)_C4ZSN)UTE3C9Y3.6F ZTXP)\
M 3&8F@DN4LYX5M2YU(#!NDS+AAK?ZQI)ZIF!&C^<V[_@0-1@!HO%HLFE*NPO
M97]>1GBDP77]R:V2QPV\K#U 3<Z)D&X6X949&VQ-.#HX.D"G\ J@L782,_ [
M(%-LF"K]HK"^W5]V\6(</S22O!IBO [F*#A&)P]C-8)9@E=FXBH&%CMC<=ED
M4/X/:+[ Z;#+G;BOD:4\2^EU[$*F1F&D[$URGUSP3XL+$%*%A)=:+&MTEHH/
M=M>99>7H;%/1)V;T"8LQC_$&E6) !55T@F81/4%IR%W-BV"%=#VNQ).<414%
M#D4<#.&7=73\O"H"/F]M>'/DE[]L:RYK&ZE)/VZP])'+G& LSM@'#A='!"1N
M93>C(BBG'<Y=CPA_HX791Y+*.4*X]*QDJC9GSIOE#-IF:7O1%Q<I?PT%%7C0
MT:>C8*+CF#G*J-Y(R#Y@5N0S1-)1&C@H0]&<7V/^L$F-4/5.FD/8_TD&41-]
M*7UZ%W.%\C^8K()Q=&H4H6G3$X\I1D=X5_GZX0UP?IT$&^\Y#T-96P^2 >A[
MA45:H3[ZLDP=.5.3,YW;OXUN76 ">]?A']S.[JV"6:*0RH,<Q)9JC,B2Q(,#
MK8?$/R@E'*%N@$ED-:K^4"IT,.EIR#;A&&X(M/^S&PM8>^^3CY\(W7_ 4*$W
MF'JHN93/[,W81.O^)N)9A,MK54;\LF-P 14I%:5C[WYF8IOA(N(XJ>:0.;IZ
M5$C2OSAV#%O_;SP[2*4D[=HA^,YH;3@!0+0G3Y172"4(RD40E/N:+][#)<80
M]MMPGD#?[4*'5T;5DWB)A#>(P^]09BTM@=^B(?FWUIM1?RB)Z5'.I/7Z&"@'
M\,F>QVP!#F]4V;[;HGR >FNGS"L*\V6M*ZE?65_=<4]!\3%STJ?P'7#9F=B6
M F7D5F84A8)FX?4&&-Y]#;++]#XX<_$@06:6_JM!"I6;D5\>/G\087/+@-OQ
M]AL/.A]C@,+,DF7!' LM$N50CVD_^D6)9?)50KDMK47D-*U<6D08:NE)^GE?
MP?<M)M0.0]R([O>)7F+X8SQY8+\GY&(*>)Z"(?LUI3=)K>0ZE8RMGW9Q^B'H
M )65I7" ';Q]*932@R&/K-HPX@E2Q5O2MK*Y%0I'U1M%((#ALTL?GQ9[;F?C
M6+]2E(7?OCD[??5=[ H'CJQ96@&HN+) "98)+('CYYJ4)"0J:%%9 Q?, NB^
M-&%S2GW*X-@S1:$W9&IEYXUU\&$/062PAV33>!>[:.RSV+FWJYE.Z=((TY\-
MQ5L:BJ*:K?BB\Y6Z/ZJALUV>XJK"7)@UMA@W3HJETPGS/"QP5+I"CI+0")>H
MHR_C(@:RFJ/E>-1KE:TIYATTBXDZZAR-*A@( [A;3)3!/Q53.)@?L;.A]63:
M"]=0R9QV8!Q+TM*!I"*&X%!#2^=%@2M;YK%H:IBLBFV+JRR)K%?[:!8&*-"X
MY=:]B?E7DXQ=H78'[M#@CJ,=N&,KGN7Q@#M"6TQ&F)DTR!J0+P;'B+0+)]3+
M2\*?\-[_;"8SS[IFWV;!Y?%S9-^5<H@]?"K)"K;;Z3 QSOS JLSA2R7]'%OD
M'U6.Q$O17Z(MU=W.*E_0B@HHHK4.X9B=1&UF=?3 24Y@'4VP!X'8NMI59[1S
MGI'1Z1_8!QGT2B&>!8MJO]7VB:\_R+U=7F^-!\_G,/#I8D$P.._&/4">#4PE
M]ODH.TZ$WEE-LAG=L"T<*GS8*\P>5Z+C8D\A7D$F='V''K;C[TK+#C_BYCV*
M+8NVSVDJH$$AAX.TDH@&RQA))232=C9II*58[=VT5LN(CDINU[[V %RVD<G-
M-*VY[!(.+&(XF%\;URH'O2"VDXH4-+(?V@$MI<3+V:BB5%+:^RJ&A-AA9@T
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M!M_@];N??O-=-#$@  ?:P%T:_Y@TL";-& 7F#+ RYL #/$E9&K E)9M6P+=
MM(7$OJT$9XC@X>\5JXL9(^0-7HB+'XM%'0<>6M1R@4L"A2OD<R^;<[1_$(H)
M]= H1DG=>B[%H$G**!4HZ4S3CS =*(-+I!5 0+'^"8FS:63&R<(H(;!"S[H3
MTK&_SQ*8<J1"YONPIL[1P>&+OAL@A95]@>L?95*8BH772%5.O3/Q=HDPJ)-Y
MR[&;#N>0]#=$,&L$<O'5$JDP8+T0)P9HM=F1*XA-=@+CBM=.02%N+7L:,)CZ
M1Y[([4!Y %:9IP6#6;'K\(;DW[<W2 _+W!UMG;F#!=J1&"*"4V3.!5$BLF M
MJ1>_?(F85I9O5<LWK<FYK:3:=E*N/$K^M*?WPI_VY.B;__YL_&GR3?N.XST[
M;L >_"/1&:U921LG5PL>UWR<IZ.T?KGQ!_SL)+&WFZ7/2@D6 1];]&P_.ON?
M7\]_.G__-3&J\2GV],G&"*I4C^BF3[%G^R\PZW!&N^AFZE:!71WP+[9R_C=/
M_?7\Z?%=J+\.C_=?/!_^^%,XGX[NG?/I^?'^P?/GCXSSB3?0%R-]^I*-NG?F
M!7@XTTLL+ ]R=F\V *],-2Y3I-GNF^*6IT_DC_<V0G?]ZMW77V]VU)X;FRIH
M6:.Y-7QR7SPPN*8G?O.!P?H'Y, @V3LX/#Z$[-!'\_'PX'!_7ML!_<W4K,#S
MWI&TGWJ2=A0Y/K>7FJ9Y6IOHG<D*5CB$;^+'KXH%B->,]8<GHB(3DU+:B)03
M* _Z-IF423J+7H]?%7F.LC2L5'9*R;/]_^P)1X9W^_$6[_:CWA5_\SKGYO;\
M\>'^X=K"T-U*//1"&S$B=.N=!;D7"W)\R!;D% 9YJG1/3^>IF49G'\VXP=3\
MFZG]E+1&^RFCCP\<9_1%4HZ2W%1[;SYF9H7,T?:3HX.#H_V=2=@&D["^WW5G
M$AZW23A::Q)^=IHG]V,2M$78Q';8WYFCS9JCHYV'LC-'P^;HZ-X\E!<'SW8>
MRE=B$G8>RLXD#)N$>_-0'IE)^,3UNYFDY>'^^>\7T?_\].ZWC28O-S<$YSG)
M)4:OBG&#DM=[N&)3^?M$_N[ 0,ER"1K<K/=X#G6 A"!VKY(ZL3L$=:?&25,9
M5(F"T8WJ9%9%@#$RBY&9 ')-J6>?8]F2OBCWV[]!$G^W'>Y].UR<_OJ8M\/%
M>&X6B=L,NS6XB35X>O+;8UZ#ITDV;C+R.WY+\P^@P+=;D1M=D;^=_/285^1O
MR<ADU6XQ;GXF8#&^?7?VF!?CV])4=NWM[..6S <LR5=G/S_F)?F*P ]W79"'
M3[=J16[STPWT>JZ%^-[]PQNL(^NLI:,R'5H_;6!B9_T< KKU/S=4H\*;G^<3
MR'+9"]I+)3/$Y$304 91/?270;^:R:ND+LI5M,R2/ X^3LH2-)S#F'V3_35]
M70A=Z.*FFFZ>W4_3S=//V'2SO7TU&W^6S]Y"\^77:7__S,DOY[^=_?X^>G]V
M^NOO;WY[\\OYV45,>>WSWT]OU/!WDR:,;7OMB_-??C]Y_\>[LRUZTKLW$@UW
MR!X_VUAOT5M5+X'D+[=&P_E1N7J)&3>E-??VKF<?QW,X7Z1H<OCB^$G,/YRE
ME;7R]E+0+3YILE6$66= BJ85-#<7)=X&6J>QSQY:MR$E/3+S))L"YA0NA-N;
MOP -^*;)H0L:KN>ZW=>T/W\M/:Z;[RWZX>"'N_06/=T_?GJW]J%U5SU^MO_T
M^=U4ZM==]LG^B\/[?]@GSZWC]'0#'4L;#*J A^''6T246_]&KY-R/(^.;LRD
M_-6\V$^K!S5/WU??V\N,[.-$?^U'K\>ODWE_3]'#R''<:$QNK:G[8%[H/E61
M-[>F=^MYMYZWYH5N6(LW>5J4T9] 5 -)_Q0B%VH_ZX=B[9;T5[,"'MP+W6Q)
M?_NV3.V27=HUVUF]MQ*1_KJ6[\T&Y^%-]Z-XH]U*W;W1U_%&N\S(MK[1+C/R
M=;P.948FN5E%OQ1YE627IGJXA\&#LYR[Q$A?8F2WG'?+>3M>Z&8K-DR(Q-%I
M42X!J6 09U 666;*:IXN=ROYJYGX!_="MTZ'G(S'19,CF?UP/N3+HO]V'^X^
MW'WX$#_<,F#.HR2?_V$8!_O]J)BL[/_,ZT7VW_\?4$L#!!0    ( (V68E:1
MLC$>_A$  %W)   .    82TR,#(S,#$S,2YX<V3M7=USXC@2?]^_0L?+S58M
M$T@R'TEMYHH0)T,= 0Y(9O=I2]B"J,9(G&TRR?WUUY)M;",;680,N3/[,$ML
M]8?ZUY):W;+]^S^>YBYZ))Y/.;NH-=\W:H@PFSN4S2YJ=^/K^N?:/[[\\LOO
M?ZO7_[@<=M$5MY=SP@+4]@@.B(-^T. !?7.(_QU-/3Y'W[CWG3[B>OV+)&KS
MQ;-'9P\!.FX<GZS?]<XGTX_DE'QNUIU/N%D__7SJU/%'^U/]%)]]/FO89XU/
MC<EOL_.F<TSLYFFCCD^:4[B)G?KGD\99_>SX]+3QZ:0Q:0*-8/KDG_OV YEC
M!!UC_OF3?U%["(+%^='1CQ\_WO\X><^]V=%QH]$\^N.V.Y)-:U%;E[+OF=9/
M$\^-VY\<B=L3[).X.<ZTQ3/J@EW>VWQ^)+K::)XTXY:"#]W F3(_P,Q><78"
MKQX\+XB?3P.WC\1M(:=1;S3KQQE)3K B2XOY<!3>K"$<!!Z=+ -RS;WY%9GB
MI0LD2_;O)7;IE!('?, E N5,@]3M 'LS$O3PG/@+;!.](;[\@I# ALX7W L0
M4RBGV)](37TO$&3'-13BV.4V#J1SBI9^W"FE_1%Q U_\51=_O7_RG=I1>:E+
MOS[#>&$D.4T32H^NF&B0<LKFV=G9T9/PLGP-<EU'MJ^+G_7F<?VD:2"VR ?+
MRX:_ZC'=+G1(1IB9#C'="W7('5=%OJ"CE'_[)=7('Z<EC1 3B-Y_,!'H$_O]
MC#\>V7S) N^YC//GD<1_F+A]EMG2\V#1,5,@3;/Z:VL5'$)-I,?-Q8\<F9@Q
M'DAZ<26ZMEA0-N7A!;@D?/8\=MPAF<83N+((Y<P.\G_GV+,][FJFDJ.%QQ?$
M"RCQTPN89/#@D>E%#=?C6?HO%T_>@QKQ?85[=NB)VT= 0MQNTHV85GC_1<T'
MZ[LD-,R;[?7"(Z:]!A(?UC@)\?]VYVWLFG8>2.RE^W_0=X=,3?L.))31+;HN
MJ,=P'U'GHA8'T9@Y%@MH\-R!F<&;2Y/6D&AZ-^P4!E52D8TL8M&Q\$3K+PWY
M7Q/5DT@^]1.XH9 =2O'[_6B=RQK_I4^</OLB?Z\/C8@X:K*!<,VM2M-E(<DE
MBR[&&&Q IMWO75F]D74%/T;];N>J-;:N1F/X]];JC?O7_8$U;(T[</..X:5#
M Q$-EP)L&\Y:'(\!O!'8FD1 KH2@M!2T$H/ZUR@1A-ZM1/UZP'B%1+M_.QA:
M7Z%)Y][J].!/:]=@;Q2A1?UD"]0S$E$H\H!_67"Z_5$R+ <88LW@@004NO-Z
M#K%!IM9#3G?F(4*+7]..@MYE=*F\XURVNJU>VQI]M:SQ3J:)?(9:R#^4@SSB
MCB3[PP2@,?O.AGH)[EJ$/[X0X</(+9Y^6Z.OU]W^MYU'=3F,M3A_VF;R!CE(
M"CJ,Z5P@K'_==<9_[@C5B)D6R<];(!GRKCARBJT'K2'\]=4:=]JM[@M0U##6
M(GI6!M$\0*'MNXRL*@W._KTUO.]8WRY;H\ZH?PUAY@@,(3>AK=[5Z.[VMC7\
MLW\]ZMST.M=@'+C7;O?O>N-.[V8 1FUWK%&/!\0OB?SNY.D<HMD0Z1/JVR[W
MEQZ!/V+9OR$I77A 6CX"!5"D@;B7T@$E2J!8"_1.ZE$E9^E9WU)H#/L]^-F6
MH\G(![1LM- VUZ$%EAF,,DPKB-30NK=Z=Y8)*AD2+0+'ZPA$Y!6T]>@K+!XP
MHXC5['8 2XZ<34Q,OXF#%HF3=20DM[IDA]+\*@A-F"H9M_XP6Z04,BT(I^L@
M1$D:R:."AN]!)"4M,+"&TA_-UH=<8BT(']1581P# :S"@5%!,#J]>Q%6#_\T
M&P,9(JWQ/ZHC(&)008O?]/M7WSK=+D24?=A5##L08O9N.I==JS4:66;14CE>
M6GP^K>,3\Y5AK^2,$M8HY%U!Z*Y;G>%]JWL'H6-K=#<TCVXW,-""]'D=),$,
M26XHS:Z"N%R!Y]]#''-OMI0K9%H,SM8Q2+&HH-V'L!B'7C> *6@$D\6@/QJG
MKHJJ5+\G;YIM-TSYZI [5C;\"3<D^<BI3HC)W D%12VJ!_"WUG#8@FVS)3!H
M]^4&VNJ9YG5T7+3@*5OZA*.$+<.S@C"-OO:'X[$UO+VR+L=FFTN%4 N&LKN7
M3.J""Q)L*FC_;K]WLXWY53JM]94=O>!1:>./QOWV/[_VN[ 4C\*DO=$(**#6
M J'LZM.<_AZ7#RH(AW4CELY.[[H_O#7/=A50:^%0]O<1)Y1B54$T=E%2&7"7
MVO2G5G%6(K6X*ZF%71=R8E4.7F,&X1A/W)_J,Y% K<<HR8Y=>TRH2)7\94/1
MSL@-]'RTZ"I9$DWUKWI@1<4X(V"R-%H0E#3)J@!8/7/GU^^,K+^1A0Z,$R7S
M45P#K!XZ2CG)<+[*I]9BDG-&(:\:53T\5H4A(QS6J;3V5W(8J8)4]8RNJR(9
M85&2F18B)=%1KB95/?1R:TI&D&WBH,5)R8,4EJ6J!TVJ.F0$B$JGA4')?V0J
M4]4SO4D)R3 4-F:L!4])8FQ3G*H>QL5U)6F+%U>G0BY:])2$PN;JE.1:)9C2
M50ZCH99#J 5#V?^OUT>J-TS4$H?9[K.(7(N%D@;(+Y%4$!&ERF&&2!&Y#I%3
M-1>05R6I'B"[R#]?D0!3]V=FO&.)6MB5=,.N4]Z1)E5RF2BE.22/A"W)Y'E(
M9L#8S DV\]#"6O2<!?P(.:+),PIY'B "\UK,N<7>=Q+X+X-)Y:.%2LEFQ!GQ
M#%; &$6<#X"!H<6-ET&5YJ %24EEY((DM:TP.FW. @_;0<OWP4\Q<[H43ZA+
M@^>MH-*ST^*FY#X2W&+N*&0OWY2U$E!E%(=DCH$IFPV()]\8QFS2G[AT)M7;
M<M"58:E%,R<9DHS"2 )*B4")C .@&NO_U7P%2/]J'D#=^0XQO^1+G@*SH:GG
MHX5.26\5UH\%VP-:*WNT7%>\CI8XHP?L$?'220=P61#F2W7)D_AI&-_L0I(6
M<26'5HCX2C"2DNM2-$K+1I'P@U^LK':-J7>/W26!F&0Y7PA9AAL2<[Y:S-5<
M71'F0@R2<E!*4"7Q33T+;@9@#J$.H0]*[B[[&'D%S:\<OS$#H9!<"T7)XSL5
MA&1UCL9T/*R1:2'8=(*G@G;7G;JYX=SY05UWR%T78NP?V'/,$'J! "V6VQWU
MB24B(1)%,@_@YV"3V%;D5]H0G4%,R *?3P=+SWX0,5L_>"!>1[R7?$9%\6>W
MSO$"!;3.HR3M2CE/2B.9$TIT0GR*5EHAJ19*Z75PL+PS?;#Q6V)WQUZSSE7K
M"DH>L)0KQ&(.R.9@8/D!G8L-WO4R )NVYMP+Z'^VR!'N0) 6?R7)5 K_.EK)
M1J%PE)9>2;?(/1$J-GZ/8M_'ISA.UKM1+IT2?TZP,+O#&?:(^+(/9;,)]JGA
MK/ JHK6NHR2Y"DZQ_A9N?Z4N8J7 25DAI0^*%4+@/QBM=$)2J8-'Q=:T_KVD
MP?-(F$?:#<S888_$#\1K6G?A-^4$:+VC]*MW8"Z1$E$B4OI&2N@!_=A:HC8'
M@P)Z!;]\ZA!OBW5E&\Y:O)5D6.%LD$A"&5$'E&,;#8G-F0T3HU2.3R_)C#)1
M[I&?0!(?+.V21^*>%&"V97'YIZBB\Z./2LJN>-[(ZB:6EI5VT>>=A'Y(*HA.
MBOVNVL7M7-B5DP6IB $'JZPY! \]SH;Q6GVYH]!E!]*U?J;D(POGJYQC$)EX
M!0?I_+Z,7D"M^DHO='F(8++O[F/A@2UQ9#99]'?@-QK.6I]0$J2%/@&24"(J
M';I4$>;TLU?&Y?8"8BU82@8TQ:A>W;IZR@K7W"-TQJPG^P'#NG<=IGOCXUV&
M \Z<KQ9!)0V903"2@F(Q*)*S.I]6^;&6VN%#+$,?0;-'(CY2[<E/7(9Y8^9S
MESHB4W.)77%,:/1 2.!&'_W=W@=V)UOK)YN>TUQ/+B3*H)0V4;XZT0=%"B&I
M$8I5JKI'6=,IL8,"2#E+6W#U:1@^[2^B2'K[*657@K6^I.0[,[X4JK'!C\!%
M,FZ4?" ':!)UJNE'*Y-U,O/ 5^+ KFS6LN'6%I&>,5NM#RB)RT0$ZJQ-&I$4
ME(BI)+8F3W"G:Y6,!# H*'>H;7/?_"&2W4K5>H:2M#1_J+R^5A<%75"L#)+:
M'!Q( V5D'FN^</DS\62\1R=+.;.^@N=L%*=UF9SW=IF_AR!V"/0NU@)EU/BU
M2JY2_'(!L]E#ST<'[B<E&;GY-045'->9MV&W/>+0X!K;6V2?2S#2PJ7D]-9?
MLPV3L^2,8M:5Q"S]C@@SD/(HM:@H6;7UUTM4' +SE%D1M18*W9O0*YPW4U_9
M,0JX_7U(%M'!MH''9QZ>&\YJAERU")9[A;KX<BN(08D<% DZ8"LM= 6;.8<P
MQ_0A$CTC+8+J6]<3IK51@N"*\P$R:9*6;2_G0B\2'GP5VRR//!#FR]0 8&3Z
M7-A+1&AA5A)-*7%_3\&<DAF=G,U(1:'8@P](>PV)[6+?IU,:YFM]O@SX%"<F
MM-.VHSMQBI?(U'J)^J!H_G2N*(% "WF8+N4^&440K;#C*"][@M5O2H.MCL64
M9*:%6GU"-.<]4G6487Y 3YIE_1 2A#7<DY7W(?&7KFE:\04"M"BKSX3FHJP>
M74I$HDCF 7QIK1&9B71\> KGI4#G,M.!^KG4*^#@:L@\/C#T?P[?[T=/_CE>
M+"B;<G$E_)LQ'NHN+\$5XH;U,0$N_JO'65)AD>TP"V.M6S*?$*^&\,27U?V+
M&K0B-<3PG%S4]'2,NJX8/3'=T\1SZ7F8>1=*7]2<95B=JR%_"4)H('.K-QY?
M+BYJ87,:D'D-!6'SP*N+7_ZYP\7;-CIP3S"J'>5W33[-?RF>@&JGGN5O>9XX
MO"#:73XG30;X6?JA.-"0]PSZ@(31)V8AD7_/!;1B31C"6C\4/&\!MOERGC;9
M%+O^RF;[4^@5L0 F-NBI V, .LZQ38"M+2K]SB7EB\RU\/369J\SY;)W'^S!
M^  !W&M%_2D<3VK#G2L?7@'VE,UTBG>#Q6(S%ND6>[?SF'CS+L?L%@=+T;WC
MQO&'S>IOHMA[=T:$4>[)#[V!7F>;>U+0>.^=N W/XXHK';98!M'KYY)Y:G.W
M2I/OO:,M,'M3R2!N[MUFFKUW*>M3'TT<\..;Z<0@7)KPC/2GU[!"M.9\R8+^
M--$W"6$ZL+(2IW#IWH:5OO_B(!-FP6NMN6/\Y!&9B0BX+V,$NKF7Q00F6(;W
M)N%Y/KA!)K1L%\,K<\X@4/>>WUZ AY_>6( 7*[3_ *\5[O7:'O?]+IYH9K_\
MQGN?,7*/G+288STMB W#(O>^?-.X*--=NMS^7N@<.^']BA8*8BEF:\.QR=IP
M_':09H_4XTSN7L5&0AQN9SZU_3+;D)+$>^]D-,7TIRW;!@T<\+8[ML#4Z;"
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M-R+>E<1C^";,TRA\$B&[VIN/[L/3I]2I@O6KJ;X:&<H GB_#T6B0K9)* )#
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MQW8K9OR+]\N/X%OX]6__!U!+ P04    " "-EF)6503@@PZV  #%*P@ $@
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M C[P,\)ZC6O81?^J*/]T\!UIN356H+N?G252Q$"LTR@"RDVT4C*TYJKO'8\
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M6!5$XH$YHVIW1MO]J+_K.;.GRK6%>E,@D[$VDVAR01,R<=&@=46-"BSR!AT
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MNICFQ]Z1.$S.%"I[].B?&LF+?VJ)P-TO9,BI_OG=DZ .1BGJBK_!.<]KR(!
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M_Q%&.#Y()W[00U-V.$65G6%*,$JX\0%7.&6)M<H3;9QWH#6EO/;BOQC)(2A
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MV7YH:AVFGJ!^ S%O3PEH8IP'E4HO0MP 0X[$,F8(Y<8#"QIH7JG'_)Z1_TB
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M'%,$=$Q1&LUB]22995@.>2NH(O\&X3&+<$TU=A5DC;:%Y:AVLSG486\%E=A
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MXCF\-P<8*X!MY ZN!70W'F(+QI<I53.Z&K@-ZX%6,CO/I2;1*(I;E;7$EMP
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MUL5@'0VO!7YKB8H[5N.=D+WK8*62GO"QC&M2>=S$E!.W!&$F(FT 8AV.@:J
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MS"YY8JV.1#I<L1WS0')@S KME!2U*VN]'+U]HM_7GJOM.M0V4->3RZN+_C>
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M@TO6H<Y%8P(GV9<SJ<R V!@= <%H@)2%=[7#S]N-YOO4_=TK1L4.#[[N?/X
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M$OT0QK"<<K$IM=:([_D\STG>HW^H?&B'.181D(=O]"?Z[ZZG&')TJ%!"0.]
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MZ;T)O?OV9\WGCD8<I6)VL0)EQACG]' HZB5:[1KP*.J")'-F:!R3K0LFC[R
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MI;C:EL,HDU$I,5=0D%NUY(^^\Q3X&VJZ%?SM?_+RYMV'B4"LG3L>,.<,"KF
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M>U@Q@(FU8453 <A5%:KA(M]4C;VH@B8+!<N=Y1V'?D$#\<:]GNFA-"/Q)9U
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M]GUIB)DGBJ-$9KIH(4/K3'<3GK%*FGML(*W,?"PER]\'4==B:!JSMUC'C]L
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M-Q@ZR.D[P+U?AYXA(^=& DOU+D"7C,PC.*:<UD'F"*#:M\J_C6"L](W&Y#]
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M*K)OXJ-:5#^(=YL\5XOG^HNAOL_7\I;\6*0B]B*<,AC%J5H#>]R'-(YC*)/
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M@A*G:0H%"1BB&'DQ]18' ;K&<7D[24;\8!9W/$IXGE":5JLFK@:K*+-RDPO
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MH.1Q))B(/,:'I< X5W5NGYC];(\]8^ON@_OF-KD@X+G!%V!K,JALO@!;JR_
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M8_V8!&'J^1Z,A. 0>8&B"*(H(F(>]WB":12%PQP[+M2;&[FTUNGH^'W[P,Y
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MD:?6M"&/8((851\;&4+B<1]*&H:A1#Y*N%5=PE<;[2D^3=>'HZ@&NCHO;]X
M6EFC7X1GYKSJ$)M][EYMX$;^./94UG^CS?CIHNX]J>T#E8$7H)[3S5^;(3VH
MXJ]C')2I[CZLHXR H\^P6]TF_6B/ NO+3_PX0@:&=FYH(?Z^4=O%JV_J/VT!
M6BP08AZ&/@D2M9?@:G^11%2Q/1$ICP,6(JN#TDXI<R/LG9*@TO+T<M@"43->
M/1NGD?G1'B+[<,X^"%R%<7;*F#9\L\_,@[#-WHM'S%YYT9,GC% 0!G$ _02E
M$/E"^T^0!PEEL0A"I%:$L?,<EGEW5CK(K-#]IG=U$ N]MG]+EI67=X0\ET%-
MDT:&?60.<IGS,F*WI#- GC(#YC7[()T!T:!L&&<=CMHJ6'5MB*L5U]TJ%SBB
M),42PS"2$40!9C"E80(I3WQ*XBB(L1$['I4P-^[;ED^KM03:(]#;0=40R'X6
M<P+/V(>LML@,JC'7:?U9Q>:>/W'RJG.=!G65G^N^<' T6QLC1QZR5;6UJIAB
MP5$B.?$9#&DHU8060NV"/ G#((J]% 6(ID;>W9.2YC:QGX5U;E5M/I>6VZ'C
M\)HM5IR -O)T'XC7D,"S?BS<!9P=D3-UH%F_N1T!9B=N<.\UN7Q8YV7V7_6)
M#/]/M?;0!/5!&7-Y_>[CC;Z\.JJIGG&S+LI<E%G=7&BOT%3Q89WK8E.*UO(F
M/4=7FJI+BM7'/_IT-@A9FC(>0BH3W4X@2" 1)(%!P@,4ID&:>E:IMG,Q;&X$
M6*D+BB8IC=;FN#N6G_2=.?]$?ZYOPBLX ][4J/P$-"ZZ+%97C<#Z[6E3&I\5
M![PX= WL$*W#,C6F6T?"9#Z#UQCC"=P-DYHU&T_%:PRFC9/C5?0;Z!]A]X)O
MEL*HA;*V[<6)G)?R,!1) '$8J3V$+WV(N8A@B+B'TR@.8\^W\J2<I\_</K2M
M.18MSFM7JZ5/YLQ1-/3>3#<V8_MYA@[+J$>JCO!UY40Z4YMIW4UNH#MP3#EZ
M[#!NKBN[+7@2<)E("GV6^A#%?@K3"'/H1XC&*(J#1%=66Y=D:4:Q]6.MF'+[
M\/&FY*V6 4BEFQWYM3")*$J(_@CI?G0HU9T5$/4A#U(>I=*+<&SEO!L TQ3=
MY(8#9$;R]F:/S-4G++9FV><&.B++YJ&3<MYS0UY2UXN_#HW.I^7[K&#+M6X8
MO2TZ&!+N1;H86DA# A'S/8A1E$"1A'X82,D]VZ#\+C%SFWI5CXZ=FK9A^)U(
MFLW)\_$9VQ_T')J16@3T@> LPKY3R,2!]7V&'L;3]UX];-Y?D7R5K>Z*&Y%7
MS<=V/4ND%P@O]6 <$K4601Z").8$XB#V>1 @+.PZMQ\3-+>YK]MB-,'-CVJ'
M4&A=[0C@**1F%. "J)%)H%51.X7KWH&C\, I)!PQP5$QDW+!*6-?LL')Z\_Q
M(6^K*WY:-Q&Z.N$S]#&/ QTOQ]62&X7(@ZD?QC ,HTBF"5=_M(JE[9$U-U9H
MC@:VNH)6V4'54OM 3M)0K;*X!R75[1I3BB%EGJ<68#+%S$>"4&*7B>0(YFGR
MBMZ+//NF]*N.8]0;705)%,]R$P!] M.-AXUO_VR,I_'NVZ,VT+_?BX=3#W^W
MI%?P\?>:W.WE[[_%58NZ*JXPHYLJ+^OMT]7#XW+])/)%$J=I$B<1Q!PGNLPE
MA9AB!J6($N8G24@\JP)7QI+G1O&M7N"9ON?VGCL&N^EV< 0P1]\A=GJ2U7^W
M+4J>&:'IO#5CS#9S)Y ;K;_<,;FOW%CN!!RG.\J=>L# _>C?-[I8J&";O,I
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M()$)"4)IU;ONB)RY4?6>FO5YO9KQGVYO;BQ9^ABJ9@SK *N1V;$+)N=E 4[
MX*KZZ1$ITQ8][3?UH-;IB<N'4<$7\=C44+V6BHX>1,XRW4+X4=<<#$(4AAQ!
MW=I--WPC$"<QA0QQ&@0H"&-.!G0D[Q%I]+9/WX9\I[$.E&1;G<&C5MJ.)?H
M-V.*<_&;ABV>8[;3$]ST8F9-& 9H."*-/DF3$H>!R2_)P^26H2Y1]8D61?E%
M3<:OW\EC\]&+*>-$$K6 X"F"2 8"4I)@&$@L<) 00>+ SAO:)69N*XE62Z#5
M!%I/6U=;)YBF7K9S(1K=P?82G1$6$/TH.'.K=0J9V*/69^BA,ZWWZH%),]4Z
MY&-1; 1?(#^1Q/="-<5]"5$<,Y@BM62(<"+4IH)P1I+%8Y70_[4D>6DV[_=%
MV+S*+P6-]U:_%7?92N_<VOH_X$VV:A;(MNDK^WA&(A!,]]43*(H@0F$$J:]
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M%A<4*]#:I.XEO@'?3(\!]O^7QF3(_C\@TB/S30B0KSP(< 1KE(. 2WV_X$&
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M/]O'M(G8^]0\R;G>^_# K8/:_"B$^F0,W<VN*E.48IWG D;,3'/"8[-CH(F
M@J5:9BB5,?(+4COI8F[3NY&PVAY48GH:^Z<8.MKX5R$SMFE?"W=3(S)"9:5N
M[4-9\*<=3&NX=RIX8J]W/SFXYF*Q4O*56ID?MI_-P!Z<)S^8O[S?JOMR(;C(
MM!01C''*K#LT@9QI!%.62T5RHC7UFNE.O<YM\C="@T9J8,5VR6!Y!>Z.%[:A
MT1S[JK8?2/!W*S2HI [((EXHA2ONZ-#GU+4>W6$X4_K1X^5AC%1Q6WT&VJR1
M$2.1%#2#+$4VZ"W/89X2!;DF)".:FVV&UPW)20]S8YIZ(1UR W(*GAN%7 7)
MR'311F,$ZZ)3]4 <<-K^I/.]4[WCN=W]X+5W#8=JC^=S"1].O#6CE.B4PRC+
MC)VAL@A2S23$*<91&A&LM5?M@0$RS(T+=H+;Q"1@O0*=B;6'WCNXCX[O?<0H
MF(],-LYP3W1YX8UA\$L-=PE>Z++#&Z+N2Q#_IH;NNC:F25L5;Y^DZ),^_/*C
MVNXCI22)(QWG,<0<99 @)2%'MJY61%E.$*,,(;^MEVO7<V/"@Y#M$@+\:9?X
M#7S]KM06?+"SRSOMH\>(N&[*QL!Y])W93KYVF88;8!,LC!'DY@]2L(V9<\<3
M[\Y\ 3G=HGFW,-"^LY6[OZ^7YHW24N3V::$USKC2&&;([-9(AA%D7&J(.">9
M5DKBQ'"5]?1R--].NO#BI'U'XTV8VFVM/,CY+V65:\2UN%\/F([6UE40C7TR
MW!+N7T M'KC=FB66/]9>--LU^,PV06OX=B,2RC0Z[6!:RZ=3P1/#IOO):^V6
M]RM#(E5%C-*827]5\JY8W1TNZ\\E@(@(S^-$"A@;RP42;MDA)P+FF>14)!)+
MO\)RUP@S.]OF[9?W?[O]]OYOOBDWKAH17TMF7)PGLVU 2X]J;]=HTG(V&3^K
M1PA4@QM# T1Y(?-H.&C=!M,5;?J6O/KP[?/G+U]_;\YH$TT)X3J!":':UKM*
M(<N(@BH7U% F4H0YN<H<M3LWDK/"@?_%[A_^'1@97<L]/8>JG[*N &!D]GFN
MNW?-J^<@N!:\&@S&1-6N?$'Q*'AU5O6.:E?/GYVHU-59 0]UKL[_>9C5]D7]
M4*M']5EM]'IS;X]*/O%E<5<-[OY4 TN4"8XI3+%0D,B,0IID'"J<F]]G+!4(
M^UAG+IW.C: :F6] 2VIP$-OE"&3X +@98Z%A'?TX_6I$O2TK'X@"65!.74YJ
M*?F <&P1>;T[;66L?3+^;QNV*K7AA/>K[?J#$7B)%[E4'*LTAC26"))8$TA)
MRJ'Y=<0$T4+F7DDFQA!R;I2W*S-?VJ.8K@I*X)<Z:Z[=(]VW"GG4 4^ R?]Z
M++?V-YY9<4?Y"MQX]*7'=F3>O;KTRE[/&[#7U 9HK$&E*\ O7WO%92A>N/1*
MKXC_(RJON( <JO"*4U]^ZXU4Q:(JAO!4A;PPNYFWF478ZRH/TG:!$*<ZBE.8
M,&FO5Y& .>.QV7IC)CE+%<N=2DU?ZFANO%_+"EK"VG0Y##3BNO'X173[N3@D
M9B/SZ5"XG,G0%8N>1&2FB9K+S \'"KO8\"0TY*K>CDJ<GQ]H?A:K8JL^F#;E
M<=S]K1"/]X]+ME6RG1UD8;X0E:<JL5D#<TA8)"%/<PHSA%&6<R1EYG5[X2_"
MW"BD)29HR^EI _H/A:.%-RK 8]MOE?"PDOXT*\H-\,;>WRH;#%\HF\M?@&DM
MJL$ G=A+PUL:ZKK!5I)MY.?-6CZ*[1]L8_,K/U4E%MARMWB3F&IA/E28$YY"
MHKGA/IIFT&RE,8HB%,G,ZT30J=<9DIR5KLX!\K,6V=X/RD=5;::*%5BO%'A2
MS#<6T&D,W*@N.+(CL]M.7M (#'82@T;DFW"&U2",@GF*N/0YL?.(!PRG_B0^
M+X<JC+5/!M'DBMB?F&?FZZ(TR:"*%89$9 HR)!7,\QBE$L=IE"?7%</JZGIN
M+/6Z*GYEZU3M$C1:MX;EH5;.OUU;KJIS$-P8:AQH1Z:ICK)4A^0DC>BCW&+X
M(S9:^:G.CE^XY-0E0"Z7F;K80OCM9<N*>_OG@UJ5RF:T_68&3RVB3*0ZT\I6
MGV V\RR'>1H)*#"26":IKOQGP^PQ>^28&[N93S0-MZGL&X#K=Y:!8'W)[:5-
MS_2@Q/'6\@9834"ERC3;3 <L)]AK]DDQFPVG U0^NTZ7YGQ=WCY_9YM[\SD^
M;@MA W;DJV+]\.QWO['-/]2V\7'*<D%BSJDM>6Z,.R0C2"-;F"?+1);D"8FD
M$Q?Z=CPW\GLN?677G<COZD7F.03];#@FL"/3GPNFH);=VU//$V-75[[QL)[(
MUR\HYAZ.@,. Z_ 4]&QL(E?"82H>? T'OG^EYT^KDFMS3RP_K;XH6Z#&&.0V
M95EY<F'\_+[X$,B :9IK&IDE(L,9)!)'D.4L@9FT9>NC&(G8*S_1&$+.;6%I
MNXBT:UWO]+31[WM-JZQ]Y<T9UY$CSY&!#D A/P9'(_Z%AWAL"W^4T1TUZ<&8
M(Q+:#RBDB"_C!S0"R)U^0&/T-=05?LML!JM=ALS&"A,ICS*5"4@I2LP60PN8
M(VD/EC,>QS$1"8O\G-_/=3.W%6 G)=B)Z>O5?A9+-_J]'J&1"?0$G!%23_6#
M$,PW_6PG$WNC]REZZG_>^_30_+55O88O504'T^K[5>7<7OL=[O(M:I5'44P1
MC"*<0Y*+&/*(,ICCC!"<92)17IGF7#J=&RLT,H.]T* EM6^^6P?,':^X R,Y
M]@UW'X@C);CT@2A8XER'+B=.I>L.PFER78]WKZR9^GI]?[]>50D:;(ZIA8@5
MY222D"4VPZ[U0Z:1/?.42I(TS6FJAQ5(/>IH;FQ3I563^]J=LBF).K &ZC&J
ME"8JERB#*9'2)J2)8$YU"J.,)TIIJ;#._$HYAL!UHB*.=W<;=6=+H%88GY:=
M#82Q&W^'P&UDSMZ+> -J(4$EY4V%WPC58SN0"%TJ]KB;EZD+VZ%L9Q'8KN=]
M;YV^JE6QWGQ<;U5ISW*;/0K+4:Z%H##*A;'S(II#G@@-DSA!613S6$:YV^72
MV?;G1K*UD*"2$E@Q72\SSJ-WZ5[H:DQ&-\Z.X/"^Y#F/B^M=SM7X3'1E,P G
MCXN97A0Z[E_.OS/1-4NOP(?;E/['KLB)_G&]6N_\E=ZOQ/I>-7?SS>>'K<MC
MPK#A,T0AT2R!>80)Q(K&E"5YE&#BG2;]0J=S8[HZ5WA1"0I^4;6HGE')3F"[
M63VA(1R9&&OTVO*"]PV4C<A_&2L!NR-((7.R7^IR^C3MCB"<S=SN^NXP FJ9
M8[OB3RA%-%,29AH12'AB3"AN3"B:JAA)KA5.O9RO3WJ8&[6T]P1^A'(*GAM[
M7 7)R%311F,$3NA4/1 !G+8_Z6SO5.]X:G<_>&U1AK?W#\OUDU)-1:E=G3@E
M39>6-^IL+\MEDTW;YD87Z[N5+=3YN4K[\7I=MHL#")F(!)$41E(+2&A"(.,B
MAE&$E"9**T2YWU'+:++.\*RFEEU)4%K=(+?* ='2#C2V#) #"TZ--_*.!_AS
M&,VQ-Y;5X%6Z@,]UW5]P:V.D[JH<&+5C]<K^M:XHL2]]>V,]K1_-T],4E1AI
M!(*7G@@MYPL5J!@)[NXR%F-U>$6B^/=E^:CDFT?K\%'W47F&G!=M087,.,(Q
MI#E6D# A(#-K"(R$PLC8EY@KK]L0?Q'F9GU^;:T+["?;R!(4E3X#\LS[C84C
MO8^*\!2\78):_)N=V]Q%-F?:C#QXM]YH56S[%N1A.>P'H1DRQ[V? -/GP!\$
MT-D<^<-:&D:'S:=4FN_FBWHPG_!WT\$GW;+T%U*E"4D(@301R.RM:0JI(AR*
M1 HFTDQAFBQ6U>6>="/ RYTZ3<>\GH[MKL>;E=\VE:_@4UU> VSV<GOZJ3D
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M-6F[5!XT64\:FVR2=JG1GIR=SUP9?55[;UBOID6<<<U5G,*$Q#DD$C'(<9I
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MM'\L4D1)G,D4(JX4)!(SF,<R@CHCYA="HT11GUM8O^[G9EC_^NG3FS_>?_@
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M=+W9'TNP/WUC-+I@I3J.4"8-.2N;KXGR!%*;$RW'F.8L4B*.,K_3HP# 3G,
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M9Z2WCJQ<6:?7O?"5KZSYR\K20:T#J)7PC)L8.&)NM#[!.(QMYMLP,:L"J'0
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MQ(C*8RV%(KX7[Y.,XU0I64_'\.9T ,\,:NN%*<?3_5I^DE&:X'*^R>3ZMCU
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MI]%!AK'-8(?")=T\-'S&Q<W4ZAGMGMEB&TS?+C%BMZL;TVBK FCI$-YEHP.
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MD;U*W%6[NMHAV:H":ET"7GQUPC#4999?Y\->4'4"9N?2J5LK77VJUAD;JG1
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M!&WT 6N%P/>M2N#3S.R%%M56R).L0@VTX['A\,/7]_'A6B-0J62,L"&&TO]
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MGEFQL*<_-]IN@YJ"\!/$L4YIS&&F$YOXAU+((Y%#0JG,1:8U8WXLL+^?T='
M1DR[8K8$]22! Z@ZLL#Y6/5, W5BF^4CLZ5FC#6W8(L7T,+.&AZV))D+@/[T
M<!R>4/QPH)=A">*XJCL,<>)QSV#?:E,D7B:W7[Y..(TC3#(,M=(1)(E$D,O4
MGLSR6 K%21XY)3%H-SJVR7\[GQ;E(_C_IG/7=/ZO(#H^N;LJWO-,-CJSF;RH
ME1:/ 2)_]^AY+/:W>;P)_FU^:D7_MIL;)OYWCP*;".!]O^NV\/Y5R8?J$F5:
MW<R4C\7SU?R)%3/KWYI'E& 8DTA#0E(&&6<4)FF""48JCG.OI?=@3V.;?XV@
MH"TI^%[+ZFF%'T;7;0D.@EG/4[<;7-[+[4DH BVXA_L9=,D]J>[;1??T"[Z.
MGT'O;F]5G<*-S>J7RLJ;_^]%J3[.#9G50K_8?*:3C$69R)4A'H61V?EC#5G*
M-<S,SE^**)-YKMTN*=Y-A_'=?]P:?>"?1E0@MK)644"@5-,Z+<^ST:^LZB0_
MKF9RH>3RT;56\OM]+<>)]#_B"^B9H"M)P0E_HP^-OQ'8XV]TP-T(6#1  \<Z
MR*".$[.(@#8D57;LL7]*KI[ _P&?U$#.Q?>/"CS5P<35/<EC%=$C;,</"K J
M+LO^H@KQL=F%Q6O^D57=Z/5[Q5S6C,2VG/2PF*^>;1.6G*I;&C8K5/D7L)?0
MRKV,5I1 L*FPT6(V/*FL^FN+P=7R3Z5F0#'Q".S>M7*6MD^98:IOAUI=R.)'
M(4U#_*5Z9+:)L[%OEO8VXWDQERNCJOWU.AKJ:']_">%[_<Z?Y0%W[O>2:B /
M\7<&?>MT_MZ"G+7]O%)E\3"K);;7%#3'D4XB"E5*K D8<TC35-I8_YQPHLSO
MO*ZG]W<SUHUG2\Q.=S\'0/7:<IX!U4#[30^4NFXV#X 0=J?YMI/WV&8>4/3
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M:9:K6&&O^]'CW8V/(+;NFWM=#FW8DS4'&A^V[O&1QT?!E41"8=L[EYSPY.P
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MU?,*L#M0&Y5 K=.ZM%2UNU\K9H>OK1KX?E_M6'JJI!(2]&!U5H((-7 5EI!
M[M9H"=IZQ\JB=@]MUYB%>C3+3/'#[$#$_$G9WHV 4U:6U7:[6GXV1;"L7)<W
M'Z]O[2OF%TT9Z5NS!BW4LJ@OL]KULSXH/5^H>_9S0KBB>9YBR#')()$HA=8=
M"&J:(X*4$B1-O&J5#JS V#88V[R>]JK)YO:L;$^S0,P7H&PV';Q)5[G8 &)-
M4E[I9-/E>=9.'?J;<5MKQOPE]+PJU2=AKW0'O]3:_UK5H[S86QO11E6\QJ55
M++%>P"PTFR_E6$(^_RJQ[S1<H>K.#BW^L)5LWVEP=FKCOI<<?JNI5,7D8Y7F
M>OFY* 6;_D.QQ:>9O+*U)S"EJ8QP J.$2DABK" 5,H="LR01.N-)1%U6O&.=
MC&U5:N0$M:# 2@J,J.#*N3;(44B/+PBA@.J9M#MAY$RS+B <23%O7J]9T/QE
M2WY'&QV$H%S46I.(T[,=;^>*6;%47PP?R>N-TT_EN-4Z+<T2'*4DQS#1*H7F
M+QPR%&&(%<NU%HA*[>5%X-+IV(B@EAE60H.MU+5#H>?)A1/HCC=U@:'L^\KN
M*(H]'2K[8!3J"L^ERV'O\CQ V+G4\WFW:Z3JZW:_JN6GGV*ZLLE\U[D()C1+
M)(\$A4C:JF<B0S#/101CF=!$)XED$OD=P[IT.[Y#UGJ7M-])TS>.U %VEC#"
M-8]ADN8:$DHB2)72$*&<"T5(3A*OF]+0H ]2\%(MP8?Y_)^UOT$/(+O1?6CH
M>J;['8:O?5M_V<@,UD('K"_B@U&P %F'+@<.@74'83?(U>/=CLX<;&$S'Y2W
MJL[37L5;6X]]J33*,@51EB;6(2R%7'($:2(C+B*<$IQ[.67L[V=L[-*(Y>D3
M<0!#1]^&\Y'IF3S6$EJWD=K;Y *< LK?X> X#*$<!P[T,JP#P'%5=R[R3SP^
M<&G<ZH^_J;*Z5ZH<!= DS54FL,B@TCBS+ES&,$$1@0P;BY#Q6.G4*3EZ'\*-
MC6(:Z1H?K('*VNX;-#=Z>J^AZ)G3 A2KK?X#'(=SN(JT1W!_[^*S^T3[SZ@S
M>P348"5EC_71C>.W]Q<V%$K**LR036]9(:]GC2]A)0M_*^Z=JL,2U]YCM3R-
MAYA]H-I]331/$2*$0)HA8JQ$C0WOJQ@2,SA93C#E4OOP?M\"CVTM:+ONBI8V
M?JM"[\/LME*,:?!Z7CTN;Z\_GBQP9F,AQ$+95((VQ,VZ4X*63N&6BJ& #[1\
M]"[NH$O*4."_768&Z]>[G)):/'V9L]GO;+E:F*7,C'_2Q#Q1E*)(8&WK=9CE
M N'<UF134"9$QWDN4*Z<TL<>ZV1L%%\E1;>B@K6LP KK7.+G,)K'63D41CTS
MZ0%X_$LA'<;)N?Y1$+R&*GKD^5GYU#<ZB<.AHD:'7QRJDM%)T5OEBTX_V_%(
MM2I']TT)TZRM5F>K8<Y7RSO%9#%]N5(V8W\QL\[:FQB]/YZM[7^[,&R\Y?7+
MV6S%IG64ST0PGE(:1U!D66KM:PE9GF@HJ4Y8QG4215Z6=A]"CHUZ:QW!5DGP
M9ZTE:-0$;3U!.XJUUA54RK8\&,VFO]+W5&[HX;X+QS/F=Q[MO@^HWVV@_8^Y
M>QR)4&?D?8@X[ %[CR#OG,[WV=?9M9$;9[6)TFF68*I@FFD$22H8Y#AFD$0I
M-[,KY4R(CM60FRZ\R'^P^L>B\8ALU4'N7/QXC:4;Y9Z'4,^$V1+N C3B]5+>
M^(WJX0L:KSMXKQ+&;Q0\4K3X[9/GYD"]4S_4;*5V<DDF2:Y$ED8PCS,*B>81
MY%H0&S'+TBBC448Z9D$]T./8S+X]R28;R0-D0CV$^JG-> ]8]LP13C">G0_U
M$)Y=,Z(&P/7]<J)Z?*9G9$4] 9%C7M1#K;Q39M032AW.C7KJQ3."8&NGK;79
MP% 6)5RF4* D@H08<F:,(9B(7.><6A\)XN<SN]N)SV<^I(?LV@QC'7ST]T#I
M9H&=!T_/[%KCLO;%#&Z"'=8]9+#BZPZ&#R?<J^#>@+_]3Y[A.;5SJ[)[P<_?
M7O"W'[>W@6A"B#W$BW)H++8,$L$P9#&IPGL$4XK@*$'>?E-!1!N;47?HIAR(
M;4HDFU6TF!DZ-W/#T<#K84S=R.E]1JIG4CL[F55@]ZF@^(9TG@HCV/"N4T$!
MW>LX%;8'WSUV9]^MS=F>66A63W6=N5M5!YJS6?U2N;4Q[]A2W=DV?V<_BZ?5
MTT2H+-9Y+J",!8<D813FDFB8QCE-4,(S)+#;IOV]5!C;@M':HU:YKVQ274,\
MST8C*&J5MO4!&QU<-['O]IF<.F7X3QC\(=8@<,*Q]T/CV OV./:VKH= "PU@
MX0 -'NMJA:V/S$("*DS^8[XFUS.6_X2O:BBWBT<%GNH3!$LK9FMA&,6T;3I^
MV!1YYB_@S\="/ +65'I^KFX7]71E,RO9=.RR]MA@]F6;B-7Z!UIF C4S%14I
M/=4H@ KFO[2_-38MY^;7+X K()LL/*RTS2WFO#YP?H%_JN+AT5+>&WEE49I>
MRR;7W$(M5PM;$Y7;Z])EK=[L+\ J^N,5A;Y6IBBKA\NEL>3LI)'JQS:!G?V-
M,2N6Q6PU7Y73ETJMN:U]+8TV%H!-S\"\4354M3W_83 P'3TK4664:O"QXK#E
MID\S/E;=X_W+0FME=GO"]%;4?<RLIP>;@NG\@2V*Y>-3N7ZX*?]J-2O!\W1E
M1JCX44@UDV9S7AC=9R\7M7#-B%NA0IS-O??4.G#8]VYB#71Z^-ZP;X\CWUV2
M,\Y =@II7_XLRDF62L(EIY!RFQM X0Q2'5'(8\5RPEDFE=/]T^FNQF9RUB;%
M;JEY\-U*ZWA%XH"PQPG#V;@-8JWY0];M/. H&B'W]_L[&GZ_?E3AO?OOXV]T
MS?U<7;'<J2=6S.K@)F/P/#&CQPV?%@^U_1G%0L:8IA!+*2 A,H<,)0IBJAG'
MF$:<>)4@<>IU;!2RD=8:&6MQP7PC;V-B^N9G=L'?C56"H]HSP33RVKO5-;(M
MD<%6YO!'D%Y0!<N)[-+GP"F//6#8S6CL\W+XA,7FFU@LBW^?FPWR\WSQ52UO
M;0;=)NC&GE-^7"A9+&TZV@AGA"0R@E$J-20922 C*88**4UH2C'*9*@4QL.H
M-#9B_5C7FC,[09O4>&\NXXNP>8L'^G0\[L+_8SZ(0>[>.^0VKI3;U-VI CI_
MJ17\U3GQ\6 9CX<=U@%R( ^DT&BR(@\[@#YYD@>6;& WC4\_GXM%]7 =&3N1
M>9Q$L9)0I%$"2:H$S-,H,DNT2' BS?_%PWAIO)5L;(ML<[94G?TNF#WLG@(;
M_U!=_#>2=\][$V0L>_;..&>$!G3.Z)CQQGT4A_/7.(3X>[MK[,CUG^&M<0C.
M8,X:!SOHR/+B4<G55-WH*]/<#].P7:C,BK.J4R-LJDMA(;.$B@@F*2.0D#B&
MG&,*<1PI;2=/PKD7B3MV/#:.OGQX6*B'JF+4;%[GC&@.E4H[^VM/7?%2>6A)
M518/LPX9:9Q'Q9&.>\"Z;[9M1+8WC%NA04OJ7@MV^2(6BBU=NQV6##W!V.$Z
MW_?#GT/5Y43>;C%;!8WB/",T9ASR/+%17RF%'*$(1C&*$-*93)D7O9TCS-@H
MKXE!>+7?+RIMP"_3JK)>4XUH\5:E<*=!)P?P_'.<D,/R#B<PU\V(5+4.-P6B
M=M09OG24*ZX#'(&<%&4TAQ>NH/D<.SBW&29OR^<?7XL_9@M5NZC_QHJ9%6)"
MB6%:2C/(4YY"@B(&663#NF))L,!Y+)1?N7*G;L?&J5L)P8,1<4VD9F>HZF0<
MY4:A\[*D'!@%-[H,CVW/Q+B3R>0"?/X;_'I] 5J _U8!7O%D?XE)CD/54ZJ1
M YV^:_*0XT"<2@=RXNV.F]X5;XHYE]L*KH8*J_HO5W-[5SI!/-5"$ 4U%PP2
M3@U-$9L_2N(LBT5&1>Y5*LJAS[%Q5$MD\$KFNK 1^%Z+[>N8Y0"^X[8V+*1]
M[VC/1=-_$^N.3ZC]JT./PVY=W2'8V;5ZO.I'0^5B.;E\,EMAP<HF78/F]BXD
MY3#!EFUPGL"<2 9S'46<Y1&CL5-%RMVFQT8J:^G<2&,/5,>YX3P >J: M6"G
MLWXXS_7#^AZ;TN:MUG0V/VVG\IX&!YFQAQ593\PC3YR;WOWS?-&^DYT016R)
MGMRL^Y&"Y/]O[]MZY-:M=-_G5P@8(&=OH#A'%"F)/ $&:+>],S['<3?L3B9!
M'@J\NI5=KNJHJKWM^?6'U*4N754J4D6IE<$\Q-G=+6FM]5'\N$BM2U[M5E@"
M4D%RJA"'N<#S97T,[+;\GY7E]'K2^O7<ESCD6[K3SAZ_'K5GBTJUJ [ -ZN(
M/Z^+I5JO[?$0+Y9]CGW.#X.;&W =M&/-_)U:0Q0N/V-Y\(KC+^6\4JGP,^:>
MK_%][H9K3CIN[3'*G7XHJ_RP'Y]M#M2';==3"LW2350"M$XYP+&-=X#:_,A(
MQI"FL<C\&H!=ECFUI;Y.3BAWR0E/=4A\GP.-;K!]3C."03C*4<8LJO2U/-QJ
M'%4J#]1BU@.CH&<8W1)?X0##"8+3IQ=NM_:CGMT7M&T"V_YGM:I.SQS%0FL6
M8Q!#:7T8& -BVQ"2Q%!/IO(L@<JO5):+6)^Y,T[QK)V"Z]IUB;3-3?_FW_G4
M"78W%@H-Y< TM/?QO5)M%IF-\=^5V%CO[X]L;182VPJUZN%U4*NF^<QTI_6Z
MHYFO-T'YP!>(H9Q$CDI1/B"\Y"BO>Z=? *985K48<)IAB0@$*8P%P"1- "$Q
M!QKE1#*=R P[Q9B^G@E3\][\"L#4-DRW9$?SFG13]#_'X ]]3CV! C#_)&_3
M= O ^+]5_QT+P-0H_$\!F/\I #/8U)I, 9A&K?^V!6 .87_- C O-/%SD:4J
MYN_,Q-[\N)'2"%@W_V?/!^!<R%A3'N< 8Z3,QCT5@ K[#]<$"D+RE.4N7FRG
ME*DYFK6B4:/BK/V/J#K?NELZ[M2[@>WV^X+!-?218%^DG G5"8D3V^JU$O_V
M9?7M?YO[ZQVU^8_=1KK[J:-0EI-A+:NX71P^2MW&,0O-)-=F^TI3RP.YR !G
M4@"$[1:79ZDD3I$ CO*F1@9&I4C558ZCGYK" N>C]'HA['9,%Q"W@5G!(1A\
MM%CO<<.Y)Q6QW3,H^_JXZ_I9YCDWSYO'E?'+?S11=#J7,)$Q!%!!"# B$M",
M*9!1@AG,4ZX2KYZ7YP1-C4.:E]]2R5;3GL&*9[%U(Y$0B W,'OW \B:-2T@$
M8HNS8D:EB4O&ON2'B]?W(X;;IHR ;:EX^VRVZ%]5V394^S'G(B8BY@D@>9("
MK',-&$,<Z 3!%*>Y@)#-ZYWZYPTK-VX<T2G3Y[5_*7FX&="JO&UR^"-22VF/
MESA;5%7.6'7.<2<V*VY66@1GME=TXL<DW8,!<P7C!%(@-=, 0]O(A!GF3C7F
M3.54Y9PW@_%NZ1AR%G@H6KFO/Q#_ERV?6?FC'0@4<B#<>#T8M .3^Q91V\\W
M:C6=15M=PQ&\$R2!6+Y;UJA4[V3V2[YWN^G: )%=BO5;M6'%XH:O*ZESP@6A
M+*= (:YM> @V:P"! %$%49[Q.-&Z;WC(.:%3#@XYJ"I@ZS;\AY)?JG@&8?Y<
M-\1^6ZS%8F4_ _0-'#D['+YA(R$@'B]H9*=M5*L;_:U5.*![Z8Y.\)B0LP)?
M*2+D$@#GXT$NWMES?_KUB16E?>R=?K^-):\[RKU?5I_?BHU:& 7DN^]B\6Q7
M_#^L5O*W8K&8(\$TCE,-<BQRXQ@A AB!"B"5PP3C5$/J53OL&F4FM\_=VF*]
MHO?WGW['OC[]_JWG#O>:T7'<!8^$^= [Y4.X=UD1;1?*G2W@@S4F^FEK3M3:
M$S#C. 2LH;;=UZ@R[M8\ &A'V_<0S_1/(;PO5_)9;.[:XH]5;P,H$TD$IH8E
M10QPB@1@9B</!$NP9#$C*G?Z@GA.P-0XL-&Q<MO:PK(^[2+. ME-;2'@&9BN
M>B#CE7789?X5N8<G'SM:!F*74?MYB)W7^4_E=\_EZDFUK=MSE F>0H!QE7RH
M)*!,:4!$EL,\%3EA3@U@7CYX:E.WULU]FAZ ='EZ]C5]X&E9JQ4X _B4K5?,
MP8/'C3;W3AFQ/^=._KWGR7B=H5-EYC0?=#C/S- E,<@U$P K&@-.F02"<&1K
MP.4">]7[.!8QM?FW32QK\LEZ?2 [@:3C$>I5^ Q];NH)C?]IZ5GK0QV1'@L8
M]USTK(%'AZ'GK^Q[ EH%].Y52K=MLVWRPJ<J8O9N:7]7N^=SQ5":8I2#.!49
MP#(6@*2( YHDF,B<QCE*_3+]?<0[O?*C)O^WNNY%%S^9"YK,?]^S3X^!<#T%
M#0SN6.>AI]IA;+&N=6^B=2SD]N_-L4+(,U)_[(*=EGJ('OG<U!^4XQ/4'L_P
MX[:VK/3\+W_YRUQQA*22,4ACG@.<:0RHK: (N4 "BDPKZ.2J[#]T:LY)%3+E
M1C<'V'332%^+!Z:'CZMMW?#KI_LI&SLB=MO+ZVG<_K2;P@>/&V5JGC*@G7(G
M_];/3=C&_^\^[:VWW^1DG@NM, .,:3/%4D(!9VD,L)9IC!&W5:)]=@-=PJ8V
M]?;2]XP'_$NQ9$M1L,7^5U(_/Z 3:;=U/Q1^ T_D/>CV%!WDBZ<+(H%6[TY1
MHZ[6+D:_7)V=[ND;>6OFHUIOWM4!ZW,!49R3! &9)01@S"A@ C&@*$\X)KD0
M>>*WF7@A87K[A5;!-FC?-[SV$$#'[XD]0!DKF+9!X]T%-'K$SYZT.5C8[.'3
M1XZ6/6G:<9#LZ<O"A4FM;Y:R"?W91?[L6&.[9(D$:Q:S%"3*^ 484@0X% IP
M&J<)C17&L5>WT2MTF9KOT#>HRF6)##Z.KD<.HXS.X"<0PPU,D&@M3T@'#.-R
MU>35X[L\(7,)_/)]9$#R;6N[[_I3*%FUQ!3B^>MS57#T[O:]6056=;K$.ZV5
M55'=V[J.J^5'M9ESC91"*0?V# 38EM" *QOC*CB"B42)ELGUD:TA5/6AAG'B
M8?^PUX:BW#.L;K[+=J9%J^-^0+_[5YC%O[<WVW*Q*_/'=14EM68+WP86@[T<
ML509Q9H Q60&,$-F3X]4#C2.,T0I)Q2)JY?MD5^-UVU5(G?U]28RQE<LZ2./
MW*NL][/]WB?1IZ-9OF=K9(RMYW)M[BS:&APU%L]LX;^!O8* HS*DRQ!"S=?W
M)P*"[>1LA)0WJ"=2=\HZ5NVA56R]*;[:WQF-;JH:5@^K-^JA9,NU5F6IY)R8
M,4)8IT!1XY1@CC0@E$M I"8,HC@ARNM >2S%I[88?5(V0J"*J#[)9+7!I]G,
MEJNO:HS9.N!U^?J&VP99O:Y_:8*N9J.^"I-:W2Z\$]OUK07 +FM1#4'SSNRA
M,/IZ%VS<QEW_KE=[BNMAL,'HN3Z&D]\S<-(\HMC\PD25JEH%RFN!<![C%"0I
MMHW!<08HR3.0QHDB4B*8D<PK</)(Q-36H%K#J%71*]^@ T@WMK\.GH%YV1,9
M_[#)L\:'"IL\%C!NV.19 X_")L]?V6]J?U*;HJPJ)MIHI0?SD.JMS$BBA8:V
M)*$4 "<IL[&1"' LL(10)BAVRD;H%C.U*;[3LH[%LWKVFN=G4'6;Z]=C-?!\
M[P.3]Z3O1B'0Q#\C9-3)WVWH2P*X<'7/]9VM'^W_;".3;VQAG9!/RO@CA8UF
MM'^X6<K#7^Q=N?VPEFG.!,X%2#(2F\TN@X!100%*:2KR1!..L)=+$$*KJ5&,
M57,6V7^C/6UGT<Z0^H_V$]W+W^W=X.EV!!E?1T]E[%$;VKEQ&[#9I1$;Y)-J
M4+!#.5-!=!K7_PH)XY'+%O3A?4/6OIFGK<H?NX^Z#^K[YHT!X=<Y5"BF28P!
M(:SJ>9V:_S*N']-"Q0EE,5?([_-IE[CI?0)]__'/[SX^W'WZJV\46P>F;EP9
M"J>!*7"KYD&$B-4TJE0-6C#R,B+!HM\Z1(T<"G?9Z..X.(=[^I'%9_&HY/.B
MZ@_%-WL'4WN4D2"8:Y$ *AD&&"8:4!%G()<0<XTPHHCY4<9EH=,CCE;G*F54
M+8M5&7U<;7R_BCO [<8F82$<F%/VL?NP6GX!#ZK\&EG%#R+5_O; ;*V=0;C&
M':] C.,@<%3><0?@)?MXW-FW4<8#^_Y>FD=NC[\_/E<E(/(\X82EAFM43  V
M=P.>V%UF+!.:X02G+/9KEG%&TM1VCDT;"%NR^5#=J-;7MV'&.8"[R28H; -S
M3&_$>C3.N(#&%<TSSCUYY 8:%PP\;J)QZ8;PC31>?C#;:P1N/YW=W;Z_M[>8
M/RQE]9S[E2&N[8':7B;O^J/:W&G;-@(C@J%.(!"4<H UXX"D"@&=HSQE J.<
M\E"-.0;0?VHD=F-;N94VKW"I-E$5.6K/39Y*ZSRMFWI530.0@WC4676#[3O6
MT=1B$F^,F[,VX?=@8%8^U;CDI]KXGR-K_BPZ73CA*+1CATL3Y6&0F45,V^;$
MH_4^&7"P1NBE,H3VD^G-,N#0^/1Z&5*-GDGPJU(57Y:W35I]6YB\JE5Q(G%V
M3M*<LEAE0*2)--O]F .:\P3@F'!BO&^NH)//W5/^U!:QO3BT8F^O^I.NS8K4
M=_%8=;05C6%KSUY6ON/CMN0,B/K 2T:C>=2J'K6ZS]KN]"=3\ .FW?>#+E0F
MOJ?T<9/S^T%SE*_?\S$]CSC[M@^U&MCX.LO<?V3EKVIS;[O?WILW_=%<^Y9M
MU)PE6C.1Q&;+@ G ,LD %;:>"(H3(4E"!/,*C1M2V:E1Z[O/]_=UZ;&G1LNF
M<?)/Q3)Z?%[*4LG-HR^?#CK<CH>S$QG$H8]UK0W@0AMYWC2"!R?:R,^BUN#:
MIZ]-CBJ;9U%K=63-#G@2/,+@A#I#'E+5<4^?1P#]Z-QZ#)G]EJ3[<B64DFLK
MX3.S1^LV#&#SX[,2SV65D/W+MX_%G'&M6((AT)28Q24W_T7,OR#E/)$QB2E,
MO(*LW,1.;9EHM:XYPJ8;VZ,A56D>K;>J^ZT2CB/@QO?A<1V8N0\A_=Q 6BL=
M[;0VKO:?P<?WX;C7#ZA +.HH=%0^] /B);-YWGW%X?M'8T[EI=?.^;HIS9[%
M+!&0""")+:F;"T-,B<H 01G,,<^E)/X'Y:=E38V-ZA/-/K5RNP#U.$>^'J91
MSGQW:C95;@/6P_? (^2QZAE)XQ^!=IM\\KCRPBVAVE)_-.]%4R.>V.]G/$X
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MOFY-B-GJ96&"YO?>[V&0MA"O-NX#]HP8WZ97;RCQ:L/HTFWB]91[A5+5]P:
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MF]KV]4#IBIVV:KNM1ZXX=R\@ Z W,.-W -?6=KB8!-@+2+D2E8-;;[Y'!/1
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MB:!]ZUQ,N;K%L!4MAJYC\<K5*YQK5H2N5.$7L&_C\W\QU\ZU@$D>2P32F$.
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M?2M9:R-#OE%+\Q^;>_.V?%:;S:)FOINEO'TN-ZQ8U#^VJ20ZQ923' &4Q#G
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M8!0JA]Y)YKC9]#XP'.75>]U\147@VGVR9U6WCZS\HM9S*&.&.-, ,64C9K@
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M*:KY3OF>O1*#NU#6;PS7"<(Z4$D34'LHK$%VC#,N))(L2V&B=L1'SHB7 B(
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M4U8NQQDTN0[*E2>%L3(M8_BB$U;7=LHWD-)ONO2Y$'2 V%M$S^JN'9G448A
M/ N6%+:(UTX2'KRG(@2J8Q>%SYOHV0E']J7CZ% %O*1)E)=7^.=OI^^OSM^^
M/KG\]>V[\S\O*T^DW/Z*SE+K>W!6/ZM>AF.\O1[_==^M37D)N&4Y$E/$:$YD
M3[P+GABI<F8VH1QK]WG?1D_EB93&Z*BMYLB39D0BL\2%Q'&[UED$+PV7H2ON
MVII(>9SFGYA$N8^8>]S2II/9/>67$49^,AS/9^9I:=$HHP3 E=28XHF$1<<
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M<C"Y5 Y30VSDG%G/DF"U@;0S<?U>_.O ,'6BE28&LW^8BW1)?8 <HK2<6,#
M4H(N)846960=!K,T8,19O;O>ROO[K0&M#YN#9=N (2HSW\:C&3X5/_'Q]@AY
MR0ME5FN9. %5)C$8PXF3TA)FLP%J30R\=O_9;?3T6V)9'S?59-\ CN[BTM?7
M?CI=GMXLDK...I6U)RIPE%"DGG@N*)$R"\52-#35]J8W$M-(1["*^9ZCQ-T
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M4.H]RW5<3AVAQE.N!*5.U[Z5_211+5FUJH!XZ(]5U4X#<#N=3$I;+'SS?$[
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MF1J@G9*!(MQK-W+?B;"^@^KZZ%G3IKRR?AK87]=*J_3N0G/[;NC#\'HX^_Z
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MW46MUWM6USM!VB\Y\@S&K(:2& ;!<@.BE"@X!IFPN<_;3K1NKRQVQ,1=5W<
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MY$-KO"J9M^;??T24D3EL^DCS&EBI4["M>?7P>FL69J5GP(2LS=',0&"TA8Q
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M-?TY6]Q=E1?,:*<KHTB-*T.@517+*!;(T1I5<O2MN^NVDZR3!N%C0&U/LW0
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M5N7H"$%E!0:U28E9Y9L?A:?7)[T/@!KI?D04+1?GDQ<7](6S]&/EBIUEE2B
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MRYG<OFR <Z^S+Y))/=XTGPD9[Z5F:;Q3U3>6.KA\'O(-[U3*'^8@&IXQEI1
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M_BJ-HU,@GF.!%"6=ABPC>%OH%\>D%H85EA\;.G1\!FR"]X[3-7^4Z";5_&[
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MR@R<%QE$1LD-_:BQ^:+I?81T!YQCE/PP=(Z0> >PN:^6EWMO+<K*02W0B\)
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M@62(W/L#T&Z)0F;<T-=!"?5JS60]71$!L#AE5<:2U5]Z LD@)1\T@62(Q#N
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M$W '$#G@):?ZF^2%OBN?PA]G4FB[F:QBE>%U7:&GXT6QD]0E61M*9K[U4\I
M$CLQ4T<BXOXHH;EZCD;?M^W L'58KIM@\"'.?L&RJ#.Q4YW\,RNS[2Z6RS^N
M' M6R(5DQ*+CAJ1+@O5UB28*7F3]"R5:-U&=0F\GCED;=#Z9XCHPE _Q6JNY
M?CM?_&L3">U"]/T">#'/E7DLP3FT$912M7K0URW6@0XK_<RM4"SGUI._FC+0
MR0T^/HS'56T'N+[-Q6\D[1KKO[Q85E5L!_-=G=H7Z_5R%B_6FR[?Q3;&/\L.
MHV:Q@*P=!"IR2\QB)MZ-1,N"%;JU3WDZU=/F9QHC^(F5V %L'SJS]12:(&+V
MLB:X6'6$ZI2!8NA02A=$]L:)V'JD]B,D35OY]X0F<ZCX.T?3E6^M0Y:%%SHA
M3I##XHN&8#V#D@7ZK%UAV+JIK%F\,]HZ\R?$U5&*Z !<0V,XX8OA3!(_M:E$
M24.2S!9!"A6"=?0K:[U/;XP0>[1=Z!.'V$/4<V*(_6J>G["$^4ZLMKA8+TJX
M%D^Z*9E9XYKF4[Y]G"+G9O*8J.HY!ZF=TX$BZD@>72VVC[EN?9,\&IFUX;;Y
M6JRGK7J^K:%W%_3%!YSG;>+7A,2S822?ZJ@H7U?3>!%!D&_"-><EN=;W^4D$
M=Y+8' %]CX4SX^FU _=@2_KUI79SA[6+W@>R'$ >#85BB5FZX32O.QM+8)KN
MFMQZ9<$#Y$P+P"<$Q6(<#?4+MMV*24XT5]$DQBE6"X'<*"<M))0A.F(UJM9-
MFP\2-"W@FJG],#@=H8,. %5+*M^5C^$<=S5I1B0=HC' 44E0W%GP1G+@F1,W
M.OM86F=>[A#1)7".4?"=R02G2+L#N+R>TV?A:OWJCV]DH_&2"2]E$C(R$,K7
M)8$A _U/ZRP%5IST(7+6WN[L(63:Q[GQ8'.ZU">$SFJYOG8^/R:<!PJ--T:X
ML.*]$P4<=PR4)9&X6,LWO$$Z"8Y)=5" 0]]P S+TTS5<[OWR::'R]+Y0&RU,
M#:-+NO\Q7WW#1-+#?'FZ//?>FJ2!>20F6 H0A,ZU1;T(Y;@4\: UKH]!Z3X"
MIKFP&BEUT5K"'5Q4=QYWKPKR#SUK[^;7Y=*KZU1ECC8A+^0Y2N8I+HX"0K <
MM$W"98J+#6^],'@L7J8M I@N'NP"&QV<D6L>7L]7Z^7%9K[DKD;B6DB8-\_1
M-Z3R\C5Y)(NM*%Z5@K7,%M_7%I?%_"VNSY)#RYGQ8/1FSF6='%XWCYN2%">O
M169L'4*,Q4M?.9-ID'I[5DP/L.G@^ PN.WI1Z,MOJ[0^22G#C0CDQ)?H3%VR
MCA U18)*(T;!8D#>NC6J&?%].=)=')!I@/$<3\0=]55!5,:CD$:0$PNZ9$?^
M*W)B7$6(,6R>'CSZUD/ FA'?EUOU/$]$$V!T?B+NU]3FXJ3K\GW]GVP*4S>?
M\WY!U^UFZW+]EVZV&_^V6-(%^G-YZZ:,BZ*]( P##.0;*\8218 4N7EE3;&"
M*^M;OS]-R_&T5:'/[NQU!L'A!]9O#^P</V]FGCS)N7VQ;>9O([#]XRVNQ9>2
M04/7_78&M@KD$T>T"G)4D4>CLS&MTPV]\#YMP>VS.\O=PO*O<PU?RZ=$C29X
M!R6$ BHG#R%)#48Z72)C0C=?BO+4/$Y;M_SLCN?D,/OK',,JF>Q$$I$T*%2N
M[^HD(V>%(-\C2@PLFZQ;%T\^'7?3UF__E8_>4&C]=0[=57U]EK$$9 C2%00E
MPV9+M03AC12L9/(<6G<3/C&+!QT_]_^/7R<@Z^ ,[NWO?%Q1/[5_7O&.5FNI
M Y+'+5WEW4+0*8/C H7U1EO3.JG3DOZ#3H__2YV>R>#1ZWJ&5W_[_=7;3Z_?
M_O;NP^\O/KU^]_;]<D$V(,39^6S]X^BFI<,^MDDWTA$<M&HSV@[!^H#?:CY@
M_OFJH\-8P4.-V652!A0K&KSR'+)BT3,OO6K>+W,?+8W&KUU][NLY141?-VK:
MRGF3$-DQGK37NF[<M#S1B4B*0>2*'+:,5B:,UI;6!G,0@1,W!K7 RSV3V$90
M4 >W^=N+6G_[KES-F;OD=G66T--_5(+L"\7C!BD>KW,RB1DN8A"<-W^VO)>8
MOE#5$ "+,;31Q7ZVC^D+YHMS?%<>$-\O/R[_<EL(ETSD(;H$"H6F7PQ"8'3Q
M6\:\,]$G)YKOQAE.YL1CLT8Q<2,KJP-#=U5;_,O%BAS=U6Y0YW;[A16RJ"01
MA*FM*TC'RS.I0')6_UAQHUJ/TW^0H(D-WMAPN&]TY<FZZ0%H6]IWI>:&Q2BM
M!N%8'<-5+) H AB%/HI<8N;-9YS>)*"31NW3%;O?*3M"RA-"))R]F17\F&8X
M3[@*\_SBV[?S&>;?P_(_<+UKH],Z6A2%50>"@>+T.X=%UO9.ZY5)GHE;D+D5
M&Q[T-5VX5,>H;S&6+"<%QJ^S\'F^6*UG:?5BGO^&\\57^NTE%U';E$I4D$K=
MADG2@N"*@>(R*\BE"&@>0<1#G]^%0W,2%)I);U(,O-AF7EXN*9R@C[HDG_N4
M0F0"Y*:].\0"+O":D:-00L2"T;A'E+_W@R<>F]E ZZ?+:U)U[]RGQ3J<[V@/
M*$L1$KS-%.45;HAV4<<[T1\24DM)\A%=W_W4B:=+-E#TB9+JQRG<YT=?I]V3
MTQ3<YPP4T@OBR=75G\;3W>6M-\D5V;P^[A"Z)KX>GCH6::VI#M#W ;_C_ +K
M4\S+Q7R3+OCG;/WEY<5JO?B*R^V^G,W^G!7YZ+@9'9RSTU)S#\S76[,.3@J!
M(T06M70Y2*_:#](=3&877FQ#K-QY3!M7<1U@\RK5>?W(?F90B81%$,VU52AO
MO/9ZF2/3V:H@5#*-L;>'C"[<XO&P=:K@G\U[ZP=,BWF:G<\V'[TH6Y'6B^(#
MKBX(%>W>8 _^JG'>98_C=.RW6L%C1*$R%$5(5<5H\-5?XS$$I6)B233/K8[U
M5GN$,X)2!<:4 LDD>:I2>/ BD3/B64C%E2R;SZ :ZU'CZ=]MAV"GQ:/&$&5U
M<'D^G%_5ED(BS>I.Q1! 1:/ &XJ]"O*B998QXV@K ?\<CQJ#X##H46.(;GH
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M;P[Q.I,Q,\ZT!48>*;'"6"W\*U!X9L+I8NQA^S$&&*5[B9E\J.G$IJF-EKH
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M              "  6XD  !A+3 Q,S$R,#(S>&5X,S(Q+FAT;5!+ 0(4 Q0
M   ( (V68E9%T5Z9T 0  ,05   4              "  7@I  !A+3 Q,S$R
M,#(S>&5X,S(R+FAT;5!+ 0(4 Q0    ( (V68E:XY$=$.)8"  $D'@ .
M          "  7HN  !A+3(P,C,P,3,Q+FAT;5!+ 0(4 Q0    ( (V68E:1
MLC$>_A$  %W)   .              "  =[$ @!A+3(P,C,P,3,Q+GAS9%!+
M 0(4 Q0    ( (V68E:D&F13$1H  ._P   2              "  0C7 @!A
M+3(P,C,P,3,Q7V-A;"YX;6Q02P$"% ,4    " "-EF)6503@@PZV  #%*P@
M$@              @ %)\0( 82TR,#(S,#$S,5]D968N>&UL4$L! A0#%
M  @ C99B5M\1%2'N0 $ 2><, !(              ( !AZ<# &$M,C R,S Q
M,S%?;&%B+GAM;%!+ 0(4 Q0    ( (V68E:;;-)^V-H  .7C"0 2
M      "  :7H! !A+3(P,C,P,3,Q7W!R92YX;6Q02P4&      L "P#" @
&K<,%

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
